PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Izaguirre, G; Qi, LX; Lima, M; Olson, ST				Izaguirre, Gonzalo; Qi, Lixin; Lima, Mary; Olson, Steven T.			Identification of Serpin Determinants of Specificity and Selectivity for Furin Inhibition through Studies of alpha(1) PDX (alpha(1)-Protease Inhibitor Portland)-Serpin B8 and Furin Active-site Loop Chimeras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protease; Protease Inhibitor; Protein Engineering; Serine Protease; Serpin; 1PDX; Furin; Proprotein Convertase; Serpin B8	PROPROTEIN CONVERTASES; SEQUENCE; ENDOPROTEASE; RECOGNITION; PROTEINS	alpha(1)-Protease inhibitor Portland (1PDX) is an engineered serpin family inhibitor of the proprotein convertase (PC), furin, that exhibits high specificity but limited selectivity for inhibiting furin over other PC family proteases. Here, we characterize serpin B8, a natural inhibitor of furin, together with 1PDX-serpin B8 and furin-PC chimeras to identify determinants of serpin specificity and selectivity for furin inhibition. Replacing reactive center loop (RCL) sequences of 1PDX with those of serpin B8 demonstrated that both the P4-P1 RXXR recognition sequence as well as the P1-P5 sequence are critical determinants of serpin specificity for furin. Alignments of PC catalytic domains revealed four variable active-site loops whose role in furin reactivity with serpin B8 was tested by engineering furin-PC loop chimeras. The furin(298-300) loop but not the other loops differentially affected furin reactivity with serpin B8 and 1PDX in a manner that depended on the serpin RCL-primed sequence. Modeling of the serpin B8-furin Michaelis complex identified serpin exosites in strand 3C close to the 298-300 loop whose substitution in 1PDX differentially affected furin reactivity depending on the furin loop and serpin RCL-primed sequences. These studies demonstrate that RCL-primed residues, strand 3C exosites, and the furin(298-300) loop are critical determinants of serpin reactivity with furin, which may be exploited in the design of specific and selective 1PDX inhibitors of PCs.	Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; Univ Illinois, Dept Periodont, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Izaguirre, G (corresponding author), 801 South Paulina St,MC 860, Chicago, IL 60612 USA.	goniza@uic.edu	Lima, Mary AS/G-1267-2012		National Institutes of Health [R37-HL39888]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R37-HL39888.	ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Basak A, 2005, J MOL MED, V83, P844, DOI 10.1007/s00109-005-0710-0; Bentele C, 2006, BIOCHEM J, V395, P449, DOI 10.1042/BJ20051947; Couture Frederic, 2011, Biomol Concepts, V2, P421; Dahlen JR, 1998, J BIOL CHEM, V273, P1851, DOI 10.1074/jbc.273.4.1851; Dementiev A, 2003, J BIOL CHEM, V278, P37881, DOI 10.1074/jbc.M305195200; Di Cera E, 1998, CHEM REV, V98, P1563, DOI 10.1021/cr960135g; Dufour EK, 1998, FEBS LETT, V426, P41, DOI 10.1016/S0014-5793(98)00307-X; Fugere M, 2002, CURR PHARM DESIGN, V8, P549, DOI 10.2174/1381612023395736; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; HOROVITZ A, 1987, J MOL BIOL, V196, P733, DOI 10.1016/0022-2836(87)90045-3; Izaguirre G, 2009, J BIOL CHEM, V284, P1550, DOI 10.1074/jbc.M807340200; Komiyama T, 2000, BIOCHEMISTRY-US, V39, P15156, DOI 10.1021/bi001907c; KWON KS, 1995, BBA-PROTEIN STRUCT M, V1247, P179, DOI 10.1016/0167-4838(94)00224-5; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leblond J, 2006, THROMB HAEMOSTASIS, V95, P243, DOI 10.1160/TH05-08-0561; LU WY, 1993, J BIOL CHEM, V268, P14583; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Osterwalder T, 2004, J NEUROSCI, V24, P5482, DOI 10.1523/JNEUROSCI.5577-03.2004; PANNELL R, 1974, BIOCHEMISTRY-US, V13, P5439, DOI 10.1021/bi00723a031; Richer MJ, 2004, P NATL ACAD SCI USA, V101, P10560, DOI 10.1073/pnas.0401406101; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Strik MC, 2002, J HISTOCHEM CYTOCHEM, V50, P1443, DOI 10.1177/002215540205001103; VanRompaey L, 1997, BIOCHEM J, V326, P507; WALKER JA, 1994, J VIROL, V68, P1213, DOI 10.1128/JVI.68.2.1213-1218.1994	32	6	6	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21802	10.1074/jbc.M113.462804	http://dx.doi.org/10.1074/jbc.M113.462804			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23744066	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000328841900030
J	Yan, S; Serna, S; Reichardt, NC; Paschinger, K; Wilson, IBH				Yan, Shi; Serna, Sonia; Reichardt, Niels-Christian; Paschinger, Katharina; Wilson, Iain B. H.			Array-assisted Characterization of a Fucosyltransferase Required for the Biosynthesis of Complex Core Modifications of Nematode N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOENZYMATIC SYNTHESIS; SUBSTRATE-SPECIFICITY; MOLECULAR-CLONING; IMMUNE-RESPONSES; GLYCOPROTEIN; MICROARRAYS; DISCOVERY; ANTIGEN; ALPHA-1,3-FUCOSYL-TRANSFERASE; IDENTIFICATION	Fucose is a common monosaccharide component of cell surfaces and is involved in many biological recognition events. Therefore, definition and exploitation of the specificity of the enzymes (fucosyltransferases) involved in fucosylation is a recurrent theme in modern glycosciences. Despite various studies, the specificities of many fucosyltransferases are still unknown, so new approaches are required to study these. The model nematode Caenorhabditis elegans expresses a wide range of fucosylated glycans, includingN-linked oligosaccharides with unusual complex core modifications. Up to three fucose residues can be present on the standard N, N'-diacetylchitobiose unit of these N-glycans, but only the fucosyltransferases responsible for transfer of two of these (the core alpha 1,3-fucosyltransferase FUT-1 and the core alpha 1,6-fucosyltransferase FUT-8) were previously characterized. By use of a glycan library in both array and solution formats, we were able to reveal that FUT-6, another C. elegans alpha 1,3-fucosyltransferase, modifies nematode glycan cores, specifically the distal N-acetylglucosamine residue; this result is in accordance with glycomic analysis of fut-6 mutant worms. This core-modifying activity of FUT-6 in vitro and in vivo is in addition to its previously determined ability to synthesize Lewis X epitopes in vitro. A larger scale synthesis of a nematode N-glycan core in vitro using all three fucosyltransferases was performed, and the nature of the glycosidic linkages was determined by NMR. FUT-6 is probably the first eukaryotic glycosyltransferase whose specificity has been redefined with the aid of glycan microarrays and so is a paradigm for the study of other unusual glycosidic linkages in model and parasitic organisms.	[Yan, Shi; Paschinger, Katharina; Wilson, Iain B. H.] Univ Bodenkultur, Dept Chem, A-1190 Vienna, Austria; [Serna, Sonia; Reichardt, Niels-Christian] CICbiomaGUNE, Biofunct Nanomat Unit, San Sebastian 20009, Spain	CIC biomaGUNE	Wilson, IBH (corresponding author), Univ Bodenkultur, Dept Chem, A-1190 Vienna, Austria.	iain.wilson@boku.ac.at	Serna, Sonia/K-5795-2014; Yan, Shi/H-9091-2013; Serna, Sonia/ABF-5345-2020; Wilson, Iain/B-3326-2009; Reichardt, Niels-Christian/K-8950-2017; biomaGUNE, CIC/J-9136-2014	Serna, Sonia/0000-0002-2085-4412; Yan, Shi/0000-0003-4949-9140; Wilson, Iain/0000-0001-8996-1518; Reichardt, Niels-Christian/0000-0002-9092-7023; Paschinger, Katharina/0000-0002-3594-7136; biomaGUNE, CIC/0000-0001-7690-0660	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [P23922, P21946]; Spanish Ministerio de Ciencia e Innovacion Projects [CTQ2008-04444/BQA, CTQ2011-27874]; Government of the Basque Country (Etortek grant); European Commission (Euroglycanarrays Marie Curie ITN) [PITN-GA-2008-215536]; Austrian Science Fund (FWF) [P 21946, P 23922] Funding Source: researchfish	Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Spanish Ministerio de Ciencia e Innovacion Projects; Government of the Basque Country (Etortek grant); European Commission (Euroglycanarrays Marie Curie ITN); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austrian Fonds zur Forderung der Wissenschaftlichen Forschung Grants P23922 (to I. B. H. W.) and P21946 (to K. P.), by Spanish Ministerio de Ciencia e Innovacion Projects CTQ2008-04444/BQA and CTQ2011-27874, by the Government of the Basque Country (Etortek grant), and by the European Commission (Euroglycanarrays Marie Curie ITN, PITN-GA-2008-215536).	Agard NJ, 2009, ACCOUNTS CHEM RES, V42, P788, DOI 10.1021/ar800267j; Aranzamendi C, 2011, EXP PARASITOL, V129, P221, DOI 10.1016/j.exppara.2011.08.015; Ban L, 2008, ANGEW CHEM INT EDIT, V47, P3396, DOI 10.1002/anie.200704998; Ban L, 2012, NAT CHEM BIOL, V8, P769, DOI [10.1038/NCHEMBIO.1022, 10.1038/nchembio.1022]; Blaxter M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001050; Blixt O, 2008, GLYCOCONJUGATE J, V25, P59, DOI 10.1007/s10719-007-9062-z; Blixt O, 2006, METHOD ENZYMOL, V415, P137, DOI 10.1016/S0076-6879(06)15009-0; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; DeBose-Boyd RA, 1998, GLYCOBIOLOGY, V8, P905, DOI 10.1093/glycob/8.9.905; Ellis SE, 2012, PARASITE IMMUNOL, V34, P285, DOI 10.1111/j.1365-3024.2011.01317.x; Fazio F, 2002, J AM CHEM SOC, V124, P14397, DOI 10.1021/ja020887u; HAGOPIAN A, 1968, ARCH BIOCHEM BIOPHYS, V128, P422, DOI 10.1016/0003-9861(68)90048-9; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; Haslam SM, 1996, J BIOL CHEM, V271, P30561, DOI 10.1074/jbc.271.48.30561; Haslam SM, 1999, J BIOL CHEM, V274, P20953, DOI 10.1074/jbc.274.30.20953; Haslam SM, 2000, GLYCOBIOLOGY, V10, P223, DOI 10.1093/glycob/10.2.223; Hein WR, 2005, VET PARASITOL, V132, P217, DOI 10.1016/j.vetpar.2005.07.006; Iskratsch T, 2009, ANAL BIOCHEM, V386, P133, DOI 10.1016/j.ab.2008.12.005; Laurent N, 2008, CHEMBIOCHEM, V9, P883, DOI 10.1002/cbic.200700692; LONGMORE GD, 1982, CARBOHYD RES, V100, P365, DOI 10.1016/S0008-6215(00)81049-6; Morelle W, 2000, GLYCOBIOLOGY, V10, P941, DOI 10.1093/glycob/10.9.941; Nguyen K, 2007, GLYCOBIOLOGY, V17, P586, DOI 10.1093/glycob/cwm023; Nyame AK, 1998, GLYCOBIOLOGY, V8, P615, DOI 10.1093/glycob/8.6.615; Park S, 2013, CHEM SOC REV, V42, P4310, DOI 10.1039/c2cs35401b; Paschinger K, 2004, J BIOL CHEM, V279, P49588, DOI 10.1074/jbc.M408978200; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Paschinger K, 2008, CARBOHYD RES, V343, P2041, DOI 10.1016/j.carres.2007.12.018; Paschinger K, 2009, GLYCOCONJUGATE J, V26, P385, DOI 10.1007/s10719-008-9155-3; Rendic D, 2007, BIOCHEM J, V402, P105, DOI 10.1042/BJ20060964; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Sanchez-Ruiz A, 2011, ANGEW CHEM INT EDIT, V50, P1801, DOI 10.1002/anie.201006304; Sardzik R, 2012, J AM CHEM SOC, V134, P4521, DOI 10.1021/ja211861m; Schubert M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002706; Serna S, 2011, J AM CHEM SOC, V133, P16495, DOI 10.1021/ja205392z; Serna S, 2010, CHEM-EUR J, V16, P13163, DOI 10.1002/chem.201001295; Shipp M, 2008, GLYCOCONJUGATE J, V25, P49, DOI 10.1007/s10719-007-9060-1; Soderman P, 2002, EUR J ORG CHEM, V2002, P1614, DOI 10.1002/1099-0690(200205)2002:10<1614::AID-EJOC1614>3.0.CO;2-1; Struwe WB, 2012, GLYCOBIOLOGY, V22, P863, DOI 10.1093/glycob/cws053; Summers RW, 2003, AM J GASTROENTEROL, V98, P2034, DOI [10.1016/S0002-9270(03)00623-3, 10.1111/j.1572-0241.2003.07660.x]; Takeuchi T, 2008, GLYCOBIOLOGY, V18, P882, DOI 10.1093/glycob/cwn077; Tawill S, 2004, INFECT IMMUN, V72, P398, DOI 10.1128/IAI.72.1.398-407.2004; Titz A, 2009, J BIOL CHEM, V284, P36223, DOI 10.1074/jbc.M109.058354; Tundup S, 2012, ANN NY ACAD SCI, V1253, pE1, DOI 10.1111/j.1749-6632.2012.06618.x; Voglmeir J, 2010, OMICS, V14, P437, DOI 10.1089/omi.2010.0035; Walti MA, 2008, J MOL BIOL, V379, P146, DOI 10.1016/j.jmb.2008.03.062; WESTON BW, 1992, J BIOL CHEM, V267, P4152; Yan S, 2012, J BIOL CHEM, V287, P28276, DOI 10.1074/jbc.M112.353128	47	26	30	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21015	21028		10.1074/jbc.M113.479147	http://dx.doi.org/10.1074/jbc.M113.479147			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754284	Green Published, hybrid			2022-12-28	WOS:000322014400023
J	Krenciute, G; Liu, SF; Yucer, N; Shi, Y; Ortiz, P; Liu, QM; Kim, BJ; Odejimi, AO; Leng, M; Qin, J; Wang, Y				Krenciute, Giedre; Liu, Shangfeng; Yucer, Nur; Shi, Yi; Ortiz, Priscilla; Liu, Qiongming; Kim, Beom-Jun; Odejimi, Abiola Ore; Leng, Mei; Qin, Jun; Wang, Yi			Nuclear BAG6-UBL4A-GET4 Complex Mediates DNA Damage Signaling and Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCYTHE; UBIQUITIN; PROTEINS; REGULATOR; APOPTOSIS; CHROMATIN; PROMOTES; CYCLE; GET3	BCL2-associated athanogene 6 (BAG6) is a member of the BAG protein family, which is implicated in diverse cellular processes including apoptosis, co-chaperone, and DNA damage response (DDR). Recently, it has been shown that BAG6 forms a stable complex with UBL4A and GET4 and functions in membrane protein targeting and protein quality control. The BAG6 sequence contains a canonical nuclear localization signal and is localized predominantly in the nucleus. However, GET4 and UBL4A are found mainly in cytoplasm. Whether GET4 and UBL4A are also involved in DDR in the context of the BAG6 complex remains unknown. Here, we provide evidence that nuclear BAG6-UBL4A-GET4 complex mediates DDR signaling and damage-induced cell death. BAG6 appears to be the central component for the process, as depletion of BAG6 leads to the loss of both UBL4A and GET4 proteins and resistance to cell killing by DNA-damaging agents. In addition, nuclear localization of BAG6 and phosphorylation of BAG6 by ATM/ATR are also required for cell killing. UBL4A and GET4 translocate to the nucleus upon DNA damage and appear to play redundant roles in cell killing, as depletion of either one has no effect but co-depletion leads to resistance. All three components of the BAG6 complex are required for optimal DDR signaling, as BAG6, and to a lesser extent, GET4 and UBL4A, regulate the recruitment of BRCA1 to sites of DNA damage. Together our results suggest that the nuclear BAG6 complex is an effector in DNA damage response pathway and its phosphorylation and nuclear localization are important determinants for its function.	[Krenciute, Giedre; Liu, Shangfeng; Yucer, Nur; Shi, Yi; Ortiz, Priscilla; Kim, Beom-Jun; Odejimi, Abiola Ore; Qin, Jun; Wang, Yi] Baylor Coll Med, Ctr Mol Discovery, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Leng, Mei; Qin, Jun; Wang, Yi] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Liu, Qiongming] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 100850, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Academy of Military Medical Sciences - China	Wang, Y (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	yiw@bcm.edu	Krenciute, Giedre/N-8094-2018; Shi, Yi/P-7972-2018	Krenciute, Giedre/0000-0003-4335-0644; Shi, Yi/0000-0002-2761-8324	National Institutes of Health [GM080703, AI036211, CA125123, RR024574]; Chinese Natural Science Foundation [31270822]; Cytometry and Cell Sorting Core at Baylor College of Medicine; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Cytometry and Cell Sorting Core at Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM080703 and Chinese Natural Science Foundation Grant 31270822. This work was also supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the National Institutes of Health Grants AI036211, CA125123, and RR024574.	BANERJI J, 1990, P NATL ACAD SCI USA, V87, P2374, DOI 10.1073/pnas.87.6.2374; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Corduan A, 2009, CELL MOL LIFE SCI, V66, P1998, DOI 10.1007/s00018-009-9198-z; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Desmots F, 2008, J BIOL CHEM, V283, P3264, DOI 10.1074/jbc.M706419200; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Manchen ST, 2001, BIOCHEM BIOPH RES CO, V287, P1075, DOI 10.1006/bbrc.2001.5701; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Mu JJ, 2007, J BIOL CHEM, V282, P17330, DOI 10.1074/jbc.C700079200; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Thress K, 1999, EMBO J, V18, P5486, DOI 10.1093/emboj/18.20.5486; Thress K, 1998, EMBO J, V17, P6135, DOI 10.1093/emboj/17.21.6135; Wakeman TP, 2012, EMBO J, V31, P2169, DOI 10.1038/emboj.2012.50; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wang Y, 2003, P NATL ACAD SCI USA, V100, P15387, DOI 10.1073/pnas.2536810100; Yong ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038085; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	23	23	26	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20547	20557		10.1074/jbc.M112.443416	http://dx.doi.org/10.1074/jbc.M112.443416			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23723067	Green Published, hybrid			2022-12-28	WOS:000321715100041
J	Okita, Y; Kamoshida, A; Suzuki, H; Itoh, K; Motohashi, H; Igarashi, K; Yamamoto, M; Ogami, T; Koinuma, D; Kato, M				Okita, Yukari; Kamoshida, Atsushi; Suzuki, Hiroyuki; Itoh, Ken; Motohashi, Hozumi; Igarashi, Kazuhiko; Yamamoto, Masayuki; Ogami, Tomohiro; Koinuma, Daizo; Kato, Mitsuyasu			Transforming Growth Factor-beta Induces Transcription Factors MafK and Bach1 to Suppress Expression of the Heme Oxygenase-1 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; REPRESSOR BACH1; CELLS; ACTIVATION; INDUCTION; BINDING; PROMOTER; ELEMENTS; CANCER; STRESS	Transforming growth factor-beta (TGF-beta) has multiple functions in embryogenesis, adult homeostasis, tissue repair, and development of cancer. Here, we report that TGF-beta suppresses the transcriptional activation of the heme oxygenase-1 (HO-1) gene, which is implicated in protection against oxidative injury and lung carcinogenesis. HO-1 is a target of the oxidative stress-responsive transcription factor Nrf2. TGF-beta did not affect the stabilization or nuclear accumulation of Nrf2 after stimulation with electrophiles. Instead, TGF-beta induced expression of transcription factors MafK and Bach1. Enhanced expression of either MafK or Bach1 was enough to suppress the electrophile-inducible expression of HO-1 even in the presence of accumulated Nrf2 in the nucleus. Knockdown of MafK and Bach1 by siRNA abolished TGF-beta-dependent suppression of HO-1. Furthermore, chromatin immunoprecipitation assays revealed that Nrf2 substitutes for Bach1 at the antioxidant response elements (E1 and E2), which are responsible for the induction of HO-1 in response to oxidative stress. On the other hand, pretreatment with TGF-beta suppressed binding of Nrf2 to both E1 and E2 but marginally increased the binding of MafK to E2 together with Smads. As TGF-beta is activated after tissue injury and in the process of cancer development, these findings suggest a novel mechanism by which damaged tissue becomes vulnerable to oxidative stress and xenobiotics.	[Okita, Yukari; Kamoshida, Atsushi; Suzuki, Hiroyuki; Kato, Mitsuyasu] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Expt Pathol, Tsukuba, Ibaraki 3058575, Japan; [Okita, Yukari; Kamoshida, Atsushi; Suzuki, Hiroyuki; Kato, Mitsuyasu] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Itoh, Ken; Motohashi, Hozumi; Yamamoto, Masayuki] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Itoh, Ken] Hirosaki Univ, Grad Sch Med, Dept Stress Response Sci, Hirosaki, Aomori 0368562, Japan; [Motohashi, Hozumi] Tohoku Univ, Grad Sch Med, Ctr Radioisotope Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Igarashi, Kazuhiko] Tohoku Univ, Grad Sch Med, Dept Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Ogami, Tomohiro; Koinuma, Daizo] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba; Hirosaki University; Tohoku University; Tohoku University; Tohoku University; University of Tokyo	Kato, M (corresponding author), Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Expt Pathol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	mit-kato@md.tsukuba.ac.jp	Motohashi, Hozumi/AAZ-2628-2020; Itoh, Ken/B-9506-2013; Koinuma, Daizo/Y-8716-2018; Yamamoto, Masayuki/A-4873-2010	Itoh, Ken/0000-0002-5518-0729; Koinuma, Daizo/0000-0001-5611-2122; Yamamoto, Masayuki/0000-0002-9073-9436; Igarashi, Kazuhiko/0000-0002-2470-2475	Japan Chemical Industry Association; Japanese Ministry of Education, Culture, Sports, Science and Technology [21390115, 23114502, 25640059]; Yasuda Medical Foundation; Public Trust and Haraguchi Memorial Cancer Research Fund;  [23159]; Grants-in-Aid for Scientific Research [25293092] Funding Source: KAKEN	Japan Chemical Industry Association; Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yasuda Medical Foundation; Public Trust and Haraguchi Memorial Cancer Research Fund; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a long range research initiative grant from the Japan Chemical Industry Association (to M. K.); Grants-in-aid for Scientific Research 21390115, 23114502, and 25640059 from the Japanese Ministry of Education, Culture, Sports, Science and Technology (to M. K.); the Yasuda Medical Foundation (to M. K.); the Public Trust and Haraguchi Memorial Cancer Research Fund (to H. S.); and Grant-in-aid 23159 for Japan Society for the Promotion of Science fellows (to Y. O.).	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Azuma H, 2005, JNCI-J NATL CANCER I, V97, P1734, DOI 10.1093/jnci/dji399; Derynck R., 2008, TGF BETA FAMILY; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Hosoya T, 2005, J BIOL CHEM, V280, P27244, DOI 10.1074/jbc.M502551200; IGARASHI K, 1995, P NATL ACAD SCI USA, V92, P7445, DOI 10.1073/pnas.92.16.7445; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Katsuoka F, 2000, EMBO J, V19, P2980, DOI 10.1093/emboj/19.12.2980; Kikuchi A, 2005, HUM GENET, V116, P354, DOI 10.1007/s00439-004-1162-2; Kim KM, 2007, CIRC RES, V101, P919, DOI 10.1161/CIRCRESAHA.107.154781; Kimura M, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706863200; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Lee BS, 2006, BIOCHEM BIOPH RES CO, V343, P965, DOI 10.1016/j.bbrc.2006.03.058; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuzaki K, 2007, HEPATOLOGY, V46, P48, DOI 10.1002/hep.21672; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Motohashi H, 1998, GENES CELLS, V3, P671, DOI 10.1046/j.1365-2443.1998.00222.x; Motohashi H, 1996, GENES CELLS, V1, P223, DOI 10.1046/j.1365-2443.1996.d01-230.x; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stadnicki A, 2009, INT IMMUNOPHARMACOL, V9, P761, DOI 10.1016/j.intimp.2009.02.014; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Sun JY, 2001, J BIOCHEM, V130, P385, DOI 10.1093/oxfordjournals.jbchem.a002997; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2004, ONCOGENE, V23, P5068, DOI 10.1038/sj.onc.1207690; Suzuki H, 2008, FEBS LETT, V582, P341, DOI 10.1016/j.febslet.2007.12.028; Tanaka Y, 2008, TOXICOL APPL PHARM, V231, P364, DOI 10.1016/j.taap.2008.05.022; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Yagi K, 2002, J BIOL CHEM, V277, P854, DOI 10.1074/jbc.M104170200; Yamamoto T, 2006, GENES CELLS, V11, P575, DOI 10.1111/j.1365-2443.2006.00965.x; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	37	44	47	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20658	20667		10.1074/jbc.M113.450478	http://dx.doi.org/10.1074/jbc.M113.450478			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23737527	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000321715100051
J	Chen, Y; Zhang, J; Ge, X; Du, J; Deb, DK; Li, YC				Chen, Yunzi; Zhang, Jing; Ge, Xin; Du, Jie; Deb, Dilip K.; Li, Yan Chun			Vitamin D Receptor Inhibits Nuclear Factor kappa B Activation by Interacting with I kappa B Kinase beta Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,25-DIHYDROXYVITAMIN D-3; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; TRANSCRIPTIONAL REPRESSION; GENE-TRANSCRIPTION; DOWN-REGULATION; P65 SUBUNIT; DNA ELEMENT; EXPRESSION; CELLS; HORMONE	1,25-Dihydroxyvitamin D (1,25(OH)(2)D-3) is known to suppress NF-kappa B activity, but the underlying mechanism remains poorly understood. Here we show that the vitamin D receptor (VDR) physically interacts with I kappa B kinase beta(IKK beta) to block NF-kappa B activation. 1,25(OH)(2)D-3 rapidly attenuates TNF alpha-induced p65 nuclear translocation and NF-kappa B activity in a VDR-dependent manner. VDR overexpression inhibits IKK beta-induced NF-kappa B activity. GST pull-down assays and coimmunoprecipitation experiments demonstrated that VDR physically interacts with IKK beta and that this interaction is enhanced by 1,25(OH)(2)D-3. Protein mapping reveals that VDR-IKK beta interaction occurs between the C-terminal portions of the VDR and IKK beta proteins. Reconstitution of VDR-/- cells with the VDR C terminus restores the ability to block TNF alpha-induced NF-kappa B activation and IL-6 up-regulation. VDR-IKK beta interaction disrupts the formation of the IKK complex and, thus, abrogates IKK beta phosphorylation at Ser-177 and abolishes IKK activity to phosphorylate I kappa B alpha. Consequently, stabilization of I kappa B alpha arrests p65/ p50 nuclear translocation. Together, these data define a novel mechanism whereby 1,25(OH)(2)D-3-VDR inhibits NF-kappa B activation.	[Chen, Yunzi; Ge, Xin; Du, Jie; Li, Yan Chun] China Med Univ, Lab Metab Dis Res & Drug Dev, Shenyang 110000, Peoples R China; [Chen, Yunzi; Deb, Dilip K.; Li, Yan Chun] Univ Chicago, Div Biol Sci, Dept Med, Chicago, IL 60637 USA; [Zhang, Jing] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China	China Medical University; University of Chicago; Nanjing University	Li, YC (corresponding author), Univ Chicago, Dept Med, 900 E 57th St,KCBD 9110, Chicago, IL 60637 USA.	cyan@medicine.bsd.uchicago.edu			National Institutes of Health [HL085793]; Foundation for Clinical Research in Inflammatory Bowel Disease (FCRIBD); government of Liaoning Province, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085793] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Clinical Research in Inflammatory Bowel Disease (FCRIBD); government of Liaoning Province, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL085793. This work was also supported by a Foundation for Clinical Research in Inflammatory Bowel Disease (FCRIBD) grant and by a research grant from the government of Liaoning Province, China.	ALROY I, 1995, MOL CELL BIOL, V15, P5789; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Chen SC, 2005, J AM SOC NEPHROL, V16, P329, DOI 10.1681/ASN.2004090797; Chen YZ, 2013, J IMMUNOL, V190, P3687, DOI 10.4049/jimmunol.1203273; Chen YZ, 2011, ARCH BIOCHEM BIOPHYS, V507, P241, DOI 10.1016/j.abb.2010.12.020; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Deb DK, 2009, AM J PHYSIOL-RENAL, V296, pF1212, DOI 10.1152/ajprenal.00002.2009; Dong XY, 2003, J BIOL CHEM, V278, P49378, DOI 10.1074/jbc.M308448200; Giarratana N, 2004, J IMMUNOL, V173, P2280, DOI 10.4049/jimmunol.173.4.2280; Harant H, 1998, FEBS LETT, V436, P329, DOI 10.1016/S0014-5793(98)01153-3; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Li YC, 2001, AM J PHYSIOL-ENDOC M, V281, pE558, DOI 10.1152/ajpendo.2001.281.3.E558; Lu XH, 2004, J CELL BIOCHEM, V92, P833, DOI 10.1002/jcb.20143; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Murayama A, 2004, EMBO J, V23, P1598, DOI 10.1038/sj.emboj.7600157; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nishishita T, 1998, J BIOL CHEM, V273, P10901, DOI 10.1074/jbc.273.18.10901; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Polly P, 2000, FASEB J, V14, P1455, DOI 10.1096/fj.14.10.1455; Riis JL, 2004, ARCH DERMATOL RES, V296, P195, DOI 10.1007/s00403-004-0509-9; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sanchez-Martinez R, 2008, MOL CELL BIOL, V28, P3817, DOI 10.1128/MCB.01909-07; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Sun J, 2006, AM J PHYSIOL-ENDOC M, V291, pE315, DOI 10.1152/ajpendo.00590.2005; Sutton ALM, 2003, MOL ENDOCRINOL, V17, P777, DOI 10.1210/me.2002-0363; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Towers TL, 1998, J BIOL CHEM, V273, P10338, DOI 10.1074/jbc.273.17.10338; YU XP, 1995, P NATL ACAD SCI USA, V92, P10990, DOI 10.1073/pnas.92.24.10990; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang Z, 2007, KIDNEY INT, V72, P193, DOI 10.1038/sj.ki.5002296	33	209	214	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19450	19458		10.1074/jbc.M113.467670	http://dx.doi.org/10.1074/jbc.M113.467670			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23671281	hybrid, Green Published			2022-12-28	WOS:000321515800013
J	Lu, DD; Han, C; Wu, T				Lu, Dongdong; Han, Chang; Wu, Tong			15-Hydroxyprostaglandin Dehydrogenase-derived 15-Keto-prostaglandin E-2 Inhibits Cholangiocarcinoma Cell Growth through Interaction with Peroxisome Proliferator-activated Receptor-gamma, SMAD2/3, and TAP63 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TUMOR-SUPPRESSOR; EXPRESSION; P63; COX-2; 15-PGDH; CYCLOOXYGENASE-2; IDENTIFICATION; INACTIVATION; MECHANISM	Prostaglandin E-2 (PGE(2)) is a potent lipid mediator that plays a key role in inflammation and carcinogenesis. NAD(+) -dependent 15-hydroxyprostaglandin dehydrogenase (15-PGDH) catalyzes the oxidation of the 15(S)-hydroxyl group of PGE(2), which leads to PGE(2) biotransformation. In this study, we showed that the 15-PGDH-derived 15-keto-PGE(2) is an endogenous peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand that causes PPAR-gamma dissociation from Smad2/3, allowing Smad2/3 association with the TGF-beta receptor I and Smad anchor for receptor activation and subsequent Smad2/3 phosphorylation and transcription activation in human cholangiocarcinoma cells. The 15-PGDH/15-keto-PGE(2)-induced Smad2/3 phosphorylation resulted in the formation of the pSmad2/3-TAP63-p53 ternary complex and their binding to the TAP63 promoter, inducing TAP63 autotranscription. The role of TAP63 in 15-PGDH/15-keto-PGE(2)-induced inhibition of tumor growth was further supported by the observation that knockdown of TAP63 prevented 15-PGDH-induced inhibition of tumor cell proliferation, colony formation, and migration. These findings disclose a novel 15-PGDH-mediated 15-keto-PGE(2) signaling cascade that interacts with PPAR-gamma, Smad2/3, and TAP63.	[Lu, Dongdong; Han, Chang; Wu, Tong] Tulane Univ, Sch Med, Dept Pathol & Lab Med, New Orleans, LA 70112 USA	Tulane University	Wu, T (corresponding author), Tulane Univ, Sch Med, Dept Pathol & Lab Med, 1430 Tulane Ave,SL-79, New Orleans, LA 70112 USA.	twu@tulane.edu			National Institutes of Health [R01 CA102325, CA106280, CA134568, DK077776]; NATIONAL CANCER INSTITUTE [R01CA102325, R01CA106280, R01CA134568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK077776, R01DK077776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health R01 CA102325, CA106280, CA134568, and DK077776 (to T. W.).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Backlund MG, 2005, J BIOL CHEM, V280, P3217, DOI 10.1074/jbc.M411221200; Backlund MG, 2008, CANCER RES, V68, P9331, DOI 10.1158/0008-5472.CAN-08-2893; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Chou WL, 2007, J BIOL CHEM, V282, P18162, DOI 10.1074/jbc.M702289200; Claria J, 1996, MOL MED, V2, P583, DOI 10.1007/BF03401642; Clish CB, 2000, J BIOL CHEM, V275, P25372, DOI 10.1074/jbc.M002863200; Clish CB, 2001, BIOCHEM BIOPH RES CO, V288, P868, DOI 10.1006/bbrc.2001.5841; Clohessy JG, 2009, CELL, V137, P28, DOI 10.1016/j.cell.2009.03.028; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X; De Rosa L, 2009, J BIOL CHEM, V284, P30574, DOI 10.1074/jbc.M109.049619; Ding YF, 2005, CARCINOGENESIS, V26, P65, DOI 10.1093/carcin/bgh277; Eruslanov E, 2009, J IMMUNOL, V182, P7548, DOI 10.4049/jimmunol.0802358; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Frank B, 2011, CARCINOGENESIS, V32, P190, DOI 10.1093/carcin/bgq231; Fu MG, 2001, J BIOL CHEM, V276, P45888, DOI 10.1074/jbc.M105490200; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Han C, 2003, HEPATOLOGY, V38, P167, DOI 10.1053/jhep.2003.50296; Herfs M, 2010, AM J PATHOL, V176, P1941, DOI 10.2353/ajpath.2010.090804; Huang GS, 2008, CANCER RES, V68, P5040, DOI 10.1158/0008-5472.CAN-07-6575; Ijichi H, 2004, ONCOGENE, V23, P1043, DOI 10.1038/sj.onc.1207222; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Kaliberova LN, 2009, MOL CANCER THER, V8, P3130, DOI 10.1158/1535-7163.MCT-09-0270; Komatsu S, 2009, ONCOGENE, V28, P3631, DOI 10.1038/onc.2009.216; Lim K, 2008, CANCER RES, V68, P553, DOI 10.1158/0008-5472.CAN-07-2295; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Lindsay J, 2011, J BIOL CHEM, V286, P3915, DOI 10.1074/jbc.M110.162511; Liu ZX, 2008, CARCINOGENESIS, V29, P1219, DOI 10.1093/carcin/bgm297; McDade SS, 2010, BIOCHEM SOC T, V38, P223, DOI 10.1042/BST0380223; Mitani Y, 2011, AM J PATHOL, V179, P391, DOI 10.1016/j.ajpath.2011.03.037; Moore AE, 2009, CARCINOGENESIS, V30, P1796, DOI 10.1093/carcin/bgp183; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; SHIMIZU Y, 1992, INT J CANCER, V52, P252, DOI 10.1002/ijc.2910520217; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Tai HH, 2011, CANCER METAST REV, V30, P409, DOI 10.1007/s10555-011-9314-z; Tatsuwaki H, 2010, CANCER SCI, V101, P550, DOI 10.1111/j.1349-7006.2009.01390.x; Thiel A, 2009, CLIN CANCER RES, V15, P4572, DOI 10.1158/1078-0432.CCR-08-2518; Tong M, 2006, CARCINOGENESIS, V27, P2170, DOI 10.1093/carcin/bgl053; Tong M, 2006, BIOCHEM PHARMACOL, V72, P701, DOI 10.1016/j.bcp.2006.06.004; Tseng-Rogenski S, 2010, AM J PATHOL, V176, P1462, DOI 10.2353/ajpath.2010.090875; Varga T, 2008, EUR J CLIN INVEST, V38, P695, DOI 10.1111/j.1365-2362.2008.02022.x; Wakimoto N, 2008, CANCER RES, V68, P6978, DOI 10.1158/0008-5472.CAN-07-5675; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; Wolf I, 2006, CANCER RES, V66, P7818, DOI 10.1158/0008-5472.CAN-05-4368; Wu T, 2005, BBA-REV CANCER, V1755, P135, DOI 10.1016/j.bbcan.2005.04.002; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101; Yan M, 2009, P NATL ACAD SCI USA, V106, P9409, DOI 10.1073/pnas.0902367106; Yang L, 2007, CANCER RES, V67, P5587, DOI 10.1158/0008-5472.CAN-06-2287	52	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19484	19502		10.1074/jbc.M113.453886	http://dx.doi.org/10.1074/jbc.M113.453886			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23687300	Green Published, hybrid			2022-12-28	WOS:000321515800016
J	Xia, Y; Yang, WW; Bu, W; Ji, HT; Zhao, XQ; Zheng, YH; Lin, X; Li, Y; Lu, ZM				Xia, Yan; Yang, Weiwei; Bu, Wen; Ji, Haitao; Zhao, Xueqiang; Zheng, Yanhua; Lin, Xin; Li, Yi; Lu, Zhimin			Differential Regulation of c-Jun Protein Plays an Instrumental Role in Chemoresistance of Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; TRANSCRIPTION FACTOR; DOWN-REGULATION; OSMOTIC-STRESS; P53 ACTIVITY; DNA-BINDING; IN-VIVO; AP-1; APOPTOSIS; DEGRADATION	The chemotherapeutic drug cisplatin (cis-diamminedichloro-platinum(II) (CDDP)) is widely used in the treatment of human cancers. However, the mechanism underlying intrinsic tumor resistance to CDDP remains elusive. Here, we demonstrate that treatment with CDDP resulted in down-regulation of c-Jun expression via caspase-9-dependent cleavage of c-Jun at Asp-65 and MEKK1-mediated ubiquitylation and degradation of c-Jun in CDDP-sensitive cancer cells. In contrast, activation of JNK2 (but not JNK1) phosphorylated and up-regulated the expression of c-Jun in CDDP-resistant cells. Activated c-Jun bound to the promoter regions of the MDR1 gene and promoted the expression of MDR1. Expression of a cleavage-resistant c-Jun mutant (D65A) suppressed CDDP-induced apoptosis of CDDP-sensitive cells, whereas depletion of JNK2, c-Jun, or MDR1 in CDDP-resistant cancer cells promoted apoptosis upon CDDP treatment. In addition, mammary gland tumors induced by polyomavirus middle T antigen in JNK2(-/-) mice were more sensitive to CDDP compared with those in JNK2(+/+) mice. These findings highlight the instrumental role of c-Jun in the resistance of tumors to treatment with CDDP and indicate that c-Jun is a molecular target for improving cancer therapy.	[Xia, Yan; Yang, Weiwei; Ji, Haitao; Zheng, Yanhua; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Xia, Yan; Yang, Weiwei; Ji, Haitao; Zheng, Yanhua; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Zhao, Xueqiang; Lin, Xin; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xia, Yan] Nanjing Univ, Model Anim Res Ctr, Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Bu, Wen; Li, Yi] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Bu, Wen; Li, Yi] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA; [Lin, Xin; Lu, Zhimin] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Nanjing University; Baylor College of Medicine; Baylor College of Medicine	Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA.	zhiminlu@mdanderson.org	yang, zheng/HGC-7753-2022; Ji, Haitao/L-1615-2013; Li, Yi/A-7635-2009	Li, Yi/0000-0002-9976-518X	National Institutes of Health [2R01 CA109035, 1R01 CA169603]; NCI [R01 CA124820, CA016672]; Ministry of Science and Technology of China [2009CB918703]; Cancer Prevention and Research Institute of Texas, American Cancer Society Research Scholar Award [RP110252]; James S. McDonnell Foundation; Sister Institution Network Fund of The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA109035, P30CA016672, R01CA169603, R01CA124820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Cancer Prevention and Research Institute of Texas, American Cancer Society Research Scholar Award; James S. McDonnell Foundation; Sister Institution Network Fund of The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01 CA109035 and 1R01 CA169603 (to Z. L.), R01 CA124820 (to Y. L.), and CA016672 (to The University of Texas MD Anderson Cancer Center) from NCI. This work was also supported by 973 Project 2009CB918703 from the Ministry of Science and Technology of China (to Y. X.) and by Research Grant RP110252 from the Cancer Prevention and Research Institute of Texas, American Cancer Society Research Scholar Award RSG-09277-01-CSM, a research grant from the James S. McDonnell Foundation, and the Sister Institution Network Fund of The University of Texas MD Anderson Cancer Center (to Z. L.).	ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOS TJ, 1988, CELL, V52, P705, DOI 10.1016/0092-8674(88)90408-4; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bu W, 2009, J MAMMARY GLAND BIOL, V14, P401, DOI 10.1007/s10911-009-9154-4; Chen HH, 2009, MOL CELL BIOL, V29, P3657, DOI 10.1128/MCB.01640-08; Chen PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010443; Cui W, 2000, MOL CARCINOGEN, V29, P219, DOI 10.1002/1098-2744(200012)29:4<219::AID-MC1004>3.0.CO;2-D; Daschner PJ, 1999, BREAST CANCER RES TR, V53, P229, DOI 10.1023/A:1006138803392; Du ZJ, 2006, P NATL ACAD SCI USA, V103, P17396, DOI 10.1073/pnas.0608607103; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hayakawa J, 1999, J BIOL CHEM, V274, P31648, DOI 10.1074/jbc.274.44.31648; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Kondo K, 2006, INT J CANCER, V118, P230, DOI 10.1002/ijc.21283; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Martin LP, 2008, CLIN CANCER RES, V14, P1291, DOI 10.1158/1078-0432.CCR-07-2238; McCabe JT, 2001, BRAIN RES BULL, V55, P347, DOI 10.1016/S0361-9230(01)00520-2; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; Reddy JP, 2010, P NATL ACAD SCI USA, V107, P3728, DOI 10.1073/pnas.0910665107; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; SHARP FR, 1991, J NEUROSCI, V11, P2321, DOI 10.1523/jneurosci.11-08-02321.1991; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Stewart DJ, 2007, CRIT REV ONCOL HEMAT, V63, P12, DOI 10.1016/j.critrevonc.2007.02.001; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Xia Y, 2007, MOL CELL BIOL, V27, P510, DOI 10.1128/MCB.01355-06; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	47	15	17	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19321	19329		10.1074/jbc.M113.475442	http://dx.doi.org/10.1074/jbc.M113.475442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23678002	Green Published, hybrid			2022-12-28	WOS:000321515800003
J	Tarumoto, Y; Kanoh, J; Ishikawa, F				Tarumoto, Yusuke; Kanoh, Junko; Ishikawa, Fuyuki			Receptor for Activated C-Kinase (RACK1) Homolog Cpc2 Facilitates the General Amino Acid Control Response through Gcn2 Kinase in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-BINDING; TRANSLATIONAL CONTROL; EUKARYOTIC TRANSLATION; SCAFFOLD PROTEIN; MAMMALIAN RACK1; STRESS-RESPONSE; RIBOSOME; INITIATION; EXPRESSION; INTERACTS	General amino acid control (GAAC) is crucial for sensing and adaptation to nutrient availability. Amino acid starvation activates protein kinase Gcn2, which plays a central role in the GAAC response by phosphorylating the alpha-subunit of eukaryotic initiation factor 2 (eIF2 alpha), leading to the translational switch to stimulate selective expression of stress-responsive genes. We report here that in fission yeast Schizosaccharomyces pombe, Cpc2, a homolog of mammalian receptor for activated C-kinase (RACK1), is important for the GAAC response. Deletion of S. pombe cpc2 impairs the amino acid starvation-induced phosphorylation of eIF2 alpha and the expression of amino acid biosynthesis genes, thereby rendering cells severely sensitive to amino acid limitation. Unlike the Saccharomyces cerevisiae Cpc2 ortholog, which normally suppresses the GAAC response, our findings suggest that S. pombe Cpc2 promotes the GAAC response. We also found that S. pombe Cpc2 is required for starvation-induced Gcn2 autophosphorylation, which is essential for Gcn2 function. These results indicate that S. pombe Cpc2 facilitates the GAAC response through the regulation of Gcn2 activation and provide a novel insight for the regulatory function of RACK1 on Gcn2-mediated GAAC response.	[Tarumoto, Yusuke; Kanoh, Junko; Ishikawa, Fuyuki] Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University	Ishikawa, F (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	fishikaw@lif.kyoto-u.ac.jp	Kanoh, Junko/AGM-9632-2022; Tarumoto, Yusuke/H-6698-2014; Ishikawa, Fuyuki/AAU-4056-2021; Tarumoto, Yusuke/AAV-5246-2020	Ishikawa, Fuyuki/0000-0002-5580-2305; Tarumoto, Yusuke/0000-0001-6652-9618	Kyoto University; Ministry of Education, Culture, Sports, Science and Technology, Japan	Kyoto University; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Kyoto University start-up grant-in-aid for young scientists (to Y. T.) and a grant-in-aid for cancer research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to F. I.).	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Baum S, 2004, BIOCHEM J, V380, P823, DOI 10.1042/BJ20031962; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003; Cherkasova V, 2010, MOL CELL BIOL, V30, P2862, DOI 10.1128/MCB.00183-10; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Garcia-Barrio M, 2002, J BIOL CHEM, V277, P30675, DOI 10.1074/jbc.M203187200; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; Gomez EB, 2005, MOL CELL BIOL, V25, P8887, DOI 10.1128/MCB.25.20.8887-8903.2005; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hoffmann B, 1999, MOL MICROBIOL, V31, P807, DOI 10.1046/j.1365-2958.1999.01219.x; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kouba T, 2012, NUCLEIC ACIDS RES, V40, P2683, DOI 10.1093/nar/gkr1083; KRUGER D, 1990, CURR GENET, V18, P211, DOI 10.1007/BF00318383; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McLeod M, 2000, MOL CELL BIOL, V20, P4016, DOI 10.1128/MCB.20.11.4016-4027.2000; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; MULLER F, 1995, MOL GEN GENET, V248, P162, DOI 10.1007/BF02190797; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Nemoto N, 2010, J MOL BIOL, V404, P183, DOI 10.1016/j.jmb.2010.09.016; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; Padyana AK, 2005, J BIOL CHEM, V280, P29289, DOI 10.1074/jbc.M504096200; Qiu HF, 1998, MOL CELL BIOL, V18, P2697, DOI 10.1128/MCB.18.5.2697; Robles MS, 2010, SCIENCE, V327, P463, DOI 10.1126/science.1180067; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Sattlegger E, 2005, J BIOL CHEM, V280, P16514, DOI 10.1074/jbc.M414566200; Sattlegger E, 2004, J BIOL CHEM, V279, P29952, DOI 10.1074/jbc.M404009200; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shor B, 2003, J BIOL CHEM, V278, P49119, DOI 10.1074/jbc.M303968200; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Udagawa T, 2008, J BIOL CHEM, V283, P22063, DOI 10.1074/jbc.M710017200; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Zhan K, 2004, GENETICS, V168, P1867, DOI 10.1534/genetics.104.031443; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808	46	12	12	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19260	19268		10.1074/jbc.M112.445270	http://dx.doi.org/10.1074/jbc.M112.445270			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671279	Green Published, hybrid			2022-12-28	WOS:000321335800058
J	Contreras, E; Schoppmeier, M; Real, MD; Rausell, C				Contreras, Estefania; Schoppmeier, Michael; Dolores Real, M.; Rausell, Carolina			Sodium Solute Symporter and Cadherin Proteins Act as Bacillus thuringiensis Cry3Ba Toxin Functional Receptors in Tribolium castaneum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TENEBRIO-MOLITOR CADHERIN; CRY1AC BINDING-PROTEINS; BRUSH-BORDER MEMBRANE; AMINOPEPTIDASE-N; ALKALINE-PHOSPHATASE; MANDUCA-SEXTA; DELTA-ENDOTOXIN; MIDGUT; EXPRESSION; OLIGOMERIZATION	Understanding how Bacillus thuringiensis (Bt) toxins interact with proteins in the midgut of susceptible coleopteran insects is crucial to fully explain the molecular bases of Bt specificity and insecticidal action. In this work, aminopeptidase N (TcAPN-I), E-cadherin (TcCad1), and sodium solute symporter (TcSSS) have been identified by ligand blot as putative Cry3Ba toxin-binding proteins in Tribolium castaneum (Tc) larvae. RNA interference knockdown of TcCad1 or TcSSS proteins resulted in decreased susceptibility to Cry3Ba toxin, demonstrating the Cry toxin receptor functionality for these proteins. In contrast, TcAPN-I silencing had no effect on Cry3Ba larval toxicity, suggesting that this protein is not relevant in the Cry3Ba toxin mode of action in Tc. Remarkable features of TcSSS protein were the presence of cadherin repeats in its amino acid sequence and that a TcSSS peptide fragment containing a sequence homologous to a binding epitope found in Manduca sexta and Tenebrio molitor Bt cadherin functional receptors enhanced Cry3Ba toxicity. This is the first time that the involvement of a sodium solute symporter protein as a Bt functional receptor has been demonstrated. The role of this novel receptor in Bt toxicity against coleopteran insects together with the lack of receptor functionality of aminopeptidase N proteins might account for some of the differences in toxin specificity between Lepidoptera and Coleoptera insect orders.	[Contreras, Estefania; Dolores Real, M.; Rausell, Carolina] Univ Valencia, Dept Genet, Fac Ciencias Biol, Dr Moliner 50, E-46100 Valencia, Spain; [Schoppmeier, Michael] Erlangen Univ, Dept Biol, Dev Biol Unit, D-91058 Erlangen, Germany	University of Valencia; University of Erlangen Nuremberg	Rausell, C (corresponding author), Univ Valencia, Dept Genet, Fac Ciencias Biol, Dr Moliner 50, E-46100 Valencia, Spain.	carolina.rausell@uv.es	Rausell, Carolina/ABG-4542-2020; Rausell, Carolina/ABG-9554-2020; Contreras, Estefania/AAZ-4659-2020; Real, M. Dolores/ABD-4252-2021	Rausell, Carolina/0000-0002-5849-9102; Contreras, Estefania/0000-0002-1822-6839; Real, M. Dolores/0000-0003-3188-9335	Ministerio de Ciencia e Innovacion [BIO 2007-67860, AGL2010-22300-C03-03]; Conselleria Valenciana d'Educacio i Ciencia	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Conselleria Valenciana d'Educacio i Ciencia	This work was supported by Ministerio de Ciencia e Innovacion Grants BIO 2007-67860 and AGL2010-22300-C03-03r Awarded with a grant from the Conselleria Valenciana d'Educacio i Ciencia.	Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Bayyareddy K, 2009, INSECT BIOCHEM MOLEC, V39, P279, DOI 10.1016/j.ibmb.2009.01.002; Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013; Chen J, 2007, P NATL ACAD SCI USA, V104, P13901, DOI 10.1073/pnas.0706011104; Chen JW, 2009, BIOCHEM J, V424, P191, DOI 10.1042/BJ20090730; Chen LZ, 2010, ARCH INSECT BIOCHEM, V73, P61, DOI 10.1002/arch.20340; Contreras E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055330; Crickmore N, 2005, TRENDS MICROBIOL, V13, P347, DOI 10.1016/j.tim.2005.06.002; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; Fabrick J, 2009, J BIOL CHEM, V284, P18401, DOI 10.1074/jbc.M109.001651; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gao YL, 2011, PEST MANAG SCI, V67, P1076, DOI 10.1002/ps.2149; Gomez I, 2001, J BIOL CHEM, V276, P28906, DOI 10.1074/jbc.M103007200; Hafkenscheid J. C, 1984, METHODS ENZYMATIC AN, VV, P2; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Hua G, 2004, J BIOL CHEM, V279, P28051, DOI 10.1074/jbc.M400237200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JONASSEN I, 1995, PROTEIN SCI, V4, P1587, DOI 10.1002/pro.5560040817; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; KNIGHT PJK, 1994, MOL MICROBIOL, V11, P429, DOI 10.1111/j.1365-2958.1994.tb00324.x; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; Likitvivatanavong S, 2011, APPL ENVIRON MICROB, V77, P24, DOI 10.1128/AEM.01852-10; Lord JC, 2010, J MICROBIOL METH, V80, P219, DOI 10.1016/j.mimet.2009.12.007; Ma G, 2012, DEV COMP IMMUNOL, V37, P184, DOI 10.1016/j.dci.2011.08.017; Martins ES, 2010, INSECT BIOCHEM MOLEC, V40, P138, DOI 10.1016/j.ibmb.2010.01.005; McNall RJ, 2003, INSECT BIOCHEM MOLEC, V33, P999, DOI 10.1016/S0965-1748(03)00114-0; Morris K, 2009, J PROTEOME RES, V8, P3889, DOI 10.1021/pr900168z; Ochoa-Campuzano C, 2007, BIOCHEM BIOPH RES CO, V362, P437, DOI 10.1016/j.bbrc.2007.07.197; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Rajagopal R, 2002, J BIOL CHEM, V277, P46849, DOI 10.1074/jbc.C200523200; Rausell C, 2004, BBA-BIOMEMBRANES, V1660, P99, DOI 10.1016/j.bbamem.2003.11.004; REUVENI M, 1991, BIOCHEM BIOPH RES CO, V181, P1089, DOI 10.1016/0006-291X(91)92049-P; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453; STEWART GSAB, 1981, BIOCHEM J, V198, P101, DOI 10.1042/bj1980101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka S, 2013, FEBS J, V280, P1782, DOI 10.1111/febs.12200; VADLAMUDI RK, 1995, J BIOL CHEM, V270, P5490, DOI 10.1074/jbc.270.10.5490; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Xie YS, 1996, CAN ENTOMOL, V128, P865, DOI 10.4039/Ent128865-5; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	48	33	37	0	35	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18013	18021		10.1074/jbc.M113.474445	http://dx.doi.org/10.1074/jbc.M113.474445			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645668	Green Published, hybrid			2022-12-28	WOS:000320721900008
J	Yu, HC; Lin, CS; Tai, WT; Liu, CY; Shiau, CW; Chen, KF				Yu, Hui-Chuan; Lin, Chen-Si; Tai, Wei-Tien; Liu, Chun-Yu; Shiau, Chung-Wai; Chen, Kuen-Feng			Nilotinib Induces Autophagy in Hepatocellular Carcinoma through AMPK Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; SIGNALING PATHWAYS; BCR-ABL; INHIBITOR; PP2A; PHOSPHORYLATION; SORAFENIB; IMATINIB; CELLS; TUMORIGENESIS	Hepatocellular carcinoma (HCC) is the most common liver cancer and the third-leading cause of cancer death worldwide. Nilotinib is an orally available receptor tyrosine kinase inhibitor approved for chronic myelogenous leukemia. This study investigated the effect of nilotinib on HCC. Nilotinib did not induce cellular apoptosis. Instead, staining with acridine orange and microtubule-associated protein 1 light chain 3 revealed that nilotinib induced autophagy in a dose- and time-dependent manner in HCC cell lines, including PLC5, Huh-7, and Hep3B. Moreover, nilotinib up-regulated the phosphryaltion of AMP-activated kinase (AMPK) and protein phosphatase PP2A inactivation were detected after nilotinib treatment. Up-regulating PP2A activity suppressed nilotinib-induced AMPK phosphorylation and autophagy, suggesting that PP2A mediates the effect of nilotinib on AMPK phosphorylation and autophagy. Our data indicate that nilotinib-induced AMPK activation is mediated by PP2A, and AMPK activation and subsequent autophagy might be a major mechanism of action of nilotinib. Growth of PLC5 tumor xenografts in BALB/c nude mice was inhibited by daily oral treatment with nilotinib. Western blot analysis showed both increased phospho-AMPK expression and decreased PP2A activity in vivo. Together, our results reveal that nilotinib induces autophagy, but not apoptosis in HCC, and that the autophagy-inducing activity is associated with PP2A-regulated AMPK phosphorylation.	[Yu, Hui-Chuan; Tai, Wei-Tien; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 100, Taiwan; [Yu, Hui-Chuan; Tai, Wei-Tien; Chen, Kuen-Feng] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Taipei 100, Taiwan; [Lin, Chen-Si] Natl Taiwan Univ Hosp, Sch Vet Med, Taipei 100, Taiwan; [Lin, Chen-Si] Coll Med, Taipei 100, Taiwan; [Liu, Chun-Yu; Shiau, Chung-Wai] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Liu, Chun-Yu] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei 112, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chen, KF (corresponding author), 7 Chung Shan South Rd, Taipei, Taiwan.	kfchen1970@ntu.edu.tw	Lin, Chen-Si/AAD-3733-2019	Lin, Chen-Si/0000-0003-2254-8344; Chen, Kuen-Feng/0000-0002-4686-7019	National Taiwan University Hospital [NTUH 101P01]; National Science Council, Taiwan [NSC99-2314-B-002-017-MY2, NSC101-2325-B-002-032]	National Taiwan University Hospital(National Taiwan University); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grants NTUH 101P01 (to K.-F. C.) from the National Taiwan University Hospital and NSC99-2314-B-002-017-MY2 (to K.-F. C.), and NSC101-2325-B-002-032 (to K.-F. C.) from the National Science Council, Taiwan.	Adnane L, 2006, METHOD ENZYMOL, V407, P597, DOI 10.1016/S0076-6879(05)07047-3; Al-Kandari FA, 2007, ANN NUCL MED, V21, P439, DOI 10.1007/s12149-007-0050-y; Allen KD, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3801; Auclair D, 2007, LEUKEMIA, V21, P439, DOI 10.1038/sj.leu.2404508; Barnard G, 2007, PRION, V1, P121, DOI 10.4161/pri.1.2.4439; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Cauchi C, 2012, CANCER CHEMOTH PHARM, V69, P977, DOI 10.1007/s00280-011-1785-7; Chen KF, 2010, ONCOGENE, V29, P6257, DOI 10.1038/onc.2010.357; Chen KF, 2011, MOL CANCER THER, V10, P892, DOI 10.1158/1535-7163.MCT-10-0794; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Forchap SL, 2012, LEUKEMIA, V26, P490, DOI 10.1038/leu.2011.231; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Gimeno-Alcaniz JV, 2003, J MOL BIOL, V333, P201, DOI 10.1016/j.jmb.2003.08.022; Govender VM, 2007, BIOSCI TRENDS, V1, P121; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hiwase DK, 2009, LEUKEMIA, V23, P1205, DOI 10.1038/leu.2009.45; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Italiano A, 2012, ANN SURG ONCOL, V19, P1551, DOI 10.1245/s10434-011-2120-6; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang MR, 2009, J PATHOL, V217, P702, DOI 10.1002/path.2509; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; Magnaudeix A, 2013, NEUROBIOL AGING, V34, P770, DOI 10.1016/j.neurobiolaging.2012.06.026; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Martinelli G, 2007, BIOL-TARGETS THER, V1, P121; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Quintas-Cardama A, 2008, FUTURE ONCOL, V4, P611, DOI 10.2217/14796694.4.5.611; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Stanevich V, 2011, MOL CELL, V41, P331, DOI 10.1016/j.molcel.2010.12.030; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013662; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Weigel MT, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3191; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhou ST, 2012, CANCER LETT, V323, P115, DOI 10.1016/j.canlet.2012.02.017	49	70	71	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18249	18259		10.1074/jbc.M112.446385	http://dx.doi.org/10.1074/jbc.M112.446385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23677989	hybrid, Green Published			2022-12-28	WOS:000320721900029
J	Anafu, AA; Bowen, CH; Chin, CR; Brass, AL; Holm, GH				Anafu, Amanda A.; Bowen, Christopher H.; Chin, Christopher R.; Brass, Abraham L.; Holm, Geoffrey H.			Interferon-inducible Transmembrane Protein 3 (IFITM3) Restricts Reovirus Cell Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; INFECTIOUS SUBVIRION PARTICLES; REVERSE GENETICS SYSTEM; WEST NILE VIRUS; MAMMALIAN REOVIRUSES; PUTATIVE AUTOCLEAVAGE; S-PALMITOYLATION; DENGUE VIRUS; HELA-CELLS; MU-1	Reoviruses are double-stranded RNA viruses that infect the mammalian respiratory and gastrointestinal tract. Reovirus infection elicits production of type I interferons (IFNs), which trigger antiviral pathways through the induction of interferon-stimulated genes (ISGs). Although hundreds of ISGs have been identified, the functions of many of these genes are unknown. The interferon-inducible transmembrane (IFITM) proteins are one class of ISGs that restrict the cell entry of some enveloped viruses, including influenza A virus. One family member, IFITM3, localizes to late endosomes, where reoviruses undergo proteolytic disassembly; therefore, we sought to determine whether IFITM3 also restricts reovirus entry. IFITM3-expressing cell lines were less susceptible to infection by reovirus, as they exhibited significantly lower percentages of infected cells in comparison to control cells. Reovirus replication was also significantly reduced in IFITM3-expressing cells. Additionally, cells expressing an shRNA targeting IFITM3 exhibited a smaller decrease in infection after IFN treatment than the control cells, indicating that endogenous IFITM3 restricts reovirus infection. However, IFITM3 did not restrict entry of reovirus infectious subvirion particles (ISVPs), which do not require endosomal proteolysis, indicating that restriction occurs in the endocytic pathway. Proteolysis of outer capsid protein mu 1 was delayed in IFITM3-expressing cells in comparison to control cells, suggesting that IFITM3 modulates the function of late endosomal compartments either by reducing the activity of endosomal proteases or delaying the proteolytic processing of virions. These data provide the first evidence that IFITM3 restricts infection by a nonenveloped virus and suggest that IFITM3 targets an increasing number of viruses through a shared requirement for endosomes during cell entry.	[Anafu, Amanda A.; Bowen, Christopher H.; Holm, Geoffrey H.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Chin, Christopher R.; Brass, Abraham L.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA	Colgate University; University of Massachusetts System; University of Massachusetts Worcester	Holm, GH (corresponding author), Colgate Univ, Dept Biol, 13 Oak Dr, Hamilton, NY 13346 USA.	gholm@colgate.edu	Holm, Geoffrey H./C-3188-2009	Chin, Christopher/0000-0002-2140-3197	National Institutes of Health Public Health Service Awards [R15 AI094440, R01 AI091786]; Charles H. Hood Foundation; Bill and Melinda Gates Foundation; Phillip T. and Susan M. Ragon Foundation; University of Massachusetts Medical School Center for AIDS Research; Colgate University Core Incentive Program; Student Diversity Research Initiative; National Science Foundation [DBI-0923310]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI094440, R01AI091786] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service Awards; Charles H. Hood Foundation; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Phillip T. and Susan M. Ragon Foundation; University of Massachusetts Medical School Center for AIDS Research; Colgate University Core Incentive Program; Student Diversity Research Initiative; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Public Health Service Awards R15 AI094440 (to G. H. H.) and R01 AI091786 (to A. L. B.). This work was also supported by the Charles H. Hood Foundation, the Bill and Melinda Gates Foundation, the Phillip T. and Susan M. Ragon Foundation, and the University of Massachusetts Medical School Center for AIDS Research. Additional support was provided by the Colgate University Core Incentive Program and Student Diversity Research Initiative.; We thank members of our laboratories for many helpful discussions and Walter Atwood, Karl Boehme, Jenna Daly, Pranav Danthi, Terence Dermody, Alexis Griffiths, Jonathan Knowlton, Bernardo Mainou, John Parker, Andrea Pruijssers, Lauren Richardson, and Yevangelina Rybak for technical assistance, reagents, and advice. The confocal microscope was purchased with support from National Science Foundation Grant DBI-0923310.	Bailey CC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002909; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; BLUMENTHAL R, 1986, BIOCHEMISTRY-US, V25, P2231, DOI 10.1021/bi00356a057; Borden EC, 2011, J INTERF CYTOK RES, V31, P1, DOI 10.1089/jir.2010.0129; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Chandran K, 2003, J VIROL, V77, P13361, DOI 10.1128/JVI.77.24.13361-13375.2003; Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002; CHARDONN.Y, 1970, VIROLOGY, V40, P478, DOI 10.1016/0042-6822(70)90190-X; Connolly JL, 2002, J VIROL, V76, P1632, DOI 10.1128/JVI.76.4.1632-1641.2002; DERMODY TS, 1993, J VIROL, V67, P2055, DOI 10.1128/JVI.67.4.2055-2063.1993; Ebert DH, 2002, J BIOL CHEM, V277, P24609, DOI 10.1074/jbc.M201107200; EVANS SS, 1993, J IMMUNOL, V150, P736; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; Fecek RJ, 2006, J IMMUNOL METHODS, V314, P30, DOI 10.1016/j.jim.2006.05.008; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; FITZGERALD DJP, 1983, P NATL ACAD SCI-BIOL, V80, P4134, DOI 10.1073/pnas.80.13.4134; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; FURLONG DB, 1988, J VIROL, V62, P246, DOI 10.1128/JVI.62.1.246-256.1988; GAUNTT CJ, 1973, INFECT IMMUN, V7, P711, DOI 10.1128/IAI.7.5.711-717.1973; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; IMAI T, 1993, J IMMUNOL, V151, P6470; JACOBS BL, 1991, J VIROL, V65, P5102, DOI 10.1128/JVI.65.9.5102-5104.1991; Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Madren JA, 2012, J VIROL, V86, P3466, DOI 10.1128/JVI.06659-11; Maginnis MS, 2008, J VIROL, V82, P3181, DOI 10.1128/JVI.01612-07; Maginnis MS, 2006, J VIROL, V80, P2760, DOI 10.1128/JVI.80.6.2760-2770.2006; Mainou BA, 2012, J VIROL, V86, P8346, DOI 10.1128/JVI.00100-12; Middleton JK, 2007, VIROLOGY, V361, P412, DOI 10.1016/j.virol.2006.11.024; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mundt E, 2007, J GEN VIROL, V88, P1319, DOI 10.1099/vir.0.82526-0; Nibert ML, 2005, J MOL BIOL, V345, P461, DOI 10.1016/j.jmb.2004.10.026; NIBERT ML, 1992, J VIROL, V66, P6408, DOI 10.1128/JVI.66.11.6408-6418.1992; NILSEN TW, 1982, J BIOL CHEM, V257, P4593; Odegard AL, 2004, J VIROL, V78, P8732, DOI 10.1128/JVI.78.16.8732-8745.2004; Parker JSL, 2000, J VIROL, V74, P1919, DOI 10.1128/JVI.74.4.1919-1930.2000; Parker JSL, 2001, J VIROL, V75, P3896, DOI 10.1128/JVI.75.8.3896-3902.2001; RATNER L, 1978, BIOCHEM BIOPH RES CO, V81, P947, DOI 10.1016/0006-291X(78)91443-2; Sarkar P, 2010, J VIROL, V84, P12723, DOI 10.1128/JVI.01385-10; Schiff L. A., 1853, FIELDS VIROLOGY, P1853; Schulz WL, 2012, J VIROL, V86, P12665, DOI 10.1128/JVI.01861-12; SETH P, 1994, BIOCHEM BIOPH RES CO, V205, P1318, DOI 10.1006/bbrc.1994.2809; Sherry B, 1998, J VIROL, V72, P1314, DOI 10.1128/JVI.72.2.1314-1323.1998; Smith RA, 2006, GENES IMMUN, V7, P113, DOI 10.1038/sj.gene.6364278; SMITH RE, 1969, VIROLOGY, V39, P791, DOI 10.1016/0042-6822(69)90017-8; Stewart MJ, 2003, VIROLOGY, V314, P92, DOI 10.1016/S0042-6822(03)00414-8; STURZENBECKER LJ, 1987, J VIROL, V61, P2351, DOI 10.1128/JVI.61.8.2351-2361.1987; Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004; Tsai B, 2007, ANNU REV CELL DEV BI, V23, P23, DOI 10.1146/annurev.cellbio.23.090506.123454; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; Wee YS, 2012, INNATE IMMUN-LONDON, V18, P834, DOI 10.1177/1753425912443392; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Wolf M, 2012, J VIROL, V86, P4009, DOI 10.1128/JVI.06667-11; Wolf M, 2011, J VIROL, V85, P2492, DOI 10.1128/JVI.02082-10; Yount JS, 2012, J BIOL CHEM, V287, P19631, DOI 10.1074/jbc.M112.362095; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]	68	86	93	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17261	17271		10.1074/jbc.M112.438515	http://dx.doi.org/10.1074/jbc.M112.438515			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23649619	Green Published, hybrid			2022-12-28	WOS:000320380600022
J	Hannemann, H; Sung, PY; Chiu, HC; Yousuf, A; Bird, J; Lim, SP; Davidson, AD				Hannemann, Holger; Sung, Po-Yu; Chiu, Han-Chen; Yousuf, Amjad; Bird, Jim; Lim, Siew Pheng; Davidson, Andrew D.			Serotype-specific Differences in Dengue Virus Non-structural Protein 5 Nuclear Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; IMPORTIN ALPHA PROTEINS; NS5 PROTEIN; VIRAL-RNA; CRYSTAL-STRUCTURE; CELLULAR PROLIFERATION; TRANSPORT RECEPTOR; SEQUENCE-BINDING; STRUCTURAL BASIS; REPLICATION	The four serotypes of dengue virus (DENV-1 to -4) cause the most important arthropod-borne viral disease of humans. DENV non-structural protein 5 (NS5) contains enzymatic activities required for capping and replication of the viral RNA genome that occurs in the host cytoplasm. However, previous studies have shown that DENV-2 NS5 accumulates in the nucleus during infection. In this study, we examined the nuclear localization of NS5 for all four DENV serotypes. We demonstrate for the first time that there are serotypic differences in NS5 nuclear localization. Whereas the DENV-2 and -3 proteins accumulate in the nucleus, DENV-1 and -4 NS5 are predominantly if not exclusively localized to the cytoplasm. Comparative studies on the DENV-2 and -4 NS5 proteins revealed that the difference in DENV-4 NS5 nuclear localization was not due to rapid nuclear export but rather the lack of a functional nuclear localization sequence. Interaction studies using DENV-2 and -4 NS5 and human importin-alpha isoforms failed to identify an interaction that supported the differential nuclear localization of NS5. siRNA knockdown of the human importin-alpha isoform KPNA2, corresponding to the murine importin-alpha isoform previously shown to bind to DENV-2 NS5, did not substantially affect DENV-2 NS5 nuclear localization, whereas knockdown of importin-beta did. The serotypic differences in NS5 nuclear localization did not correlate with differences in IL-8 gene expression. The results show that NS5 nuclear localization is not strictly required for virus replication but is more likely to have an auxiliary function in the life cycle of specific DENV serotypes.	[Hannemann, Holger; Sung, Po-Yu; Chiu, Han-Chen; Yousuf, Amjad; Bird, Jim; Davidson, Andrew D.] Univ Bristol, Fac Med & Vet Sci, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Yousuf, Amjad] Taif Univ, Coll Med, At Taif 21944, Saudi Arabia; [Lim, Siew Pheng] Novartis Inst Trop Dis, Singapore 138670, Singapore	University of Bristol; Taif University; Novartis	Davidson, AD (corresponding author), Univ Bristol, Fac Med & Vet Sci, Sch Cellular & Mol Med, Univ Walk, Bristol BS8 1TD, Avon, England.	andrew.davidson@bristol.ac.uk	Yousuf, Amjad/AGZ-4356-2022; Pheng, Lim Siew/AAG-4368-2021; Lim, Siew Pheng/P-8528-2016	Yousuf, Amjad/0000-0003-2573-8645; Pheng, Lim Siew/0000-0002-7377-5662; 	Medical Research Council [G0801973]; MRC [G0801973] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grant G0801973 (to A. D. D.).	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007; Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; CHU PWG, 1992, ARCH VIROL, V125, P177, DOI 10.1007/BF01309636; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; Davidson AD, 2009, ADV VIRUS RES, V74, P41, DOI 10.1016/S0065-3527(09)74002-3; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Depping R, 2008, BBA-MOL CELL RES, V1783, P394, DOI 10.1016/j.bbamcr.2007.12.006; Didcock L, 1999, J VIROL, V73, P9928, DOI 10.1128/JVI.73.12.9928-9933.1999; Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370; Friedrich B, 2006, MOL CELL BIOL, V26, P8697, DOI 10.1128/MCB.00708-06; Fulcher AJ, 2011, BBA-MOL CELL RES, V1813, P2176, DOI 10.1016/j.bbamcr.2011.03.019; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Hanley KA, 2002, J VIROL, V76, P525, DOI 10.1128/JVI.76.2.525-531.2002; Iglesias NG, 2011, J VIROL, V85, P5745, DOI 10.1128/JVI.02343-10; Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]; Kohler M, 2002, CELL PHYSIOL BIOCHEM, V12, P335; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09; Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234; Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Mackenzie JM, 2007, J GEN VIROL, V88, P1163, DOI 10.1099/vir.0.82552-0; Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Mason DA, 2009, J MOL EVOL, V68, P351, DOI 10.1007/s00239-009-9215-8; Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847; Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Pryor MJ, 2001, AM J TROP MED HYG, V65, P427, DOI 10.4269/ajtmh.2001.65.427; Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004; Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Reid SP, 2007, J VIROL, V81, P13469, DOI 10.1128/JVI.01097-07; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Resch W, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-65; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandrock K, 2010, TRAFFIC, V11, P198, DOI 10.1111/j.1600-0854.2009.01015.x; Seibel NM, 2007, ANAL BIOCHEM, V368, P95, DOI 10.1016/j.ab.2007.05.025; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Taylor RT, 2011, CELL HOST MICROBE, V10, P185, DOI 10.1016/j.chom.2011.08.004; Taylor SL, 2009, J VIROL, V83, P1271, DOI 10.1128/JVI.00986-08; Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x; Williams BJL, 2005, BIOCHEM J, V387, P295, DOI 10.1042/BJ20041223; World Health Organization, 2009, DENGUE GUIDELINES DI; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574; Yap LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012836; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06	73	61	62	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22621	22635		10.1074/jbc.M113.481382	http://dx.doi.org/10.1074/jbc.M113.481382			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23770669	Green Published, hybrid			2022-12-28	WOS:000330596300042
J	Ong, EC; Nesin, V; Long, CL; Bai, CX; Guz, JL; Ivanov, IP; Abramowitz, J; Birnbaumer, L; Humphrey, MB; Tsiokas, L				Ong, E-Ching; Nesin, Vasyl; Long, Courtney L.; Bai, Chang-Xi; Guz, Jan L.; Ivanov, Ivaylo P.; Abramowitz, Joel; Birnbaumer, Lutz; Humphrey, Mary Beth; Tsiokas, Leonidas			A TRPC1 Protein-dependent Pathway Regulates Osteoclast Formation and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAC CHANNEL; TERMINAL DIFFERENTIATION; ION SELECTIVITY; CA2+ SENSOR; STORE; STIM1; ORAI1; ACTIVATION; INFLUX; IDENTIFICATION	Ca2+ signaling is essential for bone homeostasis and skeletal development. Here, we show that the transient receptor potential canonical 1 (TRPC1) channel and the inhibitor of MyoD family, I-mfa, function antagonistically in the regulation of osteoclastogenesis. I-mfa null mice have an osteopenic phenotype characterized by increased osteoclast numbers and surface, which are normalized in mice lacking both Trpc1 and I-mfa. In vitro differentiation of pre-osteoclasts derived from I-mfa-deficient mice leads to an increased number of mature osteoclasts and higher bone resorption per osteoclast. These parameters return to normal levels in osteoclasts derived from double mutant mice. Consistently, whole cell currents activated in response to the depletion of intracellular Ca2+ stores are larger in pre-osteoclasts derived from I-mfa knock-out mice compared with currents in wild type mice and normalized in cells derived from double mutant mice, suggesting a cell-autonomous effect of I-mfa on TRPC1 in these cells. A new splice variant of TRPC1 (TRPC1 epsilon) was identified in early pre-osteoclasts. Heterologous expression of TRPC1 epsilon in HEK293 cells revealed that it is unique among all known TRPC1 isoforms in its ability to amplify the activity of the Ca2+ release-activated Ca2+ (CRAC) channel, mediating store-operated currents. TRPC1 epsilon physically interacts with Orai1, the pore-forming subunit of the CRAC channel, and I-mfa is recruited to the TRPC1 epsilon-Orai1 complex through TRPC1 epsilon suppressing CRAC channel activity. We propose that the positive and negative modulation of the CRAC channel by TRPC1 epsilon and I-mfa, respectively, fine-tunes the dynamic range of the CRAC channel regulating osteoclastogenesis.	[Ong, E-Ching; Nesin, Vasyl; Bai, Chang-Xi; Guz, Jan L.; Tsiokas, Leonidas] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73014 USA; [Long, Courtney L.; Humphrey, Mary Beth] Univ Oklahoma, Hlth Sci Ctr, Dept Med Rheumatol, Oklahoma City, OK 73014 USA; [Ivanov, Ivaylo P.] Natl Univ Ireland Univ Coll Cork, BioSci Inst, Cork, Ireland; [Ivanov, Ivaylo P.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Abramowitz, Joel; Birnbaumer, Lutz] NIEHS, Neurobiol Lab, Div Intramural Res, NIH,Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA; [Humphrey, Mary Beth] Vet Affairs Med Ctr, Oklahoma City, OK 73014 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University College Cork; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tsiokas, L (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St, Oklahoma City, OK 73014 USA.	ltsiokas@ouhsc.edu	Abramowitz, Joel/A-2620-2015	Tsiokas, Leonidas/0000-0002-3659-1813; Ivanov, Ivaylo/0000-0002-4793-5466; Ivanov, Ivaylo/0000-0002-6008-3261	National Institutes of Health Intramural Research Program from NIEHS [Z01 ES101684]; NIDDK [DE019398NIDCR, R01DK59599]; Oklahoma Center for Adult Stem Cells;  [P20GM103639];  [P20GM104934NIGMS]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101643, ZIAES101684] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program from NIEHS; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Oklahoma Center for Adult Stem Cells; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Project Z01 ES101684 from NIEHS (to L. B.), Grant DE019398NIDCR (to M. B. H.), Grant R01DK59599 from NIDDK, and Grants P20GM103639 and P20GM104934NIGMS (to L. T.). This work was also supported by the Oklahoma Center for Adult Stem Cells.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Chen CMA, 1996, CELL, V86, P731, DOI 10.1016/S0092-8674(00)80148-8; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Cheng KT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001025; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Hwang SY, 2012, FASEB J, V26, P1484, DOI 10.1096/fj.11-194399; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Kajiya H, 2010, CELL CALCIUM, V48, P260, DOI 10.1016/j.ceca.2010.09.010; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kraut N, 1998, EMBO J, V17, P6276, DOI 10.1093/emboj/17.21.6276; Kusano S, 2002, MOL CELL BIOL, V22, P6393, DOI 10.1128/MCB.22.18.6393-6405.2002; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma R, 2003, J BIOL CHEM, V278, P52763, DOI 10.1074/jbc.M309610200; Masuyama R, 2008, CELL METAB, V8, P257, DOI 10.1016/j.cmet.2008.08.002; McNally BA, 2012, NATURE, V482, P241, DOI 10.1038/nature10752; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Otero K, 2009, NAT IMMUNOL, V10, P734, DOI 10.1038/ni.1744; Pan WJ, 2005, P NATL ACAD SCI USA, V102, P17378, DOI 10.1073/pnas.0505922102; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Robinson LJ, 2012, LAB INVEST, V92, P1071, DOI 10.1038/labinvest.2012.72; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sakura H, 1997, DIABETOLOGIA, V40, P528, DOI 10.1007/s001250050711; Scrimgeour N, 2009, J PHYSIOL-LONDON, V587, P2903, DOI 10.1113/jphysiol.2009.170662; Shi J, 2012, FASEB J, V26, P409, DOI 10.1096/fj.11-185611; Singh BB, 2002, MOL CELL, V9, P739, DOI 10.1016/S1097-2765(02)00506-3; Snider L, 2005, MOL CELL BIOL, V25, P5061, DOI 10.1128/MCB.25.12.5061-5072.2005; Snider L, 2001, MOL CELL BIOL, V21, P1866, DOI 10.1128/MCB.21.5.1866-1873.2001; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; van der Eerden BCJ, 2005, P NATL ACAD SCI USA, V102, P17507, DOI 10.1073/pnas.0505789102; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wang YJ, 2010, SCIENCE, V330, P105, DOI 10.1126/science.1191086; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou YD, 2011, J CELL PHYSIOL, V226, P1082, DOI 10.1002/jcp.22423	58	46	48	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22219	22232		10.1074/jbc.M113.459826	http://dx.doi.org/10.1074/jbc.M113.459826			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23770672	Green Published, hybrid			2022-12-28	WOS:000330596300005
J	Komori, T; Tanaka, M; Senba, E; Miyajima, A; Morikawa, Y				Komori, Tadasuke; Tanaka, Minoru; Senba, Emiko; Miyajima, Atsushi; Morikawa, Yoshihiro			Lack of Oncostatin M Receptor beta Leads to Adipose Tissue Inflammation and Insulin Resistance by Switching Macrophage Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue; Cytokine; Inflammation; Insulin Resistance; Macrophages; Obesity	SYNTHASE ARGINASE BALANCE; DORSAL-ROOT GANGLIA; SKELETAL-MUSCLE; T-CELLS; OBESITY; MICE; EXPRESSION; ACTIVATION; FAT; HYPERINSULINEMIA	Oncostatin M (OSM), a member of the IL-6 family of cytokines, plays important roles in a variety of biological functions, including inflammatory responses. However, the roles of OSM in metabolic diseases are unknown. We herein analyzed the metabolic parameters of OSM receptor subunit-deficient (OSMR-/-) mice under normal diet conditions. At 32 weeks of age, OSMR-/- mice exhibited mature-onset obesity, severer hepatic steatosis, and insulin resistance. Surprisingly, insulin resistance without obesity was observed in OSMR-/- mice at 16 weeks of age, suggesting that insulin resistance precedes obesity in OSMR-/- mice. Both OSM and OSMR were expressed strongly in the adipose tissue and little in some other metabolic organs, including the liver and skeletal muscle. In addition, OSMR is mainly expressed in the adipose tissue macrophages (ATMs) but not in adipocytes. In OSMR-/- mice, the ATMs were polarized to M1 phenotypes with the augmentation of adipose tissue inflammation. Treatment of OSMR-/- mice with an anti-inflammatory agent, sodium salicylate, improved insulin resistance. In addition, the stimulation of a macrophage cell line, RAW264.7, and peritoneal exudate macrophages with OSM resulted in the increased expression of M2 markers, IL-10, arginase-1, and CD206. Furthermore, treatment of C57BL/6J mice with OSM increased insulin sensitivity and polarized the phenotypes of ATMs to M2. Thus, OSM suppresses the development of insulin resistance at least in part through the polarization of the macrophage phenotypes to M2, and OSMR-/- mice provide a unique mouse model of metabolic diseases.	[Komori, Tadasuke; Senba, Emiko; Morikawa, Yoshihiro] Wakayama Med Univ, Dept Anat & Neurobiol, Wakayama 6418509, Japan; [Tanaka, Minoru; Miyajima, Atsushi] Univ Tokyo, Lab Cell Growth & Differentiat, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Wakayama Medical University; University of Tokyo	Morikawa, Y (corresponding author), Wakayama Med Univ, Dept Anat & Neurobiol, 811-1 Kimiidera, Wakayama 6418509, Japan.	yoshim@wakayama-med.ac.jp			Wakayama Medical University; Wakayama Medical Award for Young Researchers	Wakayama Medical University; Wakayama Medical Award for Young Researchers	This work was supported in part by a Research Grant on Priority Areas from Wakayama Medical University and the 2012 Wakayama Medical Award for Young Researchers.	Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Grzelkowska-Kowalczyk K, 2010, CELL BIOL INT, V34, P117, DOI 10.1042/CBI20090135; Hamilton T.A., 2002, MACROPHAGE, V2, P73; Hirasaka K, 2007, DIABETES, V56, P2511, DOI 10.2337/db06-1768; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Igaz P, 2006, ENDOCRINOLOGY, V147, P1037, DOI 10.1210/en.2005-0729; Ishikawa M, 1998, DIABETES, V47, P788, DOI 10.2337/diabetes.47.5.788; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Komori T, 2005, BRAIN RES, V1049, P34, DOI 10.1016/j.brainres.2005.04.079; Komori T, 2008, J COMP NEUROL, V511, P92, DOI 10.1002/cne.21838; Komori T, 2010, J BIOL CHEM, V285, P37884, DOI 10.1074/jbc.M110.148973; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2009, NAT MED, V15, P846, DOI 10.1038/nm0809-846; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Matthews VB, 2010, DIABETOLOGIA, V53, P2431, DOI 10.1007/s00125-010-1865-y; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Miyaoka Y, 2006, J BIOL CHEM, V281, P37913, DOI 10.1074/jbc.M606089200; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; MORIKAWA Y, 1993, CELL IMMUNOL, V152, P200, DOI 10.1006/cimm.1993.1279; Morikawa Y, 2004, J NEUROSCI, V24, P1941, DOI 10.1523/JNEUROSCI.4975-03.2004; Mukouyama YS, 1998, IMMUNITY, V8, P105, DOI 10.1016/S1074-7613(00)80463-X; Munder M, 1998, J IMMUNOL, V160, P5347; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; O'Rourke RW, 2012, METABOLISM, V61, P1152, DOI 10.1016/j.metabol.2012.01.018; Odeleye OE, 1997, DIABETES, V46, P1341, DOI 10.2337/diabetes.46.8.1341; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tamura S, 2002, MECH DEVELOP, V115, P127, DOI 10.1016/S0925-4773(02)00081-3; Tamura S, 2002, DEV DYNAM, V225, P327, DOI 10.1002/dvdy.10156; Tanaka M, 1999, BLOOD, V93, P804, DOI 10.1182/blood.V93.3.804.403a16_804_815; Tanaka M, 2003, BLOOD, V102, P3154, DOI 10.1182/blood-2003-02-0367; Wallace PM, 1999, J IMMUNOL, V162, P5547; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Watt MJ, 2006, NAT MED, V12, P541, DOI 10.1038/nm1383; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246	51	50	52	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21861	10.1074/jbc.M113.461905	http://dx.doi.org/10.1074/jbc.M113.461905			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760275	hybrid, Green Published			2022-12-28	WOS:000328841900035
J	Rafidi, H; Mercado, F; Astudillo, M; Fry, WHD; Saldana, M; Carraway, KL; Sweeney, C				Rafidi, Hanine; Mercado, Francisco, III; Astudillo, Michael; Fry, William H. D.; Saldana, Matthew; Carraway, Kermit L., III; Sweeney, Colleen			Leucine-rich Repeat and Immunoglobulin Domain-containing Protein-1 (Lrigl) Negative Regulatory Action toward ErbB Receptor Tyrosine Kinases Is Opposed by Leucine-rich Repeat and Immunoglobulin Domain-containing Protein 3 (Lrig3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epidermal Growth Factor Receptor (EGFR); Protein Degradation; Receptor Tyrosine Kinase; Signal Transduction; Tumor Suppressor Gene; Lrig1; Lrig3; Growth Factor	GROWTH-FACTOR RECEPTOR; CANCER; STEM; EXPRESSION; LIGAND; UBIQUITYLATION; SUPPRESSION; ENDOCYTOSIS; REVEALS; CELLS	Lrig1 is the founding member of the Lrig family of transmembrane leucine-rich repeat proteins, which also includes Lrig2 and Lrig3. Lrig1 is a negative regulator of oncogenic receptor tyrosine kinases, including ErbB and Met receptors, and promotes receptor degradation. Lrig1 has recently emerged as both a tumor suppressor and a key regulator of epidermal and epithelial stem cell quiescence. Despite this, little is known of the mechanisms by which Lrig1 is regulated. Lrig3 was recently reported to increase ErbB receptor expression suggesting that it may function in a manner opposite to Lrig1. In this study, we explore the interaction between Lrig1 and Lrig3 and demonstrate that Lrig1 and Lrig3 functionally oppose one another. Lrig3 opposes Lrig1 negative regulatory activity and stabilizes ErbB receptors. Conversely, Lrig1 destabilizes Lrig3, limiting Lrig3's positive effects on receptors and identifying Lrig3 as a new target of Lrig1. These studies provide new insight into the regulation of Lrig1 and uncover a complex cross-talk between Lrig1 and Lrig3.	[Rafidi, Hanine; Mercado, Francisco, III; Astudillo, Michael; Fry, William H. D.; Saldana, Matthew; Carraway, Kermit L., III; Sweeney, Colleen] Univ Calif Davis, Ctr Comprehens Canc, Dept Biochem & Mol Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Sweeney, C (corresponding author), Univ Calif Davis, Ctr Comprehens Canc, Res Bldg 3,Rm 1100A,4645 2nd Ave, Sacramento, CA 95817 USA.	casweeney@ucdavis.edu			National Institutes of Health [CAI 18384, CA1 23541]; NATIONAL CANCER INSTITUTE [R01CA123541, R01CA118384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CAI 18384 (to C. S.) and CA1 23541 (to K. L. C. III).	Abraira VE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008981; Brankatschk B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002351; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; Hedman H, 2002, ACTA ONCOL, V41, P352, DOI 10.1080/028418602760169398; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Kochupurakkal BS, 2005, J BIOL CHEM, V280, P8503, DOI 10.1074/jbc.M413919200; Krig SR, 2011, MOL CANCER RES, V9, P1406, DOI 10.1158/1541-7786.MCR-11-0227; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Lee J. M., 2012, ONCOGENE, DOI 10.1038/onc.2012.551; Lill NL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003341; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lindstrom AK, 2008, INT J GYNECOL CANCER, V18, P312, DOI 10.1111/j.1525-1438.2007.01021.x; Ljuslinder I, 2007, ACTA ONCOL, V46, P1118, DOI 10.1080/02841860701426823; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nilsson J, 2003, CELL TISSUE RES, V312, P65, DOI 10.1007/s00441-003-0697-1; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Rouam S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-150; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Sheu J. J., 2013, ONCOGENE IN PRESS; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Sousa LP, 2012, P NATL ACAD SCI USA, V109, P4419, DOI 10.1073/pnas.1200164109; Stutz MA, 2008, ONCOGENE, V27, P5741, DOI 10.1038/onc.2008.185; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Thomasson M, 2003, BRIT J CANCER, V89, P1285, DOI 10.1038/sj.bjc.6601208; Thomasson M, 2011, INT J CANCER, V128, P2843, DOI 10.1002/ijc.25820; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464; Yi W, 2011, EXP CELL RES, V317, P504, DOI 10.1016/j.yexcr.2010.11.005; Zhao H, 2008, DEVELOPMENT, V135, P1283, DOI 10.1242/dev.015073	35	31	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21593	21605		10.1074/jbc.M113.486050	http://dx.doi.org/10.1074/jbc.M113.486050			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23723069	hybrid, Green Published			2022-12-28	WOS:000328841900012
J	Yang, XH; Meyer, K; Friedl, A				Yang, Xinhai; Meyer, Kristy; Friedl, Andreas			STAT5 and Prolactin Participate in a Positive Autocrine Feedback Loop That Promotes Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; N-TERMINAL FRAGMENTS; MOLECULAR-MECHANISMS; GENE-TRANSCRIPTION; RETINOIC ACID; FACTOR VEGF; EXPRESSION; CELLS; RECEPTOR; INHIBITION	We have shown previously that the murine prolactin/growth hormone family member proliferin plays a pivotal role in angiogenesis induced by the FGF2/STAT5 signaling cascade. To delineate the signaling pathway downstream of STAT5 in the human system, where proliferin does not exist, we expressed constitutively active (CA) or dominant-negative (DN) mutant STAT5A in hCMEC/D3 human brain endothelial cells. We found that conditioned medium from CA-STAT5A- but not from DN-STAT5A-overexpressing endothelial cells (EC) is sufficient to induce EC migration and tube formation but not proliferation, indicating that STAT5A regulates the secretion of autocrine proangiogenic factors. We identified prolactin (PRL) as a candidate autocrine factor. CA-STAT5A expression stimulates PRL production at the RNA and protein level, and STAT5A binds to the PRL promoter region, suggesting direct transcriptional regulation. Medium conditioned by CA-STAT5A-over-expressing EC induces phosphorylation of the PRL receptor and activates MAPK. Knockdown of PRL expression by shRNA or blocking of PRL activity with neutralizing antibodies removed the CA-STAT5A-dependent proangiogenic activity from the conditioned medium of EC. The addition of recombinant PRL restores this activity. STAT5A-induced PRL in the conditioned medium can activate STAT5, STAT1, and to a lesser extent STAT3 in hCMEC/D3 cells, suggesting the existence of a positive feedback loop between STAT5 and PRL that promotes angiogenesis. Furthermore, we find that VEGF, a potent proangiogenic factor, is induced by activation of STAT5A, and VEGF induction depends on PRL expression. These observations demonstrate a STAT5/PRL/VEGF signaling cascade in human brain EC and implicate PRL and VEGF as autocrine regulators of EC migration, invasion, and tube formation.	[Yang, Xinhai; Meyer, Kristy; Friedl, Andreas] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53705 USA; [Friedl, Andreas] William S Middleton Mem Vet Adm Med Ctr, Pathol & Lab Med Serv, Dept Vet Affairs Med Ctr, Madison, WI 53705 USA; [Friedl, Andreas] UW Carbone Canc Ctr, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System	Friedl, A (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, 6051 WIMR,MC-2275,1111 Highland Ave, Madison, WI 53705 USA.	afriedl@wisc.edu			UW Department of Pathology and Laboratory Medicine; UW Carbone Cancer Center [P30 CA014520]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000137] Funding Source: NIH RePORTER	UW Department of Pathology and Laboratory Medicine; UW Carbone Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	We thank Dr. Charles Clevenger, Northwestern University, for immunohistochemical labeling of the glioma samples and Dr. Babette Weksler, Weill Cornell Medical College, for kindly providing hCMEC/D3 cells. Korise Rasmusson helped with manuscript preparation. We thank the University of Wisconsin Translational Research Initiatives in Pathology laboratory, in part supported by the UW Department of Pathology and Laboratory Medicine and UW Carbone Cancer Center Grant P30 CA014520 for use of its facilities and services.	Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Banerjee SK, 2000, INT J ONCOL, V16, P253; Bar-Natan M, 2012, LEUKEMIA, V26, P1407, DOI 10.1038/leu.2011.338; Bernichtein S, 2003, J BIOL CHEM, V278, P35988, DOI 10.1074/jbc.M305687200; Bernichtein S, 2010, J ENDOCRINOL, V206, P1, DOI 10.1677/JOE-10-0069; Brockman JL, 2002, MOL ENDOCRINOL, V16, P774, DOI 10.1210/me.16.4.774; Brooks CL, 2012, ENDOCR REV, V33, P504, DOI 10.1210/er.2011-1040; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Castilla A, 2010, J VASC RES, V47, P45, DOI 10.1159/000231720; Ciccarelli E, 2001, J Neurosurg Sci, V45, P70; Clapp C, 1998, J ENDOCRINOL, V158, P137, DOI 10.1677/joe.0.1580137; CLAPP C, 1993, ENDOCRINOLOGY, V133, P1292, DOI 10.1210/en.133.3.1292; CLAPP C, 1992, ENDOCRINOLOGY, V130, P1380, DOI 10.1210/en.130.3.1380; Clapp C, 2006, TRENDS ENDOCRIN MET, V17, P301, DOI 10.1016/j.tem.2006.08.002; CLEVENGER CV, 1991, SCIENCE, V253, P77, DOI 10.1126/science.2063207; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Corbacho AM, 2002, J ENDOCRINOL, V173, P219, DOI 10.1677/joe.0.1730219; Corbacho AM, 2000, J ENDOCRINOL, V166, P53, DOI 10.1677/joe.0.1660053; Duenas Z, 1999, INVEST OPHTH VIS SCI, V40, P2498; FERRARA N, 1991, ENDOCRINOLOGY, V129, P896, DOI 10.1210/endo-129-2-896; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Ge GX, 2007, P NATL ACAD SCI USA, V104, P10010, DOI 10.1073/pnas.0704179104; Goffin V, 2005, ENDOCR REV, V26, P400, DOI 10.1210/er.2004-0016; Goldhar AS, 2005, MOL CELL ENDOCRINOL, V232, P9, DOI 10.1016/j.mce.2005.01.005; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris J, 2004, ANN MED, V36, P414, DOI 10.1080/07853890410033892; Hawker JR, 2003, J IMMUNOL METHODS, V274, P77, DOI 10.1016/S0022-1759(02)00437-4; Horseman ND, 1997, EMBO J, V16, P6926, DOI 10.1093/emboj/16.23.6926; Hovey RC, 2001, MOL ENDOCRINOL, V15, P819, DOI 10.1210/me.15.5.819; JACKSON D, 1994, SCIENCE, V266, P1581, DOI 10.1126/science.7527157; JACKSONGRUSBY LL, 1988, ENDOCRINOLOGY, V122, P2462, DOI 10.1210/endo-122-6-2462; KELLY PA, 1989, BIOL REPROD, V40, P27, DOI 10.1095/biolreprod40.1.27; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Ko JY, 2003, MOL CELLS, V15, P262; Komorowski J, 2000, CYTOBIOS, V101, P151; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Maeno T, 2002, AM J RESP CELL MOL, V26, P246, DOI 10.1165/ajrcmb.26.2.4509; Malaguarnera L, 2004, J CELL BIOCHEM, V93, P197, DOI 10.1002/jcb.20167; Merkle CJ, 2000, ENDOCRINE, V13, P37, DOI 10.1385/ENDO:13:1:37; Mueller MD, 2000, P NATL ACAD SCI USA, V97, P10972, DOI 10.1073/pnas.200377097; Nelson EA, 2011, BLOOD, V117, P3421, DOI 10.1182/blood-2009-11-255232; Nguyen NQN, 2006, P NATL ACAD SCI USA, V103, P14319, DOI 10.1073/pnas.0606638103; Ochoa A, 2001, INVEST OPHTH VIS SCI, V42, P1639; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; Piwnica D, 2004, MOL ENDOCRINOL, V18, P2522, DOI 10.1210/me.2004-0200; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Reuwer AQ, 2012, J CELL MOL MED, V16, P2035, DOI 10.1111/j.1582-4934.2011.01499.x; Reynolds C, 1997, ENDOCRINOLOGY, V138, P5555, DOI 10.1210/en.138.12.5555; Richards RG, 1996, J INVEST DERMATOL, V106, P1250, DOI 10.1111/1523-1747.ep12348944; Rouet V, 2010, P NATL ACAD SCI USA, V107, P15199, DOI 10.1073/pnas.0911651107; Rycyzyn MA, 2002, P NATL ACAD SCI USA, V99, P6790, DOI 10.1073/pnas.092160699; SHIVERS BD, 1989, NEUROENDOCRINOLOGY, V49, P23, DOI 10.1159/000125086; Si JT, 2002, BLOOD, V100, P4401, DOI 10.1182/blood-2001-12-0374; Struman I, 1999, P NATL ACAD SCI USA, V96, P1246, DOI 10.1073/pnas.96.4.1246; Tabruyn SP, 2005, MOL ENDOCRINOL, V19, P1932, DOI 10.1210/me.2004-0515; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wiemers DO, 2003, ENDOCRINOLOGY, V144, P313, DOI 10.1210/en.2002-220724; WILDER EL, 1986, MOL CELL BIOL, V6, P3283, DOI 10.1128/MCB.6.9.3283; Yang XH, 2012, J BIOL CHEM, V287, P6490, DOI 10.1074/jbc.M111.254631; Yang XH, 2009, CANCER RES, V69, P1668, DOI 10.1158/0008-5472.CAN-07-6385	63	40	40	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21184	21196		10.1074/jbc.M113.481119	http://dx.doi.org/10.1074/jbc.M113.481119			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23729680	Green Published, hybrid			2022-12-28	WOS:000322014400038
J	Parsons, B; Foley, E				Parsons, Brendon; Foley, Edan			The Drosophila Platelet-derived Growth Factor and Vascular Endothelial Growth Factor-Receptor Related (Pvr) Protein Ligands Pvf2 and Pvf3 Control Hemocyte Viability and Invasive Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; PDGF/VEGF RECEPTOR; MACROPHAGE-MIGRATION; BLOOD-CELLS; VEGF; MECHANISMS; MORPHOGENESIS; PROLIFERATION; MELANOGASTER; HOMOLOG	Vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) family members are essential and evolutionary conserved determinants of blood cell development and dispersal. In addition, VEGFs are integral to vascular growth and permeability with detrimental contributions to ischemic diseases and metastatic cancers. The PDGF/VEGF-receptor related (Pvr) protein is implicated in the migration and trophic maintenance of macrophage-like hemocytes in Drosophila melanogaster embryos. pvr mutants have a depleted hemocyte population and a breakdown in hemocyte distribution. Previous studies suggested redundant functions for the Pvr ligands, Pvf2 and Pvf3 in the regulation of hemocyte migration, proliferation, and size. However, the precise roles that Pvf2 and Pvf3 play in hematopoiesis remain unclear due to the lack of available mutants. To determine Pvf2 and Pvf3 functions in vivo, we generated a genomic deletion that simultaneously disrupts Pvf2 and Pvf3. From our studies, we identified contributions of Pvf2 and Pvf3 to the Pvr trophic maintenance of hemocytes. Furthermore, we uncovered a novel role for Pvfs in invasive migrations. We showed that Pvf2 and Pvf3 are not required for the directed migration of hemocytes, but act locally in epithelial cells to coordinate trans-epithelial migration of hemocytes. Our findings redefine Pvf roles in hemocyte migration and highlight novel Pvf roles in hemocyte invasive migration. These new parallels between the Pvr and PDGF/VEGF pathways extend the utility of the Drosophila embryonic system to dissect physiological and pathological roles of PDGF/VEGF-like growth factors.	[Parsons, Brendon; Foley, Edan] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Foley, E (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2S2, Canada.	efoley@ualberta.ca			Canadian Institute for Heath Research [MOP 77746]; Natural Science and Engineering Research Council (NSERC); Alberta Innovates Heath Solutions (AIHS)	Canadian Institute for Heath Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Heath Solutions (AIHS)	This work was supported in part by Canadian Institute for Heath Research Grant MOP 77746 and grants from the Natural Science and Engineering Research Council (NSERC) and Alberta Innovates Heath Solutions (AIHS).	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Bond D, 2012, J BIOL CHEM, V287, P27359, DOI 10.1074/jbc.M112.378018; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Bunt S, 2010, DEV CELL, V19, P296, DOI 10.1016/j.devcel.2010.07.019; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Esser S, 1998, J CELL SCI, V111, P1853; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Evans IR, 2013, CELL DEATH DIFFER, V20, P709, DOI 10.1038/cdd.2012.166; Evans IR, 2010, DEVELOPMENT, V137, P1625, DOI 10.1242/dev.046797; FESSLER LI, 1994, METHOD ENZYMOL, V245, P271; Fossett N, 2001, DIFFERENTIATION, V69, P83, DOI 10.1046/j.1432-0436.2001.690202.x; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848; Gerber HP, 2003, J MOL MED, V81, P20, DOI 10.1007/s00109-002-0397-4; Harris KE, 2007, MECH DEVELOP, V124, P441, DOI 10.1016/j.mod.2007.03.003; Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Macias A, 2004, INT J DEV BIOL, V48, P1087, DOI 10.1387/ijdb.041859am; McDonald JA, 2003, DEVELOPMENT, V130, P3469, DOI 10.1242/dev.00574; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Moreira S, 2010, CURR BIOL, V20, P464, DOI 10.1016/j.cub.2010.01.047; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Olofsson B, 2005, DEV BIOL, V279, P233, DOI 10.1016/j.ydbio.2004.12.020; Oostendorp RAJ, 2008, STEM CELLS, V26, P2164, DOI 10.1634/stemcells.2007-1049; Paladi M, 2004, J CELL SCI, V117, P6313, DOI 10.1242/jcs.01552; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Rosin D, 2004, DEVELOPMENT, V131, P1939, DOI 10.1242/dev.01101; Saharinen P, 2011, TRENDS MOL MED, V17, P347, DOI 10.1016/j.molmed.2011.01.015; Sahin AO, 2012, CELL ADHES MIGR, V6, P39, DOI 10.4161/cam.18975; Sears HC, 2003, DEVELOPMENT, V130, P3557, DOI 10.1242/dev.00586; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Siekhaus D, 2010, NAT CELL BIOL, V12, P605, DOI 10.1038/ncb2063; Sims D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r20; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Traver D, 2002, CELL, V108, P731, DOI 10.1016/S0092-8674(02)00686-4; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wood W, 2006, J CELL BIOL, V173, P405, DOI 10.1083/jcb.200508161; Wu YJ, 2009, CURR BIOL, V19, P1473, DOI 10.1016/j.cub.2009.07.019; Zlotoff DA, 2011, ANN NY ACAD SCI, V1217, P122, DOI 10.1111/j.1749-6632.2010.05881.x	48	37	37	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20173	20183		10.1074/jbc.M113.483818	http://dx.doi.org/10.1074/jbc.M113.483818			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23737520	Green Published, hybrid			2022-12-28	WOS:000321715100007
J	Kilgore, JA; Du, XL; Melito, L; Wei, SG; Wang, CG; Chin, HG; Posner, B; Pradhan, S; Ready, JM; Williams, NS				Kilgore, Jessica A.; Du, Xinlin; Melito, Lisa; Wei, Shuguang; Wang, Changguang; Chin, Hang Gyeong; Posner, Bruce; Pradhan, Sriharsa; Ready, Joseph M.; Williams, Noelle S.			Identification of DNMT1 Selective Antagonists Using a Novel Scintillation Proximity Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; DNA CYTOSINE-5 METHYLTRANSFERASE; DE-NOVO; MAINTENANCE METHYLATION; CHROMATIN-STRUCTURE; CPG-ISLANDS; AZACITIDINE; EXPRESSION; MUTATION; BINDING	A novel scintillation proximity high throughput assay (SPA) to identify inhibitors of DNA methyltransferases was developed and used to screen over 180,000 compounds. The majority of the validated hits shared a quinone core and several were found to generate the reactive oxygen species, H2O2. Inhibition of the production of H2O2 by the addition of catalase blocked the ability of this group of compounds to inhibit DNA methyltransferase (DNMT) activity. However, a related compound, SW155246, was identified that existed in an already reduced form of the quinone. This compound did not generate H2O2, and catalase did not block its ability to inhibit DNA methyltransferase. SW155246 showed a 30-fold preference for inhibition of human DNMT1 versus human or murine DNMT3A or -3B, inhibited global methylation in HeLa cells, and reactivated expression of the tumor suppressor gene RASSF1A in A549 cells. To our knowledge, this work represents the first description of selective chemical inhibitors of the DNMT1 enzyme.	[Kilgore, Jessica A.; Du, Xinlin; Melito, Lisa; Wei, Shuguang; Wang, Changguang; Posner, Bruce; Ready, Joseph M.; Williams, Noelle S.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chin, Hang Gyeong; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; New England Biolabs	Williams, NS (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Noelle.Williams@UTSouthwestern.edu			National Institutes of Health [P01 CA095471]; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 CA095471 (to S. L. McKnight).	Beaulieu N, 2002, J BIOL CHEM, V277, P28176, DOI 10.1074/jbc.M204734200; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceccaldi A, 2013, ACS CHEM BIOL, V8, P543, DOI 10.1021/cb300565z; Chen TP, 2007, NAT GENET, V39, P391, DOI 10.1038/ng1982; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Cyr AR, 2011, ANTIOXID REDOX SIGN, V15, P551, DOI 10.1089/ars.2010.3492; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Eads CA, 2002, CANCER RES, V62, P1296; Foulks JM, 2012, J BIOMOL SCREEN, V17, P2, DOI 10.1177/1087057111421212; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Ito K, 2004, BIOCHEM BIOPH RES CO, V315, P240, DOI 10.1016/j.bbrc.2004.01.046; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jair KW, 2006, CANCER RES, V66, P682, DOI 10.1158/0008-5472.CAN-05-1980; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Johnston PA, 2008, ASSAY DRUG DEV TECHN, V6, P505, DOI 10.1089/adt.2008.151; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Kilgore JA, 2007, METHODS, V41, P320, DOI 10.1016/j.ymeth.2006.08.008; Kok RM, 2007, CLIN CHEM LAB MED, V45, P903, DOI 10.1515/CCLM.2007.137; Kuck D, 2010, MOL CANCER THER, V9, P3015, DOI 10.1158/1535-7163.MCT-10-0609; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Min NY, 2012, BIOCHEM BIOPH RES CO, V421, P91, DOI 10.1016/j.bbrc.2012.03.120; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pfeifer GP, 2000, CURR TOP MICROBIOL, V249, P1; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Pradhan S, 2003, BIOCHEMISTRY-US, V42, P5321, DOI 10.1021/bi034160+; Prokhortchouk A, 2001, GENE DEV, V15, P1613, DOI 10.1101/gad.198501; Schluckebier G, 1997, J MOL BIOL, V265, P56, DOI 10.1006/jmbi.1996.0711; Silverman LR, 2006, J CLIN ONCOL, V24, P3895, DOI 10.1200/JCO.2005.05.4346; Suzuki M, 2004, CANCER RES, V64, P3137, DOI 10.1158/0008-5472.CAN-03-3046; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao ZJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/737535	38	32	33	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19673	19684		10.1074/jbc.M112.443895	http://dx.doi.org/10.1074/jbc.M112.443895			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23671287	hybrid, Green Published			2022-12-28	WOS:000321515800038
J	Vanderslice, P; Biediger, RJ; Woodside, DG; Brown, WS; Khounlo, S; Warier, ND; Gundlach, CW; Caivano, AR; Bornmann, WG; Maxwell, DS; McIntyre, BW; Willerson, JT; Dixon, RAF				Vanderslice, Peter; Biediger, Ronald J.; Woodside, Darren G.; Brown, Wells S.; Khounlo, Sayadeth; Warier, Navin D.; Gundlach, C. William; Caivano, Amy R.; Bornmann, William G.; Maxwell, David S.; McIntyre, Bradley W.; Willerson, James T.; Dixon, Richard A. F.			Small Molecule Agonist of Very Late Antigen-4 (VLA-4) Integrin Induces Progenitor Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-INFARCTION; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; LIGAND-BINDING; STEM-CELLS; ALPHA-4-BETA-1; RECRUITMENT; ENGRAFTMENT; CD11B/CD18; SUBUNIT	Activation of the integrin family of cell adhesion receptors on progenitor cells may be a viable approach to enhance the effects of stem cell-based therapies by improving cell retention and engraftment. Here, we describe the synthesis and characterization of the first small molecule agonist identified for the integrin alpha 4 beta 1 (also known as very late antigen-4 or VLA-4). The agonist, THI0019, was generated via two structural modifications to a previously identified alpha 4 beta 1 antagonist. THI0019 greatly enhanced the adhesion of cultured cell lines and primary progenitor cells to alpha 4 beta 1 ligands VCAM-1 and CS1 under both static and flow conditions. Furthermore, THI0019 facilitated the rolling and spreading of cells on VCAM-1 and the migration of cells toward SDF-1 alpha. Molecular modeling predicted that the compound binds at the alpha/beta subunit interface overlapping the ligand-binding site thus indicating that the compound must be displaced upon ligand binding. In support of this model, an analog of THI0019 modified to contain a photoreactive group was used to demonstrate that when cross-linked to the integrin, the compound behaves as an antagonist instead of an agonist. In addition, THI0019 showed cross-reactivity with the related integrin alpha 4 beta 7 as well as alpha 5 beta 1 and alpha L beta 2. When cross-linked to alpha L beta 2, the photoreactive analog of THI0019 remained an agonist, consistent with it binding at the alpha/beta subunit interface and not at the ligand-binding site in the inserted ("I") domain of the L subunit. Co-administering progenitor cells with a compound such as THI0019 may provide a mechanism for enhancing stem cell therapy.	[Vanderslice, Peter; Biediger, Ronald J.; Woodside, Darren G.; Khounlo, Sayadeth; Warier, Navin D.; Gundlach, C. William; Caivano, Amy R.; Willerson, James T.; Dixon, Richard A. F.] St Lukes Episcopal Hosp, Texas Heart Inst, Dept Mol Cardiol, Houston, TX 77030 USA; [Brown, Wells S.; McIntyre, Bradley W.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Bornmann, William G.; Maxwell, David S.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Saint Lukes Episcopal Hospital; Texas Heart Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Vanderslice, P (corresponding author), St Lukes Episcopal Hosp, Texas Heart Inst, Dept Mol Cardiol, Houston, TX 77030 USA.	pvanderslice@texasheart.org			National Institutes of Health Cancer Center [CA016672]; NATIONAL CANCER INSTITUTE [T32CA009598, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Rebecca Bartow, Ph.D., and Nicole Stancel, Ph.D., of the Texas Heart Institute for editorial assistance and Deenadayalan Bakthavatsalam, Ph.D., for confocal microscopy advice. The Translational Chemistry Core Facility at the University of Texas M. D. Anderson Cancer Center was the recipient of National Institutes of Health Cancer Center Support Grant CA016672.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; ARROYO AG, 1993, J BIOL CHEM, V268, P9863; Asaumi N, 2001, ANN HEMATOL, V80, P387, DOI 10.1007/s002770100309; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biediger R. J., 2001, U.S. Patent, Patent No. [6,194,448, 6194448]; Biediger R. J., 2012, International Patent, Patent No. [PCT/US2011/060996, 2011060996]; Bjorklund M, 2006, BIOCHEMISTRY-US, V45, P2862, DOI 10.1021/bi052238b; Bougie DW, 2002, BLOOD, V100, P2071, DOI 10.1182/blood.V100.6.2071.h81802002071_2071_2076; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Chavakis E, 2008, J MOL CELL CARDIOL, V45, P514, DOI 10.1016/j.yjmcc.2008.01.004; Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Coller BS, 1997, J CLIN INVEST, V100, pS57; Dobaczewski M, 2006, CELL TISSUE RES, V324, P475, DOI 10.1007/s00441-005-0144-6; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Duan HX, 2006, THROMB HAEMOSTASIS, V96, P807, DOI 10.1160/TH06-04-0199; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IRIE A, 1995, EMBO J, V14, P5550, DOI 10.1002/j.1460-2075.1995.tb00242.x; Kassir J. M., 2000, 219 ACS NAT M SAN FR; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Leone DR, 2003, J PHARMACOL EXP THER, V305, P1150, DOI 10.1124/jpet.102.047332; Lin KC, 1999, J MED CHEM, V42, P920, DOI 10.1021/jm980673g; Liu JW, 2012, CIRC-CARDIOVASC IMAG, V5, P481, DOI 10.1161/CIRCIMAGING.111.969329; Lu CF, 2004, J IMMUNOL, V173, P3972, DOI 10.4049/jimmunol.173.6.3972; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Maiguel D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001811; Newham P, 1997, J BIOL CHEM, V272, P19429, DOI 10.1074/jbc.272.31.19429; NOWLIN DM, 1993, J BIOL CHEM, V268, P20352; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; Park JY, 2007, J BIOMOL SCREEN, V12, P406, DOI 10.1177/1087057106299162; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pepinsky RB, 2002, BIOCHEMISTRY-US, V41, P7125, DOI 10.1021/bi020024d; Perin EC, 2003, CIRCULATION, V107, P2294, DOI 10.1161/01.CIR.0000070596.30552.8B; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Rose DM, 2003, J IMMUNOL, V170, P5912, DOI 10.4049/jimmunol.170.12.5912; Ruiz-Velasco N, 2000, J BIOL CHEM, V275, P7052, DOI 10.1074/jbc.275.10.7052; Schachinger V, 2008, CIRCULATION, V118, P1425, DOI 10.1161/CIRCULATIONAHA.108.777102; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schroeter MR, 2008, CIRC RES, V103, P536, DOI 10.1161/CIRCRESAHA.107.169375; Scott D., 2003, U.S. Patent, Patent No. [6,630,503, 6630503]; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Song H, 2007, STEM CELLS, V25, P1431, DOI 10.1634/stemcells.2006-0467; SZABO MC, 1995, J IMMUNOL, V154, P2112; TEIXIDO J, 1992, J CLIN INVEST, V90, P358, DOI 10.1172/JCI115870; Vanderslice P, 1997, J IMMUNOL, V158, P1710; Vanderslice P, 2010, BIOCHEM BIOPH RES CO, V400, P619, DOI 10.1016/j.bbrc.2010.08.114; Vrtovec B, 2013, CIRC RES, V112, P165, DOI 10.1161/CIRCRESAHA.112.276519; Woodside DG, 2006, J IMMUNOL, V176, P5041, DOI 10.4049/jimmunol.176.8.5041; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang W, 2006, J BIOL CHEM, V281, P37904, DOI 10.1074/jbc.M606888200; You TJ, 2002, BIOPHYS J, V82, P447, DOI 10.1016/S0006-3495(02)75409-X; Yu YM, 2012, J CELL BIOL, V196, P131, DOI 10.1083/jcb.201110023; Zhang S, 2007, CIRC RES, V100, P693, DOI 10.1161/01.RES.0000260803.98329.1c; Zhu JQ, 2010, BLOOD, V116, P5050, DOI 10.1182/blood-2010-04-281154	54	20	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19414	19428		10.1074/jbc.M113.479634	http://dx.doi.org/10.1074/jbc.M113.479634			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23703610	hybrid, Green Published			2022-12-28	WOS:000321515800010
J	Bhattacharjee, A; Oeemig, JS; Kolodziejczyk, R; Meri, T; Kajander, T; Lehtinen, MJ; Iwai, H; Jokiranta, TS; Goldman, A				Bhattacharjee, Arnab; Oeemig, Jesper S.; Kolodziejczyk, Robert; Meri, Taru; Kajander, Tommi; Lehtinen, Markus J.; Iwai, Hideo; Jokiranta, T. Sakari; Goldman, Adrian			Structural Basis for Complement Evasion by Lyme Disease Pathogen Borrelia burgdorferi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOLYTIC-UREMIC SYNDROME; ACID-BINDING PROTEIN; FACTOR-H-BINDING; TORSION ANGLE DYNAMICS; OUTER-MEMBRANE PROTEIN; REGULATORS FACTOR-H; INHIBITOR FACTOR-H; SURFACE; DOMAIN; NMR	Borrelia burgdorferi spirochetes that cause Lyme borreliosis survive for a long time in human serum because they successfully evade the complement system, an important arm of innate immunity. The outer surface protein E (OspE) of B. burgdorferi is needed for this because it recruits complement regulator factor H (FH) onto the bacterial surface to evade complement-mediated cell lysis. To understand this process at the molecular level, we used a structural approach. First, we solved the solution structure of OspE by NMR, revealing a fold that has not been seen before in proteins involved in complement regulation. Next, we solved the x-ray structure of the complex between OspE and the FH C-terminal domains 19 and 20 (FH19-20) at 2.83 angstrom resolution. The structure shows that OspE binds FH19-20 in a way similar to, but not identical with, that used by endothelial cells to bind FH via glycosaminoglycans. The observed interaction of OspE with FH19-20 allows the full function of FH in down-regulation of complement activation on the bacteria. This reveals the molecular basis for how B. burgdorferi evades innate immunity and suggests how OspE could be used as a potential vaccine antigen.	[Bhattacharjee, Arnab; Meri, Taru; Lehtinen, Markus J.; Jokiranta, T. Sakari] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland; [Bhattacharjee, Arnab; Meri, Taru; Lehtinen, Markus J.; Jokiranta, T. Sakari] Univ Helsinki, Res Programs Unit, FIN-00014 Helsinki, Finland; [Bhattacharjee, Arnab; Oeemig, Jesper S.; Kolodziejczyk, Robert; Kajander, Tommi; Iwai, Hideo; Goldman, Adrian] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Kolodziejczyk, Robert; Meri, Taru; Goldman, Adrian] Univ Helsinki, Div Biochem & Biotechnol, Dept Biosci, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki	Jokiranta, TS (corresponding author), Univ Helsinki, Haartman Inst, Haartmaninkatu 3, FIN-00014 Helsinki, Finland.	Sakari.Jokiranta@helsinki.fi	Iwaï, Hideo/A-6416-2009; Kolodziejczyk, Robert/G-9274-2015	Iwaï, Hideo/0000-0001-7376-5264; Kajander, Tommi/0000-0002-5094-227X; Goldman, Adrian/0000-0001-8032-9700; Bhattacharjee, Arnab/0000-0002-9613-7911	National Graduate School in Informational and Structural Biology graduate school; Sigrid Juselius Foundation; Academy of Finland [251700, 131413, 137995, 128646, 255922, 259793, 1252206]	National Graduate School in Informational and Structural Biology graduate school; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	Supported by the National Graduate School in Informational and Structural Biology graduate school.; Supported by the Sigrid Juselius Foundation and Academy of Finland Grant 251700.; Supported by the Sigrid Juselius Foundation and Academy of Finland Grants 131413 and 137995.; Supported by the Sigrid Juselius Foundation and Academy of Finland Grants 128646, 255922, and 259793. To whom correspondence may be addressed: Haartman Institute, Haartmaninkatu 3, University of Helsinki, FIN-00014 Helsinki, Finland. Tel.: 358-9-1911; Fax: 358-9-191-26382; E-mail: Sakari.Jokiranta@helsinki.fi.; Supported by the Sigrid Juselius Foundation and Academy of Finland Grant 1252206. To whom correspondence may be addressed: Department of Biosciences, Division of Biochemistry and Biotechnology, Viikinkaari 1, University of Helsinki, FIN-00014 Helsinki, Finland. Tel.: 358-9-1911; Fax: 358-9-191-59940; E-mail: Adrian.Goldman@helsinki.fi.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alitalo A, 2005, EUR J IMMUNOL, V35, P3043, DOI 10.1002/eji.200526354; Alitalo A, 2004, J IMMUNOL, V172, P6195, DOI 10.4049/jimmunol.172.10.6195; Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847; Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; Amdahl H, 2011, MOL IMMUNOL, V48, P697, DOI 10.1016/j.molimm.2010.11.015; Atkinson JP, 2007, J EXP MED, V204, P1245, DOI 10.1084/jem.20070664; Barbour AG, 1996, J INFECT DIS, V173, P403, DOI 10.1093/infdis/173.2.403; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; Batsford S, 1998, J INFECT DIS, V178, P1676, DOI 10.1086/314477; Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Bhattacharjee A, 2010, MOL IMMUNOL, V47, P1686, DOI 10.1016/j.molimm.2010.03.007; Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Capaldi S, 2007, J BIOL CHEM, V282, P31008, DOI 10.1074/jbc.M705399200; Centers for Disease Control and Prevention, 1996, MMWR-MORBID MORTAL W, V45, P481; Chen SY, 2011, J BACTERIOL, V193, P6724, DOI 10.1128/JB.06042-11; Chen SY, 2011, J BACTERIOL, V193, P6379, DOI 10.1128/JB.05849-11; Cordes FS, 2005, NAT STRUCT MOL BIOL, V12, P276, DOI 10.1038/nsmb902; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desveaux D, 2002, NAT STRUCT BIOL, V9, P512, DOI 10.1038/nsb814; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; FIKRIG E, 1991, J INFECT DIS, V164, P1224, DOI 10.1093/infdis/164.6.1224; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; GORDON DL, 1995, J IMMUNOL, V155, P348; Graebsch A, 2009, P NATL ACAD SCI USA, V106, P18521, DOI 10.1073/pnas.0907990106; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Haapasalo K, 2012, J IMMUNOL, V188, P426, DOI 10.4049/jimmunol.1102545; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Hefty PS, 2001, INFECT IMMUN, V69, P3618, DOI 10.1128/IAI.69.6.3618-3627.2001; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Ho DK, 2010, J IMMUNOL, V185, P1763, DOI 10.4049/jimmunol.1001244; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAM TT, 1994, INFECT IMMUN, V62, P290, DOI 10.1128/IAI.62.1.290-298.1994; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; McDowell JV, 2004, J IMMUNOL, V173, P7471, DOI 10.4049/jimmunol.173.12.7471; Meri T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003308; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Muona M, 2008, CHEMBIOCHEM, V9, P2958, DOI 10.1002/cbic.200800604; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nichesola D, 2004, BIOCHEMISTRY-US, V43, P14072, DOI 10.1021/bi0489661; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; Rose CD, 2001, J RHEUMATOL, V28, P2555; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Sharma A, 2011, J BIOL CHEM, V286, P31924, DOI 10.1074/jbc.M111.270165; STEERE AC, 1977, ANN INTERN MED, V86, P685, DOI 10.7326/0003-4819-86-6-685; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; VANDAM AP, 1993, CLIN INFECT DIS, V17, P708, DOI 10.1093/clinids/17.4.708; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Xu Q, 2009, J BIOL CHEM, V284, P25268, DOI 10.1074/jbc.M109.018564; Zipfel PF, 2008, VACCINE, V26, pI67, DOI 10.1016/j.vaccine.2008.11.015	70	41	41	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18685	18695		10.1074/jbc.M113.459040	http://dx.doi.org/10.1074/jbc.M113.459040			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658013	Green Published, hybrid			2022-12-28	WOS:000321335800005
J	Kirkwood, JS; Legette, LL; Miranda, CL; Jiang, Y; Stevens, JF				Kirkwood, Jay S.; Legette, LeeCole L.; Miranda, Cristobal L.; Jiang, Yuan; Stevens, Jan F.			A Metabolomics-driven Elucidation of the Anti-obesity Mechanisms of Xanthohumol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; ADENINE-NUCLEOTIDE TRANSLOCASE; DIET-INDUCED OBESITY; HUMULUS-LUPULUS; INSULIN SENSITIVITY; DICARBOXYLIC-ACIDS; QUINONE REDUCTASE; STRESS-RESPONSE; LIFE-SPAN; CELLS	Mild, mitochondrial uncoupling increases energy expenditure and can reduce the generation of reactive oxygen species (ROS). Activation of cellular, adaptive stress response pathways can result in an enhanced capacity to reduce oxidative damage. Together, these strategies target energy imbalance and oxidative stress, both underlying factors of obesity and related conditions such as type 2 diabetes. Here we describe a metabolomics-driven effort to uncover the anti-obesity mechanism(s) of xanthohumol (XN), a prenylated flavonoid from hops. Metabolomics analysis of fasting plasma from obese, Zucker rats treated with XN revealed decreases in products of dysfunctional fatty acid oxidation and ROS, prompting us to explore the effects of XN on muscle cell bioenergetics. At low micromolar concentrations, XN acutely increased uncoupled respiration in several different cell types, including myocytes. Tetrahydroxanthohumol also increased respiration, suggesting electrophilicity did not play a role. At higher concentrations, XN inhibited respiration in a ROS-dependent manner. In myocytes, time course metabolomics revealed acute activation of glutathione recycling and long term induction of glutathione synthesis as well as several other changes indicative of short term elevated cellular stress and a concerted adaptive response. Based on these findings, we hypothesize that XN may ameliorate metabolic syndrome, at least in part, through mitochondrial uncoupling and stress response induction. In addition, time course metabolomics appears to be an effective strategy for uncovering metabolic events that occur during a stress response.	[Kirkwood, Jay S.; Legette, LeeCole L.; Miranda, Cristobal L.; Stevens, Jan F.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Kirkwood, Jay S.; Legette, LeeCole L.; Miranda, Cristobal L.; Stevens, Jan F.] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA; [Jiang, Yuan] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Stevens, JF (corresponding author), Oregon State Univ, Linus Pauling Inst, Linus Pauling Sci Ctr 307, Corvallis, OR 97331 USA.	fred.stevens@oregonstate.edu		Jiang, Yuan/0000-0001-6409-9159; Stevens, Jan Frederik/0000-0002-6348-9347	National Institutes of Health [R21AT005294, S10RR027878, P30ES000210]; Cell Imaging and Analysis Facilities and Services Core of the Environmental Health Sciences Center, Oregon State University, NIEHS, National Institutes of Health [P30 ES00210]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R21AT005294] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell Imaging and Analysis Facilities and Services Core of the Environmental Health Sciences Center, Oregon State University, NIEHS, National Institutes of Health; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AT005294, S10RR027878, and P30ES000210.; We thank Dr. Chrissa Kioussi (Oregon State University-OSU College of Pharmacy) for the C2C12 myocytes and Jeff Morre of the OSU mass spectrometry facility. The brown preadipocytes were a kind gift from Dr. Bruce Spiegelman (Harvard Medical School Department of Cell Biology). For help with the Seahorse XF Analyzer, we acknowledge Justin X. Zhang and Jeffrey A. Greenwood, Director, Cell Imaging and Analysis Facilities and Services Core of the Environmental Health Sciences Center, Oregon State University Grant P30 ES00210, NIEHS, National Institutes of Health.	Agresti A., 2012, CATEGORICAL DATA ANA, P274; Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; Ashfaq S, 2008, HYPERTENSION, V52, P80, DOI 10.1161/HYPERTENSIONAHA.107.097386; Bell JA, 2010, J CLIN ENDOCR METAB, V95, P3400, DOI 10.1210/jc.2009-1596; BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693; Berkeley LI, 2003, J BIOCHEM MOL TOXIC, V17, P95, DOI 10.1002/jbt.10069; Bowtell JL, 2002, NUTRITION, V18, P222, DOI 10.1016/S0899-9007(01)00795-X; Brand MD, 2005, BIOCHEM J, V392, P353, DOI 10.1042/BJ20050890; Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016; Buckley BJ, 2000, AM J PHYSIOL-CELL PH, V279, pC1168, DOI 10.1152/ajpcell.2000.279.4.C1168; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; Calabrese EJ, 2009, ARCH TOXICOL, V83, P227, DOI 10.1007/s00204-009-0411-5; Camacho A, 2012, EXP NEUROL, V237, P396, DOI 10.1016/j.expneurol.2012.06.031; Dietz BM, 2005, CHEM RES TOXICOL, V18, P1296, DOI 10.1021/tx050058x; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; FDA F.D.A., 2005, GUID IND EST MAX SAF, P7; Festa M, 2011, J NAT PROD, V74, P2505, DOI 10.1021/np200390x; Findeisen HM, 2011, OBESITY, V19, P2429, DOI 10.1038/oby.2011.298; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; GREGO AV, 1995, CLIN NUTR, V14, P143, DOI 10.1016/S0261-5614(95)80011-5; Guzy J, 2010, FEBS LETT, V584, P567, DOI 10.1016/j.febslet.2009.11.098; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hirata H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049415; HUGHES RE, 1964, NATURE, V203, P1068, DOI 10.1038/2031068a0; Kirkwood JS, 2012, J BIOL CHEM, V287, P3833, DOI 10.1074/jbc.M111.316018; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lee BC, 2011, FREE RADICAL BIO MED, V50, P221, DOI 10.1016/j.freeradbiomed.2010.11.008; Lee HR, 2008, MOL CELL BIOCHEM, V318, P23, DOI 10.1007/s11010-008-9853-y; Legette L, 2012, MOL NUTR FOOD RES, V56, P466, DOI 10.1002/mnfr.201100554; Legette LL, 2013, PHYTOCHEMISTRY, V91, P236, DOI 10.1016/j.phytochem.2012.04.018; Lehmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011519; Li LX, 2011, J BIOL CHEM, V286, P17809, DOI 10.1074/jbc.M110.180893; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; Luo Y, 2007, J AM SOC MASS SPECTR, V18, P2226, DOI 10.1016/j.jasms.2007.09.015; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Marti A, 2001, INT J OBESITY, V25, P68, DOI 10.1038/sj.ijo.0801484; MASORO EJ, 1967, J BIOL CHEM, V242, P1111; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Mesquita A, 2010, P NATL ACAD SCI USA, V107, P15123, DOI 10.1073/pnas.1004432107; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Miranda CL, 2000, CANCER LETT, V149, P21, DOI 10.1016/S0304-3835(99)00328-6; MORTENSEN PB, 1992, BIOCHIM BIOPHYS ACTA, V1124, P71, DOI 10.1016/0005-2760(92)90128-I; Nozawa H, 2005, BIOCHEM BIOPH RES CO, V336, P754, DOI 10.1016/j.bbrc.2005.08.159; Ozaki S, 2008, PHYS CHEM CHEM PHYS, V10, P4449, DOI 10.1039/b803458c; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Rodriguez AM, 2001, OBES RES, V9, P579, DOI 10.1038/oby.2001.75; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Rose G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029650; Steiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025006; Stevens JF, 1997, PHYTOCHEMISTRY, V44, P1575, DOI 10.1016/S0031-9422(96)00744-3; Stevens JF, 1999, J AGR FOOD CHEM, V47, P2421, DOI 10.1021/jf990101k; Strathmann J, 2010, FASEB J, V24, P2938, DOI 10.1096/fj.10-155846; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tserng KY, 1996, METABOLISM, V45, P162, DOI 10.1016/S0026-0495(96)90047-5; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Wada F, 1977, Biochim Biophys Acta, V487, P361; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zmijewski JW, 2010, J BIOL CHEM, V285, P33154, DOI 10.1074/jbc.M110.143685; Zoll J, 2003, J CELL PHYSIOL, V194, P186, DOI 10.1002/jcp.10224	65	62	64	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19000	19013		10.1074/jbc.M112.445452	http://dx.doi.org/10.1074/jbc.M112.445452			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23673658	Green Published, hybrid			2022-12-28	WOS:000321335800036
J	Roversi, P; Ryffel, B; Togbe, D; Maillet, I; Teixeira, M; Ahmat, N; Paesen, GC; Lissina, O; Boland, W; Ploss, K; Caesar, JJE; Leonhartsberger, S; Lea, SM; Nunn, MA				Roversi, Pietro; Ryffel, Bernhard; Togbe, Dieudonnee; Maillet, Isabelle; Teixeira, Mauro; Ahmat, Nurfilza; Paesen, Guido C.; Lissina, Olga; Boland, Wilhelm; Ploss, Kerstin; Caesar, Joseph J. E.; Leonhartsberger, Susanne; Lea, Susan M.; Nunn, Miles A.			Bifunctional Lipocalin Ameliorates Murine Immune Complex-induced Acute Lung Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; TICK ORNITHODOROS-MOUBATA; AIRWAY HYPERRESPONSIVENESS; LEUKOCYTE RECRUITMENT; LIPID MEDIATORS; INHIBITOR; C5A; INFLAMMATION; GENERATION; DISEASE	Molecules that simultaneously inhibit independent or co-dependent proinflammatory pathways may have advantages over conventional monotherapeutics. OmCI is a bifunctional protein derived from blood-feeding ticks that specifically prevents complement (C)-mediated C5 activation and also sequesters leukotriene B4 (LTB4) within an internal binding pocket. Here, we examined the effect of LTB4 binding on OmCI structure and function and investigated the relative importance of C-mediated C5 activation and LTB4 in a mouse model of immune complex-induced acute lung injury (IC-ALI). We describe two crystal structures of bacterially expressed OmCI: one binding a C16 fatty acid and the other binding LTB4 (C20). We show that the C5 and LTB4 binding activities of the molecule are independent of each other and that OmCI is a potent inhibitor of experimental IC-ALI, equally dependent on both C5 inhibition and LTB4 binding for full activity. The data highlight the importance of LTB4 in IC-ALI and activation of C5 by the complement pathway C5 convertase rather than by non-C proteases. The findings suggest that dual inhibition of C5 and LTB4 may be useful for treatment of human immune complex-dependent diseases.	[Roversi, Pietro; Caesar, Joseph J. E.; Lea, Susan M.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Ryffel, Bernhard; Togbe, Dieudonnee; Maillet, Isabelle; Teixeira, Mauro] Univ Orleans, CNRS, UMR7355, F-45071 Orleans, France; [Ryffel, Bernhard] Univ Cape Town, IIDMM, ZA-7701 Cape Town, South Africa; [Togbe, Dieudonnee] ArtImmune SAS, F-45071 Orleans, France; [Ahmat, Nurfilza; Paesen, Guido C.; Lissina, Olga; Nunn, Miles A.] CEH, Wallingford OX10 8BB, Oxon, England; [Boland, Wilhelm; Ploss, Kerstin] Max Planck Inst Chem Okol, Dept Bioorgan Chem, D-07745 Jena, Germany; [Leonhartsberger, Susanne] Wacker Biotech GmbH, D-07745 Jena, Germany	University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Orleans; University of Cape Town; UK Centre for Ecology & Hydrology (UKCEH); Max Planck Society; Wacker Chemie	Nunn, MA (corresponding author), CEH, Maclean Bldg, Wallingford OX10 8BB, Oxon, England.	amn@ceh.ac.uk	Teixeira, Mauro M/A-4587-2008; Lea, Susan M/B-7678-2009; Togbe, Dieudonnee/AAE-1135-2020; Roversi, Pietro/F-8925-2011; Roversi, Pietro/AAK-4241-2021; Boland, Wilhelm/K-7762-2012	Teixeira, Mauro M/0000-0002-6944-3008; Lea, Susan M/0000-0001-9287-8053; Togbe, Dieudonnee/0000-0001-6658-414X; Roversi, Pietro/0000-0001-9280-9437; Roversi, Pietro/0000-0001-9280-9437; Boland, Wilhelm/0000-0001-6784-2534	Wellcome Trust [077082]; Agence Nationale pour la Recherche [ANR 2007 MIME-103-02]; Fondation pour la Recherche Medicale [FRM allergy DAL 2007 0822007]; Fond Europeen de Developpement Regional [FEDER Asthme 1575-32168]; Le Studium Orleans, CNRS, Orleans, France; British Biology Research Council [ALRJOD0]; Natural Environment Research Council, UK; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Fond Europeen de Developpement Regional; Le Studium Orleans, CNRS, Orleans, France; British Biology Research Council; Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by Grant 077082 from the Wellcome Trust (to S. M. L. and P. R.).; Supported by the Agence Nationale pour la Recherche (ANR 2007 MIME-103-02), the Fondation pour la Recherche Medicale (FRM allergy DAL 2007 0822007), the "Fond Europeen de Developpement Regional" (FEDER Asthme 1575-32168), and Le Studium Orleans, CNRS, Orleans, France.; Supported by Grant ALRJOD0 from the British Biology Research Council (to S. M. L. and M. N.).; Supported by the Natural Environment Research Council, UK. To whom correspondence should be addressed: CEH, Maclean Bldg., Wallingford OX10 8BB, United Kingdom. Tel.: 44-1491-692636; Fax: 44-1491-692424; E-mail: amn@ceh.ac.uk.	Allendorf DJ, 2005, J IMMUNOL, V174, P7050, DOI 10.4049/jimmunol.174.11.7050; Barnett ANR, 2013, CLIN TRANSPLANT, V27, pE216, DOI 10.1111/ctr.12102; Barratt-Due A, 2011, J IMMUNOL, V187, P4913, DOI 10.4049/jimmunol.1101000; Belanger C, 2008, IMMUNOLOGY, V124, P295, DOI 10.1111/j.1365-2567.2007.02767.x; Binder R, 1999, MOL IMMUNOL, V36, P885, DOI 10.1016/S0161-5890(99)00110-8; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bohana-Kashtan O, 2004, MOL IMMUNOL, V41, P583, DOI 10.1016/j.molimm.2004.04.007; Bosmann M, 2012, ADV EXP MED BIOL, V946, P147, DOI 10.1007/978-1-4614-0106-3_9; Czermak BJ, 1999, AM J PATHOL, V154, P1513, DOI 10.1016/S0002-9440(10)65405-3; de Lima WT, 1998, EUR J PHARMACOL, V358, P69; DeLano W.L, PYMOL MOL GRAPHICS S; Dube LM, 1999, CLIN REV ALLERG IMMU, V17, P213, DOI 10.1007/BF02737605; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FELS AOS, 1982, P NATL ACAD SCI-BIOL, V79, P7866, DOI 10.1073/pnas.79.24.7866; Fleming SD, 2008, J SURG RES, V150, P196, DOI 10.1016/j.jss.2008.02.010; FORDHUTCHINSON AW, 1990, CRIT REV IMMUNOL, V10, P1; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; Gao HW, 2006, ANNU REV PATHOL-MECH, V1, P215, DOI 10.1146/annurev.pathol.1.110304.100155; HENDERSON WR, 1991, AM REV RESPIR DIS, V143, pS86, DOI 10.1164/ajrccm/143.5_Pt_2.S86; Hepburn NJ, 2007, J BIOL CHEM, V282, P8292, DOI 10.1074/jbc.M609858200; Hicks A, 2007, EXPERT OPIN INV DRUG, V16, P1909, DOI 10.1517/13543784.16.12.1909; Holmes D, 2011, NAT REV DRUG DISCOV, V10, P798, DOI 10.1038/nrd3581; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; IMAGAWA DK, 1987, MOL IMMUNOL, V24, P1263, DOI 10.1016/0161-5890(87)90120-9; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kelly RJ, 2011, BLOOD, V117, P6786, DOI 10.1182/blood-2011-02-333997; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; KOLB WP, 1981, AM REV RESPIR DIS, V123, P226; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Leonhardsberger S., 2006, BIOPROCESS INT, V4, P64; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P841, DOI 10.1016/j.ibmb.2008.06.007; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; Miyahara N, 2005, AM J RESP CRIT CARE, V172, P161, DOI 10.1164/rccm.200502-205OC; Mulligan MS, 1996, J CLIN INVEST, V98, P503, DOI 10.1172/JCI118818; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; Ohnishi Hiroshi, 2008, Allergol Int, V57, P291, DOI 10.2332/allergolint.08-RAI-0019; Paesen GA, 2000, BBA-PROTEIN STRUCT M, V1482, P92, DOI 10.1016/S0167-4838(00)00168-0; Peng T, 2005, J CLIN INVEST, V115, P1590, DOI 10.1172/JCI22906; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; Roversi P, 2007, J MOL BIOL, V369, P784, DOI 10.1016/j.jmb.2007.03.064; Sadik CD, 2012, J LEUKOCYTE BIOL, V91, P207, DOI 10.1189/jlb.0811402; Sharma J. N., 2006, Inflammopharmacology, V14, P10, DOI 10.1007/s10787-006-1496-6; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; Steil AA, 1998, EUR J PHARMACOL, V361, P93, DOI 10.1016/S0014-2999(98)00680-3; Sun L, 2009, FASEB J, V23, P3808, DOI 10.1096/fj.09-133694; Sylvestre D, 1996, J EXP MED, V184, P2385, DOI 10.1084/jem.184.6.2385; TAVARESDELIMA W, 1989, BRAZ J MED BIOL RES, V22, P745; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Watford WT, 2000, AM J PHYSIOL-LUNG C, V279, pL790, DOI 10.1152/ajplung.2000.279.5.L790	58	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18789	18802		10.1074/jbc.M112.420331	http://dx.doi.org/10.1074/jbc.M112.420331			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23625922	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000321335800017
J	Balanis, N; Wendt, MK; Schiemann, BJ; Wang, ZH; Schiemann, WP; Carlin, CR				Balanis, Nikolas; Wendt, Michael K.; Schiemann, Barbara J.; Wang, Zhenghe; Schiemann, William P.; Carlin, Cathleen R.			Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; LIGAND-RECEPTOR COMPLEXES; EGF RECEPTOR; METASTATIC OUTGROWTH; EXTRACELLULAR-MATRIX; CELL-LINES; PROGNOSTIC VALUE; TUMOR-CELLS; PHASE-II; EXPRESSION	We previously established that overexpression of the EGF receptor (EGFR) is sufficient to induce tumor formation by otherwise nontransformed mammary epithelial cells, and that the initiation of epithelial-mesenchymal transition (EMT) is capable of increasing the invasion and metastasis of these cells. Using this breast cancer (BC) model, we find that in addition to EGF, adhesion to fibronectin (FN) activates signal transducer and activator of transcription 3 (STAT3) through EGFR-dependent and -independent mechanisms. Importantly, EMT facilitated a signaling switch from SRC-dependent EGFR: STAT3 signaling in pre-EMT cells to EGFR-independent FN: JAK2: STAT3 signaling in their post-EMT counterparts, thereby sensitizing these cells to JAK2 inhibition. Accordingly, human metastatic BC cells that failed to activate STAT3 downstream of EGFR did display robust STAT3 activity upon adhesion to FN. Furthermore, FN enhanced outgrowth in three-dimensional organo-typic cultures via a mechanism that is dependent upon beta 1 integrin, Janus kinase 2 (JAK2), and STAT3 but not EGFR. Collectively, our data demonstrate that matrix-initiated signaling is sufficient to drive STAT3 activation, a reaction that is facilitated by EMT during BC metastatic progression.	[Balanis, Nikolas; Carlin, Cathleen R.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Wendt, Michael K.; Schiemann, Barbara J.; Wang, Zhenghe; Schiemann, William P.] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Carlin, Cathleen R.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Schiemann, WP (corresponding author), Case Western Reserve Univ, Wolstein Res Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	william.schiemann@case.edu; cathleen.carlin@case.edu		Wendt, Mike/0000-0002-3665-7413	National Institutes of Health [GM081498, CA129359, CA166140, T32 HL007653]; development funds of the Case Comprehensive Cancer Center Support [CA043703]; NATIONAL CANCER INSTITUTE [R01CA127590, R00CA166140, R01CA129359, K99CA166140, P30CA043703] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); development funds of the Case Comprehensive Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081498 (to C. R. C.), CA129359 (to W. P. S.), CA166140 (to M. K. W.), and T32 HL007653 (to N. B.), and pilot project Grant CA043703 from development funds of the Case Comprehensive Cancer Center Support (to C. R. C. and Z. W.).	Balanis N, 2011, MOL BIOL CELL, V22, P4288, DOI 10.1091/mbc.E10-08-0700; Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Carey LA, 2012, J CLIN ONCOL, V30, P2615, DOI 10.1200/JCO.2010.34.5579; COFFER PJ, 1995, BIOCHEM BIOPH RES CO, V210, P74, DOI 10.1006/bbrc.1995.1629; Crooks D, 2000, MOL BIOL CELL, V11, P3559, DOI 10.1091/mbc.11.10.3559; Dawson PJ, 1996, AM J PATHOL, V148, P313; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dickler MN, 2008, CLIN CANCER RES, V14, P7878, DOI 10.1158/1078-0432.CCR-08-0141; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; FILMUS J, 1987, MOL CELL BIOL, V7, P251, DOI 10.1128/MCB.7.1.251; Flynn JF, 2009, J ONCOL, V2009, DOI 10.1155/2009/526963; Fossey SL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-125; Galliher Amy J, 2006, Future Oncol, V2, P743, DOI 10.2217/14796694.2.6.743; Guren TK, 1999, BIOCHEM BIOPH RES CO, V258, P565, DOI 10.1006/bbrc.1999.0684; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Hynes RO, 2002, COLD SPRING HARB SYM, V67, P143, DOI 10.1101/sqb.2002.67.143; Ibrahim SA, 2012, INT J CANCER, V131, pE884, DOI 10.1002/ijc.27629; Idowu MO, 2012, HUM PATHOL, V43, P364, DOI 10.1016/j.humpath.2011.05.005; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kil SJ, 1999, J BIOL CHEM, V274, P3141, DOI 10.1074/jbc.274.5.3141; Kil SJ, 2000, J CELL PHYSIOL, V185, P47, DOI 10.1002/1097-4652(200010)185:1<47::AID-JCP4>3.3.CO;2-F; Kostenko O, 2006, ONCOGENE, V25, P6604, DOI 10.1038/sj.onc.1209675; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liao HJ, 2009, CANCER RES, V69, P6179, DOI 10.1158/0008-5472.CAN-09-0049; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; McMurray JS, 2006, CHEM BIOL, V13, P1123, DOI 10.1016/j.chembiol.2006.11.001; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ng DCH, 2006, J CELL BIOL, V172, P245, DOI 10.1083/jcb.200503021; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; PRUSS RM, 1977, P NATL ACAD SCI USA, V74, P3918, DOI 10.1073/pnas.74.9.3918; Qian XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060046; Quintela I, 2005, ONCOL REP, V14, P1655; Rousseau C, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-20; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Song RXD, 2010, J STEROID BIOCHEM, V118, P219, DOI 10.1016/j.jsbmb.2009.09.018; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Tsonis AI, 2013, FEBS J, V280, P2248, DOI 10.1111/febs.12162; Ueno NT, 2011, J CANCER, V2, P324, DOI 10.7150/jca.2.324; Wendt MK, 2013, ONCOGENE, V32, P2005, DOI 10.1038/onc.2012.230; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Wendt MK, 2011, MOL BIOL CELL, V22, P2423, DOI 10.1091/mbc.E11-04-0306; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Zhu T, 1998, J BIOL CHEM, V273, P10682, DOI 10.1074/jbc.273.17.10682	60	101	103	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17954	17967		10.1074/jbc.M113.475277	http://dx.doi.org/10.1074/jbc.M113.475277			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653350	hybrid, Green Published			2022-12-28	WOS:000320721900003
J	Huang, H; Cotton, JL; Wang, Y; Rajurkar, M; Zhu, LHJ; Lewis, BC; Mao, JH				Huang, He; Cotton, Jennifer L.; Wang, Yang; Rajurkar, Mihir; Zhu, Lihua J.; Lewis, Brian C.; Mao, Junhao			Specific Requirement of Gli Transcription Factors in Hedgehog-mediated Intestinal Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ASPECTS; SMOOTH-MUSCLE; MOUSE; SHH; ROLES; HOMEOSTASIS; OSTEOBLAST; SKELETON; STOMACH; PATHWAY	Hedgehog (Hh) signaling is involved in multiple aspects of embryonic gut development, including mesenchymal growth and smooth muscle differentiation. The Gli family transcription factors is thought to collectively mediate Hh signaling in mammals. However, the function of different Gli proteins in gut development remains uncharacterized. Here, we genetically dissect the contribution of Gli transcriptional activation and de-repression in intestinal growth and patterning. We find that removal of the Gli3 repressor is dispensable for intestinal development and does not play a major role in Hh-controlled gut development. However, Gli2 activation is able to fully rescue the Smoothened (Smo)-null intestinal phenotype, suggesting that the Gli2 transcription factor is the main effector for Hh signaling in the intestine. To understand further the molecular mechanism underlying Hh/Gli function in the developing gut, we identify a subset of small leucine-rich glycoproteins (SLRPs) that may function downstream of Hh signaling in the mesenchyme. We show that osteoglycin, a SLRP, inhibits Hh-induced differentiation toward the smooth muscle lineage in C3H10T1/2 pluripotent mesenchymal cells. Taken together, our study reveals, for the first time, the distinct roles of Gli proteins in intestine development and suggests SLRPs as novel regulators of smooth muscle cell differentiation.	[Huang, He; Cotton, Jennifer L.; Rajurkar, Mihir; Mao, Junhao] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Zhu, Lihua J.; Lewis, Brian C.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Huang, He] Cent S Univ, Xiangya Sch Med, Dept Histol & Embryol, Changsha 410013, Hunan, Peoples R China; [Wang, Yang] Univ Massachusetts MassBiol, Boston, MA 02126 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Central South University; University of Massachusetts System; University of Massachusetts Boston	Mao, JH (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.	junhao.mao@umassmed.edu	Rajurkar, Mihir/I-6238-2019	Rajurkar, Mihir/0000-0002-0573-1705; Zhu, Lihua/0000-0001-7416-0590; Cotton, Jennifer/0000-0003-0106-1801	National Institutes of Health [T32 CA130807]; American Cancer Society [20376-RSG-11-040-01-DDC]; Charles H. Hood Foundation; Worcester Biomedical Research Foundation; National Natural Science Foundation of China [81141068]; NATIONAL CANCER INSTITUTE [T32CA130807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Charles H. Hood Foundation; Worcester Biomedical Research Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Training Grant T32 CA130807 (to J. L. C.). This work was also supported by American Cancer Society Grant 20376-RSG-11-040-01-DDC, the Charles H. Hood Foundation and Worcester Biomedical Research Foundation (to J. M.), and National Natural Science Foundation of China Grant 81141068 (to H. H.).	Bai CB, 2002, DEVELOPMENT, V129, P4753; Blaess S, 2008, DEVELOPMENT, V135, P2093, DOI 10.1242/dev.015990; Bredrup C, 2005, INVEST OPHTH VIS SCI, V46, P420, DOI 10.1167/iovs.04-0804; Cain JE, 2011, J CLIN INVEST, V121, P1199, DOI 10.1172/JCI45523; Ding Q, 1998, DEVELOPMENT, V125, P2533; Hilton MJ, 2005, DEVELOPMENT, V132, P4339, DOI 10.1242/dev.02025; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hui C. C., 2011, ANN REV CELL DEV BIO, V27; Joeng KS, 2009, DEVELOPMENT, V136, P4177, DOI 10.1242/dev.041624; Kim JH, 2005, DEV DYNAM, V234, P984, DOI 10.1002/dvdy.20542; Kolterud A, 2009, GASTROENTEROLOGY, V137, P618, DOI 10.1053/j.gastro.2009.05.002; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Madison BB, 2005, DEVELOPMENT, V132, P279, DOI 10.1242/dev.01576; Majava M, 2007, HUM MUTAT, V28, P336, DOI 10.1002/humu.20444; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; MCHUGH KM, 1995, DEV DYNAM, V204, P278, DOI 10.1002/aja.1002040306; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Altaba ARI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002540; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; van den Brink GR, 2007, PHYSIOL REV, V87, P1343, DOI 10.1152/physrev.00054.2006; van Dop WA, 2010, GASTROENTEROLOGY, V139, P1665, DOI 10.1053/j.gastro.2010.07.045; Verzi MP, 2009, GASTROENTEROLOGY, V136, P1701, DOI 10.1053/j.gastro.2009.01.009; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Yu J, 2002, DEVELOPMENT, V129, P5301; Zacharias WJ, 2011, DEV BIOL, V355, P152, DOI 10.1016/j.ydbio.2011.04.025; Zacharias WJ, 2010, GASTROENTEROLOGY, V138, P2368, DOI 10.1053/j.gastro.2010.02.057; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	36	29	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17589	17596		10.1074/jbc.M113.467498	http://dx.doi.org/10.1074/jbc.M113.467498			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645682	Green Published, hybrid			2022-12-28	WOS:000320380600050
J	Johnson, EF; Stout, CD				Johnson, Eric F.; Stout, C. David			Structural Diversity of Eukaryotic Membrane Cytochrome P450s	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRYSTAL-STRUCTURE; STEROL 14-ALPHA-DEMETHYLASE; SUBSTRATE-BINDING; 3-DIMENSIONAL STRUCTURE; ANGSTROM RESOLUTION; MASS-SPECTROMETRY; MOLECULAR-WEIGHT; COMPLEX; 2B4; MECHANISM	X-ray crystal structures are available for 29 eukaryotic microsomal, chloroplast, or mitochondrial cytochrome P450s, including two non-monooxygenase P450s. These structures provide a basis for understanding structure-function relations that underlie their distinct catalytic activities. Moreover, structural plasticity has been characterized for individual P450s that aids in understanding substrate binding in P450s that mediate drug clearance.	[Johnson, Eric F.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Stout, C. David] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Johnson, EF (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	johnson@scripps.edu			National Institutes of Health from NIGMS [R01 GM031001]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031001] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM031001 from NIGMS. This is the third article in the Thematic Minireview Series on Cytochrome P450.	Akhtar M, 2011, J STEROID BIOCHEM, V125, P2, DOI 10.1016/j.jsbmb.2010.11.003; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Berka K, 2011, J PHYS CHEM A, V115, P11248, DOI 10.1021/jp204488j; BLACK SD, 1992, FASEB J, V6, P680, DOI 10.1096/fasebj.6.2.1537456; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Chiang CW, 2006, J MOL BIOL, V364, P266, DOI 10.1016/j.jmb.2006.09.039; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Cosme J, 2000, J BIOL CHEM, V275, P2545, DOI 10.1074/jbc.275.4.2545; Cruciani G, 2005, J MED CHEM, V48, P6970, DOI 10.1021/jm050529c; Davydov DR, 2012, J BIOL CHEM, V287, P6797, DOI 10.1074/jbc.M111.325654; de Groot MJ, 2006, DRUG DISCOV TODAY, V11, P601, DOI 10.1016/j.drudis.2006.05.001; Denisov IG, 2012, J INORG BIOCHEM, V108, P150, DOI 10.1016/j.jinorgbio.2011.11.026; Denisov IG, 2012, ARCH BIOCHEM BIOPHYS, V519, P91, DOI 10.1016/j.abb.2011.12.017; DeVore NM, 2012, J BIOL CHEM, V287, P26576, DOI 10.1074/jbc.M112.372813; DeVore NM, 2012, FEBS J, V279, P1621, DOI 10.1111/j.1742-4658.2011.08412.x; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; DUBOIS RN, 1981, P NATL ACAD SCI-BIOL, V78, P1028, DOI 10.1073/pnas.78.2.1028; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Ewen KM, 2011, BBA-PROTEINS PROTEOM, V1814, P111, DOI 10.1016/j.bbapap.2010.06.003; Gay SC, 2011, BIOCHEMISTRY-US, V50, P4903, DOI 10.1021/bi200482g; Gay SC, 2010, BIOCHEMISTRY-US, V49, P8709, DOI 10.1021/bi100914z; Gay SC, 2010, MOL PHARMACOL, V77, P529, DOI 10.1124/mol.109.062570; Gay SC, 2009, BIOCHEMISTRY-US, V48, P4762, DOI 10.1021/bi9003765; Ghosh D, 2012, J MED CHEM, V55, P8464, DOI 10.1021/jm300930n; Ghosh D, 2010, J STEROID BIOCHEM, V118, P197, DOI 10.1016/j.jsbmb.2009.09.012; GOTOH O, 1992, J BIOL CHEM, V267, P83; Halpert JR, 2011, DRUG METAB DISPOS, V39, P1113, DOI 10.1124/dmd.111.039719; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hargrove TY, 2012, J LIPID RES, V53, P311, DOI 10.1194/jlr.M021865; Headlam MJ, 2003, BBA-BIOMEMBRANES, V1617, P96, DOI 10.1016/j.bbamem.2003.09.007; HECKER M, 1989, J BIOL CHEM, V264, P141; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Kirchmair J, 2012, J CHEM INF MODEL, V52, P617, DOI 10.1021/ci200542m; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Lepesheva GI, 2010, J BIOL CHEM, V285, P25582, DOI 10.1074/jbc.M110.133215; Lepesheva GI, 2010, J BIOL CHEM, V285, P1773, DOI 10.1074/jbc.M109.067470; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; Li YC, 2008, J BIOL CHEM, V283, P2917, DOI 10.1074/jbc.M707470200; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; Mast N, 2012, MOL PHARMACOL, V82, P824, DOI 10.1124/mol.112.080424; Mast N, 2011, J BIOL CHEM, V286, P5607, DOI 10.1074/jbc.M110.188433; Mast N, 2010, J BIOL CHEM, V285, P31783, DOI 10.1074/jbc.M110.143313; Mast N, 2009, ARCH BIOCHEM BIOPHYS, V483, P81, DOI 10.1016/j.abb.2009.01.002; NABI N, 1980, BIOCHEM BIOPH RES CO, V97, P687, DOI 10.1016/0006-291X(80)90319-8; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Ozalp C, 2006, BIOCHEMISTRY-US, V45, P4629, DOI 10.1021/bi051372t; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Poulos T. L., 2005, CYTOCHROME P450 STRU, P87; POULOS TL, 1985, J BIOL CHEM, V260, P6122; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; Reynald RL, 2012, J BIOL CHEM, V287, P44581, DOI 10.1074/jbc.M112.424895; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Roberts AG, 2011, BIOCHEMISTRY-US, V50, P10804, DOI 10.1021/bi200924t; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Sevrioukova IF, 2012, ARCH BIOCHEM BIOPHYS, V520, P108, DOI 10.1016/j.abb.2012.02.018; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; Sevrioukova IF, 2010, P NATL ACAD SCI USA, V107, P18422, DOI 10.1073/pnas.1010693107; Shah MB, 2012, BIOCHEMISTRY-US, V51, P7225, DOI 10.1021/bi300894z; Shah MB, 2011, MOL PHARMACOL, V80, P1047, DOI 10.1124/mol.111.074427; Sirim D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-34; Smith BD, 2007, J BIOL CHEM, V282, P17306, DOI 10.1074/jbc.M702361200; Strushkevich N, 2008, J MOL BIOL, V380, P95, DOI 10.1016/j.jmb.2008.03.065; Strushkevich N, 2013, MOL ENDOCRINOL, V27, P315, DOI 10.1210/me.2012-1287; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Sun H, 2010, CHEM BIOL DRUG DES, V75, P3, DOI 10.1111/j.1747-0285.2009.00899.x; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Von Wachenfeldt C, 1995, CYTOCHROME P450 STRU, P183; Wang A, 2012, J BIOL CHEM, V287, P10834, DOI 10.1074/jbc.M111.307918; Wang A, 2011, J BIOL CHEM, V286, P5736, DOI 10.1074/jbc.M110.204420; Wang B, 2009, DRUG METAB REV, V41, P573, DOI 10.1080/03602530903118729; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Wester MR, 2003, BIOCHEMISTRY-US, V42, P9335, DOI 10.1021/bi034556l; Wester MR, 2003, BIOCHEMISTRY-US, V42, P6370, DOI 10.1021/bi0273922; Wilderman PR, 2010, J BIOL CHEM, V285, P38602, DOI 10.1074/jbc.M110.180646; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532; Yano JK, 2006, J MED CHEM, V49, P6987, DOI 10.1021/jm060519r; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zhang HM, 2013, BIOCHEMISTRY-US, V52, P355, DOI 10.1021/bi301567z; Zhang W, 2008, J MOL BIOL, V384, P349, DOI 10.1016/j.jmb.2008.09.037; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200; Zhao YG, 2007, BIOCHEMISTRY-US, V46, P11559, DOI 10.1021/bi7011614	99	72	74	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17082	17090		10.1074/jbc.R113.452805	http://dx.doi.org/10.1074/jbc.R113.452805			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632020	Green Published, hybrid			2022-12-28	WOS:000320380600006
J	Regot, S; de Nadal, E; Rodriguez-Navarro, S; Gonzalez-Novo, A; Perez-Fernandez, J; Gadal, O; Seisenbacher, G; Ammerer, G; Posas, F				Regot, Sergi; de Nadal, Eulalia; Rodriguez-Navarro, Susana; Gonzalez-Novo, Alberto; Perez-Fernandez, Jorge; Gadal, Olivier; Seisenbacher, Gerhard; Ammerer, Gustav; Posas, Francesc			The Hog1 Stress-activated Protein Kinase Targets Nucleoporins to Control mRNA Export upon Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; OSMOTIC-STRESS; MAP KINASE; TRANSCRIPTIONAL RESPONSE; REGULATORY MECHANISMS; SIGNAL-TRANSDUCTION; CELL-CYCLE; POL-II	The control of mRNA biogenesis is exerted at several steps. In response to extracellular stimuli, stress-activated protein kinases (SAPK) modulate gene expression to maximize cell survival. In yeast, the Hog1 SAPK plays a key role in reprogramming the gene expression pattern required for cell survival upon osmostress by acting during transcriptional initiation and elongation. Here, we genetically show that an intact nuclear pore complex is important for cell survival and maximal expression of stress-responsive genes. The Hog1 SAPK associates with nuclear pore complex components and directly phosphorylates the Nup1, Nup2, and Nup60 components of the inner nuclear basket. Mutation of those factors resulted in a deficient export of stress-responsive genes upon stress. Association of Nup1, Nup2, and Nup60 to stress-responsive promoters occurs upon stress depending on Hog1 activity. Accordingly, STL1 gene territory is maintained at the nuclear periphery upon osmostress in a Hog1-dependent manner. Cells containing non-phosphorylatable mutants in Nup1 or Nup2 display reduced expression of stress-responsive genes. Together, proper mRNA biogenesis of stress-responsive genes requires of the coordinate action of synthesis and export machineries by the Hog1 SAPK.	[Regot, Sergi; de Nadal, Eulalia; Gonzalez-Novo, Alberto; Seisenbacher, Gerhard; Posas, Francesc] Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain; [Rodriguez-Navarro, Susana] Ctr Invest Principe Felipe, E-46012 Valencia, Spain; [Perez-Fernandez, Jorge; Gadal, Olivier] Univ Toulouse, CNRS, Lab Biol Mol Eucaryote, F-31000 Toulouse, France; [Ammerer, Gustav] Univ Vienna, Max F Perutz Labs, Dept Biochem, A-1030 Vienna, Austria	Pompeu Fabra University; Prince Felipe Research Center; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	de Nadal, E (corresponding author), Univ Pompeu Fabra, Dept Ciencies Expt & Salut, Cell Signaling Unit, E-08003 Barcelona, Spain.	eulalia.nadal@upf.edu; francesc.posas@upf.edu	Perez-Fernandez, Jorge/F-6937-2010; Seisenbacher, Gerhard/K-8562-2014; Seisenbacher, Gerhard/ABE-6162-2020; de Nadal, Eulàlia/J-8178-2014; Posas, Francesc/K-1364-2013; Rodríguez-Navarro, Susana/B-5182-2014; Gadal, Olivier/A-4731-2008	Perez-Fernandez, Jorge/0000-0002-0018-5493; de Nadal, Eulàlia/0000-0003-0039-5607; Posas, Francesc/0000-0002-4164-7076; Rodríguez-Navarro, Susana/0000-0001-7472-3111; Gadal, Olivier/0000-0001-9421-0831; Regot, Sergi/0000-0001-9786-3897	MINECO (Spanish government) [BFU2012-33503]; Consolider Ingenio program [CSD2007-0015]; Fundacion Marcelino Botin [BFU2011-26722]; MINECO [BFU2011-23418]; Agence Nationale de la Recherche (Nucleopol and ODynRib-Jeune chercheur program); Jeune equipe from Fondation pour la Recherche Medicale; ICREA Academia (Generalitat de Catalunya)	MINECO (Spanish government)(Spanish Government); Consolider Ingenio program(Spanish Government); Fundacion Marcelino Botin; MINECO(Spanish Government); Agence Nationale de la Recherche (Nucleopol and ODynRib-Jeune chercheur program)(French National Research Agency (ANR)); Jeune equipe from Fondation pour la Recherche Medicale; ICREA Academia (Generalitat de Catalunya)(ICREAGeneralitat de Catalunya)	This work was supported by MINECO (Spanish government) Grant BFU2012-33503, the Consolider Ingenio 2010 program (Grant CSD2007-0015), the Fundacion Marcelino Botin (to F. P.), and Grant BFU2011-26722 (to E. d. N.).; Supported by the MINECO Grant BFU2011-23418.; Supported by Agence Nationale de la Recherche (Nucleopol and ODynRib-Jeune chercheur program) and Jeune equipe from Fondation pour la Recherche Medicale.; Recipients of an ICREA Academia (Generalitat de Catalunya).	Abruzzi KC, 2006, EMBO J, V25, P4253, DOI 10.1038/sj.emboj.7601305; Ahmed S, 2007, TRENDS GENET, V23, P396, DOI 10.1016/j.tig.2007.05.009; Ahmed S, 2010, NAT CELL BIOL, V12, P111, DOI 10.1038/ncb2011; Aitchison JD, 2012, GENETICS, V190, P855, DOI 10.1534/genetics.111.127803; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Berger AB, 2008, NAT METHODS, V5, P1031, DOI 10.1038/nmeth.1266; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Brickner DG, 2010, MOL BIOL CELL, V21, P3421, DOI 10.1091/mbc.E10-01-0065; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Capelson M, 2009, EMBO REP, V10, P697, DOI 10.1038/embor.2009.147; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Choder Mordechai, 2011, Cell Logist, V1, P37, DOI 10.4161/cl.1.1.14465; Cook KE, 2012, G3-GENES GENOM GENET, V2, P1129, DOI 10.1534/g3.112.003251; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Green EM, 2012, MOL BIOL CELL, V23, P1367, DOI 10.1091/mbc.E11-06-0547; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Liang Y, 2011, CURR OPIN CELL BIOL, V23, P65, DOI 10.1016/j.ceb.2010.09.008; Light WH, 2010, MOL CELL, V40, P112, DOI 10.1016/j.molcel.2010.09.007; Lim RYH, 2008, INT REV CEL MOL BIO, V267, P299, DOI 10.1016/S1937-6448(08)00632-1; Luthra R, 2007, J BIOL CHEM, V282, P3042, DOI 10.1074/jbc.M608741200; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Nadal-Ribelles M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r106; Ni L, 2009, GENE DEV, V23, P1351, DOI 10.1101/gad.1781909; Pascual-Ahuir A, 2006, METHODS, V40, P272, DOI 10.1016/j.ymeth.2006.06.007; Pelet S, 2011, SCIENCE, V332, P732, DOI 10.1126/science.1198851; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Powrie EA, 2011, RNA, V17, P134, DOI 10.1261/rna.1210411; Proft M, 1999, MOL CELL BIOL, V19, P537; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Ruiz-Roig C, 2012, MOL BIOL CELL, V23, P4286, DOI 10.1091/mbc.E12-04-0289; Saito H, 2012, GENETICS, V192, P289, DOI 10.1534/genetics.112.140863; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Sole C, 2011, EMBO J, V30, P3274, DOI 10.1038/emboj.2011.227; Taddei A, 2007, CURR OPIN CELL BIOL, V19, P305, DOI 10.1016/j.ceb.2007.04.012; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Therizols P, 2010, P NATL ACAD SCI USA, V107, P2025, DOI 10.1073/pnas.0914187107; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Weake VM, 2010, NAT REV GENET, V11, P426, DOI 10.1038/nrg2781; Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200; Zapater M, 2007, MOL CELL BIOL, V27, P3900, DOI 10.1128/MCB.00089-07; Zhou HJ, 2013, NAT PROTOC, V8, P461, DOI 10.1038/nprot.2013.010	72	26	26	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17384	17398		10.1074/jbc.M112.444042	http://dx.doi.org/10.1074/jbc.M112.444042			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645671	hybrid, Green Published			2022-12-28	WOS:000320380600031
J	Vecchiarelli, AG; Havey, JC; Ing, LL; Wong, EOY; Waples, WG; Funnell, BE				Vecchiarelli, Anthony G.; Havey, James C.; Ing, Lori L.; Wong, Erin O. Y.; Waples, William G.; Funnell, Barbara E.			Dissection of the ATPase Active Site of P1 ParA Reveals Multiple Active Forms Essential for Plasmid Partition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROKARYOTIC DNA SEGREGATION; ESCHERICHIA-COLI; NONSPECIFIC DNA; BINDING SITE; PROTEIN PARA; F-PLASMID; LOCALIZATION; SYSTEM; SOPA; OSCILLATION	The segregation, or partition, of bacterial plasmids is driven by the action of plasmid-encoded partition ATPases, which work to position plasmids inside the cell. The most common type of partition ATPase, generally called ParA, is represented by the P1 plasmid ParA protein. ParA interacts with P1 ParB (the site-specific DNA binding protein that recognizes the parS partition site), and interacts with the bacterial chromosome via an ATP-dependent nonspecific DNA binding activity. ParA also regulates expression of the par genes by acting as a transcriptional repressor. ParA requires ATP for multiple steps and in different ways during the partition process. Here, we analyze the properties of mutations in P1 ParA that are altered in a key lysine in the Walker A motif of the ATP binding site. Four different residues at this position (Lys, Glu, Gln, Arg) result in four different phenotypes in vivo. We focus particularly on the arginine substitution (K122R) because it results in a worse-than-null and dominant-negative phenotype called ParPD. We show that ParAK122R binds and hydrolyzes ATP, although the latter activity is reduced compared with wild-type. ParAK122R interacts with ParB, but the consequences of the interaction are damaged. The ability of ParB to stimulate the ATPase activity of ParA in vitro and its repressor activity in vivo is defective. The K122R mutation specifically damages the disassembly of ParA-ParB-DNA partition complexes, which we believe explains the ParPD phenotype in vivo.	[Vecchiarelli, Anthony G.; Havey, James C.; Ing, Lori L.; Wong, Erin O. Y.; Waples, William G.; Funnell, Barbara E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto	Funnell, BE (corresponding author), Univ Toronto, Dept Mol Genet, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	b.funnell@utoronto.ca	Vecchiarelli, Anthony/H-5978-2019	Vecchiarelli, Anthony/0000-0002-6198-3245; Funnell, Barbara/0000-0002-1828-6567	Canadian Institutes of Health Grant [37997]; University of Toronto fellowships	Canadian Institutes of Health Grant(Canadian Institutes of Health Research (CIHR)); University of Toronto fellowships(University of Toronto)	This work was supported by Canadian Institutes of Health Grant 37997 (to B. E. F.) and University of Toronto fellowships (to A. G. V. and J. C. H.).	Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Bouet JY, 1999, EMBO J, V18, P1415, DOI 10.1093/emboj/18.5.1415; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; DAVEY MJ, 1994, J BIOL CHEM, V269, P29908; Davis MA, 1996, MOL MICROBIOL, V21, P1029, DOI 10.1046/j.1365-2958.1996.721423.x; DAVIS MA, 1992, MOL MICROBIOL, V6, P1141, DOI 10.1111/j.1365-2958.1992.tb01552.x; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Ebersbach G, 2004, MOL MICROBIOL, V52, P385, DOI 10.1111/j.1365-2958.2004.04002.x; Ebersbach G, 2001, P NATL ACAD SCI USA, V98, P15078, DOI 10.1073/pnas.261569598; Erdmann N, 1999, P NATL ACAD SCI USA, V96, P14905, DOI 10.1073/pnas.96.26.14905; FRIEDMAN SA, 1988, PLASMID, V19, P103, DOI 10.1016/0147-619X(88)90049-2; Fung E, 2001, EMBO J, V20, P4901, DOI 10.1093/emboj/20.17.4901; Funnell BE, 2004, PLASMID BIOLOGY, P81; FUNNELL BE, 1988, J BACTERIOL, V170, P954, DOI 10.1128/JB.170.2.954-960.1988; FUNNELL BE, 1988, P NATL ACAD SCI USA, V85, P6657, DOI 10.1073/pnas.85.18.6657; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Hatano T, 2007, MOL MICROBIOL, V64, P1198, DOI 10.1111/j.1365-2958.2007.05728.x; Hatano T, 2010, MOL MICROBIOL, V78, P1182, DOI 10.1111/j.1365-2958.2010.07398.x; Havey JC, 2012, NUCLEIC ACIDS RES, V40, P801, DOI 10.1093/nar/gkr747; HAYES F, 1994, MOL MICROBIOL, V11, P249, DOI 10.1111/j.1365-2958.1994.tb00305.x; Hester CM, 2007, P NATL ACAD SCI USA, V104, P20326, DOI 10.1073/pnas.0705196105; Hwang LC, 2013, EMBO J, V32, P1238, DOI 10.1038/emboj.2013.34; Kaur T, 2011, VIROLOGY, V421, P192, DOI 10.1016/j.virol.2011.09.027; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Leonard TA, 2005, PHILOS T R SOC B, V360, P523, DOI 10.1098/rstb.2004.1608; Leonard TA, 2005, EMBO J, V24, P270, DOI 10.1038/sj.emboj.7600530; Libante V, 2001, J MOL BIOL, V314, P387, DOI 10.1006/jmbi.2001.5158; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Lutkenhaus J, 2012, TRENDS MICROBIOL, V20, P411, DOI 10.1016/j.tim.2012.05.002; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moller-Jensen J, 2002, EMBO J, V21, P3119, DOI 10.1093/emboj/cdf320; PAL SK, 1986, J MOL BIOL, V192, P275, DOI 10.1016/0022-2836(86)90364-5; Quisel JD, 1999, MOL CELL, V4, P665, DOI 10.1016/S1097-2765(00)80377-9; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Ringgaard S, 2011, GENE DEV, V25, P1544, DOI 10.1101/gad.2061811; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Rodionov O, 2004, MOL MICROBIOL, V52, P1215, DOI 10.1111/j.1365-2958.2004.04055.x; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Silhavy T. J., 1984, EXPT GENE FUSIONS; Slavcev RA, 2005, J BACTERIOL, V187, P1227, DOI 10.1128/JB.187.4.1227-1237.2005; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Vecchiarelli AG, 2012, MOL MICROBIOL, V86, P513, DOI 10.1111/mmi.12017; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Youngren B, 1997, MOL MICROBIOL, V25, P1023, DOI 10.1046/j.1365-2958.1997.4761842.x	47	16	16	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17823	17831		10.1074/jbc.M113.469981	http://dx.doi.org/10.1074/jbc.M113.469981			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632076	Green Published, hybrid			2022-12-28	WOS:000320380600071
J	Zhou, PP; Wang, ZL; Yuan, XJ; Zhou, CH; Liu, LL; Wan, XL; Zhang, F; Ding, XD; Wang, CG; Xiong, SD; Wang, Z; Yuan, JD; Li, Q; Zhang, Y				Zhou, Peipei; Wang, Zhilong; Yuan, Xiujie; Zhou, Cuihong; Liu, Lulu; Wan, Xiaoling; Zhang, Feng; Ding, Xiaodan; Wang, Chuangui; Xiong, Sidong; Wang, Zhen; Yuan, Jinduo; Li, Qiang; Zhang, Yan			Mixed Lineage Leukemia 5 (MLL5) Protein Regulates Cell Cycle Progression and E2F1-responsive Gene Expression via Association with Host Cell Factor-1 (HCF-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; HERPES-SIMPLEX-VIRUS; CHROMOSOME BAND 7Q22; HISTONE METHYLTRANSFERASE; PROTEOLYTIC CLEAVAGE; COACTIVATOR HCF-1; DNA-REPLICATION; O-GLCNACYLATION; MAMMALIAN CDC6; E2F	Trithorax group proteins methylate lysine 4 of histone 3 (H3K4) at active gene promoters. MLL5 protein, a member of the Trithorax protein family, has been implicated in the control of the cell cycle progression; however, the underlying molecular mechanism(s) have not been fully determined. In this study, we found that the MLL5 protein can associate with the cell cycle regulator "host cell factor" (HCF-1). The interaction between MLL5 and HCF-1 is mediated by the "HCF-1 binding motif" (HBM) of the MLL5 protein and the Kelch domain of the HCF-1 protein. Confocal microscopy showed that the MLL5 protein largely colocalized with HCF-1 in the nucleus. Knockdown of MLL5 resulted in reduced cell proliferation and cell cycle arrest in the G(1) phase. Moreover, down-regulation of E2F1 target gene expression and decreased H3K4me3 levels at E2F1-responsive promoters were observed in MLL5 knockdown cells. Additionally, the core subunits, including ASH2L, RBBP5, and WDR5, that are necessary for effective H3K4 methyltransferase activities of the Trithorax protein complexes, were absent in the MLL5 complex, suggesting that a distinct mechanism may be used by MLL5 for exerting its H3K4 methyltransferase activity. Together, our findings demonstrate that MLL5 could associate with HCF-1 and then be recruited to E2F1-responsive promoters to stimulate H3K4 trimethylation and transcriptional activation, thereby facilitating the cell cycle G(1) to S phase transition.	[Zhou, Peipei; Wang, Zhilong; Yuan, Xiujie; Zhou, Cuihong; Liu, Lulu; Wan, Xiaoling; Zhang, Feng; Ding, Xiaodan; Zhang, Yan] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China; [Liu, Lulu; Wan, Xiaoling; Xiong, Sidong] Soochow Univ, Inst Biol & Med Sci, Suzhou 215123, Jiangsu, Peoples R China; [Wang, Chuangui] E China Normal Univ, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Wang, Chuangui] E China Normal Univ, Coll Life Sci, Shanghai 200241, Peoples R China; [Wang, Zhen; Yuan, Jinduo] Shandong Normal Univ, Key Lab Anim Resistence Shandong Prov, Dept Biotechnol, Jinan 250014, Shandong, Peoples R China; [Li, Qiang] Fudan Univ, Childrens Hosp, Shanghai 201102, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Soochow University - China; East China Normal University; East China Normal University; Shandong Normal University; Fudan University	Zhang, Y (corresponding author), 411 Hefei Rd, Shanghai 200025, Peoples R China.	yan_zhang@sibs.ac.cn	Wan, Xiaoling/T-1813-2019; 周, 翠红/ACA-7979-2022; Wang, Zhen/GYI-9962-2022	Wang, Zhen/0000-0002-1215-1661	National Natural Science Foundation of China [30971672, 81090410, 81270618]; National Basic Research Program of China [2010CB945600, 2011CB966300]; 100 Talent Program of the Chinese Academy of Sciences; Shanghai Pujiang Program [11PJ1401800]; Ministry of Education of China [20093704120004]; Shandong Province [BS2010SW031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); 100 Talent Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Pujiang Program(Shanghai Pujiang Program); Ministry of Education of China(Ministry of Education, China); Shandong Province	This work was supported by National Natural Science Foundation of China Grants 30971672, 81090410, and 81270618, National Basic Research Program of China Grants 2010CB945600 and 2011CB966300, and grants from the 100 Talent Program of the Chinese Academy of Sciences (to Y. Z.), Shanghai Pujiang Program Grant 11PJ1401800 (to Q. L.), Research Fund for the Doctoral Program from Ministry of Education of China Grant 20093704120004, and Award Research Funds for Young Scholars from Shandong Province Grant BS2010SW031 (to J. Y.).	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Austenaa L, 2012, IMMUNITY, V36, P572, DOI 10.1016/j.immuni.2012.02.016; Blais A, 2004, CURR OPIN GENET DEV, V14, P527, DOI 10.1016/j.gde.2004.07.003; Cao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014102; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Chang F, 2008, INT J BIOCHEM CELL B, V40, P2472, DOI 10.1016/j.biocel.2008.04.012; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Daou S, 2011, P NATL ACAD SCI USA, V108, P2747, DOI 10.1073/pnas.1013822108; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; Deng LW, 2004, P NATL ACAD SCI USA, V101, P757, DOI 10.1073/pnas.2036345100; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Fischer K, 1997, BLOOD, V89, P2036, DOI 10.1182/blood.V89.6.2036; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Johnson David G., 1998, Frontiers in Bioscience, V3, pD447; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kratz CP, 2001, GENOMICS, V77, P171, DOI 10.1006/geno.2001.6636; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; La Boissiere S, 1999, EMBO J, V18, P480; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Liu H, 2009, BLOOD, V113, P1395, DOI 10.1182/blood-2008-11-185801; Lubitz S, 2007, MOL BIOL CELL, V18, P2356, DOI 10.1091/mbc.E06-11-1060; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Mangone M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009020; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Narayanan A, 2005, J BIOL CHEM, V280, P1369, DOI 10.1074/jbc.M410178200; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; Peng H, 2010, P NATL ACAD SCI USA, V107, P2461, DOI 10.1073/pnas.0911128107; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; Wilson AC, 2000, MOL CELL BIOL, V20, P6721, DOI 10.1128/MCB.20.18.6721-6730.2000; Wilson AC, 1997, MOL CELL BIOL, V17, P6139, DOI 10.1128/MCB.17.10.6139; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Woo RA, 2003, CELL CYCLE, V2, P316, DOI 10.4161/cc.2.4.468; Yagi H, 1998, BLOOD, V92, P108, DOI 10.1182/blood.V92.1.108.413k11_108_117; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Zargar ZU, 2012, TRANSCR-AUSTIN, V3, P187, DOI 10.4161/trns.20711; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905	56	44	51	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17532	17543		10.1074/jbc.M112.439729	http://dx.doi.org/10.1074/jbc.M112.439729			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629655	Green Published, hybrid			2022-12-28	WOS:000320380600044
J	Minassian, NA; Gibbs, A; Shih, AY; Liu, Y; Neff, RA; Sutton, SW; Mirzadegan, T; Connor, J; Fellows, R; Husovsky, M; Nelson, S; Hunter, MJ; Flinspach, M; Wickenden, AD				Minassian, Natali A.; Gibbs, Alan; Shih, Amy Y.; Liu, Yi; Neff, Robert A.; Sutton, Steven W.; Mirzadegan, Tara; Connor, Judith; Fellows, Ross; Husovsky, Matthew; Nelson, Serena; Hunter, Michael J.; Flinspach, Mack; Wickenden, Alan D.			Analysis of the Structural and Molecular Basis of Voltage-sensitive Sodium Channel Inhibition by the Spider Toxin Huwentoxin-IV (mu-TRTX-Hh2a)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARANTULA TOXINS; HAINANTOXIN-IV; VENOM PEPTIDES; DOMAIN-II; MUTATIONS; SENSORS; PROTEIN; SCN9A; PAIN; BINDING	Voltage-gated sodium channels (VGSCs) are essential to the normal function of the vertebrate nervous system. Aberrant function of VGSCs underlies a variety of disorders, including epilepsy, arrhythmia, and pain. A large number of animal toxins target these ion channels and may have significant therapeutic potential. Most of these toxins, however, have not been characterized in detail. Here, by combining patch clamp electrophysiology and radioligand binding studies with peptide mutagenesis, NMR structure determination, and molecular modeling, we have revealed key molecular determinants of the interaction between the tarantula toxin huwentoxin-IV and two VGSC isoforms, Nav1.7 and Nav1.2. Nine huwentoxin-IV residues (F6A, P11A, D14A, L22A, S25A, W30A, K32A, Y33A, and I35A) were important for block of Nav1.7 and Nav1.2. Importantly, molecular dynamics simulations and NMR studies indicated that folding was normal for several key mutants, suggesting that these amino acids probably make specific interactions with sodium channel residues. Additionally, we identified several amino acids (F6A, K18A, R26A, and K27A) that are involved in isoform-specific VGSC interactions. Our structural and functional data were used to model the docking of huwentoxin-IV into the domain II voltage sensor of Nav1.7. The model predicts that a hydrophobic patch composed of Trp-30 and Phe-6, along with the basic Lys-32 residue, docks into a groove formed by the Nav1.7 S1-S2 and S3-S4 loops. These results provide new insight into the structural and molecular basis of sodium channel block by huwentoxin-IV and may provide a basis for the rational design of toxin-based peptides with improved VGSC potency and/or selectivity.	[Minassian, Natali A.; Liu, Yi; Neff, Robert A.; Sutton, Steven W.; Wickenden, Alan D.] Janssen Res & Dev LLC, Dept Neurosci Discovery, San Diego, CA 92121 USA; [Connor, Judith; Fellows, Ross; Husovsky, Matthew; Nelson, Serena; Hunter, Michael J.; Flinspach, Mack] Janssen Res & Dev LLC, Dept Biol Res, San Diego, CA 92121 USA; [Gibbs, Alan] Janssen Res & Dev LLC, Dept Biol Struct, San Diego, CA 92121 USA; [Shih, Amy Y.; Mirzadegan, Tara] Janssen Res & Dev LLC, Dept Comp Aided Drug Design, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Wickenden, AD (corresponding author), Janssen Res & Dev LLC, 3210 Merryfield Row, San Diego, CA 92121 USA.	awickend@its.jnj.com	Gibbs, Alan/P-9912-2019	Gibbs, Alan/0000-0002-4305-6755; Neff, Robert/0000-0002-7550-4348				Ahmad S, 2007, HUM MOL GENET, V16, P2114, DOI 10.1093/hmg/ddm160; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Burgoyne NJ, 2006, BIOINFORMATICS, V22, P1335, DOI 10.1093/bioinformatics/btl079; Cannon SC, 2000, KIDNEY INT, V57, P772, DOI 10.1046/j.1523-1755.2000.00914.x; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P533, DOI 10.1016/B978-012164491-8/50009-9; Chagot B, 2004, PROTEIN SCI, V13, P1197, DOI 10.1110/ps.03584304; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Escoubas P, 2006, MOL DIVERS, V10, P545, DOI 10.1007/s11030-006-9050-4; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Fiorucci S, 2010, BIOPHYS J, V98, P1921, DOI 10.1016/j.bpj.2009.12.4332; Gallivan JP, 2000, J AM CHEM SOC, V122, P870, DOI 10.1021/ja991755c; Goldberg YP, 2007, CLIN GENET, V71, P311, DOI 10.1111/j.1399-0004.2007.00790.x; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Herzig V, 2011, NUCLEIC ACIDS RES, V39, pD653, DOI 10.1093/nar/gkq1058; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; King GF, 2004, TOXICON, V43, P471, DOI 10.1016/j.toxicon.2004.02.001; King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Lee S, 2010, BIOCHEMISTRY-US, V49, P5134, DOI 10.1021/bi100246u; Li DL, 2004, J BIOL CHEM, V279, P37734, DOI 10.1074/jbc.M405765200; LIANG SP, 1993, TOXICON, V31, P969, DOI 10.1016/0041-0101(93)90256-I; Liu Y, 2011, ASSAY DRUG DEV TECHN, V9, P628, DOI 10.1089/adt.2011.0375; Liu Y, 2012, J PEPT SCI, V18, P643, DOI 10.1002/psc.2451; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; Middleton RE, 2002, BIOCHEMISTRY-US, V41, P14734, DOI 10.1021/bi026546a; Mouhat S, 2005, J PEPT SCI, V11, P65, DOI 10.1002/psc.630; Noble D, 2002, P NATL ACAD SCI USA, V99, P5755, DOI 10.1073/pnas.102171699; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Roland BL, 1999, ENDOCRINOLOGY, V140, P5736, DOI 10.1210/en.140.12.5736; Saez NJ, 2010, TOXINS, V2, P2851, DOI 10.3390/toxins2122851; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Spassov VZ, 2002, J PHYS CHEM B, V106, P8726, DOI 10.1021/jp020674r; Takahashi H, 2000, J MOL BIOL, V297, P771, DOI 10.1006/jmbi.2000.3609; Wang JM, 2004, J GEN PHYSIOL, V123, P455, DOI 10.1085/jgp.200309005; Wood DLA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-375; Wood JN, 2004, J NEUROBIOL, V61, P55, DOI 10.1002/neu.20094; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Xiao YC, 2010, MOL PHARMACOL, V78, P1124, DOI 10.1124/mol.110.066332; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153; Yogeeswari P, 2004, CURR DRUG TARGETS, V5, P589, DOI 10.2174/1389450043345227; Zhang JZ, 2012, J BIOL CHEM, V287, P30719, DOI 10.1074/jbc.M112.370742; Zhang JZ, 2011, J BIOL CHEM, V286, P33641, DOI 10.1074/jbc.M111.282509	54	60	63	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22707	22720		10.1074/jbc.M113.461392	http://dx.doi.org/10.1074/jbc.M113.461392			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23760503	Green Published, hybrid			2022-12-28	WOS:000330596300049
J	Jin, SX; Arai, J; Tian, XJ; Kumar-Singh, R; Feig, LA				Jin, Shan-Xue; Arai, Junko; Tian, Xuejun; Kumar-Singh, Rajendra; Feig, Larry A.			Acquisition of Contextual Discrimination Involves the Appearance of a RAS-GRF1/p38 Mitogen-activated Protein (MAP) Kinase-mediated Signaling Pathway That Promotes Long Term Potentiation (LTP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamate Receptors Ionotropic (AMPA; NMDA); Neurobiology; Neurons; p38 MAPK; RAS; Signal Transduction; Synaptic Plasticity; RAS-GRF; Hippocampus	GLUR2-LACKING AMPA RECEPTORS; SYNAPTIC PLASTICITY; NMDA RECEPTOR; GLUTAMATE RECEPTORS; COMPLEX-FORMATION; MICE LACKING; ERK PATHWAY; RAS; MEMORY; STIMULATION	RAS-GRF1 is a guanine nucleotide exchange factor with the ability to activate RAS and RAC GTPases in response to elevated calcium levels. We previously showed that beginning at 1 month of age, RAS-GRF1 mediates NMDA-type glutamate receptor (NMDAR)-induction of long term depression in the CA1 region of the hippocampus of mice. Here we show that beginning at 2 months of age, when mice first acquire the ability to discriminate between closely related contexts, RAS-GRF1 begins to contribute to the induction of long term potentiation (LTP) in the CA1 hippocampus by mediating the action of calcium-permeable, AMPA-type glutamate receptors (CP-AMPARs). Surprisingly, LTP induction by CP-AMPARs through RAS-GRF1 occurs via activation of p38 MAP kinase rather than ERK MAP kinase, which has more frequently been linked to LTP. Moreover, contextual discrimination is blocked by knockdown of Ras-Grf1 expression specifically in the CA1 hippocampus, infusion of a p38 MAP kinase inhibitor into the CA1 hippocampus, or the injection of an inhibitor of CP-AMPARs. These findings implicate the CA1 hippocampus in the developmentally dependent capacity to distinguish closely related contexts through the appearance of a novel LTP-supporting signaling pathway.	[Jin, Shan-Xue; Arai, Junko; Tian, Xuejun; Feig, Larry A.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Kumar-Singh, Rajendra] Tufts Univ, Sch Med, Dept Ophthalmol, Boston, MA 02111 USA	Tufts University; Tufts University	Feig, LA (corresponding author), Tufts Univ, Sch Med, Dept Biochem, 136 Harrison Ave, Boston, MA 02111 USA.	larry.feig@tufts.edu		Kumar-Singh, Rajendra/0000-0002-7754-0713	National Institutes of Health [R01 MH083324]; Tufts Center for Neuroscience Research [P30 NS047243]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Center for Neuroscience Research; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 MH083324 (to L. A. F.) and Grant P30 NS047243 through the Tufts Center for Neuroscience Research.	Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Albensi BC, 2007, EXP NEUROL, V204, P1, DOI 10.1016/j.expneurol.2006.12.009; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Buchsbaum RJ, 2003, J BIOL CHEM, V278, P18833, DOI 10.1074/jbc.M207876200; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Butler MP, 2004, NEUROSCIENCE, V124, P319, DOI 10.1016/j.neuroscience.2003.11.040; Cashman SM, 2002, MOL THER, V6, P813, DOI 10.1006/mthe.2002.0806; Connolly BA, 2005, MOL CELL BIOL, V25, P4602, DOI 10.1128/MCB.25.11.4602-4614.2005; d'Isa R, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00078; Dumas TC, 2005, HIPPOCAMPUS, V15, P562, DOI 10.1002/hipo.20077; Duncan K, 2012, HIPPOCAMPUS, V22, P389, DOI 10.1002/hipo.20933; Fasano S, 2009, BIOL PSYCHIAT, V66, P758, DOI 10.1016/j.biopsych.2009.03.014; Feig Larry A, 2011, Genes Cancer, V2, P306, DOI 10.1177/1947601911408077; Giese KP, 2001, NEUROPHARMACOLOGY, V41, P791, DOI 10.1016/S0028-3908(01)00096-X; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Izumi Y, 2008, HIPPOCAMPUS, V18, P258, DOI 10.1002/hipo.20383; Jin SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011732; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kesner RP, 2010, BEHAV BRAIN RES, V215, P299, DOI 10.1016/j.bbr.2009.12.029; Klesse LJ, 1999, MICROSC RES TECHNIQ, V45, P210, DOI 10.1002/(SICI)1097-0029(19990515/01)45:4/5<210::AID-JEMT4>3.3.CO;2-6; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Langston RF, 2010, BEHAV BRAIN RES, V215, P275, DOI 10.1016/j.bbr.2010.07.006; Li SM, 2006, CURR BIOL, V16, P2303, DOI 10.1016/j.cub.2006.10.028; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Man HY, 2011, CURR OPIN NEUROBIOL, V21, P291, DOI 10.1016/j.conb.2011.01.001; Peineau S, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-22; Perez Y, 1999, NEUROSCIENCE, V90, P747, DOI 10.1016/S0306-4522(98)00531-4; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Rozov A, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00022; RUDY JW, 1994, BEHAV NEUROSCI, V108, P227, DOI 10.1037/0735-7044.108.2.227; Rush AM, 2002, J NEUROSCI, V22, P6121; Saleshando G, 2000, NEUROSCI LETT, V288, P119, DOI 10.1016/S0304-3940(00)01210-6; Selcher JC, 2003, LEARN MEMORY, V10, P26, DOI 10.1101/lm.51103; Silingardi D, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00084; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tian XJ, 2006, J BIOL CHEM, V281, P7578, DOI 10.1074/jbc.M512060200; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Trempolec N, 2013, CELL, V152, P656, DOI [10.1016/j.cell.2013.01.029, 10.1016/j.cell.2013.01.047]; Wiltgen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012818; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yassa MA, 2011, HIPPOCAMPUS, V21, P968, DOI 10.1002/hipo.20808; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	49	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21703	21713		10.1074/jbc.M113.471904	http://dx.doi.org/10.1074/jbc.M113.471904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23766509	Green Published, hybrid			2022-12-28	WOS:000328841900022
J	Tsukamoto, T; Inoue, K; Kandori, H; Sudo, Y				Tsukamoto, Takashi; Inoue, Keiichi; Kandori, Hideki; Sudo, Yuki			Thermal and Spectroscopic Characterization of a Proton Pumping Rhodopsin from an Extreme Thermophile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Receptor; Membrane Proteins; Membrane Transport; Photobiology; Photoreceptors; Protein Denaturation; Rhodopsin; Ion Pump; Retinal; Thermal Stability	SCHIFF-BASE COUNTERION; PHARAONIS PHOBORHODOPSIN; SENSORY RHODOPSIN; PROTEORHODOPSIN; BACTERIORHODOPSIN; XANTHORHODOPSIN; IDENTIFICATION; TRANSLOCATION; PROTEINS; ARCHAEA	So far retinylidene proteins (approximate to rhodopsin) have not been discovered in thermophilic organisms. In this study we investigated and characterized a microbial rhodopsin derived from the extreme thermophilic bacterium Thermus thermophilus, which lives in a hot spring at around 75 degrees C. The gene for the retinylidene protein, named thermophilic rhodopsin (TR), was chemically synthesized with codon optimization. The codon optimized TR protein was functionally expressed in the cell membranes of Escherichia coli cells and showed active proton transport upon photoillumination. Spectroscopic measurements revealed that the purified TR bound only all-trans-retinal as a chromophore and showed an absorption maximum at 530 nm. In addition, TR exhibited both photocycle kinetics and pH-dependent absorption changes, which are characteristic of rhodopsins. Of note, time-dependent thermal denaturation experiments revealed that TR maintained its absorption even at 75 degrees C, and the denaturation rate constant of TR was much lower than those of other proton pumping rhodopsins such as archaerhodopsin-3 (200 x), Haloquadratum walsbyi bacteriorhodopsin (by 10-times), and Gloeobacter rhodopsin (100 x). Thus, these results suggest that microbial rhodopsins are also distributed among thermophilic organisms and have high stability. TR should allow the investigation of the molecular mechanisms of ion transport and protein folding.	[Tsukamoto, Takashi; Sudo, Yuki] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Nagoya, Aichi 4668555, Japan; [Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Sudo, Yuki] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Nagoya University; Nagoya Institute of Technology; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Sudo, Y (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648602, Japan.	z47867a@cc.nagoya-u.ac.jp	Tsukamoto, Takashi/F-3993-2017; Inoue, Keiichi/AEO-3337-2022; Sudo, Yuki/AGY-0493-2022	Tsukamoto, Takashi/0000-0002-6348-6664; Inoue, Keiichi/0000-0002-6898-4347; Sudo, Yuki/0000-0001-8155-9356	Japanese Ministry of Education, Culture, Sports, Science, and Technology [23687019, 23657100]; Grants-in-Aid for Scientific Research [23657100, 24655009] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants 23687019 and 23657100 (to Y.S).	Balashov SP, 2007, CELL MOL LIFE SCI, V64, P2323, DOI 10.1007/s00018-007-7167-y; Balashov SP, 2012, BIOCHEMISTRY-US, V51, P5748, DOI 10.1021/bi300409m; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Balashov SP, 2000, BBA-BIOENERGETICS, V1460, P75, DOI 10.1016/S0005-2728(00)00131-6; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bergo VB, 2009, J BIOL CHEM, V284, P2836, DOI 10.1074/jbc.M803792200; Brown LS, 2006, PHOTOCH PHOTOBIO SCI, V5, P538, DOI 10.1039/b514537f; Brown LS, 2004, PHOTOCH PHOTOBIO SCI, V3, P555, DOI 10.1039/b315527g; DeLong EF, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000359; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Hedlund BP, 2011, GEOBIOLOGY, V9, P471, DOI 10.1111/j.1472-4669.2011.00295.x; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; Ikeda D, 2007, BIOCHEMISTRY-US, V46, P5365, DOI 10.1021/bi700143g; Ikeura Y, 2003, PHOTOCHEM PHOTOBIOL, V77, P96, DOI 10.1562/0031-8655(2003)077<0096:AOPPSR>2.0.CO;2; Imasheva ES, 2006, PHOTOCHEM PHOTOBIOL, V82, P1406, DOI 10.1562/2006-01-15-RA-776; Jencks W. P., 1987, CATALYSIS CHEM ENZYM, P599; Jung KH, 2007, PHOTOCHEM PHOTOBIOL, V83, P63, DOI 10.1562/2006-03-20-IR-853; Kawanabe A, 2009, J AM CHEM SOC, V131, P16439, DOI 10.1021/ja904855g; Kitajima-Ihara T, 2008, J BIOL CHEM, V283, P23533, DOI 10.1074/jbc.M802990200; Kraj JM, 2008, BIOCHEMISTRY-US, V47, P3447, DOI 10.1021/bi7018964; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; MARTI T, 1991, J BIOL CHEM, V266, P18674; Miranda MRM, 2009, BIOPHYS J, V96, P1471, DOI 10.1016/j.bpj.2008.11.026; Mori A, 2013, CHEM PHYS, V419, P23, DOI 10.1016/j.chemphys.2012.11.020; Murugapiran S. K., 2013, GENOME ANNOUNC, V1; OESTERHELT D, 1973, EUR J BIOCHEM, V40, P453, DOI 10.1111/j.1432-1033.1973.tb03214.x; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; Petrovskaya LE, 2010, FEBS LETT, V584, P4193, DOI 10.1016/j.febslet.2010.09.005; Sharma AK, 2008, ENVIRON MICROBIOL, V10, P1039, DOI 10.1111/j.1462-2920.2007.01525.x; Sharma AK, 2006, TRENDS MICROBIOL, V14, P463, DOI 10.1016/j.tim.2006.09.006; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 2001, BBA-BIOMEMBRANES, V1515, P92, DOI 10.1016/S0005-2736(01)00394-7; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Spudich JL, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P1, DOI 10.1002/352760510X.ch1; Sudo Y, 2003, PHOTOCHEM PHOTOBIOL, V78, P511, DOI 10.1562/0031-8655(2003)078<0511:IONPPS>2.0.CO;2; Sudo Y, 2001, PHOTOCHEM PHOTOBIOL, V74, P489, DOI 10.1562/0031-8655(2001)074<0489:PPBTIC>2.0.CO;2; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2013, J BIOL CHEM, V288, P20624, DOI 10.1074/jbc.M113.475533; Sudo Y, 2011, J BIOL CHEM, V286, P11328, DOI 10.1074/jbc.M110.187948; Sudo Y, 2011, J BIOL CHEM, V286, P5967, DOI 10.1074/jbc.M110.190058; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P10136, DOI 10.1021/bi901338d; Tamogami J, 2012, BIOCHEMISTRY-US, V51, P9290, DOI 10.1021/bi300940p; Tsukamoto T, 2013, FEBS LETT, V587, P322, DOI 10.1016/j.febslet.2012.12.022; YAN B, 1991, BIOCHEMISTRY-US, V30, P10686, DOI 10.1021/bi00108a012; Yoshitsugu M, 2008, ANGEW CHEM INT EDIT, V47, P3923, DOI 10.1002/anie.200705989; Yoshizawa S, 2012, ENVIRON MICROBIOL, V14, P1240, DOI 10.1111/j.1462-2920.2012.02702.x	48	41	42	1	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21581	21592		10.1074/jbc.M113.479394	http://dx.doi.org/10.1074/jbc.M113.479394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23740255	Green Published, hybrid			2022-12-28	WOS:000328841900011
J	Ruan, GX; Kazlauskas, A				Ruan, Guo-Xiang; Kazlauskas, Andrius			Lactate Engages Receptor Tyrosine Kinases Axl, Tie2, and Vascular Endothelial Growth Factor Receptor 2 to Activate Phosphoinositide 3-Kinase/Akt and Promote Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; DEPENDENT ACTIVATION; EXPRESSION; METABOLISM; HYPOXIA; METASTASES; RESISTANCE; SURVIVAL; PREDICT; TUMORS	Although a high level of lactate is quintessential to both tumors and wound healing, the manner by which lactate impacts endothelial cells to promote angiogenesis and thereby create or restore vascular perfusion to growing tissues has not been fully elucidated. Here we report that lactate activated the PI3K/Akt pathway in primary human endothelial cells. Furthermore, activating this signaling pathway was required for lactate-stimulated organization of endothelial cells into tubes and for sprouting of vessels from mouse aortic explants. Lactate engaged the PI3K/Akt pathway via ligand-mediated activation of the three receptor tyrosine kinases Axl, Tie2, and VEGF receptor 2. Neutralizing the ligands for these receptor tyrosine kinases, pharmacologically inhibiting their kinase activity or suppressing their expression largely eliminated the ability of cells and explants to respond to lactate. Elucidating the mechanism by which lactate communicates with endothelial cells presents a previously unappreciated opportunity to improve our understanding of the angiogenic program and to govern it.	[Ruan, Guo-Xiang; Kazlauskas, Andrius] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Kazlauskas, A (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	andrius_kazlauskas@meei.harvard.edu			National Institutes of Health [EY018344]; Juvenile Diabetes Research Foundation Advanced Postdoctoral Fellowship [102011367]; NATIONAL EYE INSTITUTE [R01EY018344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation Advanced Postdoctoral Fellowship(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY018344 (to A. K.). This work was also supported by Juvenile Diabetes Research Foundation Advanced Postdoctoral Fellowship 102011367 (to G. X. R.).	Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Beckert S, 2006, WOUND REPAIR REGEN, V14, P321, DOI 10.1111/j.1743-6109.2006.00127.x; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Brizel DM, 2001, INT J RADIAT ONCOL, V51, P349, DOI 10.1016/S0360-3016(01)01630-3; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Constant JS, 2000, WOUND REPAIR REGEN, V8, P353, DOI 10.1046/j.1524-475x.2000.00353.x; De Saedeleer CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046571; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; HUNT TK, 1978, AM J SURG, V135, P328, DOI 10.1016/0002-9610(78)90061-2; Im E, 2005, MOL BIOL CELL, V16, P3488, DOI 10.1091/mbc.E04-11-1029; Im E, 2010, MOL CELL BIOL, V30, P2401, DOI 10.1128/MCB.01275-09; JENSEN JA, 1986, LAB INVEST, V54, P574; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Klinghoffer RA, 1996, MOL CELL BIOL, V16, P5905; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kontos CD, 1998, MOL CELL BIOL, V18, P4131, DOI 10.1128/MCB.18.7.4131; Kumar VBS, 2007, J CELL PHYSIOL, V211, P477, DOI 10.1002/jcp.20955; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lu HS, 2005, J BIOL CHEM, V280, P41928, DOI 10.1074/jbc.M508718200; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Martin V, 2008, HISTOL HISTOPATHOL, V23, P773, DOI 10.14670/HH-23.773; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; Naumov GN, 2008, APMIS, V116, P569, DOI 10.1111/j.1600-0463.2008.01213.x; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Peters KG, 1998, BRIT J CANCER, V77, P51, DOI 10.1038/bjc.1998.8; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Porporato PE, 2012, ANGIOGENESIS, V15, P581, DOI 10.1007/s10456-012-9282-0; Rahimi N, 1999, MOL BIOL CELL, V10, P3401, DOI 10.1091/mbc.10.10.3401; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; Ruan GX, 2011, EXP EYE RES, V93, P570, DOI 10.1016/j.exer.2010.06.016; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Sjostrand M, 2000, AM J PHYSIOL-ENDOC M, V279, pE1097, DOI 10.1152/ajpendo.2000.279.5.E1097; Sonveaux P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033418; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Stratmann A, 1998, AM J PATHOL, V153, P1459, DOI 10.1016/S0002-9440(10)65733-1; Ushio-Fukai M, 2007, ANTIOXID REDOX SIGN, V9, P731, DOI 10.1089/ars.2007.1556; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; Vegran F, 2011, CANCER RES, V71, P2550, DOI 10.1158/0008-5472.CAN-10-2828; Walenta S, 2000, CANCER RES, V60, P916; Walenta S, 1997, AM J PATHOL, V150, P409; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Willam C, 2000, CIRC RES, V87, P370; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567	51	112	115	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21161	21172		10.1074/jbc.M113.474619	http://dx.doi.org/10.1074/jbc.M113.474619			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754286	hybrid, Green Published			2022-12-28	WOS:000322014400036
J	Liu, HX; Stone, SL				Liu, Hongxia; Stone, Sophia L.			Cytoplasmic Degradation of the Arabidopsis Transcription Factor ABSCISIC ACID INSENSITIVE 5 Is Mediated by the RING-type E3 Ligase KEEP ON GOING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABI5; PROTEINS; GROWTH; GENE; UBIQUITINATION; LOCALIZATION; EXPRESSION; DIVERSITY; SIGNALS; BINDING	To mitigate the effects of environmental stress the abscisic acid (ABA)-responsive transcription factor ABI5 is required to delay growth of germinated seedlings. In the absence of stress, KEEP ON GOING(KEG) E3 is required to maintain low levels of ABI5. However, the mechanism underlying KEG-dependent turnover of ABI5 is not known. In addition, localization studies place KEG at the trans-Golgi network, whereas ABI5 is nuclear. Here we show that KEG interacts directly with ABI5 via its conserved C3 region. Interactions between KEG and ABI5 were observed in the cytoplasm and trans-Golgi network only when the RING domain of KEG was inactivated or when ABI5 was stabilized via mutations. Deletion of the C-terminal region of ABI5 or substituting lysine 344 for alanine (K344A) prohibited protein turnover. Furthermore, ABI5 is observed in the cytoplasm of Arabidopsis thaliana root cells when the K344A mutation is combined with the deletion of a nuclear localization signal. Other lysine mutations (K353A, K364A, and K376A) in conjunction with the nuclear localization signal deletion did not result in cytoplasmic accumulation of ABI5. Loss of lysine 344 did not affect the ability of ABI5 to promote ABA responses, which demonstrates that the mutant transcription factor is still functional. Based on the results, a model is suggested where KEG targets ABI5 for degradation in the cytoplasm, thus reducing nuclear accumulation of the transcription factor in the absence of ABA.	[Liu, Hongxia; Stone, Sophia L.] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada	Dalhousie University	Stone, SL (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4R2, Canada.	sophia.stone@dal.ca		Stone, Sophia/0000-0003-2140-6037	Natural Science and Engineering Research Council of Canada; Human Frontier Science Program Center Developmental Award	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Human Frontier Science Program Center Developmental Award	This work was supported in part by a Natural Science and Engineering Research Council of Canada grant and Human Frontier Science Program Center Developmental Award (to S.L.S.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bensmihen S, 2002, PLANT CELL, V14, P1391, DOI 10.1105/tpc.000869; Brocard IM, 2002, PLANT PHYSIOL, V129, P1533, DOI 10.1104/pp.005793; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Finkelstein R, 2005, PLANT MOL BIOL, V59, P253, DOI 10.1007/s11103-005-8767-2; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Gu YN, 2011, PLANT PHYSIOL, V155, P1827, DOI 10.1104/pp.110.171785; Hammond-Martel I, 2012, CELL SIGNAL, V24, P410, DOI 10.1016/j.cellsig.2011.10.009; Igarashi D, 2001, PLANT CELL, V13, P2483, DOI 10.1105/tpc.13.11.2483; Kim SY, 2002, PLANT PHYSIOL, V130, P688, DOI 10.1104/pp.003566; Kircher S, 1999, J CELL BIOL, V144, P201, DOI 10.1083/jcb.144.2.201; Lee J, 2010, ASIAN NURS RES, V4, P1, DOI 10.1016/S1976-1317(10)60001-1; Liu HX, 2011, PLANT SIGNAL BEHAV, V6, P344, DOI 10.4161/psb.6.3.13914; Liu HX, 2010, PLANT CELL, V22, P2630, DOI 10.1105/tpc.110.076075; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Lopez-Molina L, 2003, GENE DEV, V17, P410, DOI 10.1101/gad.1055803; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Lu Q, 2010, PLANT J, V61, P259, DOI 10.1111/j.1365-313X.2009.04048.x; Meier I, 2011, CURR OPIN PLANT BIOL, V14, P538, DOI 10.1016/j.pbi.2011.06.005; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Smalle J, 2003, PLANT CELL, V15, P965, DOI 10.1105/tpc.009217; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Strieter ER, 2012, ACS CHEM BIOL, V7, P52, DOI 10.1021/cb2004059; Suo Y, 2004, PROTOPLASMA, V224, P79, DOI 10.1007/s00709-004-0050-x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Wang F, 2009, PLANT CELL, V21, P2378, DOI 10.1105/tpc.108.065433	32	80	82	2	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20267	20279		10.1074/jbc.M113.465369	http://dx.doi.org/10.1074/jbc.M113.465369			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720747	hybrid, Green Published			2022-12-28	WOS:000321715100016
J	Quinlan, BD; Gardner, MR; Joshi, VR; Chiang, JJ; Farzan, M				Quinlan, Brian D.; Gardner, Matthew R.; Joshi, Vinita R.; Chiang, Jessica J.; Farzan, Michael			Direct Expression and Validation of Phage-selected Peptide Variants in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMBINATORIAL ANTIBODY LIBRARIES; RATIONAL DESIGN; DISPLAY; PROTEIN; NEUTRALIZATION; VIRUS; CD4; GLYCOPROTEIN; PREDICTION; FRAGMENTS	Phage display is a key technology for the identification and maturation of high affinity peptides, antibodies, and other proteins. However, limitations of bacterial expression restrict the range and sensitivity of assays that can be used to evaluate phage-selected variants. To address this problem, selected genes are typically transferred to mammalian expression vectors, a major rate-limiting step in the iterative improvement of peptides and proteins. Here we describe a system that combines phage display and efficient mammalian expression in a single vector, pDQ1. This system permits immediate expression of phage-selected genes as IgG1-Fc fusions in mammalian cells, facilitating the rapid, sensitive characterization of a large number of library outputs for their biochemical and functional properties. We demonstrate the utility of this system by improving the ability of a CD4-mimetic peptide to bind the HIV-1 envelope glycoprotein and neutralize HIV-1 entry. We further improved the potency of the resulting peptide, CD4mim6, by limiting its ability to induce the CD4-bound conformation of the envelope glycoprotein. Thus, CD4mim6 and its variants can be used to investigate the properties of the HIV-1 envelope glycoprotein, and pDQ1 can accelerate the discovery of new peptides and proteins through phage display.	[Quinlan, Brian D.; Gardner, Matthew R.; Joshi, Vinita R.; Farzan, Michael] Scripps Res Inst, Dept Infect Dis, Jupiter, FL 33458 USA; [Quinlan, Brian D.; Gardner, Matthew R.; Chiang, Jessica J.] Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Immunobiol, Southborough, MA 01772 USA	Scripps Research Institute; Harvard University	Quinlan, BD (corresponding author), Scripps Res Inst, Dept Infect Dis, 130 Scripps Way, Jupiter, FL 33458 USA.	bquinlan@scripps.edu; mfarzan@scripps.edu		Farzan, Michael/0000-0002-2990-5319; Joshi, Vinita/0000-0002-3032-137X; Gardner, Matthew/0000-0003-2872-7597	National Institutes of Health through the NIAID [R01 AI080324, P01 AI100263]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100263, R01AI091476, R01AI080324] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI080324 and P01 AI100263 through the NIAID (to M. F.).	BARBAS CF, 1991, P NATL ACAD SCI USA, V88, P7978, DOI 10.1073/pnas.88.18.7978; Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Dorfman T, 2006, J BIOL CHEM, V281, P28529, DOI 10.1074/jbc.M602732200; Hotzel I, 2011, PROTEIN ENG DES SEL, V24, P679, DOI 10.1093/protein/gzr039; Huang CC, 2005, STRUCTURE, V13, P755, DOI 10.1016/j.str.2005.03.006; Kwong JA, 2011, J VIROL, V85, P7563, DOI 10.1128/JVI.00630-11; Li B, 2009, J BIOL CHEM, V284, P35605, DOI 10.1074/jbc.M109.035170; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Martin L, 2003, NAT BIOTECHNOL, V21, P71, DOI 10.1038/nbt768; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; Rader C, 1997, CURR OPIN BIOTECH, V8, P503, DOI 10.1016/S0958-1669(97)80075-4; Ray K, 2001, CLIN EXP IMMUNOL, V125, P94, DOI 10.1046/j.1365-2249.2001.01515.x; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; SMITH GP, 1993, METHOD ENZYMOL, V217, P228; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Valadon P, 2006, P NATL ACAD SCI USA, V103, P407, DOI 10.1073/pnas.0506938103; Vita C, 1998, BIOPOLYMERS, V47, P93, DOI 10.1002/(SICI)1097-0282(1998)47:1<93::AID-BIP10>3.3.CO;2-B; ZETTLMEISSL G, 1990, DNA CELL BIOL, V9, P347, DOI 10.1089/dna.1990.9.347; Zhu H, 1999, NUCLEIC ACIDS RES, V27, P910, DOI 10.1093/nar/27.3.910; Zwick MB, 1998, ANAL BIOCHEM, V264, P87, DOI 10.1006/abio.1998.2793	26	9	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18803	18810		10.1074/jbc.M113.452839	http://dx.doi.org/10.1074/jbc.M113.452839			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23667257	Green Published, hybrid			2022-12-28	WOS:000321335800018
J	Rohira, AD; Chen, CY; Allen, JR; Johnson, DL				Rohira, Aarti D.; Chen, Chun-Yuan; Allen, Justin R.; Johnson, Deborah L.			Covalent Small Ubiquitin-like Modifier (SUMO) Modification of Maf1 Protein Controls RNA Polymerase III-dependent Transcription Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TATA-BINDING PROTEIN; NEGATIVE REGULATOR; CELL-PROLIFERATION; GENE-EXPRESSION; ONCOGENESIS	RNA polymerase (pol) III transcribes genes that determine biosynthetic capacity. Induction of these genes is required for oncogenic transformation. The transcriptional repressor, Maf1, plays a central role in the repression of these and other genes that promote oncogenesis. Our studies identify an important new role for SUMOylation in repressing RNA pol III-dependent transcription. We show that a key mechanism by which this occurs is through small ubiquitin-like modifier (SUMO) modification of Maf1 by both SUMO1 and SUMO2. Mutation of each lysine residue revealed that Lys-35 is the major SUMOylation site on Maf1 and that the deSUMOylase, SENP1, is responsible for controlling Maf1K35 SUMOylation. SUMOylation of Maf1 is unaffected by rapamycin inhibition of mammalian target of rapamycin (mTOR) and mTOR-dependent Maf1 phosphorylation. By preventing SUMOylation at Lys-35, Maf1 is impaired in its ability to both repress transcription and suppress colony growth. Although SUMOylation does not alter Maf1 subcellular localization, Maf1K35R is defective in its ability to associate with RNA pol III. This impairs Maf1 recruitment to tRNA gene promoters and its ability to facilitate the dissociation of RNA pol III from these promoters. These studies identify a novel role for SUMOylation in controlling Maf1 and RNA pol III-mediated transcription. Given the emerging roles of SENP1, Maf1, and RNA pol III transcription in oncogenesis, our studies support the idea that deSUMOylation of Maf1 and induction of its gene targets play a critical role in cancer development.	[Johnson, Deborah L.] Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90033 USA; [Johnson, Deborah L.] Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA	University of Southern California	Johnson, DL (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, 2011 Zonal Ave, Los Angeles, CA 90033 USA.	johnsond@usc.edu			National Institutes of Health [CA108614]; NATIONAL CANCER INSTITUTE [R01CA108614, R01CA074138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA108614 (to D. L. J.).	Bawa-Khalfe Tasneem, 2010, Genes Cancer, V1, P748; Boguta M, 2013, BBA-GENE REGUL MECH, V1829, P376, DOI 10.1016/j.bbagrm.2012.11.004; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Fromm JA, 2008, MOL CELL BIOL, V28, P6483, DOI 10.1128/MCB.00288-08; Han Y, 2010, J BIOL CHEM, V285, P12906, DOI 10.1074/jbc.M109.071431; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Johnson DL, 2008, SCIENCE, V320, P461, DOI 10.1126/science.1158680; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Johnson SAS, 2003, MOL CELL BIOL, V23, P3043, DOI 10.1128/MCB.23.9.3043-3051.2003; Kantidakis T, 2010, P NATL ACAD SCI USA, V107, P11823, DOI 10.1073/pnas.1005188107; Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200; Li X, 2008, CELL DEATH DIFFER, V15, P739, DOI 10.1038/sj.cdd.4402303; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; McDoniels-Silvers AL, 2002, CLIN CANCER RES, V8, P1127; Michels AA, 2010, MOL CELL BIOL, V30, P3749, DOI 10.1128/MCB.00319-10; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Pluta K, 2001, MOL CELL BIOL, V21, P5031, DOI 10.1128/MCB.21.15.5031-5040.2001; Sarge KD, 2011, INT REV CEL MOL BIO, V288, P167, DOI 10.1016/B978-0-12-386041-5.00004-2; Shor B, 2010, J BIOL CHEM, V285, P15380, DOI 10.1074/jbc.M109.071639; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002; Wang Q, 2013, ONCOGENE, V32, P2493, DOI 10.1038/onc.2012.250; Zhong SP, 2007, MOL CELL BIOL, V27, P54, DOI 10.1128/MCB.01365-06	25	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19288	19295		10.1074/jbc.M113.473744	http://dx.doi.org/10.1074/jbc.M113.473744			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23673667	Green Published, hybrid			2022-12-28	WOS:000321335800061
J	Soteriou, D; Iskender, B; Byron, A; Humphries, JD; Borg-Bartolo, S; Haddock, MC; Baxter, MA; Knight, D; Humphries, MJ; Kimber, SJ				Soteriou, Despina; Iskender, Banu; Byron, Adam; Humphries, Jonathan D.; Borg-Bartolo, Simon; Haddock, Marie-Claire; Baxter, Melissa A.; Knight, David; Humphries, Martin J.; Kimber, Susan J.			Comparative Proteomic Analysis of Supportive and Unsupportive Extracellular Matrix Substrates for Human Embryonic Stem Cell Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; PROTEIN-INTERACTION NETWORKS; TERM SELF-RENEWAL; MASS-SPECTROMETRY; CONDITIONED MEDIA; FEEDER LAYERS; TGF-BETA; RECOMBINANT VITRONECTIN; SHOTGUN PROTEOMICS; CULTURE-CONDITIONS	Human embryonic stem cells (hESCs) are pluripotent cells that have indefinite replicative potential and the ability to differentiate into derivatives of all three germ layers. hESCs are conventionally grown on mitotically inactivated mouse embryonic fibroblasts (MEFs) or feeder cells of human origin. In addition, feeder-free culture systems can be used to support hESCs, in which the adhesive substrate plays a key role in the regulation of stem cell self-renewal or differentiation. Extracellular matrix (ECM) components define the microenvironment of the niche for many types of stem cells, but their role in the maintenance of hESCs remains poorly understood. We used a proteomic approach to characterize in detail the composition and interaction networks of ECMs that support the growth of self-renewing hESCs. Whereas many ECM components were produced by supportive and unsupportive MEF and human placental stromal fibroblast feeder cells, some proteins were only expressed in supportive ECM, suggestive of a role in the maintenance of pluripotency. We show that identified candidate molecules can support attachment and self-renewal of hESCs alone (fibrillin-1) or in combination with fibronectin (perlecan, fibulin-2), in the absence of feeder cells. Together, these data highlight the importance of specific ECM interactions in the regulation of hESC phenotype and provide a resource for future studies of hESC self-renewal.	[Soteriou, Despina; Iskender, Banu; Borg-Bartolo, Simon; Haddock, Marie-Claire; Baxter, Melissa A.; Kimber, Susan J.] Univ Manchester, Fac Life Sci, North West Embryon Stem Cell Ctr, Manchester M13 9NT, Lancs, England; [Byron, Adam; Humphries, Jonathan D.; Humphries, Martin J.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9NT, Lancs, England; [Knight, David] Univ Manchester, Fac Life Sci, Biol Mass Spectrometry Core Facil, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Kimber, SJ (corresponding author), Univ Manchester, Fac Life Sci, North West Embryon Stem Cell Ctr, Manchester M13 9NT, Lancs, England.	sue.kimber@manchester.ac.uk	Byron, Adam/C-4871-2008; iskender, banu/ABB-8185-2021; Byron, Adam/AID-5111-2022; Humphries, Jonathan D./AAE-7760-2022	Byron, Adam/0000-0002-5939-9883; iskender, banu/0000-0001-7122-1589; Humphries, Jonathan D./0000-0002-8953-7079; Knight, David/0000-0001-8895-8560; Humphries, Martin/0000-0002-4331-6967; Kimber, Susan/0000-0002-0568-6342; Borg-Bartolo, Simon/0000-0002-6968-9518	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D014638/1]; Northwest Regional Development Agency; Wellcome Trust [045225, 074941]; BBSRC; Republic of Turkey Ministry of National Education; University of Manchester; Biotechnology and Biological Sciences Research Council [BB/D014638/1, BB/J021636/1, BB/D014530/1] Funding Source: researchfish; Medical Research Council [G0300484, G0801057, G0700092] Funding Source: researchfish; Wellbeing of Women [RG1442] Funding Source: researchfish; BBSRC [BB/D014638/1, BB/D014530/1, BB/J021636/1] Funding Source: UKRI; MRC [G0700092, G0801057, G0300484] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Northwest Regional Development Agency; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Republic of Turkey Ministry of National Education(Ministry of National Education - Turkey); University of Manchester; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellbeing of Women(Wellbeing of Women (WoW)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/D014638/1 (to S. J. K.), a grant from the Northwest Regional Development Agency (to S. J. K.), Wellcome Trust Grants 045225 and 074941 (to M. J. H.), a BBSRC Ph.D. studentship (to D. S.), and a Republic of Turkey Ministry of National Education Ph.D. scholarship (to B. I.). The mass spectrometer used in this study was purchased with grants from the BBSRC, Wellcome Trust, and the University of Manchester Strategic Fund.	Abraham S, 2010, ACTA BIOMATER, V6, P4622, DOI 10.1016/j.actbio.2010.07.029; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Baxter MA, 2009, STEM CELL RES, V3, P28, DOI 10.1016/j.scr.2009.03.002; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Byron A, 2011, SCI SIGNAL 2, V4; Byron A, 2013, INT J EXP PATHOL, V94, P75, DOI 10.1111/iep.12011; Cain SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048634; Camarasa MV, 2010, IN VITRO CELL DEV-AN, V46, P386, DOI 10.1007/s11626-010-9291-5; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Chautard E, 2009, BIOINFORMATICS, V25, P690, DOI 10.1093/bioinformatics/btp025; Chin ACP, 2007, J BIOTECHNOL, V130, P320, DOI 10.1016/j.jbiotec.2007.04.013; Darabi R, 2008, CELL CYCLE, V7, P1732, DOI 10.4161/cc.7.12.6159; Faye C, 2009, J BIOL CHEM, V284, P22029, DOI 10.1074/jbc.M109.002840; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Harkness L, 2008, STEM CELL RES, V1, P219, DOI 10.1016/j.scr.2008.06.001; Hongisto H, 2012, STEM CELL RES, V8, P97, DOI 10.1016/j.scr.2011.08.005; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes C, 2012, MOL CELL PROTEOMICS, V11, P1924, DOI 10.1074/mcp.M112.020057; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Hunt GC, 2012, EXP CELL RES, V318, P1820, DOI 10.1016/j.yexcr.2012.06.009; Hyslop Louise A., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009804; Intoh A, 2009, PROTEOMICS, V9, P126, DOI 10.1002/pmic.200800496; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Klim JR, 2010, NAT METHODS, V7, P989, DOI 10.1038/NMETH.1532; Klimanskaya I, 2005, LANCET, V365, P1636, DOI 10.1016/S0140-6736(05)66473-2; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lim JWE, 2002, PROTEOMICS, V2, P1187, DOI 10.1002/1615-9861(200209)2:9<1187::AID-PROT1187>3.0.CO;2-T; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu N, 2007, J CELL PHYSIOL, V211, P279, DOI 10.1002/jcp.20978; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; McKay TR, 2011, STEM CELL RES, V7, P154, DOI 10.1016/j.scr.2011.04.005; McQuade LR, 2009, J PROTEOME RES, V8, P5642, DOI 10.1021/pr900597s; Miyazaki T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2231; Montes R, 2009, CELL RES, V19, P698, DOI 10.1038/cr.2009.35; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Park JH, 2003, BIOL REPROD, V69, P2007, DOI 10.1095/biolreprod.103.017467; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prowse ABJ, 2005, PROTEOMICS, V5, P978, DOI 10.1002/pmic.200401087; Prowse ABJ, 2007, J PROTEOME RES, V6, P3796, DOI 10.1021/pr0702262; Prowse ABJ, 2010, BIOMATERIALS, V31, P8281, DOI 10.1016/j.biomaterials.2010.07.037; Richards M, 2003, STEM CELLS, V21, P546, DOI 10.1634/stemcells.21-5-546; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Sakaki-Yumoto M, 2013, BBA-GEN SUBJECTS, V1830, P2280, DOI 10.1016/j.bbagen.2012.08.008; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Seebacher J, 2011, CELL, V144, P1000, DOI 10.1016/j.cell.2011.02.025; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616; Stojkovic P, 2005, STEM CELLS, V23, P306, DOI 10.1634/stemcells.2004-0137; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Unwin RD, 2003, EXP HEMATOL, V31, P1147, DOI 10.1016/j.exphem.2003.08.012; Van Hoof D, 2008, STEM CELL RES, V1, P169, DOI 10.1016/j.scr.2008.05.003; VIGNY M, 1988, J CELL PHYSIOL, V137, P321, DOI 10.1002/jcp.1041370216; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Wang GW, 2005, BIOCHEM BIOPH RES CO, V330, P934, DOI 10.1016/j.bbrc.2005.03.058; Wilson R, 2010, MOL CELL PROTEOMICS, V9, P1296, DOI 10.1074/mcp.M000014-MCP201; Wu JM, 2009, NAT METHODS, V6, P75, DOI [10.1038/nmeth.1282, 10.1038/NMETH.1282]; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zybailov B, 2005, ANAL CHEM, V77, P6218, DOI 10.1021/ac050846r	79	41	42	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18716	18731		10.1074/jbc.M113.463372	http://dx.doi.org/10.1074/jbc.M113.463372			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658023	Green Published, hybrid			2022-12-28	WOS:000321335800008
J	Yao, JH; Liu, XK; Sakuno, T; Li, WZ; Xi, YX; Aravamudhan, P; Joglekar, A; Li, W; Watanabe, Y; He, XW				Yao, Jianhui; Liu, Xingkun; Sakuno, Takeshi; Li, Wenzhu; Xi, Yuanxin; Aravamudhan, Pavithra; Joglekar, Ajit; Li, Wei; Watanabe, Yoshinori; He, Xiangwei			Plasticity and Epigenetic Inheritance of Centromere-specific Histone H3 (CENP-A)-containing Nucleosome Positioning in the Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENP-A NUCLEOSOMES; CHROMOSOME SEGREGATION; HETEROCHROMATIN INTEGRITY; CHROMATIN; PROTEIN; KINETOCHORE; VPS75; RNAI; ORGANIZATION; MAINTENANCE	Nucleosomes containing the specific histone H3 variant CENP-A mark the centromere locus on each chromatin and initiate kinetochore assembly. For the common type of regional centromeres, little is known in molecular detail of centromeric chromatin organization, its propagation through cell division, and how distinct organization patterns may facilitate kinetochore assembly. Here, we show that in the fission yeast S. pombe, a relatively small number of CENP-A/Cnp1 nucleosomes are found within the centromeric core and that their positioning relative to underlying DNA varies among genetically homogenous cells. Consistent with the flexible positioning of Cnp1 nucleosomes, a large portion of the endogenous centromere is dispensable for its essential activity in mediating chromosome segregation. We present biochemical evidence that Cnp1 occupancy directly correlates with silencing of the underlying reporter genes. Furthermore, using a newly developed pedigree analysis assay, we demonstrated the epigenetic inheritance of Cnp1 positioning and quantified the rate of occasional repositioning of Cnp1 nucleosomes throughout cell generations. Together, our results reveal the plasticity and the epigenetically inheritable nature of centromeric chromatin organization.	[Yao, Jianhui; Liu, Xingkun; Li, Wenzhu; He, Xiangwei] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA; [Xi, Yuanxin; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sakuno, Takeshi; Watanabe, Yoshinori] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Chromosome Dynam, Tokyo 1130032, Japan; [Aravamudhan, Pavithra; Joglekar, Ajit] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Tokyo; University of Michigan System; University of Michigan	He, XW (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza T926, Houston, TX 77030 USA.	xhe@bcm.edu	Sakuno, Takeshi/Y-9478-2019; Yao, Jianhui/D-1952-2014	Joglekar, Ajit/0000-0002-0607-5332; Li, Wei/0000-0001-9931-5990; Watanabe, Yoshinori/0000-0002-5488-4812	National Institutes of Health [GM068676]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068676] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21000010] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant GM068676 (to X. H.). This work was also supported by a Grant-in-Aid for Specially Promoted Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to Y.W.).	ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Black BE, 2008, CURR OPIN CELL BIOL, V20, P91, DOI 10.1016/j.ceb.2007.11.007; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Buscaino A, 2010, CURR OPIN GENET DEV, V20, P118, DOI 10.1016/j.gde.2010.01.006; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Castillo AG, 2007, PLOS GENET, V3, P1264, DOI 10.1371/journal.pgen.0030121; Choi ES, 2011, J BIOL CHEM, V286, P23600, DOI 10.1074/jbc.M111.228510; Coffman VC, 2011, J CELL BIOL, V195, P563, DOI 10.1083/jcb.201106078; Dohke K, 2008, GENES CELLS, V13, P1027, DOI 10.1111/j.1365-2443.2008.01225.x; Dunleavy EM, 2007, MOL CELL, V28, P1029, DOI 10.1016/j.molcel.2007.10.010; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Gassmann R, 2012, NATURE, V484, P534, DOI 10.1038/nature10973; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Ishii K, 2008, SCIENCE, V321, P1088, DOI 10.1126/science.1158699; Ishii K, 2009, CURR OPIN MICROBIOL, V12, P616, DOI 10.1016/j.mib.2009.09.007; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Ketel C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000400; Lando D, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120078; Lawrimore J, 2011, J CELL BIOL, V195, P573, DOI 10.1083/jcb.201106036; Mellone BG, 2009, BIOCHEM CELL BIOL, V87, P255, DOI 10.1139/O08-121; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nechemia-Arbely Y, 2012, EXP CELL RES, V318, P1353, DOI 10.1016/j.yexcr.2012.04.007; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Przewloka MR, 2009, ANNU REV GENET, V43, P439, DOI 10.1146/annurev-genet-102108-134310; Ribeiro SA, 2010, P NATL ACAD SCI USA, V107, P10484, DOI 10.1073/pnas.1002325107; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Scott KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001099; Sekulic N, 2012, TRENDS BIOCHEM SCI, V37, P220, DOI 10.1016/j.tibs.2012.01.003; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Selth L, 2007, J BIOL CHEM, V282, P12358, DOI 10.1074/jbc.C700012200; Selth LA, 2009, MOL CELL BIOL, V29, P4220, DOI 10.1128/MCB.01882-08; Song JS, 2008, GENOME RES, V18, P1064, DOI 10.1101/gr.075374.107; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Takayama Y, 2008, MOL BIOL CELL, V19, P682, DOI 10.1091/mbc.E07-05-0504; Torras-Llort M, 2009, EMBO J, V28, P2337, DOI 10.1038/emboj.2009.174; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107	56	13	13	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19184	19196		10.1074/jbc.M113.471276	http://dx.doi.org/10.1074/jbc.M113.471276			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23661703	Green Published, hybrid			2022-12-28	WOS:000321335800052
J	Fujiwara, Y; Takeshita, K; Nakagawa, A; Okamura, Y				Fujiwara, Yuichiro; Takeshita, Kohei; Nakagawa, Atsushi; Okamura, Yasushi			Structural Characteristics of the Redox-sensing Coiled Coil in the Voltage-gated H+ Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON CHANNEL; 2 PORES; PROTEIN; HV1; DOMAIN	Oxidation is an important biochemical defense mechanism, but it also elicits toxicity; therefore, oxidation must be under strict control. In phagocytotic events in neutrophils, the voltage-gated H+ (Hv) channel is a key regulator of the production of reactive oxygen species against invading bacteria. The cytoplasmic domain of the Hv channel forms a dimeric coiled coil underpinning a dimerized functional unit. Importantly, in the alignment of the coiled-coil core, a conserved cysteine residue forms a potential intersubunit disulfide bond. In this study, we solved the crystal structures of the coiled-coil domain in reduced, oxidized, and mutated (Cys -> Ser) states. The crystal structures indicate that a pair of Cys residues forms an intersubunit disulfide bond dependent on the redox conditions. CD spectroscopy revealed that the disulfide bond increases the thermal stability of the coiled-coil protein. We also reveal that two thiol modifier molecules are able to bind to Cys in a redox-dependent manner without disruption of the dimeric coiled-coil assembly. Thus, the biochemical properties of the cytoplasmic coiled-coil domain in the Hv channel depend on the redox condition, which may play a role in redox sensing in the phagosome.	[Fujiwara, Yuichiro; Takeshita, Kohei; Okamura, Yasushi] Osaka Univ, Grad Sch Med, Dept Physiol, Osaka 5650871, Japan; [Takeshita, Kohei; Nakagawa, Atsushi] Osaka Univ, Inst Prot Res, Res Ctr State Art Funct Prot Anal, Osaka 5650871, Japan; [Nakagawa, Atsushi; Okamura, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Fujiwara, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Physiol, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	fujiwara@phys2.med.osaka-u.ac.jp	Fujiwara, Yuichiro/GOP-2340-2022; Nakagawa, Atsushi/M-5731-2019; Nakagawa, Atsushi/D-4329-2009	Fujiwara, Yuichiro/0000-0002-9628-4073; Nakagawa, Atsushi/0000-0002-1700-7861; Nakagawa, Atsushi/0000-0002-1700-7861	KAKENHI; Hiroshi and Aya Irisawa Memorial Promotion Award for Young Physiologists; Grants-in-Aid for Scientific Research [25670108] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hiroshi and Aya Irisawa Memorial Promotion Award for Young Physiologists; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI grants-in-aid for scientific research (to Y. F. and Y. O.) and the Hiroshi and Aya Irisawa Memorial Promotion Award for Young Physiologists (to Y. F.).	Chakraborty S, 2010, J AM CHEM SOC, V132, P13240, DOI 10.1021/ja101812c; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Devasagayam T P A, 2004, J Assoc Physicians India, V52, P794; El Chemaly A, 2012, MOL CELL ENDOCRINOL, V353, P82, DOI 10.1016/j.mce.2011.10.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujiwara Y, 2013, J PHYSIOL-LONDON, V591, P627, DOI 10.1113/jphysiol.2012.243006; Fujiwara Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1823; Gonzalez C, 2010, NAT STRUCT MOL BIOL, V17, P51, DOI 10.1038/nsmb.1739; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Li SJ, 2010, J BIOL CHEM, V285, P12047, DOI 10.1074/jbc.M109.040360; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sahinoglu Tulin, 1996, Methods (Orlando), V9, P628, DOI 10.1006/meth.1996.0069; Sakata S, 2010, P NATL ACAD SCI USA, V107, P2313, DOI 10.1073/pnas.0911868107; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Shinkai A, 2007, J MOL BIOL, V372, P1293, DOI 10.1016/j.jmb.2007.07.051; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Su B, 2008, CURR ALZHEIMER RES, V5, P525, DOI 10.2174/156720508786898451; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tombola F, 2010, NAT STRUCT MOL BIOL, V17, P44, DOI 10.1038/nsmb.1738; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; ZHOU NE, 1993, BIOCHEMISTRY-US, V32, P3178, DOI 10.1021/bi00063a033	28	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17968	17975		10.1074/jbc.M113.459024	http://dx.doi.org/10.1074/jbc.M113.459024			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23667254	Green Published, hybrid			2022-12-28	WOS:000320721900004
J	Kaan, HYK; Major, J; Tkocz, K; Kozielski, F; Rosenfeld, SS				Kaan, Hung Yi Kristal; Major, Jennifer; Tkocz, Katarzyna; Kozielski, Frank; Rosenfeld, Steven S.			"Snapshots" of Ispinesib-induced Conformational Changes in the Mitotic Kinesin Eg5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC INHIBITION; MONASTROL INHIBITION; CRYSTAL-STRUCTURE; SMALL-MOLECULE; NECK-LINKER; MOTOR; MODEL; MECHANISM; KINETICS; BINDING	Kinesins comprise a superfamily of molecular motors that drive a wide variety of cellular physiologies, from cytoplasmic transport to formation of the bipolar spindle in mitosis. These differing roles are reflected in corresponding polymorphisms in key kinesin structural elements. One of these is a unique loop and stem motif found in all kinesins and referred to as loop 5 (L5). This loop is longest in the mitotic kinesin Eg5 and is the target for a number of small molecule inhibitors, including ispinesib, which is being used in clinical trials in patients with cancer. In this study, we have used x-ray crystallography to identify a new structure of an Eg5-ispinesib complex and have combined this with transient state kinetics to identify a plausible sequence of conformational changes that occur in response to ispinesib binding. Our results demonstrate that ispinesib-induced structural changes in L5 from Eg5 lead to subsequent changes in the conformation of the switch II loop and helix and in the neck linker. We conclude that L5 in Eg5 simultaneously regulates the structure of both the ATP binding site and the motor's mechanical elements that generate force.	[Kaan, Hung Yi Kristal; Tkocz, Katarzyna; Kozielski, Frank] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Major, Jennifer; Rosenfeld, Steven S.] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Beatson Institute; Cleveland Clinic Foundation	Kozielski, F (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	f.kozielski@beatson.gla.ac.uk; rosenfs@ccf.org			National Institutes of Health [GM102875]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM102875 (to S. S. R.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Beer TM, 2008, CLIN GENITOURIN CANC, V6, P103, DOI 10.3816/CGC.2008.n.016; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Burris HA, 2011, INVEST NEW DRUG, V29, P467, DOI 10.1007/s10637-009-9374-x; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endow SA, 2010, J CELL SCI, V123, P3420, DOI 10.1242/jcs.064113; Garcia-Saez I, 2004, J MOL BIOL, V340, P1107, DOI 10.1016/j.jmb.2004.05.053; Goulet A, 2012, J BIOL CHEM, V287, P44654, DOI 10.1074/jbc.M112.404228; Kaan HYK, 2010, BIOCHEM J, V425, P55, DOI 10.1042/BJ20091207; Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108; Kwok BH, 2006, NAT CHEM BIOL, V2, P480, DOI 10.1038/nchembio812; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Maliga Z, 2006, J BIOL CHEM, V281, P7977, DOI 10.1074/jbc.M511955200; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Rosenfeld SS, 1996, J BIOL CHEM, V271, P9473, DOI 10.1074/jbc.271.16.9473; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Talapatra SK, 2012, ACTA CRYSTALLOGR D, V68, P1311, DOI 10.1107/S0907444912027965; Tcherniuk S, 2010, BIOCHEM PHARMACOL, V79, P864, DOI 10.1016/j.bcp.2009.11.001; TRYBUS KM, 1982, BIOCHEMISTRY-US, V21, P1284, DOI 10.1021/bi00535a028; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	33	24	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18588	18598		10.1074/jbc.M113.462648	http://dx.doi.org/10.1074/jbc.M113.462648			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23658017	Green Published, hybrid			2022-12-28	WOS:000320721900058
J	Kline, ER; Shupe, J; Gilbert-Ross, M; Zhou, W; Marcus, AI				Kline, Erik R.; Shupe, John; Gilbert-Ross, Melissa; Zhou, Wei; Marcus, Adam I.			LKB1 Represses Focal Adhesion Kinase (FAK) Signaling via a FAK-LKB1 Complex to Regulate FAK Site Maturation and Directional Persistence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; CELL POLARITY; LUNG-CANCER; TYROSINE PHOSPHORYLATION; TUMOR PROGRESSION; PROTEIN-KINASE; METASTASIS; MIGRATION; ACTIVATION; INVASION	Liver kinase beta 1 (LKB1, also known as STK11) is a serine/threonine kinase that has multiple cellular functions including the regulation of cell polarity and motility. Murine proteomic studies show that LKB1 loss causes aberrant adhesion signaling; however, the mechanistic underpinnings of this relationship are unknown. We show that cells stably depleted of LKB1 or its co-activator STRAD alpha have increased phosphorylation of focal adhesion kinase (FAK) at Tyr(397)/Tyr(861) and enhanced adhesion to fibronectin. LKB1 associates in a complex with FAK and LKB1 accumulation at the cellular leading edge is mutually excluded from regions of activated Tyr(397)-FAK. LKB1-compromised cells lack directional persistence compared with wildtype cells, but this is restored through subsequent pharmacological FAK inhibition or depletion, showing that cell directionality is mediated through LKB1-FAK signaling. Live cell confocal imaging reveals that LKB1-compromised cells lack normal FAK site maturation and turnover, suggesting that defects in adhesion and directional persistence are caused by aberrant adhesion dynamics. Furthermore, re-expression of full-length wildtype or the LKB1 N-terminal domain repressed FAK activity, whereas the kinase domain or C-terminal domain alone did not, indicating that FAK suppression is potentially regulated through the LKB1 N-terminal domain. Based upon these results, we conclude that LKB1 serves as a FAK repressor to stabilize focal adhesion sites, and when LKB1 function is compromised, aberrant FAK signaling ensues, resulting in rapid FAK site maturation and poor directional persistence.	[Kline, Erik R.; Shupe, John; Gilbert-Ross, Melissa; Zhou, Wei; Marcus, Adam I.] Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	Emory University	Marcus, AI (corresponding author), 1365-C Clifton Rd,Rm 4092-C, Atlanta, GA 30322 USA.	aimarcu@emory.edu		Gilbert-Ross, Melissa/0000-0002-1960-8302; Shupe, John/0000-0001-6011-557X	National Institutes of Health [1R01CA142858, PO1 Supplement 3PO1CA116676-05S2]; American Cancer Society Research Scholar Grant [RSG-08-035-01-CSM]; American Cancer Society Postdoctoral Training Grant [PF-11-125-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA142858, P01CA116676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Research Scholar Grant(American Cancer Society); American Cancer Society Postdoctoral Training Grant(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01CA142858 (to A. I. M.) and PO1 Supplement 3PO1CA116676-05S2 (to A. I. M. and W. Z.), American Cancer Society Research Scholar Grant RSG-08-035-01-CSM (to A. I. M.), and American Cancer Society Postdoctoral Training Grant PF-11-125-01-CSM (to E. R. K.).	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Bai XM, 2009, ONCOL REP, V21, P129, DOI 10.3892/or_00000199; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Brenman JE, 2007, CELL CYCLE, V6, P2755, DOI 10.4161/cc.6.22.4927; Calalb MB, 1996, BIOCHEM BIOPH RES CO, V228, P662, DOI 10.1006/bbrc.1996.1714; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Carretero J, 2010, CANCER CELL, V17, P547, DOI 10.1016/j.ccr.2010.04.026; Clasper S, 2008, CANCER RES, V68, P7293, DOI 10.1158/0008-5472.CAN-07-6506; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eggers CM, 2012, J BIOL CHEM, V287, P18758, DOI 10.1074/jbc.M111.316422; Engl T, 2006, NEOPLASIA, V8, P290, DOI 10.1593/neo.05694; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Feng Y, 2012, CANCER RES, V72, P6502, DOI 10.1158/0008-5472.CAN-12-1909; Fiorilli P, 2008, LAB INVEST, V88, P1143, DOI 10.1038/labinvest.2008.89; Forcet C, 2005, HUM MOL GENET, V14, P1283, DOI 10.1093/hmg/ddi139; Hamadi A, 2009, CELL MOL LIFE SCI, V66, P324, DOI 10.1007/s00018-008-8424-4; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Lim ST, 2010, J BIOL CHEM, V285, P21526, DOI 10.1074/jbc.M110.129999; Lim YM, 2004, J BIOL CHEM, V279, P29060, DOI 10.1074/jbc.M401183200; Marcus Adam I, 2007, Methods Mol Med, V137, P125, DOI 10.1007/978-1-59745-442-1_9; Marignani PA, 2001, J BIOL CHEM, V276, P32415, DOI 10.1074/jbc.C100207200; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Myers JP, 2012, J CELL SCI, V125, P2918, DOI 10.1242/jcs.100107; Nobumoto A, 2008, GLYCOBIOLOGY, V18, P735, DOI 10.1093/glycob/cwn062; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Raveh S, 2009, CANCER LETT, V282, P137, DOI 10.1016/j.canlet.2008.12.021; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schafer-Hales K, 2007, MOL CANCER THER, V6, P1317, DOI 10.1158/1535-7163.MCT-06-0703; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; SCHALLER MD, 1992, P NATL ACAD SCI USA, V89, P5192, DOI 10.1073/pnas.89.11.5192; Scheswohl Danielle M, 2008, J Mol Signal, V3, P1, DOI 10.1186/1750-2187-3-1; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; SCHLAEPFER DD, 1994, NATURE, V372, P786; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Slack-Davis JK, 2009, CANCER RES, V69, P1469, DOI 10.1158/0008-5472.CAN-08-2678; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Tang J, 2008, CELL MOL LIFE SCI, V65, P2933, DOI 10.1007/s00018-008-8315-8; Thaiparambil JT, 2012, MOL CELL BIOL, V32, P3203, DOI 10.1128/MCB.00418-12; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Xu XJ, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-77; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zhong DS, 2008, MOL CANCER THER, V7, P809, DOI 10.1158/1535-7163.MCT-07-0559	57	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17663	17674		10.1074/jbc.M112.444620	http://dx.doi.org/10.1074/jbc.M112.444620			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23637231	Green Published, hybrid			2022-12-28	WOS:000320380600057
J	Liu, MY; Liu, J; Mehrotra, D; Liu, YT; Guo, Y; Baldera-Aguayo, PA; Mooney, VL; Nour, AM; Yan, ECY				Liu, Monica Yun; Liu, Jian; Mehrotra, Devi; Liu, Yuting; Guo, Ying; Baldera-Aguayo, Pedro A.; Mooney, Victoria L.; Nour, Adel M.; Yan, Elsa C. Y.			Thermal Stability of Rhodopsin and Progression of Retinitis Pigmentosa COMPARISON OF S186W AND D190N RHODOPSIN MUTANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE RAMAN ANALYSIS; SCHIFF-BASE STABILITY; HYDROGEN-BOND NETWORK; HIGH-LEVEL EXPRESSION; MOLECULAR-MECHANISM; BOVINE RHODOPSIN; DARK NOISE; LIGHT; ACTIVATION; MUTATIONS	Over 100 point mutations in the rhodopsin gene have been associated with retinitis pigmentosa (RP), a family of inherited visual disorders. Among these, we focused on characterizing the S186W mutation. We compared the thermal properties of the S186W mutant with another RP-causing mutant, D190N, and with WT rhodopsin. To assess thermal stability, we measured the rate of two thermal reactions contributing to the thermal decay of rhodopsin as follows: thermal isomerization of 11-cis-retinal and hydrolysis of the protonated Schiff base linkage between the 11-cis-retinal chromophore and opsin protein. We used UV-visible spectroscopy and HPLC to examine the kinetics of these reactions at 37 and 55 degrees C for WT and mutant rhodopsin purified from HEK293 cells. Compared with WT rhodopsin and the D190N mutant, the S186W mutation dramatically increases the rates of both thermal isomerization and dark state hydrolysis of the Schiff base by 1-2 orders of magnitude. The results suggest that the S186W mutant thermally destabilizes rhodopsin by disrupting a hydrogen bond network at the receptor's active site. The decrease in the thermal stability of dark state rhodopsin is likely to be associated with higher levels of dark noise that undermine the sensitivity of rhodopsin, potentially accounting for night blindness in the early stages of RP. Further studies of the thermal stability of additional pathogenic rhodopsin mutations in conjunction with clinical studies are expected to provide insight into the molecular mechanism of RP and test the correlation between rhodopsin's thermal stability and RP progression in patients.	[Liu, Monica Yun; Mehrotra, Devi] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Liu, Jian; Liu, Yuting; Guo, Ying; Baldera-Aguayo, Pedro A.; Mooney, Victoria L.; Yan, Elsa C. Y.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Nour, Adel M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Yan, ECY (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.	elsa.yan@yale.edu		Liu, Monica Yun/0000-0003-3936-9377; Yan, Elsa/0000-0002-3583-1627; Baldera-Aguayo, Pedro/0000-0002-9457-3859	Yale College Dean's Research Fellowship; Yale-Howard Hughes Medical Institute International Research Fellowship; Research Experience for Peruvian Undergraduates research fellowship; Universidad Nacional de Ingenieria research fellowship; Patronato de la Universidad Nacional de Ingenieria research fellowship; Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica research fellowship; National Science Foundation Fellowship [DGE-0644492]; National Science Foundation CAREER Award [MCB-0955407]; Direct For Biological Sciences [0955407] Funding Source: National Science Foundation	Yale College Dean's Research Fellowship; Yale-Howard Hughes Medical Institute International Research Fellowship; Research Experience for Peruvian Undergraduates research fellowship; Universidad Nacional de Ingenieria research fellowship; Patronato de la Universidad Nacional de Ingenieria research fellowship; Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica research fellowship; National Science Foundation Fellowship(National Science Foundation (NSF)); National Science Foundation CAREER Award(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Recipient of the Yale College Dean's Research Fellowship.; Recipient of the Yale-Howard Hughes Medical Institute International Research Fellowship.; Recipient of the Research Experience for Peruvian Undergraduates, Universidad Nacional de Ingenieria, Patronato de la Universidad Nacional de Ingenieria, and Consejo Nacional de Ciencia, Tecnologia e Innovacion Tecnologica research fellowships.; Recipient of the National Science Foundation Fellowship DGE-0644492.; Recipient of National Science Foundation CAREER Award MCB-0955407. To whom correspondence should be addressed. Tel.: 203-436-2509; Fax: 203-432-6144; E-mail: elsa.yan@yale.edu.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; ASHMORE JF, 1977, NATURE, V270, P69, DOI 10.1038/270069a0; BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; Berson EL, 1996, P NATL ACAD SCI USA, V93, P4526, DOI 10.1073/pnas.93.10.4526; Bhatti MT, 2006, CURR NEUROL NEUROSCI, V6, P403, DOI 10.1007/s11910-996-0021-z; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; DAVIDSON FF, 1994, P NATL ACAD SCI USA, V91, P4029, DOI 10.1073/pnas.91.9.4029; DRYJA TP, 1993, NAT GENET, V4, P280, DOI 10.1038/ng0793-280; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611; FISHMAN GA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1582, DOI 10.1001/archopht.1992.01080230082026; FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152; Gleim S., 2008, VISUAL TRANSDUCTION, P171; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HUBBARD R, 1951, P NATL ACAD SCI USA, V37, P69, DOI 10.1073/pnas.37.2.69; HUG SJ, 1990, BIOCHEMISTRY-US, V29, P1475, DOI 10.1021/bi00458a019; Hwa J, 1999, P NATL ACAD SCI USA, V96, P1932, DOI 10.1073/pnas.96.5.1932; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Janz JM, 2003, VISION RES, V43, P2991, DOI 10.1016/j.visres.2003.08.010; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Kalloniatis Michael, 2004, Clin Exp Optom, V87, P65; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kennan A, 2005, TRENDS GENET, V21, P103, DOI 10.1016/j.tig.2004.12.001; KITO Y, 1968, NATURE, V218, P955, DOI 10.1038/218955a0; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu J, 2011, J BIOL CHEM, V286, P38408, DOI 10.1074/jbc.M111.280602; Liu J, 2011, J BIOL CHEM, V286, P27622, DOI 10.1074/jbc.M111.233312; Liu J, 2009, J AM CHEM SOC, V131, P8750, DOI 10.1021/ja903154u; Ludeke S, 2005, J MOL BIOL, V353, P345, DOI 10.1016/j.jmb.2005.08.039; Ludeke S, 2006, BIOPOLYMERS, V83, P159, DOI 10.1002/bip.20540; Luo DG, 2011, SCIENCE, V332, P1307, DOI 10.1126/science.1200172; Matias-Florentino M, 2009, CURR EYE RES, V34, P1050, DOI 10.3109/02713680903283169; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; MIN KC, 1993, J BIOL CHEM, V268, P9400; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; OZAKI K, 1986, VISION RES, V26, P691, DOI 10.1016/0042-6989(86)90083-0; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Pan DH, 2002, J AM CHEM SOC, V124, P4857, DOI 10.1021/ja012666e; PAPERMASTER DS, 1974, BIOCHEMISTRY-US, V13, P2438, DOI 10.1021/bi00708a031; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; RANDALL CE, 1991, J AM CHEM SOC, V113, P3473, DOI 10.1021/ja00009a037; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ridge KD, 2007, J BIOL CHEM, V282, P9297, DOI 10.1074/jbc.R600032200; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Ruther K., 1995, CLIN FEATURES AUTOSO, P303; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Sancho-Pelluz J, 2012, MOL MED, V18, P549, DOI 10.2119/molmed.2011.00475; Sandberg MN, 2011, J AM CHEM SOC, V133, P2808, DOI 10.1021/ja1094183; SCHOENLEIN RW, 1991, SCIENCE, V254, P412, DOI 10.1126/science.1925597; SHASTRY BS, 1994, AM J MED GENET, V52, P467, DOI 10.1002/ajmg.1320520413; Shintani K, 2009, OPTOMETRY, V80, P384, DOI 10.1016/j.optm.2008.01.026; Smith SO, 2010, ANNU REV BIOPHYS, V39, P309, DOI 10.1146/annurev-biophys-101209-104901; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Tsui I, 2008, CURR EYE RES, V33, P1014, DOI 10.1080/02713680802484645; WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189; Yan ECY, 2003, P NATL ACAD SCI USA, V100, P9262, DOI 10.1073/pnas.1531970100; Yan ECY, 2004, BIOCHEMISTRY-US, V43, P10867, DOI 10.1021/bi0400148; Yan ECY, 2002, BIOCHEMISTRY-US, V41, P3620, DOI 10.1021/bi0160011; Yan ECY, 2007, J PHYS CHEM C, V111, P8843, DOI 10.1021/jp067172o	74	21	21	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17698	17712		10.1074/jbc.M112.397257	http://dx.doi.org/10.1074/jbc.M112.397257			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625926	Green Published, hybrid			2022-12-28	WOS:000320380600060
J	Liberman, R; Cotter, K; Baleja, JD; Forgac, M				Liberman, Rachel; Cotter, Kristina; Baleja, James D.; Forgac, Michael			Structural Analysis of the N-terminal Domain of Subunit a of the Yeast Vacuolar ATPase (V-ATPase) Using Accessibility of Single Cysteine Substitutions to Chemical Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; SITE-DIRECTED MUTAGENESIS; H+-ATPASE; CRYSTAL-STRUCTURE; MUTATIONAL ANALYSIS; TRANSMEMBRANE SEGMENTS; MEMBRANE TOPOLOGY; 100-KDA SUBUNIT; VPH1P; IDENTIFICATION	The vacuolar ATPase (V-ATPase) is a multisubunit complex that carries out ATP-driven proton transport. It is composed of a peripheral V-1 domain that hydrolyzes ATP and an integral V-0 domain that translocates protons. Subunit a is a 100-kDa integral membrane protein (part of V-0) that possesses an N-terminal cytoplasmic domain and a C-terminal hydrophobic domain. Although the C-terminal domain functions in proton transport, the N-terminal domain is critical for intracellular targeting and regulation of V-ATPase assembly. Despite its importance, there is currently no high resolution structure for subunit a of the V-ATPase. Recently, the crystal structure of the N-terminal domain of the related subunit I from the archaebacterium Meiothermus ruber was reported. We have used homology modeling to construct a model of the N-terminal domain of Vph1p, one of two isoforms of subunit a expressed in yeast. To test this model, unique cysteine residues were introduced into a Cys-less form of Vph1p and their accessibility to modification by the sulfhydryl reagent 3-(N-maleimido-propionyl) biocytin (MPB) was determined. In addition, accessibility of introduced cysteine residues to MPB modification was compared in the V1V0 complex and the free V-0 domain to identify residues protected from modification by the presence of V-1. The results provide an experimental test of the proposed model and have identified regions of the N-terminal domain of subunit a that likely serve as interfacial contact sites with the peripheral V-1 domain. The possible significance of these results for in vivo regulation of V-ATPase assembly is discussed.	[Liberman, Rachel; Cotter, Kristina; Forgac, Michael] Tufts Univ, Dept Mol Physiol & Pharmacol, Sch Med, Boston, MA 02111 USA; [Baleja, James D.] Tufts Univ, Dept Biochem, Sch Med, Boston, MA 02111 USA; [Liberman, Rachel; Cotter, Kristina; Forgac, Michael] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cellular & Mol Physiol, Boston, MA 02111 USA; [Baleja, James D.; Forgac, Michael] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Biochem, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University; Tufts University	Forgac, M (corresponding author), Tufts Univ, Dept Mol Physiol & Pharmacol, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM34478]; Tufts University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034478, R01GM034478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by in part National Institutes of Health Grant GM34478 (to M. F.).; Supported in part by a Sackler Dean's Fellow award from Tufts University.	BAYER EA, 1985, ANAL BIOCHEM, V149, P529, DOI 10.1016/0003-2697(85)90609-8; Benlekbir S, 2012, NAT STRUCT MOL BIOL, V19, P1356, DOI 10.1038/nsmb.2422; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Cain BD, 2000, J BIOENERG BIOMEMBR, V32, P365, DOI 10.1023/A:1005575919638; Cross RL, 2004, FEBS LETT, V576, P1, DOI 10.1016/j.febslet.2004.08.065; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Diakov Theodore T, 2010, J Biol Chem, V285, P23771, DOI 10.1074/jbc.M110.110122; Dip PV, 2012, J BIOENERG BIOMEMBR, V44, P341, DOI 10.1007/s10863-012-9442-3; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; FENG Y, 1992, J BIOL CHEM, V267, P5817; Fillingame RH, 2002, BBA-BIOENERGETICS, V1555, P29, DOI 10.1016/S0005-2728(02)00250-5; Finnigan GC, 2012, J BIOL CHEM, V287, P19487, DOI 10.1074/jbc.M112.343814; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Hosokawa H, 2013, J BIOL CHEM, V288, P5896, DOI 10.1074/jbc.M112.409169; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; KANE PM, 1995, J BIOL CHEM, V270, P17025; KANE PM, 1992, J BIOL CHEM, V267, P447; Kawasaki-Nishi S, 2003, J BIOL CHEM, V278, P41908, DOI 10.1074/jbc.M308026200; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487; Leng XH, 1999, J BIOL CHEM, V274, P14655, DOI 10.1074/jbc.274.21.14655; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Liu Q, 1997, J BIOL CHEM, V272, P11750, DOI 10.1074/jbc.272.18.11750; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Owegi MA, 2006, J BIOL CHEM, V281, P30001, DOI 10.1074/jbc.M605006200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Parsons LS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046960; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Qin A, 2012, INT J BIOCHEM CELL B, V44, P1422, DOI 10.1016/j.biocel.2012.05.014; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Shao E, 2003, J BIOL CHEM, V278, P12985, DOI 10.1074/jbc.M212096200; Shum WWC, 2009, J EXP BIOL, V212, P1753, DOI 10.1242/jeb.027284; Srinivasan S, 2011, J MOL BIOL, V412, P14, DOI 10.1016/j.jmb.2011.07.014; Toei M, 2011, J BIOL CHEM, V286, P35176, DOI 10.1074/jbc.M111.273409; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; VIK SB, 1994, J BIOL CHEM, V269, P30364; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200	58	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22798	22808		10.1074/jbc.M113.460295	http://dx.doi.org/10.1074/jbc.M113.460295			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23740254	hybrid, Green Published			2022-12-28	WOS:000330596300057
J	Ross, JS; Hu, W; Rosen, B; Snider, AJ; Obeid, LM; Cowart, LA				Ross, Jessica S.; Hu, Wei; Rosen, Bess; Snider, Ashley J.; Obeid, Lina M.; Cowart, L. Ashley			Sphingosine Kinase 1 Is Regulated by Peroxisome Proliferator-activated Receptor alpha in Response to Free Fatty Acids and Is Essential for Skeletal Muscle Interleukin-6 Production and Signaling in Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; INDUCED INSULIN-RESISTANCE; MYOGENIC DIFFERENTIATION; CERAMIDE BIOSYNTHESIS; ADIPOSE-TISSUE; DEPENDENT ACTIVATION; GENE-EXPRESSION; DOWN-REGULATION; CELL-GROWTH; PPAR-ALPHA	We previously demonstrated that sphingosine kinase 1 (Sphk1) expression and activity are up-regulated by exogenous palmitate (PAL) in a skeletal muscle model system and in diet-induced obesity in mice; however, potential functions and in vivo relevance of this have not been addressed. Here, we aimed to determine the mechanism by which PAL regulates SphK1 in muscle, and to determine potential roles for its product, sphingosine-1-phosphate (S1P), in muscle biology in the context of obesity. Cloning and analysis of the mouse Sphk1 promoter revealed a peroxisome proliferator-activated receptor (PPAR) alpha cis-element that mediated activation of a reporter under control of the Sphk1 promoter; direct interaction of PPAR alpha was demonstrated by chromatin immunoprecipitation. PAL treatment induced the proinflammatory cytokine interleukin (IL)-6 in a manner dependent on SphK1, and this was attenuated by inhibition of the sphingosine-1-phosphate receptor 3 (S1PR3). Diet-induced obesity in mice demonstrated that IL-6 expression in muscle, but not adipose tissue, increased in obesity, but this was attenuated in Sphk1(-/-)mice. Moreover, plasma IL-6 levels were significantly decreased in obese Sphk1(-/-) mice relative to obese wild type mice, and muscle, but not adipose tissue IL-6 signaling was activated. These data indicate that PPAR alpha regulates Sphk1 expression in the context of fatty acid oversupply and links PAL to muscle IL-6 production. Moreover, this function of SphK1 in diet-induced obesity suggests a potential role for SphK1 in obesity-associated pathological outcomes.	[Ross, Jessica S.; Hu, Wei; Cowart, L. Ashley] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Ross, Jessica S.] Med Univ S Carolina, Dept Mol & Cellular Biol, Charleston, SC 29425 USA; [Ross, Jessica S.] Med Univ S Carolina, Pathobiol Program, Charleston, SC 29425 USA; [Snider, Ashley J.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Rosen, Bess] Boston Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02118 USA; [Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11790 USA; [Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northpoint, NY 11768 USA; [Snider, Ashley J.; Cowart, L. Ashley] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Cowart, LA (corresponding author), Med Univ S Carolina, Ralph H Johnson Vet Affairs Med Ctr, Dept Biochem & Mol Biol, 173 Ashley Ave,MSC509, Charleston, SC 29425 USA.	cowartl@musc.edu		obeid, lina/0000-0002-0734-0847	National Institutes of Health COBREaward [P20 RR017677]; Veterans Affairs Merit award; GAANN fellowship in Lipidomics and Systems Biology; Office of the Director of the National Institutes of Health [C06 RR018823]; National Center for Research Resources; Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina Grant [P30 CA138313]; Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE Grant [P20 RR017677]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823, P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072643] Funding Source: NIH RePORTER	National Institutes of Health COBREaward(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit award(US Department of Veterans Affairs); GAANN fellowship in Lipidomics and Systems Biology; Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina Grant; Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health COBREaward P20 RR017677 (to L. A. C.), a Veterans Affairs Merit award, and a GAANN fellowship in Lipidomics and Systems Biology (to J. S. R.). Lipidomic analysis was performed by the Medical University of South Carolina Lipidomic Core supported by the National Center for Research Resources and the Office of the Director of the National Institutes of Health through Grant C06 RR018823. Research was supported in part by the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina Grant P30 CA138313, and the Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE Grant P20 RR017677.	AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; Anelli V, 2008, J BIOL CHEM, V283, P3365, DOI 10.1074/jbc.M708241200; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Benamer N, 2011, BIOCHEM BIOPH RES CO, V408, P6, DOI 10.1016/j.bbrc.2011.03.072; Betanzos-Cabrera G, 2012, NUTR HOSP, V27, P1196, DOI 10.3305/nh.2012.27.4.5842; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bruni P, 2008, CELL MOL LIFE SCI, V65, P3725, DOI 10.1007/s00018-008-8236-6; Cammarota R, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-112; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chavez JA, 2005, J BIOL CHEM, V280, P20148, DOI 10.1074/jbc.M412769200; Coll T, 2010, ENDOCRINOLOGY, V151, P537, DOI 10.1210/en.2009-0874; Cowart LA, 2009, TRENDS ENDOCRIN MET, V20, P34, DOI 10.1016/j.tem.2008.09.004; DeOliveira CC, 2012, MOL CELL ENDOCRINOL, V361, P92, DOI 10.1016/j.mce.2012.03.016; Djouadi F, 2005, J CLIN ENDOCR METAB, V90, P1791, DOI 10.1210/jc.2004-1936; Drastich P, 2011, FOLIA MICROBIOL, V56, P185, DOI 10.1007/s12223-011-0018-0; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Fernandez-Real JM, 2003, ENDOCR REV, V24, P278, DOI 10.1210/er.2002-0010; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Forman BM, 1996, ANN NY ACAD SCI, V804, P266, DOI 10.1111/j.1749-6632.1996.tb18621.x; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Green CJ, 2011, BIOCHEM J, V435, P463, DOI 10.1042/BJ20101517; Gurgui M, 2010, CELL SIGNAL, V22, P1727, DOI 10.1016/j.cellsig.2010.06.013; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hansen BC, 1999, ANN NY ACAD SCI, V892, P1, DOI 10.1111/j.1749-6632.1999.tb07782.x; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hoene M, 2013, AM J PHYSIOL-CELL PH, V304, pC128, DOI 10.1152/ajpcell.00025.2012; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hu W, 2011, J BIOL CHEM, V286, P16596, DOI 10.1074/jbc.M110.186916; Hu W, 2009, J LIPID RES, V50, P1852, DOI 10.1194/jlr.M800635-JLR200; Imamura T, 2001, GENOMICS, V76, P117, DOI 10.1006/geno.2001.6607; Jove M, 2005, ENDOCRINOLOGY, V146, P3087, DOI 10.1210/en.2004-1560; Keller C, 2001, FASEB J, V15, P2748, DOI 10.1096/fj.01-0507fje; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kleuser B, 1998, CANCER RES, V58, P1817; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Lempiainen P, 1999, CIRCULATION, V100, P123, DOI 10.1161/01.CIR.100.2.123; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Matsubara T, 2012, CELL METAB, V15, P38, DOI 10.1016/j.cmet.2011.12.002; Mckay BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006027; Meacci E, 2003, BBA-MOL CELL BIOL L, V1633, P133, DOI 10.1016/S1388-1981(03)00106-9; Meacci E, 2008, J CELL PHYSIOL, V214, P210, DOI 10.1002/jcp.21187; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mitrou P, 2011, EXP CLIN ENDOCR DIAB, V119, P484, DOI 10.1055/s-0030-1269846; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Nakade Y, 2003, BBA-MOL CELL BIOL L, V1635, P104, DOI 10.1016/j.bbalip.2003.11.001; Olivera A, 1999, FASEB J, V13, P1593, DOI 10.1096/fasebj.13.12.1593; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Paik JH, 2001, J BIOL CHEM, V276, P11830, DOI 10.1074/jbc.M009422200; Pedersen BK, 2008, PHYSIOL REV, V88, P1379, DOI 10.1152/physrev.90100.2007; Pedersen Bente Klarlund, 2011, J Exp Biol, V214, P337, DOI 10.1242/jeb.048074; Pettus BJ, 2004, CURR MOL MED, V4, P405, DOI 10.2174/1566524043360573; Pyne S, 2000, BIOCHEM J, V349, P385, DOI 10.1042/0264-6021:3490385; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Ren B, 1996, J BIOL CHEM, V271, P17167, DOI 10.1074/jbc.271.29.17167; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Ringseis R, 2011, MOL NUTR FOOD RES, V55, P109, DOI 10.1002/mnfr.201000424; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Samad F, 2011, ADV EXP MED BIOL, V721, P67, DOI 10.1007/978-1-4614-0650-1_5; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Schrauwen P, 2007, P NUTR SOC, V66, P33, DOI 10.1017/S0029665107005277; Schrauwen-Hinderling VB, 2005, OBES RES, V13, P2088, DOI 10.1038/oby.2005.259; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Sobue S, 2005, J NEUROCHEM, V95, P940, DOI 10.1111/j.1471-4159.2005.03399.x; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124, DOI 10.1152/ajpheart.2000.279.5.H2124; SPRINGER ML, 1997, CURRENT PROTOCOLS HU; Steensberg A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1272, DOI 10.1152/ajpendo.00255.2002; Steensberg A, 2000, J PHYSIOL-LONDON, V529, P237, DOI 10.1111/j.1469-7793.2000.00237.x; Straczkowski M, 2007, DIABETOLOGIA, V50, P2366, DOI 10.1007/s00125-007-0781-2; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Toth KG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017392; Turpin SM, 2009, J PHYSIOL-LONDON, V587, P1593, DOI 10.1113/jphysiol.2008.166033; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Veret J, 2013, BBA-MOL CELL BIOL L, V1831, P251, DOI 10.1016/j.bbalip.2012.10.003; Vusse G. V. D., 1996, HDB PHYSL 12, P952; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Xia P, 1998, P NATL ACAD SCI USA, V95, P14196, DOI 10.1073/pnas.95.24.14196; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Zanin M, 2008, AM J PHYSIOL-CELL PH, V294, pC36, DOI 10.1152/ajpcell.00164.2007; Zhao CQ, 2008, J LIPID RES, V49, P2323, DOI 10.1194/jlr.M800143-JLR200; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	100	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22193	2206		10.1074/jbc.M113.477786	http://dx.doi.org/10.1074/jbc.M113.477786			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23766515	Green Published, hybrid			2022-12-28	WOS:000330596300002
J	Nandi, S; Cioce, M; Yeung, YG; Nieves, E; Tesfa, L; Lin, HS; Hsu, AW; Halenbeck, R; Cheng, HY; Gokhan, S; Mehler, MF; Stanley, ER				Nandi, Sayan; Cioce, Mario; Yeung, Yee-Guide; Nieves, Edward; Tesfa, Lydia; Lin, Haishan; Hsu, Amy W.; Halenbeck, Robert; Cheng, Hui-Yong; Gokhan, Solen; Mehler, Mark F.; Stanley, E. Richard			Receptor-type Protein-tyrosine Phosphatase zeta Is a Functional Receptor for Interleukin-34	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Brain; Cell Surface Receptor; Interleukin; Phosphotyrosine Signaling; Tyrosine Protein Phosphatase (Tyrosine Phosphatase); CSF-1 Receptor; Development; Glioblastoma; Neurobiology; Signal Transduction	STIMULATING FACTOR-I; CHONDROITIN SULFATE PROTEOGLYCAN; GROWTH-ASSOCIATED MOLECULE; HIGH-AFFINITY BINDING; TENASCIN-R; CSF-1 RECEPTOR; ZETA/RPTP-BETA; CELL-MIGRATION; RPTP-BETA; 6B4 PROTEOGLYCAN/PHOSPHACAN	Interleukin-34 (IL-34) is highly expressed in brain. IL-34 signaling via its cognate receptor, colony-stimulating factor-1 receptor (CSF-1R), is required for the development of microglia. However, the differential expression of IL-34 and the CSF-1R in brain suggests that IL-34 may signal via an alternate receptor. By IL-34 affinity chromatography of solubilized mouse brain membrane followed by mass spectrometric analysis, we identified receptor-type protein-tyrosine phosphatase (PTP-), a cell surface chondroitin sulfate (CS) proteoglycan, as a novel IL-34 receptor. PTP- is primarily expressed on neural progenitors and glial cells and is highly expressed in human glioblastomas. IL-34 selectively bound PTP- in CSF-1R-deficient U251 human glioblastoma cell lysates and inhibited the proliferation, clonogenicity, and motility of U251 cells in a PTP--dependent manner. These effects were correlated with an increase in tyrosine phosphorylation of the previously identified PTP- downstream effectors focal adhesion kinase and paxillin. IL-34 binding to U251 cells was abrogated by chondroitinase ABC treatment, and CS competed with IL-34 for binding to the extracellular domain of PTP- and to the cells, indicating a dependence of binding on PTP- CS moieties. This study identifies an alternate receptor for IL-34 that may mediate its action on novel cellular targets.	[Nandi, Sayan; Cioce, Mario; Yeung, Yee-Guide; Nieves, Edward; Tesfa, Lydia; Stanley, E. Richard] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Cheng, Hui-Yong] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Dept Neurol, Bronx, NY 10461 USA; [Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Dept Neurosci, Bronx, NY 10461 USA; [Gokhan, Solen; Mehler, Mark F.] Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Dept Psychiat & Behav Sci, Bronx, NY 10461 USA; [Lin, Haishan; Hsu, Amy W.; Halenbeck, Robert] Five Prime Therapeut Inc, San Francisco, CA 94080 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Stanley, ER (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	richard.stanley@einstein.yu.edu	Stanley, Evan R/J-9154-2013; Cioce, Mario/R-9734-2017	Stanley, Evan R/0000-0002-2910-2065; Cioce, Mario/0000-0001-8129-6664	National Institutes of Health [CA32551, CA26504, 5P30-CA13330, NS071571, P30HD071593, 1S10RR019352]; F. M. Kirby Foundation; Alpern Family Foundation; Mildred and Bernard H. Kayden Foundation; Roslyn and Leslie Goldstein Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD071593] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA026504, R01CA026504, R01CA032551, P30CA013330] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F. M. Kirby Foundation; Alpern Family Foundation; Mildred and Bernard H. Kayden Foundation; Roslyn and Leslie Goldstein Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA32551 and CA26504 (to E. R. S.), 5P30-CA13330 (a cancer center grant to the Albert Einstein College of Medicine), NS071571 and P30HD071593 (to M. F. M. and S. G.), and 1S10RR019352 (a shared instrumentation grant to the Einstein Laboratory for Macromolecular Analysis and Proteomics). This work was also supported by the F. M. Kirby, Alpern Family, Mildred and Bernard H. Kayden, and Roslyn and Leslie Goldstein Foundations (to M. F. M. and S. G.).	BARNEA G, 1994, J BIOL CHEM, V269, P14349; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chihara T, 2010, CELL DEATH DIFFER, V17, P1917, DOI 10.1038/cdd.2010.60; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Chow JPH, 2008, J BIOL CHEM, V283, P30879, DOI 10.1074/jbc.M802976200; Dai XM, 2004, J BONE MINER RES, V19, P1441, DOI 10.1359/JBMR.040514; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Diamantopoulou Z, 2012, J BIOL CHEM, V287, P40339, DOI 10.1074/jbc.M112.405852; Edmonds BT, 1996, J CELL SCI, V109, P2705; El Ayachi I, 2011, J COMP NEUROL, V519, P2379, DOI 10.1002/cne.22632; Feng ZJ, 2010, ONCOGENE, V29, P5416, DOI 10.1038/onc.2010.282; Foehr ED, 2006, CANCER RES, V66, P2271, DOI 10.1158/0008-5472.CAN-05-1221; Fujikawa A, 2011, J BIOL CHEM, V286, P37137, DOI 10.1074/jbc.M111.270140; Fukada M, 2006, FEBS LETT, V580, P4051, DOI 10.1016/j.febslet.2006.06.041; Fukazawa N, 2008, MOL CELL BIOL, V28, P4494, DOI 10.1128/MCB.00074-08; Garwood J, 1999, J NEUROSCI, V19, P3888; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Guleria I, 2000, NAT MED, V6, P589, DOI 10.1038/75074; Harroch S, 2000, MOL CELL BIOL, V20, P7706, DOI 10.1128/MCB.20.20.7706-7715.2000; Harroch S, 2002, NAT GENET, V32, P411, DOI 10.1038/ng1004; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Huynh D, 2009, GASTROENTEROLOGY, V137, P136, DOI 10.1053/j.gastro.2009.03.004; Kawachi H, 2001, P NATL ACAD SCI USA, V98, P6593, DOI 10.1073/pnas.041608698; KRUEGER NX, 1992, P NATL ACAD SCI USA, V89, P7417, DOI 10.1073/pnas.89.16.7417; Lafont D, 2009, BEHAV BRAIN RES, V201, P29, DOI 10.1016/j.bbr.2009.01.025; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; LEVY JB, 1993, J BIOL CHEM, V268, P10573; LI W, 1991, EMBO J, V10, P277, DOI 10.1002/j.1460-2075.1991.tb07948.x; LI YS, 1990, SCIENCE, V250, P1690, DOI 10.1126/science.2270483; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Liu HL, 2012, BBA-PROTEINS PROTEOM, V1824, P938, DOI 10.1016/j.bbapap.2012.04.012; Lu KV, 2005, J BIOL CHEM, V280, P26953, DOI 10.1074/jbc.M502614200; Ma XL, 2012, STRUCTURE, V20, P676, DOI 10.1016/j.str.2012.02.010; Maeda N, 1999, J BIOL CHEM, V274, P12474, DOI 10.1074/jbc.274.18.12474; Maeda N, 1996, J BIOL CHEM, V271, P21446, DOI 10.1074/jbc.271.35.21446; MAEDA N, 1995, NEUROSCIENCE, V67, P23, DOI 10.1016/0306-4522(94)00069-H; Maeda N, 1998, J CELL BIOL, V142, P203, DOI 10.1083/jcb.142.1.203; Majeti R, 1998, SCIENCE, V279, P88, DOI 10.1126/science.279.5347.88; MAUREL P, 1994, P NATL ACAD SCI USA, V91, P2512, DOI 10.1073/pnas.91.7.2512; Meng K, 2000, P NATL ACAD SCI USA, V97, P2603, DOI 10.1073/pnas.020487997; Mikelis C, 2009, FASEB J, V23, P1459, DOI 10.1096/fj.08-117564; Milev P, 1998, J BIOL CHEM, V273, P6998, DOI 10.1074/jbc.273.12.6998; Milev P, 1996, J BIOL CHEM, V271, P15716, DOI 10.1074/jbc.271.26.15716; MORGAN C, 1987, J CELL PHYSIOL, V130, P420, DOI 10.1002/jcp.1041300316; Muller S, 2003, ONCOGENE, V22, P6661, DOI 10.1038/sj.onc.1206763; Muramatsu H, 2004, J CELL SCI, V117, P5405, DOI 10.1242/jcs.01423; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Nishiwaki T, 1998, J BIOCHEM-TOKYO, V123, P458; Pariser H, 2005, BIOCHEM BIOPH RES CO, V335, P232, DOI 10.1016/j.bbrc.2005.07.060; Pariser H, 2005, BIOCHEM BIOPH RES CO, V332, P664, DOI 10.1016/j.bbrc.2005.05.007; Peles E, 1998, TRENDS BIOCHEM SCI, V23, P121, DOI 10.1016/S0968-0004(98)01195-5; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Pixley FJ, 2001, MOL CELL BIOL, V21, P1795, DOI 10.1128/MCB.21.5.1795-1809.2001; Polykratis A, 2005, J BIOL CHEM, V280, P22454, DOI 10.1074/jbc.M414407200; Qi MS, 2001, J BIOL CHEM, V276, P15868, DOI 10.1074/jbc.M005911200; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; ROUSSEL MF, 1987, NATURE, V325, P549, DOI 10.1038/325549a0; Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211; Sakurai T, 1996, J NEUROSCI RES, V43, P694, DOI 10.1002/(SICI)1097-4547(19960315)43:6<694::AID-JNR6>3.3.CO;2-9; SHERR CJ, 1985, CELL, V41, P665, DOI 10.1016/S0092-8674(85)80047-7; Shintani T, 1998, NEUROSCI LETT, V247, P135, DOI 10.1016/S0304-3940(98)00295-X; SHITARA K, 1994, J BIOL CHEM, V269, P20189; Ulbricht U, 2006, J NEUROCHEM, V98, P1497, DOI 10.1111/j.1471-4159.2006.04022.x; von Holst A, 2006, J NEUROSCI, V26, P4082, DOI 10.1523/JNEUROSCI.0422-06.2006; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Woodworth A, 2004, J BIOL CHEM, V279, P10413, DOI 10.1074/jbc.M312466200; Woodworth A, 2002, J BIOL CHEM, V277, P50941, DOI 10.1074/jbc.M209876200; Xiao ZC, 1997, J BIOL CHEM, V272, P32092, DOI 10.1074/jbc.272.51.32092; Yeung YG, 2008, ANAL BIOCHEM, V382, P135, DOI 10.1016/j.ab.2008.07.034; Yeung YG, 2003, MOL CELL PROTEOMICS, V2, P1143, DOI 10.1074/mcp.R300009-MCP200; YEUNG YG, 1987, P NATL ACAD SCI USA, V84, P1268, DOI 10.1073/pnas.84.5.1268; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yu WF, 2012, J BIOL CHEM, V287, P13694, DOI 10.1074/jbc.M112.355610; Zheng YH, 2009, MOL CELL, V35, P11, DOI 10.1016/j.molcel.2009.06.013	80	101	114	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21972	10.1074/jbc.M112.442731	http://dx.doi.org/10.1074/jbc.M112.442731			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23744080	Green Published, hybrid			2022-12-28	WOS:000328841900044
J	Arede, P; Botelho, T; Guevara, T; Uson, I; Oliveira, DC; Gomis-Ruth, FX				Arede, Pedro; Botelho, Tiago; Guevara, Tibisay; Uson, Isabel; Oliveira, Duarte C.; Xavier Gomis-Rueth, F.			Structure-Function Studies of the Staphylococcal Methicillin Resistance Antirepressor MecR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT GLUCOKINASE; ANTIBIOTIC-SENSOR DOMAIN; BLAR PENICILLIN-RECEPTOR; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; CRYSTAL-STRUCTURE; GLUCOSE-TRANSPORTER; SIGNAL-TRANSDUCTION; REGULATORY ROLE; AUREUS	Methicillin resistance in Staphylococcus aureus is elicited by the MecI-MecR1-MecA axis encoded by the mec locus. Recently, MecR2 was also identified as a regulator of mec through binding of the methicillin repressor, MecI. Here we show that plasmid-encoded full-length MecR2 restores resistance in a sensitive S. aureus mecR2 deletion mutant of the resistant strain N315. The crystal structure of MecR2 reveals an N-terminal DNA-binding domain, an intermediate scaffold domain, and a C-terminal dimerization domain that contributes to oligomerization. The protein shows structural similarity to ROK (repressors, open reading frames, and kinases) family proteins, which bind DNA and/or sugar molecules. We found that functional cell-based assays of three point mutants affecting residues participating in sugar binding in ROK proteins had no effect on the resistance phenotype. By contrast, MecR2 bound short double-stranded DNA oligonucleotides nonspecifically, and a deletion mutant affecting the N-terminal DNA-binding domain showed a certain effect on activity, thus contributing to resistance less than the wild-type protein. Similarly, a deletion mutant, in which a flexible segment of intermediate scaffold domain had been replaced by four glycines, significantly reduced MecR2 function, thus indicating that this domain may likewise be required for activity. Taken together, these results provide the structural basis for the activity of a methicillin antirepressor, MecR2, which would sequester MecI away from its cognate promoter region and facilitate its degradation.	[Botelho, Tiago; Guevara, Tibisay; Xavier Gomis-Rueth, F.] CSIC, Mol Biol Inst Barcelona, Dept Biol Struct, Proteolysis Lab, E-08028 Barcelona, Catalonia, Spain; [Arede, Pedro; Oliveira, Duarte C.] Univ Nova Lisboa, Dept Life Sci, Ctr Microbiol Resources, Fac Ciencias & Tecnol, P-2829516 Quinta Da Torre, Caparica, Portugal; [Uson, Isabel] CSIC, Mol Biol Inst Barcelona, Inst Catalana Recerca & Estudis Avancats, E-08028 Barcelona, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Universidade Nova de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA	Gomis-Ruth, FX (corresponding author), CSIC, Mol Biol Inst Barcelona, Dept Biol Struct, Proteolysis Lab, E-08028 Barcelona, Catalonia, Spain.	fxgr@ibmb.csic.es	Arede, Pedro/H-1690-2015	Arede, Pedro/0000-0002-5693-3147; Oliveira, Duarte/0000-0002-9591-1039; Guevara Puig, Tibisay/0000-0002-1366-8507; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Oliveira Botelho, Tiago/0000-0002-2456-8421	European Union [FP7-HEALTH-F3-2009-223101, FP7-HEALTH-2010-261460, FP7-PEOPLE-2011-290246, FP7-HEALTH-2012-306029-2]; Fundacio La Marato de TV3 [100372]; European Synchrotron Radiation Facility; Foundation for Science and Technology from the Portuguese Ministry for Science and Higher Education [SFRH/ BD/38316/2007, SFRH/BD/15852/ 2005];  [BFU2012-32862];  [BIO2009-10334];  [CSD2006-00015];  [POCTI/BIA-MIC/60320/2004];  [PTDC/BIA-MIC/64071/2006];  [SNF200020/125020/1]; ICREA Funding Source: Custom	European Union(European Commission); Fundacio La Marato de TV3; European Synchrotron Radiation Facility; Foundation for Science and Technology from the Portuguese Ministry for Science and Higher Education; ; ; ; ; ; ; ICREA(ICREA)	This work was supported in part by the European Union through Grant FP7-HEALTH-F3-2009-223101 (AntiPathoGN), Grant FP7-HEALTH-2010-261460 (Gums & Joints), Grant FP7-PEOPLE-2011-290246 (RAPID), and Grant FP7-HEALTH-2012-306029-2 (TRIGGER). This work was also supported by Grants BFU2012-32862, BIO2009-10334, and CSD2006-00015 from Spanish Ministries; Grant 2009SGR1036 from the National Government of Catalonia; Grant 100372 from Fundacio La Marato de TV3; and Grants POCTI/BIA-MIC/60320/2004, PTDC/BIA-MIC/64071/2006, and SNF200020/125020/1 from Portuguese agencies. Funding provided by the European Synchrotron Radiation Facility partially covered for the cost of data collection.; Recipient of Fellowship SFRH/ BD/38316/2007 from the Foundation for Science and Technology from the Portuguese Ministry for Science and Higher Education.; Recipient of Fellowship SFRH/BD/15852/ 2005 from the Foundation for Science and Technology from the Portuguese Ministry for Science and Higher Education.	Amoroso A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002571; [Anonymous], 2011, J ANTIMICROB CHEM S4; Archer GL, 2001, SCIENCE, V291, P1915, DOI 10.1126/science.1059671; Arede P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002816; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berzigotti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036400; Birck C, 2004, J AM CHEM SOC, V126, P13945, DOI 10.1021/ja044742u; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; Carranza C., 1999, AFMB ACTIVITY REPORT, P89; Cha J, 2007, BIOCHEMISTRY-US, V46, P7822, DOI 10.1021/bi7005459; Clarke SR, 2001, J ANTIMICROB CHEMOTH, V47, P377, DOI 10.1093/jac/47.4.377; COHEN S, 1968, J BACTERIOL, V95, P1368, DOI 10.1128/JB.95.4.1368-1374.1968; DAHL MK, 1995, J BACTERIOL, V177, P5467, DOI 10.1128/jb.177.19.5467-5472.1995; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Diego I, 2013, J BIOL CHEM, V288, P14287, DOI 10.1074/jbc.M112.444927; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Duval V, 2003, MOL MICROBIOL, V48, P1553, DOI 10.1046/j.1365-2958.2003.03520.x; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Filee P, 2002, MOL MICROBIOL, V44, P685, DOI 10.1046/j.1365-2958.2002.02888.x; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Garcia-Castellanos R, 2004, J BIOL CHEM, V279, P17888, DOI 10.1074/jbc.M313123200; Garcia-Castellanos R, 2003, J BIOL CHEM, V278, P39897, DOI 10.1074/jbc.M307199200; GARTNER D, 1988, J BACTERIOL, V170, P3102; GERONIMUS LH, 1957, J BACTERIOL, V73, P28, DOI 10.1128/JB.73.1.28-34.1957; Hanique S, 2004, J BIOL CHEM, V279, P14264, DOI 10.1074/jbc.M313488200; Hansen T, 2002, J BACTERIOL, V184, P5955, DOI 10.1128/JB.184.21.5955-5965.2002; HARTMAN BJ, 1986, ANTIMICROB AGENTS CH, V29, P85, DOI 10.1128/AAC.29.1.85; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Holm L., CURR PROTOC BIOINFOR; Kabsch W., 2001, INT TABLES CRYSTALLO, P730, DOI [10.1107/97809553602060000001, DOI 10.1107/97809553602060000001]; Kawai S, 2005, J BIOSCI BIOENG, V99, P320, DOI 10.1263/jbb.99.320; Kerff F, 2003, BIOCHEMISTRY-US, V42, P12835, DOI 10.1021/bi034976a; KRAEMER GR, 1990, CURR MICROBIOL, V21, P373, DOI 10.1007/BF02199440; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee SJ, 2000, EMBO J, V19, P5353, DOI 10.1093/emboj/19.20.5353; Lewis RA, 2000, J ANTIMICROB CHEMOTH, V45, P139, DOI 10.1093/jac/45.2.139; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Llarrull LI, 2012, BIOCHEMISTRY-US, V51, P4642, DOI 10.1021/bi300429p; Llarrull LI, 2011, J BIOL CHEM, V286, P38148, DOI 10.1074/jbc.M111.288985; Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535; Lunin VV, 2004, J BACTERIOL, V186, P6915, DOI 10.1128/JB.186.20.6915-6927.2004; Mallorqui-Fernandez G, 2004, FEMS MICROBIOL LETT, V235, P1, DOI 10.1016/j.femsle.2004.04.035; Marrero A, 2006, J MOL BIOL, V361, P506, DOI 10.1016/j.jmb.2006.06.046; Mukai T, 2004, J BIOL CHEM, V279, P50591, DOI 10.1074/jbc.M408126200; Nam TW, 2008, P NATL ACAD SCI USA, V105, P3751, DOI 10.1073/pnas.0709295105; Nam TW, 2001, EMBO J, V20, P491, DOI 10.1093/emboj/20.3.491; Nocek BP, 2010, J MOL BIOL, V397, P617, DOI 10.1016/j.jmb.2010.01.062; Oliveira DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023287; Plumbridge J, 2002, CURR OPIN MICROBIOL, V5, P187, DOI 10.1016/S1369-5274(02)00296-5; Rammelkamp CH, 1942, P SOC EXP BIOL MED, V51, P386, DOI 10.3181/00379727-51-13986; RICHARME G, 1983, BIOCHIM BIOPHYS ACTA, V742, P16, DOI 10.1016/0167-4838(83)90353-9; Rodriguez DD, 2009, NAT METHODS, V6, P651, DOI [10.1038/NMETH.1365, 10.1038/nmeth.1365]; Safo MK, 2006, ACTA CRYSTALLOGR F, V62, P320, DOI 10.1107/S1744309106009742; Safo MK, 2005, J BACTERIOL, V187, P1833, DOI 10.1128/JB.187.5.1833-1844.2005; SCHELLENBERG GD, 1984, J BIOL CHEM, V259, P6826; Schiefner A, 2005, J BIOL CHEM, V280, P29073, DOI 10.1074/jbc.M504215200; SENANAYAKE SD, 1995, MOL BIOTECHNOL, V4, P13, DOI 10.1007/BF02907467; SHAMANNA DK, 1979, J BACTERIOL, V139, P64, DOI 10.1128/JB.139.1.64-70.1979; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; SIZEMORE C, 1991, MOL GEN GENET, V227, P377, DOI 10.1007/BF00273926; STORRS MJ, 1988, ANTIMICROB AGENTS CH, V32, P1174, DOI 10.1128/AAC.32.8.1174; Tanaka Y, 2000, EMBO J, V19, P5344, DOI 10.1093/emboj/19.20.5344; TITGEMEYER F, 1994, MICROBIOL-UK, V140, P2349, DOI 10.1099/13500872-140-9-2349; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Weller TMA, 1999, J ANTIMICROB CHEMOTH, V43, P15, DOI 10.1093/jac/43.1.15; Zhang HZ, 2001, SCIENCE, V291, P1962, DOI 10.1126/science.1055144	72	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21267	21278		10.1074/jbc.M112.448134	http://dx.doi.org/10.1074/jbc.M112.448134			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23733184	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000322014400047
J	Cooper, RS; Altenberg, GA				Cooper, Rebecca S.; Altenberg, Guillermo A.			Association/Dissociation of the Nucleotide-binding Domains of the ATP-binding Cassette Protein MsbA Measured during Continuous Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-ELECTRON RESONANCE; ABC TRANSPORTER MSBA; ENERGY-TRANSFER; P-GLYCOPROTEIN; ALTERNATING ACCESS; CATALYTIC CYCLE; MOVEMENT; SITES; DIMER	In ATP-binding cassette proteins, the two nucleotide-binding domains (NBDs) work as dimers to bind and hydrolyze ATP, but the molecular mechanism of nucleotide hydrolysis is controversial. It is still unresolved whether hydrolysis leads to dissociation of the ATP-induced dimers or partial opening of the dimers such that the NBDs remain in contact during the hydrolysis cycle. We studied the bacterial lipid flippase MsbA by luminescence resonance energy transfer (LRET). The LRET signal between optical probes reacted with single-cysteine mutants was employed to follow NBD association/dissociation in real time. The intermonomer distances calculated from LRET data indicate that the NBDs separate completely following ATP hydrolysis, even in the presence of mM MgATP, and that the dissociation occurs following each hydrolysis cycle. The results support association/dissociation, as opposed to constant contact models, for the mode of operation of ATP-binding cassette proteins.	[Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; Texas Tech Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center	Altenberg, GA (corresponding author), Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA.	g.altenberg@ttuhsc.edu		Altenberg, Guillermo/0000-0002-8932-740X	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; Cancer Prevention & Research Institute of Texas Grant [RP101073]; American Heart Association Predoctoral Fellowship [11PRE7360046]; Lubbock Chapter of the Achievement Rewards for College Scientists Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention & Research Institute of Texas Grant; American Heart Association Predoctoral Fellowship(American Heart Association); Lubbock Chapter of the Achievement Rewards for College Scientists Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM79629 and 3R01GM079629-03S1. This work was also supported by Cancer Prevention & Research Institute of Texas Grant RP101073 (to G. A. A.), American Heart Association Predoctoral Fellowship 11PRE7360046 (to R. S. C.), and a scholarship from the Lubbock Chapter of the Achievement Rewards for College Scientists Foundation (to R. S. C.).	Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Bai J., 2011, PLOS ONE, V6; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen JY, 1999, BIOCONJUGATE CHEM, V10, P311, DOI 10.1021/bc980113w; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Fiori MC, 2012, J BIOL CHEM, V287, P40826, DOI 10.1074/jbc.M112.383281; Heyduk T, 2001, ANAL BIOCHEM, V289, P60, DOI 10.1006/abio.2000.4925; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; HUANG C, 1973, J AM CHEM SOC, V95, P234, DOI 10.1021/ja00782a042; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 2007, J BIOL CHEM, V282, P22793, DOI 10.1074/jbc.M700809200; Jones PM, 2011, BIOPHYS J, V100, P3025, DOI 10.1016/j.bpj.2011.05.028; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Jones PM, 2009, PROTEINS, V75, P387, DOI 10.1002/prot.22250; Knauf PA, 2004, BLOOD CELL MOL DIS, V32, P360, DOI 10.1016/j.bcmd.2004.01.007; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Posson DJ, 2008, NEURON, V59, P98, DOI 10.1016/j.neuron.2008.05.006; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Rambhadran A, 2011, J BIOL CHEM, V286, P16953, DOI 10.1074/jbc.M111.224576; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Westfahl KM, 2008, BIOCHEMISTRY-US, V47, P13878, DOI 10.1021/bi801745u; Xiao M, 2001, J AM CHEM SOC, V123, P7067, DOI 10.1021/ja0031669; Zoghbi ME, 2012, J BIOL CHEM, V287, P14994, DOI 10.1074/jbc.M112.340281; Zoghbi ME, 2012, J BIOL CHEM, V287, P4157, DOI 10.1074/jbc.M111.318378; Zou P, 2010, BIOPHYS J, V98, pL18, DOI 10.1016/j.bpj.2009.12.4193; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	41	34	36	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20785	20796		10.1074/jbc.M113.477976	http://dx.doi.org/10.1074/jbc.M113.477976			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23723071	Green Published, hybrid			2022-12-28	WOS:000322014400003
J	Gummesson, B; Lovmar, M; Nystrom, T				Gummesson, Bertil; Lovmar, Martin; Nystrom, Thomas			A Proximal Promoter Element Required for Positive Transcriptional Control by Guanosine Tetraphosphate and DksA Protein during the Stringent Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNIVERSAL STRESS-PROTEIN; GROWTH-RATE CONTROL; ESCHERICHIA-COLI; RIBOSOMAL-RNA; RECOGNITION ELEMENT; SECONDARY CHANNEL; IN-VIVO; PPGPP; POLYMERASE; INITIATION	The alarmone guanosine tetraphosphate (ppGpp) acts as both a positive and a negative regulator of gene expression in the presence of DksA, but the underlying mechanisms of this differential control are unclear. Here, using uspA hybrid promoters, we show that an AT-rich discriminator region is crucial for positive control by ppGpp/DksA. The AT-rich discriminator makes the RNA polymerase-promoter complex extremely stable and therefore easily saturated with RNA polymerase. A more efficient transcription is achieved when the RNA polymerase-promoter complex is destabilized with ppGpp/DksA. We found that exchanging the AT-rich discriminator of uspA with the GC-rich rrnB-P1 discriminator made the uspA promoter negatively regulated by ppGpp/DksA both in vivo and in vitro. In addition, the GC-rich discriminator destabilized the RNA polymerase-promoter complex, and the effect of ppGpp/DksA on the kinetic properties of the promoter was reversed. We propose that the transcription initiation rate from promoters with GC-rich discriminators, in contrast to the uspA-promoter, is not limited by the stability of the open complex. The findings are discussed in view of models for both direct and indirect effects of ppGpp/DksA on transcriptional trade-offs.	[Gummesson, Bertil; Lovmar, Martin; Nystrom, Thomas] Gothenburg Univ, Dept Chem & Mol Biol, S-41390 Gothenburg, Sweden	University of Gothenburg	Nystrom, T (corresponding author), Gothenburg Univ, Dept Chem & Mol Biol, Medicinaregatan 9C, S-41390 Gothenburg, Sweden.	thomas.nystrom@cmb.gu.se	Gummesson, Bertil/AAG-5333-2019	Gummesson, Bertil/0000-0002-9814-885X	Swedish Natural Research Council; Knut and Alice Wallenberg Foundation (Wallenberg Scholar Award)	Swedish Natural Research Council(Swedish Research Council); Knut and Alice Wallenberg Foundation (Wallenberg Scholar Award)	This work was supported by grants from the Swedish Natural Research Council and the Knut and Alice Wallenberg Foundation (Wallenberg Scholar Award).	Aberg A, 2008, MOL MICROBIOL, V67, P1223, DOI 10.1111/j.1365-2958.2008.06115.x; ALBERTSON NH, 1994, FEMS MICROBIOL LETT, V117, P181, DOI 10.1111/j.1574-6968.1994.tb06762.x; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; Battesti A, 2006, MOL MICROBIOL, V62, P1048, DOI 10.1111/j.1365-2958.2006.05442.x; Bremer H, 2003, BIOCHIMIE, V85, P597, DOI 10.1016/S0300-9084(03)00105-6; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; CASHEL M, 1969, J BIOL CHEM, V244, P3133; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; Chatterji D, 2001, CURR OPIN MICROBIOL, V4, P160, DOI 10.1016/S1369-5274(00)00182-X; Costanzo A, 2006, J BACTERIOL, V188, P4627, DOI 10.1128/JB.01981-05; DEBOER HA, 1979, CELL, V17, P201, DOI 10.1016/0092-8674(79)90308-8; Dennis PP, 2004, MICROBIOL MOL BIOL R, V68, P639, DOI 10.1128/MMBR.68.4.639-668.2004; Dykxhoorn DM, 1996, MOL MICROBIOL, V19, P483, DOI 10.1046/j.1365-2958.1996.384913.x; ELLIOTT T, 1984, CELL, V36, P211, DOI 10.1016/0092-8674(84)90091-6; Farewell A, 1996, J BACTERIOL, V178, P6443, DOI 10.1128/jb.178.22.6443-6450.1996; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Gummesson B, 2009, EMBO J, V28, P2209, DOI 10.1038/emboj.2009.181; Gustavsson N, 2002, MOL MICROBIOL, V43, P107, DOI 10.1046/j.1365-2958.2002.02720.x; Haugen SP, 2008, P NATL ACAD SCI USA, V105, P3292, DOI [10.1073/pnas.0709513105, 10.1073/pnas.07095l3105]; Haugen SP, 2006, CELL, V125, P1069, DOI 10.1016/j.cell.2006.04.034; JENSEN KF, 1990, MICROBIOL REV, V54, P89, DOI 10.1128/MMBR.54.2.89-100.1990; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Kvint K, 2000, MOL MICROBIOL, V35, P435, DOI 10.1046/j.1365-2958.2000.01714.x; LEIRMO S, 1991, J MOL BIOL, V220, P555, DOI 10.1016/0022-2836(91)90100-K; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x; Lennon CW, 2012, GENE DEV, V26, P2634, DOI 10.1101/gad.204693.112; Magnusson LU, 2007, J BACTERIOL, V189, P5193, DOI 10.1128/JB.00330-07; Magnusson LU, 2003, J BIOL CHEM, V278, P968, DOI 10.1074/jbc.M209881200; Mechold U, 2013, NUCLEIC ACIDS RES, V41, P6175, DOI 10.1093/nar/gkt302; Miller J. H, 1972, EXPT MOL GENETICS; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; NYSTROM T, 1994, MOL MICROBIOL, V11, P537, DOI 10.1111/j.1365-2958.1994.tb00334.x; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Ross W, 2013, MOL CELL, V50, P420, DOI 10.1016/j.molcel.2013.03.021; Ross W, 2009, METHODS, V47, P13, DOI 10.1016/j.ymeth.2008.10.018; Rutherford ST, 2007, J MOL BIOL, V366, P1243, DOI 10.1016/j.jmb.2006.12.013; Rutherford ST, 2009, GENE DEV, V23, P236, DOI 10.1101/gad.1745409; RYALS J, 1982, J BACTERIOL, V151, P1261, DOI 10.1128/JB.151.3.1261-1268.1982; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; STENT GS, 1961, P NATL ACAD SCI USA, V47, P2005, DOI 10.1073/pnas.47.12.2005; Teich A, 1999, BIOTECHNOL PROGR, V15, P123, DOI 10.1021/bp980102h; TRAVERS AA, 1980, J BACTERIOL, V141, P973, DOI 10.1128/JB.141.2.973-976.1980; TRAVERS AA, 1984, NUCLEIC ACIDS RES, V12, P2605, DOI 10.1093/nar/12.6.2605; Vinella D, 2005, MOL MICROBIOL, V56, P958, DOI 10.1111/j.1365-2958.2005.04601.x; Wagner R., 2000, TRANSCRIPTION REGULA, p[72, 309]; WANNER BL, 1977, J BACTERIOL, V130, P212, DOI 10.1128/JB.130.1.212-222.1977; XIAO H, 1991, J BIOL CHEM, V266, P5980; ZACHARIAS M, 1989, EMBO J, V8, P3357, DOI 10.1002/j.1460-2075.1989.tb08498.x; ZACHARIAS M, 1991, BIOCHIMIE, V73, P699, DOI 10.1016/0300-9084(91)90050-B; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908; Zuo YH, 2013, MOL CELL, V50, P430, DOI 10.1016/j.molcel.2013.03.020	60	22	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21055	21064		10.1074/jbc.M113.479998	http://dx.doi.org/10.1074/jbc.M113.479998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23749992	hybrid, Green Published			2022-12-28	WOS:000322014400026
J	Muili, KA; Jin, SQ; Orabi, AI; Eisses, JF; Javed, TA; Le, TM; Bottino, R; Jayaraman, T; Husain, SZ				Muili, Kamaldeen A.; Jin, Shunqian; Orabi, Abrahim I.; Eisses, John F.; Javed, Tanveer A.; Le, Tianming; Bottino, Rita; Jayaraman, Thotalla; Husain, Sohail Z.			Pancreatic Acinar Cell Nuclear Factor kappa B Activation Because of Bile Acid Exposure Is Dependent on Calcineurin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; TRYPSINOGEN ACTIVATION; ZYMOGEN ACTIVATION; TISSUE-DAMAGE; CA2+ RELEASE; PKC-EPSILON; CALCIUM; RECEPTORS; ISOFORMS; DELTA	Biliary pancreatitis is the most common etiology of acute pancreatitis, accounting for 30-60% of cases. A dominant theory for the development of biliary pancreatitis is the reflux of bile into the pancreatic duct and subsequent exposure to pancreatic acinar cells. Bile acids are known to induce aberrant Ca2+ signals in acinar cells as well as nuclear translocation of NF-kappa B. In this study, we examined the role of the downstream Ca2+ target calcineurin on NF-kappa B translocation. Freshly isolated mouse acinar cells were infected for 24 h with an adenovirus expressing an NF-kappa B luciferase reporter. The bile acid taurolithocholic acid-3-sulfate caused NF-kappa B activation at concentrations (500 mu M) that were associated with cell injury. We show that the NF-kappa B inhibitor Bay 11-7082 (1 mu M) blocked translocation and injury. Pretreatment with the Ca2+ chelator 1,2-bis(o-aminophenoxy) ethane-N, N, N', N'-tetraacetic acid, the calcineurin inhibitors FK506 and cyclosporine A, or use of acinar cells from calcineurin A beta-deficient mice each led to reduced NF-kappa B activation with taurolithocholic acid-3-sulfate. Importantly, these manipulations did not affect LPS-induced NF-kappa B activation. A critical upstream regulator of NF-kappa B activation is protein kinase C, which translocates to the membranes of various organelles in the active state. We demonstrate that pharmacologic and genetic inhibition of calcineurin blocks translocation of the PKC-delta isoform. In summary, bile-induced NF-kappa B activation and acinar cell injury are mediated by calcineurin, and a mechanism for this important early inflammatory response appears to be upstream at the level of PKC translocation.	[Muili, Kamaldeen A.; Jin, Shunqian; Orabi, Abrahim I.; Eisses, John F.; Javed, Tanveer A.; Le, Tianming; Husain, Sohail Z.] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Bottino, Rita; Jayaraman, Thotalla] Univ Pittsburgh, Med Ctr, Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Husain, SZ (corresponding author), UPMC, Childrens Hosp Pittsburgh, Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	sohail.husain@chp.edu		Husain, Sohail Z/0000-0003-3012-1308	National Institutes of Health [DK083327, DK093491]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093491, T32DK007017, T32DK071492, R01DK083327] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083327 and DK093491 (to S. Z. H.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; [Anonymous], 1773, BIOCH BIOPHYS ACTA, P483; [Anonymous], PANCREAPEDIA EXOCRIN; Awla D, 2012, GASTROENTEROLOGY, V143, P1352, DOI 10.1053/j.gastro.2012.07.098; Awla D, 2011, INFLAMM RES, V60, P1093, DOI 10.1007/s00011-011-0370-1; Bai HX, 2011, J PEDIATR GASTR NUTR, V52, P262, DOI 10.1097/MPG.0b013e3182061d75; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; BASTANI B, 1995, BBA-MOL CELL RES, V1269, P307, DOI 10.1016/0167-4889(95)00120-0; Baumann B, 2007, J CLIN INVEST, V117, P1502, DOI 10.1172/JCI30876; Booth DM, 2011, GASTROENTEROLOGY, V140, P2116, DOI 10.1053/j.gastro.2011.02.054; Bottino R., 2012, J TRANSPLANT, V2012; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P9398, DOI 10.1073/pnas.152665399; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen XQ, 2002, GASTROENTEROLOGY, V122, P448, DOI 10.1053/gast.2002.31060; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; D'Andrea M, 2006, J CELL PHYSIOL, V207, P379, DOI 10.1002/jcp.20585; Ethridge RT, 2002, J AM COLL SURGEONS, V195, P497, DOI 10.1016/S1072-7515(02)01222-X; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; Frischbutter S, 2011, EUR J IMMUNOL, V41, P2349, DOI 10.1002/eji.201041052; Gerasimenko JV, 2011, P NATL ACAD SCI USA, V108, P5873, DOI 10.1073/pnas.1016534108; Gerasimenko JV, 2006, J BIOL CHEM, V281, P40154, DOI 10.1074/jbc.M606402200; Gukovskaya AS, 2004, AM J PHYSIOL-GASTR L, V286, pG204, DOI 10.1152/ajpgi.00088.2003; Gukovsky I, 2013, GASTROENTEROLOGY, V144, P26, DOI 10.1053/j.gastro.2012.11.016; Han B, 2000, AM J PHYSIOL-CELL PH, V278, pC344, DOI 10.1152/ajpcell.2000.278.2.C344; HOFMANN AF, 1984, J LIPID RES, V25, P1477; Hogan PG, 2005, CURR BIOL, V15, pR442, DOI 10.1016/j.cub.2005.06.006; Huang HJ, 2013, GASTROENTEROLOGY, V144, P202, DOI 10.1053/j.gastro.2012.09.059; Husain SZ, 2007, AM J PHYSIOL-GASTR L, V292, pG1594, DOI 10.1152/ajpgi.00500.2006; Husain SZ, 2012, AM J PHYSIOL-GASTR L, V302, pG1423, DOI 10.1152/ajpgi.00546.2011; Ji BA, 2009, J BIOL CHEM, V284, P17488, DOI 10.1074/jbc.M109.005520; JONES BA, 1987, ANN SURG, V205, P123, DOI 10.1097/00000658-198702000-00003; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kim JY, 2002, GASTROENTEROLOGY, V122, P1941, DOI 10.1053/gast.2002.33617; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Kim MJ, 2001, PANCREATOLOGY, V1, P36, DOI 10.1159/000055790; Li CW, 2004, AM J PHYSIOL-GASTR L, V287, pG764, DOI 10.1152/ajpgi.00111.2004; Lipp P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004556; Long J, 2005, WORLD J GASTROENTERO, V11, P4277; Lowenfels Albert B, 2005, Curr Gastroenterol Rep, V7, P90, DOI 10.1007/s11894-005-0045-6; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579; Muili K., 2011, PANCREAPEDIA EXOCRIN, DOI [10.3998/panc.2011.4, DOI 10.3998/PANC.2011.4]; Muili KA, 2013, J BIOL CHEM, V288, P570, DOI 10.1074/jbc.M112.428896; Muili KA, 2012, AM J PHYSIOL-GASTR L, V302, pG898, DOI 10.1152/ajpgi.00545.2011; Murat A, 2000, J BIOL CHEM, V275, P40867, DOI 10.1074/jbc.M008071200; Neuhofer P, 2013, GASTROENTEROLOGY, V144, P192, DOI 10.1053/j.gastro.2012.09.058; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Opie EL, 1909, J EXP MED, V11, P561, DOI 10.1084/jem.11.4.561; Orabi AI, 2011, J BIOL CHEM, V286, P14090, DOI 10.1074/jbc.M110.196832; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Perides G, 2010, GASTROENTEROLOGY, V138, P715, DOI 10.1053/j.gastro.2009.10.052; POLLO DA, 1994, BBA-MOL CELL RES, V1224, P127, DOI 10.1016/0167-4889(94)90120-1; Ricordi C., 1995, METHODS CELL TRANSPL; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Satoh A, 2006, AM J PHYSIOL-GASTR L, V291, pG432, DOI 10.1152/ajpgi.00579.2005; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shah AU, 2009, AM J PHYSIOL-GASTR L, V297, pG967, DOI 10.1152/ajpgi.00181.2009; Shah SA, 2006, INT J CANCER, V118, P532, DOI 10.1002/ijc.21365; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tando Y, 1999, AM J PHYSIOL-GASTR L, V277, pG678, DOI 10.1152/ajpgi.1999.277.3.G678; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; van Geenen EJM, 2010, NAT REV GASTRO HEPAT, V7, P495, DOI 10.1038/nrgastro.2010.114; Villalba M, 1999, J IMMUNOL, V163, P5813; Vincent F, 2006, CARDIOVASC RES, V71, P97, DOI 10.1016/j.cardiores.2006.03.012; Voronina S, 2002, J PHYSIOL-LONDON, V540, P49, DOI 10.1113/jphysiol.2002.017525; Voronina SG, 2010, GASTROENTEROLOGY, V138, P1976, DOI 10.1053/j.gastro.2010.01.037; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Wu Bechien U, 2010, Curr Gastroenterol Rep, V12, P83, DOI 10.1007/s11894-010-0091-6; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zhao Zhi-cheng, 2004, J Zhejiang Univ Sci, V5, P477, DOI 10.1631/jzus.2004.0477	80	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21065	21073		10.1074/jbc.M113.471425	http://dx.doi.org/10.1074/jbc.M113.471425			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23744075	hybrid, Green Published			2022-12-28	WOS:000322014400027
J	Loffler, MG; Birkenfeld, AL; Philbrick, KM; Belman, JP; Habtemichael, EN; Booth, CJ; Castorena, CM; Choi, CS; Jornayvaz, FR; Gassaway, BM; Lee, HY; Cartee, GD; Philbrick, W; Shulman, GI; Samuel, VT; Bogan, JS				Loeffler, Michael G.; Birkenfeld, Andreas L.; Philbrick, Katerina M.; Belman, Jonathan P.; Habtemichael, Estifanos N.; Booth, Carmen J.; Castorena, Carlos M.; Choi, Cheol Soo; Jornayvaz, Francois R.; Gassaway, Brandon M.; Lee, Hui-Young; Cartee, Gregory D.; Philbrick, William; Shulman, Gerald I.; Samuel, Varman T.; Bogan, Jonathan S.			Enhanced Fasting Glucose Turnover in Mice with Disrupted Action of TUG Protein in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREATINE-KINASE GENE; HEAVY-CHAIN ISOFORM; CELL-SURFACE GLUT4; INSULIN-RESISTANCE; TRANSGENIC MICE; KNOCKOUT MICE; C-CBL; TRANSPORTER TRANSLOCATION; VESICLE TRAFFICKING; ENERGY-EXPENDITURE	Insulin stimulates glucose uptake in 3T3-L1 adipocytes in part by causing endoproteolytic cleavage of TUG (tether containing a ubiquitin regulatory X (UBX) domain for glucose transporter 4 (GLUT4)). Cleavage liberates intracellularly sequestered GLUT4 glucose transporters for translocation to the cell surface. To test the role of this regulation in muscle, we used mice with muscle-specific transgenic expression of a truncated TUG fragment, UBX-Cter. This fragment causes GLUT4 translocation in unstimulated 3T3-L1 adipocytes. We predicted that transgenic mice would have GLUT4 translocation in muscle during fasting. UBX-Cter expression caused depletion of PIST (PDZ domain protein interacting specifically with TC10), which transmits an insulin signal to TUG. Whereas insulin stimulated TUG proteolysis in control muscles, proteolysis was constitutive in transgenic muscles. Fasting transgenic mice had decreased plasma glucose and insulin concentrations compared with controls. Whole-body glucose turnover was increased during fasting but not during hyperinsulinemic clamp studies. In muscles with the greatest UBX-Cter expression, 2-deoxyglucose uptake during fasting was similar to that in control muscles during hyperinsulinemic clamp studies. Fasting transgenic mice had increased muscle glycogen, and GLUT4 targeting to T-tubule fractions was increased 5.7-fold. Whole-body oxygen consumption (VO2), carbon dioxide production (VCO2), and energy expenditure were increased by 12-13%. After 3 weeks on a high fat diet, the decreased fasting plasma glucose in transgenic mice compared with controls was more marked, and increased glucose turnover was not observed; the transgenic mice continued to have an increased metabolic rate. We conclude that insulin stimulates TUG proteolysis to translocate GLUT4 in muscle, that this pathway impacts systemic glucose homeostasis and energy metabolism, and that the effects of activating this pathway are maintained during high fat diet-induced insulin resistance in mice.	[Loeffler, Michael G.; Birkenfeld, Andreas L.; Philbrick, Katerina M.; Belman, Jonathan P.; Habtemichael, Estifanos N.; Choi, Cheol Soo; Jornayvaz, Francois R.; Lee, Hui-Young; Philbrick, William; Shulman, Gerald I.; Samuel, Varman T.; Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, New Haven, CT 06520 USA; [Belman, Jonathan P.; Bogan, Jonathan S.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Gassaway, Brandon M.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Booth, Carmen J.] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Castorena, Carlos M.; Cartee, Gregory D.] Univ Michigan, Sch Kinesiol, Muscle Biol Lab, Ann Arbor, MI 48109 USA; [Samuel, Varman T.] Vet Affairs Med Ctr, West Haven, CT 06516 USA	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Bogan, JS (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol & Metab, POB 208020, New Haven, CT 06520 USA.	jonathan.bogan@yale.edu	Bogan, Jonathan S/A-1575-2010; Löffler, Michael/F-1748-2013; Jornayvaz, François/AAL-2134-2020; Gassaway, Brandon Mark/AAU-7548-2021; Shulman, Gerald I./P-7176-2019; Birkenfeld, Andreas L./U-3954-2019	Bogan, Jonathan S/0000-0001-6463-8466; Löffler, Michael/0000-0002-6529-9723; Gassaway, Brandon Mark/0000-0002-6102-2356; Shulman, Gerald I./0000-0003-1529-5668; Birkenfeld, Andreas L./0000-0003-1407-9023; Belman, Jonathan/0000-0002-1051-6938; Cartee, Gregory/0000-0001-5311-1722; Jornayvaz, Francois/0000-0001-9425-3137; Lee, Hui-Young/0000-0002-3464-6382	National Institutes of Health [DK075772, DK092661, DK071771, DK40936, T32DK007058, T32GM007205, TL1RR024137, F30DK093198]; American Diabetes Association [1-12-BS-16]; W.M. Keck Foundation; German Research Foundation [BI1292/4-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071771, P30DK020572, U24DK059635, U2CDK059635, P30DK079310, R01DK040936, R01DK075772, T32DK007058, F30DK093198, P30DK045735, R01DK092661] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); W.M. Keck Foundation(W.M. Keck Foundation); German Research Foundation(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK075772 and DK092661 (to J.S.B); DK071771 (to G.D.C.); DK40936 (to G.I.S.); T32GM007205, TL1RR024137, and F30DK093198 (to J.P.B); and T32DK007058 (to E.N.H.). This work was also supported by American Diabetes Association Grant 1-12-BS-16 and the W.M. Keck Foundation (to J.S.B.).; 1 Supported by German Research Foundation Grant BI1292/4-1.	Ahn MY, 2004, J BIOL CHEM, V279, P21526, DOI 10.1074/jbc.M307740200; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Bao SC, 1997, METABOLISM, V46, P1349, DOI 10.1016/S0026-0495(97)90243-2; Bogan JS, 2012, J BIOL CHEM, V287, P23932, DOI 10.1074/jbc.M112.339457; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2001, MOL CELL BIOL, V21, P4785, DOI 10.1128/MCB.21.14.4785-4806.2001; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Brozinick JT, 1997, BIOCHEM J, V321, P75, DOI 10.1042/bj3210075; Cartee GD, 2007, APPL PHYSIOL NUTR ME, V32, P557, DOI 10.1139/H07-026; Castorena CM, 2011, J APPL PHYSIOL, V111, P1106, DOI 10.1152/japplphysiol.00631.2011; Chang L, 2007, ENDOCRINOLOGY, V148, P27, DOI 10.1210/en.2006-1167; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; DEEMS RO, 1994, DIABETOLOGIA, V37, P1097, DOI 10.1007/s001250050222; Donoviel DB, 1996, MOL CELL BIOL, V16, P1649; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Govers R, 2004, MOL CELL BIOL, V24, P6456, DOI 10.1128/MCB.24.14.6456-6466.2004; GULVE EA, 1994, J BIOL CHEM, V269, P18366; Gupte A, 2006, BIOCHEM BIOPH RES CO, V342, P751, DOI 10.1016/j.bbrc.2006.02.023; HANSEN PA, 1995, J BIOL CHEM, V270, P1679; Hart Y, 2013, MOL CELL, V49, P213, DOI 10.1016/j.molcel.2013.01.004; Hatakeyama H, 2013, MOL BIOL CELL, V24, P809, DOI 10.1091/mbc.E12-10-0725; Hatakeyama H, 2011, TRAFFIC, V12, P1805, DOI 10.1111/j.1600-0854.2011.01279.x; Hicks SW, 2005, J BIOL CHEM, V280, P28944, DOI 10.1074/jbc.M504937200; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; JAYNES JB, 1988, MOL CELL BIOL, V8, P62, DOI 10.1128/MCB.8.1.62; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Langer O, 2000, CLIN OBSTET GYNECOL, V43, P283, DOI 10.1097/00003081-200006000-00006; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Liu J, 2003, J BIOL CHEM, V278, P36754, DOI 10.1074/jbc.M300664200; Liu J, 2002, MOL CELL BIOL, V22, P3599, DOI 10.1128/MCB.22.11.3599-3609.2002; LIU ML, 1993, P NATL ACAD SCI USA, V90, P11346, DOI 10.1073/pnas.90.23.11346; Maianu L, 2001, J CLIN ENDOCR METAB, V86, P5450, DOI 10.1210/jc.86.11.5450; Minami A, 2003, DIABETES, V52, P2657, DOI 10.2337/diabetes.52.11.2657; Minokoshi Y, 2003, J BIOL CHEM, V278, P33609, DOI 10.1074/jbc.R300019200; Mitra P, 2004, J BIOL CHEM, V279, P37431, DOI 10.1074/jbc.C400180200; Molero JC, 2004, J CLIN INVEST, V114, P1326, DOI [10.1172/JCI200421480, 10.1172/JCI21480]; Neudauer CL, 1998, CURR BIOL, V8, P1151, DOI 10.1016/S0960-9822(07)00486-1; Nguyen QGV, 2003, J BIOL CHEM, V278, P46494, DOI 10.1074/jbc.M308194200; Orme CM, 2012, J BIOL CHEM, V287, P6679, DOI 10.1074/jbc.M111.284232; Park SY, 2005, AM J PHYSIOL-ENDOC M, V289, pE30, DOI 10.1152/ajpendo.00251.2004; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; PIETRINI G, 1992, P NATL ACAD SCI USA, V89, P8414, DOI 10.1073/pnas.89.18.8414; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; REN JM, 1995, J CLIN INVEST, V95, P429, DOI 10.1172/JCI117673; Rubin BR, 2009, VITAM HORM, V80, P155, DOI 10.1016/S0083-6729(08)00607-9; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sbodio JI, 2007, J BIOL CHEM, V282, P29874, DOI 10.1074/jbc.M705794200; Sbodio JI, 2006, J BIOL CHEM, V281, P27924, DOI 10.1074/jbc.M603276200; Schertzer JD, 2009, ENDOCRINOLOGY, V150, P1935, DOI 10.1210/en.2008-1372; Szekeres F, 2012, AM J PHYSIOL-ENDOC M, V303, pE524, DOI 10.1152/ajpendo.00605.2011; Thurmond DC, 2000, EMBO J, V19, P3565, DOI 10.1093/emboj/19.14.3565; TREADWAY JL, 1994, J BIOL CHEM, V269, P29956; Tsao TS, 1996, DIABETES, V45, P28, DOI 10.2337/diabetes.45.1.28; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Wang HY, 2013, BIOCHEM J, V449, P479, DOI 10.1042/BJ20120702; Williams D, 2006, MOL BIOL CELL, V17, P5346, DOI 10.1091/mbc.E06-05-0386; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; YOUN JH, 1993, DIABETES, V42, P757, DOI 10.2337/diabetes.42.5.757; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012; Zorzano Antonio, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0324s31	72	17	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20135	20150		10.1074/jbc.M113.458075	http://dx.doi.org/10.1074/jbc.M113.458075			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23744065	Green Published, hybrid			2022-12-28	WOS:000321715100004
J	Murase, S				Murase, Sachiko			Signal Transducer and Activator of Transcription 3 (STAT3) Degradation by Proteasome Controls a Developmental Switch in Neurotrophin Dependence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM DEPRESSION; ELEMENT MODULATORY FACTOR; TUMOR-SUPPRESSOR PROTEIN; OCCURRING CELL-DEATH; PARKINSONS-DISEASE; NEURONAL SURVIVAL; NERVOUS-SYSTEM; CALCINEURIN; UBIQUITIN; PATHWAY	Neonatal brains develop through a program that eliminates about half of the neurons. During this period, neurons depend on neurotrophins for their survival. Recently, we reported that, at the conclusion of the naturally occurring death period, neurons become neurotrophin-independent and, further, that this developmental switch is achieved by the emergence of a second survival pathway mediated by signal transducer and activator of transcription 3 (STAT3). Here I show that calcineurin plays a key role in controlling the developmental switch in mouse hippocampal neurons. Calcineurin promotes the degradation of STAT3 via the ubiquitin-proteasome pathway. Inhibition of calcineurin acutely increases total levels of STAT3 as well as its activated forms, resulting in decreased levels of the tumor suppressor p53 and its proapoptotic target, Bax. In vivo and in vitro, calcineurin regulates levels of STAT3 and neurotrophin dependence. TMF/ARA 160 (TATA element modulatory factor/androgen receptor co-activator 160), the key mediator of STAT3 ubiquitination, is required for calcineurin-dependent STAT3 degradation. Thus, these results show that the ubiquitin-proteasome pathway controls the critical developmental switch of neurotrophin dependence in the newborn hippocampus.	NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Murase, S (corresponding author), NINDS, Mol Biol Lab, NIH, 35 Lincoln Dr,Bldg 35,Rm 1C1014, Bethesda, MD 20892 USA.	sachikom@ninds.nih.gov	Murase, Sachiko/AAC-5496-2022	Murase, Sachiko/0000-0002-9078-0471	National Institutes of Health, NINDS, Intramural Research Program	National Institutes of Health, NINDS, Intramural Research Program	This work was supported, in whole or in part, by the National Institutes of Health, NINDS, Intramural Research Program.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; ARRIGO AP, 1988, NATURE, V331, P192, DOI 10.1038/331192a0; Ballas N, 2001, NEURON, V31, P353, DOI 10.1016/S0896-6273(01)00371-3; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6; Conaway JW, 1998, BBA-REV CANCER, V1377, pM49, DOI 10.1016/S0304-419X(97)00035-8; CUNNINGHAM MG, 1993, J NEUROSCI METH, V47, P105, DOI 10.1016/0165-0270(93)90026-N; Daino H, 2000, BLOOD, V95, P2577; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; De-Fraja C, 2000, INT J DEV NEUROSCI, V18, P439, DOI 10.1016/S0736-5748(00)00007-1; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; FERREIRA A, 1993, MOL BIOL CELL, V4, P1225, DOI 10.1091/mbc.4.12.1225; FERRER I, 1994, NEUROSCI LETT, V182, P77, DOI 10.1016/0304-3940(94)90210-0; Foster TC, 2001, J NEUROSCI, V21, P4066, DOI 10.1523/JNEUROSCI.21-11-04066.2001; GARCIA JA, 1992, P NATL ACAD SCI USA, V89, P9372, DOI 10.1073/pnas.89.20.9372; GOULD E, 1991, J COMP NEUROL, V304, P408, DOI 10.1002/cne.903040306; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hirsch C, 2006, TRENDS CELL BIOL, V16, P657, DOI 10.1016/j.tcb.2006.10.006; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Hsiao PW, 1999, J BIOL CHEM, V274, P22373, DOI 10.1074/jbc.274.32.22373; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Liang HY, 1999, J BIOL CHEM, V274, P19846, DOI 10.1074/jbc.274.28.19846; Luoma JI, 2008, J NEUROSCI, V28, P3159, DOI 10.1523/JNEUROSCI.5227-07.2008; Mansuy IM, 1998, CELL, V92, P39, DOI 10.1016/S0092-8674(00)80897-1; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; Michod D, 2012, NEURON, V74, P122, DOI 10.1016/j.neuron.2012.02.021; Mori K, 2002, FEBS LETT, V520, P127, DOI 10.1016/S0014-5793(02)02803-X; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Murase S, 2006, J NEUROSCI, V26, P9750, DOI 10.1523/JNEUROSCI.2745-06.2006; Murase S, 2012, J NEUROSCI, V32, P15511, DOI 10.1523/JNEUROSCI.2940-12.2012; Murase S, 2011, J NEUROSCI, V31, P7791, DOI 10.1523/JNEUROSCI.0202-11.2011; Niu GL, 2005, MOL CELL BIOL, V25, P7432, DOI 10.1128/MCB.25.17.7432-7440.2005; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PALLEN CJ, 1985, ARCH BIOCHEM BIOPHYS, V237, P281, DOI 10.1016/0003-9861(85)90279-6; Perry E, 2004, ONCOGENE, V23, P8908, DOI 10.1038/sj.onc.1208149; Porta S, 2007, EUR J NEUROSCI, V26, P1213, DOI 10.1111/j.1460-9568.2007.05749.x; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; SCHREIBER SL, 1992, CELL, V70, P365, DOI 10.1016/0092-8674(92)90158-9; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Schwartz Y, 1998, FEBS LETT, V434, P339, DOI 10.1016/S0014-5793(98)01003-5; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	57	15	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20151	20161		10.1074/jbc.M113.470583	http://dx.doi.org/10.1074/jbc.M113.470583			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23733189	Green Published, hybrid			2022-12-28	WOS:000321715100005
J	Baldridge, RD; Xu, P; Graham, TR				Baldridge, Ryan D.; Xu, Peng; Graham, Todd R.			Type IV P-type ATPases Distinguish Mono-versus Diacyl Phosphatidylserine Using a Cytofacial Exit Gate in the Membrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PLASMA-MEMBRANE; SACCHAROMYCES-CEREVISIAE; AMINOPHOSPHOLIPID TRANSLOCASE; CRYSTAL-STRUCTURE; IDENTIFICATION; TRANSPORT; ACYLTRANSFERASE; SPECIFICITY; COMPLEX; INTERNALIZATION	Type IV P-type ATPases (P4-ATPases) use the energy from ATP to "flip" phospholipid across a lipid bilayer, facilitating membrane trafficking events and maintaining the characteristic plasma membrane phospholipid asymmetry. Preferred translocation substrates for the budding yeast P4-ATPases Dnf1 and Dnf2 include lysophosphatidylcholine, lysophosphatidylethanolamine, derivatives of phosphatidylcholine and phosphatidylethanolamine containing a 7-nitro-2-1,3-benzoxadiazol-4-yl (NBD) group on the sn-2 C6 position, and were presumed to include phosphatidylcholine and phosphatidylethanolamine species with two intact acyl chains. Wepreviously identified several mutations in Dnf1 transmembrane (TM) segments 1 through 4 that greatly enhance recognition and transport of NBD phosphatidylserine (NBD-PS). Here we show that most of these Dnf1 mutants cannot flip diacylated PS to the cytosolic leaflet to establish PS asymmetry. However, mutation of a highly conserved asparagine (Asn-550) inTM3allowed Dnf1 to restore plasma membrane PS asymmetry in a strain deficient for the P4-ATPase Drs2, the primary PS flippase. Moreover, Dnf1 N550 mutants could replace the Drs2 requirement for growth at low temperature. A screen for additional Dnf1 mutants capable of replacing Drs2 function identified substitutions of TM1 and 2 residues, within a region called the exit gate, that permit recognition of dually acylated PS. These TM1, 2, and 3 residues coordinate with the "proline + 4" residue within TM4 to determine substrate preference at the exit gate. Moreover, residues from Atp8a1, a mammalian ortholog of Drs2, in these positions allow PS recognition by Dnf1. These studies indicate that Dnf1 poorly recognizes diacylated phospholipid and define key substitutions enabling recognition of endogenous PS.	[Baldridge, Ryan D.; Xu, Peng; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Graham, TR (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	tr.graham@vanderbilt.edu	Xu, Peng/O-8615-2014; Xu, Peng/A-1082-2015	Xu, Peng/0000-0001-7103-3692; Baldridge, Ryan/0000-0001-7158-7812	National Institutes of Health [GM62367]; Cellular and Molecular Microbiology Training Program [T32AI007611-11]; Vanderbilt Ingram Cancer Center [P30 CA68485]; Vanderbilt Digestive Disease Research Center [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062367, R01GM107978] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular and Molecular Microbiology Training Program; Vanderbilt Ingram Cancer Center; Vanderbilt Digestive Disease Research Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62367 (to T. R. G.). This work was also supported by Cellular and Molecular Microbiology Training Program T32AI007611-11 (to R. D. B.), by Vanderbilt Ingram Cancer Center Grant P30 CA68485, and by Vanderbilt Digestive Disease Research Center Grant DK058404.	ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baldridge RD, 2013, P NATL ACAD SCI USA, V110, pE358, DOI 10.1073/pnas.1216948110; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Blankman JL, 2013, P NATL ACAD SCI USA, V110, P1500, DOI 10.1073/pnas.1217121110; Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Chen S, 2006, TRAFFIC, V7, P1503, DOI 10.1111/j.1600-0854.2006.00485.x; Coleman JA, 2009, J BIOL CHEM, V284, P32670, DOI 10.1074/jbc.M109.047415; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Dhar MS, 2004, J NUTR, V134, P799, DOI 10.1093/jn/134.4.799; Ding JT, 2000, J BIOL CHEM, V275, P23378, DOI 10.1074/jbc.M910319199; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Ferrannini E, 2013, DIABETES, V62, P1730, DOI 10.2337/db12-0707; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Hanson PK, 2001, J BIOL CHEM, V276, P9861, DOI 10.1074/jbc.M009065200; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; Jain S, 2007, J BIOL CHEM, V282, P30562, DOI 10.1074/jbc.M706326200; Kato U, 2013, J BIOL CHEM, V288, P4922, DOI 10.1074/jbc.M112.402701; KEAN LS, 1993, J CELL BIOL, V123, P1403, DOI 10.1083/jcb.123.6.1403; Levano K, 2012, J NEUROCHEM, V120, P302, DOI 10.1111/j.1471-4159.2011.07543.x; Natarajan P, 2004, P NATL ACAD SCI USA, V101, P10614, DOI 10.1073/pnas.0404146101; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Onat OE, 2013, EUR J HUM GENET, V21, P281, DOI 10.1038/ejhg.2012.170; PALMGREN MG, 1994, J BIOL CHEM, V269, P3027; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Riekhof WR, 2007, J BIOL CHEM, V282, P36853, DOI 10.1074/jbc.M706718200; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Smriti, 2007, BIOCHEMISTRY-US, V46, P2249, DOI 10.1021/bi061333x; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Stevens HC, 2008, J BIOL CHEM, V283, P35060, DOI 10.1074/jbc.M802379200; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Viehweger K, 2002, PLANT CELL, V14, P1509, DOI 10.1105/tpc.002329; Voelker DR, 2000, BBA-MOL CELL BIOL L, V1486, P97, DOI 10.1016/S1388-1981(00)00051-2; Wang L, 2004, DEV BIOL, V267, P203, DOI 10.1016/j.ydbio.2003.11.004; Wilson D. S., 2001, CURR PROTOC MOL BIOL, V51, P831; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423; Xu Q, 2012, FEBS LETT, V586, P1803, DOI 10.1016/j.febslet.2012.05.018; Yabas M, 2011, NAT IMMUNOL, V12, P441, DOI 10.1038/ni.2011; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P16586, DOI 10.1073/pnas.0904293106; Zhu XJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002853	46	38	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19516	19527		10.1074/jbc.M113.476911	http://dx.doi.org/10.1074/jbc.M113.476911			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23709217	Green Published, hybrid			2022-12-28	WOS:000321515800018
J	Howard, MT; Carlson, BA; Anderson, CB; Hatfield, DL				Howard, Michael T.; Carlson, Bradley A.; Anderson, Christine B.; Hatfield, Dolph L.			Translational Redefinition of UGA Codons Is Regulated by Selenium Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; SELENOCYSTEINE TRANSFER-RNA; 3 UNTRANSLATED REGION; MESSENGER-RNA; DIETARY SELENIUM; RAT-LIVER; MEDIATED DECAY; SELENOPROTEIN; SEQUENCES; METHYLATION	Incorporation of selenium into similar to 25 mammalian selenoproteins occurs by translational recoding whereby in-frame UGA codons are redefined to encode the selenium containing amino acid, selenocysteine (Sec). Here we applied ribosome profiling to examine the effect of dietary selenium levels on the translational mechanisms controlling selenoprotein synthesis in mouse liver. Dietary selenium levels were shown to control gene-specific selenoprotein expression primarily at the translation level by differential regulation of UGA redefinition and Sec incorporation efficiency, although effects on translation initiation and mRNA abundance were also observed. Direct evidence is presented that increasing dietary selenium causes a vast increase in ribosome density downstream of UGA-Sec codons for a subset of selenoprotein mRNAs and that the selenium-dependent effects on Sec incorporation efficiency are mediated in part by the degree of Sec-tRNA([Ser]Sec) Um34 methylation. Furthermore, we find evidence for translation in the 5'-UTRs for a subset of selenoproteins and for ribosome pausing near the UGA-Sec codon in those mRNAs encoding the selenoproteins most affected by selenium availability. These data illustrate how dietary levels of the trace element selenium can alter the readout of the genetic code to affect the expression of an entire class of proteins.	[Howard, Michael T.; Anderson, Christine B.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; [Carlson, Bradley A.; Hatfield, Dolph L.] NCI, Mol Biol Selenium Sect, Lab Canc Prevent, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Howard, MT (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	mhoward@genetics.utah.edu			National Institutes of Health (NIH) [21ES022716]; Intramural Research Program of the NIH, NCI, Center for Cancer Research; University of Utah; NATIONAL CANCER INSTITUTE [ZIABC010767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES022716] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the NIH, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Utah; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health (NIH Grant R21ES022716; to M. T. H.) and the Intramural Research Program of the NIH, NCI, Center for Cancer Research (to D. L. H.). This work was also supported by a University of Utah Seed grant (to M. T. H.).	[Anonymous], 1979, CHINESE MED J-PEKING, V92, P477; Arava Y, 2005, NUCLEIC ACIDS RES, V33, P2421, DOI 10.1093/nar/gki331; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; Berry MJ, 2001, BIOFACTORS, V14, P17, DOI 10.1002/biof.5520140104; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Carlson BA, 2007, J BIOL CHEM, V282, P32591, DOI 10.1074/jbc.M707036200; CHRISTENSEN MJ, 1992, J NUTR, V122, P1620, DOI 10.1093/jn/122.8.1620; Copeland PR, 1999, J BIOL CHEM, V274, P25447, DOI 10.1074/jbc.274.36.25447; DIAMOND AM, 1993, J BIOL CHEM, V268, P14215; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Fletcher JE, 2000, RNA, V6, P1573, DOI 10.1017/S1355838200000625; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Gu QP, 2002, BIOMETALS, V15, P411, DOI 10.1023/A:1020241032336; Hadley KB, 2001, J NUTR BIOCHEM, V12, P693, DOI 10.1016/S0955-2863(01)00189-9; Hatfield DL, 2012, SELENIUM: ITS MOLECULAR BIOLOGY AND ROLE IN HUMAN HEALTH, THIRD EDITION, P1, DOI 10.1007/978-1-4614-1025-6; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; HILL KE, 1992, BIOCHEM BIOPH RES CO, V185, P260, DOI 10.1016/S0006-291X(05)80984-2; HILL KE, 1993, P NATL ACAD SCI USA, V90, P537, DOI 10.1073/pnas.90.2.537; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; Howard MT, 2007, RNA, V13, P912, DOI 10.1261/rna.473907; Howard MT, 2005, EMBO J, V24, P1596, DOI 10.1038/sj.emboj.7600642; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kim JY, 2011, BIOCHEM BIOPH RES CO, V409, P814, DOI 10.1016/j.bbrc.2011.05.096; Kim LK, 2000, RNA, V6, P1306, DOI 10.1017/S1355838200000388; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LEI XG, 1995, J NUTR, V125, P1438; Low SC, 2000, EMBO J, V19, P6882, DOI 10.1093/emboj/19.24.6882; Mariotti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033066; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; Nasim MT, 2000, J BIOL CHEM, V275, P14846, DOI 10.1074/jbc.275.20.14846; Nuttall KL, 2006, ANN CLIN LAB SCI, V36, P409; SHEN QC, 1993, J BIOL CHEM, V268, P11463; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; Squires JE, 2007, MOL CELL BIOL, V27, P7848, DOI 10.1128/MCB.00793-07; Stoytcheva Z, 2006, MOL CELL BIOL, V26, P9177, DOI 10.1128/MCB.00856-06; Sunde RA, 2011, ADV NUTR, V2, P138, DOI 10.3945/an.110.000240; TOYODA N, 1995, MOL CELL BIOL, V15, P5100; Weiss SL, 1998, RNA, V4, P816, DOI 10.1017/S1355838298971990; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Yanagitani K, 2009, MOL CELL, V34, P191, DOI 10.1016/j.molcel.2009.02.033; YANG GQ, 1983, AM J CLIN NUTR, V37, P872, DOI 10.1093/ajcn/37.5.872	48	66	68	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19401	19413		10.1074/jbc.M113.481051	http://dx.doi.org/10.1074/jbc.M113.481051			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696641	Green Published, hybrid			2022-12-28	WOS:000321515800009
J	Sunku, K; de Groot, HJM; Pandit, A				Sunku, Kiran; de Groot, Huub. J. M.; Pandit, Anjali			Insights into the Photoprotective Switch of the Major Light-harvesting Complex II (LHCII) A PRESERVED CORE OF ARGININE-GLUTAMATE INTERLOCKED HELICES COMPLEMENTED BY ADJUSTABLE LOOPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHYLL-A/B-COMPLEX; ENERGY-DISSIPATION; PHOTOSYSTEM-I; CHLAMYDOMONAS-REINHARDTII; EXCITONIC INTERACTIONS; PERTURBATION-THEORY; CRYSTAL-STRUCTURE; PIGMENT-BINDING; PROTEIN; MECHANISM	Light-harvesting antennae of the LHC family form transmembrane three-helix bundles of which two helices are interlocked by conserved arginine-glutamate (Arg-Glu) ion pairs that form ligation sites for chlorophylls. The antenna proteins of photosystem II have an intriguing dual function. In excess light, they can switch their conformation from a light-harvesting into a photoprotective state, in which the excess and harmful excitation energies are safely dissipated as heat. Here we applied magic angle spinning NMR and selective Arg isotope enrichment as a noninvasive method to analyze the Arg structures of the major light-harvesting complex II (LHCII). The conformations of the Arg residues that interlock helix A and B appear to be preserved in the light-harvesting and photoprotective state. Several Arg residues have very downfield-shifted proton NMR responses, indicating that they stabilize the complex by strong hydrogen bonds. For the Arg C-alpha chemical shifts, differences are observed between LHCII in the active, light-harvesting and in the photoprotective, quenched state. These differences are attributed to a conformational change of the Arg residue in the stromal loop region. We conclude that the interlocked helices of LHCII form a rigid core. Consequently, the LHCII conformational switch does not involve changes in A/B helix tilting but likely involves rearrangements of the loops and helical segments close to the stromal and lumenal ends.	[Sunku, Kiran; de Groot, Huub. J. M.] Leiden Univ, Dept Solid State NMR, Leiden Inst Chem, Gorlaeus Lab, NL-2300 RA Leiden, Netherlands; [Pandit, Anjali] Vrije Univ Amsterdam, Biophys Grp, Dept Phys & Astron, Fac Sci, NL-1081 HV Amsterdam, Netherlands	Leiden University; Leiden University - Excl LUMC; Vrije Universiteit Amsterdam	Pandit, A (corresponding author), Vrije Univ Amsterdam, Dept Phys, Fac Sci, De Boelelaan 1081A, NL-1081 HV Amsterdam, Netherlands.	a.pandit@vu.nl	de Groot, Huub J. M./J-4741-2012; de Groot, Huub/GXV-7380-2022	de Groot, Huub J. M./0000-0002-8796-1212; sunku, kiran/0000-0002-3343-8493	HARVEST Marie Curie Research Training Network [PITN-GA-2009-238017]	HARVEST Marie Curie Research Training Network	This work was supported by the HARVEST Marie Curie Research Training Network (Grant PITN-GA-2009-238017).	ABRAHAM RJ, 1983, J AM CHEM SOC, V105, P5734, DOI 10.1021/ja00356a005; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; Barros T, 2009, BBA-BIOENERGETICS, V1787, P753, DOI 10.1016/j.bbabio.2009.03.012; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Berera R, 2006, P NATL ACAD SCI USA, V103, P5343, DOI 10.1073/pnas.0508530103; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Bode S, 2009, P NATL ACAD SCI USA, V106, P12311, DOI 10.1073/pnas.0903536106; Bonente G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000577; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; DITCHFIELD R, 1981, CHEM PHYS, V63, P185, DOI 10.1016/0301-0104(81)80320-5; Dockter C, 2012, J BIOL CHEM, V287, P2915, DOI 10.1074/jbc.M111.307728; Drop B, 2011, J BIOL CHEM, V286, P44878, DOI 10.1074/jbc.M111.301101; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Facelli JC, 1998, J PHYS CHEM B, V102, P2111, DOI 10.1021/jp9800970; Ferrante P, 2012, J BIOL CHEM, V287, P16276, DOI 10.1074/jbc.M111.316729; Germano M, 2002, FEBS LETT, V525, P121, DOI 10.1016/S0014-5793(02)03100-9; Goral TK, 2010, PLANT J, V62, P948, DOI [10.1111/j.1365-313X.2010.04207.x, 10.1111/j.0960-7412.2010.04207.x]; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2012, PHILOS T R SOC B, V367, P3455, DOI 10.1098/rstb.2012.0069; Ilioaia C, 2011, J BIOL CHEM, V286, P27247, DOI 10.1074/jbc.M111.234617; Johnson MP, 2011, PLANT SIGNAL BEHAV, V6, P1386, DOI 10.4161/psb.6.9.16503; Johnson MP, 2011, PLANT CELL, V23, P1468, DOI 10.1105/tpc.110.081646; Kim T, 2010, BIOPHYS J, V99, P175, DOI 10.1016/j.bpj.2010.04.015; Kirchhoff H, 2011, P NATL ACAD SCI USA, V108, P20248, DOI 10.1073/pnas.1104141109; Kruger TPJ, 2010, BIOPHYS J, V98, P3093, DOI 10.1016/j.bpj.2010.03.028; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liao PN, 2012, PHOTOSYNTH RES, V111, P237, DOI 10.1007/s11120-011-9690-9; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; MCWEENY R, 1962, PHYS REV, V126, P1028, DOI 10.1103/PhysRev.126.1028; MIEHLICH B, 1989, CHEM PHYS LETT, V157, P200, DOI 10.1016/0009-2614(89)87234-3; Miloslavina Y, 2008, FEBS LETT, V582, P3625, DOI 10.1016/j.febslet.2008.09.044; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; MURAKAMI S, 1970, J CELL BIOL, V47, P332, DOI 10.1083/jcb.47.2.332; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Pandit A, 2013, BBA-BIOENERGETICS, V1827, P738, DOI 10.1016/j.bbabio.2013.02.015; Pandit A, 2012, PHOTOSYNTH RES, V111, P219, DOI 10.1007/s11120-011-9674-9; Pandit A, 2011, BIOPHYS J, V101, P2507, DOI 10.1016/j.bpj.2011.09.055; Pandit A, 2011, BBA-BIOENERGETICS, V1807, P437, DOI 10.1016/j.bbabio.2011.01.007; Pandit A, 2010, J PHYS CHEM B, V114, P6207, DOI 10.1021/jp100688u; Pandit A, 2010, BIOCHEMISTRY-US, V49, P478, DOI 10.1021/bi9016236; Park SH, 2005, J MOL BIOL, V350, P310, DOI 10.1016/j.jmb.2005.05.004; Pascal AA, 2005, NATURE, V436, P134, DOI 10.1038/nature03795; Peers G, 2009, NATURE, V462, P518, DOI 10.1038/nature08587; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P167, DOI 10.1016/j.bbabio.2011.04.007; RUBAN AV, 1992, BIOCHIM BIOPHYS ACTA, V1102, P30, DOI 10.1016/0005-2728(92)90061-6; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; Szabo I, 2005, EMBO REP, V6, P629, DOI 10.1038/sj.embor.7400460; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; van Gammeren AJ, 2005, J BIOMOL NMR, V31, P279, DOI 10.1007/s10858-005-1604-8; van Gammeren AJ, 2005, J AM CHEM SOC, V127, P3213, DOI 10.1021/ja044215a; van Oort B, 2011, PHYS CHEM CHEM PHYS, V13, P12614, DOI 10.1039/c1cp20331b; Walters RG, 1996, P NATL ACAD SCI USA, V93, P14204, DOI 10.1073/pnas.93.24.14204; Wawrzyniak PK, 2008, PHYS CHEM CHEM PHYS, V10, P6971, DOI 10.1039/b810457c; WOLINSKI K, 1990, J AM CHEM SOC, V112, P8251, DOI 10.1021/ja00179a005; WOLINSKI K, 1980, MOL PHYS, V41, P1419, DOI 10.1080/00268978000103631; Yang CH, 2008, BBA-BIOENERGETICS, V1777, P1463, DOI 10.1016/j.bbabio.2008.08.009	62	10	10	1	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19796	19804		10.1074/jbc.M113.456111	http://dx.doi.org/10.1074/jbc.M113.456111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23629658	Green Published, hybrid			2022-12-28	WOS:000321515800048
J	Ortiz, D; Gossack, L; Quast, U; Bryan, J				Ortiz, David; Gossack, Lindsay; Quast, Ulrich; Bryan, Joseph			Reinterpreting the Action of ATP Analogs on K-ATP Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE POTASSIUM CHANNELS; CONSERVED GLUTAMATE RESIDUE; NUCLEOTIDE-BINDING DOMAINS; SULFONYLUREA RECEPTOR 1; CRYSTAL-STRUCTURE; ABC TRANSPORTER; ESTERS ACTIVATE; COA ESTERS; MECHANISM; INHIBITION	Neuroendocrine-type K-ATP channels, (SUR1/Kir6.2)(4), couple the transmembrane flux of K+, and thus membrane potential, with cellular metabolism in various cell types including insulin-secreting beta-cells. Mutant channels with reduced activity are a cause of congenital hyperinsulinism, whereas hyperactive channels are a cause of neonatal diabetes. Acurrent regulatory model proposes that ATP hydrolysis is required to switch SUR1 into post-hydrolytic conformations able to antagonize the inhibitory action of nucleotide binding at the Kir6.2 pore, thus coupling enzymatic and channel activities. Alterations in SUR1 ATPase activity are proposed to contribute to neonatal diabetes and type 2 diabetes risk. The regulatory model is partly based on the reduced ability of ATP analogs such as adenosine 5'-(beta,gamma-imino)triphosphate (AMP-PNP) and adenosine 5'-O-(thiotriphosphate) (ATP gamma S) to stimulate channel activity, presumably by reducing hydrolysis. This study uses a substitution at the catalytic glutamate, SUR1E1507Q, with a significantly increased affinity for ATP, to probe the action of these ATP analogs on conformational switching. ATP gamma S, a slowly hydrolyzable analog, switches SUR1 conformations, albeit with reduced affinity. Nonhydrolyzable AMP-PNP and adenosine 5'-(beta,gamma-methylenetriphosphate) (AMP-PCP) alone fail to switch SUR1, but do reverse ATP-induced switching. AMP-PCP displaces 8-azido-[P-32] ATP from the noncanonical NBD1 of SUR1. This is consistent with structural data on an asymmetric bacterial ABC protein that shows that AMP-PNP binds selectively to the noncanonical NBD to prevent conformational switching. The results imply that MgAMP-PNP and MgAMP-PCP (AMP-PxP) fail to activate K-ATP channels because they do not support NBD dimerization and conformational switching, rather than by limiting enzymatic activity.	[Bryan, Joseph] Pacific NW Diabet Res Inst, Seattle, WA 98122 USA; [Quast, Ulrich] Eberhard Karls Univ Hosp & Clin, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol & Expt Therapy, D-72074 Tubingen, Germany	Pacific Northwest Diabetes Research Institute (PNDRI); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bryan, J (corresponding author), Pacific NW Diabet Res Inst, 720 Broadway, Seattle, WA 98122 USA.	jbryan@pnri.org			American Diabetes Association [ADA 1-10-BS21]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008280] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Diabetes Association Grant ADA 1-10-BS21 (to J. B.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; Alekseev AE, 2005, J MOL CELL CARDIOL, V38, P895, DOI 10.1016/j.yjmcc.2005.02.022; ASHCROFT FM, 1989, J PHYSIOL-LONDON, V416, P349, DOI 10.1113/jphysiol.1989.sp017765; Babenko AP, 2008, J BIOL CHEM, V283, P8778, DOI 10.1074/jbc.C700243200; Baukrowitz T, 2000, EUR J BIOCHEM, V267, P5842, DOI 10.1046/j.1432-1327.2000.01672.x; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Best L, 2011, J PHYSIOL-LONDON, V589, P1307, DOI 10.1113/jphysiol.2010.200741; Branstrom R, 2004, DIABETOLOGIA, V47, P277, DOI 10.1007/s00125-003-1299-x; Branstrom R, 1997, J BIOL CHEM, V272, P17390, DOI 10.1074/jbc.272.28.17390; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Christesen H. B. T., 2005, HORM RES, V64, P135; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; de Wet H, 2007, FEBS J, V274, P3532, DOI 10.1111/j.1742-4658.2007.05879.x; DUNNE MJ, 1989, FEBS LETT, V250, P262, DOI 10.1016/0014-5793(89)80734-3; DUNNE MJ, 1990, BRIT J PHARMACOL, V99, P169, DOI 10.1111/j.1476-5381.1990.tb14672.x; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Fan Z, 1999, J GEN PHYSIOL, V114, P251, DOI 10.1085/jgp.114.2.251; FINDLAY I, 1987, PFLUG ARCH EUR J PHY, V410, P313, DOI 10.1007/BF00580282; FINDLAY I, 1988, J MEMBRANE BIOL, V101, P83, DOI 10.1007/BF01872823; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; HEHL S, 1994, EUR BIOPHYS J BIOPHY, V23, P231, DOI 10.1007/BF00213573; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; LEDERER WJ, 1989, J PHYSIOL-LONDON, V419, P193, DOI 10.1113/jphysiol.1989.sp017869; Loffler-Walz C, 1998, BRIT J PHARMACOL, V123, P1395, DOI 10.1038/sj.bjp.0701756; Lubelski J, 2006, BIOCHEMISTRY-US, V45, P648, DOI 10.1021/bi051276s; Mannikko R, 2011, DIABETES, V60, P1813, DOI 10.2337/db10-1583; Matsuo M, 2005, J MOL CELL CARDIOL, V38, P907, DOI 10.1016/j.yjmcc.2004.11.021; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Ortiz D, 2012, J BIOL CHEM, V287, P17985, DOI 10.1074/jbc.M112.349019; Pratt EB, 2011, CHANNELS, V5, P314, DOI 10.4161/chan.5.4.16510; Pratt EB, 2011, J GEN PHYSIOL, V137, P299, DOI 10.1085/jgp.201010557; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Proks P, 2010, J GEN PHYSIOL, V136, P389, DOI 10.1085/jgp.201010475; Qin L, 2008, BIOCHEMISTRY-US, V47, P13952, DOI 10.1021/bi801532g; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Riedel MJ, 2003, DIABETES, V52, P2630, DOI 10.2337/diabetes.52.10.2630; Schulze D, 2003, J PHYSIOL-LONDON, V552, P357, DOI 10.1113/jphysiol.2003.047035; SCHWANSTECHER C, 1994, BRIT J PHARMACOL, V111, P302, DOI 10.1111/j.1476-5381.1994.tb14060.x; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; SCHWANSTECHER M, 1992, BRIT J PHARMACOL, V105, P531, DOI 10.1111/j.1476-5381.1992.tb09014.x; Shyng SL, 2000, P NATL ACAD SCI USA, V97, P937, DOI 10.1073/pnas.97.2.937; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; TAKANO M, 1990, AM J PHYSIOL, V258, pH45, DOI 10.1152/ajpheart.1990.258.1.H45; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; TREHERNE JM, 1992, P ROY SOC B-BIOL SCI, V247, P121, DOI 10.1098/rspb.1992.0017; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; Wyman J, 1990, BINDING LINKAGE FUNC; YOUNT RG, 1975, ADV ENZYMOL RAMB, V43, P1; Zingman LV, 2001, NEURON, V31, P233, DOI 10.1016/S0896-6273(01)00356-7	62	21	21	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18894	18902		10.1074/jbc.M113.476887	http://dx.doi.org/10.1074/jbc.M113.476887			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23665564	hybrid, Green Published			2022-12-28	WOS:000321335800027
J	Ranaweera, RS; Yang, XL				Ranaweera, Ruchira S.; Yang, Xiaolu			Auto-ubiquitination of Mdm2 Enhances Its Substrate Ubiquitin Ligase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYMES; IN-VIVO; P53; DEGRADATION; UBIQUITYLATION; ACTIVATION; CASPASES; DOMAINS; COMPLEX; CHAINS	The RING domain E3 ubiquitin ligase Mdm2 is the master regulator of the tumor suppressor p53. It targets p53 for proteasomal degradation, restraining the potent activity of p53 and enabling cell survival and proliferation. Like most E3 ligases, Mdm2 can also ubiquitinate itself. How Mdm2 auto-ubiquitination may influence its substrate ubiquitin ligase activity is undefined. Here we show that auto-ubiquitination of Mdm2 is an activating event. Mdm2 that has been conjugated to polyubiquitin chains, but not to single ubiquitins, exhibits substantially enhanced activity to polyubiquitinate p53. Mechanistically, auto-ubiquitination of Mdm2 facilitates the recruitment of the E2 ubiquitin-conjugating enzyme. This occurs through non-covalent interactions between the ubiquitin chains on Mdm2 and the ubiquitin binding domain on E2s. Mutations that diminish the noncovalent interactions render auto-ubiquitination unable to stimulate Mdm2 substrate E3 activity. These results suggest a model in which polyubiquitin chains on an E3 increase the local concentration of E2 enzymes and permit the processivity of substrate ubiquitination. They also support the notion that autocatalysis may be a prevalent mode for turning on the activity of latent enzymes.	[Yang, Xiaolu] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Yang, Xiaolu] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Yang, XL (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, 421 Curie Blvd, Philadelphia, PA 19104 USA.	xyang@mail.med.upenn.edu		Ranaweera, Ruchira/0000-0002-0671-2936	National Institutes of Health [CA08868]; NATIONAL CANCER INSTITUTE [F32CA008868, P30CA016520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA08868 (to X. Y.).	Beal RE, 1998, BIOCHEMISTRY-US, V37, P2925, DOI 10.1021/bi972514p; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Chang DW, 2003, EMBO J, V22, P4132, DOI 10.1093/emboj/cdg414; Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Huang L, 2011, P NATL ACAD SCI USA, V108, P12001, DOI 10.1073/pnas.1102309108; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Kawai H, 2007, CANCER RES, V67, P6026, DOI 10.1158/0008-5472.CAN-07-1313; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Poyurovsky MV, 2007, EMBO J, V26, P90, DOI 10.1038/sj.emboj.7601465; Saville MK, 2004, J BIOL CHEM, V279, P42169, DOI 10.1074/jbc.M403362200; Tang J, 2006, NAT CELL BIOL, V8, P855, DOI 10.1038/ncb1442; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Yang XL, 1998, MOL CELL, V1, P319, DOI 10.1016/S1097-2765(00)80032-5; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	30	43	46	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18939	18946		10.1074/jbc.M113.454470	http://dx.doi.org/10.1074/jbc.M113.454470			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671280	Green Published, hybrid			2022-12-28	WOS:000321335800031
J	Wen, KK; McKane, M; Rubenstein, PA				Wen, Kuo-Kuang; McKane, Melissa; Rubenstein, Peter A.			Importance of a Lys(113)-Glu(195) Intermonomer Ionic Bond in F-actin Stabilization and Regulation by Yeast Formins Bni1p and Bnr1p	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONS; BINDING; POLYMERIZATION; ACTG1; NUCLEATION; RESIDUES; INSIGHT; COMPLEX; LYSINE; SITE	Proper actin cytoskeletal function requires actin's ability to generate a stable filament and requires that this reaction be regulated by actin-binding proteins via allosteric effects on the actin. Aproposed ionic interaction in the actin filament interior between Lys(113) of one monomer and Glu(195) of a monomer in the apposing strand potentially fosters cross-strand stabilization and allosteric communication between the filament interior and exterior. We interrupted the potential interaction by creating either K113E or E195K actin. By combining the two, we also reversed the interaction with a K113E/E195K (E/K) mutant. In all cases, we isolated viable cells expressing only the mutant actin. Either single mutant cell displays significantly decreased growth in YPD medium. This deficit is rescued in the double mutant. All three mutants display abnormal phalloidin cytoskeletal staining. K113E actin exhibits a critical concentration of polymerization 4 times higher than WT actin, nucleates more poorly, and forms shorter filaments. Restoration of the ionic bond, E/K, eliminates most of these problems. E195K actin behaves much more like WT actin, indicating accommodation of the neighboring lysines. Both Bni1 and Bnr1 formin FH1-FH2 fragment accelerate polymerization of WT, E/K, and to a lesser extent E195K actin. Bni1p FH1-FH2 dramatically inhibits K113E actin polymerization, consistent with barbed end capping. However, Bnr1p FH1-FH2 restores K113E actin polymerization, forming single filaments. In summary, the proposed ionic interaction plays an important role in filament stabilization and in the propagation of allosteric changes affecting formin regulation in an isoform-specific fashion.	[Wen, Kuo-Kuang; McKane, Melissa; Rubenstein, Peter A.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Iowa	Rubenstein, PA (corresponding author), Univ Iowa, Roy A & Lucille A Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA.	peter-rubenstein@uiowa.edu		Rubenstein, Peter/0000-0003-1225-4414	National Institutes of Health [DC8803]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC008803, R01DC008803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC8803 (to P. A. R.).	Boldogh IR, 2005, GENE, V354, P28, DOI 10.1016/j.gene.2005.03.049; Bugyi B, 2006, J BIOL CHEM, V281, P10727, DOI 10.1074/jbc.M510252200; Bugyi B, 2010, ANNU REV BIOPHYS, V39, P449, DOI 10.1146/annurev-biophys-051309-103849; Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Clark MG, 2007, GENETICS, V176, P1527, DOI 10.1534/genetics.107.072066; Durer ZAO, 2011, J MOL BIOL, V414, P204, DOI 10.1016/j.jmb.2011.09.035; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2003, J CELL BIOL, V163, P1057, DOI 10.1083/jcb.200308144; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Goley ED, 2010, P NATL ACAD SCI USA, V107, P8159, DOI 10.1073/pnas.0911668107; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Ishikita H, 2010, FEBS LETT, V584, P3464, DOI 10.1016/j.febslet.2010.07.003; Kruth KA, 2012, J BIOL CHEM, V287, P27217, DOI 10.1074/jbc.M112.377283; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Laing NG, 2009, HUM MUTAT, V30, P1267, DOI 10.1002/humu.21059; Lee CY, 2013, P NATL ACAD SCI USA, V110, P5022, DOI 10.1073/pnas.1218407110; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Malloy LE, 2012, J BIOL CHEM, V287, P28398, DOI 10.1074/jbc.M112.371914; McKane M, 2006, J BIOL CHEM, V281, P29916, DOI 10.1074/jbc.M602251200; Morin M, 2009, HUM MOL GENET, V18, P3075, DOI 10.1093/hmg/ddp249; Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Papp G, 2006, BIOPHYS J, V91, P2564, DOI 10.1529/biophysj.106.087775; Riviere JB, 2012, NAT GENET, V44, P440, DOI 10.1038/ng.1091; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; RUBENSTEIN PA, 1990, BIOESSAYS, V12, P309, DOI 10.1002/bies.950120702; Sahoo N, 2006, MOL BIOL CELL, V17, P895, DOI 10.1091/mbc.E05-06-0512; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHMIDT DE, 1971, BIOCHEMISTRY-US, V10, P1249; Stokasimov E, 2008, J BIOL CHEM, V283, P34844, DOI 10.1074/jbc.M804419200; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; Thompson ME, 2013, NAT STRUCT MOL BIOL, V20, P111, DOI 10.1038/nsmb.2462; Ujfalusi Z, 2010, J PHOTOCH PHOTOBIO B, V98, P7, DOI 10.1016/j.jphotobiol.2009.10.001; Wen KK, 2003, J BIOL CHEM, V278, P48386, DOI 10.1074/jbc.M308980200; Wen KK, 2010, J BIOL CHEM, V285, P21185, DOI 10.1074/jbc.M110.121426; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286	42	7	7	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19140	19153		10.1074/jbc.M113.474122	http://dx.doi.org/10.1074/jbc.M113.474122			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23653364	hybrid, Green Published			2022-12-28	WOS:000321335800048
J	Bianchetti, CM; Harmann, CH; Takasuka, TE; Hura, GL; Dyer, K; Fox, BG				Bianchetti, Christopher M.; Harmann, Connor H.; Takasuka, Taichi E.; Hura, Gregory L.; Dyer, Kevin; Fox, Brian G.			Fusion of Dioxygenase and Lignin-binding Domains in a Novel Secreted Enzyme from Cellulolytic Streptomyces sp SirexAA-E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; PROTOCATECHUATE 3,4-DIOXYGENASE; CRYSTAL-STRUCTURE; KEY ENZYME; CELL-WALL; 1,2-DIOXYGENASE; SUBSTRATE; CLEAVAGE; CRYSTALLOGRAPHY; BIOSYNTHESIS	Streptomyces sp. SirexAA-E is a highly cellulolytic bacterium isolated from an insect/microbe symbiotic community. When grown on lignin-containing biomass, it secretes SACTE_2871, an aromatic ring dioxygenase domain fused to a family 5/12 carbohydrate-binding module (CBM 5/12). Here we present structural and catalytic studies of this novel fusion enzyme, thus providing insight into its function. The dioxygenase domain has the core beta-sandwich fold typical of this enzyme family but lacks a dimerization domain observed in other intradiol dioxygenases. Consequently, the x-ray structure shows that the enzyme is monomeric and the Fe(III)-containing active site is exposed to solvent in a shallow depression on a planar surface. Purified SACTE_2871 catalyzes the O-2-dependent intradiol cleavage of catechyl compounds from lignin biosynthetic pathways, but not their methylated derivatives. Binding studies show that SACTE_2871 binds synthetic lignin polymers and chitin through the interactions of the CBM 5/12 domain, representing a new binding specificity for this fold-family. Based on its unique structural features and functional properties, we propose that SACTE_2871 contributes to the invasive nature of the insect/microbial community by destroying precursors needed by the plant for de novo lignin biosynthesis as part of its natural wounding response.	[Bianchetti, Christopher M.; Harmann, Connor H.; Takasuka, Taichi E.; Fox, Brian G.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Hura, Gregory L.; Dyer, Kevin] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Fox, BG (corresponding author), Univ Wisconsin, 433 Babcock Dr, Madison, WI 53706 USA.	bgfox@biochem.wisc.edu	Takasuka, Taichi/AAF-9441-2020	Takasuka, Taichi/0000-0002-4413-2924; Hura, Greg/0000-0003-0501-8464	United States Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; College of Agricultural and Life Sciences, Department of Biochemistry; Graduate School of the University of Wisconsin; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant [085P1000817]; DOE program Integrated Diffraction Analysis Technologies [IDAT-DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); College of Agricultural and Life Sciences, Department of Biochemistry; Graduate School of the University of Wisconsin; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor Grant; DOE program Integrated Diffraction Analysis Technologies(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Dr. Craig A. Bingman (University of Wisconsin Center for Eukaryotic Structural Genomics) for access to crystallization robotics, Grzegory Sabat (Biotechnology Center, University of Wisconsin-Madison) for assistance with mass spectrometry, Dr. John Ralph and Dr. Yuki Tobimatsu (Great Lakes Bioenergy Research Center, University of Wisconsin) for gifts of synthetic lignins and 5-OH-ferulate, and Dr. Curtis Wilkerson and Saunia Withers (Great Lakes Bioenergy Research Center, Michigan State University) for the gift of the caffeoyl-CoA synthesis enzyme Nt4CL1. We also thank Dr. Ralph for many stimulating discussions on the complexities of lignin. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-ENG-38. Use of the Life Science Collaborative Access Team at the Advanced Photon Source was supported by the College of Agricultural and Life Sciences, Department of Biochemistry, the Graduate School of the University of Wisconsin, the Michigan Economic Development Corporation, and Michigan Technology Tri-Corridor Grant 085P1000817). X-ray scattering studies at the SIBYLS was supported by DOE program Integrated Diffraction Analysis Technologies (IDAT-DE-AC02-05CH11231).	Adams AS, 2011, ISME J, V5, P1323, DOI 10.1038/ismej.2011.14; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akagi K, 2006, J BIOCHEM, V139, P483, DOI 10.1093/jb/mvj062; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; Beuerle T, 2002, ANAL BIOCHEM, V302, P305, DOI 10.1006/abio.2001.5574; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Blommel PG, 2006, PROTEIN EXPRES PURIF, V47, P562, DOI 10.1016/j.pep.2005.11.007; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Brown CK, 2004, ANNU REV MICROBIOL, V58, P555, DOI 10.1146/annurev.micro.57.030502.090927; Brun E, 1997, BIOCHEMISTRY-US, V36, P16074, DOI 10.1021/bi9718494; Carnegie AJ, 2006, ANN FOREST SCI, V63, P119, DOI 10.1051/forest:2005104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dagley S, 1971, Adv Microb Physiol, V6, P1, DOI 10.1016/S0065-2911(08)60066-1; Denness L, 2011, PLANT PHYSIOL, V156, P1364, DOI 10.1104/pp.111.175737; Ferraroni M, 2004, J BIOL CHEM, V279, P27646, DOI 10.1074/jbc.M401692200; Ferraroni M, 2005, J BIOL CHEM, V280, P21144, DOI 10.1074/jbc.M500666200; Ferraroni M, 2006, J MOL BIOL, V360, P788, DOI 10.1016/j.jmb.2006.05.046; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; GILKES NR, 1992, J BIOL CHEM, V267, P6743; Gonzales-Vigil E, 2011, P NATL ACAD SCI USA, V108, P5897, DOI 10.1073/pnas.1016157108; Grabber JH, 2008, BIOMACROMOLECULES, V9, P2510, DOI 10.1021/bm800528f; Hoebeke E. R., 2005, Newsletter of the Michigan Entomological Society, V50, P24; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Ikegami T, 2000, J BIOL CHEM, V275, P13654, DOI 10.1074/jbc.275.18.13654; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; KUKOR JJ, 1983, SCIENCE, V220, P1161, DOI 10.1126/science.220.4602.1161; Matera I, 2010, J STRUCT BIOL, V170, P548, DOI 10.1016/j.jsb.2009.12.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Micalella C, 2011, BBA-PROTEINS PROTEOM, V1814, P817, DOI 10.1016/j.bbapap.2010.09.008; OHLENDORF DH, 1988, NATURE, V336, P403, DOI 10.1038/336403a0; Ohmiya K, 1997, BIOTECHNOL GENET ENG, V14, P365, DOI 10.1080/02648725.1997.10647949; Orville AM, 1997, BIOCHEMISTRY-US, V36, P10039, DOI 10.1021/bi970468n; Orville AM, 1997, BIOCHEMISTRY-US, V36, P10052, DOI 10.1021/bi970469f; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Ralph J, 2010, PHYTOCHEM REV, V9, P65, DOI 10.1007/s11101-009-9141-9; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; SEIDMAN MM, 1969, J BACTERIOL, V97, P1192, DOI 10.1128/JB.97.3.1192-1197.1969; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; STOCKIGT J, 1975, Z NATURFORSCH C, V30, P352; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tobimatsu Y, 2012, CHEMSUSCHEM, V5, P676, DOI 10.1002/cssc.201100573; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vetting MW, 2000, STRUCTURE, V8, P429, DOI 10.1016/S0969-2126(00)00122-2; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; WHITTAKER JW, 1990, METHOD ENZYMOL, V188, P82; WHITTAKER JW, 1984, J BIOL CHEM, V259, P4466; WHITTAKER JW, 1984, J BIOL CHEM, V259, P4476	60	22	23	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18574	18587		10.1074/jbc.M113.475848	http://dx.doi.org/10.1074/jbc.M113.475848			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653358	Green Published, hybrid			2022-12-28	WOS:000320721900057
J	Chiu, TT; Sun, Y; Koshkina, A; Klip, A				Chiu, Tim Ting; Sun, Yi; Koshkina, Alexandra; Klip, Amira			Rac-1 Superactivation Triggers Insulin-independent Glucose Transporter 4 (GLUT4) Translocation That Bypasses Signaling Defects Exerted by c-Jun N-terminal kinase (JNK)- and Ceramide-induced Insulin Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE CELLS; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN-KINASE; PLECKSTRIN HOMOLOGY DOMAIN; NUCLEOTIDE-EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; RICTOR-MTOR COMPLEX; PHOSPHATIDYLINOSITOL 3-KINASE; AKT PHOSPHORYLATION; GLUCOSE-UPTAKE; L6 MYOTUBES	Insulin activates a cascade of signaling molecules, including Rac-1, Akt, and AS160, to promote the net gain of glucose transporter 4 (GLUT4) at the plasma membrane of muscle cells. Interestingly, constitutively active Rac-1 expression results in a hormone-independent increase in surface GLUT4; however, the molecular mechanism and significance behind this effect remain unresolved. Using L6 myoblasts stably expressing myc-tagged GLUT4, we found that overexpression of constitutively active but not wild-type Rac-1 sufficed to drive GLUT4 translocation to the membrane of comparable magnitude with that elicited by insulin. Stimulation of endogenous Rac-1 by Tiam1 overexpression elicited a similar hormone-independent gain in surface GLUT4. This effect on GLUT4 traffic could also be reproduced by acutely activating a Rac-1 construct via rapamycin-mediated heterodimerization. Strategies triggering Rac-1 "superactivation" (i.e. to levels above those attained by insulin alone) produced a modest gain in plasma membrane phosphatidylinositol 3,4,5-trisphosphate, moderate Akt activation, and substantial AS160 phosphorylation, which translated into GLUT4 translocation and negated the requirement for IRS-1. This unique signaling capacity exerted by Rac-1 superactivation bypassed the defects imposed by JNK- and ceramide-induced insulin resistance and allowed full and partial restoration of the GLUT4 translocation response, respectively. We propose that potent elevation of Rac-1 activation alone suffices to drive insulin-independent GLUT4 translocation in muscle cells, and such a strategy might be exploited to bypass signaling defects during insulin resistance.	[Chiu, Tim Ting; Sun, Yi; Koshkina, Alexandra; Klip, Amira] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Chiu, Tim Ting; Klip, Amira] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Klip, A (corresponding author), Hosp Sick Children, Cell Biol Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	amira@sickkids.ca			Canadian Institutes of Health Research (CIHR) [7307]; CIHR; Research Training Centre from the Hospital for Sick Children; Canadian Diabetes Association	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Research Training Centre from the Hospital for Sick Children; Canadian Diabetes Association	This work was supported in part by Canadian Institutes of Health Research (CIHR) Grant 7307 (to A. K.).; Supported by studentships from the CIHR and the Research Training Centre from the Hospital for Sick Children.; Supported by a fellowship from the Canadian Diabetes Association.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; BARON AD, 1988, AM J PHYSIOL, V255, pE769, DOI 10.1152/ajpendo.1988.255.6.E769; Bilan Phillip J., 2009, Archives of Physiology and Biochemistry, V115, P176, DOI 10.1080/13813450903079314; Bohdanowicz M, 2011, METHODS MOL BIOL, V748, P183, DOI 10.1007/978-1-61779-139-0_13; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Bruss MD, 2005, DIABETES, V54, P41, DOI 10.2337/diabetes.54.1.41; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chiu TT, 2010, MOL BIOL CELL, V21, P3529, DOI 10.1091/mbc.E10-04-0316; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Crompton AM, 2000, J BIOL CHEM, V275, P25751, DOI 10.1074/jbc.M002050200; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Fazakerley DJ, 2010, J BIOL CHEM, V285, P1653, DOI 10.1074/jbc.M109.051185; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Gallay N, 2009, LEUKEMIA, V23, P1029, DOI 10.1038/leu.2008.395; GARVEY WT, 1988, J CLIN INVEST, V81, P1528, DOI 10.1172/JCI113485; Gray A, 1999, BIOCHEM J, V344, P929, DOI 10.1042/0264-6021:3440929; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Habegger KM, 2012, ENDOCRINOLOGY, V153, P2130, DOI 10.1210/en.2011-2099; Hajduch E, 2001, DIABETOLOGIA, V44, P173, DOI 10.1007/s001250051596; Henstridge DC, 2012, DIABETOLOGIA, V55, P2769, DOI 10.1007/s00125-012-2652-8; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Huang C, 2005, J BIOL CHEM, V280, P19426, DOI 10.1074/jbc.M412317200; Huynh N, 2010, BBA-MOL CELL RES, V1803, P1106, DOI 10.1016/j.bbamcr.2010.05.007; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Ishikura S, 2008, ACTA PHYSIOL, V192, P61, DOI 10.1111/j.1748-1716.2007.01778.x; Ishikura S, 2008, AM J PHYSIOL-CELL PH, V295, pC1016, DOI 10.1152/ajpcell.00277.2008; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jebailey L, 2004, MOL ENDOCRINOL, V18, P359, DOI 10.1210/me.2003-0294; JeBailey L, 2007, DIABETES, V56, P394, DOI 10.2337/db06-0823; Kewalramani G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026947; Khayat ZA, 2000, J CELL SCI, V113, P279; KINSELLA BT, 1991, J BIOL CHEM, V266, P9786; Mao K, 2008, J MOL CELL CARDIOL, V44, P429, DOI 10.1016/j.yjmcc.2007.10.016; McManus EJ, 2004, EMBO J, V23, P2071, DOI 10.1038/sj.emboj.7600218; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Ng Y, 2010, J BIOL CHEM, V285, P2255, DOI 10.1074/jbc.M109.060236; Niu WY, 2010, AM J PHYSIOL-ENDOC M, V298, pE1058, DOI 10.1152/ajpendo.00773.2009; Patel N, 2003, MOL CELL BIOL, V23, P4611, DOI 10.1128/MCB.23.13.4611-4626.2003; Randhawa VK, 2008, J BIOL CHEM, V283, P27208, DOI 10.1074/jbc.M804282200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Somwar R, 2001, J BIOL CHEM, V276, P46079, DOI 10.1074/jbc.M109093200; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Stratford S, 2001, BIOCHEM J, V354, P359, DOI 10.1042/0264-6021:3540359; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Sylow L., 2013, DIABETES IN PRESS; Talior-Volodarsky I, 2008, J BIOL CHEM, V283, P25115, DOI 10.1074/jbc.M801750200; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Tanti JF, 2009, CURR OPIN PHARMACOL, V9, P753, DOI 10.1016/j.coph.2009.07.004; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Teruel T, 2001, DIABETES, V50, P2563, DOI 10.2337/diabetes.50.11.2563; Thong FSL, 2007, DIABETES, V56, P414, DOI 10.2337/db06-0900; Tong P, 2001, J CLIN INVEST, V108, P371, DOI 10.1172/JCI12348; Torok D, 2004, J CELL SCI, V117, P5447, DOI 10.1242/jcs.01421; Ueda S, 2008, BIOL CELL, V100, P645, DOI 10.1042/BC20070160; Ueda S, 2010, FASEB J, V24, P2254, DOI 10.1096/fj.09-137380; Ueyama A, 1999, AM J PHYSIOL-ENDOC M, V277, pE572, DOI 10.1152/ajpendo.1999.277.3.E572; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang HW, 2012, MOL CELL, V47, P281, DOI 10.1016/j.molcel.2012.05.007; Zaid H, 2008, BIOCHEM J, V413, P201, DOI 10.1042/BJ20080723	79	35	38	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17520	17531		10.1074/jbc.M113.467647	http://dx.doi.org/10.1074/jbc.M113.467647			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640896	Green Published, hybrid			2022-12-28	WOS:000320380600043
J	Malik, RU; Ritt, M; DeVree, BT; Neubig, RR; Sunahara, RK; Sivaramakrishnan, S				Malik, Rabia U.; Ritt, Michael; DeVree, Brian T.; Neubig, Richard R.; Sunahara, Roger K.; Sivaramakrishnan, Sivaraj			Detection of G Protein-selective G Protein-coupled Receptor (GPCR) Conformations in Live Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2) ADRENERGIC-RECEPTOR; TERNARY COMPLEX MODEL; BETA(2)-ADRENERGIC RECEPTOR; CONSTITUTIVE ACTIVATION; RETINITIS-PIGMENTOSA; SYNTHETIC PEPTIDES; CRYSTAL-STRUCTURE; ADENYLYL-CYCLASE; INVERSE AGONISTS; MOLECULAR-BASIS	Although several recent studies have reported that GPCRs adopt multiple conformations, it remains unclear how subtle conformational changes are translated into divergent downstream responses. In this study, we report on a novel class of FRET-based sensors that can detect the ligand/mutagenic stabilization of GPCR conformations that promote interactions with G proteins in live cells. These sensors rely on the well characterized interaction between a GPCR and the C terminus of a G alpha subunit. We use these sensors to elucidate the influence of the highly conserved (E/D) RY motif on GPCR conformation. Specifically, Glu/Asp but not Arg mutants of the (E/D) RY motif are known to enhance basal GPCR signaling. Hence, it is unclear whether ionic interactions formed by the (E/D) RY motif ( ionic lock) are necessary to stabilize basal GPCR states. We find that mutagenesis of the beta 2-AR (E/D) RY ionic lock enhances interaction with G(s). However, only Glu/Asp but not Arg mutants increase G protein activation. In contrast, mutagenesis of the opsin (E/D) RY ionic lock does not alter its interaction with transducin. Instead, opsin-specific ionic interactions centered on residue Lys-296 are both necessary and sufficient to promote interactions with transducin. Effective suppression of beta 2-AR basal activity by inverse agonist ICI 118,551 requires ionic interactions formed by the (E/D) RY motif. In contrast, the inverse agonist metoprolol suppresses interactions with G(s) and promotes G(i) binding, with concomitant pertussis toxin-sensitive inhibition of adenylyl cyclase activity. Taken together, these studies validate the use of the new FRET sensors while revealing distinct structural mechanisms for ligand-dependent GPCR function.	[Malik, Rabia U.; Ritt, Michael; Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [DeVree, Brian T.; Neubig, Richard R.; Sunahara, Roger K.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Sivaramakrishnan, Sivaraj] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Sivaramakrishnan, S (corresponding author), Dept Cell & Dev Biol, 3045 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	sivaraj@umich.edu	soler, martha maricel m gomez/L-6025-2014; DeVree, Brian T/F-6205-2011; Sunahara, Roger/AAJ-8667-2020	soler, martha maricel m gomez/0000-0002-4412-8108; Neubig, Richard/0000-0003-0501-0008; DeVree, Brian/0000-0003-0582-8125	American Heart Association National Scientist Development Grant [13SDG14270009]; McKay award; Rackham Merit fellowship	American Heart Association National Scientist Development Grant(American Heart Association); McKay award; Rackham Merit fellowship	This work was supported by American Heart Association National Scientist Development Grant 13SDG14270009 and McKay award (to S. S.) and the Rackham Merit fellowship (to R. U. M.).	Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bockenhauer S, 2011, J PHYS CHEM B, V115, P13328, DOI 10.1021/jp204843r; CHIDIAC P, 1994, MOL PHARMACOL, V45, P490; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chuang JZ, 2004, J CLIN INVEST, V114, P131, DOI 10.1172/JCI200421136; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Clark MJ, 2004, J PHARMACOL EXP THER, V310, P215, DOI 10.1124/jpet.103.064824; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Conklin BR, 1996, MOL PHARMACOL, V50, P885; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Harrison C, 2003, LIFE SCI, V74, P489, DOI 10.1016/j.lfs.2003.07.005; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Kahsai AW, 2011, NAT CHEM BIOL, V7, P692, DOI [10.1038/NCHEMBIO.634, 10.1038/nchembio.634]; Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101; KJELSBERG MA, 1992, J BIOL CHEM, V267, P1430; Lem J, 2004, TRENDS MOL MED, V10, P150, DOI 10.1016/j.molmed.2004.02.009; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Locht C, 2011, FEBS J, V278, P4668, DOI 10.1111/j.1742-4658.2011.08237.x; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Musarella M. A., 2011, J OPHTHALMOL, P1; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Onaran HO, 2012, NAT CHEM BIOL, V8, P674, DOI 10.1038/nchembio.1024; Rao VR, 1996, ANNU REV BIOPH BIOM, V25, P287; RASENICK MM, 1994, J BIOL CHEM, V269, P21519; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Rudling JE, 2000, BRIT J PHARMACOL, V131, P933, DOI 10.1038/sj.bjp.0703644; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sivaramakrishnan S, 2011, P NATL ACAD SCI USA, V108, P20467, DOI 10.1073/pnas.1116066108; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vilardaga JP, 2005, NAT CHEM BIOL, V1, P25, DOI 10.1038/nchembio705; Wacker D, 2010, J AM CHEM SOC, V132, P11443, DOI 10.1021/ja105108q; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106	44	49	49	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17167	17178		10.1074/jbc.M113.464065	http://dx.doi.org/10.1074/jbc.M113.464065			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629648	hybrid, Green Published			2022-12-28	WOS:000320380600014
J	Svensson, KJ; Christianson, HC; Wittrup, A; Bourseau-Guilmain, E; Lindqvist, E; Svensson, LM; Morgelin, M; Belting, M				Svensson, Katrin J.; Christianson, Helena C.; Wittrup, Anders; Bourseau-Guilmain, Erika; Lindqvist, Eva; Svensson, Lena M.; Morgelin, Matthias; Belting, Mattias			Exosome Uptake Depends on ERK1/2-Heat Shock Protein 27 Signaling and Lipid Raft-mediated Endocytosis Negatively Regulated by Caveolin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROVESICLES; CELLS; PATHWAY; TRANSFORMATION; CANCER; SIMIAN-VIRUS-40; BIOGENESIS; MECHANISMS; REVEALS; PROVIDE	The role of exosomes in cancer can be inferred from the observation that they transfer tumor cell derived genetic material and signaling proteins, resulting in e.g. increased tumor angiogenesis and metastasis. However, the membrane transport mechanisms and the signaling events involved in the uptake of these virus-like particles remain ill-defined. We now report that internalization of exosomes derived from glioblastoma (GBM) cells involves nonclassical, lipid raft-dependent endocytosis. Importantly, we show that the lipid raft-associated protein caveolin-1 (CAV1), in analogy with its previously described role in virus uptake, negatively regulates the uptake of exosomes. We find that exosomes induce the phosphorylation of several downstream targets known to associate with lipid rafts as signaling and sorting platforms, such as extracellular signal-regulated kinase-1/2 (ERK1/2) and heat shock protein 27 (HSP27). Interestingly, exosome uptake appears dependent on unperturbed ERK1/2-HSP27 signaling, and ERK1/2 phosphorylation is under negative influence by CAV1 during internalization of exosomes. These findings significantly advance our general understanding of exosome-mediated uptake and offer potential strategies for how this pathway may be targeted through modulation of CAV1 expression and ERK1/2 signaling.	[Svensson, Katrin J.; Christianson, Helena C.; Wittrup, Anders; Bourseau-Guilmain, Erika; Lindqvist, Eva; Belting, Mattias] Lund Univ, Sect Oncol, Dept Clin Sci, SE-22184 Lund, Sweden; [Svensson, Lena M.] Lund Univ, Immunol Sect, Dept Expt Med Sci, SE-22184 Lund, Sweden; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, Sect Clin & Expt Infect Med, SE-22184 Lund, Sweden; [Wittrup, Anders] Harvard Univ, Sch Med, Boston Childrens Hosp, Program Mol & Cellular Med, Boston, MA 02115 USA; [Belting, Mattias] Skane Univ Hosp, Dept Oncol, SE-22241 Lund, Sweden	Lund University; Lund University; Lund University; Harvard University; Boston Children's Hospital; Harvard Medical School; Lund University; Skane University Hospital	Svensson, KJ (corresponding author), Lund Univ, Sect Oncol, Dept Clin Sci, Barngatan 2B, SE-22185 Lund, Sweden.	Katrin.Svensson@med.lu.se	Svensson, Katrin J./AAA-4770-2021	Svensson, Katrin J./0000-0001-5376-5128; Wittrup, Anders/0000-0003-4918-0500; Belting, Mattias/0000-0003-1585-5434	Swedish Cancer Fund; Swedish Research Council; Swedish Society of Medicine; Physiographic Society, Lund; Crafoordska Foundation; Gunnar Nilsson Foundation; Lundbergs Foundation; Kamprad Foundation; Skane University Hospital; Governmental Funding of Clinical Research within the National Health Services	Swedish Cancer Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Physiographic Society, Lund; Crafoordska Foundation; Gunnar Nilsson Foundation; Lundbergs Foundation; Kamprad Foundation; Skane University Hospital; Governmental Funding of Clinical Research within the National Health Services	This work was supported by grants from the Swedish Cancer Fund; the Swedish Research Council; the Swedish Society of Medicine; the Physiographic Society, Lund; the Crafoordska, Gunnar Nilsson, Lundbergs, and Kamprad Foundations; the Skane University Hospital donation funds; and the Governmental Funding of Clinical Research within the National Health Services (to A. L. F.).	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Baroni M, 2007, FASEB J, V21, P1926, DOI 10.1096/fj.06-7238com; Belting M, 2008, J CELL BIOL, V183, P1187, DOI 10.1083/jcb.200810038; Chen HY, 2006, INT J BIOCHEM CELL B, V38, P1402, DOI 10.1016/j.biocel.2006.02.006; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Engelman JA, 1998, FEBS LETT, V428, P205, DOI 10.1016/S0014-5793(98)00470-0; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Fujioka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016324; Gosens R, 2006, AM J PHYSIOL-LUNG C, V291, pL523, DOI 10.1152/ajplung.00013.2006; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Koppers-Lalic D, 2013, ADV DRUG DELIVER REV, V65, P348, DOI 10.1016/j.addr.2012.07.006; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Medina RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002584; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Razandi M, 2010, MOL CELL BIOL, V30, P3249, DOI 10.1128/MCB.01354-09; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sasai K, 2007, ONCOGENE, V26, P449, DOI 10.1038/sj.onc.1209792; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Svensson KJ, 2011, P NATL ACAD SCI USA, V108, P13147, DOI 10.1073/pnas.1104261108; Williams TM, 2005, AM J PHYSIOL-CELL PH, V288, pC494, DOI 10.1152/ajpcell.00458.2004; Wittrup A, 2010, P NATL ACAD SCI USA, V107, P13342, DOI 10.1073/pnas.1002622107	40	435	447	7	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17713	17724		10.1074/jbc.M112.445403	http://dx.doi.org/10.1074/jbc.M112.445403			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23653359	hybrid, Green Published			2022-12-28	WOS:000320380600061
J	Ye, F; Zhang, J; Liu, HC; Hilgenfeld, R; Zhang, RH; Kong, XQ; Li, LC; Lu, JY; Zhang, XL; Li, DH; Jiang, HL; Yang, CG; Luo, C				Ye, Fei; Zhang, Jie; Liu, Hongchuan; Hilgenfeld, Rolf; Zhang, Ruihan; Kong, Xiangqian; Li, Lianchun; Lu, Junyan; Zhang, Xinlei; Li, Donghai; Jiang, Hualiang; Yang, Cai-Guang; Luo, Cheng			Helix Unfolding/Refolding Characterizes the Functional Dynamics of Staphylococcus aureus Clp Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ENERGY LANDSCAPE; STRESS TOLERANCE; BETA-LACTONES; RECOGNITION; VIRULENCE; INSIGHTS; ASSOCIATION; ACTIVATION; TERMINUS	The ATP-dependent Clp protease (ClpP) plays an essential role not only in the control of protein quality but also in the regulation of bacterial pathogen virulence, making it an attractive target for antibacterial treatment. We have previously determined the crystal structures of Staphylococcus aureus ClpP (SaClpP) in two different states, extended and compressed. To investigate the dynamic switching of ClpP between these states, we performed a series of molecular dynamics simulations. During the structural transition, the long and straight helix E in the extended SaClpP monomer underwent an unfolding/refolding process, resulting in a kinked helix very similar to that in the compressed monomer. As a stable intermediate in the molecular dynamics simulation, the compact state was suggested and subsequently identified in x-ray crystallographic experiment. Our combined studies also determined that Ala(140) acted as a "hinge" during the transition between the extended and compressed states, and Glu(137) was essential for stabilizing the compressed state. Overall, this study provides molecular insights into the dynamics and mechanism of the functional conformation changes of SaClpP. Given the highly conserved sequences of ClpP proteins among different species, these findings potentially reflect a switching mechanism for the dynamic process shared in the whole ClpP family in general and thus aid in better understand the principles of Clp protease assembly and function.	[Ye, Fei; Zhang, Jie; Liu, Hongchuan; Hilgenfeld, Rolf; Zhang, Ruihan; Kong, Xiangqian; Li, Lianchun; Lu, Junyan; Zhang, Xinlei; Jiang, Hualiang; Yang, Cai-Guang; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Hilgenfeld, Rolf] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, D-23538 Lubeck, Germany; [Zhang, Xinlei] Fourth Mil Med Univ, Sch Pharm, Xian 710032, Peoples R China; [Li, Donghai] Nanjing Univ, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China; [Yang, Cai-Guang] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Lubeck; Air Force Military Medical University; Nanjing University; Lanzhou University	Jiang, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China.	hljiang@mail.shcnc.ac.cn; yangcg@simm.ac.cn; cluo@mail.shcnc.ac.cn	zhang, ruihan/GZA-3812-2022; Kong, Xiangqian/J-4500-2017; Hilgenfeld, Rolf/C-9675-2011	Kong, Xiangqian/0000-0002-9596-7825; Lu, Junyan/0000-0002-9211-0746; Zhang, Ruihan/0000-0002-7350-1370	National High Technology Research and Development Program of China [2012AA020302]; National Natural Science Foundation of China [21172234, 90913010, 81230076, 21210003, 21021063]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" [2013ZX09507-004]; Key Project of Chinese National Programs for Fundamental Research and Development [2009CB918502]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2010T1S6]; Deutsche Forschungsgemeinschaft Cluster of Excellence [306]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program"; Key Project of Chinese National Programs for Fundamental Research and Development; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists; Deutsche Forschungsgemeinschaft Cluster of Excellence(German Research Foundation (DFG))	This work was supported in part by National High Technology Research and Development Program of China Grant 2012AA020302; National Natural Science Foundation of China Grants 21172234, 90913010, 81230076, 21210003, and 21021063; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program" Grant 2013ZX09507-004; and Key Project of Chinese National Programs for Fundamental Research and Development Grant 2009CB918502.; Supported by a Chinese Academy of Sciences Visiting Professorship for Senior International Scientists, Grant 2010T1S6, and by Deutsche Forschungsgemeinschaft Cluster of Excellence 306.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bottcher T, 2008, J AM CHEM SOC, V130, P14400, DOI 10.1021/ja8051365; Bottcher T, 2008, ANGEW CHEM INT EDIT, V47, P4600, DOI 10.1002/anie.200705768; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; BUSHEY MM, 1989, J CHROMATOGR, V480, P301, DOI 10.1016/S0021-9673(01)84299-0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; El Bakkouri M, 2010, J MOL BIOL, V404, P456, DOI 10.1016/j.jmb.2010.09.051; Fletcher R., 1980, PRACTICAL METHODS OP, V1, P1; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Frees D, 2003, MOL MICROBIOL, V48, P1565, DOI 10.1046/j.1365-2958.2003.03524.x; Gabdoulline RR, 1997, BIOPHYS J, V72, P1917, DOI 10.1016/S0006-3495(97)78838-6; Garcia AE, 2001, PROTEINS, V42, P345, DOI 10.1002/1097-0134(20010215)42:3<345::AID-PROT50>3.0.CO;2-H; Geiger SR, 2011, ANGEW CHEM INT EDIT, V50, P5748, DOI 10.1002/anie.201100666; Gersch M, 2012, J BIOL CHEM, V287, P9484, DOI 10.1074/jbc.M111.336222; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Gribun A, 2005, J BIOL CHEM, V280, P16185, DOI 10.1074/jbc.M414124200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Ingvarsson H, 2007, ACTA CRYSTALLOGR D, V63, P249, DOI 10.1107/S0907444906050530; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kang SG, 2004, J STRUCT BIOL, V148, P338, DOI 10.1016/j.jsb.2004.07.004; Kim DY, 2008, J MOL BIOL, V379, P760, DOI 10.1016/j.jmb.2008.04.036; Kimber MS, 2010, STRUCTURE, V18, P798, DOI 10.1016/j.str.2010.04.008; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; Lee BG, 2011, MOL CELLS, V32, P589, DOI 10.1007/s10059-011-0197-1; Lee BG, 2010, NAT STRUCT MOL BIOL, V17, P471, DOI 10.1038/nsmb.1787; Li DHS, 2010, CHEM BIOL, V17, P959, DOI 10.1016/j.chembiol.2010.07.008; Maglica Z, 2009, STRUCTURE, V17, P508, DOI 10.1016/j.str.2009.02.014; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Maurizi MR, 1998, BIOCHEMISTRY-US, V37, P7778, DOI 10.1021/bi973093e; Michel A, 2006, J BACTERIOL, V188, P5783, DOI 10.1128/JB.00074-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papaleo E, 2009, J MOL GRAPH MODEL, V27, P889, DOI 10.1016/j.jmgm.2009.01.006; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Szyk A, 2006, J STRUCT BIOL, V156, P165, DOI 10.1016/j.jsb.2006.03.013; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Walsh C, 2005, CHEM REV, V105, P391, DOI 10.1021/cr030100y; WARSHEL A, 1991, ANNU REV BIOPHYS BIO, V20, P267, DOI 10.1146/annurev.biophys.20.1.267; Williams KJ, 2009, CURR OPIN INVEST DR, V10, P157; Wong P, 2004, J STRUCT BIOL, V146, P79, DOI 10.1016/j.jsb.2003.11.006; YANG AS, 1994, J MOL BIOL, V237, P602, DOI 10.1006/jmbi.1994.1258; Zhang J, 2011, J BIOL CHEM, V286, P37590, DOI 10.1074/jbc.M111.277848; Zhou RH, 2001, P NATL ACAD SCI USA, V98, P14931, DOI 10.1073/pnas.201543998	54	32	32	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17643	17653		10.1074/jbc.M113.452714	http://dx.doi.org/10.1074/jbc.M113.452714			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625918	hybrid, Green Published			2022-12-28	WOS:000320380600055
J	Sundivakkam, PC; Natarajan, V; Malik, AB; Tiruppathi, C				Sundivakkam, Premanand C.; Natarajan, Viswanathan; Malik, Asrar B.; Tiruppathi, Chinnaswamy			Store-operated Ca2(+) Entry (SOCE) Induced by Protease-activated Receptor-1 Mediates STIM1 Protein Phosphorylation to Inhibit SOCE in Endothelial Cells through AMP-activated Protein Kinase and p38 beta Mitogen-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; P38 MAP-KINASES; CA2+ ENTRY; CALCIUM-ENTRY; TRPC1 EXPRESSION; TARGET SITES; CHANNELS; PATHWAY; ORAI1; CRAC	The Ca2(+) sensor STIM1 is crucial for activation of store-operated Ca2(+) entry (SOCE) through transient receptor potential canonical and Orai channels. STIM1 phosphorylation serves as an "off switch" for SOCE. However, the signaling pathway for STIM1 phosphorylation is unknown. Here, we show that SOCE activates AMP-activated protein kinase (AMPK); its effector p38 beta mitogen-activated protein kinase (p38 beta MAPK) phosphorylates STIM1, thus inhibiting SOCE in human lung microvascular endothelial cells. Activation of AMPK using 5-aminoimidazole- 4-carboxamide-1-beta-D-ribofuranoside (AICAR) resulted in STIM1 phosphorylation on serine residues and prevented protease-activated receptor-1 (PAR-1)-induced Ca2(+) entry. Furthermore, AICAR pretreatment blocked PAR-1-induced increase in the permeability of mouse lung microvessels. Activation of SOCE with thrombin caused phosphorylation of isoform beta 1 but not beta 2 of theAMPKcatalytic subunit. Moreover, knockdown of AMPK beta 1 augmented SOCE induced by thrombin. Interestingly, SB203580, a selective inhibitor of p38 MAPK, blocked STIM1 phosphorylation and led to sustained STIM1puncta formation and Ca2(+) entry. Of the three p38 MAPK isoforms expressed in endothelial cells, p38 beta knockdown prevented PAR-1-mediated STIM1 phosphorylation and potentiated SOCE. In addition, inhibition of the SOCE downstream target CaM kinase kinase beta (CaMKK beta) or knockdown of AMPK beta 1 suppressed PAR-1-mediated phosphorylation of p38 beta and hence STIM1. Thus, our findings demonstrate that SOCE activates CaMKK beta-AMPK beta 1-p38 beta MAPK signaling to phosphorylate STIM1, thereby suppressing endothelial SOCE and permeability responses.	Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Ctr Lung & Vasc Biol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tiruppathi, C (corresponding author), Univ Illinois, Dept Pharmacol MC868, Coll Med, 835 South Wolcott Ave, Chicago, IL 60612 USA.	tiruc@uic.edu		Malik, Asrar/0000-0002-8205-7128	National Institutes of Health [GM058531, P01HL077806]; postdoctoral fellowship from Midwest Affiliate American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806, P01HL060678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058531] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); postdoctoral fellowship from Midwest Affiliate American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM058531 and P01HL077806. This work was also supported by a postdoctoral fellowship from Midwest Affiliate American Heart Association (to P.C.S.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Bair AM, 2009, J BIOL CHEM, V284, P563, DOI 10.1074/jbc.M803984200; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Creighton J, 2011, FASEB J, V25, P3356, DOI 10.1096/fj.10-179218; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Ferrari G, 2012, MOL CANCER RES, V10, P605, DOI 10.1158/1541-7786.MCR-11-0507; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kaneider NC, 2007, NAT IMMUNOL, V8, P1303, DOI 10.1038/ni1525; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lee KP, 2010, FEBS LETT, V584, P2022, DOI 10.1016/j.febslet.2009.11.078; Lemieux K, 2003, FASEB J, V17, P1658, DOI 10.1096/fj.02-1125com; Li J, 2005, CIRC RES, V97, P872, DOI 10.1161/01.RES.0000187458.77026.10; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Liu C, 2010, J BIOL CHEM, V285, P15346, DOI 10.1074/jbc.M110.102491; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Paria BC, 2004, AM J PHYSIOL-LUNG C, V287, pL1303, DOI 10.1152/ajplung.00240.2004; Paria BC, 2006, J BIOL CHEM, V281, P20715, DOI 10.1074/jbc.M600722200; Pozo-Guisado E, 2010, J CELL SCI, V123, P3084, DOI 10.1242/jcs.067215; Risco A, 2012, P NATL ACAD SCI USA, V109, P11200, DOI 10.1073/pnas.1207290109; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Sundivakkam PC, 2009, AM J PHYSIOL-CELL PH, V296, pC403, DOI 10.1152/ajpcell.00470.2008; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Thors B, 2011, BBA-MOL CELL RES, V1813, P322, DOI 10.1016/j.bbamcr.2010.12.001; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsoyi K, 2011, BRIT J PHARMACOL, V162, P1498, DOI 10.1111/j.1476-5381.2010.01126.x; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008	43	41	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					17030	17041		10.1074/jbc.M112.411272	http://dx.doi.org/10.1074/jbc.M112.411272			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625915	Green Published, hybrid			2022-12-28	WOS:000320378900074
J	Wallin, H; Abrahamson, M; Ekstrom, U				Wallin, Hanna; Abrahamson, Magnus; Ekstrom, Ulf			Cystatin C Properties Crucial for Uptake and Inhibition of Intracellular Target Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE PROTEINASE-INHIBITORS; BREAST-CANCER CELLS; CATHEPSIN-B; PROTEASE INHIBITORS; ESCHERICHIA-COLI; REACTIVE-SITE; EXPRESSION; INVASION; RECEPTOR; BINDING	To elucidate the molecular requirements for cancer cell internalization of the extracellular cysteine protease inhibitor cystatin C, 12 variants of the protein were produced and used for uptake experiments in MCF-7 cells. Variants with alterations in the cysteine cathepsin binding region (( Delta 1-10)-, K5A-, R8G-, (R8G, L9G, V10G)-, (R8G, L9G, V10G, W106G)-, and W106Gcystatin C) were internalized to a very low extent compared with the wild-type inhibitor. Substitutions of N39 in the legumain binding region (N39K-and N39A-cystatin C) decreased the internalization and (R24A, R25A)-cystatin C, with substitutions of charged residues not involved in enzyme inhibition, was not taken up at all. Two variants, W106F-and K75A-cystatin C, showed that the internalization can be positively affected by engineering of the cystatin molecule. Microscopy revealed vesicular co-localization of internalized cystatin C with the lysosomal marker proteins cathepsin D and legumain. Activities of both cysteine cathepsins and legumain, possible target enzymes associated with cancer cell invasion and metastasis, were down-regulated in cell homogenates following cystatin C uptake. A positive effect on regulation of intracellular enzyme activity by a cystatin variant selected from uptake properties was illustrated by incubating cells with W106Fcystatin C. This resulted in more efficient down-regulation of intracellular legumain activity than when cells were incubated with wild-type cystatin C. Uptake experiments in prostate cancer cells corroborated that the cystatin C internalization is generally relevant and confirmed an increased uptake of W106F-cystatin C, in PC3 cells. Thus, intracellular cysteine proteases involved in cancer-promoting processes might be controled by cystatin uptake.	[Wallin, Hanna; Abrahamson, Magnus; Ekstrom, Ulf] Lund Univ, Dept Lab Med, SE-22185 Lund, Sweden	Lund University	Abrahamson, M (corresponding author), Lund Univ, Univ Hosp, Dept Lab Med, Div Clin Chem & Pharmacol, SE-22185 Lund, Sweden.	Magnus.Abrahamson@med.lu.se	Abrahamson, Magnus/CAG-9507-2022		Faculty of Medicine at Lund University and BioCARE; Swedish Research Council [05196]; Osterberg Foundation	Faculty of Medicine at Lund University and BioCARE; Swedish Research Council(Swedish Research CouncilEuropean Commission); Osterberg Foundation	This study was supported by the Faculty of Medicine at Lund University and BioCARE, and in part by grants from the Swedish Research Council (no. 05196) and the A. Osterberg Foundation.	ABRAHAMSON M, 1988, FEBS LETT, V236, P14, DOI 10.1016/0014-5793(88)80276-X; ABRAHAMSON M, 1991, BIOCHEM J, V273, P621, DOI 10.1042/bj2730621; ABRAHAMSON M, 1986, J BIOL CHEM, V261, P1282; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Alvarez-Fernandez M, 2005, J BIOL CHEM, V280, P18221, DOI 10.1074/jbc.M411914200; BASTHOLM L, 1994, BIOTECH HISTOCHEM, V69, P61, DOI 10.3109/10520299409106263; Bjork I, 1996, BIOCHEMISTRY-US, V35, P10720, DOI 10.1021/bi960420u; Briggs JJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-17; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; CHAUHAN SS, 1991, CANCER RES, V51, P1478; Chen XB, 2010, BIOCHEM BIOPH RES CO, V391, P1070, DOI 10.1016/j.bbrc.2009.12.022; Cheng T, 2006, J BIOL CHEM, V281, P15893, DOI 10.1074/jbc.M600694200; Coulibaly S, 1999, INT J CANCER, V83, P526, DOI 10.1002/(SICI)1097-0215(19991112)83:4<526::AID-IJC15>3.3.CO;2-D; DALBOGE H, 1989, GENE, V79, P325, DOI 10.1016/0378-1119(89)90214-X; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Ekstrom U, 2008, FEBS J, V275, P4571, DOI 10.1111/j.1742-4658.2008.06600.x; HALL A, 1995, J BIOL CHEM, V270, P5115, DOI 10.1074/jbc.270.10.5115; Ishibashi O, 1999, Cancer Biochem Biophys, V17, P69; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; KOBAYASHI H, 1991, J BIOL CHEM, V266, P5147; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Kolkhorst V, 1998, J CANCER RES CLIN, V124, P598, DOI 10.1007/s004320050221; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; LINDAHL P, 1992, BIOCHEM J, V281, P49, DOI 10.1042/bj2810049; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; OLAFSSON I, 1988, SCAND J CLIN LAB INV, V48, P573, DOI 10.3109/00365518809085775; Pulukuri SM, 2009, ONCOGENE, V28, P2829, DOI 10.1038/onc.2009.134; Qiu J, 2008, LAB INVEST, V88, P910, DOI 10.1038/labinvest.2008.66; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; SCADDAN PB, 1993, INVAS METAST, V13, P301; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; Sotiropoulou G, 1997, J BIOL CHEM, V272, P903, DOI 10.1074/jbc.272.2.903; Vasiljeva O, 2008, BIOCHIMIE, V90, P380, DOI 10.1016/j.biochi.2007.10.004; Vasiljeva O, 2006, CANCER RES, V66, P5242, DOI 10.1158/0008-5472.CAN-05-4463; Wallin H, 2010, BIOCHIMIE, V92, P1625, DOI 10.1016/j.biochi.2010.08.011; Xing R, 1998, BIOCHEM J, V336, P667, DOI 10.1042/bj3360667; Xing RY, 1998, CANCER RES, V58, P904	37	26	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					17019	17029		10.1074/jbc.M113.453449	http://dx.doi.org/10.1074/jbc.M113.453449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23629651	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000320378900073
J	Kubiak, X; de la Sierra-Gallay, IL; Chaffotte, AF; Pluvinage, B; Weber, P; Haouz, A; Dupret, JM; Rodrigues-Lima, F				Kubiak, Xavier; de la Sierra-Gallay, Ines Li; Chaffotte, Alain F.; Pluvinage, Benjamin; Weber, Patrick; Haouz, Ahmed; Dupret, Jean-Marie; Rodrigues-Lima, Fernando			Structural and Biochemical Characterization of an Active Arylamine N-Acetyltransferase Possessing a Non-canonical Cys-His-Glu Catalytic Triad	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; BACILLUS-ANTHRACIS; ESCHERICHIA-COLI; PROTEIN; MECHANISM; IDENTIFICATION; STABILITY; BINDING; SULFAMETHOXAZOLE; INTERMEDIATE	Arylamine N-acetyltransferases (NATs), a class of xenobiotic-metabolizing enzymes, catalyze the acetylation of aromatic amine compounds through a strictly conserved Cys-His-Asp catalytic triad. Each residue is essential for catalysis in both prokaryotic and eukaryotic NATs. Indeed, in(HUMAN) NAT2 variants, mutation of the Asp residue to Asn, Gln, or Glu dramatically impairs enzyme activity. However, a putative atypical NAT harboring a catalytic triad Glu residue was recently identified in Bacillus cereus ((BACCR)NAT3) but has not yet been characterized. We report here the crystal structure and functional characterization of this atypical NAT. The overall fold of (BACCR) NAT3 and the geometry of its Cys-His-Glu catalytic triad are similar to those present in functional NATs. Importantly, the enzyme was found to be active and to acetylate prototypic arylamine NAT substrates. In contrast to (HUMAN) NAT2, the presence of a Glu or Asp in the triad of (BACCR) NAT3 did not significantly affect enzyme structure or function. Computational analysis identified differences in residue packing and steric constraints in the active site of (BACCR) NAT3 that allow it to accommodate a Cys-His-Glu triad. These findings overturn the conventional view, demonstrating that the catalytic triad of this family of acetyltransferases is plastic. Moreover, they highlight the need for further study of the evolutionary history of NATs and the functional significance of the predominant Cys-His-Asp triad in both prokaryotic and eukaryotic forms.	[Kubiak, Xavier; Pluvinage, Benjamin; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, Sorbonne Paris Cite, CNRS EAC4413, Unite Biol Fonctionnelle & Adaptat, F-75013 Paris, France; [de la Sierra-Gallay, Ines Li] Univ Paris 11, CNRS UMR8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France; [Chaffotte, Alain F.] Inst Pasteur, Unite Resonance Magnet Nucl Biomol, F-75015 Paris, France; [Weber, Patrick; Haouz, Ahmed] Inst Pasteur, CNRS UMR3528, F-75724 Paris, France	UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS EAC4413, Unite Biol Fonctionnelle & Adaptat, 4 Rue Marie Andree Lagroua Weill Halle, F-75013 Paris, France.	fernando.rodrigues-lima@univ-paris-diderot.fr		Li de la Sierra-Gallay, Ines/0000-0003-2770-7439; HAOUZ, Ahmed/0000-0003-1196-1635	Universite Paris Diderot-Paris 7; Delegation Generale de l'Armement (DGA); Institut Pasteur Paris; CNRS; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; DGA	Universite Paris Diderot-Paris 7; Delegation Generale de l'Armement (DGA); Institut Pasteur Paris; CNRS(Centre National de la Recherche Scientifique (CNRS)); French Infrastructure for Integrated Structural Biology (FRISBI); DGA	This work was supported in part by the Universite Paris Diderot-Paris 7, Delegation Generale de l'Armement (DGA), the Institut Pasteur Paris, the CNRS and French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INSB-05-01.; Supported by a fellowship from the DGA. Present address: Biochemistry and Microbiology, University of Victoria, Victoria, British Columbia BC V8P 5C2, Canada.	Bricogne G., 2011, BUSTER VERSION 2 10; Brooke EW, 2003, BIOORGAN MED CHEM, V11, P1227, DOI 10.1016/S0968-0896(02)00642-9; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chu XM, 2008, APPL MICROBIOL BIOT, V80, P615, DOI 10.1007/s00253-008-1566-3; Cleland WW, 1995, FASEB J, V9, P1585, DOI 10.1096/fasebj.9.15.8529838; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; DUPRET JM, 1992, J BIOL CHEM, V267, P7381; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fullam E, 2008, J MOL BIOL, V375, P178, DOI 10.1016/j.jmb.2007.10.019; Glenn AE, 2010, FEBS LETT, V584, P3158, DOI 10.1016/j.febslet.2010.05.063; Gonnelli G, 2012, J BIOTECHNOL, V161, P287, DOI 10.1016/j.jbiotec.2012.06.020; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hammarstrom P, 1999, J BIOL CHEM, V274, P32897, DOI 10.1074/jbc.274.46.32897; Hein DW, 2002, MUTAT RES-FUND MOL M, V506, P65, DOI 10.1016/S0027-5107(02)00153-7; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; King SM, 1999, PROTEINS, V35, P313, DOI 10.1002/(SICI)1097-0134(19990515)35:3<313::AID-PROT5>3.3.CO;2-T; Krekel F, 2000, BIOCHEMISTRY-US, V39, P12671, DOI 10.1021/bi001310x; Kubiak X, 2013, EXPERT OPIN DRUG MET, V9, P349, DOI 10.1517/17425255.2013.742505; Kubiak X, 2012, ACTA CRYSTALLOGR F, V68, P196, DOI 10.1107/S1744309111053942; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le HT, 2009, J MOL BIOL, V393, P58, DOI 10.1016/j.jmb.2009.07.072; LONDON J, 1974, EUR J BIOCHEM, V47, P409, DOI 10.1111/j.1432-1033.1974.tb03707.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehta D. K., 2005, TRANSGLUTAMINASES FA; MITRAKI A, 1987, EUR J BIOCHEM, V163, P29, DOI 10.1111/j.1432-1033.1987.tb10732.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pillay D, 2010, PROTEIN EXPRES PURIF, V74, P264, DOI 10.1016/j.pep.2010.06.021; Pluvinage B, 2007, BIOCHEMISTRY-US, V46, P7069, DOI 10.1021/bi700351w; Pluvinage B, 2011, FEBS LETT, V585, P3947, DOI 10.1016/j.febslet.2011.10.041; Rajasekaran M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025801; RIDDLE B, 1971, J BIOL CHEM, V246, P3250; Rodrigues-Lima F, 2002, BIOCHEM BIOPH RES CO, V293, P783, DOI 10.1016/S0006-291X(02)00299-1; Rodrigues-Lima F, 2001, BIOCHEM J, V356, P327, DOI 10.1042/0264-6021:3560327; Saleh L, 2011, BIOCHEMISTRY-US, V50, P10576, DOI 10.1021/bi200810j; Sandy J, 2005, BIOCHEM J, V390, P115, DOI 10.1042/BJ20050277; Sandy J, 2005, PROTEIN SCI, V14, P775, DOI 10.1110/ps.041163505; Sikora AL, 2008, BIOCHEMISTRY-US, V47, P10781, DOI 10.1021/bi800398c; Sim E, 2012, ADV PHARMACOL, V63, P169, DOI 10.1016/B978-0-12-398339-8.00005-7; Sim E, 2008, TOXICOLOGY, V254, P170, DOI 10.1016/j.tox.2008.08.022; Sinclair JC, 2000, NAT STRUCT BIOL, V7, P560; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Southworth MW, 2000, EMBO J, V19, P5019, DOI 10.1093/emboj/19.18.5019; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang HQ, 2004, BIOCHEMISTRY-US, V43, P8234, DOI 10.1021/bi0497244; WEBER WW, 1985, PHARMACOL REV, V37, P25; Westwood Isaac M., 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-3; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu H, 2007, J BIOL CHEM, V282, P30189, DOI 10.1074/jbc.M704138200; Xu Q, 2004, PROTEIN SCI, V13, P1851, DOI 10.1110/ps.04699904; Zang Y, 2007, PHARMACOGENET GENOM, V17, P37, DOI 10.1097/01.fpc.0000236325.73186.2c; Zhou X, 2009, FEBS J, V276, P6928, DOI 10.1111/j.1742-4658.2009.07389.x	53	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22493	22505		10.1074/jbc.M113.468595	http://dx.doi.org/10.1074/jbc.M113.468595			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23770703	Green Published, hybrid			2022-12-28	WOS:000330596300030
J	Rolain, T; Bernard, E; Beaussart, A; Degand, H; Courtin, P; Egge-Jacobsen, W; Bron, PA; Morsomme, P; Kleerebezem, M; Chapot-Chartier, MP; Dufrene, YF; Hols, P				Rolain, Thomas; Bernard, Elvis; Beaussart, Audrey; Degand, Herve; Courtin, Pascal; Egge-Jacobsen, Wolfgang; Bron, Peter A.; Morsomme, Pierre; Kleerebezem, Michiel; Chapot-Chartier, Marie-Pierre; Dufrene, Yves F.; Hols, Pascal			O-Glycosylation as a Novel Control Mechanism of Peptidoglycan Hydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOBACILLUS-PLANTARUM WCFS1; DIAMINO ACID ENDOPEPTIDASE; LACTOCOCCUS-LACTIS; TEICHOIC-ACIDS; STAPHYLOCOCCUS-AUREUS; CELL-SEPARATION; BACTERIAL-PEPTIDOGLYCAN; N-ACETYLGLUCOSAMINIDASE; LISTERIA-MONOCYTOGENES; PROTEIN GLYCOSYLATION	Acm2, the major autolysin of Lactobacillus plantarum, is a tripartite protein. Its catalytic domain is surrounded by an O-glycosylated N-terminal region rich in Ala, Ser, and Thr (AST domain), which is of low complexity and unknown function, and a C-terminal region composed of five SH3b peptidoglycan (PG) binding domains. Here, we investigate the contribution of these two accessory domains and of O-glycosylation to Acm2 functionality. We demonstrate that Acm2 is an N-acetylglucosaminidase and identify the pattern of O-glycosylation (21 mono-N-acetylglucosamines) of its AST domain. The O-glycosylation process is species-specific as Acm2 purified from Lactococcus lactis is not glycosylated. We therefore explored the functional role of O-glycosylation by purifying different truncated versions of Acm2 that were either glycosylated or nonglycosylated. We show that SH3b domains are able to bind PG and are responsible for Acm2 targeting to the septum of dividing cells, whereas the AST domain and its O-glycosylation are not involved in this process. Notably, our data reveal that the lack of O-glycosylation of the AST domain significantly increases Acm2 enzymatic activity, whereas removal of SH3b PG binding domains dramatically reduces this activity. Based on this antagonistic role, we propose a model in which access of the Acm2 catalytic domain to its substrate may be hindered by the AST domain where O-glycosylation changes its conformation and/or mediates interdomain interactions. To the best of our knowledge, this is the first time that O-glycosylation is shown to control the activity of a bacterial enzyme.	[Rolain, Thomas; Bernard, Elvis; Beaussart, Audrey; Degand, Herve; Morsomme, Pierre; Dufrene, Yves F.; Hols, Pascal] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Bernard, Elvis; Courtin, Pascal; Chapot-Chartier, Marie-Pierre] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Bernard, Elvis; Courtin, Pascal; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, F-78350 Jouy En Josas, France; [Egge-Jacobsen, Wolfgang] Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; [Bron, Peter A.; Kleerebezem, Michiel] TI Food & Nutr, NL-6709 PA Wageningen, Netherlands; [Bron, Peter A.; Kleerebezem, Michiel] NIZO Food Res, NL-6718 ZB Ede, Netherlands; [Bron, Peter A.] Kluyver Ctr Genom Ind Fermentat, NL-2628 BC Delft, Netherlands; [Kleerebezem, Michiel] Wageningen Univ, Host Microbe Interact Grp, NL-6708 WD Wageningen, Netherlands	Universite Catholique Louvain; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; University of Oslo; Top Institute Food & Nutrition; NIZO Food Research; Wageningen University & Research	Hols, P (corresponding author), Catholic Univ Louvain, Inst Sci Vie, 5 Pl Croix Sud,L7-07-06, B-1348 Louvain, Belgium.	Pascal.Hols@uclouvain.be	Morsomme, Pierre/AAD-9600-2019; Beaussart, Audrey/N-5645-2016; Kleerebezem, Michiel/AAT-2078-2021	Beaussart, Audrey/0000-0002-4602-3019; Morsomme, Pierre/0000-0001-7780-7230; Dufrene, Yves/0000-0002-7289-4248; Kleerebezem, Michiel/0000-0001-8552-2235; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	National Foundation for Scientific Research (FNRS); Universite catholique de Louvain (Fonds Speciaux de Recherche); Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme); Research Department of the Communaute francaise de Belgique (Concerted Research Action); Institut National de la Recherche Agronomique; Research Foundation for Industry and Agriculture (FRIA); Marie Curie fellowship for Early Stage Research Training (EST) of the FP6 LabHealth project [MEST-CT-2004-514428]	National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain (Fonds Speciaux de Recherche); Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme); Research Department of the Communaute francaise de Belgique (Concerted Research Action); Institut National de la Recherche Agronomique; Research Foundation for Industry and Agriculture (FRIA)(Fonds de la Recherche Scientifique - FNRS); Marie Curie fellowship for Early Stage Research Training (EST) of the FP6 LabHealth project(European Commission)	This work was supported in part by the National Foundation for Scientific Research (FNRS), the Universite catholique de Louvain (Fonds Speciaux de Recherche), Technical and Cultural Affairs (Interuniversity Poles of Attraction Programme), and the Research Department of the Communaute francaise de Belgique (Concerted Research Action) (in support of the teams of P. H. and Y. F. D.) and by the Institut National de la Recherche Agronomique (Jeune Equipe grant in support of the team of M.-P. C.-C.).; Held a doctoral fellowship from the Research Foundation for Industry and Agriculture (FRIA).; Recipient of a Marie Curie fellowship for Early Stage Research Training (EST) of the FP6 LabHealth project (MEST-CT-2004-514428).	Andre G, 2008, J BACTERIOL, V190, P7079, DOI 10.1128/JB.00519-08; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bublitz M, 2009, MOL MICROBIOL, V71, P1509, DOI 10.1111/j.1365-2958.2009.06619.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charbonneau ME, 2012, MOL MICROBIOL, V83, P894, DOI 10.1111/j.1365-2958.2012.07973.x; Cheng Q, 2007, APPL MICROBIOL BIOT, V74, P1284, DOI 10.1007/s00253-006-0771-1; Claes IJJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031588; CORNETT JB, 1978, J BACTERIOL, V135, P153, DOI 10.1128/JB.135.1.153-160.1978; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; Eldholm V, 2010, MOL MICROBIOL, V76, P905, DOI 10.1111/j.1365-2958.2010.07143.x; Eugster MR, 2012, J BACTERIOL, V194, P6498, DOI 10.1128/JB.00808-12; Fletcher CM, 2009, CELL, V137, P321, DOI 10.1016/j.cell.2009.02.041; Francius G, 2009, NAT PROTOC, V4, P939, DOI 10.1038/nprot.2009.65; Frankel MB, 2012, J BIOL CHEM, V287, P10460, DOI 10.1074/jbc.M111.336404; Fredriksen L, 2012, J BACTERIOL, V194, P325, DOI 10.1128/JB.06314-11; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Huard C, 2003, MICROBIOL-SGM, V149, P695, DOI 10.1099/mic.0.25875-0; KAWAMURA T, 1983, J BIOL CHEM, V258, P9514; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; Kuipers OP, 1997, TRENDS BIOTECHNOL, V15, P135, DOI 10.1016/S0167-7799(97)01029-9; Layec S, 2009, MOL MICROBIOL, V71, P1205, DOI 10.1111/j.1365-2958.2009.06595.x; Lebeer S, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-15; Low LY, 2005, J BIOL CHEM, V280, P35433, DOI 10.1074/jbc.M502723200; Lu JZQ, 2006, J BIOL CHEM, V281, P549, DOI 10.1074/jbc.M509691200; Moens S, 1997, ARCH MICROBIOL, V168, P169, DOI 10.1007/s002030050484; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Odintsov SG, 2004, J MOL BIOL, V335, P775, DOI 10.1016/j.jmb.2003.11.009; Otzen D, 2012, MOL MICROBIOL, V83, P879, DOI 10.1111/j.1365-2958.2012.07972.x; Palumbo E, 2006, J BACTERIOL, V188, P3709, DOI 10.1128/JB.188.10.3709-3715.2006; Pavan S, 2000, APPL ENVIRON MICROB, V66, P4427, DOI 10.1128/AEM.66.10.4427-4432.2000; Perez-Dorado I, 2010, NAT STRUCT MOL BIOL, V17, P576, DOI 10.1038/nsmb.1817; Regulski K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032301; Rodriguez-Rubio L, 2012, APPL ENVIRON MICROB, V78, P2241, DOI 10.1128/AEM.07621-11; Rolain T, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-137; Ruggiero A, 2010, STRUCTURE, V18, P1184, DOI 10.1016/j.str.2010.06.007; Sambrook J., 2002, MOL CLONING LAB MANU; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; Serrano LM, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-29; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Vik A, 2012, MOL MICROBIOL, V85, P1166, DOI 10.1111/j.1365-2958.2012.08166.x; Vik A, 2009, P NATL ACAD SCI USA, V106, P4447, DOI 10.1073/pnas.0809504106; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WEBSTER JR, 1981, APPL ENVIRON MICROB, V41, P371, DOI 10.1128/AEM.41.2.371-374.1981; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Yamamoto H, 2008, MOL MICROBIOL, V70, P297, DOI 10.1111/j.1365-2958.2008.06397.x; Yang DC, 2012, MOL MICROBIOL, V85, P768, DOI 10.1111/j.1365-2958.2012.08138.x; Zarschler K, 2010, GLYCOBIOLOGY, V20, P787, DOI 10.1093/glycob/cwq035	56	28	30	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22233	22247		10.1074/jbc.M113.470716	http://dx.doi.org/10.1074/jbc.M113.470716			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23760506	Green Published, hybrid			2022-12-28	WOS:000330596300006
J	Mattoo, RUH; Sharma, SK; Priya, S; Finka, A; Goloubinoff, P				Mattoo, Rayees U. H.; Sharma, Sandeep K.; Priya, Smriti; Finka, Andrija; Goloubinoff, Pierre			Hsp110 Is a Bona Fide Chaperone Using ATP to Unfold Stable Misfolded Polypeptides and Reciprocally Collaborate with Hsp70 to Solubilize Protein Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE; MOLECULAR CHAPERONES; DNAK; BINDING; GRPE; MECHANISM; SYSTEM; CONFORMATION; DOMAIN; GROEL	Structurally and sequence-wise, the Hsp110s belong to a subfamily of the Hsp70 chaperones. Like the classical Hsp70s, members of the Hsp110 subfamily can bind misfolding polypeptides and hydrolyze ATP. However, they apparently act as a mere subordinate nucleotide exchange factors, regulating the ability of Hsp70 to hydrolyze ATP and convert stable protein aggregates into native proteins. Using stably misfolded and aggregated polypeptides as substrates in optimized in vitro chaperone assays, we show that the human cytosolic Hsp110s (HSPH1 and HSPH2) are bona fide chaperones on their own that collaborate with Hsp40 (DNAJA1 and DNAJB1) to hydrolyze ATP and unfold and thus convert stable misfolded polypeptides into natively refolded proteins. Moreover, equimolar Hsp70 (HSPA1A) and Hsp110 ( HSPH1) formed a powerful molecular machinery that optimally reactivated stable luciferase aggregates in an ATP- and DNAJA1-dependent manner, in a disaggregation mechanism whereby the two paralogous chaperones alternatively activate the release of bound unfolded polypeptide substrates from one another, leading to native protein refolding.	[Mattoo, Rayees U. H.; Sharma, Sandeep K.; Priya, Smriti; Finka, Andrija; Goloubinoff, Pierre] Univ Lausanne, Fac Biol & Med, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Sharma, Sandeep K.] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland	University of Lausanne; University of Zurich	Goloubinoff, P (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland.	Pierre.Goloubinoff@unil.ch	Sharma, Sandeep K./ABH-2409-2021; Sharma, Sandeep K./F-7420-2010; Mattoo, Rayees/AAK-5052-2021	Sharma, Sandeep K./0000-0002-0039-7883; Sharma, Sandeep K./0000-0002-0039-7883; Mattoo, Rayees/0000-0002-3204-6367; Priya, Smriti/0000-0002-3858-9207; Finka, Andrija/0000-0001-7608-4771; Goloubinoff, Pierre/0000-0002-4802-0807	Faculty of Biology and Medicine of Lausanne University of Lausanne; Swiss National Fund [31003A-140512/1]	Faculty of Biology and Medicine of Lausanne University of Lausanne; Swiss National Fund(Swiss National Science Foundation (SNSF))	This work was supported in part by the Faculty of Biology and Medicine of Lausanne University of Lausanne and by Grant 31003A-140512/1 from the Swiss National Fund.	Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baneyx F, 2010, NAT CHEM BIOL, V6, P880, DOI 10.1038/nchembio.468; Ben-Zvi A, 2004, J BIOL CHEM, V279, P37298, DOI 10.1074/jbc.M405627200; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; Brehmer D, 2004, J BIOL CHEM, V279, P27957, DOI 10.1074/jbc.M403558200; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cabrita LD, 2010, CURR OPIN STRUC BIOL, V20, P33, DOI 10.1016/j.sbi.2010.01.005; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; De Los Rios P, 2012, NAT CHEM BIOL, V8, P226, DOI 10.1038/nchembio.791; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Finka A, 2013, CELL STRESS CHAPERON, V18, P591, DOI 10.1007/s12192-013-0413-3; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Hinault MP, 2006, J MOL NEUROSCI, V30, P249, DOI 10.1385/JMN:30:3:249; Hinault MP, 2011, NEURODEGENER DIS, V8, P397, DOI 10.1159/000324514; Hinault MP, 2010, J BIOL CHEM, V285, P38173, DOI 10.1074/jbc.M110.127753; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Knappe D, 2011, CHEMBIOCHEM, V12, P874, DOI 10.1002/cbic.201000792; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Natalello A, 2013, J MOL BIOL, V425, P1158, DOI 10.1016/j.jmb.2012.12.025; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; Polier S, 2010, J MOL BIOL, V401, P696, DOI 10.1016/j.jmb.2010.07.004; Priya S, 2013, FEBS LETT, V587, P1981, DOI 10.1016/j.febslet.2013.05.014; Priya S, 2013, P NATL ACAD SCI USA, V110, P7199, DOI 10.1073/pnas.1219867110; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rudiger S, 2001, EMBO J, V20, P1042, DOI 10.1093/emboj/20.5.1042; Rungeling E, 1999, FEMS MICROBIOL LETT, V170, P119; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Sharma SK, 2011, PROTEINS, V79, P1991, DOI 10.1002/prot.23024; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Siegenthaler RK, 2006, J BIOL CHEM, V281, P34448, DOI 10.1074/jbc.M606382200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Voellmy R, 2004, CELL STRESS CHAPERON, V9, P122, DOI 10.1379/CSC-14R.1; Weiss YG, 2007, CRIT CARE MED, V35, P2128, DOI 10.1097/01.CCM.0000278915.78030.74; Wisen S, 2010, ACS CHEM BIOL, V5, P611, DOI 10.1021/cb1000422; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083	61	108	109	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21399	21411		10.1074/jbc.M113.479253	http://dx.doi.org/10.1074/jbc.M113.479253			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23737532	Green Published, hybrid			2022-12-28	WOS:000322014400058
J	Trazzi, S; Fuchs, C; Valli, E; Perini, G; Bartesaghi, R; Ciani, E				Trazzi, Stefania; Fuchs, Claudia; Valli, Emanuele; Perini, Giovanni; Bartesaghi, Renata; Ciani, Elisabetta			RETRACTED: The Amyloid Precursor Protein (APP) Triplicated Gene Impairs Neuronal Precursor Differentiation and Neurite Development through Two Different Domains in the Ts65Dn Mouse Model for Down Syndrome (Retracted article. See vol. 295, pg. 3392, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							ALZHEIMER-DISEASE; SONIC HEDGEHOG; GROWTH-FACTOR; PROLIFERATION; NEUROGENESIS; NOTCH; PATHWAY; REGION; INVOLVEMENT; GLIOGENESIS	Intellectual disability in Down syndrome (DS) appears to be related to severe proliferation impairment during brain development. Recent evidence shows that it is not only cellular proliferation that is heavily compromised in DS, but also cell fate specification and dendritic maturation. The amyloid precursor protein (APP), a gene that is triplicated in DS, plays a key role in normal brain development by influencing neural precursor cell proliferation, cell fate specification, and neuronal maturation. APP influences these processes via two separate domains, the APP intracellular domain (AICD) and the soluble secreted APP. We recently found that the proliferation impairment of neuronal precursors (NPCs) from the Ts65Dn mouse model for DS was caused by derangement of the Shh pathway due to overexpression of patched1(Ptch1), its inhibitory regulator. Ptch1 overexpression was related to increased levels within the APP/AICD system. The overall goal of this study was to determine whether APP contributes to neurogenesis impairment in DS by influencing in addition to proliferation, cell fate specification, and neurite development. We found that normalization of APP expression restored the reduced neuronogenesis, the increased astrogliogenesis, and the reduced neurite length of trisomic NPCs, indicating that APP overexpression underpins all aspects of neurogenesis impairment. Moreover, we found that two different domains of APP impair neuronal differentiation and maturation in trisomic NPCs. The APP/AICD system regulates neuronogenesis and neurite length through the Shh pathway, whereas the APP/secreted AP system promotes astrogliogenesis through an IL-6-associated signaling cascade. These results provide novel insight into the mechanisms underlying brain development alterations in DS.	[Trazzi, Stefania; Fuchs, Claudia; Bartesaghi, Renata; Ciani, Elisabetta] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy; [Valli, Emanuele; Perini, Giovanni] Univ Bologna, Dept Pharm & Biotechnol, I-40126 Bologna, Italy; [Perini, Giovanni] Univ Bologna, Interdept Ctr Ind Res HST ICIR, I-40064 Bologna, Italy	University of Bologna; University of Bologna; University of Bologna	Ciani, E (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, Piazza Porta San Donato 2, I-40126 Bologna, Italy.	elisabetta.ciani@unibo.it	Ciani, Elisabetta/AAL-6462-2020	Valli, Emanuele/0000-0002-0928-8624; ciani, elisabetta/0000-0003-3130-5168	University of Bologna; Fondation Jerome Lejeune	University of Bologna; Fondation Jerome Lejeune	This work was supported by grants from the University of Bologna through funding for basic research (to E. C. and R. B.) and by a grant from the "Fondation Jerome Lejeune" (to R. B.).	Altaba ARI, 1998, DEVELOPMENT, V125, P2203; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Baratchi S, 2012, HIPPOCAMPUS, V22, P1517, DOI 10.1002/hipo.20988; BECKER LE, 1991, CAN J NEUROL SCI, V18, P170, DOI 10.1017/S0317167100031644; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Bianchi P, 2010, BRAIN PATHOL, V20, P106, DOI 10.1111/j.1750-3639.2008.00246.x; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Brewster R, 1998, NATURE, V393, P579, DOI 10.1038/31242; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Contestabile A, 2009, BRAIN PATHOL, V19, P224, DOI 10.1111/j.1750-3639.2008.00168.x; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Fischer DF, 2005, FASEB J, V19, P1451, DOI 10.1096/fj.04-3395.com; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Guidi S, 2011, BRAIN PATHOL, V21, P361, DOI 10.1111/j.1750-3639.2010.00459.x; Hammond R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007007; Haydar TF, 2000, J NEUROSCI, V20, P4156; Hewitt CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011561; Jhoo JH, 2004, BEHAV BRAIN RES, V155, P185, DOI 10.1016/j.bbr.2004.04.012; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Korbel JO, 2009, P NATL ACAD SCI USA, V106, P12031, DOI 10.1073/pnas.0813248106; Kulbatski I, 2009, J HISTOCHEM CYTOCHEM, V57, P405, DOI 10.1369/jhc.2008.951814; Kwak YD, 2006, STEM CELLS DEV, V15, P381, DOI 10.1089/scd.2006.15.381; Kwak YD, 2011, EUR J PHARMACOL, V650, P18, DOI 10.1016/j.ejphar.2010.09.015; Kwak YD, 2010, NEUROTOX RES, V18, P328, DOI 10.1007/s12640-010-9170-6; Liu DP, 2003, BIOTECHNIQUES, V35, P1170, DOI 10.2144/03356st02; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022126; Ma QF, 1997, J NEUROSCI, V17, P3644; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Muller T, 2008, PROG NEUROBIOL, V85, P393, DOI 10.1016/j.pneurobio.2008.05.002; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Ohsawa I, 1999, EUR J NEUROSCI, V11, P1907, DOI 10.1046/j.1460-9568.1999.00601.x; Olson LE, 2004, DEV DYNAM, V230, P581, DOI 10.1002/dvdy.20079; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; Rachidi M, 2008, EUR J PAEDIATR NEURO, V12, P168, DOI 10.1016/j.ejpn.2007.08.010; Raychaudhuri M, 2011, INT J ALZHEIMERS DIS; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Reinholdt LG, 2009, CHROMOSOMA, V118, P723, DOI 10.1007/s00412-009-0230-8; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Roper RJ, 2006, P NATL ACAD SCI USA, V103, P1452, DOI 10.1073/pnas.0510750103; ROSS MH, 1984, NEUROLOGY, V34, P909, DOI 10.1212/WNL.34.7.909; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Sanchez-Camacho C, 2009, BIOESSAYS, V31, P1013, DOI 10.1002/bies.200900063; Sasaki N, 2010, MOL CELL NEUROSCI, V45, P335, DOI 10.1016/j.mcn.2010.07.006; SCHMIDTSIDOR B, 1990, CLIN NEUROPATHOL, V9, P181; SCHULZ E, 1992, J HIRNFORSCH, V33, P37; TAKASHIMA S, 1989, BRAIN DEV-JPN, V11, P131, DOI 10.1016/S0387-7604(89)80082-8; Trazzi S, 2011, HUM MOL GENET, V20, P1560, DOI 10.1093/hmg/ddr033; Voronova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019174; Wang L, 2007, J BIOL CHEM, V282, P32462, DOI 10.1074/jbc.M706880200; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou ZD, 2011, CELL ADHES MIGR, V5, P280, DOI 10.4161/cam.5.4.16986	56	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20817	20829		10.1074/jbc.M113.451088	http://dx.doi.org/10.1074/jbc.M113.451088			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23740250	hybrid, Green Published			2022-12-28	WOS:000322014400006
J	Amie, SM; Daly, MB; Noble, E; Schinazi, RF; Bambara, RA; Kim, B				Amie, Sarah M.; Daly, Michele B.; Noble, Erin; Schinazi, Raymond F.; Bambara, Robert A.; Kim, Baek			Anti-HIV Host Factor SAMHD1 Regulates Viral Sensitivity to Nucleoside Reverse Transcriptase Inhibitors via Modulation of Cellular Deoxyribonucleoside Triphosphate (dNTP) Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION FACTOR SAMHD1; IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIRETROVIRAL THERAPY; DENDRITIC CELLS; INFECTION; TOXICITY; REPLICATION; LYMPHOCYTES; PROGRESSION; KINETICS	Newly identified anti-HIV host factor, SAMHD1, restricts replication of lentiviruses such as HIV-1, HIV-2, and simian immunodeficiency virus in macrophages by enzymatically hydrolyzing and depleting cellular dNTPs, which are the substrates of viral DNA polymerases. HIV-2 and some simian immunodeficiency viruses express viral protein X (VPX), which counteracts SAMHD1 and elevates cellular dNTPs, enhancing viral replication in macrophages. Because nucleoside reverse transcriptase inhibitors (NRTIs), the most commonly used anti-HIV drugs, compete against cellular dNTPs for incorporation into proviral DNA, we tested whether SAMHD1 directly affects the efficacy of NRTIs in inhibiting HIV-1. We found that reduction of SAMHD1 levels with the use of virus-like particles expressing Vpx-and SAMHD1-specific shRNA subsequently elevates cellular dNTPs and significantly decreases HIV-1 sensitivity to various NRTIs in macrophages. However, virus-like particles +Vpx treatment of activated CD4(+) T cells only minimally reduced NRTI efficacy. Furthermore, with the use of HPLC, we could not detect SAMHD1-mediated hydrolysis of NRTI-triphosphates, verifying that the reduced sensitivity of HIV-1 to NRTIs upon SAMHD1 degradation is most likely caused by the elevation in cellular dNTPs.	[Amie, Sarah M.; Daly, Michele B.; Noble, Erin; Bambara, Robert A.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res, Decatur, GA 30033 USA; [Schinazi, Raymond F.] Vet Affairs Med Ctr, Decatur, GA 30033 USA; [Kim, Baek] Emory Univ, Ctr Drug Discovery, Dept Pediat, Atlanta, GA 30322 USA	University of Rochester; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Emory University	Kim, B (corresponding author), Emory Univ, Ctr Drug Discovery, Dept Pediat, 1760 Haygood Dr, Atlanta, GA 30322 USA.	baek.kim@emory.edu	Schinazi, Raymond F/B-6777-2017		National Institutes of Health Grant [AI077401, AI049781, GM049573]; Cellular, Biochemical, and Molecular Sciences Training Grant [GM068411]; Oral Cellular and Molecular Biology Training Grant [DE007202]; Department of Veterans Affairs; National Institutes of Health Centers for AIDS Research (CFAR) [5P30-AI-50409]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049781, R01AI077401, P30AI050409, R01AI049781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM068411, R01GM104198, R01GM049573] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cellular, Biochemical, and Molecular Sciences Training Grant; Oral Cellular and Molecular Biology Training Grant; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health Centers for AIDS Research (CFAR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077401 (to B. K.), AI049781 (to B. K.), GM049573 (to R. A. B.), Cellular, Biochemical, and Molecular Sciences Training Grant GM068411 (to S. M. A.), and Oral Cellular and Molecular Biology Training Grant DE007202 (to E. N.). This study was additionally funded by National Institutes of Health Grant 5P30-AI-50409 Centers for AIDS Research (CFAR) and the Department of Veterans Affairs.	AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Aquaro S, 2002, J MED VIROL, V68, P479, DOI 10.1002/jmv.10245; Aquaro S, 1997, J LEUKOCYTE BIOL, V62, P138, DOI 10.1002/jlb.62.1.138; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Chugh P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-11; Clements J E, 1994, Immunol Ser, V60, P589; De Clercq E, 2009, INT J ANTIMICROB AG, V33, P307, DOI 10.1016/j.ijantimicag.2008.10.010; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Erb P, 2000, ARCH INTERN MED, V160, P1134, DOI 10.1001/archinte.160.8.1134; Fassati A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-74; Feng JY, 2001, J BIOL CHEM, V276, P23832, DOI 10.1074/jbc.M101156200; Feng JY, 2004, ANTIMICROB AGENTS CH, V48, P1300, DOI 10.1128/AAC.48.4.1300-1306.2004; Gavegnano Christina, 2009, Antiviral Chemistry & Chemotherapy, V20, P63, DOI 10.3851/IMP1374; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kim B, 1997, METHODS, V12, P318, DOI 10.1006/meth.1997.0485; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lee H, 2003, BIOCHEMISTRY-US, V42, P14711, DOI 10.1021/bi035596s; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Marchant D, 2006, J GEN VIROL, V87, P411, DOI 10.1099/vir.0.81391-0; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Roshal M, 2003, J BIOL CHEM, V278, P25879, DOI 10.1074/jbc.M303948200; Schneider B, 1998, J BIOL CHEM, V273, P11491, DOI 10.1074/jbc.273.19.11491; Singh DK, 1999, J GEN VIROL, V80, P1437, DOI 10.1099/0022-1317-80-6-1437; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029	38	37	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20683	20691		10.1074/jbc.M113.472159	http://dx.doi.org/10.1074/jbc.M113.472159			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23744077	Green Published, hybrid			2022-12-28	WOS:000321715100053
J	Chandra, A; Lan, SH; Zhu, J; Siclari, VA; Qin, L				Chandra, Abhishek; Lan, Shenghui; Zhu, Ji; Siclari, Valerie A.; Qin, Ling			Epidermal Growth Factor Receptor (EGFR) Signaling Promotes Proliferation and Survival in Osteoprogenitors by Increasing Early Growth Response 2 (EGR2) Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; FINGER TRANSCRIPTION FACTOR; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; REGULATORY FACTORS; BONE-FORMATION; IN-VITRO; T-CELLS; APOPTOSIS; PATHWAY	Maintaining bone architecture requires continuous generation of osteoblasts from osteoprogenitor pools. Our previous study of mice with epidermal growth factor receptor (EGFR) specifically inactivated in osteoblast lineage cells revealed that EGFR stimulates bone formation by expanding the population of mesenchymal progenitors. EGFR ligands are potent regulators for the osteoprogenitor pool, but the underlying mechanisms are largely unknown. Here we demonstrate that activation of EGFR increases the number of osteoprogenitors by promoting cell proliferation and suppressing either serum depletion-induced or TNF alpha-induced apoptosis mainly through the MAPK/ERK pathway. Mouse calvarial organ culture revealed that EGF elevated the number of proliferative cells and decreased the number of apoptotic cells, which led to increased osteoblasts. Microarray analysis of MC3T3 cells, an osteoprogenitor cell line, revealed that EGFR signaling stimulates the expression of MCL1, an antiapoptotic protein, and a family of EGR transcription factors (EGR1, -2, and -3). The up-regulation of MCL1 and EGR2 by EGF was further confirmed in osteoprogenitors close to the calvarial bone surface. Overexpression of NAB2, a co-repressor for EGRs, attenuated the EGF-induced increase in osteoprogenitor number. Interestingly, knocking down the expression of EGR2, but not EGR1 or -3, resulted in a similar effect. Using inhibitor, adenovirus overexpression, and siRNA approaches, we demonstrate that EGFR signaling activates the MAPK/ERK pathway to stimulate the expression of EGR2, which in turn leads to cell growth and MCL1-mediated cell survival. Taken together, our data clearly demonstrate that EGFR-induced EGR2 expression is critical for osteoprogenitor maintenance and new bone formation.	[Chandra, Abhishek; Lan, Shenghui; Zhu, Ji; Siclari, Valerie A.; Qin, Ling] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Lan, Shenghui] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Orthopaed, Wuhan 430022, Hunan, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Huazhong University of Science & Technology	Qin, L (corresponding author), Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, 424 Stemmler Hall,36th St, Philadelphia, PA 19104 USA.	qinling@mail.med.upenn.edu	Chandra, Abhishek/AAG-8781-2020	Chandra, Abhishek/0000-0001-9423-9669	National Institutes of Health [K01 DK071988]; Penn Center for Musculoskeletal Disorders [P30AR050950]; New Jersey Stem Cell Research Grant; Penn Institute on Aging pilot grant;  [NCI R25 CA101871-07]; NATIONAL CANCER INSTITUTE [R25CA101871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095803, K01DK071988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn Center for Musculoskeletal Disorders; New Jersey Stem Cell Research Grant; Penn Institute on Aging pilot grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K01 DK071988 (to L. Q.), Penn Center for Musculoskeletal Disorders Grant P30AR050950 (NIAMS/National Institutes of Health), and Grant NCI R25 CA101871-07 (to V. S.). This work was also supported by a New Jersey Stem Cell Research Grant (to L. Q.) and a Penn Institute on Aging pilot grant (to L. Q.).	Akgul C, 2009, CELL MOL LIFE SCI, V66, P1326, DOI 10.1007/s00018-008-8637-6; Bellantuono I, 2009, BBA-MOL BASIS DIS, V1792, P364, DOI 10.1016/j.bbadis.2009.01.008; Bertrand-Duchesne MP, 2010, J PERIODONTAL RES, V45, P87, DOI 10.1111/j.1600-0765.2009.01205.x; Bradley EW, 2008, J BIOL CHEM, V283, P8055, DOI 10.1074/jbc.M709500200; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Ehrengruber MU, 2000, GENE, V258, P63, DOI 10.1016/S0378-1119(00)00445-5; Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320; Friedman MS, 2006, J CELL BIOCHEM, V98, P538, DOI 10.1002/jcb.20719; Gabet Y, 2010, BLOOD, V116, P3964, DOI 10.1182/blood-2010-01-263830; Gineitis D, 2001, J BIOL CHEM, V276, P24531, DOI 10.1074/jbc.M102678200; GRONTHOS S, 1995, BLOOD, V85, P929, DOI 10.1182/blood.V85.4.929.bloodjournal854929; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Kirsch KH, 1996, ONCOGENE, V12, P963; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Leclerc N, 2004, J MOL ENDOCRINOL, V33, P175, DOI 10.1677/jme.0.0330175; Levi G, 1996, DEVELOPMENT, V122, P113; Li SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018498; Mohammad Khalid S., 2008, V455, P37, DOI 10.1007/978-1-59745-104-8_3; NG KW, 1983, CALCIFIED TISSUE INT, V35, P624, DOI 10.1007/BF02405105; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Parfitt AM, 1997, J BONE MINER RES, V12, P1864, DOI 10.1359/jbmr.1997.12.11.1864; Poirier R, 2008, FRONT NEUROSCI-SWITZ, V2, P47, DOI 10.3389/neuro.01.002.2008; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Qin L, 2005, J BIOL CHEM, V280, P3974, DOI 10.1074/jbc.M409807200; RANGNEKAR VM, 1990, NUCLEIC ACIDS RES, V18, P2749, DOI 10.1093/nar/18.9.2749; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; SHALHOUB V, 1992, J CELL BIOCHEM, V50, P425, DOI 10.1002/jcb.240500411; Soulez M, 2010, STEM CELLS, V28, P810, DOI 10.1002/stem.403; Srinivasan R, 2006, J BIOL CHEM, V281, P15129, DOI 10.1074/jbc.M600775200; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176; Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; Zaman G, 2012, J BIOL CHEM, V287, P3946, DOI 10.1074/jbc.M111.252742; Zhang XR, 2011, J BONE MINER RES, V26, P1022, DOI 10.1002/jbmr.295; Zhu FC, 2012, J CELL PHYSIOL, V227, P2677, DOI 10.1002/jcp.23010; Zhu HY, 2010, CELLS TISSUES ORGANS, V192, P211, DOI 10.1159/000313417; Zhu J, 2007, J BIOL CHEM, V282, P26656, DOI 10.1074/jbc.M705064200; Zhu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050099; Zhu J, 2011, J CELL BIOCHEM, V112, P1749, DOI 10.1002/jcb.23094	46	76	80	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20488	20498		10.1074/jbc.M112.447250	http://dx.doi.org/10.1074/jbc.M112.447250			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720781	hybrid, Green Published			2022-12-28	WOS:000321715100036
J	Spera, JM; Herrmann, CK; Roset, MS; Comerci, DJ; Ugalde, JE				Spera, Juan M.; Herrmann, Claudia K.; Roset, Mara S.; Comerci, Diego J.; Ugalde, Juan E.			A Brucella Virulence Factor Targets Macrophages to Trigger B-cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-CRUZI INFECTION; PROLINE RACEMASE; MYOSIN-IIA; BACTERIAL PATHOGENS; HOST-CELLS; PROTEIN; IDENTIFICATION; SYSTEM; ACTIN; TRANSLOCATION	Brucella spp. and Trypanosoma cruzi are two intracellular pathogens that have no evolutionary common origins but share a similar lifestyle as they establish chronic infections for which they have to circumvent the host immune response. Both pathogens have a virulence factor (prpA in Brucella and tcPrac in T. cruzi) that induces B-cell proliferation and promotes the establishment of the chronic phase of the infectious process. We show here that, even though PrpA promotes B-cell proliferation, it targets macrophages in vitro and is translocated to the cytoplasm during the intracellular replication phase. We observed that PrpA-treated macrophages induce the secretion of a soluble factor responsible for B-cell proliferation and identified nonmuscular myosin IIA (NMM-IIA) as a receptor required for binding and function of this virulence factor. Finally, we show that the Trypanosoma cruzi homologue of PrpA also targets macrophages to induce B-cell proliferation through the same receptor, indicating that this virulence strategy is conserved between a bacterial and a protozoan pathogen.	[Spera, Juan M.; Herrmann, Claudia K.; Roset, Mara S.; Comerci, Diego J.; Ugalde, Juan E.] Univ Nacl San Martin, Inst Invest Biotecnol Dr Rodolfo A Ugalde, IIB INTECH, Natl Res Council Argentina CONICET, RA-1650 Buenos Aires, DF, Argentina; [Comerci, Diego J.] CNEA, Grp Pecuario, RA-1429 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA)	Spera, JM (corresponding author), Univ Nacl San Martin, Inst Invest Biotecnol Dr Rodolfo A Ugalde, IIB INTECH, UNSAM, Ave 25 Mayo Francia,Campus Miguelete, RA-1650 Buenos Aires, DF, Argentina.	jugalde@iibintech.com.ar		Comerci, Diego J./0000-0003-1949-4226; Roset, Mara/0000-0003-0487-199X	National Institutes of Health from the NIAID [AI078891]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT-PRH08-230]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078891] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI078891 from the NIAID (to J.E.U.). This work was also supported by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) Grant PICT-PRH08-230 (to J.E.U.).	Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodsky IE, 2009, NAT CELL BIOL, V11, P521, DOI 10.1038/ncb0509-521; Chamond N, 2005, MOL MICROBIOL, V58, P46, DOI 10.1111/j.1365-2958.2005.04808.x; Chamond N, 2003, J BIOL CHEM, V278, P15484, DOI 10.1074/jbc.M210830200; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Coutinho L, 2009, MEM I OSWALDO CRUZ, V104, P1055, DOI 10.1590/S0074-02762009000800001; ELBOUHDIDI A, 1994, PARASITE IMMUNOL, V16, P69, DOI 10.1111/j.1365-3024.1994.tb00325.x; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Goytia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000885; Hornef MW, 2002, NAT IMMUNOL, V3, P1033, DOI 10.1038/ni1102-1033; Marchesini MI, 2011, CELL MICROBIOL, V13, P1261, DOI 10.1111/j.1462-5822.2011.01618.x; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Krzewski K, 2006, J CELL BIOL, V173, P121, DOI 10.1083/jcb.200509076; Spera JM, 2006, P NATL ACAD SCI USA, V103, P16514, DOI 10.1073/pnas.0603362103; Marchesini MI, 2004, MICROB PATHOGENESIS, V37, P95, DOI 10.1016/j.micpath.2004.06.001; MAUPIN P, 1994, J CELL SCI, V107, P3077; MINOPRIO PM, 1986, SCAND J IMMUNOL, V24, P661, DOI 10.1111/j.1365-3083.1986.tb02185.x; Morimura S, 2011, BIOCHEM BIOPH RES CO, V404, P834, DOI 10.1016/j.bbrc.2010.12.069; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; OLDEN K, 1976, CELL, V8, P383, DOI 10.1016/0092-8674(76)90150-1; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Reina-San-Martin B, 2000, NAT MED, V6, P890, DOI 10.1038/78651; Rey M, 2002, J IMMUNOL, V169, P5410, DOI 10.4049/jimmunol.169.10.5410; Reyes A, 2011, NUCLEIC ACIDS RES, V39, P5098, DOI 10.1093/nar/gkr052; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sanborn KB, 2009, J IMMUNOL, V182, P6969, DOI 10.4049/jimmunol.0804337; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Young EJ, 2008, INFECTION, V36, P578, DOI 10.1007/s15010-008-8090-3	32	15	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20208	20216		10.1074/jbc.M113.453282	http://dx.doi.org/10.1074/jbc.M113.453282			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720774	Green Published, hybrid			2022-12-28	WOS:000321715100010
J	Ben, JJ; Zhang, Y; Zhou, RM; Zhang, HY; Zhu, XD; Li, XY; Zhang, HW; Li, N; Zhou, XD; Bai, H; Yang, Q; Li, DH; Xu, Y; Chen, Q				Ben, Jingjing; Zhang, Yan; Zhou, Rongmei; Zhang, Haiyang; Zhu, Xudong; Li, Xiaoyu; Zhang, Hanwen; Li, Nan; Zhou, Xiaodan; Bai, Hui; Yang, Qing; Li, Donghai; Xu, Yong; Chen, Qi			Major Vault Protein Regulates Class A Scavenger Receptor-mediated Tumor Necrosis Factor-alpha Synthesis and Apoptosis in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; ATHEROSCLEROSIS; CELLS; STRESS; RESISTANCE; INDUCTION; ENGAGEMENT; EXPRESSION; THERAPIES; CAVEOLIN	Atherosclerosis is considered a disease of chronic inflammation largely initiated and perpetuated by macrophage-dependent synthesis and release of pro-inflammatory mediators. Class A scavenger receptor (SR-A) expressed on macrophages plays a key role in this process. However, how SR-A-mediated pro-inflammatory response is modulated in macrophages remains ill defined. Here through immunoprecipitation coupled with mass spectrometry, we reported major vault protein (MVP) as a novel binding partner for SR-A. The interaction between SR-A and MVP was confirmed by immunofluorescence staining and chemical cross-linking assay. Treatment of macrophages with fucoidan, a SR-A ligand, led to a marked increase in TNF-alpha production, which was attenuated by MVP depletion. Further analysis revealed that SR-A stimulated TNF-alpha synthesis in macrophages via the caveolin- instead of clathrin-mediated endocytic pathway linked to p38 and JNK, but not ERK, signaling pathways. Importantly, fucoidan invoked an enrichment of MVP in lipid raft, a caveolin-reliant membrane structure, and enhanced the interaction among SR-A, caveolin, and MVP. Finally, we demonstrated that MVP elimination ameliorated SR-A-mediated apoptosis in macrophages. As such, MVP may fine-tune SR-A activity in macrophages which contributes to the development of atherosclerosis.	[Ben, Jingjing; Zhang, Yan; Zhou, Rongmei; Zhu, Xudong; Li, Xiaoyu; Zhang, Hanwen; Li, Nan; Zhou, Xiaodan; Bai, Hui; Yang, Qing; Xu, Yong; Chen, Qi] Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, Atherosclerosis Res Ctr, Nanjing 210029, Jiangsu, Peoples R China; [Ben, Jingjing; Xu, Yong; Chen, Qi] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Haiyang; Li, Donghai] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University	Chen, Q (corresponding author), Nanjing Med Univ, Key Lab Cardiovasc Dis & Mol Intervent, Atherosclerosis Res Ctr, Nanjing 210029, Jiangsu, Peoples R China.	qichen@njmu.edu.cn			National Basic Research Program 973 [2012CB517503, 2011CB503903, 2012CB945003]; National Natural Science Foundation of China [81070120, 81230070, 81000118, 31000323, 31070672]; College Natural Science Foundation of Jiangsu [10KJB310005]; Qinglan Project of Jiangsu; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); College Natural Science Foundation of Jiangsu; Qinglan Project of Jiangsu; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Basic Research Program 973 Grants 2012CB517503, 2011CB503903, and 2012CB945003, National Natural Science Foundation of China Grant 81070120, and National Natural Science Foundation of China Key Grant 81230070 (to Q. C.); National Natural Science Foundation of China Grant 81000118, College Natural Science Foundation of Jiangsu Grant 10KJB310005, and Qinglan Project of Jiangsu (to J. B.); National Natural Science Foundation of China Grants 31000323 and 31070672 (to D. L.); and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions.	Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Ben JJ, 2009, J MOL CELL CARDIOL, V47, P646, DOI 10.1016/j.yjmcc.2009.08.011; Berger W, 2009, CELL MOL LIFE SCI, V66, P43, DOI 10.1007/s00018-008-8364-z; Brown JM, 2007, AM J RESP CELL MOL, V36, P43, DOI 10.1165/rcmb.2006-0197OC; Cheng AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033917; Coller SP, 2001, J LEUKOCYTE BIOL, V70, P142; Cuschieri J, 2007, ANTIOXID REDOX SIGN, V9, P1485, DOI 10.1089/ars.2007.1670; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Dortet L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002168; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; Hu Y, 2002, INT J CANCER, V97, P149, DOI 10.1002/ijc.1590; Ikeda R, 2008, EXP CELL RES, V314, P3017, DOI 10.1016/j.yexcr.2008.07.001; Kim E, 2006, FEBS J, V273, P793, DOI 10.1111/j.1742-4658.2006.05112.x; Klingenberg R, 2009, EUR HEART J, V30, P2838, DOI 10.1093/eurheartj/ehp477; Kolli S, 2004, J BIOL CHEM, V279, P29374, DOI 10.1074/jbc.M313955200; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Kzhyshkowska J, 2012, IMMUNOBIOLOGY, V217, P492, DOI 10.1016/j.imbio.2012.02.015; Lara PC, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-148; Li DH, 2008, J BIOL CHEM, V283, P1553, DOI 10.1074/jbc.M706981200; Liang P, 2010, BIOCHEM CELL BIOL, V88, P445, DOI [10.1139/O09-166, 10.1139/o09-166]; Liu S, 2012, HEPATOLOGY, V56, P57, DOI 10.1002/hep.25642; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Nakamura T, 2002, BIOCHEM BIOPH RES CO, V290, P858, DOI 10.1006/bbrc.2001.6271; Oz HS, 2009, DIGEST DIS SCI, V54, P2561, DOI 10.1007/s10620-008-0673-4; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; Ryu SJ, 2008, CELL DEATH DIFFER, V15, P1673, DOI 10.1038/cdd.2008.96; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Usui HK, 2007, DIABETES, V56, P363, DOI 10.2337/db06-0359; Xu Y, 2012, NEUROSCIENCE, V218, P35, DOI 10.1016/j.neuroscience.2012.05.036; Yi CL, 2005, CANCER RES, V65, P5835, DOI 10.1158/0008-5472.CAN-05-0423; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200; Zhu XD, 2011, J BIOL CHEM, V286, P8231, DOI 10.1074/jbc.M110.145888	36	31	33	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20076	20084		10.1074/jbc.M112.449538	http://dx.doi.org/10.1074/jbc.M112.449538			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23703615	Green Published, hybrid			2022-12-28	WOS:000321515800069
J	Li, YR; Cai, WL; Wang, C; Yao, CF; Bao, XM; Deng, H; Girton, J; Johansen, J; Johansen, KM				Li, Yeran; Cai, Weili; Wang, Chao; Yao, Changfu; Bao, Xiaomin; Deng, Huai; Girton, Jack; Johansen, Jorgen; Johansen, Kristen M.			Domain Requirements of the JIL-1 Tandem Kinase for Histone H3 Serine 10 Phosphorylation and Chromatin Remodeling in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSITION-EFFECT VARIEGATION; H3S10 PHOSPHORYLATION; DOSAGE COMPENSATION; STATISTICAL-MODEL; MAP KINASE; DROSOPHILA; MSK1; PROTEINS; MEMBER	The JIL-1 kinase localizes to Drosophila polytene chromosome interbands and phosphorylates histone H3 at interphase, counteracting histone H3 lysine 9 dimethylation and gene silencing. JIL-1 can be divided into four main domains, including an NH2-terminal domain, two separate kinase domains, and a COOH-terminal domain. In this study, we characterize the domain requirements of the JIL-1 kinase for histone H3 serine 10 (H3S10) phosphorylation and chromatin remodeling in vivo. We show that a JIL-1 construct without the NH2-terminal domain is without H3S10 phosphorylation activity despite the fact that it localizes properly to polytene interband regions and that it contains both kinase domains. JIL-1 is a double kinase, and we demonstrate that both kinase domains of JIL-1 are required to be catalytically active for H3S10 phosphorylation to occur. Furthermore, we provide evidence that JIL-1 is phosphorylated at serine 424 and that this phosphorylation is necessary for JIL-1 H3S10 phosphorylation activity. Thus, these data are compatible with a model where the NH2-terminal domain of JIL-1 is required for chromatin complex interactions that position the kinase domain(s) for catalytic activity in the context of the state of higher order nucleosome packaging and chromatin structure and where catalytic H3S10 phosphorylation activity mediated by the first kinase domain is dependent on autophosphorylation of serine 424 by the second kinase domain. Furthermore, using a lacO repeat tethering system to target mutated JIL-1 constructs with or without catalytic activity, we show that the epigenetic H3S10 phosphorylation mark itself functions as a causative regulator of chromatin structure independently of any structural contributions from the JIL-1 protein.	[Li, Yeran; Cai, Weili; Wang, Chao; Yao, Changfu; Bao, Xiaomin; Deng, Huai; Girton, Jack; Johansen, Jorgen; Johansen, Kristen M.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Johansen, J (corresponding author), Iowa State Univ, Dept Biochem Biophys & Mol Biol, Mol Biol Bldg, Ames, IA 50011 USA.	jorgen@iastate.edu; kristen@iastate.edu	Cai, Weili/B-7691-2013	Bao, Xiaomin/0000-0002-8845-5012	National Institutes of Health [GM62916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM62916 (to K. M. J. and J. J.).	Bao XM, 2008, J BIOL CHEM, V283, P32741, DOI 10.1074/jbc.M806227200; Cai Weili, 2010, J Vis Exp, DOI 10.3791/1748; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Deng H, 2005, CHROMOSOMA, V114, P173, DOI 10.1007/s00412-005-0006-8; Deng H, 2008, DEVELOPMENT, V135, P699, DOI 10.1242/dev.015362; Deng HA, 2010, GENETICS, V185, P1183, DOI 10.1534/genetics.110.117150; Dyson MH, 2005, J CELL SCI, V118, P2247, DOI 10.1242/jcs.02373; Ji Y, 2005, J NEUROBIOL, V64, P157, DOI 10.1002/neu.20131; Jin Y, 2000, J CELL BIOL, V149, P1005, DOI 10.1083/jcb.149.5.1005; Jin Y, 1999, MOL CELL, V4, P129, DOI 10.1016/S1097-2765(00)80195-1; Johansen KM, 1999, CRIT REV EUKAR GENE, V9, P267, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.110; Johansen KM, 2009, METHODS, V48, P387, DOI 10.1016/j.ymeth.2009.02.019; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lerach S, 2005, GENESIS, V43, P213, DOI 10.1002/gene.20172; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Regnard C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001327; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Sambrook J., 2001, MOL CLONING LAB MANU; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Wang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062484; Wang C, 2012, FLY, V6, P93, DOI 10.4161/fly.20029; Wang C, 2011, J CELL SCI, V124, P4309, DOI 10.1242/jcs.092585; Wang C, 2011, GENETICS, V188, P745, DOI 10.1534/genetics.111.129353; Wang CI, 2013, NAT STRUCT MOL BIOL, V20, P202, DOI 10.1038/nsmb.2477; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Zhang WG, 2006, DEVELOPMENT, V133, P229, DOI 10.1242/dev.02199; Zhang WG, 2003, GENETICS, V165, P1341	33	7	7	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19441	19449		10.1074/jbc.M113.464271	http://dx.doi.org/10.1074/jbc.M113.464271			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23723094	Green Published, hybrid			2022-12-28	WOS:000321515800012
J	Tugues, S; Honjo, S; Konig, C; Padhan, N; Kroon, J; Gualandi, L; Li, XJ; Barkefors, I; Thijssen, VL; Griffioen, AW; Claesson-Welsh, L				Tugues, Sonia; Honjo, Satoshi; Konig, Christian; Padhan, Narendra; Kroon, Jeffrey; Gualandi, Laura; Li, Xiujuan; Barkefors, Irmeli; Thijssen, Victor L.; Griffioen, Arjan W.; Claesson-Welsh, Lena			Tetraspanin CD63 Promotes Vascular Endothelial Growth Factor Receptor 2-beta 1 Integrin Complex Formation, Thereby Regulating Activation and Downstream Signaling in Endothelial Cells in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; TYROSINE PHOSPHORYLATION; ENRICHED MICRODOMAINS; HUMAN-MELANOMA; ANGIOGENESIS; PROTEINS; SURFACE; SRC; MECHANISMS; MIGRATION	CD63 is a member of the transmembrane-4 glycoprotein superfamily (tetraspanins) implicated in the regulation of membrane protein trafficking, leukocyte recruitment, and adhesion processes. We have investigated the involvement of CD63 in endothelial cell (EC) signaling downstream of beta 1 integrin and VEGF. We report that silencing of CD63 in primary ECs arrested capillary sprouting and tube formation in vitro because of impaired adhesion and migration of ECs. Mechanistically, CD63 associated with both beta 1 integrin and the main VEGF receptor on ECs, VEGFR2. Our data suggest that CD63 serves to bridge between beta 1 integrin and VEGFR2 because CD63 silencing disrupted VEGFR2-beta 1 integrin complex formation identified using proximity ligation assays. Signaling downstream of beta 1 integrin and VEGFR2 was attenuated in CD63-silenced cells, although their cell surface expression levels remained unaffected. CD63 was furthermore required for efficient internalization of VEGFR2 in response to VEGF. Importantly, systemic delivery of VEGF failed to potently induce VEGFR2 phosphorylation and downstream signaling in CD63-deficient mouse lungs. Taken together, our findings demonstrate a previously unrecognized role for CD63 in coordinated integrin and receptor tyrosine kinase signaling in vitro and in vivo.	[Tugues, Sonia; Honjo, Satoshi; Konig, Christian; Padhan, Narendra; Kroon, Jeffrey; Gualandi, Laura; Li, Xiujuan; Claesson-Welsh, Lena] Uppsala Univ, Dept Immunol Genet & Pathol, Rudbeck Lab, S-75185 Uppsala, Sweden; [Barkefors, Irmeli] Uppsala Univ, Dept Med Biochem & Microbiol, Biomed Ctr, S-75123 Uppsala, Sweden; [Thijssen, Victor L.; Griffioen, Arjan W.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Angiogenesis Lab, NL-1007 MB Amsterdam, Netherlands	Uppsala University; Uppsala University; Vrije Universiteit Amsterdam	Tugues, S (corresponding author), Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland.	tugues@immunology.uzh.ch	Kroon, Jeffrey/AAL-2588-2021; König, Christian/G-1895-2015; Thijssen, Victor LJL/B-2792-2009; li, xiu/GXV-1745-2022	Kroon, Jeffrey/0000-0001-9983-6614; König, Christian/0000-0001-7671-231X; Thijssen, Victor LJL/0000-0002-6146-1842; 	Swedish Cancer Foundation; Swedish Science Council; Knut and Alice Wallenberg Foundation; Spanish Ministry of Science and Education; Spanish Association of Liver Diseases; Manpei Suzuki Diabetes Foundation; Japan Society for the Promotion of Science	Swedish Cancer Foundation; Swedish Science Council; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Spanish Ministry of Science and Education(Spanish Government); Spanish Association of Liver Diseases; Manpei Suzuki Diabetes Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Swedish Cancer Foundation, the Swedish Science Council, and the Knut and Alice Wallenberg Foundation (to L. C.-W.).; Supported by a postdoctoral grant from the Spanish Ministry of Science and Education and the Spanish Association of Liver Diseases. To whom correspondence should be addressed. Present address: Inst. of Experimental Immunology, University of Zurich, 8057 Zurich, Switzerland. Tel.: 41-44-6353709; Fax: 41-44-6356883; E-mail: tugues@immunology.uzh.ch.; Supported by a postdoctoral grant from Manpei Suzuki Diabetes Foundation and the Japan Society for the Promotion of Science.	Bailey RL, 2011, BIOCHEM SOC T, V39, P1667, DOI 10.1042/BST20110745; Berditchevski F, 1997, J BIOL CHEM, V272, P2595, DOI 10.1074/jbc.272.5.2595; Berditchevski F, 1996, MOL BIOL CELL, V7, P193, DOI 10.1091/mbc.7.2.193; Berditchevski F, 2001, J CELL SCI, V114, P4143; BERDITCHEVSKI F, 1995, J BIOL CHEM, V270, P17784, DOI 10.1074/jbc.270.30.17784; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chen TT, 2010, J CELL BIOL, V188, P595, DOI 10.1083/jcb.200906044; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Doyle EL, 2011, BLOOD, V118, P4265, DOI 10.1182/blood-2010-11-321489; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Eliceiri BP, 2001, CURR OPIN CELL BIOL, V13, P563, DOI 10.1016/S0955-0674(00)00252-0; Heijnen HFG, 2003, J THROMB HAEMOST, V1, P1161, DOI 10.1046/j.1538-7836.2003.00316.x; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 1998, CURR OPIN CELL BIOL, V10, P578, DOI 10.1016/S0955-0674(98)80032-X; HOTTA H, 1988, CANCER RES, V48, P2955; Hupalowska A, 2012, TRAFFIC, V13, P9, DOI 10.1111/j.1600-0854.2011.01249.x; Iizuka S, 2011, MOL CELL BIOL, V31, P783, DOI 10.1128/MCB.00912-10; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Israels SJ, 2001, THROMB HAEMOSTASIS, V85, P134; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kamisasanuki T, 2011, BIOCHEM BIOPH RES CO, V413, P128, DOI 10.1016/j.bbrc.2011.08.068; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Koyama Y, 1998, BIOCHEM BIOPH RES CO, V246, P841, DOI 10.1006/bbrc.1998.8725; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Lee M, 2005, J BIOL CHEM, V280, P125, DOI 10.1074/jbc.M408858200; Lekishvili T, 2008, J CELL SCI, V121, P685, DOI 10.1242/jcs.020347; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Mahabeleshwar GH, 2007, CIRC RES, V101, P570, DOI 10.1161/CIRCRESAHA.107.155655; Mannion BA, 1996, J IMMUNOL, V157, P2039; Mantegazza AR, 2004, BLOOD, V104, P1183, DOI 10.1182/blood-2004-01-0104; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Radford KJ, 1996, BIOCHEM BIOPH RES CO, V222, P13, DOI 10.1006/bbrc.1996.0690; Radford KJ, 1997, J IMMUNOL, V158, P3353; Ramjaun AR, 2009, INT J BIOCHEM CELL B, V41, P521, DOI 10.1016/j.biocel.2008.05.030; Ross RS, 2004, CARDIOVASC RES, V63, P381, DOI 10.1016/j.cardiores.2004.04.027; Schroder J, 2009, MOL CELL BIOL, V29, P1083, DOI 10.1128/MCB.01163-08; Skubitz KM, 1996, J IMMUNOL, V157, P3617; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; TOOTHILL VJ, 1990, J IMMUNOL, V145, P283; VISCHER UM, 1993, BLOOD, V82, P1184, DOI 10.1182/blood.V82.4.1184.1184; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yunta M, 2003, CELL SIGNAL, V15, P559, DOI 10.1016/S0898-6568(02)00147-X; Zhang XF, 2005, J CELL PHYSIOL, V202, P205, DOI 10.1002/jcp.20106	51	37	40	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19060	19071		10.1074/jbc.M113.468199	http://dx.doi.org/10.1074/jbc.M113.468199			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23632027	Green Published, hybrid			2022-12-28	WOS:000321335800041
J	Wiesinger, C; Kunze, M; Regelsberger, G; Forss-Petter, S; Berger, J				Wiesinger, Christoph; Kunze, Markus; Regelsberger, Guenther; Forss-Petter, Sonja; Berger, Johannes			Impaired Very Long-chain Acyl-CoA beta-Oxidation in Human X-linked Adrenoleukodystrophy Fibroblasts Is a Direct Consequence of ABCD1 Transporter Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEROXISOMAL MEMBRANE-PROTEIN; FATTY-ACIDS; SACCHAROMYCES-CEREVISIAE; SKIN FIBROBLASTS; CHILDHOOD ADRENOLEUKODYSTROPHY; ZELLWEGER-SYNDROME; EXPRESSION; LOCALIZATION; SYNTHETASE; ALDP	X-linked adrenoleukodystrophy (X-ALD), an inherited peroxisomal disorder, is caused by mutations in the ABCD1 gene encoding the peroxisomal ATP-binding cassette (ABC) transporter ABCD1 (adrenoleukodystrophy protein, ALDP). Biochemically, X-ALD is characterized by an accumulation of very long-chain fatty acids and partially impaired peroxisomal beta-oxidation. In this study, we used primary human fibroblasts from X-ALD and Zellweger syndrome patients to investigate the peroxisomal beta-oxidation defect. Our results show that the degradation of C26:0-CoA esters is as severely impaired as degradation of unesterified very long-chain fatty acids in X-ALD and is abolished in Zellweger syndrome. Interestingly, the beta-oxidation rates for both C26:0-CoA and C22:0-CoA were similarly affected, although C22:0 does not accumulate in patient fibroblasts. Furthermore, we show that the beta-oxidation defect in X-ALD is directly caused by ABCD1 dysfunction as blocking ABCD1 function with a specific antibody reduced beta-oxidation to levels observed in X-ALD fibroblasts. By quantification of mRNA and protein levels of the peroxisomal ABC transporters and by blocking with specific antibodies, we found that residual beta-oxidation activity toward C26:0-CoA in X-ALD fibroblasts is mediated by ABCD3, although the efficacy of ABCD3 appeared to be much lower than that of ABCD1. Finally, using isolated peroxisomes, we show that beta-oxidation of C26:0-CoA is independent of additional CoA but requires a cytosolic factor of >10-kDa molecular mass that is resistant to N-ethylmaleimide and heat inactivation. In conclusion, our findings in human cells suggest that, in contrast to yeast cells, very long-chain acyl-CoA esters are transported into peroxisomes by ABCD1 independently of additional synthetase activity.	[Wiesinger, Christoph; Kunze, Markus; Forss-Petter, Sonja; Berger, Johannes] Med Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria; [Regelsberger, Guenther] Med Univ Vienna, Inst Neurol, A-1097 Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Berger, J (corresponding author), Med Univ Vienna, Dept Pathobiol Nervous Syst, Ctr Brain Res, Spitalgasse 4, A-1090 Vienna, Austria.	johannes.berger@meduniwien.ac.at	Berger, Johannes/A-9122-2014	Berger, Johannes/0000-0003-0182-2658; Regelsberger, Gunther/0000-0002-3233-1491; Wiesinger, Christoph/0000-0003-1257-4522	European Union [HEALTH-F2-2010-241622]	European Union(European Commission)	This work was supported by FP7 European Union Project "LEUKOTREAT" Grant HEALTH-F2-2010-241622.	Agrimi G, 2012, BIOCHEM J, V443, P241, DOI 10.1042/BJ20111420; Antonenkov VD, 2005, CELL MOL LIFE SCI, V62, P2886, DOI 10.1007/s00018-005-5233-x; Berger J, 1999, EUR J BIOCHEM, V265, P719, DOI 10.1046/j.1432-1327.1999.00772.x; Berger J, 2010, BRAIN PATHOL, V20, P845, DOI 10.1111/j.1750-3639.2010.00393.x; Bezman L, 2001, ANN NEUROL, V49, P512, DOI 10.1002/ana.101; Braiterman LT, 1998, HUM MOL GENET, V7, P239, DOI 10.1093/hmg/7.2.239; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; Ferrer I, 2010, BRAIN PATHOL, V20, P817, DOI 10.1111/j.1750-3639.2010.00390.x; Flavigny E, 1999, FEBS LETT, V448, P261, DOI 10.1016/S0014-5793(99)00379-8; Guimaraes CP, 2004, BBA-MOL BASIS DIS, V1689, P235, DOI 10.1016/j.bbadis.2004.04.001; HASHMI M, 1986, FEBS LETT, V196, P247, DOI 10.1016/0014-5793(86)80256-3; Hettema EH, 1996, EMBO J, V15, P3813, DOI 10.1002/j.1460-2075.1996.tb00755.x; Hillebrand M, 2007, J BIOL CHEM, V282, P26997, DOI 10.1074/jbc.M702122200; Hinz A, 2012, BIOCHEMISTRY-US, V51, P4981, DOI 10.1021/bi300128f; Hipfner DR, 1999, J BIOL CHEM, V274, P15420, DOI 10.1074/jbc.274.22.15420; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; Jia ZZ, 2007, J BIOL CHEM, V282, P20573, DOI 10.1074/jbc.M700568200; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kashiwayama Y, 2009, EXP CELL RES, V315, P190, DOI 10.1016/j.yexcr.2008.10.031; Kemp S, 1998, NAT MED, V4, P1261, DOI 10.1038/3242; Kemp S, 2012, BBA-MOL BASIS DIS, V1822, P1465, DOI 10.1016/j.bbadis.2012.03.012; Kunze M, 2011, J BIOL CHEM, V286, P45048, DOI 10.1074/jbc.M111.301853; Langmann T, 2003, CLIN CHEM, V49, P230, DOI 10.1373/49.2.230; LAZO O, 1988, P NATL ACAD SCI USA, V85, P7647, DOI 10.1073/pnas.85.20.7647; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McGuinness MC, 2003, MOL CELL BIOL, V23, P744, DOI 10.1128/MCB.23.2.744-753.2003; Morita M, 2012, BBA-MOL BASIS DIS, V1822, P1387, DOI 10.1016/j.bbadis.2012.02.009; Moser AB, 1999, PRENATAL DIAG, V19, P46, DOI 10.1002/(SICI)1097-0223(199901)19:1<46::AID-PD501>3.0.CO;2-E; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Ofman R, 2010, EMBO MOL MED, V2, P90, DOI 10.1002/emmm.201000061; Sanders RJ, 2005, J LIPID RES, V46, P1001, DOI 10.1194/jlr.M400510-JLR200; Sandhir R, 1998, J LIPID RES, V39, P2161; SCHUTGENS RBH, 1993, CLIN CHEM, V39, P1632; Shani N, 1996, ANN NY ACAD SCI, V804, P770, DOI 10.1111/j.1749-6632.1996.tb18697.x; SINGH H, 1987, ARCH BIOCHEM BIOPHYS, V254, P526, DOI 10.1016/0003-9861(87)90133-0; Smith BT, 2000, EXP CELL RES, V254, P309, DOI 10.1006/excr.1999.4757; Steinberg SJ, 1999, ANN NEUROL, V46, P409, DOI 10.1002/1531-8249(199909)46:3<409::AID-ANA18>3.0.CO;2-9; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; Unterberger U, 2007, CLIN BIOCHEM, V40, P1037, DOI 10.1016/j.clinbiochem.2007.04.015; van Roermund CWT, 2012, J BIOL CHEM, V287, P20144, DOI 10.1074/jbc.M111.332833; van Roermund CWT, 2011, BBA-MOL CELL BIOL L, V1811, P148, DOI 10.1016/j.bbalip.2010.11.010; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352; WANDERS RJA, 1987, CLIN CHIM ACTA, V165, P321, DOI 10.1016/0009-8981(87)90177-X; WANDERS RJA, 1988, J INHERIT METAB DIS, V11, P173, DOI 10.1007/BF01804228; WATKINS PA, 1991, ARCH BIOCHEM BIOPHYS, V289, P329, DOI 10.1016/0003-9861(91)90419-J; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Watkins PA, 2012, BBA-MOL BASIS DIS, V1822, P1411, DOI 10.1016/j.bbadis.2012.02.010	51	92	95	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19269	19279		10.1074/jbc.M112.445445	http://dx.doi.org/10.1074/jbc.M112.445445			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671276	Green Published, hybrid			2022-12-28	WOS:000321335800059
J	Wilson, PC; Lee, MH; Appleton, KM; El-Shewy, HM; Morinelli, TA; Peterson, YK; Luttrell, LM; Jaffa, AA				Wilson, Parker C.; Lee, Mi-Hye; Appleton, Kathryn M.; El-Shewy, Hesham M.; Morinelli, Thomas A.; Peterson, Yuri K.; Luttrell, Louis M.; Jaffa, Ayad A.			The Arrestin-selective Angiotensin AT(1) Receptor Agonist [Sar(1),Ile(4),Ile(8)]-AngII Negatively Regulates Bradykinin B-2 Receptor Signaling via AT(1)-B-2 Receptor Heterodimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KALLIKREIN-KININ SYSTEM; OXIDE-GENERATING VASODILATORS; VASCULAR SMOOTH-MUSCLE; G-PROTEIN; BETA-ARRESTIN; NITRIC-OXIDE; IN-VIVO; DIABETIC-NEPHROPATHY; HEART-FAILURE; BIASED LIGAND	The renin-angiotensin and kallikrein-kinin systems are key regulators of vascular tone and inflammation. Angiotensin II, the principal effector of the renin-angiotensin system, promotes vasoconstriction by activating angiotensin AT(1) receptors. The opposing effects of the kallikrein-kinin system are mediated by bradykinin acting on B-1 and B-2 bradykinin receptors. The renin-angiotensin and kallikrein-kinin systems engage in cross-talk at multiple levels, including the formation of AT(1)-B-2 receptor heterodimers. In primary vascular smooth muscle cells, we find that the arrestin pathway-selective AT(1) agonist, [Sar(1),Ile(4),Ile(8)]-AngII, but not the neutral AT(1) antagonist, losartan, inhibits endogenous B-2 receptor signaling. In a transfected HEK293 cell model that recapitulates this effect, we find that the actions of [Sar(1), Ile(4), Ile(8)]-AngII require the AT(1) receptor and result from arrestin-dependent co-internalization of AT(1)-B-2 heterodimers. BRET50 measurements indicate that AT(1) and B-2 receptors efficiently heterodimerize. In cells expressing both receptors, pretreatment with [Sar(1),Ile(4),Ile(8)]-AngII blunts B-2 receptor activation of G(q/11)-dependent intracellular calcium influx and G(i/o)-dependent inhibition of adenylyl cyclase. In contrast, [Sar(1),Ile(4),Ile(8)]-AngII has no effect on B-2 receptor ligand affinity or bradykinin-induced arrestin3 recruitment. Both radioligand binding assays and quantitative microscopy-based analysis demonstrate that [Sar(1),Ile(4),Ile(8)]-AngII promotes internalization of AT(1)-B-2 heterodimers. Thus, [Sar(1),Ile(4),Ile(8)]-AngII exerts lateral allosteric modulation of B-2 receptor signaling by binding to the orthosteric ligand binding site of the AT(1) receptor and promoting co-sequestration of AT(1)-B-2 heterodimers. Given the opposing roles of the renin-angiotensin and kallikrein-kinin systems in vivo, the distinct properties of arrestin pathway-selective and neutral AT(1) receptor ligands may translate into different pharmacologic actions.	[Wilson, Parker C.; Lee, Mi-Hye; El-Shewy, Hesham M.; Morinelli, Thomas A.; Luttrell, Louis M.; Jaffa, Ayad A.] Med Univ S Carolina, Coll Med, Dept Med, Charleston, SC 29425 USA; [Luttrell, Louis M.] Med Univ S Carolina, Coll Med, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Appleton, Kathryn M.; Peterson, Yuri K.] Med Univ S Carolina, Coll Pharm, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Luttrell, Louis M.] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA; [Jaffa, Ayad A.] Amer Univ Beirut, Dept Biochem, Beirut 11072020, Lebanon; [Jaffa, Ayad A.] Amer Univ Beirut, Dept Mol Genet, Beirut 11072020, Lebanon	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; American University of Beirut; American University of Beirut	Luttrell, LM (corresponding author), Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, 96 Jonathan Lucas St,Suite 816CSB,MSC624, Charleston, SC 29425 USA.	luttrell@musc.edu		Luttrell, Louis/0000-0003-2805-6949; Wilson, Parker/0000-0001-8647-9662	National Institutes of Health [R01 HL087986, HL077192, R01 DK55524, F30 DK083208]; National Center for Research Resources [S10 RR027777]; Research Service of the Ralph H. Johnson Veterans Affairs Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027777] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077192, R01HL087986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK083208, R01DK055524] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research Service of the Ralph H. Johnson Veterans Affairs Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL087986 and HL077192 (to A. A. J.), R01 DK55524 (to L. M. L.), and F30 DK083208 (to P. C. W.) and National Center for Research Resources Grant S10 RR027777 (to T. A. M. and L. M. L.). This work was also supported by the Research Service of the Ralph H. Johnson Veterans Affairs Medical Center.	AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; AbdAlla S, 2001, NAT MED, V7, P1003, DOI 10.1038/nm0901-1003; AbdAlla S, 2005, J MOL NEUROSCI, V26, P185, DOI 10.1385/JMN:26:2-3:185; Achour L, 2011, METHODS MOL BIOL, V756, P183, DOI 10.1007/978-1-61779-160-4_9; Appleton KM, 2013, METHOD ENZYMOL, V522, P229, DOI 10.1016/B978-0-12-407865-9.00013-3; Barki-Harrington L, 2003, CIRCULATION, V108, P1611, DOI 10.1161/01.CIR.0000092166.30360.78; Binkowski BF, 2011, METHODS MOL BIOL, V756, P263, DOI 10.1007/978-1-61779-160-4_14; Boerrigter G, 2012, CIRC-HEART FAIL, V5, P627, DOI 10.1161/CIRCHEARTFAILURE.112.969220; Boerrigter G, 2011, CIRC-HEART FAIL, V4, P770, DOI 10.1161/CIRCHEARTFAILURE.111.962571; Bonde MM, 2011, REGUL PEPTIDES, V167, P21, DOI 10.1016/j.regpep.2010.11.003; BRINER VA, 1993, AM J PHYSIOL, V264, pF322, DOI 10.1152/ajprenal.1993.264.2.F322; Devi LA, 2001, TRENDS PHARMACOL SCI, V22, P532, DOI 10.1016/S0165-6147(00)01799-5; Duka I, 2001, CIRC RES, V88, P275, DOI 10.1161/01.RES.88.3.275; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; GARG UC, 1989, J CLIN INVEST, V83, P1774, DOI 10.1172/JCI114081; GARG UC, 1989, AM J PHYSIOL, V257, pF60, DOI 10.1152/ajprenal.1989.257.1.F60; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gul R, 2012, CARDIORENAL MED, V2, P268, DOI 10.1159/000343456; Hamdan FF, 2005, J BIOMOL SCREEN, V10, P463, DOI 10.1177/1087057105275344; Hansen JL, 2009, J BIOL CHEM, V284, P1831, DOI 10.1074/jbc.M804607200; Hermann A, 1999, IMMUNOPHARMACOLOGY, V45, P135, DOI 10.1016/S0162-3109(99)00066-1; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Jaffa AA, 2003, DIABETES, V52, P1215, DOI 10.2337/diabetes.52.5.1215; Jaffa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044714; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kichuk MR, 1996, CIRCULATION, V94, P44, DOI 10.1161/01.CIR.94.1.44; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Lee MH, 2008, J BIOL CHEM, V283, P2088, DOI 10.1074/jbc.M706892200; Leonard AP, 2013, MICROSC MICROANAL, V19, P150, DOI 10.1017/S1431927612014067; Luttrell LM, 2011, METHODS MOL BIOL, V756, P3, DOI 10.1007/978-1-61779-160-4_1; Lyngso C, 2009, MOL CELL ENDOCRINOL, V302, P203, DOI 10.1016/j.mce.2008.09.018; Maione A, 2011, NEPHROL DIAL TRANSPL, V26, P2827, DOI 10.1093/ndt/gfq792; MOMBOULI JV, 1995, ANNU REV PHARMACOL, V35, P679, DOI 10.1146/annurev.pa.35.040195.003335; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Quitterer U, 2011, BIOCHEM BIOPH RES CO, V409, P544, DOI 10.1016/j.bbrc.2011.05.041; Sainz IM, 2007, THROMB HAEMOSTASIS, V98, P77, DOI 10.1160/Th07-04-0250; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Schmaier AH, 2003, AM J PHYSIOL-REG I, V285, pR1, DOI 10.1152/ajpregu.00535.2002; Schmaier AH, 2002, J CLIN INVEST, V109, P1007, DOI 10.1172/JCI200215490; Schmaier AH, 2008, INT IMMUNOPHARMACOL, V8, P161, DOI 10.1016/j.intimp.2007.08.022; Schremmer-Danninger E, 1998, BIOCHEM BIOPH RES CO, V243, P246, DOI 10.1006/bbrc.1997.7999; Simaan M, 2005, CELL SIGNAL, V17, P1074, DOI 10.1016/j.cellsig.2004.12.001; Siragy HM, 1997, HYPERTENSION, V29, P757, DOI 10.1161/01.HYP.29.3.757; Spillmann F, 2002, INT IMMUNOPHARMACOL, V2, P1823, DOI 10.1016/S1567-5769(02)00174-1; Tan Y, 2004, AM J PHYSIOL-HEART C, V286, pH926, DOI 10.1152/ajpheart.00757.2003; Tan Y, 2007, AM J PHYSIOL-RENAL, V293, pF1026, DOI 10.1152/ajprenal.00203.2007; Thomas WG, 2000, J BIOL CHEM, V275, P2893, DOI 10.1074/jbc.275.4.2893; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Xu ZG, 2009, NEPHROL DIAL TRANSPL, V24, P1744, DOI 10.1093/ndt/gfn703; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873; Zhang Q, 2012, EXP BIOL MED, V237, P903, DOI 10.1258/ebm.2012.012032; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	56	38	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18872	18884		10.1074/jbc.M113.472381	http://dx.doi.org/10.1074/jbc.M113.472381			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23661707	Green Published, hybrid			2022-12-28	WOS:000321335800025
J	Honaker, MT; Acchione, M; Zhang, W; Mannervik, B; Atkins, WM				Honaker, Matthew T.; Acchione, Mauro; Zhang, Wei; Mannervik, Bengt; Atkins, William M.			Enzymatic Detoxication, Conformational Selection, and the Role of Molten Globule Active Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE TRANSFERASE A1-1; HIGH CATALYTIC EFFICIENCY; LIPID-PEROXIDATION; S-TRANSFERASE; SUBSTRATE-SELECTIVITY; CRYSTAL-STRUCTURES; INDUCED FIT; PROMISCUITY; MECHANISM; DYNAMICS	The role of conformational ensembles in enzymatic reactions remains unclear. Discussion concerning "induced fit" versus "conformational selection" has, however, ignored detoxication enzymes, which exhibit catalytic promiscuity. These enzymes dominate drug metabolism and determine drug-drug interactions. The detoxication enzyme glutathione transferase A1-1 (GSTA1-1), exploits a molten globule-like active site to achieve remarkable catalytic promiscuity wherein the substrate-free conformational ensemble is broad with barrierless transitions between states. A quantitative index of catalytic promiscuity is used to compare engineered variants of GSTA1-1 and the catalytic promiscuity correlates strongly with characteristics of the thermodynamic partition function, for the substrate-free enzymes. Access to chemically disparate transition states is encoded by the substrate-free conformational ensemble. Pre-steady state catalytic data confirm an extension of the conformational selection model, wherein different substrates select different starting conformations. The kinetic liability of the conformational breadth is minimized by a smooth landscape. We propose that "local" molten globule behavior optimizes detoxication enzymes.	[Honaker, Matthew T.; Acchione, Mauro; Atkins, William M.] Univ Washington, Dept Med Chem, Seattle, WA 98195 USA; [Zhang, Wei; Mannervik, Bengt] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden	University of Washington; University of Washington Seattle; Stockholm University	Atkins, WM (corresponding author), Box 357610, Seattle, WA 98177 USA.	winky@uw.edu			National Institutes of Health [GM862284]; Swedish Research Council; Swedish Cancer Society	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work was supported, in whole or in part, by National Institutes of Health Grant GM862284 (to W. M. A.) and the Swedish Research Council and Swedish Cancer Society (to B. M.).	AINSLIE GR, 1972, J BIOL CHEM, V247, P7088; Armstrong RN, 1997, CHEM RES TOXICOL, V10, P2, DOI 10.1021/tx960072x; Balogh LM, 2009, BIOCHEMISTRY-US, V48, P7698, DOI 10.1021/bi900895b; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Blikstad C, 2008, BBA-GEN SUBJECTS, V1780, P1458, DOI 10.1016/j.bbagen.2008.07.007; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Dong D, 2012, XENOBIOTICA, V42, P808, DOI 10.3109/00498254.2012.663515; Ekonomiuk D, 2009, PROTEIN SCI, V18, P1003, DOI 10.1002/pro.110; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Fersht A, 2002, STRUCTURE MECH PROTE, P139; Freire E, 1995, Methods Mol Biol, V40, P191; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; FRIEDEN C, 1970, J BIOL CHEM, V245, P5788; Grahn E, 2006, ACTA CRYSTALLOGR D, V62, P197, DOI 10.1107/S0907444905039296; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Honaker MT, 2011, J BIOL CHEM, V286, P42770, DOI 10.1074/jbc.M111.304386; Hou L, 2007, J BIOL CHEM, V282, P23264, DOI 10.1074/jbc.M700868200; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Ibarra C, 2001, BIOCHEMISTRY-US, V40, P10614, DOI 10.1021/bi010672h; Jackson CJ, 2009, P NATL ACAD SCI USA, V106, P21631, DOI 10.1073/pnas.0907548106; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Le Trong I, 2002, PROTEINS, V48, P618, DOI 10.1002/prot.10162; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; MANNERVIK B, 1988, CRC CR REV BIOCH MOL, V23, P283, DOI 10.3109/10409238809088226; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Munoz V, 2004, P NATL ACAD SCI USA, V101, P17646, DOI 10.1073/pnas.0405829101; Naganathan AN, 2005, J AM CHEM SOC, V127, P17970, DOI 10.1021/ja055996y; Nath A, 2008, BIOCHEMISTRY-US, V47, P157, DOI 10.1021/bi701448p; Nilsson LO, 2000, P NATL ACAD SCI USA, V97, P9408, DOI 10.1073/pnas.150084897; Pervushin K, 2007, NAT STRUCT MOL BIOL, V14, P1202, DOI 10.1038/nsmb1325; Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389; Vamvaca K, 2004, P NATL ACAD SCI USA, V101, P12860, DOI 10.1073/pnas.0404109101; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; WANG RW, 1989, ARCH BIOCHEM BIOPHYS, V269, P536, DOI 10.1016/0003-9861(89)90137-9; Weikl TR, 2009, PROTEINS, V75, P104, DOI 10.1002/prot.22223; Zhan YP, 2004, BIOCHEMISTRY-US, V43, P7244, DOI 10.1021/bi0363329; Zhang W, 2012, BIOCHEM J, V445, P39, DOI 10.1042/BJ20120136	38	34	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18599	18611		10.1074/jbc.M112.445767	http://dx.doi.org/10.1074/jbc.M112.445767			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649628	Green Published, hybrid			2022-12-28	WOS:000320721900059
J	Yoo, EJ; Cooke, NE; Liebhaber, SA				Yoo, Eung Jae; Cooke, Nancy E.; Liebhaber, Stephen A.			Identification of a Secondary Promoter within the Human B Cell Receptor Component Gene hCD79b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-HYPERSENSITIVE SITES; GROWTH-HORMONE GENE; LOCUS-CONTROL REGION; ANTIGEN RECEPTORS; CD79B GENE; CHROMATIN; TRANSCRIPTION; BETA; ALPHA; ACTIVATION	The human B cell-specific protein, CD79b (also known as Ig beta and B29) constitutes an essential signal transduction component of the B cell receptor. Although its function is central to the triggering of B cell terminal differentiation in response to antigen stimulation, the transcriptional determinants that control CD79b gene expression remain poorly defined. In the present study, we explored these determinants using a series of hCD79b transgenic mouse models. Remarkably, we observed that the previously described hCD79b promoter along with its associated enhancer elements and first exon could be deleted without appreciable loss of hCD79b transcriptional activity or tissue specificity. In this deletion setting, a secondary promoter located within exon 2 maintained full levels and specificity of hCD79b transcription. Of note, this secondary promoter was also active, albeit at lower levels, in the wild-type hCD79b locus. The activity of the secondary promoter was dependent on the action(s) of a conserved sequence element mapping to a chromatin DNase I hypersensitive site located within intron 1. mRNA generated from this secondary promoter is predicted to encode an Ig beta protein lacking a signal sequence and thus unable to serve normal B cell receptor function. Although the physiologic role of the hCD79b secondary promoter and its encoded protein remain unclear, the current data suggest that it has the capacity to play a role in normal as well as pathologic states in B cell proliferation and function.	[Liebhaber, Stephen A.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Liebhaber, SA (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, 415 Curie Blvd,CRB 560A, Philadelphia, PA 19104 USA.	liebhabe@upenn.edu			National Institutes of Health [DK019525, DK050306, CA016520]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD025147] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, P30DK050306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the University of Pennsylvania Transgenic and Chimeric Mouse Facility (supported by National Institutes of Health P30 Grants DK019525, DK050306, and CA016520) for generation of the transgenic mice.	Anish R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005103; Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; Bennani-Baiti IM, 1998, GENOMICS, V48, P258, DOI 10.1006/geno.1997.5171; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Cajiao I, 2004, EMBO J, V23, P3854, DOI 10.1038/sj.emboj.7600365; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Crawford GE, 2004, P NATL ACAD SCI USA, V101, P992, DOI 10.1073/pnas.0307540100; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Dobbs AK, 2007, J IMMUNOL, V179, P2055, DOI 10.4049/jimmunol.179.4.2055; Ferrari S, 2007, J EXP MED, V204, P2047, DOI 10.1084/jem.20070264; GOLD MR, 1991, P NATL ACAD SCI USA, V88, P3436, DOI 10.1073/pnas.88.8.3436; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gordon MS, 2000, P NATL ACAD SCI USA, V97, P5504, DOI 10.1073/pnas.090087097; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; He HSHS, 2012, GENOME RES, V22, P1015, DOI 10.1101/gr.133280.111; HIRZMANN J, 1993, NUCLEIC ACIDS RES, V21, P3597, DOI 10.1093/nar/21.15.3597; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Huang XG, 2011, PATHOL INT, V61, P122, DOI 10.1111/j.1440-1827.2010.02634.x; JACOBS SM, 1994, CANCER GENET CYTOGEN, V75, P31, DOI 10.1016/0165-4608(94)90212-7; JACOBS SM, 1994, ONCOGENE, V9, P227; Ji XJ, 2003, MOL CELL BIOL, V23, P899, DOI 10.1128/MCB.23.3.899-907.2003; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Kimura AP, 2007, MOL CELL BIOL, V27, P6555, DOI 10.1128/MCB.00273-07; Komatsu A, 2002, EUR J BIOCHEM, V269, P1227, DOI 10.1046/j.1432-1033.2002.02757.x; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Malone CS, 2002, J IMMUNOL, V168, P3369, DOI 10.4049/jimmunol.168.7.3369; OMORI SA, 1993, P NATL ACAD SCI USA, V90, P11723, DOI 10.1073/pnas.90.24.11723; PARANJAPE SM, 1994, ANNU REV BIOCHEM, V63, P265, DOI 10.1146/annurev.biochem.63.1.265; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P4537, DOI 10.1073/pnas.0400678101; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; SHENKAR R, 1991, MOL CELL BIOL, V11, P1813, DOI 10.1128/MCB.11.4.1813; Shewchuk BM, 1999, J BIOL CHEM, V274, P35725, DOI 10.1074/jbc.274.50.35725; STALDER J, 1980, CELL, V20, P451, DOI 10.1016/0092-8674(80)90631-5; Thompson AA, 1997, BLOOD, V90, P1387, DOI 10.1182/blood.V90.4.1387.1387_1387_1394; Thompson AA, 1996, BLOOD, V87, P666, DOI 10.1182/blood.V87.2.666.bloodjournal872666; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Yoo EJ, 2006, MOL CELL BIOL, V26, P5569, DOI 10.1128/MCB.00405-06; Yoo EJ, 2012, MOL CELL BIOL, V32, P2020, DOI 10.1128/MCB.06650-11; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	45	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18353	18365		10.1074/jbc.M113.461988	http://dx.doi.org/10.1074/jbc.M113.461988			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649625	Green Published, hybrid			2022-12-28	WOS:000320721900039
J	Zhou, Z; Jing, C; Zhang, LY; Takeo, F; Kim, H; Huang, Y; Liu, ZH; Wan, Y				Zhou, Zhuan; Jing, Chao; Zhang, Liyong; Takeo, Fujita; Kim, Hyun; Huang, Yi; Liu, Zhihua; Wan, Yong			Regulation of Rad17 Protein Turnover Unveils an Impact of Rad17-APC Cascade in Breast Carcinogenesis and Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; SACCHAROMYCES-CEREVISIAE; GENOMIC INSTABILITY; ANTICANCER BARRIER; REPLICATION STRESS; GENOTOXIC STRESS; CHECKPOINT GENE; CANCER; REPAIR; HRAD17	Aberrant regulation of DNA damage checkpoint function leads to genome instability that in turn can predispose cellular tissues to become cancerous. Previous works from us and others demonstrated the role of Rad17 in either activation or termination of DNA damage checkpoint function. In the current study, we have revealed the unexpected accumulation of Rad17 in various types of breast cancer cell lines as well as human breast cancer tissues. We observed that Rad17 protein turnover rate in breast epithelial cells is much faster than in breast cancer cells, where the turnover of Rad17 is regulated by the Cdh1/APC pathway. We further observed that Rad17-mediated checkpoint function is modulated by proteolysis. Stabilization of Rad17 disrupts cellular response to chemotherapeutic drug-induced DNA damage and enhances cellular transformation. In addition, manipulation of Rad17 by RNA interference or stabilization of Rad17 significantly sensitize breast cancer cell to various chemotherapeutic drugs. Our present results indicate the manipulation of Rad17 proteolysis could be a valuable approach to sensitize breast cancer cell to the chemotherapeutic treatment despite of the critical role in governing DNA damage response and cellular recovery from genotoxic stress.	[Zhou, Zhuan; Zhang, Liyong; Takeo, Fujita; Kim, Hyun; Wan, Yong] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15213 USA; [Zhou, Zhuan; Zhang, Liyong; Takeo, Fujita; Kim, Hyun; Wan, Yong] Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Jing, Chao; Liu, Zhihua] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China; [Jing, Chao; Liu, Zhihua] Peking Union Med Coll, Beijing 100021, Peoples R China; [Takeo, Fujita] Natl Canc Ctr Hosp East, Kashiwa, Chiba 2770882, Japan; [Huang, Yi] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National Cancer Center - Japan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, ZH (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn; yow4@pitt.edu	Huang, Yi/AAW-7892-2021	Huang, Yi/0000-0002-9982-117X; Zhang, Liyong/0000-0002-6952-7463	National Institutes of Health [R01CA154695]; Pittsburgh Woman Cancer Fund; Breast Cancer Research Foundation grant; National Nature Science Foundation of China [30928029]; NATIONAL CANCER INSTITUTE [R01CA154695] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pittsburgh Woman Cancer Fund; Breast Cancer Research Foundation grant; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by National Institutes of Health Grant R01CA154695, a Pittsburgh Woman Cancer Fund and Breast Cancer Research Foundation grant, and National Nature Science Foundation of China Grant 30928029.	Allan JM, 2005, NAT REV CANCER, V5, P943, DOI 10.1038/nrc1749; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bao SD, 1999, CANCER RES, V59, P2023; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartek J, 2007, CELL CYCLE, V6, P2344, DOI 10.4161/cc.6.19.4754; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Budzowska M, 2004, EMBO J, V23, P3548, DOI 10.1038/sj.emboj.7600353; Chini CCS, 2004, DNA REPAIR, V3, P1033, DOI 10.1016/j.dnarep.2004.03.001; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Dean FB, 1998, GENOMICS, V54, P424, DOI 10.1006/geno.1998.5587; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hopkins KM, 2003, CANCER RES, V63, P5291; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kataoka A, 2001, CLIN CANCER RES, V7, P2815; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Kobayashi M, 2004, GENES CELLS, V9, P291, DOI 10.1111/j.1356-9597.2004.00728.x; Li L, 1999, ONCOGENE, V18, P1689, DOI 10.1038/sj.onc.1202469; Ma CX, 2013, BREAST CANCER RES TR, V137, P483, DOI 10.1007/s10549-012-2378-9; Nouspikel T, 2008, DNA REPAIR, V7, P1155, DOI 10.1016/j.dnarep.2008.03.015; Paulovich AG, 1997, GENETICS, V145, P45; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Sasaki H, 2001, LUNG CANCER, V34, P47, DOI 10.1016/S0169-5002(01)00223-9; Shinohara M, 2003, GENETICS, V164, P855; Siede W, 1996, NUCLEIC ACIDS RES, V24, P1669, DOI 10.1093/nar/24.9.1669; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Wang X, 2003, GENE DEV, V17, P965, DOI 10.1101/gad.1065103; Wang X, 2001, CANCER RES, V61, P7417; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zhang LY, 2006, CLIN CANCER RES, V12, P1639, DOI 10.1158/1078-0432.CCR-05-1858; Zimmerman ES, 2004, MOL CELL BIOL, V24, P9286, DOI 10.1128/MCB.24.21.9286-9294.2004	39	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18134	18145		10.1074/jbc.M113.456962	http://dx.doi.org/10.1074/jbc.M113.456962			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23637229	Green Published, hybrid			2022-12-28	WOS:000320721900019
J	Ghosh, B; Satyshur, KA; Czajkowski, C				Ghosh, Borna; Satyshur, Kenneth A.; Czajkowski, Cynthia			Propofol Binding to the Resting State of the Gloeobacter violaceus Ligand-gated Ion Channel (GLIC) Induces Structural Changes in the Inter- and Intrasubunit Transmembrane Domain (TMD) Cavities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; X-RAY-STRUCTURE; GABA(A) RECEPTOR; CYS-LOOP; BENZODIAZEPINE MODULATION; GENERAL-ANESTHETICS; AGONIST BINDING; A RECEPTOR; SITES; IDENTIFICATION	General anesthetics exert many of their CNS actions by binding to and modulating membrane-embedded pentameric ligand-gated ion channels (pLGICs). The structural mechanisms underlying how anesthetics modulate pLGIC function remain largely unknown. GLIC, a prokaryotic pLGIC homologue, is inhibited by general anesthetics, suggesting anesthetics stabilize a closed channel state, but in anesthetic- bound GLIC crystal structures the channel appears open. Here, using functional GLIC channels expressed in oocytes, we examined whether propofol induces structural rearrangements in the GLIC transmembrane domain (TMD). Residues in the GLIC TMD that frame intrasubunit and intersubunit water-accessible cavities were individually mutated to cysteine. We measured and compared the rates of modification of the introduced cysteines by sulfhydryl-reactive reagents in the absence and presence of propofol. Propofol slowed the rate of modification of L240C (intersubunit) and increased the rate of modification of T254C (intrasubunit), indicating that propofol binding induces structural rearrangements in these cavities that alter the local environment near these residues. Propofol acceleration of T254C modification suggests that in the resting state propofol does not bind in the TMD intrasubunit cavity as observed in the crystal structure of GLIC with bound propofol (Nury, H., Van Renterghem, C., Weng, Y., Tran, A., Baaden, M., Dufresne, V., Changeux, J. P., Sonner, J. M., Delarue, M., and Corringer, P. J. (2011) Nature 469, 428 - 431). In silico docking using a GLIC closed channel homology model suggests propofol binds to intersubunit sites in the TMD in the resting state. Propofol-induced motions in the intersubunit cavity were distinct from motions associated with channel activation, indicating propofol stabilizes a novel closed state.	[Ghosh, Borna; Czajkowski, Cynthia] Univ Wisconsin, Mol Biophys Program, Madison, WI 53711 USA; [Satyshur, Kenneth A.; Czajkowski, Cynthia] Univ Wisconsin, Dept Neurosci, Madison, WI 53711 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Czajkowski, C (corresponding author), Univ Wisconsin, Dept Neurosci, 601 Sci Dr, Madison, WI 53711 USA.	cmczajko@wisc.edu		Satyshur, Kenneth/0000-0001-9371-2493; Ghosh, Borna/0000-0003-1952-6523	National Institutes of Health [34727]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 34727 (NINDS; to C. C.).	Ahrens J, 2008, ANESTH ANALG, V107, P1875, DOI 10.1213/ane.0b013e3181875a31; Akk G., 2008, V182, P53, DOI 10.1007/978-3-540-74806-9_3; Baenziger JE, 2011, NEUROPHARMACOLOGY, V60, P116, DOI 10.1016/j.neuropharm.2010.08.007; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Boileau AJ, 1999, J NEUROSCI, V19, P10213; Borghese CM, 2003, J PHARMACOL EXP THER, V307, P42, DOI 10.1124/jpet.102.053710; Brannigan G, 2010, P NATL ACAD SCI USA, V107, P14122, DOI 10.1073/pnas.1008534107; Chen QA, 2010, BIOPHYS J, V99, P1801, DOI 10.1016/j.bpj.2010.07.023; Chen YH, 2006, J BIOL CHEM, V281, P18184, DOI 10.1074/jbc.M600349200; Chiara DC, 2013, BIOPHYS J, V104, p636A, DOI 10.1016/j.bpj.2012.11.3513; Collins T, 2010, MOL PHARMACOL, V78, P198, DOI 10.1124/mol.110.064295; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Hamouda AK, 2011, J BIOL CHEM, V286, P20466, DOI 10.1074/jbc.M111.219071; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Koltchine VV, 1999, MOL PHARMACOL, V56, P1087, DOI 10.1124/mol.56.5.1087; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liu RY, 2012, ANESTH ANALG, V114, P947, DOI 10.1213/ANE.0b013e31824c4def; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Morlock EV, 2011, MOL PHARMACOL, V80, P14, DOI 10.1124/mol.110.069542; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Morris KDW, 2004, MOL PHARMACOL, V66, P56, DOI 10.1124/mol.66.1.56; Mowrey D, 2013, J AM CHEM SOC, V135, P2172, DOI 10.1021/ja307275v; Murail S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002710; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Sancar F, 2011, NEUROPHARMACOLOGY, V60, P520, DOI 10.1016/j.neuropharm.2010.11.009; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; Trattnig SM, 2012, J BIOL CHEM, V287, P25241, DOI 10.1074/jbc.M112.360370; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Venkatachalan SP, 2007, PFLUG ARCH EUR J PHY, V454, P155, DOI 10.1007/s00424-006-0183-1; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Willenbring D, 2011, BIOPHYS J, V101, P1905, DOI 10.1016/j.bpj.2011.09.026; Williams DB, 2002, J NEUROSCI, V22, P7417; Ye Q, 1998, J BIOL CHEM, V273, P3314, DOI 10.1074/jbc.273.6.3314; Zeller A., 2008, V182, P31, DOI 10.1007/978-3-540-74806-9_2; Zhu FQ, 2010, P NATL ACAD SCI USA, V107, P19814, DOI 10.1073/pnas.1009313107; Zhu FQ, 2009, BIOPHYS J, V97, P2456, DOI 10.1016/j.bpj.2009.08.020	60	26	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17420	17431		10.1074/jbc.M113.464040	http://dx.doi.org/10.1074/jbc.M113.464040			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640880	Green Published, hybrid			2022-12-28	WOS:000320380600034
J	Shaltiel-Karyo, R; Frenkel-Pinter, M; Rockenstein, E; Patrick, C; Levy-Sakin, M; Schiller, A; Egoz-Matia, N; Masliah, E; Segal, D; Gazit, E				Shaltiel-Karyo, Ronit; Frenkel-Pinter, Moran; Rockenstein, Edward; Patrick, Christina; Levy-Sakin, Michal; Schiller, Abigail; Egoz-Matia, Nirit; Masliah, Eliezer; Segal, Daniel; Gazit, Ehud			A Blood-Brain Barrier (BBB) Disrupter Is Also a Potent alpha-Synuclein (alpha-syn) Aggregation Inhibitor A NOVEL DUAL MECHANISM OF MANNITOL FOR THE TREATMENT OF PARKINSON DISEASE (PD)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA MODEL; CHAPERONES; PATHWAYS; PROTEINS; DYNAMICS; SYSTEM; ROLES; BETA	The development of disease-modifying therapy for Parkinson disease has been a main drug development challenge, including the need to deliver the therapeutic agents to the brain. Here, we examined the ability of mannitol to interfere with the aggregation process of alpha-synuclein in vitro and in vivo in addition to its blood-brain barrier-disrupting properties. Using in vitro studies, we demonstrated the effect of mannitol on alpha-synuclein aggregation. Although low concentration of mannitol inhibited the formation of fibrils, high concentration significantly decreased the formation of tetramers and high molecular weight oligomers and shifted the secondary structure of alpha-synuclein from alpha-helical to a different structure, suggesting alternative potential pathways for aggregation. When administered to a Parkinson Drosophila model, mannitol dramatically corrected its behavioral defects and reduced the amount of alpha-synuclein aggregates in the brains of treated flies. In the mThy1-human alpha-synuclein transgenic mouse model, a decrease in alpha-synuclein accumulation was detected in several brain regions following treatment, suggesting that mannitol promotes alpha-synuclein clearance in the cell bodies. It appears that mannitol has a general neuroprotective effect in the transgenic treated mice, which includes the dopaminergic system. We therefore suggest mannitol as a basis for a dual mechanism therapeutic agent for the treatment of Parkinson disease.	[Shaltiel-Karyo, Ronit; Frenkel-Pinter, Moran; Levy-Sakin, Michal; Schiller, Abigail; Egoz-Matia, Nirit; Segal, Daniel; Gazit, Ehud] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Segal, Daniel] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Rockenstein, Edward; Patrick, Christina; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA	Tel Aviv University; Tel Aviv University; University of California System; University of California San Diego	Segal, D (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	dsegal@post.tau.ac.il; ehudg@post.tau.ac.il	Gazit, Ehud/C-3715-2011; Gazit, Ehud/M-8026-2019; Gazit, Ehud/AHE-9332-2022	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Lipton, Stuart/0000-0002-3490-1259; Segal, Daniel/0000-0002-6777-505X	Parkinson's Disease Foundation; Lord Alliance Family Trust; National Institutes of Health [AG18440, AG022074, NS057096]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, R01AG018440, P01AG022074, R37AG018440] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; Lord Alliance Family Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by the Parkinson's Disease Foundation and the Lord Alliance Family Trust (to D. S.) and by National Institutes of Health Grants AG18440, AG022074, and NS057096 (to E. M.).	Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001; Butler Tracy, 2007, Brain, V130, pe78, DOI 10.1093/brain/awm119; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; de Boer AG, 2007, ANNU REV PHARMACOL, V47, P323, DOI 10.1146/annurev.pharmtox.47.120505.105237; Elbaz A, 2002, J CLIN EPIDEMIOL, V55, P25, DOI 10.1016/S0895-4356(01)00425-5; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fleming SM, 2006, NEUROSCIENCE, V142, P1245, DOI 10.1016/j.neuroscience.2006.07.005; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Forno LS, 1996, J NEUROPATH EXP NEUR, V55, P259, DOI 10.1097/00005072-199603000-00001; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Gabathuler R, 2010, NEUROBIOL DIS, V37, P48, DOI 10.1016/j.nbd.2009.07.028; Hashimoto M, 2004, J MOL NEUROSCI, V24, P343, DOI 10.1385/JMN:24:3:343; Holthauzen LMF, 2007, PROTEIN SCI, V16, P293, DOI 10.1110/ps.062610407; Ikeda M, 2002, BIOCHEM BIOPH RES CO, V291, P669, DOI 10.1006/bbrc.2002.6495; Leong SL, 2009, NEUROCHEM RES, V34, P1838, DOI 10.1007/s11064-009-9986-8; Liu XR, 2005, CURR OPIN DRUG DISC, V8, P505; Lu DN, 2006, BIOPHYS J, V90, P3224, DOI 10.1529/biophysj.105.071761; Malek AM, 1998, STROKE, V29, P2631, DOI 10.1161/01.STR.29.12.2631; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; Pan GY, 2000, ACTA PHARMACOL SIN, V21, P613; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Rajan RS, 2011, CURR MED CHEM, V18, P1; Richmon JD, 1995, NEUROSCI LETT, V202, P1, DOI 10.1016/0304-3940(95)12208-7; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Ruijter GJG, 2003, EUKARYOT CELL, V2, P690, DOI 10.1128/EC.2.4.690-698.2003; Samiotakis A, 2009, INT J MOL SCI, V10, P572, DOI 10.3390/ijms10020572; Scherzer-Attali R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011101; Shaltiel-Karyo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013863; Shults CW, 2005, J NEUROSCI, V25, P10689, DOI 10.1523/JNEUROSCI.3527-05.2005; SIPE JD, 1992, ANNU REV BIOCHEM, V61, P947, DOI 10.1146/annurev.bi.61.070192.004503; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; SUZUKI J, 1985, STROKE, V16, P695, DOI 10.1161/01.STR.16.4.695; Tofaris GK, 2005, MOVEMENT DISORD, V20, pS37, DOI 10.1002/mds.20538; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; WETZEL R, 1994, TRENDS BIOTECHNOL, V12, P193, DOI 10.1016/0167-7799(94)90082-5	41	68	69	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17579	17588		10.1074/jbc.M112.434787	http://dx.doi.org/10.1074/jbc.M112.434787			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23637226	hybrid, Green Published			2022-12-28	WOS:000320380600049
J	Crichton, PG; Harding, M; Ruprecht, JJ; Lee, Y; Kunji, ERS				Crichton, Paul G.; Harding, Marilyn; Ruprecht, Jonathan J.; Lee, Yang; Kunji, Edmund R. S.			Lipid, Detergent, and Coomassie Blue G-250 Affect the Migration of Small Membrane Proteins in Blue Native Gels MITOCHONDRIAL CARRIERS MIGRATE AS MONOMERS NOT DIMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gel Electrophoresis; Membrane Proteins; Mitochondrial Transport; Protein Aggregation; Transporters; Detergent Micelle	ADP/ATP CARRIER; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-CHARACTERIZATION; OLIGOMERIC STRUCTURE; UNCOUPLING PROTEIN; ESCHERICHIA-COLI; BINDING-PROTEIN; INNER MEMBRANE; ELECTROPHORESIS; PURIFICATION	Blue native gel electrophoresis is a popular method for the determination of the oligomeric state of membrane proteins. Studies using this technique have reported that mitochondrial carriers are dimeric (composed of two approximate to 32-kDa monomers) and, in some cases, can form physiologically relevant associations with other proteins. Here, we have scrutinized the behavior of the yeast mitochondrial ADP/ATP carrier AAC3 in blue native gels. We find that the apparent mass of AAC3 varies in a detergent- and lipid-dependent manner (from approximate to 60 to approximate to 130 kDa) that is not related to changes in the oligomeric state of the protein, but reflects differences in the associated detergent-lipid micelle and Coomassie Blue G-250 used in this technique. Higher oligomeric state species are only observed under less favorable solubilization conditions, consistent with aggregation of the protein. Calibration with an artificial covalent AAC3 dimer indicates that the mass observed for solubilized AAC3 and other mitochondrial carriers corresponds to a monomer. Size exclusion chromatography of purified AAC3 in dodecyl maltoside under blue native gel-like conditions shows that the mass of the monomer is approximate to 120 kDa, but appears smaller on gels (approximate to 60 kDa) due to the unusually high amount of bound negatively charged dye, which increases the electrophoretic mobility of the protein-detergent-dye micelle complex. Our results show that bound lipid, detergent, and Coomassie stain alter the behavior of mitochondrial carriers on gels, which is likely to be true for other small membrane proteins where the associated lipid-detergent micelle is large when compared with the mass of the protein.	[Crichton, Paul G.; Harding, Marilyn; Ruprecht, Jonathan J.; Lee, Yang; Kunji, Edmund R. S.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England		Kunji, ERS (corresponding author), MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.	ek@mrc-mbu.cam.ac.uk	Kunji, Edmund/AAH-2362-2020	Kunji, Edmund/0000-0002-0610-4500; Ruprecht, Jonathan/0000-0002-1838-7245; Crichton, Paul/0000-0003-3786-8359	Medical Research Council; European Membrane Protein Consortium [LSHG-CT-2004-504601]; European Drug Initiative on Channels and Transporters [HEALTH-F4-2007-201924]; MRC [MC_U105663139] Funding Source: UKRI; Medical Research Council [MC_U105663139] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Membrane Protein Consortium; European Drug Initiative on Channels and Transporters; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council and by the European Membrane Protein Consortium via Contract LSHG-CT-2004-504601 (E-MeP) and by the European Drug Initiative on Channels and Transporters via contract HEALTH-F4-2007-201924 (EDICT).	AQUILA H, 1978, EUR J BIOCHEM, V85, P549, DOI 10.1111/j.1432-1033.1978.tb12270.x; AQUILA H, 1987, FEBS LETT, V212, P1, DOI 10.1016/0014-5793(87)81546-6; Bamber L, 2007, J MOL BIOL, V371, P388, DOI 10.1016/j.jmb.2007.05.072; Bamber L, 2007, P NATL ACAD SCI USA, V104, P10830, DOI 10.1073/pnas.0703969104; Bamber L, 2006, P NATL ACAD SCI USA, V103, P16224, DOI 10.1073/pnas.0607640103; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOCK MR, 1982, BIOCHEM BIOPH RES CO, V109, P471, DOI 10.1016/0006-291X(82)91745-4; BRANDOLIN G, 1980, BIOCHIM BIOPHYS ACTA, V592, P592, DOI 10.1016/0005-2728(80)90103-6; Cannon B, 1979, Methods Enzymol, V55, P65; CAPOBIANCO L, 2004, J BIOCHEM MOL BIOL, V37, P515; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Dyall SD, 2003, J BIOL CHEM, V278, P26757, DOI 10.1074/jbc.M302700200; Faustin B, 2004, J BIOL CHEM, V279, P20411, DOI 10.1074/jbc.M314259200; Gan SW, 2011, ANAL BIOCHEM, V416, P100, DOI 10.1016/j.ab.2011.05.007; HACKENBERG H, 1980, BIOCHEMISTRY-US, V19, P548, DOI 10.1021/bi00544a024; Hatanaka T, 1999, BIOCHEM BIOPH RES CO, V262, P726, DOI 10.1006/bbrc.1999.1283; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; KLINGENBERG M, 1989, EUR J BIOCHEM, V180, P123, DOI 10.1111/j.1432-1033.1989.tb14622.x; Kunji ERS, 2010, BBA-BIOENERGETICS, V1797, P817, DOI 10.1016/j.bbabio.2010.03.023; Kunji ERS, 2008, METHODS, V46, P62, DOI 10.1016/j.ymeth.2008.10.020; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Kunji ERS, 2003, J BIOL CHEM, V278, P36985, DOI 10.1074/jbc.C300304200; LIN CS, 1980, FEBS LETT, V113, P304, DOI 10.1016/0014-5793(80)80614-4; LIN CS, 1982, BIOCHEMISTRY-US, V21, P2950, DOI 10.1021/bi00541a023; Ma JC, 2008, J APPL CRYSTALLOGR, V41, P1150, DOI 10.1107/S0021889808033797; MAJIMA E, 1995, J BIOL CHEM, V270, P29548, DOI 10.1074/jbc.270.49.29548; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Nury H, 2008, BIOCHEMISTRY-US, V47, P12319, DOI 10.1021/bi801053m; PALMIERI F, 1993, J BIOENERG BIOMEMBR, V25, P525, DOI 10.1007/BF01108409; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri L, 1999, MOL MICROBIOL, V31, P569, DOI 10.1046/j.1365-2958.1999.01197.x; Palmisano A, 1998, BIOCHEM J, V333, P151, DOI 10.1042/bj3330151; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+; Raunser S, 2009, J MOL BIOL, V387, P619, DOI 10.1016/j.jmb.2009.02.005; RICCIO P, 1975, FEBS LETT, V56, P133, DOI 10.1016/0014-5793(75)80127-X; Robinson AJ, 2008, P NATL ACAD SCI USA, V105, P17766, DOI 10.1073/pnas.0809580105; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; SARASTE M, 1982, FEBS LETT, V144, P250, DOI 10.1016/0014-5793(82)80648-0; Schroers A, 1998, J BIOL CHEM, V273, P14269, DOI 10.1074/jbc.273.23.14269; Truscott KN, 2002, MOL CELL BIOL, V22, P7780, DOI 10.1128/MCB.22.22.7780-7789.2002; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2010, MOL CELL PROTEOMICS, V9, P2149, DOI 10.1074/mcp.M900526-MCP200	48	49	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22163	22173		10.1074/jbc.M113.484329	http://dx.doi.org/10.1074/jbc.M113.484329			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23744064	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000328841900059
J	van den Berg, MCW; van Gogh, IJA; Smits, AMM; van Triest, M; Dansen, TB; Visscher, M; Polderman, PE; Vliem, MJ; Rehmann, H; Burgering, BMT				van den Berg, Maaike C. W.; van Gogh, Inkie J. A.; Smits, Alida M. M.; van Triest, Miranda; Dansen, Tobias B.; Visscher, Marieke; Polderman, Paulien E.; Vliem, Marjolein J.; Rehmann, Holger; Burgering, Boudewijn M. T.			The Small GTPase RALA Controls c-Jun N-terminal Kinase-mediated FOXO Activation by Regulation of a JIP1 Scaffold Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; MAP Kinases (MAPKs); Reactive Oxygen Species (ROS); Scaffold Proteins; Signal Transduction; Small GTPases; Transcription Factors	EMBRYONIC STEM-CELLS; FORKHEAD BOX O; PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; SYNERGISTIC ACTIVATION; TRANSCRIPTION FACTORS; OXIDATIVE STRESS; LIFE-SPAN; CELLULAR-TRANSFORMATION; EFFECTOR COMPLEX	FOXO (forkhead box O) transcription factors are tumor suppressors and increase the life spans of model organisms. Cellular stress, in particular oxidative stress caused by an increase in levels of reactive oxygen species (ROS), activates FOXOs through JNK-mediated phosphorylation. Importantly, JNK regulation of FOXO is evolutionarily conserved. Here we identified the pathway that mediates ROS-induced JNK-dependent FOXO regulation. Following increased ROS, RALA is activated by the exchange factor RLF (RalGDS-like factor), which is in complex with JIP1 (C-Jun-amino-terminal-interacting protein 1) and JNK. Active RALA consequently regulates assembly and activation of MLK3, MKK4, and JNK onto the JIP1 scaffold. Furthermore, regulation of FOXO by RALA and JIP1 is conserved in C. elegans, where both ral-1 and jip-1 depletion impairs heat shock-induced nuclear translocation of the FOXO orthologue DAF16.	[van den Berg, Maaike C. W.; van Gogh, Inkie J. A.; Smits, Alida M. M.; van Triest, Miranda; Dansen, Tobias B.; Visscher, Marieke; Polderman, Paulien E.; Vliem, Marjolein J.; Rehmann, Holger; Burgering, Boudewijn M. T.] Univ Med Ctr Utrecht, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Burgering, BMT (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Univ Weg 100,STR 3-201, NL-3584 CG Utrecht, Netherlands.	b.m.t.burgering@umcutrecht.nl		Dansen, Tobias/0000-0001-5259-8815	Dutch Cancer Society; Center for Biomedical Genetics; Cancer Genomics Center	Dutch Cancer Society(KWF Kankerbestrijding); Center for Biomedical Genetics; Cancer Genomics Center	This work was supported by grants from the Dutch Cancer Society, the Center for Biomedical Genetics, and the Cancer Genomics Center.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Balakireva M, 2006, MOL CELL BIOL, V26, P8953, DOI 10.1128/MCB.00506-06; Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Bock BC, 2000, J BIOL CHEM, V275, P14231, DOI 10.1074/jbc.275.19.14231; Bridge D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011686; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Chien YC, 2003, EMBO REP, V4, P800, DOI 10.1038/sj.embor.embor899; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; de Keizer PLJ, 2011, ANTIOXID REDOX SIGN, V14, P1093, DOI 10.1089/ars.2010.3403; de Keizer PLJ, 2010, CANCER RES, V70, P8526, DOI 10.1158/0008-5472.CAN-10-1563; De Ruiter ND, 2000, MOL CELL BIOL, V20, P8480, DOI 10.1128/MCB.20.22.8480-8488.2000; De Ruiter ND, 2001, MOL CELL BIOL, V21, P8225, DOI 10.1128/MCB.21.23.8225-8235.2001; deGroot RP, 1997, J BIOL CHEM, V272, P2319; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Du Y, 2005, J BIOL CHEM, V280, P42984, DOI 10.1074/jbc.M502671200; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Figueroa C, 2003, J BIOL CHEM, V278, P47922, DOI 10.1074/jbc.M307357200; Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145; Frankel P, 2005, EMBO J, V24, P54, DOI 10.1038/sj.emboj.7600497; Frische EW, 2007, EMBO J, V26, P5083, DOI 10.1038/sj.emboj.7601922; Girardin SE, 2001, EMBO J, V20, P3437, DOI 10.1093/emboj/20.13.3437; Hao YS, 2008, MOL CELL BIOL, V28, P2851, DOI 10.1128/MCB.01917-07; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Henry DO, 2000, MOL CELL BIOL, V20, P8084, DOI 10.1128/MCB.20.21.8084-8092.2000; Heo JY, 2011, ANTIOXID REDOX SIGN, V14, P689, DOI 10.1089/ars.2009.2984; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hofer F, 1998, CURR BIOL, V8, P839, DOI 10.1016/S0960-9822(98)70327-6; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Hu SQ, 2012, J BIOL CHEM, V287, P2364, DOI 10.1074/jbc.M111.227124; Jullien-Flores V, 2000, J CELL SCI, V113, P2837; Kim AH, 2003, J BIOL CHEM, V278, P29830, DOI 10.1074/jbc.M305349200; Kim AH, 2002, NEURON, V35, P697, DOI 10.1016/S0896-6273(02)00821-8; Kishimoto H, 2003, J BIOL CHEM, V278, P16595, DOI 10.1074/jbc.M213182200; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lawler S, 1998, CURR BIOL, V8, P1387, DOI 10.1016/S0960-9822(98)00019-0; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Marasa BS, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000442; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; Mitchell L, 2013, ANTIOXID REDOX SIGN, V18, P250, DOI 10.1089/ars.2012.4687; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Nakashima S, 1999, EMBO J, V18, P3629, DOI 10.1093/emboj/18.13.3629; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Park HS, 2002, J BIOL CHEM, V277, P2573, DOI 10.1074/jbc.M110299200; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sawamoto K, 1999, J CELL BIOL, V146, P361, DOI 10.1083/jcb.146.2.361; Song JJ, 2005, J BIOL CHEM, V280, P26845, DOI 10.1074/jbc.M502318200; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Urano T, 1996, EMBO J, V15, P810, DOI 10.1002/j.1460-2075.1996.tb00416.x; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van Drogen F, 2002, CURR BIOL, V12, pR53, DOI 10.1016/S0960-9822(01)00672-8; Wada T, 2001, J BIOL CHEM, V276, P30892, DOI 10.1074/jbc.M011780200; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; White MA, 1996, J BIOL CHEM, V271, P16439, DOI 10.1074/jbc.271.28.16439; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Wolthuis RMF, 1998, CURR BIOL, V8, P471, DOI 10.1016/S0960-9822(98)70183-6; Wolthuis RMF, 1997, EMBO J, V16, P6748, DOI 10.1093/emboj/16.22.6748; Zand TP, 2011, DEV CELL, V20, P84, DOI 10.1016/j.devcel.2010.12.004	71	22	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21729	21741		10.1074/jbc.M113.463885	http://dx.doi.org/10.1074/jbc.M113.463885			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23770673	hybrid, Green Published			2022-12-28	WOS:000328841900024
J	Allsopp, RC; Farmer, LK; Fryatt, AG; Evans, RJ				Allsopp, Rebecca C.; Farmer, Louise K.; Fryatt, Alistair G.; Evans, Richard J.			P2X Receptor Chimeras Highlight Roles of the Amino Terminus to Partial Agonist Efficacy, the Carboxyl Terminus to Recovery from Desensitization, and Independent Regulation of Channel Transitions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ION-CHANNEL; ATP-BINDING; TRANSMEMBRANE DOMAIN; P-2X RECEPTOR; MUTAGENESIS; ANTAGONIST; ACTIVATION; DEPENDENCE; SUBUNITS; POTENCY	P2X receptor subtypes can be distinguished by their sensitivity to ATP analogues and selective antagonists. We have used chimeras between human P2X1 and P2X2 receptors to address the contribution of the extracellular ligand binding loop, transmembrane segments (TM1 and TM2), and intracellular amino and carboxyl termini to the action of partial agonists (higher potency and efficacy of BzATP and Ap5A at P2X1 receptors) and antagonists. Sensitivity to the antagonists NF449, suramin, and PPADS was conferred by the nature of the extracellular loop (e.g. nanomolar for NF449 at P2X1 and P2X2-1EXT and micromolar at P2X2 and P2X1-2EXT). In contrast, the effectiveness of partial agonists was similar to P2X1 levels for both of the loop transfers, suggesting that interactions with the rest of the receptor played an important role. Swapping TM2 had reciprocal effects on partial agonist efficacy. However, TM1 swaps increased partial agonist efficacy at both chimeras, and this was similar for swaps of both TM1 and 2. Changing the amino terminus had no effect on agonist potency but increased partial agonist efficacy at P2X2-1N and decreased it at P2X1-2N chimeras, demonstrating that potency and efficacy can be independently regulated. Chimeras and point mutations also identified residues in the carboxyl terminus that regulated recovery from channel desensitization. These results show that interactions among the intracellular, transmembrane, and extracellular portions of the receptor regulate channel properties and suggest that transitions to channel opening, the behavior of the open channel, and recovery from the desensitized state can be controlled independently.	[Allsopp, Rebecca C.; Farmer, Louise K.; Fryatt, Alistair G.; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk		Farmer, Louise/0000-0002-9462-2606	Wellcome Trust; British Heart Foundation; British Heart Foundation [FS/09/059/27972, PG/11/64/28772] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by the Wellcome Trust and the British Heart Foundation.	Allsopp RC, 2011, J BIOL CHEM, V286, P44691, DOI 10.1074/jbc.M111.303917; Allsopp RC, 2011, J BIOL CHEM, V286, P29207, DOI 10.1074/jbc.M111.260364; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Brandle U, 1997, FEBS LETT, V404, P294, DOI 10.1016/S0014-5793(97)00128-2; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Buell G, 1996, EMBO J, V15, P55, DOI 10.1002/j.1460-2075.1996.tb00333.x; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; Chaumont S, 2008, P NATL ACAD SCI USA, V105, P12063, DOI 10.1073/pnas.0803008105; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Cook SP, 1997, NEUROPHARMACOLOGY, V36, P1303, DOI 10.1016/S0028-3908(97)00132-9; DELCASTILLO J, 1957, PROC R SOC SER B-BIO, V146, P369; El-Ajouz S, 2012, BRIT J PHARMACOL, V165, P390, DOI 10.1111/j.1476-5381.2011.01534.x; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; Haines WR, 2001, J BIOL CHEM, V276, P32793, DOI 10.1074/jbc.M104216200; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; He ML, 2003, J BIOL CHEM, V278, P10182, DOI 10.1074/jbc.M209094200; Hulsmann M, 2003, EUR J PHARMACOL, V470, P1, DOI 10.1016/S0014-2999(03)01761-8; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang R, 2012, EMBO J, V31, P2134, DOI 10.1038/emboj.2012.75; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Michel AD, 2008, BRIT J PHARMACOL, V155, P738, DOI 10.1038/bjp.2008.306; Nicke A, 2009, J BIOL CHEM, V284, P25813, DOI 10.1074/jbc.M109.033134; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pratt EB, 2005, J NEUROSCI, V25, P7359, DOI 10.1523/JNEUROSCI.5189-04.2005; Rettinger J, 2004, J BIOL CHEM, V279, P6426, DOI 10.1074/jbc.M306987200; Rettinger J, 2003, J GEN PHYSIOL, V121, P451, DOI 10.1085/jgp.200208730; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Schwarz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041269; Sim JA, 2008, J BIOL CHEM, V283, P29841, DOI 10.1074/jbc.M802523200; Stoop R, 1999, MOL PHARMACOL, V56, P973, DOI 10.1124/mol.56.5.973; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; Werner P, 1996, P NATL ACAD SCI USA, V93, P15485, DOI 10.1073/pnas.93.26.15485; Xu XJ, 2012, J CELL SCI, V125, P3776, DOI 10.1242/jcs.099374; Young MT, 2008, J BIOL CHEM, V283, P26241, DOI 10.1074/jbc.M804458200; Young MT, 2010, TRENDS BIOCHEM SCI, V35, P83, DOI 10.1016/j.tibs.2009.09.006	40	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21412	21421		10.1074/jbc.M113.464651	http://dx.doi.org/10.1074/jbc.M113.464651			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23740251	hybrid, Green Published			2022-12-28	WOS:000322014400059
J	Du, HJ; Huang, YZ; Zaghlula, M; Walters, E; Cox, TC; Massiah, MA				Du, Haijuan; Huang, Yongzhao; Zaghlula, Manar; Walters, Erica; Cox, Timothy C.; Massiah, Michael A.			The MID1 E3 Ligase Catalyzes the Polyubiquitination of Alpha4 (alpha 4), a Regulatory Subunit of Protein Phosphatase 2A (PP2A) NOVEL INSIGHTS INTO MID1-MEDIATED REGULATION of PP2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE SIGNAL-TRANSDUCTION; SYNDROME GENE MID1; OPITZ-SYNDROME; UBIQUITIN LIGASE; BINDING; RING; EXPRESSION; REVEALS; MICROTUBULES; COMPLEX	Alpha4 (alpha 4) is a key regulator of protein phosphatase 2A (PP2A) and mTOR in steps essential for cell-cycle progression. alpha 4 forms a complex with PP2A and MID1, a microtubule-associated ubiquitin E3 ligase that facilitates MID1-dependent regulation of PP2A and the dephosphorylation of MID1 by PP2A. Ectopic overexpression of alpha 4 is associated with hepatocellular carcinomas, breast cancer, and invasive adenocarcinomas. Here, we provide data suggesting that alpha 4 is regulated by ubiquitin-dependent degradation mediated by MID1. In cells stably expressing a dominant-negative form of MID1, significantly elevated levels of alpha 4 were observed. Treatment of cells with the specific proteasome inhibitor, lactacystin, resulted in a 3-fold increase in alpha 4 in control cells and a similar level in mutant cells. Using in vitro assays, individual MID1 E3 domains facilitated monoubiquitination of alpha 4, whereas full-length MID1 as well as RING-Bbox1 and RING-Bbox1-Bbox2 constructs catalyzed its polyubiquitination. In a novel non-biased functional screen, we identified a leucine to glutamine substitution at position 146 within Bbox1 that abolished MID1-alpha 4interaction and the subsequent polyubiquitination of alpha 4, indicating that direct binding to Bbox1 was necessary for the polyubiquitination of alpha 4. The mutant had little impact on the RING E3 ligase functionality of MID1. Mass spectrometry data confirmed Western blot analysis that ubiquitination of alpha 4 occurs only within the last 105 amino acids. These novel findings identify a new role for MID1 and a mechanism of regulation of alpha 4 that is likely to impact the stability and activity level of PP2Ac.	[Du, Haijuan; Zaghlula, Manar; Walters, Erica; Massiah, Michael A.] George Washington Univ, Dept Chem, Washington, DC 20052 USA; [Huang, Yongzhao; Cox, Timothy C.] Univ Washington, Seattle Childrens Res Inst, Ctr Dev Biol & Regenerat Med, Seattle, WA 98101 USA; [Cox, Timothy C.] Univ Washington, Dept Pediat, Seattle, WA 98101 USA; [Cox, Timothy C.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia	George Washington University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Monash University	Massiah, MA (corresponding author), George Washington Univ, Dept Chem, 725 21st NW,Rm 107, Washington, DC 20052 USA.	massiah@gwu.edu			NICHD, National Institutes of Health Core Grant [5P30HD040677-10]; Div Of Molecular and Cellular Bioscience [1052520] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER	NICHD, National Institutes of Health Core Grant; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to Dr. Yetrib Hathout (Children's National Medical Center, Washington D. C.) for help with the acquisition and analysis of the mass spectrometry data and to Drs. Blair Hopwood and Leila Belle and to Terri King for technical assistance. The mass spectrometry studies were supported in part by NICHD, National Institutes of Health Core Grant 5P30HD040677-10.	Aranda-Orgilles B, 2008, HUM GENET, V123, P163, DOI 10.1007/s00439-007-0456-6; Aranda-Orgilles B, 2011, J BIOL CHEM, V286, P39945, DOI 10.1074/jbc.M111.224451; Aranda-Orgilles B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003507; Bell JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037470; BERLETH ES, 1990, BIOCHEM BIOPH RES CO, V171, P705, DOI 10.1016/0006-291X(90)91203-5; Berti C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-9; Buchner G, 1999, HUM MOL GENET, V8, P1397, DOI 10.1093/hmg/8.8.1397; Chen LP, 2011, ONCOGENE, V30, P2943, DOI 10.1038/onc.2011.20; Chuang E, 2000, IMMUNITY, V13, P313, DOI 10.1016/S1074-7613(00)00031-5; Smetana JHC, 2006, BBA-PROTEINS PROTEOM, V1764, P724, DOI 10.1016/j.bbapap.2006.01.018; Cox TC, 2000, HUM MOL GENET, V9, P2553, DOI 10.1093/hmg/9.17.2553; De Falco F, 2003, AM J MED GENET A, V120A, P222, DOI 10.1002/ajmg.a.10265; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Du HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028877; Everett AD, 2002, DEV DYNAM, V224, P461, DOI 10.1002/dvdy.10125; Graham JM, 2003, AM J MED GENET A, V123A, P37, DOI 10.1002/ajmg.a.20504; Granata A, 2003, DEV BIOL, V258, P397, DOI 10.1016/S0012-1606(03)00131-3; Han XF, 2011, J MOL BIOL, V407, P505, DOI 10.1016/j.jmb.2011.01.048; INUI S, 1995, J IMMUNOL, V154, P2714; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Kong M, 2007, J BIOL CHEM, V282, P29712, DOI 10.1074/jbc.M703159200; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Massiah MA, 2006, J MOL BIOL, V358, P532, DOI 10.1016/j.jmb.2006.02.009; Massiah MA, 2007, J MOL BIOL, V369, P1, DOI 10.1016/j.jmb.2007.03.017; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Okamoto K, 2009, FEBS LETT, V583, P2710, DOI 10.1016/j.febslet.2009.07.021; Onda M, 1997, GENOMICS, V46, P373, DOI 10.1006/geno.1997.5048; Pickart CM, 2000, NAT CELL BIOL, V2, pE139, DOI 10.1038/35019610; Sakashita S, 2011, PATHOL INT, V61, P130, DOI 10.1111/j.1440-1827.2011.02644.x; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Tao H, 2008, BIOCHEMISTRY-US, V47, P2450, DOI 10.1021/bi7018496; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Wang XJ, 2012, FEBS LETT, V586, P1390, DOI 10.1016/j.febslet.2012.02.049; Watkins GR, 2012, J BIOL CHEM, V287, P24207, DOI 10.1074/jbc.M112.368613; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yang J, 2007, BIOCHEMISTRY-US, V46, P8807, DOI 10.1021/bi7007118; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	44	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21341	21350		10.1074/jbc.M113.481093	http://dx.doi.org/10.1074/jbc.M113.481093			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23740247	Green Published, hybrid			2022-12-28	WOS:000322014400053
J	Radu, M; Rawat, SJ; Beeser, A; Iliuk, A; Tao, WA; Chernoff, J				Radu, Maria; Rawat, Sonali J.; Beeser, Alexander; Iliuk, Anton; Tao, Weiguo Andy; Chernoff, Jonathan			ArhGAP15, a Rac-specific GTPase-activating Protein, Plays a Dual Role in Inhibiting Small GTPase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO GTPASES; MEMBRANE PROTRUSIONS; PAK KINASES; BINDING; P21-ACTIVATED-KINASE-1; PHOSPHORYLATION; REGULATORS; PATHWAY; GAPS	Signaling from small GTPases is a tightly regulated process. In this work we used a protein microarray screen to identify the Rac-specific GAP, ArhGAP15, as a substrate of the Rac effectors Pak1 and Pak2. In addition to serving as a substrate of Pak1/2, we found that ArhGAP15, via its PH domain, bound to these kinases. The association of ArhGAP15 to Pak1/2 resulted in mutual inhibition of GAP and kinase catalytic activity, respectively. Knock-down of ArhGAP15 resulted in activation of Pak1/2, both indirectly, as a result of Rac activation, and directly, as a result of disruption of the ArhGAP15/Pak complex. Our data suggest that ArhGAP15 plays a dual negative role in regulating small GTPase signaling, by acting at the level of the GTPase itself, as well interacting with its effector, Pak kinase.	[Radu, Maria; Beeser, Alexander; Chernoff, Jonathan] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Rawat, Sonali J.] Drexel Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19102 USA; [Iliuk, Anton; Tao, Weiguo Andy] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA	Fox Chase Cancer Center; Drexel University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Chernoff, J (corresponding author), Fox Chase Canc Ctr, Canc Biol Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	Jonathan.Chernoff@fccc.edu	Tao, Weiguo/AAL-2777-2020; Tao, Andy/N-1290-2019; Rawat, Sonali/N-7827-2014; Chernoff, Jonathan/I-7631-2014	Tao, Weiguo/0000-0002-5535-5517; Chernoff, Jonathan/0000-0002-4803-7836; Iliuk, Anton/0000-0002-2914-1363	National Institutes of Health [R01 CA58836, R01 CA098830, R01 GM088317]; Fox Chase Cancer Center Grant [P30 CA006927]; state of Pennsylvania; NATIONAL CANCER INSTITUTE [R01CA058836, R01CA098830, R01CA142928, P30CA006927, T32CA009035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Chase Cancer Center Grant; state of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants R01 CA58836 and R01 CA098830 (to J. C.) and R01 GM088317 (to W. A. T.) from the National Institutes of Health and Fox Chase Cancer Center Grant P30 CA006927, as well as by an appropriation from the state of Pennsylvania.	Arias-Romero LE, 2010, ONCOGENE, V29, P5839, DOI 10.1038/onc.2010.318; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bobak D, 1997, ONCOGENE, V15, P2179, DOI 10.1038/sj.onc.1201396; Chow HY, 2012, CANCER RES, V72, P5966, DOI 10.1158/0008-5472.CAN-12-2246; Costa C, 2011, BLOOD, V118, P1099, DOI 10.1182/blood-2010-12-324756; De la Mota-Peynado A, 2011, J BIOL CHEM, V286, P13603, DOI 10.1074/jbc.M110.181743; DerMardirossian CM, 2006, METHOD ENZYMOL, V406, P80, DOI 10.1016/S0076-6879(06)06007-1; Ding F, 2011, CURR TOP MED CHEM, V11, P2879, DOI 10.2174/156802611798281357; Gamblin SJ, 1998, CURR OPIN STRUC BIOL, V8, P195, DOI 10.1016/S0959-440X(98)80038-9; Garcia-Mata R, 2007, TRENDS CELL BIOL, V17, P36, DOI 10.1016/j.tcb.2006.11.004; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Geltz NR, 1998, BLOOD, V91, P930, DOI 10.1182/blood.V91.3.930.930_930_939; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Guo DG, 2010, MOL CELL BIOCHEM, V334, P99, DOI 10.1007/s11010-009-0327-7; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Iliuk A, 2011, METHODS MOL BIOL, V790, P277, DOI 10.1007/978-1-61779-319-6_21; Iliuk AB, 2010, MOL CELL PROTEOMICS, V9, P2162, DOI 10.1074/mcp.M110.000091; JOHNSSON N, 1988, EMBO J, V7, P2435, DOI 10.1002/j.1460-2075.1988.tb03089.x; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Murray BW, 2010, P NATL ACAD SCI USA, V107, P9446, DOI 10.1073/pnas.0911863107; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Pai SY, 2010, DIS MARKERS, V29, P177, DOI [10.1155/2010/380291, 10.3233/DMA-2010-0738]; Rathinam R, 2011, FRONT BIOSCI-LANDMRK, V16, P2561, DOI 10.2741/3872; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Seoh ML, 2003, FEBS LETT, V539, P131, DOI 10.1016/S0014-5793(03)00213-8; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Szczepanowska J, 2009, ACTA BIOCHIM POL, V56, P225; Van den Broeke C, 2011, VIRUS RES, V155, P376, DOI 10.1016/j.virusres.2010.11.003; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Zenke FT, 2004, J BIOL CHEM, V279, P18392, DOI 10.1074/jbc.M400084200	38	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21117	21125		10.1074/jbc.M113.459719	http://dx.doi.org/10.1074/jbc.M113.459719			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760270	Green Published, hybrid			2022-12-28	WOS:000322014400032
J	Rico, AI; Krupka, M; Vicente, M				Rico, Ana Isabel; Krupka, Marcin; Vicente, Miguel			In the Beginning, Escherichia coli Assembled the Proto-ring: An Initial Phase of Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CELL-DIVISION; CRYSTAL-STRUCTURE; BACTERIAL CYTOKINESIS; CYTOSKELETAL PROTEIN; FTSZ POLYMERIZATION; SELF-INTERACTION; ZIPA; MEMBRANE; MINC; RECONSTITUTION	Cell division in Escherichia coli begins by assembling three proteins, FtsZ, FtsA, and ZipA, to form a proto-ring at midcell. These proteins nucleate an assembly of at least 35 components, the divisome. The structuring of FtsZ to form a ring and the processes that effect constriction have been explained by alternative but not mutually exclusive mechanisms. We discuss how FtsA and ZipA provide anchoring of the cytoplasmic FtsZ to the membrane and how a temporal sequence of alternative protein interactions may operate in the maturation and stability of the proto-ring. How the force needed for constriction is generated and how the proto-ring proteins relate to peptidoglycan synthesis remain as the main challenges for future research.	[Rico, Ana Isabel; Krupka, Marcin; Vicente, Miguel] CSIC, CNB, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Vicente, M (corresponding author), CSIC, CNB, Plaza Murillo 2, E-28049 Madrid, Spain.	mvicente@cnb.csic.es	Rico, Ana Isabel/A-5242-2010	Rico, Ana Isabel/0000-0001-6021-3970	Spanish Ministerio de Educacion y Ciencia Grant [BIO2011-28941-C03-01]; European Union Grant (DIVINOCELL) [FP7-223431]; Human Frontier Science Program Grant [RGP0050/2010]	Spanish Ministerio de Educacion y Ciencia Grant(German Research Foundation (DFG)); European Union Grant (DIVINOCELL); Human Frontier Science Program Grant(Human Frontier Science Program)	This work was supported by Spanish Ministerio de Educacion y Ciencia Grant BIO2011-28941-C03-01, European Union Grant FP7-223431 (DIVINOCELL), and Human Frontier Science Program Grant RGP0050/2010 (all to M. V.).	Aarsman MEG, 2005, MOL MICROBIOL, V55, P1631, DOI 10.1111/j.1365-2958.2005.04502.x; Bernard CS, 2007, MOL MICROBIOL, V64, P1289, DOI 10.1111/j.1365-2958.2007.05738.x; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bertsche U, 2006, MOL MICROBIOL, V61, P675, DOI 10.1111/j.1365-2958.2006.05280.x; Biteen JS, 2012, CHEMPHYSCHEM, V13, P1007, DOI 10.1002/cphc.201100686; Bramkamp M, 2009, CURR OPIN MICROBIOL, V12, P683, DOI 10.1016/j.mib.2009.10.002; Busiek KK, 2012, J BACTERIOL, V194, P1989, DOI 10.1128/JB.06683-11; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Camberg JL, 2009, P NATL ACAD SCI USA, V106, P10614, DOI 10.1073/pnas.0904886106; Cho HB, 2011, P NATL ACAD SCI USA, V108, P3773, DOI 10.1073/pnas.1018674108; Coltharp C, 2012, CELL MICROBIOL, V14, P1808, DOI 10.1111/cmi.12024; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; Corbin BD, 2007, J BACTERIOL, V189, P3026, DOI 10.1128/JB.01581-06; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; Dajkovic A, 2010, MOL MICROBIOL, V78, P651, DOI 10.1111/j.1365-2958.2010.07352.x; Delaye L, 2010, BIOESSAYS, V32, P281, DOI 10.1002/bies.200900161; Derouaux A, 2008, J BACTERIOL, V190, P1831, DOI 10.1128/JB.01377-07; Diaz JF, 2001, J BIOL CHEM, V276, P17307, DOI 10.1074/jbc.M010920200; Dubarry N, 2010, MOL MICROBIOL, V78, P1088, DOI 10.1111/j.1365-2958.2010.07412.x; Dubarry N, 2010, EMBO J, V29, P597, DOI 10.1038/emboj.2009.381; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; ERICKSON HP, 1995, CELL, V80, P367, DOI 10.1016/0092-8674(95)90486-7; Erickson HP, 1997, TRENDS CELL BIOL, V7, P362, DOI 10.1016/S0962-8924(97)01108-2; Fraipont C, 2011, MICROBIOL-SGM, V157, P251, DOI 10.1099/mic.0.040071-0; Galli E, 2010, MOL MICROBIOL, V76, P1514, DOI 10.1111/j.1365-2958.2010.07183.x; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Ghosh B, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051924; Ghosh B, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.178101; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Gonzalez MD, 2010, J BACTERIOL, V192, P2757, DOI 10.1128/JB.01609-09; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Gundogdu ME, 2011, EMBO J, V30, P617, DOI 10.1038/emboj.2010.345; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; HELMSTETTER C, 1968, COLD SPRING HARB SYM, V33, P809, DOI 10.1101/SQB.1968.033.01.093; Rico AI, 2010, MOL MICROBIOL, V76, P760, DOI 10.1111/j.1365-2958.2010.07134.x; Jimenez M, 2011, J BIOL CHEM, V286, P11236, DOI 10.1074/jbc.M110.194365; Juarez JR, 2010, J BACTERIOL, V192, P4134, DOI 10.1128/JB.00364-10; Krupka M, 2012, J BIOL CHEM, V287, P7756, DOI 10.1074/jbc.M111.311563; Lan GH, 2009, P NATL ACAD SCI USA, V106, P121, DOI 10.1073/pnas.0807963106; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Li G, 2012, MOL MICROBIOL, V84, P276, DOI 10.1111/j.1365-2958.2012.08021.x; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Lopez-Montero I, 2013, BBA-BIOMEMBRANES, V1828, P687, DOI 10.1016/j.bbamem.2012.11.003; Lopez-Montero I, 2013, FASEB J, V27, P3363, DOI 10.1096/fj.12-224337; Low HH, 2004, J MOL BIOL, V341, P839, DOI 10.1016/j.jmb.2004.05.031; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Mannik J, 2012, P NATL ACAD SCI USA, V109, P6957, DOI 10.1073/pnas.1120854109; Martos A, 2012, TRENDS CELL BIOL, V22, P634, DOI 10.1016/j.tcb.2012.09.003; Martos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039829; Mendieta J, 2009, J MOL BIOL, V390, P17, DOI 10.1016/j.jmb.2009.05.018; Milam SL, 2012, BIOPHYS J, V103, P59, DOI 10.1016/j.bpj.2012.05.035; Mingorance J, 2004, MOLECULES IN TIME AND SPACE: BACTERIAL SHAPE, DIVISON AND PHYLOGENY, P173, DOI 10.1007/0-306-48579-6_9; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Monahan LG, 2009, MOL MICROBIOL, V74, P1004, DOI 10.1111/j.1365-2958.2009.06914.x; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Pazos M, 2013, J BIOL CHEM, V288, P3219, DOI 10.1074/jbc.M112.434944; Peters NT, 2011, J BACTERIOL, V193, P4973, DOI 10.1128/JB.00316-11; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Pichoff S, 2012, MOL MICROBIOL, V83, P151, DOI 10.1111/j.1365-2958.2011.07923.x; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Potluri LP, 2012, J BACTERIOL, V194, P5334, DOI 10.1128/JB.00859-12; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; Shen B, 2011, J BACTERIOL, V193, P367, DOI 10.1128/JB.01095-10; Shen B, 2010, MOL MICROBIOL, V75, P1285, DOI 10.1111/j.1365-2958.2010.07055.x; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Shiomi D, 2007, MOL MICROBIOL, V66, P1396, DOI 10.1111/j.1365-2958.2007.05998.x; Shiomi D, 2007, J BACTERIOL, V189, P236, DOI 10.1128/JB.00666-06; Skoog K, 2012, BIOCHEMISTRY-US, V51, P1407, DOI 10.1021/bi2015647; Small E, 2007, J MOL BIOL, V369, P210, DOI 10.1016/j.jmb.2007.03.025; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	94	59	59	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20830	20836		10.1074/jbc.R113.479519	http://dx.doi.org/10.1074/jbc.R113.479519			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23740256	Green Published, hybrid			2022-12-28	WOS:000322014400007
J	Young, LC; McDonald, DW; Hendzel, MJ				Young, Leah C.; McDonald, Darin W.; Hendzel, Michael J.			Kdm4b Histone Demethylase Is a DNA Damage Response Protein and Confers a Survival Advantage following gamma-Irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFICATIONS PREDICT PROGNOSIS; H3 LYSINE 4; JMJD2 FAMILY; METHYLATION; CANCER; METHYLTRANSFERASE; HETEROCHROMATIN; TRIMETHYLATION; G9A; PROLIFERATION	DNA damage evokes a complex and highly coordinated DNA damage response (DDR) that is integral to the suppression of genomic instability. Double-strand breaks (DSBs) are considered the most deleterious form damage. Evidence suggests that trimethylation of histone H3 lysine 9 (H3K9me3) presents a barrier to DSB repair. Also, global levels of histone methylation are clinically predictive for several tumor types. Therefore, demethylation of H3K9 may be an important step in the repair of DSBs. The KDM4 subfamily of demethylases removes H3K9 tri- and dimethylation and contributes to the regulation of cellular differentiation and proliferation; mutation or aberrant expression of KDM4 proteins has been identified in several human tumors. We hypothesize that members of the KDM4 subfamily may be components of the DDR. We found that Kdm4b-enhanced GFP (EGFP) and KDM4D-EGFP were recruited rapidly to DNA damage induced by laser micro-irradiation. Focusing on the clinically relevant Kdm4b, we found that recruitment was dependent on poly(ADP-ribose) polymerase 1 activity as well as Kdm4b demethylase activity. The Kdm4 proteins did not measurably accumulate at gamma-irradiation-induced gamma H2AX foci. Nevertheless, increased levels of Kdm4b were associated with decreased numbers of gamma H2AX foci 6 h after irradiation as well as increased cell survival. Finally, we found that levels of H3K9me2 and H3K9me3 were decreased at early time points after 2 gray of gamma-irradiation. Taken together, these data demonstrate that Kdm4b is a DDR protein and that overexpression of Kdm4b may contribute to the failure of anti-cancer therapy that relies on the induction of DNA damage.	Univ Alberta, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; Univ Alberta, Dept Expt Oncol, Fac Med & Dent, Edmonton, AB T6G 1Z2, Canada	University of Alberta; University of Alberta	Hendzel, MJ (corresponding author), Univ Alberta, Dept Oncol, Cross Canc Inst, 11560 Univ Ave, Edmonton, AB T6G 1Z2, Canada.	mhendzel@ualberta.ca	Hendzel, Michael/C-3391-2009; Young, Leah/AAN-3579-2020; Young, Leah C/B-9051-2012	Hendzel, Michael/0000-0002-9603-7945; Young, Leah C/0000-0001-7156-1006	Alberta Cancer Foundation; Canadian Institutes of Health Research	Alberta Cancer Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Alberta Cancer Foundation and the Canadian Institutes of Health Research.	Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Boehler C, 2011, P NATL ACAD SCI USA, V108, P2783, DOI 10.1073/pnas.1016574108; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Cann KL, 2011, BIOCHEM CELL BIOL, V89, P45, DOI 10.1139/O10-113; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Casas-Delucchi CS, 2012, NUCLEIC ACIDS RES, V40, P159, DOI 10.1093/nar/gkr723; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Ellinger J, 2010, INT J CANCER, V127, P2360, DOI 10.1002/ijc.25250; Ellinger J, 2010, PROSTATE, V70, P61, DOI 10.1002/pros.21038; Elsheikh SE, 2009, CANCER RES, V69, P3802, DOI 10.1158/0008-5472.CAN-08-3907; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He CC, 2012, HUM PATHOL, V43, P1425, DOI 10.1016/j.humpath.2011.11.003; Heit R, 2009, J CELL SCI, V122, P2957, DOI 10.1242/jcs.045351; Hillringhaus L, 2011, J BIOL CHEM, V286, P41616, DOI 10.1074/jbc.M111.283689; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Hoseok I, 2010, CANCER EPIDEM BIOMAR, V19, P566, DOI 10.1158/1055-9965.EPI-09-0980; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Kim TD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034618; Kim TD, 2012, J CELL BIOCHEM, V113, P1368, DOI 10.1002/jcb.24009; Kondo Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002037; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Li WJ, 2011, BIOCHEM BIOPH RES CO, V416, P372, DOI 10.1016/j.bbrc.2011.11.045; Liu G, 2009, ONCOGENE, V28, P4491, DOI 10.1038/onc.2009.297; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Mallette FA, 2012, CELL REP, V2, P1233, DOI 10.1016/j.celrep.2012.09.033; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; McManus KJ, 2006, J BIOL CHEM, V281, P8888, DOI 10.1074/jbc.M505323200; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Park YS, 2008, ANN SURG ONCOL, V15, P1968, DOI 10.1245/s10434-008-9927-9; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Robin P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r270; Rossetto D, 2010, CLIN CANCER RES, V16, P4543, DOI 10.1158/1078-0432.CCR-10-0513; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Song JS, 2012, PATHOL INT, V62, P182, DOI 10.1111/j.1440-1827.2011.02776.x; Sousa FG, 2012, CARCINOGENESIS, V33, P1433, DOI 10.1093/carcin/bgs132; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tamagawa H, 2012, ONCOL REP, V27, P637, DOI 10.3892/or.2011.1547; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Tzao C, 2009, MODERN PATHOL, V22, P252, DOI 10.1038/modpathol.2008.172; Wang JL, 2010, BIOL REPROD, V82, P105, DOI 10.1095/biolreprod.109.078055; Wei YK, 2008, MOL CARCINOGEN, V47, P701, DOI 10.1002/mc.20413; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Yin DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027154; Young LC, 2013, BIOCHEM CELL BIOL, V91, P369, DOI 10.1139/bcb-2012-0054; Zheng H, 2013, ONCOGENE, DOI [10.1038/onc.2013.6, DOI 10.1038/0NC.2013.6]	60	104	105	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21376	21388		10.1074/jbc.M113.491514	http://dx.doi.org/10.1074/jbc.M113.491514			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23744078	hybrid, Green Published			2022-12-28	WOS:000322014400056
J	Kang, MS; Ko, YP; Liang, XW; Ross, CL; Liu, Q; Murray, BE; Hook, M				Kang, Mingsong; Ko, Ya-Ping; Liang, Xiaowen; Ross, Cana L.; Liu, Qing; Murray, Barbara E.; Hoeoek, Magnus			Collagen-binding Microbial Surface Components Recognizing Adhesive Matrix Molecule (MSCRAMM) of Gram-positive Bacteria Inhibit Complement Activation via the Classical Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; ENTEROCOCCUS-FAECALIS; EXPERIMENTAL ENDOCARDITIS; EXTRACELLULAR-MATRIX; STREPTOCOCCUS-MUTANS; FIBRONECTIN-BINDING; SUBCOMPONENT C1Q; VIRULENCE FACTOR; HUG MODEL; PROTEIN	Members of a family of collagen-binding microbial surface components recognizing adhesive matrix molecules (MSCRAMMs) from Gram-positive bacteria are established virulence factors in several infectious diseases models. Here, we report that these adhesins also can bind C1q and act as inhibitors of the classical complement pathway. Molecular analyses of Cna from Staphylococcus aureus suggested that this prototype MSCRAMM bound to the collagenous domain of C1q and interfered with the interactions of C1r with C1q. As a result, C1r(2)C1s(2) was displaced from C1q, and the C1 complex was deactivated. This novel function of the Cna-like MSCRAMMs represents a potential immune evasion strategy that could be used by numerous Gram-positive pathogens.	[Kang, Mingsong; Ko, Ya-Ping; Liang, Xiaowen; Ross, Cana L.; Liu, Qing; Hoeoek, Magnus] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Inflammatory & Infect Dis, Houston, TX 77030 USA; [Murray, Barbara E.] Univ Texas Houston, Sch Med, Dept Med, Div Infect Dis, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston	Hook, M (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Inflammatory & Infect Dis, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mhook@ibt.tamhsc.edu	KANG, MINGSONG/A-9211-2017	KANG, MINGSONG/0000-0002-8795-2973; Liang, Xiaowen/0000-0002-6174-2951	National Institutes of Health [AI020624, AI047923]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI020624, R37AI047923, R01AI020624, R01AI047923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI020624 (to M. H.) and AI047923 (to B. E. M.). A patent (pending) application has been filed based on some results in this study.	Abranches J, 2011, INFECT IMMUN, V79, P2277, DOI 10.1128/IAI.00767-10; Bally I, 2009, J BIOL CHEM, V284, P19340, DOI 10.1074/jbc.M109.004473; BRODSKYDOYLE B, 1976, BIOCHEM J, V159, P279, DOI 10.1042/bj1590279; Chen JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019097; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; DEBRACCO MM, 1974, ARTHRITIS RHEUM-US, V17, P121; Elasri MO, 2002, BONE, V30, P275, DOI 10.1016/S8756-3282(01)00632-9; FIGUEROA JE, 1991, CLIN MICROBIOL REV, V4, P359, DOI 10.1128/CMR.4.3.359-395.1991; Fink DL, 2002, INFECT IMMUN, V70, P4902, DOI 10.1128/IAI.70.9.4902-4907.2002; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Hienz SA, 1996, J INFECT DIS, V174, P83, DOI 10.1093/infdis/174.1.83; Ho DK, 2012, J IMMUNOL, V188, P4450, DOI 10.4049/jimmunol.1103149; Itoh S, 2010, MOL IMMUNOL, V47, P932, DOI 10.1016/j.molimm.2009.09.027; Johansson A, 2001, CLIN ORTHOP RELAT R, P241; Kreikemeyer B, 2005, J BIOL CHEM, V280, P33228, DOI 10.1074/jbc.M502896200; Krishnan V, 2011, ADV EXP MED BIOL, V715, P175, DOI 10.1007/978-94-007-0940-9_11; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Laarman AJ, 2012, J IMMUNOL, V188, P386, DOI 10.4049/jimmunol.1102162; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lannergard J, 2003, FEMS MICROBIOL LETT, V222, P69, DOI 10.1016/S0378-1097(03)00222-2; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; MacKichan JK, 2008, INFECT IMMUN, V76, P788, DOI 10.1128/IAI.01174-07; McAleese FM, 2001, J BIOL CHEM, V276, P29969, DOI 10.1074/jbc.M102389200; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; Nakano K, 2010, ARCH ORAL BIOL, V55, P34, DOI 10.1016/j.archoralbio.2009.11.008; Nakano K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1491; Nallapareddy SR, 2003, MOL MICROBIOL, V47, P1733, DOI 10.1046/j.1365-2958.2003.03417.x; Nallapareddy SR, 2008, INFECT IMMUN, V76, P4120, DOI 10.1128/IAI.00376-08; PATTI JM, 1994, CURR OPIN CELL BIOL, V6, P752, DOI 10.1016/0955-0674(94)90104-X; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PATTI JM, 1994, INFECT IMMUN, V62, P152, DOI 10.1128/IAI.62.1.152-161.1994; PERKINS SJ, 1985, BIOCHEM J, V228, P13, DOI 10.1042/bj2280013; Pinkston KL, 2011, J BACTERIOL, V193, P4317, DOI 10.1128/JB.05026-11; Ponnuraj K, 2003, CELL, V115, P217, DOI 10.1016/S0092-8674(03)00809-2; Ram S, 2001, J EXP MED, V193, P281, DOI 10.1084/jem.193.3.281; Rhem MN, 2000, INFECT IMMUN, V68, P3776, DOI 10.1128/IAI.68.6.3776-3779.2000; Rich RL, 1999, J BIOL CHEM, V274, P26939, DOI 10.1074/jbc.274.38.26939; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; Rooijakkers SHM, 2007, MOL IMMUNOL, V44, P23, DOI 10.1016/j.molimm.2006.06.011; Ross CL, 2012, J BIOL CHEM, V287, P34856, DOI 10.1074/jbc.M112.371054; SCHUMAKER VN, 1981, J MOL BIOL, V148, P191, DOI 10.1016/0022-2836(81)90511-8; Sillanpaa J, 2009, J BACTERIOL, V191, P6643, DOI 10.1128/JB.00909-09; Singh KV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000716; Skattum L, 2011, MOL IMMUNOL, V48, P1643, DOI 10.1016/j.molimm.2011.05.001; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; Wagner C, 2007, CELL MICROBIOL, V9, P450, DOI 10.1111/j.1462-5822.2006.00802.x; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Xu Y, 2004, J BIOL CHEM, V279, P51760, DOI 10.1074/jbc.M406417200; Xu Y, 2004, J INFECT DIS, V189, P2323, DOI 10.1086/420851; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	50	83	84	2	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20520	20531		10.1074/jbc.M113.454462	http://dx.doi.org/10.1074/jbc.M113.454462			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720782	Green Published, hybrid			2022-12-28	WOS:000321715100039
J	Chandrasekaran, S; Ghosh, J; Port, GC; Koh, EI; Caparon, MG				Chandrasekaran, Sukantha; Ghosh, Joydeep; Port, Gary C.; Koh, Eun-ik; Caparon, Michael G.			Analysis of Polymorphic Residues Reveals Distinct Enzymatic and Cytotoxic Activities of the Streptococcus pyogenes NAD(+) Glycohydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; CYTOLYSIN-MEDIATED TRANSLOCATION; HELICOBACTER-PYLORI; STREPTOLYSIN-O; TISSUE TROPISM; TOXIN; GENE; PROTEIN; VACA; ASSOCIATION	The Streptococcus pyogenes NAD(+) glycohydrolase (SPN) is secreted from the bacterial cell and translocated into the host cell cytosol where it contributes to cell death. Recent studies suggest that SPN is evolving and has diverged into NAD(+) glycohydrolase-inactive variants that correlate with tissue tropism. However, the role of SPN in both cytotoxicity and niche selection are unknown. To gain insight into the forces driving the adaptation of SPN, a detailed comparison of representative glycohydrolase activity-proficient and -deficient variants was conducted. Of a total 454 amino acids, the activity-deficient variants differed at only nine highly conserved positions. Exchanging residues between variants revealed that no one single residue could account for the inability of the deficient variants to cleave the glycosidic bond of beta-NAD(+) into nicotinamide and ADP-ribose; rather, reciprocal changes at 3 specific residues were required to both abolish activity of the proficient version and restore full activity to the deficient variant. Changing any combination of 1 or 2 residues resulted in intermediate activity. However, a change to any 1 residue resulted in a significant decrease in enzyme efficiency. A similar pattern involving multiple residues was observed for comparison with a second highly conserved activity-deficient variant class. Remarkably, despite differences in glycohydrolase activity, all versions of SPN were equally cytotoxic to cultured epithelial cells. These data indicate that the glycohydrolase activity of SPN may not be the only contribution the toxin has to the pathogenesis of S. pyogenes and that both versions of SPN play an important role during infection.	[Chandrasekaran, Sukantha; Ghosh, Joydeep; Port, Gary C.; Koh, Eun-ik; Caparon, Michael G.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Caparon, MG (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave,Box 8230, St Louis, MO 63110 USA.	caparon@borcim.wustl.edu			National Institutes of Health from the United States Public Health Service [AI064721]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064721] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI064721 from the United States Public Health Service.	ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Bessen DE, 2011, J BACTERIOL, V193, P6651, DOI 10.1128/JB.05263-11; Bricker AL, 2005, INFECT IMMUN, V73, P6562, DOI 10.1128/IAI.73.10.6562-6566.2005; Bricker AL, 2002, MOL MICROBIOL, V44, P257, DOI 10.1046/j.1365-2958.2002.02876.x; CAPARON MG, 1991, METHOD ENZYMOL, V204, P556; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Ghosh J, 2006, MOL MICROBIOL, V62, P1203, DOI 10.1111/j.1365-2958.2006.05430.x; Ghosh J, 2010, J BIOL CHEM, V285, P5683, DOI 10.1074/jbc.M109.070300; HANSKI E, 1992, INFECT IMMUN, V60, P5119, DOI 10.1128/IAI.60.12.5119-5125.1992; Ji XH, 2002, FEMS MICROBIOL LETT, V206, P253, DOI 10.1016/S0378-1097(01)00543-2; Ji YD, 1996, INFECT IMMUN, V64, P503, DOI 10.1128/IAI.64.2.503-510.1996; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; KARASAWA T, 1995, FEMS MICROBIOL LETT, V130, P201; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kushner S. H., 1978, IMPROVED METHOD TRAN, P17; Lizano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003450; Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2; Magassa N, 2010, EMBO REP, V11, P400, DOI 10.1038/embor.2010.37; Meehl MA, 2005, PLOS PATHOG, V1, P362, DOI 10.1371/journal.ppat.0010035; Michos A, 2006, J BIOL CHEM, V281, P8216, DOI 10.1074/jbc.M511674200; PEREZCASAL J, 1993, MOL MICROBIOL, V8, P809, DOI 10.1111/j.1365-2958.1993.tb01628.x; Riddle DJ, 2010, J BACTERIOL, V192, P3735, DOI 10.1128/JB.00234-10; SCOTT JR, 1986, J EXP MED, V164, P1641, DOI 10.1084/jem.164.5.1641; Smith CL, 2011, STRUCTURE, V19, P192, DOI 10.1016/j.str.2010.12.013; Stevens DL, 2000, J INFECT DIS, V182, P1117, DOI 10.1086/315850; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Tatsuno I, 2007, MICROBIOL-SGM, V153, P4253, DOI 10.1099/mic.0.2007/009555-0; van Doorn LJ, 1999, GASTROENTEROLOGY, V116, P823, DOI 10.1016/S0016-5085(99)70065-X; Zhang S, 2006, INFECT IMMUN, V74, P4200, DOI 10.1128/IAI.00493-06	30	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20064	20075		10.1074/jbc.M113.481556	http://dx.doi.org/10.1074/jbc.M113.481556			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689507	hybrid, Green Published			2022-12-28	WOS:000321515800068
J	Hifumi, E; Fujimoto, N; Arakawa, M; Saito, E; Matsumoto, S; Kobayashi, N; Uda, T				Hifumi, Emi; Fujimoto, Naoko; Arakawa, Mitsue; Saito, Eri; Matsumoto, Shingo; Kobayashi, Nobuyuki; Uda, Taizo			Biochemical Features of a Catalytic Antibody Light Chain, 22F6, Prepared from Human Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-HYDROLYZING ACTIVITY; IGG ANTIBODIES; PEPTIDE; BINDING; HEAVY; AUTOANTIBODIES; SEQUENCE; ABILITY; VIRUS; GP41	Human antibody light chains belonging to subgroup II of germ line genes were amplified by a seminested PCR technique using B-lymphocytes taken from a human adult infected with influenza virus. Each gene of the human light chains was transferred into the Escherichia coli system. The recovered light chain was highly purified using a two-step purification system. Light chain 22F6 showed interesting catalytic features. The light chain cleaved a peptide bond of synthetic peptidyl-4-methyl-coumaryl-7-amide (MCA) substrates, such as QAR-MCA and EAR-MCA, indicating amidase activity. It also hydrolyzed a phosphodiester bond of both DNA and RNA. From the analysis of amino acid sequences and molecular modeling, the 22F6 light chain possesses two kinds of active sites as amidase and nuclease in close distances. The 22F6 catalytic light chain could suppress the infection of influenza virus type A (H1N1) of Madin-Darby canine kidney cells in an in vitro assay. In addition, the catalytic light chain clearly inhibited the infection of the influenza virus of BALB/c mice via nasal administration in an in vivo assay. In the experiment, the titer in the serum of the mice coinfected with the 22F6 light chain and H1N1 virus became considerably lowered compared with that of 22F6-non-coinfected mice. Note that the catalytic light chain was prepared from human peripheral lymphocyte and plays an important role in preventing infection by influenza virus. Considering the fact that the human light chain did not show any acute toxicity for mice, our procedure developed in this study must be unique and noteworthy for developing new drugs.	[Hifumi, Emi] Oita Univ, Res Ctr Appl Med Engn, Oita 8701192, Japan; [Fujimoto, Naoko; Saito, Eri; Matsumoto, Shingo; Uda, Taizo] Oita Univ, Dept Appl Chem, Fac Engn, Oita 8701192, Japan; [Arakawa, Mitsue] Oita Univ, Dept Nursing, Fac Med, Yufu City, Oita 8795593, Japan; [Kobayashi, Nobuyuki] Nagasaki Univ, Sch Pharmaceut Sci, Nagasaki 8528521, Japan; [Hifumi, Emi; Uda, Taizo] JST CREST Japan Sci & Technol Corp, Kawaguchi, Saitama 3320012, Japan	Oita University; Oita University; Oita University; Nagasaki University	Hifumi, E (corresponding author), Oita Univ, Res Ctr Appl Med Engn, Dan Noharu 700, Oita 8701192, Japan.	e-hifumi@oita-u.ac.jp		Uda, Taizo/0000-0001-8146-7902	Japan Science and Technology Agency (CREST/"Establishment of Innovative Manufacturing Technology Based on Nanoscience")	Japan Science and Technology Agency (CREST/"Establishment of Innovative Manufacturing Technology Based on Nanoscience")	This work was supported by the Japan Science and Technology Agency (CREST/"Establishment of Innovative Manufacturing Technology Based on Nanoscience").	Adachi K, 2008, ARCH VIROL, V153, P15, DOI 10.1007/s00705-007-1051-9; Andrievskaya OA, 2002, IMMUNOL LETT, V81, P191, DOI 10.1016/S0165-2478(02)00006-8; Durova OM, 2009, MOL IMMUNOL, V47, P87, DOI 10.1016/j.molimm.2008.12.020; GAO QS, 1994, J BIOL CHEM, V269, P32389; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Gololobov GV, 1997, MOL IMMUNOL, V34, P1083, DOI 10.1016/S0161-5890(97)00129-6; Hatiuchi K, 2003, IMMUNOL LETT, V86, P249, DOI 10.1016/S0165-2478(03)00030-0; Hifumi E, 2003, BIOTECHNOL BIOENG, V84, P485, DOI 10.1002/bit.10806; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Hifumi E, 2000, APPL BIOCHEM BIOTECH, V83, P209, DOI 10.1385/ABAB:83:1-3:209; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Hifumi E, 2012, FASEB J, V26, P1607, DOI 10.1096/fj.11-195339; Hifumi E, 2011, J AM CHEM SOC, V133, P15015, DOI 10.1021/ja203922r; Kanyshkova TG, 1997, FEBS LETT, V416, P23, DOI 10.1016/S0014-5793(97)01163-0; Kim YR, 2006, J BIOL CHEM, V281, P15287, DOI 10.1074/jbc.M600937200; Kolesnikov AV, 2000, P NATL ACAD SCI USA, V97, P13526, DOI 10.1073/pnas.200360497; Kozyr AV, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/683829; Krasnorutskii MA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1065, DOI 10.1134/S0006297911090124; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Lee D. C. W., 2007, Signal Transduction, V7, P64, DOI 10.1002/sita.200600117; Matsuura K, 1998, BIOCHEM BIOPH RES CO, V243, P719, DOI 10.1006/bbrc.1998.8164; MATSUURA K, 1994, BIOCHEM BIOPH RES CO, V204, P57, DOI 10.1006/bbrc.1994.2425; MEI S, 1991, J BIOL CHEM, V266, P15571; Mitsuda Y, 2004, BIOTECHNOL BIOENG, V86, P217, DOI 10.1002/bit.20031; Ohara K, 2004, BIOCHEM BIOPH RES CO, V315, P612, DOI 10.1016/j.bbrc.2004.01.094; Okochi N, 2007, APPL MICROBIOL BIOT, V77, P597, DOI 10.1007/s00253-007-1197-0; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Parkhomenko TA, 2010, BIOCHIMIE, V92, P545, DOI 10.1016/j.biochi.2010.01.022; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Ponomarenko NA, 2007, BIOCHEMISTRY-US, V46, P14598, DOI 10.1021/bi7013954; Redegeld FA, 2003, TRENDS IMMUNOL, V24, P181, DOI 10.1016/S1471-4906(03)00059-0; Rodkey LS, 2000, APPL BIOCHEM BIOTECH, V83, P95, DOI 10.1385/ABAB:83:1-3:95; Sapparapu G, 2009, J BIOL CHEM, V284, P24622, DOI 10.1074/jbc.M109.011858; Schmidt NJ, 1989, DIAGNOSTIC PROCEDURE, V6th, P51; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Smirnov I, 2011, P NATL ACAD SCI USA, V108, P15954, DOI 10.1073/pnas.1108460108; SUN M, 1994, J IMMUNOL, V153, P5121; Takizawa N, 2010, VIROLOGY, V401, P248, DOI 10.1016/j.virol.2010.02.030; Thiagarajan P, 2000, BIOCHEMISTRY-US, V39, P6459, DOI 10.1021/bi992588w; Uda T, 2004, J BIOSCI BIOENG, V97, P143, DOI 10.1016/S1389-1723(04)70183-8; Wootla B, 2011, BLOOD, V117, P2257, DOI 10.1182/blood-2010-07-296103	44	13	14	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19558	19568		10.1074/jbc.M113.454579	http://dx.doi.org/10.1074/jbc.M113.454579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23677996	Green Published, hybrid			2022-12-28	WOS:000321515800022
J	Kunugi, M; Takabayashi, A; Tanaka, A				Kunugi, Motoshi; Takabayashi, Atsushi; Tanaka, Ayumi			Evolutionary Changes in Chlorophyllide a Oxygenase (CAO) Structure Contribute to the Acquisition of a New Light-harvesting Complex in Micromonas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN COMPLEXES; PROCHLOROTHRIX-HOLLANDICA; CRYSTAL-STRUCTURE; PHOTOSYSTEM-II; A/B-PROTEIN; ANTENNA; CYANOBACTERIA; DEGRADATION; CONVERSION; INSIGHTS	Chlorophyll b is found in photosynthetic prokaryotes and primary and secondary endosymbionts, although their light-harvesting systems are quite different. Chlorophyll b is synthesized from chlorophyll a by chlorophyllide a oxygenase (CAO), which is a Rieske-mononuclear iron oxygenase. Comparison of the amino acid sequences of CAO among photosynthetic organisms elucidated changes in the domain structures of CAO during evolution. However, the evolutionary relationship between the light-harvesting system and the domain structure of CAO remains unclear. To elucidate this relationship, we investigated the CAO structure and the pigment composition of chlorophyll-protein complexes in the prasinophyte Micromonas. The Micromonas CAO is composed of two genes, MpCAO1 and MpCAO2, that possess Rieske and mononuclear iron-binding motifs, respectively. Only when both genes were introduced into the chlorophyll b-less Arabidopsis mutant (ch1-1) was chlorophyll b accumulated, indicating that cooperation between the two subunits is required to synthesize chlorophyll b. Although Micromonas has a characteristic light-harvesting system in which chlorophyll b is incorporated into the core antennas of reaction centers, chlorophyll b was also incorporated into the core antennas of reaction centers of the Arabidopsis transformants that contained the two Micromonas CAO proteins. Based on these results, we discuss the evolutionary relationship between the structures of CAO and light-harvesting systems.	[Kunugi, Motoshi; Takabayashi, Atsushi; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Takabayashi, Atsushi; Tanaka, Ayumi] Japan Core Res Evolutionary Sci & Technol, Sapporo, Hokkaido 0600819, Japan	Hokkaido University	Takabayashi, A (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Kita Ku, N19 W8, Sapporo, Hokkaido 0600819, Japan.	takabayashi@pop.lowtem.hokudai.ac.jp	Tanaka, Ayumi/D-9003-2012; Takabayashi, Atsushi/G-1998-2011; Takabayashi, Atsushi/AAH-6025-2020	Takabayashi, Atsushi/0000-0003-1100-7462; Takabayashi, Atsushi/0000-0003-1100-7462	Japan Society for the Promotion of Science [23770035, 24370017]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Young Scientists 23770035 (to A. Takabayashi) and by Scientific Research 24370017 (to A. Tanaka) from the Japan Society for the Promotion of Science.	Adir N, 2005, PHOTOSYNTH RES, V85, P15, DOI 10.1007/s11120-004-2143-y; ANDERSON JM, 1980, BIOCHIM BIOPHYS ACTA, V591, P113, DOI 10.1016/0005-2728(80)90225-X; ANDERSON JM, 1978, FEBS LETT, V92, P227, DOI 10.1016/0014-5793(78)80760-1; Bibby TS, 2003, NATURE, V424, P1051, DOI 10.1038/nature01933; Chen M, 2010, SCIENCE, V329, P1318, DOI 10.1126/science.1191127; D'Ordine RL, 2009, J MOL BIOL, V392, P481, DOI 10.1016/j.jmb.2009.07.022; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; Garczarek L, 2000, P NATL ACAD SCI USA, V97, P4098, DOI 10.1073/pnas.070040897; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Harada J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060026; Hirashima M, 2006, J BIOL CHEM, V281, P15385, DOI 10.1074/jbc.M602903200; Horie Y, 2009, J BIOL CHEM, V284, P17449, DOI 10.1074/jbc.M109.008912; Ito H, 1996, J BIOL CHEM, V271, P1475, DOI 10.1074/jbc.271.3.1475; Jakoncic J, 2007, FEBS J, V274, P2470, DOI 10.1111/j.1742-4658.2007.05783.x; Kouril R, 2012, BBA-BIOENERGETICS, V1817, P2, DOI 10.1016/j.bbabio.2011.05.024; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lepetit B, 2007, BIOCHEMISTRY-US, V46, P9813, DOI 10.1021/bi7008344; Martins BM, 2005, STRUCTURE, V13, P817, DOI 10.1016/j.str.2005.03.008; Nagata N, 2004, PLANTA, V218, P1019, DOI 10.1007/s00425-003-1181-6; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; Renger T, 2010, CHEMPHYSCHEM, V11, P1141, DOI 10.1002/cphc.200900932; Sakuraba Y, 2012, PLANT CELL PHYSIOL, V53, P505, DOI 10.1093/pcp/pcs006; Sakuraba Y, 2010, PLANT CELL PHYSIOL, V51, P1055, DOI 10.1093/pcp/pcq050; Sakuraba Y, 2009, J BIOL CHEM, V284, P36689, DOI 10.1074/jbc.M109.008144; Satoh S, 2001, J BIOL CHEM, V276, P4293, DOI 10.1074/jbc.M008238200; Satoh S, 2006, PLANT CELL PHYSIOL, V47, P1622, DOI 10.1093/pcp/pcl026; Schmid VHR, 2008, CELL MOL LIFE SCI, V65, P3619, DOI 10.1007/s00018-008-8333-6; Shimoda Y, 2012, PLANT J, V72, P501, DOI 10.1111/j.1365-313X.2012.05095.x; Six C, 2005, MOL BIOL EVOL, V22, P2217, DOI 10.1093/molbev/msi220; Takabayashi A, 2011, PLANT CELL PHYSIOL, V52, P2103, DOI 10.1093/pcp/pcr138; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; TANAKA A, 1991, PLANT CELL PHYSIOL, V32, P195, DOI 10.1093/oxfordjournals.pcp.a078064; Tanaka R, 2005, PHOTOSYNTH RES, V85, P327, DOI 10.1007/s11120-005-6807-z; Tanaka R, 2011, BBA-BIOENERGETICS, V1807, P968, DOI 10.1016/j.bbabio.2011.01.002; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Tanaka R, 2010, ADV PHOTOSYNTH RESP, V31, P55; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomitani A, 1999, NATURE, V400, P159, DOI 10.1038/22101; Tsugama D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-22; van der Staay GWM, 1998, PLANT MOL BIOL, V36, P709, DOI 10.1023/A:1005930210515; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Yamasato A, 2005, PLANT CELL, V17, P1585, DOI 10.1105/tpc.105.031518; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	48	20	22	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19330	19341		10.1074/jbc.M113.462663	http://dx.doi.org/10.1074/jbc.M113.462663			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23677999	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000321515800004
J	Lagakos, WS; Guan, XD; Ho, SY; Sawicki, LR; Corsico, B; Kodukula, S; Murota, K; Stark, RE; Storch, J				Lagakos, William S.; Guan, Xudong; Ho, Shiu-Ying; Rodriguez Sawicki, Luciana; Corsico, Betina; Kodukula, Sarala; Murota, Kaeko; Stark, Ruth E.; Storch, Judith			Liver Fatty Acid-binding Protein Binds Monoacylglycerol in Vitro and in Mouse Liver Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL CACO-2 CELLS; ENDOCANNABINOID SYSTEM; DIFFERENT MECHANISMS; MEMBRANES; TRANSPORT; IDENTIFICATION; ABSORPTION; VESICLES; SITE	Liver fatty acid-binding protein (LFABP; FABP1) is expressed both in liver and intestinal mucosa. Mice null for LFABP were recently shown to have altered metabolism of not only fatty acids but also monoacylglycerol, the two major products of dietary triacylglycerol hydrolysis (Lagakos, W. S., Gajda, A. M., Agellon, L., Binas, B., Choi, V., Mandap, B., Russnak, T., Zhou, Y. X., and Storch, J. (2011) Am. J. Physiol. Gastrointest. Liver Physiol. 300, G803-G814). Nevertheless, the binding and transport of monoacylglycerol (MG) by LFABP are uncertain, with conflicting reports in the literature as to whether this single chain amphiphile is in fact bound by LFABP. In the present studies, gel filtration chromatography of liver cytosol from LFABP(-/-) mice shows the absence of the low molecular weight peak of radiolabeled monoolein present in the fractions that contain LFABP in cytosol from wild type mice, indicating that LFABP binds sn-2 MG in vivo. Furthermore, solution-state NMR spectroscopy demonstrates two molecules of sn-2 monoolein bound in the LFABP binding pocket in positions similar to those found for oleate binding. Equilibrium binding affinities are similar to 2-fold lower for MG compared with fatty acid. Finally, kinetic studies examining the transfer of a fluorescent MG analog show that the rate of transfer of MG is 7-fold faster from LFABP to phospholipid membranes than from membranes to membranes and occurs by an aqueous diffusion mechanism. These results provide strong support for monoacylglycerol as a physiological ligand for LFABP and further suggest that LFABP functions in the efficient intracellular transport of MG.	[Lagakos, William S.; Ho, Shiu-Ying; Kodukula, Sarala; Storch, Judith] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Storch, Judith] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Guan, Xudong; Stark, Ruth E.] CUNY, Grad Ctr, New York, NY 10031 USA; [Guan, Xudong; Stark, Ruth E.] Inst Macromol Assemblies, New York, NY 10031 USA; [Rodriguez Sawicki, Luciana; Corsico, Betina] Univ Nacl La Plata, Inst Invest Bioquim La Plata, Fac Ciencias Med, RA-1900 La Plata, Argentina; [Murota, Kaeko] Kinki Univ, Dept Life Sci, Fac Sci & Engn, Osaka 5778502, Japan	Rutgers State University New Brunswick; Rutgers State University New Brunswick; City University of New York (CUNY) System; National University of La Plata; Kindai University (Kinki University)	Storch, J (corresponding author), Rutgers State Univ, Dept Nutr Sci, 96 Lipman Dr, New Brunswick, NJ 08901 USA.	storch@aesop.rutgers.edu	Murota, Kaeko/GRO-6464-2022	Storch, Judith/0000-0001-5482-1777	National Institutes of Health [DK-38389]; National Center for Research Resources [2G12 RR03060]; National Institute on Minority Health and Health Disparities [8G12MD007603]; City University of New York [80209]; New Jersey Agricultural Experiment Station; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK038389, R01DK038389] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); City University of New York; New Jersey Agricultural Experiment Station; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grant DK-38389 (to J. S.) and Grant 2G12 RR03060 from the National Center for Research Resources and Grant 8G12MD007603 from the National Institute on Minority Health and Health Disparities for additional infrastructural support at The City College of New York. This work was also supported by City University of New York Collaborative Grant 80209 (to R. E. S.) and funds from the New Jersey Agricultural Experiment Station (to J. S.).	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN RE, 1992, BIOCHIM BIOPHYS ACTA, V1113, P375, DOI 10.1016/0304-4157(92)90007-W; Chon SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043962; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P711, DOI 10.1021/bi00402a033; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; DiPatrizio NV, 2011, P NATL ACAD SCI USA, V108, P12904, DOI 10.1073/pnas.1104675108; EPSTEIN LF, 1994, BIOCHEM BIOPH RES CO, V204, P163, DOI 10.1006/bbrc.1994.2440; Francis F., 2007, THESIS CITY U NEW YO; FUJITA M, 1995, EUR J BIOCHEM, V233, P406, DOI 10.1111/j.1432-1033.1995.406_2.x; GLASSTONE S, 1941, THEORY RATE PROCESSE; GLATZ JFC, 1983, ANAL BIOCHEM, V132, P89, DOI 10.1016/0003-2697(83)90429-3; Gomori G, 1942, J LAB CLIN MED, V27, P955; Guan X., 2011, THESIS CITY U NEW YO; Hansen KB, 2011, J CLIN ENDOCR METAB, V96, pE1409, DOI 10.1210/jc.2011-0647; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; He Y, 2011, BIOCHEMISTRY-US, V50, P1283, DOI 10.1021/bi101307h; Ho SP, 2001, AM J PHYSIOL-CELL PH, V281, pC1106, DOI 10.1152/ajpcell.2001.281.4.C1106; Hsu KT, 1996, J BIOL CHEM, V271, P13317, DOI 10.1074/jbc.271.23.13317; Huang C, 1974, Methods Enzymol, V32, P485; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KEUPER HJK, 1985, CHEM PHYS LIPIDS, V38, P159, DOI 10.1016/0009-3084(85)90064-7; KIM HK, 1992, J BIOL CHEM, V267, P77; Lagakos WS, 2011, AM J PHYSIOL-GASTR L, V300, pG803, DOI 10.1152/ajpgi.00229.2010; Maccarrone M, 2010, ANNU REV NUTR, V30, P423, DOI 10.1146/annurev.nutr.012809.104701; Martin GG, 2003, J BIOL CHEM, V278, P21429, DOI 10.1074/jbc.M300287200; MATAYOSHI ED, 1981, BIOPHYS J, V35, P215, DOI 10.1016/S0006-3495(81)84783-2; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Murota K, 2005, J NUTR, V135, P1626, DOI 10.1093/jn/135.7.1626; Narayanan VS, 1996, BIOCHEMISTRY-US, V35, P7466, DOI 10.1021/bi952979k; OCKNER RK, 1990, MOL CELL BIOCHEM, V98, P3; PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587; Phan CT, 2001, FRONT BIOSCI-LANDMRK, V6, pD299, DOI 10.2741/Phan; ROSEMAN MA, 1980, BIOCHEMISTRY-US, V19, P439, DOI 10.1021/bi00544a006; SCOTT TG, 1970, J AM CHEM SOC, V92, P687, DOI 10.1021/ja00706a043; STORCH J, 1993, MOL CELL BIOCHEM, V123, P45, DOI 10.1007/BF01076474; STORCH J, 1990, J BIOL CHEM, V265, P7827; STORCH J, 1986, BIOCHEMISTRY-US, V25, P1717, DOI 10.1021/bi00355a041; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storr MA, 2007, CURR OPIN PHARMACOL, V7, P575, DOI 10.1016/j.coph.2007.08.008; Thompson J, 1997, J BIOL CHEM, V272, P7140, DOI 10.1074/jbc.272.11.7140; Thumser AEA, 2000, J LIPID RES, V41, P647; THUMSER AEA, 1994, BIOCHEM J, V301, P801, DOI 10.1042/bj3010801; Thumser AEA, 1996, BIOCHEM J, V320, P729, DOI 10.1042/bj3200729; TSO P, 2006, BIOCH PHYSL ASPECTS, P125; Wang H, 2002, BIOCHEMISTRY-US, V41, P5453, DOI 10.1021/bi011914g; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WOOTAN MG, 1993, BIOCHEMISTRY-US, V32, P8622, DOI 10.1021/bi00084a033	52	31	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19805	19815		10.1074/jbc.M113.473579	http://dx.doi.org/10.1074/jbc.M113.473579			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23658011	Green Published, hybrid			2022-12-28	WOS:000321515800049
J	Li, CR; Ebert, PJR; Li, QJ				Li, Chaoran; Ebert, Peter J. R.; Li, Qi-Jing			T Cell Receptor (TCR) and Transforming Growth Factor beta (TGF-beta) Signaling Converge on DNA (Cytosine-5)-methyltransferase to Control forkhead box protein 3 (foxp3) Locus Methylation and Inducible Regulatory T Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXP3; METHYLTRANSFERASE 1; GENE-EXPRESSION; CUTTING EDGE; KINASE-B; INDUCTION; LINEAGE; PROTEIN; MAINTENANCE; RESPONSES	Naive T cells can be induced to differentiate into Foxp3(+) regulatory T cells (iTregs) upon suboptimal T cell receptor (TCR) stimulus or TCR stimulus in conjunction with TGF-beta signaling; however, we do not fully understand how these signals coordinately control foxp3 expression. Here, we show that strong TCR activation, in terms of both duration and ligand affinity, causes the accumulation of DNA (cytosine-5)-methyltransferase 1 (DNMT1) and DNMT3b and their specific enrichment at the foxp3 locus, which leads to increased CpG methylation and inhibits foxp3 transcription. During this process the augmentation of DNMT1 is regulated through at least two post-transcriptional mechanisms; that is, strong TCR signal inactivates GSK3 beta to rescue DNMT1 protein from proteasomal degradation, and strong TCR signal suppresses miR-148a to derepress DNMT1 mRNA translation. Meanwhile, TGF-beta signaling antagonizes DNMT1 accumulation via activation of p38 MAP kinase. Thus, independent of transcription factor activation, TCR and TGF-beta signals converge on DNMT1 to modulate the expression of foxp3 epigenetically, which marks mother cell iTreg lineage choice within the genome of differentiating daughter cells.	[Li, Chaoran; Li, Qi-Jing] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Ebert, Peter J. R.] Genentech Inc, San Francisco, CA 94080 USA	Duke University; Roche Holding; Genentech	Li, QJ (corresponding author), Duke Univ, Med Ctr, Dept Immunol, 207 Res Dr, Durham, NC 27710 USA.	Qi-Jing.Li@Duke.edu			National Institutes of Health [RAI091878A, RAI091878B]; American Diabetes Association [1-10-JF-28]; American Cancer Society [RSG-10-157-01-LIB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI091878, R01AI091878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RAI091878A and RAI091878B (NIAID). This work was also supported by grants from the American Diabetes Association (1-10-JF-28) and the American Cancer Society (RSG-10-157-01-LIB).	Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CONSTANT S, 1995, J EXP MED, V182, P1591, DOI 10.1084/jem.182.5.1591; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Ebert PJR, 2008, IMMUNITY, V29, P734, DOI 10.1016/j.immuni.2008.09.014; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; GOODE N, 1992, J BIOL CHEM, V267, P16878; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Janson PCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001612; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim GD, 2002, EMBO J, V21, P4183, DOI 10.1093/emboj/cdf401; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Pan W, 2010, J IMMUNOL, V184, P6773, DOI 10.4049/jimmunol.0904060; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Purvis HA, 2010, BLOOD, V116, P4829, DOI 10.1182/blood-2010-03-272153; REAY PA, 1994, J IMMUNOL, V152, P3946; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474; SEDER RA, 1992, J EXP MED, V176, P1091, DOI 10.1084/jem.176.4.1091; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Sun LD, 2007, CELL SIGNAL, V19, P2255, DOI 10.1016/j.cellsig.2007.06.014; SZYF M, 1991, J BIOL CHEM, V266, P10027; Tao X, 1997, J IMMUNOL, V158, P4237; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	58	35	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19127	19139		10.1074/jbc.M113.453357	http://dx.doi.org/10.1074/jbc.M113.453357			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23687305	hybrid, Green Published			2022-12-28	WOS:000321335800047
J	Kong, GY; Du, J; Liu, YG; Meline, B; Chang, YI; Ranheim, EA; Wang, JY; Zhang, J				Kong, Guangyao; Du, Juan; Liu, Yangang; Meline, Benjamin; Chang, Yuan-I; Ranheim, Erik A.; Wang, Jinyong; Zhang, Jing			Notch1 Gene Mutations Target KRAS G12D-expressing CD8(+) Cells and Contribute to Their Leukemogenic Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER STEM-CELLS; ONCOGENIC NRAS; T-ALL; MOLECULAR PATHOGENESIS; ACTIVATION; PATHWAYS; EVENTS; MODEL; STAGE	Acute T-cell lymphoblastic leukemia/lymphoma (T-ALL) is an aggressive hematopoietic malignancy affecting both children and adults. Previous studies of T-ALL mouse models induced by different genetic mutations have provided highly diverse results on the issues of T-cell leukemia/lymphomainitiating cells (T-LICs) and potential mechanisms contributing to T-LIC transformation. Here, we show that oncogenic Kras (Kras G12D) expressed from its endogenous locus is a potent inducer of T-ALL even in a less sensitized BALB/c background. Notch1 mutations, including exon 34 mutations and recently characterized type 1 and 2 deletions, are detected in 100% of Kras G12D-induced T-ALL tumors. Although these mutations are not detected at the pre-leukemia stage, incremental up-regulation of NOTCH1 surface expression is observed at the pre-leukemia and leukemia stages. As secondary genetic hits in the Kras G12D model, Notch1 mutations target CD8(+) T-cells but not hematopoietic stem cells to further promote T-ALL progression. Pre-leukemia T-cells without detectable Notch1 mutations do not induce T-ALL in secondary recipient mice compared with T-ALL tumor cells with Notch1 mutations. We found huge variations in T-LIC frequency and immunophenotypes of cells enriched for T-LICs. Unlike Pten deficiency-induced T-ALL, oncogenic Kras-initiated T-ALL is not associated with up-regulation of the Wnt/beta-catenin pathway. Our results suggest that up-regulation of NOTCH1 signaling, through either overexpression of surface NOTCH1 or acquired gain-of-function mutations, is involved in both T-ALL initiation and progression. Notch1 mutations and Kras G12D contribute cooperatively to leukemogenic transformation of normal T-cells.	[Kong, Guangyao; Du, Juan; Liu, Yangang; Chang, Yuan-I; Wang, Jinyong; Zhang, Jing] Univ Wisconsin Madison, McArdle Lab Canc Res, Madison, WI 53706 USA; [Meline, Benjamin] Univ Wisconsin Madison, Dept Mol & Cellular Pharmacol, Madison, WI 53706 USA; [Ranheim, Erik A.] Univ Wisconsin, Carbone Canc Ctr, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, J (corresponding author), Univ Wisconsin Madison, McArdle Lab Canc Res, Madison, WI 53706 USA.	zhang@oncology.wisc.edu	Chang, Yuan-I/AAY-1711-2021; Kong, Guangyao/L-2162-2013; Ranheim, Erik/AAY-6505-2021		National Institutes of Health from NCI [R01 CA152108, P30 CA014520]; Elsa Pardee Foundation; Greater Milwaukee Foundation; American Society of Hematology; V Foundation for Cancer Research; University of Wisconsin Carbone Cancer Center; NATIONAL CANCER INSTITUTE [R01CA152108, P30CA014520] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Elsa Pardee Foundation; Greater Milwaukee Foundation; American Society of Hematology; V Foundation for Cancer Research; University of Wisconsin Carbone Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA152108 (to J. Z.) and P30 CA014520 (to the University of Wisconsin Comprehensive Cancer Center) from NCI. This work was also supported by a research grant from the Elsa Pardee Foundation, a Shaw Scientist Award from the Greater Milwaukee Foundation, an ASH Scholar Award from the American Society of Hematology, a V Scholar Award from the V Foundation for Cancer Research, and an Investigator Initiated Grant from the University of Wisconsin Carbone Cancer Center (to J. Z.).	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Bagley BN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003034; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; BRUNNING RD, 2001, PATHOLOGY GENETICS T, P110; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Du J, 2013, LEUKEMIA, V27, P754, DOI 10.1038/leu.2012.251; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Genot E, 2000, CURR OPIN IMMUNOL, V12, P289, DOI 10.1016/S0952-7915(00)00089-3; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Guo ZY, 2007, BLOOD, V109, P5463, DOI 10.1182/blood-2006-11-059071; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kindler T, 2008, BLOOD, V112, P3373, DOI 10.1182/blood-2008-03-147587; Li XY, 2008, J EXP MED, V205, P2851, DOI 10.1084/jem.20081561; Mansour MR, 2007, CLIN CANCER RES, V13, P6964, DOI 10.1158/1078-0432.CCR-07-1474; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; Perentesis JP, 2004, LEUKEMIA, V18, P685, DOI 10.1038/sj.leu.2403272; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Teitell MA, 2009, ANNU REV PATHOL-MECH, V4, P175, DOI 10.1146/annurev.pathol.4.110807.092227; Uckun FM, 1997, J CLIN ONCOL, V15, P2214, DOI 10.1200/JCO.1997.15.6.2214; van Grotel M, 2008, LEUKEMIA, V22, P124, DOI 10.1038/sj.leu.2404957; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; von Lintig FC, 2000, CLIN CANCER RES, V6, P1804; Wang JY, 2011, BLOOD, V118, P368, DOI 10.1182/blood-2010-12-326058; Wang JY, 2010, BLOOD, V116, P5991, DOI 10.1182/blood-2010-04-281527; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829	32	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18219	18227		10.1074/jbc.M113.475376	http://dx.doi.org/10.1074/jbc.M113.475376			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23673656	hybrid, Green Published			2022-12-28	WOS:000320721900026
J	Otsu, W; Kurooka, T; Otsuka, Y; Sato, K; Inaba, M				Otsu, Wataru; Kurooka, Takao; Otsuka, Yayoi; Sato, Kota; Inaba, Mutsumi			A New Class of Endoplasmic Reticulum Export Signal Phi X Phi X Phi for Transmembrane Proteins and Its Selective Interaction with Sec24C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL TUBULAR-ACIDOSIS; ANION-EXCHANGER 1; ERYTHROCYTE-MEMBRANE BAND-3; ER EXPORT; COPII COAT; CONDUCTANCE REGULATOR; NEUTROPHIL ELASTASE; CYTOPLASMIC DOMAIN; PLASMA-MEMBRANE; BINDING-SITES	Protein export from the endoplasmic reticulum (ER) depends on the interaction between a signal motif on the cargo and a cargo recognition site on the coatomer protein complex II. A hydrophobic sequence in the N terminus of the bovine anion exchanger 1 (AE1) anion exchanger facilitated the ER export of human AE1 Delta 11, an ER-retained AE1 mutant, through interaction with a specific Sec24 isoform. The cell surface expression and N-glycan processing of various substitution mutants or chimeras of human and bovine AE1 proteins and their Delta 11 mutants in HEK293 cells were examined. The N-terminal sequence (V/L/F)X(I/L)X(M/L), (VSIPM30)-V-26 in bovine AE1, which is comparable with Phi X Phi X Phi, acted as the ER export signal for AE1 and AE1 Delta 11 (Phi is a hydrophobic amino acid, and X is any amino acid). The AE1-Ly49E chimeric protein possessing the Phi X Phi X Phi motif exhibited effective cell surface expression and N-glycan maturation via the coatomer protein complex II pathway, whereas a chimera lacking this motif was retained in the ER. A synthetic polypeptide containing the N terminus of bovine AE1 bound the Sec23A-Sec24C complex through a selective interaction with Sec24C. Co-transfection of Sec24C-AAA, in which the residues (LIL897)-L-895 (the binding site for another ER export signal motif IXM on Sec24C and Sec24D) were mutated to (895)AAA(897), specifically increased ER retention of the AE1-Ly49E chimera. These findings demonstrate that the Phi X Phi X Phi sequence functions as a novel signal motif for the ER export of cargo proteins through an exclusive interaction with Sec24C.	[Otsu, Wataru; Kurooka, Takao; Otsuka, Yayoi; Sato, Kota; Inaba, Mutsumi] Hokkaido Univ, Mol Med Lab, Grad Sch Vet Med, Dept Vet Clin Sci, Sapporo, Hokkaido 0600818, Japan	Hokkaido University	Inaba, M (corresponding author), Hokkaido Univ, Mol Med Lab, Grad Sch Vet Med, Sapporo, Hokkaido 0600818, Japan.	inazo@vetmed.hokudai.ac.jp		Otsu, Wataru/0000-0002-5930-1954	Japan Society for the Promotion of Science [19208027, 22658095, 23658257]; Research Fellowship for Young Scientist from Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Fellowship for Young Scientist from Japan Society for the Promotion of Science	This work was supported by Grants-in-Aid for Scientific Research 19208027, 22658095, and 23658257 (to M. I.) from the Japan Society for the Promotion of Science.; Supported by a Research Fellowship for Young Scientist from Japan Society for the Promotion of Science.	Adachi H, 2010, JPN J VET RES, V58, P101; Adachi H, 2009, JPN J VET RES, V57, P135; Alper SL, 2006, EXP PHYSIOL, V91, P153, DOI 10.1113/expphysiol.2005.031765; ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875; Benson KF, 2003, NAT GENET, V35, P90, DOI 10.1038/ng1224; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Devonald MAJ, 2003, NAT GENET, V33, P125, DOI 10.1038/ng1082; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Gillon AD, 2012, BBA-MOL CELL BIOL L, V1821, P1040, DOI 10.1016/j.bbalip.2012.01.005; GOMEZ S, 1993, J BIOL CHEM, V268, P19593; Horwitz M, 2004, TRENDS MOL MED, V10, P163, DOI 10.1016/j.molmed.2004.02.002; Inaba M, 1996, J CLIN INVEST, V97, P1804, DOI 10.1172/JCI118610; Ito D, 2006, J CELL SCI, V119, P3602, DOI 10.1242/jcs.03101; Khoriaty R, 2012, BLOOD, V120, P31, DOI 10.1182/blood-2012-01-292086; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Mancias JD, 2005, TRAFFIC, V6, P278, DOI 10.1111/j.1600-0854.2005.00279.x; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; MICHAELY P, 1995, J BIOL CHEM, V270, P22050, DOI 10.1074/jbc.270.37.22050; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759; Nufer O, 2002, J CELL SCI, V115, P619; Okkenhaug H, 2006, FASEB J, V20, P2390, DOI 10.1096/fj.05-5588fje; Quilty JA, 2002, BIOCHEM J, V368, P895, DOI 10.1042/BJ20020574; Russell C, 2010, TRAFFIC, V11, P303, DOI 10.1111/j.1600-0854.2009.01026.x; Sucic S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230037; Tanner MJA, 2002, CURR OPIN HEMATOL, V9, P133, DOI 10.1097/00062752-200203000-00009; Toye AM, 2004, J CELL SCI, V117, P1399, DOI 10.1242/jcs.00974; Toye AM, 2002, BLOOD, V99, P342, DOI 10.1182/blood.V99.1.342; Tzetis M, 2001, HUM GENET, V108, P216, DOI 10.1007/s004390100467; Van Beneden K, 2001, J IMMUNOL, V166, P4302, DOI 10.4049/jimmunol.166.7.4302; Van Dort HM, 1998, J BIOL CHEM, V273, P14819, DOI 10.1074/jbc.273.24.14819; Wang CC, 2012, J VET MED SCI, V74, P17, DOI 10.1292/jvms.11-0345; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Williamson RC, 2008, J CELL SCI, V121, P3422, DOI 10.1242/jcs.035584; Yenchitsomanus Pa-Thai, 2005, J Mol Genet Med, V1, P49; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390; Zhang DC, 2000, BLOOD, V96, P2925; Zhou Z, 2005, BIOCHEMISTRY-US, V44, P15115, DOI 10.1021/bi050931t; Zhu QS, 2003, J BIOL CHEM, V278, P3112, DOI 10.1074/jbc.M207797200	45	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18521	18532		10.1074/jbc.M112.443325	http://dx.doi.org/10.1074/jbc.M112.443325			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23658022	Green Published, hybrid			2022-12-28	WOS:000320721900053
J	Ho, JCS; Storm, P; Rydstrom, A; Ben, BW; Alsin, F; Sullivan, L; Ambite, I; Mok, KH; Northen, T; Svanborg, C				Ho, James C. S.; Storm, Petter; Rydstrom, Anna; Ben Bowen; Alsin, Fredrik; Sullivan, Louise; Ambite, Ines; Mok, K. H.; Northen, Trent; Svanborg, Catharina			Lipids as Tumoricidal Components of Human alpha-Lactalbumin Made Lethal to Tumor Cells (HAMLET) UNIQUE AND SHARED EFFECTS ON SIGNALING AND DEATH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID UPTAKE; APOPTOSIS-LIKE MECHANISM; AP2 GENE-EXPRESSION; OLEIC-ACID; CYTOTOXIC COMPLEXES; FOURIER HOLOGRAPHY; EQUINE LYSOZYME; CANCER; PROTEIN; METABOLISM	Long-chain fatty acids are internalized by receptor-mediated mechanisms or receptor-independent diffusion across cytoplasmic membranes and are utilized as nutrients, building blocks, and signaling intermediates. Here we describe how the association of long-chain fatty acids to a partially unfolded, extracellular protein can alter the presentation to target cells and cellular effects. HAMLET ( human alpha-lactalbumin made lethal to tumor cells) is a tumoricidal complex of partially unfolded alpha-lactalbumin and oleic acid (OA). As OA lacks independent tumoricidal activity at concentrations equimolar to HAMLET, the contribution of the lipid has been debated. We show by natural abundance C-13 NMR that the lipid in HAMLET is deprotonated and by chromatography that oleate rather than oleic acid is the relevant HAMLET constituent. Compared with HAMLET, oleate ( 175 mu M) showed weak effects on ion fluxes and gene expression. Unlike HAMLET, which causes metabolic paralysis, fatty acid metabolites were less strongly altered. The functional overlap increased with higher oleate concentrations ( 500 mu M). Cellular responses to OA were weak or absent, suggesting that deprotonation favors cellular interactions of fatty acids. Fatty acids may thus exert some of their essential effects on host cells when in the deprotonated state and when presented in the context of a partially unfolded protein.	[Svanborg, Catharina] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol MIG, S-22362 Lund, Sweden; [Ben Bowen; Alsin, Fredrik; Northen, Trent] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Sullivan, Louise; Mok, K. H.] Trinity Coll Dublin, Inst Biomed Sci, Coll Green, Dublin 2, Ireland	Lund University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Trinity College Dublin	Svanborg, C (corresponding author), Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol MIG, Solvegatan 23, S-22362 Lund, Sweden.	catharina.svanborg@med.lu.se	Ambite, Ines/AAG-6615-2020; Ho, James CS/ADQ-2735-2022; Ho, James CS/AAF-8197-2022	Ho, James CS/0000-0002-6131-1297; Ho, James CS/0000-0002-6131-1297; Northen, Trent/0000-0001-8404-3259; Ambite, Ines/0000-0003-1470-671X; Rydstrom, Anna/0000-0002-3404-7195; Mok, K Hun/0000-0003-3663-2002; Storm, Petter/0000-0002-7655-3731	National Institutes of Health [U54 CA 112970]; Sharon D. Lund Foundation grant; American Cancer Society; Swedish Cancer Society; Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation; Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Danish Council for Independent Research (Medical Sciences); NATIONAL CANCER INSTITUTE [U54CA112970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sharon D. Lund Foundation grant; American Cancer Society(American Cancer Society); Swedish Cancer Society(Swedish Cancer Society); Medical Faculty (Lund University); Soderberg Foundation; Segerfalk Foundation; Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Lund City Jubileumsfond; John and Augusta Persson Foundation for Medical Research; Maggie Stephens Foundation; Gunnar Nilsson Cancer Foundation; Inga-Britt and Arne Lundberg Foundation; HJ Forssman Foundation for Medical Research; Royal Physiographic Society; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 CA 112970. This study was also supported by a Sharon D. Lund Foundation grant and by the American Cancer Society, the Swedish Cancer Society, the Medical Faculty (Lund University), the Soderberg Foundation, the Segerfalk Foundation, the Anna-Lisa and Sven-Erik Lundgren Foundation for Medical Research, the Knut and Alice Wallenberg Foundation, the Lund City Jubileumsfond, the John and Augusta Persson Foundation for Medical Research, the Maggie Stephens Foundation, the Gunnar Nilsson Cancer Foundation, the Inga-Britt and Arne Lundberg Foundation, and the HJ Forssman Foundation for Medical Research and the Royal Physiographic Society. Support was also obtained from the Danish Council for Independent Research (Medical Sciences).	Aits S, 2009, INT J CANCER, V124, P1008, DOI 10.1002/ijc.24076; AMRI EZ, 1991, J LIPID RES, V32, P1449; ANDERSON MP, 1990, P NATL ACAD SCI USA, V87, P7334, DOI 10.1073/pnas.87.18.7334; Baumann A, 2012, J MOL BIOL, V418, P90, DOI 10.1016/j.jmb.2012.02.006; Bhatt AP, 2012, P NATL ACAD SCI USA, V109, P11818, DOI 10.1073/pnas.1205995109; Brest P, 2007, CANCER RES, V67, P11327, DOI 10.1158/0008-5472.CAN-07-1153; Calder PC, 1997, ANN NUTR METAB, V41, P203, DOI 10.1159/000177997; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P1881, DOI 10.1021/bi00406a013; Covey SD, 2007, BIOCHEM BIOPH RES CO, V355, P67, DOI 10.1016/j.bbrc.2007.01.135; Cuche E, 1999, OPT LETT, V24, P291, DOI 10.1364/OL.24.000291; Das UN, 2005, PROSTAG LEUKOTR ESS, V72, P173, DOI 10.1016/j.plefa.2004.10.016; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DISTEL RJ, 1992, J BIOL CHEM, V267, P5937; Dubois F, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2357174; Duringer C, 2003, J BIOL CHEM, V278, P42131, DOI 10.1074/jbc.M306462200; Fischer W, 2004, CANCER RES, V64, P2105, DOI 10.1158/0008-5472.CAN-03-2661; GRIMALDI PA, 1992, P NATL ACAD SCI USA, V89, P10930, DOI 10.1073/pnas.89.22.10930; Gustafsson L, 2004, NEW ENGL J MED, V350, P2663, DOI 10.1056/NEJMoa032454; Gustafsson L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005229; Gustafsson M, 2004, OPT LASER ENG, V41, P553, DOI 10.1016/S0143-8166(02)00214-2; Hajri T, 2002, ANNU REV NUTR, V22, P383, DOI 10.1146/annurev.nutr.22.020402.130846; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kanicky JR, 2002, J COLLOID INTERF SCI, V256, P201, DOI 10.1006/jcis.2001.8009; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Liskova K, 2011, EUR J LIPID SCI TECH, V113, P1207, DOI 10.1002/ejlt.201100109; Liskova K, 2010, J AGR FOOD CHEM, V58, P4421, DOI 10.1021/jf903901j; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Mashek DG, 2006, CURR OPIN LIPIDOL, V17, P274, DOI 10.1097/01.mol.0000226119.20307.2b; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Mossberg AK, 2010, J UROLOGY, V183, P1590, DOI 10.1016/j.juro.2009.12.008; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; NOZAKA M, 1978, BIOCHEMISTRY-US, V17, P3753, DOI 10.1021/bi00611a013; PERMYAKOV EA, 1985, BIOPHYS CHEM, V21, P21, DOI 10.1016/0301-4622(85)85003-1; Permyakovz SE, 2012, BIOL CHEM, V393, P85, DOI 10.1515/BC-2011-230; Pettersson J, 2006, BIOCHEM BIOPH RES CO, V345, P260, DOI 10.1016/j.bbrc.2006.04.081; Pettersson-Kastberg J, 2009, J MOL BIOL, V394, P994, DOI 10.1016/j.jmb.2009.09.026; Pettersson-Kastberg J, 2009, ANN MED, V41, P162, DOI 10.1080/07853890802502614; Pohl J, 2004, BIOCHEMISTRY-US, V43, P4179, DOI 10.1021/bi035743m; Puthia M, 2014, GUT, V63, P131, DOI 10.1136/gutjnl-2012-303715; Schnars U., 2005, DIGITAL HOLOGRAPHY D; Sebesta M, 2005, OPT LETT, V30, P471, DOI 10.1364/OL.30.000471; Storm P, 2011, ONCOGENE, V30, P4765, DOI 10.1038/onc.2011.196; Storm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058578; Svanborg C, 2003, ADV CANCER RES, V88, P1; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 2003, PROTEIN SCI, V12, P2805, DOI 10.1110/ps.0231103; Svensson M, 2003, PROTEIN SCI, V12, P2794, DOI 10.1110/ps.0231003; Tolin S, 2010, FEBS J, V277, P163, DOI 10.1111/j.1742-4658.2009.07466.x; Vukojevic V, 2010, LANGMUIR, V26, P14782, DOI 10.1021/la1026416; Wilhelm K, 2009, FEBS J, V276, P3975, DOI 10.1111/j.1742-4658.2009.07107.x; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zherelova OM, 2009, J BIOENERG BIOMEMBR, V41, P229, DOI 10.1007/s10863-009-9222-x	58	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17460	17471		10.1074/jbc.M113.468405	http://dx.doi.org/10.1074/jbc.M113.468405			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629662	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000320380600038
J	Li, J; Zhang, YJ; Liu, YC; Dai, X; Li, WY; Cai, X; Yin, Y; Wang, Q; Xue, YX; Wang, C; Li, DM; Hou, DX; Jiang, XH; Zhang, JF; Zen, K; Chen, X; Zhang, CY				Li, Jing; Zhang, Yujing; Liu, Yuchen; Dai, Xin; Li, Wenyang; Cai, Xing; Yin, Yuan; Wang, Qiang; Xue, Yunxing; Wang, Cheng; Li, Dameng; Hou, Dongxia; Jiang, Xiaohong; Zhang, Junfeng; Zen, Ke; Chen, Xi; Zhang, Chen-Yu			Microvesicle-mediated Transfer of MicroRNA-150 from Monocytes to Endothelial Cells Promotes Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYB; DISEASES; OBESITY; MACROPHAGES; MECHANISMS; MIGRATION; CANCER; TARGET	Recent studies by our group and others show that microRNAs can be actively secreted into the extracellular environment through microvesicles (MVs) and function as secretory signaling molecules that influence the recipient cell phenotypes. Here we investigate the role of monocyte-secreted miR-150 in promoting the capillary tube formation of endothelial cells and in enhancing angiogenesis. In vitro capillary tube formation and in vivo angiogenesis assays showed that monocyte-derived MVs have strong pro-angiogenic activities. By depleting miR-150 from monocytic MVs and increasing miR-150 in MVs derived from cells that normally contain low levels of miR-150, we further demonstrated that the miR-150 content accounted for the pro-angiogenic activity of monocytic MVs in these assays. Using tumor-implanted mice and ob/ob mice as models, we revealed that miR-150 secretion, which is increased for diseases such as cancers and diabetes, significantly promotes angiogenesis. The delivery of anti-miR-150 antisense oligonucleotides into tumor-implanted mice and ob/ob mice via MVs, however, strongly reduced angiogenesis in both types of mice. Our results collectively demonstrate that secretion of miR-150 via MVs can promote angiogenesis in vitro and in vivo, and we also present a novel microRNA-based therapeutic approach for disease treatment.	[Li, Jing; Zhang, Yujing; Liu, Yuchen; Li, Wenyang; Cai, Xing; Yin, Yuan; Wang, Cheng; Li, Dameng; Hou, Dongxia; Jiang, Xiaohong; Zhang, Junfeng; Zen, Ke; Chen, Xi; Zhang, Chen-Yu] Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Dai, Xin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Gastroenterol, Shanghai 200025, Peoples R China; [Wang, Qiang; Xue, Yunxing] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Thorac Surg, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Shanghai Jiao Tong University; Nanjing University	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, 22 Hankou Rd, Nanjing 210093, Jiangsu, Peoples R China.	kzen@nju.edu.cn; xichen@nju.edu.cn; cyzhang@nju.edu.cn	Wang, Cheng/O-7206-2016; 殷, 媛/GSE-4523-2022; Yin, Yuan/AAG-1707-2020	Wang, Cheng/0000-0002-1834-2119; Liu, Yuchen/0000-0001-8922-9976	National Natural Science Foundation of China [31200969, 31200874, 81101330, 31271378, 81250044]; National Science Fund for Distinguished Young Scholars [81025019]; Natural Science Foundation of Jiangsu Province [BK2011013, BK2012014]; program for New Century Excellent Talents in University from the Ministry of Education, China [NCET-12-0261]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); program for New Century Excellent Talents in University from the Ministry of Education, China	This work was supported by National Natural Science Foundation of China Grants 31200969, 31200874, 81101330, 31271378, and 81250044, National Science Fund for Distinguished Young Scholars Grant 81025019, and Natural Science Foundation of Jiangsu Province Grants BK2011013 and BK2012014. This work was also supported by the program for New Century Excellent Talents in University from the Ministry of Education, China (NCET-12-0261).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Dirkx AEM, 2006, J LEUKOCYTE BIOL, V80, P1183, DOI 10.1189/jlb.0905495; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Malinda Katherine M., 2009, V467, P287, DOI 10.1007/978-1-59745-241-0_17; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Moldovan L, 2005, EXP SUPPL, V94, P127; Moldovan NI, 2002, J HEMATOTH STEM CELL, V11, P179, DOI 10.1089/152581602753658394; Naldini Antonella, 2005, Current Drug Targets - Inflammation and Allergy, V4, P3, DOI 10.2174/1568010053622830; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	22	146	165	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23586	23596		10.1074/jbc.M113.489302	http://dx.doi.org/10.1074/jbc.M113.489302			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23766514	hybrid, Green Published			2022-12-28	WOS:000330598200062
J	Kim, HS; Montana, V; Jang, HJ; Parpura, V; Kim, JA				Kim, Hae-Suk; Montana, Vedrana; Jang, Hyun-Ju; Parpura, Vladimir; Kim, Jeong-a			Epigallocatechin Gallate (EGCG) Stimulates Autophagy in Vascular Endothelial Cells A POTENTIAL ROLE FOR REDUCING LIPID ACCUMULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GREEN TEA POLYPHENOL; ENDOPLASMIC-RETICULUM STRESS; MAMMALIAN AUTOPHAGY; INSULIN-RESISTANCE; ENERGETIC BALANCE; GLUTAMATE RELEASE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; METABOLISM	Epigallocatechin gallate (EGCG) is a major polyphenol in green tea that has beneficial effects in the prevention of cardiovascular disease. Autophagy is a cellular process that protects cells from stressful conditions. To determine whether the beneficial effect of EGCG is mediated by a mechanism involving autophagy, the roles of the EGCG-stimulated autophagy in the context of ectopic lipid accumulation were investigated. Treatment with EGCG increased formation of LC3-II and autophagosomes in primary bovine aortic endothelial cells (BAEC). Activation of calmodulin-dependent protein kinase kinase beta was required for EGCG-induced LC3-II formation, as evidenced by the fact that EGCG-induced LC3-II formation was significantly impaired by knockdown of calmodulin-dependent protein kinase kinase beta. This effect is most likely due to cytosolic Ca2+ load. To determine whether EGCG affects palmitate-induced lipid accumulation, the effects of EGCG on autophagic flux and co-localization of lipid droplets and autophagolysosomes were examined. EGCG normalized the palmitate-induced impairment of autophagic flux. Accumulation of lipid droplets by palmitate was markedly reduced by EGCG. Blocking autophagosomal degradation opposed the effect of EGCG in ectopic lipid accumulation, suggesting the action of EGCG is through autophagosomal degradation. The mechanism for this could be due to the increased co-localization of lipid droplets and autophagolysosomes. Co-localization of lipid droplets with LC3 and lysosome was dramatically increased when the cells were treated with EGCG and palmitate compared with the cells treated with palmitate alone. Collectively, these findings suggest that EGCG regulates ectopic lipid accumulation through a facilitated autophagic flux and further imply that EGCG may be a potential therapeutic reagent to prevent cardiovascular complications.	[Kim, Hae-Suk; Jang, Hyun-Ju; Kim, Jeong-a] Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA; [Kim, Jeong-a] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Civitan Int Res Ctr,Dept Mol Cellular Pathol, Ctr Glial Biol Med,Atom Force Microscopy & Nanote, Birmingham, AL 35294 USA; [Montana, Vedrana; Parpura, Vladimir] Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Civitan Int Res Ctr,Dept Neurobiol, Ctr Glial Biol Med,Atom Force Microscopy & Nanote, Birmingham, AL 35294 USA; [Kim, Jeong-a] Univ Alabama Birmingham, Comprehens Diabet Ctr, Birmingham, AL 35294 USA; [Parpura, Vladimir] Univ Rijeka, Dept Biotechnol, Rijeka 51000, Croatia	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Rijeka	Kim, JA (corresponding author), Univ Alabama Birmingham, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA.	jakim@uab.edu			National Institutes of Health [P60 DK-079626]; American Diabetes Association [1-09-JF-33, 1-12-BS-99]; American Heart Association [13GRNT17220057]; National Science Foundation [CBET 0943343]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P60 DK-079626 (to University of Alabama at Birmingham Diabetes Research Training Center-sponsored Pilot and Feasibility Program). This work was also supported by American Diabetes Association Grants 1-09-JF-33 and 1-12-BS-99 (to J. K.), American Heart Association Grant 13GRNT17220057 (to J. K.), and National Science Foundation Grant CBET 0943343 (to V. P.).	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; Ahn J, 2008, J HEPATOL, V49, P1019, DOI 10.1016/j.jhep.2008.08.012; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2006, AUTOPHAGY, V2, P138, DOI 10.4161/auto.2.2.2405; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Chen D, 2012, BIOORGAN MED CHEM, V20, P3031, DOI 10.1016/j.bmc.2012.03.002; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052347; Chimal-Monroy J, 2011, IUBMB LIFE, V63, P922, DOI 10.1002/iub.563; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; de Boer VCJ, 2006, MECH AGEING DEV, V127, P618, DOI 10.1016/j.mad.2006.02.007; De Meyer GRY, 2009, BBA-MOL CELL RES, V1793, P1485, DOI 10.1016/j.bbamcr.2008.12.011; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332, DOI 10.5551/jat.3939; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Huang CH, 2009, MOL NUTR FOOD RES, V53, P1156, DOI 10.1002/mnfr.200800592; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Kim JA, 2007, J BIOL CHEM, V282, P13736, DOI 10.1074/jbc.M609725200; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kolattukudy PE, 2012, CIRC RES, V110, P174, DOI 10.1161/CIRCRESAHA.111.243212; Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255; Lara-Castro C, 2008, ENDOCRIN METAB CLIN, V37, P841, DOI 10.1016/j.ecl.2008.09.002; Las G, 2011, J BIOL CHEM, V286, P42534, DOI 10.1074/jbc.M111.242412; Lee JHW, 2009, J HYDRO-ENVIRON RES, V3, P1, DOI 10.1016/j.jher.2009.05.002; Lee MS, 2009, PHYTOTHER RES, V23, P1088, DOI 10.1002/ptr.2737; Lee William, 2008, Front Neuroeng, V1, P2, DOI 10.3389/neuro.16.002.2008; Li W, 2011, BIOCHEM PHARMACOL, V81, P1152, DOI 10.1016/j.bcp.2011.02.015; Malarkey EB, 2008, GLIA, V56, P821, DOI 10.1002/glia.20656; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Montana V, 2004, J NEUROSCI, V24, P2633, DOI 10.1523/JNEUROSCI.3770-03.2004; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Potenza MA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1378, DOI 10.1152/ajpendo.00698.2006; Racioppi L, 2012, J BIOL CHEM, V287, P31658, DOI 10.1074/jbc.R112.356485; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reiter CEN, 2010, ENDOCRINOLOGY, V151, P103, DOI 10.1210/en.2009-0997; Reyes RC, 2009, NEUROCHEM INT, V55, P2, DOI 10.1016/j.neuint.2008.12.018; Rodriguez-Navarro JA, 2012, P NATL ACAD SCI USA, V109, pE705, DOI 10.1073/pnas.1113036109; Satoh M, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-19; Shang LB, 2011, AUTOPHAGY, V7, P924, DOI 10.4161/auto.7.8.15860; Singh R, 2011, AGING-US, V3, P934, DOI 10.18632/aging.100393; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Singh R, 2010, RESULTS PROBL CELL D, V52, P35, DOI 10.1007/978-3-642-14426-4_4; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Sohle J, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-20; Sridhar S, 2012, J PATHOL, V226, P255, DOI 10.1002/path.3025; Stout RF, 2011, CELL CALCIUM, V50, P98, DOI 10.1016/j.ceca.2011.05.016; Suganami T, 2012, ENDOCR J, V59, P849, DOI 10.1507/endocrj.EJ12-0271; Tan SH, 2012, J BIOL CHEM, V287, P14364, DOI 10.1074/jbc.M111.294157; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Weidberg H, 2009, DEV CELL, V16, P628, DOI 10.1016/j.devcel.2009.05.001; Witczak CA, 2007, DIABETES, V56, P1403, DOI 10.2337/db06-1230; Younce C, 2012, CELL PHYSIOL BIOCHEM, V30, P307, DOI 10.1159/000339066; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046749; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009	65	141	153	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22693	22705		10.1074/jbc.M113.477505	http://dx.doi.org/10.1074/jbc.M113.477505			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23754277	hybrid, Green Published			2022-12-28	WOS:000330596300048
J	Lee, JKH; Pearson, JD; Maser, BE; Ingham, RJ				Lee, Jason K. H.; Pearson, Joel D.; Maser, Brandon E.; Ingham, Robert J.			Cleavage of the JunB Transcription Factor by Caspases Generates a Carboxyl-terminal Fragment That Inhibits Activator Protein-1 Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AP-1 Transcription Factor; Apoptosis; Caspase; Gene Transcription; Jun Transcription Factor; Inflammasome	LARGE-CELL LYMPHOMA; NF-KAPPA-B; REED-STERNBERG CELLS; C-JUN; NPM-ALK; DOWN-REGULATION; MEDIATED CLEAVAGE; HODGKIN LYMPHOMA; CD30 PROMOTER; IN-VITRO	The activator protein-1 (AP-1) family transcription factor, JunB, is an important regulator of proliferation, apoptosis, differentiation, and the immune response. In this report, we show that JunB is cleaved in a caspase-dependent manner in apoptotic anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma cell lines and that ectopically expressed JunB is cleaved in murine RAW 264.7 macrophage cells treated with the NALP1b inflammasome activator, anthrax lethal toxin. In both cases, we identify aspartic acid 137 as the caspase cleavage site and demonstrate that JunB can be directly cleaved in vitro by multiple caspases at this site. Cleavage of JunB at aspartic acid 137 separates the N-terminal transactivation domain from the C-terminal DNA binding and dimerization domains, and we show that the C-terminal cleavage fragment retains both DNA binding activity and the ability to interact with AP-1 family transcription factors. Furthermore, this fragment interferes with the binding of full-length JunB to AP-1 sites and inhibits AP-1-dependent transcription. In summary, we have identified and characterized a novel mechanism of JunB post-translational modification and demonstrate that the C-terminal JunB caspase cleavage product functions as a potent inhibitor of AP-1-dependent transcription.	[Lee, Jason K. H.; Pearson, Joel D.; Maser, Brandon E.; Ingham, Robert J.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB T6G 2E1, Canada	University of Alberta	Ingham, RJ (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Katz Grp Ctr Pharm & Hlth Res 6 065, Edmonton, AB T6G 2E1, Canada.	ringham@ualberta.ca	Pearson, Joel/AFK-9248-2022	Maser, Brandon/0000-0002-9427-0022; Lee, Jason/0000-0001-8875-607X	Natural Sciences and Engineering Research Council of Canada; Alberta Cancer Foundation/Alberta Innovates Health Solutions	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Cancer Foundation/Alberta Innovates Health Solutions	This work was supported by operating grants from the Natural Sciences and Engineering Research Council of Canada and the Alberta Cancer Foundation/Alberta Innovates Health Solutions (to R.J.I.).	Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Barkett M, 2001, BBA-GEN SUBJECTS, V1526, P25, DOI 10.1016/S0304-4165(01)00092-7; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BROWN PH, 1994, ONCOGENE, V9, P791; BROWN PH, 1993, ONCOGENE, V8, P877; Caffrey DR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-381; Charvet C, 2003, ONCOGENE, V22, P4557, DOI 10.1038/sj.onc.1206778; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; CHIU R, 1989, CELL, V59, P979, DOI 10.1016/0092-8674(89)90754-X; Cordoba-Rodriguez R, 2004, J BIOL CHEM, V279, P20563, DOI 10.1074/jbc.C300539200; Darnowski JW, 2006, J BIOL CHEM, V281, P17707, DOI 10.1074/jbc.M600088200; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Drakos E, 2004, MODERN PATHOL, V17, P109, DOI 10.1038/modpathol.3800039; Farras R, 2008, MOL CELL BIOL, V28, P4173, DOI 10.1128/MCB.01620-07; Flygare J, 2000, EUR J BIOCHEM, V267, P5977, DOI 10.1046/j.1432-1327.2000.01675.x; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Han Y, 2006, LEUKEMIA, V20, P1602, DOI 10.1038/sj.leu.2404323; HIRAI SI, 1989, EMBO J, V8, P1433, DOI 10.1002/j.1460-2075.1989.tb03525.x; Hsu FYY, 2007, CANCER INVEST, V25, P240, DOI 10.1080/07357900701206372; Inghirami G, 2011, SEMIN DIAGN PATHOL, V28, P190, DOI 10.1053/j.semdp.2011.03.002; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; King P, 1998, J BIOL CHEM, V273, P8699, DOI 10.1074/jbc.273.15.8699; Krippner-Heidenreich A, 2005, MOL CELL BIOL, V25, P3704, DOI 10.1128/MCB.25.9.3704-3714.2005; Laimer D, 2012, NAT MED, V18, P1699, DOI 10.1038/nm.2966; Levkau B, 1999, NAT CELL BIOL, V1, P227, DOI 10.1038/12050; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; Mathas S, 2002, EMBO J, V21, P4104, DOI 10.1093/emboj/cdf389; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Narayanan K, 2004, J BIOL CHEM, V279, P44294, DOI 10.1074/jbc.M403511200; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; Passegue E, 2002, NAT GENET, V30, P158, DOI 10.1038/ng790; Pearson JD, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-229; Pearson JD, 2011, INT J CLIN EXP PATHO, V4, P124; Perez-Benavente B, 2013, ONCOGENE, V32, P2189, DOI 10.1038/onc.2012.235; Rassidakis GZ, 2005, MODERN PATHOL, V18, P1365, DOI 10.1038/modpathol.3800419; Ravi R, 1998, CANCER RES, V58, P882; Schonthaler HB, 2011, ANN RHEUM DIS, V70, pI109, DOI 10.1136/ard.2010.140533; Schorpp-Kistner M, 1999, EMBO J, V18, P934, DOI 10.1093/emboj/18.4.934; SCHUTTE J, 1989, CELL, V59, P987, DOI 10.1016/0092-8674(89)90755-1; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Staber PB, 2007, BLOOD, V110, P3374, DOI 10.1182/blood-2007-02-071258; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Watanabe M, 2003, AM J PATHOL, V163, P633, DOI 10.1016/S0002-9440(10)63690-5; Watanabe M, 2005, CANCER RES, V65, P7628, DOI 10.1158/0008-5472.CAN-05-0925; Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x; Zhao M, 2009, BIOCHEM BIOPH RES CO, V382, P508, DOI 10.1016/j.bbrc.2009.03.024	52	5	5	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21482	21495		10.1074/jbc.M113.485672	http://dx.doi.org/10.1074/jbc.M113.485672			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23749999	Green Published, hybrid			2022-12-28	WOS:000328841900002
J	Baines, A; Parkinson, K; Sim, JA; Bragg, L; Thompson, CRL; North, RA				Baines, Abigail; Parkinson, Katie; Sim, Joan A.; Bragg, Laricia; Thompson, Christopher R. L.; North, R. Alan			Functional Properties of Five Dictyostelium discoideum P2X Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE VACUOLE; ATP; ACTIVATION; CHANNELS; OSMOREGULATION; MECHANISM	The Dictyostelium discoideum genome encodes five proteins that share weak sequence similarity with vertebrate P2X receptors. Unlike vertebrate P2X receptors, these proteins are not expressed on the surface of cells, but populate the tubules and bladders of the contractile vacuole. In this study, we expressed humanized cDNAs of P2XA, P2XB, P2XC, P2XD, and P2XE in human embryonic kidney cells and altered the ionic and proton environment in an attempt to reflect the situation in amoeba. Recording of whole-cell membrane currents showed that four receptors operated as ATP-gated channels (P2XA, P2XB, P2XD, and P2XE). At P2XA receptors, ATP was the only effective agonist of 17 structurally related putative ligands that were tested. Extracellular sodium, compared with potassium, strongly inhibited ATP responses in P2XB, P2XD, and P2XE receptors. Increasing the proton concentration (pH 6.2) accelerated desensitization at P2XA receptors and decreased currents at P2XD receptors, but increased the currents at P2XB and P2XE receptors. Dictyostelium lacking P2XA receptors showed impaired regulatory volume decrease in hypotonic solution. This phenotype was readily rescued by overexpression of P2XA and P2XD receptors, partially rescued by P2XB and P2XE receptors, and not rescued by P2XC receptors. The failure of the nonfunctional receptor P2XC to restore the regulatory volume decrease highlights the importance of ATP activation of P2X receptors for a normal response to hypo-osmotic shock, and the weak rescue by P2XB and P2XE receptors indicates that there is limited functional redundancy among Dictyostelium P2X receptors.	[Baines, Abigail; Parkinson, Katie; Thompson, Christopher R. L.; North, R. Alan] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Sim, Joan A.; Bragg, Laricia; North, R. Alan] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Thompson, CRL (corresponding author), Univ Manchester, Michael Smith Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.	christopher.thompson@manchester.ac.uk; r.a.north@manchester.ac.uk	North, Richard/GQA-6156-2022		Medial Research Council; Wellcome Trust [095643/Z/11/Z09]; MRC [G0900069] Funding Source: UKRI; Medical Research Council [G0900069] Funding Source: researchfish	Medial Research Council; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the Medial Research Council (to C. R. L. T. and R. A. N.) and a Wellcome Trust Investigator Award 095643/Z/11/Z09 (to C. R. L. T.).	Allen RD, 2000, BIOESSAYS, V22, P1035; Becker M, 1999, EMBO J, V18, P3305, DOI 10.1093/emboj/18.12.3305; Browne LE, 2011, NAT NEUROSCI, V14, P17, DOI 10.1038/nn.2705; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Bush J, 1996, MOL BIOL CELL, V7, P1623, DOI 10.1091/mbc.7.10.1623; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Essid M, 2012, MOL BIOL CELL, V23, P1267, DOI 10.1091/mbc.E11-06-0576; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Gabriel D, 1999, J CELL SCI, V112, P3995; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Ludlow MJ, 2009, J BIOL CHEM, V284, P35227, DOI 10.1074/jbc.M109.045674; Malchow D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-31; Moreno SNJ, 2009, J EUKARYOT MICROBIOL, V56, P208, DOI 10.1111/j.1550-7408.2009.00404.x; NOLTA KV, 1994, J BIOL CHEM, V269, P2225; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; PATTERSON DJ, 1980, BIOL REV, V55, P1, DOI 10.1111/j.1469-185X.1980.tb00686.x; RIDDICK DH, 1968, AM J PHYSIOL, V215, P736, DOI 10.1152/ajplegacy.1968.215.3.736; Sivaramakrishnan V, 2013, CHANNELS, V7, P43, DOI 10.4161/chan.22737; Sivaramakrishnan V, 2012, J BIOL CHEM, V287, P28315, DOI 10.1074/jbc.M112.372565; Stelmashenko O, 2012, MOL PHARMACOL, V82, P760, DOI 10.1124/mol.112.080903; Stoop R, 1997, J NEUROPHYSIOL, V78, P1837, DOI 10.1152/jn.1997.78.4.1837; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; Temesvari LA, 1996, J CELL SCI, V109, P1479	27	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20992	21000		10.1074/jbc.M112.445346	http://dx.doi.org/10.1074/jbc.M112.445346			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23740252	Green Published, hybrid			2022-12-28	WOS:000322014400021
J	Frazier, SJ; Cohen, BN; Lester, HA				Frazier, Shawnalea J.; Cohen, Bruce N.; Lester, Henry A.			An Engineered Glutamate-gated Chloride (GluCl) Channel for Sensitive, Consistent Neuronal Silencing by Ivermectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER RETENTION SIGNAL; ACETYLCHOLINE-RECEPTOR; ENDOPLASMIC-RETICULUM; SURFACE EXPRESSION; GABA(B) RECEPTOR; M2 DOMAIN; ACTIVATION; PROTEINS; IDENTIFICATION; MUTATION	A modified invertebrate glutamate-gated Cl- channel (GluCl alpha beta) was previously employed to allow pharmacologically induced silencing of electrical activity in CNS neurons upon exposure to the anthelmintic drug ivermectin (IVM). Usefulness of the previous receptor was limited by 1) the high concentration of IVM necessary to elicit a consistent silencing phenotype, raising concern about potential side effects, and 2) the variable extent of neuronal spike suppression, due to variations in the co-expression levels of the fluorescent protein-tagged alpha and beta subunits. To address these issues, mutant receptors generated via rational protein engineering strategies were examined for improvement. Introduction of a gain-of-function mutation (L9'F) in the second transmembrane domain of the alpha subunit appears to facilitate beta subunit incorporation and substantially increase heteromeric GluCl alpha beta sensitivity to IVM. Removal of an arginine-based endoplasmic reticulum retention motif (RSR mutated to AAA) from the intracellular loop of the beta subunit further promotes heteromeric expression at the plasma membrane possibly by preventing endoplasmic reticulum-associated degradation of the beta subunit rather than simply reducing endoplasmic reticulum retention. A monomeric XFP (mXFP) mutation that prevents fluorescent protein dimerization complements the mutant channel effects. Expression of the newly engineered GluCl opt alpha-mXFP L9'F + opt beta-mXFP Y182F RSR_ AAA receptor in dissociated neuronal cultures markedly increases conductance and reduces variability in spike suppression at 1 nM IVM. This receptor, named "GluClv2.0," is an improved tool for IVM-induced silencing.	[Frazier, Shawnalea J.] CALTECH, Pasadena, CA 91125 USA; [Frazier, Shawnalea J.; Cohen, Bruce N.; Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Lester, HA (corresponding author), CALTECH, Div Biol, MC 156-29,1200 E Calif Blvd, Pasadena, CA 91125 USA.	lester@caltech.edu			National Institutes of Health [NS034407, EY018502, MH088550]; McKnight Foundation; NATIONAL EYE INSTITUTE [R21EY018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC1MH088550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034407, R37NS034407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS034407, EY018502, and MH088550. This work was also supported by the McKnight Foundation.	Adelsberger H, 2000, EUR J PHARMACOL, V394, P163, DOI 10.1016/S0014-2999(00)00164-3; Bertrand S, 1997, NEUROREPORT, V8, P3591, DOI 10.1097/00001756-199711100-00034; Bianchi MT, 2001, NEUROPHARMACOLOGY, V41, P737, DOI 10.1016/S0028-3908(01)00132-0; BLOUNT P, 1990, J CELL BIOL, V111, P2613, DOI 10.1083/jcb.111.6.2613; Bonifacino J. S., 1991, CURR OPIN CELL BIOL, V3, P592; BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; Boyd GW, 2003, J BIOL CHEM, V278, P27681, DOI 10.1074/jbc.M304938200; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Burdett EC, 1997, CONTEMP TOP LAB ANIM, V36, P73; Chang YC, 1999, BIOPHYS J, V77, P2542, DOI 10.1016/S0006-3495(99)77089-X; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; CULLY DF, 1994, NATURE, V371, P707, DOI 10.1038/371707a0; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FILATOV GN, 1995, MOL PHARMACOL, V48, P379; Gleitsman KR, 2009, BIOPHYS J, V96, P3168, DOI 10.1016/j.bpj.2008.12.3949; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Green WN, 1999, J GEN PHYSIOL, V113, P163, DOI 10.1085/jgp.113.2.163; Haubensak W, 2010, NATURE, V468, P270, DOI 10.1038/nature09553; Herman MA, 2007, J NEUROSCI, V27, P9736, DOI 10.1523/JNEUROSCI.3009-07.2007; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Kearney PC, 1996, NEURON, V17, P1221, DOI 10.1016/S0896-6273(00)80252-4; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; KLAUSNER RD, 1990, CELL, V62, P611, DOI 10.1016/0092-8674(90)90104-M; Kosolapov AV, 2000, J MEMBRANE BIOL, V174, P191, DOI 10.1007/s002320001043; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Li YX, 1998, J NEUROSCI, V18, P10231; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lynagh T, 2010, J BIOL CHEM, V285, P14890, DOI 10.1074/jbc.M110.107789; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; MERLIE JP, 1983, CELL, V34, P747, DOI 10.1016/0092-8674(83)90531-7; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Moroni M, 2006, J MOL NEUROSCI, V30, P95, DOI 10.1385/JMN:30:1:95; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nelson ME, 2003, MOL PHARMACOL, V63, P332, DOI 10.1124/mol.63.2.332; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Pan ZH, 1997, P NATL ACAD SCI USA, V94, P6490, DOI 10.1073/pnas.94.12.6490; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Shan Q, 2003, J NEUROCHEM, V86, P498, DOI 10.1046/j.1471-4159.2003.01872.x; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Slimko EM, 2002, J NEUROSCI, V22, P7373; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Thompson SA, 1999, BRIT J PHARMACOL, V127, P1349, DOI 10.1038/sj.bjp.0702687; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zacharias David A, 2002, Sci STKE, V2002, ppe23, DOI 10.1126/stke.2002.131.pe23; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhou Y, 2003, J NEUROSCI, V23, P9004	67	30	30	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21029	21042		10.1074/jbc.M112.423921	http://dx.doi.org/10.1074/jbc.M112.423921			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23720773	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000322014400024
J	Cui, GY; Freeman, CS; Knotts, T; Prince, CZ; Kuang, C; McCarty, NA				Cui, Guiying; Freeman, Cody S.; Knotts, Taylor; Prince, Chengyu Z.; Kuang, Christopher; McCarty, Nael A.			Two Salt Bridges Differentially Contribute to the Maintenance of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Channel Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL; VOLTAGE SENSOR; PORE ARCHITECTURE; PERMEANT IONS; ACTIVATION; MUTATIONS; ALTER; TRANSPORTER; INHIBITION; DOMAINS	Previous studies have identified two salt bridges in human CFTR chloride ion channels, Arg(352)-Asp(993) and Arg(347)-Asp(924), that are required for normal channel function. In the present study, we determined how the two salt bridges cooperate to maintain the open pore architecture of CFTR. Our data suggest that Arg(347) not only interacts with Asp(924) but also interacts with Asp(993). The tripartite interaction Arg(347)-Asp(924)-Asp(993) mainly contributes to maintaining a stable s2 open subconductance state. The Arg352-Asp993 salt bridge, in contrast, is involved in stabilizing both the s2 and full (f) open conductance states, with the main contribution being to the f state. The s1 subconductance state does not require either salt bridge. In confirmation of the role of Arg(352) and Asp(993), channels bearing cysteines at these sites could be latched into a full open state using the bifunctional cross-linker 1,2-ethanediyl bismethanethiosulfonate, but only when applied in the open state. Channels remained latched open even after washout of ATP. The results suggest that these interacting residues contribute differently to stabilizing the open pore in different phases of the gating cycle.	[McCarty, Nael A.] Emory Univ, Sch Med, Div Pulmonol Allergy Immunol Cyst Fibrosis & Slee, Cyst Fibrosis Res Ctr,Dept Pediat, Atlanta, GA 30322 USA; Childrens Healthcare Atlanta, Atlanta, GA 30322 USA	Emory University; Children's Healthcare of Atlanta (CHOA)	McCarty, NA (corresponding author), Emory Univ, Sch Med, Div Pulmonol Allergy Immunol Cyst Fibrosis & Slee, Cyst Fibrosis Res Ctr,Dept Pediat, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	namccar@emory.edu			National Institutes of Health Grant [R01-DK056481]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056481, R01DK075016] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-DK056481 (to N. M.).	Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Bai YH, 2011, J GEN PHYSIOL, V138, P495, DOI 10.1085/jgp.201110705; Bai YH, 2010, J GEN PHYSIOL, V136, P293, DOI 10.1085/jgp.201010480; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Craven KB, 2008, J BIOL CHEM, V283, P14728, DOI 10.1074/jbc.M710463200; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; Cui GY, 2012, PFLUG ARCH EUR J PHY, V463, P405, DOI 10.1007/s00424-011-1035-1; Dawson DC, 1997, J GEN PHYSIOL, V110, P337, DOI 10.1085/jgp.110.4.337; DeCaen PG, 2011, P NATL ACAD SCI USA, V108, P18825, DOI 10.1073/pnas.1116449108; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Fuller MD, 2007, J BIOL CHEM, V282, P37545, DOI 10.1074/jbc.M708079200; Fuller MD, 2005, BIOPHYS J, V89, P3960, DOI 10.1529/biophysj.105.060731; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Holstead RG, 2011, J MEMBRANE BIOL, V243, P15, DOI 10.1007/s00232-011-9388-0; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; Kunzelmann K, 1997, FEBS LETT, V400, P341, DOI 10.1016/S0014-5793(96)01414-7; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; MARCHAIS D, 1979, J PHYSIOL-LONDON, V297, P9, DOI 10.1113/jphysiol.1979.sp013025; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Moroni A, 2006, NAT CHEM BIOL, V2, P572, DOI 10.1038/nchembio1106-572; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; RIORDAN JR, 1989, SCIENCE, V245, P1066; RIORDAN JR, 1992, BIOCHIM BIOPHYS ACTA, V1101, P221, DOI 10.1016/0005-2728(92)90230-Y; Schneggenburger R, 1997, NEURON, V18, P167, DOI 10.1016/S0896-6273(01)80055-6; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Wang WY, 2011, J GEN PHYSIOL, V138, P165, DOI 10.1085/jgp.201110605; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200; Zhang ZR, 2005, J BIOL CHEM, V280, P458, DOI 10.1074/jbc.M409626200	35	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20758	20767		10.1074/jbc.M113.476226	http://dx.doi.org/10.1074/jbc.M113.476226			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23709221	Green Published, hybrid			2022-12-28	WOS:000321715100060
J	Jelk, J; Gao, NG; Serricchio, M; Signorell, A; Schmidt, RS; Bangs, JD; Acosta-Serrano, A; Lehrman, MA; Butikofer, P; Menon, AK				Jelk, Jennifer; Gao, Ningguo; Serricchio, Mauro; Signorell, Aita; Schmidt, Remo S.; Bangs, James D.; Acosta-Serrano, Alvaro; Lehrman, Mark A.; Buetikofer, Peter; Menon, Anant K.			Glycoprotein Biosynthesis in a Eukaryote Lacking the Membrane Protein Rft1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASSISTED CARBOHYDRATE ELECTROPHORESIS; LIPID-LINKED OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; TRYPANOSOMA-BRUCEI; N-GLYCOSYLATION; QUALITY-CONTROL; GENE; TRANSLOCATION; EXPRESSION; MOVEMENT	Mature dolichol-linked oligosaccharides (mDLOs) needed for eukaryotic protein N-glycosylation are synthesized by a multistep pathway in which the biosynthetic lipid intermediate Man(5)GlcNAc(2)-PP-dolichol (M5-DLO) flips from the cytoplasmic to the luminal face of the endoplasmic reticulum. The endoplasmic reticulum membrane protein Rft1 is intimately involved in mDLO biosynthesis. Yeast genetic analyses implicated Rft1 as the M5-DLO flippase, but because biochemical tests challenged this assignment, the function of Rft1 remains obscure. To understand the role of Rft1, we sought to analyze mDLO biosynthesis in vivo in the complete absence of the protein. Rft1 is essential for yeast viability, and no Rft1-null organisms are currently available. Here, we exploited Trypanosoma brucei (Tb), an early diverging eukaryote whose Rft1 homologue functions in yeast. We report that TbRft1-null procyclic trypanosomes grow nearly normally. They have normal steady-state levels of mDLO and significant N-glycosylation, indicating robust M5-DLO flippase activity. Remarkably, the mutant cells have 30-100-fold greater steady-state levels of M5-DLO than wild-type cells. All N-glycans in the TbRft1-null cells originate from mDLO indicating that the M5-DLO excess is not available for glycosylation. These results suggest that rather than facilitating M5-DLO flipping, Rft1 facilitates conversion of M5-DLO to mDLO by another mechanism, possibly by acting as an M5-DLO chaperone.	[Signorell, Aita; Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Jelk, Jennifer; Serricchio, Mauro; Schmidt, Remo S.; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland; [Gao, Ningguo; Lehrman, Mark A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Bangs, James D.] SUNY Buffalo, Dept Microbiol & Immunol, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Acosta-Serrano, Alvaro] Univ Liverpool, Liverpool Sch Trop Med, Dept Parasitol, Liverpool L3 5QA, Merseyside, England; [Acosta-Serrano, Alvaro] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England	Cornell University; University of Bern; University of Texas System; University of Texas Southwestern Medical Center Dallas; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Liverpool School of Tropical Medicine; University of Liverpool; Liverpool School of Tropical Medicine	Lehrman, MA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA.	Mark.Lehrman@UTSouthwestern.edu; peter.buetikofer@ibmm.unibe.ch; akm2003@med.cornell.edu	Acosta-Serrano, Alvaro/L-5503-2015; Menon, Anant/AAN-8663-2021	Acosta-Serrano, Alvaro/0000-0002-2576-7959; Menon, Anant/0000-0001-6924-2698; Schmidt, Remo S./0000-0002-6599-9201; Serricchio, Mauro/0000-0002-7094-9807	National Institutes of Health [AI35739, GM38545, GM71041]; Swiss National Science Foundation [31003A-130815]; Wellcome Trust [093691MA]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI035739, R01AI035739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038545, R01GM071041, R56GM038545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI35739 (to J. D. B.), GM38545 (to M. A. L.), and GM71041 (to A. K. M.). This work was also supported by Swiss National Science Foundation Grant 31003A-130815 (to P. B.) and Wellcome Trust Grant 093691MA (to A. A. S.).	Acosta-Serrano A, 2004, EUKARYOT CELL, V3, P255, DOI 10.1128/EC.3.2.255-263.2004; Alexander DL, 2002, J CELL SCI, V115, P3253; Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Chalat M, 2012, J BIOL CHEM, V287, P15523, DOI 10.1074/jbc.M112.343038; Frank CG, 2008, NATURE, V454, pE3, DOI 10.1038/nature07165; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; Gao NG, 2006, METHOD ENZYMOL, V415, P3, DOI 10.1016/S0076-6879(06)15001-6; Gao NG, 2011, MOL BIOL CELL, V22, P2994, DOI 10.1091/mbc.E11-04-0286; Gao XD, 2004, GLYCOBIOLOGY, V14, P559, DOI 10.1093/glycob/cwh072; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; Hennet T, 2012, BBA-GEN SUBJECTS, V1820, P1306, DOI 10.1016/j.bbagen.2012.02.001; Hwa KY, 2000, MOL BIOCHEM PARASIT, V111, P173, DOI 10.1016/S0166-6851(00)00310-8; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; Larkin A, 2011, BIOCHEMISTRY-US, V50, P4411, DOI 10.1021/bi200346n; LENNARZ WJ, 1987, BIOCHEMISTRY-US, V26, P7205, DOI 10.1021/bi00397a001; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Noffz C, 2009, GLYCOBIOLOGY, V19, P472, DOI 10.1093/glycob/cwp001; PARODI AJ, 1993, GLYCOBIOLOGY, V3, P193, DOI 10.1093/glycob/3.3.193; Peck RF, 2008, MOL MICROBIOL, V68, P933, DOI 10.1111/j.1365-2958.2008.06195.x; Rush JS, 2009, J BIOL CHEM, V284, P19835, DOI 10.1074/jbc.M109.000893; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; Sanyal S, 2009, P NATL ACAD SCI USA, V106, P767, DOI 10.1073/pnas.0810225106; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Schenk B, 2001, GLYCOBIOLOGY, V11, p61R, DOI 10.1093/glycob/11.5.61R; Schenk B, 2001, J CLIN INVEST, V108, P1687, DOI 10.1172/JCI200113419; Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109; SNIDER MD, 1984, CELL, V36, P753, DOI 10.1016/0092-8674(84)90355-6; Vleugels W, 2009, HUM MUTAT, V30, P1428, DOI 10.1002/humu.21085; WASSLER M, 1993, J CELL BIOL, V123, P285, DOI 10.1083/jcb.123.2.285; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	36	18	18	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20616	20623		10.1074/jbc.M113.479642	http://dx.doi.org/10.1074/jbc.M113.479642			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720757	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000321715100047
J	Vytla, VS; Ochs, RS				Vytla, Veeravenkata S.; Ochs, Raymond S.			Metformin Increases Mitochondrial Energy Formation in L6 Muscle Cell Cultures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; HEPATIC GLUCONEOGENESIS; GLUCOSE-TRANSPORT; RESPIRATORY-CHAIN; CANCER CELLS; COMPLEX I; AMP; RAT; PHOSPHORYLATION	A popular hypothesis for the action of metformin, the widely used anti-diabetes drug, is the inhibition of mitochondrial respiration, specifically at complex I. This is consistent with metformin stimulation of glucose uptake by muscle and inhibition of gluconeogenesis by liver. Yet, mitochondrial inhibition is inconsistent with metformin stimulation of fatty acid oxidation in both tissues. In this study, we measured mitochondrial energy production in intact cells adapting an in vivo technique of phosphocreatine (PCr) formation following energy interruption ("PCr recovery") to cell cultures. Metformin increased PCr recovery from either dinitrophenol (DNP) or azide in L6 cells. We found that metformin alone had no effect on cell viability as measured by total ATP concentration, trypan blue exclusion, or 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction. However, treatments with low concentrations of DNP or azide reversibly decreased ATP concentration. Metformin increased 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide reduction during recovery from either agent. Viability measured by trypan blue exclusion indicated that cells were intact under these conditions. We also found that metformin increased free AMP and, to a smaller extent, free ADP concentrations in cells, an action that was duplicated by a structurally unrelated AMP deaminase inhibitor. We conclude that, in intact cells, metformin can lead to a stimulation of energy formation, rather than an inhibition.	[Vytla, Veeravenkata S.; Ochs, Raymond S.] St Johns Univ, Sch Pharm & Hlth Sci, Dept Pharmaceut Sci, Queens, NY 11439 USA	Saint John's University	Vytla, VS (corresponding author), St Johns Univ, Sch Pharm & Hlth Sci, Dept Pharmaceut Sci, Queens, NY 11439 USA.	vsatyavylta@gmail.com; ochsr@stjohns.edu	Nili, Mona/P-5570-2016					BAILEY CJ, 1992, DIABETES CARE, V15, P755, DOI 10.2337/diacare.15.6.755; Barreto-Torres GA, 2013, FASEB J, V27; BAUR H, 1975, H-S Z PHYSIOL CHEM, V356, P827, DOI 10.1515/bchm2.1975.356.s1.827; Ben Sahra I, 2010, CANCER RES, V70, P2465, DOI 10.1158/0008-5472.CAN-09-2782; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; BLEI ML, 1993, J PHYSIOL-LONDON, V465, P203, DOI 10.1113/jphysiol.1993.sp019673; BRIDGER WA, 1983, CELL ATP; Bruckbauer A, 2013, DIABETES METAB SYNDR, V6, P93, DOI 10.2147/DMSO.S40840; Brunmair B, 2004, DIABETES, V53, P1052, DOI 10.2337/diabetes.53.4.1052; Buler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049863; Calabro AR, 2008, TOXICOL IN VITRO, V22, P1273, DOI 10.1016/j.tiv.2008.02.023; Carvalho C, 2008, MOL CELL BIOCHEM, V308, P75, DOI 10.1007/s11010-007-9614-3; Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345; Cornell N. W., 1983, ISOLATION CHARACTERI, P11; Silva FMD, 2010, MOL CELL BIOCHEM, V340, P283, DOI 10.1007/s11010-010-0429-2; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2004, BIOCHEM J, V382, P877, DOI 10.1042/BJ20040885; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2006, GASTROENTEROLOGY, V131, P973, DOI 10.1053/j.gastro.2006.07.032; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoek JB, 2006, GASTROENTEROLOGY, V131, P974, DOI 10.1053/j.gastro.2006.07.033; Hoek JB, 2006, GASTROENTEROLOGY, V130, P2234, DOI 10.1053/j.gastro.2006.05.009; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Janjetovic K, 2011, EUR J PHARMACOL, V651, P41, DOI 10.1016/j.ejphar.2010.11.005; JANJIC D, 1992, DIABETOLOGIA, V35, P482, DOI 10.1007/BF02342448; KLIP A, 1992, ENDOCRINOLOGY, V130, P2535, DOI 10.1210/en.130.5.2535; Koh HJ, 2010, P NATL ACAD SCI USA, V107, P15541, DOI 10.1073/pnas.1008131107; Lanaspa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048801; Misra P, 2008, EXPERT OPIN THER TAR, V12, P91, DOI 10.1517/14728222.12.1.91; Misra P, 2007, INDIAN J MED RES, V125, P389; Morioka K, 2005, INT J MOL MED, V15, P449; Musi N, 2006, CURR MED CHEM, V13, P583, DOI 10.2174/092986706776055724; OCHS RS, 1978, ARCH BIOCHEM BIOPHYS, V190, P193, DOI 10.1016/0003-9861(78)90267-9; Otto M, 2003, DIABETES OBES METAB, V5, P189, DOI 10.1046/j.1463-1326.2003.00263.x; Ouyang JY, 2011, J BIOL CHEM, V286, P1, DOI 10.1074/jbc.M110.121806; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; PETTY RD, 1995, J BIOLUM CHEMILUM, V10, P29, DOI 10.1002/bio.1170100105; PRESSMAN BC, 1963, J BIOL CHEM, V238, P401; Ronner P, 1999, ANAL BIOCHEM, V275, P208, DOI 10.1006/abio.1999.4317; SCHAFER G, 1972, EUR J BIOCHEM, V27, P364, DOI 10.1111/j.1432-1033.1972.tb01846.x; Simmons A, 2013, FASEB J, V27; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Stumvoll M, 2007, ENDOCR RES, V32, P39, DOI 10.1080/07435800701743828; Suwa M, 2006, J APPL PHYSIOL, V101, P1685, DOI 10.1152/japplphysiol.00255.2006; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Walker J, 2005, BIOCHEM J, V385, P485, DOI 10.1042/BJ20040694; WARBURG O, 1956, SCIENCE, V124, P269; WISEMAN RW, 1995, J BIOL CHEM, V270, P12428, DOI 10.1074/jbc.270.21.12428; Yuan L, 2002, CHINESE MED J-PEKING, V115, P1843; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	59	30	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20369	20377		10.1074/jbc.M113.482646	http://dx.doi.org/10.1074/jbc.M113.482646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720772	Green Published, hybrid			2022-12-28	WOS:000321715100025
J	Jones, TE; de Pouplana, LR; Alexander, RW				Jones, Thomas E.; Ribas de Pouplana, Llus; Alexander, Rebecca W.			Evidence for Late Resolution of the AUX Codon Box in Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA-SYNTHETASE; AMINO-ACID SPECIFICITIES; ZINC-BINDING DOMAIN; TRANSLATIONAL FIDELITY; LYSIDINE SYNTHETASE; MAXIMUM-LIKELIHOOD; GENOMIC SEQUENCE; STRUCTURAL BASIS; ACCEPTOR STEM; GENETIC-CODE	Recognition strategies for tRNA aminoacylation are ancient and highly conserved, having been selected very early in the evolution of the genetic code. In most cases, the trinucleotide anticodons of tRNA are important identity determinants for aminoacylation by cognate aminoacyl-tRNA synthetases. However, a degree of ambiguity exists in the recognition of certain tRNA(Ile) isoacceptors that are initially transcribed with the methionine-specifying CAU anticodon. In most organisms, the C34 wobble position in these tRNA(Ile) precursors is rapidly modified to lysidine to prevent recognition by methionyl-tRNA synthetase (MRS) and production of a chimeric Met-tRNA(Ile) that would compromise translational fidelity. In certain bacteria, however, lysidine modification is not required for MRS rejection, indicating that this recognition strategy is not universally conserved and may be relatively recent. To explore the actual distribution of lysidine-dependent tRNA(Ile) rejection by MRS, we have investigated the ability of bacterial MRSs from different clades to differentiate cognate tRNA(CAU)(Met) from near-cognate tRNA(CAU)(Ile). Discrimination abilities vary greatly and appear unrelated to phylogenetic or structural features of the enzymes or sequence determinants of the tRNA. Our data indicate that tRNA(Ile) identity elements were established late and independently in different bacterial groups. We propose that the observed variation in MRS discrimination ability reflects differences in the evolution of genetic code machineries of emerging bacterial clades.	[Jones, Thomas E.; Alexander, Rebecca W.] Wake Forest Univ, Dept Chem, Winston Salem, NC 27109 USA; [Jones, Thomas E.; Ribas de Pouplana, Llus] Inst Catalana Reserca Estudis Avancats, Barcelona 08010, Catalonia, Spain	Wake Forest University; ICREA	de Pouplana, LR (corresponding author), Inst Res Biomed, Barcelona 08208, Catalonia, Spain.	lluisribas@irbbarcelona.org; alexanr@wfu.edu			National Science Foundation [MCB-0448243]; Spanish Ministry of Science and Technology [BIO2009-09776]; ICREA Funding Source: Custom	National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA(ICREA)	This work was supported by National Science Foundation Grant MCB-0448243 (to R. W. A.) and Spanish Ministry of Science and Technology Grant BIO2009-09776 (to L. R. d. P.).	Banerjee P, 2009, BIOCHEMISTRY-US, V48, P10113, DOI 10.1021/bi9012275; Brown JR, 2003, EMBO REP, V4, P692, DOI 10.1038/sj.embor.embor881; Cusack S, 1997, CURR OPIN STRUC BIOL, V7, P881, DOI 10.1016/S0959-440X(97)80161-3; de Pouplana LR, 2001, CELL, V104, P191, DOI 10.1016/S0092-8674(01)00204-5; de Pouplana LR, 2000, CELL MOL LIFE SCI, V57, P865, DOI 10.1007/PL00000729; Fabret C, 2011, MOL MICROBIOL, V80, P1062, DOI 10.1111/j.1365-2958.2011.07630.x; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; FOURMY D, 1995, BIOCHEMISTRY-US, V34, P15681, DOI 10.1021/bi00048a012; FOURMY D, 1993, J MOL BIOL, V231, P1078, DOI 10.1006/jmbi.1993.1353; FOURMY D, 1993, J MOL BIOL, V231, P1068, DOI 10.1006/jmbi.1993.1352; Gomes AC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r206; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hellmuth K, 2000, NUCLEIC ACIDS RES, V28, P4604, DOI 10.1093/nar/28.23.4604; Ikeuchi Y, 2005, MOL CELL, V19, P235, DOI 10.1016/j.molcel.2005.06.007; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; Jones TE, 2008, MOL CELL, V29, P401, DOI 10.1016/j.molcel.2007.12.021; Jones TE, 2011, P NATL ACAD SCI USA, V108, P6933, DOI 10.1073/pnas.1019033108; KOWALD A, 1993, J THEOR BIOL, V160, P493, DOI 10.1006/jtbi.1993.1032; Kuratani M, 2007, STRUCTURE, V15, P1642, DOI 10.1016/j.str.2007.09.020; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mandal D, 2010, P NATL ACAD SCI USA, V107, P2872, DOI 10.1073/pnas.0914869107; Mechulam Y, 1999, J MOL BIOL, V294, P1287, DOI 10.1006/jmbi.1999.3339; MEINNEL T, 1993, J MOL BIOL, V229, P26, DOI 10.1006/jmbi.1993.1005; MURAMATSU T, 1988, NATURE, V336, P179, DOI 10.1038/336179a0; NAGEL GM, 1991, P NATL ACAD SCI USA, V88, P8121, DOI 10.1073/pnas.88.18.8121; Nakanishi K, 2009, NATURE, V461, P1144, DOI 10.1038/nature08474; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Sasaki Y, 2002, NUCLEIC ACIDS RES, V30, P5293, DOI 10.1093/nar/gkf667; SCHIMMEL P, 1993, P NATL ACAD SCI USA, V90, P8763, DOI 10.1073/pnas.90.19.8763; SCHULMAN LH, 1988, SCIENCE, V242, P765, DOI 10.1126/science.3055296; SCHULMAN LH, 1991, PROG NUCL ACID RES M, V41, P23; Sherlin LD, 2001, RNA, V7, P1671; Silva FJ, 2006, NUCLEIC ACIDS RES, V34, P6015, DOI 10.1093/nar/gkl739; Soma A, 2003, MOL CELL, V12, P689, DOI 10.1016/S1097-2765(03)00346-0; Taniguchi T, 2013, NUCLEIC ACIDS RES, V41, P2621, DOI 10.1093/nar/gks1344; Tomita K, 1999, NUCLEIC ACIDS RES, V27, P4291, DOI 10.1093/nar/27.21.4291	40	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19625	19632		10.1074/jbc.M112.449249	http://dx.doi.org/10.1074/jbc.M112.449249			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696642	Green Published, hybrid			2022-12-28	WOS:000321515800028
J	Shavkunov, AS; Wildburger, NC; Nenov, MN; James, TF; Buzhdygan, TP; Panova-Elektronova, NI; Green, TA; Veselenak, RL; Bourne, N; Laezza, F				Shavkunov, Alexander S.; Wildburger, Norelle C.; Nenov, Miroslav N.; James, Thomas F.; Buzhdygan, Tetyana P.; Panova-Elektronova, Neli I.; Green, Thomas A.; Veselenak, Ronald L.; Bourne, Nigel; Laezza, Fernanda			The Fibroblast Growth Factor 14.Voltage-gated Sodium Channel Complex Is a New Target of Glycogen Synthase Kinase 3 (GSK3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR HOMOLOGOUS FACTOR; PROTEIN-PROTEIN INTERACTIONS; FIBROBLAST-GROWTH-FACTOR-14 GENE; CRYSTAL-STRUCTURE; C-TERMINUS; PHOSPHORYLATION; IDENTIFICATION; MODULATION; MUTATION; KINASE-3-BETA	The FGF14 protein controls biophysical properties and subcellular distribution of neuronal voltage-gated Na+ (Nav) channels through direct binding to the channel C terminus. To gain insights into the dynamic regulation of this protein/protein interaction complex, we employed the split luciferase complementation assay to screen a small molecule library of kinase inhibitors against the FGF14.Nav1.6 channel complex and identified inhibitors of GSK3 as hits. Through a combination of a luminescence-based counter-screening, co-immunoprecipitation, patch clamp electrophysiology, and quantitative confocal immunofluorescence, we demonstrate that inhibition of GSK3 reduces the assembly of the FGF14.Nav channel complex, modifies FGF14-dependent regulation of Na+ currents, and induces dissociation and subcellular redistribution of the native FGF14 . Nav channel complex in hippocampal neurons. These results further emphasize the role of FGF14 as a critical component of the Nav channel macromolecular complex, providing evidence for an novel GSK3-dependent signaling pathway that might control excitability through specific protein/protein interactions.	[Shavkunov, Alexander S.; Wildburger, Norelle C.; Nenov, Miroslav N.; James, Thomas F.; Panova-Elektronova, Neli I.; Green, Thomas A.; Laezza, Fernanda] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Wildburger, Norelle C.; James, Thomas F.; Buzhdygan, Tetyana P.] Univ Texas Med Branch, Grad Program Neurosci, Galveston, TX 77555 USA; [Wildburger, Norelle C.] Univ Texas Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA; [Green, Thomas A.; Laezza, Fernanda] Univ Texas Med Branch, Addict Res Ctr, Galveston, TX 77555 USA; [Veselenak, Ronald L.; Bourne, Nigel] Univ Texas Med Branch, Dept Pediat Vaccinol, Galveston, TX 77555 USA; [Bourne, Nigel] Univ Texas Med Branch, Galveston Natl Lab, Assay Dev Serv Div, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Laezza, F (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Addict Res Ctr, Ctr Biomed Engn, 301 Univ Blvd, Galveston, TX 77555 USA.	felaezza@utmb.edu	Laezza, Fernanda/X-4076-2019; Buzhdygan, Tetyana/AAN-4245-2021; Nenov, Miroslav/C-5252-2008; Laezza, Fernanda/L-6019-2016	Laezza, Fernanda/0000-0003-1141-1852; Nenov, Miroslav/0000-0001-6000-2372; Laezza, Fernanda/0000-0003-1141-1852; Wildburger, Norelle C./0000-0002-0036-8927; Shavkunov, Alexander/0000-0003-2390-9391	National Institutes of Health Grant, NIMH [MH095995]; NIAID [5UC7A107008304]; NCATS [UL1TR000071]; PhRMA Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095995] Funding Source: NIH RePORTER	National Institutes of Health Grant, NIMH; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); PhRMA Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH095995 from NIMH (to F. L.) and 5UC7A107008304 from NIAID (to N. B.) and by Clinical and Translational Science Award UL1TR000071 from NCATS (to F. L.). This work was also supported by a Research starter grant from the PhRMA Foundation (to F. L.).	Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Berendt FJ, 2010, J PROTEOME RES, V9, P1976, DOI 10.1021/pr901171q; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Dover K, 2010, J PHYSIOL-LONDON, V588, P3695, DOI 10.1113/jphysiol.2010.192559; Eldar-Finkelman H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00032; Garrido JJ, 2001, EMBO J, V20, P5950, DOI 10.1093/emboj/20.21.5950; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2007, NEURON, V55, P449, DOI 10.1016/j.neuron.2007.07.006; Goslin K., 1998, CULTURING NERVE CELL, P339; Hernandez F, 2010, EXP NEUROL, V223, P322, DOI 10.1016/j.expneurol.2009.09.011; Jope RS, 2006, CURR DRUG TARGETS, V7, P1421, DOI 10.2174/1389450110607011421; Kim WY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00044; Kim YT, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00048; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Li XH, 2010, NEUROPSYCHOPHARMACOL, V35, P2143, DOI 10.1038/npp.2010.105; Liao YX, 2010, BRAIN, V133, P1403, DOI 10.1093/brain/awq057; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Polter AM, 2012, CELL SIGNAL, V24, P265, DOI 10.1016/j.cellsig.2011.09.009; Rinnab L, 2008, NEOPLASIA, V10, P624, DOI 10.1593/neo.08248; Schiavon E, 2006, J BIOL CHEM, V281, P20326, DOI 10.1074/jbc.M600565200; Schutz SV, 2010, J CELL BIOCHEM, V109, P1192, DOI 10.1002/jcb.22500; Shakkottai VG, 2009, NEUROBIOL DIS, V33, P81, DOI 10.1016/j.nbd.2008.09.019; Shavkunov A, 2012, ASSAY DRUG DEV TECHN, V10, P148, DOI 10.1089/adt.2011.413; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wang CJ, 2011, J BIOL CHEM, V286, P24253, DOI 10.1074/jbc.M111.245803; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Wei EQ, 2011, TRENDS CARDIOVAS MED, V21, P199, DOI 10.1016/j.tcm.2012.05.010; Wildburger NC, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00080; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	45	66	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19370	19385		10.1074/jbc.M112.445924	http://dx.doi.org/10.1074/jbc.M112.445924			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23640885	Green Published, hybrid			2022-12-28	WOS:000321515800007
J	Wang, ZP; Fu, M; Wang, LF; Liu, JJ; Li, YH; Brakebusch, C; Mei, QB				Wang, Zhipeng; Fu, Meng; Wang, Lifeng; Liu, Juanjuan; Li, Yuhua; Brakebusch, Cord; Mei, Qibing			p21-Activated Kinase 1 (PAK1) Can Promote ERK Activation in a Kinase-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHORYLATION; CANCER	PAK1 plays an important role in proliferation and tumorigenesis, at least partially by promoting ERK phosphorylation of C-RAF (Ser-338) or MEK1 (Ser-298). We observed how that overexpression of a kinase-dead mutant form of PAK1 increased phosphorylation of MEK1/2 (Ser-217/Ser-221) and ERK (Thr-202/Tyr-204), although phosphorylation of B-RAF (Ser-445) and C-RAF (Ser-338) remained unchanged. Furthermore, increased activation of the PAK1 activator Rac1 induced the formation of a triple complex of Rac1, PAK1, and MEK1 independent of the kinase activity of PAK1. These data suggest that PAK1 can stimulate MEK activity in a kinase-independent manner, probably by serving as a scaffold to facilitate interaction of C-RAF.	[Wang, Zhipeng; Liu, Juanjuan; Li, Yuhua; Mei, Qibing] Fourth Mil Med Univ, Key Lab Gastrointestinal Pharmacol Chinese Mat Me, State Adm Tradit Chinese Med, Dept Pharmacol,Sch Pharm, Xian 710032, Peoples R China; [Fu, Meng] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, Xian 710032, Peoples R China; [Wang, Zhipeng; Wang, Lifeng] Fourth Mil Med Univ, Sch Basic Med, Dept Biochem & Mol Biol, Xian 710032, Peoples R China; [Brakebusch, Cord] Univ Copenhagen, Inst Biomed, BRIC, DK-2200 Copenhagen, Denmark	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; University of Copenhagen	Mei, QB (corresponding author), Fourth Mil Med Univ, Key Lab Gastrointestinal Pharmacol Chinese Mat Me, State Adm Tradit Chinese Med, Dept Pharmacol,Sch Pharm, Xian 710032, Peoples R China.	qbmei@fmmu.edu.cn	Li, yu/HHZ-5236-2022; fu, meng/GZG-3120-2022	Brakebusch, Cord/0000-0002-9342-1634; fu, meng/0000-0002-8867-0951	Danish Cancer Foundation; National Natural Science Foundation of China [81071689]	Danish Cancer Foundation(Danish Cancer Society); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Danish Cancer Foundation (to C. B.) and the National Natural Science Foundation of China (Grant 81071689).	Beeser A, 2005, J BIOL CHEM, V280, P36609, DOI 10.1074/jbc.M502306200; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Dumesic PA, 2009, J CELL BIOL, V185, P409, DOI 10.1083/jcb.200804038; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Eswaran J, 2012, CLIN CANCER RES, V18, P3743, DOI 10.1158/1078-0432.CCR-11-1952; Higuchi M, 2008, NAT CELL BIOL, V10, P1356, DOI 10.1038/ncb1795; Huynh N, 2010, BBA-MOL CELL RES, V1803, P1106, DOI 10.1016/j.bbamcr.2010.05.007; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Wang Z, 2010, ONCOGENE, V29, P3362, DOI 10.1038/onc.2010.95	12	44	49	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20093	20099		10.1074/jbc.M112.426023	http://dx.doi.org/10.1074/jbc.M112.426023			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23653349	Green Published, hybrid			2022-12-28	WOS:000321515800071
J	Akhatib, B; Onnerfjord, P; Gawri, R; Ouellet, J; Jarzem, P; Heinegard, D; Mort, J; Roughley, P; Haglund, L				Akhatib, Bashar; Onnerfjord, Patrik; Gawri, Rahul; Ouellet, Jean; Jarzem, Peter; Heinegard, Dick; Mort, John; Roughley, Peter; Haglund, Lisbet			Chondroadherin Fragmentation Mediated by the Protease HTRA1 Distinguishes Human Intervertebral Disc Degeneration from Normal Aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-BACK-PAIN; SERINE-PROTEASE; EXTRACELLULAR-MATRIX; CATHEPSIN-K; ARTICULAR-CARTILAGE; PROTEOGLYCANS; EXPRESSION; AGGRECAN; PROTEINS; COLLAGEN	Chondroadherin, a member of the leucine-rich repeat family, has previously been demonstrated to be fragmented in some juveniles with idiopathic scoliosis. This observation led us to investigate adults with disc degeneration. Immunoblotting analysis demonstrated that non-degenerate discs from three different age groups show no chondroadherin fragmentation. Furthermore, the chondroadherin fragments in adult degenerate disc and the juvenile scoliotic disc were compared via immunoblot analysis and appeared to have a similar size. We then investigated whether or not chondroadherin fragmentation increases with the severity of disc degeneration. Three different samples with different severities were chosen from the same disc, and chondroadherin fragmentation was found to be more abundant with increasing severity of degeneration. This observation led us to the creation of a neoepitope antibody to the cleavage site observed. We then observed that the cleavage site in adult degenerate discs and juvenile scoliotic discs was identical as confirmed by the neoepitope antibody. Consequently, investigation of the protease capable of cleaving chondroadherin at this site was necessary. In vitro digests of disc tissue demonstrated that ADAMTS-4 and -5; cathepsins K, B, and L; and MMP-3, -7, -12, and -13 were incapable of cleavage of chondroadherin at this site and that HTRA1 was indeed the only protease capable. Furthermore, increased protein levels of the processed form of HTRA1 were demonstrated in degenerate disc tissues via immunoblotting. The results suggest that chondroadherin fragmentation can be used as a biomarker to distinguish the processes of disc degeneration from normal aging.	[Akhatib, Bashar; Gawri, Rahul; Haglund, Lisbet] McGill Univ, Orthopaed Res Lab, Montreal, PQ H3G 1A4, Canada; [Onnerfjord, Patrik; Ouellet, Jean; Jarzem, Peter; Heinegard, Dick] Lund Univ, Biomed Ctr C12, Dept Clin Sci, Lund Sect Rheumatol, SE-22184 Lund, Sweden; [Ouellet, Jean; Jarzem, Peter] McGill Scoliosis & Spine Grp, Montreal, PQ H3A 1A1, Canada; [Mort, John; Roughley, Peter] Shriners Hosp Children, Genet Unit, Montreal, PQ H3G 1A6, Canada	McGill University; Lund University; McGill University	Haglund, L (corresponding author), McGill Univ, Orthopaed Res Lab, 1650 Cedar Ave,Rm C-9173, Montreal, PQ H3G 1A4, Canada.	lisbet.haglund@orl.mcgill.ca	Gawri, Rahul/I-3784-2019; Onnerfjord, Patrik/R-3131-2019; Haglund, Lisbet/N-3095-2013	Gawri, Rahul/0000-0001-9415-1739; Onnerfjord, Patrik/0000-0002-2345-2937; Haglund, Lisbet/0000-0002-1288-2149	AO Foundation Switzerland Research Grants [S-09-108, S-11-92H]; Scoliosis Research Society	AO Foundation Switzerland Research Grants; Scoliosis Research Society	This work was supported by AO Foundation Switzerland Research Grants S-09-108 and S-11-92H and the Scoliosis Research Society.	Ariga K, 2001, SPINE, V26, P2666, DOI 10.1097/00007632-200112150-00007; Bachmeier BE, 2009, EUR SPINE J, V18, P1573, DOI 10.1007/s00586-009-1031-8; Bertram H, 2006, BIOCHEM BIOPH RES CO, V342, P963, DOI 10.1016/j.bbrc.2006.02.048; Billington CJ, 2000, BIOCHEM BIOPH RES CO, V276, P924, DOI 10.1006/bbrc.2000.3553; BLOCHBERGER TC, 1992, J BIOL CHEM, V267, P20613; Brown S, 2012, EUR SPINE J, V21, pS154, DOI 10.1007/s00586-012-2179-1; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Chamberland A, 2009, J BIOL CHEM, V284, P27352, DOI 10.1074/jbc.M109.037051; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Crean JKG, 1997, SPINE, V22, P2877, DOI 10.1097/00007632-199712150-00010; Danfelter M, 2007, J BIOL CHEM, V282, P36933, DOI 10.1074/jbc.M702491200; Durigova M, 2011, MATRIX BIOL, V30, P145, DOI 10.1016/j.matbio.2010.10.007; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; FISHER LW, 1989, J BIOL CHEM, V264, P4571; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Gruber HE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3454; Haglund L, 2013, J BIOL CHEM, V288, P995, DOI 10.1074/jbc.M112.430512; Haglund L, 2009, SPINE, V34, P1513, DOI 10.1097/BRS.0b013e3181a8d001; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; JOHNSTONE B, 1995, SPINE, V20, P674, DOI 10.1097/00007632-199503150-00008; LARSSON T, 1991, J BIOL CHEM, V266, P20428; Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652; Le Maitre CL, 2006, BIOTECH HISTOCHEM, V81, P125, DOI 10.1080/10520290601005298; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; Lotz JC, 1998, SPINE, V23, P2493, DOI 10.1097/00007632-199812010-00004; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; Mizuno M, 1996, CALCIFIED TISSUE INT, V59, P163, DOI 10.1007/s002239900103; Nie GY, 2005, DEV DYNAM, V233, P1102, DOI 10.1002/dvdy.20399; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; Onnerfjord P, 2012, J BIOL CHEM, V287, P18913, DOI 10.1074/jbc.M111.298968; Peferoen M, 1988, Methods Mol Biol, V3, P395, DOI 10.1385/0-89603-126-8:395; Polur I, 2010, HISTOL HISTOPATHOL, V25, P599, DOI 10.14670/HH-25.599; Roberts S, 2000, SPINE, V25, P3005, DOI 10.1097/00007632-200012010-00007; Roughley PJ, 2002, BIOCHEM SOC T, V30, P869, DOI 10.1042/BST0300869; Shen ZX, 1998, BIOCHEM J, V330, P549, DOI 10.1042/bj3300549; Singh N, 2011, ARCH BIOCHEM BIOPHYS, V516, P85, DOI 10.1016/j.abb.2011.10.007; Sivan SS, 2006, J BIOL CHEM, V281, P13009, DOI 10.1074/jbc.M600296200; Struglics A, 2012, BIOCHEM J, V446, P213, DOI 10.1042/BJ20120274; Sztrolovics R, 1997, BIOCHEM J, V326, P235, DOI 10.1042/bj3260235; Tiaden AN, 2012, J BIOL CHEM, V287, P21335, DOI 10.1074/jbc.M112.341032; Tiaden AN, 2013, AM J PATHOL, V182, P1482, DOI 10.1016/j.ajpath.2013.02.003; Yu J, 2005, SPINE, V30, P1815, DOI 10.1097/01.brs.0000173899.97415.5b; Yurube T, 2010, J ORTHOP RES, V28, P1026, DOI 10.1002/jor.21116	44	33	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19280	19287		10.1074/jbc.M112.443010	http://dx.doi.org/10.1074/jbc.M112.443010			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23673665	Green Published, hybrid			2022-12-28	WOS:000321335800060
J	Chugunov, AO; Koromyslova, AD; Berkut, AA; Peigneur, S; Tytgat, J; Polyansky, AA; Pentkovsky, VM; Vassilevski, AA; Grishin, EV; Efremov, RG				Chugunov, Anton O.; Koromyslova, Anna D.; Berkut, Antonina A.; Peigneur, Steve; Tytgat, Jan; Polyansky, Anton A.; Pentkovsky, Vladimir M.; Vassilevski, Alexander A.; Grishin, Eugene V.; Efremov, Roman G.			Modular Organization of alpha-Toxins from Scorpion Venom Mirrors Domain Structure of Their Targets, Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MOLECULAR-BASIS; RECEPTOR-SITE; SPATIAL STRUCTURE; BUTHUS-EUPEUS; NEUROTOXIN M9; RAT-BRAIN; PURIFICATION; PEPTIDE; INSECT	To gain success in the evolutionary "arms race," venomous animals such as scorpions produce diverse neurotoxins selected to hit targets in the nervous system of prey. Scorpion alpha-toxins affect insect and/or mammalian voltage-gated sodium channels (Na(v)s) and thereby modify the excitability of muscle and nerve cells. Although more than 100 alpha-toxins are known and a number of them have been studied into detail, the molecular mechanism of their interaction with Na(v)s is still poorly understood. Here, we employ extensive molecular dynamics simulations and spatial mapping of hydrophobic/hydrophilic properties distributed over the molecular surface of alpha-toxins. It is revealed that despite the small size and relatively rigid structure, these toxins possess modular organization from structural, functional, and evolutionary perspectives. The more conserved and rigid " core module" is supplemented with the " specificity module" (SM) that is comparatively flexible and variable and determines the taxon (mammal versus insect) specificity of alpha-toxin activity. We further show that SMs in mammal toxins are more flexible and hydrophilic than in insect toxins. Concomitant sequence-based analysis of the extracellular loops of Na(v)s suggests that alpha-toxins recognize the channels using both modules. We propose that the core module binds to the voltage-sensing domain IV, whereas the more versatile SM interacts with the pore domain in repeat I of Na(v)s. These findings corroborate and expand the hypothesis on different functional epitopes of toxins that has been reported previously. In effect, we propose that the modular structure in toxins evolved to match the domain architecture of Na(v)s.	[Chugunov, Anton O.; Koromyslova, Anna D.; Berkut, Antonina A.; Polyansky, Anton A.; Vassilevski, Alexander A.; Grishin, Eugene V.; Efremov, Roman G.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Koromyslova, Anna D.] Moscow MV Lomonosov State Univ, Moscow 119991, Russia; [Berkut, Antonina A.; Pentkovsky, Vladimir M.; Efremov, Roman G.] State Univ, Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Russia; [Peigneur, Steve; Tytgat, Jan] Univ Louvain, Lab Toxicol & Pharmacol, B-3000 Louvain, Belgium; [Polyansky, Anton A.] Max F Perutz Labs GmbH, Lab Computat Biophys, AT-1030 Vienna, Austria	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; Moscow Institute of Physics & Technology	Chugunov, AO (corresponding author), Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia.	batch2k@yandex.ru; avas@ibch.ru	Polyansky, Anton A/J-2145-2018; Vassilevski, Alexander/S-3824-2016; Chugunov, Anton O/D-1058-2009; Koromyslova, Anna/AAU-8672-2020; Berkut, Antonina/AAE-4247-2019; Roman, Efremov/A-7460-2014	Polyansky, Anton A/0000-0002-1011-2706; Vassilevski, Alexander/0000-0002-1359-0076; Chugunov, Anton O/0000-0003-1331-3949; Roman, Efremov/0000-0002-5474-4721; Tytgat, Jan/0000-0003-1778-6022; Peigneur, Steve/0000-0003-0504-5702	Ministry of Education and Science of the Russian Federation [P818, 07.514.11.4127, 8794]; Russian Foundation for Basic Research [11-04-01606, 10-04-01217]; Russian Academy of Sciences; Russian Federation; F.W.O. Vlaanderen Grants [G.0433.12, G.A071.10N, G.0257.08]; Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy [IUAP7/10]; KU Leuven Grant [OT/12/081]	Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences(Russian Academy of Sciences); Russian Federation(Russian Federation); F.W.O. Vlaanderen Grants; Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office); KU Leuven Grant	This work was supported by the Ministry of Education and Science of the Russian Federation (Contracts P818, 07.514.11.4127, and 8794), by the Russian Foundation for Basic Research (Grants 11-04-01606 and 10-04-01217), and by the "Basic Fundamental Research for Nanotechnologies and Nanomaterials" and "Molecular and Cell Biology" programs of the Russian Academy of Sciences.; Recipient of the Stipend of the President of the Russian Federation.; Supported by F.W.O. Vlaanderen Grants G.0433.12, G.A071.10N, and G.0257.08; IUAP7/10 (Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy), and KU Leuven Grant OT/12/081.	Andavan GSB, 2011, CURR MED CHEM, V18, P377; Andreev YA, 2010, ANAL BIOCHEM, V407, P144, DOI 10.1016/j.ab.2010.07.023; Arnon T, 2005, INSECT BIOCHEM MOLEC, V35, P187, DOI 10.1016/j.ibmb.2004.11.005; Ben-Shimon A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002288; Benkhadir K, 2004, PEPTIDES, V25, P151, DOI 10.1016/j.peptides.2004.01.009; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Borchani L, 1997, TOXICON, V35, P365, DOI 10.1016/S0041-0101(96)00173-0; Bosmans F, 2007, TOXICON, V49, P142, DOI 10.1016/j.toxicon.2006.09.023; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cao ZY, 2004, J PEPT RES, V64, P33, DOI 10.1111/j.1399-3011.2004.00164.x; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cohen L, 2007, J BIOL CHEM, V282, P29424, DOI 10.1074/jbc.M704651200; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; del Rio-Portilla F, 2004, EUR J BIOCHEM, V271, P2504, DOI 10.1111/j.1432-1033.2004.04181.x; DeLano WL, 2002, PYMOL USERS MANUAL; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Dong XL, 2011, CURR COMPUT-AID DRUG, V7, P181, DOI 10.2174/157340911796504332; Dudley SC, 2000, J GEN PHYSIOL, V116, P679, DOI 10.1085/jgp.116.5.679; EFREMOV RG, 1992, J PROTEIN CHEM, V11, P665, DOI 10.1007/BF01024968; Efremov RG, 2007, CURR MED CHEM, V14, P393, DOI 10.2174/092986707779941050; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; Gordon D, 1996, J BIOL CHEM, V271, P8034, DOI 10.1074/jbc.271.14.8034; Gordon D, 2007, TOXICON, V49, P452, DOI 10.1016/j.toxicon.2006.11.016; Guan RJ, 2004, J MOL BIOL, V341, P1189, DOI 10.1016/j.jmb.2004.06.067; Gur M, 2011, J BIOL CHEM, V286, P35209, DOI 10.1074/jbc.M111.259507; Gurevitz M, 2001, FASEB J, V15, P1201, DOI 10.1096/fj.00-0571hyp; Gurevitz M, 2012, TOXICON, V60, P502, DOI 10.1016/j.toxicon.2012.03.022; Hamon A, 2002, EUR J BIOCHEM, V269, P3920, DOI 10.1046/j.1432-1033.2002.03065.x; Hasegawa K, 2012, BIOORGAN MED CHEM, V20, P5410, DOI 10.1016/j.bmc.2012.03.041; He XL, 1999, J MOL BIOL, V292, P125, DOI 10.1006/jmbi.1999.3036; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hille B, 2001, ION CHANNELS EXCITAB, P1; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Kahn R, 2009, J BIOL CHEM, V284, P20684, DOI 10.1074/jbc.M109.021303; Karbat I, 2004, J BIOL CHEM, V279, P31679, DOI 10.1074/jbc.M402048200; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Krimm I, 1999, J MOL BIOL, V285, P1749, DOI 10.1006/jmbi.1998.2418; Landon C, 1996, EUR J BIOCHEM, V236, P395, DOI 10.1111/j.1432-1033.1996.00395.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li HM, 1999, ACTA CRYSTALLOGR D, V55, P341, DOI 10.1107/S0907444998006593; Little MJ, 1998, FEBS LETT, V439, P246, DOI 10.1016/S0014-5793(98)01378-7; Liu LH, 2005, FASEB J, V19, P594, DOI 10.1096/fj.04-2485fje; Lopreato GF, 2001, P NATL ACAD SCI USA, V98, P7588, DOI 10.1073/pnas.131171798; Luo MJ, 1997, TOXICON, V35, P723, DOI 10.1016/S0041-0101(96)00146-8; MARTIN MF, 1984, TOXICON, V22, P279, DOI 10.1016/0041-0101(84)90028-X; NOREL R, 1995, J MOL BIOL, V252, P263, DOI 10.1006/jmbi.1995.0493; NOREL R, 1994, PROTEIN ENG, V7, P39, DOI 10.1093/protein/7.1.39; PASHKOV VS, 1988, BIOPHYS CHEM, V31, P121, DOI 10.1016/0301-4622(88)80016-4; PASHKOV VS, 1986, BIOORG KHIM+, V12, P1306; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Petrov D, 2011, J AM CHEM SOC, V133, P7016, DOI 10.1021/ja110577e; Polanski J, 2000, COMPUT CHEM, V24, P615, DOI 10.1016/S0097-8485(00)00064-4; Polyansky AA, 2012, J PHYS CHEM LETT, V3, P973, DOI 10.1021/jz300103p; Pyrkov TV, 2008, SAR QSAR ENVIRON RES, V19, P91, DOI 10.1080/10629360701844092; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Rogers JC, 1996, J BIOL CHEM, V271, P15950, DOI 10.1074/jbc.271.27.15950; Schuler LD, 2001, J COMPUT CHEM, V22, P1205, DOI 10.1002/jcc.1078; Shlyapnikov YM, 2008, PROTEIN EXPRES PURIF, V60, P89, DOI 10.1016/j.pep.2008.03.011; Snyder J. P., 1993, FLATTENING EARTH 200, P112; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Sun YM, 2003, J BIOL CHEM, V278, P24125, DOI 10.1074/jbc.M211931200; Tanrikulu Y, 2008, NAT REV DRUG DISCOV, V7, P667, DOI 10.1038/nrd2615; Tugarinov V, 1997, BIOCHEMISTRY-US, V36, P2414, DOI 10.1021/bi961497l; VOLKOVA TM, 1984, BIOORG KHIM+, V10, P979; VOLKOVA TM, 1985, BIOORG KHIM+, V11, P1445; Wang CG, 2003, BIOCHEMISTRY-US, V42, P4699, DOI 10.1021/bi0270438; Wang JT, 2011, P NATL ACAD SCI USA, V108, P15426, DOI 10.1073/pnas.1112320108; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; Wu HM, 1999, PURE APPL CHEM, V71, P1157, DOI 10.1351/pac199971061157; Ye X, 2005, J MOL BIOL, V353, P788, DOI 10.1016/j.jmb.2005.08.068; Zhang JZ, 2011, J BIOL CHEM, V286, P33641, DOI 10.1074/jbc.M111.282509; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhu SY, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012054; Zhu SY, 2004, J MOL EVOL, V58, P145, DOI 10.1007/s00239-003-2534-2; Zilberberg N, 1997, J BIOL CHEM, V272, P14810, DOI 10.1074/jbc.272.23.14810	81	26	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19014	19027		10.1074/jbc.M112.431650	http://dx.doi.org/10.1074/jbc.M112.431650			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23637230	hybrid, Green Published			2022-12-28	WOS:000321335800037
J	Matsuda, M; Tamura, K; Wakui, H; Maeda, A; Ohsawa, M; Kanaoka, T; Azushima, K; Uneda, K; Haku, S; Tsurumi-Ikeya, Y; Toya, Y; Maeshima, Y; Yamashita, A; Umemura, S				Matsuda, Miyuki; Tamura, Kouichi; Wakui, Hiromichi; Maeda, Akinobu; Ohsawa, Masato; Kanaoka, Tomohiko; Azushima, Kengo; Uneda, Kazushi; Haku, Sona; Tsurumi-Ikeya, Yuko; Toya, Yoshiyuki; Maeshima, Yohei; Yamashita, Akio; Umemura, Satoshi			Upstream Stimulatory Factors 1 and 2 Mediate the Transcription of Angiotensin II Binding and Inhibitory Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED PROTEIN; FAMILIAL COMBINED HYPERLIPIDEMIA; CONVOLUTED TUBULE CELLS; TYPE-1 RECEPTOR; GENE-EXPRESSION; INTERACTING MOLECULE; FACTOR USF; DOWN-REGULATION; KIDNEY-DISEASE; INFUSED MICE	The angiotensin II type 1 receptor (AT1R)-associated protein (ATRAP/Agtrap) promotes constitutive internalization of the AT1R so as to specifically inhibit the pathological activation of its downstream signaling yet preserve the base-line physiological signaling activity of the AT1R. Thus, tissue-specific regulation of Agtrap expression is relevant to the pathophysiology of cardiovascular and renal disease. However, the regulatory mechanism of Agtrap gene expression has not yet been fully elucidated. In this study, we show that the proximal promoter region from -150 to +72 of the mouse Agtrap promoter, which contains the X-box, E-box, and GC-box consensus motifs, is able to elicit substantial transcription of the Agtrap gene. Among these binding motifs, we showed that the E-box specifically binds upstream stimulatory factor (Usf) 1 and Usf2, which are known E-box-binding transcription factors. It is indicated that the E-box-Usf1/Usf2 binding regulates Agtrap expression because of the following: 1) mutation of the E-box to prevent Usf1/Usf2 binding reduces Agtrap promoter activity; 2) knockdown of Usf1 or Usf2 affects both endogenous Agtrap mRNA and Agtrap protein expression, and 3) the decrease in Agtrap mRNA expression in the afflicted kidney by unilateral ureteral obstruction is accompanied by changes in Usf1 and Usf2 mRNA. Furthermore, the results of siRNA transfection in mouse distal convoluted tubule cells and those of unilateral ureteral obstruction in the afflicted mouse kidney suggest that Usf1 decreases but Usf2 increases the Agtrap gene expression by binding to the E-box. The results also demonstrate a functional E-box-USF1/USF2 interaction in the human AGTRAP promoter, thereby suggesting that a strategy of modulating the E-box-USF1/USF2 binding has novel therapeutic potential.	[Matsuda, Miyuki; Tamura, Kouichi; Wakui, Hiromichi; Maeda, Akinobu; Ohsawa, Masato; Kanaoka, Tomohiko; Azushima, Kengo; Uneda, Kazushi; Haku, Sona; Tsurumi-Ikeya, Yuko; Toya, Yoshiyuki; Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2360004, Japan; [Maeshima, Yohei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Med & Clin Sci, Okayama 7008558, Japan; [Yamashita, Akio] Yokohama City Univ, Grad Sch Med, Dept Mol Biol, Yokohama, Kanagawa 2360004, Japan	Yokohama City University; Okayama University; Yokohama City University	Tamura, K (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2360004, Japan.	tamukou@med.yokohama-cu.ac.jp		Azushima, Kengo/0000-0002-5136-0730	Health and Labor Sciences Research grant; Japanese Ministry of Education, Science, Sports and Culture; Salt Science Research Foundation [1134]; Kidney Foundation, Japan [JKFB13-17]; Novartis Foundation for Gerontological Research; Grants-in-Aid for Scientific Research [23591193, 25460906] Funding Source: KAKEN	Health and Labor Sciences Research grant(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Salt Science Research Foundation; Kidney Foundation, Japan(Kidney Foundation, Japan); Novartis Foundation for Gerontological Research(Novartis Foundation for Gerontological Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Health and Labor Sciences Research grant, the Japanese Ministry of Education, Science, Sports and Culture, the Salt Science Research Foundation Grant 1134, the Kidney Foundation, Japan, Grant JKFB13-17, and the Novartis Foundation for Gerontological Research (2012).	Azuma K, 2007, HYPERTENSION, V50, P926, DOI 10.1161/HYPERTENSIONAHA.107.096115; Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; Bu Y, 2007, J BIOL CHEM, V282, P26725, DOI 10.1074/jbc.M702885200; Carabana J, 2005, J IMMUNOL, V174, P4144, DOI 10.4049/jimmunol.174.7.4144; Chen BH, 2012, BIOCHEM J, V446, P89, DOI 10.1042/BJ20111942; Coon H, 2005, HUM GENET, V117, P444, DOI 10.1007/s00439-005-1340-x; Daviet L, 1999, J BIOL CHEM, V274, P17058, DOI 10.1074/jbc.274.24.17058; Dejima T, 2011, J HYPERTENS, V29, P1919, DOI 10.1097/HJH.0b013e32834a5a46; Dickson ME, 2008, CIRC RES, V103, P940, DOI 10.1161/CIRCRESAHA.108.180653; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FRIEDMAN PA, 1995, KIDNEY INT, V48, P1427, DOI 10.1038/ki.1995.432; Fukui T, 2003, HYPERTENS RES, V26, P979, DOI 10.1291/hypres.26.979; GESEK FA, 1995, AM J PHYSIOL-RENAL, V268, pF89, DOI 10.1152/ajprenal.1995.268.1.F89; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; Hein L, 1997, MOL ENDOCRINOL, V11, P1266, DOI 10.1210/me.11.9.1266; Henrion AA, 1996, MAMM GENOME, V7, P803, DOI 10.1007/s003359900241; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Horiuchi M, 2012, CLIN SCI, V123, P193, DOI 10.1042/CS20110677; Jiang B, 2003, MOL CELL BIOL, V23, P6117, DOI 10.1128/MCB.23.17.6117-6128.2003; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; KUIPERS OP, 1991, NUCLEIC ACIDS RES, V19, P4558, DOI 10.1093/nar/19.16.4558; Lim M, 2010, LAB INVEST, V90, P222, DOI 10.1038/labinvest.2009.128; Liu S, 2007, AM J PHYSIOL-RENAL, V293, pF1727, DOI 10.1152/ajprenal.00316.2007; Lopez-Ilasaca M, 2003, MOL BIOL CELL, V14, P5038, DOI 10.1091/mbc.E03-06-0383; Ma ZC, 2008, J ALLERGY CLIN IMMUN, V121, P1006, DOI 10.1016/j.jaci.2007.11.015; Masuda S, 2010, AM J PHYSIOL-RENAL, V299, pF720, DOI 10.1152/ajprenal.00667.2009; Matsuda M, 2011, PHYSIOL GENOMICS, V43, P884, DOI 10.1152/physiolgenomics.00005.2011; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; Mogi M, 2007, ARTERIOSCL THROM VAS, V27, P2532, DOI 10.1161/ATVBAHA.107.144154; Navar LG, 2011, HYPERTENSION, V57, P355, DOI 10.1161/HYPERTENSIONAHA.110.163519; Ng MCY, 2005, DIABETOLOGIA, V48, P2018, DOI 10.1007/s00125-005-1914-0; Nowak M, 2005, MOL CELL BIOL, V25, P1537, DOI 10.1128/MCB.25.4.1537-1548.2005; Olave NC, 2010, J CELL BIOCHEM, V111, P720, DOI 10.1002/jcb.22760; Oshita A, 2006, HYPERTENSION, V48, P671, DOI 10.1161/01.HYP.0000238141.99816.47; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; Park S, 2012, HYPERTENSION, V59, P1212, DOI 10.1161/HYPERTENSIONAHA.112.192971; Purvis TL, 2010, GENE, V460, P20, DOI 10.1016/j.gene.2010.03.015; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rohman MS, 2005, KIDNEY INT, V67, P1410, DOI 10.1111/j.1523-1755.2005.00218.x; Sakai M, 2007, AM J PHYSIOL-RENAL, V292, pF1526, DOI 10.1152/ajprenal.00451.2006; Sanchez AP, 2011, AM J PHYSIOL-RENAL, V301, pF271, DOI 10.1152/ajprenal.00221.2011; Satoh M, 2001, J AM SOC NEPHROL, V12, P317, DOI 10.1681/ASN.V122317; SAWADOGO M, 1988, J BIOL CHEM, V263, P11994; Schoenhard JA, 2003, J MOL CELL CARDIOL, V35, P473, DOI 10.1016/S0022-2828(03)00051-8; Shi LH, 2009, AM J PHYSIOL-RENAL, V296, pF257, DOI 10.1152/ajprenal.90493.2008; Shigenaga A, 2008, HYPERTENSION, V52, P672, DOI 10.1161/HYPERTENSIONAHA.108.117341; Sirito M, 1998, P NATL ACAD SCI USA, V95, P3758, DOI 10.1073/pnas.95.7.3758; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; SWICK AG, 1989, NUCLEIC ACIDS RES, V17, P9291, DOI 10.1093/nar/17.22.9291; TAMURA K, 1993, J BIOL CHEM, V268, P15024; TAMURA K, 1992, NUCLEIC ACIDS RES, V20, P3617, DOI 10.1093/nar/20.14.3617; TAMURA K, 1994, J CLIN INVEST, V94, P1959, DOI 10.1172/JCI117547; Tamura K, 2000, P NATL ACAD SCI USA, V97, P8513, DOI 10.1073/pnas.100519097; Tamura K, 2007, CURR HYPERTENS REP, V9, P121, DOI 10.1007/s11906-007-0022-6; Tamura K, 2013, CURR PHARM DESIGN, V19, P3043; Tanaka Y, 2005, FEBS LETT, V579, P1579, DOI 10.1016/j.febslet.2005.01.068; Tsurumi Y, 2006, KIDNEY INT, V69, P488, DOI 10.1038/sj.ki.5000130; Vallet VS, 1997, J BIOL CHEM, V272, P21944, DOI 10.1074/jbc.272.35.21944; Vallet VS, 1998, J BIOL CHEM, V273, P20175, DOI 10.1074/jbc.273.32.20175; van Deursen D, 2008, DIABETOLOGIA, V51, P2078, DOI 10.1007/s00125-008-1125-6; Viollet B, 1996, J BIOL CHEM, V271, P1405, DOI 10.1074/jbc.271.3.1405; Wakui H, 2010, AM J PHYSIOL-RENAL, V299, pF991, DOI 10.1152/ajprenal.00738.2009; Wakui H, 2010, HYPERTENSION, V55, P1157, DOI 10.1161/HYPERTENSIONAHA.109.147207	64	11	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19238	19249		10.1074/jbc.M113.451054	http://dx.doi.org/10.1074/jbc.M113.451054			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23653383	Green Published, hybrid			2022-12-28	WOS:000321335800056
J	Bankston, AN; Li, WQ; Zhang, H; Ku, L; Liu, GL; Papa, F; Zhao, LX; Bibb, JA; Cambi, F; Tiwari-Woodruff, SK; Feng, Y				Bankston, Andrew N.; Li, Wenqi; Zhang, Hui; Ku, Li; Liu, Guanglu; Papa, Filomena; Zhao, Lixia; Bibb, James A.; Cambi, Franca; Tiwari-Woodruff, Seema K.; Feng, Yue			p39, the Primary Activator for Cyclin-dependent Kinase 5 (Cdk5) in Oligodendroglia, Is Essential for Oligodendroglia Differentiation and Myelin Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT; NERVOUS-SYSTEM; CELL-MIGRATION; RAT-BRAIN; TYROSINE KINASE; MESSENGER-RNA; WHITE-MATTER; EXPRESSION; PHOSPHORYLATION; REMYELINATION	Cyclin-dependent kinase 5 (Cdk5) plays key roles in normal brain development and function. Dysregulation of Cdk5 may cause neurodegeneration and cognitive impairment. Besides the well demonstrated role of Cdk5 in neurons, emerging evidence suggests the functional requirement of Cdk5 in oligodendroglia (OL) and CNS myelin development. However, whether neurons and OLs employ similar or distinct mechanisms to regulate Cdk5 activity remains elusive. We report here that in contrast to neurons that harbor high levels of two Cdk5 activators, p35 and p39, OLs express abundant p39 but negligible p35. In addition, p39 is selectively up-regulated in OLs during differentiation along with elevated Cdk5 activity, whereas p35 expression remains unaltered. Specific knockdown of p39 by siRNA significantly attenuates Cdk5 activity and OL differentiation without affecting p35. Finally, expression of p39, but not p35, is increased during myelin repair, and remyelination is impaired in p39(-/-) mice. Together, these results reveal that neurons and OLs harbor distinct preference of Cdk5 activators and demonstrate important functions of p39-dependent Cdk5 activation in OL differentiation during de novo myelin development and myelin repair.	[Bankston, Andrew N.; Li, Wenqi; Zhang, Hui; Ku, Li; Liu, Guanglu; Zhao, Lixia; Feng, Yue] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Cambi, Franca] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Bibb, James A.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Bibb, James A.] Univ Texas SW Med Ctr Dallas, Dept Neurol & Neurotherapeut, Dallas, TX 75390 USA; [Tiwari-Woodruff, Seema K.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	Emory University; University of Kentucky; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Los Angeles	Feng, Y (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	yfeng@emory.edu	Zhang, Hui/G-4770-2016; Papa, Frederico O/M-4310-2013	Papa, Frederico O/0000-0002-5858-8535; Feng, Yue/0000-0002-7905-2182	National Institutes of Health [NS053905, NS053905-03S2, MH083711, DA033485, NS073855, T32GM008602]; National Multiple Sclerosis Society [NMSSRG 4010-A]; Emory University Research Committee grant; National Institutes of Health Shared Instrument Program [S10 RR026827-01A1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075198, R01NS053905, R01NS073855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Emory University Research Committee grant; National Institutes of Health Shared Instrument Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS053905 (to Y. F.), NS053905-03S2 (to F. C.), and MH083711, DA033485, and NS073855 (to J. A. B.). This work was also supported by National Multiple Sclerosis Society Grant NMSSRG 4010-A (to Y. F.) and an Emory University Research Committee grant (to Y. F.).; Supported by National Institutes of Health Training Grant T32GM008602.; We thank Dr. Zixu Mao for the p39 construct, Dr. Nancy Ip for the anti-p39 antibody, and Gabriel Mettlach for technical assistance. We also thank Jennifer Strange for excellent technical assistance with the FACS isolation of OL. The FACS sorting facility at the University of Kentucky is supported in part by the National Institutes of Health Shared Instrument Program (S10 RR026827-01A1).	Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; An JH, 2009, J PROTEOME RES, V8, P2873, DOI 10.1021/pr900020q; Bankston AN, 2013, NEUROSCI BULL, V29, P216, DOI 10.1007/s12264-013-1321-3; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibbb JA, 2001, J BIOL CHEM, V276, P14490, DOI 10.1074/jbc.M007197200; Brinkkoetter PT, 2010, KIDNEY INT, V77, P690, DOI 10.1038/ki.2009.548; Cai XH, 1997, NEUROSCI RES, V28, P355, DOI 10.1016/S0168-0102(97)00063-1; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Chen YT, 2007, J BIOL CHEM, V282, P23553, DOI 10.1074/jbc.M702045200; Cheung ZH, 2012, TRENDS CELL BIOL, V22, P169, DOI 10.1016/j.tcb.2011.11.003; Crawford DK, 2009, J NEUROSCI METH, V182, P25, DOI 10.1016/j.jneumeth.2009.05.013; Delalle I, 1997, J NEUROCYTOL, V26, P283, DOI 10.1023/A:1018500617374; Fancy SPJ, 2010, EXP NEUROL, V225, P18, DOI 10.1016/j.expneurol.2009.12.020; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Filippova N, 2012, J BIOL CHEM, V287, P32277, DOI 10.1074/jbc.M112.353912; Gold BT, 2012, BBA-MOL BASIS DIS, V1822, P416, DOI 10.1016/j.bbadis.2011.07.009; Grant P, 2001, EUR J BIOCHEM, V268, P1534, DOI 10.1046/j.1432-1033.2001.02025.x; He XJ, 2011, NEUROCHEM RES, V36, P1293, DOI 10.1007/s11064-010-0391-0; Honjyo Y, 1999, NEUROREPORT, V10, P3375, DOI 10.1097/00001756-199911080-00022; Humbert S, 2000, J CELL SCI, V113, P975; Humbert S, 2000, NEUROREPORT, V11, P2213, DOI 10.1097/00001756-200007140-00030; Kansy JW, 2004, J NEUROCHEM, V91, P374, DOI 10.1111/j.1471-4159.2004.02723.x; Ko J, 2001, J NEUROSCI, V21, P6758; Lau AG, 2010, P NATL ACAD SCI USA, V107, P15945, DOI 10.1073/pnas.1002929107; Lazaro JB, 1997, J CELL SCI, V110, P1251; LEW J, 1992, J BIOL CHEM, V267, P13383; Liebl J, 2010, J BIOL CHEM, V285, P35932, DOI 10.1074/jbc.M110.126177; Lilja L, 2001, J BIOL CHEM, V276, P34199, DOI 10.1074/jbc.M103776200; Liu R, 2008, P NATL ACAD SCI USA, V105, P7570, DOI 10.1073/pnas.0712306105; LOUIS JC, 1992, J NEUROSCI RES, V31, P193, DOI 10.1002/jnr.490310125; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Miyamoto Y, 2007, J CELL SCI, V120, P4355, DOI 10.1242/jcs.018218; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Philpott A, 1997, GENE DEV, V11, P1409, DOI 10.1101/gad.11.11.1409; Ren Y, 2013, INT J NEUROPSYCHOPH, V16, P691, DOI 10.1017/S1461145712001095; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Tang XM, 1998, J CELL BIOCHEM, V68, P128, DOI 10.1002/(SICI)1097-4644(19980101)68:1<128::AID-JCB13>3.0.CO;2-D; Tripathi BK, 2009, MOL CELL BIOL, V29, P6488, DOI 10.1128/MCB.01098-09; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wu DC, 2000, NEUROCHEM RES, V25, P923, DOI 10.1023/A:1007544106645; Yang Y, 2013, DEV BIOL IN PRESS; Zhao LX, 2006, MOL BIOL CELL, V17, P4179, DOI 10.1091/mbc.E06-04-0355; Zheng M, 1998, J NEUROBIOL, V35, P141, DOI 10.1002/(SICI)1097-4695(199805)35:2<141::AID-NEU2>3.0.CO;2-4; Zhu H, 2012, GLIA, V60, P69, DOI 10.1002/glia.21248	55	12	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18047	18057		10.1074/jbc.M113.453688	http://dx.doi.org/10.1074/jbc.M113.453688			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645679	hybrid, Green Published			2022-12-28	WOS:000320721900011
J	Bjorkelid, C; Bergfors, T; Raichurkar, AKV; Mukherjee, K; Malolanarasimhan, K; Bandodkar, B; Jones, TA				Bjorkelid, Christofer; Bergfors, Terese; Raichurkar, Anand Kumar V.; Mukherjee, Kakoli; Malolanarasimhan, Krishnan; Bandodkar, Balachandra; Jones, T. Alwyn			Structural and Biochemical Characterization of Compounds Inhibiting Mycobacterium tuberculosis Pantothenate Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A; FEEDBACK-REGULATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ENZYME ACTION; LOCATION; GENE; REFINEMENT; QUALITY; ERRORS	Mycobacterium tuberculosis, the bacterial causative agent of tuberculosis, currently affects millions of people. The emergence of drug-resistant strains makes development of new antibiotics targeting the bacterium a global health priority. Pantothenate kinase, a key enzyme in the universal biosynthesis of the essential cofactor CoA, was targeted in this study to find new tuberculosis drugs. The biochemical characterizations of two new classes of compounds that inhibit pantothenate kinase from M. tuberculosis are described, along with crystal structures of their enzyme-inhibitor complexes. These represent the first crystal structures of this enzyme with engineered inhibitors. Both classes of compounds bind in the active site of the enzyme, overlapping with the binding sites of the natural substrate and product, pantothenate and phosphopantothenate, respectively. One class of compounds also interferes with binding of the cofactor ATP. The complexes were crystallized in two crystal forms, one of which is in a new space group for this enzyme and diffracts to the highest resolution reported for any pantothenate kinase structure. These two crystal forms allowed, for the first time, modeling of the cofactor-binding loop in both open and closed conformations. The structures also show a binding mode of ATP different from that previously reported for the M. tuberculosis enzyme but similar to that in the pantothenate kinases of other organisms.	[Bjorkelid, Christofer; Bergfors, Terese; Jones, T. Alwyn] Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, SE-75124 Uppsala, Sweden; [Raichurkar, Anand Kumar V.; Mukherjee, Kakoli; Malolanarasimhan, Krishnan; Bandodkar, Balachandra] AstraZeneca India Private Ltd, Bangalore 560024, Karnataka, India	Uppsala University; AstraZeneca	Bjorkelid, C (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Biomed Ctr, Box 596, SE-75124 Uppsala, Sweden.	christofer@xray.bmc.uu.se		Bjorkelid, Christofer/0000-0002-2780-7424	Foundation for Strategic Research; Uppsala University; Swedish Research Council	Foundation for Strategic Research; Uppsala University; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Foundation for Strategic Research, the Swedish Research Council, and Uppsala University.	Awasthy D, 2010, MICROBIOL-SGM, V156, P2691, DOI 10.1099/mic.0.040717-0; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brand LA, 2005, J BIOL CHEM, V280, P20185, DOI 10.1074/jbc.C500044200; Chetnani B, 2011, ACTA CRYSTALLOGR D, V67, P774, DOI 10.1107/S0907444911024462; Chetnani B, 2010, J MOL BIOL, V400, P171, DOI 10.1016/j.jmb.2010.04.064; Chetnani B, 2009, ACTA CRYSTALLOGR D, V65, P312, DOI 10.1107/S0907444909002170; Das S, 2006, ACTA CRYSTALLOGR D, V62, P628, DOI 10.1107/S0907444906012728; DUNN SD, 1979, J BACTERIOL, V140, P805, DOI 10.1128/JB.140.3.805-808.1979; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Harris M, 2001, ACTA CRYSTALLOGR D, V57, P1201, DOI 10.1107/S0907444901007697; Ivey RA, 2004, J BIOL CHEM, V279, P35622, DOI 10.1074/jbc.M403152200; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rock CO, 2002, GENE, V291, P35, DOI 10.1016/S0378-1119(02)00564-4; SONG WJ, 1994, J BIOL CHEM, V269, P27051; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; Venkatraman J, 2012, J BIOMOL SCREEN, V17, P293, DOI 10.1177/1087057111423069; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang K, 2006, J BACTERIOL, V188, P5532, DOI 10.1128/JB.00469-06; Yun M, 2000, J BIOL CHEM, V275, P28093; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	34	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18260	18270		10.1074/jbc.M113.476473	http://dx.doi.org/10.1074/jbc.M113.476473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23661699	Green Published, hybrid			2022-12-28	WOS:000320721900030
J	de Araujo, MEG; Stasyk, T; Taub, N; Ebner, HL; Furst, B; Filipek, P; Weys, SR; Hess, MW; Lindner, H; Kremser, L; Huber, LA				de Araujo, Mariana E. G.; Stasyk, Taras; Taub, Nicole; Ebner, Hannes L.; Fuerst, Beatrix; Filipek, Przemyslaw; Weys, Sabine R.; Hess, Michael W.; Lindner, Herbert; Kremser, Leopold; Huber, Lukas A.			Stability of the Endosomal Scaffold Protein LAMTOR3 Depends on Heterodimer Assembly and Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY CONTROL; CELL-LINE; COMPLEX; SIGNAL; P14; BINDING; MP1; P21(WAF1/CIP1); ACTIVATION; RAGULATOR	LAMTOR3 (MP1) and LAMTOR2 (p14) form a heterodimer as part of the larger Ragulator complex that is required for MAPK and mTOR1 signaling from late endosomes/lysosomes. Here, we show that loss of LAMTOR2 (p14) results in an unstable cytosolic monomeric pool of LAMTOR3 (MP1). Monomeric cytoplasmic LAMTOR3 is rapidly degraded in a proteasome-dependent but lysosome-independent manner. Mutational analyses indicated that the turnover of the protein is dependent on ubiquitination of several lysine residues. Similarly, other Ragulator subunits, LAMTOR1 (p18), LAMTOR4 (c7orf59), and LAMTOR5 (HBXIP), are degraded as well upon the loss of LAMTOR2. Thus the assembly of the Ragulator complex is monitored by cellular quality control systems, most likely to prevent aberrant signaling at the convergence of mTOR and MAPK caused by a defective Ragulator complex.	[de Araujo, Mariana E. G.; Stasyk, Taras; Taub, Nicole; Fuerst, Beatrix; Filipek, Przemyslaw; Weys, Sabine R.; Huber, Lukas A.] Med Univ Innsbruck, Bioctr, Div Cell Biol, A-6020 Innsbruck, Austria; [Lindner, Herbert; Kremser, Leopold] Med Univ Innsbruck, Bioctr, Core Facil Prot Microanal, A-6020 Innsbruck, Austria; [Ebner, Hannes L.; Hess, Michael W.] Med Univ Innsbruck, Div Histol & Embryol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Huber, LA (corresponding author), Med Univ Innsbruck, Bioctr, Div Cell Biol, Innrain 80-82, A-6020 Innsbruck, Austria.	lukas.a.huber@i-med.ac.at	Hess, Michael/AAE-1985-2019; Huber, Lukas Alfons/AAM-3499-2021	Hess, Michael/0000-0002-5154-3553; Stasyk, Taras/0000-0003-0568-6841; Eca Guimaraes de Araujo, Mariana/0000-0003-0576-2680; Huber, Lukas Alfons/0000-0003-1116-2120; Schider, Nicole/0000-0002-3579-3667	FWF Austrian Science Fund Special Research Program "Cell Proliferation and Cell Death in Tumors" [SFB021, P19486-B12]; Austrian Proteomics Platform APP Austrian Genome Program, GEN-AU; Austrian Bundesministerium fur Bildung, Wissenschaft, und Kultur	FWF Austrian Science Fund Special Research Program "Cell Proliferation and Cell Death in Tumors"; Austrian Proteomics Platform APP Austrian Genome Program, GEN-AU; Austrian Bundesministerium fur Bildung, Wissenschaft, und Kultur	This work was supported by FWF Austrian Science Fund Special Research Program "Cell Proliferation and Cell Death in Tumors" Grant SFB021 (to L. A. H.) and Grant P19486-B12 (to M. W. H.) and by funds from the Austrian Proteomics Platform APP Austrian Genome Program, GEN-AU (to L. A. H.).; Recipient of the Bertha von Suttner Grant from the Austrian Bundesministerium fur Bildung, Wissenschaft, und Kultur.	Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Bohn G, 2007, NAT MED, V13, P38, DOI 10.1038/nm1528; Brahma A, 2007, ARCH BIOCHEM BIOPHYS, V460, P85, DOI 10.1016/j.abb.2006.11.031; Brown MD, 2009, CELL SIGNAL, V21, P462, DOI 10.1016/j.cellsig.2008.11.013; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; CATLING AD, 1995, MOL CELL BIOL, V15, P5214; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; CHOWDARY DR, 1994, MOL CELL BIOL, V14, P1997, DOI 10.1128/MCB.14.3.1997; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Coulombe P, 2004, MOL CELL BIOL, V24, P6140, DOI 10.1128/MCB.24.14.6140-6150.2004; Cui QZ, 2008, J MOL BIOL, V379, P787, DOI 10.1016/j.jmb.2008.04.035; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoshino D, 2011, J BIOL CHEM, V286, P3139, DOI 10.1074/jbc.M110.159715; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kurzbauer R, 2004, P NATL ACAD SCI USA, V101, P10984, DOI 10.1073/pnas.0403435101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lunin VV, 2004, J BIOL CHEM, V279, P23422, DOI 10.1074/jbc.M401648200; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Qian CM, 2005, J MOL BIOL, V347, P309, DOI 10.1016/j.jmb.2005.01.031; Salerno M, 2005, MOL CELL BIOL, V25, P1379, DOI 10.1128/MCB.25.4.1379-1388.2005; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Stasyk T, 2010, PROTEOMICS, V10, P4117, DOI 10.1002/pmic.201000258; Taub N, 2012, J CELL SCI, V125, P2698, DOI 10.1242/jcs.100073; Teis D, 2002, DEV CELL, V3, P803, DOI 10.1016/S1534-5807(02)00364-7; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; THOMPSON WC, 1979, P NATL ACAD SCI USA, V76, P1318, DOI 10.1073/pnas.76.3.1318; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Wunderlich W, 2001, J CELL BIOL, V152, P765, DOI 10.1083/jcb.152.4.765	43	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18228	18242		10.1074/jbc.M112.349480	http://dx.doi.org/10.1074/jbc.M112.349480			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653355	Green Published, hybrid			2022-12-28	WOS:000320721900027
J	Makthal, N; Rastegari, S; Sanson, M; Ma, Z; Olsen, RJ; Helmann, JD; Musser, JM; Kumaraswami, M				Makthal, Nishanth; Rastegari, Sheila; Sanson, Misu; Ma, Zhen; Olsen, Randall J.; Helmann, John D.; Musser, James M.; Kumaraswami, Muthiah			Crystal Structure of Peroxide Stress Regulator from Streptococcus pyogenes Provides Functional Insights into the Mechanism of Oxidative Stress Sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUR HOMOLOGS; PERR; IRON; VIRULENCE; PROTEIN; GENE; DNA; TRANSCRIPTION; SUPEROXIDE; REGULON	Regulation of oxidative stress responses by the peroxide stress regulator (PerR) is critical for the in vivo fitness and virulence of group A Streptococcus. To elucidate the molecular mechanism of DNA binding, peroxide sensing, and gene regulation by PerR, we performed biochemical and structural characterization of PerR. Sequence-specific DNA binding by PerR does not require regulatory metal occupancy. However, metal binding promotes higher affinity PerR-DNA interactions. PerR metallated with iron directly senses peroxide stress and dissociates from operator sequences. The crystal structure revealed that PerR exists as a homodimer with two metal-binding sites per subunit as follows: a structural zinc site and a regulatory metal site that is occupied in the crystals by nickel. The regulatory metal-binding site in PerR involves a previously unobserved HXH motif located in its unique N-terminal extension. Mutational analysis of the regulatory site showed that the PerR metal ligands are involved in regulatory metal binding, and integrity of this site is critical for group A Streptococcus virulence. Interestingly, the metal-binding HXH motif is not present in the structurally characterized members of ferric uptake regulator (Fur) family but is fully conserved among PerR from the genus Streptococcus. Thus, it is likely that the PerR orthologs from streptococci share a common mechanism of metal binding, peroxide sensing, and gene regulation that is different from that of well characterized PerR from Bacillus subtilis. Together, our findings provide key insights into the peroxide sensing and regulation of the oxidative stress-adaptive responses by the streptococcal subfamily of PerR.	[Makthal, Nishanth; Rastegari, Sheila; Sanson, Misu; Olsen, Randall J.; Musser, James M.; Kumaraswami, Muthiah] Methodist Hosp Syst, Ctr Mol & Translat Human Infect Dis Res, Methodist Hosp Res Inst, Houston, TX 77030 USA; [Makthal, Nishanth; Rastegari, Sheila; Sanson, Misu; Olsen, Randall J.; Musser, James M.; Kumaraswami, Muthiah] Methodist Hosp Syst, Dept Pathol & Genom Med, Houston, TX 77030 USA; [Ma, Zhen; Helmann, John D.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; The Methodist Hospital System; The Methodist Hospital - Houston; Cornell University	Kumaraswami, M (corresponding author), Methodist Hosp Syst, Dept Pathol & Genom Med, Houston, TX 77030 USA.	mkumaraswami@tmhs.org	Makthal, Nishanth/J-8609-2019	Makthal, Nishanth/0000-0003-3464-8537; Helmann, John/0000-0002-3832-3249	American Heart Association Scientist Development grant; Office of Science, Office of Basic Energy Sciences, Material Sciences Division, of the United States Department of Energy at Lawrence Berkeley National Laboratory	American Heart Association Scientist Development grant(American Heart Association); Office of Science, Office of Basic Energy Sciences, Material Sciences Division, of the United States Department of Energy at Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	This work was supported in part by an American Heart Association Scientist Development grant (to M. K.).; We thank the beamline scientists and staff at Advanced Light Source beamline 8.3.1 for their great help with data collection. We also acknowledge the Advanced Light Source supported by the Director, Office of Science, Office of Basic Energy Sciences, Material Sciences Division, of the United States Department of Energy at Lawrence Berkeley National Laboratory.	Ahn BE, 2006, MOL MICROBIOL, V59, P1848, DOI 10.1111/j.1365-2958.2006.05065.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x; Brenot A, 2007, MOL MICROBIOL, V63, P1185, DOI 10.1111/j.1365-2958.2006.05577.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher J, 2012, P NATL ACAD SCI USA, V109, P10047, DOI 10.1073/pnas.1118321109; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; CONDON S, 1987, FEMS MICROBIOL LETT, V46, P269, DOI 10.1111/j.1574-6968.1987.tb02465.x; DeLano W.L, PYMOL MOL GRAPHICS S; Delany I, 2001, MOL MICROBIOL, V42, P1297, DOI 10.1046/j.1365-2958.2001.02696.x; Dian C, 2011, MOL MICROBIOL, V79, P1260, DOI 10.1111/j.1365-2958.2010.07517.x; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dubbs JM, 2012, J BACTERIOL, V194, P5495, DOI 10.1128/JB.00304-12; Faulkner MJ, 2012, J BACTERIOL, V194, P1226, DOI 10.1128/JB.06566-11; Faulkner MJ, 2011, ANTIOXID REDOX SIGN, V15, P175, DOI 10.1089/ars.2010.3682; Fuangthong M, 2003, J BACTERIOL, V185, P6348, DOI 10.1128/JB.185.21.6348-6357.2003; Gibson CM, 2000, J BACTERIOL, V182, P448, DOI 10.1128/JB.182.2.448-455.2000; Grifantini Renata, 2011, J Bacteriol, V193, P6539, DOI 10.1128/JB.05924-11; Gryllos I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000145; Herbig AF, 2001, MOL MICROBIOL, V41, P849, DOI 10.1046/j.1365-2958.2001.02543.x; Huffman JL, 2002, CURR OPIN STRUC BIOL, V12, P98, DOI 10.1016/S0959-440X(02)00295-6; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jacquamet L, 2009, MOL MICROBIOL, V73, P20, DOI 10.1111/j.1365-2958.2009.06753.x; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; King KY, 2000, J BACTERIOL, V182, P5290, DOI 10.1128/JB.182.19.5290-5299.2000; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lee JW, 2006, J BIOL CHEM, V281, P23567, DOI 10.1074/jbc.M603968200; Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26, P27; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li J, 1997, P NATL ACAD SCI USA, V94, P13251, DOI 10.1073/pnas.94.24.13251; Lucana DOD, 2000, MOL GEN GENET, V264, P341; Lucarelli D, 2007, J BIOL CHEM, V282, P9914, DOI 10.1074/jbc.M609974200; Lukomski S, 2000, INFECT IMMUN, V68, P535, DOI 10.1128/IAI.68.2.535-542.2000; Nunoshiba T, 1999, J BIOL CHEM, V274, P34832, DOI 10.1074/jbc.274.49.34832; Olsen RJ, 2009, CELL MICROBIOL, V11, P1, DOI 10.1111/j.1462-5822.2008.01225.x; Ricci S, 2002, INFECT IMMUN, V70, P4968, DOI 10.1128/IAI.70.9.4968-4976.2002; Robinson JM, 2009, HISTOCHEM CELL BIOL, V131, P465, DOI 10.1007/s00418-009-0565-5; Sheikh MA, 2009, MOL MICROBIOL, V72, P1208, DOI 10.1111/j.1365-2958.2009.06718.x; Shelburne SA, 2011, MOL MICROBIOL, V82, P1481, DOI 10.1111/j.1365-2958.2011.07902.x; Shin JH, 2011, P NATL ACAD SCI USA, V108, P5045, DOI 10.1073/pnas.1017744108; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P501, DOI 10.1107/S0907444998012657; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traore DAK, 2006, MOL MICROBIOL, V61, P1211, DOI 10.1111/j.1365-2958.2006.05313.x; Traore DAK, 2009, NAT CHEM BIOL, V5, P53, DOI 10.1038/nchembio.133; van Vliet AHM, 1999, J BACTERIOL, V181, P6371, DOI 10.1128/JB.181.20.6371-6376.1999; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102	50	43	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18311	18324		10.1074/jbc.M113.456590	http://dx.doi.org/10.1074/jbc.M113.456590			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645680	hybrid, Green Published			2022-12-28	WOS:000320721900035
J	Sasser, TL; Lawrence, G; Karunakaran, S; Brown, C; Fratti, RA				Sasser, Terry L.; Lawrence, Gus; Karunakaran, Surya; Brown, Christopher; Fratti, Rutilio A.			The Yeast ATP-binding Cassette (ABC) Transporter Ycf1p Enhances the Recruitment of the Soluble SNARE Vam7p to Vacuoles for Efficient Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; VERTEX RING DOMAIN; SACCHAROMYCES-CEREVISIAE; PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; HOMOTYPIC FUSION; HOPS COMPLEX; PROTEIN; DOCKING; LIPIDS; CELLS	The Saccharomyces cerevisiae vacuole contains five ATP-binding cassette class C (ABCC) transporters, including Ycf1p, a family member that was originally characterized as a Cd2+ transporter. Ycf1p has also been found to physically interact with a wide array of proteins, including factors that regulate vacuole homeostasis. In this study, we examined the role of Ycf1p and other ABCC transporters in the regulation of vacuole homotypic fusion. We found that deletion of YCF1 attenuated in vitro vacuole fusion by up to 40% relative to wild-type vacuoles. Plasmid-expressed wild-type Ycf1p rescued the deletion phenotype; however, Ycf1p containing a mutation of the conserved Lys-669 to Met in the Walker A box of the first nucleotide-binding domain (Ycf1p(K669M)) was unable to complement the fusion defect of ycf1 Delta vacuoles. This indicates that the ATPase activity of Ycf1p is required for its function in regulating fusion. In addition, we found that deleting YCF1 caused a striking decrease in vacuolar levels of the soluble SNARE Vam7p, whereas total cellular levels were not altered. The attenuated fusion of ycf1 Delta vacuoles was rescued by the addition of recombinant Vam7p to in vitro experiments. Thus, Ycf1p contributes in the recruitment of Vam7p to the vacuole for efficient membrane fusion.	[Sasser, Terry L.; Lawrence, Gus; Karunakaran, Surya; Brown, Christopher; Fratti, Rutilio A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Fratti, RA (corresponding author), Univ Illinois, Dept Biochem, 419 Roger Adams Lab,B-4,600 S Mathews Ave, Urbana, IL 61801 USA.	rfratti@illinois.edu			National Institutes of Health [GM101132]; University of Illinois Research Board; National Science Foundation-Cellular and Molecular Mechanics and BioNanotechnology Integrative Graduate Education Research Training fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Illinois Research Board; National Science Foundation-Cellular and Molecular Mechanics and BioNanotechnology Integrative Graduate Education Research Training fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM101132 (to R. A. F.). This work was also supported by a grant from the University of Illinois Research Board (to R. A. F.).; Supported by a National Science Foundation-Cellular and Molecular Mechanics and BioNanotechnology Integrative Graduate Education Research Training fellowship.	Bared SM, 2004, MOL BIOL CELL, V15, P5399, DOI 10.1091/mbc.E04-03-0182; Boeddinghaus C, 2002, J CELL BIOL, V157, P79, DOI 10.1083/jcb.200112098; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; Collins KM, 2007, P NATL ACAD SCI USA, V104, P8755, DOI 10.1073/pnas.0702290104; Efe JA, 2005, CURR OPIN CELL BIOL, V17, P402, DOI 10.1016/j.ceb.2005.06.002; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Eitzen G, 2001, EMBO J, V20, P5650, DOI 10.1093/emboj/20.20.5650; Fratti RA, 2004, J CELL BIOL, V167, P1087, DOI 10.1083/jcb.200409068; Fratti RA, 2007, J BIOL CHEM, V282, P14861, DOI 10.1074/jbc.M700971200; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Ganeshan R, 2003, J BIOL CHEM, V278, P2876, DOI 10.1074/jbc.M211790200; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Goldstein AL, 1999, YEAST, V15, P507, DOI 10.1002/(SICI)1097-0061(199904)15:6<507::AID-YEA369>3.0.CO;2-P; Gueldry O, 2003, EUR J BIOCHEM, V270, P2486, DOI 10.1046/j.1432-1033.2003.03620.x; Gulshan K, 2011, TRAFFIC, V12, P1257, DOI 10.1111/j.1600-0854.2011.01228.x; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JONES EW, 1982, GENETICS, V102, P665; Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200; Jun Y, 2007, P NATL ACAD SCI USA, V104, P13010, DOI 10.1073/pnas.0700970104; Karunakaran S, 2013, TRAFFIC, V14, P650, DOI 10.1111/tra.12064; Karunakaran S, 2012, J CELL SCI, V125, P1683, DOI 10.1242/jcs.091900; Lee ME, 2011, GENETICS, V188, P859, DOI 10.1534/genetics.111.130724; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mayer A, 2000, MOL BIOL CELL, V11, P807, DOI 10.1091/mbc.11.3.807; Merz AJ, 2004, J CELL BIOL, V164, P195, DOI 10.1083/jcb.200310105; Michell RH, 2006, TRENDS BIOCHEM SCI, V31, P52, DOI 10.1016/j.tibs.2005.11.013; Ortiz DF, 1997, J BIOL CHEM, V272, P15358, DOI 10.1074/jbc.272.24.15358; Parrish WR, 2004, MOL BIOL CELL, V15, P3567, DOI 10.1091/mbc.E04-03-0209; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Paumi CM, 2009, MICROBIOL MOL BIOL R, V73, P577, DOI 10.1128/MMBR.00020-09; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Petrovic S, 2000, YEAST, V16, P561, DOI 10.1002/(SICI)1097-0061(200004)16:6<561::AID-YEA551>3.0.CO;2-L; Qiu QS, 2010, J CELL SCI, V123, P3266, DOI 10.1242/jcs.067637; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sasser TL, 2012, BIOCHEM J, V448, P365, DOI 10.1042/BJ20120847; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051; SZCZYPKA MS, 1994, J BIOL CHEM, V269, P22853; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Ungermann C, 1998, EMBO J, V17, P3269, DOI 10.1093/emboj/17.12.3269; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang L, 2003, J CELL BIOL, V160, P365, DOI 10.1083/jcb.200209095; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Wemmie JA, 1997, MOL MICROBIOL, V25, P683, DOI 10.1046/j.1365-2958.1997.5061868.x; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; YAMAMOTO A, 1995, MOL BIOL CELL, V6, P525, DOI 10.1091/mbc.6.5.525	57	16	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18300	18310		10.1074/jbc.M112.441089	http://dx.doi.org/10.1074/jbc.M112.441089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23658021	Green Published, hybrid			2022-12-28	WOS:000320721900034
J	Schramm, C; Edwards, MA; Krenz, M				Schramm, Christine; Edwards, Michelle A.; Krenz, Maike			New Approaches to Prevent LEOPARD Syndrome-associated Cardiac Hypertrophy by Specifically Targeting Shp2-dependent Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; TYROSINE-PHOSPHATASE SHP-2; NOONAN-SYNDROME; MICE LACKING; PTPN11 GENE; VENTRICULAR HYPERTROPHY; GLUCOSE-HOMEOSTASIS; GROWTH; MUTATIONS; CARDIOMYOPATHY	In LEOPARD syndrome (LS) patients, mutations in the protein tyrosine phosphatase Shp2 cause hypertrophic cardiomyopathy. The prohypertrophic effects of mutant Shp2 are mediated downstream by hyperactivation of mammalian target of rapamycin. Our goal was to further define the signaling cascade that is essential for the underlying pathomechanism, thus expanding the list of potential future therapeutic targets. Using cultured neonatal rat cardiomyocytes with adenoviral gene delivery and pharmacological inhibitors, we found that hypertrophy induced by a particularly aggressive LS mutation in Shp2 depends on hyperactivation of Akt and focal adhesion kinase as well as mammalian target of rapamycin. Dissecting domain-specific functions of Shp2 using double and truncation mutants, we determined that the hypertrophic effects of mutant Shp2 depend on the two SH2 domains and on an intact catalytic center. The latter finding prompted us to test the efficacy of a Shp2 inhibitor targeted directly at the catalytic pocket. This compound, PHPS1, effectively prevented mutant Shp2-induced hypertrophy. In summary, we identified three novel targets for pharmacological therapy of LS-associated cardiac hypertrophy. Of particular importance is the finding that intervention directly at the mutant Shp2 protein is effective because this would facilitate custom-tailored therapeutic approaches for patients carrying LS mutations in Shp2.	[Schramm, Christine; Edwards, Michelle A.; Krenz, Maike] Univ Missouri, Dept Med Pharmacol & Physiol, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Krenz, M (corresponding author), Dalton Cardiovasc Res Ctr, 134 Res Pk Dr, Columbia, MO 65211 USA.	krenzm@missouri.edu		Krenz, Maike/0000-0003-3784-287X	American Heart Association [0635472N]; University of Missouri research board grant	American Heart Association(American Heart Association); University of Missouri research board grant	This work was supported in part by American Heart Association Scientist Development Grant 0635472N (to M. K.) and by a University of Missouri research board grant (to M. K).	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Cerrato F, 2008, CARDIOL YOUNG, V18, P575, DOI 10.1017/S104795110800320X; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; DeBosch B, 2006, J BIOL CHEM, V281, P32841, DOI 10.1074/jbc.M513087200; Dhandapany PS, 2011, J MOL CELL CARDIOL, V51, P4, DOI 10.1016/j.yjmcc.2011.03.001; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; DiMichele LA, 2009, CIRC RES, V104, P1201, DOI 10.1161/CIRCRESAHA.109.195941; Doherty JT, 2010, GENESIS, V48, P492, DOI 10.1002/dvg.20650; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Edouard T, 2010, MOL CELL BIOL, V30, P2498, DOI 10.1128/MCB.00646-09; Faienza MF, 2009, PEDIATR CARDIOL, V30, P1012, DOI 10.1007/s00246-009-9473-7; Feng H, 2012, ONCOGENE, V31, P2691, DOI 10.1038/onc.2011.436; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; GORLIN RJ, 1969, AM J DIS CHILD, V117, P652, DOI 10.1001/archpedi.1969.02100030654006; Hanna N, 2006, FEBS LETT, V580, P2477, DOI 10.1016/j.febslet.2006.03.088; Heidkamp MC, 2002, CIRC RES, V90, P1282, DOI 10.1161/01.RES.0000023201.41774.EA; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Ishida H, 2011, AM J PHYSIOL-HEART C, V301, pH1531, DOI 10.1152/ajpheart.00216.2011; Jakob S, 2008, J BIOL CHEM, V283, P33155, DOI 10.1074/jbc.M805138200; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Krenz M, 2005, CIRC RES, V97, P813, DOI 10.1161/01.RES.0000186194.06514.b0; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Manes S, 1999, MOL CELL BIOL, V19, P3125; Marian AJ, 2010, EUR J CLIN INVEST, V40, P360, DOI 10.1111/j.1365-2362.2010.02268.x; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Merritt R, 2006, BBA-MOL CELL RES, V1763, P45, DOI 10.1016/j.bbamcr.2005.11.013; Mollmann H, 2008, J INT MED RES, V36, P810; Nakamura T, 2007, J CLIN INVEST, V117, P2123, DOI 10.1172/JCI30756; Oishi K, 2009, HUM MOL GENET, V18, P193, DOI 10.1093/hmg/ddn336; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Schramm C, 2012, AM J PHYSIOL-HEART C, V302, pH231, DOI 10.1152/ajpheart.00665.2011; Stewart RA, 2010, DEV CELL, V18, P750, DOI [10.1016/j.devcel.2010.03.009, 10.1016/j.devce1.2010.03.009]; Takahashi K, 2005, EUR J PEDIATR, V164, P497, DOI 10.1007/s00431-005-1679-y; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Vadali K, 2007, IUBMB LIFE, V59, P709, DOI 10.1080/15216540701694245; von Wichert G, 2003, EMBO J, V22, P5023, DOI 10.1093/emboj/cdg492; Wang LJ, 2002, CIRC RES, V91, P821, DOI 10.1161/01.RES.0000041029.97988.E9; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005	45	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18335	18344		10.1074/jbc.M113.483800	http://dx.doi.org/10.1074/jbc.M113.483800			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23673659	Green Published, hybrid			2022-12-28	WOS:000320721900037
J	Menyhard, DK; Kiss-Szeman, A; Tichy-Racs, E; Hornung, B; Radi, K; Szeltner, Z; Domokos, K; Szamosi, I; Naray-Szabo, G; Polgar, L; Harmat, V				Menyhard, Dora K.; Kiss-Szeman, Anna; Tichy-Racs, Eva; Hornung, Balazs; Radi, Krisztina; Szeltner, Zoltan; Domokos, Klarissza; Szamosi, Ilona; Naray-Szabo, Gabor; Polgar, Laszlo; Harmat, Veronika			A Self-compartmentalizing Hexamer Serine Protease from Pyrococcus Horikoshii SUBSTRATE SELECTION ACHIEVED THROUGH MULTIMERIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL-PEPTIDASE-IV; BETA-PROPELLER DOMAIN; AEROPYRUM-PERNIX K1; CRYSTAL-STRUCTURE; PROLYL OLIGOPEPTIDASE; ACYLPEPTIDE HYDROLASE; HALOALKANE DEHALOGENASE; ACYLAMINOACYL PEPTIDASE; ALPHA/BETA-HYDROLASE; MOLECULAR-DYNAMICS	Oligopeptidases impose a size limitation on their substrates, the mechanism of which has long been under debate. Here we present the structure of a hexameric serine protease, an oligopeptidase from Pyrococcus horikoshii (PhAAP), revealing a complex, self-compartmentalized inner space, where substrates may access the monomer active sites passing through a double-gated "check-in" system, first passing through a pore on the hexamer surface and then turning to enter through an even smaller opening at the monomers' domain interface. This substrate screening strategy is unique within the family. We found that among oligopeptidases, a residue of the catalytic apparatus is positioned near an amylogenic beta-edge, which needs to be protected to prevent aggregation, and we found that different oligopeptidases use different strategies to achieve such an end. We propose that self-assembly within the family results in characteristically different substrate selection mechanisms coupled to different multimerization states.	[Harmat, Veronika] Eotvos Lorand Univ, Hungarian Acad Sci, Prot Modeling Res Grp, H-1117 Budapest, Hungary; [Kiss-Szeman, Anna; Tichy-Racs, Eva; Hornung, Balazs; Radi, Krisztina; Naray-Szabo, Gabor; Harmat, Veronika] Eotvos Lorand Univ, Inst Chem, Lab Struct Chem & Biol, H-1117 Budapest, Hungary; [Szeltner, Zoltan; Domokos, Klarissza; Szamosi, Ilona; Polgar, Laszlo] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, H-1113 Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Harmat, V (corresponding author), Eotvos Lorand Univ, Inst Chem, Pazmany Peter Setany 1-A, H-1117 Budapest, Hungary.	veronika@chem.elte.hu	Menyhárd, Dóra K./AAE-4527-2021; Harmat, Veronika/B-8033-2016	Menyhárd, Dóra K./0000-0002-0095-5531; Harmat, Veronika/0000-0002-1866-9904	Hungarian Scientific Research Fund (OTKA) [PD101095, NK101072, NK67800]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by Hungarian Scientific Research Fund (OTKA) Grants PD101095, NK101072, and NK67800.	Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biswal BK, 2008, J MOL BIOL, V381, P897, DOI 10.1016/j.jmb.2008.06.030; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bosch J, 2007, ACTA CRYSTALLOGR D, V63, P179, DOI 10.1107/S0907444906045471; Cha SS, 2010, EMBO J, V29, P3520, DOI 10.1038/emboj.2010.226; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Clark LA, 2005, PROTEIN SCI, V14, P653, DOI 10.1110/ps.041017305; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Duysen EG, 2001, J PHARMACOL EXP THER, V299, P528; Eldrup AB, 2010, BIOORG MED CHEM LETT, V20, P571, DOI 10.1016/j.bmcl.2009.11.091; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel M, 2006, J MOL BIOL, V355, P768, DOI 10.1016/j.jmb.2005.11.014; Engel M, 2003, P NATL ACAD SCI USA, V100, P5063, DOI 10.1073/pnas.0230620100; ERLANDSSON R, 1991, ONCOGENE, V6, P1293; FRANKEN SM, 1991, EMBO J, V10, P1297, DOI 10.1002/j.1460-2075.1991.tb07647.x; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Fuxreiter M, 2005, PROTEINS, V60, P504, DOI 10.1002/prot.20508; Goettig P, 2002, EMBO J, V21, P5343, DOI 10.1093/emboj/cdf552; Harmat V, 2011, J BIOL CHEM, V286, P1987, DOI 10.1074/jbc.M110.169862; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hiramatsu H, 2003, BIOCHEM BIOPH RES CO, V302, P849, DOI 10.1016/S0006-291X(03)00258-4; Hofmann B, 1998, J MOL BIOL, V279, P889, DOI 10.1006/jmbi.1998.1802; JOSHUATOR L, 1995, SCIENCE, V269, P945, DOI 10.1126/science.7638617; Juhasz R, 2007, PROTEINS, V69, P633, DOI 10.1002/prot.21522; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim JS, 2002, J MOL BIOL, V324, P1041, DOI 10.1016/S0022-2836(02)01153-1; Kim KK, 1997, STRUCTURE, V5, P1571, DOI 10.1016/S0969-2126(97)00306-7; Kiss AL, 2008, J STRUCT BIOL, V162, P312, DOI 10.1016/j.jsb.2008.01.012; Kiss AL, 2007, J MOL BIOL, V368, P509, DOI 10.1016/j.jmb.2007.02.025; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; McLuskey K, 2010, J BIOL CHEM, V285, P39249, DOI 10.1074/jbc.M110.156679; Medrano FJ, 1998, EMBO J, V17, P1, DOI 10.1093/emboj/17.1.1; Monincova M, 2007, APPL ENVIRON MICROB, V73, P2005, DOI 10.1128/AEM.02416-06; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAYLOR SL, 1989, GENOMICS, V4, P355, DOI 10.1016/0888-7543(89)90342-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Palmieri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025888; PATHAK D, 1990, J MOL BIOL, V214, P497, DOI 10.1016/0022-2836(90)90196-S; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Prokop Z, 2010, ANGEW CHEM INT EDIT, V49, P6111, DOI 10.1002/anie.201001753; Richards PG, 2000, MOL PHARMACOL, V58, P577, DOI 10.1124/mol.58.3.577; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; ROULD MA, 1991, NATURE, V352, P213, DOI 10.1038/352213a0; SCALONI A, 1992, J LAB CLIN MED, V120, P546; Schmidt A, 2008, J BIOL CHEM, V283, P21827, DOI 10.1074/jbc.M801056200; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soldi G, 2005, BIOPHYS J, V89, P4234, DOI 10.1529/biophysj.105.067538; Stefani M, 2004, BBA-MOL BASIS DIS, V1739, P5, DOI 10.1016/j.bbadis.2004.08.004; Szeltner Z, 2002, J BIOL CHEM, V277, P42613, DOI 10.1074/jbc.M208043200; Szeltner Z, 2008, CURR PROTEIN PEPT SC, V9, P96; Szeltner Z, 2009, BBA-PROTEINS PROTEOM, V1794, P1204, DOI 10.1016/j.bbapap.2009.03.004; Thoms S, 2011, J STRUCT BIOL, V175, P362, DOI 10.1016/j.jsb.2011.06.008; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Zhang ZM, 2008, BBA-PROTEINS PROTEOM, V1784, P1176, DOI 10.1016/j.bbapap.2008.05.011	63	15	15	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17884	17894		10.1074/jbc.M113.451534	http://dx.doi.org/10.1074/jbc.M113.451534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632025	hybrid, Green Published			2022-12-28	WOS:000320380600076
J	Seki, T; Gong, LJ; Williams, AJ; Sakai, N; Todi, SV; Paulson, HL				Seki, Takahiro; Gong, Lijie; Williams, Aislinn J.; Sakai, Norio; Todi, Sokol V.; Paulson, Henry L.			JosD1, a Membrane-targeted Deubiquitinating Enzyme, Is Activated by Ubiquitination and Regulates Membrane Dynamics, Cell Motility, and Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYGLUTAMINE DISEASE PROTEIN; MACHADO-JOSEPH-DISEASE; INDUCED MACROPINOCYTOSIS; ATAXIN-3; SUBSTRATE; CHAINS	The functional diversity of deubiquitinating enzymes (DUBs) is not well understood. The MJD family of DUBs consists of four cysteine proteases that share a catalytic "Josephin" domain. The family is named after the DUB ATXN3, which causes the neuro-degenerative disease Machado-Joseph disease. The two closely related Josephin domain-containing (JosD) proteins 1 and 2 consist of little more than the Josephin domain. To gain insight into the properties of Josephin domains, we investigated JosD1 and JosD2. JosD1 and JosD2 were found to differ fundamentally in many respects. In vitro, only JosD2 can cleave ubiquitin chains. In contrast, JosD1 cleaves ubiquitin chains only after it is monoubiquitinated, a form of posttranslational-dependent regulation shared with ATXN3. A significant fraction of JosD1 is monoubiquitinated in diverse mouse tissues. In cell-based studies, JosD2 localizes to the cytoplasm whereas JosD1 preferentially localizes to the plasma membrane, particularly when ubiquitinated. The membrane occupancy by JosD1 suggests that it could participate in membrane-dependent events such as cell motility and endocytosis. Indeed, time-lapse imaging revealed that JosD1 enhances membrane dynamics and cell motility. JosD1 also influences endocytosis in cultured cells by increasing the uptake of endocytic markers of macropinocytosis while decreasing those for clathrin- and caveolae-mediated endocytosis. Our results establish that two closely related DUBs differ markedly in activity and function and that JosD1, a membrane-associated DUB whose activity is regulated by ubiquitination, helps regulate membrane dynamics, cell motility, and endocytosis.	[Seki, Takahiro; Gong, Lijie; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Seki, Takahiro; Sakai, Norio] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Pharmacol Neurosci, Hiroshima 7348551, Japan; [Williams, Aislinn J.] Univ Iowa, Program Neurosci, Iowa City, IA 52242 USA; [Williams, Aislinn J.] Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA; [Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA	University of Michigan System; University of Michigan; Hiroshima University; University of Iowa; University of Iowa; Wayne State University; Wayne State University	Paulson, HL (corresponding author), Univ Michigan, Dept Neurol, 109 Zina Pitcher Pl,BSRB 4100, Ann Arbor, MI 48109 USA.	henryp@umich.edu	Williams, Aislinn/T-5661-2017; Sakai, Norio/AAM-5822-2021; Williams, Aislinn/V-2742-2019	Williams, Aislinn/0000-0002-8139-2303; Sakai, Norio/0000-0002-6648-8761; Williams, Aislinn/0000-0002-8139-2303; Seki, Takahiro/0000-0002-9894-4768	National Institutes of Health [R00 NS064097, R01 NS038712]; Grants-in-Aid for Scientific Research [25293061] Funding Source: KAKEN; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038712, R00NS064097] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R00 NS064097 (to S. V. T.) and R01 NS038712 (to H. L. P.).	Al Soraj M, 2012, J CONTROL RELEASE, V161, P132, DOI 10.1016/j.jconrel.2012.03.015; Amyere M, 2002, INT J MED MICROBIOL, V291, P487; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Burrows JF, 2012, FRONT BIOSCI-LANDMRK, V17, P1184, DOI 10.2741/3980; Costa MD, 2012, PROG NEUROBIOL, V97, P239, DOI 10.1016/j.pneurobio.2011.11.006; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hubsman MW, 2007, BIOCHEM J, V404, P487, DOI 10.1042/BJ20061696; Kabayama H, 2009, MOL CELL NEUROSCI, V40, P27, DOI 10.1016/j.mcn.2008.08.009; Kolpak AL, 2009, J NEUROSCI, V29, P10488, DOI 10.1523/JNEUROSCI.2355-09.2009; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee E, 2002, TRAFFIC, V3, P186, DOI 10.1034/j.1600-0854.2002.030304.x; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Loch CM, 2012, BBA-MOL CELL RES, V1823, P2069, DOI 10.1016/j.bbamcr.2012.05.006; Orme M, 2012, EMBO J, V31, P1, DOI 10.1038/emboj.2011.452; Prieto-Sanchez RM, 2006, ONCOGENE, V25, P2961, DOI 10.1038/sj.onc.1209333; RACOOSIN EL, 1992, J CELL SCI, V102, P867; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Schaefer A, 2012, BIOCHEM J, V442, P13, DOI 10.1042/BJ20111815; Seki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031232; Sippl W, 2011, FUTURE ONCOL, V7, P619, DOI [10.2217/FON.11.39, 10.2217/fon.11.39]; Todi SV, 2007, J BIOL CHEM, V282, P29348, DOI 10.1074/jbc.M704126200; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tsou WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043112; Tzvetkov N, 2007, BIOL CHEM, V388, P973, DOI 10.1515/BC.2007.107; Weeks SD, 2011, J BIOL CHEM, V286, P4555, DOI 10.1074/jbc.M110.177360; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200	33	44	52	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17145	17155		10.1074/jbc.M113.463406	http://dx.doi.org/10.1074/jbc.M113.463406			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625928	hybrid, Green Published			2022-12-28	WOS:000320380600012
J	Estrada, DF; Laurence, JS; Scott, EE				Estrada, D. Fernando; Laurence, Jennifer S.; Scott, Emily E.			Substrate-modulated Cytochrome P450 17A1 and Cytochrome b7(5) Interactions Revealed by NMR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							17,20-LYASE ACTIVITY; P450 OXIDOREDUCTASE; ABIRATERONE ACETATE; STRUCTURAL-ANALYSIS; MASS-SPECTROMETRY; CATIONIC CHARGES; BINDING-SITE; HUMAN CYP17; B(5); REDUCTASE	The membrane heme protein cytochrome b(5) (b(5)) can enhance, inhibit, or have no effect on cytochrome P450 (P450) catalysis, depending on the specific P450, substrate, and reaction conditions, but the structural basis remains unclear. Here the interactions between the soluble domain of microsomal b(5) and the catalytic domain of the bifunctional steroidogenic cytochrome P450 17A1 (CYP17A1) were investigated. CYP17A1 performs both steroid hydroxylation, which is unaffected by b5, and an androgen-forming lyase reaction that is facilitated 10-fold by b5. NMR chemical shift mapping of b5 titrations with CYP17A1 indicates that the interaction occurs in an intermediate exchange regime and identifies charged surface residues involved in the protein/protein interface. The role of these residues is confirmed by disruption of the complex upon mutagenesis of either the anionic b(5) residues (Glu-48 or Glu-49) or the corresponding cationic CYP17A1 residues (Arg-347, Arg-358, or Arg-449). Cytochrome b(5) binding to CYP17A1 is also mutually exclusive with binding of NADPH-cytochrome P450 reductase. To probe the differential effects of b(5) on the two CYP17A1mediated reactions and, thus, communication between the superficial b(5) binding site and the buried CYP17A1 active site, CYP17A1/b(5) complex formation was characterized with either hydroxylase or lyase substrates bound to CYP17A1. Significantly, the CYP17A1/b(5) interaction is stronger when the hydroxylase substrate pregnenolone is present in the CYP17A1 active site than when the lyase substrate 17 alpha-hydroxypregnenolone is in the active site. These findings form the basis for a clearer understanding of this important interaction by directly measuring the reversible binding of the two proteins, providing evidence of communication between the CYP17A1 active site and the superficial proximal b(5) binding site.	[Estrada, D. Fernando; Scott, Emily E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Laurence, Jennifer S.] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Scott, EE (corresponding author), Univ Kansas, Dept Med Chem, 1251 Wescoe Hall Dr, Lawrence, KS 66045 USA.	eescott@ku.edu	Laurence, Jennifer/N-8027-2013	Laurence, Jennifer/0000-0002-1686-5979	NIGMSNational Institutes of Health [F32 GM103069, R01 GM076343]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM103069, R01GM076343] Funding Source: NIH RePORTER	NIGMSNational Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NIGMSNational Institutes of Health Grant F32 GM103069 (to D.F.E.) and R01 GM076343 (to E.E.S.).	Akhtar MK, 2005, J ENDOCRINOL, V187, P267, DOI 10.1677/joe.1.06375; Akhtar M, 2011, J STEROID BIOCHEM, V125, P2, DOI 10.1016/j.jsbmb.2010.11.003; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Attard G, 2009, CANCER RES, V69, P4937, DOI 10.1158/0008-5472.CAN-08-4531; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Banci L, 1997, EUR J BIOCHEM, V249, P270, DOI 10.1111/j.1432-1033.1997.t01-1-00270.x; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Durley RCE, 1996, ACTA CRYSTALLOGR D, V52, P65, DOI 10.1107/S0907444995007827; Gao QX, 2006, J BIOL CHEM, V281, P20404, DOI 10.1074/jbc.M601785200; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Gilep AA, 2001, ARCH BIOCHEM BIOPHYS, V390, P215, DOI 10.1006/abbi.2001.2372; GORSKY LD, 1986, DRUG METAB DISPOS, V14, P89; HALL PF, 1991, J STEROID BIOCHEM, V40, P527, DOI 10.1016/0960-0760(91)90272-7; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Lee-Robichaud P, 2004, J STEROID BIOCHEM, V92, P119, DOI 10.1016/j.jsbmb.2004.07.005; Lee-Robichaud P, 1999, BIOCHEM J, V342, P309, DOI 10.1042/0264-6021:3420309; LeeRobichaud P, 1997, BIOCHEM J, V321, P857, DOI 10.1042/bj3210857; LIN D, 1994, MOL ENDOCRINOL, V8, P392, DOI 10.1210/me.8.3.392; Liu Y, 2007, J ANDROL, V28, P453, DOI 10.2164/jandrol.106.002006; Miller WL, 2012, J CLIN ENDOCR METAB, V97, P59, DOI 10.1210/jc.2011-2161; Miller WL, 1998, ENDOCR RES, V24, P817, DOI 10.3109/07435809809032692; Mulrooney SB, 2004, BBA-GEN SUBJECTS, V1674, P319, DOI 10.1016/j.bbagen.2004.08.001; Naffin-Olivos JL, 2006, BIOCHEMISTRY-US, V45, P755, DOI 10.1021/bi051623y; NEW MI, 1970, J CLIN INVEST, V49, P1930, DOI 10.1172/JCI106412; Nguyen AD, 2009, ENDOCRINOLOGY, V150, P1748, DOI 10.1210/en.2008-1303; Nunez M, 2010, J BIOMOL NMR, V47, P289, DOI 10.1007/s10858-010-9428-6; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU, p[133, 448]; Pechurskaya TA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P806, DOI 10.1134/S0006297908070092; Peng HM, 2013, BIOCHEMISTRY-US, V52, P210, DOI 10.1021/bi301384n; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; SCHENKMAN JB, 1994, ARCH BIOCHEM BIOPHYS, V314, P234, DOI 10.1006/abbi.1994.1435; SHEN AL, 1989, J BIOL CHEM, V264, P7584; Sherbet DP, 2003, J BIOL CHEM, V278, P48563, DOI 10.1074/jbc.M307586200; VERGERES G, 1992, J BIOL CHEM, V267, P12583; Xia CW, 2011, P NATL ACAD SCI USA, V108, P13486, DOI 10.1073/pnas.1106632108; Yamazaki H, 2001, J BIOL CHEM, V276, P30885, DOI 10.1074/jbc.M105011200; YANAGIBASHI K, 1986, J BIOL CHEM, V261, P8429; Zamaratskaia G, 2008, ANIMAL, V2, P190, DOI 10.1017/S1751731107001103; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r	48	69	70	3	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					17008	17018		10.1074/jbc.M113.468926	http://dx.doi.org/10.1074/jbc.M113.468926			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23620596	Green Published, hybrid			2022-12-28	WOS:000320378900072
J	Sussman, RT; Stanek, TJ; Esteso, P; Gearhart, JD; Knudsen, KE; Mcmahon, SB				Sussman, Robyn T.; Stanek, Timothy J.; Esteso, Paul; Gearhart, John D.; Knudsen, Karen E.; Mcmahon, Steven B.			The Epigenetic Modifier Ubiquitin-specific Protease 22 (USP22) Regulates Embryonic Stem Cell Differentiation via Transcriptional Repression of Sex-determining Region Y-box 2 (SOX2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2B UBIQUITYLATION; SAGA COMPLEX; PLURIPOTENCY FACTORS; HUMAN FIBROBLASTS; MOUSE; EXPRESSION; GENES; RNA; H3; METHYLATION	Pluripotent embryonic stem cells (ESCs) undergo self-renewal until stimulated to differentiate along specific lineage pathways. Many of the transcriptional networks that drive reprogramming of a self-renewing ESC to a differentiating cell have been identified. However, fundamental questions remain unanswered about the epigenetic programs that control these changes in gene expression. Here we report that the histone ubiquitin hydrolase ubiquitin-specific protease 22 (USP22) is a critical epigenetic modifier that controls this transition from self-renewal to differentiation. USP22 is induced as ESCs differentiate and is necessary for differentiation into all three germ layers. We further report that USP22 is a transcriptional repressor of the locus encoding the core pluripotency factor sex-determining region Y-box 2 (SOX2) in ESCs, and this repression is required for efficient differentiation. USP22 occupies the Sox2 promoter and hydrolyzes monoubiquitin from ubiquitylated histone H2B and blocks transcription of the Sox2 locus. Our study reveals an epigenetic mechanism that represses the core pluripotency transcriptional network in ESCs, allowing ESCs to transition from a state of self-renewal into lineage-specific differentiation programs.	[Sussman, Robyn T.; Stanek, Timothy J.; Knudsen, Karen E.; Mcmahon, Steven B.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Canc Biol, Philadelphia, PA 19107 USA; [Esteso, Paul; Gearhart, John D.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA	Jefferson University; University of Pennsylvania	Mcmahon, SB (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Canc Biol, 233 S 10th St,609 BLSB, Philadelphia, PA 19107 USA.	Steven.McMahon@jefferson.edu		McMahon, Steven/0000-0002-3405-1768; Knudsen, Karen/0000-0002-1301-890X; Sussman, Robyn/0000-0002-4057-9622; Stanek, Timothy/0000-0001-9192-4978	CellCentric Ltd.; NATIONAL CANCER INSTITUTE [F31CA165475] Funding Source: NIH RePORTER	CellCentric Ltd.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	S. B. McMahon and K. K. Knudsen are paid scientific consultants to CellCentric Ltd., a biotechnology company focused on identification of small molecules targeting epigenetic regulators.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Andreu-Agullo C, 2012, NATURE, V481, P195, DOI 10.1038/nature10712; Atanassov BS, 2011, EMBO REP, V12, P924, DOI 10.1038/embor.2011.140; Atanassov BS, 2009, MOL CELL, V35, P352, DOI 10.1016/j.molcel.2009.06.015; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bazzoli E, 2012, CELL STEM CELL, V11, P836, DOI 10.1016/j.stem.2012.09.012; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chipumuro E, 2012, FASEB J, V26, P842, DOI 10.1096/fj.11-189498; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Fuchs G, 2012, MOL CELL, V46, P662, DOI 10.1016/j.molcel.2012.05.023; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; GOLDSTEIN DJ, 1980, P NATL ACAD SCI-BIOL, V77, P2857, DOI 10.1073/pnas.77.5.2857; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Karpiuk O, 2012, MOL CELL, V46, P705, DOI 10.1016/j.molcel.2012.05.022; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lang G, 2011, MOL CELL BIOL, V31, P3734, DOI 10.1128/MCB.05231-11; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Lopez-Juarez A, 2012, CELL STEM CELL, V10, P531, DOI 10.1016/j.stem.2012.04.008; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mujtaba S, 2008, NAT CELL BIOL, V10, P1114, DOI 10.1038/ncb1772; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Parsons XH, 2011, JOVE-J VIS EXP, DOI 10.3791/3273; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pera MF, 2000, J CELL SCI, V113, P5; Ring KL, 2012, CELL STEM CELL, V11, P100, DOI 10.1016/j.stem.2012.05.018; Rizzino A, 2013, STEM CELLS, V31, P1033, DOI 10.1002/stem.1352; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; Sene KH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-85; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shogren-Knaak M, 2006, CELL CYCLE, V5, P1361, DOI 10.4161/cc.5.13.2891; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; Weake VM, 2011, GENE DEV, V25, P1499, DOI 10.1101/gad.2046211; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang John H, 2005, Pathophysiology, V12, P63, DOI 10.1016/j.pathophys.2005.01.003; Zhang XY, 2008, CELL CYCLE, V7, P1522, DOI 10.4161/cc.7.11.5962; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhao WX, 2012, MOLECULES, V17, P6196, DOI 10.3390/molecules17066196; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	70	59	63	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24234	24246		10.1074/jbc.M113.469783	http://dx.doi.org/10.1074/jbc.M113.469783			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23760504	Green Published, hybrid			2022-12-28	WOS:000330611400061
J	Chen, DQ; Yue, HJ; Spiering, MM; Benkovic, SJ				Chen, Danqi; Yue, Hongjun; Spiering, Michelle M.; Benkovic, Stephen J.			Insights into Okazaki Fragment Synthesis by the T4 Replisome THE FATE OF LAGGING-STRAND HOLOENZYME COMPONENTS AND THEIR INFLUENCE ON OKAZAKI FRAGMENT SIZE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; COLI DNA-REPLICATION; LEADING-STRAND; SLIDING CLAMP; ESCHERICHIA-COLI; BACTERIOPHAGE-T4; POLYMERASE; ARCHITECTURE; REVEALS; FORK	In this study, we employed a circular replication substrate with a low priming site frequency (1 site/1.1 kb) to quantitatively examine the size distribution and formation pattern of Okazaki fragments. Replication reactions by the T4 replisome on this substrate yielded a patterned series of Okazaki fragments whose size distribution shifted through collision and signaling mechanisms as the gp44/62 clamp loader levels changed but was insensitive to changes in the gp43 polymerase concentration, as expected for a processive, recycled lagging-strand polymerase. In addition, we showed that only one gp45 clamp is continuously associated with the replisome and that no additional clamps accumulate on the DNA, providing further evidence that the clamp departs, whereas the polymerase is recycled upon completion of an Okazaki fragment synthesis cycle. We found no support for the participation of a third polymerase in Okazaki fragment synthesis.	[Chen, Danqi; Yue, Hongjun; Spiering, Michelle M.; Benkovic, Stephen J.] Penn State Univ, Dept Chem, Wartik Labs, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, Wartik Labs, University Pk, PA 16802 USA.	sjb1@psu.edu	Spiering, Michelle M/B-8789-2016		National Institutes of Health Grant [RO1 GM13306]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM013306] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM13306 (to S. J. B.).	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; Arumugam SR, 2009, J BIOL CHEM, V284, P29283, DOI 10.1074/jbc.M109.029926; Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Berdis AJ, 1998, P NATL ACAD SCI USA, V95, P11128, DOI 10.1073/pnas.95.19.11128; BURKE RL, 1985, J BIOL CHEM, V260, P1711; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; DEBYSER Z, 1994, CELL, V77, P157, DOI 10.1016/0092-8674(94)90243-7; Downey CD, 2010, MOL CELL, V37, P481, DOI 10.1016/j.molcel.2010.01.013; Georgescu RE, 2012, NAT STRUCT MOL BIOL, V19, P113, DOI 10.1038/nsmb.2179; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Ishmael FT, 2003, J BIOL CHEM, V278, P3145, DOI 10.1074/jbc.M209858200; KABOORD BF, 1995, CURR BIOL, V5, P149, DOI 10.1016/S0960-9822(95)00036-4; Kadyrov FA, 2001, J BIOL CHEM, V276, P29559, DOI 10.1074/jbc.M101310200; Kurth I, 2013, NATURE, V496, P119, DOI 10.1038/nature11988; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee SJ, 2011, CURR OPIN CHEM BIOL, V15, P580, DOI 10.1016/j.cbpa.2011.07.024; Lia G, 2012, SCIENCE, V335, P328, DOI 10.1126/science.1210400; Lionnet T, 2007, P NATL ACAD SCI USA, V104, P19790, DOI 10.1073/pnas.0709793104; Manosas M, 2009, NAT CHEM BIOL, V5, P904, DOI 10.1038/nchembio.236; Morrical SW, 1996, J BIOL CHEM, V271, P20198, DOI 10.1074/jbc.271.33.20198; Nelson SW, 2008, J BIOL CHEM, V283, P22838, DOI 10.1074/jbc.M802762200; Norcum MT, 2005, P NATL ACAD SCI USA, V102, P3623, DOI 10.1073/pnas.0500713102; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; O'Donnell M, 2006, J BIOL CHEM, V281, P10653, DOI 10.1074/jbc.R500028200; Perumal SK, 2013, P NATL ACAD SCI USA, V110, P99, DOI 10.1073/pnas.1212748110; Perumal SK, 2010, METHODS, V51, P277, DOI 10.1016/j.ymeth.2010.02.011; REDDY MK, 1993, P NATL ACAD SCI USA, V90, P3211, DOI 10.1073/pnas.90.8.3211; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Salinas F, 2000, P NATL ACAD SCI USA, V97, P7196, DOI 10.1073/pnas.97.13.7196; Sexton DJ, 1998, BIOCHEMISTRY-US, V37, P7749, DOI 10.1021/bi980088h; Su'etsugu M, 2011, MOL CELL, V41, P720, DOI 10.1016/j.molcel.2011.02.024; Tanner NA, 2011, EMBO J, V30, P1830, DOI 10.1038/emboj.2011.84; Trakselis MA, 2003, J BIOL CHEM, V278, P49839, DOI 10.1074/jbc.M307405200; Trakselis MA, 2001, P NATL ACAD SCI USA, V98, P8368, DOI 10.1073/pnas.111006698; WU CA, 1992, J BIOL CHEM, V267, P4064; Yang JS, 2006, MOL CELL, V21, P153, DOI 10.1016/j.molcel.2005.11.029; Yang JS, 2005, J BIOL CHEM, V280, P25416, DOI 10.1074/jbc.M501847200; Yang JS, 2004, P NATL ACAD SCI USA, V101, P8289, DOI 10.1073/pnas.0402625101; Yang JS, 2003, J BIOL CHEM, V278, P49828, DOI 10.1074/jbc.M307406200; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yao NY, 2009, P NATL ACAD SCI USA, V106, P13236, DOI 10.1073/pnas.0906157106; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4; Zhuang ZH, 2006, BIOCHEMISTRY-US, V45, P7976, DOI 10.1021/bi0601205	44	6	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20807	20816		10.1074/jbc.M113.485961	http://dx.doi.org/10.1074/jbc.M113.485961			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23729670	Green Published, hybrid			2022-12-28	WOS:000322014400005
J	Kang, MS; Baek, SH; Chun, YS; Moore, AZ; Landman, N; Berman, D; Yang, HO; Morishima-Kawashima, M; Osawa, S; Funamoto, S; Ihara, Y; Di Paolo, G; Park, JH; Chung, S; Kim, TW				Kang, Min Suk; Baek, Seung-Hoon; Chun, Yoon Sun; Moore, A. Zenobia; Landman, Natalie; Berman, Diego; Yang, Hyun Ok; Morishima-Kawashima, Maho; Osawa, Satoko; Funamoto, Satoru; Ihara, Yasuo; Di Paolo, Gilbert; Park, Jeong Hill; Chung, Sungkwon; Kim, Tae-Wan			Modulation of Lipid Kinase PI4KII alpha Activity and Lipid Raft Association of Presenilin 1 Underlies gamma-Secretase Inhibition by Ginsenoside (20S)-Rg3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-PRECURSOR-PROTEIN; ALZHEIMERS-DISEASE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INTRAMEMBRANE PROTEOLYSIS; BETA-PEPTIDE; COGNITIVE PERFORMANCE; NATURAL-PRODUCTS; CHOLESTEROL; HYPOTHESIS; REVEALS	Amyloid beta-peptide (A beta) pathology is an invariant feature of Alzheimer disease, preceding any detectable clinical symptoms by more than a decade. To this end, we seek to identify agents that can reduce A beta levels in the brain via novel mechanisms. We found that (20S)-Rg3, a triterpene natural compound known as ginsenoside, reduced A beta levels in cultured primary neurons and in the brains of a mouse model of Alzheimer disease. The (20S)-Rg3 treatment induced a decrease in the association of presenilin 1 (PS1) fragments with lipid rafts where catalytic components of the gamma-secretase complex are enriched. The A beta-lowering activity of (20S)-Rg3 directly correlated with increased activity of phosphatidylinositol 4-kinase II alpha (PI4KII alpha), a lipid kinase that mediates the rate-limiting step in phosphatidylinositol 4,5-bisphosphate synthesis. PI4KII alpha overexpression recapitulated the effects of (20S)-Rg3, whereas reduced expression of PI4KII alpha abolished the A beta-reducing activity of (20S)-Rg3 in neurons. Our results substantiate an important role for PI4KII alpha and phosphoinositide modulation in gamma-secretase activity and A beta biogenesis.	[Kang, Min Suk; Moore, A. Zenobia; Landman, Natalie; Berman, Diego; Di Paolo, Gilbert; Kim, Tae-Wan] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Kang, Min Suk; Moore, A. Zenobia; Landman, Natalie; Berman, Diego; Di Paolo, Gilbert; Kim, Tae-Wan] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Baek, Seung-Hoon] Ajou Univ, Coll Pharm, Suwon 443749, South Korea; [Chun, Yoon Sun; Chung, Sungkwon] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Physiol, Suwon 440746, South Korea; [Yang, Hyun Ok] Korea Inst Sci & Technol, Gangneung Inst, Nat Prod Res Ctr, Kangnung 210340, Gangwon Do, South Korea; [Morishima-Kawashima, Maho] Hokkaido Univ, Fac Pharmaceut Sci, Dept Mol Neuropathol, Sapporo, Hokkaido 0600808, Japan; [Osawa, Satoko] Univ Tokyo, Fac Med, Dept Neuropathol, Tokyo 1130033, Japan; [Funamoto, Satoru; Ihara, Yasuo] Doshisha Univ, Fac Life & Med Sci, Dept Neuropathol, Kyoto 6100394, Japan; [Park, Jeong Hill] Seoul Natl Univ, Coll Pharm, Pharmaceut Sci Res Inst, Seoul 151742, South Korea	Columbia University; Columbia University; Ajou University; Sungkyunkwan University (SKKU); Korea Institute of Science & Technology (KIST); Hokkaido University; University of Tokyo; Doshisha University; Seoul National University (SNU)	Kim, TW (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA.	twk16@columbia.edu	CHUNG, SUNGKWON/ABF-8293-2021		National Institutes of Health [R01 NS074536, R01 NS056049]; Korea Society of Ginseng; National Research Foundation of Korea [2009-0072220]; Ministry of Education, Science and Technology; Samsung Biomedical Research Institute [B-A8-003]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056049, R01NS074536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Society of Ginseng; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Samsung Biomedical Research Institute(Samsung); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS074536 (to T.-W. K.) and R01 NS056049 (to G. D. P.). This work was also supported by a grant from the Korea Society of Ginseng (to T.-W. K.).; Supported by Basic Science Research Program Grant 2009-0072220 through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology and by Samsung Biomedical Research Institute Grant B-A8-003.	Baek SH, 2012, J GINSENG RES, V36, P119, DOI 10.5142/jgr.2012.36.2.119; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Barylko B, 2009, J BIOL CHEM, V284, P9994, DOI 10.1074/jbc.M900724200; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Chen F, 2006, FASEB J, V20, P1269, DOI 10.1096/fj.05-5530fje; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Di Paolo G, 2011, NAT REV NEUROSCI, V12, P284, DOI 10.1038/nrn3012; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Frere Samuel G, 2012, Subcell Biochem, V59, P131, DOI 10.1007/978-94-007-3015-1_5; Golde TE, 2011, NEURON, V69, P203, DOI 10.1016/j.neuron.2011.01.002; Golub T, 2005, J CELL BIOL, V169, P151, DOI 10.1083/jcb.200407058; Guo J, 2003, P NATL ACAD SCI USA, V100, P3995, DOI 10.1073/pnas.0230488100; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heo JH, 2008, EUR J NEUROL, V15, P865, DOI 10.1111/j.1468-1331.2008.02157.x; Heo JH, 2011, J GINSENG RES, V35, P457, DOI 10.5142/jgr.2011.35.4.457; Hien TT, 2010, TOXICOL APPL PHARM, V246, P171, DOI 10.1016/j.taap.2010.05.008; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holmes O, 2012, BIOCHEMISTRY-US, V51, P3565, DOI 10.1021/bi300303g; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hwang YP, 2010, TOXICOL APPL PHARM, V242, P18, DOI 10.1016/j.taap.2009.09.009; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kang M. S., 2006, ALZHEIMERS DEMENT, V2, pS490; Karran E, 2011, NAT REV DRUG DISCOV, V10, P698, DOI 10.1038/nrd3505; Kim SK, 2011, J GINSENG RES, V35, P389, DOI 10.5142/jgr.2011.35.4.389; Kim YC, 1998, J NEUROSCI RES, V53, P426, DOI 10.1002/(SICI)1097-4547(19980815)53:4<426::AID-JNR4>3.3.CO;2-K; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Kwon SW, 2001, J CHROMATOGR A, V921, P335, DOI 10.1016/S0021-9673(01)00869-X; Lan TH, 2011, BIOCHEM PHARMACOL, V82, P148, DOI 10.1016/j.bcp.2011.04.001; Landman N, 2004, CYTOKINE GROWTH F R, V15, P337, DOI 10.1016/j.cytogfr.2004.04.001; Landman N, 2006, P NATL ACAD SCI USA, V103, P19524, DOI 10.1073/pnas.0604954103; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Lee ST, 2008, ALZ DIS ASSOC DIS, V22, P222, DOI 10.1097/WAD.0b013e31816c92e6; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; McIntire LBJ, 2012, J NEUROSCI, V32, P15271, DOI 10.1523/JNEUROSCI.2034-12.2012; Minogue S, 2010, J LIPID RES, V51, P2314, DOI 10.1194/jlr.M005751; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Okada H, 2010, FASEB J, V24, P2783, DOI 10.1096/fj.09-146357; Osawa S, 2008, J BIOL CHEM, V283, P19283, DOI 10.1074/jbc.M705954200; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Park IH, 2002, ARCH PHARM RES, V25, P837, DOI 10.1007/BF02977001; Park IH, 2002, ARCH PHARM RES, V25, P428, DOI 10.1007/BF02976595; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Reay JL, 2005, J PSYCHOPHARMACOL, V19, P357, DOI 10.1177/0269881105053286; Schmidt Stephen D., 2004, V299, P279; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Shibata S, 2001, J KOREAN MED SCI, V16, pS28, DOI 10.3346/jkms.2001.16.S.S28; Simons JP, 2009, P NATL ACAD SCI USA, V106, P11535, DOI 10.1073/pnas.0903011106; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tong J, 2008, BIOPHYS J, V94, P125, DOI 10.1529/biophysj.107.110536; Trinchese F, 2004, ANN NEUROL, V55, P801, DOI 10.1002/ana.20101; Urban S, 2005, P NATL ACAD SCI USA, V102, P1883, DOI 10.1073/pnas.0408306102; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Volpicelli-Daley LA, 2010, J BIOL CHEM, V285, P28708, DOI 10.1074/jbc.M110.132191; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Waugh MG, 2006, J BIOL CHEM, V281, P3757, DOI 10.1074/jbc.M506527200; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wesnes KA, 2000, PSYCHOPHARMACOLOGY, V152, P353, DOI 10.1007/s002130000533; Williams P, 2011, NAT PROD REP, V28, P48, DOI 10.1039/c0np00027b; Winkler E, 2012, J BIOL CHEM, V287, P21326, DOI 10.1074/jbc.M112.356659; Wrigley JDJ, 2005, J BIOL CHEM, V280, P12523, DOI 10.1074/jbc.M413086200	81	29	32	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20868	20882		10.1074/jbc.M112.445734	http://dx.doi.org/10.1074/jbc.M112.445734			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23723072	hybrid, Green Published			2022-12-28	WOS:000322014400011
J	Khasnavis, S; Ghosh, A; Roy, A; Pahan, K				Khasnavis, Saurabh; Ghosh, Anamitra; Roy, Avik; Pahan, Kalipada			Castration Induces Parkinson Disease Pathologies in Young Male Mice via Inducible Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MODEL; ALPHA-SYNUCLEIN; CELLS; GDNF; ACTIVATION; NEURODEGENERATION; CYTOTOXICITY; PATHOGENESIS; GEMFIBROZIL; INHIBITION	Although Parkinson disease (PD) is a progressive neurodegenerative disorder, available animal models do not exhibit irreversible neurodegeneration, and this is a major obstacle in finding out an effective drug against this disease. Here we delineate a new irreversible model to study PD pathogenesis. The model is based on simple castration of young male mice. Levels of inducible nitricoxide synthase (iNOS), glial markers (glial fibrillary acidic protein and CD11b), and alpha-synuclein were higher in nigra of castrated male mice than normal male mice. On the other hand, after castration, the level of glial-derived neurotrophic factor (GDNF) markedly decreased in the nigra of male mice. Accordingly, castration also induced the loss of tyrosine hydroxylase-positive neurons in the nigra and decrease in tyrosine hydroxylase-positive fibers and neurotransmitters in the striatum. Reversal of nigrostriatal pathologies in castrated male mice by subcutaneous implantation of 5 alpha-dihydrotestosterone pellets validates an important role of male sex hormone in castration-induced nigrostriatal pathology. Interestingly, castration was unable to cause glial activation, decrease nigral GDNF, augment the death of nigral dopaminergic neurons, induce the loss of striatal fibers, and impair neurotransmitters in iNOS(-/-) male mice. Furthermore, we demonstrate that iNOS-derived NO is responsible for decreased expression of GDNF in activated astrocytes. Together, our results suggest that castration induces nigrostriatal pathologies via iNOS-mediated decrease in GDNF. These results are important because castrated young male mice may be used as a simple, toxin-free, and nontransgenic animal model to study PD-related nigrostriatal pathologies, paving the way for easy drug screening against PD.	[Khasnavis, Saurabh; Ghosh, Anamitra; Roy, Avik; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA	Rush University	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 W Harrison St,Suite Cohn 320, Chicago, IL 60612 USA.	kalipada_pahan@rush.edu	Khasnavis, Saurabh/K-2249-2019; Ghosh, Anamitra/C-5118-2015	Ghosh, Anamitra/0000-0001-9740-2070	National Institutes of Health Grants [NS64564, NS71479]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071479, R21NS064564] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS64564 and NS71479.	Akama KT, 1998, P NATL ACAD SCI USA, V95, P5795, DOI 10.1073/pnas.95.10.5795; Burke RE, 2006, J NEURAL TRANSM-SUPP, P41; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Davidoff MS, 2005, HISTOCHEM CELL BIOL, V124, P313, DOI 10.1007/s00418-005-0024-x; Dietz GPH, 2006, BRAIN RES, V1082, P61, DOI 10.1016/j.brainres.2006.01.083; DLUZEN DE, 1989, J NEUROENDOCRINOL, V1, P285, DOI 10.1111/j.1365-2826.1989.tb00117.x; DRAPIER JC, 1988, J IMMUNOL, V140, P2829; Ghosh A, 2007, P NATL ACAD SCI USA, V104, P18754, DOI 10.1073/pnas.0704908104; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Ghosh A, 2012, J BIOL CHEM, V287, P38922, DOI 10.1074/jbc.M112.365148; Ghosh A, 2012, J BIOL CHEM, V287, P27189, DOI 10.1074/jbc.M112.346932; Goldberg MS, 2003, J BIOL CHEM, V278, P43628, DOI 10.1074/jbc.M308947200; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Hoffer BJ, 2011, NAT REV NEUROL, V7, P600, DOI 10.1038/nrneurol.2011.149; Hunot S, 1996, NEUROSCIENCE, V72, P355, DOI 10.1016/0306-4522(95)00578-1; Kenangil G, 2009, CLIN NEUROL NEUROSUR, V111, P412, DOI 10.1016/j.clineuro.2008.11.019; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Kurz MJ, 2007, NEUROSCI LETT, V429, P39, DOI 10.1016/j.neulet.2007.09.060; Liberatore GT, 1999, NAT MED, V5, P1403; Liu XJ, 2002, J BIOL CHEM, V277, P39312, DOI 10.1074/jbc.M205107200; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Meredith Gloria E, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS112, DOI 10.1016/j.parkreldis.2008.04.012; MERRILL JE, 1993, J IMMUNOL, V151, P2132; Mitchell E, 2006, J CLIN NEUROSCI, V13, P133, DOI 10.1016/j.jocn.2005.02.014; Mondal S, 2012, J NEUROIMMUNE PHARM, V7, P544, DOI 10.1007/s11481-012-9377-9; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Okun MS, 2004, J NEUROL NEUROSUR PS, V75, P165; Okun MS, 2002, ARCH NEUROL-CHICAGO, V59, P1750, DOI 10.1001/archneur.59.11.1750; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; OURESHI GA, 1995, NEUROREPORT, V6, P1642, DOI 10.1097/00001756-199508000-00013; RADI R, 1991, J BIOL CHEM, V266, P4244; Rocca WA, 2008, NEUROLOGY, V70, P200, DOI 10.1212/01.wnl.0000280573.30975.6a; Roy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038113; Roy A, 2011, NEUROSCIENTIST, V17, P244, DOI 10.1177/1073858410385006; Ruffoli R, 2008, BRAIN RES, V1229, P218, DOI 10.1016/j.brainres.2008.06.116; Saha RN, 2006, ANTIOXID REDOX SIGN, V8, P929, DOI 10.1089/ars.2006.8.929; Tamas A, 2006, ENDOCRINE, V29, P275, DOI 10.1385/ENDO:29:2:275; Tan EK, 2007, HUM MUTAT, V28, P641, DOI 10.1002/humu.20507; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; WINK DA, 1991, SCIENCE, V254, P1001, DOI 10.1126/science.1948068; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002	43	36	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20843	20855		10.1074/jbc.M112.443556	http://dx.doi.org/10.1074/jbc.M112.443556			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23744073	Green Published, hybrid			2022-12-28	WOS:000322014400009
J	Xu, J; Xu, M; Brown, T; Rossi, GC; Hurd, YL; Inturrisi, CE; Pasternak, GW; Pan, YX				Xu, Jin; Xu, Ming; Brown, Taylor; Rossi, Grace C.; Hurd, Yasmin L.; Inturrisi, Charles E.; Pasternak, Gavril W.; Pan, Ying-Xian			Stabilization of the mu-Opioid Receptor by Truncated Single Transmembrane Splice Variants through a Chaperone-like Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; UP-REGULATION; MORPHINE-6-BETA-GLUCURONIDE ANALGESIA; ANTISENSE OLIGODEOXYNUCLEOTIDES; MORPHINE ANALGESIA; OPIATE RECEPTORS; QUALITY-CONTROL; BINDING-SITES; MOR-1; PROTEIN	The mu-opioid receptor gene, OPRM1, undergoes extensive alternative pre-mRNA splicing, as illustrated by the identification of an array of splice variants generated by both 5' and 3' alternative splicing. The current study reports the identification of another set of splice variants conserved across species that are generated through exon skipping or insertion that encodes proteins containing only a single transmembrane (TM) domain. Using a Tet-Off system, we demonstrated that the truncated single TM variants can dimerize with the full-length 7-TM mu-opioid receptor (MOR-1) in the endoplasmic reticulum, leading to increased expression of MOR-1 at the protein level by a chaperone-like function that minimizes endoplasmic reticulum-associated degradation. In vivo antisense studies suggested that the single TM variants play an important role in morphine analgesia, presumably through modulation of receptor expression levels. Our studies suggest the functional roles of truncated receptors in other G protein-coupled receptor families.	[Xu, Jin; Xu, Ming; Brown, Taylor; Pasternak, Gavril W.; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA; [Xu, Jin; Xu, Ming; Brown, Taylor; Pasternak, Gavril W.; Pan, Ying-Xian] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Rossi, Grace C.] Long Isl Univ, CW Post Coll, Dept Psychol, Brookville, NY 11568 USA; [Hurd, Yasmin L.] Mt Sinai Sch Med, Dept Psychiat & Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Inturrisi, Charles E.; Pasternak, Gavril W.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai; Cornell University	Pasternak, GW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Neurol, 1275 York Ave, New York, NY 10065 USA.	pasterng@mskcc.org; pany@mskcc.org	Rossi, Grace/AIC-2739-2022	Brown, Taylor/0000-0001-9817-2094	National Institutes of Health, NIDA [DA013997, DA029244, DA02615, DA06241, DA07242, DA15446, DA01457, DA07274, DA05130]; NCI, National Institutes of Health [CA08748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013997, R01DA015446, T32DA007274, P60DA005130, R01DA007242, T32DA007242, R01DA002615, R01DA001457, P50DA005130, R01DA006241, R37DA007242, R56DA002615, R21DA029244] Funding Source: NIH RePORTER	National Institutes of Health, NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health, NIDA, Grants DA013997 and DA029244 (to Y. X. P.); DA02615, DA06241, and DA07242 (to G. W. P.); DA15446 (to Y. L. H.); and DA01457, DA07274, and DA05130 (to C. E. I.); and Core Grant CA08748 from the NCI, National Institutes of Health (to Memorial Sloan-Kettering Cancer Center).	Abbadie C, 2000, NEUROSCIENCE, V100, P141, DOI 10.1016/S0306-4522(00)00248-7; Abbadie C, 2000, J COMP NEUROL, V419, P244, DOI 10.1002/(SICI)1096-9861(20000403)419:2<244::AID-CNE8>3.0.CO;2-R; Abbadie C, 2001, NEUROREPORT, V12, P3069, DOI 10.1097/00001756-200110080-00017; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; BARAN A, 1975, LIFE SCI, V17, P633, DOI 10.1016/0024-3205(75)90101-0; BARE LA, 1994, FEBS LETT, V354, P213, DOI 10.1016/0014-5793(94)01129-X; Bolan EA, 2004, SYNAPSE, V51, P11, DOI 10.1002/syn.10277; Chaipatikul V, 2003, J PHARMACOL EXP THER, V305, P909, DOI 10.1124/jpet.102.046219; Chaipatikul V, 2003, MOL PHARMACOL, V64, P32, DOI 10.1124/mol.64.1.32; Chang A, 1998, EUR J PHARMACOL, V351, P189, DOI 10.1016/S0014-2999(98)00366-5; CHEN Y, 1993, MOL PHARMACOL, V44, P8; Chen Y, 2006, J PHARMACOL EXP THER, V319, P765, DOI 10.1124/jpet.106.107987; Choi HS, 2006, BIOCHEM BIOPH RES CO, V343, P1132, DOI 10.1016/j.bbrc.2006.03.084; CONNELLY CD, 1994, LIFE SCI, V54, pPL369, DOI 10.1016/0024-3205(94)90037-X; Du Y.-L., 1996, Society for Neuroscience Abstracts, V22, P1766; Du Y.-L., 1997, Society for Neuroscience Abstracts, V23, P1206; EPPLER CM, 1993, J BIOL CHEM, V268, P26447; Foley K.M, 1985, N ENGL J MED, V313, P84; Foley KM, 1996, SCI AM, V275, P164, DOI 10.1038/scientificamerican0996-164; GaveriauxRuff C, 1997, MOL BRAIN RES, V48, P298, DOI 10.1016/S0169-328X(97)00109-5; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Gomes I, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0007.2000; He SQ, 2011, NEURON, V69, P120, DOI 10.1016/j.neuron.2010.12.001; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kolesnikov YA, 1997, P NATL ACAD SCI USA, V94, P8220, DOI 10.1073/pnas.94.15.8220; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Leskela TT, 2007, J BIOL CHEM, V282, P23171, DOI 10.1074/jbc.M610896200; Lupp A, 2011, REGUL PEPTIDES, V167, P9, DOI 10.1016/j.regpep.2010.09.004; Majumdar S, 2012, J MED CHEM, V55, P6352, DOI 10.1021/jm300305c; Majumdar S, 2011, P NATL ACAD SCI USA, V108, P19778, DOI 10.1073/pnas.1115231108; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Markkanen PMH, 2008, J BIOL CHEM, V283, P29086, DOI 10.1074/jbc.M801880200; MILLAN MJ, 1988, J PHARMACOL EXP THER, V247, P721; Mogil JS, 1996, J PHARMACOL EXP THER, V276, P532; Pan YX, 2009, P NATL ACAD SCI USA, V106, P4917, DOI 10.1073/pnas.0811586106; Pan YX, 1999, MOL PHARMACOL, V56, P396, DOI 10.1124/mol.56.2.396; Pan YX, 2003, BIOCHEM BIOPH RES CO, V301, P1057, DOI 10.1016/S0006-291X(03)00089-5; Pan YX, 2001, P NATL ACAD SCI USA, V98, P14084, DOI 10.1073/pnas.241296098; Pan YX, 1998, FEBS LETT, V435, P65, DOI 10.1016/S0014-5793(98)01039-4; Pan YX, 2002, GENE, V295, P97, DOI 10.1016/S0378-1119(02)00825-9; Pasternak G.W., 2013, PHARM REV IN PRESS; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; Payne R, 1992, PRINCIPLES DRUG THER, P268; PERT CB, 1973, SCIENCE, V182, P1359, DOI 10.1126/science.182.4119.1359; PICK CG, 1993, J PHARMACOL EXP THER, V265, P166; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; ROSSI G, 1994, LIFE SCI, V54, pPL375, DOI 10.1016/0024-3205(94)90038-8; ROSSI GC, 1995, NEUROSCI LETT, V198, P99, DOI 10.1016/0304-3940(95)11977-5; ROSSI GC, 1995, FEBS LETT, V369, P192, DOI 10.1016/0014-5793(95)00757-Z; Rossi GC, 1996, NEUROSCI LETT, V216, P1; ROTHMAN RB, 1991, PEPTIDES, V12, P151, DOI 10.1016/0196-9781(91)90182-O; Schuller AGP, 1999, NAT NEUROSCI, V2, P151, DOI 10.1038/5706; STANDIFER KM, 1994, NEURON, V12, P805, DOI 10.1016/0896-6273(94)90333-6; Tanowitz M, 2008, J BIOL CHEM, V283, P35614, DOI 10.1074/jbc.M806588200; THOMPSON RC, 1993, NEURON, V11, P903, DOI 10.1016/0896-6273(93)90120-G; WANG JB, 1993, P NATL ACAD SCI USA, V90, P10230, DOI 10.1073/pnas.90.21.10230; Wannemacher KM, 2007, J PHARMACOL EXP THER, V323, P614, DOI 10.1124/jpet.107.125500; WOLOZIN BL, 1981, P NATL ACAD SCI-BIOL, V78, P6181, DOI 10.1073/pnas.78.10.6181; Xu J, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-41; Xu J, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-9; Xu J, 2009, J NEUROCHEM, V108, P962, DOI 10.1111/j.1471-4159.2008.05833.x; Yang CM, 2007, P NATL ACAD SCI USA, V104, P15394, DOI 10.1073/pnas.0610878104; YOBURN BC, 1985, LIFE SCI, V36, P2325, DOI 10.1016/0024-3205(85)90322-4; YOBURN BC, 1988, LIFE SCI, V42, P1689, DOI 10.1016/0024-3205(88)90034-3; ZIMPRICH A, 1995, FEBS LETT, V359, P142, DOI 10.1016/0014-5793(95)00028-8; ZIMPRICH A, 1994, REGUL PEPTIDES, V54, P347, DOI 10.1016/0167-0115(94)90531-2; Zimprich A, 1995, NEUROREPORT, V7, P54, DOI 10.1097/00001756-199512000-00012	69	45	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21211	21227		10.1074/jbc.M113.458687	http://dx.doi.org/10.1074/jbc.M113.458687			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760268	Green Published, hybrid			2022-12-28	WOS:000322014400043
J	Zhou, CW; Huang, ZL; Ding, L; Deel, ME; Arain, FM; Murray, CR; Patel, RS; Flanagan, CD; Gallagher, MJ				Zhou, Chengwen; Huang, Zhiling; Ding, Li; Deel, M. Elizabeth; Arain, Fazal M.; Murray, Clark R.; Patel, Ronak S.; Flanagan, Christopher D.; Gallagher, Martin J.			Altered Cortical GABA(A) Receptor Composition, Physiology, and Endocytosis in a Mouse Model of a Human Genetic Absence Epilepsy Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITORY SYNAPTIC CURRENTS; PHOSPHO-DEPENDENT BINDING; GABAERGIC INHIBITION; NMDA RECEPTORS; AP2 COMPLEX; MUTATION; ALPHA-1; BRAIN; TRAFFICKING; NEURONS	Patients with generalized epilepsy exhibit cerebral cortical disinhibition. Likewise, mutations in the inhibitory ligand-gated ion channels, GABA(A) receptors (GABA(A)Rs), cause generalized epilepsy syndromes in humans. Recently, we demonstrated that heterozygous knock-out (Het(alpha 1)KO) of the human epilepsy gene, the GABA(A)R alpha 1 subunit, produced absence epilepsy in mice. Here, we determined the effects of Het(alpha 1)KO on the expression and physiology of GABA(A)Rs in the mouse cortex. We found that Het(alpha 1)KO caused modest reductions in the total and surface expression of the beta 2 subunit but did not alter beta 1 or beta 3 subunit expression, results consistent with a small reduction of GABAARs. Cortices partially compensated for Het(alpha 1)KO by increasing the fraction of residual alpha 1 subunit on the cell surface and by increasing total and surface expression of alpha 3, but not alpha 2, subunits. Co-immunoprecipitation experiments revealed that Het(alpha 1)KO increased the fraction of alpha 1 subunits, and decreased the fraction of alpha 3 subunits, that associated in hybrid alpha 1 alpha 3 beta gamma receptors. Patch clamp electrophysiology studies showed that Het(alpha 1)KO layer VI cortical neurons exhibited reduced inhibitory postsynaptic current peak amplitudes, prolonged current rise and decay times, and altered responses to benzodiazepine agonists. Finally, application of inhibitors of dynamin-mediated endocytosis revealed that Het(alpha 1)KO reduced base-line GABA(A)R endocytosis, an effect that probably contributes to the observed changes in GABA(A)R expression. These findings demonstrate that Het(alpha 1)KO exerts two principle disinhibitory effects on cortical GABA(A)R-mediated inhibitory neurotransmission: 1) a modest reduction of GABA(A)R number and 2) a partial compensation with GABA(A)R isoforms that possess physiological properties different from those of the otherwise predominant alpha 1 beta gamma GABA(A)Rs.	[Zhou, Chengwen; Huang, Zhiling; Ding, Li; Deel, M. Elizabeth; Arain, Fazal M.; Murray, Clark R.; Patel, Ronak S.; Flanagan, Christopher D.; Gallagher, Martin J.] Vanderbilt Univ, Dept Neurol, Nashville, TN 37232 USA	Vanderbilt University	Gallagher, MJ (corresponding author), Vanderbilt Univ, Dept Neurol, 6114 Med Res Bldg 3,465 21st Ave S, Nashville, TN 37232 USA.	Martin.Gallagher@Vanderbilt.edu		Gallagher, Martin/0000-0002-3537-4200	National Institutes of Health [R01 NS064286, K02 NS055979]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K02NS055979, R01NS064286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS064286 and K02 NS055979 (to M. J. G.).	Arain FM, 2012, EPILEPSIA, V53, pE161, DOI 10.1111/j.1528-1167.2012.03596.x; Bagley DC, 2012, J BIOL CHEM, V287, P25577, DOI 10.1074/jbc.M112.354043; Barberis A, 2007, EUR J NEUROSCI, V25, P2726, DOI 10.1111/j.1460-9568.2007.05530.x; Benke D, 2004, J BIOL CHEM, V279, P43654, DOI 10.1074/jbc.M407154200; Chen GJ, 2006, J NEUROSCI, V26, P2513, DOI 10.1523/JNEUROSCI.4712-05.2006; Cossette P, 2002, NAT GENET, V31, P184, DOI 10.1038/ng885; Dennis SH, 2011, J NEUROSCI, V31, P11941, DOI 10.1523/JNEUROSCI.1183-11.2011; Ding L, 2010, J BIOL CHEM, V285, P26390, DOI 10.1074/jbc.M110.142299; Fedi M, 2008, CEREB CORTEX, V18, P664, DOI 10.1093/cercor/bhm100; Gallagher MJ, 2007, P NATL ACAD SCI USA, V104, P12999, DOI 10.1073/pnas.0700163104; Gallagher MJ, 2005, J BIOL CHEM, V280, P37995, DOI 10.1074/jbc.M508305200; Goodkin HP, 2008, J NEUROSCI, V28, P2527, DOI 10.1523/JNEUROSCI.3426-07.2008; Gorrie G. H., 1997, J NEUROSCI; Grueter BA, 2008, J NEUROSCI, V28, P9261, DOI 10.1523/JNEUROSCI.2886-08.2008; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Heller EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039572; Herring D, 2005, NEUROPHARMACOLOGY, V48, P181, DOI 10.1016/j.neuropharm.2004.09.015; Hutcheon B, 2004, EUR J NEUROSCI, V19, P2475, DOI 10.1111/j.0953-816X.2004.03349.x; Jia F, 2009, J PHARMACOL EXP THER, V328, P1000, DOI 10.1124/jpet.108.146084; Kang JQ, 2009, J NEUROSCI, V29, P2833, DOI 10.1523/JNEUROSCI.4512-08.2009; Kang-Park MH, 2004, NEUROPHARMACOLOGY, V46, P1, DOI 10.1016/S0028-3908(03)00340-X; Kim JY, 2007, NEURON, V54, P933, DOI 10.1016/j.neuron.2007.05.026; Kittler JT, 2008, P NATL ACAD SCI USA, V105, P3616, DOI 10.1073/pnas.0707920105; Kittler JT, 2005, P NATL ACAD SCI USA, V102, P14871, DOI 10.1073/pnas.0506653102; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kittler JT, 2000, J NEUROSCI, V20, P7972; Klausberger T, 2001, J BIOL CHEM, V276, P16024, DOI 10.1074/jbc.M009508200; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Kralic JE, 2002, J PHARMACOL EXP THER, V302, P1037, DOI 10.1124/jpet.102.036665; Kralic JE, 2006, J COMP NEUROL, V495, P408, DOI 10.1002/cne.20866; Lachance-Touchette P, 2011, EUR J NEUROSCI, V34, P237, DOI 10.1111/j.1460-9568.2011.07767.x; Lagier S, 2007, P NATL ACAD SCI USA, V104, P7259, DOI 10.1073/pnas.0701846104; Liu WH, 2006, P NATL ACAD SCI USA, V103, P18338, DOI 10.1073/pnas.0604560103; Lo WY, 2008, J BIOL CHEM, V283, P29740, DOI 10.1074/jbc.M802856200; Luttjohann A, 2011, NEUROSCIENCE, V188, P125, DOI 10.1016/j.neuroscience.2011.04.038; Maljevic S, 2006, ANN NEUROL, V59, P983, DOI 10.1002/ana.20874; Mann EO, 2008, CURR OPIN NEUROL, V21, P155, DOI 10.1097/WCO.0b013e3282f52f5f; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Minier F, 2004, P NATL ACAD SCI USA, V101, P7769, DOI 10.1073/pnas.0400220101; Moyer JR, 1998, J NEUROSCI METH, V86, P35, DOI 10.1016/S0165-0270(98)00143-5; Ogris W, 2006, J NEUROCHEM, V96, P136, DOI 10.1111/j.1471-4159.2005.03509.x; Paz JT, 2011, NAT NEUROSCI, V14, P1167, DOI 10.1038/nn.2896; Peden DR, 2008, J PHYSIOL-LONDON, V586, P965, DOI 10.1113/jphysiol.2007.145375; Petroski RE, 2006, J PHARMACOL EXP THER, V317, P369, DOI 10.1124/jpet.105.096701; Picton AJ, 2007, BRAIN RES, V1165, P40, DOI 10.1016/j.brainres.2007.06.050; Polack PO, 2007, J NEUROSCI, V27, P6590, DOI 10.1523/JNEUROSCI.0753-07.2007; Popik P, 2006, J PHARMACOL EXP THER, V319, P1244, DOI 10.1124/jpet.106.107201; Puzzolo E, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-8; Rannals MD, 2011, J NEUROSCI, V31, P17701, DOI 10.1523/JNEUROSCI.4476-11.2011; Robertson SD, 2010, J NEUROSCI, V30, P11305, DOI 10.1523/JNEUROSCI.0126-10.2010; Rudy B, 2011, DEV NEUROBIOL, V71, P45, DOI 10.1002/dneu.20853; Rula EY, 2008, J NEUROSCI, V28, P6196, DOI 10.1523/JNEUROSCI.0443-08.2008; Saliba RS, 2008, J BIOL CHEM, V283, P18538, DOI 10.1074/jbc.M802077200; Saliba RS, 2012, EMBO J, V31, P2937, DOI 10.1038/emboj.2012.109; Sasaki S, 2006, J NEUROSCI, V26, P3056, DOI 10.1523/JNEUROSCI.5422-05.2006; Schneider Gasser E. M., 2007, EUR J NEUROSCI, V25, P3287, DOI DOI 10.1111/J.1460-9568.2007.05558.X; Schofield CM, 2009, P NATL ACAD SCI USA, V106, P7630, DOI 10.1073/pnas.0811326106; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sieghart W, 2006, ADV PHARMACOL, V54, P231, DOI 10.1016/S1054-3589(06)54010-4; Sur C, 2001, J NEUROSCI, V21, P3409, DOI 10.1523/JNEUROSCI.21-10-03409.2001; Tan HO, 2007, P NATL ACAD SCI USA, V104, P17536, DOI 10.1073/pnas.0708440104; Terunuma M, 2008, J NEUROSCI, V28, P376, DOI 10.1523/JNEUROSCI.4346-07.2008; Tretter V, 1997, J NEUROSCI, V17, P2728; Varkevisser R, 2013, PFLUG ARCH EUR J PHY, V465, P247, DOI 10.1007/s00424-012-1189-5; VERDOORN TA, 1994, MOL PHARMACOL, V45, P475; Vicini S, 2001, J NEUROSCI, V21, P3009, DOI 10.1523/JNEUROSCI.21-09-03009.2001; Yee BK, 2005, P NATL ACAD SCI USA, V102, P17154, DOI 10.1073/pnas.0508752102; Yu ZY, 2006, BRAIN RES, V1099, P73, DOI 10.1016/j.brainres.2006.04.118; Zeller A, 2008, MOL PHARMACOL, V73, P282, DOI 10.1124/mol.107.038828; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhou CW, 2011, J NEUROSCI, V31, P18211, DOI 10.1523/JNEUROSCI.4838-11.2011	71	34	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21458	21472		10.1074/jbc.M112.444372	http://dx.doi.org/10.1074/jbc.M112.444372			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23744069	Green Published, hybrid			2022-12-28	WOS:000322014400063
J	Cabeza, JM; Acosta, J; Ales, E				Cabeza, Jose M.; Acosta, Jorge; Ales, Eva			Mechanisms of Granule Membrane Recapture following Exocytosis in Intact Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADRENAL CHROMAFFIN CELLS; FROG NEUROMUSCULAR JUNCTION; HIGH-CALCIUM CONCENTRATIONS; KISS-AND-RUN; FUSION PORE; SECRETORY VESICLE; CAPACITANCE MEASUREMENTS; TRANSMITTER RELEASE; COMPOUND EXOCYTOSIS; HISTAMINE-RELEASE	In secretory cells, several exocytosis-coupled forms of endocytosis have been proposed including clathrin-mediated endocytosis, kiss-and-run endocytosis, cavicapture, and bulk endocytosis. These forms of endocytosis can be induced under different conditions, but their detailed molecular mechanisms and functions are largely unknown. We studied exocytosis and endocytosis in mast cells with both perforated-patch and whole-cell configurations of the patch clamp technique using cell capacitance measurements in combination with amperometric serotonin detection. We found that intact mast cells exhibit an early endocytosis that follows exocytosis induced by compound 48/80. Direct observation of individual exocytic and endocytic events showed a higher percentage of capacitance flickers (27.3%) and off-steps (11.4%) in intact mast cells than in dialyzed cells (5.4% and 2.9%, respectively). Moreover, we observed a type of endocytosis of large pieces of membrane that were likely formed by cumulative fusion of several secretory granules with the cell membrane. We also identified "large-capacitance flickers" that occur after large endocytosis events. Pore conductance analysis indicated that these transient events may represent "compound cavicapture," most likely due to the flickering of a dilated fusion pore. Using fluorescence imaging of individual exocytic and endocytic events we observed that granules can fuse to granules already fused with the plasma membrane, and then the membranes and dense cores of fused granules are internalized. Altogether, our results suggest that stimulated exocytosis in intact mast cells is followed by several forms of compensatory endocytosis, including kiss-and-run endocytosis and a mechanism for efficient retrieval of the compound membrane of several secretory granules through a single membrane fission event.	[Cabeza, Jose M.; Acosta, Jorge; Ales, Eva] Univ Seville, Fac Med, Dept Fisiol Med & Biofis, E-41009 Seville, Spain	University of Sevilla	Ales, E (corresponding author), Univ Seville, Fac Med, Dpto Fisiol Med & Biofis, Av Sanchez Pizjuan 4, E-41009 Seville, Spain.	eales@us.es	Acosta-Lopez, Jorge/H-6271-2015; Ales, Eva/E-6315-2010	Acosta-Lopez, Jorge/0000-0003-1349-4495; Ales, Eva/0000-0002-5536-4616; Cabeza Fernandez, Jose Maria/0000-0002-1784-6219	Ministerio de Ciencia e Innovacion ISCIII; Fondos FEDER Grant [PI11/00257]	Ministerio de Ciencia e Innovacion ISCIII(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Fondos FEDER Grant	This work was supported by the Ministerio de Ciencia e Innovacion ISCIII and Fondos FEDER Grant PI11/00257 (to E.A.).	Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ANDERSON P, 1973, ACTA PHYSIOL SCAND, V88, P359, DOI 10.1111/j.1748-1716.1973.tb05465.x; Angleson JK, 1999, NAT NEUROSCI, V2, P440, DOI 10.1038/8107; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; BLOOM GD, 1967, ACTA PHYSIOL SCAND, V71, P257, DOI 10.1111/j.1748-1716.1967.tb03733.x; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; DETOLEDO GA, 1990, J CELL BIOL, V110, P1033, DOI 10.1083/jcb.110.4.1033; DETOLEDO GA, 1990, J GEN PHYSIOL, V95, P397, DOI 10.1085/jgp.95.3.397; FERNANDEZ JM, 1987, FEBS LETT, V216, P89, DOI 10.1016/0014-5793(87)80762-7; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Fernandez-Chacon R, 1999, J BIOL CHEM, V274, P32551, DOI 10.1074/jbc.274.46.32551; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Fulop T, 2005, J NEUROSCI, V25, P7324, DOI 10.1523/JNEUROSCI.2042-05.2005; Fulop T, 2006, BIOCHEM J, V399, P111, DOI 10.1042/BJ20060654; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; He LM, 2009, NATURE, V459, P93, DOI 10.1038/nature07860; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holroyd P, 2002, P NATL ACAD SCI USA, V99, P16806, DOI 10.1073/pnas.222677399; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; LINDAU M, 1986, NATURE, V319, P150, DOI 10.1038/319150a0; Lollike K, 2002, J LEUKOCYTE BIOL, V71, P973; Cabeza JM, 2010, TRAFFIC, V11, P1579, DOI 10.1111/j.1600-0854.2010.01120.x; MONCK JR, 1990, P NATL ACAD SCI USA, V87, P7804, DOI 10.1073/pnas.87.20.7804; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Oberhauser AF, 1996, P NATL ACAD SCI USA, V93, P14349, DOI 10.1073/pnas.93.25.14349; OBERHAUSER AF, 1992, BIOPHYS J, V61, P800, DOI 10.1016/S0006-3495(92)81884-2; Oberhauser AF, 1996, BIOPHYS J, V71, P1131, DOI 10.1016/S0006-3495(96)79315-3; OBERHAUSER AF, 1995, J PHYSIOLOGY-PARIS, V89, P71, DOI 10.1016/0928-4257(96)80553-5; Paillart C, 2003, J NEUROSCI, V23, P4092; Perrais D, 2004, J PHYSIOL-LONDON, V560, P413, DOI 10.1113/jphysiol.2004.064410; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; ROHLICH P, 1971, ACTA BIOL ACAD SCI H, V22, P197; ROSENBOOM H, 1994, P NATL ACAD SCI USA, V91, P5267, DOI 10.1073/pnas.91.12.5267; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; SCEPEK S, 1993, EMBO J, V12, P1811, DOI 10.1002/j.1460-2075.1993.tb05829.x; Segovia M, 2010, P NATL ACAD SCI USA, V107, P19032, DOI 10.1073/pnas.1014070107; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; SPRUCE AE, 1990, NEURON, V4, P643, DOI 10.1016/0896-6273(90)90192-I; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Taraska JW, 2004, P NATL ACAD SCI USA, V101, P8780, DOI 10.1073/pnas.0401316101; Tsuboi T, 2004, J BIOL CHEM, V279, P47115, DOI 10.1074/jbc.M408179200; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Xue L, 2011, ACTA PHARMACOL SIN, V32, P280, DOI 10.1038/aps.2010.212	53	22	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20293	20305		10.1074/jbc.M113.459065	http://dx.doi.org/10.1074/jbc.M113.459065			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23709219	hybrid, Green Published			2022-12-28	WOS:000321715100018
J	Ghorpade, DS; Holla, S; Sinha, AY; Alagesan, SK; Balaji, KN				Ghorpade, Devram Sampat; Holla, Sahana; Sinha, Akhauri Yash; Alagesan, Senthil Kumar; Balaji, Kithiganahalli Narayanaswamy			Nitric Oxide and KLF4 Protein Epigenetically Modify Class II Transactivator to Repress Major Histocompatibility Complex II Expression during Mycobacterium bovis Bacillus Calmette-Guerin Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ALVEOLAR MACROPHAGES; TROPHOBLAST NONCODING RNA; MHC CLASS-I; INTERFERON-GAMMA; TRANSCRIPTION FACTORS; DENDRITIC CELLS; ANTIGEN PRESENTATION; 19-KDA LIPOPROTEIN; GENE-EXPRESSION; UP-REGULATION	Pathogenic mycobacteria employ several immune evasion strategies such as inhibition of class II transactivator (CIITA) and MHC-II expression, to survive and persist in host macrophages. However, precise roles for specific signaling components executing down-regulation of CIITA/MHC-II have not been adequately addressed. Here, we demonstrate that Mycobacterium bovis bacillus Calmette-Guerin (BCG)-mediated TLR2 signaling-induced iNOS/NO expression is obligatory for the suppression of IFN-gamma-induced CIITA/MHC-II functions. Significantly, NOTCH/PKC/MAPK-triggered signaling cross-talk was found critical for iNOS/NO production. NO responsive recruitment of a bifunctional transcription factor, KLF4, to the promoter of CIITA during M. bovis BCG infection of macrophages was essential to orchestrate the epigenetic modifications mediated by histone methyltransferase EZH2 or miR-150 and thus calibrate CIITA/MHC-II expression. NO-dependent KLF4 regulated the processing and presentation of ovalbumin by infected macrophages to reactive T cells. Altogether, our study delineates a novel role for iNOS/NO/KLF4 in dictating the mycobacterial capacity to inhibit CIITA/MHC-II-mediated antigen presentation by infected macrophages and thereby elude immune surveillance.	[Ghorpade, Devram Sampat; Holla, Sahana; Sinha, Akhauri Yash; Alagesan, Senthil Kumar; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in		Holla, Sahana/0000-0001-5186-0180	Department of Biotechnology (DBT); Department of Science and Technology (DST); Council for Scientific and Industrial Research (CSIR); Indian Council of Medical Research (ICMR), Government of India; Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA); Indian Institute of Science; CSIR	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR)); Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA); Indian Institute of Science; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Departments of Biotechnology (DBT) and Science and Technology (DST), Council for Scientific and Industrial Research (CSIR), Indian Council of Medical Research (ICMR), Government of India, and the Indo-French Center for Promotion of Advanced Research (IFCPAR/CEFIPRA). Infrastructure was supported by the ICMR (Center for Advanced Study in Molecular Medicine), DST (FIST), and University Grants Commission (UGC, special assistance to K. N. B.), and fellowships from the Indian Institute of Science (to S. H. and A. Y. S.) and CSIR (to D. S. G.).	Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Bang KWA, 2000, BLOOD, V95, P1735, DOI 10.1182/blood.V95.5.1735.005k47_1735_1742; Bansal K, 2011, J BIOL CHEM, V286, P37032, DOI 10.1074/jbc.M111.260414; Bansal K, 2011, J BIOL CHEM, V286, P5823, DOI 10.1074/jbc.M110.192393; Bansal K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004911; Bansal K, 2009, J LEUKOCYTE BIOL, V85, P804, DOI 10.1189/jlb.0908561; Berendji D, 1999, MOL MED, V5, P721, DOI 10.1007/BF03402096; Bjerke GA, 2011, MOL CELL BIOL, V31, P3723, DOI 10.1128/MCB.01456-10; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Chuang JC, 2007, PEDIATR RES, V61, p24R, DOI 10.1203/pdr.0b013e3180457684; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Evans PM, 2010, MOL CELL BIOL, V30, P372, DOI 10.1128/MCB.00063-09; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Gehring AJ, 2004, J IMMUNOL, V173, P2660, DOI 10.4049/jimmunol.173.4.2660; Geirsson A, 2003, TRANSPLANTATION, V76, P387, DOI 10.1097/01.TP.0000073612.04525.46; Geirsson A, 2003, BIOCHEM BIOPH RES CO, V301, P718, DOI 10.1016/S0006-291X(03)00028-7; Ghorpade DS, 2012, MOL CELL BIOL, V32, P2239, DOI 10.1128/MCB.06597-11; Ghorpade DS, 2011, J BIOL CHEM, V286, P31347, DOI 10.1074/jbc.M111.232413; Giroux M, 2003, J IMMUNOL, V171, P4187, DOI 10.4049/jimmunol.171.8.4187; Hodapp T, 2012, EUR RESPIR J, V40, P152, DOI 10.1183/09031936.00175611; Holland SM, 1998, J INFECT DIS, V178, P1095, DOI 10.1086/515670; Jagannath C, 1998, NITRIC OXIDE-BIOL CH, V2, P174, DOI 10.1006/niox.1998.9999; Kapoor N, 2010, J IMMUNOL, V184, P3117, DOI 10.4049/jimmunol.0903174; Kaufmann SHE, 2005, NEW ENGL J MED, V353, P2423, DOI 10.1056/NEJMp058131; Kimura H, 2000, ANAL BIOCHEM, V283, P27, DOI 10.1006/abio.2000.4614; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mashruwala MA, 2011, TUBERCULOSIS, V91, pS82, DOI 10.1016/j.tube.2011.10.016; Masri F, 2010, ANN THORAC MED, V5, P123, DOI 10.4103/1817-1737.65036; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.43.25526; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Pattenden SG, 2002, EMBO J, V21, P1978, DOI 10.1093/emboj/21.8.1978; Pecora ND, 2009, CELL IMMUNOL, V254, P94, DOI 10.1016/j.cellimm.2008.07.002; Pennini ME, 2006, J IMMUNOL, V176, P4323, DOI 10.4049/jimmunol.176.7.4323; PILZ RB, 1995, FASEB J, V9, P552, DOI 10.1096/fasebj.9.7.7737465; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8; Rodriguez N, 2008, J LEUKOCYTE BIOL, V84, P1585, DOI 10.1189/jlb.0508304; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Satoh A, 2004, AM J PHYSIOL-GASTR L, V287, pG582, DOI 10.1152/ajpgi.00087.2004; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; Siddiqui S, 2011, J LEUKOCYTE BIOL, V89, P457, DOI 10.1189/jlb.0610357; Sims TN, 2001, AM J TRANSPLANT, V1, P211, DOI 10.1034/j.1600-6143.2001.001003211.x; Skaletz-Rorowski A, 2005, CARDIOVASC RES, V67, P142, DOI 10.1016/j.cardiores.2005.03.009; Skeiky YAW, 2006, NAT REV MICROBIOL, V4, P469, DOI 10.1038/nrmicro1419; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Sugawara I, 2003, MICROBIOL IMMUNOL, V47, P327, DOI 10.1111/j.1348-0421.2003.tb03404.x; Swamynathan Shivalingappa K., 2010, Human Genomics, V4, P263; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Trinath J, 2012, J INFECT DIS, V205, P694, DOI 10.1093/infdis/jir820; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; van der Veen RC, 2000, CELL IMMUNOL, V206, P125, DOI 10.1006/cimm.2000.1741; Vangapandu H, 2009, GENE THER MOL BIOL, V13A, P194; Velez CD, 2009, IMMUNOLOGY, V127, P73, DOI 10.1111/j.1365-2567.2008.02924.x; Wang Y, 2005, J IMMUNOL, V174, P5687, DOI 10.4049/jimmunol.174.9.5687; Wu F, 2008, J CELL PHYSIOL, V217, P207, DOI 10.1002/jcp.21495; Zika E, 2003, MOL CELL BIOL, V23, P3091, DOI 10.1128/MCB.23.9.3091-3102.2003	66	22	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20592	20606		10.1074/jbc.M113.472183	http://dx.doi.org/10.1074/jbc.M113.472183			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23733190	Green Published, hybrid			2022-12-28	WOS:000321715100045
J	Sheikh, IA; Koley, H; Chakrabarti, MK; Hoque, KM				Sheikh, Irshad Ali; Koley, Hemanta; Chakrabarti, Manoj K.; Hoque, Kazi Mirajul			The Epac1 Signaling Pathway Regulates Cl- Secretion via Modulation of Apical KCNN4c Channels in Diarrhea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; INTERMEDIATE-CONDUCTANCE; CHLORIDE SECRETION; K+ CHANNELS; ANION SECRETION; ION-TRANSPORT; ELECTROLYTE TRANSPORT; BASAL ACTIVITY; RABBIT COLON; CYCLIC-AMP	The apical membrane of intestinal epithelia expresses intermediate conductance K+ channel (KCNN4), which provides the driving force for Cl- secretion. However, its role in diarrhea and regulation by Epac1 is unknown. Previously we have established that Epac1 upon binding of cAMP activates a PKA-independent mechanism of Cl- secretion via stimulation of Rap2-phospholipase C epsilon-[Ca2+](i) signaling. Here we report that Epac1 regulates surface expression of KCNN4c channel through its downstream Rap1A-RhoA-Rho-associated kinase (ROCK) signaling pathway for sustained Cl- secretion. Depletion of Epac1 protein and apical addition of TRAM-34, a specific KCNN4 inhibitor, significantly abolished cAMP-stimulated Cl- secretion and apical K+ conductance (I-K(ap)) in T84WT cells. The current-voltage relationship of basolaterally permeabilized monolayers treated with Epac1 agonist 8-(4-chlorophenylthio)-2'-O- methyladenosine 3',5'-cyclic monophosphate showed the presence of an inwardly rectifying and TRAM-34-sensitive K+ channel in T84WT cells that was absent in Epac1KDT84 cells. Reconstructed confocal images in Epac1KDT84 cells revealed redistribution of KCNN4c proteins into subapical intracellular compartment, and a biotinylation assay showed similar to 83% lower surface expression of KCNN4c proteins compared with T84WT cells. Further investigation revealed that an Epac1 agonist activates Rap1 to facilitate I-K(ap). Both RhoA inhibitor (GGTI298) and ROCK inhibitor (H1152) significantly reduced cAMP agonist-stimulated I-K(ap), whereas the latter additionally reduced colocalization of KCNN4c with the apical membrane marker wheat germ agglutinin in T84WT cells. In vivo mouse ileal loop experiments showed reduced fluid accumulation by TRAM-34, GGTI298, or H1152 when injected together with cholera toxin into the loop. We conclude that Rap1A-dependent signaling of Epac1 involving RhoA-ROCK is an important regulator of intestinal fluid transport via modulation of apical KCNN4c channels, a finding with potential therapeutic value in diarrheal diseases.	[Sheikh, Irshad Ali; Chakrabarti, Manoj K.; Hoque, Kazi Mirajul] Natl Inst Cholera & Enter Dis, Div Mol Pathophysiol, Kolkata 700010, India; [Koley, Hemanta] Natl Inst Cholera & Enter Dis, Div Microbiol, Kolkata 700010, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED)	Hoque, KM (corresponding author), Natl Inst Cholera & Enter Dis, Div Mol Pathophysiol, P-33 CIT Rd, Kolkata 700010, India.	kmh_niced@yahoo.co.in	Kazi, Mirajul Hoque/AAR-5291-2021		Government of India, Ministry of Science and Technology, Department of Biotechnology [BT/HRD/35/02/07/2009]	Government of India, Ministry of Science and Technology, Department of Biotechnology	This work was supported in part by Government of India, Ministry of Science and Technology, Department of Biotechnology Grant BT/HRD/35/02/07/2009 (to K. M. H.).	Almassy J, 2012, J GEN PHYSIOL, V139, P121, DOI 10.1085/jgp.201110718; Barmeyer C, 2010, AM J PHYSIOL-CELL PH, V299, pC251, DOI 10.1152/ajpcell.00091.2009; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; BARRETT KE, 1993, AM J PHYSIOL, V265, pC859; Barrett KE, 2008, ADV PHYSIOL EDUC, V32, P25, DOI 10.1152/advan.00092.2007; Begenisich T, 2004, J BIOL CHEM, V279, P47681, DOI 10.1074/jbc.M409627200; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Broere N, 2007, J BIOL CHEM, V282, P37575, DOI 10.1074/jbc.M704878200; Caron E, 2003, J CELL SCI, V116, P435, DOI 10.1242/jcs.00238; Chan HC, 1996, AM J PHYSIOL-CELL PH, V271, pC469, DOI 10.1152/ajpcell.1996.271.2.C469; COOK DI, 1989, J MEMBRANE BIOL, V110, P139, DOI 10.1007/BF01869469; DE SN, 1953, J PATHOL BACTERIOL, V66, P559, DOI 10.1002/path.1700660228; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dubyak GR, 2004, ADV PHYSIOL EDUC, V28, P143, DOI 10.1152/advan.00046.2004; Duffey ME, 2012, FASEB J, V26; Eid AH, 2008, AM J PHYSIOL-HEART C, V295, pH266, DOI 10.1152/ajpheart.00084.2008; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Geibel JP, 2005, ANNU REV PHYSIOL, V67, P471, DOI 10.1146/annurev.physiol.67.031103.153530; Gerlach AC, 2000, J BIOL CHEM, V275, P585, DOI 10.1074/jbc.275.1.585; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Greger R, 1997, COMP BIOCHEM PHYS A, V118, P271, DOI 10.1016/S0300-9629(96)00304-0; Hamilton KL, 2012, AM J PHYSIOL-RENAL, V302, pF1069, DOI 10.1152/ajprenal.00646.2011; Hoque KM, 2010, J GEN PHYSIOL, V135, P43, DOI 10.1085/jgp.200910339; Jeyaraj SC, 2012, AM J PHYSIOL-CELL PH, V303, pC499, DOI 10.1152/ajpcell.00461.2011; Keely SJ, 2000, ANN NY ACAD SCI, V915, P67; Kiela PR, 2009, CURR OPIN GASTROEN, V25, P87, DOI 10.1097/MOG.0b013e3283260900; Kumar NSN, 2010, AM J PHYSIOL-GASTR L, V299, pG707, DOI 10.1152/ajpgi.00101.2010; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Matos JE, 2007, ACTA PHYSIOL, V189, P251, DOI 10.1111/j.1748-1716.2006.01646.x; Mun EC, 1998, GASTROENTEROLOGY, V114, P1257, DOI 10.1016/S0016-5085(98)70432-9; Murtazina R, 2011, AM J PHYSIOL-CELL PH, V301, pC126, DOI 10.1152/ajpcell.00311.2010; Palmer ML, 2008, J PHYSIOL-LONDON, V586, P717, DOI 10.1113/jphysiol.2007.142877; Petri WA, 2008, J CLIN INVEST, V118, P1277, DOI 10.1172/JCI34005; Pochynyuk O, 2007, EXP BIOL MED, V232, P1258, DOI 10.3181/0703-MR-76; Pochynyuk O, 2006, J BIOL CHEM, V281, P26520, DOI 10.1074/jbc.M603716200; REINHART PH, 1991, J NEUROSCI, V11, P1627; Rufo PA, 1996, J CLIN INVEST, V98, P2066, DOI 10.1172/JCI119012; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; Sarker R, 2008, MOL BIOL CELL, V19, P3859, DOI 10.1091/mbc.E08-01-0019; Singh SK, 2012, AM J PHYSIOL-CELL PH, V302, pC1353, DOI 10.1152/ajpcell.00216.2011; Strohmeier GR, 1997, J CLIN INVEST, V99, P2588, DOI 10.1172/JCI119447; Turnheim K, 2002, BBA-BIOMEMBRANES, V1560, P51, DOI 10.1016/S0005-2736(01)00456-4; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Warth R, 2003, J MEMBRANE BIOL, V193, P67, DOI 10.1007/s00232-002-2001-9; Warth R, 1999, PFLUG ARCH EUR J PHY, V438, P437, DOI 10.1007/s004240051059; WELSH MJ, 1987, PHYSIOL REV, V67, P1143, DOI 10.1152/physrev.1987.67.4.1143; Wulff H, 2007, CURR MED CHEM, V14, P1437, DOI 10.2174/092986707780831186	49	21	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20404	20415		10.1074/jbc.M113.467860	http://dx.doi.org/10.1074/jbc.M113.467860			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720748	hybrid, Green Published			2022-12-28	WOS:000321715100028
J	Zheng, CL; Page, RC; Das, V; Nix, JC; Wigren, E; Misra, S; Zhang, B				Zheng, Chunlei; Page, Richard C.; Das, Vaijayanti; Nix, Jay C.; Wigren, Edvard; Misra, Saurav; Zhang, Bin			Structural Characterization of Carbohydrate Binding by LMAN1 Protein Provides New Insight into the Endoplasmic Reticulum Export of Factors V (FV) and VIII (FVIII)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TO-GOLGI TRANSPORT; CRYSTAL-STRUCTURE; LECTIN ERGIC-53; COMBINED DEFICIENCY; RECOGNITION DOMAIN; RECEPTOR COMPLEX; MOLECULAR-BASIS; ER EXPORT; RELEASE; PH	LMAN1 (ERGIC-53) is a key mammalian cargo receptor responsible for the export of a subset of glycoproteins from the endoplasmic reticulum. Together with its soluble coreceptor MCFD2, LMAN1 transports coagulation factors V (FV) and VIII (FVIII). Mutations in LMAN1 or MCFD2 cause the genetic bleeding disorder combined deficiency of FV and FVIII (F5F8D). The LMAN1 carbohydrate recognition domain (CRD) binds to both glycoprotein cargo and MCFD2 in a Ca2+-dependent manner. To understand the biochemical basis and regulation of LMAN1 binding to glycoprotein cargo, we solved crystal structures of the LMAN1-CRD bound to Man-alpha-1,2-Man, the terminal carbohydrate moiety of high mannose glycans. Our structural data, combined with mutagenesis and in vitro binding assays, define the central mannose-binding site on LMAN1 and pinpoint histidine 178 and glycines 251/252 as critical residues for FV/FVIII binding. We also show that mannobiose binding is relatively independent of pH in the range relevant for endoplasmic reticulum-to-Golgi traffic, but is sensitive to lowered Ca2+ concentrations. The distinct LMAN1/MCFD2 interaction is maintained at these lowered Ca2+ concentrations. Our results suggest that compartmental changes in Ca2+ concentration regulate glycoprotein cargo binding and release from the LMAN1 center dot MCFD2 complex in the early secretory pathway.	[Zheng, Chunlei; Das, Vaijayanti; Zhang, Bin] Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44195 USA; [Page, Richard C.; Misra, Saurav] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Nix, Jay C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Mol Biol Consortium, Berkeley, CA 94720 USA; [Wigren, Edvard] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Cleveland Clinic Foundation; Cleveland Clinic Foundation; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Karolinska Institutet	Zhang, B (corresponding author), Cleveland Clin Lerner Res Inst, Genom Med Inst, 9500 Euclid Ave,NE50, Cleveland, OH 44195 USA.	zhangb@ccf.org		Zheng, Chunlei/0000-0002-9737-461X; Page, Richard/0000-0002-3006-3171; Misra, Saurav/0000-0002-1385-8554	National Institutes of Health [HL094505, GM080271, T32 HL007914]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094505, T32HL007914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094505 (to B. Z.) and GM080271 (to S. M.) and Postdoctoral Fellowship T32 HL007914 (to R. C. P.). This work was also supported by a postdoctoral fellowship from the American Heart Association (to C. Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200; Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708; Arias-Moreno X, 2008, J BIOL CHEM, V283, P22670, DOI 10.1074/jbc.M802153200; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bentley M, 2010, MOL BIOL CELL, V21, P1033, DOI 10.1091/mbc.E09-10-0914; Byrne SL, 2010, J MOL BIOL, V396, P130, DOI 10.1016/j.jmb.2009.11.023; Cho S, 2011, TRAFFIC, V12, P42, DOI 10.1111/j.1600-0854.2010.01132.x; Cunningham MA, 2003, J THROMB HAEMOST, V1, P2360, DOI 10.1046/j.1538-7836.2003.00415.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Guy JE, 2008, J MOL BIOL, V381, P941, DOI 10.1016/j.jmb.2008.06.042; Hauri HP, 2000, J CELL SCI, V113, P587; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Kawasaki N, 2008, BLOOD, V111, P1972, DOI 10.1182/blood-2007-06-097022; Kogler E. J., 2008, THESIS U BASEL; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Montero M, 1997, J CELL BIOL, V139, P601, DOI 10.1083/jcb.139.3.601; Neve EPA, 2005, J MOL BIOL, V354, P556, DOI 10.1016/j.jmb.2005.09.077; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Nishio M, 2010, P NATL ACAD SCI USA, V107, P4034, DOI 10.1073/pnas.0908526107; Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x; Olson LJ, 2008, J BIOL CHEM, V283, P10124, DOI 10.1074/jbc.M708994200; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Pezzati R, 1997, MOL BIOL CELL, V8, P1501, DOI 10.1091/mbc.8.8.1501; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Reiterer V, 2010, TRAFFIC, V11, P1044, DOI 10.1111/j.1600-0854.2010.01078.x; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Van Baelen K, 2003, BIOCHEM BIOPH RES CO, V306, P430, DOI 10.1016/S0006-291X(03)00977-X; Velloso LM, 2003, J MOL BIOL, V334, P845, DOI 10.1016/j.jmb.2003.10.031; Velloso LM, 2002, J BIOL CHEM, V277, P15979, DOI 10.1074/jbc.M112098200; Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377; Wigren E, 2010, FEBS LETT, V584, P878, DOI 10.1016/j.febslet.2010.02.009; Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153; Zheng CL, 2010, BLOOD, V116, P5698, DOI 10.1182/blood-2010-04-278325; Zheng CL, 2010, BLOOD, V115, P1081, DOI 10.1182/blood-2009-09-241877	49	31	31	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20499	20509		10.1074/jbc.M113.461434	http://dx.doi.org/10.1074/jbc.M113.461434			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23709226	hybrid, Green Published			2022-12-28	WOS:000321715100037
J	Dickson, CF; Rich, AM; D'Avigdor, WMH; Collins, DAT; Lowry, JA; Mollan, TL; Khandros, E; Olson, JS; Weiss, MJ; Mackay, JP; Lay, PA; Gell, DA				Dickson, Claire F.; Rich, Anne M.; D'Avigdor, William M. H.; Collins, Daniel A. T.; Lowry, Jason A.; Mollan, Todd L.; Khandros, Eugene; Olson, John S.; Weiss, Mitchell J.; Mackay, Joel P.; Lay, Peter A.; Gell, David A.			alpha-Hemoglobin-stabilizing Protein (AHSP) Perturbs the Proximal Heme Pocket of Oxy-alpha-hemoglobin and Weakens the Iron-Oxygen Bond	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCATTERING XAFS ANALYSES; SITE MOLECULAR-STRUCTURE; CARBON-MONOXIDE COMPLEX; HUMAN ADULT HEMOGLOBIN; RED-BLOOD-CELLS; ESCHERICHIA-COLI; HYDROGEN-PEROXIDE; ACTIVE-SITE; BETA-THALASSEMIA; NITRIC-OXIDE	alpha-Hemoglobin (alpha Hb)-stabilizing protein (AHSP) is a molecular chaperone that assists hemoglobin assembly. AHSP induces changes in alpha Hb heme coordination, but how these changes are facilitated by interactions at the alpha Hb center dot AHSP interface is not well understood. To address this question we have used NMR, x-ray absorption spectroscopy, and ligand binding measurements to probe alpha Hb conformational changes induced by AHSP binding. NMR chemical shift analyses of free CO-alpha Hb and CO-alpha Hb center dot AHSP indicated that the seven helical elements of the native alpha Hb structure are retained and that the heme Fe(II) remains coordinated to the proximal His-87 side chain. However, chemical shift differences revealed alterations of the F, G, and H helices and the heme pocket of CO-alpha Hb bound to AHSP. Comparisons of iron-ligand geometry using extended x-ray absorption fine structure spectroscopy showed that AHSP binding induces a small 0.03 angstrom lengthening of the Fe-O-2 bond, explaining previous reports that AHSP decreases alpha Hb O-2 affinity roughly 4-fold and promotes autooxidation due primarily to a 3-4-fold increase in the rate of O-2 dissociation. Pro-30 mutations diminished NMR chemical shift changes in the proximal heme pocket, restored normal O-2 dissociation rate and equilibrium constants, and reduced O-2-alpha Hb autooxidation rates. Thus, the contacts mediated by Pro-30 in wild-type AHSP promote alpha Hb autooxidation by introducing strain into the proximal heme pocket. As a chaperone, AHSP facilitates rapid assembly of alpha Hb into Hb when beta Hb is abundant but diverts alpha Hb to a redox resistant holding state when beta Hb is limiting.	[Dickson, Claire F.; Collins, Daniel A. T.; Gell, David A.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Rich, Anne M.; Lay, Peter A.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [D'Avigdor, William M. H.; Lowry, Jason A.; Mackay, Joel P.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Mollan, Todd L.; Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Khandros, Eugene; Weiss, Mitchell J.] Univ Penn, Cell & Mol Biol Grp, Philadelphia, PA 19104 USA	University of Tasmania; University of Sydney; University of Sydney; Rice University; University of Pennsylvania	Gell, DA (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, 17 Liverpool St, Hobart, Tas 7000, Australia.	david.gell@utas.edu.au	Lay, Peter A/B-4698-2014; Weiss, Mitchell J/W-9814-2018; Mackay, Joel/D-6834-2011	Lay, Peter A/0000-0002-3232-2720; Weiss, Mitchell J/0000-0003-2460-3036; Olson, John/0000-0002-0760-5403; Collins, Daniel/0000-0001-5261-8054; Gell, David/0000-0003-0382-1181; Mackay, Joel/0000-0001-7508-8033	National Institutes of Health (NIH) [HL47020, GM35649, HL110900]; Institute of Biosciences and Bioengineering NIH [GM008362]; Australian Research Council (ARC); National Health and Medical Research Council; Robert A. Welch Foundation [C-0612]; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020, P01HL110900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649, T32GM008362] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute of Biosciences and Bioengineering NIH; Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grants HL47020, GM35649, and HL110900 (all to J. S. O.) and Institute of Biosciences and Bioengineering NIH Biotechnology Predoctoral Training Grant GM008362 (to T. L. M.). This work was also supported by the Australian Research Council (ARC) (to P. A. L., J. P. M., and D. A. G.), an ARC Australian Professorial Fellowship (to P. A. L.), a National Health and Medical Research Council Senior Research Fellowship (to J. P. M.), and Robert A. Welch Foundation Grant C-0612 (to J. S. O. and T. L. M.).	Amer J, 2003, EUR J HAEMATOL, V70, P84, DOI 10.1034/j.1600-0609.2003.00011.x; ANTONINI E, 1966, J MOL BIOL, V17, P29, DOI 10.1016/S0022-2836(66)80092-X; Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r; BEYCHOK S, 1967, J BIOL CHEM, V242, P2460; BINSTED N, 1992, BIOCHEMISTRY-US, V31, P12117, DOI 10.1021/bi00163a021; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; BRUNORI M, 1966, J BIOL CHEM, V241, P5238; BUCCI E, 1965, J BIOL CHEM, V240, pP551; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Capece L, 2006, J AM CHEM SOC, V128, P12455, DOI 10.1021/ja0620033; Chance MR, 1996, BIOCHEMISTRY-US, V35, P9014, DOI 10.1021/bi9605503; CRAMER SP, 1988, NUCL INSTRUM METH A, V266, P586, DOI 10.1016/0168-9002(88)90449-4; DALVIT C, 1987, J MOL BIOL, V194, P329, DOI 10.1016/0022-2836(87)90379-2; DALVIT C, 1987, FEBS LETT, V213, P289, DOI 10.1016/0014-5793(87)81507-7; De Franceschi L, 2011, HAEMATOL-HEMATOL J, V96, P1595, DOI 10.3324/haematol.2011.043612; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; dos Santos CO, 2004, EXP HEMATOL, V32, P157, DOI 10.1016/j.exphem.2003.11.002; Eaton W A, 1981, Methods Enzymol, V76, P175; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; ELLIS PJ, 1995, J SYNCHROTRON RADIAT, V2, P190, DOI 10.1107/S0909049595006789; Feng L, 2005, NATURE, V435, P697, DOI 10.1038/nature03609; Feng L, 2004, CELL, V119, P629, DOI 10.1016/j.cell.2004.11.025; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gell DA, 2009, J BIOL CHEM, V284, P29462, DOI 10.1074/jbc.M109.027045; George GN, 2012, J SYNCHROTRON RADIAT, V19, P875, DOI 10.1107/S090904951203943X; GERACI G, 1969, BIOCHEMISTRY-US, V8, P1848, DOI 10.1021/bi00833a011; Geraci G, 1981, Methods Enzymol, V76, P262; GILL FM, 1973, J CLIN INVEST, V52, P3057, DOI 10.1172/JCI107504; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Giordano PC, 2007, HEMOGLOBIN, V31, P179, DOI 10.1080/03630260701289490; GIULIVI C, 1994, METHOD ENZYMOL, V231, P490; Goddard TD, 2006, SPARKY; Hamdane D, 2007, J BIOL CHEM, V282, P6398, DOI 10.1074/jbc.M610543200; Hasnain SS, 1999, J SYNCHROTRON RADIAT, V6, P852, DOI 10.1107/S0909049599006792; JAMESON GB, 1980, J AM CHEM SOC, V102, P3224, DOI 10.1021/ja00529a055; JOSHI W, 1983, J LAB CLIN MED, V102, P46; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kachalova GS, 1999, SCIENCE, V284, P473, DOI 10.1126/science.284.5413.473; Khandros E, 2012, J BIOL CHEM, V287, P11325, DOI 10.1074/jbc.M111.313205; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kim-Shapiro DB, 2006, ARTERIOSCL THROM VAS, V26, P697, DOI 10.1161/01.ATV.0000204350.44226.9a; Kong Y, 2004, J CLIN INVEST, V114, P1457, DOI 10.1172/JCI200421982; Lai MI, 2006, BRIT J HAEMATOL, V133, P675, DOI 10.1111/j.1365-2141.2006.06075.x; Leecharoenkiat A, 2011, BLOOD CELL MOL DIS, V47, P143, DOI 10.1016/j.bcmd.2011.06.005; Levina A, 2005, COORDIN CHEM REV, V249, P141, DOI 10.1016/j.ccr.2004.10.008; Li R, 2000, J INORG BIOCHEM, V82, P93, DOI 10.1016/S0162-0134(00)00151-3; LOOKER D, 1994, METHOD ENZYMOL, V231, P364; Lukin JA, 2000, P NATL ACAD SCI USA, V97, P10354, DOI 10.1073/pnas.190254697; MARTINEAU L, 1992, EUR J BIOCHEM, V205, P661, DOI 10.1111/j.1432-1033.1992.tb16826.x; Mollan TL, 2013, J BIOL CHEM, V288, P4288, DOI 10.1074/jbc.M112.412064; Mollan TL, 2012, J BIOL CHEM, V287, P11338, DOI 10.1074/jbc.M111.313247; Nagababu E, 2000, BIOCHEMISTRY-US, V39, P12503, DOI 10.1021/bi992170y; Nasimuzzaman M, 2010, AM J HEMATOL, V85, P820, DOI 10.1002/ajh.21829; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PELTON JG, 1993, PROTEIN SCI, V2, P543; REED CA, 1977, P NATL ACAD SCI USA, V74, P1780, DOI 10.1073/pnas.74.5.1780; Reeder BJ, 2004, ANTIOXID REDOX SIGN, V6, P954, DOI 10.1089/ars.2004.6.954; Reeder BJ, 2010, ANTIOXID REDOX SIGN, V13, P1087, DOI 10.1089/ars.2009.2974; Rich A. M., 1997, THESIS U SYDNEY SYDN; Rich AM, 1998, INORG CHEM, V37, P5743, DOI 10.1021/ic9714549; Rich AM, 1998, J AM CHEM SOC, V120, P10827, DOI 10.1021/ja980253g; Santiveri CM, 2004, J BIOL CHEM, V279, P34963, DOI 10.1074/jbc.M405016200; SCHULMAN HM, 1974, BIOCHEM BIOPH RES CO, V56, P220, DOI 10.1016/S0006-291X(74)80337-2; SCOTT MD, 1993, J CLIN INVEST, V91, P1706, DOI 10.1172/JCI116380; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simplaceanu V, 2000, BIOPHYS J, V79, P1146, DOI 10.1016/S0006-3495(00)76368-5; SPIRO TG, 1974, J AM CHEM SOC, V96, P338, DOI 10.1021/ja00809a004; Srinoun K, 2009, HAEMATOL-HEMATOL J, V94, P1211, DOI 10.3324/haematol.2009.005827; Straub AC, 2012, NATURE, V491, P473, DOI 10.1038/nature11626; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; TOMODA A, 1978, BIOCHEM J, V171, P329, DOI 10.1042/bj1710329; Tran ATT, 2004, BBA-PROTEINS PROTEOM, V1701, P75, DOI 10.1016/j.bbapap.2004.06.003; Tran ATT, 2003, BBA-PROTEINS PROTEOM, V1650, P59, DOI 10.1016/S1570-9639(03)00202-4; VALDES R, 1977, J BIOL CHEM, V252, P74; Vasseur C, 2011, AM J HEMATOL, V86, P199, DOI 10.1002/ajh.21918; Vasseur-Godbillon C, 2006, PROTEIN ENG DES SEL, V19, P91, DOI 10.1093/protein/gzj006; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6; Yu X, 2007, J CLIN INVEST, V117, P1856, DOI 10.1172/JCI31664; Yu X, 2009, BLOOD, V113, P5961, DOI 10.1182/blood-2008-12-196030; ZHANG Y, 1992, J AM CHEM SOC, V114, P9189, DOI 10.1021/ja00049a062; Zhou SP, 2006, J BIOL CHEM, V281, P32611, DOI 10.1074/jbc.M607311200	85	12	12	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19986	20001		10.1074/jbc.M112.437509	http://dx.doi.org/10.1074/jbc.M112.437509			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696640	hybrid, Green Published			2022-12-28	WOS:000321515800063
J	Huang, HY; Hu, XX; Eno, CO; Zhao, GP; Li, C; White, C				Huang, Huiya; Hu, Xiangxin; Eno, Colins O.; Zhao, Guoping; Li, Chi; White, Carl			An Interaction between Bcl-x(L) and the Voltage-dependent Anion Channel (VDAC) Promotes Mitochondrial Ca2+ Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE; BCL-XL; ENDOPLASMIC-RETICULUM; APOPTOSIS REGULATION; OUTER-MEMBRANE; INNER MEMBRANE; CYTOCHROME-C; CALCIUM; PROTEIN; MODULATION	The role of the antiapoptotic protein Bcl-x(L) in regulating mitochondrial Ca2+ ([Ca2+](mito)) handling was examined in wild-type (WT) and Bcl-x(L) knock-out (Bcl-x(L)-KO) mouse embryonic fibroblast cells. Inositol 1,4,5-trisphosphate-generating agonist evoked cytosolic Ca2+ transients that produced a larger [Ca2+] mito uptake in WT cells compared with Bcl-x(L)-KO. In permeabilized cells, stepping external [Ca2+] from 0 to 3+ M also produced a larger [Ca2+](mito) uptake in WT; moreover, the [Ca2+](mito) uptake capacity of Bcl-x(L)-KO cells was restored by re-expression of mitochondrially targeted Bcl-x(L). Bcl-x(L) enhancement of [Ca2+](mito) uptake persisted after dissipation of the mitochondrial membrane potential but was absent in mitoplasts lacking an outer mitochondrial membrane. The outer membrane-localized voltage-dependent anion channel (VDAC) is a known Ca2+ permeability pathway that directly interacts with Bcl-x(L). Bcl-x(L) interacted with VDAC1 and -3 isoforms, and peptides based on the VDAC sequence disrupted Bcl-x(L) binding. Peptides reduced [Ca2+](mito) uptake in WT but were without effect in Bcl-xL-KO cells. In addition, peptides reduced [Ca2+](mito) uptake in VDAC1 and VDAC3 knock-out but not VDAC1 and -3 double knock-out mouse embryonic fibroblast cells, confirming that Bcl-x(L) interacts functionally with VDAC1 and -3 but not VDAC2. Thus, an interaction between Bcl-x(L) and VDAC promotes matrix Ca2+ accumulation by increasing Ca2+ transfer across the outer mitochondrial membrane.	[Huang, Huiya; Hu, Xiangxin; White, Carl] Rosalind Franklin Univ Med & Sci, Dept Physiol & Biophys, N Chicago, IL 60064 USA; [Eno, Colins O.; Zhao, Guoping; Li, Chi] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Eno, Colins O.; Zhao, Guoping; Li, Chi] Univ Louisville, Dept Med, Louisville, KY 40202 USA; [Eno, Colins O.; Zhao, Guoping; Li, Chi] Univ Louisville, Dept Pharmacol, Louisville, KY 40202 USA; [Eno, Colins O.; Zhao, Guoping; Li, Chi] Univ Louisville, Dept Toxicol, Louisville, KY 40202 USA	Rosalind Franklin University Medical & Science; University of Louisville; University of Louisville; University of Louisville; University of Louisville	White, C (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Physiol & Biophys, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	carl.white@rosalindfranklin.edu		White, Carl/0000-0002-0535-6968	National Institutes of Health [CA106599, RR018733]; American Heart Association scientist development grant; Rosalind Franklin University; Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE [K01CA106599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association scientist development grant(American Heart Association); Rosalind Franklin University; Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA106599 and RR018733 (to C. L.). This work was also supported by an American Heart Association scientist development grant and Rosalind Franklin University (to C. W.) and funding from the Kentucky Lung Cancer Research Program (to C. L.).	Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Bathori G, 2006, J BIOL CHEM, V281, P17347, DOI 10.1074/jbc.M600906200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chen R, 2004, J CELL BIOL, V166, P193, DOI 10.1083/jcb.200309146; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Csordas G, 2002, EMBO J, V21, P2198, DOI 10.1093/emboj/21.9.2198; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Decaudin D, 1997, CANCER RES, V57, P62; Distelhorst CW, 2011, CELL CALCIUM, V50, P234, DOI 10.1016/j.ceca.2011.05.011; Duchen MR, 2008, CELL CALCIUM, V44, P1, DOI 10.1016/j.ceca.2008.02.001; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Eckenrode EF, 2010, J BIOL CHEM, V285, P13678, DOI 10.1074/jbc.M109.096040; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Eno CO, 2012, MOL BIOL CELL, V23, P2605, DOI 10.1091/mbc.E12-02-0090; Fiebig AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-213; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Huizing M, 1998, J BIOENERG BIOMEMBR, V30, P277, DOI 10.1023/A:1020501021222; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kowaltowski AJ, 2000, AM J PHYSIOL-CELL PH, V279, pC852, DOI 10.1152/ajpcell.2000.279.3.C852; Li C, 2007, P NATL ACAD SCI USA, V104, P12565, DOI 10.1073/pnas.0702489104; Malia TJ, 2007, BIOCHEMISTRY-US, V46, P514, DOI 10.1021/bi061577h; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Monaco G, 2012, CELL DEATH DIFFER, V19, P295, DOI 10.1038/cdd.2011.97; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Pavlov E, 2005, BBA-BIOENERGETICS, V1710, P96, DOI 10.1016/j.bbabio.2005.09.006; Rapizzi E, 2002, J CELL BIOL, V159, P613, DOI 10.1083/jcb.200205091; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Roy SS, 2009, EMBO REP, V10, P1341, DOI 10.1038/embor.2009.219; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Shimizu S, 2000, ONCOGENE, V19, P4309, DOI 10.1038/sj.onc.1203788; Shimizu S, 1998, P NATL ACAD SCI USA, V95, P1455, DOI 10.1073/pnas.95.4.1455; Szabadkai G, 2004, MOL CELL, V16, P59, DOI 10.1016/j.molcel.2004.09.026; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Szanda G, 2010, CELL CALCIUM, V48, P168, DOI 10.1016/j.ceca.2010.08.005; Tan WZ, 2007, BBA-BIOMEMBRANES, V1768, P2510, DOI 10.1016/j.bbamem.2007.06.002; Vander Heiden MG, 1999, MOL CELL, V3, P159; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zhong F, 2006, J CELL BIOL, V172, P127, DOI 10.1083/jcb.200506189	54	100	100	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19870	19881		10.1074/jbc.M112.448290	http://dx.doi.org/10.1074/jbc.M112.448290			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720737	hybrid, Green Published			2022-12-28	WOS:000321515800054
J	Stephenson, HN; John, CM; Naz, N; Gundogdu, O; Dorrell, N; Wren, BW; Jarvis, GA; Bajaj-Elliott, M				Stephenson, Holly N.; John, Constance M.; Naz, Neveda; Gundogdu, Ozan; Dorrell, Nick; Wren, Brendan W.; Jarvis, Gary A.; Bajaj-Elliott, Mona			Campylobacter jejuni Lipooligosaccharide Sialylation, Phosphorylation, and Amide/Ester Linkage Modifications Fine-tune Human Toll-like Receptor 4 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEISSERIA-MENINGITIDIS; DENDRITIC CELLS; SIALIC ACIDS; LIPID-A; 2,3-DIAMINO-2,3-DIDEOXY-D-GLUCOSE; LIPOPOLYSACCHARIDES; PHOSPHOETHANOLAMINE; BIOSYNTHESIS; INDUCTION; INFECTION	Campylobacter jejuni is a leading cause of acute gastroenteritis. C. jejuni lipooligosaccharide (LOS) is a potent activator of Toll-like receptor (TLR) 4-mediated innate immunity. Structural variations of the LOS have been previously reported in the oligosaccharide (OS) moiety, the disaccharide lipid A (LA) backbone, and the phosphorylation of the LA. Here, we studied LOS structural variation between C. jejuni strains associated with different ecological sources and analyzed their ability to activate TLR4 function. MALDI-TOF MS was performed to characterize structural variation in both the OS and LA among 15 different C. jejuni isolates. Cytokine induction in THP-1 cells and primary monocytes was correlated with LOS structural variation in each strain. Additionally, structural variation was correlated with the source of each strain. OS sialylation, increasing abundance of LA D-glucosamine versus 2,3-diamino-2,3-dideoxy-D-glucose, and phosphorylation status all correlated with TLR4 activation as measured in THP-1 cells and monocytes. Importantly, LOS-induced inflammatory responses were similar to those elicited by live bacteria, highlighting the prominent contribution of the LOS component in driving host immunity. OS sialylation status but not LA structure showed significant association with strains clustering with livestock sources. Our study highlights how variations in three structural components of C. jejuni LOS alter TLR4 activation and consequent monocyte activation.	[Stephenson, Holly N.; Bajaj-Elliott, Mona] UCL, Infect Dis & Microbiol Unit, Inst Child Hlth, London WC1N 1EH, England; [John, Constance M.; Jarvis, Gary A.] Vet Affairs Med Ctr, Dept Lab Med, San Francisco, CA 94121 USA; [John, Constance M.; Jarvis, Gary A.] Univ Calif San Francisco, San Francisco, CA 94121 USA; [Naz, Neveda; Gundogdu, Ozan; Dorrell, Nick; Wren, Brendan W.] Univ London London Sch Hyg & Trop Med, Dept Pathogen Mol Biol, London WC1E 7HT, England	University of London; University College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine	Jarvis, GA (corresponding author), Vet Affairs Med Ctr, Dept 111W1, 4150 Clement St, San Francisco, CA 94121 USA.	Gary.Jarvis@ucsf.edu		Gundogdu, Ozan/0000-0002-3550-0545; Bajaj-Elliott, Mona/0000-0002-5234-576X; Jarvis, Gary/0000-0002-7576-3702; Dorrell, Nick/0000-0003-1144-6502	Sandler Family Foundation; Gordon and Betty Moore Foundation; National Institutes of Health (NIH)/NCI Cancer Center Support Grant [P30 CA082103]; NIH/National Center for Research Resources (NCRR) [S10RR029446-01]; UCSF Mass Spectrometry Facility; NIH/NCRR [P41RR001614]; Biotechnology and Biological Sciences Research Council [EGA16167, BB/C519670/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA082103] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614, S10RR029446] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000727] Funding Source: NIH RePORTER	Sandler Family Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Institutes of Health (NIH)/NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UCSF Mass Spectrometry Facility; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Veterans Affairs(US Department of Veterans Affairs)	We gratefully acknowledge the University of California, San Francisco (UCSF) Mass Spectrometry Core Facility, which is supported by the Sandler Family Foundation, the Gordon and Betty Moore Foundation, and National Institutes of Health (NIH)/NCI Cancer Center Support Grant P30 CA082103, and the NIH/National Center for Research Resources (NCRR) Shared Instrumentation Grant S10RR029446-01 (to H. E. Witkowska), and the UCSF Mass Spectrometry Facility (A. L. Burlingame, Director), which is supported by NIH/NCRR Grant P41RR001614.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; BEUTLER B, 1990, J INVEST DERMATOL, V95, pS81, DOI 10.1111/1523-1747.ep12874797; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Cekic C, 2009, J BIOL CHEM, V284, P31982, DOI 10.1074/jbc.M109.046383; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Cullen TW, 2013, INFECT IMMUN, V81, P430, DOI 10.1128/IAI.01046-12; Cullen TW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002454; Cullen TW, 2012, J BIOL CHEM, V287, P3326, DOI 10.1074/jbc.M111.321737; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dzieciatkowska M, 2007, BIOCHEMISTRY-US, V46, P14704, DOI 10.1021/bi701229k; Gardner TJ, 2011, CLIN INFECT DIS, V53, P26, DOI 10.1093/cid/cir249; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Gundogdu O, 2011, J BACTERIOL, V193, P4238, DOI 10.1128/JB.05189-11; Hepworth PJ, 2011, ENVIRON MICROBIOL, V13, P1549, DOI 10.1111/j.1462-2920.2011.02461.x; Hu L, 2006, INFECT IMMUN, V74, P2697, DOI 10.1128/IAI.74.5.2697-2705.2006; JARVIS GA, 1987, INFECT IMMUN, V55, P174, DOI 10.1128/IAI.55.1.174-180.1987; Javed MA, 2012, INFECT IMMUN, V80, P2361, DOI 10.1128/IAI.00151-12; John CM, 2012, INFECT IMMUN, V80, P4014, DOI 10.1128/IAI.00506-12; John CM, 2009, J BIOL CHEM, V284, P21515, DOI 10.1074/jbc.M109.004887; John CM, 2009, J LIPID RES, V50, P424, DOI 10.1194/jlr.M800184-JLR200; Kemp R, 2005, APPL ENVIRON MICROB, V71, P1876, DOI 10.1128/AEM.71.4.1876-1882.2005; Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014; Lepper PM, 2005, CELL MICROBIOL, V7, P519, DOI 10.1111/j.1462-5822.2005.00482.x; Liu MF, 2010, J IMMUNOL, V185, P6974, DOI 10.4049/jimmunol.1000953; Lock K, 2004, IMMUNOBIOLOGY, V209, P199, DOI 10.1016/j.imbio.2004.04.007; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; MORAN AP, 1991, J BACTERIOL, V173, P618, DOI 10.1128/jb.173.2.618-626.1991; MORAN AP, 1991, EUR J BIOCHEM, V198, P459, DOI 10.1111/j.1432-1033.1991.tb16036.x; Mortensen NP, 2009, MICROBES INFECT, V11, P988, DOI 10.1016/j.micinf.2009.07.004; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; PHILLIPS NJ, 1993, BIOCHEMISTRY-US, V32, P2003, DOI 10.1021/bi00059a017; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rathinam VAK, 2009, INFECT IMMUN, V77, P2499, DOI 10.1128/IAI.01562-08; Scott NE, 2012, J BIOL CHEM, V287, P29384, DOI 10.1074/jbc.M112.380212; Szymanski CM, 2003, J BIOL CHEM, V278, P24509, DOI 10.1074/jbc.M301273200; van Mourik A, 2010, J BIOL CHEM, V285, P15828, DOI 10.1074/jbc.M110.102061; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x	42	32	34	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19661	19672		10.1074/jbc.M113.468298	http://dx.doi.org/10.1074/jbc.M113.468298			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23629657	Green Published, hybrid			2022-12-28	WOS:000321515800037
J	Garcia-Fontana, C; Reyes-Darias, JA; Munoz-Martinez, F; Alfonso, C; Morel, B; Ramos, JL; Krell, T				Garcia-Fontana, Cristina; Antonio Reyes-Darias, Jose; Munoz-Martinez, Francisco; Alfonso, Carlos; Morel, Bertrand; Ramos, Juan Luis; Krell, Tino			High Specificity in CheR Methyltransferase Function CheR2 OF PSEUDOMONAS PUTIDA IS ESSENTIAL FOR CHEMOTAXIS, WHEREAS CheR1 IS INVOLVED IN BIOFILM FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; LIGAND-BINDING REGIONS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; BACTERIAL CHEMOTAXIS; CHEMOSENSORY SYSTEM; SIGNAL-TRANSDUCTION; COVALENT MODIFICATION; S-ADENOSYLMETHIONINE; TWITCHING MOTILITY	Chemosensory pathways are a major signal transduction mechanism in bacteria. CheR methyltransferases catalyze the methylation of the cytosolic signaling domain of chemoreceptors and are among the core proteins of chemosensory cascades. These enzymes have primarily been studied Escherichia coli and Salmonella typhimurium, which possess a single CheR involved in chemotaxis. Many other bacteria possess multiple cheR genes. Because the sequences of chemoreceptor signaling domains are highly conserved, it remains to be established with what degree of specificity CheR paralogues exert their activity. We report here a comparative analysis of the three CheR paralogues of Pseudomonas putida. Isothermal titration calorimetry studies show that these paralogues bind the product of the methylation reaction, S-adenosylhomocysteine, with much higher affinity (K-D of 0.14-2.2 mu M) than the substrate S-adenosylmethionine (K-D of 22-43 mu M), which indicates product feedback inhibition. Product binding was particularly tight for CheR2. Analytical ultracentrifugation experiments demonstrate that CheR2 is monomeric in the absence and presence of S-adenosylmethionine or S-adenosylhomocysteine. Methylation assays show that CheR2, but not the other paralogues, methylates the McpS and McpT chemotaxis receptors. The mutant in CheR2 was deficient in chemotaxis, whereas mutation of CheR1 and CheR3 had either no or little effect on chemotaxis. In contrast, biofilm formation of the CheR1 mutant was largely impaired but not affected in the other mutants. We conclude that CheR2 forms part of a chemotaxis pathway, and CheR1 forms part of a chemosensory route that controls biofilm formation. Data suggest that CheR methyltransferases act with high specificity on their cognate chemoreceptors.	[Garcia-Fontana, Cristina; Antonio Reyes-Darias, Jose; Munoz-Martinez, Francisco; Ramos, Juan Luis; Krell, Tino] CSIC, Estn Expt Zaidin, Environm Protect Dept, E-18008 Granada, Spain; [Antonio Reyes-Darias, Jose] Poligono Ind Juncaril, Bioiliberis R&D, Granada 18210, Spain; [Alfonso, Carlos] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Morel, Bertrand] Univ Granada, Fac Ciencias, Dept Quim Fis, E-18071 Granada, Spain; [Morel, Bertrand] Univ Granada, Fac Ciencias, Inst Biotecnol, E-18071 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Granada; University of Granada	Krell, T (corresponding author), CSIC, Estn Expt Zaidin, C Prof Albareda 1, E-18008 Granada, Spain.	tino.krell@eez.csic.es	Fontana, Cristina Garcia/AAJ-4536-2021; Alfonso, Carlos/K-1316-2014; Krell, Tino/G-7296-2015; Fontana, Cristina Garcia/L-8184-2014	Fontana, Cristina Garcia/0000-0002-9328-6022; Alfonso, Carlos/0000-0001-7165-4800; Krell, Tino/0000-0002-9040-3166; Fontana, Cristina Garcia/0000-0002-9328-6022; Morel, Bertrand/0000-0002-2708-8589; Munoz-Martinez, Francisco/0000-0001-8416-0092; Ramos, Juan L./0000-0002-8731-7435	FEDER; Fondo Social Europeo through Junta de Andalucia [P09-RNM-4509, CVI-7335]; Spanish Ministry for Economy and Competitiveness [Bio2010-16937, BIO2010-17227]	FEDER(European Commission); Fondo Social Europeo through Junta de Andalucia; Spanish Ministry for Economy and Competitiveness(Spanish Government)	This work was supported by FEDER funds and Fondo Social Europeo through Junta de Andalucia Grants P09-RNM-4509 and CVI-7335 (to T. K.) and Spanish Ministry for Economy and Competitiveness Grants Bio2010-16937 (to T. K.) and BIO2010-17227 (to J. L. R.).	Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906; BINSTOCK J, 1984, METHOD ENZYMOL, V106, P310; Blaszczyk U, 2003, J PROTEIN CHEM, V22, P285, DOI 10.1023/A:1025024604677; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; CAMPILLO JE, 1982, FEBS LETT, V138, P71, DOI 10.1016/0014-5793(82)80397-9; DARZINS A, 1994, MOL MICROBIOL, V11, P137, DOI 10.1111/j.1365-2958.1994.tb00296.x; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Djordjevic S, 1998, NAT STRUCT BIOL, V5, P446, DOI 10.1038/nsb0698-446; Djordjevic S, 1997, STRUCTURE, V5, P545, DOI 10.1016/S0969-2126(97)00210-4; Duque E, 2004, ENVIRON MICROBIOL, V6, P1021, DOI 10.1111/j.1462-2920.2004.00621.x; ELY B, 1986, GENETICS, V114, P717; Espinosa-Urgel M, 2004, APPL ENVIRON MICROB, V70, P5190, DOI 10.1128/AEM.70.9.5190-5198.2004; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Ferrandez A, 2002, J BACTERIOL, V184, P4374, DOI 10.1128/JB.184.16.4374-4383.2002; Fillet S, 2011, P NATL ACAD SCI USA, V108, P15372, DOI 10.1073/pnas.1018894108; Fulcher NB, 2010, MOL MICROBIOL, V76, P889, DOI 10.1111/j.1365-2958.2010.07135.x; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Hamer R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-3; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; JONES KS, 1992, J BIOL CHEM, V267, P16037; Kanungpean D, 2011, MICROBIOL-SGM, V157, P1279, DOI 10.1099/mic.0.047399-0; Kato J, 1999, BIOSCI BIOTECH BIOCH, V63, P155, DOI 10.1271/bbb.63.155; Kearns DB, 2001, J BACTERIOL, V183, P763, DOI 10.1128/JB.183.2.763-767.2001; Kedracka-Krok S, 2003, EUR J BIOCHEM, V270, P4564, DOI 10.1046/j.1432-1033.2003.03856.x; Krell T, 2011, ENVIRON MICROBIOL, V13, P1115, DOI 10.1111/j.1462-2920.2010.02383.x; Krell T, 2008, MICROB BIOTECHNOL, V1, P126, DOI 10.1111/j.1751-7915.2007.00013.x; Lacal J, 2013, J APPL MICROBIOL, V114, P923, DOI 10.1111/jam.12076; Lacal J, 2011, ENVIRON MICROBIOL, V13, P1733, DOI 10.1111/j.1462-2920.2011.02493.x; Lacal J, 2011, J MOL RECOGNIT, V24, P378, DOI 10.1002/jmr.1101; Lacal J, 2010, ENVIRON MICROBIOL, V12, P2873, DOI 10.1111/j.1462-2920.2010.02325.x; Lacal J, 2010, J BIOL CHEM, V285, P23124, DOI 10.1074/jbc.M110.110403; Lazova MD, 2011, P NATL ACAD SCI USA, V108, P13870, DOI 10.1073/pnas.1108608108; LeMoual H, 1996, J MOL BIOL, V261, P568, DOI 10.1006/jmbi.1996.0483; Li GY, 2000, CELL, V100, P357, DOI 10.1016/S0092-8674(00)80671-6; Llamas MA, 2003, J BACTERIOL, V185, P4707, DOI 10.1128/JB.185.16.4707-4716.2003; MASDUKI A, 1995, J BACTERIOL, V177, P948, DOI 10.1128/jb.177.4.948-952.1995; Min TJL, 2012, P NATL ACAD SCI USA, V109, P9869, DOI 10.1073/pnas.1120218109; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Molina L, 2011, ENVIRON MICROBIOL, V13, P2315, DOI 10.1111/j.1462-2920.2011.02492.x; Munoz-Martinez F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045810; Muppirala UK, 2009, PROTEIN SCI, V18, P1702, DOI 10.1002/pro.170; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; O'Connor JR, 2012, MOL MICROBIOL, V86, P720, DOI 10.1111/mmi.12013; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Pineda-Molina E, 2012, P NATL ACAD SCI USA, V109, P18926, DOI 10.1073/pnas.1201400109; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; Ramos JL, 2009, CURR OPIN MICROBIOL, V12, P215, DOI 10.1016/j.mib.2009.02.001; Rodriguez-Herva JJ, 2007, ENVIRON MICROBIOL, V9, P1550, DOI 10.1111/j.1462-2920.2007.01276.x; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shiomi D, 2002, J BIOL CHEM, V277, P42325, DOI 10.1074/jbc.M202001200; SIMMS SA, 1991, J BIOL CHEM, V266, P12741; SIMMS SA, 1987, J BIOL CHEM, V262, P8537; Sourjik V, 2012, CURR OPIN CELL BIOL, V24, P262, DOI 10.1016/j.ceb.2011.11.008; STOCK JB, 1981, CELL, V27, P37, DOI 10.1016/0092-8674(81)90358-5; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TERWILLIGER TC, 1984, J BIOL CHEM, V259, P7719; Timmis KN, 2002, ENVIRON MICROBIOL, V4, P779, DOI 10.1046/j.1462-2920.2002.00365.x; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Vladimirov N, 2009, BIOL CHEM, V390, P1097, DOI 10.1515/BC.2009.130; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Yi X, 2002, BBA-PROTEIN STRUCT M, V1596, P28, DOI 10.1016/S0167-4838(01)00314-4; Yuan JH, 2012, NATURE, V484, P233, DOI 10.1038/nature10964; Zhulin IB, 2001, ADV MICROB PHYSIOL, V45, P157, DOI 10.1016/S0065-2911(01)45004-1	67	25	29	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18987	18999		10.1074/jbc.M113.472605	http://dx.doi.org/10.1074/jbc.M113.472605			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23677992	Green Published, hybrid			2022-12-28	WOS:000321335800035
J	Gu, L; Liu, C; Guo, ZF				Gu, Lei; Liu, Cong; Guo, Zhefeng			Structural Insights into A beta 42 Oligomers Using Site-directed Spin Labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA OLIGOMERS; AGGREGATION BEHAVIOR; ALZHEIMERS-DISEASE; SIDE-CHAINS; PROTEIN; SHEET; MOTION; FIBRIL; EPR; STABILIZATION	Oligomerization of the 42-residue peptide A beta 42 plays a key role in the pathogenesis of Alzheimer disease. Despite great academic and medical interest, the structures of these oligomers have not been well characterized. Site-directed spin labeling combined with electron paramagnetic resonance spectroscopy is a powerful approach for studying structurally ill-defined systems, but its application in amyloid oligomer structure study has not been systematically explored. Here we report a comprehensive structural study on a toxic A beta 42 oligomer, called globulomer, using site-directed spin labeling complemented by other techniques. Transmission electron microscopy shows that these oligomers are globular structures with diameters of similar to 7-8 nm. Circular dichroism shows primarily beta-structures. X-ray powder diffraction suggests a highly ordered intrasheet hydrogen-bonding network and a heterogeneous intersheet packing. Residue-level mobility analysis on spin labels introduced at 14 different positions shows a structured state and a disordered state at all labeling sites. Side chain mobility analysis suggests that structural order increases from N- to C-terminal regions. Intermolecular distance measurements at 14 residue positions suggest that C-terminal residues Gly-29-Val-40 form a tightly packed core with intermolecular distances in a narrow range of 11.5-12.5 angstrom. These intermolecular distances rule out the existence of fibril-like parallel in-register beta-structures and strongly suggest an antiparallel beta-sheet arrangement in A beta 42 globulomers.	[Gu, Lei; Guo, Zhefeng] Univ Calif Los Angeles, Dept Neurol, Brain Res Inst, Inst Mol Biol, Los Angeles, CA 90095 USA; [Liu, Cong] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles	Guo, ZF (corresponding author), Univ Calif Los Angeles, Dept Neurol, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	zhefeng@ucla.edu	Guo, Zhefeng/A-2069-2013; Gu, Lei/GWQ-6785-2022	Guo, Zhefeng/0000-0003-1992-7255; 	Alzheimer's Association [NIRG-09-133555]; American Health Assistance Foundation [A2010362]	Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation	This work was supported by the Alzheimer's Association (Grant NIRG-09-133555) and American Health Assistance Foundation (Grant A2010362).	Agopian A, 2012, BIOCHEM J, V447, P43, DOI 10.1042/BJ20120034; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Budil DE, 1996, J MAGN RESON SER A, V120, P155, DOI 10.1006/jmra.1996.0113; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Columbus L, 2002, TRENDS BIOCHEM SCI, V27, P288, DOI 10.1016/S0968-0004(02)02095-9; Columbus L, 2001, BIOCHEMISTRY-US, V40, P3828, DOI 10.1021/bi002645h; Cunningham TF, 2012, BIOCHEMISTRY-US, V51, P6350, DOI 10.1021/bi300328w; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Eckert A, 2008, J MOL MED, V86, P1255, DOI 10.1007/s00109-008-0391-6; Fanucci GE, 2006, CURR OPIN STRUC BIOL, V16, P644, DOI 10.1016/j.sbi.2006.08.008; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Gu L, 2012, J BIOL CHEM, V287, P9081, DOI 10.1074/jbc.M111.292086; Guo ZF, 2007, PROTEIN SCI, V16, P1069, DOI 10.1110/ps.062739107; Habicht G, 2007, P NATL ACAD SCI USA, V104, P19232, DOI 10.1073/pnas.0703793104; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hillen H, 2010, J NEUROSCI, V30, P10369, DOI 10.1523/JNEUROSCI.5721-09.2010; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hoyer W, 2008, P NATL ACAD SCI USA, V105, P5099, DOI 10.1073/pnas.0711731105; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lietzow MA, 2004, BIOCHEMISTRY-US, V43, P3137, DOI 10.1021/bi0360962; Liu C, 2011, J AM CHEM SOC, V133, P6736, DOI 10.1021/ja200222n; Lopez CJ, 2012, BIOCHEMISTRY-US, V51, P6568, DOI 10.1021/bi3005686; Ma BY, 2011, J BIOL CHEM, V286, P34244, DOI 10.1074/jbc.M111.241141; Ma BY, 2010, J BIOL CHEM, V285, P37102, DOI 10.1074/jbc.M110.133488; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Morgado I, 2012, P NATL ACAD SCI USA, V109, P12503, DOI 10.1073/pnas.1206433109; Ngo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047248; Ngo S, 2011, BIOCHEM BIOPH RES CO, V414, P512, DOI 10.1016/j.bbrc.2011.09.097; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Sandberg A, 2010, P NATL ACAD SCI USA, V107, P15595, DOI 10.1073/pnas.1001740107; Sarroukh R, 2011, CELL MOL LIFE SCI, V68, P1429, DOI 10.1007/s00018-010-0529-x; Schneider D. J., 1989, SPIN LABELING THEORY, P1; Selkoe DJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004457; Shafrir Y, 2010, PROTEINS, V78, P3458, DOI 10.1002/prot.22832; Shahnawaz M, 2007, BIOCHEM BIOPH RES CO, V359, P801, DOI 10.1016/j.bbrc.2007.05.186; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Vandersteen A, 2012, FEBS LETT, V586, P4088, DOI 10.1016/j.febslet.2012.10.022; Veluraja K, 2011, BIOCHEM BIOPH RES CO, V406, P570, DOI 10.1016/j.bbrc.2011.02.092; Yamamoto N, 2004, J NEUROCHEM, V90, P62, DOI 10.1111/j.1471-4159.2004.02459.x; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904	59	57	59	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18673	18683		10.1074/jbc.M113.457739	http://dx.doi.org/10.1074/jbc.M113.457739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23687299	Green Published, hybrid			2022-12-28	WOS:000321335800004
J	Nan, R; Tetchner, S; Rodriguez, E; Pao, PJ; Gor, J; Lengyel, I; Perkins, SJ				Nan, Ruodan; Tetchner, Stuart; Rodriguez, Elizabeth; Pao, Po-Jung; Gor, Jayesh; Lengyel, Imre; Perkins, Stephen J.			Zinc-induced Self-association of Complement C3b and Factor H IMPLICATIONS FOR INFLAMMATION AND AGE-RELATED MACULAR DEGENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY; SEDIMENTATION-VELOCITY; SCATTERING DATA; FACTOR-B; FACTOR-I; BINDING; POLYMORPHISM; VARIANT; PROTEIN; LIGAND	The sub-retinal pigment epithelial deposits that are a hallmark of age-related macular degeneration contain both C3b and millimolar levels of zinc. C3 is the central protein of complement, whereas C3u is formed by the spontaneous hydrolysis of the thioester bridge in C3. During activation, C3 is cleaved to form active C3b, then C3b is inactivated by Factor I and Factor H to form the C3c and C3d fragments. The interaction of zinc with C3 was quantified using analytical ultracentrifugation and x-ray scattering. C3, C3u, and C3b associated strongly in >100 mu M zinc, whereas C3c and C3d showed weak association. With zinc, C3 forms soluble oligomers, whereas C3u and C3b precipitate. We conclude that the C3, C3u, and C3b association with zinc depended on the relative positions of C3d and C3c in each protein. Computational predictions showed that putative weak zinc binding sites with different capacities exist in all five proteins, in agreement with experiments. Factor H forms large oligomers in >10 mu M zinc. In contrast to C3b or Factor H alone, the solubility of the central C3b-Factor H complex was much reduced at 60 mu M zinc and even more so at >100 mu M zinc. The removal of the C3b-Factor H complex by zinc explains the reduced C3u/C3b inactivation rates by zinc. Zinc-induced precipitation may contribute to the initial development of sub-retinal pigment epithelial deposits in the retina as well as reducing the progression to advanced age-related macular degeneration in higher risk patients.	[Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Lengyel, Imre] UCL Inst Ophthalmol, Dept Ocular Biol & Therapeut, London EC1V 9EL, England	University of London; University College London; University of London; University College London	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@ucl.ac.uk	Lengyel, Imre/B-5217-2009	Lengyel, Imre/0000-0001-7467-2174	Medical Research Council; Wellcome Trust; Fight For Sight; Mercer Fund from Fight for Sight; Bill Brown Charitable Trust; BBSRC [BB/E013104/1] Funding Source: UKRI; MRC [G0801724] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: researchfish; Medical Research Council [G0801724] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Fight For Sight; Mercer Fund from Fight for Sight; Bill Brown Charitable Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (to R. N.), the Wellcome Trust (to S. T.), and Fight For Sight (to P.-J. P.).; Supported by the Mercer Fund from Fight for Sight, the Special Trustees of Moorfields Eye Hospital, and the Bill Brown Charitable Trust.	An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; BIRD AC, 1992, BRIT J OPHTHALMOL, V76, P166, DOI 10.1136/bjo.76.3.166; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Blom AM, 2003, ARCH BIOCHEM BIOPHYS, V418, P108, DOI 10.1016/j.abb.2003.08.018; Bok D, 2005, P NATL ACAD SCI USA, V102, P7053, DOI 10.1073/pnas.0502819102; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Craddock TJA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033552; CROSSLEY LG, 1980, BIOCHEM J, V191, P173, DOI 10.1042/bj1910173; DODDS AW, 1993, METHOD ENZYMOL, V223, P46; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; GALIN MA, 1962, INVEST OPHTH VISUAL, V1, P142; Gilbert HE, 2005, J MOL BIOL, V346, P859, DOI 10.1016/j.jmb.2004.12.006; Glatter O., 1982, SMALL ANGLE XRAY SCA, P17; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Grahn BH, 2001, J AM COLL NUTR, V20, P106, DOI 10.1080/07315724.2001.10719022; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Guinier A., 1955, SMALL ANGLE SCATTERI, P126; Guthridge JM, 2001, BIOCHEMISTRY-US, V40, P5931, DOI 10.1021/bi0101749; Guymer R, 1998, RETINAL PIGMENT EPIT, P693; Haase H, 2010, CELLULAR AND MOLECULAR BIOLOGY OF METALS, P181, DOI 10.1201/9781420059984-c8; Hageman GS, 2006, ANN MED, V38, P592, DOI 10.1080/07853890601097030; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Kajander T, 2011, P NATL ACAD SCI USA, V108, P2897, DOI 10.1073/pnas.1017087108; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Khan S, 2012, BIOCHEM J, V444, P417, DOI 10.1042/BJ20120183; Klein ML, 2008, OPHTHALMOLOGY, V115, P1019, DOI 10.1016/j.ophtha.2008.01.036; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Krezel A, 2006, J BIOL INORG CHEM, V11, P1049, DOI 10.1007/s00775-006-0150-5; Law S.K.A., 1995, COMPLEMENT; Lengyel I, 2007, EXP EYE RES, V84, P772, DOI 10.1016/j.exer.2006.12.015; Lengyel I, 2008, EXPERT REV OPHTHALMO, V3, P1, DOI 10.1586/17469899.3.1.1; Li KY, 2008, J MOL BIOL, V384, P137, DOI 10.1016/j.jmb.2008.08.084; Li KY, 2010, BIOCHEM J, V431, P63, DOI 10.1042/BJ20100759; Luo C, 2011, MOL VIS, V17, P1588; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Maret W, 2009, CHEM REV, V109, P4682, DOI 10.1021/cr800556u; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Nan R, 2011, J MOL BIOL, V408, P714, DOI 10.1016/j.jmb.2011.03.006; Nan R, 2008, J MOL BIOL, V384, P1341, DOI 10.1016/j.jmb.2008.10.030; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; NEWSOME DA, 1992, CURR EYE RES, V11, P213, DOI 10.3109/02713689209001772; Nolan EM, 2009, ACCOUNTS CHEM RES, V42, P193, DOI 10.1021/ar8001409; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Okemefuna AI, 2010, J BIOL CHEM, V285, P1053, DOI 10.1074/jbc.M109.044529; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; PERKINS SJ, 1991, BIOCHEMISTRY-US, V30, P2847, DOI 10.1021/bi00225a017; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Perkins SJ, 2012, IMMUNOBIOLOGY, V217, P281, DOI 10.1016/j.imbio.2011.10.003; Perkins SJ, 2011, METHODS, V54, P181, DOI 10.1016/j.ymeth.2011.01.004; Schmidt C, 2008, REV ECON POLIT, V118, P3; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sodhi JS, 2004, J MOL BIOL, V342, P307, DOI 10.1016/j.jmb.2004.07.019; Spencer KL, 2007, HUM MOL GENET, V16, P1986, DOI 10.1093/hmg/ddm146; Szakonyi G, 2001, SCIENCE, V292, P1725, DOI 10.1126/science.1059118; Tsiftsoglou SA, 2004, J IMMUNOL, V173, P367, DOI 10.4049/jimmunol.173.1.367; Ugarte M, 2001, PROG NEUROBIOL, V64, P219, DOI 10.1016/S0301-0082(00)00057-5; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263; Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618	74	33	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19197	19210		10.1074/jbc.M113.476143	http://dx.doi.org/10.1074/jbc.M113.476143			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23661701	hybrid, Green Published			2022-12-28	WOS:000321335800053
J	Sharpe, LJ; Brown, AJ				Sharpe, Laura J.; Brown, Andrew J.			Controlling Cholesterol Synthesis beyond 3-Hydroxy-3-methylglutaryl-CoA Reductase (HMGCR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							STEROL-REGULATORY-ELEMENT; COENZYME-A REDUCTASE; COA REDUCTASE; SQUALENE EPOXIDASE; ENDOPLASMIC-RETICULUM; BINDING PROTEINS; NF-Y; LIPID DROPLETS; TRANSCRIPTIONAL REGULATION; HOMEOSTATIC-RESPONSES	3-Hydroxy-3-methylglutaryl-CoA reductase (HMGCR) is the target of the statins, important drugs that lower blood cholesterol levels and treat cardiovascular disease. Consequently, the regulation of HMGCR has been investigated in detail. However, this enzyme acts very early in the cholesterol synthesis pathway, with similar to 20 subsequent enzymes needed to produce cholesterol. How they are regulated is largely unexplored territory, but there is growing evidence that enzymes beyond HMGCR serve as flux-controlling points. Here, we introduce some of the known regulatory mechanisms affecting enzymes beyond HMGCR and highlight the need to further investigate their control.	[Sharpe, Laura J.; Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Sharpe, Laura J.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney	Brown, AJ (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	aj.brown@unsw.edu.au		Sharpe, Laura/0000-0002-9896-294X	National Health and Medical Research Council [APP1008081]; National Heart Foundation of Australia [G11S5757]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	This work was supported by National Health and Medical Research Council Grant APP1008081 and National Heart Foundation of Australia Grant G11S5757 (to A. J. B.).	Belic A, 2013, COMPUT BIOL MED, V43, P471, DOI 10.1016/j.compbiomed.2013.02.017; Bennati AM, 2008, FEBS J, V275, P5034, DOI 10.1111/j.1742-4658.2008.06637.x; BLOCH K, 1965, SCIENCE, V150, P19, DOI 10.1126/science.150.3692.19; Burg JS, 2011, PROG LIPID RES, V50, P403, DOI 10.1016/j.plipres.2011.07.002; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; Dang HX, 2009, J BIOL CHEM, V284, P6218, DOI 10.1074/jbc.M803702200; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; FERGUSON JB, 1977, J BIOL CHEM, V252, P5381; Fernandez C, 2002, BIOCHEM J, V366, P109, DOI 10.1042/BJ20011777; Fernandez-Hernando C, 2013, ARTERIOSCL THROM VAS, V33, P178, DOI 10.1161/ATVBAHA.112.300144; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; GONZALEZ R, 1979, ARCH BIOCHEM BIOPHYS, V196, P574, DOI 10.1016/0003-9861(79)90310-2; Guan GM, 1997, J BIOL CHEM, V272, P10295; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; He MA, 2011, J CLIN INVEST, V121, P976, DOI 10.1172/JCI42650; HIDAKA Y, 1990, J LIPID RES, V31, P2087; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Ingrid C.GELISSEN, 2011, [Frontiers in Biology, 生物学前沿], V6, P197; Inoue J, 1998, J BIOCHEM-TOKYO, V123, P1191; Ishibashi T, 2002, BIOCHEM BIOPH RES CO, V292, P1293, DOI 10.1006/bbrc.2002.2012; Ishimoto K, 2010, BIOCHEM J, V429, P347, DOI 10.1042/BJ20091511; Jansen M, 2013, FASEB J, V27, P865, DOI 10.1096/fj.12-211235; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Kim JH, 2001, J BIOL CHEM, V276, P18153, DOI 10.1074/jbc.M101661200; Kristiana I, 2012, J BIOL CHEM, V287, P33897, DOI 10.1074/jbc.M112.360537; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; LANGE Y, 1991, J BIOL CHEM, V266, P21439; Lange Y, 2008, J BIOL CHEM, V283, P1445, DOI 10.1074/jbc.M706967200; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Leichner GS, 2011, J BIOL CHEM, V286, P32150, DOI 10.1074/jbc.M111.278036; Li Jie Jack, 2009, TRIUMPH HEART STORY; Lim L, 2012, CELL DEATH DIFFER, V19, P416, DOI 10.1038/cdd.2011.105; Lusa S, 2003, J BIOL CHEM, V278, P19844, DOI 10.1074/jbc.M212503200; Luu W, 2012, BBA-MOL CELL RES, V1823, P458, DOI 10.1016/j.bbamcr.2011.09.017; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Mazein A, 2013, BIOCHEM PHARMACOL, V86, P56, DOI 10.1016/j.bcp.2013.03.021; McDonald JG, 2012, J LIPID RES, V53, P1399, DOI 10.1194/jlr.D022285; Medina MW, 2013, CURR OPIN LIPIDOL, V24, P147, DOI 10.1097/MOL.0b013e32835cf284; Medina MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019420; Metherall JE, 1996, J BIOL CHEM, V271, P2627, DOI 10.1074/jbc.271.5.2627; Misawa K, 2003, J BIOL CHEM, V278, P36176, DOI 10.1074/jbc.M302387200; Mokashi V, 2005, ARCH BIOCHEM BIOPHYS, V433, P474, DOI 10.1016/j.abb.2004.10.002; Murphy C, 2006, BBA-MOL CELL BIOL L, V1761, P1213, DOI 10.1016/j.bbalip.2006.08.015; Nagai M, 2002, BIOCHEM BIOPH RES CO, V295, P74, DOI 10.1016/S0006-291X(02)00623-X; Nagashima S, 2012, ARTERIOSCL THROM VAS, V32, P1824, DOI 10.1161/ATVBAHA.111.240754; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Ohashi M, 2003, J BIOL CHEM, V278, P36819, DOI 10.1074/jbc.M301408200; Ohnesorg T, 2005, J STEROID BIOCHEM, V94, P259, DOI 10.1016/j.jsbmb.2005.01.012; Porter FD, 2011, J LIPID RES, V52, P6, DOI 10.1194/jlr.R009548; Porter JR, 2012, J THEOR BIOL, V300, P232, DOI 10.1016/j.jtbi.2012.01.037; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; ROITELMAN J, 1992, J BIOL CHEM, V267, P25264; Sakakura Y, 2001, BIOCHEM BIOPH RES CO, V286, P176, DOI 10.1006/bbrc.2001.5375; Schiavoni G, 2010, BBA-MOL CELL BIOL L, V1801, P587, DOI 10.1016/j.bbalip.2010.01.013; Schoenheimer R, 1933, J BIOL CHEM, V103, P439; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; SPENCER TA, 1985, J BIOL CHEM, V260, P3391; Sukhanova A, 2013, CANCER DISCOV, V3, P96, DOI 10.1158/2159-8290.CD-12-0031; Ta MT, 2012, FEBS J, V279, P4231, DOI 10.1111/febs.12015; Takano M, 2004, J BIOL CHEM, V279, P13265, DOI 10.1074/jbc.M308854200; Taramino S, 2010, BBA-MOL CELL BIOL L, V1801, P1232, DOI 10.1016/j.bbalip.2010.07.006; Thomas S, 1998, ADV ENZYME REGUL, V38, P65, DOI 10.1016/S0065-2571(97)00012-5; Vallett SM, 1996, J BIOL CHEM, V271, P12247, DOI 10.1074/jbc.271.21.12247; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wang YJ, 2008, MOL PHARMACOL, V74, P1716, DOI 10.1124/mol.108.048538; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Wong J, 2008, J BIOL CHEM, V283, P700, DOI 10.1074/jbc.M706416200; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Xue T, 2013, J PROTEOME RES, V12, P1754, DOI 10.1021/pr301100r; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1350, DOI 10.1016/j.bbalip.2012.07.006; Zerenturk EJ, 2012, BBA-MOL CELL BIOL L, V1821, P1269, DOI 10.1016/j.bbalip.2011.11.009; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhu J, 2010, J LIPID RES, V51, P1312, DOI 10.1194/jlr.M001586	81	219	227	2	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18707	18715		10.1074/jbc.R113.479808	http://dx.doi.org/10.1074/jbc.R113.479808			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23696639	Green Published, hybrid			2022-12-28	WOS:000321335800007
J	Maryon, EB; Molloy, SA; Yu, KIH; Kaplan, JH				Maryon, Edward B.; Molloy, Shannon A.; Yu, Kristin Ivy Huijun; Kaplan, Jack H.			Rate and Regulation of Copper Transport by Human Copper Transporter 1 (hCTR1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOCHEMICAL-CHARACTERIZATION; STIMULATED ENDOCYTOSIS; TRANSMEMBRANE DOMAIN; HUMAN CTR1; CELLS; MECHANISM; MOUSE; IDENTIFICATION; COMPONENTS; KINETICS	Human copper transporter 1 (hCTR1) is a homotrimer of a 190-amino acid monomer having three transmembrane domains believed to form a pore for copper permeation through the plasma membrane. The hCTR1-mediated copper transport mechanism is not well understood, nor has any measurement been made of the rate at which copper ions are transported by hCTR1. In this study, we estimated the rate of copper transport by the hCTR1 trimer in cultured cells using Cu-64 uptake assays and quantification of plasma membrane hCTR1. For endogenous hCTR1, we estimated a turnover number of about 10 ions/trimer/s. When overexpressed in HEK293 cells, a second transmembrane domain mutant of hCTR1 (H139R) had a 3-fold higher Km value and a 4-fold higher turnover number than WT. Truncations of the intracellular C-terminal tail and an AAA substitution of the putative metal-binding HCH C-terminal tripeptide (thought to be required for transport) also exhibited elevated transport rates and K-m values when compared with WT hCTR1. Unlike WT hCTR1, H139R and the C-terminal mutants did not undergo regulatory endocytosis in elevated copper. hCTR1 mutants combining methionine substitutions that block transport (M150L, M154L) on the extracellular side of the pore and the high transport H139R or AAA intracellular side mutations exhibited the blocked transport of M150L, M154L, confirming that Cu+ first interacts with the methionines during permeation. Our results show that hCTR1 elements on the intracellular side of the hCTR1 pore, including the carboxyl tail, are not essential for permeation, but serve to regulate the rate of copper entry.	[Maryon, Edward B.; Molloy, Shannon A.; Yu, Kristin Ivy Huijun; Kaplan, Jack H.] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kaplan, JH (corresponding author), Univ Illinois, Coll Med, Dept Biochem & Mol Genet, 900 S Ashland Ave, Chicago, IL 60607 USA.	kaplanj@uic.edu		Kaplan, Jack/0000-0002-7048-6574	National Institutes of Health [P01 GM067166]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM067166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 GM067166 (to J. H. K.).	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; BRAHM J, 1983, J PHYSIOL-LONDON, V339, P339, DOI 10.1113/jphysiol.1983.sp014720; BRAHM J, 1977, J GEN PHYSIOL, V70, P283, DOI 10.1085/jgp.70.3.283; Cabrera A, 2008, BIOMETALS, V21, P525, DOI 10.1007/s10534-008-9139-6; De Feo CJ, 2010, J MEMBRANE BIOL, V234, P113, DOI 10.1007/s00232-010-9239-4; De Feo CJ, 2009, P NATL ACAD SCI USA, V106, P4237, DOI 10.1073/pnas.0810286106; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Eisses JF, 2002, J BIOL CHEM, V277, P29162, DOI 10.1074/jbc.M203652200; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Guo Y, 2004, J BIOL CHEM, V279, P17428, DOI 10.1074/jbc.M401493200; Gupta A, 2009, FORM METHOD SYST DES, V35, P1, DOI 10.1007/s10703-009-0072-2; Holzer AK, 2004, CLIN CANCER RES, V10, P6744, DOI 10.1158/1078-0432.CCR-04-0748; Hua HQ, 2010, J BIOL INORG CHEM, V15, P107, DOI 10.1007/s00775-009-0599-0; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; JORGENSEN PL, 1986, KIDNEY INT, V29, P10, DOI 10.1038/ki.1986.3; Karakossian MH, 2005, J MEMBRANE BIOL, V203, P65, DOI 10.1007/s00232-004-0732-5; Klomp AEM, 2003, BIOCHEM J, V370, P881, DOI 10.1042/BJ20021128; Klomp AEM, 2002, BIOCHEM J, V364, P497, DOI 10.1042/BJ20011803; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Liang ZD, 2009, MOL PHARMACOL, V76, P843, DOI 10.1124/mol.109.056416; MacPherson IS, 2007, CELL MOL LIFE SCI, V64, P2887, DOI 10.1007/s00018-007-7310-9; Maryon EB, 2007, BIOMETALS, V20, P355, DOI 10.1007/s10534-006-9066-3; Maryon EB, 2007, J BIOL CHEM, V282, P20376, DOI 10.1074/jbc.M701806200; Maryon EB, 2009, J BIOL CHEM, V284, P28104, DOI 10.1074/jbc.M109.044925; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; McMillin GA, 2009, AM J CLIN PATHOL, V131, P160, DOI 10.1309/AJCP7Z9KBFINVGYF; Molloy SA, 2009, J BIOL CHEM, V284, P29704, DOI 10.1074/jbc.M109.000166; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Pope CR, 2012, CURR TOP MEMBR, V69, P97, DOI 10.1016/B978-0-12-394390-3.00004-5; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Schushan M, 2010, P NATL ACAD SCI USA, V107, P10908, DOI 10.1073/pnas.0914717107; Tsigelny IF, 2012, CELL BIOCHEM BIOPHYS, V63, P223, DOI 10.1007/s12013-012-9358-x; WIRTH PL, 1985, J NATL CANCER I, V75, P277; Wu XB, 2009, J BIOL CHEM, V284, P4112, DOI 10.1074/jbc.M807909200; Zhou B, 1997, P NATL ACAD SCI USA, V94, P7481, DOI 10.1073/pnas.94.14.7481; Zimnicka AM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702653200; Zimnicka AM, 2011, AM J PHYSIOL-CELL PH, V300, pC588, DOI 10.1152/ajpcell.00054.2010	40	47	49	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18035	18046		10.1074/jbc.M112.442426	http://dx.doi.org/10.1074/jbc.M112.442426			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23658018	Green Published, hybrid			2022-12-28	WOS:000320721900010
J	Raleiras, P; Kellers, P; Lindblad, P; Styring, S; Magnuson, A				Raleiras, Patrcia; Kellers, Petra; Lindblad, Peter; Styring, Stenbjorn; Magnuson, Ann			Isolation and Characterization of the Small Subunit of the Uptake Hydrogenase from the Cyanobacterium Nostoc punctiforme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAIN PCC 7120; NIFE HYDROGENASE; DESULFOVIBRIO-GIGAS; 4FE-4S CLUSTER; OXIDATION-REDUCTION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; TRANSCRIPTION; FERREDOXIN; PROTEIN	In nitrogen-fixing cyanobacteria, hydrogen evolution is associated with hydrogenases and nitrogenase, making these enzymes interesting targets for genetic engineering aimed at increased hydrogen production. Nostoc punctiforme ATCC 29133 is a filamentous cyanobacterium that expresses the uptake hydrogenase HupSL in heterocysts under nitrogen-fixing conditions. Little is known about the structural and biophysical properties of HupSL. The small subunit, HupS, has been postulated to contain three iron-sulfur clusters, but the details regarding their nature have been unclear due to unusual cluster binding motifs in the amino acid sequence. We now report the cloning and heterologous expression of Nostoc punctiforme HupS as a fusion protein, f-HupS. We have characterized the anaerobically purified protein by UV-visible and EPR spectroscopies. Our results show that f-HupS contains three iron-sulfur clusters. UV-visible absorption of f-HupS has bands similar to 340 and 420 nm, typical for iron-sulfur clusters. The EPR spectrum of the oxidized f-HupS shows a narrow g = 2.023 resonance, characteristic of a low-spin (S = 1/2) [3Fe-4S] cluster. The reduced f-HupS presents complex EPR spectra with overlapping resonances centered on g = 1.94, g = 1.91, and g = 1.88, typical of low-spin (S = 1/2) [4Fe-4S] clusters. Analysis of the spectroscopic data allowed us to distinguish between two species attributable to two distinct [4Fe-4S] clusters, in addition to the [3Fe-4S] cluster. This indicates that f-HupS binds [4Fe-4S] clusters despite the presence of unusual coordinating amino acids. Furthermore, our expression and purification of what seems to be an intact HupS protein allows future studies on the significance of ligand nature on redox properties of the iron-sulfur clusters of HupS.	[Raleiras, Patrcia; Kellers, Petra; Lindblad, Peter; Styring, Stenbjorn; Magnuson, Ann] Uppsala Univ, Dept Chem, Angstrom Lab, SE-75120 Uppsala, Sweden	Uppsala University	Magnuson, A (corresponding author), Uppsala Univ, Dept Chem, Angstrom Lab, Bx 523, SE-75120 Uppsala, Sweden.	ann.magnuson@kemi.uu.se	Magnuson, Ann/D-6132-2016; Raleiras, Patrícia/A-2375-2016; Lindblad, Peter/D-1809-2009; Lindblad, Peter/ABC-4091-2020; Styring, Stenbjörn/L-8414-2016	Magnuson, Ann/0000-0002-7918-4441; Raleiras, Patrícia/0000-0001-7898-7827; Lindblad, Peter/0000-0001-7256-0275; Styring, Stenbjörn/0000-0002-2803-9244	Knut and Alice Wallenberg Foundation; Swedish Energy Agency	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC))	This work was supported by the Knut and Alice Wallenberg Foundation and the Swedish Energy Agency.	Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; Bingemann R, 2000, EUR J BIOCHEM, V267, P6612, DOI 10.1046/j.1432-1327.2000.01755.x; Busch JLH, 1997, BIOCHEM J, V323, P95, DOI 10.1042/bj3230095; CAMMACK R, 1977, BIOCHIM BIOPHYS ACTA, V490, P311, DOI 10.1016/0005-2795(77)90006-X; Camsund D, 2011, FEMS MICROBIOL LETT, V316, P152, DOI 10.1111/j.1574-6968.2010.02206.x; CLEMENTS AP, 1994, J BACTERIOL, V176, P2689, DOI 10.1128/JB.176.9.2689-2693.1994; Dasgupta CN, 2010, INT J HYDROGEN ENERG, V35, P10218, DOI 10.1016/j.ijhydene.2010.06.029; Davis GD, 1999, BIOTECHNOL BIOENG, V65, P382, DOI 10.1002/(SICI)1097-0290(19991120)65:4<382::AID-BIT2>3.3.CO;2-9; Dementin S, 2006, J AM CHEM SOC, V128, P5209, DOI 10.1021/ja060233b; Dementin S, 2008, INT J HYDROGEN ENERG, V33, P1503, DOI 10.1016/j.ijhydene.2007.09.046; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; Devine E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-53; Fischer J, 1996, ARCH MICROBIOL, V165, P289, DOI 10.1007/s002030050329; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; Germer F, 2009, J BIOL CHEM, V284, P36462, DOI 10.1074/jbc.M109.028795; Green J, 1996, BIOCHEM J, V316, P887, DOI 10.1042/bj3160887; Hansel A, 2001, FEMS MICROBIOL LETT, V201, P59, DOI 10.1111/j.1574-6968.2001.tb10733.x; Hilberg M, 2012, J BIOL INORG CHEM, V17, P49, DOI 10.1007/s00775-011-0828-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee HS, 2010, TRENDS BIOTECHNOL, V28, P262, DOI 10.1016/j.tibtech.2010.01.007; Leitao E, 2005, APPL ENVIRON MICROB, V71, P4567, DOI 10.1128/AEM.71.8.4567-4576.2005; Lindberg P, 2012, APPL ENVIRON MICROB, V78, P273, DOI 10.1128/AEM.05957-11; LINDBLAD P, 1990, PROTOPLASMA, V159, P9, DOI 10.1007/BF01326630; Matias PM, 2001, J BIOL INORG CHEM, V6, P63, DOI 10.1007/s007750000167; Moura J. J.G., 2001, HDB METALLOPROTEINS, P553; Ogata H, 2002, J AM CHEM SOC, V124, P11628, DOI 10.1021/ja012645k; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Rather LJ, 2011, BBA-PROTEINS PROTEOM, V1814, P1609, DOI 10.1016/j.bbapap.2011.05.023; Rousset M, 1998, P NATL ACAD SCI USA, V95, P11625, DOI 10.1073/pnas.95.20.11625; Schroder O, 2007, J BIOL INORG CHEM, V12, P212, DOI 10.1007/s00775-006-0185-7; Seabra R, 2009, FEMS MICROBIOL LETT, V292, P57, DOI 10.1111/j.1574-6968.2008.01471.x; Stout CD, 2001, HDB METALLOPROTEINS, P560; Styring S, 2012, FARADAY DISCUSS, V155, P357, DOI 10.1039/c1fd00113b; SUMMERS ML, 1995, J BACTERIOL, V177, P6184, DOI 10.1128/jb.177.21.6184-6194.1995; Tamagnini P, 2007, FEMS MICROBIOL REV, V31, P692, DOI 10.1111/j.1574-6976.2007.00085.x; TEIXEIRA M, 1989, J BIOL CHEM, V264, P16435; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Uppoor R, 1996, Pharm Dev Technol, V1, P127, DOI 10.3109/10837459609029887; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0	44	12	12	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18345	18352		10.1074/jbc.M113.468587	http://dx.doi.org/10.1074/jbc.M113.468587			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649626	hybrid, Green Published			2022-12-28	WOS:000320721900038
J	Cakir, I; Cyr, NE; Perello, M; Litvinov, BP; Romero, A; Stuart, RC; Nillni, EA				Cakir, Isin; Cyr, Nicole E.; Perello, Mario; Litvinov, Bogdan Patedakis; Romero, Amparo; Stuart, Ronald C.; Nillni, Eduardo A.			Obesity Induces Hypothalamic Endoplasmic Reticulum Stress and Impairs Proopiomelanocortin (POMC) Post-translational Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; PROTHYROTROPIN-RELEASING HORMONE; MELANOCYTE-STIMULATING HORMONE; PRO-NEUROPEPTIDE-Y; LEPTIN RESISTANCE; PARAVENTRICULAR NUCLEUS; PROHORMONE CONVERTASES; MESSENGER-RNA; ER STRESS; GLUCOSE-HOMEOSTASIS	It was shown previously that abnormal prohormone processing or inactive proconverting enzymes that are responsible for this processing cause profound obesity. Our laboratory demonstrated earlier that in the diet-induced obesity (DIO) state, the appetite-suppressing neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) is reduced, yet the mRNA of its precursor protein proopiomelanocortin (POMC) remained unaltered. It was also shown that the DIO condition promotes the development of endoplasmic reticulum (ER) stress and leptin resistance. In the current study, using an in vivo model combined with in vitro experiments, we demonstrate that obesity-induced ER stress obstructs the post-translational processing of POMC by decreasing proconverting enzyme 2, which catalyzes the conversion of adrenocorticotropin to alpha-MSH, thereby decreasing alpha-MSH peptide production. This novel mechanism of ER stress affecting POMC processing in DIO highlights the importance of ER stress in regulating central energy balance in obesity.	[Cakir, Isin; Cyr, Nicole E.; Perello, Mario; Litvinov, Bogdan Patedakis; Romero, Amparo; Stuart, Ronald C.; Nillni, Eduardo A.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Endocrinol,Dept Med, Providence, RI 02907 USA; [Cakir, Isin; Nillni, Eduardo A.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Nillni, EA (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Endocrinol, 55 Claverick St,3rd Floor,Rm 320, Providence, RI 02903 USA.	Eduardo_Nillni@Brown.edu		Romero-Pico, Amparo/0000-0001-5104-6998; Perello, Mario/0000-0003-2114-6765; cakir, isin/0000-0003-4293-7267	National Institutes of Health, NIDDK [R01 DK085916-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085916] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant R01 DK085916-01 (to E. A. N.).	Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; BARNEA A, 1982, BRAIN RES, V232, P345, DOI 10.1016/0006-8993(82)90278-5; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brakch N, 1997, BIOCHEMISTRY-US, V36, P16309, DOI 10.1021/bi9714767; Challis BG, 2002, HUM MOL GENET, V11, P1997, DOI 10.1093/hmg/11.17.1997; Choi SJ, 2010, AM J PHYSIOL-ENDOC M, V298, pE1122, DOI 10.1152/ajpendo.00006.2010; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Cottrell EC, 2008, PHYSIOL BEHAV, V94, P17, DOI 10.1016/j.physbeh.2007.11.017; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; EMESON RB, 1986, J NEUROSCI, V6, P837; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009; Furukawa H, 1999, DIABETES, V48, P1395, DOI 10.2337/diabetes.48.7.1395; Gamber KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030485; GRAMSCH C, 1980, BRAIN RES, V192, P109, DOI 10.1016/0006-8993(80)91012-4; Guan XM, 1998, NEUROREPORT, V9, P3415, DOI 10.1097/00001756-199810260-00015; Guo L, 2004, P NATL ACAD SCI USA, V101, P11797, DOI 10.1073/pnas.0403165101; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Huang XF, 2003, BRAIN RES, V992, P9, DOI 10.1016/j.brainres.2003.08.019; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Jansen E, 1997, BIOCHEM J, V328, P69, DOI 10.1042/bj3280069; Jing EX, 2004, ENDOCRINOLOGY, V145, P1503, DOI 10.1210/en.2003-0834; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Ladriere L, 2010, J CLIN ENDOCR METAB, V95, P1442, DOI 10.1210/jc.2009-2322; Levin BE, 1997, AM J PHYSIOL-REG I, V273, pR725, DOI 10.1152/ajpregu.1997.273.2.R725; Levin BE, 2003, AM J PHYSIOL-REG I, V285, pR1184, DOI 10.1152/ajpregu.00267.2003; Lloyd DJ, 2006, HUM MOL GENET, V15, P1884, DOI 10.1093/hmg/ddl111; Mandl J, 2009, TRENDS ENDOCRIN MET, V20, P194, DOI 10.1016/j.tem.2009.01.003; Mercer JG, 2005, BIOCHEM SOC T, V33, P1068, DOI [10.1042/BST0331068, 10.1042/BST20051068]; Miki T, 2009, DIABETES, V58, P2863, DOI 10.2337/db09-0158; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Muller L, 1997, J CELL BIOL, V139, P625, DOI 10.1083/jcb.139.3.625; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; NILLNI EA, 1995, J NEUROCHEM, V65, P2462; Nillni EA, 2002, J BIOL CHEM, V277, P48587, DOI 10.1074/jbc.M206702200; Nillni EA, 2007, ENDOCRINOLOGY, V148, P4191, DOI 10.1210/en.2007-0173; Nillni EA, 2010, FRONT NEUROENDOCRIN, V31, P134, DOI 10.1016/j.yfrne.2010.01.001; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; ORWOLL E, 1979, ENDOCRINOLOGY, V104, P1845, DOI 10.1210/endo-104-6-1845; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Paquet L, 1996, J NEUROSCI, V16, P964; Perello M, 2007, ENDOCRINOLOGY, V148, P4952, DOI 10.1210/en.2007-0522; Perello M, 2007, AM J PHYSIOL-ENDOC M, V292, pE1348, DOI 10.1152/ajpendo.00466.2006; Perello M, 2006, ENDOCRINOLOGY, V147, P3296, DOI 10.1210/en.2005-1533; Perello M, 2006, ENDOCRINOLOGY, V147, P2705, DOI 10.1210/en.2005-1609; Perello M, 2010, AM J PHYSIOL-ENDOC M, V299, pE976, DOI 10.1152/ajpendo.00448.2010; Plum L, 2009, NAT MED, V15, P1195, DOI 10.1038/nm.2026; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanchez VC, 2004, J CLIN INVEST, V114, P357, DOI 10.1172/jci200421620; Sasaki A, 2003, J BIOL CHEM, V278, P2432, DOI 10.1074/jbc.C200608200; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schulz C, 2012, ENDOCRINOLOGY, V153, P143, DOI 10.1210/en.2011-1586; Song JQ, 2012, INT J BIOL SCI, V8, P265, DOI 10.7150/ijbs.3660; Torri C, 2002, PEPTIDES, V23, P1063, DOI 10.1016/S0196-9781(02)00030-X; von Eggelkraut-Gottanka R, 2003, CHEMBIOCHEM, V4, P425, DOI 10.1002/cbic.200200546; Wang N, 2009, MOL CELL ENDOCRINOL, V307, P89, DOI 10.1016/j.mce.2009.03.001; Wiley JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009135; Wisse BE, 2007, SCIENCE, V318, P928, DOI 10.1126/science.1148032; Wisse BE, 2009, CELL METAB, V10, P241, DOI 10.1016/j.cmet.2009.09.003; Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194; Xu AW, 2007, ENDOCRINOLOGY, V148, P72, DOI 10.1210/en.2006-1119; Xu Y, 2011, ANN NY ACAD SCI, V1243, P1, DOI 10.1111/j.1749-6632.2011.06248.x; Yu YH, 2009, BEHAV BRAIN RES, V205, P50, DOI 10.1016/j.bbr.2009.07.003	69	73	77	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17675	17688		10.1074/jbc.M113.475343	http://dx.doi.org/10.1074/jbc.M113.475343			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640886	Green Published, hybrid			2022-12-28	WOS:000320380600058
J	Arao, Y; Hamilton, KJ; Coons, LA; Korach, KS				Arao, Yukitomo; Hamilton, Katherine J.; Coons, Laurel A.; Korach, Kenneth S.			Estrogen Receptor alpha L543A,L544A Mutation Changes Antagonists to Agonists, Correlating with the Ligand Binding Domain Dimerization Associated with DNA Binding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; ACTIVATION; MODE	Aligand-dependent nuclear transcription factor, ER alpha has two transactivating functional domains (AF), AF-1 and AF-2. AF-1 is localized in the N-terminal region, and AF-2 is distributed in the C-terminal ligand-binding domain (LBD) of the ER alpha protein. Helix 12 (H12) in the LBD is a component of the AF-2, and the configuration of H12 is ligand-inducible to an active or inactive form. We demonstrated previously that the ER alpha mutant (AF2ER) possessing L543A,L544A mutations in H12 disrupts AF-2 function and reverses antagonists such as fulvestrant/ICI182780 (ICI) or 4-hydoxytamoxifen (OHT) into agonists in the AF2ER knock-in mouse. Our previous in vitro studies suggested that the mode of AF2ER activation is similar to the partial agonist activity of OHT for WT-ER alpha. However, it is still unclear how antagonists activate ER alpha. To understand the molecular mechanism of antagonist reversal activity, we analyzed the correlation between the ICI-dependent estrogen-responsive element-mediated transcription activity of AF2ER and AF2ER-LBD dimerization activity. We report here that ICI-dependent AF2ER activation correlated with the activity of AF2ER-LBD homodimerization. Prevention of dimerization impaired the ICI-dependent ERE binding and transcription activity of AF2ER. The dislocation of H12 caused ICI-dependent LBD homodimerization involving the F-domain, the adjoining region of H12. Furthermore, F-domain truncation also strongly depressed the dimerization of WT-ER alpha-LBD with antagonists but not with E2. AF2ER activation levels with ICI, OHT, and raloxifene were parallel with the degree of AF2ER-LBD homodimerization, supporting a mechanism that antagonist-dependent LBD homodimerization involving the F-domain results in antagonist reversal activity of H12-mutated ER alpha.	[Arao, Yukitomo; Hamilton, Katherine J.; Coons, Laurel A.; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA; [Coons, Laurel A.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Korach, KS (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	korach@niehs.nih.gov	Arao, Yukitomo/AAL-1665-2021	Korach, Kenneth/0000-0002-7765-418X; Coons, Laurel/0000-0001-7132-2996; Arao, Yukitomo/0000-0003-1560-351X	National Institutes of Health, National Institute of Environmental Health Sciences [Z01ES70065]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070065, ZIAES070065] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Intramural Research Program of the National Institutes of Health, National Institute of Environmental Health Sciences Grant Z01ES70065 (to K. S. K.).	Arao Y, 2011, P NATL ACAD SCI USA, V108, P14986, DOI 10.1073/pnas.1109180108; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chang CY, 1999, MOL CELL BIOL, V19, P8226; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; FAWELL SE, 1990, CELL, V60, P953, DOI 10.1016/0092-8674(90)90343-D; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Hilmi K, 2012, MOL CELL BIOL, V32, P3823, DOI 10.1128/MCB.00290-12; Howell A, 2006, ENDOCR-RELAT CANCER, V13, P689, DOI 10.1677/erc.1.00846; LEES JA, 1990, MOL CELL BIOL, V10, P5529, DOI 10.1128/MCB.10.10.5529; Lupien M, 2007, MOL ENDOCRINOL, V21, P797, DOI 10.1210/me.2006-0074; MAHFOUDI A, 1995, P NATL ACAD SCI USA, V92, P4206, DOI 10.1073/pnas.92.10.4206; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Metivier R, 2002, MOL CELL, V10, P1019, DOI 10.1016/S1097-2765(02)00746-3; Nemmers L. A., 1991, ENDOCRINOLOGY; Pike ACW, 2001, STRUCTURE, V9, P145, DOI 10.1016/S0969-2126(01)00568-8; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; Schwartz JA, 1997, J STEROID BIOCHEM, V62, P173, DOI 10.1016/S0960-0760(97)00028-9; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014	24	20	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21105	21116		10.1074/jbc.M113.463455	http://dx.doi.org/10.1074/jbc.M113.463455			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23733188	hybrid, Green Published			2022-12-28	WOS:000322014400031
J	Burger, K; Muhl, B; Rohrmoser, M; Coordes, B; Heidemann, M; Kellner, M; Gruber-Eber, A; Heissmeyer, V; Strasser, K; Eick, D				Burger, Kaspar; Muehl, Bastian; Rohrmoser, Michaela; Coordes, Britta; Heidemann, Martin; Kellner, Markus; Gruber-Eber, Anita; Heissmeyer, Vigo; Straesser, Katja; Eick, Dirk			Cyclin-dependent Kinase 9 Links RNA Polymerase II Transcription to Processing of Ribosomal RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; P-TEFB; PRERIBOSOMAL RNA; TERMINAL DOMAIN; H/ACA SNORNAS; BOX C/D; SITE; SNRNA; LOCALIZATION; METHYLATION	Ribosome biogenesis is a process required for cellular growth and proliferation. Processing of ribosomal RNA (rRNA) is highly sensitive to flavopiridol, a specific inhibitor of cyclin-dependent kinase 9 (Cdk9). Cdk9 has been characterized as the catalytic subunit of the positive transcription elongation factor b(P-TEFb) of RNA polymerase II (RNAPII). Here we studied the connection between RNAPII transcription and rRNA processing. We show that inhibition of RNAPII activity by alpha-amanitin specifically blocks processing of rRNA. The block is characterized by accumulation of 3' extended unprocessed 47 S rRNAs and the entire inhibition of other 47 S rRNA-specific processing steps. The transcription rate of rRNA is moderately reduced after inhibition of Cdk9, suggesting that defective 3' processing of rRNA negatively feeds back on RNAPI transcription. Knockdown of Cdk9 caused a strong reduction of the levels of RNAPII-transcribed U8 small nucleolar RNA, which is essential for 3' rRNA processing in mammalian cells. Our data demonstrate a pivotal role of Cdk9 activity for coupling of RNAPII transcription with small nucleolar RNA production and rRNA processing.	[Burger, Kaspar; Muehl, Bastian; Rohrmoser, Michaela; Heidemann, Martin; Kellner, Markus; Gruber-Eber, Anita; Eick, Dirk] Helmholtz Ctr Munich, Ctr Integrated Prot Sci Munich, Dept Mol Epigenet, D-81377 Munich, Germany; [Coordes, Britta; Straesser, Katja] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Coordes, Britta; Straesser, Katja] Univ Munich, Dept Biochem, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany; [Heissmeyer, Vigo] Helmholtz Ctr Munich, Inst Mol Immunol, D-81377 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Eick, D (corresponding author), Helmholtz Ctr Munich, Inst Clin Mol Biol & Tumor Genet, Dept Mol Epigenet, Marchioninistr 25, D-81377 Munich, Germany.	eick@helmholtz-muenchen.de		Strasser, Katja/0000-0003-3533-5516; Heissmeyer, Vigo/0000-0002-2263-8545	Deutsche Forschungsgemeinschaft (DFG) [SFB684, SFB-TR5, SFB646]; Deutsche Jose Carreras Leukamie-Stiftung e.V. [F09/03]; European Research Grant; Boehringer Ingelheim Fonds	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Jose Carreras Leukamie-Stiftung e.V.; European Research Grant; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	This work was supported by the Deutsche Forschungsgemeinschaft (DFG; SFB684 and SFB-TR5) and Deutsche Jose Carreras Leukamie-Stiftung e.V. (Project F09/03; to D. E.), DFG (SFB646), and European Research Grant (to K. S.) Boehringer Ingelheim Fonds (to B. C).	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; Ballarino M, 2005, MOL CELL BIOL, V25, P5396, DOI 10.1128/MCB.25.13.5396-5403.2005; BARTOLOMEI MS, 1987, MOL CELL BIOL, V7, P586, DOI 10.1128/MCB.7.2.586; Braglia P, 2011, NUCLEIC ACIDS RES, V39, P1439, DOI 10.1093/nar/gkq894; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Christopher KJ, 2012, DEV BIOL, V368, P382, DOI 10.1016/j.ydbio.2012.06.008; Cleary MD, 2005, NAT BIOTECHNOL, V23, P232, DOI 10.1038/nbt1061; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Denissov S, 2011, EMBO REP, V12, P231, DOI 10.1038/embor.2011.8; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Glasmacher E, 2010, NAT IMMUNOL, V11, P725, DOI 10.1038/ni.1902; GORENSTEIN C, 1976, P NATL ACAD SCI USA, V73, P1547, DOI 10.1073/pnas.73.5.1547; Heidemann M, 2012, RNA BIOL, V9, P1144, DOI 10.4161/rna.21726; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Knox AA, 2011, MOL CELL BIOL, V31, P2404, DOI 10.1128/MCB.05067-11; Liu HB, 2005, J CELL PHYSIOL, V203, P251, DOI 10.1002/jcp.20224; Medlin J, 2005, EMBO J, V24, P4154, DOI 10.1038/sj.emboj.7600876; Meininghaus M, 2000, J BIOL CHEM, V275, P24375, DOI 10.1074/jbc.M001883200; MELVIN WT, 1978, EUR J BIOCHEM, V92, P373, DOI 10.1111/j.1432-1033.1978.tb12756.x; Mullineux ST, 2012, BIOCHIMIE, V94, P1521, DOI 10.1016/j.biochi.2012.02.001; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; Newman DR, 2000, RNA, V6, P861, DOI 10.1017/S1355838200992446; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; PECULIS BA, 1994, GENE DEV, V8, P2241, DOI 10.1101/gad.8.18.2241; PECULIS BA, 1993, CELL, V73, P1233, DOI 10.1016/0092-8674(93)90651-6; Peculis BA, 1997, MOL CELL BIOL, V17, P3702, DOI 10.1128/MCB.17.7.3702; Prieto JL, 2008, BBA-MOL CELL RES, V1783, P2116, DOI 10.1016/j.bbamcr.2008.07.004; Richard P, 2006, MOL CELL BIOL, V26, P2540, DOI 10.1128/MCB.26.7.2540-2549.2006; Richard P, 2006, EMBO REP, V7, P590, DOI 10.1038/sj.embor.7400715; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Schmerwitz UK, 2011, ARTERIOSCL THROM VAS, V31, P280, DOI 10.1161/ATVBAHA.110.213934; Shore SM, 2005, GENE, V350, P51, DOI 10.1016/j.gene.2005.01.015; Shore SM, 2003, GENE, V307, P175, DOI 10.1016/S0378-1119(03)00466-9; Sims RJ, 2011, SCIENCE, V332, P99, DOI 10.1126/science.1202663; Sirri V, 2002, J CELL BIOL, V156, P969, DOI 10.1083/jcb.200201024; Srivastava L, 2010, MOL CELL BIOL, V30, P2947, DOI 10.1128/MCB.00226-10; Staley JP, 2009, CURR OPIN CELL BIOL, V21, P109, DOI 10.1016/j.ceb.2009.01.003; Tran EJ, 2003, EMBO J, V22, P3930, DOI 10.1093/emboj/cdg368; VIJAYRAGHAVAN U, 1989, GENE DEV, V3, P1206, DOI 10.1101/gad.3.8.1206; WARNER JR, 1972, J MOL BIOL, V65, P243, DOI 10.1016/0022-2836(72)90280-X; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Windhager L, 2012, GENOME RES, V22, P2031, DOI 10.1101/gr.131847.111; Zhang DW, 2012, GENET RES INT, V2012, DOI 10.1155/2012/347214	58	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21173	21183		10.1074/jbc.M113.483719	http://dx.doi.org/10.1074/jbc.M113.483719			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23744076	Green Published, hybrid			2022-12-28	WOS:000322014400037
J	Hu, JC; Choi, JH; Gaddameedhi, S; Kemp, MG; Reardon, JT; Sancar, A				Hu, Jinchuan; Choi, Jun-Hyuk; Gaddameedhi, Shobhan; Kemp, Michael G.; Reardon, Joyce T.; Sancar, Aziz			Nucleotide Excision Repair in Human Cells FATE OF THE EXCISED OLIGONUCLEOTIDE CARRYING DNA DAMAGE IN VIVO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-COUPLED REPAIR; REPLICATION PROTEIN-A; RNA-POLYMERASE-II; XERODERMA-PIGMENTOSUM; PYRIMIDINE DIMERS; THYMINE DIMER; HUMAN-FIBROBLASTS; COCKAYNE-SYNDROME; NUCLEASE; MECHANISM	Nucleotide excision repair is the sole mechanism for removing the major UV photoproducts from genomic DNA in human cells. In vitro with human cell-free extract or purified excision repair factors, the damage is removed from naked DNA or nucleosomes in the form of 24- to 32-nucleotide-long oligomers (nominal 30-mer) by dual incisions. Whether the DNA damage is removed from chromatin in vivo in a similar manner and what the fate of the excised oligomer was has not been known previously. Here, we demonstrate that dual incisions occur in vivo identical to the in vitro reaction. Further, we show that transcription-coupled repair, which operates in the absence of the XPC protein, also generates the nominal 30-mer in UV-irradiated XP-C mutant cells. Finally, we report that the excised 30-mer is released from the chromatin in complex with the repair factors TFIIH and XPG. Taken together, our results show the congruence of in vivo and in vitro data on nucleotide excision repair in humans.	[Hu, Jinchuan; Choi, Jun-Hyuk; Gaddameedhi, Shobhan; Kemp, Michael G.; Reardon, Joyce T.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Choi, Jun-Hyuk] Korea Res Inst Stand & Sci, Dept Metrol Qual Life, Ctr Bioanal, Taejon 305340, South Korea	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Korea Research Institute of Standards & Science (KRISS)	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Campus Box 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	GADDAMEEDHI, SHOBHAN/M-4358-2014; GADDAMEEDHI, SHOBHAN/GZM-8298-2022; gaddameedhi, shobhan/N-8695-2013; Kemp, Michael G./AAT-1545-2021; Hu, Jinchuan/V-9913-2017	GADDAMEEDHI, SHOBHAN/0000-0002-4978-6951; Kemp, Michael G./0000-0001-8203-0745; Hu, Jinchuan/0000-0001-7096-0195	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32833.	Araujo SJ, 2001, MOL CELL BIOL, V21, P2281, DOI 10.1128/MCB.21.7.2281-2291.2001; BOLING ME, 1966, BIOCHIM BIOPHYS ACTA, V123, P26, DOI 10.1016/0005-2787(66)90155-9; Cleaver JE, 1999, HUM MUTAT, V14, P9, DOI 10.1002/(SICI)1098-1004(1999)14:1<9::AID-HUMU2>3.3.CO;2-Y; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; DOETSCH PW, 1985, NUCLEIC ACIDS RES, V13, P3285, DOI 10.1093/nar/13.9.3285; DRAPKIN R, 1994, NATURE, V368, P769, DOI 10.1038/368769a0; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gaddameedhi S, 2010, CANCER RES, V70, P4922, DOI 10.1158/0008-5472.CAN-10-0095; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hara R, 2002, MOL CELL BIOL, V22, P6779, DOI 10.1128/MCB.22.19.6779-6787.2002; Hara R, 2000, MOL CELL BIOL, V20, P9173, DOI 10.1128/MCB.20.24.9173-9181.2000; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; Kemp MG, 2012, J BIOL CHEM, V287, P22889, DOI 10.1074/jbc.M112.374447; LABELLE M, 1982, PHOTOCHEM PHOTOBIOL, V36, P319, DOI 10.1111/j.1751-1097.1982.tb04381.x; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; Mu D, 1997, J BIOL CHEM, V272, P7570, DOI 10.1074/jbc.272.12.7570; Mu D, 1997, J BIOL CHEM, V272, P28971, DOI 10.1074/jbc.272.46.28971; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Reardon JT, 2006, METHOD ENZYMOL, V408, P189, DOI 10.1016/S0076-6879(06)08012-8; Reardon JT, 2005, PROG NUCLEIC ACID RE, V79, P183, DOI 10.1016/S0079-6603(04)79004-2; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Selby CP, 1997, NUCLEIC ACIDS RES, V25, P787, DOI 10.1093/nar/25.4.787; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; VANHOFFEN A, 1995, EMBO J, V14, P360, DOI 10.1002/j.1460-2075.1995.tb07010.x; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VENEMA J, 1991, MOL CELL BIOL, V11, P4128, DOI 10.1128/MCB.11.8.4128; Wang D, 2003, BIOCHEMISTRY-US, V42, P6747, DOI 10.1021/bi034264k; WEINFELD M, 1986, BIOCHEMISTRY-US, V25, P2656, DOI 10.1021/bi00357a055; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61	36	66	67	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20918	20926		10.1074/jbc.M113.482257	http://dx.doi.org/10.1074/jbc.M113.482257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23749995	Green Published, hybrid			2022-12-28	WOS:000322014400015
J	Majumder, A; Gopalakrishna, KN; Cheguru, P; Gakhar, L; Artemyev, NO				Majumder, Anurima; Gopalakrishna, Kota N.; Cheguru, Pallavi; Gakhar, Lokesh; Artemyev, Nikolai O.			Interaction of Aryl Hydrocarbon Receptor-interacting Protein-like 1 with the Farnesyl Moiety	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; X-RAY SOLUTION; SECONDARY STRUCTURE; CGMP-PHOSPHODIESTERASE; SOLUTION SCATTERING; BETA-SUBUNIT; AIPL1; ROD; MUTATIONS; MODEL	Aryl hydrocarbon receptor-interacting protein-like 1 (AIPL1) is a photoreceptor specific chaperone of the visual effector enzyme phosphodiesterase-6 (PDE6). AIPL1 has been shown to bind the farnesylated PDE6A subunit. Mutations in AIPL1 are thought to destabilize PDE6 and thereby cause Leber congenital amaurosis type 4 (LCA4), a severe form of childhood blindness. Here, we examined the solution structure of AIPL1 by small angle x-ray scattering. A structural model of AIPL1 with the best fit to the scattering data features two independent FK506-binding protein (FKBP)-like and tetratricopeptide repeat domains. Guided by the model, we tested the hypothesis that AIPL1 directly binds the farnesyl moiety. Our studies revealed high affinity binding of the farnesylated-Cys probe to the FKBP-like domain of AIPL1, thus uncovering a novel function of this domain. Mutational analysis of the potential farnesyl-binding sites on AIPL1 identified two critical residues, Cys-89 and Leu-147, located in close proximity in the structure model. The L147A mutation and the LCA-linked C89R mutation prevented the binding of the farnesyl-Cys probe to AIPL1. Furthermore, Cys-89 and Leu-147 flank the unique insert region of AIPL1, deletion of which also abolished the farnesyl interaction. Our results suggest that the binding of PDE6A farnesyl is essential to normal function of AIPL1 and its disruption is one of the mechanisms underlying LCA.	[Majumder, Anurima; Gopalakrishna, Kota N.; Cheguru, Pallavi; Artemyev, Nikolai O.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Gakhar, Lokesh] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Gakhar, Lokesh] Univ Iowa, Prot Crystallog Facil, Iowa City, IA 52242 USA; [Artemyev, Nikolai O.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Artemyev, NO (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	nikolai-artemyev@uiowa.edu	Gakhar, Lokesh/F-2113-2010; Gakhar, Lokesh/P-8356-2019	Gakhar, Lokesh/0000-0002-3319-1902; Gakhar, Lokesh/0000-0002-3319-1902; Artemyev, Nikolai/0000-0002-5266-6854	Department of Energy program Integrated Diffraction Analysis Technologies (IDAT) [DE-AC02-05CH11231]; NATIONAL EYE INSTITUTE [R01EY010843, R01EY012682] Funding Source: NIH RePORTER	Department of Energy program Integrated Diffraction Analysis Technologies (IDAT); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank the staff at the SIBYLS beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, for SAXS data collection. The SIBYLS beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, is supported in part by the Department of Energy program Integrated Diffraction Analysis Technologies (IDAT) under Contract DE-AC02-05CH11231.	Akey DT, 2002, HUM MOL GENET, V11, P2723, DOI 10.1093/hmg/11.22.2723; ANANT JS, 1992, J BIOL CHEM, V267, P687; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; CATTY P, 1991, EUR J BIOCHEM, V199, P263, DOI 10.1111/j.1432-1033.1991.tb16119.x; Chacon P, 2000, J MOL BIOL, V299, P1289, DOI 10.1006/jmbi.2000.3784; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Cote RH, 2004, INT J IMPOT RES, V16, pS28, DOI 10.1038/sj.ijir.3901212; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Dhamaraj S, 2004, ARCH OPHTHALMOL-CHIC, V122, P1029, DOI 10.1001/archopht.122.7.1029; Dryja TP, 1999, INVEST OPHTH VIS SCI, V40, P1859; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gallon VA, 2004, BBA-MOL BASIS DIS, V1690, P141, DOI 10.1016/j.bbadis.2004.06.012; Galvin JA, 2005, RETINA-J RET VIT DIS, V25, P919, DOI 10.1097/00006982-200510000-00016; Gopalakrishna KN, 2011, J BIOL CHEM, V286, P28954, DOI 10.1074/jbc.M111.268821; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Hidalgo-De-Quintana J, 2008, INVEST OPHTH VIS SCI, V49, P2878, DOI 10.1167/iovs.07-1576; Ismail SA, 2011, NAT CHEM BIOL, V7, P942, DOI [10.1038/nchembio.686, 10.1038/NCHEMBIO.686]; KAPLAN J, 1990, HUM GENET, V85, P635; Karan S, 2008, VISION RES, V48, P442, DOI 10.1016/j.visres.2007.08.020; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; Kolandaivelu S, 2009, J BIOL CHEM, V284, P30853, DOI 10.1074/jbc.M109.036780; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Kosmaoglou M, 2008, PROG RETIN EYE RES, V27, P434, DOI 10.1016/j.preteyeres.2008.03.001; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kriehuber T., 2013, BIOCHEMISTR IN PRESS; Liu XQ, 2004, P NATL ACAD SCI USA, V101, P13903, DOI 10.1073/pnas.0405160101; Lucke C., 2013, BIOCHEMISTR IN PRESS; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Ramamurthy V, 2003, P NATL ACAD SCI USA, V100, P12630, DOI 10.1073/pnas.2134194100; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwartz ML, 2006, ADV EXP MED BIOL, V572, P89; Sinars CR, 2003, P NATL ACAD SCI USA, V100, P868, DOI 10.1073/pnas.0231020100; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Storer CL, 2011, TRENDS ENDOCRIN MET, V22, P481, DOI 10.1016/j.tem.2011.08.001; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Trivellin G, 2011, J ENDOCRINOL, V210, P137, DOI 10.1530/JOE-11-0054; van der Spuy J, 2006, ADV EXP MED BIOL, V572, P471; van der Spuy J, 2002, HUM MOL GENET, V11, P823, DOI 10.1093/hmg/11.7.823; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu BL, 2004, P NATL ACAD SCI USA, V101, P8348, DOI 10.1073/pnas.0305969101; Zhang HB, 2004, J BIOL CHEM, V279, P407, DOI 10.1074/jbc.M306559200	56	26	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21320	21328		10.1074/jbc.M113.476242	http://dx.doi.org/10.1074/jbc.M113.476242			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23737531	Green Published, hybrid			2022-12-28	WOS:000322014400051
J	Cheung, R; Espenshade, PJ				Cheung, Rocky; Espenshade, Peter J.			Structural Requirements for Sterol Regulatory Element-binding Protein (SREBP) Cleavage in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DSC E3 LIGASE; SCHIZOSACCHAROMYCES-POMBE; CRYPTOCOCCUS-NEOFORMANS; PROPROTEIN CONVERTASES; ENDOPLASMIC-RETICULUM; ASPERGILLUS-FUMIGATUS; TRANSCRIPTION FACTOR; DNA-BINDING; GENE; DEGRADATION	Sterol regulatory element-binding proteins (SREBPs) are central regulators of cellular lipid synthesis and homeostasis. Mammalian SREBPs are proteolytically activated and liberated from the membrane by Golgi Site-1 and Site-2 proteases. Fission yeast SREBPs, Sre1 and Sre2, employ a different mechanism that genetically requires the Golgi Dsc E3 ligase complex for cleavage activation. Here, we established Sre2 as a model to define structural requirements for SREBP cleavage. We showed that Sre2 cleavage does not require the N-terminal basic helix-loop-helix zipper transcription factor domain, thus separating cleavage of Sre2 from its transcription factor function. From a mutagenesis screen of 94 C-terminal residues of Sre2, we isolated 15 residues required for cleavage and further identified a glycine-leucine sequence required for Sre2 cleavage. Importantly, the glycine-leucine sequence is located at a conserved distance before the first transmembrane segment of both Sre1 and Sre2 and cleavage occurs in between this sequence and the membrane. Bioinformatic analysis revealed a broad conservation of this novel glycin-eleucine motif in SREBP homologs of ascomycete fungi, including the opportunistic human pathogen Aspergillus fumigatus where SREBP is required for virulence. Consistent with this, the sequence was also required for cleavage of the oxygen-responsive transcription factor Sre1 and adaptation to hypoxia, demonstrating functional conservation of this cleavage recognition motif. These cleavage mutants will aid identification of the fungal SREBP protease and facilitate functional dissection of the Dsc E3 ligase required for SREBP activation and fungal pathogenesis.	[Cheung, Rocky; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol Rm 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu		Cheung, Rocky/0000-0001-6736-9687	National Institutes of Health [HL077588]; Department of Cell Biology, Johns Hopkins University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Cell Biology, Johns Hopkins University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL077588 (to P.J.E.). This work was also supported by an Isaac Morris Hay and Lucille Elizabeth Hay graduate fellowship award (to R.C.) from the Department of Cell Biology, Johns Hopkins University School of Medicine.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Bien CM, 2009, MOL MICROBIOL, V74, P672, DOI 10.1111/j.1365-2958.2009.06895.x; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; Chang YC, 2007, MOL MICROBIOL, V64, P614, DOI 10.1111/j.1365-2958.2007.05676.x; Chang YC, 2009, EUKARYOT CELL, V8, P1770, DOI 10.1128/EC.00207-09; Chun CD, 2007, PLOS PATHOG, V3, P225, DOI 10.1371/journal.ppat.0030022; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Duncan EA, 1997, J BIOL CHEM, V272, P12778, DOI 10.1074/jbc.272.19.12778; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hughes BT, 2009, J BIOL CHEM, V284, P20512, DOI 10.1074/jbc.M109.002436; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee CYS, 2011, MOL CELL, V44, P225, DOI 10.1016/j.molcel.2011.08.031; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Lee SJ, 2003, SCIENCE, V302, P1571, DOI 10.1126/science.1088372; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Porter JR, 2012, MOL BIOL CELL, V23, P3764, DOI 10.1091/mbc.E12-06-0451; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Seidah NG, 1998, ANN NY ACAD SCI, V839, P9, DOI 10.1111/j.1749-6632.1998.tb10727.x; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Willger SD, 2012, EUKARYOT CELL, V11, P1557, DOI 10.1128/EC.00252-12; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Wilson RA, 2009, NAT REV MICROBIOL, V7, P185, DOI 10.1038/nrmicro2032	34	9	9	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20351	20360		10.1074/jbc.M113.482224	http://dx.doi.org/10.1074/jbc.M113.482224			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23729666	Green Published, hybrid			2022-12-28	WOS:000321715100023
J	Han, J; Hou, W; Lu, CS; Goldstein, LA; Stolz, DB; Watkins, SC; Rabinowich, H				Han, Jie; Hou, Wen; Lu, Caisheng; Goldstein, Leslie A.; Stolz, Donna B.; Watkins, Simon C.; Rabinowich, Hannah			Interaction between Her2 and Beclin-1 Proteins Underlies a New Mechanism of Reciprocal Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE INHIBITOR; TARGETING AUTOPHAGY; APOPTOSIS; TRAIL; TUMORIGENESIS; RECEPTOR; CELLS; DISRUPTION; RESISTANCE; INDUCTION	Beclin-1 is a key regulator of autophagy that functions in the context of two phase-specific complexes in the initiation and maturation of autophagosomes. Its known interacting proteins include autophagy effectors, Bcl-2 family members, and organelle membrane anchor proteins. Here we report a newly identified interaction between Beclin-1 and the protein tyrosine kinase receptor Her2. We demonstrate that in Her2-expressing breast carcinoma cells that do not succumb to lapatinib, this Her1/2 inhibitor disrupts the cell surface interaction between Her2 and Beclin-1. The data suggest that the ensuing autophagic response is correlatively associated with the release of Beclin-1 from its complex with Her2 and with the subsequent increase in cytosolic Beclin-1. Upon its interaction with Her2, Beclin-1 up-regulates the phosphorylation levels of Her2 and Akt. The Beclin-1 evolutionarily conserved domain is required both for the interaction of Beclin-1 with Her2 and for the increased Her2 and Akt phosphorylation. These findings shed new light on mechanisms involved in lapatinib-mediated autophagy in Her2-expressing breast carcinoma cell lines and in Beclin-1 signaling in these cells.	[Han, Jie; Hou, Wen; Lu, Caisheng; Goldstein, Leslie A.; Rabinowich, Hannah] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Stolz, Donna B.; Watkins, Simon C.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rabinowich, H (corresponding author), Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Res Pavilion Rm G17C,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	rabinow@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [RO1 CA134776]; Department of Defense Grant [W81XWH-12-1-0228]; The Pittsburgh Foundation; NATIONAL CANCER INSTITUTE [R01CA134776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Grant(United States Department of Defense); The Pittsburgh Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA134776 (to H.R.). This work was also supported by Department of Defense Grant W81XWH-12-1-0228 (to H.R.) and The Pittsburgh Foundation (to J.H.).	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Calabretta B, 2011, LEUKEMIA LYMPHOMA, V52, P54, DOI 10.3109/10428194.2010.546913; Chaachouay H, 2011, RADIOTHER ONCOL, V99, P287, DOI 10.1016/j.radonc.2011.06.002; Chen YS, 2011, DIS ESOPHAGUS, V24, P437, DOI 10.1111/j.1442-2050.2010.01156.x; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; Gong C, 2013, ONCOGENE, V32, P2261, DOI 10.1038/onc.2012.252; Gorzalczany Y, 2011, CANCER LETT, V310, P207, DOI 10.1016/j.canlet.2011.07.002; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Han J, 2007, J BIOL CHEM, V282, P16223, DOI 10.1074/jbc.M611186200; Han J, 2010, J BIOL CHEM, V285, P22473, DOI 10.1074/jbc.M109.081042; Han J, 2010, J BIOL CHEM, V285, P22461, DOI 10.1074/jbc.M109.086587; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Herrero-Martin G, 2009, EMBO J, V28, P677, DOI 10.1038/emboj.2009.8; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hou W, 2008, AUTOPHAGY, V4, P940, DOI 10.4161/auto.6769; Huang H. L., 2011, PLOS ONE, V6; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Ito H, 2005, INT J ONCOL, V26, P1401; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; John S, 2008, CANCER RES, V68, P7855, DOI 10.1158/0008-5472.CAN-07-5875; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lainey E, 2011, BIOCHEM PHARMACOL, V82, P1457, DOI 10.1016/j.bcp.2011.05.011; Levy JMM, 2011, PHARMACOL THERAPEUT, V131, P130, DOI 10.1016/j.pharmthera.2011.03.009; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Livesey KM, 2009, CURR OPIN INVEST DR, V10, P1269; Marino G, 2011, CURR OPIN CELL BIOL, V23, P198, DOI 10.1016/j.ceb.2010.10.001; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Pulaski BA, 2001, CURRENT PROTOCOLS IM; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Reilly RT, 2000, CANCER RES, V60, P3569; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Shen SS, 2012, AUTOPHAGY, V8, P1, DOI 10.4161/auto.8.1.16618; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Yue ZY, 2002, NEURON, V35, P921, DOI 10.1016/S0896-6273(02)00861-9; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	50	46	50	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20315	20325		10.1074/jbc.M113.461350	http://dx.doi.org/10.1074/jbc.M113.461350			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23703612	Green Published, hybrid			2022-12-28	WOS:000321715100020
J	Beck, A; Speicher, T; Stoerger, C; Sell, T; Dettmer, V; Jusoh, SA; Abdulmughni, A; Cavalie, A; Philipp, SE; Zhu, MX; Helms, V; Wissenbach, U; Flockerzi, V				Beck, Andreas; Speicher, Tilman; Stoerger, Christof; Sell, Thomas; Dettmer, Viviane; Jusoh, Siti A.; Abdulmughni, Ammar; Cavalie, Adolfo; Philipp, Stephan E.; Zhu, Michael X.; Helms, Volkhard; Wissenbach, Ulrich; Flockerzi, Veit			Conserved Gating Elements in TRPC4 and TRPC5 Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OF-FUNCTION MUTATIONS; S4-S5 LINKER; TRPV3; PREDICTION; KV1.2; GENE	TRPC4 and TRPC5 proteins share 65% amino acid sequence identity and form Ca2+ -permeable nonselective cation channels. They are activated by stimulation of receptors coupled to the phosphoinositide signaling cascade. Replacing a conserved glycine residue within the cytosolic S4-S5 linker of both proteins by a serine residue forces the channels into an open conformation. Expression of the TRPC4(G503S) and TRPC5(G504S) mutants causes cell death, which could be prevented by buffering the Ca2+ of the culture medium. Current- voltage relationships of the TRPC4G(503S) and TRPC5(G504S) mutant ion channels resemble that of fully activated TRPC4 and TRPC5 wild- type channels, respectively. Modeling the structure of the transmembrane domains and the pore region (S4-S6) of TRPC4 predicts a conserved serine residue within the C- terminal sequence of the predicted S6 helix as a potential interaction site. Introduction of a second mutation (S623A) into TRPC4(G503S) suppressed the constitutive activation and partially rescued its function. These results indicate that the S4-S5 linker is a critical constituent of TRPC4/C5 channel gating and that disturbance of its sequence allows channel opening independent of any sensor domain.	[Cavalie, Adolfo; Philipp, Stephan E.] Univ Saarland, D-66421 Homburg, Germany; [Jusoh, Siti A.; Abdulmughni, Ammar; Helms, Volkhard] Univ Saarland, Zentrum Bioinformat, D-66123 Saarbrucken, Germany; [Jusoh, Siti A.] Univ Teknol MARA, Fac Pharm, Bandar Puncak Alam 42300, Malaysia; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Saarland University; Saarland University; University of Texas System; University of Texas Health Science Center Houston		andreas.beck@uniklinikum-saarland.de	Jusoh, Siti Azma/A-3646-2010; Philipp, Stephan/AAR-7519-2020	Jusoh, Siti Azma/0000-0002-9028-5681; Helms, Volkhard/0000-0002-2180-9154; Philipp, Stephan/0000-0003-1959-9167; Sell, Thomas/0000-0002-5138-3967; Abdulmughni, Ammar/0000-0002-5837-5943	Deutsche Forschungsgemeinschaft [SFB894]; Homburg Forschungsforderungsprogramm HOMFOR; Forschungskommission der Universitat des Saarlandes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Homburg Forschungsforderungsprogramm HOMFOR; Forschungskommission der Universitat des Saarlandes	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB894 (to A. B., S. E. P., and V. F.), the Homburg Forschungsforderungsprogramm HOMFOR (to A. B., C. S., and S. E. P.), and the Forschungskommission der Universitat des Saarlandes (to A. B., S. E. P., U. W., and V. F.).	Asakawa M, 2006, J INVEST DERMATOL, V126, P2664, DOI 10.1038/sj.jid.5700468; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Gross SA, 2009, J BIOL CHEM, V284, P34423, DOI 10.1074/jbc.M109.018192; Hong YS, 2002, J BIOL CHEM, V277, P33884, DOI 10.1074/jbc.M204075200; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kalia J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01523; Krakow D, 2009, AM J HUM GENET, V84, P307, DOI 10.1016/j.ajhg.2009.01.021; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Lai-Cheong JE, 2012, BRIT J DERMATOL, V167, P440, DOI 10.1111/j.1365-2133.2012.11115.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li MH, 2011, ADV EXP MED BIOL, V704, P1, DOI 10.1007/978-94-007-0265-3_1; Lin ZM, 2012, AM J HUM GENET, V90, P558, DOI 10.1016/j.ajhg.2012.02.006; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; McKay RR, 2000, BIOCHEM J, V351, P735, DOI 10.1042/0264-6021:3510735; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; Myers BR, 2008, J GEN PHYSIOL, V132, P481, DOI 10.1085/jgp.200810104; Obukhov AG, 2005, J NEUROSCI, V25, P1234, DOI 10.1523/JNEUROSCI.4451-04.2005; Obukhov AG, 2008, J CELL PHYSIOL, V216, P162, DOI 10.1002/jcp.21388; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Philipp S, 1998, EMBO J, V17, P4274, DOI 10.1093/emboj/17.15.4274; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; Su ZW, 2007, P NATL ACAD SCI USA, V104, P19607, DOI 10.1073/pnas.0708584104; Tsvilovskyy VV, 2009, GASTROENTEROLOGY, V137, P1415, DOI 10.1053/j.gastro.2009.06.046; Verma P, 2010, CHANNELS, V4, P319, DOI 10.4161/chan.4.4.12905; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Xiao R, 2008, CELL CALCIUM, V43, P334, DOI 10.1016/j.ceca.2007.06.004; Zimmermann K, 2011, P NATL ACAD SCI USA, V108, P18114, DOI 10.1073/pnas.1115387108	40	37	37	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19471	19483		10.1074/jbc.M113.478305	http://dx.doi.org/10.1074/jbc.M113.478305			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23677990	hybrid, Green Published			2022-12-28	WOS:000321515800015
J	Fujita, M; Ieguchi, K; Cedano-Prieto, DM; Fong, A; Wilkerson, C; Chen, JQ; Wu, M; Lo, SH; Cheung, ATW; Wilson, MD; Cardiff, RD; Borowsky, AD; Takada, YK; Takada, Y				Fujita, Masaaki; Ieguchi, Katsuaki; Cedano-Prieto, Dora M.; Fong, Andrew; Wilkerson, Charles; Chen, Jane Q.; Wu, Mac; Lo, Su-Hao; Cheung, Anthony T. W.; Wilson, Machelle D.; Cardiff, Robert D.; Borowsky, Alexander D.; Takada, Yoko K.; Takada, Yoshikazu			An Integrin Binding-defective Mutant of Insulin-like Growth Factor-1 (R36E/R37E IGF1) Acts as a Dominant-negative Antagonist of the IGF1 Receptor (IGF1R) and Suppresses Tumorigenesis but Still Binds to IGF1R	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX-FORMATION; HUMAN BREAST-CANCER; ALPHA-V-BETA-3; DOMAIN; CELLS; ALPHA-6-BETA-4; MECHANISM; SYSTEM; MODEL	Insulin-like growth factor-1 (IGF1) is a major therapeutic target for cancer. We recently reported that IGF1 directly binds to integrins (alpha v beta 3 and alpha 6 beta 4) and induces ternary complex formation (integrin-IGF1-IGF1 receptor (IGF1R)) and that the integrin binding-defective mutant of IGF1 (R36E/R37E) is defective in signaling and ternary complex formation. These findings predict that R36E/R37E competes with WT IGF1 for binding to IGF1R and inhibits IGF signaling. Here, we described that excess R36E/R37E suppressed cell viability increased by WT IGF1 in vitro in non-transformed cells. We studied the effect of R36E/R37E on viability and tumorigenesis in cancer cell lines. We did not detect an effect of WTIGF1 or R36E/R37E in cancer cells under anchorage-dependent conditions. However, under anchorage-independent conditions, WT IGF1 enhanced cell viability and induced signals, whereas R36E/R37E did not. Notably, excess R36E/R37E suppressed cell viability and signaling induced by WTIGF1 under anchorage-independent conditions. Using cancer cells stably expressing WTIGF1 or R36E/R37E, we determined that R36E/R37E suppressed tumorigenesis in vivo, whereas WT IGF1 markedly enhanced it. R36E/R37E suppressed the binding of WT IGF1 to the cell surface and the subsequent ternary complex formation induced by WT IGF1. R36E/R37E suppressed activation of IGF1R by insulin. WT IGF1, but not R36E/R37E, induced ternary complex formation with the IGF1R/insulin receptor hybrid. These findings suggest that 1) IGF1 induces signals under anchorage-independent conditions and that 2) R36E/R37E acts as a dominant-negative inhibitor of IGF1R (IGF1 decoy). Our results are consistent with a model in which ternary complex formation is critical for IGF signaling.	[Fujita, Masaaki; Ieguchi, Katsuaki; Cedano-Prieto, Dora M.; Fong, Andrew; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Dermatol, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA; [Fujita, Masaaki; Ieguchi, Katsuaki; Cedano-Prieto, Dora M.; Lo, Su-Hao; Takada, Yoko K.; Takada, Yoshikazu] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA; [Fong, Andrew; Wilkerson, Charles; Chen, Jane Q.; Cheung, Anthony T. W.; Cardiff, Robert D.; Borowsky, Alexander D.] Univ Calif Davis, Sch Med, Dept Pathol, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA; [Wu, Mac] Univ Calif Davis, Sch Med, Dept Surg, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA; [Wilson, Machelle D.] Univ Calif Davis, Sch Med, Div Biostat, Clin & Translat Sci Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Takada, Y (corresponding author), UC Davis Sch Med, Dept Dermatol, Suite 3300,4645 2nd Ave, Sacramento, CA 95817 USA.	ytakada@ucdavis.edu	Borowsky, Alexander D/S-5404-2017	Wilson, Machelle/0000-0003-1734-2755; CEDANO-PRIETO, DORA MARIA/0000-0002-4204-2175; Lo, Su Hao/0000-0002-2675-9387; takada, yoshikazu/0000-0001-5481-9589	National Institutes of Health [CA13015, HL096640]; United States Department of Defense [W81XWH-10-10312]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096640] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA13015 (to Y. T.) and HL096640 (to M. W.). This work also was supported by United States Department of Defense Grant W81XWH-10-10312 (to Y. T.).	Akakura N, 2006, CANCER RES, V66, P9691, DOI 10.1158/0008-5472.CAN-06-1686; Chaves J, 2011, ANTI-CANCER DRUG, V22, P206, DOI 10.1097/CAD.0b013e32834258a1; Cheung ATW, 1997, INT J ONCOL, V11, P69; Clemmons DR, 2007, GROWTH HORM IGF RES, V17, P265, DOI 10.1016/j.ghir.2007.01.004; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Feldman JP, 2009, J APPL QUANT METHODS, V4, P455, DOI DOI 10.1111/J.2042-3306.2010.TB05629.X; Fox EM, 2011, CANCER RES, V71, P6773, DOI 10.1158/0008-5472.CAN-11-1295; Fujita M, 2013, J BIOL CHEM, V288, P3059, DOI 10.1074/jbc.M112.412536; Fujita M, 2012, J IMMUNOL, V189, P5809, DOI 10.4049/jimmunol.1200889; Fujita M, 2012, J BIOL CHEM, V287, P12491, DOI 10.1074/jbc.M111.304170; FUKAZAWA H, 1995, ANAL BIOCHEM, V228, P83, DOI 10.1006/abio.1995.1318; Girnita A, 2004, CANCER RES, V64, P236, DOI 10.1158/0008-5472.CAN-03-2522; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ieguchi K, 2010, J BIOL CHEM, V285, P31388, DOI 10.1074/jbc.M110.113878; Jones John I., 1995, Progress in Growth Factor Research, V6, P319, DOI 10.1016/0955-2235(95)00015-1; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2387, DOI 10.1073/pnas.041606398; Mira E, 1999, ENDOCRINOLOGY, V140, P1657, DOI 10.1210/en.140.4.1657; Mizushima H, 2009, J CELL SCI, V122, P4277, DOI 10.1242/jcs.054551; Mori S, 2008, J BIOL CHEM, V283, P18066, DOI 10.1074/jbc.M801213200; Mori S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057927; Pandini G, 1999, CLIN CANCER RES, V5, P1935; PAPA V, 1993, CANCER RES, V53, P3736; Perks CM, 2007, ONCOGENE, V26, P5966, DOI 10.1038/sj.onc.1210397; Saegusa J, 2009, J BIOL CHEM, V284, P24106, DOI 10.1074/jbc.M109.013201; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Vella V, 2001, J CLIN PATHOL-MOL PA, V54, P121, DOI 10.1136/mp.54.3.121; Yamaji S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010273; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11217, DOI 10.1073/pnas.95.19.11217	30	23	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19593	19603		10.1074/jbc.M113.470872	http://dx.doi.org/10.1074/jbc.M113.470872			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696648	hybrid, Green Published			2022-12-28	WOS:000321515800025
J	Jiang, LL; Che, MX; Zhao, J; Zhou, CJ; Xie, MY; Li, HY; He, JH; Hu, HY				Jiang, Lei-Lei; Che, Mei-Xia; Zhao, Jian; Zhou, Chen-Jie; Xie, Mu-Yun; Li, Hai-Yin; He, Jian-Hua; Hu, Hong-Yu			Structural Transformation of the Amyloidogenic Core Region of TDP-43 Protein Initiates Its Aggregation and Cytoplasmic Inclusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS A-BETA-42 PEPTIDE; HUMAN ALPHA-SYNUCLEIN; FIBRIL FORMATION; SPLICING REGULATION; TERMINAL FRAGMENTS; RNA DEPLETION; HUMAN-DISEASE; MUTATIONS	TDP-43 (TAR DNA-binding protein of 43 kDa) is a major deposited protein in amyotrophic lateral sclerosis and frontotemporal dementia with ubiquitin. A great number of genetic mutations identified in the flexible C-terminal region are associated with disease pathologies. We investigated the molecular determinants of TDP-43 aggregation and its underlying mechanisms. We identified a hydrophobic patch (residues 318-343) as the amyloidogenic core essential for TDP-43 aggregation. Biophysical studies demonstrated that the homologous peptide formed a helix-turn-helix structure in solution, whereas it underwent structural transformation from an alpha-helix to a beta-sheet during aggregation. Mutation or deletion of this core region significantly reduced the aggregation and cytoplasmic inclusions of full-length TDP-43 (or TDP-35 fragment) in cells. Thus, structural transformation of the amyloidogenic core initiates the aggregation and cytoplasmic inclusion formation of TDP-43. This particular core region provides a potential therapeutic target to design small-molecule compounds for mitigating TDP-43 proteinopathies.	[Jiang, Lei-Lei; Che, Mei-Xia; Zhao, Jian; Zhou, Chen-Jie; Li, Hai-Yin; Hu, Hong-Yu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China; [Xie, Mu-Yun; He, Jian-Hua] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201204, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Hu, HY (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China.	hyhu@sibcb.ac.cn	Che, Meixia/Q-2119-2019; Hu, Hong-Yu/AAQ-2633-2020	Che, Meixia/0000-0002-4515-1414; 	National Basic Research Program of China [2012CB911003, 2011CB911104]; National Natural Science Foundation of China [31270773, 10979070]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2012CB911003 and 2011CB911104 and National Natural Science Foundation of China Grants 31270773 and 10979070.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Barmada SJ, 2010, REV NEUROSCIENCE, V21, P251; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Borroni B, 2009, HUM MUTAT, V30, pE974, DOI 10.1002/humu.21100; Budini M, 2012, J BIOL CHEM, V287, P7512, DOI 10.1074/jbc.M111.288720; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Che MX, 2011, FASEB J, V25, P2344, DOI 10.1096/fj.10-174482; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gsponer J, 2012, CELL REP, V2, P1425, DOI 10.1016/j.celrep.2012.09.036; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Hu HY, 2001, BIOPOLYMERS, V62, P15, DOI 10.1002/1097-0282(2001)62:1<15::AID-BIP30>3.0.CO;2-J; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Kroth H, 2012, J BIOL CHEM, V287, P34786, DOI 10.1074/jbc.M112.357665; Lamberto GR, 2009, P NATL ACAD SCI USA, V106, P21057, DOI 10.1073/pnas.0902603106; Li HT, 2002, BIOPOLYMERS, V64, P221, DOI 10.1002/bip.10179; Neary D, 2000, J NEUROL SCI, V180, P15, DOI 10.1016/S0022-510X(00)00425-1; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, INT J MOL SCI, V10, P232, DOI 10.3390/ijms10010232; Nishimoto Y, 2010, J BIOL CHEM, V285, P608, DOI 10.1074/jbc.M109.022012; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Wang IF, 2008, TRENDS MOL MED, V14, P479, DOI 10.1016/j.molmed.2008.09.001; Wurth C, 2002, J MOL BIOL, V319, P1279, DOI 10.1016/S0022-2836(02)00399-6; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Zhang T, 2012, J BIOL CHEM, V287, P8371, DOI 10.1074/jbc.M111.311977; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhou HX, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000887	46	90	92	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19614	19624		10.1074/jbc.M113.463828	http://dx.doi.org/10.1074/jbc.M113.463828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689371	hybrid, Green Published			2022-12-28	WOS:000321515800027
J	Mikati, MA; Grintsevich, EE; Reisler, E				Mikati, Mouna A.; Grintsevich, Elena E.; Reisler, Emil			Drebrin-induced Stabilization of Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC SPINE MORPHOGENESIS; F-ACTIN; MENTAL-RETARDATION; CROSS-LINKING; BRAIN PROTEIN; DOWN-SYNDROME; IN-VIVO; BINDING; POLYMERIZATION; TROPOMYOSIN	Drebrin is a mammalian neuronal protein that binds to and organizes filamentous actin (F-actin) in dendritic spines, the receptive regions of most excitatory synapses that play a crucial role in higher brain functions. Here, the structural effects of drebrin on F-actin were examined in solution. Depolymerization and differential scanning calorimetry assays show that F-actin is stabilized by the binding of drebrin. Drebrin inhibits depolymerization mainly at the barbed end of F-actin. Full-length drebrin and its C-terminal truncated constructs were used to clarify the domain requirements for these effects. The actin binding domain of drebrin decreases the intrastrand disulfide cross-linking of Cys-41 (in the DNase I binding loop) to Cys-374 (C-terminal) but increases the interstrand disulfide cross-linking of Cys-265 (hydrophobic loop) to Cys-374 in the yeast mutants Q41C and S265C, respectively. We also demonstrate, using solution biochemistry methods and EM, the rescue of filament formation by drebrin in different cases of longitudinal interprotomer contact perturbation: the T203C/C374S yeast actin mutant and grimelysin-cleaved skeletal actin (between Gly-42 and Val-43). Additionally, we show that drebrin rescues the polymerization of V266G/L267G, a hydrophobic loop yeast actin mutant with an impaired lateral interface formation between the two filament strands. Overall, our data suggest that drebrin stabilizes actin filaments through its effect on their interstrand and intrastrand contacts.	[Mikati, Mouna A.; Grintsevich, Elena E.; Reisler, Emil] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Reisler, Emil] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Reisler, E (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 407 Charles E Young Dr East, Los Angeles, CA 90095 USA.	reisler@mbi.ucla.edu			United States Public Health Service Grant [GM 077190]; UCLA Molecular Biology Institute Whitcome Pre-doctoral Training Program; National Institutes of Health [1S10RR23057]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077190] Funding Source: NIH RePORTER	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); UCLA Molecular Biology Institute Whitcome Pre-doctoral Training Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Service Grant GM 077190 (to E. R.). This work was also supported by the UCLA Molecular Biology Institute Whitcome Pre-doctoral Training Program (to M. A. M.).; We thank Dr. Peter Rubenstein for the yeast cell line-expressing actin mutant V266G/L267G. We also thank Dr. M. Quinlan for the heterodimeric capping protein, Dr. S. Khaitlina for grimelysin, and the Electron Imaging Center for Nano Machines at the California Nano Systems Institute, University of California Los Angeles, for the use of instruments (supported in part by National Institutes of Health Grant 1S10RR23057).	Aoki C, 2005, J COMP NEUROL, V483, P383, DOI 10.1002/cne.20449; Bobkov AA, 2002, J MOL BIOL, V323, P739, DOI 10.1016/S0022-2836(02)01008-2; Bozhokina E, 2008, BIOCHEM BIOPH RES CO, V367, P888, DOI 10.1016/j.bbrc.2008.01.003; Capani F, 2001, BRAIN RES, V923, P1, DOI 10.1016/S0006-8993(01)03189-4; Cheng C Yan, 2011, Spermatogenesis, V1, P291; FIFKOVA E, 1982, J CELL BIOL, V95, P345, DOI 10.1083/jcb.95.1.345; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2011, P NATL ACAD SCI USA, V108, P20568, DOI 10.1073/pnas.1110109108; Grintsevich EE, 2008, J MOL BIOL, V377, P395, DOI 10.1016/j.jmb.2007.12.073; Grintsevich EE, 2010, J MOL BIOL, V398, P542, DOI 10.1016/j.jmb.2010.03.039; Hayashi K, 1996, J NEUROSCI, V16, P7161; Hayashi K, 1999, EXP CELL RES, V253, P673, DOI 10.1006/excr.1999.4663; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Ikeda K, 1996, DEV BRAIN RES, V91, P227, DOI 10.1016/0165-3806(95)00181-6; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; ISHIKAWA R, 1994, J BIOL CHEM, V269, P29928; Ishikawa R, 2007, BIOCHEM BIOPH RES CO, V359, P398, DOI 10.1016/j.bbrc.2007.05.123; Kim E, 2000, J MOL BIOL, V299, P421, DOI 10.1006/jmbi.2000.3727; Klenchin VA, 2006, J MOL BIOL, V362, P140, DOI 10.1016/j.jmb.2006.07.001; KOJIMA N, 1993, MOL BRAIN RES, V19, P101, DOI 10.1016/0169-328X(93)90154-H; Kojima N, 2007, NEUROSCI RES, V58, P1, DOI 10.1016/j.neures.2007.02.003; Kostyukova AS, 2008, ADV EXP MED BIOL, V644, P283; Kudryashov DS, 2006, J MOL BIOL, V358, P785, DOI 10.1016/j.jmb.2006.02.029; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; KUROKAWA H, 1990, BIOCHEM BIOPH RES CO, V168, P451, DOI 10.1016/0006-291X(90)92342-W; MATUS A, 1982, P NATL ACAD SCI-BIOL, V79, P7590, DOI 10.1073/pnas.79.23.7590; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Paavilainen VO, 2008, J CELL BIOL, V182, P51, DOI 10.1083/jcb.200803100; Pivovarova AV, 2010, FEBS J, V277, P3812, DOI 10.1111/j.1742-4658.2010.07782.x; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; PURPURA DP, 1974, SCIENCE, V186, P1126, DOI 10.1126/science.186.4169.1126; Quintero-Monzon O, 2005, MOL BIOL CELL, V16, P3128, DOI 10.1091/mbc.E05-01-0059; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Sasaki Y, 1996, J NEUROCHEM, V66, P980; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Sharma S, 2011, NANO LETT, V11, P825, DOI 10.1021/nl104159v; Shim KS, 2002, NEUROSCI LETT, V324, P209, DOI 10.1016/S0304-3940(02)00210-0; SHIRAO T, 1986, DEV BRAIN RES, V29, P233, DOI 10.1016/0165-3806(86)90099-4; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Takahashi H, 2003, J NEUROSCI, V23, P6586; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Wen KK, 2000, J BIOL CHEM, V275, P40594, DOI 10.1074/jbc.M007201200; WISNIEWSKI KE, 1991, AM J MED GENET, V38, P476, DOI 10.1002/ajmg.1320380267; Yamashiro S, 2012, CYTOSKELETON, V69, P337, DOI 10.1002/cm.21031	46	56	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19926	19938		10.1074/jbc.M113.472647	http://dx.doi.org/10.1074/jbc.M113.472647			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696644	hybrid, Green Published			2022-12-28	WOS:000321515800058
J	Pearson, EL; Moore, CL				Pearson, Erika L.; Moore, Claire L.			Dismantling Promoter-driven RNA Polymerase II Transcription Complexes in Vitro by the Termination Factor Rat1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; ELONGATION COMPLEX; EXONUCLEASE XRN2; BUDDING YEAST; NASCENT RNA; GENE; SITE; INITIATION; PROTEIN	Proper RNA polymerase II (Pol II) transcription termination is essential to generate stable transcripts, to prevent interference at downstream loci, and to recycle Pol II back to the promoter (1-3). As such, termination is an intricately controlled process that is tightly regulated by a variety of different cis- and trans-acting factors (4, 5). Although many eukaryotic termination factors have been identified to date, the details of the precise molecular mechanisms governing termination remain to be elucidated. We devised an in vitro transcription system to study specific Pol II termination. We show for the first time that the exonucleolytic Rat1.Rai1 complex can elicit the release of stalled Pol II in vitro and can do so in the absence of other factors. We also find that Rtt103, which interacts with the Pol II C-terminal domain (CTD) and with Rat1, can rescue termination activity of an exonucleolytically deficient Rat1 mutant. In light of our findings, we posit a model whereby functional nucleolytic activity is not the feature of Rat1 that ultimately promotes termination. Degradation of the nascent transcript allows Rat1 to pursue Pol II in a guided fashion and arrive at the site of RNA exit from Pol II. Upon this arrival, however, it is perhaps the specific and direct contact between Rat1 and Pol II that transmits the signal to terminate transcription.	[Pearson, Erika L.; Moore, Claire L.] Tufts Univ, Dept Mol Biol & Microbiol, Sch Med, Boston, MA 02111 USA	Tufts University	Moore, CL (corresponding author), Tufts Univ, Dept Mol Biol & Microbiol, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	claire.moore@tufts.edu			National Institutes of Health [GM68887]; National Science Foundation [MCB-1244043]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068887] Funding Source: NIH RePORTER; Direct For Biological Sciences [1244043] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Institutes of Health Grant GM68887 and National Science Foundation Grant MCB-1244043 (to C. L. M.).	AMBERG DC, 1992, GENE DEV, V6, P1173, DOI 10.1101/gad.6.7.1173; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; Dengl S, 2009, J BIOL CHEM, V284, P21270, DOI 10.1074/jbc.M109.013847; Domecq C, 2010, PROTEIN EXPRES PURIF, V69, P83, DOI 10.1016/j.pep.2009.06.016; Epshtein V, 2010, NATURE, V463, P245, DOI 10.1038/nature08669; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; Gu WG, 1996, P NATL ACAD SCI USA, V93, P6935, DOI 10.1073/pnas.93.14.6935; Hammell CM, 2002, MOL CELL BIOL, V22, P6441, DOI 10.1128/MCB.22.18.6441-6457.2002; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Hogan BP, 2002, J BIOL CHEM, V277, P967, DOI 10.1074/jbc.M108737200; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Jimeno-Gonzalez S, 2010, MOL CELL, V37, P580, DOI 10.1016/j.molcel.2010.01.019; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; KENNA M, 1993, MOL CELL BIOL, V13, P341, DOI 10.1128/MCB.13.1.341; Kim H, 2010, NAT STRUCT MOL BIOL, V17, P1279, DOI 10.1038/nsmb.1913; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306; LUE NF, 1989, SCIENCE, V246, P661, DOI 10.1126/science.2510298; Lunde BM, 2010, NAT STRUCT MOL BIOL, V17, P1195, DOI 10.1038/nsmb.1893; Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Mischo HE, 2013, BBA-GENE REGUL MECH, V1829, P174, DOI 10.1016/j.bbagrm.2012.10.003; Mukundan B, 2011, J BIOL CHEM, V286, P37053, DOI 10.1074/jbc.C111.295915; PLATT T, 1994, MOL MICROBIOL, V11, P983, DOI 10.1111/j.1365-2958.1994.tb00376.x; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Sikorski TW, 2012, J BIOL CHEM, V287, P35397, DOI 10.1074/jbc.M112.391581; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; SNYDER M, 1988, MOL CELL BIOL, V8, P2184, DOI 10.1128/MCB.8.5.2184; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TANAKA S, 1994, NUCLEIC ACIDS RES, V22, P3904, DOI 10.1093/nar/22.19.3904; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; WOONTNER M, 1990, J BIOL CHEM, V265, P8979; Xiang S, 2009, NATURE, V458, P784, DOI 10.1038/nature07731; Zhang ZQ, 2005, GENE DEV, V19, P1572, DOI 10.1101/gad.1296305	41	27	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19750	19759		10.1074/jbc.M112.434985	http://dx.doi.org/10.1074/jbc.M112.434985			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689372	Green Published, hybrid			2022-12-28	WOS:000321515800044
J	Allende, ML; Sipe, LM; Tuymetova, G; Wilson-Henjum, KL; Chen, WP; Proia, RL				Allende, Maria L.; Sipe, Laura M.; Tuymetova, Galina; Wilson-Henjum, Kelsey L.; Chen, Weiping; Proia, Richard L.			Sphingosine-1-phosphate Phosphatase 1 Regulates Keratinocyte Differentiation and Epidermal Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY BARRIER; CELL-DEATH; IN-VITRO; SKIN; PHOSPHOHYDROLASE; SPHINGOLIPIDS; CERAMIDE; METABOLISM; EXPRESSION; RECEPTOR	Sphingosine 1-phosphate (S1P) is a bioactive lipid whose levels are tightly regulated by its synthesis and degradation. Intracellularly, S1P is dephosphorylated by the actions of two S1P-specific phosphatases, sphingosine-1-phosphate phosphatases 1 and 2. To identify the physiological functions of S1P phosphatase 1, we have studied mice with its gene, Sgpp1, deleted. Sgpp1(-/-) mice appeared normal at birth, but during the 1st week of life they exhibited stunted growth and suffered desquamation, with most dying before weaning. Both Sgpp1(-/-) pups and surviving adults exhibited multiple epidermal abnormalities. Interestingly, the epidermal permeability barrier developed normally during embryogenesis in Sgpp1(-/-) mice. Keratinocytes isolated from the skin of Sgpp1(-/-) pups had increased intracellular S1P levels and displayed a gene expression profile that indicated overexpression of genes associated with keratinocyte differentiation. The results reveal S1P metabolism as a regulator of keratinocyte differentiation and epidermal homeostasis.	[Allende, Maria L.; Sipe, Laura M.; Tuymetova, Galina; Wilson-Henjum, Kelsey L.; Chen, Weiping; Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Proia, RL (corresponding author), NIDDK, Genet Dev & Dis Branch, Bldg 10,Rm 9D-06,10 Ctr Dr MSC 1821, Bethesda, MD 20892 USA.	rp36y@nih.gov	Chen, Weiping/C-9550-2011; Proia, Richard L/A-7908-2012	Proia, Richard/0000-0003-0456-1270	National Institutes of Health from NIDDK [P30 CA138313, P20 RR017677]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056018, ZIADK056014] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health grants from NIDDK, Grant P30 CA138313 (to Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina), and Grant P20 RR017677 (to Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE).	Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Breart B, 2011, J EXP MED, V208, P1267, DOI 10.1084/jem.20102551; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Celli A, 2012, J INVEST DERMATOL, V132, P1188, DOI 10.1038/jid.2011.447; Denda M, 2000, BIOCHEM BIOPH RES CO, V272, P134, DOI 10.1006/bbrc.2000.2739; Elias PM, 1998, J INVEST DERMATOL, V110, P399, DOI 10.1046/j.1523-1747.1998.00151.x; ELIAS PM, 1991, ADV LIPID RES, V24, P1; ELIAS PM, 1992, SEMIN DERMATOL, V11, P176; Feingold KR, 2009, J LIPID RES, V50, pS417, DOI 10.1194/jlr.R800039-JLR200; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Harris IR, 1997, J INVEST DERMATOL, V109, P783, DOI 10.1111/1523-1747.ep12340962; Herzinger T, 2007, AM J CLIN DERMATOL, V8, P329, DOI 10.2165/00128071-200708060-00002; Holleran WM, 2006, FEBS LETT, V580, P5456, DOI 10.1016/j.febslet.2006.08.039; HOLLERAN WM, 1991, J CLIN INVEST, V88, P1338, DOI 10.1172/JCI115439; Hong JH, 2008, J INVEST DERMATOL, V128, P2166, DOI 10.1038/jid.2008.66; Hwang J, 2011, P NATL ACAD SCI USA, V108, P11566, DOI 10.1073/pnas.1019658108; Kim DS, 2004, CELL SIGNAL, V16, P89, DOI 10.1016/S0898-6568(03)00114-1; Kwon YB, 2007, J LIPID RES, V48, P1936, DOI 10.1194/jlr.M700185-JLR200; Le Stunff H, 2002, J BIOL CHEM, V277, P8920, DOI 10.1074/jbc.M109968200; Le Stunff H, 2004, J BIOL CHEM, V279, P34290, DOI 10.1074/jbc.M404907200; Le Stunff H, 2002, BBA-MOL CELL BIOL L, V1582, P8, DOI 10.1016/S1388-1981(02)00132-4; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; Lepine S, 2011, J BIOL CHEM, V286, P44380, DOI 10.1074/jbc.M111.257519; LI LW, 1995, J CELL PHYSIOL, V163, P105, DOI 10.1002/jcp.1041630112; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; MANSBRIDGE JN, 1987, J INVEST DERMATOL, V89, P253, DOI 10.1111/1523-1747.ep12471216; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; OLIVERA A, 2013, BIOCHIM BIOPHYS ACTA, V183, P193; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Saitoh M, 2007, NEUROSCI LETT, V417, P165, DOI 10.1016/j.neulet.2007.01.083; Schmitz EI, 2012, MOL CELL BIOCHEM, V371, P165, DOI 10.1007/s11010-012-1433-5; Schuette CG, 2001, GLYCOBIOLOGY, V11, p81R, DOI 10.1093/glycob/11.6.81R; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2000, FEBS LETT, V476, P55, DOI 10.1016/S0014-5793(00)01670-7; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Uchida Y, 2008, J DERMATOL SCI, V51, P77, DOI 10.1016/j.jdermsci.2008.01.002; Vasireddy V, 2007, HUM MOL GENET, V16, P471, DOI 10.1093/hmg/ddl480; Vogler R, 2003, J INVEST DERMATOL, V120, P693, DOI 10.1046/j.1523-1747.2003.12096.x; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; ZUHERINGDORF DM, 2004, J CELL BIOCHEM, V92, P937	63	28	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18381	18391		10.1074/jbc.M113.478420	http://dx.doi.org/10.1074/jbc.M113.478420			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23637227	hybrid, Green Published			2022-12-28	WOS:000320721900041
J	Thirkettle, S; Decock, J; Arnold, H; Pennington, CJ; Jaworski, DM; Edwards, DR				Thirkettle, Sally; Decock, Julie; Arnold, Hugh; Pennington, Caroline J.; Jaworski, Diane M.; Edwards, Dylan R.			Matrix Metalloproteinase 8 (Collagenase 2) Induces the Expression of Interleukins 6 and 8 in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-2; ESTROGEN-RECEPTOR; IL-8 EXPRESSION; STEM-CELLS; MICE; INVASION; MMP-8; TUMORIGENESIS; INFLAMMATION; METASTASIS	Matrix metalloproteinase 8 (MMP-8) is a tumor-suppressive protease that cleaves numerous substrates, including matrix proteins and chemokines. In particular, MMP-8 proteolytically activates IL-8 and, thereby, regulates neutrophil chemotaxis in vivo. We explored the effects of expression of either a WT or catalytically inactive (E198A) mutant version of MMP-8 in human breast cancer cell lines. Analysis of serum-free conditioned media from three breast cancer cell lines (MCF-7, SKBR- 3, and MDA-MB-231) expressing WT MMP-8 revealed elevated levels of IL-6 and IL-8. This increase was mirrored at the mRNA level and was dependent on MMP-8 catalytic activity. However, sustained expression of WT MMP-8 by breast cancer cells was non-permissive for long-term growth, as shown by reduced colony formation compared with cells expressing either control vector or E198A mutantMMP-8. In long-term culture of transfected MDA-MB-231 cells, expression of WT but not E198A mutant MMP-8 was lost, with IL-6 and IL-8 levels returning to base line. Rare clonal isolates ofMDA-MB-231cells expressing WT MMP-8 were generated, and these showed constitutively high levels of IL-6 and IL-8, although production of the interleukins was no longer dependent upon MMP-8 activity. These studies support a causal connection between MMP-8 activity and the IL-6/IL-8 network, with an acute response to MMP-8 involving induction of the proinflammatory mediators, which may in part serve to compensate for the deleterious effects of MMP-8 on breast cancer cell growth. This axis may be relevant to the recognized ability of MMP-8 to orchestrate the innate immune system in inflammation in vivo.	[Thirkettle, Sally; Decock, Julie; Arnold, Hugh; Pennington, Caroline J.; Edwards, Dylan R.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Jaworski, Diane M.] Univ Vermont Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA	University of East Anglia; University of Vermont	Edwards, DR (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	dylan.edwards@uea.ac.uk	Edwards, Dylan R/B-4734-2009; Decock, Julie/A-1453-2010	Edwards, Dylan R/0000-0002-3292-2064; Decock, Julie/0000-0002-4409-100X	Big C PhD studentship; Breast Cancer Campaign, Cancer Research-UK; European Union	Big C PhD studentship; Breast Cancer Campaign, Cancer Research-UK(Cancer Research UK); European Union(European Commission)	This work was supported by a Big C PhD studentship (to S.T.); by the Breast Cancer Campaign, Cancer Research-UK; and by European Union FP6 (Cancerdegradome) and FP7 (SaveMe) projects.	Agarwal D, 2003, DIFFERENTIATION, V71, P114, DOI 10.1046/j.1432-0436.2003.710202.x; Albaiceta GM, 2010, AM J RESP CELL MOL, V43, P555, DOI 10.1165/rcmb.2009-0034OC; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Blackburn JS, 2009, ONCOGENE, V28, P4237, DOI 10.1038/onc.2009.272; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Chernov AV, 2010, J BIOL CHEM, V285, P19647, DOI 10.1074/jbc.M109.088153; Decock J, 2007, CANCER RES, V67, P10214, DOI 10.1158/0008-5472.CAN-07-1683; Decock J, 2011, J CELL MOL MED, V15, P1254, DOI 10.1111/j.1582-4934.2011.01302.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Folgueras AR, 2008, J BIOL CHEM, V283, P9465, DOI 10.1074/jbc.M709522200; Freund A, 2004, ONCOGENE, V23, P6105, DOI 10.1038/sj.onc.1207815; Freund A, 2003, ONCOGENE, V22, P256, DOI 10.1038/sj.onc.1206113; Garcia-Prieto E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013242; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Gutierrez-Fernandez A, 2008, CANCER RES, V68, P2755, DOI 10.1158/0008-5472.CAN-07-5154; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Hartman ZC, 2011, CANCER RES, V71, P4380, DOI 10.1158/0008-5472.CAN-11-0308; HASTY KA, 1990, J BIOL CHEM, V265, P11421; Hernandez M, 2011, J PERIODONTAL RES, V46, P58, DOI 10.1111/j.1600-0765.2010.01310.x; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Howells GL, 1997, J CELL SCI, V110, P881; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Kees T, 2011, J MAMMARY GLAND BIOL, V16, P189, DOI 10.1007/s10911-011-9224-2; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Korpi JT, 2008, BRIT J CANCER, V98, P766, DOI 10.1038/sj.bjc.6604239; Kuula H, 2009, INFECT IMMUN, V77, P850, DOI 10.1128/IAI.00873-08; Lin M, 2008, AM J PATHOL, V173, P144, DOI 10.2353/ajpath.2008.080081; Lin Y, 2004, INT J CANCER, V109, P507, DOI 10.1002/ijc.11724; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Montel V, 2004, CANCER RES, V64, P1687, DOI 10.1158/0008-5472.CAN-03-2047; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Rallabhandi P, 2008, J BIOL CHEM, V283, P24314, DOI 10.1074/jbc.M804800200; Rokavec M, 2012, MOL CELL, V45, P777, DOI 10.1016/j.molcel.2012.01.015; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; Shpacovitch VM, 2004, J LEUKOCYTE BIOL, V76, P388, DOI 10.1189/jlb.0503221; Stadlmann S, 2003, EUR J CANCER, V39, P2499, DOI 10.1016/j.ejca.2003.08.011; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V377, P622, DOI 10.1016/j.bbrc.2008.10.018; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Van Lint P, 2006, CYTOKINE GROWTH F R, V17, P217, DOI 10.1016/j.cytogfr.2006.04.001; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843	49	39	44	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16282	16294		10.1074/jbc.M113.464230	http://dx.doi.org/10.1074/jbc.M113.464230			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23632023	hybrid, Green Published			2022-12-28	WOS:000320378900008
J	Geetha, T; Rege, SD; Mathews, SE; Meakin, SO; White, MF; Babu, JR				Geetha, Thangiah; Rege, Shraddha D.; Mathews, Salome E.; Meakin, Susan O.; White, Morris F.; Babu, Jeganathan Ramesh			Nerve Growth Factor Receptor TrkA, a New Receptor in Insulin Signaling Pathway in PC12 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL GLUCOSE-UPTAKE; TROPHIC FACTORS; ALZHEIMER-TYPE; SUBSTRATE-1; PROTEIN; SURVIVAL; BINDING; KINASE; IRS-1; DIFFERENTIATION	TrkA is a cell surface transmembrane receptor tyrosine kinase for nerve growth factor (NGF). TrkA has an NPXY motif and kinase regulatory loop similar to insulin receptor (INSR) suggesting that NGF -> TrkA signaling might overlap with insulin -> INSR signaling. During insulin or NGF stimulation TrkA, insulin receptor substrate-1 (IRS-1), INSR (and presumably other proteins) forms a complex in PC12 cells. In PC12 cells, tyrosine phosphorylation of INSR and IRS-1 is dependent upon the functional TrkA kinase domain. Moreover, expression of TrkA kinase-inactive mutant blocked the activation of Akt and Erk5 in response to insulin or NGF. Based on these data, we propose that TrkA participates in insulin signaling pathway in PC12 cells.	[Geetha, Thangiah; Rege, Shraddha D.; Mathews, Salome E.; Babu, Jeganathan Ramesh] Auburn Univ, Dept Nutr Dietet & Hospitality Management, Auburn, AL 36849 USA; [Geetha, Thangiah] Auburn Univ, Dept Phys Sci, Montgomery, AL 36117 USA; [Meakin, Susan O.] Univ Western Ontario, Robarts Res Inst, Lab Neural Signaling, Mol Brain Res Grp, London, ON N6A 5K8, Canada; [White, Morris F.] Childrens Hosp Boston, Dept Endocrinol, Boston, MA 02115 USA; [White, Morris F.] Howard Hughes Med Inst, Boston, MA 02115 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Western University (University of Western Ontario); Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Geetha, T (corresponding author), Auburn Univ, Dept Nutr Dietet & Hospitality Management, Auburn, AL 36849 USA.	thangge@auburn.edu; jeganrb@auburn.edu	Meakin, Susan/K-8823-2013; Thangiah, Geetha/W-6796-2019	Meakin, Susan/0000-0003-2469-6615; Ramesh Babu, Jeganathan/0000-0002-3719-932X; Rege, Shraddha/0000-0002-6942-4878	New Faculty Startup Fund from Auburn University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038712, R01DK098655] Funding Source: NIH RePORTER	New Faculty Startup Fund from Auburn University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the New Faculty Startup Fund from Auburn University (to J. R. B.).	Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; BARBACID M, 1991, BIOCHIM BIOPHYS ACTA, V1072, P115, DOI 10.1016/0304-419X(91)90010-I; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BERG MM, 1992, J BIOL CHEM, V267, P13; Chao MV, 2000, J NEUROSCI RES, V59, P353, DOI 10.1002/(SICI)1097-4547(20000201)59:3<353::AID-JNR8>3.3.CO;2-J; CHEN DI, 1995, MOL CELL BIOL, V15, P4711; Craft S, 1996, NEUROBIOL AGING, V17, P123, DOI 10.1016/0197-4580(95)02002-0; CRAFT S, 1993, BEHAV NEUROSCI, V107, P926; Delahaye L, 2000, ENDOCRINOLOGY, V141, P621, DOI 10.1210/en.141.2.621; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; FUJISAWA Y, 1991, BIOL PSYCHIAT, V30, P1219, DOI 10.1016/0006-3223(91)90158-I; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Geetha T, 2012, J BIOL CHEM, V287, P29672, DOI 10.1074/jbc.M111.322404; Greenlee MHW, 2003, J NEUROSCI RES, V73, P518, DOI 10.1002/jnr.10684; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; HE WM, 1995, J BIOL CHEM, V270, P23258, DOI 10.1074/jbc.270.40.23258; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Hoyer S, 1996, ANN NY ACAD SCI, V777, P374, DOI 10.1111/j.1749-6632.1996.tb34448.x; Kaplan DR, 1997, CURR OPIN CELL BIOL, V9, P213, DOI 10.1016/S0955-0674(97)80065-8; Lee J, 1997, BIOCHEMISTRY-US, V36, P2701, DOI 10.1021/bi961815g; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Meakin SO, 1999, J BIOL CHEM, V274, P9861, DOI 10.1074/jbc.274.14.9861; Miranda C, 2001, J CELL PHYSIOL, V186, P35; ONEILL TJ, 1994, MOL CELL BIOL, V14, P6433, DOI 10.1128/MCB.14.10.6433; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; SawkaVerhelle D, 1996, J BIOL CHEM, V271, P5980, DOI 10.1074/jbc.271.11.5980; Uemura E, 2006, EXP NEUROL, V198, P48, DOI 10.1016/j.expneurol.2005.10.035; Uemura E, 2001, EXP NEUROL, V170, P270, DOI 10.1006/exnr.2001.7719; Valverde AM, 2001, MOL CELL BIOL, V21, P2269, DOI 10.1128/MCB.21.7.2269-2280.2001; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Watson RT, 2001, RECENT PROG HORM RES, V56, P175, DOI 10.1210/rp.56.1.175; Wickelgren I, 1998, SCIENCE, V280, P517, DOI 10.1126/science.280.5363.517; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	36	19	20	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					23807	23813		10.1074/jbc.M112.436279	http://dx.doi.org/10.1074/jbc.M112.436279			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23749991	Green Published, hybrid			2022-12-28	WOS:000330611400020
J	Prots, I; Veber, V; Brey, S; Campioni, S; Buder, K; Riek, R; Bohm, KJ; Winner, B				Prots, Iryna; Veber, Vanesa; Brey, Stefanie; Campioni, Silvia; Buder, Katrin; Riek, Roland; Boehm, Konrad J.; Winner, Beate			alpha-Synuclein Oligomers Impair Neuronal Microtubule-Kinesin Interplay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alpha-Synuclein; Kinesin; Microtubules; Neurodegeneration; Transport; Neurite; Oligomers	PARKINSONS-DISEASE MODELS; MULTIPLE SYSTEM ATROPHY; AXONAL-TRANSPORT; NEURODEGENERATIVE DISEASES; TUBULIN POLYMERIZATION; TAU PHOSPHORYLATION; LEWY BODIES; PROTEIN; ACCUMULATION; TOXICITY	Early -synuclein (-Syn)-induced alterations are neurite pathologies resulting in Lewy neurites. -Syn oligomers are a toxic species in synucleinopathies and are suspected to cause neuritic pathology. To investigate how -Syn oligomers may be linked to aberrant neurite pathology, we modeled different stages of -Syn aggregation in vitro and investigated the interplay of -Syn aggregates with proteins involved in axonal transport. The interaction of wild type -Syn (WTS) and -Syn variants (E57K, A30P, and aSyn(30-110)) with kinesin, tubulin, and the microtubule (MT)-associated proteins, MAP2 and Tau, is stronger for multimers than for monomers. WTS seeds but not -Syn oligomers significantly and dose-dependently reduced Tau-promoted MT assembly in vitro. In contrast, MT gliding velocity across kinesin-coated surfaces was significantly decreased in the presence of -Syn oligomers but not WTS seeds or fibrils (aSyn(30-110) multimers). In a human dopaminergic neuronal cell line, mild overexpression of the oligomerizing E57K -Syn variant significantly impaired neurite network morphology without causing profound cell death. In accordance with these findings, MT stability, neuritic kinesin, and neuritic kinesin-dependent cargoes were significantly reduced by the presence of -Syn oligomers. In summary, different -Syn species act divergently on the axonal transport machinery. These findings provide new insights into -Syn oligomer-driven neuritic pathology as one of the earliest events in synucleinopathies.	[Prots, Iryna; Veber, Vanesa; Brey, Stefanie; Winner, Beate] Univ Klinikum Erlangen, Jr Res Grp 3, Interdisciplinary Ctr Clin Res, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Campioni, Silvia; Riek, Roland] Swiss Fed Inst Technol Zurich, Lab Phys Chem, HCI F 225, CH-8093 Zurich, Switzerland; [Buder, Katrin; Boehm, Konrad J.] Fritz Lipmann Inst eV, Leibniz Inst Age Res, D-07745 Jena, Germany	University of Erlangen Nuremberg; Swiss Federal Institutes of Technology Domain; ETH Zurich; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI)	Winner, B (corresponding author), Univ Klinikum Erlangen, Jr Res Grp 3, Interdisciplinary Ctr Clin Res, Nikolaus Fiebiger Ctr Mol Med, Glueckstr 6, D-91054 Erlangen, Germany.	beate.winner@med.uni-erlangen.de	Prots, Iryna/O-7982-2018; Winner, Beate/K-3730-2012; Winner, Beate/O-8213-2019	Prots, Iryna/0000-0001-9561-0909; Winner, Beate/0000-0002-6909-0564; Winner, Beate/0000-0002-6909-0564; Riek, Roland/0000-0002-6333-066X	ELAN (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsf6derung) Fonds [11.08.19.1]; Interdisciplinary Center for Clinical Research [IZKF N3]; Bavarian Ministry of Sciences, Research; German Federal Ministry of Education and Research (BMBF) [01GQ113]	ELAN (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsf6derung) Fonds; Interdisciplinary Center for Clinical Research; Bavarian Ministry of Sciences, Research; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by ELAN (Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsf6derung) Fonds Grant 11.08.19.1 (to I. P.); the Interdisciplinary Center for Clinical Research (IZKF N3, Universitaetsklinikum Erlangen); the Bavarian Ministry of Sciences, Research, and the Arts in the framework of the Bavarian Molecular Biosystems Research Network (BioSysNet); and German Federal Ministry of Education and Research (BMBF) Grant 01GQ113.	Alim MA, 2004, J ALZHEIMERS DIS, V6, P435; Alim MA, 2002, J BIOL CHEM, V277, P2112, DOI 10.1074/jbc.M102981200; Bohm KJ, 1997, CELL MOTIL CYTOSKEL, V37, P226, DOI 10.1002/(SICI)1097-0169(1997)37:3<226::AID-CM4>3.0.CO;2-4; Chen L, 2007, BIOCHEM BIOPH RES CO, V356, P548, DOI 10.1016/j.bbrc.2007.02.163; Chu YP, 2012, BRAIN, V135, P2058, DOI 10.1093/brain/aws133; Chung CY, 2009, J NEUROSCI, V29, P3365, DOI 10.1523/JNEUROSCI.5427-08.2009; D'Andrea MR, 2001, NEUROSCI LETT, V306, P137, DOI 10.1016/S0304-3940(01)01811-0; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; Esposito A, 2007, NEUROBIOL DIS, V26, P521, DOI 10.1016/j.nbd.2007.01.014; Esteves AR, 2010, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.005.2009; Geddes JW, 2005, EXP NEUROL, V192, P244, DOI 10.1016/j.expneurol.2004.12.002; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HERZOG W, 1978, EUR J BIOCHEM, V92, P1, DOI 10.1111/j.1432-1033.1978.tb12716.x; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Kalchishkova N, 2008, J MOL BIOL, V382, P127, DOI 10.1016/j.jmb.2008.06.092; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; Kim M, 2008, BIOCHEM BIOPH RES CO, V365, P628, DOI 10.1016/j.bbrc.2007.11.020; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2006, EUR J NEUROSCI, V24, P3153, DOI 10.1111/j.1460-9568.2006.05210.x; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Nakayama K, 2012, BIOCHEM BIOPH RES CO, V417, P1170, DOI 10.1016/j.bbrc.2011.12.092; Nakayama K, 2009, AM J PATHOL, V174, P1471, DOI 10.2353/ajpath.2009.080503; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Payton JE, 2001, MOL BRAIN RES, V95, P138, DOI 10.1016/S0169-328X(01)00257-1; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Scholz D, 2011, J NEUROCHEM, V119, P957, DOI 10.1111/j.1471-4159.2011.07255.x; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Sharma M, 2012, NEUROLOGY, V79, P659, DOI 10.1212/WNL.0b013e318264e353; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; SHELANSK.ML, 1973, P NATL ACAD SCI USA, V70, P765, DOI 10.1073/pnas.70.3.765; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeda A, 1998, AM J PATHOL, V152, P367; Utton MA, 2005, J CELL SCI, V118, P4645, DOI 10.1242/jcs.02558; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wersinger C, 2005, BIOCHEMISTRY-US, V44, P13612, DOI 10.1021/bi050402p; Winner B, 2012, J NEUROSCI, V32, P16906, DOI 10.1523/JNEUROSCI.2723-12.2012; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou RM, 2010, MOL BIOL REP, V37, P3183, DOI 10.1007/s11033-009-9899-2	53	103	103	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21742	21754		10.1074/jbc.M113.451815	http://dx.doi.org/10.1074/jbc.M113.451815			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23744071	Green Published, hybrid			2022-12-28	WOS:000328841900025
J	Zhang, XM; Hernandez, I; Rei, D; Mair, W; Laha, JK; Cornwell, ME; Cuny, GD; Tsai, LH; Steen, JAJ; Kosik, KS				Zhang, Xuemei; Hernandez, Israel; Rei, Damien; Mair, Waltraud; Laha, Joydev K.; Cornwell, Madison E.; Cuny, Gregory D.; Tsai, Li-Huei; Steen, Judith A. J.; Kosik, Kenneth S.			Diaminothiazoles Modify Tau Phosphorylation and Improve the Tauopathy in Mouse Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; CDK (Cyclin-dependent Kinase); Glycogen Synthase Kinase 3; Neurodegenerative Diseases; Protein Phosphorylation; Kinase Inhibitor; Tauopathy	PAIRED HELICAL FILAMENTS; SYNAPTIC PLASTICITY; PROTEIN; CDK5; NEURODEGENERATION; AGGREGATION; INHIBITORS; SUBUNIT; DISEASE; IDENTIFICATION	Although Tau accumulation is a feature of several neurodegenerative conditions, treatment options for these conditions are nonexistent. Targeting Tau kinases represents a potential therapeutic approach. Small molecules in the diaminothiazole class are potent Tau kinase inhibitors that target CDK5 and GSK3. Lead compounds from the series have IC50 values toward CDK5/p25 and GSK3 in the low nanomolar range and no observed toxicity in the therapeutic dose range. Neuronal protective effects and decreased PHF-1 immunoreactivity were observed in two animal models, 3xTg-AD and CK-p25. Treatment nearly eliminated Sarkosyl-insoluble Tau with the most prominent effect on the phosphorylation at Ser-404. Treatment also induced the recovery of memory in a fear conditioning assay. Given the contribution of both CDK5/p25 and GSK3 to Tau phosphorylation, effective treatment of tauopathies may require dual kinase targeting.	[Zhang, Xuemei; Hernandez, Israel; Cornwell, Madison E.; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Rei, Damien; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Mair, Waltraud; Steen, Judith A. J.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Mair, Waltraud; Steen, Judith A. J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Laha, Joydev K.; Cuny, Gregory D.] Brigham & Womens Hosp, Lab Drug Discovery Neurodegenerat, Harvard NeuroDiscovery Ctr, Cambridge, MA 02139 USA; [Laha, Joydev K.; Cuny, Gregory D.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA	University of California System; University of California Santa Barbara; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	kenneth.kosik@lifesci.ucsb.edu		Cuny, Gregory/0000-0002-3188-4748; Laha, Joydev/0000-0003-0481-5891	National Institutes of Health [U01 AG033931]; NATIONAL INSTITUTE ON AGING [U01AG033931] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant U01 AG033931 (to K. S. K.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ahn JS, 2005, CHEM BIOL, V12, P811, DOI 10.1016/j.chembiol.2005.05.011; [Anonymous], 2013, KEYST S MOL CELL BIO; BEAUDETTE KN, 1993, J BIOL CHEM, V268, P20825; Chai XY, 2011, J BIOL CHEM, V286, P34457, DOI 10.1074/jbc.M111.229633; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hawasli AH, 2007, NAT NEUROSCI, V10, P880, DOI 10.1038/nn1914; HEIKKILA RE, 1984, SCIENCE, V224, P1451, DOI 10.1126/science.6610213; Helal CJ, 2009, BIOORG MED CHEM LETT, V19, P5703, DOI 10.1016/j.bmcl.2009.08.019; Helal CJ, 2004, BIOORG MED CHEM LETT, V14, P5521, DOI 10.1016/j.bmcl.2004.09.006; Hitchcock SA, 2006, J MED CHEM, V49, P7559, DOI 10.1021/jm060642i; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; ISHIGURO K, 1994, FEBS LETT, V342, P203, DOI 10.1016/0014-5793(94)80501-6; ISHIGURO K, 1992, J BIOL CHEM, V267, P10897; Kvilekval K, 2010, BIOINFORMATICS, V26, P544, DOI 10.1093/bioinformatics/btp699; Laha JK, 2011, BIOORG MED CHEM LETT, V21, P2098, DOI 10.1016/j.bmcl.2011.01.140; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Dominguez JM, 2012, J BIOL CHEM, V287, P893, DOI 10.1074/jbc.M111.306472; Noble W, 2003, NEURON, V38, P555, DOI 10.1016/S0896-6273(03)00259-9; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oh KJ, 2010, INT J ALZHEIMERS DIS, V2010, DOI DOI 10.4061/2010/780102; OLNEY JW, 1974, BRAIN RES, V77, P507, DOI 10.1016/0006-8993(74)90640-4; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Piedrahita D, 2010, J NEUROSCI, V30, P13966, DOI 10.1523/JNEUROSCI.3637-10.2010; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schmechel D.E., 2008, ALZHEIMERS DEMENT, V4, pT483, DOI [10.1016/j.jalz.2008.05.1455, DOI 10.1016/J.JALZ.2008.05.1455]; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Selenica ML, 2007, BRIT J PHARMACOL, V152, P959, DOI 10.1038/sj.bjp.0707471; Singh S, 2009, J PROTEOME RES, V8, P2201, DOI 10.1021/pr800654s; SLOOT WN, 1994, J NEUROCHEM, V62, P205; Sundaram JR, 2013, J NEUROSCI, V33, P334, DOI 10.1523/JNEUROSCI.3593-12.2013; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Wang MS, 2009, BIOCHEM BIOPH RES CO, V386, P526, DOI 10.1016/j.bbrc.2009.06.077; Wischik C, 2009, J NUTR HEALTH AGING, V13, P367, DOI 10.1007/s12603-009-0046-5	42	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							22042	10.1074/jbc.M112.436402	http://dx.doi.org/10.1074/jbc.M112.436402			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23737518	hybrid, Green Published			2022-12-28	WOS:000328841900050
J	Ebel, P; Dorp, KV; Petrasch-Parwez, E; Zlomuzica, A; Kinugawa, K; Mariani, J; Minich, D; Ginkel, C; Welcker, J; Degen, J; Eckhardt, M; Dere, E; Dormann, P; Willecke, K				Ebel, Philipp; Dorp, Katharina vom; Petrasch-Parwez, Elisabeth; Zlomuzica, Armin; Kinugawa, Kiyoka; Mariani, Jean; Minich, David; Ginkel, Christina; Welcker, Jochen; Degen, Joachim; Eckhardt, Matthias; Dere, Ekrem; Doermann, Peter; Willecke, Klaus			Inactivation of Ceramide Synthase 6 in Mice Results in an Altered Sphingolipid Metabolism and Behavioral Abnormalities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(DIHYDRO)CERAMIDE SYNTHASE; MEMBRANE-LIPIDS; EXPRESSION; BRAIN; SPECIFICITY; INHIBITION; PRINCIPLES; ABLATION; MEMBERS; SYSTEM	The N-acyl chain length of ceramides is determined by the specificity of different ceramide synthases (CerS). The CerS family in mammals consists of six members with different substrate specificities and expression patterns. We have generated and characterized a mouse line harboring an enzymatically inactive ceramide synthase 6 (CerS6KO) gene and lacz reporter cDNA coding for beta-galactosidase directed by the CerS6 promoter. These mice display a decrease in C16:0 containing sphingolipids. Relative to wild type tissues the amount of C16:0 containing sphingomyelin in kidney is similar to 35%, whereas we find a reduction of C16:0 ceramide content in the small intestine to about 25%. The CerS6KO mice show behavioral abnormalities including a clasping abnormality of their hind limbs and a habituation deficit. LacZ reporter expression in the brain reveals CerS6 expression in hippocampus, cortex, and the Purkinje cell layer of the cerebellum. Using newly developed antibodies that specifically recognize the CerS6 protein we show that the endogenous CerS6 protein is N-glycosylated and expressed in several tissues of mice, mainly kidney, small and large intestine, and brain.	[Ebel, Philipp; Minich, David; Ginkel, Christina; Degen, Joachim; Willecke, Klaus] Univ Bonn, Mol Genet Life & Med Sci Inst LIMES, D-53115 Bonn, Germany; [Dorp, Katharina vom; Doermann, Peter] Univ Bonn, Inst Mol Physiol & Biotechnol Plants, D-53115 Bonn, Germany; [Eckhardt, Matthias] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Petrasch-Parwez, Elisabeth] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-44801 Bochum, Germany; [Zlomuzica, Armin; Dere, Ekrem] Ruhr Univ Bochum, Mental Hlth Res & Treatment Ctr, D-44780 Bochum, Germany; [Kinugawa, Kiyoka; Mariani, Jean; Dere, Ekrem] Hop Charles Foix, Inst Longevite, F-94205 Paris, France; [Kinugawa, Kiyoka; Mariani, Jean; Dere, Ekrem] Univ Paris 06, F-75005 Paris, France; [Welcker, Jochen] Max Delbrueck Ctr, Dept Neurosci, D-13125 Berlin, Germany	University of Bonn; University of Bonn; University of Bonn; Ruhr University Bochum; Ruhr University Bochum; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Charles-Foix - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Willecke, K (corresponding author), Univ Bonn, Mol Genet Life & Med Sci Inst, Carl Troll Str 31, D-53115 Bonn, Germany.	k.willecke@uni-bonn.de	Dere, Ekrem/Y-3872-2019; Dere, Ekrem/F-3879-2018; Kinugawa, Kiyoka/AAM-7853-2020	Dere, Ekrem/0000-0001-7823-7778; Kinugawa, Kiyoka/0000-0001-6914-6102; Mariani, Jean/0000-0002-2701-1581	German Research Foundation through Collaborative Research Centre [SFB-645, B2, B5, Z4];  [DE1149/6-1]	German Research Foundation through Collaborative Research Centre; 	This work was supported by the German Research Foundation through Collaborative Research Centre Grants SFB-645 projects B2 (to K. W.), B5 (to M. E.), and Z4 (to P. D.), and DE1149/6-1 (to E. D.).	Becker I, 2008, HISTOCHEM CELL BIOL, V129, P233, DOI 10.1007/s00418-007-0344-0; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; Cuellar TL, 2008, P NATL ACAD SCI USA, V105, P5614, DOI 10.1073/pnas.0801689105; Dere E, 2002, J NEUROSCI METH, V122, P65, DOI 10.1016/S0165-0270(02)00274-1; Dere E, 2002, GENES BRAIN BEHAV, V1, P204, DOI 10.1034/j.1601-183X.2002.10402.x; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Gantois I, 2007, P NATL ACAD SCI USA, V104, P4182, DOI 10.1073/pnas.0611625104; Gierl MS, 2006, GENE DEV, V20, P2465, DOI 10.1101/gad.381806; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Homma D, 2011, J BIOL CHEM, V286, P1445, DOI 10.1074/jbc.M110.159426; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Kim HJ, 2012, J LIPID RES, V53, P1701, DOI 10.1194/jlr.D025627; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Petrasch-Parwez E, 2004, J COMP NEUROL, V479, P181, DOI 10.1002/cne.20327; Petrasch-Parwez E, 2007, J COMP NEUROL, V501, P716, DOI 10.1002/cne.21272; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Requardt RP, 2009, GLIA, V57, P680, DOI 10.1002/glia.20796; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Schiffmann S, 2012, J IMMUNOL, V188, P5723, DOI 10.4049/jimmunol.1103109; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Stiban J, 2010, ADV EXP MED BIOL, V688, P60; Sun Y, 2008, HUM MOL GENET, V17, P2345, DOI 10.1093/hmg/ddn135; Tabatadze N, 2010, J NEUROSCI RES, V88, P2940, DOI 10.1002/jnr.22438; Tidhar R, 2012, J BIOL CHEM, V287, P3197, DOI 10.1074/jbc.M111.280271; VANECHTEN G, 1993, J BIOL CHEM, V268, P5341; Venkataraman K, 2002, FEBS LETT, V528, P3, DOI 10.1016/S0014-5793(02)03248-9; Wells D, 1993, Methods Mol Biol, V18, P217, DOI 10.1385/0-89603-245-0:217; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wewer V, 2011, J LIPID RES, V52, P1039, DOI 10.1194/jlr.D013987; Wheeler D, 2008, BRAIN, V131, P3092, DOI 10.1093/brain/awn190; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Yamashita T, 2005, GENESIS, V43, P175, DOI 10.1002/gene.20167; Zhao LH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002063; Zlomuzica A, 2012, DEV NEUROSCI-BASEL, V34, P277, DOI 10.1159/000339305	49	55	56	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21433	21447		10.1074/jbc.M113.479907	http://dx.doi.org/10.1074/jbc.M113.479907			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760501	Green Published, hybrid			2022-12-28	WOS:000322014400061
J	Meyer, F; Ehlers, E; Steadman, A; Waterbury, T; Cao, MX; Zhang, LW				Meyer, Florencia; Ehlers, Erica; Steadman, Andrew; Waterbury, Thomas; Cao, Mingxia; Zhang, Luwen			TLR-TRIF Pathway Enhances the Expression of KSHV Replication and Transcription Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED-HERPESVIRUS; EPSTEIN-BARR-VIRUS; TOLL-LIKE RECEPTORS; INTERFERON REGULATORY FACTOR-7; RTA PROMOTES DEGRADATION; HUMAN B-LYMPHOCYTES; KAPOSIS-SARCOMA; LYTIC REPLICATION; GENE-EXPRESSION; SELECTIVE EXPRESSION	Kaposi's sarcoma-associated herpesvirus (KSHV) is a human gamma-herpesvirus. KSHV replication and transcription activator (RTA) is necessary and sufficient for KSHV reactivation from latency. Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns, act through adaptors, and initiate innate and adaptive immune responses against pathogens. Toll/interleukin-1-receptor domain containing adaptor protein inducing interferon-beta (TRIF) is an adaptor associated with TLR3 and TLR4 signaling, and is closely related to antiviral signaling to activate type I interferon (IFN) production. We previously found that KSHVRTA degrades TRIF indirectly and blocks TLR3 pathways. In this report, we find that TRIF, as well as TLR3 activation, enhances KSHVRTA protein expression. The C-terminal region of the RTA is involved in the responding TRIF-mediated enhancement. The degradation of TRIF and the enhancement of RTA expression are using two different pathways. The enhancement by TLR-TRIF is at least partially via promoting translational efficiency of RTA mRNA. Finally, the receptor-interacting protein 1 (RIP1) may be involved in TRIF-mediated enhancement of RTA expression, but not in the RTA-mediated degradation of TRIF. Therefore, the activation of TLR-TRIF pathway enhances KSHV RTA protein expression, and KSHV RTA in turn degrades TRIF to block innate immunity. The putative KSHV-TLR-adaptor-interacting loop may be a critical element to evade and usurp host innate immunity in KSHV life-cycle.	[Meyer, Florencia; Ehlers, Erica; Steadman, Andrew; Waterbury, Thomas; Cao, Mingxia; Zhang, Luwen] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA; [Zhang, Luwen] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Zhang, LW (corresponding author), Univ Nebraska, Sch Biol Sci, Nebraska Ctr Virol, Morrison Ctr 238, 4240 Fair St, Lincoln, NE 68583 USA.	lzhang2@unl.edu	Meyer, Florencia/V-3406-2019		National Institutes of Health [CA138213, RR15635]; Department of Defense-Army Medical Research [W81XWH-12-1-0225]; NATIONAL CANCER INSTITUTE [R01CA138213] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense-Army Medical Research(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by National Institutes of Health Grants CA138213, RR15635, and Grant W81XWH-12-1-0225 (to L. Z.) from the Department of Defense-Army Medical Research.	Ahmad H, 2011, J BIOL CHEM, V286, P7865, DOI 10.1074/jbc.M110.191452; Bourke E, 2003, BLOOD, V102, P956, DOI 10.1182/blood-2002-11-3355; Deng HY, 2002, BLOOD, V100, P1919, DOI 10.1182/blood-2002-01-0015; Dong XN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001001; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fitzner N, 2008, CLIN VACCINE IMMUNOL, V15, P138, DOI 10.1128/CVI.00257-07; Gais P, 2010, J IMMUNOL, V184, P5842, DOI 10.4049/jimmunol.0902456; Gargano LM, 2008, J VIROL, V82, P3853, DOI 10.1128/JVI.02577-07; Gargano LM, 2009, J VIROL, V83, P1474, DOI 10.1128/JVI.01717-08; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Gwack Y, 2002, J BIOL CHEM, V277, P6438, DOI 10.1074/jbc.M108289200; Gwack Y, 2001, J VIROL, V75, P6245, DOI 10.1128/JVI.75.13.6245-6248.2001; Gwack Y, 2001, J VIROL, V75, P1909, DOI 10.1128/JVI.75.4.1909-1917.2001; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Huye LE, 2007, MOL CELL BIOL, V27, P2910, DOI 10.1128/MCB.02256-06; Jiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001569; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Liao W, 2003, J VIROL, V77, P3809, DOI 10.1128/JVI.77.6.3809-3815.2003; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Moore P., 2001, VIROLOGY, P2803; Moore P S, 1998, J Natl Cancer Inst Monogr, P65; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; TAKEDA K, 2007, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1412S77; Valente RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043317; Wang SZ, 2001, J VIROL, V75, P11961, DOI 10.1128/JVI.75.24.11961-11973.2001; Wen HJ, 2010, J VIROL, V84, P7448, DOI 10.1128/JVI.00024-10; West J, 2008, J VIROL, V82, P5440, DOI 10.1128/JVI.02590-07; West JA, 2011, J VIROL, V85, P895, DOI 10.1128/JVI.01007-10; West JT, 2003, ONCOGENE, V22, P5150, DOI 10.1038/sj.onc.1206555; Woo CW, 2012, NAT CELL BIOL, V14, P192, DOI 10.1038/ncb2408; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Xu DS, 2008, J VIROL, V82, P6251, DOI 10.1128/JVI.00163-08; Xu DS, 2007, J VIROL, V81, P6068, DOI 10.1128/JVI.02743-06; Xu DS, 2006, J BIOL CHEM, V281, P9163, DOI 10.1074/jbc.M511884200; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang ZL, 2008, J VIROL, V82, P3590, DOI 10.1128/JVI.02229-07; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhang J, 2005, J VIROL, V79, P5640, DOI 10.1128/JVI.79.9.5640-5652.2005; Zhang J, 2004, J BIOL CHEM, V279, P46335, DOI 10.1074/jbc.M403966200; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhang LW, 2004, VIROLOGY, V323, P141, DOI 10.1016/j.virol.2004.03.007; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001; Zhang LW, 1999, MOL CELL BIOL, V19, P3216; Zhang LW, 2000, J VIROL, V74, P1061, DOI 10.1128/JVI.74.3.1061-1068.2000; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999	63	19	20	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20435	20442		10.1074/jbc.M113.487421	http://dx.doi.org/10.1074/jbc.M113.487421			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23723066	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000321715100031
J	Plitzko, B; Ott, G; Reichmann, D; Henderson, CJ; Wolf, CR; Mendel, R; Bittner, F; Clement, B; Havemeyer, A				Plitzko, Birte; Ott, Gudrun; Reichmann, Debora; Henderson, Colin J.; Wolf, C. Roland; Mendel, Ralf; Bittner, Florian; Clement, Bernd; Havemeyer, Antje			The Involvement of Mitochondrial Amidoxime Reducing Components 1 and 2 and Mitochondrial Cytochrome b(5) in N-Reductive Metabolism in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETOXIFICATION; HYDROXYLAMINE; PROTEIN; MARC; RAT; BENZAMIDOXIME; PURIFICATION; PEROXISOMES; ACTIVATION; EXPRESSION	The mitochondrial amidoxime reducing component mARC is a recently discovered molybdenum enzyme in mammals. mARC is not active as a standalone protein, but together with the electron transport proteins NADH-cytochrome b(5) reductase (CYB5R) and cytochrome b(5) (CYB5), it catalyzes the reduction of N-hydroxylated compounds such as amidoximes. The mARC-containing enzyme system is therefore considered to be responsible for the activation of amidoxime prodrugs. All hitherto analyzed mammalian genomes code for two mARC genes (also referred to as MOSC1 and MOSC2), which share high sequence similarities. By RNAi experiments in two different human cell lines, we demonstrate for the first time that both mARC proteins are capable of reducing N-hydroxylated substrates in cell metabolism. The extent of involvement is highly dependent on the expression level of the particular mARC protein. Furthermore, the mitochondrial isoform of CYB5 (CYB5B) is clearly identified as an essential component of the mARC-containing N-reductase system in human cells. The participation of the microsomal isoform (CYB5A) in N-reduction could be excluded by siRNA-mediated down-regulation in HEK-293 cells and knock-out in mice. Using heme-free apo-CYB5, the contribution of mitochondrial CYB5 to N-reductive catalysis was proven to strictly depend on heme. Finally, we created recombinant CYB5B variants corresponding to four nonsynonymous single nucleotide polymorphisms (SNPs). Investigated mutations of the heme protein seemed to have no significant impact on N-reductive activity of the reconstituted enzyme system.	[Plitzko, Birte; Ott, Gudrun; Clement, Bernd; Havemeyer, Antje] Univ Kiel, Inst Pharmaceut, Dept Pharmaceut & Med Chem, D-24118 Kiel, Germany; [Reichmann, Debora; Mendel, Ralf; Bittner, Florian] Braunschweig Univ Technol, Dept Plant Biol, D-38023 Braunschweig, Germany; [Henderson, Colin J.; Wolf, C. Roland] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Jacqui Wood Canc Ctr, Dundee DD1 9SY, Scotland	University of Kiel; Braunschweig University of Technology; University of Dundee	Havemeyer, A (corresponding author), Univ Kiel, Inst Pharmaceut, Dept Pharmaceut & Med Chem, Gutenbergstr 76, D-24118 Kiel, Germany.	ahavemeyer@pharmazie.uni-kiel.de	Henderson, Colin/AAE-7141-2019	Henderson, Colin/0000-0002-4764-639X; Wolf, Charles Roland/0000-0002-6969-0113	Deutsche Forschungsgemeinschaft (DFG) [CL56/9-1, ME 1266/24-1]; Cancer Research UK [10822] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cancer Research UK(Cancer Research UK)	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants CL56/9-1 and ME 1266/24-1.	Altuve A, 2001, BIOCHEMISTRY-US, V40, P9469, DOI 10.1021/bi010636i; Andersson S, 2005, DRUG METAB DISPOS, V33, P570, DOI 10.1124/dmd.104.002972; Aslibekyan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048663; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; BERNHEIM ML, 1972, ENZYMOLOGIA, V43, P167; BORGESE N, 1993, FEBS LETT, V325, P70, DOI 10.1016/0014-5793(93)81416-W; Clement B, 2005, DRUG METAB DISPOS, V33, P1740, DOI 10.1124/dmd.105.005249; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; DARRIGO A, 1993, J BIOL CHEM, V268, P2802; Estabrook R W, 1978, Methods Enzymol, V52, P212; Froriep D, 2013, XENOBIOTICA, V43, P780, DOI 10.3109/00498254.2013.767481; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Havemeyer A, 2011, DRUG METAB REV, V43, P524, DOI 10.3109/03602532.2011.608682; Havemeyer A, 2010, DRUG METAB DISPOS, V38, P1917, DOI 10.1124/dmd.110.032813; Hille R, 2011, COORDIN CHEM REV, V255, P1179, DOI 10.1016/j.ccr.2010.11.034; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; KADLUBAR FF, 1974, ARCH BIOCHEM BIOPHYS, V162, P83, DOI 10.1016/0003-9861(74)90107-6; Klein JM, 2012, J BIOL CHEM, V287, P42795, DOI 10.1074/jbc.M112.419424; Kotrbova V, 2009, PROTEIN EXPRES PURIF, V66, P203, DOI 10.1016/j.pep.2009.03.011; Kotthaus J, 2011, BIOCHEM J, V433, P383, DOI 10.1042/BJ20100960; Krompholz N, 2012, CHEM RES TOXICOL, V25, P2443, DOI 10.1021/tx300298m; Kurian JR, 2007, PHARMACOGENET GENOM, V17, P597, DOI 10.1097/FPC.0b013e328011aaff; Kurian JR, 2004, J PHARMACOL EXP THER, V311, P1171, DOI 10.1124/jpet.104.072389; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malik AN, 2007, BIOCHEM BIOPH RES CO, V357, P237, DOI 10.1016/j.bbrc.2007.03.132; McLaughlin LA, 2010, MOL PHARMACOL, V78, P269, DOI 10.1124/mol.110.064246; Mikula M, 2011, FUNCT INTEGR GENOMIC, V11, P215, DOI 10.1007/s10142-010-0200-5; Mulrooney SB, 2000, PROTEIN EXPRES PURIF, V19, P173, DOI 10.1006/prep.2000.1228; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; Rhoads K, 2011, TOXICOL SCI, V121, P245, DOI 10.1093/toxsci/kfr073; RodriguezMaranon MJ, 1996, BIOCHEMISTRY-US, V35, P16378, DOI 10.1021/bi961895o; Sacco JC, 2012, PHARMACOGENET GENOM, V22, P733, DOI 10.1097/FPC.0b013e328357a735; Sacco JC, 2010, PHARMACOGENET GENOM, V20, P26, DOI 10.1097/FPC.0b013e3283343296; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yamazaki H, 2001, J BIOL CHEM, V276, P30885, DOI 10.1074/jbc.M105011200	40	33	33	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20228	20237		10.1074/jbc.M113.474916	http://dx.doi.org/10.1074/jbc.M113.474916			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23703616	Green Published, hybrid			2022-12-28	WOS:000321715100012
J	Scott, SA; Xiang, Y; Mathews, TP; Cho, HP; Myers, DS; Armstrong, MD; Tallman, KA; O'Reilly, MC; Lindsley, CW; Brown, HA				Scott, Sarah A.; Xiang, Yun; Mathews, Thomas P.; Cho, Hyekyung P.; Myers, David S.; Armstrong, Michelle D.; Tallman, Keri A.; O'Reilly, Matthew C.; Lindsley, Craig W.; Brown, H. Alex			Regulation of Phospholipase D Activity and Phosphatidic Acid Production after Purinergic (P2Y(6)) Receptor Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; ADP-RIBOSYLATION FACTOR; FUNCTIONAL EXPRESSION; KINETIC-ANALYSIS; ACTIVATION; CLONING; ISOFORM; DESIGN; ALPHA; IDENTIFICATION	Phosphatidic acid (PA) is a lipid second messenger located at the intersection of several lipid metabolism and cell signaling events including membrane trafficking, survival, and proliferation. Generation of signaling PA has long been primarily attributed to the activation of phospholipase D (PLD). PLD catalyzes the hydrolysis of phosphatidylcholine into PA. A variety of both receptor-tyrosine kinase and G-protein-coupled receptor stimulations have been shown to lead to PLD activation and PA generation. This study focuses on profiling the PA pool upon P2Y(6) receptor signaling manipulation to determine the major PA producing enzymes. Here we show that PLD, although highly active, is not responsible for the majority of stable PA being produced upon UDP stimulation of the P2Y(6) receptor and that PA levels are tightly regulated. By following PA flux in the cell we show that PLD is involved in an initial increase in PA upon receptor stimulation; however, when PLD is blocked, the cell compensates by increasing PA production from other sources. We further delineate the P2Y(6) signaling pathway showing that phospholipase C beta 3 (PLC beta 3), PLC delta 1, DGK zeta and PLD are all downstream of receptor activation. We also show that DGK zeta is a novel negative regulator of PLD activity in this system that occurs through an inhibitory mechanism with PKC alpha. These results further define the downstream events resulting in PA production in the P2Y(6) receptor signaling pathway.	[Scott, Sarah A.; Xiang, Yun; Mathews, Thomas P.; Cho, Hyekyung P.; Myers, David S.; Armstrong, Michelle D.; Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Cho, Hyekyung P.; O'Reilly, Matthew C.; Lindsley, Craig W.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA; [Tallman, Keri A.; O'Reilly, Matthew C.; Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Lindsley, Craig W.; Brown, H. Alex] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Brown, HA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA.	alex.brown@vanderbilt.edu			National Institutes of Health Grants/Molecular Libraries Probe Production Centers Network [U54 MH084659, P01-ES013125, U54 069338, T32 MH093366]; McDonnell Foundation for Brain Cancer Research; NATIONAL CANCER INSTITUTE [T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES013125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH093366, U54MH084659] Funding Source: NIH RePORTER	National Institutes of Health Grants/Molecular Libraries Probe Production Centers Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McDonnell Foundation for Brain Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants/Molecular Libraries Probe Production Centers Network U54 MH084659, Grants P01-ES013125 and U54 069338, and Grant T32 MH093366 (postdoctoral training in CNS Drug Discovery Research (to T. P. M.). This work also supported in part by The McDonnell Foundation for Brain Cancer Research.	Berg KA, 2003, J PHARMACOL EXP THER, V304, P200, DOI 10.1124/jpet.102.042564; BILLAH MM, 1989, J BIOL CHEM, V264, P9069; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Bunting M, 1996, J BIOL CHEM, V271, P10230, DOI 10.1074/jbc.271.17.10230; Callender HL, 2007, ANAL CHEM, V79, P263, DOI 10.1021/ac061083q; Chalifa-Caspi V, 1998, NEUROCHEM RES, V23, P589, DOI 10.1023/A:1022422418388; Colley WC, 1997, CURR BIOL, V7, P191, DOI 10.1016/S0960-9822(97)70090-3; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; Communi D, 1995, J BIOL CHEM, V270, P30849, DOI 10.1074/jbc.270.52.30849; DAWSON RMC, 1967, BIOCHEM J, V102, P205, DOI 10.1042/bj1020205; Exton JH, 1997, J BIOL CHEM, V272, P15579, DOI 10.1074/jbc.272.25.15579; Exton JH, 1999, BBA-MOL CELL BIOL L, V1439, P121, DOI 10.1016/S1388-1981(99)00089-X; EXTON JH, 1990, J BIOL CHEM, V265, P1; FILTZ TM, 1994, MOL PHARMACOL, V46, P8; Foster DA, 2003, MOL CANCER RES, V1, P789; Freyberg Z, 2002, MOL BIOL CELL, V13, P3930, DOI 10.1091/mbc.02-04-0059; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Henage LG, 2006, J BIOL CHEM, V281, P3408, DOI 10.1074/jbc.M508800200; Hu TH, 2005, BIOCHEM BIOPH RES CO, V327, P1047, DOI 10.1016/j.bbrc.2004.12.117; Huang P, 2007, EXPERT OPIN THER TAR, V11, P707, DOI 10.1517/14728222.11.5.707; Ivanova PT, 2007, METHOD ENZYMOL, V432, P21, DOI 10.1016/S0076-6879(07)32002-8; Jiang Y, 2000, BIOCHEM PHARMACOL, V59, P763, DOI 10.1016/S0006-2952(99)00395-0; King BF, 1998, TRENDS PHARMACOL SCI, V19, P506, DOI 10.1016/S0165-6147(98)01271-1; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Lavieri R, 2009, BIOORG MED CHEM LETT, V19, P2240, DOI 10.1016/j.bmcl.2009.02.125; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lewis JA, 2009, BIOORG MED CHEM LETT, V19, P1916, DOI 10.1016/j.bmcl.2009.02.057; Lindsley CW, 2012, NEUROPSYCHOPHARMACOL, V37, P301, DOI 10.1038/npp.2011.178; Lundstrom K, 2009, METHODS MOL BIOL, V552, P51, DOI 10.1007/978-1-60327-317-6_4; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; Milne SB, 2010, NAT CHEM BIOL, V6, P205, DOI 10.1038/NCHEMBIO.311; Myers DS, 2011, BBA-MOL CELL BIOL L, V1811, P748, DOI 10.1016/j.bbalip.2011.05.015; Neary JT, 1999, J NEUROSCI, V19, P4211, DOI 10.1523/jneurosci.19-11-04211.1999; Nicholas RA, 1996, MOL PHARMACOL, V50, P224; Park SK, 1997, J BIOL CHEM, V272, P29263, DOI 10.1074/jbc.272.46.29263; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; Pettitt TR, 2001, BIOCHEM J, V360, P707, DOI 10.1042/0264-6021:3600707; PURKISS J, 1992, BIOCHEM PHARMACOL, V43, P1235, DOI 10.1016/0006-2952(92)90497-7; Ralevic V, 1998, PHARMACOL REV, V50, P413; RANDALL RW, 1990, FEBS LETT, V264, P87, DOI 10.1016/0014-5793(90)80772-B; Rincon E, 2012, PROG LIPID RES, V51, P1, DOI 10.1016/j.plipres.2011.10.001; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Seidler L, 1996, PHARMACOL TOXICOL, V78, P249, DOI 10.1111/j.1600-0773.1996.tb00213.x; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; SINGER WD, 1995, J BIOL CHEM, V270, P14944, DOI 10.1074/jbc.270.25.14944; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Steed P. M., 2001, Current Pharmaceutical Biotechnology, V2, P241, DOI 10.2174/1389201013378644; Su WJ, 2009, FUTURE ONCOL, V5, P1477, DOI [10.2217/fon.09.110, 10.2217/FON.09.110]; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Tallman KA, 2013, J LIPID RES, V54, P859, DOI 10.1194/jlr.D033332; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; von Kugelgen I, 2011, ADV PHARMACOL, V61, P373, DOI 10.1016/B978-0-12-385526-8.00012-6; Walker SJ, 2000, J BIOL CHEM, V275, P15665, DOI 10.1074/jbc.M000076200; Walker Stephanie J., 2003, V237, P89; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Yang CY, 2012, INT J BIOCHEM CELL B, V44, P1346, DOI 10.1016/j.biocel.2012.05.006; YANG SF, 1967, J BIOL CHEM, V242, P477; Ye Q, 2013, J MOL BIOL, V425, P755, DOI 10.1016/j.jmb.2012.11.035	61	16	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20477	20487		10.1074/jbc.M113.451708	http://dx.doi.org/10.1074/jbc.M113.451708			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23723068	Green Published, hybrid			2022-12-28	WOS:000321715100035
J	Takeuchi, K; Morizane, Y; Kamami-Levy, C; Suzuki, J; Kayama, M; Cai, WY; Miller, JW; Vavvas, DG				Takeuchi, Kimio; Morizane, Yuki; Kamami-Levy, Cynthia; Suzuki, Jun; Kayama, Maki; Cai, Wenyi; Miller, Joan W.; Vavvas, Demetrios G.			AMP-dependent Kinase Inhibits Oxidative Stress-induced Caveolin-1 Phosphorylation and Endocytosis by Suppressing the Dissociation between c-Abl and Prdx1 Proteins in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXAMIDE RIBONUCLEOTIDE AICAR; PAG GENE-PRODUCT; TYROSINE KINASE; GLUCOKINASE TRANSLOCATION; PHYSIOLOGICAL INHIBITOR; SRC KINASE; ACTIVATION; MICE; PERMEABILITY; PATHWAY	Caveolin-1 is the primary structural component of endothelial caveolae that is essential for transcellular trafficking of albumin and is also a critical scaffolding protein that regulates the activity of signaling molecules in caveolae. Phosphorylation of caveolin-1 plays a fundamental role in the mechanism of oxidant-induced vascular hyper permeability. However, the regulatory mechanism of caveolin-1 phosphorylation remains unclear. Here we identify a previously unexpected role for AMPK in inhibition of caveolin-1 phosphorylation under oxidative stress. A pharmacological activator of AMPK, 5-amino-4-imidazole carboxamide riboside (AICAR), inhibited oxidative stress-induced phosphorylation of both caveolin-1 and c-Abl, which is the major kinase of caveolin-1, and endocytosis of albumin in human umbilical vein endothelial cell. These effects were abolished by treatment with two specific inhibitors of AICAR, dipyridamole, and 5-iodotubericidin. Consistently, knockdown of the catalytic AMPK alpha subunit by siRNA abolished the inhibitory effect of AICAR on oxidant-induced phosphorylation of both caveolin-1 and c-Abl. Pretreatment with specific c-Abl inhibitor, imatinib mesylate, and knock down of c-Abl significantly decreased the caveolin-1 phosphorylation after H2O2 exposure and abolished the inhibitory effect of AICAR on the caveolin-1 phosphorylation. Interestingly, knockdown of Prdx-1, an antioxidant enzyme associated with c-Abl, increased phosphorylation of both caveolin-1 and c-Abl and abolished the inhibitory effect of AICAR on the caveolin-1 phosphorylation. Furthermore, co-immunoprecipitation experiment showed that AICAR suppressed the oxidant-induced dissociation between c-Abl and Prdx1. Overall, our results suggest that activation of AMPK inhibits oxidative stress-induced caveolin-1 phosphorylation and endocytosis, and this effect is mediated in part by stabilizing the interaction between c-Abl and Prdx-1.	[Takeuchi, Kimio; Morizane, Yuki; Kamami-Levy, Cynthia; Suzuki, Jun; Kayama, Maki; Cai, Wenyi; Miller, Joan W.; Vavvas, Demetrios G.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Retina Serv,Angiogenesis Lab,Dept Ophthalmol, Boston, MA 02114 USA; [Morizane, Yuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama 7008558, Japan	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Okayama University	Vavvas, DG (corresponding author), 243 Charles St, Boston, MA 02114 USA.	Demetrios_Vavvas@meei.harvard.edu		Vavvas, Demetrios/0000-0002-8622-6478; Kamami-Levy, Cynthia/0000-0002-5770-5269; Miller, Joan/0000-0003-2046-3996	National Institutes of Health [EY014104]; Research to Prevent Blindness Foundation; Lions Eye Research Fund; Fight for Sight Grant in Aid; Harvard Ophthalmology Department; Yeatts Family Fund; Bausch and Lomb Japan Vitreoretinal fellowship; NATIONAL EYE INSTITUTE [P30EY014104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Lions Eye Research Fund; Fight for Sight Grant in Aid; Harvard Ophthalmology Department; Yeatts Family Fund; Bausch and Lomb Japan Vitreoretinal fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant EY014104 (NEI). This work was also supported by an unrestricted grant to Massachusetts Eye and Ear Infirmary from the Research to Prevent Blindness Foundation (to D. G. V. and J. W. M.), the Lions Eye Research Fund (to D. G. V. and J. W. M.), the Fight for Sight Grant in Aid (to D. G. V.), the Harvard Ophthalmology Department (to D. G. V.), Yeatts Family Fund (to D. G. V. and J. W. M.), and a Bausch and Lomb Japan Vitreoretinal fellowship (to K. T., Y. M., J. S., and M. K.).	Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Bess E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020848; Cao HM, 2002, J BIOL CHEM, V277, P8771, DOI 10.1074/jbc.C100661200; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Ceolotto G, 2007, ARTERIOSCL THROM VAS, V27, P2627, DOI 10.1161/ATVBAHA.107.155762; Creighton J, 2011, FASEB J, V25, P3356, DOI 10.1096/fj.10-179218; Deng G, 2010, INT J OBESITY, V34, P165, DOI 10.1038/ijo.2009.205; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gayard M, 2011, ARTERIOSCL THROM VAS, V31, P2634, DOI 10.1161/ATVBAHA.111.228304; GLENNEY JR, 1992, P NATL ACAD SCI USA, V89, P10517, DOI 10.1073/pnas.89.21.10517; Goirand F, 2007, J PHYSIOL-LONDON, V581, P1163, DOI 10.1113/jphysiol.2007.132589; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Hagerkvist R, 2006, CELL BIOL INT, V30, P1013, DOI 10.1016/j.cellbi.2006.08.006; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hu GC, 2009, MICROVASC RES, V77, P21, DOI 10.1016/j.mvr.2008.10.002; Jeyabalan J, 2012, J ENDOCRINOL, V212, P277, DOI 10.1530/JOE-11-0306; Ko YG, 1998, J CELL BIOCHEM, V71, P524, DOI 10.1002/(SICI)1097-4644(19981215)71:4<524::AID-JCB7>3.3.CO;2-2; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kumar S, 2003, MOL PHARMACOL, V63, P276, DOI 10.1124/mol.63.2.276; Lassila M, 2004, ARTERIOSCL THROM VAS, V24, P935, DOI 10.1161/01.ATV.0000124105.39900.db; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minshall RD, 2003, AM J PHYSIOL-LUNG C, V285, pL1179, DOI 10.1152/ajplung.00242.2003; Morell M, 2007, PROTEOMICS, V7, P1023, DOI 10.1002/pmic.200600966; Morizane Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199398; Mueller BA, 2009, CURR PHARM DESIGN, V15, P120, DOI 10.2174/138161209787002933; Mukhtar MH, 2008, AM J PHYSIOL-REG I, V294, pR766, DOI 10.1152/ajpregu.00593.2007; Prosperi MT, 1998, FEBS LETT, V423, P39, DOI 10.1016/S0014-5793(98)00057-X; Razani B, 2001, J BIOL CHEM, V276, P38121; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sanguinetti AR, 2003, CELL SIGNAL, V15, P289, DOI 10.1016/S0898-6568(02)00090-6; Sanz P, 2008, CURR PROTEIN PEPT SC, V9, P478, DOI 10.2174/138920308785915254; Sun SW, 2010, ACTA PHARMACOL SIN, V31, P1336, DOI 10.1038/aps.2010.87; Sun Y, 2011, METHODS MOL BIOL, V763, P303, DOI 10.1007/978-1-61779-191-8_21; Sun Y, 2009, CIRC RES, V105, P676, DOI 10.1161/CIRCRESAHA.109.201673; Suzuki J, 2012, INVEST OPHTH VIS SCI, V53, P4158, DOI 10.1167/iovs.11-9323; Suzuki J, 2011, INVEST OPHTH VIS SCI, V52, P6565, DOI 10.1167/iovs.11-7331; Theodoropoulou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052852; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Volonte D, 2001, J BIOL CHEM, V276, P8094, DOI 10.1074/jbc.M009245200; Wang F, 2013, TOXICOLOGY, V305, P10, DOI 10.1016/j.tox.2012.12.004; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wong CM, 2002, J BIOL CHEM, V277, P5385, DOI 10.1074/jbc.M106846200; Xing JJ, 2013, AM J PATHOL, V182, P1021, DOI 10.1016/j.ajpath.2012.11.022	52	38	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20581	20591		10.1074/jbc.M113.460832	http://dx.doi.org/10.1074/jbc.M113.460832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23723070	Green Published, hybrid			2022-12-28	WOS:000321715100044
J	Chehade, MH; Loiseau, L; Lombard, M; Pecqueur, L; Ismail, A; Smadja, M; Golinelli-Pimpaneau, B; Mellot-Draznieks, C; Hamelin, O; Aussel, L; Kieffer-Jaquinod, S; Labessan, N; Barras, F; Fontecave, M; Pierrel, F				Chehade, Mahmoud Hajj; Loiseau, Laurent; Lombard, Murielle; Pecqueur, Ludovic; Ismail, Alexandre; Smadja, Myriam; Golinelli-Pimpaneau, Beatrice; Mellot-Draznieks, Caroline; Hamelin, Olivier; Aussel, Laurent; Kieffer-Jaquinod, Sylvie; Labessan, Natty; Barras, Frederic; Fontecave, Marc; Pierrel, Fabien			ubiI, a New Gene in Escherichia coli Coenzyme Q Biosynthesis, Is Involved in Aerobic C5-hydroxylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYBENZOATE HYDROXYLASE; UBIQUINONE BIOSYNTHESIS; IDENTIFICATION; YEAST; DEFICIENCY; COMPLEXES; SUBSTRATE; MUTATION; KINASE; MUTANT	Coenzyme Q (ubiquinone or Q) is a redox-active lipid found in organisms ranging from bacteria to mammals in which it plays a crucial role in energy-generating processes. Q biosynthesis is a complex pathway that involves multiple proteins. In this work, we show that the uncharacterized conserved visC gene is involved in Q biosynthesis in Escherichia coli, and we have renamed it ubiI. Based on genetic and biochemical experiments, we establish that the UbiI protein functions in the C5-hydroxylation reaction. A strain deficient in ubiI has a low level of Q and accumulates a compound derived from the Q biosynthetic pathway, which we purified and characterized. We also demonstrate that UbiI is only implicated in aerobic Q biosynthesis and that an alternative enzyme catalyzes the C5-hydroxylation reaction in the absence of oxygen. We have solved the crystal structure of a truncated form of UbiI. This structure shares many features with the canonical FAD-dependent para-hydroxybenzoate hydroxylase and represents the first structural characterization of a monooxygenase involved in Q biosynthesis. Site-directed mutagenesis confirms that residues of the flavin binding pocket of UbiI are important for activity. With our identification of UbiI, the three monooxygenases necessary for aerobic Q biosynthesis in E. coli are known.	[Chehade, Mahmoud Hajj; Hamelin, Olivier; Pierrel, Fabien] CEA, Inst Rech Technol & Sci Vivant, Lab Chim & Biol Met, F-38054 Grenoble, France; [Chehade, Mahmoud Hajj; Hamelin, Olivier; Pierrel, Fabien] CNRS, UMR5249, F-38054 Grenoble, France; [Chehade, Mahmoud Hajj; Hamelin, Olivier; Pierrel, Fabien] Univ Grenoble 1, UMR5249, F-38041 Grenoble, France; [Loiseau, Laurent; Aussel, Laurent; Barras, Frederic] Aix Marseille Univ, Lab Chim Bacterienne, UMR7283, Inst Microbiol Mediterranee, F-13009 Marseille, France; [Lombard, Murielle; Pecqueur, Ludovic; Ismail, Alexandre; Smadja, Myriam; Golinelli-Pimpaneau, Beatrice; Mellot-Draznieks, Caroline; Labessan, Natty; Fontecave, Marc] CNRS, Coll France, FRE3488, Lab Chim Proc Biol, F-75005 Paris, France; [Kieffer-Jaquinod, Sylvie] Univ Grenoble 1, CEA, INSERM, Lab Biol Grande Echelle,U1038, F-38054 Grenoble 9, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Pierrel, F (corresponding author), CEA Grenoble, IRTSV, Lab Chim & Biol Met, Bat K,P272,17 Rue Martyrs, F-38054 Grenoble 9, France.	fabien.pierrel@cea.fr	Golinelli, Beatrice/ABB-8347-2021; Lombard, Murielle/E-4974-2019; PIERREL, Fabien/M-6016-2014	Golinelli, Beatrice/0000-0001-8248-4704; Lombard, Murielle/0000-0002-4775-3494; PIERREL, Fabien/0000-0003-2083-3002; Pecqueur, Ludovic/0000-0002-0396-699X; Barras, Frederic/0000-0003-3458-2574; Aussel, Laurent/0000-0001-5239-4556	Agence Nationale de la Recherche [JCJC SVSE 8-2011]; Sup'Biotech	Agence Nationale de la Recherche(French National Research Agency (ANR)); Sup'Biotech	This work was supported by Agence Nationale de la Recherche Grant JCJC SVSE 8-2011, Project pABACoQ (to F. P.) and Sup'Biotech (to A. I.).	ALEXANDER K, 1978, BIOCHEMISTRY-US, V17, P4750, DOI 10.1021/bi00615a024; ALEXANDER K, 1978, BIOCHEMISTRY-US, V17, P4745, DOI 10.1021/bi00615a023; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bentinger M, 2010, BIOCHEM BIOPH RES CO, V396, P74, DOI 10.1016/j.bbrc.2010.02.147; Boyd JM, 2011, J BACTERIOL, V193, P887, DOI 10.1128/JB.00730-10; CORRELL CC, 1992, SCIENCE, V258, P1604, DOI 10.1126/science.1280857; COX GB, 1969, J BACTERIOL, V99, P450, DOI 10.1128/JB.99.2.450-458.1969; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Gulmezian M, 2007, ARCH BIOCHEM BIOPHYS, V467, P144, DOI 10.1016/j.abb.2007.08.009; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hsu AY, 1996, BIOCHEMISTRY-US, V35, P9797, DOI 10.1021/bi9602932; Kwon O, 2000, FEMS MICROBIOL LETT, V186, P157, DOI 10.1016/S0378-1097(00)00134-8; Lagier-Tourenne C, 2008, AM J HUM GENET, V82, P661, DOI 10.1016/j.ajhg.2007.12.024; Lee PT, 1997, J BACTERIOL, V179, P1748, DOI 10.1128/jb.179.5.1748-1754.1997; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; NAKAHIGASHI K, 1992, J BACTERIOL, V174, P7352, DOI 10.1128/jb.174.22.7352-7359.1992; Nowicka B, 2010, BBA-BIOENERGETICS, V1797, P1587, DOI 10.1016/j.bbabio.2010.06.007; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; PALFEY BA, 1994, BIOCHEMISTRY-US, V33, P1545, DOI 10.1021/bi00172a035; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Poon WW, 2000, J BACTERIOL, V182, P5139, DOI 10.1128/JB.182.18.5139-5146.2000; Poon WW, 1999, J BIOL CHEM, V274, P21665, DOI 10.1074/jbc.274.31.21665; SCHREUDER HA, 1989, J MOL BIOL, V208, P679, DOI 10.1016/0022-2836(89)90158-7; Shestopalov AI, 1997, FEBS LETT, V404, P272, DOI 10.1016/S0014-5793(97)00143-9; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Xia CW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230532; Xie LTX, 2012, J BIOL CHEM, V287, P23571, DOI 10.1074/jbc.M112.360354; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009	31	33	35	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20085	20092		10.1074/jbc.M113.480368	http://dx.doi.org/10.1074/jbc.M113.480368			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23709220	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000321515800070
J	Floss, DM; Mrotzek, S; Klocker, T; Schroder, J; Grotzinger, J; Rose-John, S; Scheller, J				Floss, Doreen M.; Mrotzek, Simone; Kloecker, Tobias; Schroeder, Jutta; Groetzinger, Joachim; Rose-John, Stefan; Scheller, Juergen			Identification of Canonical Tyrosine-dependent and Non-canonical Tyrosine-independent STAT3 Activation Sites in the Intracellular Domain of the Interleukin 23 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; CYTOKINE; IL-23; CELLS; IL-12; ROLES; EXPRESSION; RESPONSES; IMMUNITY; ANTIBODY	Signaling of interleukin 23 (IL-23) via the IL-23 receptor (IL-23R) and the shared IL-12 receptor beta 1 (IL-12R beta 1) controls innate and adaptive immune responses and is involved in the differentiation and expansion of IL-17-producing CD4(+) T helper (T(H)17) cells. Activation of signal transducer and activator of transcription 3 (STAT3) appears to be the major signaling pathway of IL-23, and STAT binding sites were predicted in the IL-23R but not in the IL-12R beta 1 chain. Using site-directed mutagenesis and deletion variants of the murine and human IL-23R, we showed that the predicted STAT binding sites (pYXXQ; including Tyr-504 and Tyr-626 in murine IL-23R and Tyr-484 and Tyr-611 in human IL-23R) mediated STAT3 activation. Furthermore, we identified two uncommon STAT3 binding/activation sites within the murine IL-23R. First, the murine IL-23R carried the Y(542)PNFQ sequence, which acts as an unusual Src homology 2 (SH2) domain-binding protein activation site of STAT3. Second, we identified a non-canonical, phosphotyrosine-independent STAT3 activation motif within the IL-23R. A third predicted site, Tyr-416 in murine and Tyr-397 in human IL-23R, is involved in the activation of PI3K/Akt and the MAPK pathway leading to STAT3-independent proliferation of Ba/F3 cells upon stimulation with IL-23. In contrast to IL-6-induced short term STAT3 phosphorylation, cellular activation by IL-23 resulted in a slower but long term STAT3 phosphorylation, indicating that the IL-23R might not be a major target of negative feedback inhibition by suppressor of cytokine signaling (SOCS) proteins. In summary, we characterized IL-23-dependent signal transduction with a focus on STAT3 phosphorylation and identified canonical tyrosine-dependent and non-canonical tyrosine-independent STAT3 activation sites in the IL-23R.	[Floss, Doreen M.; Mrotzek, Simone; Kloecker, Tobias; Schroeder, Jutta; Scheller, Juergen] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany; [Groetzinger, Joachim; Rose-John, Stefan] Univ Kiel, Inst Biochem, Fac Med, D-24118 Kiel, Germany	Heinrich Heine University Dusseldorf; University of Kiel	Scheller, J (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fac Med, D-40225 Dusseldorf, Germany.	jscheller@uni-duesseldorf.de	Scheller, Jürgen/K-5290-2015; Rose-John, Stefan/A-7998-2010	Rose-John, Stefan/0000-0002-7519-3279	Deutsche Forschungsgemeinschaft (Bonn, Germany) [SCHE 907/2-1]; Forschungskommission of Heinrich-Heine-University Dusseldorf (Medical Faculty) [08/2011]	Deutsche Forschungsgemeinschaft (Bonn, Germany)(German Research Foundation (DFG)); Forschungskommission of Heinrich-Heine-University Dusseldorf (Medical Faculty)	This work was supported by Deutsche Forschungsgemeinschaft (Bonn, Germany) Grants SCHE 907/2-1 and by Forschungskommission of Heinrich-Heine-University Dusseldorf (Medical Faculty) Grant 08/2011.	Althoff K, 2001, BIOCHEM J, V353, P663, DOI 10.1042/0264-6021:3530663; Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; CASE RD, 1994, J BIOL CHEM, V269, P10467; Chen Z, 2006, P NATL ACAD SCI USA, V103, P8137, DOI 10.1073/pnas.0600666103; Cho ML, 2006, J IMMUNOL, V176, P5652, DOI 10.4049/jimmunol.176.9.5652; Cocco C, 2010, BLOOD, V116, P3887, DOI 10.1182/blood-2009-10-248245; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; de Paus RA, 2008, MOL IMMUNOL, V45, P3889, DOI 10.1016/j.molimm.2008.06.029; Demoulin JB, 1996, MOL CELL BIOL, V16, P4710; Dumoutier L, 2009, J BIOL CHEM, V284, P26377, DOI 10.1074/jbc.M109.007955; Eulenfeld R, 2012, EUR J CELL BIOL, V91, P486, DOI 10.1016/j.ejcb.2011.09.010; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Ketteler R, 2002, GENE THER, V9, P477, DOI 10.1038/sj.gt.3301653; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Li XX, 1997, MOL CELL BIOL, V17, P2048, DOI 10.1128/MCB.17.4.2048; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Naeger LK, 1999, J BIOL CHEM, V274, P1875, DOI 10.1074/jbc.274.4.1875; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Ohtani T, 2000, IMMUNITY, V12, P95, DOI 10.1016/S1074-7613(00)80162-4; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pidasheva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025038; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Sarin R, 2011, P NATL ACAD SCI USA, V108, P9560, DOI 10.1073/pnas.1017854108; STAHL N, 1995, SCIENCE, V267, P1349, DOI 10.1126/science.7871433; Suthaus J, 2010, MOL BIOL CELL, V21, P2797, DOI 10.1091/mbc.E10-03-0240; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Ward AC, 1999, BLOOD, V93, P113, DOI 10.1182/blood.V93.1.113.401k33_113_124; Wiederkehr-Adam M, 2003, J BIOL CHEM, V278, P16117, DOI 10.1074/jbc.M300261200; Yao BB, 1999, ARCH BIOCHEM BIOPHYS, V368, P147, DOI 10.1006/abbi.1999.1302; Zheng Y, 2011, BLOOD, V118, P156, DOI 10.1182/blood-2010-01-266320	53	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19386	19400		10.1074/jbc.M112.432153	http://dx.doi.org/10.1074/jbc.M112.432153			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23673666	hybrid, Green Published			2022-12-28	WOS:000321515800008
J	Arimori, T; Kawamoto, N; Shinya, S; Okazaki, N; Nakazawa, M; Miyatake, K; Fukamizo, T; Ueda, M; Tamada, T				Arimori, Takao; Kawamoto, Noriko; Shinya, Shoko; Okazaki, Nobuo; Nakazawa, Masami; Miyatake, Kazutaka; Fukamizo, Tamo; Ueda, Mitsuhiro; Tamada, Taro			Crystal Structures of the Catalytic Domain of a Novel Glycohydrolase Family 23 Chitinase from Ralstonia sp A-471 Reveals a Unique Arrangement of the Catalytic Residues for Inverting Chitin Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SEQUENCE SIMILARITIES; 2.0 ANGSTROM RESOLUTION; GOOSE-TYPE LYSOZYME; X-RAY-DIFFRACTION; GLYCOSYL HYDROLASES; HEVEA-BRASILIENSIS; ACTIVE-SITE; SUBSTRATE; COMPLEX; MECHANISMS	Chitinase C from Ralstonia sp. A-471 (Ra-ChiC) has a catalytic domain sequence similar to goose-type (G-type) lysozymes and, unlike other chitinases, belongs to glycohydrolase (GH) family 23. Using NMR spectroscopy, however, Ra-ChiC was found to interact only with the chitin dimer but not with the peptidoglycan fragment. Here we report the crystal structures of wild-type, E141Q, and E162Q of the catalytic domain of Ra-ChiC with or without chitin oligosaccharides. Ra-ChiC has a substrate-binding site including a tunnel-shaped cavity, which determines the substrate specificity. Mutation analyses based on this structural information indicated that a highly conserved Glu-141 acts as a catalytic acid, and that Asp-226 located at the roof of the tunnel activates a water molecule as a catalytic base. The unique arrangement of the catalytic residues makes a clear contrast to the other GH23 members and also to inverting GH19 chitinases.	[Arimori, Takao; Okazaki, Nobuo; Tamada, Taro] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Tokai, Ibaraki 3191195, Japan; [Kawamoto, Noriko; Nakazawa, Masami; Miyatake, Kazutaka; Ueda, Mitsuhiro] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka 5998531, Japan; [Shinya, Shoko; Fukamizo, Tamo] Kinki Univ, Dept Adv Biosci, Nara, Nara 6318505, Japan	Japan Atomic Energy Agency; Osaka Metropolitan University; Kindai University (Kinki University)	Tamada, T (corresponding author), Japan Atom Energy Agcy, Quantum Beam Sci Directorate, 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	tamada.taro@jaea.go.jp	Fukamizo, Tamo/AAY-7251-2020	Okazaki, Nobuo/0000-0003-3553-2894; Tamada, Taro/0000-0003-1419-8022; Arimori, Takao/0000-0002-6063-5572				Bokma E, 1997, FEBS LETT, V411, P161, DOI 10.1016/S0014-5793(97)00682-0; BOLLER T, 1983, PLANTA, V157, P22, DOI 10.1007/BF00394536; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Guerin DMA, 2002, J MOL BIOL, V316, P1061, DOI 10.1006/jmbi.2001.5404; HART PJ, 1995, J MOL BIOL, V248, P402, DOI 10.1006/jmbi.1995.0230; Helland R, 2009, CELL MOL LIFE SCI, V66, P2585, DOI 10.1007/s00018-009-0063-x; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOLM L, 1994, FEBS LETT, V340, P129, DOI 10.1016/0014-5793(94)80187-8; Huet J, 2008, BIOCHEMISTRY-US, V47, P8283, DOI 10.1021/bi800655u; IMOTO T, 1971, AGR BIOL CHEM TOKYO, V35, P1154, DOI 10.1080/00021369.1971.10860050; Iseli B, 1996, FEBS LETT, V382, P186, DOI 10.1016/0014-5793(96)00174-3; JEKEL PA, 1991, EUR J BIOCHEM, V200, P123, DOI 10.1111/j.1432-1033.1991.tb21057.x; Karlsen S, 1996, ACTA CRYSTALLOGR D, V52, P105, DOI 10.1107/S0907444995008468; Kawamura S, 2006, J BIOCHEM, V140, P75, DOI 10.1093/jb/mvj125; Kezuka Y, 2006, J MOL BIOL, V358, P472, DOI 10.1016/j.jmb.2006.02.013; Kim SK, 2005, CARBOHYD POLYM, V62, P357, DOI 10.1016/j.carbpol.2005.08.012; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; Monzingo AF, 1996, NAT STRUCT BIOL, V3, P133, DOI 10.1038/nsb0296-133; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muzzarelli RAA, 1999, EXS, V87, P293; Okazaki N, 2011, ACTA CRYSTALLOGR F, V67, P494, DOI 10.1107/S1744309111004751; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parsiegla G, 1998, EMBO J, V17, P5551, DOI 10.1093/emboj/17.19.5551; Petersen L, 2009, J PHYS CHEM B, V113, P7331, DOI 10.1021/jp811470d; Song HK, 1996, ACTA CRYSTALLOGR D, V52, P289, DOI 10.1107/S0907444995009061; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Synstad B, 2004, EUR J BIOCHEM, V271, P253, DOI 10.1046/j.1432-1033.2003.03923.x; Tamada T, 2004, ACTA CRYSTALLOGR D, V60, P13, DOI 10.1107/S0907444903020778; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tews I, 1997, J AM CHEM SOC, V119, P7954, DOI 10.1021/ja970674i; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ueda M, 2003, EUR J BIOCHEM, V270, P2513, DOI 10.1046/j.1432-1033.2003.03624.x; Ueda M, 2009, APPL MICROBIOL BIOT, V81, P1077, DOI 10.1007/s00253-008-1676-y; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; Watanabe T, 1999, MICROBIOL-SGM, V145, P3353, DOI 10.1099/00221287-145-12-3353; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Wohlkonig A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015388	45	26	29	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18696	18706		10.1074/jbc.M113.462135	http://dx.doi.org/10.1074/jbc.M113.462135			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658014	Green Published, hybrid			2022-12-28	WOS:000321335800006
J	Chemes, LB; Noval, MG; Sanchez, IE; de Prat-Gay, G				Chemes, Lucia B.; Noval, Maria G.; Sanchez, Ignacio E.; de Prat-Gay, Gonzalo			Folding of a Cyclin Box LINKING MULTITARGET BINDING TO MARGINAL STABILITY, OLIGOMERIZATION, AND AGGREGATION OF THE RETINOBLASTOMA TUMOR SUPPRESSOR AB POCKET DOMAIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P53 CORE DOMAIN; DIFFERENTIAL SCANNING CALORIMETRY; DNA-BINDING; MUTANT P53; CELL-CYCLE; THERMODYNAMIC STABILITY; FAMILIAL RETINOBLASTOMA; INCOMPLETE PENETRANCE; MOLTEN GLOBULE; WILD-TYPE	The retinoblastoma tumor suppressor (Rb) controls the proliferation, differentiation, and survival of cells in most eukaryotes with a role in the fate of stem cells. Its inactivation by mutation or oncogenic viruses is required for cellular transformation and eventually carcinogenesis. The high conservation of the Rb cyclin fold prompted us to investigate the link between conformational stability and ligand binding properties of the RbAB pocket domain. RbAB unfolding presents a three-state transition involving cooperative secondary and tertiary structure changes and a partially folded intermediate that can oligomerize. The first transition corresponds to unfolding of the metastable B subdomain containing the binding site for the LXCXE motif present in cellular and viral targets, and the second transition corresponds to the stable A subdomain. The low thermodynamic stability of RbAB translates into a propensity to rapidly oligomerize and aggregate at 37 degrees C (T-50 = 28 min) that is suppressed by human papillomavirus E7 and E2F peptide ligands, suggesting that Rb is likely stabilized in vivo through binding to target proteins. We propose that marginal stability and associated oligomerization may be conserved for function as a "hub" protein, allowing the formation of multiprotein complexes, which could constitute a robust mechanism to retain its cell cycle regulatory role throughout evolution. Decreased stability and oligomerization are shared with the p53 tumor suppressor, suggesting a link between folding and function in these two essential cell regulators that are inactivated in most cancers and operate within multitarget signaling pathways.	[Chemes, Lucia B.; Noval, Maria G.; de Prat-Gay, Gonzalo] Fdn Inst Leloir, Prot Struct Funct & Engn Lab, RA-1405 Buenos Aires, DF, Argentina; [Chemes, Lucia B.; Noval, Maria G.; de Prat-Gay, Gonzalo] Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina; [Chemes, Lucia B.; Sanchez, Ignacio E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Prot Physiol Lab, Buenos Aires, DF, Argentina; [Chemes, Lucia B.; Sanchez, Ignacio E.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Inst Quim Biol, Buenos Aires, DF, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	de Prat-Gay, G (corresponding author), Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Ave Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.	gpg@leloir.org.ar	Noval, Maria Gabriela/GLV-0239-2022	Chemes, Lucia Beatriz/0000-0003-0192-9906; Prat Gay, Gonzalo/0000-0001-5748-6863; Sanchez, Ignacio Enrique/0000-0003-4284-9013	Instituto Nacional de Cancer (Ministerio de Salud de la Nacion, Argentina); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); CONICET	Instituto Nacional de Cancer (Ministerio de Salud de la Nacion, Argentina); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by a grant for basic research from the Instituto Nacional de Cancer (Ministerio de Salud de la Nacion, Argentina).; Holds a postdoctoral fellowship from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET).; Holds a graduate fellowship from CONICET.	Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; Baker BM, 1996, BIOPHYS J, V71, P2049, DOI 10.1016/S0006-3495(96)79403-1; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Brockwell DJ, 2007, CURR OPIN STRUC BIOL, V17, P30, DOI 10.1016/j.sbi.2007.01.003; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Burke JR, 2012, GENE DEV, V26, P1156, DOI 10.1101/gad.189837.112; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Butler JS, 2006, PROTEIN SCI, V15, P2457, DOI 10.1110/ps.062324206; Butler JS, 2005, J MOL BIOL, V350, P906, DOI 10.1016/j.jmb.2005.05.060; Cao LH, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-55; Chemes LB, 2011, J MOL BIOL, V412, P267, DOI 10.1016/j.jmb.2011.07.015; Chemes LB, 2010, FEBS J, V277, P973, DOI 10.1111/j.1742-4658.2009.07540.x; Coschi C. H., 2010, GENES DEV; Cremades N, 2006, TRENDS BIOCHEM SCI, V31, P494, DOI 10.1016/j.tibs.2006.07.001; Cross FR, 2011, PHILOS T R SOC B, V366, P3532, DOI 10.1098/rstb.2011.0078; de Souza RF, 2010, BBA-GENE REGUL MECH, V1799, P302, DOI 10.1016/j.bbagrm.2009.10.006; DeGregori J, 2004, J CELL SCI, V117, P3411, DOI 10.1242/jcs.01189; Dick FA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-26; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Gast K, 2005, PROTEIN FOLDING HANDBOOK, P673, DOI 10.1002/9783527619498.ch19; GIBSON TJ, 1994, NUCLEIC ACIDS RES, V22, P946, DOI 10.1093/nar/22.6.946; Gidalevitz T, 2010, CURR OPIN STRUC BIOL, V20, P23, DOI 10.1016/j.sbi.2009.11.001; Grossmann JG, 2001, BIOCHEMISTRY-US, V40, P6267, DOI 10.1021/bi0028946; Gunbin KV, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-224; Gutzat R, 2012, TRENDS PLANT SCI, V17, P139, DOI 10.1016/j.tplants.2011.12.001; Han JH, 2007, NAT REV MOL CELL BIO, V8, P319, DOI 10.1038/nrm2144; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hassler M, 2007, MOL CELL, V28, P371, DOI 10.1016/j.molcel.2007.08.023; Hayashi F, 1998, BIOCHEMISTRY-US, V37, P7941, DOI 10.1021/bi9801098; Isaac CE, 2006, MOL CELL BIOL, V26, P3659, DOI 10.1128/MCB.26.9.3659-3671.2006; Ishimaru D, 2003, J MOL BIOL, V333, P443, DOI 10.1016/j.jmb.2003.08.026; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; Khoo KH, 2009, J BIOL CHEM, V284, P30974, DOI 10.1074/jbc.M109.033183; Kim HY, 1997, NAT STRUCT BIOL, V4, P390, DOI 10.1038/nsb0597-390; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; KRATZKE RA, 1994, ONCOGENE, V9, P1321; Lamber EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058463; Lee C, 2002, GENE DEV, V16, P3199, DOI 10.1101/gad.1046102; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; LEPOCK JR, 1992, BIOCHEMISTRY-US, V31, P12706, DOI 10.1021/bi00165a023; Lohmann DR, 1999, HUM MUTAT, V14, P283, DOI 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Natan E, 2011, J MOL BIOL, V409, P358, DOI 10.1016/j.jmb.2011.03.047; Nichols NM, 2002, BIOCHEMISTRY-US, V41, P170, DOI 10.1021/bi011736r; Noble MEM, 1997, TRENDS BIOCHEM SCI, V22, P482, DOI 10.1016/S0968-0004(97)01144-4; Otterson GA, 1999, AM J HUM GENET, V65, P1040, DOI 10.1086/302581; Park Y, 2008, CELL CYCLE, V7, P2384, DOI 10.4161/cc.6363; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Rodriguez-Larrea D, 2006, J MOL BIOL, V360, P715, DOI 10.1016/j.jmb.2006.05.009; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Sage J, 2012, GENE DEV, V26, P1409, DOI 10.1101/gad.193730.112; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Sastre-Garau X, 2011, PATHOL BIOL, V59, P127, DOI 10.1016/j.patbio.2010.07.007; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Silva JL, 2006, BBA-PROTEINS PROTEOM, V1764, P443, DOI 10.1016/j.bbapap.2005.11.012; Singh M, 2005, J BIOL CHEM, V280, P37868, DOI 10.1074/jbc.M504877200; Smal C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036457; Tang KS, 1999, J MOL BIOL, V285, P1869, DOI 10.1006/jmbi.1998.2420; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Valverde JR, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-53; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Witkiewicz AK, 2011, CELL CYCLE, V10, P2497, DOI 10.4161/cc.10.15.16776; Xiao SF, 2010, J MOL BIOL, V401, P274, DOI 10.1016/j.jmb.2010.05.070; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Zlotnick A, 1999, BIOCHEMISTRY-US, V38, P14644, DOI 10.1021/bi991611a	73	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18923	18938		10.1074/jbc.M113.467316	http://dx.doi.org/10.1074/jbc.M113.467316			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23632018	Green Published, hybrid			2022-12-28	WOS:000321335800030
J	Tagami, T; Yamashita, K; Okuyama, M; Mori, H; Yao, M; Kimura, A				Tagami, Takayoshi; Yamashita, Keitaro; Okuyama, Masayuki; Mori, Haruhide; Yao, Min; Kimura, Atsuo			Molecular Basis for the Recognition of Long-chain Substrates by Plant alpha-Glucosidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTASE-GLUCOAMYLASE; SUBSITE AFFINITIES; SPECIFICITY; SEEDS; CONSERVATION; PURIFICATION; FORMS	Sugar beet alpha-glucosidase (SBG), a member of glycoside hydrolase family 31, shows exceptional long-chain specificity, exhibiting higher k(cat)/K-m values for longer malto-oligosaccharides. However, its amino acid sequence is similar to those of other short chain-specific alpha-glucosidases. To gain structural insights into the long-chain substrate recognition of SBG, a crystal structure complex with the pseudotetrasaccharide acarbose was determined at 1.7 angstrom resolution. The active site pocket of SBG is formed by a (beta/alpha)(8) barrel domain and a long loop (N-loop) bulging from the N-terminal domain similar to other related enzymes. Two residues (Phe-236 and Asn-237) in the N-loop are important for the long-chain specificity. Kinetic analysis of an Asn-237 mutant enzyme and a previous study of a Phe-236 mutant enzyme demonstrated that these residues create subsites +2 and +3. The structure also indicates that Phe-236 and Asn-237 guide the reducing end of long substrates to subdomain b2, which is an additional element inserted into the (beta/alpha)(8) barrel domain. Subdomain b2 of SBG includes Ser-497, which was identified as the residue at subsite +4 by site-directed mutagenesis.	[Tagami, Takayoshi; Okuyama, Masayuki; Mori, Haruhide; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Yamashita, Keitaro; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Okuyama, M (corresponding author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9,Nishi 9, Sapporo, Hokkaido 0608589, Japan.	okuyama@abs.agr.hokudai.ac.jp; kimura@abs.agr.hokudai.ac.jp	yao, min/F-5287-2011; Okuyama, Masayuki/D-8739-2012; Mori, Haruhide/AAV-6374-2021; Mori, Haruhide/B-7777-2012; Tagami, Takayoshi/Q-3953-2019	yao, min/0000-0003-1687-5904; Okuyama, Masayuki/0000-0001-7013-6032; Mori, Haruhide/0000-0001-7346-9131; Yamashita, Keitaro/0000-0002-5442-7582; Tagami, Takayoshi/0000-0002-4004-1558				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHIBA S, 1979, AGR BIOL CHEM TOKYO, V43, P237, DOI 10.1080/00021369.1979.10863439; DeLano W.L, PYMOL MOL GRAPHICS S; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; HIZUKURI S, 1978, CARBOHYD RES, V63, P261, DOI 10.1016/S0008-6215(00)80950-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; IM H, 1995, CARBOHYD RES, V277, P145, DOI 10.1016/0008-6215(95)00212-C; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; Imperiali B, 1995, BIOORGAN MED CHEM, V3, P1565, DOI 10.1016/0968-0896(95)00142-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KITA A, 1991, AGR BIOL CHEM TOKYO, V55, P2327, DOI 10.1080/00021369.1991.10870952; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; MATSUI H, 1978, AGR BIOL CHEM TOKYO, V42, P1855, DOI 10.1080/00021369.1978.10863265; Nakai H, 2007, J BIOCHEM, V142, P491, DOI 10.1093/jb/mvm174; Nakai H, 2007, BIOCHIMIE, V89, P49, DOI 10.1016/j.biochi.2006.09.014; Okuyama M, 2005, ENZYME MICROB TECH, V37, P472, DOI 10.1016/j.enzmictec.2004.06.018; Quezada-Calvillo R, 2007, J NUTR, V137, P1725, DOI 10.1093/jn/137.7.1725; Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3; Sato F, 2005, BIOSCI BIOTECH BIOCH, V69, P1905, DOI 10.1271/bbb.69.1905; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; SUGIMOTO M, 1995, BIOSCI BIOTECH BIOCH, V59, P673, DOI 10.1271/bbb.59.673; Tagami T, 2013, BBA-PROTEINS PROTEOM, V1834, P329, DOI 10.1016/j.bbapap.2012.08.007; Tan KM, 2010, FASEB J, V24, P3939, DOI 10.1096/fj.10-156257; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Yu SK, 2008, IUBMB LIFE, V60, P798, DOI 10.1002/iub.125	33	66	67	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19296	19303		10.1074/jbc.M113.465211	http://dx.doi.org/10.1074/jbc.M113.465211			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23687304	Green Published, hybrid			2022-12-28	WOS:000321335800062
J	Basurto-Islas, G; Grundke-Iqbal, I; Tung, YC; Liu, F; Iqbal, K				Basurto-Islas, Gustavo; Grundke-Iqbal, Inge; Tung, Yunn Chyn; Liu, Fei; Iqbal, Khalid			Activation of Asparaginyl Endopeptidase Leads to Tau Hyperphosphorylation in Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; FOCAL CEREBRAL-ISCHEMIA; ABNORMAL HYPERPHOSPHORYLATION; OXIDATIVE STRESS; SET; LEGUMAIN; BRAIN; INHIBITORS; PHOSPHORYLATION; DEGRADATION	Neurofibrillary pathology of abnormally hyperphosphorylated Tau is a key lesion of Alzheimer disease and other tauopathies, and its density in the brain directly correlates with dementia. The phosphorylation of Tau is regulated by protein phosphatase 2A, which in turn is regulated by inhibitor 2, I-2(PP2A). In acidic conditions such as generated by brain ischemia and hypoxia, especially in association with hyperglycemia as in diabetes, I-2(PP2A) is cleaved by asparaginyl endopeptidase at Asn-175 into the N-terminal fragment (I-2(PP2A)) and the C-terminal fragment (I-2CTF). Both I-2NTF and I-2CTF are known to bind to the catalytic subunit of protein phosphatase 2A and inhibit its activity. Here we show that the level of activated asparaginyl endopeptidase is significantly increased, and this enzyme and I-2(PP2A) translocate, respectively, from neuronal lysosomes and nucleus to the cytoplasm where they interact and are associated with hyperphosphorylated Tau in Alzheimer disease brain. Asparaginyl endopeptidase from Alzheimer disease brain could cleave GST-I-2(PP2A), except when I-2(PP2A) was mutated at the cleavage site Asn-175 to Gln. Finally, an induction of acidosis by treatment with kainic acid or pH 6.0 medium activated asparaginyl endopeptidase and consequently produced the cleavage of I-2(PP2A), inhibition of protein phosphatase 2A, and hyperphosphorylation of Tau, and the knockdown of asparaginyl endopeptidase with siRNA abolished this pathway in SH-SY5Y cells. These findings suggest the involvement of brain acidosis in the etiopathogenesis of Alzheimer disease, and asparaginyl endopeptidase-I-2(PP2A)-protein phosphatase 2A-Tau hyperphosphorylation pathway as a therapeutic target.	[Basurto-Islas, Gustavo; Grundke-Iqbal, Inge; Tung, Yunn Chyn; Liu, Fei; Iqbal, Khalid] New York State Inst Basic Res Dev Disabil, Dept Neurochem, Staten Isl, NY 10314 USA	Institute for Basic Research in Developmental Disabilities	Iqbal, K (corresponding author), New York State Inst Basic Res Dev Disabil, Dept Neurochem, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	khalid.iqbal.ibr@gmail.com		Basurto-Islas, Gustavo/0000-0002-9401-140X	National Institutes of Health Grant [AG019158]; New York State Office of People with Developmental Disabilities; NATIONAL INSTITUTE ON AGING [R01AG019158] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Office of People with Developmental Disabilities; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG019158. This work was also supported by the New York State Office of People with Developmental Disabilities.	ADACHI Y, 1994, J BIOL CHEM, V269, P2258; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Andrade V, 2011, J HEPATOL, V55, P626, DOI 10.1016/j.jhep.2010.12.022; Arnaud L, 2011, FEBS LETT, V585, P2653, DOI 10.1016/j.febslet.2011.07.020; Back T, 2000, ANN NEUROL, V47, P485, DOI 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.3.CO;2-#; Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Bolognin S, 2012, ACTA NEUROPATHOL, V123, P133, DOI 10.1007/s00401-011-0908-x; Canela N, 2003, J BIOL CHEM, V278, P1158, DOI 10.1074/jbc.M207497200; Castellani RJ, 2004, AGEING RES REV, V3, P319, DOI 10.1016/j.arr.2004.01.002; CATALDO AM, 1990, BRAIN RES, V513, P181, DOI 10.1016/0006-8993(90)90456-L; CATALDO AM, 1991, P NATL ACAD SCI USA, V88, P10998, DOI 10.1073/pnas.88.24.10998; Chen JM, 2001, BIOL CHEM, V382, P777, DOI 10.1515/BC.2001.093; Chen JM, 2000, BIOCHEM J, V352, P327, DOI 10.1042/0264-6021:3520327; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Clerin V, 2008, ATHEROSCLEROSIS, V201, P53, DOI 10.1016/j.atherosclerosis.2008.01.016; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; Fang BY, 2010, INT J NEUROSCI, V120, P591, DOI 10.3109/00207454.2010.505353; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Gong CX, 2001, BRAIN RES PROTOC, V6, P134, DOI 10.1016/S1385-299X(00)00046-5; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; Graham JM, 2001, CURRENT PROTOCOLS CE, V3, P1; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Halfon S, 1998, FEBS LETT, V438, P114, DOI 10.1016/S0014-5793(98)01281-2; Iqbal K, 2005, ANN NEUROL, V58, P748, DOI 10.1002/ana.20639; Ishizaki T, 2010, J CEREBR BLOOD F MET, V30, P1756, DOI 10.1038/jcbfm.2010.39; Katayose Y, 2000, J BIOL CHEM, V275, P9209, DOI 10.1074/jbc.275.13.9209; Kreuzaler PA, 2011, NAT CELL BIOL, V13, P303, DOI 10.1038/ncb2171; Lam BD, 2012, CYTOM PART A, V81A, P81, DOI 10.1002/cyto.a.21153; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu C, 2003, CANCER RES, V63, P2957; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Manoury B, 1998, NATURE, V396, P695, DOI 10.1038/25379; Miura Y, 2010, BIOL PHARM BULL, V33, P22, DOI 10.1248/bpb.33.22; MORGAN JM, 1994, J PATHOL, V174, P301, DOI 10.1002/path.1711740410; Morita Y, 2007, FEBS LETT, V581, P1417, DOI 10.1016/j.febslet.2007.02.064; Ni DTN, 2003, J BIOL CHEM, V278, P38980, DOI 10.1074/jbc.M305930200; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Pirchl M, 2009, NEUROPSYCHIATRIE, V23, P187; Pivtoraiko VN, 2009, ANTIOXID REDOX SIGN, V11, P481, DOI [10.1089/ars.2008.2263, 10.1089/ARS.2008.2263]; Pratt MR, 2009, CHEM BIOL, V16, P1001, DOI 10.1016/j.chembiol.2009.07.011; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Tsujio I, 2005, FEBS LETT, V579, P363, DOI 10.1016/j.febslet.2004.11.097; TURK B, 1993, BIOCHEMISTRY-US, V32, P375, DOI 10.1021/bi00052a046; Wang JZ, 2007, EUR J NEUROSCI, V25, P59, DOI 10.1111/j.1460-9568.2006.05226.x; Wang XC, 2010, FASEB J, V24, P4420, DOI 10.1096/fj.10-158477; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Wu BH, 2010, J BIOL CHEM, V285, P1790, DOI 10.1074/jbc.M109.049064; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; YATES CM, 1990, J NEUROCHEM, V55, P1624, DOI 10.1111/j.1471-4159.1990.tb04948.x	57	76	76	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17495	17507		10.1074/jbc.M112.446070	http://dx.doi.org/10.1074/jbc.M112.446070			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640887	Green Published, hybrid			2022-12-28	WOS:000320380600041
J	Brown, NG; Chow, DC; Ruprecht, KE; Palzkill, T				Brown, Nicholas G.; Chow, Dar-Chone; Ruprecht, Kevin E.; Palzkill, Timothy			Identification of the beta-Lactamase Inhibitor Protein-II (BLIP-II) Interface Residues Essential for Binding Affinity and Specificity for Class A beta-Lactamases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-EXFOLIATUS SMF19; HOT-SPOTS; MODULAR ARCHITECTURE; DRUG DISCOVERY; BIOCHEMICAL-CHARACTERIZATION; STRUCTURAL BIOLOGY; IMMUNITY PROTEIN; ASSOCIATION; COMPLEX; TEM-1	The interactions between beta-lactamase inhibitory proteins (BLIPs) and beta-lactamases have been used as model systems to understand the principles of affinity and specificity in protein-protein interactions. The most extensively studied tight binding inhibitor, BLIP, has been characterized with respect to amino acid determinants of affinity and specificity for binding beta-lactamases. BLIP-II, however, shares no sequence or structural homology to BLIP and is a femtomolar to picomolar potency inhibitor, and the amino acid determinants of binding affinity and specificity are unknown. In this study, alanine scanning mutagenesis was used in combination with determinations of on and off rates for each mutant to define the contribution of residues on the BLIP-II binding surface to both affinity and specificity toward four beta-lactamases of diverse sequence. The residues making the largest contribution to binding energy are heavily biased toward aromatic amino acids near the center of the binding surface. In addition, substitutions that reduce binding energy do so by increasing off rates without impacting on rates. Also, residues with large contributions to binding energy generally exhibit low temperature factors in the structures of complexes. Finally, with the exception of D206A, BLIP-II alanine substitutions exhibit a similar trend of effect for all beta-lactamases, i.e., a substitution that reduces affinity for one beta-lactamase usually reduces affinity for all beta-lactamases tested.	[Brown, Nicholas G.; Chow, Dar-Chone; Palzkill, Timothy] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Brown, Nicholas G.; Ruprecht, Kevin E.; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Palzkill, Timothy] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Palzkill, T (corresponding author), 1 Baylor Plaza, Houston, TX 77030 USA.	timothyp@bcm.tmc.edu		Brown, Nicholas/0000-0002-6141-0164	National Institutes of Health Grant [AI32956, 1 T90 DA022885-04]; Biomedical Discovery Training Program of the Gulf Coast Consortia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI032956, R01AI032956, R37AI032956] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022885] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Discovery Training Program of the Gulf Coast Consortia; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant AI32956 (to T. P.) and a training fellowship from the Biomedical Discovery Training Program of the Gulf Coast Consortia supported by National Institutes of Health Grant 1 T90 DA022885-04.	Alsallaq R, 2008, PROTEINS, V71, P320, DOI 10.1002/prot.21679; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Brown NG, 2010, PROTEIN ENG DES SEL, V23, P469, DOI 10.1093/protein/gzq017; Brown N. G., 2013, ANTIMICROB IN PRESS; Brown NG, 2011, J BIOL CHEM, V286, P32723, DOI 10.1074/jbc.M111.265058; Brown NG, 2010, J MOL BIOL, V404, P832, DOI 10.1016/j.jmb.2010.10.008; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; CURTIS MD, 1991, MOL MICROBIOL, V5, P2727, DOI 10.1111/j.1365-2958.1991.tb01981.x; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; DORAN JL, 1990, J BACTERIOL, V172, P4909, DOI 10.1128/jb.172.9.4909-4918.1990; Dutta S, 2010, J MOL BIOL, V398, P747, DOI 10.1016/j.jmb.2010.03.058; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Gretes M, 2009, J MOL BIOL, V389, P289, DOI 10.1016/j.jmb.2009.03.058; Guruprasad K, 2004, INT J BIOL MACROMOL, V34, P55, DOI 10.1016/j.ijbiomac.2004.03.003; Hadjebi O, 2008, BBA-MOL CELL RES, V1783, P1467, DOI 10.1016/j.bbamcr.2008.03.015; Hanes MS, 2011, PROTEINS, V79, P1267, DOI 10.1002/prot.22961; Hanes MS, 2009, BIOCHEMISTRY-US, V48, P9185, DOI 10.1021/bi9007963; Ishii Y, 2007, INT J ANTIMICROB AG, V29, P159, DOI 10.1016/j.ijantimicag.2006.09.005; Janin J, 1997, PROTEINS, V28, P153, DOI 10.1002/(SICI)1097-0134(199706)28:2<153::AID-PROT4>3.0.CO;2-G; Jubb H, 2012, TRENDS PHARMACOL SCI, V33, P241, DOI 10.1016/j.tips.2012.03.006; Kang SG, 2000, J BIOL CHEM, V275, P16851; Kuhlmann UC, 2000, J MOL BIOL, V301, P1163, DOI 10.1006/jmbi.2000.3945; Kuzu G, 2012, CURR OPIN STRUC BIOL, V22, P367, DOI 10.1016/j.sbi.2012.04.004; Lim D, 2001, NAT STRUCT BIOL, V8, P848, DOI 10.1038/nsb1001-848; Materon IC, 2003, ANTIMICROB AGENTS CH, V47, P2040, DOI 10.1128/AAC.47.6.2040-2042.2003; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Park HU, 1998, MICROBIOL-SGM, V144, P2161, DOI 10.1099/00221287-144-8-2161; Petrosino J, 1999, J BIOL CHEM, V274, P2394, DOI 10.1074/jbc.274.4.2394; Potapov V, 2008, J MOL BIOL, V384, P109, DOI 10.1016/j.jmb.2008.08.078; Reichmann D, 2007, J MOL BIOL, V365, P663, DOI 10.1016/j.jmb.2006.09.076; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Scott DE, 2013, CHEMBIOCHEM, V14, P332, DOI 10.1002/cbic.201200521; Stachyra T, 2009, J ANTIMICROB CHEMOTH, V64, P326, DOI 10.1093/jac/dkp197; STRYNADKA NCJ, 1994, NATURE, V368, P657, DOI 10.1038/368657a0; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P290, DOI 10.1038/nsb0396-290; Surade S, 2012, CHEM BIOL, V19, P42, DOI 10.1016/j.chembiol.2011.12.013; Thiel P, 2012, ANGEW CHEM INT EDIT, V51, P2012, DOI 10.1002/anie.201107616; Thompson J.D., 2002, CURRENT PROTOCOLS BI; Wang JH, 2007, J BIOL CHEM, V282, P17676, DOI 10.1074/jbc.M611548200; Yuan J, 2011, J MOL BIOL, V406, P730, DOI 10.1016/j.jmb.2011.01.014; Yuan J, 2009, J MOL BIOL, V389, P401, DOI 10.1016/j.jmb.2009.04.028; Zhang Z, 2004, J BIOL CHEM, V279, P42860, DOI 10.1074/jbc.M406157200; Zhang Z, 2003, J BIOL CHEM, V278, P45706, DOI 10.1074/jbc.M308572200; Zhou HX, 1997, BIOPHYS J, V73, P2441, DOI 10.1016/S0006-3495(97)78272-9	51	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17156	17166		10.1074/jbc.M113.463521	http://dx.doi.org/10.1074/jbc.M113.463521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625930	Green Published, hybrid			2022-12-28	WOS:000320380600013
J	Gaitonde, P; Ramakrishnan, R; Chin, J; Kelleher, RJ; Bankert, RB; Balu-Iyer, SV				Gaitonde, Puneet; Ramakrishnan, Radha; Chin, Jamie; Kelleher, Raymond J., Jr.; Bankert, Richard B.; Balu-Iyer, Sathy V.			Exposure to Factor VIII Protein in the Presence of Phosphatidylserine Induces Hypo-responsiveness toward Factor VIII Challenge in Hemophilia A Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLEROGENIC DENDRITIC CELLS; REGULATORY T-CELL; TGF-BETA; TOLERANCE; INHIBITORS; IMMUNITY; MECHANISMS; THERAPY	Administration of recombinant factor VIII (FVIII), an important co-factor in blood clotting cascade, elicits unwanted anti-FVIII antibodies in hemophilia A (HA) patients. Previously, FVIII associated with phosphatidylserine (PS) showed significant reduction in the anti-FVIII antibody response in HA mice. The reduction in the immune response to FVIII-PS could be due either to a failure of the immune system to recognize the antigen (i.e. immunological ignorance) or to an active induction of an antigen-specific nonresponsiveness (i.e. immunological tolerance). If it were a result of tolerance, one would predict that pre-exposure to FVIII-PS would render the mice hypo-responsive to a subsequent FVIII challenge. Here, we have demonstrated that naive HA mice that were pretreated with FVIII-PS showed a significantly reduced FVIII immune response to further challenge with native FVIII and that this decreased responsiveness could be adoptively transferred to other mice. An increase in number of FoxP3-expressing CD4(+) regulatory T-cells (Treg) was observed for the FVIII-PS-immunized group as compared with animals that received FVIII alone, suggesting the involvement of Treg in PS-mediated hypo-responsiveness. The PS-mediated reduction in antibody response was reversed by the co-administration of function-blocking anti-TGF-beta antibody with FVIII-PS. The decreased response to FVIII induced by FVIII-PS was determined to be antigen-specific because the immune response to another non-cross-reactive antigen (ovalbumin) was not altered. These results are consistent with the notion that FVIII-PS is tolerogenic and suggest that immunization with this tolerogenic form of the protein could be a useful treatment option to minimize immunogenicity of FVIII and other protein-based therapeutics.	[Gaitonde, Puneet; Ramakrishnan, Radha; Chin, Jamie; Balu-Iyer, Sathy V.] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14214 USA; [Kelleher, Raymond J., Jr.; Bankert, Richard B.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Balu-Iyer, SV (corresponding author), SUNY Buffalo, Dept Pharmaceut Sci, 359 Kapoor Hall, Buffalo, NY 14214 USA.	svb@buffalo.edu	Ramakrishnan, Radha/AAC-2464-2020		National Institutes of Health [R01 HL-70227]; NATIONAL CANCER INSTITUTE [R01CA131407, R01CA108970] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070227] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL-70227 (to S. V. B.).	Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gaitonde P, 2011, CLIN IMMUNOL, V138, P135, DOI 10.1016/j.clim.2010.10.006; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lollar P, 2001, ADV EXP MED BIOL, V489, P65; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Purohit VS, 2005, J BIOL CHEM, V280, P17593, DOI 10.1074/jbc.M500163200; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Ramani K, 2008, J PHARM SCI-US, V97, P1386, DOI 10.1002/jps.21102; Skupsky J, 2010, CURR OPIN MOL THER, V12, P509; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Su RJ, 2011, MOL THER, V19, P1896, DOI 10.1038/mt.2011.134; Sule G, 2012, HUM GENE THER, V23, P769, DOI 10.1089/hum.2011.225; VERBRUGGEN B, 1995, THROMB HAEMOSTASIS, V73, P247; Wan YY, 2008, J CLIN IMMUNOL, V28, P647, DOI 10.1007/s10875-008-9251-y; Waters B, 2009, J THROMB HAEMOST, V7, P1446, DOI 10.1111/j.1538-7836.2009.03538.x; Wiestner A, 2002, BLOOD, V100, P3426, DOI 10.1182/blood-2002-03-0765; Zhang AH, 2011, BLOOD, V117, P2223, DOI 10.1182/blood-2010-06-293324	20	22	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17051	17056		10.1074/jbc.C112.396325	http://dx.doi.org/10.1074/jbc.C112.396325			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23649621	Green Published, hybrid			2022-12-28	WOS:000320380600001
J	Wang, YJ; Shankar, SR; Kher, D; Ling, BMT; Taneja, R				Wang, Yaju; Shankar, Shilpa Rani; Kher, Devaki; Ling, Belinda Mei Tze; Taneja, Reshma			Sumoylation of the Basic Helix-Loop-Helix Transcription Factor Sharp-1 Regulates Recruitment of the Histone Methyltransferase G9a and Function in Myogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; SUMO MODIFICATION; EXPRESSION; REPRESSION; PROTEINS; INHIBITION; UBIQUITIN; DEC2	Sumoylation is an important post-translational modification that alters the activity of many transcription factors. However, the mechanisms that link sumoylation to alterations in chromatin structure, which culminate in tissue specific gene expression, are not fully understood. In this study, we demonstrate that SUMO modification of the transcription factor Sharp-1 is required for its full transcriptional repression activity and function as an inhibitor of skeletal muscle differentiation. Sharp-1 is modified by sumoylation at two conserved lysine residues 240 and 255. Mutation of these SUMO acceptor sites in Sharp-1 does not impact its subcellular localization but attenuates its ability to act as a transcriptional repressor and inhibit myogenic differentiation. Consistently, co-expression of the SUMO protease SENP1 with wild type Sharp-1 abrogates Sharp-1-dependent inhibition of myogenesis. Interestingly, sumoylation acts as a signal for recruitment of the co-repressor G9a. Thus, enrichment of G9a, and histone H3 lysine 9 dimethylation (H3K9me2), a signature of G9a activity, is dramatically reduced at muscle promoters in cells expressing sumoylation-defective Sharp-1. Our findings demonstrate how sumoylation of Sharp-1 exerts an impact on chromatin structure and transcriptional repression of muscle gene expression through recruitment of G9a.	[Wang, Yaju; Shankar, Shilpa Rani; Kher, Devaki; Ling, Belinda Mei Tze; Taneja, Reshma] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore	National University of Singapore	Taneja, R (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.	phsrt@nus.edu.sg	Taneja, Reshma/F-9658-2014	Taneja, Reshma/0000-0002-2151-2094; Reshma, Taneja/0000-0001-6214-6177	Singapore Ministry of Health National Medical Research Council Exploratory/Development grant	Singapore Ministry of Health National Medical Research Council Exploratory/Development grant	This work was supported by the Singapore Ministry of Health National Medical Research Council Exploratory/Development grant (to R.T.). Both authors contributed equally to this work.	Azmi S, 2004, J BIOL CHEM, V279, P52643, DOI 10.1074/jbc.M409188200; Azmi S, 2003, J BIOL CHEM, V278, P20098, DOI 10.1074/jbc.M210427200; Azmi S, 2002, MECH DEVELOP, V114, P181, DOI 10.1016/S0925-4773(02)00049-7; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Fujimoto K, 2001, BIOCHEM BIOPH RES CO, V280, P164, DOI 10.1006/bbrc.2000.4133; Fujimoto K, 2007, INT J MOL MED, V19, P925; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2003, CURR OPIN GENET DEV, V13, P108, DOI 10.1016/S0959-437X(03)00021-2; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Gregoire S, 2005, MOL CELL BIOL, V25, P2273, DOI 10.1128/MCB.25.6.2273-2287.2005; Gulbagci NT, 2009, EMBO REP, V10, P79, DOI 10.1038/embor.2008.207; Gupta V, 2006, BIOCHEM BIOPH RES CO, V345, P74, DOI 10.1016/j.bbrc.2006.03.232; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Lee MB, 2005, MOL CELL BIOL, V25, P1879, DOI 10.1128/MCB.25.5.1879-1890.2005; Li YX, 2002, BIOCHEM J, V367, P413, DOI 10.1042/BJ20020514; Ling BMT, 2012, MOL BIOL CELL, V23, P4778, DOI 10.1091/mbc.E12-04-0311; Ling BMT, 2012, P NATL ACAD SCI USA, V109, P841, DOI 10.1073/pnas.1111628109; Luan ZD, 2013, CELL MOL LIFE SCI, V70, P1793, DOI 10.1007/s00018-012-1220-1; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Riquelme C, 2006, J CELL MOL MED, V10, P132, DOI 10.1111/j.1582-4934.2006.tb00295.x; Riquelme C, 2006, EXP CELL RES, V312, P2132, DOI 10.1016/j.yexcr.2006.03.016; Rossner MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002762; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sun Hong, 2007, Transl Oncogenomics, V2, P107; Wang JP, 2012, INT J NUMER ANAL MOD, V9, P1; Wang YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043137; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7	32	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17654	17662		10.1074/jbc.M113.463257	http://dx.doi.org/10.1074/jbc.M113.463257			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23637228	Green Published, hybrid			2022-12-28	WOS:000320380600056
J	Wiseman, SL; Shimizu, Y; Palfrey, C; Nairn, AC				Wiseman, Shari L.; Shimizu, Yoshio; Palfrey, Clive; Nairn, Angus C.			Proteasomal Degradation of Eukaryotic Elongation Factor-2 Kinase (EF2K) Is Regulated by cAMP-PKA Signaling and the SCF beta TRCP Ubiquitin E3 Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; TRANSLATIONAL CONTROL; MTOR INHIBITOR; PC12 CELLS; FACTOR-II; PHOSPHORYLATION; MEMORY; ACTIVATION; DEPTOR; GROWTH	Protein translation and degradation are critical for proper protein homeostasis, yet it remains unclear how these processes are dynamically regulated, or how they may directly balance or synergize with each other. An important translational control mechanism is the Ca2+/calmodulin-dependent phosphorylation of eukaryotic elongation factor-2 (eEF-2) by eukaryotic elongation factor-2 kinase (EF2K), which inhibits elongation of nascent polypeptide chains during translation. We previously described a reduction of EF2K activity in PC12 cells treated with NGF or forskolin. Here, we show that both forskolin- and IGF-1-mediated reductions of EF2K activity in PC12 cells are due to decreased EF2K protein levels, and this is attenuated by application of the proteasome inhibitor, MG132. We further demonstrate that proteasome-mediated degradation of EF2K occurs in response to A2A-type adenosine receptor stimulation, and that activation of protein kinase A (PKA) or phospho-mimetic mutation of the previously characterized PKA site, Ser-499, were sufficient to induce EF2K turnover in PC12 cells. A similar EF2K degradation mechanism was observed in primary neurons and HEK cells. Expression of a dominant-negative form of Cul1 in HEK cells demonstrated that EF2K levels are regulated by an SCF-type ubiquitin E3 ligase. Specifically, EF2K binds to the F-box proteins, beta TRCP1 and beta TRCP2, and beta TRCP regulates EF2K levels and polyubiquitylation. We propose that the proteasomal degradation of EF2K provides a mechanistic link between activity-dependent protein synthesis and degradation.	[Wiseman, Shari L.; Nairn, Angus C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA; [Shimizu, Yoshio] Mannari Hosp, Dept Psychiat, Okayama 7000071, Japan; [Palfrey, Clive] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Yale University; University of Chicago	Nairn, AC (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 34 Pk St, New Haven, CT 06508 USA.	angus.nairn@yale.edu		Nairn, Angus/0000-0002-7075-0195; Wiseman, Shari/0000-0001-7868-9723	National Institutes of Health [DA018343, DA10044, 1F31 DA029361]; State of Connecticut, Department of Mental Health and Addiction Services; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343, F31DA029361, P01DA010044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut, Department of Mental Health and Addiction Services; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA018343 and DA10044 (to A. C. N.) and 1F31 DA029361 (to S. L. W.). Support was also obtained from the State of Connecticut, Department of Mental Health and Addiction Services.	Arora S, 2005, CANCER RES, V65, P3806, DOI 10.1158/0008-5472.CAN-04-4036; Artinian J, 2008, EUR J NEUROSCI, V27, P3009, DOI 10.1111/j.1460-9568.2008.06262.x; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; BRADY MJ, 1990, J NEUROCHEM, V54, P1034, DOI 10.1111/j.1471-4159.1990.tb02354.x; Browne GJ, 2004, J BIOL CHEM, V279, P12220, DOI 10.1074/jbc.M309773200; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Diggle TA, 2001, BIOCHEM J, V353, P621, DOI 10.1042/0264-6021:3530621; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; Kruiswijk F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002718; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; MACKIE KP, 1989, J BIOL CHEM, V264, P1748; Marin P, 1997, J NEUROSCI, V17, P3445; MITSUI K, 1993, J BIOL CHEM, V268, P13422; Nairn AC, 2001, PROG MOLEC, V27, P91; NAIRN AC, 1987, J BIOL CHEM, V262, P14265; PALFREY HC, 1987, J BIOL CHEM, V262, P9785; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; PICCIOTTO MR, 1992, J BIOL CHEM, V267, P12742; REDPATH NT, 1993, BIOCHEM J, V293, P31, DOI 10.1042/bj2930031; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Setoyama D, 2007, P NATL ACAD SCI USA, V104, P18001, DOI 10.1073/pnas.0706952104; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wiseman S. L., 2009, HDB CELL SIGNALING, P587; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029	39	13	14	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17803	17811		10.1074/jbc.M113.477182	http://dx.doi.org/10.1074/jbc.M113.477182			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640883	Green Published, hybrid			2022-12-28	WOS:000320380600069
J	Pracheil, T; Liu, ZC				Pracheil, Tammy; Liu, Zhengchang			Tiered Assembly of the Yeast Far3-7-8-9-10-11 Complex at the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-ASSOCIATED PROTEIN; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; GENETIC INTERACTIONS; SEXUAL DEVELOPMENT; NEUROSPORA-CRASSA; GCKIII PROTEINS; PHOSPHATASE 2A; GROWTH-CONTROL; FISSION YEAST	Target of rapamycin signaling is a conserved, essential pathway integrating nutritional cues with cell growth and proliferation. The target of rapamycin kinase exists in two distinct complexes, TORC1 and TORC2. It has been reported that protein phosphatase 2A (PP2A) and the Far3-7-8-9-10-11 complex (Far complex) negatively regulate TORC2 signaling in yeast. The Far complex, originally identified as factors required for pheromone-induced cell cycle arrest, and PP2A form the yeast counterpart of the STRIPAK complex, which was first isolated in mammals. The cellular localization of the Far complex has yet to be fully characterized. Here, we show that the Far complex localizes to the endoplasmic reticulum (ER) by analyzing functional GFP-tagged Far proteins in vivo. We found that Far9 and Far10, two homologous proteins each with a tail-anchor domain, localize to the ER in mutant cells lacking the other Far complex components. Far3, Far7, and Far8 form a subcomplex, which is recruited to the ERby Far9/10. The Far3-7-8-complex in turn recruits Far11 to the ER. Finally, we show that the tail-anchor domain of Far9 is required for its optimal function in TORC2 signaling. Our study reveals tiered assembly of the yeast Far complex at the ER and a function for Far complex's ER localization in TORC2 signaling.	[Pracheil, Tammy; Liu, Zhengchang] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA	University of Louisiana System; University of New Orleans	Liu, ZC (corresponding author), Univ New Orleans, Dept Biol Sci, 2000 Lakeshore Dr, New Orleans, LA 70148 USA.	zliu5@uno.edu			National Institutes of Health [1R15GM094772-01A1]; State of Louisiana Board of Regents Grant [LEQSF(2008-11)-RD-A-31]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM094772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Louisiana Board of Regents Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R15GM094772-01A1. This work was also supported by State of Louisiana Board of Regents Grant LEQSF(2008-11)-RD-A-31.	Amberg DC., 2005, METHODS YEAST GENETI; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Bloemendal S, 2012, MOL MICROBIOL, V84, P310, DOI 10.1111/j.1365-2958.2012.08024.x; Bloemendal S, 2010, EUKARYOT CELL, V9, P1856, DOI 10.1128/EC.00186-10; Borgese N, 2011, BBA-BIOMEMBRANES, V1808, P937, DOI 10.1016/j.bbamem.2010.07.010; Byers JT, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-48; Ceccarelli DF, 2011, J BIOL CHEM, V286, P25056, DOI 10.1074/jbc.M110.213777; Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.e04-07-0564; FERGUSON B, 1994, CELL MOL BIOL RES, V40, P223; Fidalgo M, 2010, J CELL SCI, V123, P1274, DOI 10.1242/jcs.061341; Frost A, 2012, CELL, V149, P1339, DOI 10.1016/j.cell.2012.04.028; Fu C, 2011, EUKARYOT CELL, V10, P1100, DOI 10.1128/EC.05003-11; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Grand EK, 2004, GENE CHROMOSOME CANC, V40, P78, DOI 10.1002/gcc.20023; Guzzo RM, 2005, AM J PHYSIOL-HEART C, V288, pH1810, DOI 10.1152/ajpheart.01015.2004; Guzzo RM, 2004, BIOCHEM J, V381, P599, DOI 10.1042/BJ20031723; Guzzo RM, 2004, J CELL SCI, V117, P2271, DOI 10.1242/jcs.01079; Helliwell SB, 1998, GENETICS, V148, P99; Horecka J, 1996, GENETICS, V144, P905; Hou MC, 2000, CURR BIOL, V10, P619, DOI 10.1016/S0960-9822(00)00492-9; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; JAZWINSKI SM, 1990, METHOD ENZYMOL, V182, P154; Kamada Y, 2010, AUTOPHAGY, V6, P415, DOI 10.4161/auto.6.3.11390; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; Kemp HA, 2003, MOL CELL BIOL, V23, P1750, DOI 10.1128/MCB.23.5.1750-1763.2003; Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585; Lai FJ, 2011, FEMS YEAST RES, V11, P72, DOI 10.1111/j.1567-1364.2010.00691.x; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li XF, 2010, J BIOL CHEM, V285, P24099, DOI 10.1074/jbc.M110.128470; Lisa-Santamaria P, 2012, J BIOL CHEM, V287, P29636, DOI 10.1074/jbc.M112.344192; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Nader M, 2012, AM J PHYSIOL-HEART C, V302, pH1138, DOI 10.1152/ajpheart.00872.2011; Niles BJ, 2012, P NATL ACAD SCI USA, V109, P1536, DOI 10.1073/pnas.1117563109; Pracheil T, 2012, GENETICS, V190, P1325, DOI 10.1534/genetics.111.138305; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Sekito T, 2002, MOL BIOL CELL, V13, P795, DOI 10.1091/mbc.01-10-0473; Simonin AR, 2010, FUNGAL GENET BIOL, V47, P855, DOI 10.1016/j.fgb.2010.06.010; Singh NS, 2011, CURR BIOL, V21, P1968, DOI 10.1016/j.cub.2011.10.051; SPRAGUE GF, 1991, METHOD ENZYMOL, V194, P77; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wielowieyski PA, 2000, J BIOL CHEM, V275, P38474, DOI 10.1074/jbc.M007682200; Xiang QJ, 2002, GENETICS, V160, P169; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Zheng XJ, 2010, J CLIN INVEST, V120, P2795, DOI 10.1172/JCI39679	48	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16986	16997		10.1074/jbc.M113.451674	http://dx.doi.org/10.1074/jbc.M113.451674			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625923	Green Published, hybrid			2022-12-28	WOS:000320378900070
J	Oner, SS; Vural, A; Lanier, SM				Oner, Sukru S.; Vural, Ali; Lanier, Stephen M.			Translocation of Activator of G-protein Signaling 3 to the Golgi Apparatus in Response to Receptor Activation and Its Effect on the trans-Golgi Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; HETEROTRIMERIC G-PROTEINS; BETA-GAMMA COMPLEX; HEROIN-SEEKING BEHAVIOR; PLASMA-MEMBRANE; REGULATOR AGS3; INDEPENDENT ACTIVATORS; MEDIATED REGULATION; ALPHA-SUBUNITS; IMAGE-ANALYSIS	Group II activators of G-protein signaling play diverse functional roles through their interaction with G alpha(i), G alpha(t), and G alpha(o) via a G-protein regulatory (GPR) motif that serves as a docking site for G alpha-GDP. We recently reported the regulation of the AGS3-G alpha(i) signaling module by a cell surface, seven-transmembrane receptor. Upon receptor activation, AGS3 reversibly dissociates from the cell cortex, suggesting that it may function as a signal transducer with downstream signaling implications, and this question is addressed in the current report. In HEK-293 and COS-7 cells expressing the alpha(2A/D)-AR and G alpha(i3), receptor activation resulted in the translocation of endogenous AGS3 and AGS3-GFP from the cell cortex to a juxtanuclear region, where it co-localized with markers of the Golgi apparatus (GA). The agonist-induced translocation of AGS3 was reversed by the alpha(2)-AR antagonist rauwolscine. The TPR domain of AGS3 was required for agonist-induced translocation of AGS3 from the cell cortex to the GA, and the translocation was blocked by pertussis toxin pretreatment or by the phospholipase C beta inhibitor U73122. Agonist-induced translocation of AGS3 to the GA altered the functional organization and protein sorting at the trans-Golgi network. The regulated movement of AGS3 between the cell cortex and the GA offers unexpected mechanisms for modulating protein secretion and/or endosome recycling events at the trans-Golgi network.	[Oner, Sukru S.; Vural, Ali; Lanier, Stephen M.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA	Medical University of South Carolina	Lanier, SM (corresponding author), Med Univ S Carolina, Dept Pharmacol, 179 Ashley Ave, Charleston, SC 29425 USA.	lanier@musc.edu	Oner, Sukru/K-8032-2012	Oner, Sukru/0000-0002-8864-7356; Lanier, Stephen/0000-0002-2740-7607	National Institutes of Health [DA025896]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA025896 (to S. M. L.).	Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Anel AMD, 2005, J CELL BIOL, V169, P83, DOI 10.1083/jcb.200412089; Azpiazu I, 2006, CELL SIGNAL, V18, P1190, DOI 10.1016/j.cellsig.2005.09.007; Blumer JB, 2012, ACTA PHYSIOL, V204, P202, DOI 10.1111/j.1748-1716.2011.02327.x; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Chatterjee TK, 2000, J BIOL CHEM, V275, P24013, DOI 10.1074/jbc.M002082200; Chauhan S, 2012, BIOCHEM J, V446, P445, DOI 10.1042/BJ20111882; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; Anel AMD, 2007, BIOCHEM J, V406, P157, DOI 10.1042/BJ20070359; Doherty D, 2012, AM J HUM GENET, V90, P1088, DOI 10.1016/j.ajhg.2012.04.008; Garcia-Marcos M, 2011, MOL BIOL CELL, V22, P673, DOI 10.1091/mbc.E10-08-0738; Garcia-Marcos M, 2012, P NATL ACAD SCI USA, V109, P1961, DOI 10.1073/pnas.1120538109; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Giguere PM, 2012, J BIOL CHEM, V287, P31270, DOI 10.1074/jbc.M112.394379; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Groves B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008877; Hewavitharana T, 2012, CELL SIGNAL, V24, P25, DOI 10.1016/j.cellsig.2011.08.014; Hofler C, 2011, J NEUROSCI, V31, P11553, DOI 10.1523/JNEUROSCI.2072-11.2011; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jamora C, 1997, CELL, V91, P617, DOI 10.1016/S0092-8674(00)80449-3; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Klein RR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191783; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; Nadella R, 2010, J AM SOC NEPHROL, V21, P1275, DOI 10.1681/ASN.2009121224; Oner SS, 2013, J BIOL CHEM, V288, P3003, DOI 10.1074/jbc.M112.418467; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Pizzinat N, 2001, J BIOL CHEM, V276, P16601, DOI 10.1074/jbc.M007573200; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Regner KR, 2011, FASEB J, V25, P1844, DOI 10.1096/fj.10-169797; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Sato M, 2006, P NATL ACAD SCI USA, V103, P797, DOI 10.1073/pnas.0507467103; Sato M, 2011, J BIOL CHEM, V286, P17766, DOI 10.1074/jbc.M111.219816; Sato M, 2009, J BIOL CHEM, V284, P31431, DOI 10.1074/jbc.M109.014068; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHWANINGER R, 1992, J CELL BIOL, V119, P1077, DOI 10.1083/jcb.119.5.1077; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Vural A, 2010, MOL CELL BIOL, V30, P1528, DOI 10.1128/MCB.01018-09; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; WILSON BS, 1993, P NATL ACAD SCI USA, V90, P1681, DOI 10.1073/pnas.90.5.1681; Yamaguchi T, 2000, FEBS LETT, V470, P25, DOI 10.1016/S0014-5793(00)01284-9; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yao LN, 2006, P NATL ACAD SCI USA, V103, P7877, DOI 10.1073/pnas.0602661103; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	63	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 16	2013	288	33					24091	24103		10.1074/jbc.M112.444505	http://dx.doi.org/10.1074/jbc.M112.444505			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302NO	23770668	Green Published, hybrid			2022-12-28	WOS:000330611400045
J	Balasuriya, D; Goetze, TA; Barrera, NP; Stewart, AP; Suzuki, Y; Edwardson, JM				Balasuriya, Dilshan; Goetze, Tom A.; Barrera, Nelson P.; Stewart, Andrew P.; Suzuki, Yuki; Edwardson, J. Michael			alpha-Amino-3-hydroxy-5-methyl-4-isoxazole Propionic Acid (AMPA) and N-Methyl-D-aspartate (NMDA) Receptors Adopt Different Subunit Arrangements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atomic Force Microscopy; Cell Surface Receptor; Glutamate Receptors; Ionotropic (AMPA; NMDA); Protein Complexes; Single-particle Analysis	ATOMIC-FORCE MICROSCOPY; CRYSTAL-STRUCTURE; STOICHIOMETRY; REVEALS	Ionotropic glutamate receptors are widely distributed in the central nervous system and play a major role in excitatory synaptic transmission. All three ionotropic glutamate subfamilies (i.e. AMPA-type, kainate-type, and NMDA-type) assemble as tetramers of four homologous subunits. There is good evidence that both heteromeric AMPA and kainate receptors have a 2:2 subunit stoichiometry and an alternating subunit arrangement. Recent studies based on presumed structural homology have indicated that NMDA receptors adopt the same arrangement. Here, we use atomic force microscopy imaging of receptor-antibody complexes to show that whereas the GluA1/GluA2 AMPA receptor assembles with an alternating (i.e. 1/2/1/2) subunit arrangement, the GluN1/GluN2A NMDA receptor adopts an adjacent (i.e. 1/1/2/2) arrangement. We conclude that the two types of ionotropic glutamate receptor are built in different ways from their constituent subunits. This surprising finding necessitates a reassessment of the assembly of these important receptors.	[Balasuriya, Dilshan; Goetze, Tom A.; Stewart, Andrew P.; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Barrera, Nelson P.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Fisiol, Santiago, Chile; [Suzuki, Yuki] Kyoto Univ, Dept Chem, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	University of Cambridge; Pontificia Universidad Catolica de Chile; Kyoto University	Edwardson, JM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	jme1000@cam.ac.uk	Suzuki, Yuki/H-9950-2015; Goetze, Tom/I-1891-2013	Suzuki, Yuki/0000-0003-1848-0105; Barrera, Nelson/0000-0001-7825-1406	Wellcome Trust; Millennium Science Initiative [P10-035F, Fondecyt 1120169]; Jean Shanks Foundation; James Baird Fund of the University of Cambridge	Wellcome Trust(Wellcome TrustEuropean Commission); Millennium Science Initiative; Jean Shanks Foundation; James Baird Fund of the University of Cambridge	This work was supported in part by the Wellcome Trust (to J. M. E.), the Millennium Science Initiative P10-035F and Fondecyt 1120169 (to N. P. B.), the Jean Shanks Foundation (to A. P. S.), and the James Baird Fund of the University of Cambridge (to A. P. S.).	Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Barrera NP, 2005, P NATL ACAD SCI USA, V102, P12595, DOI 10.1073/pnas.0503253102; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Clayton A, 2009, J MOL BIOL, V392, P1125, DOI 10.1016/j.jmb.2009.07.082; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Lee CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017165; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Meddows E, 2001, J BIOL CHEM, V276, P18795, DOI 10.1074/jbc.M101382200; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P2053, DOI 10.1093/nar/gkp042; Papadakis M, 2004, J BIOL CHEM, V279, P14703, DOI 10.1074/jbc.M313446200; Qiu S, 2005, J BIOL CHEM, V280, P24923, DOI 10.1074/jbc.M413915200; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; Riou M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035134; Salussolia CL, 2011, J NEUROSCI, V31, P11295, DOI 10.1523/JNEUROSCI.5612-10.2011; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stroebel D, 2011, NEUROPHARMACOLOGY, V60, P151, DOI 10.1016/j.neuropharm.2010.07.003; Suzuki Y, 2013, J BIOL CHEM, V288, P778, DOI 10.1074/jbc.M112.422311; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510	27	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21987	10.1074/jbc.M113.469205	http://dx.doi.org/10.1074/jbc.M113.469205			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760273	hybrid, Green Published			2022-12-28	WOS:000328841900045
J	Arora, S; Bhardwaj, A; Singh, S; Srivastava, SK; McClellan, S; Nirodi, CS; Piazza, GA; Grizzle, WE; Owen, LB; Singh, AP				Arora, Sumit; Bhardwaj, Arun; Singh, Seema; Srivastava, Sanjeev K.; McClellan, Steven; Nirodi, Chaitanya S.; Piazza, Gary A.; Grizzle, William E.; Owen, Laurie B.; Singh, Ajay P.			An Undesired Effect of Chemotherapy GEMCITABINE PROMOTES PANCREATIC CANCER CELL INVASIVENESS THROUGH REACTIVE OXYGEN SPECIES-DEPENDENT, NUCLEAR FACTOR kappa B- AND HYPOXIA-INDUCIBLE FACTOR 1 alpha-MEDIATED UP-REGULATION OF CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CHEMOKINE RECEPTOR CXCR4; EXPRESSION; ACTIVATION; APOPTOSIS; PROTEIN; INHIBITION; RESISTANCE; GROWTH; AKT	Recently, we have shown that CXCL12/CXCR4 signaling plays an important role in gemcitabine resistance of pancreatic cancer (PC) cells. Here, we explored the effect of gemcitabine on this resistance mechanism. Our data demonstrate that gemcitabine induces CXCR4 expression in two PC cell lines (MiaPaCa and Colo357) in a dose- and time-dependent manner. Gemcitabine-induced CXCR4 expression is dependent on reactive oxygen species (ROS) generation because it is abrogated by pretreatment of PC cells with the free radical scavenger N-acetyl-L-cysteine. CXCR4 up-regulation by gemcitabine correlates with time-dependent accumulation of NF-kappa B and HIF-1 alpha in the nucleus. Enhanced binding of NF-kappa B and HIF-1 alpha to the CXCR4 promoter is observed in gemcitabine-treated PC cells, whereas their silencing by RNA interference causes suppression of gemcitabine-induced CXCR4 expression. ROS induction upon gemcitabine treatment precedes the nuclear accumulation of NF-kappa B and HIF-1 alpha, and suppression of ROS diminishes these effects. The effect of ROS on NF-kappa B and HIF-1 alpha is mediated through activation of ERK1/2 and Akt, and their pharmacological inhibition also suppresses gemcitabine-induced CXCR4 up-regulation. Interestingly, our data demonstrate that nuclear accumulation of NF-kappa B results from phosphorylation-induced degradation of I kappa B alpha, whereas HIF-1 alpha up-regulation is NF-kappa B-dependent. Lastly, our data demonstrate that gemcitabine-treated PC cells are more motile and exhibit significantly greater invasiveness against a CXCL12 gradient. Together, these findings reinforce the role of CXCL12/CXCR4 signaling in gemcitabine resistance and point toward an unintended and undesired effect of chemotherapy.	[Arora, Sumit; Bhardwaj, Arun; Singh, Seema; Srivastava, Sanjeev K.; McClellan, Steven; Nirodi, Chaitanya S.; Piazza, Gary A.; Owen, Laurie B.; Singh, Ajay P.] Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, Mobile, AL 36604 USA; [Grizzle, William E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Singh, Ajay P.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA	University of South Alabama; University of Alabama System; University of Alabama Birmingham; University of South Alabama	Singh, AP (corresponding author), Univ S Alabama, Dept Oncol Sci, Mitchell Canc Inst, 1660 Springhill Ave, Mobile, AL 36604 USA.	asingh@usouthal.edu	Singh, Ajay/AAF-4414-2020	Piazza, Gary/0000-0003-4418-887X; Singh, Ajay/0000-0003-3492-6330	NCI National Institutes of Health [CA167137, CA169829, CA129364]; Department of Defense/United States Army [PC110545]; University of South Alabama Mitchell Cancer Institute; NATIONAL CANCER INSTITUTE [R03CA169829, R21CA167137, P50CA101955, R01CA129364] Funding Source: NIH RePORTER	NCI National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense/United States Army; University of South Alabama Mitchell Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI National Institutes of Health Grants CA167137, CA169829, and CA129364. This work was also supported by Department of Defense/United States Army Grant PC110545 and the University of South Alabama Mitchell Cancer Institute.	Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Arora S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021573; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Calvani M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038388; Chua YL, 2010, J BIOL CHEM, V285, P31277, DOI 10.1074/jbc.M110.158485; Donadelli M, 2007, BBA-MOL CELL RES, V1773, P1095, DOI 10.1016/j.bbamcr.2007.05.002; Du J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025213, 10.1371/journal.pone.0026204]; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Fryer RA, 2011, ANTICANCER RES, V31, P3747; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; Jung SN, 2008, CARCINOGENESIS, V29, P713, DOI 10.1093/carcin/bgn032; Koshiba T, 2000, CLIN CANCER RES, V6, P3530; Long J, 2011, EXPERT OPIN THER TAR, V15, P817, DOI 10.1517/14728222.2011.566216; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Marchesi F, 2004, CANCER RES, V64, P8420, DOI 10.1158/0008-5472.CAN-04-1343; Marechal R, 2009, BRIT J CANCER, V100, P1444, DOI 10.1038/sj.bjc.6605020; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Oh YS, 2012, ONCOL REP, V28, P2239, DOI 10.3892/or.2012.2063; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Park KR, 2011, CANCER LETT, V312, P178, DOI 10.1016/j.canlet.2011.08.001; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; Singh S, 2010, BRIT J CANCER, V103, P1671, DOI 10.1038/sj.bjc.6605968; Sun HL, 2007, ONCOGENE, V26, P3941, DOI 10.1038/sj.onc.1210169; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Sung B, 2008, CANCER RES, V68, P8938, DOI 10.1158/0008-5472.CAN-08-2155; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Thomas RM, 2008, GUT, V57, P1555, DOI 10.1136/gut.2007.143941; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Voutsadakis IA, 2011, WORLD J GASTRO ONCOL, V3, P153, DOI 10.4251/wjgo.v3.i11.153; Wang ZW, 2011, NAT REV GASTRO HEPAT, V8, P27, DOI 10.1038/nrgastro.2010.188; Warsame R, 2012, EXPERT REV ANTICANC, V12, P1327, DOI [10.1586/ERA.12.115, 10.1586/era.12.115]; Wei YY, 2008, MOL CARCINOGEN, V47, P526, DOI 10.1002/mc.20411; Wong A, 2009, DRUG METAB REV, V41, P77, DOI 10.1080/03602530902741828; Wu CJ, 2011, TOXICOL IN VITRO, V25, P1834, DOI 10.1016/j.tiv.2011.09.024; Xiao HF, 2013, J AGR FOOD CHEM, V61, P1509, DOI 10.1021/jf3050268; Yokoi K, 2004, CLIN CANCER RES, V10, P2299, DOI 10.1158/1078-0432.CCR-03-0488; Zhao YP, 2006, J SURG RES, V136, P325, DOI 10.1016/j.jss.2006.06.031	42	118	121	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21197	21207		10.1074/jbc.M113.484576	http://dx.doi.org/10.1074/jbc.M113.484576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23740244	Green Published, hybrid			2022-12-28	WOS:000322014400039
J	Liu, ZH; Cai, TF; Zhu, Q; Deng, MC; Li, JY; Zhou, X; Zhang, F; Li, D; Li, J; Liu, Y; Hu, WJ; Liang, SP				Liu, Zhonghua; Cai, Tianfu; Zhu, Qi; Deng, Meichun; Li, Jiayan; Zhou, Xi; Zhang, Fan; Li, Dan; Li, Jing; Liu, Yu; Hu, Weijun; Liang, Songping			Structure and Function of Hainantoxin-III, a Selective Antagonist of Neuronal Tetrodotoxin-sensitive Voltage-gated Sodium Channels Isolated from the Chinese Bird Spider Ornithoctonus hainana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUWENTOXIN-IV; DOMAIN-II; PROTX-II; MOLECULAR-MECHANISMS; SECONDARY STRUCTURE; TARANTULA TOXINS; SCORPION TOXINS; RECEPTOR-SITE; CYSTINE KNOT; ACTIVATION	In the present study, we investigated the structure and function of hainantoxin-III (HNTX-III), a 33-residue polypeptide from the venom of the spider Ornithoctonus hainana. It is a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels. HNTX-III suppressed Nav1.7 current amplitude without significantly altering the activation, inactivation, and repriming kinetics. Short extreme depolarizations partially activated the toxin-bound channel, indicating voltage-dependent inhibition of HNTX-III. HNTX-III increased the deactivation of the Nav1.7 current after extreme depolarizations. The HNTX-III.Nav1.7 complex was gradually dissociated upon prolonged strong depolarizations in a voltage-dependent manner, and the unbound toxin rebound to Nav1.7 after a long repolarization. Moreover, analysis of chimeric channels showed that the DIIS3-S4 linker was critical for HNTX-III binding to Nav1.7. These data are consistent with HNTX-III interacting with Nav1.7 site 4 and trapping the domain II voltage sensor in the closed state. The solution structure of HNTX-III was determined by two-dimensional NMR and shown to possess an inhibitor cystine knot motif. Structural analysis indicated that certain basic, hydrophobic, and aromatic residues mainly localized in the C terminus may constitute an amphiphilic surface potentially involved in HNTX-III binding to Nav1.7. Taken together, our results show that HNTX-III is distinct from beta-scorpion toxins and other beta-spider toxins in its mechanism of action and binding specificity and affinity. The present findings contribute to our understanding of the mechanism of toxin-sodium channel interaction and provide a useful tool for the investigation of the structure and function of sodium channel isoforms and for the development of analgesics.	[Liu, Zhonghua; Cai, Tianfu; Zhu, Qi; Li, Jiayan; Zhou, Xi; Zhang, Fan; Li, Dan; Li, Jing; Hu, Weijun; Liang, Songping] Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China; [Deng, Meichun] Cent S Univ, Sch Life Sci, Dept Biochem, Changsha 410013, Hunan, Peoples R China; [Liu, Yu] Hunan Inst Sci & Technol, Coll Chem & Chem Engn, Yueyang 414006, Hunan, Peoples R China	Hunan Normal University; Central South University; Hunan Institute of Science & Technology	Liu, ZH (corresponding author), Hunan Normal Univ, Coll Life Sci, Changsha 410081, Hunan, Peoples R China.	liuzh@hunnu.edu.cn; liangsp@hunnu.edu.cn			National Basic Research Program of China (973 Program) [2010CB529801, 2012CB22305]; National Science Foundation [31070699, 31170746, 31100764]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by National Basic Research Program of China (973 Program) Grants 2010CB529801 and 2012CB22305 (to S. L.) and National Science Foundation Projects 31070699 and 31170746 (to Z. L.) and 31100764 (to M. D.).	Billen B, 2008, CURR PHARM DESIGN, V14, P2492, DOI 10.2174/138161208785777423; Billen B, 2010, J BIOL CHEM, V285, P18545, DOI 10.1074/jbc.M110.125211; Bosmans F, 2006, MOL PHARMACOL, V69, P419, DOI 10.1124/mol.105.015941; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Cestele S, 2000, BIOCHIMIE, V82, P883, DOI 10.1016/S0300-9084(00)01174-3; Choudhary G, 2007, CHANNELS, V1, P344, DOI 10.4161/chan.5112; Cohen L, 2005, J BIOL CHEM, V280, P5045, DOI 10.1074/jbc.M408427200; Corzo G, 2007, J BIOL CHEM, V282, P4643, DOI 10.1074/jbc.M605403200; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Dubin AE, 2010, J CLIN INVEST, V120, P3760, DOI 10.1172/JCI42843; Ekberg J, 2006, INT J BIOCHEM CELL B, V38, P2005, DOI 10.1016/j.biocel.2006.06.008; Escoubas P, 2009, EXPERT REV PROTEOMIC, V6, P221, DOI 10.1586/EPR.09.45; GRAY WR, 1993, PROTEIN SCI, V2, P1732, DOI 10.1002/pro.5560021017; GRAY WR, 1993, PROTEIN SCI, V2, P1749, DOI 10.1002/pro.5560021018; He QY, 2008, NUCLEIC ACIDS RES, V36, pD293, DOI 10.1093/nar/gkm832; He QZ, 2010, TOXICON, V56, P644, DOI 10.1016/j.toxicon.2010.05.013; Herzog RI, 2003, J PHYSIOL-LONDON, V551, P741, DOI 10.1113/jphysiol.2003.047357; Hu ZH, 1997, J PHYSIOL-LONDON, V501, P67, DOI 10.1111/j.1469-7793.1997.067bo.x; Kahn R, 2009, J BIOL CHEM, V284, P20684, DOI 10.1074/jbc.M109.021303; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Lee CH, 2008, CHANNELS, V2, P407, DOI 10.4161/chan.2.6.7429; Li DL, 2003, FEBS LETT, V555, P616, DOI 10.1016/S0014-5793(03)01303-6; Li DL, 2004, J BIOL CHEM, V279, P37734, DOI 10.1074/jbc.M405765200; Liu Y, 2012, J PEPT SCI, V18, P643, DOI 10.1002/psc.2451; Liu Z, 2003, CELL MOL LIFE SCI, V60, P972, DOI 10.1007/s00018-003-2354-x; Liu ZH, 2013, PROTEIN PEPTIDE LETT, V20, P761, DOI 10.2174/0929866511320070005; McDonough SI, 1997, MOL PHARMACOL, V52, P1095, DOI 10.1124/mol.52.6.1095; PALLAGHY PK, 1994, PROTEIN SCI, V3, P1833, DOI 10.1002/pro.5560031022; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Priest BT, 2007, TOXICON, V49, P194, DOI 10.1016/j.toxicon.2006.09.014; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Sokolov S, 2008, MOL PHARMACOL, V73, P1020, DOI 10.1124/mol.107.041046; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Tang X, 2010, J PROTEOME RES, V9, P2550, DOI 10.1021/pr1000016; Wang JT, 2011, P NATL ACAD SCI USA, V108, P15426, DOI 10.1073/pnas.1112320108; Wang MC, 2012, PEPTIDES, V34, P19, DOI 10.1016/j.peptides.2011.10.029; Wang W, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-16; Wilson M, 2011, J PETROL, V52, P1, DOI 10.1093/petrology/egq092; Wilson MJ, 2011, J PHARMACOL EXP THER, V338, P687, DOI 10.1124/jpet.110.178343; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEIN NUCL ACI; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Xiao YC, 2010, MOL PHARMACOL, V78, P1124, DOI 10.1124/mol.110.066332; Yamaji N, 2009, J BIOL CHEM, V284, P24568, DOI 10.1074/jbc.M109.030841; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zhang JZ, 2012, J BIOL CHEM, V287, P30719, DOI 10.1074/jbc.M112.370742; Zhang JZ, 2011, J BIOL CHEM, V286, P33641, DOI 10.1074/jbc.M111.282509	57	46	49	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20392	20403		10.1074/jbc.M112.426627	http://dx.doi.org/10.1074/jbc.M112.426627			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23703613	hybrid, Green Published			2022-12-28	WOS:000321715100027
J	Remacle, AG; Shiryaev, SA; Golubkov, VS; Freskos, JN; Brown, MA; Karwa, AS; Naik, AD; Howard, CP; Sympson, CJ; Strongin, AY				Remacle, Albert G.; Shiryaev, Sergey A.; Golubkov, Vladislav S.; Freskos, John N.; Brown, Michael A.; Karwa, Amolkumar S.; Naik, Arati D.; Howard, Carol P.; Sympson, Carolyn J.; Strongin, Alex Y.			Non-destructive and Selective Imaging of the Functionally Active, Pro-invasive Membrane Type-1 Matrix Metalloproteinase (MT1-MMP) Enzyme in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CARCINOMA CELLS; EXTRACELLULAR-MATRIX; TISSUE INHIBITORS; TUMOR-CELLS; 1-MATRIX METALLOPROTEINASE; INTRACELLULAR ACTIVATION; INTEGRIN ALPHA-V-BETA-3; TRANSMIGRATION PROGRAM; COLLAGENASE MT1-MMP; MALIGNANT-CELLS	Proteolytic activity of cell surface-associated MT1-matrix metalloproteinase (MMP) (MMP-14) is directly related to cell migration, invasion, and metastasis. MT1-MMPis regulated as a proteinase by activation and conversion of the latent proenzyme into the active enzyme, and also via inhibition by tissue inhibitors of MMPs (TIMPs) and self-proteolysis. MT1-MMP is also regulated as a membrane protein through its internalization and recycling. Routine immunohistochemistry, flow cytometry, reverse transcription-PCR, and immunoblotting methodologies do not allow quantitative imaging and assessment of the cell-surface levels of the active, TIMP-free MT1-MMP enzyme. Here, we developed a fluorescent reporter prototype that targets the cellular active MT1-MMP enzyme alone. The reporter (MP-3653) represents a liposome tagged with a fluorochrome and functionalized with a PEG chain spacer linked to an inhibitory hydroxamate warhead. Our studies using the MP-3653 reporter and its inactive derivative demonstrated that MP-3653 can be efficiently used not only to visualize the trafficking of MT1-MMP through the cell compartment, but also to quantify the femtomolar range amounts of the cell surface-associated active MT1-MMP enzyme in multiple cancer cell types, including breast carcinoma, fibrosarcoma, and melanoma. Thus, the levels of the naturally expressed, fully functional, active cellular MT1-MMP enzyme are roughly equal to 1 x 10(5) molecules/cell, whereas these levels are in a 1 x 10(6) range in the cells with the enforced MT1-MMP expression. We suggest that the reporter we developed will contribute to the laboratory studies of MT1-MMP and then, ultimately, to the design of novel, more efficient prognostic approaches and personalized cancer therapies.	[Remacle, Albert G.; Shiryaev, Sergey A.; Golubkov, Vladislav S.; Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Freskos, John N.; Brown, Michael A.; Karwa, Amolkumar S.; Naik, Arati D.; Howard, Carol P.; Sympson, Carolyn J.] Mallinckrodt LLC, Hazelwood, MO 63042 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.	strongin@sanfordburnham.org	Golubkov, Vladislav/L-6828-2017; Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	National Institutes of Health [R01CA83017, R01CA157328, R01DE022757]; Mallinckrodt LLC; NATIONAL CANCER INSTITUTE [R01CA157328, R01CA083017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mallinckrodt LLC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA83017, R01CA157328, and R01DE022757 and by a Sponsored Research Agreement with Mallinckrodt LLC (to A. Y. S.).	Barbolina MV, 2008, SEMIN CELL DEV BIOL, V19, P24, DOI 10.1016/j.semcdb.2007.06.008; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chen EI, 2003, J BIOL CHEM, V278, P17158, DOI 10.1074/jbc.M210324200; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Edwards DR, 1996, INT J OBESITY, V20, pS9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Gingras D, 2010, BBA-MOL CELL RES, V1803, P142, DOI 10.1016/j.bbamcr.2009.04.011; Golubkov VS, 2007, J BIOL CHEM, V282, P36283, DOI 10.1074/jbc.M706290200; Golubkov VS, 2011, J BIOL CHEM, V286, P34215, DOI 10.1074/jbc.M111.264036; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Golubkov VS, 2010, J BIOL CHEM, V285, P27726, DOI 10.1074/jbc.M110.135442; Gonzalo P, 2010, BIOFACTORS, V36, P248, DOI 10.1002/biof.99; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary KB, 2002, J EXP MED, V195, P295, DOI 10.1084/jem.20010815; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Kridel SJ, 2002, J BIOL CHEM, V277, P23788, DOI 10.1074/jbc.M111574200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Lowery A, 2011, J CONTROL RELEASE, V150, P117, DOI 10.1016/j.jconrel.2010.11.006; Manjappa AS, 2011, J CONTROL RELEASE, V150, P2, DOI 10.1016/j.jconrel.2010.11.002; Maquoi E, 2000, J BIOL CHEM, V275, P11368, DOI 10.1074/jbc.275.15.11368; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Mimori K, 2008, ANN SURG ONCOL, V15, P2934, DOI 10.1245/s10434-008-9916-z; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Ota I, 2009, P NATL ACAD SCI USA, V106, P20318, DOI 10.1073/pnas.0910962106; Ouyang MX, 2010, CANCER RES, V70, P2204, DOI 10.1158/0008-5472.CAN-09-3698; PEI DQ, 1995, NATURE, V375, P244, DOI 10.1038/375244a0; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Perentes JY, 2011, CANCER RES, V71, P4527, DOI 10.1158/0008-5472.CAN-10-4376; Radichev IA, 2010, J BIOL CHEM, V285, P16076, DOI 10.1074/jbc.M110.107094; Remacle A, 2003, J CELL SCI, V116, P3905, DOI 10.1242/jcs.00710; Remacle AG, 2006, ONCOGENE, V25, P5648, DOI 10.1038/sj.onc.1209572; Remacle AG, 2005, J CELL SCI, V118, P4975, DOI 10.1242/jcs.02610; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Remacle AG, 2011, J BIOL CHEM, V286, P21002, DOI 10.1074/jbc.M110.200139; Rogers T. E., 2012, United States Patent, Patent No. [92286 - 858688 (007210US), 92286858688]; Rozanov DV, 2006, CANCER RES, V66, P6258, DOI 10.1158/0008-5472.CAN-06-0539; Rozanov DV, 2004, EXP CELL RES, V293, P81, DOI 10.1016/j.yexcr.2003.10.006; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Rozanov DV, 2002, FEBS LETT, V527, P51, DOI 10.1016/S0014-5793(02)03153-8; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; Shiryaev SA, 2009, J BIOL CHEM, V284, P30615, DOI 10.1074/jbc.M109.041244; Shiryaev SA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004952; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Strongin AY, 2010, BBA-MOL CELL RES, V1803, P133, DOI 10.1016/j.bbamcr.2009.04.009; Strongin AY, 2006, CANCER METAST REV, V25, P87, DOI 10.1007/s10555-006-7892-y; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Takahashi M, 2002, ONCOGENE, V21, P5861, DOI 10.1038/sj.onc.1205755; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Yang LY, 2009, BIOTECHNOL BIOENG, V102, P521, DOI 10.1002/bit.22066; Yonemura Y, 2000, CLIN EXP METASTAS, V18, P321, DOI 10.1023/A:1010887014669; Zhai YL, 2005, CANCER RES, V65, P6543, DOI 10.1158/0008-5472.CAN-05-0231; Zhao T, 2010, J CONTROL RELEASE, V144, P109, DOI 10.1016/j.jconrel.2010.01.023	70	15	16	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20568	20580		10.1074/jbc.M113.471508	http://dx.doi.org/10.1074/jbc.M113.471508			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23733191	hybrid, Green Published			2022-12-28	WOS:000321715100043
J	Chiara, DC; Jayakar, SS; Zhou, XJ; Zhang, X; Savechenkov, PY; Bruzik, KS; Miller, KW; Cohen, JB				Chiara, David C.; Jayakar, Selwyn S.; Zhou, Xiaojuan; Zhang, Xi; Savechenkov, Pavel Y.; Bruzik, Karol S.; Miller, Keith W.; Cohen, Jonathan B.			Specificity of Intersubunit General Anesthetic-binding Sites in the Transmembrane Domain of the Human alpha 1 beta 3 gamma 2 gamma-Aminobutyric Acid Type A (GABA(A)) Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; SUBUNIT INTERFACES; BETA-3 SUBUNIT; ETOMIDATE; PROPOFOL; IDENTIFICATION; POTENCIES; PHARMACOLOGY; ACTIVATION; MECHANISMS	GABA type A receptors (GABA(A)R), the brain's major inhibitory neurotransmitter receptors, are the targets for many general anesthetics, including volatile anesthetics, etomidate, propofol, and barbiturates. Howsuch structurally diverse agents can act similarly as positive allosteric modulators of GABA(A) Rs remains unclear. Previously, photoreactive etomidate analogs identified two equivalent anesthetic-binding sites in the transmembrane domain at the beta(+)-alpha(-) subunit interfaces, which also contain the GABA-binding sites in the extracellular domain. Here, we used R-[H-3]5-allyl-1-methyl-5-(m-trifluoromethyl-diazirynylphenyl) barbituric acid (R-mTFD-MPAB), a potent stereospecific barbiturate anesthetic, to photolabel expressed human alpha 1 beta 3 gamma 2 GABA(A)Rs. Protein microsequencing revealed that R-[3H]mTFD-MPAB did not photolabel the etomidate sites at the alpha(+) -beta(-) subunit interfaces. Instead, it photolabeled sites at the alpha(+) -beta(-) and gamma(+) -beta(-) subunit interfaces in the transmembrane domain. On the (similar to)-side, alpha 1M3 was labeled at Ala-291 and Tyr294 and gamma 2M3 at Ser-301, and on the (-)-side, beta 3M1 was labeled at Met-227. These residues, like those in the etomidate site, are located at subunit interfaces near the synaptic side of the transmembrane domain. The selectivity of R-etomidate for the beta(+) -alpha(-) interface relative to the alpha(+) -beta(-)/gamma(+)-beta(-) interfaces was > 100-fold, whereas that of R-mTFD-MPAB for its sites was > 50-fold. Each ligand could enhance photoincorporation of the other, demonstrating allosteric interactions between the sites. The structural heterogeneity of barbiturate, etomidate, and propofol derivatives is accommodated by varying selectivities for these two classes of sites. Wehypothesize that binding at any of these homologous intersubunit sites is sufficient for anesthetic action and that this explains to some degree the puzzling structural heterogeneity of anesthetics.	[Chiara, David C.; Jayakar, Selwyn S.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Miller, Keith W.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhou, Xiaojuan; Zhang, Xi; Miller, Keith W.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Savechenkov, Pavel Y.; Bruzik, Karol S.] Univ Illinois, Deparment Med Chem & Pharmacognosy, Chicago, IL 60612 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cohen, JB (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	jonathan_cohen@hms.harvard.edu		Jayakar, Selwyn/0000-0002-5792-6408; Zhang, Xi/0000-0003-2755-7901	National Institutes of Health, USPHS [GM-58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448, P01GM055876] Funding Source: NIH RePORTER	National Institutes of Health, USPHS(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-58448 from USPHS.	Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; BRAUER AW, 1984, ANAL BIOCHEM, V137, P134, DOI 10.1016/0003-2697(84)90359-2; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Chen ZW, 2012, MOL PHARMACOL, V82, P408, DOI 10.1124/mol.112.078410; Chiara DC, 2012, BIOCHEMISTRY-US, V51, P836, DOI 10.1021/bi201772m; CRIMMINS DL, 1990, ANAL BIOCHEM, V187, P27, DOI 10.1016/0003-2697(90)90412-3; DODSON BA, 1990, BRIT J PHARMACOL, V101, P710, DOI 10.1111/j.1476-5381.1990.tb14145.x; Dostalova Z, 2010, PROTEIN SCI, V19, P1728, DOI 10.1002/pro.456; Drexler B, 2011, CAN J ANESTH, V58, P178, DOI 10.1007/s12630-010-9414-1; FIRESTONE LL, 1986, MOL CELLULAR MECH AN, P455; Forman SA, 2012, CURR OPIN ANESTHESIO, V25, P411, DOI 10.1097/ACO.0b013e328354feea; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Greenfield LJ, 2002, NEUROPHARMACOLOGY, V42, P502, DOI 10.1016/S0028-3908(01)00196-4; Hamouda AK, 2013, J NEUROSCI, V33, P485, DOI 10.1523/JNEUROSCI.3483-12.2013; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Husain SS, 2006, J MED CHEM, V49, P4818, DOI 10.1021/jm051207b; Husain SS, 2010, J MED CHEM, V53, P6432, DOI 10.1021/jm100498u; Husain SS, 1999, J MED CHEM, V42, P3300, DOI 10.1021/jm9806300; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kamiya Y, 1999, ANESTHESIOLOGY, V90, P1704, DOI 10.1097/00000542-199906000-00028; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Krasowski MD, 2001, J PHARMACOL EXP THER, V297, P338; LEESON S, 1975, J PHARMACOL EXP THER, V195, P251; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Li GD, 2009, J BIOL CHEM, V284, P11771, DOI 10.1074/jbc.C900016200; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Meyer H, 1901, ARCH EXP PATHOL PHAR, V46, P338, DOI 10.1007/BF01978064; MIDDLETON RE, 1991, BIOCHEMISTRY-US, V30, P6987, DOI 10.1021/bi00242a026; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Overton C. E., 1991, STUDIES NARCOSIS CON; Ramerstorfer J, 2011, J NEUROSCI, V31, P870, DOI 10.1523/JNEUROSCI.5012-10.2011; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Ruesch D, 2012, ANESTHESIOLOGY, V116, P47, DOI 10.1097/ALN.0b013e31823d0c36; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Savechenkov PY, 2012, J MED CHEM, V55, P6554, DOI 10.1021/jm300631e; SCOTT MG, 1988, BIOCHEM BIOPH RES CO, V155, P1353, DOI 10.1016/S0006-291X(88)81290-7; Serafini R, 2000, J PHYSIOL-LONDON, V524, P649, DOI 10.1111/j.1469-7793.2000.00649.x; Sieghart W, 2012, BRIT J PHARMACOL, V166, P476, DOI 10.1111/j.1476-5381.2011.01779.x; Siegwart Roberta, 2003, BMC Pharmacol, V3, P13, DOI 10.1186/1471-2210-3-13; Sigel E, 2005, MED CHEM REV ONLINE, V2, P251, DOI [10.2174/1567203054065673, DOI 10.2174/1567203054065673]; Stewart DS, 2011, J MED CHEM, V54, P8124, DOI 10.1021/jm200943f; TICKU MK, 1985, EUR J PHARMACOL, V112, P1, DOI 10.1016/0014-2999(85)90232-8; TURNER DM, 1989, J PHARMACOL EXP THER, V248, P960; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Zeller A, 2007, MOL PHARMACOL, V71, P852, DOI 10.1124/mol.106.030049; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	55	111	111	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19343	19357		10.1074/jbc.M113.479725	http://dx.doi.org/10.1074/jbc.M113.479725			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23677991	Green Published, hybrid			2022-12-28	WOS:000321515800005
J	Friis, S; Sales, KU; Godiksen, S; Peters, DE; Lin, CY; Vogel, LK; Bugge, TH				Friis, Stine; Sales, Katiuchia Uzzun; Godiksen, Sine; Peters, Diane E.; Lin, Chen-Yong; Vogel, Lotte K.; Bugge, Thomas H.			A Matriptase-Prostasin Reciprocal Zymogen Activation Complex with Unique Features PROSTASIN AS A NON-ENZYMATIC CO-FACTOR FOR MATRIPTASE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; EPIDERMAL BARRIER FUNCTION; SERINE-PROTEASE INHIBITOR; HAIR FOLLICLE DEVELOPMENT; NEURAL-TUBE CLOSURE; PLASMINOGEN ACTIVATION; CELL-SURFACE; PLACENTAL DEVELOPMENT; MONOCLONAL-ANTIBODY; PROTEOLYTIC CASCADE	Matriptase and prostasin are part of a cell surface proteolytic pathway critical for epithelial development and homeostasis. Here we have used a reconstituted cell-based system and transgenic mice to investigate the mechanistic interrelationship between the two proteases. We show that matriptase and prostasin form a reciprocal zymogen activation complex with unique features. Prostasin serves as a critical co-factor for matriptase activation. Unexpectedly, however, prostasin-induced matriptase activation requires neither prostasin zymogen conversion nor prostasin catalytic activity. Prostasin zymogen conversion to active prostasin is dependent on matriptase but does not require matriptase zymogen conversion. Consistent with these findings, wild type prostasin, activation cleavage site-mutated prostasin, and catalytically inactive prostasin all were biologically active in vivo when overexpressed in the epidermis of transgenic mice, giving rise to a severe skin phenotype. Our finding of non-enzymatic stimulation of matriptase activation by prostasin and activation of prostasin by the matriptase zymogen provides a tentative mechanistic explanation for several hitherto unaccounted for genetic and biochemical observations regarding these two membrane-anchored serine proteases and their downstream targets.	[Bugge, Thomas H.] NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Sales, Katiuchia Uzzun] NIDCR, Clin Res Core, NIH, Bethesda, MD 20892 USA; [Friis, Stine; Godiksen, Sine; Vogel, Lotte K.] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Godiksen, Sine] Univ Copenhagen, Fac Sci, Dept Biol, DK-2200 Copenhagen, Denmark; [Peters, Diane E.] Tufts Univ, Sch Med, Program Pharmacol & Expt Therapeut, Boston, MA 02111 USA; Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Copenhagen; University of Copenhagen; Tufts University; Georgetown University	Bugge, TH (corresponding author), NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	sales, katiuchia u/J-4880-2012	sales, katiuchia/0000-0002-3768-5790; Vogel, Lotte K./0000-0001-9920-0982; Peters, Diane/0000-0003-4185-6203	National Institutes of Health, NIDCR, Intramural Research Program; Harboe Foundation; Lundbeck Foundation; Foundation of 17.12.1981; Augustinus Foundation; Kobmand Kristian Kjaer og Hustrus Foundation; Kjaer-Foundation; Dagmar Marshalls Foundation; Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Foundation; Grosserer Valdemar Foersom og Hustru Thyra Foersoms Foundation; Fabrikant Einar Willumsens Mindelegat; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; Lundbeck Foundation [R93-2011-8735] Funding Source: researchfish	National Institutes of Health, NIDCR, Intramural Research Program; Harboe Foundation; Lundbeck Foundation(Lundbeckfonden); Foundation of 17.12.1981; Augustinus Foundation; Kobmand Kristian Kjaer og Hustrus Foundation; Kjaer-Foundation; Dagmar Marshalls Foundation; Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Foundation; Grosserer Valdemar Foersom og Hustru Thyra Foersoms Foundation; Fabrikant Einar Willumsens Mindelegat; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Lundbeck Foundation(Lundbeckfonden)	This work was supported, in whole or in part, by the National Institutes of Health, NIDCR, Intramural Research Program (to T. H. B). This work was also supported by the Harboe Foundation, the Lundbeck Foundation, and the Foundation of 17.12.1981 (to S. F.) and the Augustinus Foundation, the Kobmand Kristian Kjaer og Hustrus Foundation, the Kjaer-Foundation, the Dagmar Marshalls Foundation, the Snedkermester Sophus Jacobsen og Hustru Astrid Jacobsens Foundation, the Grosserer Valdemar Foersom og Hustru Thyra Foersoms Foundation, and Fabrikant Einar Willumsens Mindelegat (to S.G.).	ALAM J, 1990, ANAL BIOCHEM, V188, P245, DOI 10.1016/0003-2697(90)90601-5; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bergum C, 2012, J CELL PHYSIOL, V227, P1604, DOI 10.1002/jcp.22877; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Cheng MF, 2007, EUR J DERMATOL, V17, P375; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; ELLIS V, 1991, J BIOL CHEM, V266, P12752; ELLIS V, 1993, J BIOL CHEM, V268, P4806; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Frateschi S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1162; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Inouye K, 2010, J BIOL CHEM, V285, P33394, DOI 10.1074/jbc.M110.115816; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Nonoguchi H., 2002, J CLIN INVEST, V109, P401; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Shipway A, 2004, BIOCHEM BIOPH RES CO, V324, P953, DOI 10.1016/j.bbrc.2004.09.123; Spacek DV, 2010, EXP DERMATOL, V19, P527, DOI 10.1111/j.1600-0625.2009.01054.x; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tong ZY, 2004, AM J PHYSIOL-LUNG C, V287, pL928, DOI 10.1152/ajplung.00160.2004; Tseng IC, 2008, AM J PHYSIOL-CELL PH, V295, pC423, DOI 10.1152/ajpcell.00164.2008; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483	51	61	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19028	19039		10.1074/jbc.M113.469932	http://dx.doi.org/10.1074/jbc.M113.469932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23673661	Green Published, hybrid			2022-12-28	WOS:000321335800038
J	Yang, SJ; Jan, YH; Gray, JP; Mishin, V; Heck, DE; Laskin, DL; Laskin, JD				Yang, Shaojun; Jan, Yi-Hua; Gray, Joshua P.; Mishin, Vladimir; Heck, Diane E.; Laskin, Debra L.; Laskin, Jeffrey D.			Sepiapterin Reductase Mediates Chemical Redox Cycling in Lung Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; THIOREDOXIN REDUCTASE; HYDROXYSTEROID DEHYDROGENASE; CYTOCHROME-P450 REDUCTASE; CARBONYL REDUCTASE; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; BINDING MODE; TETRAHYDROBIOPTERIN; PARAQUAT	In the lung, chemical redox cycling generates highly toxic reactive oxygen species that can cause alveolar inflammation and damage to the epithelium, as well as fibrosis. In this study, we identified a cytosolic NADPH-dependent redox cycling activity in mouse lung epithelial cells as sepiapterin reductase (SPR), an enzyme important for the biosynthesis of tetrahydrobiopterin. Human SPR was cloned and characterized. In addition to reducing sepiapterin, SPR mediated chemical redox cycling of bipyridinium herbicides and various quinones; this activity was greatest for 1,2-naphthoquinone followed by 9,10-phenanthrenequinone, 1,4-naphthoquinone, menadione, and 2,3-dimethyl-1,4-naphthoquinone. Whereas redox cycling chemicals inhibited sepiapterin reduction, sepiapterin had no effect on redox cycling. Additionally, inhibitors such as dicoumarol, N-acetylserotonin, and indomethacin blocked sepiapterin reduction, with no effect on redox cycling. Non-redox cycling quinones, including benzoquinone and phenylquinone, were competitive inhibitors of sepiapterin reduction but noncompetitive redox cycling inhibitors. Site-directed mutagenesis of the SPR C-terminal substrate-binding site (D257H) completely inhibited sepiapterin reduction but had minimal effects on redox cycling. These data indicate that SPR-mediated reduction of sepiapterin and redox cycling occur by distinct mechanisms. The identification of SPR as a key enzyme mediating chemical redox cycling suggests that it may be important in generating cytotoxic reactive oxygen species in the lung. This activity, together with inhibition of sepiapterin reduction by redox-active chemicals and consequent deficiencies in tetrahydrobiopterin, may contribute to tissue injury.	[Yang, Shaojun; Laskin, Jeffrey D.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, Piscataway, NJ 08854 USA; [Jan, Yi-Hua; Mishin, Vladimir; Laskin, Debra L.] Rutgers State Univ, Dept Pharmacol & Toxicol, Piscataway, NJ 08854 USA; [Gray, Joshua P.] US Coast Guard Acad, Dept Sci, New London, CT 06320 USA; [Heck, Diane E.] New York Med Coll, Dept Environm Hlth Sci, Valhalla, NY 10595 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; New York Medical College	Laskin, JD (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Environm & Occupat Med, 170 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	jlaskin@eohsi.rutgers.edu		Gray, Joshua/0000-0003-4146-7902; Gray, Joshua/0000-0002-9704-3845; Laskin, Debra/0000-0003-1832-7311	National Institutes of Health [R01GM034310, R01ES004738, R01CA132624, U54AR055073, P30ES005022]; NATIONAL CANCER INSTITUTE [R01CA132624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR055073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004738, P30ES005022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM034310, R01ES004738, R01CA132624, U54AR055073, and P30ES005022.	Agarwal A, 2011, CRIT REV BIOTECHNOL, V31, P264, DOI 10.3109/07388551.2010.527823; Auerbach G, 1997, EMBO J, V16, P7219, DOI 10.1093/emboj/16.24.7219; Backes WL, 2003, PHARMACOL THERAPEUT, V98, P221, DOI 10.1016/S0163-7258(03)00031-7; Barrett EG, 1998, AM J PHYSIOL-LUNG C, V275, pL1110, DOI 10.1152/ajplung.1998.275.6.L1110; Blau N, 2011, MOL GENET METAB, V104, pS2, DOI 10.1016/j.ymgme.2011.08.017; Bonafe L, 2001, AM J HUM GENET, V69, P269, DOI 10.1086/321970; Bonneh-Barkay D, 2005, MOL BRAIN RES, V134, P52, DOI 10.1016/j.molbrainres.2004.11.005; BUTLER J, 1993, BIOCHIM BIOPHYS ACTA, V1161, P73, DOI 10.1016/0167-4838(93)90198-Z; Cohen G. M., 1987, BR J CANC S, V8, P46; Crabtree MJ, 2011, NITRIC OXIDE-BIOL CH, V25, P81, DOI 10.1016/j.niox.2011.04.004; Curtius H C, 1984, Adv Neurol, V40, P463; Day BJ, 1999, P NATL ACAD SCI USA, V96, P12760, DOI 10.1073/pnas.96.22.12760; DICKER E, 1991, BIOCHEM PHARMACOL, V42, P529, DOI 10.1016/0006-2952(91)90315-V; Farrugia R, 2007, MOL GENET METAB, V90, P277, DOI 10.1016/j.ymgme.2006.10.013; FERRE J, 1988, CLIN CHIM ACTA, V174, P271, DOI 10.1016/0009-8981(88)90053-8; Fujimoto K, 2001, CHEM-BIOL INTERACT, V130, P825, DOI 10.1016/S0009-2797(00)00238-6; Fujimoto K, 1999, BBA-PROTEIN STRUCT M, V1431, P306, DOI 10.1016/S0167-4838(99)00054-0; Fulton D, 2001, J PHARMACOL EXP THER, V299, P818; Fussell KC, 2011, FREE RADICAL BIO MED, V50, P874, DOI 10.1016/j.freeradbiomed.2010.12.035; Gray JP, 2007, J BIOL CHEM, V282, P7939, DOI 10.1074/jbc.M611817200; Ham SW, 2004, BIOORG MED CHEM LETT, V14, P4103, DOI 10.1016/j.bmcl.2004.05.009; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Homma D, 2011, J BIOL CHEM, V286, P1445, DOI 10.1074/jbc.M110.159426; KATOH S, 1971, ARCH BIOCHEM BIOPHYS, V146, P202, DOI 10.1016/S0003-9861(71)80057-7; KIMBROUGH RD, 1970, TOXICOL APPL PHARM, V17, P679, DOI 10.1016/0041-008X(70)90042-6; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Kovacic P, 2009, REV ENVIRON CONTAM T, V201, P41, DOI 10.1007/978-1-4419-0032-6_2; KUBOTA S, 1977, J BIOCHEM-TOKYO, V81, P187, DOI 10.1093/oxfordjournals.jbchem.a131434; Mandel JS, 2012, REGUL TOXICOL PHARM, V62, P385, DOI 10.1016/j.yrtph.2011.10.004; Marin A, 1997, BRIT J CANCER, V76, P923, DOI 10.1038/bjc.1997.485; Matsunaga T, 2011, FREE RADICAL RES, V45, P848, DOI 10.3109/10715762.2011.585648; MAU BL, 1990, FREE RADICAL RES COM, V8, P365, DOI 10.3109/10715769009053370; Mishin VA, 2004, BIOCHEM PHARMACOL, V68, P747, DOI 10.1016/j.bcp.2004.05.004; O'Donnell BV, 1993, BIOCH J 1, V290, P41; Oppermann UCT, 1997, BIOCHEMISTRY-US, V36, P34, DOI 10.1021/bi961803v; Osman AM, 2003, J APPL TOXICOL, V23, P209, DOI 10.1002/jat.908; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park HS, 2009, RESPIROLOGY, V14, P27, DOI 10.1111/j.1440-1843.2008.01447.x; Radak Z, 2011, MOL ASPECTS MED, V32, P305, DOI 10.1016/j.mam.2011.10.010; RASHBASTEP J, 1994, MOL PHARMACOL, V45, P150; Roginsky VA, 1999, CHEM-BIOL INTERACT, V121, P177, DOI 10.1016/S0009-2797(99)00099-X; Shultz CA, 2011, CHEM RES TOXICOL, V24, P2153, DOI 10.1021/tx200294c; SMITH GK, 1992, J BIOL CHEM, V267, P5599; SUEOKA T, 1985, BIOCHIM BIOPHYS ACTA, V843, P193, DOI 10.1016/0304-4165(85)90139-4; Supangat S, 2006, J BIOL CHEM, V281, P2249, DOI 10.1074/jbc.M509343200; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; TANI Y, 1994, NEUROSCI LETT, V181, P169, DOI 10.1016/0304-3940(94)90586-X; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Verbeekac MM, 2008, MOL GENET METAB, V94, P403, DOI 10.1016/j.ymgme.2008.04.003; Wang Y, 2010, MOL CANCER THER, V9, P1852, DOI 10.1158/1535-7163.MCT-09-1098; Wang Y, 2008, FREE RADICAL BIO MED, V44, P1169, DOI 10.1016/j.freeradbiomed.2007.12.013; Werner ER, 2011, BIOCHEM J, V438, P397, DOI 10.1042/BJ20110293; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Wolff DJ, 1997, ARCH BIOCHEM BIOPHYS, V338, P73, DOI 10.1006/abbi.1996.9811; Yang S, 2006, AM J HUM GENET, V78, P575, DOI 10.1086/501372; YUBISUI T, 1980, J BIOL CHEM, V255, P2454; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	58	18	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19221	19237		10.1074/jbc.M112.402164	http://dx.doi.org/10.1074/jbc.M112.402164			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23640889	Green Published, hybrid			2022-12-28	WOS:000321335800055
J	Zhang, YY; Zhao, Y; Li, H; Li, YH; Cai, XL; Shen, Y; Shi, H; Li, LL; Liu, Q; Zhang, XD; Ye, LH				Zhang, Yingyi; Zhao, Yu; Li, Hang; Li, Yinghui; Cai, Xiaoli; Shen, Yu; Shi, Hui; Li, Leilei; Liu, Qian; Zhang, Xiaodong; Ye, Lihong			The Nuclear Import of Oncoprotein Hepatitis B X-interacting Protein Depends on Interacting with c-Fos and Phosphorylation of Both Proteins in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; PROMOTE PROLIFERATION; TRANSPORT RECEPTORS; CENTROSOME DYNAMICS; CELLULAR TARGET; HBXIP; JUN; EXPRESSION; ERK1/2; SIGNAL	Aberrant nuclear localization of oncogenic transcription factors and coactivators always leads to the development of cancer. We have reported that the oncoprotein hepatitis B X-interacting protein (HBXIP) acts as a novel transcriptional coactivator to promote proliferation and migration of breast cancer cells. However, the mechanism of regulating the nuclear import of HBXIP remains unclear. In the present study, we found that HBXIP interacted with c-Fos through their leucine zipper domains in vitro and in vivo. Interestingly, the leucine zipper mutant of HBXIP (or c-Fos) was unavailable to bind to c-Fos (or HBXIP), resulting in the disappearance of nuclear localization of HBXIP. Moreover, we revealed that the nuclear import of HBXIP was required for phosphorylation of c-Fos at Thr232, Thr325, Thr331, and Ser374 by ERK1/2. In addition, the mutant of HBXIP at the Ser108 phosphorylation site failed to import into the nucleus. Strikingly, we found that the kinase ataxia telangiectasia mutated (ATM) phosphorylated HBXIP at Ser108. The knockdown of ATM by siRNA remarkably decreased the levels of serine phosphorylation and blocked the nuclear import of HBXIP. Then, we identified that ATM could bind to HBXIP. Moreover, we validated that the nuclear import of HBXIP contributed to its nuclear function. Therefore, we conclude that the nuclear import of the oncoprotein HBXIP requires interaction with c-Fos through their leucine zipper domains and phosphorylation of both proteins in breast cancer cells. Thus, our findings provide new insights into the mechanism of the nuclear import of HBXIP. Therapeutically, the block of the nuclear import of HBXIP is significant in breast cancer.	[Zhang, Yingyi; Zhao, Yu; Li, Hang; Li, Yinghui; Cai, Xiaoli; Shen, Yu; Shi, Hui; Li, Leilei; Liu, Qian; Ye, Lihong] Nankai Univ, Coll Life Sci, Dept Biochem, Tianjin 300071, Peoples R China; [Zhang, Xiaodong] Nankai Univ, Coll Life Sci, Inst Mol Biol, Dept Canc Res, Tianjin 300071, Peoples R China	Nankai University; Nankai University	Zhang, XD (corresponding author), Nankai Univ, Coll Life Sci, Inst Mol Biol, Dept Canc Res, Tianjin 300071, Peoples R China.	zhangxd@nankai.edu.cn; yelihong@nankai.edu.cn	Li, Leilei/AAE-4472-2020; zhao, yu/AAD-9494-2021					Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Belguise K, 2012, ONCOGENE, V31, P4889, DOI 10.1038/onc.2011.659; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Burgos-Rivera B, 2008, PLANT MOL BIOL, V68, P619, DOI 10.1007/s11103-008-9398-1; Chambellan A, 2009, NITRIC OXIDE-BIOL CH, V20, P143, DOI 10.1016/j.niox.2008.12.004; Chatterjee TK, 2003, J BIOL CHEM, V278, P30272, DOI 10.1074/jbc.M212688200; Chiu CZ, 2010, CLIN SCI, V119, P273, DOI 10.1042/CS20100084; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cui W, 2010, CANCER BIOL THER, V10, P232; Cui WJ, 2012, FEBS LETT, V586, P766, DOI 10.1016/j.febslet.2012.01.039; Fujii R, 2006, CANCER RES, V66, P9099, DOI 10.1158/0008-5472.CAN-06-1886; Garcia-Saez I, 2011, J MOL BIOL, V405, P331, DOI 10.1016/j.jmb.2010.10.046; Higashi N, 2004, GENES CELLS, V9, P233, DOI 10.1111/j.1356-9597.2004.00715.x; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Katche C, 2010, P NATL ACAD SCI USA, V107, P349, DOI 10.1073/pnas.0912931107; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee SH, 2003, ADV DRUG DELIVER REV, V55, P717, DOI 10.1016/S0169-409X(03)00052-8; Liu Q, 2013, INT J CANCER, V133, P1310, DOI 10.1002/ijc.28154; Liu SP, 2012, J BIOL CHEM, V287, P30228, DOI 10.1074/jbc.M112.343947; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Malnou CE, 2010, J BIOL CHEM, V285, P6552, DOI 10.1074/jbc.M109.032680; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Ndlovu MN, 2009, MOL CELL BIOL, V29, P5488, DOI 10.1128/MCB.01657-08; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; RANSONE LJ, 1989, GENE DEV, V3, P770, DOI 10.1101/gad.3.6.770; Rodriguez J, 2010, J CELL BIOL, V191, P967, DOI 10.1083/jcb.201004067; Romano G, 2012, P NATL ACAD SCI USA, V109, P16570, DOI 10.1073/pnas.1207917109; SONOBE MH, 1995, ONCOGENE, V10, P689; Sun MN, 2012, J MOL CELL BIOL, V4, P304, DOI 10.1093/jmcb/mjs048; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Wang FZ, 2007, ACTA PHARMACOL SIN, V28, P431, DOI 10.1111/j.1745-7254.2007.00531.x; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Wen YF, 2008, J BIOL CHEM, V283, P2793, DOI 10.1074/jbc.M708419200; Xu FQ, 2013, CANCER LETT, V333, P124, DOI 10.1016/j.canlet.2013.01.029; Yamaguchi K, 2005, J BIOL CHEM, V280, P32569, DOI 10.1074/jbc.M503201200; Yoneda Y, 1997, J BIOCHEM, V121, P811; Yue L, 2013, CARCINOGENESIS, V34, P927, DOI 10.1093/carcin/bgs399; Zhu YWT, 2009, J BIOL CHEM, V284, P14485, DOI 10.1074/jbc.M900935200	48	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18961	18974		10.1074/jbc.M113.458638	http://dx.doi.org/10.1074/jbc.M113.458638			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23667255	Green Published, hybrid			2022-12-28	WOS:000321335800033
J	Onal, M; Piemontese, M; Xiong, JH; Wang, YY; Han, L; Ye, SQ; Komatsu, M; Selig, M; Weinstein, RS; Zhao, HB; Jilka, RL; Almeida, M; Manolagas, SC; O'Brien, CA				Onal, Melda; Piemontese, Marilina; Xiong, Jinhu; Wang, Yiying; Han, Li; Ye, Shiqiao; Komatsu, Masaaki; Selig, Martin; Weinstein, Robert S.; Zhao, Haibo; Jilka, Robert L.; Almeida, Maria; Manolagas, Stavros C.; O'Brien, Charles A.			Suppression of Autophagy in Osteocytes Mimics Skeletal Aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRABECULAR BONE LOSS; OSTEOCLAST FORMATION; TARGETED DELETION; RANKL EXPRESSION; OXIDATIVE STRESS; BMP ANTAGONIST; MICE; CELLS; GENE; OSTEOPOROSIS	Bone mass declines with age but the mechanisms responsible remain unclear. Here we demonstrate that deletion of a conditional allele for Atg7, a gene essential for autophagy, from osteocytes caused low bone mass in 6-month-old male and female mice. Cancellous bone volume and cortical thickness were decreased, and cortical porosity increased, in conditional knock-out mice compared with control littermates. These changes were associated with low osteoclast number, osteoblast number, bone formation rate, and wall width in the cancellous bone of conditional knock-out mice. In addition, oxidative stress was higher in the bones of conditional knock-out mice as measured by reactive oxygen species levels in the bone marrow and by p66(shc) phosphorylation in L6 vertebra. Each of these changes has been previously demonstrated in the bones of old versus young adult mice. Thus, these results demonstrate that suppression of autophagy in osteocytes mimics, in many aspects, the impact of aging on the skeleton and suggest that a decline in autophagy with age may contribute to the low bone mass associated with aging.	[Onal, Melda; Piemontese, Marilina; Xiong, Jinhu; Wang, Yiying; Han, Li; Ye, Shiqiao; Weinstein, Robert S.; Zhao, Haibo; Jilka, Robert L.; Almeida, Maria; Manolagas, Stavros C.; O'Brien, Charles A.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Onal, Melda; Piemontese, Marilina; Xiong, Jinhu; Wang, Yiying; Han, Li; Ye, Shiqiao; Weinstein, Robert S.; Zhao, Haibo; Jilka, Robert L.; Almeida, Maria; Manolagas, Stavros C.; O'Brien, Charles A.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Prot Metab Project, Tokyo 1568506, Japan; [Selig, Martin] Massachusetts Gen Hosp, Pathol Serv, Electron Microscopy Unit, Boston, MA 02114 USA; [Selig, Martin] Harvard Univ, Sch Med, Boston, MA 02114 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; Tokyo Metropolitan Institute of Medical Science; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	O'Brien, CA (corresponding author), Univ Arkansas Med Sci, 4301 W Markham St,MS 587, Little Rock, AR 72205 USA.	caobrien@uams.edu	O'Brien, Charles A./AAL-5078-2020; Ye, Shiqiao/N-2873-2015; xiong, jinhu/E-1849-2011; Liu, Juan/J-5155-2015; Zhao, Haibo/ABG-9729-2021; Komatsu, Masaaki/B-8321-2011	Ye, Shiqiao/0000-0003-1529-7102; Komatsu, Masaaki/0000-0001-7672-7722; ZHAO, HAIBO/0000-0003-0836-7555; Almeida, Maria/0000-0002-6722-9200; Piemontese, Marilina/0000-0002-9296-1348	National Institutes of Health [AG13918, AR049794]; Central Arkansas Veteran's Healthcare System [1I01BX000294]; UAMS Translational Research Institute [UL1RR029884]; UAMS tobacco settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000294] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Central Arkansas Veteran's Healthcare System; UAMS Translational Research Institute; UAMS tobacco settlement funds; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants AG13918 (to S. C. M.) and AR049794 (to C. A. O.) and the Central Arkansas Veteran's Healthcare System (Merit Review 1I01BX000294, to C. A. O.). Additional support was provided by the UAMS Translational Research Institute (UL1RR029884) and by UAMS tobacco settlement funds.	Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; Di Gregorio GB, 2001, J CLIN INVEST, V107, P803, DOI 10.1172/JCI11653; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Emerton KB, 2010, BONE, V46, P577, DOI 10.1016/j.bone.2009.11.006; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Galli C, 2008, ENDOCRINOLOGY, V149, P146, DOI 10.1210/en.2007-0734; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Jilka RL, 2013, BONE, V54, P264, DOI 10.1016/j.bone.2012.11.038; Jilka RL, 2010, AGING CELL, V9, P851, DOI 10.1111/j.1474-9726.2010.00616.x; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y, 2007, J DENT RES, V86, P320, DOI 10.1177/154405910708600404; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Martin-Millan M, 2010, MOL ENDOCRINOL, V24, P323, DOI 10.1210/me.2009-0354; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Miao DS, 2004, ENDOCRINOLOGY, V145, P2046, DOI 10.1210/en.2003-1097; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; O'Brien CA, 2004, ENDOCRINOLOGY, V145, P1835, DOI 10.1210/en.2003-0990; O'Brien CA, 2005, AM J PHYSIOL-ENDOC M, V289, pE784, DOI 10.1152/ajpendo.00029.2005; PARFITT AM, 1995, J BONE MINER RES, V10, P466; Riggs BL, 2008, J BONE MINER RES, V23, P205, DOI 10.1359/JBMR.071020; Salminen A, 2009, TRENDS MOL MED, V15, P217, DOI 10.1016/j.molmed.2009.03.004; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Shahnazari M, 2012, BONE, V50, P628, DOI 10.1016/j.bone.2011.11.010; Sheng MHC, 2013, BONE, V52, P133, DOI 10.1016/j.bone.2012.09.027; Silbermann M, 1987, Compr Gerontol A, V1, P45; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Vellai T, 2009, TRENDS CELL BIOL, V19, P487, DOI 10.1016/j.tcb.2009.07.007; Weinstein RS, 2010, AGING CELL, V9, P147, DOI 10.1111/j.1474-9726.2009.00545.x; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; XI H, 1993, TOXICOL APPL PHARM, V120, P29, DOI 10.1006/taap.1993.1083; Xia XC, 2010, J BONE MINER RES, V25, P2479, DOI 10.1002/jbmr.160; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200	53	133	146	3	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17432	17440		10.1074/jbc.M112.444190	http://dx.doi.org/10.1074/jbc.M112.444190			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645674	hybrid, Green Published			2022-12-28	WOS:000320380600035
J	Kononova, O; Litvinov, RI; Zhmurov, A; Alekseenko, A; Cheng, CH; Agarwal, S; Marx, KA; Weisel, JW; Barsegov, V				Kononova, Olga; Litvinov, Rustem I.; Zhmurov, Artem; Alekseenko, Andrey; Cheng, Chia Ho; Agarwal, Silvi; Marx, Kenneth A.; Weisel, John W.; Barsegov, Valeri			Molecular Mechanisms, Thermodynamics, and Dissociation Kinetics of Knob-Hole Interactions in Fibrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION MOLECULES; FORMS CATCH BONDS; CRYSTAL-STRUCTURES; SYNTHETIC PEPTIDES; ESSENTIAL DYNAMICS; SLIP BONDS; FRAGMENT-D; POLYMERIZATION; BINDING; LIGANDS	Polymerization of fibrin, the primary structural protein of blood clots and thrombi, occurs through binding of knobs 'A' and 'B' in the central nodule of fibrin monomer to complementary holes 'a' and 'b' in the gamma- and beta-nodules, respectively, of another monomer. We characterized the A:a and B:b knob-hole interactions under varying solution conditions using molecular dynamics simulations of the structural models of fibrin(ogen) fragment D complexed with synthetic peptides GPRP (knob 'A' mimetic) and GHRP (knob 'B' mimetic). The strength of A:a and B:b knob-hole complexes was roughly equal, decreasing with pulling force; however, the dissociation kinetics were sensitive to variations in acidity (pH 5-7) and temperature (T = 25-37 degrees C). There were similar structural changes in holes 'a' and 'b' during forced dissociation of the knob-hole complexes: elongation of loop I, stretching of the interior region, and translocation of the moveable flap. The disruption of the knob-hole interactions was not an "all-or-none" transition as it occurred through distinct two-step or single step pathways with or without intermediate states. The knob-hole bonds were stronger, tighter, and more brittle at pH 7 than at pH 5. The B:b knob-hole bonds were weaker, looser, and more compliant than the A:a knob-hole bonds at pH 7 but stronger, tighter, and less compliant at pH 5. Surprisingly, the knob-hole bonds were stronger, not weaker, at elevated temperature (T = 37 degrees C) compared with T = 25 degrees C due to the helix-to-coil transition in loop I that helps stabilize the bonds. These results provide detailed qualitative and quantitative characteristics underlying the most significant non-covalent interactions involved in fibrin polymerization.	[Kononova, Olga; Zhmurov, Artem; Cheng, Chia Ho; Agarwal, Silvi; Marx, Kenneth A.; Barsegov, Valeri] Univ Massachusetts, Dept Chem, Lowell, MA 01854 USA; [Kononova, Olga; Zhmurov, Artem; Alekseenko, Andrey; Barsegov, Valeri] Moscow Inst Phys & Technol, Moscow 141700, Moscow Region, Russia; [Litvinov, Rustem I.; Weisel, John W.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Massachusetts System; University of Massachusetts Lowell; Moscow Institute of Physics & Technology; University of Pennsylvania	Weisel, JW (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	weisel@mail.med.upenn.edu; Valeri_Barsegov@uml.edu	Kononova, Olga/ABB-3741-2020; Alekseenko, Andrey/C-9812-2013; Kononova, Olga G/C-8698-2014; Barsegov, Valeri/A-6203-2014; Zhmurov, Artem A/F-4455-2012; Litvinov, Rustem/E-5291-2011	Kononova, Olga/0000-0001-9267-312X; Alekseenko, Andrey/0000-0003-4906-7241; Zhmurov, Artem A/0000-0002-4414-8352; Litvinov, Rustem/0000-0003-0643-1496; Barsegov, Valeri/0000-0003-1994-3917	National Institutes of Health [HL030954, HL090774]; American Heart Association [09SDG2460023]; Russian Ministry of Education and Science [14.A18.21.1239]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL090774, R01HL030954, R01HL090774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL030954 and HL090774 (to J. W. W.). This work was also supported by American Heart Association Grant 09SDG2460023 (to V. B.) and Russian Ministry of Education and Science Grant 14.A18.21.1239 (to V. B.).	Ajjan Ramzi A, 2005, Expert Rev Cardiovasc Ther, V3, P1047, DOI 10.1586/14779072.3.6.1047; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Andrews RK, 2008, J CLIN INVEST, V118, P3009, DOI 10.1172/JCI36883; Averett LE, 2008, LANGMUIR, V24, P4979, DOI 10.1021/la703264x; Bailey KM, 2012, ADV PHARMACOL, V65, P63, DOI 10.1016/B978-0-12-397927-8.00004-X; Barsegov V, 2006, J PHYS CHEM B, V110, P26403, DOI 10.1021/jp0653306; Barsegov V, 2005, P NATL ACAD SCI USA, V102, P1835, DOI 10.1073/pnas.0406938102; Buch I, 2011, J CHEM THEORY COMPUT, V7, P1765, DOI 10.1021/ct2000638; Chen W, 2010, J BIOL CHEM, V285, P35967, DOI 10.1074/jbc.M110.155770; Chernysh IN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00879; Cooper AV, 2003, BLOOD, V102, P535, DOI 10.1182/blood-2002-10-3150; Doolittle RF, 2006, BIOCHEMISTRY-US, V45, P2657, DOI 10.1021/bi0524767; Doolittle RF, 2003, J THROMB HAEMOST, V1, P1559, DOI 10.1046/j.1538-7836.2003.00278.x; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Everse SJ, 1998, BIOCHEMISTRY-US, V37, P8637, DOI 10.1021/bi9804129; Ferry J. D., 1988, BIOL SYNTHETIC POLYM, P41; Gorkun OV, 2006, BIOCHEMISTRY-US, V45, P14843, DOI 10.1021/bi061430q; Hayward Steven, 2008, V443, P89, DOI 10.1007/978-1-59745-177-2_5; HENSCHEN A, 1983, ANN NY ACAD SCI, V408, P28, DOI 10.1111/j.1749-6632.1983.tb23232.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kostelansky MS, 2002, BIOCHEMISTRY-US, V41, P12124, DOI 10.1021/bi0261894; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LAUDANO AP, 1978, P NATL ACAD SCI USA, V75, P3085, DOI 10.1073/pnas.75.7.3085; LAUDANO AP, 1980, BIOCHEMISTRY-US, V19, P1013, DOI 10.1021/bi00546a028; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; Litvinov RI, 2005, BLOOD, V106, P2944, DOI 10.1182/blood-2005-05-2039; Litvinov RI, 2007, BLOOD, V109, P130, DOI 10.1182/blood-2006-07-033910; Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pratt KP, 1997, P NATL ACAD SCI USA, V94, P7176, DOI 10.1073/pnas.94.14.7176; SHAINOFF JR, 1979, SCIENCE, V204, P200, DOI 10.1126/science.155308; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Spraggon G, 1997, NATURE, V389, P455, DOI 10.1038/38947; Stabenfeldt SE, 2010, BLOOD, V116, P1352, DOI 10.1182/blood-2009-11-251801; Standeven KF, 2005, BLOOD REV, V19, P275, DOI 10.1016/j.blre.2005.01.003; Watson JW, 2011, BIOCHEMISTRY-US, V50, P9923, DOI 10.1021/bi201406c; Weisel JW, 2008, SCIENCE, V320, P456, DOI 10.1126/science.1154210; Weisel JW, 2013, BLOOD, V121, P1712, DOI 10.1182/blood-2012-09-306639; Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; WEISEL JW, 1992, BIOPHYS J, V63, P111, DOI 10.1016/S0006-3495(92)81594-1; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Yakovenko O, 2008, J BIOL CHEM, V283, P11596, DOI 10.1074/jbc.M707815200; Yang Z, 2000, P NATL ACAD SCI USA, V97, P14156, DOI 10.1073/pnas.97.26.14156; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zhmurov A, 2010, PROTEINS, V78, P2984, DOI 10.1002/prot.22824; Zhmurov A, 2011, STRUCTURE, V19, P1615, DOI 10.1016/j.str.2011.08.013; Zhmurov A, 2012, J AM CHEM SOC, V134, P20396, DOI 10.1021/ja3076428	53	24	24	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22681	22692		10.1074/jbc.M113.472365	http://dx.doi.org/10.1074/jbc.M113.472365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23720752	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000330596300047
J	Baptista-Hon, DT; Deeb, TZ; Lambert, JJ; Peters, JA; Hales, TG				Baptista-Hon, Daniel T.; Deeb, Tarek Z.; Lambert, Jeremy J.; Peters, John A.; Hales, Tim G.			The Minimum M3-M4 Loop Length of Neurotransmitter-activated Pentameric Receptors Is Critical for the Structural Integrity of Cytoplasmic Portals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cys-loop Receptors; GABA Receptors; Glycine Receptors; Ion Channels; Nicotinic Acetylcholine Receptors; Serotonin; Structural Biology	NICOTINIC ACETYLCHOLINE-RECEPTOR; SINGLE-CHANNEL CONDUCTANCE; GATED ION-CHANNEL; X-RAY-STRUCTURE; 5-HT3 RECEPTORS; FUNCTIONAL-PROPERTIES; SUBUNIT; PERMEATION; DETERMINANTS; EXPRESSION	The 5-HT(3)A receptor homology model, based on the partial structure of the nicotinic acetylcholine receptor from Torpedo marmorata, reveals an asymmetric ion channel with five portals framed by adjacent helical amphipathic (HA) stretches within the 114-residue loop between the M3 and M4 membrane-spanning domains. The positive charge of Arg-436, located within the HA stretch, is a rate-limiting determinant of single channel conductance (). Further analysis reveals that positive charge and volume of residue 436 are determinants of 5-HT(3)A receptor inward rectification, exposing an additional role for portals. A structurally unresolved stretch of 85 residues constitutes the bulk of the M3-M4 loop, leaving a >45- gap in the model between M3 and the HA stretch. There are no additional structural data for this loop, which is vestigial in bacterial pentameric ligand-gated ion channels and was largely removed for crystallization of the Caenorhabditis elegans glutamate-activated pentameric ligand-gated ion channels. We created 5-HT3A subunit loop truncation mutants, in which sequences framing the putative portals were retained, to determine the minimum number of residues required to maintain their functional integrity. Truncation to between 90 and 75 amino acids produced 5-HT(3)A receptors with unaltered rectification. Truncation to 70 residues abolished rectification and increased . These findings reveal a critical M3-M4 loop length required for functions attributable to cytoplasmic portals. Examination of all 44 subunits of the human neurotransmitter-activated Cys-loop receptors reveals that, despite considerable variability in their sequences and lengths, all M3-M4 loops exceed 70 residues, suggesting a fundamental requirement for portal integrity.	[Baptista-Hon, Daniel T.; Hales, Tim G.] Univ Dundee, Inst Acad Anaesthesia, Dundee DD1 9SY, Scotland; [Lambert, Jeremy J.; Peters, John A.] Univ Dundee, Div Neurosci, Dundee DD1 9SY, Scotland; [Deeb, Tarek Z.; Hales, Tim G.] George Washington Univ, Dept Physiol & Pharmacol, Washington, DC 20037 USA	University of Dundee; University of Dundee; George Washington University	Hales, TG (corresponding author), Univ Dundee, Inst Acad Anaesthesia, Dundee DD1 9SY, Scotland.	t.g.hales@dundee.ac.uk	Baptista-Hon, Daniel/AAI-6776-2021	Baptista-Hon, Daniel/0000-0002-5358-1035	National Science Foundation [0818741]; Tenovus Scotland	National Science Foundation(National Science Foundation (NSF)); Tenovus Scotland	This work was supported by grants from the National Science Foundation (0818741) and Tenovus Scotland.	Baptista-Hon DT, 2012, BRIT J PHARMACOL, V165, P693, DOI 10.1111/j.1476-5381.2011.01582.x; Bar-Lev DD, 2011, J BIOL CHEM, V286, P43830, DOI 10.1074/jbc.M111.282715; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brown AM, 1998, J PHYSIOL-LONDON, V507, P653, DOI 10.1111/j.1469-7793.1998.653bs.x; Chiara DC, 2009, MOL PHARMACOL, V75, P1084, DOI 10.1124/mol.108.054353; Davies PA, 2003, J BIOL CHEM, V278, P712, DOI 10.1074/jbc.M208814200; Davies PA, 1999, NATURE, V397, P359, DOI 10.1038/16941; Deeb TZ, 2007, J BIOL CHEM, V282, P6172, DOI 10.1074/jbc.M607698200; Haghighi AP, 1998, J NEUROSCI, V18, P4050; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hanna MC, 2000, J NEUROCHEM, V75, P240, DOI 10.1046/j.1471-4159.2000.0750240.x; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; HUSSY N, 1994, J PHYSIOL-LONDON, V481, P311, DOI 10.1113/jphysiol.1994.sp020441; Jones S, 2003, NEUROSCIENCE, V119, P629, DOI 10.1016/S0306-4522(03)00202-1; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kukhtina V, 2006, J NEUROCHEM, V97, P63, DOI 10.1111/j.1471-4159.2005.03468.x; LAMBERT JJ, 1989, BRIT J PHARMACOL, V97, P27, DOI 10.1111/j.1476-5381.1989.tb11920.x; Livesey MR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.219618; Livesey MR, 2008, J BIOL CHEM, V283, P19301, DOI 10.1074/jbc.M802406200; Lo WY, 2008, J BIOL CHEM, V283, P29740, DOI 10.1074/jbc.M802856200; Luscher B, 2011, NEURON, V70, P385, DOI 10.1016/j.neuron.2011.03.024; McKinnon NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035563; MOSS SJ, 1992, SCIENCE, V257, P661, DOI 10.1126/science.1323140; Niesler B, 2003, GENE, V310, P101, DOI 10.1016/S0378-1119(03)00503-1; Sine SM, 2012, PHYSIOL REV, V92, P1189, DOI 10.1152/physrev.00015.2011; Stewart A, 2003, NEUROPHARMACOLOGY, V44, P214, DOI 10.1016/S0028-3908(02)00376-3; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200	31	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21558	21568		10.1074/jbc.M113.481689	http://dx.doi.org/10.1074/jbc.M113.481689			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23740249	Green Published, hybrid			2022-12-28	WOS:000328841900009
J	Harikumar, KG; Cawston, EE; Lam, PCH; Patil, A; Orry, A; Henke, BR; Abagyan, R; Christopoulos, A; Sexton, PM; Miller, LJ				Harikumar, Kaleeckal G.; Cawston, Erin E.; Lam, Polo C. H.; Patil, Achyut; Orry, Andrew; Henke, Brad R.; Abagyan, Ruben; Christopoulos, Arthur; Sexton, Patrick M.; Miller, Laurence J.			Molecular Basis for Benzodiazepine Agonist Action at the Type 1 Cholecystokinin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING; LIGAND; OPTIMIZATION; 3-(1H-INDAZOL-3-YLMETHYL)-1,5-BENZODIAZEPINES; 1,5-BENZODIAZEPINES; POCKETOME; DISCOVERY	Understanding the molecular basis of drug action can facilitate development of more potent and selective drugs. Here, we explore the molecular basis for action of a unique small molecule ligand that is a type 1 cholecystokinin (CCK) receptor agonist and type 2 CCK receptor antagonist, GI181771X. We characterize its binding utilizing structurally related radioiodinated ligands selective for CCK receptor subtypes that utilize the same allosteric ligand-binding pocket, using wild-type receptors and chimeric constructs exchanging the distinct residues lining this pocket. Intracellular calcium assays were performed to determine biological activity. Molecular models for docking small molecule agonists to the type 1 CCK receptor were developed using a ligand-guided refinement approach. The optimal model was distinct from the previous antagonist model for the same receptor and was mechanistically consistent with the current mutagenesis data. This study revealed a key role for Leu(7.39) that was predicted to interact with the isopropyl group in the N1 position of the benzodiazepine that acts as a "trigger" for biological activity. The molecular model was predictive of binding of other small molecule agonists, effectively distinguishing these from 1065 approved drug decoys with an area under curve value of 99%. The model also selectively enriched for agonist compounds, with 130 agonists identified by ROC analysis when seeded in 2175 non-agonist ligands of the type 1 CCK receptor (area under curve 78%). Benzodiazepine agonists in this series docked in consistent pose within this pocket, with a key role played by Leu7.39, whereas the role of this residue was less clear for chemically distinct agonists.	[Harikumar, Kaleeckal G.; Cawston, Erin E.; Patil, Achyut; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lam, Polo C. H.; Orry, Andrew; Abagyan, Ruben] Molsoft LLC, La Jolla, CA 92037 USA; [Henke, Brad R.] GlaxoSmithKline Inc, Metab Pathways & Cardiovasc Therapy Area Unit, Res Triangle Pk, NC 27709 USA; [Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA; [Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Dept Drug Discovery Biol, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Christopoulos, Arthur; Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia	Mayo Clinic; Mayo Clinic Phoenix; GlaxoSmithKline; University of California System; University of California San Diego; Monash University; Monash University	Miller, LJ (corresponding author), 13400 East Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008	Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Patil, Achyut/0000-0002-5151-3207	National Institutes of Health [R01 DK032878, U01 GM094612, U54 GM094618]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094612, U54GM094618] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK032878 (to L. J. M.), U01 GM094612 (to R. A.), and U54 GM094618 (to R. A.).	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Akgun E, 2009, J MED CHEM, V52, P2138, DOI 10.1021/jm801439x; An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; [Anonymous], 2004, AM J PHYSIOL-GASTR L; Aquino CJ, 1996, J MED CHEM, V39, P562, DOI 10.1021/jm950626d; BALLESTEROS JA, 1992, BIOPHYS J, V62, P107, DOI 10.1016/S0006-3495(92)81794-0; Berna MJ, 2007, CURR OPIN PHARMACOL, V7, P583, DOI 10.1016/j.coph.2007.09.011; Cawston EE, 2012, J BIOL CHEM, V287, P18618, DOI 10.1074/jbc.M111.335646; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Dockray GJ, 2004, BEST PRACT RES CL EN, V18, P555, DOI 10.1016/j.beem.2004.07.003; Dockray GJ, 2012, CURR OPIN ENDOCRINOL, V19, P8, DOI 10.1097/MED.0b013e32834eb77d; Gao F, 2008, BIOORG MED CHEM LETT, V18, P4401, DOI 10.1016/j.bmcl.2008.06.053; Hadac EM, 2006, J MED CHEM, V49, P850, DOI 10.1021/jm049072h; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Harikumar KG, 2013, LIPIDS, V48, P231, DOI 10.1007/s11745-012-3744-4; Harikumar KG, 2002, J BIOL CHEM, V277, P18552, DOI 10.1074/jbc.M201164200; Henke BR, 1996, J MED CHEM, V39, P2655, DOI 10.1021/jm960249k; Henke BR, 1997, J MED CHEM, V40, P2706, DOI 10.1021/jm970265x; Hirst GC, 1996, J MED CHEM, V39, P5236, DOI 10.1021/jm9601664; Katritch V, 2010, PROTEINS, V78, P197, DOI 10.1002/prot.22507; Kufareva I, 2012, NUCLEIC ACIDS RES, V40, pD535, DOI 10.1093/nar/gkr825; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; PEARSON R K, 1987, Pancreas, V2, P79, DOI 10.1097/00006676-198701000-00012; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Totrov M, 2008, CHEM BIOL DRUG DES, V71, P15, DOI 10.1111/j.1747-0285.2007.00605.x; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Warr W, 2009, J COMPUT AID MOL DES, V23, P195, DOI 10.1007/s10822-009-9260-9	31	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21082	21095		10.1074/jbc.M113.480715	http://dx.doi.org/10.1074/jbc.M113.480715			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754289	Green Published, hybrid			2022-12-28	WOS:000322014400029
J	Rice, AJ; Alvarez, FJD; Schultz, KM; Klug, CS; Davidson, AL; Pinkett, HW				Rice, Austin J.; Alvarez, Frances J. D.; Schultz, Kathryn M.; Klug, Candice S.; Davidson, Amy L.; Pinkett, Heather W.			EPR Spectroscopy of MolB(2)C(2)-A Reveals Mechanism of Transport for a Bacterial Type II Molybdate Importer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; ESCHERICHIA-COLI; BINDING-PROTEIN; BTUCD-F; ATP; INSIGHTS; POWER	In bacteria, ATP-binding cassette (ABC) transporters are vital for the uptake of nutrients and cofactors. Based on differences in structure and activity, ABC importers are divided into two types. Type I transporters have been well studied and employ a tightly regulated alternating access mechanism. Less is known about Type II importers, but much of what we do know has been observed in studies of the vitamin B-12 importer BtuC(2)D(2). MolB(2)C(2) (formally known as HI1470/71) is also a Type II importer, but its substrate, molybdate, is similar to 10-fold smaller than vitamin B12. To understand mechanistic differences among Type II importers, we focused our studies on MolBC, for which alternative conformations may be required to transport its relatively small substrate. To investigate the mechanism of MolBC, we employed disulfide cross-linking and EPR spectroscopy. From these studies, we found that nucleotide binding is coupled to a conformational shift at the periplasmic gate. Unlike the larger conformational changes in BtuCD-F, this shift in MolBC-A is akin to unlocking a swinging door: allowing just enough space for molybdate to slip into the cell. The lower cytoplasmic gate, identified in BtuCD-F as "gate I," remains open throughout the MolBC-A mechanism, and cytoplasmic gate II closes in the presence of nucleotide. Combining our results, we propose a peristaltic mechanism for MolBC-A, which gives new insight in the transport of small substrates by a Type II importer.	[Rice, Austin J.; Davidson, Amy L.; Pinkett, Heather W.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Alvarez, Frances J. D.; Davidson, Amy L.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Schultz, Kathryn M.; Klug, Candice S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA	Northwestern University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Medical College of Wisconsin	Pinkett, HW (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	h-pinkett@northwestern.edu	Pinkett, Heather Wendy/M-9235-2014	Alvarez, Frances/0000-0001-9742-6064	National Science Foundation [MCB1121872]; National Institutes of Health [S10 RR022422, P41 EB001980, GM070515]; National Institutes of Health Molecular Biophysics Training Grant from NIGMS [T32 GM008382]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008382, R01GM070515, R56GM070515] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Molecular Biophysics Training Grant from NIGMS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by in part by National Science Foundation Grant MCB1121872. DEER instrumentation was funded by National Institutes of Health Grant S10 RR022422. DEER spectroscopy was carried out at the National Biomedical EPR Center, which is supported by National Institutes of Health Grant P41 EB001980.; Supported in part by National Institutes of Health Molecular Biophysics Training Grant T32 GM008382 from NIGMS.; Supported by National Institutes of Health Grant GM070515.	Altenbach C, 2001, BIOCHEMISTRY-US, V40, P15471, DOI 10.1021/bi011544w; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dean M, 2001, J LIPID RES, V42, P1007; Ernst R, 2010, FEBS J, V277, P540, DOI 10.1111/j.1742-4658.2009.07485.x; Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Holland I. B., 2003, ABC PROTEINS BACTERI; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Joseph B, 2011, J BIOL CHEM, V286, P41008, DOI 10.1074/jbc.M111.269472; Korkhov VM, 2012, NATURE, V490, P367, DOI 10.1038/nature11442; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Lewinson O, 2010, NAT STRUCT MOL BIOL, V17, P332, DOI 10.1038/nsmb.1770; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Mattle D, 2010, J MOL BIOL, V404, P220, DOI 10.1016/j.jmb.2010.09.005; Newstead S, 2009, STRUCTURE, V17, P1213, DOI 10.1016/j.str.2009.07.009; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Tirado-Lee L, 2011, STRUCTURE, V19, P1701, DOI 10.1016/j.str.2011.10.004; Vigonsky E, 2013, P NATL ACAD SCI USA, V110, P5440, DOI 10.1073/pnas.1213598110; Wang B, 2009, J MEMBRANE BIOL, V231, P1, DOI 10.1007/s00232-009-9200-6; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417	31	18	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21228	21235		10.1074/jbc.M113.483495	http://dx.doi.org/10.1074/jbc.M113.483495			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23709218	Green Published, hybrid			2022-12-28	WOS:000322014400044
J	Cao, ZP; Zhang, RW; Li, JX; Huang, HS; Zhang, DY; Zhang, JJ; Gao, JM; Chen, JY; Huang, CS				Cao, Zipeng; Zhang, Ruowen; Li, Jingxia; Huang, Haishan; Zhang, Dongyun; Zhang, Jingjie; Gao, Jimin; Chen, Jingyuan; Huang, Chuanshu			X-linked Inhibitor of Apoptosis Protein (XIAP) Regulation of Cyclin D1 Protein Expression and Cancer Cell Anchorage-independent Growth via Its E3 Ligase-mediated Protein Phosphatase 2A/c-Jun Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATOR PROTEIN-1; AP-1 ACTIVITY; UV-RADIATION; CL41 CELLS; C-JUN; INDUCTION; PATHWAY; TRANSFORMATION; IAPS	The X-linked inhibitor of apoptosis protein (XIAP) is a well known potent inhibitor of apoptosis; however, it is also involved in other cancer cell biological behavior. In the current study, we discovered that XIAP and its E3 ligase played a crucial role in regulation of cyclin D1 expression in cancer cells. We found that deficiency of XIAP expression resulted in a marked reduction in cyclin D1 expression. Consistently, cell cycle transition and anchorage-independent cell growth were also attenuated in XIAP-deficient cancer cells compared with those of the parental wild-type cells. Subsequent studies demonstrated that E3 ligase activity within the RING domain of XIAP is crucial for its ability to regulate cyclin D1 transcription, cell cycle transition, and anchorage-independent cell growth by up-regulating transactivation of c-Jun/AP-1. Moreover, we found that E3 ligase within RING domain was required for XIAP inhibition of phosphatase PP2A activity by up-regulation of PP2A phosphorylation at Tyr-307 in its catalytic subunit. Such PP2A phosphorylation and inactivation resulted in phosphorylation and activation of its downstream target c-Jun in turn leading to cyclin D1 expression. Collectively, our studies uncovered a novel function of E3 ligase activity of XIAP in the up-regulation of cyclin D1 expression, providing significant insight into the understanding of the biomedical significance of overexpressed XIAP in cancer development, further offering a new molecular basis for utilizing XIAP E3 ligase as a cancer therapeutic target.	[Cao, Zipeng; Zhang, Ruowen; Li, Jingxia; Huang, Haishan; Zhang, Dongyun; Zhang, Jingjie; Huang, Chuanshu] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY 10987 USA; [Cao, Zipeng; Chen, Jingyuan] Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian 710032, Shannxi, Peoples R China; [Huang, Haishan; Gao, Jimin] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Zhejiang, Peoples R China	New York University; Air Force Military Medical University; Wenzhou Medical University	Gao, JM (corresponding author), Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Zhejiang, Peoples R China.	jimingao@yahoo.com; jy_chen@fmmu.edu.cn; Chuanshu.huang@nyumc.org	Zhang, Jing/HII-4294-2022; Zhang, Jing/GWZ-7332-2022	Huang, Chuanshu/0000-0003-4133-5096; Zhang, Ruowen/0000-0003-1403-2356	National Institute of Health from the NCI [CA112557]; National Institute of Health from the NIEHS [ES000260]; National Natural Science Foundation of China [NSFC81229002, NSFC9102970]; NATIONAL CANCER INSTITUTE [P30CA016087, R01CA112557, R01CA177665, P01CA165980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institute of Health from the NCI; National Institute of Health from the NIEHS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA112557 from the NCI and ES000260 from the NIEHS. This work was also supported by National Natural Science Foundation of China Grants NSFC81229002 and NSFC9102970.	Akyurek N, 2006, CANCER-AM CANCER SOC, V107, P1844, DOI 10.1002/cncr.22219; Al-Murrani SWK, 1999, BIOCHEM J, V341, P293, DOI 10.1042/0264-6021:3410293; ALBERTS AS, 1993, MOL CELL BIOL, V13, P2104, DOI 10.1128/MCB.13.4.2104; Arber N, 1997, CANCER RES, V57, P1569; Arber N, 1996, GASTROENTEROLOGY, V110, P669, DOI 10.1053/gast.1996.v110.pm8608874; Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Byrd JC, 2002, BLOOD, V99, P1038, DOI 10.1182/blood.V99.3.1038; Che YF, 2012, AM J PATHOL, V180, P1798, DOI 10.1016/j.ajpath.2012.01.016; CHEN J, 1994, J BIOL CHEM, V269, P7957; Cooper SJ, 2003, MOL CANCER RES, V1, P848; CORDONCARDO C, 1995, AM J PATHOL, V147, P545; Dubrez-Daloz L, 2008, CELL CYCLE, V7, P1036, DOI 10.4161/cc.7.8.5783; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Fong WG, 2000, GENOMICS, V70, P113, DOI 10.1006/geno.2000.6364; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Kluger HM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-6; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Kozar K, 2005, CELL CYCLE, V4, P388, DOI 10.4161/cc.4.3.1551; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Li JX, 2004, J CELL BIOL, V165, P77, DOI 10.1083/jcb.200401004; Liu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035682; Liu JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176982; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Luo WJ, 2008, J BIOL CHEM, V283, P8624, DOI 10.1074/jbc.M707860200; Ma JJ, 2009, EUR J OBSTET GYN R B, V146, P222, DOI 10.1016/j.ejogrb.2009.06.011; Nagi C, 2007, ANN DIAGN PATHOL, V11, P402, DOI 10.1016/j.anndiagpath.2006.12.012; Neil JR, 2009, J BIOL CHEM, V284, P21209, DOI 10.1074/jbc.M109.018374; Nemoto T, 2004, EXP MOL PATHOL, V76, P253, DOI 10.1016/j.yexmp.2004.01.001; O'Shaughnessy RFL, 2009, DEVELOPMENT, V136, P3423, DOI 10.1242/dev.037010; Ouyang WM, 2008, ENVIRON HEALTH PERSP, V116, P1, DOI 10.1289/ehp.10403; Ouyang WM, 2005, CANCER RES, V65, P9287, DOI 10.1158/0008-5472.CAN-05-0469; Palmqvist R, 2000, AM J PATHOL, V157, P1947, DOI 10.1016/S0002-9440(10)64833-X; Schimmer AD, 2006, CELL DEATH DIFFER, V13, P179, DOI 10.1038/sj.cdd.4401826; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Song L, 2007, MOL CELL BIOL, V27, P2713, DOI 10.1128/MCB.00657-06; Song L, 2006, J CELL BIOL, V175, P607, DOI 10.1083/jcb.200602149; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tong QS, 2005, CANCER GENE THER, V12, P509, DOI 10.1038/sj.cgt.7700813; Wang J, 2005, CANCER RES, V65, P6601, DOI 10.1158/0008-5472.CAN-04-4184; Wang R, 2009, AURIS NASUS LARYNX, V36, P332, DOI 10.1016/j.anl.2008.08.006; Yang L, 2003, CANCER RES, V63, P6815; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yu JX, 2012, J BIOL CHEM, V287, P13752, DOI 10.1074/jbc.M111.337469; Zhang DY, 2007, CARCINOGENESIS, V28, P883, DOI 10.1093/carcin/bgl186; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhang DY, 2009, TOXICOL APPL PHARM, V235, P18, DOI 10.1016/j.taap.2008.11.002; Zhang JJ, 2012, TOXICOL APPL PHARM, V263, P218, DOI 10.1016/j.taap.2012.06.012	55	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20238	20247		10.1074/jbc.M112.448365	http://dx.doi.org/10.1074/jbc.M112.448365			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720779	Green Published, hybrid			2022-12-28	WOS:000321715100013
J	Mamenko, M; Zaika, OL; Boukelmoune, N; Berrout, J; O'Neil, RG; Pochynyuk, O				Mamenko, Mykola; Zaika, Oleg L.; Boukelmoune, Nabila; Berrout, Jonathan; O'Neil, Roger G.; Pochynyuk, Oleh			Discrete Control of TRPV4 Channel Function in the Distal Nephron by Protein Kinases A and C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; PRINCIPAL CELLS; CALCIUM-ENTRY; K+ SECRETION; FLOW; KIDNEY; LOCALIZATION; TRAFFICKING; INHIBITION; ACTIVATION	We have recently documented that the Ca2+-permeable TRPV4 channel, which is abundantly expressed in distal nephron cells, mediates cellular Ca2+ responses to elevated luminal flow. In this study, we combined Fura-2-based [Ca2+](i) imaging with immunofluorescence microscopy in isolated split-opened distal nephrons of C57BL/6 mice to probe the molecular determinants of TRPV4 activity and subcellular distribution. We found that activation of the PKC pathway with phorbol 12-myristate 13-acetate significantly increased [Ca2+](i) responses to flow without affecting the subcellular distribution of TRPV4. Inhibition of PKC with bisindolylmaleimide I diminished cellular responses to elevated flow. In contrast, activation of the PKA pathway with forskolin did not affect TRPV4-mediated [Ca2+](i) responses to flow but markedly shifted the subcellular distribution of the channel toward the apical membrane. These actions were blocked with the specific PKA inhibitor H-89. Concomitant activation of the PKA and PKC cascades additively enhanced the amplitude of flow-induced [Ca2+](i) responses and greatly increased basal [Ca2+](i) levels, indicating constitutive TRPV4 activation. This effect was precluded by the selective TRPV4 antagonist HC-067047. Therefore, the functional status of the TRPV4 channel in the distal nephron is regulated by two distinct signaling pathways. Although the PKA-dependent cascade promotes TRPV4 trafficking and translocation to the apical membrane, the PKC-dependent pathway increases the activity of the channel on the plasma membrane.	[Mamenko, Mykola; Zaika, Oleg L.; Boukelmoune, Nabila; Berrout, Jonathan; O'Neil, Roger G.; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Pochynyuk, O (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin, Houston, TX 77030 USA.	oleh.m.pochynyuk@uth.tmc.edu	Mamenko, Mykola/I-6061-2015	Mamenko, Mykola/0000-0001-8683-0715; Boukelmoune, Nabila/0000-0001-5098-6187	National Institutes of Health from NIDDK [DK095029]; S&R Foundation Ryuji Ueno award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095029] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; S&R Foundation Ryuji Ueno award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK095029 from NIDDK (to O.P.). This work was also supported by an S&R Foundation Ryuji Ueno award (to O.P.).	Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; Cai ZQ, 2000, AM J PHYSIOL-RENAL, V279, pF270, DOI 10.1152/ajprenal.2000.279.2.F270; Dietrich A, 2010, J AM SOC NEPHROL, V21, P736, DOI 10.1681/ASN.2009090948; Du J, 2012, J AM SOC NEPHROL, V23, P1172, DOI 10.1681/ASN.2011100972; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Galizia L, 2012, J CELL BIOCHEM, V113, P580, DOI 10.1002/jcb.23382; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Goel M, 2006, AM J PHYSIOL-RENAL, V290, pF1241, DOI 10.1152/ajprenal.00376.2005; Goel M, 2007, AM J PHYSIOL-RENAL, V293, pF1476, DOI 10.1152/ajprenal.00186.2007; Goel M, 2010, AM J PHYSIOL-RENAL, V298, pF988, DOI 10.1152/ajprenal.00586.2009; Gradilone SA, 2010, GASTROENTEROLOGY, V139, P304, DOI 10.1053/j.gastro.2010.04.010; Hovater MB, 2008, PURINERG SIGNAL, V4, P155, DOI 10.1007/s11302-007-9072-0; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Liu W, 2007, AM J PHYSIOL-RENAL, V293, pF227, DOI 10.1152/ajprenal.00057.2007; Liu W, 2009, AM J PHYSIOL-RENAL, V297, pF904, DOI 10.1152/ajprenal.90685.2008; Mamenko M, 2012, HYPERTENSION, V60, P1234, DOI 10.1161/HYPERTENSIONAHA.112.200469; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Mamenko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022824; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Nilius B, 2013, EMBO REP, V14, P152, DOI 10.1038/embor.2012.219; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Nilius B, 2010, PFLUG ARCH EUR J PHY, V460, P437, DOI 10.1007/s00424-010-0788-2; Pluznick JL, 2006, AM J PHYSIOL-RENAL, V291, pF517, DOI 10.1152/ajprenal.00118.2006; Pochynyuk O, 2013, PFLUG ARCH EUR J PHY, V465, P177, DOI 10.1007/s00424-012-1190-z; Siroky BJ, 2006, AM J PHYSIOL-RENAL, V290, pF1320, DOI 10.1152/ajprenal.00463.2005; Taniguchi J, 1998, J MEMBRANE BIOL, V164, P35, DOI 10.1007/s002329900391; Taniguchi J, 2007, AM J PHYSIOL-RENAL, V292, pF667, DOI 10.1152/ajprenal.00458.2005; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Woda CB, 2002, AM J PHYSIOL-RENAL, V283, pF437, DOI 10.1152/ajprenal.00316.2001; Woudenberg-Vrenken TE, 2009, NAT REV NEPHROL, V5, P441, DOI 10.1038/nrneph.2009.100; Wu L, 2007, AM J PHYSIOL-RENAL, V293, pF1699, DOI 10.1152/ajprenal.00462.2006; Xu C, 2009, AM J PHYSIOL-RENAL, V296, pF1464, DOI 10.1152/ajprenal.90542.2008; Yamaguchi T, 1997, AM J KIDNEY DIS, V30, P703, DOI 10.1016/S0272-6386(97)90496-0; Zaika O, 2013, J AM SOC NEPHROL, V24, P604, DOI 10.1681/ASN.2012050442; Zaika O, 2011, AM J PHYSIOL-RENAL, V300, pF1105, DOI 10.1152/ajprenal.00606.2010	40	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20306	20314		10.1074/jbc.M113.466797	http://dx.doi.org/10.1074/jbc.M113.466797			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23709216	Green Published, hybrid			2022-12-28	WOS:000321715100019
J	Tsukamoto, K; Wales, TE; Daniels, K; Pal, R; Sheng, R; Cho, W; Stafford, W; Engen, JR; Krieger, M; Kocher, O				Tsukamoto, Kosuke; Wales, Thomas E.; Daniels, Kathleen; Pal, Rinku; Sheng, Ren; Cho, Wonhwa; Stafford, Walter; Engen, John R.; Krieger, Monty; Kocher, Olivier			Noncanonical Role of the PDZ4 Domain of the Adaptor Protein PDZK1 in the Regulation of the Hepatic High Density Lipoprotein Receptor Scavenger Receptor Class B, Type I (SR-BI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; E-DEFICIENT MICE; APOLIPOPROTEIN-E; HYDROGEN-EXCHANGE; HOMOLOGOUS RECOMBINATION; SEDIMENTATION-VELOCITY; SURFACE LOCALIZATION; TARGETED DISRUPTION; CRYSTAL-STRUCTURE; COMPLEX REVEALS	The four PDZ (PDZ1 to PDZ4) domain-containing adaptor protein PDZK1 controls the expression, localization, and function of the HDL receptor scavenger receptor class B, type I (SR-BI), in hepatocytes in vivo. This control depends on both the PDZ4 domain and the binding of SR-BI's cytoplasmic C terminus to the canonical peptide-binding sites of either the PDZ1 or PDZ3 domain (no binding to PDZ2 or PDZ4). Using transgenic mice expressing in the liver domain deletion (Delta PDZ2 or Delta PDZ3), domain replacement (PDZ2 -> 1), or target peptide binding-negative (PDZ4(G389P)) mutants of PDZK1, we found that neither PDZ2 nor PDZ3 nor the canonical target peptide binding activity of PDZ4 were necessary for hepatic SR-BI regulatory activity. Immunohistochemical studies established that the localization of PDZK1 on hepatocyte cell surface membranes in vivo is dependent on its PDZ4 domain and the presence of SR-BI. Analytical ultracentrifugation and hydrogen deuterium exchange mass spectrometry suggested that the requirement of PDZ4 for localization and SR-BI regulation is not due to PDZ4-mediated oligomerization or induction of conformational changes in the PDZ123 portion of PDZK1. However, surface plasmon resonance analysis showed that PDZ4, but not the other PDZ domains, can bind vesicles that mimic the plasma membrane. Thus, PDZ4 may potentiate PDZK1's regulation of SR-BI by promoting its lipid-mediated attachment to the cytoplasmic membrane. Our results show that not all of the PDZ domains of a multi-PDZ domain-containing adaptor protein are required for its biological activities and that both canonical target peptide binding and noncanonical (peptide binding-independent) capacities of PDZ domains may be employed by a single such adaptor for optimal in vivo activity.	[Tsukamoto, Kosuke; Krieger, Monty] MIT, Dept Biol, Cambridge, MA 02139 USA; [Wales, Thomas E.; Engen, John R.] Northeastern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Daniels, Kathleen; Pal, Rinku; Kocher, Olivier] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Daniels, Kathleen; Pal, Rinku; Kocher, Olivier] Harvard Univ, Sch Med, Vasc Biol Res Ctr, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Sheng, Ren; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Stafford, Walter] Boston Biomed Res Inst, Watertown, MA 02472 USA	Massachusetts Institute of Technology (MIT); Northeastern University; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Boston Biomedical Research Institute	Krieger, M (corresponding author), MIT, Dept Biol, Rm 68-483,77 Massachusetts Ave, Cambridge, MA 02139 USA.	krieger@mit.edu; okocher@bidmc.harvard.edu	Stafford, Walter/ABC-6553-2020	Engen, John R./0000-0002-6918-9476; Wales, Thomas E./0000-0001-6133-5689	National Institutes of Health [HL077780, HL52212, HL66105, GM68849, GM086507, GM101135]; Waters Corp.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066105, R01HL052212, R01HL077780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068849, R01GM101135, R01GM086507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Waters Corp.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077780 (to O. K.), HL52212 and HL66105 (to M. K.), GM68849 (to W. C.), and GM086507 and GM101135 (to J. R. E.). This work was also supported by a research collaboration with the Waters Corp. (to J. R. E.).	Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Chen Y, 2012, MOL CELL, V46, P226, DOI 10.1016/j.molcel.2012.02.012; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fanning AS, 2007, J BIOL CHEM, V282, P37710, DOI 10.1074/jbc.M707255200; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Fenske SA, 2008, J BIOL CHEM, V283, P22097, DOI 10.1074/jbc.M800029200; Fenske SA, 2009, J BIOL CHEM, V284, P5797, DOI 10.1074/jbc.M808211200; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Iacob RE, 2012, J AM SOC MASS SPECTR, V23, P1003, DOI 10.1007/s13361-012-0377-z; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Im YJ, 2003, J BIOL CHEM, V278, P48099, DOI 10.1074/jbc.M306919200; Im YJ, 2003, J BIOL CHEM, V278, P8501, DOI 10.1074/jbc.M212263200; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 1999, LAB INVEST, V79, P1161; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kocher O, 2011, J BIOL CHEM, V286, P25171, DOI 10.1074/jbc.M111.242362; Kocher O, 2010, J BIOL CHEM, V285, P34999, DOI 10.1074/jbc.M110.164418; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; LaLonde DP, 2009, BIOCHEMISTRY-US, V48, P2261, DOI 10.1021/bi802089k; Mineo C, 2012, CURR OPIN LIPIDOL, V23, P487, DOI 10.1097/MOL.0b013e328357ba61; MORRISON JR, 1994, J BIOL CHEM, V269, P13911; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; SIMONET WS, 1993, J BIOL CHEM, V268, P8221; Stafford W., 1994, METHODS ENZYMOLOGY B, P478; Stafford WF, 2000, METHOD ENZYMOL, V323, P302; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Thomson RB, 2005, P NATL ACAD SCI USA, V102, P13331, DOI 10.1073/pnas.0506578102; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Wang PJ, 2005, J BIOL CHEM, V280, P30143, DOI 10.1074/jbc.M503969200; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2006, J BIOL CHEM, V281, P28975, DOI 10.1074/jbc.M603802200; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079; Zimmermann P, 2006, BBA-MOL CELL BIOL L, V1761, P947, DOI 10.1016/j.bbalip.2006.04.003	55	11	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19845	19860		10.1074/jbc.M113.460170	http://dx.doi.org/10.1074/jbc.M113.460170			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720744	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000321515800052
J	Yadav, PK; Yamada, K; Chiku, T; Koutmos, M; Banerjee, R				Yadav, Pramod Kumar; Yamada, Kazuhiro; Chiku, Taurai; Koutmos, Markos; Banerjee, Ruma			Structure and Kinetic Analysis of H2S Production by Human Mercaptopyruvate Sulfurtransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE BETA-SYNTHASE; HYDROGEN-SULFIDE; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; ACTIVE-SITE; CRYSTAL-STRUCTURE; THIOREDOXIN; ACID; RAT; RHODANESE; DEFENSE	Mercaptopyruvate sulfurtransferase (MST) is a source of endogenous H2S, a gaseous signaling molecule implicated in a wide range of physiological processes. The contribution of MST versus the other two H2S generators, cystathionine beta-synthase and gamma-cystathionase, has been difficult to evaluate because many studies on MST have been conducted at high pH and have used varied reaction conditions. In this study, we have expressed, purified, and crystallized human MST in the presence of the substrate 3-mercaptopyruvate (3-MP). The kinetics of H2S production by MST from 3-MP was studied at pH 7.4 in the presence of various physiological persulfide acceptors: cysteine, dihydrolipoic acid, glutathione, homocysteine, and thioredoxin, and in the presence of cyanide. The crystal structure of MST reveals a mixture of the product complex containing pyruvate and an active site cysteine persulfide (Cys(248)-SSH) and a nonproductive intermediate in which 3-MP is covalently linked via a disulfide bond to an active site cysteine. The crystal structure analysis allows us to propose a detailed mechanism for MST in which an Asp-His-Ser catalytic triad is positioned to activate the nucleophilic cysteine residue and participate in general acid-base chemistry, whereas our kinetic analysis indicates that thioredoxin is likely to be the major physiological persulfide acceptor for MST.	[Yadav, Pramod Kumar; Chiku, Taurai; Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Yamada, Kazuhiro; Koutmos, Markos] Uniformed Serv Univ Hlth Sci, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	University of Michigan System; University of Michigan; Uniformed Services University of the Health Sciences - USA	Banerjee, R (corresponding author), Univ Michigan, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010	Yadav, Pramod K./0000-0003-0026-1684; Koutmos, Markos/0000-0003-0933-6312	National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984.	Abe K, 1996, J NEUROSCI, V16, P1066; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alphey MS, 2003, J BIOL CHEM, V278, P48219, DOI 10.1074/jbc.M307187200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; CRAWHALL JC, 1968, SCIENCE, V160, P419, DOI 10.1126/science.160.3826.419; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; HOLMGREN A, 2008, REDOX BIOCH; JARABAK R, 1978, ARCH BIOCHEM BIOPHYS, V185, P458, DOI 10.1016/0003-9861(78)90189-3; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; KATAOKA H, 1993, J CHROMATOGR-BIOMED, V615, P197, DOI 10.1016/0378-4347(93)80333-Y; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Linden DR, 2010, ANTIOXID REDOX SIGN, V12, P1135, DOI 10.1089/ars.2009.2885; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikami Y, 2011, BIOCHEM J, V439, P479, DOI 10.1042/BJ20110841; Modis K, 2013, FASEB J, V27, P601, DOI 10.1096/fj.12-216507; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagahara N, 2005, J BIOL CHEM, V280, P34569, DOI 10.1074/jbc.M505643200; Nagahara N, 2004, BIOCHIMIE, V86, P723, DOI 10.1016/j.biochi.2004.08.002; NAGAHARA N, 1995, J BIOL CHEM, V270, P16230, DOI 10.1074/jbc.270.27.16230; Nagahara N, 1996, J BIOL CHEM, V271, P27395, DOI 10.1074/jbc.271.44.27395; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nagahara N, 1999, HISTOL HISTOPATHOL, V14, P1277, DOI 10.14670/HH-14.1277; Nakamura T, 2000, EUR J BIOCHEM, V267, P5621, DOI 10.1046/j.1432-1327.2000.01633.x; Olson KR, 2010, ANTIOXID REDOX SIGN, V12, P1219, DOI 10.1089/ars.2009.2921; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RETEY J, 1990, ANGEW CHEM INT EDIT, V29, P355, DOI 10.1002/anie.199003551; Schrodinger L. L. C., 2010, PYMOL MOL GRAPH SYST; Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2011, BIOCHEMISTRY-US, V50, P419, DOI 10.1021/bi1010893; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Spallarossa A, 2004, J MOL BIOL, V335, P583, DOI 10.1016/j.jmb.2003.10.072; Su D, 2007, BIOCHEMISTRY-US, V46, P6903, DOI 10.1021/bi700152b; Turanov AA, 2010, METHOD ENZYMOL, V474, P245, DOI 10.1016/S0076-6879(10)74014-3; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Westrop GD, 2009, J BIOL CHEM, V284, P33485, DOI 10.1074/jbc.M109.054320; Whitfield NL, 2008, AM J PHYSIOL-REG I, V294, pR1930, DOI 10.1152/ajpregu.00025.2008; Williams RAM, 2003, J BIOL CHEM, V278, P1480, DOI 10.1074/jbc.M209395200; Yadav PK, 2012, J BIOL CHEM, V287, P43464, DOI 10.1074/jbc.M112.414722; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667	44	154	156	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20002	20013		10.1074/jbc.M113.466177	http://dx.doi.org/10.1074/jbc.M113.466177			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23698001	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000321515800064
J	Madura, F; Rizkallah, PJ; Miles, KM; Holland, CJ; Bulek, AM; Fuller, A; Schauenburg, AJA; Miles, JJ; Liddy, N; Sami, M; Li, Y; Hossain, M; Baker, BM; Jakobsen, BK; Sewell, AK; Cole, DK				Madura, Florian; Rizkallah, Pierre J.; Miles, Kim M.; Holland, Christopher J.; Bulek, Anna M.; Fuller, Anna; Schauenburg, Andrea J. A.; Miles, John J.; Liddy, Nathaniel; Sami, Malkit; Li, Yi; Hossain, Moushumi; Baker, Brian M.; Jakobsen, Bent K.; Sewell, Andrew K.; Cole, David K.			T-cell Receptor Specificity Maintained by Altered Thermodynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; HIGH-AFFINITY; PEPTIDE-MHC; DIRECTED EVOLUTION; CRYSTAL-STRUCTURES; CROSS-REACTIVITY; STRUCTURAL BASIS; TCR-BINDING; CRYSTALLIZATION; RECOGNITION	The T-cell receptor (TCR) recognizes peptides bound to major histocompatibility molecules (MHC) and allows T-cells to interrogate the cellular proteome for internal anomalies from the cell surface. The TCR contacts both MHC and peptide in an interaction characterized by weak affinity (K-D = 100 nM to 270 mu M). We used phage-display to produce a melanoma-specific TCR (alpha 24 beta 17) with a 30,000-fold enhanced binding affinity (K-D = 0.6 nM) to aid our exploration of the molecular mechanisms utilized to maintain peptide specificity. Remarkably, although the enhanced affinity was mediated primarily through new TCR-MHC contacts, alpha 24 beta 17 remained acutely sensitive to modifications at every position along the peptide backbone, mimicking the specificity of the wild type TCR. Thermodynamic analyses revealed an important role for solvation in directing peptide specificity. These findings advance our understanding of the molecular mechanisms that can govern the exquisite peptide specificity characteristic of TCR recognition.	[Madura, Florian; Rizkallah, Pierre J.; Miles, Kim M.; Holland, Christopher J.; Bulek, Anna M.; Fuller, Anna; Schauenburg, Andrea J. A.; Miles, John J.; Liddy, Nathaniel; Sewell, Andrew K.; Cole, David K.] Cardiff Univ, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Miles, John J.] Queensland Inst Med Res, Human Immun Lab, Brisbane, Qld 4006, Australia; [Liddy, Nathaniel; Sami, Malkit; Li, Yi; Jakobsen, Bent K.] Immunocore Ltd, Abingdon OX14 4RX, Oxon, England; [Miles, John J.] Univ Queensland, Sch Med, Brisbane, Qld 4006, Australia; [Hossain, Moushumi; Baker, Brian M.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	Cardiff University; QIMR Berghofer Medical Research Institute; University of Queensland; University of Notre Dame	Cole, DK (corresponding author), Cardiff Univ, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	coledk@cf.ac.uk	Baker, Brian/B-4584-2009; Rizkallah, Pierre J/A-5367-2012; Miles, John J/ABC-1105-2020; Sewell, Andrew/GPT-4220-2022	Baker, Brian/0000-0002-0864-0964; Rizkallah, Pierre J/0000-0002-9290-0369; Miles, John J/0000-0001-5506-6304; Sewell, Andrew/0000-0003-3194-3135; Cole, David/0000-0003-0028-9396; Fuller, Anna/0000-0002-8655-6741	UK Biotechnology and Biological Sciences Research Council [BB/H001085/1]; Tenovus Foundation; National Institute of General Medical Sciences, National Institutes of Health [GM067079]; Tenovus Ph.D. studentship; Research Councils UK fellowship; Australian National Health and Medical Research Council (NHMRC) career development fellowship; Wellcome Trust Research Career Development Fellowship [WT095767]; BBSRC [BB/H001085/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish; Tenovus Cancer Care [PhD2009/L20] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067079] Funding Source: NIH RePORTER	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tenovus Foundation; National Institute of General Medical Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Tenovus Ph.D. studentship; Research Councils UK fellowship(UK Research & Innovation (UKRI)); Australian National Health and Medical Research Council (NHMRC) career development fellowship(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Research Career Development Fellowship(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tenovus Cancer Care; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the UK Biotechnology and Biological Sciences Research Council (BB/H001085/1), a studentship from the Tenovus Foundation and in part by the National Institute of General Medical Sciences, National Institutes of Health (GM067079).; Funded by a Tenovus Ph.D. studentship.; Supported by a Research Councils UK fellowship.; Supported by an Australian National Health and Medical Research Council (NHMRC) career development fellowship.; Supported by Wellcome Trust Research Career Development Fellowship (WT095767). To whom correspondence should be addressed. Tel.: 442920687006; E-mail: coledk@cf.ac.uk.	Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Armstrong KM, 2008, J MOL RECOGNIT, V21, P275, DOI 10.1002/jmr.896; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Borbulevych OY, 2007, J MOL BIOL, V372, P1123, DOI 10.1016/j.jmb.2007.07.025; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Bulek AM, 2012, J IMMUNOL METHODS, V382, P203, DOI 10.1016/j.jim.2012.06.007; Bulek AM, 2012, NAT IMMUNOL, V13, P283, DOI 10.1038/ni.2206; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Cole DK, 2008, MOL IMMUNOL, V45, P2700, DOI 10.1016/j.molimm.2007.12.009; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2007, PROTEINS, V67, P65, DOI 10.1002/prot.21176; Cole DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1665; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Cole DK, 2009, J BIOL CHEM, V284, P27281, DOI 10.1074/jbc.M109.022509; Cole DK, 2006, EUR J IMMUNOL, V36, P170, DOI 10.1002/eji.200535424; DeLano W.L, PYMOL MOL GRAPHICS S; Dunn SM, 2006, PROTEIN SCI, V15, P710, DOI 10.1110/ps.051936406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garboczi DN, 1996, J IMMUNOL, V157, P5403; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Gostick E, 2007, EUR J IMMUNOL, V37, P479, DOI 10.1002/eji.200636243; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; Gura T, 2002, NATURE, V417, P584, DOI 10.1038/417584a; Holland CJ, 2012, SCI REP-UK, V2, DOI 10.1038/srep00629; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Irving M, 2012, J BIOL CHEM, V287, P23068, DOI 10.1074/jbc.M112.357673; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kieke MC, 1999, P NATL ACAD SCI USA, V96, P5651, DOI 10.1073/pnas.96.10.5651; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miles JJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001198; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Scott DR, 2011, J MOL BIOL, V414, P385, DOI 10.1016/j.jmb.2011.10.006; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Sliz P, 2001, J IMMUNOL, V167, P3276, DOI 10.4049/jimmunol.167.6.3276; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wooldridge L, 2012, J BIOL CHEM, V287, P1168, DOI 10.1074/jbc.M111.289488; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Wucherpfennig KW, 2007, SEMIN IMMUNOL, V19, P216, DOI 10.1016/j.smim.2007.02.012; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845	52	28	29	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18766	18775		10.1074/jbc.M113.464560	http://dx.doi.org/10.1074/jbc.M113.464560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23698002	Green Published, Green Accepted, Green Submitted, hybrid			2022-12-28	WOS:000321335800012
J	Yogalingam, G; Hwang, S; Ferreira, JCB; Mochly-Rosen, D				Yogalingam, Gouri; Hwang, Sunhee; Ferreira, Julio C. B.; Mochly-Rosen, Daria			Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Phosphorylation by Protein Kinase C delta (PKC delta) Inhibits Mitochondria Elimination by Lysosomal-like Structures following Ischemia and Reoxygenation-induced Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE PHOSPHORYLATION; REPERFUSION INJURY; MITOPHAGY; AUTOPHAGY; ACTIVATION; PARKIN; RECEPTOR; TRANSLOCATION; MEMBRANE; CARDIOPROTECTION	After cardiac ischemia and reperfusion or reoxygenation (I/R), damaged mitochondria propagate tissue injury by promoting cell death. One possible mechanism to protect from I/R-induced injury is the elimination of damaged mitochondria by mitophagy. Here we identify new molecular events that lead to mitophagy using a cell culture model and whole hearts subjected to I/R. We found that I/R induces glyceraldehyde-3-phosphate dehydrogenase (GAPDH) association with mitochondria and promotes direct uptake of damaged mitochondria into multiorganellar lysosomal-like (LL) structures for elimination independently of the macroautophagy pathway. We also found that protein kinase C delta (PKC delta) inhibits GAPDH-driven mitophagy by phosphorylating the mitochondrially associated GAPDH at threonine 246 following I/R. Phosphorylated GAPDH promotes the accumulation of mitochondria at the periphery of LL structures, which coincides with increased mitochondrial permeability. Either inhibition of PKC delta or expression of a phosphorylation-defective GAPDH mutant during I/R promotes a reduction in mitochondrial mass and apoptosis, thus indicating rescued mitophagy. Taken together, we identified a GAPDH/PKC delta signaling switch, which is activated during oxidative stress to regulate the balance between cell survival by mitophagy and cell death due to accumulation of damaged mitochondria.	[Yogalingam, Gouri; Hwang, Sunhee; Ferreira, Julio C. B.; Mochly-Rosen, Daria] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Mochly-Rosen, D (corresponding author), CCSR, Rm 3145A,269 Campus Dr, Stanford, CA 94305 USA.	mochly@stanford.edu	Ferreira, Julio/L-4687-2019; Ferreira, Julio Cesar Batista/I-3177-2012; Ferreira, Julio Cesar Batista/AEU-0494-2022	Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Mochly-Rosen, Daria/0000-0002-6691-8733	National Institutes of Health [HL052141]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant HL052141 (to D. M. R.).	ASHMARINA LI, 1988, FEBS LETT, V231, P413, DOI 10.1016/0014-5793(88)80861-5; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; Chen Y, 2013, SCIENCE, V340, P471, DOI 10.1126/science.1231031; Churchill EN, 2005, ARCH BIOCHEM BIOPHYS, V439, P194, DOI 10.1016/j.abb.2005.05.007; Churchill EN, 2005, CIRC RES, V97, P78, DOI 10.1161/01.RES.0000173896.32522.6e; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; CUERVO AM, 1994, J BIOL CHEM, V269, P26374; Cuervo AM, 2000, TRAFFIC, V1, P570, DOI 10.1034/j.1600-0854.2000.010707.x; Cuervo AM, 2003, EMBO J, V22, P47, DOI 10.1093/emboj/cdg002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dorn GW, 2010, J CARDIOVASC TRANSL, V3, P374, DOI 10.1007/s12265-010-9174-x; Farre JC, 2009, CURR OPIN CELL BIOL, V21, P522, DOI 10.1016/j.ceb.2009.04.015; Gao Y, 2006, J BIOL CHEM, V281, P18394, DOI 10.1074/jbc.M601112200; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; Gottlieb RA, 2011, AUTOPHAGY, V7, P1573, DOI 10.4161/auto.7.12.18175; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; HARDWICK JS, 1995, P NATL ACAD SCI USA, V92, P4527, DOI 10.1073/pnas.92.10.4527; Honda HM, 2006, CARDIOVASC DRUG THER, V20, P425, DOI 10.1007/s10557-006-0642-0; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Hwang NR, 2009, BIOCHEM J, V423, P253, DOI 10.1042/BJ20090854; Ikeno F, 2007, CARDIOVASC RES, V73, P699, DOI 10.1016/j.cardiores.2006.12.011; Inagaki K, 2003, CIRCULATION, V108, P2304, DOI 10.1161/01.CIR.0000101682.24138.36; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2010, AUTOPHAGY, V6, P433, DOI 10.4161/auto.6.3.11420; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kim I, 2011, ANTIOXID REDOX SIGN, V14, P1919, DOI 10.1089/ars.2010.3768; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; Mijaljica D, 2011, AUTOPHAGY, V7, P673, DOI 10.4161/auto.7.7.14733; MORERO RD, 1985, BIOCHEMISTRY-US, V24, P1904, DOI 10.1021/bi00329a015; Murriel CL, 2004, J BIOL CHEM, V279, P47985, DOI 10.1074/jbc.M405071200; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Okamoto K, 2009, AUTOPHAGY, V5, P1203, DOI 10.4161/auto.5.8.9830; Prasad A, 2009, CIRCULATION, V120, P2105, DOI 10.1161/CIRCULATIONAHA.108.814640; QIN SF, 1995, BIOCHEM J, V308, P347, DOI 10.1042/bj3080347; Qvit Nir, 2010, Drug Discov Today Dis Mech, V7, pe87, DOI 10.1016/j.ddmec.2010.07.001; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Sala-Mercado JA, 2010, CIRCULATION, V122, pS179, DOI 10.1161/CIRCULATIONAHA.109.928242; SCHIEVEN GL, 1993, J BIOL CHEM, V268, P16688; Sun Y, 2012, J BIOL CHEM, V287, P40652, DOI 10.1074/jbc.M112.419721; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wild P, 2010, NAT CELL BIOL, V12, P104, DOI 10.1038/ncb0210-104; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	54	76	76	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18947	18960		10.1074/jbc.M113.466870	http://dx.doi.org/10.1074/jbc.M113.466870			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23653351	Green Published, hybrid			2022-12-28	WOS:000321335800032
J	Doyle, TM; Jaentschke, B; Van Domselaar, G; Hashem, AM; Farnsworth, A; Forbes, NE; Li, CG; Wang, JZ; He, RT; Brown, EG; Li, XG				Doyle, Tracey M.; Jaentschke, Bozena; Van Domselaar, Gary; Hashem, Anwar M.; Farnsworth, Aaron; Forbes, Nicole E.; Li, Changgui; Wang, Junzhi; He, Runtao; Brown, Earl G.; Li, Xuguang			The Universal Epitope of Influenza A Viral Neuraminidase Fundamentally Contributes to Enzyme Activity and Viral Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS NEURAMINIDASE; 3-DIMENSIONAL STRUCTURE; ANTIGENIC VARIATION; FLUOROMETRIC ASSAY; ANTIBODIES; GLYCOPROTEIN; SUBTYPES; FUSION; ENTRY; SYSTEM	The only universally conserved sequence among all influenza A viral neuraminidases is located between amino acids 222 and 230. However, the potential roles of these amino acids remain largely unknown. Through an array of experimental approaches including mutagenesis, reverse genetics, and growth kinetics, we found that this sequence could markedly affect viral replication. Additional experiments revealed that enzymes with mutations in this region demonstrated substantially decreased catalytic activity, substrate binding, and thermostability. Consistent with viral replication analyses and enzymatic studies, protein modeling suggests that these amino acids could either directly bind to the substrate or contribute to the formation of the active site in the enzyme. Collectively, these findings reveal the essential role of this unique region in enzyme function and viral growth, which provides the basis for evaluating the validity of this sequence as a potential target for antiviral intervention and vaccine development.	[Doyle, Tracey M.; Jaentschke, Bozena; Hashem, Anwar M.; Farnsworth, Aaron; Li, Xuguang] Hlth Canada, Ctr Vaccine Evaluat, Biol & Genet Therapies Directorate, Hlth Prod & Food Branch, Ottawa, ON K1A 0K9, Canada; [Van Domselaar, Gary; He, Runtao] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB R3E 3R2, Canada; [Hashem, Anwar M.] King Abdulaziz Univ, Fac Med, Dept Med Microbiol & Parasitol, Jeddah 21413, Saudi Arabia; [Li, Changgui; Wang, Junzhi] Natl Inst Food & Drug Control, Beijing 100050, Peoples R China; [Doyle, Tracey M.; Hashem, Anwar M.; Forbes, Nicole E.; Brown, Earl G.; Li, Xuguang] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Doyle, Tracey M.; Hashem, Anwar M.; Forbes, Nicole E.; Brown, Earl G.; Li, Xuguang] Univ Ottawa, Ctr Emerging Pathogens Res, Ottawa, ON K1H 8M5, Canada	Health Canada; Public Health Agency of Canada; King Abdulaziz University; National Institute of Food & Drug Control - China; University of Ottawa; University of Ottawa	Li, XG (corresponding author), Hlth Canada, Sir FG Banting Res Ctr, Ctr Vaccine Evaluat, A-L 2201E,251 Sir Frederick Banting Driveway, Ottawa, ON K1A 0K9, Canada.	Sean.Li@hc-sc.gc.ca	Hashem, Anwar/E-9411-2011; Hashem, Anwar M/B-2301-2017	Hashem, Anwar M/0000-0002-8471-7011; Forbes, Nicole/0000-0002-2645-695X	Canadian Regulatory Strategy for Biotechnology; Canadian Institutes of Health Research Pandemic Preparedness Team Grant [TPA-90188]; Natural Sciences and Engineering Research Council of Canada; King Abdulaziz University through the Saudi Arabian Cultural Bureau in Canada	Canadian Regulatory Strategy for Biotechnology; Canadian Institutes of Health Research Pandemic Preparedness Team Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); King Abdulaziz University through the Saudi Arabian Cultural Bureau in Canada	This work was supported in part by the Canadian Regulatory Strategy for Biotechnology (to X. L.) and Canadian Institutes of Health Research Pandemic Preparedness Team Grant TPA-90188 (to E. G. B.).; Supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada.; Supported by a scholarship from King Abdulaziz University through the Saudi Arabian Cultural Bureau in Canada.	AIR GM, 1989, PROTEINS, V6, P341, DOI 10.1002/prot.340060402; BAKER AT, 1987, PROTEINS, V2, P111, DOI 10.1002/prot.340020205; Basak A, 2002, FEBS LETT, V514, P333, DOI 10.1016/S0014-5793(02)02394-3; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; COLMAN PM, 1994, PROTEIN SCI, V3, P1687, DOI 10.1002/pro.5560031007; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; COLMAN PM, 1989, PHILOS T R SOC B, V323, P511, DOI 10.1098/rstb.1989.0028; COLMAN PM, 1992, IMMUNOL CELL BIOL, V70, P209, DOI 10.1038/icb.1992.26; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Fuchs W, 2012, J VIROL, V86, P8002, DOI 10.1128/JVI.00690-12; Govorkova EA, 2013, CURR TOP MICROBIOL, V370, P273, DOI 10.1007/82_2011_198; Gravel C, 2010, VACCINE, V28, P5774, DOI 10.1016/j.vaccine.2010.06.075; GRIFFIN JA, 1983, VIROLOGY, V125, P324, DOI 10.1016/0042-6822(83)90205-2; Hashem AM, 2012, HUM VACC IMMUNOTHER, V8, P425, DOI 10.4161/hv.19109; Hashem AM, 2010, BIOCHEM BIOPH RES CO, V403, P247, DOI 10.1016/j.bbrc.2010.11.030; Hashem AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008350; Hatta Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001139; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Ilyushina NA, 2012, J VIROL, V86, P4724, DOI 10.1128/JVI.06774-11; Klenk H D, 1988, Adv Virus Res, V34, P247, DOI 10.1016/S0065-3527(08)60520-5; LAVER WG, 1984, MICROBIOL SCI, V1, P37; LIM WA, 1992, BIOCHEMISTRY-US, V31, P4324, DOI 10.1021/bi00132a025; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Liu Qinfang, 2009, J Mol Genet Med, V3, P225; Monera OD, 1996, PROTEIN ENG, V9, P353, DOI 10.1093/protein/9.4.353; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Su B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008495; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WEBSTER RG, 1978, ANNU REV GENET, V12, P415, DOI 10.1146/annurev.ge.12.120178.002215; Wei CJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004273; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102	43	20	20	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18283	18289		10.1074/jbc.M113.468884	http://dx.doi.org/10.1074/jbc.M113.468884			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645684	Green Published, hybrid			2022-12-28	WOS:000320721900032
J	Marion, JD; Roberts, CF; Call, RJ; Forbes, JL; Nelson, KT; Bell, JE; Bell, JK				Marion, James D.; Roberts, Charlotte F.; Call, R. Jason; Forbes, Jonathan L.; Nelson, Kristina T.; Bell, J. Ellis; Bell, Jessica K.			Mechanism of Endogenous Regulation of the Type I Interferon Response by Suppressor of I kappa B Kinase epsilon (SIKE), a Novel Substrate of TANK-binding Kinase 1 (TBK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; INNATE IMMUNE-RESPONSE; KINETIC MECHANISM; CRYSTAL-STRUCTURE; VIRUS-INFECTION; IKK-EPSILON; RIG-I; ACTIVATION; PHOSPHORYLATION; IRF-3	TANK-binding kinase 1 (TBK1) serves as a key convergence point in multiple innate immune signaling pathways. In response to receptor-mediated pathogen detection, TBK1 phosphorylation promotes production of pro-inflammatory cytokines and type I interferons. Increasingly, TBK1 dysregulation has been linked to autoimmune disorders and cancers, heightening the need to understand the regulatory controls of TBK1 activity. Here, we describe the mechanism by which suppressor of IKK epsilon (SIKE) inhibits TBK1-mediated phosphorylation of interferon regulatory factor 3 (IRF3), which is essential to type I interferon production. Kinetic analyses showed that SIKE not only inhibits IRF3 phosphorylation but is also a high affinity TBK1 substrate. With respect to IRF3 phosphorylation, SIKE functioned as a mixed-type inhibitor (K-i,K- app = 350 nM) rather than, given its status as a TBK1 substrate, as a competitive inhibitor. TBK1 phosphorylation of IRF3 and SIKE displayed negative cooperativity. Both substrates shared a similar K-m value at low substrate concentrations (similar to 50 nM) but deviated >8-fold at higher substrate concentrations (IRF3 = 3.5 mu M; SIKE = 0.4 mu M). TBK1-SIKE interactions were modulated by SIKE phosphorylation, clustered in the C-terminal portion of SIKE (Ser-133, -185, -187, -188, -190, and -198). These sites exhibited striking homology to the phosphorylation motif of IRF3. Mutagenic probing revealed that phosphorylation of Ser-185 controlled TBK1-SIKE interactions. Taken together, our studies demonstrate for the first time that SIKE functions as a TBK1 substrate and inhibits TBK1-mediated IRF3 phosphorylation by forming a high affinity TBK1-SIKE complex. These findings provide key insights into the endogenous control of a critical catalytic hub that is achieved not by direct repression of activity but by redirection of catalysis through substrate affinity.	[Marion, James D.; Roberts, Charlotte F.; Call, R. Jason; Forbes, Jonathan L.; Bell, Jessica K.] Virginia Commonwealth Univ, Biochem & Mol Biol Dept, Richmond, VA 23298 USA; [Nelson, Kristina T.] Virginia Commonwealth Univ, Dept Chem, Richmond, VA 23298 USA; [Bell, Jessica K.] Virginia Commonwealth Univ, Inst Struct Biol & Drug Discovery, Richmond, VA 23298 USA; [Bell, Jessica K.] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23298 USA; [Bell, Jessica K.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Bell, J. Ellis] Univ Richmond, Dept Chem, Richmond, VA 23173 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Richmond	Bell, JK (corresponding author), Biochem & Mol Biol Dept, POB 980614, Richmond, VA 23298 USA.	jbell6@vcu.edu	Bell, Jessica/I-3893-2013	Bell, Jessica/0000-0003-1455-3274	Thomas F. and Kate Miller Jeffress Memorial Trust [J1016]	Thomas F. and Kate Miller Jeffress Memorial Trust	This work was supported by Thomas F. and Kate Miller Jeffress Memorial Trust Grant J1016 (to J. K. B.).	An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; BELL JE, 1976, J BIOL CHEM, V251, P3003; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Burke JR, 1998, J BIOL CHEM, V273, P12041, DOI 10.1074/jbc.273.20.12041; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; DALZIEL K, 1957, ACTA CHEM SCAND, V11, P1706, DOI 10.3891/acta.chem.scand.11-1706; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gleason CE, 2011, J BIOL CHEM, V286, P35663, DOI 10.1074/jbc.M111.267567; Grand EK, 2004, GENE CHROMOSOME CANC, V40, P78, DOI 10.1002/gcc.20023; Hammaker D, 2012, RHEUMATOLOGY, V51, P610, DOI 10.1093/rheumatology/ker154; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Huynh QK, 2002, J BIOL CHEM, V277, P12550, DOI 10.1074/jbc.M111526200; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Lin A, 2010, AM J PATHOL, V176, P108, DOI 10.2353/ajpath.2010.090256; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; Munoz MC, 2009, J ENDOCRINOL, V201, P185, DOI 10.1677/JOE-08-0276; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Oganesyan G, 2008, J BIOL CHEM, V283, P802, DOI 10.1074/jbc.M704755200; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Panne D, 2007, J BIOL CHEM, V282, P22816, DOI 10.1074/jbc.M703019200; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Paz S, 2006, CELL MOL BIOL, V52, P17, DOI 10.1170/T694; Peet GW, 1999, J BIOL CHEM, V274, P32655, DOI 10.1074/jbc.274.46.32655; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shen RR, 2011, ONCOGENE, V30, P631, DOI 10.1038/onc.2010.493; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Wang BX, 2012, TRENDS IMMUNOL, V33, P190, DOI 10.1016/j.it.2012.01.004; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	52	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18612	18623		10.1074/jbc.M112.440859	http://dx.doi.org/10.1074/jbc.M112.440859			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649622	hybrid, Green Published			2022-12-28	WOS:000320721900060
J	Uchiyama, T; Miyazaki, K; Yaoi, K				Uchiyama, Taku; Miyazaki, Kentaro; Yaoi, Katsuro			Characterization of a Novel beta-Glucosidase from a Compost Microbial Metagenome with Strong Transglycosylation Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMITE NEOTERMES-KOSHUNENSIS; SULFOLOBUS-SOLFATARICUS; SUBSTRATE-SPECIFICITY; ASPERGILLUS-ORYZAE; TRICHODERMA-REESEI; PURIFICATION; GLYCOSIDASE; CLONING; EXPRESSION; TOLERANCE	The beta-glucosidase encoded by the td2f2 gene was isolated from a compost microbial metagenomic library by functional screening. The protein was identified to be a member of the glycoside hydrolase family 1 and was overexpressed in Escherichia coli, purified, and biochemically characterized. The recombinant beta-glucosidase, Td2F2, exhibited enzymatic activity with beta-glycosidic substrates, with preferences for glucose, fucose, and galactose. Hydrolysis occurred at the nonreducing end and in an exo manner. The order of catalytic efficiency for glucodisaccharides and cellooligosaccharides was sophorose > cellotetraose > cellotriose > laminaribiose > cellobiose > cellopentaose > gentiobiose, respectively. Intriguingly, the p-nitrophenyl-beta-D-glucopyranoside hydrolysis activity of Td2F2 was activated by various monosaccharides and sugar alcohols. At a D-glucose concentration of 1000 mM, enzyme activity was 6.7-fold higher than that observed in the absence of D-glucose. With 31.3 mM D-glucose, Td2F2 catalyzed transglycosylation to generate sophorose, laminaribiose, cellobiose, and gentiobiose. Transglycosylation products were detected under all activated conditions, suggesting that the activity enhancement induced by monosaccharides and sugar alcohols may be due to the transglycosylation activity of the enzyme. These results show that Td2F2 obtained from a compost microbial metagenome may be a potent candidate for industrial applications.	[Uchiyama, Taku; Miyazaki, Kentaro; Yaoi, Katsuro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Yaoi, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	k-yaoi@aist.go.jp	Yaoi, Katsuro/K-1491-2018; Miyazaki, Kentaro/F-7022-2010	Yaoi, Katsuro/0000-0002-4037-0087; Miyazaki, Kentaro/0000-0002-4349-566X	New Energy and Industrial Technology Development Organization; Grants-in-Aid for Scientific Research [24119515] Funding Source: KAKEN	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by in part by grants from the New Energy and Industrial Technology Development Organization.	Aguilar CF, 1997, J MOL BIOL, V271, P789, DOI 10.1006/jmbi.1997.1215; Bhatia Y, 2002, CRIT REV BIOTECHNOL, V22, P375, DOI 10.1080/07388550290789568; CHEN HZ, 1992, BIOCHIM BIOPHYS ACTA, V1121, P54, DOI 10.1016/0167-4838(92)90336-C; Decker CH, 2001, APPL MICROBIOL BIOT, V55, P157, DOI 10.1007/s002530000462; Di Lauro B, 2006, EXTREMOPHILES, V10, P301, DOI 10.1007/s00792-005-0500-1; Fang ZM, 2010, J MICROBIOL BIOTECHN, V20, P1351, DOI 10.4014/jmb.1003.03011; Hancock SM, 2005, CHEMBIOCHEM, V6, P866, DOI 10.1002/cbic.200400341; Hong J, 2006, APPL MICROBIOL BIOT, V73, P80, DOI 10.1007/s00253-006-0428-0; Jeng WY, 2011, J STRUCT BIOL, V173, P46, DOI 10.1016/j.jsb.2010.07.008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Marques AR, 2003, BIOCHEM J, V370, P793, DOI 10.1042/BJ20021249; McIlvaine TC, 1921, J BIOL CHEM, V49, P183; Nomura T, 2008, J BIOL CHEM, V283, P34650, DOI 10.1074/jbc.M806953200; NUCCI R, 1993, BIOTECHNOL APPL BIOC, V17, P239; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PEREZPONS JA, 1995, BBA-PROTEIN STRUCT M, V1251, P145, DOI 10.1016/0167-4838(95)00074-5; Riou C, 1998, APPL ENVIRON MICROB, V64, P3607; Suzuki H, 2006, J BIOL CHEM, V281, P30251, DOI 10.1074/jbc.M605726200; Uchima CA, 2011, APPL MICROBIOL BIOT, V89, P1761, DOI 10.1007/s00253-010-2963-y; Uchiyama T, 2008, NAT PROTOC, V3, P1202, DOI 10.1038/nprot.2008.96; Vladimir K, 1997, CHEM SOC REV, V26, P463; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; WOODWARD J, 1982, ENZYME MICROB TECH, V4, P73, DOI 10.1016/0141-0229(82)90084-9; Zanoelo FF, 2004, FEMS MICROBIOL LETT, V240, P137, DOI 10.1016/j.femsle.2004.09.021; Zhou JM, 2002, PLANT PHYSIOL, V129, P1252, DOI 10.1104/pp.010863	26	92	100	3	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18325	18334		10.1074/jbc.M113.471342	http://dx.doi.org/10.1074/jbc.M113.471342			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23661705	Green Published, hybrid			2022-12-28	WOS:000320721900036
J	Krishnamoorthy, GP; Guida, T; Alfano, L; Avilla, E; Santoro, M; Carlomagno, F; Melillo, RM				Krishnamoorthy, Gnana Prakasam; Guida, Teresa; Alfano, Luigi; Avilla, Elvira; Santoro, Massimo; Carlomagno, Francesca; Melillo, Rosa Marina			Molecular Mechanism of 17-Allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL Receptor Tyrosine Kinase Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METASTATIC BREAST-CANCER; MYELOID-LEUKEMIA CELLS; THERAPEUTIC TARGET; CHAPERONE COMPLEX; TRANSFORMING GENE; LUNG-CANCER; ATP BINDING; E3 LIGASE; IN-VIVO; PHASE-I	The receptor tyrosine kinase AXL is overexpressed in many cancer types including thyroid carcinomas and has well established roles in tumor formation and progression. Proper folding, maturation, and activity of several oncogenic receptor tyrosine kinases require HSP90 chaperoning. HSP90 inhibition by the antibiotic geldanamycin or its derivative 17-allylamino-17-demethoxygeldanamycin (17-AAG) causes destabilization of its client proteins. Here we show that AXL is a novel client protein of HSP90. 17-AAG induced a time- and dose-dependent down-regulation of endogenous or ectopically expressed AXL protein, thereby inhibiting AXL-mediated signaling and biological activity. 17-AAG-induced AXL down-regulation specifically affected fully glycosylated mature receptor present on cell membrane. By using biotin and [S-35] methionine labeling, we showed that 17-AAG caused depletion of membrane-localized AXL by mediating its degradation in the intracellular compartment, thus restricting its exposure on the cell surface. 17-AAG induced AXL polyubiquitination and subsequent proteasomal degradation; under basal conditions, AXL co-immunoprecipitated with HSP90. Upon 17-AAG treatment, AXL associated with the cochaperone HSP70 and the ubiquitin E3 ligase carboxyl terminus	[Krishnamoorthy, Gnana Prakasam; Guida, Teresa; Alfano, Luigi; Avilla, Elvira; Santoro, Massimo; Carlomagno, Francesca; Melillo, Rosa Marina] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy; [Santoro, Massimo; Carlomagno, Francesca; Melillo, Rosa Marina] Consiglio Nazl Ric G Salvatore, Ist Endocrinol & Oncol Sperimentale, I-80131 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Carlomagno, F (corresponding author), Ist Endocrinol & Oncol Sperimentale, Dipartimento Med Mol & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy.	francesca.carlomagno@unina.it; rosmelil@unina.it	Krishnamoorthy, Gnana P./J-8660-2019; Alfano, Luigi/B-8330-2015; melillo, rosa marina/O-5255-2015	Alfano, Luigi/0000-0002-4516-9956; MELILLO, Rosa Marina/0000-0002-9233-5275	Associazione Italiana per la Ricerca sul Cancro; Istituto Superiore di Oncologia, Project "Sviluppo di nuovi farmaci capaci alterare il microambiente tumorale e ripristinare la risposta immune anti-tumorale" (Alleanza Contro il Cancro) of the Health Ministry, Italian Ministero della Salute Grant [PIO-2]; Istituto Superiore di Oncologia, Project "Molecular diagnostic and prognostic markers of thyroid neoplasis" of the Health Ministry, Italian Ministero della Salute Grant [PIO-2, RF-CAM-353005]; Ministero dell'Universita e della Ricerca [E61J11000300001, E61J10000210001]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Istituto Superiore di Oncologia, Project "Sviluppo di nuovi farmaci capaci alterare il microambiente tumorale e ripristinare la risposta immune anti-tumorale" (Alleanza Contro il Cancro) of the Health Ministry, Italian Ministero della Salute Grant; Istituto Superiore di Oncologia, Project "Molecular diagnostic and prognostic markers of thyroid neoplasis" of the Health Ministry, Italian Ministero della Salute Grant; Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by the Associazione Italiana per la Ricerca sul Cancro, the Istituto Superiore di Oncologia, Project "Sviluppo di nuovi farmaci capaci alterare il microambiente tumorale e ripristinare la risposta immune anti-tumorale" (Alleanza Contro il Cancro), Project "Molecular diagnostic and prognostic markers of thyroid neoplasis" RF-CAM-353005 of the Health Ministry, Italian Ministero della Salute Grant PIO-2, and Ministero dell'Universita e della Ricerca Grants E61J11000300001 and E61J10000210001.	Alfano L, 2010, J CLIN ENDOCR METAB, V95, P3552, DOI 10.1210/jc.2009-2315; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Amann J, 2005, CANCER RES, V65, P226; Avilla E, 2011, CANCER RES, V71, P1792, DOI 10.1158/0008-5472.CAN-10-2186; Carlomagno F, 1996, EMBO J, V15, P2717, DOI 10.1002/j.1460-2075.1996.tb00632.x; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Dufies M, 2011, ONCOTARGET, V2, P874, DOI 10.18632/oncotarget.360; Farina AR, 2009, ONCOGENE, V28, P4075, DOI 10.1038/onc.2009.256; Fumo G, 2004, BLOOD, V103, P1078, DOI 10.1182/blood-2003-07-2477; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Ghosh AK, 2011, BLOOD, V117, P1928, DOI 10.1182/blood-2010-09-305649; GOTTARDI CJ, 1995, AM J PHYSIOL-RENAL, V268, pF285, DOI 10.1152/ajprenal.1995.268.2.F285; Guida T, 2007, CLIN CANCER RES, V13, P3363, DOI 10.1158/1078-0432.CCR-06-2667; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Hong CC, 2008, CANCER LETT, V268, P314, DOI 10.1016/j.canlet.2008.04.017; Huang F, 2010, CANCER RES, V70, P7221, DOI 10.1158/0008-5472.CAN-10-0391; Hubbard J, 2011, INVEST NEW DRUG, V29, P473, DOI 10.1007/s10637-009-9381-y; Iyer G, 2012, CANCER CHEMOTH PHARM, V69, P1089, DOI 10.1007/s00280-011-1789-3; Kundrat L, 2010, BIOCHEMISTRY-US, V49, P7428, DOI 10.1021/bi100386w; Li Y, 2009, ONCOGENE, V28, P3442, DOI 10.1038/onc.2009.212; Liu L, 2009, CANCER RES, V69, P6871, DOI 10.1158/0008-5472.CAN-08-4490; Matei D, 2007, J BIOL CHEM, V282, P445, DOI 10.1074/jbc.M607012200; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Neckers L, 1999, INVEST NEW DRUG, V17, P361, DOI 10.1023/A:1006382320697; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Ramalingam SS, 2008, CLIN CANCER RES, V14, P3456, DOI 10.1158/1078-0432.CCR-07-5088; Rankin EB, 2010, CANCER RES, V70, P7570, DOI 10.1158/0008-5472.CAN-10-1267; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Sausville EA, 2003, CURR CANCER DRUG TAR, V3, P377, DOI 10.2174/1568009033481831; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; STITT TN, 1995, CELL, V80, P661, DOI 10.1016/0092-8674(95)90520-0; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Tikhomirov O, 2003, CANCER RES, V63, P39; Welch WJ, 1991, CURR OPIN CELL BIOL, V3, P1033, DOI 10.1016/0955-0674(91)90125-I; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhout PC, 2003, J BIOL CHEM, V278, P13829, DOI 10.1074/jbc.M209640200	51	36	37	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17481	17494		10.1074/jbc.M112.439422	http://dx.doi.org/10.1074/jbc.M112.439422			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629654	Green Published, hybrid			2022-12-28	WOS:000320380600040
J	Akiyama, BM; Gomez, A; Stone, MD				Akiyama, Benjamin M.; Gomez, Anastassia; Stone, Michael D.			A Conserved Motif in Tetrahymena thermophila Telomerase Reverse Transcriptase Is Proximal to the RNA Template and Is Essential for Boundary Definition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ribonuclear Protein (RNP); RNA; RNA-binding Protein; Telomerase; Telomeres	CATALYTIC SUBUNIT TERT; BINDING DOMAIN; PROTEIN; RIBONUCLEOPROTEIN; HOLOENZYME; SEQUENCE; LOOP; DNA	The ends of linear chromosomes are extended by telomerase, a ribonucleoprotein complex minimally consisting of a protein subunit called telomerase reverse transcriptase (TERT) and the telomerase RNA (TER). TERT functions by reverse transcribing a short template region of TER into telomeric DNA. Proper assembly of TERT and TER is essential for telomerase activity; however, a detailed understanding of how TERT interacts with TER is lacking. Previous studies have identified an RNA binding domain (RBD) within TERT, which includes three evolutionarily conserved sequence motifs: CP2, CP, and T. Here, we used site-directed hydroxyl radical probing to directly identify sites of interaction between the TERT RBD and TER, revealing that the CP2 motif is in close proximity to a conserved region of TER known as the template boundary element (TBE). Gel shift assays on CP2 mutants confirmed that the CP2 motif is an RNA binding determinant. Our results explain previous work that established that mutations to the CP2 motif of TERT and to the TBE of TER both permit misincorporation of nucleotides into the growing DNA strand beyond the canonical template. Taken together, these results suggest a model in which the CP2 motif binds the TBE to strictly define which TER nucleotides can be reverse transcribed.	[Akiyama, Benjamin M.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Gomez, Anastassia; Stone, Michael D.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Akiyama, Benjamin M.; Stone, Michael D.] Univ Calif Santa Cruz, Ctr RNA Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Stone, MD (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, 1156 High St, Santa Cruz, CA 95064 USA.	mds@ucsc.edu			National Institutes of Health [GM095850, T32 GM8646, T34 GM007910-31]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095850, T34GM007910, T32GM008646] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM095850 (to M. D. S.) and National Institutes of Health Training Grants T32 GM8646 (to B. M. A.) and T34 GM007910-31 (to A. G.).	Akiyama BM, 2012, RNA, V18, P653, DOI 10.1261/rna.031377.111; Berman AJ, 2011, NAT STRUCT MOL BIOL, V18, P1371, DOI 10.1038/nsmb.2174; Berman AJ, 2010, MOL CELL BIOL, V30, P4965, DOI 10.1128/MCB.00827-10; Bosoy D, 2003, J BIOL CHEM, V278, P3882, DOI 10.1074/jbc.M210645200; Bryan TM, 2000, MOL CELL, V6, P493, DOI 10.1016/S1097-2765(00)00048-4; Culver GM, 2000, METHOD ENZYMOL, V318, P461; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; HEILEK GM, 1995, P NATL ACAD SCI USA, V92, P1113, DOI 10.1073/pnas.92.4.1113; Hengesbach M, 2011, CURR OPIN CHEM BIOL, V15, P845, DOI 10.1016/j.cbpa.2011.10.008; Jiang JS, 2013, NATURE, V496, P187, DOI 10.1038/nature12062; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Lai CK, 2001, MOL CELL BIOL, V21, P990, DOI 10.1128/MCB.21.4.990-1000.2001; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Lin J, 2004, P NATL ACAD SCI USA, V101, P14713, DOI 10.1073/pnas.0405879101; Miller MC, 2000, EMBO J, V19, P4412, DOI 10.1093/emboj/19.16.4412; Mitchell M, 2010, NAT STRUCT MOL BIOL, V17, P513, DOI 10.1038/nsmb.1777; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; O'Connor CM, 2005, J BIOL CHEM, V280, P17533, DOI 10.1074/jbc.M501211200; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Richards RJ, 2006, NUCLEIC ACIDS RES, V34, P816, DOI 10.1093/nar/gkj481; Robart AR, 2010, RNA, V16, P563, DOI 10.1261/rna.1936410; Rouda S, 2007, STRUCTURE, V15, P1403, DOI 10.1016/j.str.2007.09.007; Sperger JM, 2001, BIOCHEMISTRY-US, V40, P7005, DOI 10.1021/bi0103359; Stone MD, 2007, NATURE, V446, P458, DOI 10.1038/nature05600; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; Vulliamy TJ, 2008, BIOCHIMIE, V90, P122, DOI 10.1016/j.biochi.2007.07.017; Wu JY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1033	30	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22141	22149		10.1074/jbc.M113.452425	http://dx.doi.org/10.1074/jbc.M113.452425			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760279	Green Published, hybrid			2022-12-28	WOS:000328841900057
J	Lopez-Pelegrin, M; Cerda-Costa, N; Martinez-Jimenez, F; Cintas-Pedrola, A; Canals, A; Peinado, JR; Marti-Renom, MA; Lopez-Otin, C; Arolas, JL; Gomis-Ruth, FX				Lopez-Pelegrin, Mar; Cerda-Costa, Nuria; Martinez-Jimenez, Francisco; Cintas-Pedrola, Anna; Canals, Albert; Peinado, Juan R.; Marti-Renom, Marc A.; Lopez-Otin, Carlos; Arolas, Joan L.; Xavier Gomis-Rueth, F.			A Novel Family of Soluble Minimal Scaffolds Provides Structural Insight into the Catalytic Domains of Integral Membrane Metallopeptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM SENSOR; CRYSTAL-STRUCTURES; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; SNAKE-VENOM; ACTIVE-SITE; DRUG DESIGN; PROTEIN; METALLOPROTEASE; ARCHITECTURE	In the search for structural models of integral-membrane metallopeptidases (MPs), we discovered three related proteins from thermophilic prokaryotes, which we grouped into a novel family called "minigluzincins." We determined the crystal structures of the zymogens of two of these (Pyrococcus abyssi proabylysin and Methanocaldococcus jannaschii projannalysin), which are soluble and, with similar to 100 residues, constitute the shortest structurally characterized MPs to date. Despite relevant sequence and structural similarity, the structures revealed two unique mechanisms of latency maintenance through the C-terminal segments previously unseen in MPs as follows: intramolecular, through an extended tail, in proabylysin, and crosswise intermolecular, through a helix swap, inprojannalysin. In addition, structural and sequence comparisons revealed large similarity with MPs of the gluzincin tribe such as thermolysin, leukotriene A4 hydrolase relatives, and cowrins. Noteworthy, gluzincins mostly contain a glutamate as third characteristic zinc ligand, whereas minigluzincins have a histidine. Sequence and structural similarity further allowed us to ascertain that minigluzincins are very similar to the catalytic domains of integral membrane MPs of the MEROPS database families M48 and M56, such as FACE1, HtpX, Oma1, and BlaR1/MecR1, which are provided with trans-membrane helices flanking or inserted into a minigluzincin-like catalytic domain. In a time where structural biochemistry of integral-membrane proteins in general still faces formidable challenges, the minigluzincin soluble minimal scaffold may contribute to our understanding of the working mechanisms of these membrane MPs and to the design of novel inhibitors through structure-aided rational drug design approaches.	[Lopez-Pelegrin, Mar; Cerda-Costa, Nuria; Cintas-Pedrola, Anna; Peinado, Juan R.; Arolas, Joan L.; Xavier Gomis-Rueth, F.] CSIC, Mol Biol Inst Barcelona, Dept Biol Struct, Proteolysis Lab, E-08028 Barcelona, Spain; [Martinez-Jimenez, Francisco; Marti-Renom, Marc A.] Ctr Nacl Anal Genom, Genome Biol Grp, Barcelona 08028, Spain; [Martinez-Jimenez, Francisco; Marti-Renom, Marc A.] Ctr Genom Regulat, Gene Regulat Stem Cells & Canc Program, Barcelona 08003, Spain; [Canals, Albert] CSIC, Mol Biol Inst Barcelona, E-08028 Barcelona, Spain; [Canals, Albert] Inst Res Biomed, Barcelona 08028, Spain; [Lopez-Otin, Carlos] Univ Oviedo, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol, E-33006 Oviedo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Oviedo; University of Oviedo; Instituto Universitario de Oncologia de Asturias	Arolas, JL (corresponding author), CSIC, Mol Biol Inst Barcelona, Dept Biol Struct, Proteolysis Lab, C Baldiri Reixac 15-21, E-08028 Barcelona, Spain.	jlacri@ibmb.csic.es; xgrcri@ibmb.csic.es	Marti-Renom, Marc/A-1836-2010; Peinado, Juan R/A-3450-2011; Marti-Renom, Marc A./Y-8803-2019; López-Otín, Carlos/AAB-2106-2020; Canals, Albert/ABH-3354-2020	Marti-Renom, Marc/0000-0002-0151-4279; Peinado, Juan R/0000-0002-0004-7963; Marti-Renom, Marc A./0000-0002-0151-4279; López-Otín, Carlos/0000-0001-6964-1904; Gomis-Ruth, F. Xavier/0000-0002-6848-6874; Lopez Arolas, Joan/0000-0002-4198-5016; Martinez-Jimenez, Francisco/0000-0001-7804-1134	Fundacio "La Marato de TV3" [2009-100732, 2009SGR1036]; Consejo Superior de Investigaciones Cientificas; Spanish Ministry for Science and Technology, Ministry of Economy and Competitiveness; FSE;  [FP7-HEALTH-F3-2009-223101];  [FP7-HEALTH-2010-261460];  [FP7-PEOPLE-2011-ITN-290246];  [FP7-HEALTH- 2012-306029-2];  [BFU2010-19310];  [BFU2012-32862];  [CSD2006-00015]	Fundacio "La Marato de TV3"; Consejo Superior de Investigaciones Cientificas; Spanish Ministry for Science and Technology, Ministry of Economy and Competitiveness; FSE(European Social Fund (ESF)); ; ; ; ; ; ; 	This work was supported in part by European, Spanish, and Catalan Agency Grants FP7-HEALTH-F3-2009-223101 "AntiPathoGN," FP7-HEALTH-2010-261460 "Gums&Joints," FP7-PEOPLE-2011-ITN-290246 "RAPID," FP7-HEALTH- 2012-306029-2 "TRIGGER," BFU2010-19310, BFU2012-32862, CSD2006-00015, Fundacio "La Marato de TV3" Grants 2009-100732 and 2009SGR1036, postdoctoral JAE contract from Consejo Superior de Investigaciones Cientificas (co-funded by FSE), and two FPI Ph.D. fellowships from the Spanish Ministry for Science and Technology, currently part of the Ministry of Economy and Competitiveness.	Addlagatta A, 2006, P NATL ACAD SCI USA, V103, P13339, DOI 10.1073/pnas.0606167103; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arinaminpathy Y, 2009, DRUG DISCOV TODAY, V14, P1130, DOI 10.1016/j.drudis.2009.08.006; Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; Barrowman J, 2009, BIOL CHEM, V390, P761, DOI 10.1515/BC.2009.080; Bauvois Cedric, 2008, J Biol Chem, V283, P23315, DOI 10.1074/jbc.M802158200; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Berzigotti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036400; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Birck C, 2004, J AM CHEM SOC, V126, P13945, DOI 10.1021/ja044742u; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Botelho TO, 2011, J BIOL CHEM, V286, P25697, DOI 10.1074/jbc.M111.247437; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carranza C., 1999, 9039 CNRSUPR, P89; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davey J, 2004, EXPERT OPIN THER TAR, V8, P165, DOI 10.1517/eott.8.2.165.30250; Debreczeni JE, 2012, ACTA CRYSTALLOGR D, V68, P425, DOI 10.1107/S0907444912000200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Freije JMP, 1999, GENOMICS, V58, P270, DOI 10.1006/geno.1999.5834; Freije JMP, 2012, CURR OPIN CELL BIOL, V24, P757, DOI 10.1016/j.ceb.2012.08.009; FujimuraKamada K, 1997, J CELL BIOL, V136, P271, DOI 10.1083/jcb.136.2.271; Gao XA, 2010, P NATL ACAD SCI USA, V107, P17569, DOI 10.1073/pnas.1005681107; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; Goulas T, 2011, P NATL ACAD SCI USA, V108, P1856, DOI 10.1073/pnas.1012173108; GREER J, 1994, J MED CHEM, V37, P1035, DOI 10.1021/jm00034a001; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hao HH, 2012, FUTURE MICROBIOL, V7, P1315, DOI [10.2217/FMB.12.107, 10.2217/fmb.12.107]; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Hardt K, 1997, MOL MICROBIOL, V23, P935, DOI 10.1046/j.1365-2958.1997.2761642.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOLMES MA, 1981, BIOCHEMISTRY-US, V20, P6912, DOI 10.1021/bi00527a026; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Hubschle CB, 2012, ACTA CRYSTALLOGR A, V68, pS152, DOI 10.1107/S0108767312097085; JANIN J, 1990, J BIOL CHEM, V265, P16027; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaser M, 2003, J BIOL CHEM, V278, P46414, DOI 10.1074/jbc.M305584200; Kerff F, 2003, BIOCHEMISTRY-US, V42, P12835, DOI 10.1021/bi034976a; Kim H, 2006, P NATL ACAD SCI USA, V103, P11142, DOI 10.1073/pnas.0604075103; Kochan G, 2011, P NATL ACAD SCI USA, V108, P7745, DOI 10.1073/pnas.1101262108; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Kyrieleis OJP, 2005, J MOL BIOL, V349, P787, DOI 10.1016/j.jmb.2005.03.070; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Llarrull LI, 2012, BIOCHEMISTRY-US, V51, P4642, DOI 10.1021/bi300429p; Llarrull LI, 2010, CURR OPIN MICROBIOL, V13, P551, DOI 10.1016/j.mib.2010.09.008; Mallorqui-Fernandez G, 2004, FEMS MICROBIOL LETT, V235, P1, DOI 10.1016/j.femsle.2004.04.035; Marrero A, 2006, J MOL BIOL, V361, P506, DOI 10.1016/j.jmb.2006.06.046; MATTHEWS BW, 1972, NATURE-NEW BIOL, V238, P37, DOI 10.1038/newbio238037a0; McBride H, 2010, CURR BIOL, V20, pR274, DOI 10.1016/j.cub.2010.02.011; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; MCKERROW JH, 1987, J BIOL CHEM, V262, P5943; Oganesyan V, 2003, ACTA CRYSTALLOGR D, V59, P1219, DOI 10.1107/S0907444903011028; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pryor EE, 2013, SCIENCE, V339, P1600, DOI 10.1126/science.1232048; Quigley A, 2013, SCIENCE, V339, P1604, DOI 10.1126/science.1231513; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sheldrick GM, 2011, ACTA CRYSTALLOGR A, V67, pC13, DOI 10.1107/S0108767311099727; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Takeda S, 2012, BBA-PROTEINS PROTEOM, V1824, P164, DOI 10.1016/j.bbapap.2011.04.009; Takeda S, 2009, SEMIN CELL DEV BIOL, V20, P146, DOI 10.1016/j.semcdb.2008.07.009; Tallant C, 2006, J BIOL CHEM, V281, P17920, DOI 10.1074/jbc.M600907200; Tallant C, 2010, J BIOL CHEM, V285, P13951, DOI 10.1074/jbc.M109.083378; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Terstappen GC, 2001, TRENDS PHARMACOL SCI, V22, P23, DOI 10.1016/S0165-6147(00)01584-4; Tholander F, 2008, CHEM BIOL, V15, P920, DOI 10.1016/j.chembiol.2008.07.018; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wilke MS, 2004, J BIOL CHEM, V279, P47278, DOI 10.1074/jbc.M407054200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Wolfe MS, 2009, J BIOL CHEM, V284, P13969, DOI 10.1074/jbc.R800039200; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Gomis-Ruth FX, 2012, BBA-PROTEINS PROTEOM, V1824, P157, DOI 10.1016/j.bbapap.2011.04.014; Zhan CY, 2005, ACTA CRYSTALLOGR F, V61, P959, DOI 10.1107/S1744309105031131; ZHU YF, 1992, J BACTERIOL, V174, P6171, DOI 10.1128/JB.174.19.6171-6178.1992	99	26	26	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21279	21294		10.1074/jbc.M113.476580	http://dx.doi.org/10.1074/jbc.M113.476580			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23733187	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000322014400048
J	Chaudhary, P; Sharma, R; Sahu, M; Vishwanatha, JK; Awasthi, S; Awasthi, YC				Chaudhary, Pankaj; Sharma, Rajendra; Sahu, Mukesh; Vishwanatha, Jamboor K.; Awasthi, Sanjay; Awasthi, Yogesh C.			4-Hydroxynonenal Induces G(2)/M Phase Cell Cycle Arrest by Activation of the Ataxia Telangiectasia Mutated and Rad3-related Protein (ATR)/Checkpoint Kinase 1 (Chk1) Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; GLUTATHIONE TRANSFERASE A4-4; LIPID-PEROXIDATION PRODUCTS; HIGH CATALYTIC EFFICIENCY; DOUBLE-STRAND BREAKS; HUMAN P53 GENE; HISTONE H2AX; OXIDATIVE STRESS; CARBON-TETRACHLORIDE; S-TRANSFERASES	4-Hydroxynonenal (HNE) has been widely implicated in the mechanisms of oxidant-induced toxicity, but the detrimental effects of HNE associated with DNA damage or cell cycle arrest have not been thoroughly studied. Here we demonstrate for the first time that HNE caused G(2)/M cell cycle arrest of hepatocellular carcinoma HepG2 (p53 wild type) and Hep3B (p53 null) cells that was accompanied with decreased expression of CDK1 and cyclin B1 and activation of p21 in a p53-independent manner. HNE treatment suppressed the Cdc25C level, which led to inactivation of CDK1. HNE-induced phosphorylation of Cdc25C at Ser-216 resulted in its translocation from nucleus to cytoplasm, thereby facilitating its degradation via the ubiquitin-mediated proteasomal pathway. This phosphorylation of Cdc25C was regulated by activation of the ataxia telangiectasia and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) pathway. The role of HNE in the DNA double strand break was strongly suggested by a remarkable increase in comet tail formation and H2A.X phosphorylation in HNE-treated cells in vitro. This was supported by increased in vivo phosphorylation of H2A. X in mGsta4 null mice that have impaired HNE metabolism and increased HNE levels in tissues. HNE-mediated ATR/Chk1 signaling was inhibited byATRkinase inhibitor (caffeine). Additionally, most of the signaling effects of HNE on cell cycle arrest were attenuated in hGSTA4 transfected cells, thereby indicating the involvement of HNE in these events. A novel role of GSTA4-4 in the maintenance of genomic integrity is also suggested.	[Chaudhary, Pankaj; Sharma, Rajendra; Sahu, Mukesh; Vishwanatha, Jamboor K.; Awasthi, Yogesh C.] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX 76107 USA; [Chaudhary, Pankaj; Sharma, Rajendra; Sahu, Mukesh; Vishwanatha, Jamboor K.; Awasthi, Yogesh C.] Univ N Texas, Hlth Sci Ctr, Inst Canc Res, Ft Worth, TX 76107 USA; [Awasthi, Sanjay] City Hope Comprehens Canc Ctr, Dept Diabet Endocrinol & Metab, Duarte, CA 91010 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; City of Hope	Awasthi, YC (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	Yogesh.Awasthi@unthsc.edu	Awasthi, Sanjay/R-4904-2019	Awasthi, Sanjay/0000-0002-5214-5717; Chaudhary, Pankaj/0000-0003-0518-4120; Vishwanatha, Jamboor/0000-0002-0266-6020	National Institutes of Health [ES012171, EY004396, CA77495, 1P20 MD006882]; NATIONAL CANCER INSTITUTE [R01CA077495] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R55EY004396, R01EY004396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012171] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants ES012171 and EY004396 (to Y. C. A.), CA77495 (to S. A.), and 1P20 MD006882 (to J. K. V.).	Abel EL, 2010, JNCI-J NATL CANCER I, V102, P1663, DOI 10.1093/jnci/djq392; Awasthi YC, 2005, METHOD ENZYMOL, V401, P379, DOI 10.1016/S0076-6879(05)01024-4; Awasthi YC, 2008, FREE RADICAL BIO MED, V45, P111, DOI 10.1016/j.freeradbiomed.2008.04.007; Awasthi Yogesh C., 2003, Molecular Aspects of Medicine, V24, P219; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barrera G, 2004, FREE RADICAL BIO MED, V37, P597, DOI 10.1016/j.freeradbiomed.2004.05.023; BHATNAGAR A, 1995, CIRC RES, V76, P293, DOI 10.1161/01.RES.76.2.293; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Bruns CM, 1999, J MOL BIOL, V288, P427, DOI 10.1006/jmbi.1999.2697; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burcham PC, 1998, MUTAGENESIS, V13, P287, DOI 10.1093/mutage/13.3.287; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Chaudhary P, 2010, BIOCHEMISTRY-US, V49, P6263, DOI 10.1021/bi100517x; Chen F, 2002, P NATL ACAD SCI USA, V99, P1990, DOI 10.1073/pnas.032428899; Chen JJ, 1996, MOL CELL BIOL, V16, P4673; Cheng JZ, 2001, J BIOL CHEM, V276, P41213, DOI 10.1074/jbc.M106838200; Chung FL, 2003, MUTAT RES-FUND MOL M, V531, P25, DOI 10.1016/j.mrfmmm.2003.07.001; Chung FL, 2000, CANCER RES, V60, P1507; de Feraudy S, 2010, P NATL ACAD SCI USA, V107, P6870, DOI 10.1073/pnas.1002175107; Dianzani Mario Umberto, 2003, Molecular Aspects of Medicine, V24, P263; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; Engle MR, 2004, TOXICOL APPL PHARM, V194, P296, DOI 10.1016/j.taap.2003.10.001; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Feng ZH, 2004, P NATL ACAD SCI USA, V101, P8598, DOI 10.1073/pnas.0402794101; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Godschalk R, 2002, CARCINOGENESIS, V23, P2081, DOI 10.1093/carcin/23.12.2081; Goodarzi Aaron A, 2003, Prog Cell Cycle Res, V5, P393; Hall-Jackson CA, 1999, ONCOGENE, V18, P6707, DOI 10.1038/sj.onc.1203077; Hartley DP, 1999, TOXICOL APPL PHARM, V161, P23, DOI 10.1006/taap.1999.8788; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hu WW, 2002, CARCINOGENESIS, V23, P1781, DOI 10.1093/carcin/23.11.1781; Hubatsch I, 1998, BIOCHEM J, V330, P175, DOI 10.1042/bj3300175; Hussain SP, 2000, P NATL ACAD SCI USA, V97, P12770, DOI 10.1073/pnas.220416097; Laurora S, 2005, FREE RADICAL BIO MED, V38, P215, DOI 10.1016/j.freeradbiomed.2004.10.014; Li J, 2006, BIOCHEMISTRY-US, V45, P12253, DOI 10.1021/bi060780+; Liu QH, 2000, GENE DEV, V14, P1448; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Marnett L J, 1994, IARC Sci Publ, P151; Marnett LJ, 2001, TRENDS GENET, V17, P214, DOI 10.1016/S0168-9525(01)02239-9; Medema RH, 2012, ONCOGENE, V31, P2601, DOI 10.1038/onc.2011.451; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; Nakashima Izumi, 2003, Molecular Aspects of Medicine, V24, P231, DOI 10.1016/S0098-2997(03)00018-9; Negre-Salvayre Anne, 2003, Molecular Aspects of Medicine, V24, P251, DOI 10.1016/S0098-2997(03)00020-7; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Pizzimenti S, 1999, FREE RADICAL BIO MED, V26, P1578, DOI 10.1016/S0891-5849(99)00022-2; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; Porter Lisa A, 2003, Prog Cell Cycle Res, V5, P335; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; Sharma A, 2008, ARCH BIOCHEM BIOPHYS, V480, P85, DOI 10.1016/j.abb.2008.09.016; Sharma R, 2004, ANTIOXID REDOX SIGN, V6, P289, DOI 10.1089/152308604322899350; Singh SP, 2010, J GERONTOL A-BIOL, V65, P14, DOI 10.1093/gerona/glp165; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Tenzer A., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P35, DOI 10.2174/1568011033353533; Timofeev O, 2010, J BIOL CHEM, V285, P16978, DOI 10.1074/jbc.M109.096552; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Vatsyayan R, 2012, BIOCHEM BIOPH RES CO, V417, P346, DOI 10.1016/j.bbrc.2011.11.113; Vatsyayan R, 2011, EXP EYE RES, V92, P147, DOI 10.1016/j.exer.2010.11.010; Wacker M, 2001, CHEM-BIOL INTERACT, V137, P269, DOI 10.1016/S0009-2797(01)00259-9; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yang A, 2000, NAT REV MOL CELL BIO, V1, P199, DOI 10.1038/35043127; Yang YS, 2003, J BIOL CHEM, V278, P41380, DOI 10.1074/jbc.M305766200; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhivotovsky B, 2004, NAT REV MOL CELL BIO, V5, P752, DOI 10.1038/nrm1443	73	42	45	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20532	20546		10.1074/jbc.M113.467662	http://dx.doi.org/10.1074/jbc.M113.467662			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23733185	Green Published, hybrid			2022-12-28	WOS:000321715100040
J	Liu, GL; Sengupta, PK; Jamal, B; Yang, HY; Bouchie, MP; Lindner, V; Varelas, X; Kukuruzinska, MA				Liu, Gangli; Sengupta, Pritam K.; Jamal, Basem; Yang, Hsiao-Ying; Bouchie, Meghan P.; Lindner, Volkhard; Varelas, Xaralabos; Kukuruzinska, Maria A.			N-Glycosylation Induces the CTHRC1 Protein and Drives Oral Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX REPEAT; E-CADHERIN; MOLECULAR PATHOGENESIS; SIGNALING PATHWAY; BETA-CATENIN; GENE DPAGT1; EXPRESSION; PROMOTES; CARCINOMA; GROWTH	Oral squamous cell carcinoma (OSCC) is one of the most pernicious malignancies, but the mechanisms underlying its development and progression are poorly understood. One of the key pathways implicated in OSCC is the canonical Wnt/beta-catenin signaling pathway. Previously, we reported that canonical Wnt signaling functions in a positive feedback loop with the DPAGT1 gene, a principal regulator of the metabolic pathway of protein N-glycosylation, to hyperglycosylate E-cadherin and reduce intercellular adhesion. Here, we show that in OSCC, DPAGT1 and canonical Wnt signaling converge to up-regulate CTHRC1 (collagen triple helix repeat containing 1), an N-glycoprotein implicated in tumor invasion and metastasis. We found that in human OSCC specimens, amplification of the levels of CTHRC1 was associated with its hyperglycosylation. Partial inhibition of DPAGT1 expression in OSCC CAL27 cells reduced CTHRC1 abundance by increasing protein turnover, indicating that N-glycosylation stabilizes CTHRC1. Additionally, canonical Wnt signaling promoted beta-catenin/T-cell factor transcriptional activity at the CTHRC1 promoter to further elevate CTHRC1 levels. We demonstrate that DPAGT1 promotes cell migration and drives the localization of CTHRC1 to cells at the leading edge of a wound front coincident with drastic changes in cell morphology. We propose that in OSCC, dysregulation of canonical Wnt signaling and DPAGT1-dependent N-glycosylation induces CTHRC1, thereby driving OSCC cell migration and tumor spread.	[Liu, Gangli] Shandong Univ, Sch Stomatol, Jinan 250100, Shandong, Peoples R China; [Sengupta, Pritam K.; Yang, Hsiao-Ying; Bouchie, Meghan P.; Kukuruzinska, Maria A.] Boston Univ, Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Jamal, Basem] King Abdulaziz Univ, Jeddah 22254, Saudi Arabia; [Lindner, Volkhard] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Varelas, Xaralabos] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Shandong University; Boston University; King Abdulaziz University; Maine Medical Center; Boston University	Kukuruzinska, MA (corresponding author), Dept Mol & Cell Biol, Boston Univ Med Campus,72 E Concord St,E428, Boston, MA 02118 USA.	mkukuruz@bu.edu	Varelas, Xaralabos/ABB-9141-2020	Varelas, Xaralabos/0000-0002-2882-4541; Jamal, Basem/0000-0003-0021-8651; Kukukruzinska, Maria/0000-0001-5314-1454	National Institutes of Health [R01 DE15304]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DE15304.	Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Contessa JN, 2008, CANCER RES, V68, P3803, DOI 10.1158/0008-5472.CAN-07-6389; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Goto M, 2010, CLIN CANCER RES, V16, P65, DOI 10.1158/1078-0432.CCR-09-1122; Guturi KKN, 2012, J BIOL CHEM, V287, P18287, DOI 10.1074/jbc.M111.324798; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Huang GTJ, 1998, MOL CELL BIOCHEM, V181, P97, DOI 10.1023/A:1006877929614; Jamal B, 2012, ORAL ONCOL, V48, P523, DOI 10.1016/j.oraloncology.2012.01.010; Katoh M, 2005, ONCOL REP, V14, P1583; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mendelsohn R, 2007, CANCER RES, V67, P9771, DOI 10.1158/0008-5472.CAN-06-4580; Nita-Lazar M, 2010, EXP CELL RES, V316, P1871, DOI 10.1016/j.yexcr.2010.02.008; Nita-Lazar M, 2009, CANCER RES, V69, P5673, DOI 10.1158/0008-5472.CAN-08-4512; Park EH, 2013, CARCINOGENESIS, V34, P694, DOI 10.1093/carcin/bgs378; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Perez-Ordonez B, 2006, J CLIN PATHOL, V59, P445, DOI 10.1136/jcp.2003.007641; Perez-Sayans M, 2012, ORAL ONCOL, V48, P56, DOI 10.1016/j.oraloncology.2011.09.001; Polakis P, 2000, GENE DEV, V14, P1837; Priyadarsini RV, 2012, ORAL ONCOL, V48, P33, DOI 10.1016/j.oraloncology.2011.08.008; Pyagay P, 2005, CIRC RES, V96, P261, DOI 10.1161/01.RES.0000154262.07264.12; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Sengupta PK, 2013, J CELL SCI, V126, P484, DOI 10.1242/jcs.113035; Sengupta PK, 2010, J BIOL CHEM, V285, P31164, DOI 10.1074/jbc.M110.149195; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Shibamoto S, 1998, GENES CELLS, V3, P659; Tang L, 2006, CLIN CANCER RES, V12, P3716, DOI 10.1158/1078-0432.CCR-06-0030; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wang P, 2012, CANCER SCI, V103, P1327, DOI 10.1111/j.1349-7006.2012.02292.x; Watanabe S, 2011, GLYCOBIOLOGY, V21, P482, DOI 10.1093/glycob/cwq186; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yang F, 2006, CELL SIGNAL, V18, P679, DOI 10.1016/j.cellsig.2005.06.015	41	47	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20217	20227		10.1074/jbc.M113.473785	http://dx.doi.org/10.1074/jbc.M113.473785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23703614	Green Published, hybrid			2022-12-28	WOS:000321715100011
J	Lindemann, C; Lupilova, N; Muller, A; Warscheid, B; Meyer, HE; Kuhlmann, K; Eisenacher, M; Leichert, LI				Lindemann, Claudia; Lupilova, Nataliya; Mueller, Alexandra; Warscheid, Bettina; Meyer, Helmut E.; Kuhlmann, Katja; Eisenacher, Martin; Leichert, Lars I.			Redox Proteomics Uncovers Peroxynitrite-sensitive Proteins That Help Escherichia coli to Overcome Nitrosative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALPAIN ACTIVATOR PROTEIN; ASPARAGINE SYNTHETASE-B; EXPRESSION; INHIBITOR; NITRATION; RESPONSES; TOXICITY; SWITCHES; ENZYME	Peroxynitrite is a highly reactive chemical species with antibacterial properties that are synthesized in immune cells. In a proteomic approach, we identified specific target proteins of peroxynitrite-induced modifications in Escherichia coli. Although peroxynitrite caused a fairly indiscriminate nitration of tyrosine residues, reversible modifications of protein thiols were highly specific. We used a quantitative redox proteomic method based on isotope-coded affinity tag chemistry and identified four proteins consistently thiol-modified in cells treated with peroxynitrite as follows: AsnB, FrmA, MaeB, and RidA. All four were required for peroxynitrite stress tolerance in vivo. Three of the identified proteins were modified at highly conserved cysteines, and MaeB and FrmA are known to be directly involved in the oxidative and nitrosative stress response in E. coli. In in vitro studies, we could show that the activity of RidA, a recently discovered enamine/imine deaminase, is regulated in a specific manner by the modification of its single conserved cysteine. Mutation of this cysteine 107 to serine generated a constitutively active protein that was not susceptible to peroxynitrite.	[Lindemann, Claudia; Lupilova, Nataliya; Mueller, Alexandra; Meyer, Helmut E.; Kuhlmann, Katja; Eisenacher, Martin; Leichert, Lars I.] Ruhr Univ Bochum, Med Proteome Ctr, D-44780 Bochum, Germany; [Warscheid, Bettina] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Warscheid, Bettina] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	Ruhr University Bochum; University of Freiburg; University of Freiburg	Leichert, LI (corresponding author), Ruhr Univ Bochum, Med Proteome Ctr, Univ Str 150, D-44780 Bochum, Germany.	lars.leichert@ruhr-uni-bochum.de	Eisenacher, Martin/J-8044-2014; Leichert, Lars I./B-4762-2009	Eisenacher, Martin/0000-0003-2687-7444; Leichert, Lars I./0000-0002-5666-9681; Warscheid, Bettina/0000-0001-5096-1975; Baumann, Alexandra/0000-0002-6527-5262	"NRW-Ruckkehrerprogramm" of the German State of North Rhine-Westphalia; Excellence Initiative of the German Federal Government [EXC 294 BIOSS]; P.U.R.E. Project of the German State of North Rhine-Westphalia, Germany; Excellence Initiative of the German State Government [EXC 294 BIOSS]	"NRW-Ruckkehrerprogramm" of the German State of North Rhine-Westphalia; Excellence Initiative of the German Federal Government; P.U.R.E. Project of the German State of North Rhine-Westphalia, Germany; Excellence Initiative of the German State Government	This work was supported in part by a grant from the "NRW-Ruckkehrerprogramm" of the German State of North Rhine-Westphalia (to L. I. L.).; Supported by grants from the Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS).; Supported by the P.U.R.E. Project of the German State of North Rhine-Westphalia, Germany.	Alvarez B, 2003, AMINO ACIDS, V25, P295, DOI 10.1007/s00726-003-0018-8; Antelmann H, 2011, ANTIOXID REDOX SIGN, V14, P1049, DOI 10.1089/ars.2010.3400; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; BOEHLEIN SK, 1994, J BIOL CHEM, V269, P7450; Brandes N, 2007, MOL MICROBIOL, V66, P901, DOI 10.1111/j.1365-2958.2007.05964.x; Brandes N, 2009, ANTIOXID REDOX SIGN, V11, P997, DOI 10.1089/ARS.2008.2285; Brandes N, 2011, J BIOL CHEM, V286, P41893, DOI 10.1074/jbc.M111.296236; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Butterfield DA, 2012, ANTIOXID REDOX SIGN, V17, P1487, DOI 10.1089/ars.2012.4742; Conte Lo M., 2012, OXIDATIVE STRESS RED, P1; Creighton T. E., 1990, PROTEIN STRUCTURE PR, P155; Farkas A, 2004, BIOCHEM J, V383, P165, DOI 10.1042/BJ20040668; Ferrer-Sueta G, 2009, ACS CHEM BIOL, V4, P161, DOI 10.1021/cb800279q; Goldstein S, 2005, CHEM REV, V105, P2457, DOI 10.1021/cr0307087; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Held JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.R111.013037; Hurst JK, 1997, CHEM RES TOXICOL, V10, P802, DOI 10.1021/tx970008v; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P446, DOI 10.1016/0003-9861(92)90433-W; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Leichert L. I., 2013, OXIDATIVE STRESS RED, P157; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Lindemann Claudia, 2012, Methods Mol Biol, V893, P387, DOI 10.1007/978-1-61779-885-6_24; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marla SS, 1997, P NATL ACAD SCI USA, V94, P14243, DOI 10.1073/pnas.94.26.14243; McLean S, 2010, J BIOL CHEM, V285, P20724, DOI 10.1074/jbc.M109.085506; Melloni E, 1998, J BIOL CHEM, V273, P12827, DOI 10.1074/jbc.273.21.12827; Morishita R, 1999, J BIOL CHEM, V274, P20688, DOI 10.1074/jbc.274.29.20688; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Schmiedeknecht G, 1996, EUR J BIOCHEM, V242, P339, DOI 10.1111/j.1432-1033.1996.0339r.x; Seth D, 2012, SCIENCE, V336, P470, DOI 10.1126/science.1215643; Singh R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002682; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Volz K, 1999, PROTEIN SCI, V8, P2428; Wang H, 2012, J PROTEOME RES, V11, P412, DOI 10.1021/pr200918f; Wilkins MR, 1999, METH MOL B, V112, P531; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Wong C, 2000, BIOTECHNIQUES, V28, P426, DOI 10.2144/00283bm07; WOOD PM, 1988, BIOCHEM J, V253, P287, DOI 10.1042/bj2530287; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718; Zheng M, 2000, BIOCHEM PHARMACOL, V59, P1, DOI 10.1016/S0006-2952(99)00289-0; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	49	26	27	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19698	19714		10.1074/jbc.M113.457556	http://dx.doi.org/10.1074/jbc.M113.457556			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696645	Green Published, hybrid			2022-12-28	WOS:000321515800040
J	Ravn, P; Madhurantakam, C; Kunze, S; Matthews, E; Priest, C; O'Brien, S; Collinson, A; Papworth, M; Fritsch-Fredin, M; Jermutus, L; Benthem, L; Gruetter, M; Jackson, RH				Ravn, Peter; Madhurantakam, Chaithanya; Kunze, Susan; Matthews, Evelyn; Priest, Claire; O'Brien, Siobhan; Collinson, Andie; Papworth, Monika; Fritsch-Fredin, Maria; Jermutus, Lutz; Benthem, Lambertus; Gruetter, Markus; Jackson, Ronald H.			Structural and Pharmacological Characterization of Novel Potent and Selective Monoclonal Antibody Antagonists of Glucose-dependent Insulinotropic Polypeptide Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; PROTEIN-COUPLED-RECEPTOR; HIGH-FAT DIET; GLUCAGON RECEPTOR; PHAGE DISPLAY; IN-VITRO; AFFINITY MATURATION; RIBOSOME DISPLAY; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE	Glucose-dependent insulinotropic polypeptide (GIP) is an endogenous hormonal factor (incretin) that, upon binding to its receptor (GIPr; a class B G-protein-coupled receptor), stimulates insulin secretion by beta cells in the pancreas. There has been a lack of potent inhibitors of the GIPr with prolonged in vivo exposure to support studies on GIP biology. Here we describe the generation of an antagonizing antibody to the GIPr, using phage and ribosome display libraries. Gipg013 is a specific competitive antagonist with equally high potencies to mouse, rat, dog, and human GIP receptors with a K-i of 7 nM for the human GIPr. Gipg013 antagonizes the GIP receptor and inhibits GIP-induced insulin secretion in vitro and in vivo. A crystal structure of Gipg013 Fab in complex with the human GIPr extracellular domain (ECD) shows that the antibody binds through a series of hydrogen bonds from the complementarity-determining regions of Gipg013 Fab to the N-terminal alpha-helix of GIPr ECD as well as to residues around its highly conserved glucagon receptor subfamily recognition fold. The antibody epitope overlaps with the GIP binding site on the GIPr ECD, ensuring competitive antagonism of the receptor. This well characterized antagonizing antibody to the GIPr will be useful as a tool to further understand the biological roles of GIP.	[Ravn, Peter; Kunze, Susan; Matthews, Evelyn; O'Brien, Siobhan; Collinson, Andie; Papworth, Monika; Jermutus, Lutz; Jackson, Ronald H.] MedImmune, Dept Antibody Discovery & Prot Engn, Cambridge CB21 6GH, England; [Madhurantakam, Chaithanya; Gruetter, Markus] Univ Zurich, Dept Biochem, CH-8057 Zurich, Switzerland; [Priest, Claire] AstraZeneca R&D Alderley Pk, Discovery Sci, Alderley Pk SK10 4GT, Cheshire, England; [Fritsch-Fredin, Maria; Benthem, Lambertus] AstraZeneca R&D, Biosci, S-43183 Molndal, Sweden	AstraZeneca; Medimmune; University of Zurich; AstraZeneca; AstraZeneca	Ravn, P (corresponding author), MedImmune, Dept Antibody Discovery & Prot Engn, Milstein Bldg,Granta Pk, Cambridge CB21 6GH, England.	ravnp@medimmune.com	Madhurantakam, Chaithanya/AAP-5197-2020; Madhurantakam, Chaithanya/F-3652-2010; Jermutus, Lutz/AAU-2047-2020	Collinson, Andie/0000-0001-7465-8313; Madhurantakam, Chaithanya/0000-0002-1967-8538				Althage MC, 2008, J BIOL CHEM, V283, P18365, DOI 10.1074/jbc.M710466200; Bazarsuren A, 2002, BIOPHYS CHEM, V96, P305, DOI 10.1016/S0301-4622(02)00023-6; Brubaker PL, 2007, TRENDS ENDOCRIN MET, V18, P240, DOI 10.1016/j.tem.2007.06.005; Buggy J, 1996, HORM METAB RES, V28, P215, DOI 10.1055/s-2007-979167; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Edwards BM, 2003, J MOL BIOL, V334, P103, DOI 10.1016/j.jmb.2003.09.054; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finlay WJ, 2009, J MOL BIOL, V388, P541, DOI 10.1016/j.jmb.2009.03.019; Flatt PR, 2008, DIABETIC MED, V25, P759, DOI 10.1111/j.1464-5491.2008.02455.x; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Fulurija A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003163; Gault VA, 2002, J ENDOCRINOL, V175, P525, DOI 10.1677/joe.0.1750525; Gault VA, 2002, BIOCHEM BIOPH RES CO, V290, P1420, DOI 10.1006/bbrc.2002.6364; Gelling RW, 1997, REGUL PEPTIDES, V69, P151, DOI 10.1016/S0167-0115(97)00009-8; Getty-Kaushik L, 2006, OBESITY, V14, P1124, DOI 10.1038/oby.2006.129; Groves M, 2006, J IMMUNOL METHODS, V313, P129, DOI 10.1016/j.jim.2006.04.002; Gu W, 2010, AM J PHYSIOL-ENDOC M, V299, pE624, DOI 10.1152/ajpendo.00102.2010; Hansotia T, 2004, DIABETES, V53, P1326, DOI 10.2337/diabetes.53.5.1326; Harris GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035129; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Hinke SA, 2001, BBA-PROTEIN STRUCT M, V1547, P143, DOI 10.1016/S0167-4838(01)00181-9; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Irwin N, 2009, BIOL CHEM, V390, P75, DOI 10.1515/BC.2009.002; Irwin N, 2012, BRIT J NUTR, V108, P46, DOI 10.1017/S0007114511005228; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040156; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019682; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lewis JT, 2000, ENDOCRINOLOGY, V141, P3710, DOI 10.1210/en.141.10.3710; Liu LM, 2011, BIOLOGICALS, V39, P205, DOI 10.1016/j.biologicals.2011.06.002; Lloyd C, 2009, PROTEIN ENG DES SEL, V22, P159, DOI 10.1093/protein/gzn058; MCCAFFERTY J, 1994, APPL BIOCHEM BIOTECH, V47, P157, DOI 10.1007/BF02787932; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKnight A, 1997, J VIROL, V71, P1692, DOI 10.1128/JVI.71.2.1692-1696.1997; Meier JJ, 2002, REGUL PEPTIDES, V107, P1, DOI 10.1016/S0167-0115(02)00039-3; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nakamura T, 2012, DIABETES OBES METAB, V14, P511, DOI 10.1111/j.1463-1326.2011.01555.x; Nauck MA, 2009, EUR J INTERN MED, V20, pS303, DOI 10.1016/j.ejim.2009.05.012; Osbourn JK, 1998, NAT BIOTECHNOL, V16, P778, DOI 10.1038/nbt0898-778; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Ravn P, 2004, J MOL BIOL, V343, P985, DOI 10.1016/j.jmb.2004.08.052; Ravn P, 2012, METHODS MOL BIOL, V805, P213, DOI 10.1007/978-1-61779-379-0_12; Tschop MH, 2012, DIABETES, V61, P1309, DOI 10.2337/db12-0272; Tseng CC, 1996, J CLIN INVEST, V98, P2440, DOI 10.1172/JCI119060; Ugleholdt R, 2011, J BIOL CHEM, V286, P44632, DOI 10.1074/jbc.M111.311779; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Villemagne D, 2006, J IMMUNOL METHODS, V313, P140, DOI 10.1016/j.jim.2006.04.001; Vilsboll T, 2002, DIABETOLOGIA, V45, P1111, DOI 10.1007/s00125-002-0878-6; West AP, 2001, P NATL ACAD SCI USA, V98, P3744, DOI 10.1073/pnas.051625298; WHEELER MB, 1995, ENDOCRINOLOGY, V136, P4629, DOI 10.1210/en.136.10.4629; Wright LM, 2000, ACTA CRYSTALLOGR D, V56, P573, DOI 10.1107/S090744490000233X; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009	58	61	76	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19760	19772		10.1074/jbc.M112.426288	http://dx.doi.org/10.1074/jbc.M112.426288			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689510	Green Published, hybrid			2022-12-28	WOS:000321515800045
J	Xiao, YG; Peng, YH; Wan, J; Tang, GY; Chen, YW; Tang, J; Ye, WC; Ip, NY; Shi, L				Xiao, Yangui; Peng, Yinghui; Wan, Jun; Tang, Genyun; Chen, Yuewen; Tang, Jing; Ye, Wen-Cai; Ip, Nancy Y.; Shi, Lei			The Atypical Guanine Nucleotide Exchange Factor Dock4 Regulates Neurite Differentiation through Modulation of Rac1 GTPase and Actin Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; HIPPOCAMPAL-NEURONS; AXONAL OUTGROWTH; RHO-GEFS; FAMILY; PROTEINS; INTERACTS; DISORDER; PHOSPHORYLATION; IDENTIFICATION	Precise regulation of neurite growth and differentiation determines accurate formation of synaptic connections, whose disruptions are frequently associated with neurological disorders. Dedicator of cytokinesis 4 (Dock4), an atypical guanine nucleotide exchange factor for Rac1, is found to be associated with neuropsychiatric diseases, including autism and schizophrenia. Nonetheless, the neuronal function of Dock4 is only beginning to be understood. Using mouse neuroblastoma (Neuro-2a) cells as a model, this study identifies that Dock4 is critical for neurite differentiation and extension. This regulation is through activation of Rac1 and modulation of the dynamics of actin-enriched protrusions on the neurites. In cultured hippocampal neurons, Dock4 regulates the establishment of the axon-dendrite polarity and the arborization of dendrites, two critical processes during neural differentiation. Importantly, a microdeletion Dock4 mutant linked to autism and dyslexia that lacks the GEF domain leads to defective neurite outgrowth and neuronal polarization. Further analysis reveals that the SH3 domain-mediated interaction of Dock4 is required for its activity toward neurite differentiation, whereas its proline-rich C terminus is not essential for this regulation. Together, our findings reveal an important role of Dock4 for neurite differentiation during early neuronal development.	[Xiao, Yangui; Peng, Yinghui; Tang, Genyun; Chen, Yuewen; Ye, Wen-Cai; Ip, Nancy Y.; Shi, Lei] Jinan Univ, Joint Lab Neurosci & Innovat Drug Res, JNU HKUST, Guangzhou 510632, Guangdong, Peoples R China; [Wan, Jun] Shenzhen PKU HKUST Med Ctr, Biomed Res Inst, Shenzhen Key Lab Neuronal Struct Biol, Shenzhen 518036, Guangdong, Peoples R China; [Wan, Jun; Chen, Yuewen; Tang, Jing; Ip, Nancy Y.; Shi, Lei] Hong Kong Univ Sci & Technol, Div Life Sci, Clear Water Bay, Hong Kong, Peoples R China; [Chen, Yuewen; Tang, Jing; Ip, Nancy Y.; Shi, Lei] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Clear Water Bay, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Jinan University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Shi, L (corresponding author), JNU HKUST Joint Lab Neurosci & Innovat Drug Res, Rm606,2nd Bldg Sci & Technol,601 Huang Pu Ave, Guangzhou 510632, Guangdong, Peoples R China.	shilei@ust.hk		Ip, Nancy Yuk-Yu/0000-0002-2763-8907; Shi, Lei/0000-0001-8695-3432	National Natural Science Foundation of China [81101015]; Research Fund for the Doctoral Program of Higher Education of China [20110001120103]; Fundamental Research Funds for the Central Universities of China [21612205]; Bureau of Science and Information Technology of Guangzhou Municipality [2011J2200048]; Science, Industry, Trade and Information Technology Commission of Shenzhen Municipality [JC201005260217A]; Program of Introducing Talents of Discipline to Universities of China (111 Project) [B13038]; National Program on Key Basic Research Project (973 Program) [2013CB530900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Bureau of Science and Information Technology of Guangzhou Municipality; Science, Industry, Trade and Information Technology Commission of Shenzhen Municipality; Program of Introducing Talents of Discipline to Universities of China (111 Project); National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China for Young Scholars Grant 81101015; by Research Fund for the Doctoral Program of Higher Education of China Grant 20110001120103; by Fundamental Research Funds for the Central Universities of China Grant 21612205; by Bureau of Science and Information Technology of Guangzhou Municipality for Young Scholars Grant 2011J2200048; by Science, Industry, Trade and Information Technology Commission of Shenzhen Municipality for Distinguished Young Scholars Grant JC201005260217A; by Program of Introducing Talents of Discipline to Universities of China (111 Project) Grant B13038; and by National Program on Key Basic Research Project (973 Program) Grant 2013CB530900.	Alkelai A, 2012, INT J NEUROPSYCHOPH, V15, P459, DOI 10.1017/S1461145711000903; Biersmith B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016120; Chen Q, 2001, AM J PATHOL, V159, P1597, DOI 10.1016/S0002-9440(10)63005-2; Chen Q, 2009, J NEUROSCI, V29, P118, DOI 10.1523/JNEUROSCI.3985-08.2009; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; de Silva MG, 2003, J MED GENET, V40, P733, DOI 10.1136/jmg.40.10.733; Detera-Wadleigh SD, 2007, PSYCHIAT GENET, V17, P274, DOI 10.1097/YPG.0b013e328133f352; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Hiramoto-Yamaki N, 2010, J CELL BIOL, V190, P461, DOI 10.1083/jcb.201005141; Ip JPK, 2012, NAT NEUROSCI, V15, P39, DOI 10.1038/nn.2972; Kalkman HO, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-10; Kanai A, 2008, IUBMB LIFE, V60, P467, DOI 10.1002/iub.67; Kasri NN, 2008, PFLUG ARCH EUR J PHY, V455, P787, DOI 10.1007/s00424-007-0385-1; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Kim JY, 2011, J BIOL CHEM, V286, P37615, DOI 10.1074/jbc.M111.268029; Li XL, 2008, NAT NEUROSCI, V11, P28, DOI 10.1038/nn2022; Lu MJ, 2005, CURR BIOL, V15, P371, DOI 10.1016/j.cub.2005.01.050; Maestrini E, 2010, MOL PSYCHIATR, V15, P954, DOI 10.1038/mp.2009.34; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Miyamoto Y, 2010, CELL SIGNAL, V22, P175, DOI 10.1016/j.cellsig.2009.09.036; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Pagnamenta AT, 2010, BIOL PSYCHIAT, V68, P320, DOI 10.1016/j.biopsych.2010.02.002; Pan J, 2005, J NEUROCHEM, V93, P571, DOI 10.1111/j.1471-4159.2005.03106.x; Poelmans G, 2011, MOL PSYCHIATR, V16, P365, DOI 10.1038/mp.2010.105; Premkumar L, 2010, J BIOL CHEM, V285, P13211, DOI 10.1074/jbc.M110.102517; SHEA TB, 1985, DEV BRAIN RES, V21, P307, DOI 10.1016/0165-3806(85)90220-2; Shearer KD, 2012, TRENDS NEUROSCI, V35, P733, DOI 10.1016/j.tins.2012.08.005; Shi L, 2007, P NATL ACAD SCI USA, V104, P16347, DOI 10.1073/pnas.0706626104; Ueda S, 2008, J NEUROSCI RES, V86, P3052, DOI 10.1002/jnr.21763; Ueda S, 2013, MOL BIOL CELL, V24, P1602, DOI 10.1091/mbc.E12-11-0782; Upadhyay G, 2008, ONCOGENE, V27, P5845, DOI 10.1038/onc.2008.202; Vinci G, 2007, MOL HUM REPROD, V13, P685, DOI 10.1093/molehr/gam045; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Wu G, 1998, J NEUROCYTOL, V27, P1, DOI 10.1023/A:1006910001869; Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yang YT, 2012, NAT NEUROSCI, V15, P1201, DOI 10.1038/nn.3171; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006	44	50	50	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20034	20045		10.1074/jbc.M113.458612	http://dx.doi.org/10.1074/jbc.M113.458612			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720743	hybrid, Green Published			2022-12-28	WOS:000321515800066
J	Dhamija, S; Winzen, R; Doerrie, A; Behrens, G; Kuehne, N; Schauerte, C; Neumann, E; Dittrich-Breiholz, O; Kracht, M; Holtmann, H				Dhamija, Sonam; Winzen, Reinhard; Doerrie, Anneke; Behrens, Gesine; Kuehne, Nancy; Schauerte, Celina; Neumann, Elena; Dittrich-Breiholz, Oliver; Kracht, Michael; Holtmann, Helmut			Interleukin-17 (IL-17) and IL-1 Activate Translation of Overlapping Sets of mRNAs, Including That of the Negative Regulator of Inflammation, MCPIP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AU-RICH ELEMENT; NF-KAPPA-B; INDUCED PROTEIN-1; GENE-EXPRESSION; 3'-UNTRANSLATED REGION; TRANSCRIPTION FACTOR; CYTOKINE; CELLS; IDENTIFICATION; STABILIZATION	Changes in gene expression during inflammation are in part caused by post-transcriptional mechanisms. A transcriptome-wide screen for changes in ribosome occupancy indicated that the inflammatory cytokine IL-17 activates translation of a group of mRNAs that overlaps partially with those affected similarly by IL-1. Included are mRNAs of I kappa B zeta and of MCPIP1, important regulators of the quality and course of immune and inflammatory responses. Evidence for increased ribosome association of these mRNAs was also obtained in LPS-activated RAW264.7 macrophages and human peripheral blood mononuclear cells. Like IL-1, IL-17 activated translation of I kappa B zeta mRNA by counteracting the function of a translational silencing element in its 3'-UTR defined previously. Translational silencing of MCPIP1 mRNA in unstimulated cells resulted from the combined suppressive activities of its 5'-UTR, which contains upstream open reading frames, and of its 3'-UTR, which silences independently of the 5'-UTR. Only the silencing function of the 3'-UTR was counteracted by IL-17 as well as by IL-1. Translational silencing by the 3'-UTR was dependent on a putative stem-loop-forming region previously associated with rapid degradation of the mRNA. The results suggest that translational control exerted by IL-1 and IL-17 plays an important role in the coordination of an inflammatory reaction.	[Dhamija, Sonam; Winzen, Reinhard; Doerrie, Anneke; Behrens, Gesine; Kuehne, Nancy; Schauerte, Celina; Dittrich-Breiholz, Oliver; Holtmann, Helmut] Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany; [Neumann, Elena] Univ Giessen, Kerckhoff Clin Bad Nauheim, Dept Internal Med & Rheumatol, D-61231 Bad Nauheim, Germany; [Kracht, Michael] Univ Giessen, Rudolf Buchheim Inst Pharmacol, D-35392 Giessen, Germany	Hannover Medical School; Justus Liebig University Giessen; Kerckhoff Clinic; Justus Liebig University Giessen	Holtmann, H (corresponding author), Hannover Med Sch, Inst Biochem, D-30623 Hannover, Germany.	holtmann.helmut@mh-hannover.de	Neumann, Elena/A-1418-2011; Dhamija, Sonam/AAJ-2093-2020	Dhamija, Sonam/0000-0002-9569-2729; Kuhne, Nancy/0000-0002-9418-7296; Kracht, Michael/0000-0002-8501-043X	Deutsche Forschungsgemeinschaft [SFB 566/A10, SFB 566/Z2, Ho 1116/5]; Deutsche Krebshilfe	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by Grants SFB 566/A10, SFB 566/Z2, and Ho 1116/5 from the Deutsche Forschungsgemeinschaft and by a grant from the Deutsche Krebshilfe.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bulek K, 2011, NAT IMMUNOL, V12, P844, DOI 10.1038/ni.2080; Cai XY, 1998, IMMUNOL LETT, V62, P51, DOI 10.1016/S0165-2478(98)00027-3; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Datta S, 2010, J IMMUNOL, V184, P1484, DOI 10.4049/jimmunol.0902423; Dhamija S, 2011, J BIOL CHEM, V286, P33279, DOI 10.1074/jbc.M111.264754; Dhamija S, 2010, J BIOL CHEM, V285, P29165, DOI 10.1074/jbc.M110.146365; Faour WH, 2003, J BIOL CHEM, V278, P26897, DOI 10.1074/jbc.M212790200; Gaffen SL, 2011, CURR OPIN IMMUNOL, V23, P613, DOI 10.1016/j.coi.2011.07.006; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Hartupee J, 2009, J IMMUNOL, V182, P1660, DOI 10.4049/jimmunol.182.3.1660; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; Jura J, 2008, BBA-GENE REGUL MECH, V1779, P383, DOI 10.1016/j.bbagrm.2008.04.006; Kasza A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-14; Katz Y, 2001, ARTHRITIS RHEUM-US, V44, P2176, DOI 10.1002/1529-0131(200109)44:9<2176::AID-ART371>3.0.CO;2-4; Liang J, 2008, J BIOL CHEM, V283, P6337, DOI 10.1074/jbc.M707861200; Liang J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-182; Liang JA, 2010, J EXP MED, V207, P2959, DOI 10.1084/jem.20092641; Maniati E, 2010, ONCOGENE, V29, P5653, DOI 10.1038/onc.2010.367; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; Milner JD, 2011, CURR OPIN IMMUNOL, V23, P784, DOI 10.1016/j.coi.2011.09.006; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Neumann E, 2002, GENE THER, V9, P1508, DOI 10.1038/sj.gt.3301811; Niu J, 2008, J BIOL CHEM, V283, P14542, DOI 10.1074/jbc.M802139200; Niu JL, 2009, CLIN SCI, V117, P95, DOI 10.1042/CS20080581; Ohba T, 2012, FEBS J, V279, P211, DOI 10.1111/j.1742-4658.2011.08416.x; Qi DF, 2011, J BIOL CHEM, V286, P41692, DOI 10.1074/jbc.M111.276006; Qi YF, 2010, FEBS LETT, V584, P3065, DOI 10.1016/j.febslet.2010.05.040; Rubsamen D, 2012, RNA, V18, P1910, DOI 10.1261/rna.033019.112; Ryzhakov G, 2011, J IMMUNOL, V187, P5357, DOI 10.4049/jimmunol.1100917; Skalniak L, 2009, FEBS J, V276, P5892, DOI 10.1111/j.1742-4658.2009.07273.x; Sparna T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-226; Sun DX, 2011, NAT IMMUNOL, V12, P853, DOI 10.1038/ni.2081; Suzuki HI, 2011, MOL CELL, V44, P424, DOI 10.1016/j.molcel.2011.09.012; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; Watanabe S, 2007, BIOCHEM BIOPH RES CO, V356, P785, DOI 10.1016/j.bbrc.2007.03.044; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Winzen R, 2007, MOL CELL BIOL, V27, P8388, DOI 10.1128/MCB.01493-07; Xu NH, 1998, NUCLEIC ACIDS RES, V26, P558, DOI 10.1093/nar/26.2.558; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496	45	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19250	19259		10.1074/jbc.M113.452649	http://dx.doi.org/10.1074/jbc.M113.452649			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658019	Green Published, hybrid			2022-12-28	WOS:000321335800057
J	Moik, D; Bottcher, A; Makhina, T; Grashoff, C; Bulus, N; Zent, R; Fassler, R				Moik, Daniel; Boettcher, Anika; Makhina, Tatiana; Grashoff, Carsten; Bulus, Nada; Zent, Roy; Faessler, Reinhard			Mutations in the Paxillin-binding Site of Integrin-linked Kinase (ILK) Destabilize the Pseudokinase Domain and Cause Embryonic Lethality in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; ALPHA-PARVIN; MOLECULAR DISSECTION; STRUCTURAL BASIS; ADAPTER PROTEIN; IN-VITRO; VASCULOGENESIS; LOCALIZATION; COMPLEX; PINCH	Integrin-linked kinase (ILK) localizes to focal adhesions (FAs) where it regulates cell spreading, migration, and growth factor receptor signaling. Previous reports showed that overexpressed ILK in which Val(386) and Thr(387) were substituted with glycine residues (ILK-VT/GG) could neither interact with paxillin nor localize to FA in cells expressing endogenous wild-type ILK, implying that paxillin binding to ILK is required for its localization to FAs. Here, we show that introducing this mutation into the germ line of mice (ILK-VT/GG) caused vasculogenesis defects, resulting in a general developmental delay and death at around embryonic day 12.5. Fibroblasts isolated from ILK-VT/GG mice contained mutant ILK in FAs, showed normal adhesion to and spreading on extracellular matrix substrates but displayed impaired migration. Biochemical analysis revealed that VT/GG substitutions decreased ILK protein stability leading to decreased ILK levels and reduced binding to paxillin and alpha-parvin. Because paxillin depletion did not affect ILK localization to FAs, the embryonic lethality and the in vitro migration defects are likely due to the reduced levels of ILK-VT/GG and diminished binding to parvins.	[Moik, Daniel; Boettcher, Anika; Makhina, Tatiana; Faessler, Reinhard] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Grashoff, Carsten] Max Planck Inst Biochem, Mechanotransduct Res Grp, D-82152 Martinsried, Germany; [Bulus, Nada; Zent, Roy] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN 37232 USA; [Zent, Roy] Vet Affairs Med Ctr, Dept Med, Nashville, TN 37232 USA	Max Planck Society; Max Planck Society; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Fassler, R (corresponding author), Max Planck Inst Biochem, Dept Mol Med, Klopferspitz 18, D-82152 Martinsried, Germany.	faessler@biochem.mpg.de			Max Planck Society; Veterans Affairs Merit Review Grants [1I01BX002196-01, DK075594, DK069221, DK083187]; O'Brien Center [DK79341-01]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079341, R01DK083187, R01DK075594] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002196] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); Veterans Affairs Merit Review Grants(US Department of Veterans Affairs); O'Brien Center; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Max Planck Society (to R. F.); Veterans Affairs Merit Review Grants 1I01BX002196-01, DK075594, DK069221, and DK083187; the O'Brien Center DK79341-01; and an American Heart Association established investigator award (to R. Z.).	Aoyagi Y, 2005, BIOCHEM BIOPH RES CO, V331, P1061, DOI 10.1016/j.bbrc.2005.03.225; Azimifar SB, 2012, J CELL SCI, V125, P435, DOI 10.1242/jcs.091652; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Boulter E, 2006, FASEB J, V20, P1489, DOI 10.1096/fj.05-4579fje; Chen D, 2004, AM J PHYSIOL-RENAL, V287, pF602, DOI 10.1152/ajprenal.00015.2004; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; FASSLER R, 1995, GENE DEV, V9, P1896, DOI 10.1101/gad.9.15.1896; Friedrich EB, 2004, MOL CELL BIOL, V24, P8134, DOI 10.1128/MCB.24.18.8134-8144.2004; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; JAT PS, 1986, J VIROL, V59, P746, DOI 10.1128/JVI.59.3.746-750.1986; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Lorenz K, 2007, J CELL BIOL, V177, P501, DOI 10.1083/jcb.200608125; Lorenz S, 2008, STRUCTURE, V16, P1521, DOI 10.1016/j.str.2008.08.007; MARTIN JS, 1995, ANN NY ACAD SCI, V752, P300, DOI 10.1111/j.1749-6632.1995.tb17439.x; Meyer M, 2012, J CELL SCI, V125, P5690, DOI 10.1242/jcs.108167; Moik DV, 2011, J CELL SCI, V124, P414, DOI 10.1242/jcs.075960; Montanez E, 2009, EMBO J, V28, P3132, DOI 10.1038/emboj.2009.295; Nikolopoulos SN, 2002, J BIOL CHEM, V277, P1568, DOI 10.1074/jbc.M108612200; Nikolopoulos SN, 2001, J BIOL CHEM, V276, P23499, DOI 10.1074/jbc.M102163200; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Radovanac K, 2013, EMBO J, V32, P1409, DOI 10.1038/emboj.2013.90; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stanchi F, 2009, J CELL SCI, V122, P1800, DOI 10.1242/jcs.044602; Stiegler AL, 2012, J BIOL CHEM, V287, P32566, DOI 10.1074/jbc.M112.367342; Theiler K., 1989, HOUSE MOUSE ATLAS EM, P26; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Wade R, 2002, ONCOGENE, V21, P96, DOI 10.1038/sj.onc.1205013; Wang XX, 2008, J BIOL CHEM, V283, P21113, DOI 10.1074/jbc.M801270200; Wickstrom SA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005116; Wickstrom SA, 2010, DEV CELL, V19, P574, DOI 10.1016/j.devcel.2010.09.007; Widmaier M, 2012, J CELL SCI, V125, P1839, DOI 10.1242/jcs.093864; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	39	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18863	18871		10.1074/jbc.M113.470476	http://dx.doi.org/10.1074/jbc.M113.470476			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658024	Green Published, hybrid			2022-12-28	WOS:000321335800024
J	Li, XN; Liu, X; Xu, WY; Zhou, P; Gao, P; Jiang, SS; Lobie, PE; Zhu, T				Li, Xiaoni; Liu, Xin; Xu, Weiyi; Zhou, Peng; Gao, Ping; Jiang, Songshan; Lobie, Peter E.; Zhu, Tao			c-MYC-regulated miR-23a/24-2/27a Cluster Promotes Mammary Carcinoma Cell Invasion and Hepatic Metastasis by Targeting Sprouty2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; MIR-23A-SIMILAR-TO-27A-SIMILAR-TO-24-2 CLUSTER; COMPUTATIONAL METHODS; TRANSCRIPTION FACTORS; MICRORNAS; ANGIOGENESIS; PROTEIN; EXPRESSION	Emerging evidence indicates that the miR-23a/24-2/27a cluster may possess a causal role in mammary tumorigenesis and function as a novel class of oncogenes. However, the regulatory mechanism of the miR-23a/24-2/27a cluster in mammary carcinoma cell invasion and migration is still largely unknown. We observed that the expression levels of miR-23a, miR-24-2 and miR-27a were significantly higher in breast cancer with lymph node metastasis, compared with that from patients without lymph node metastasis or normal tissue. Forced expression of the miR-23a/24-2/27a cluster promoted mammary carcinoma cell migration, invasion, and hepatic metastasis, through targeting Sprouty2 (SPRY2) and consequent activation of p44/42 MAPK. Epidermal growth factor induced the expression of the transcription factor c-MYC, which promoted the expression of mature miR-23a, miR-24-2, and miR-27a and subsequently decreased expression of SPRY2 and activated p44/42 MAPK to promote mammary carcinoma cell migration and invasion. We therefore suggest a novel link between epidermal growth factor and the miR-23a/24-2/27a cluster via the regulation of c-MYC, providing the potential for the miR-23a/24-2/27a cluster to be used as biomarker in the diagnosis and/or treatment of breast cancer.	[Li, Xiaoni; Liu, Xin; Gao, Ping; Zhu, Tao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Li, Xiaoni; Liu, Xin; Gao, Ping; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Xu, Weiyi; Zhou, Peng; Jiang, Songshan] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Weiyi; Zhou, Peng; Jiang, Songshan] Sun Yat Sen Univ, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore; [Lobie, Peter E.] Natl Univ Singapore, Dept Pharmacol, Singapore 117456, Singapore; [Lobie, Peter E.] Natl Univ Singapore, Natl Canc Inst Singapore, Natl Univ Hlth Syst, Singapore 117456, Singapore	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University; Sun Yat Sen University; National University of Singapore; National University of Singapore; National University of Singapore	Lobie, PE (corresponding author), Natl Univ Singapore, Ctr Life Sci, Canc Sci Inst Singapore, 03-06C,28 Med Dr, Singapore 117456, Singapore.	csipel@nus.edu.sg; zhut@ustc.edu.cn	Zhu, Tao/H-3495-2018		National Key Scientific Program of China [2012CB934002, 2010CB912804]; National Natural Science Foundation of China [30971492, 81272925]; Cancer Science Institute of Singapore; Senior Foreign Expert Plan [6DW2012340015J]; S&T Plan of Guangzhou [2012J4100082]	National Key Scientific Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cancer Science Institute of Singapore; Senior Foreign Expert Plan; S&T Plan of Guangzhou	This work was supported by National Key Scientific Program of China Grants 2012CB934002 and 2010CB912804, National Natural Science Foundation of China Grants 30971492 and 81272925, the Cancer Science Institute of Singapore and the Senior Foreign Expert Plan (Grant 6DW2012340015J), and the S&T Plan of Guangzhou (Grant 2012J4100082).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Bicknell R, 2004, ANNU REV PHARMACOL, V44, P219, DOI 10.1146/annurev.pharmtox.44.101802.121650; Blenkiron C, 2007, HUM MOL GENET, V16, pR106, DOI 10.1093/hmg/ddm056; Brandvold KA, 2000, ONCOGENE, V19, P2780, DOI 10.1038/sj.onc.1203589; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chhabra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-232; Chhabra R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005848; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Ellis IO, 2003, PATHOLOGY GENETICS T, P9; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Evdokimova V, 2009, CELL CYCLE, V8, P2901, DOI 10.4161/cc.8.18.9537; Fitzgerald K, 2005, CURR OPIN DRUG DISC, V8, P557; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gartel AL, 2008, SEMIN CANCER BIOL, V18, P103, DOI 10.1016/j.semcancer.2008.01.008; Guarneri V, 2009, ONCOLOGIST, V14, P645, DOI 10.1634/theoncologist.2009-0078; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Gutierrez MC, 2005, J CLIN ONCOL, V23, P2469, DOI 10.1200/JCO.2005.01.172; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Janda E, 2002, ONCOGENE, V21, P5148, DOI 10.1038/sj.onc.1205661; Jiang X, 2004, J THROMB HAEMOST, V2, P93, DOI 10.1111/j.1538-7836.2004.00545.x; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Liu JD, 2008, CURR OPIN CELL BIOL, V20, P214, DOI 10.1016/j.ceb.2008.01.006; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Ma YH, 2010, CANCER LETT, V298, P150, DOI 10.1016/j.canlet.2010.06.012; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Martins PAD, 2010, CURR DRUG TARGETS, V11, P900, DOI 10.2174/138945010791591322; Maziere P, 2007, DRUG DISCOV TODAY, V12, P452, DOI 10.1016/j.drudis.2007.04.002; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Milanezi F, 2008, EXPERT REV MOL DIAGN, V8, P417, DOI 10.1586/14737159.8.4.417; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mukhina S, 2004, P NATL ACAD SCI USA, V101, P15166, DOI 10.1073/pnas.0405881101; Nanba D, 2008, J CELL PHYSIOL, V214, P465, DOI 10.1002/jcp.21233; Ngo CV, 2000, CELL GROWTH DIFFER, V11, P201; Osada H, 2007, CARCINOGENESIS, V28, P2, DOI 10.1093/carcin/bgl185; Pawlicki JM, 2010, TRENDS CELL BIOL, V20, P52, DOI 10.1016/j.tcb.2009.10.004; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Qian PX, 2012, CANCER RES, V72, P6036, DOI 10.1158/0008-5472.CAN-12-1507; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Sakuma K, 2012, P NATL ACAD SCI USA, V109, P7776, DOI 10.1073/pnas.1111135109; Skaftnesmo KO, 2007, CURR PHARM BIOTECHNO, V8, P320, DOI 10.2174/138920107783018390; Tsuji T, 2008, CANCER RES, V68, P10377, DOI 10.1158/0008-5472.CAN-08-1444; Utsumi Toshiaki, 2007, Breast Cancer, V14, P194, DOI 10.2325/jbcs.959; van Cruijsen H, 2005, INT J CANCER, V117, P883, DOI 10.1002/ijc.21479; Watanabe Y, 2007, METHOD ENZYMOL, V427, P65, DOI 10.1016/S0076-6879(07)27004-1; Williams AH, 2009, CURR OPIN CELL BIOL, V21, P461, DOI 10.1016/j.ceb.2009.01.029; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Yuan XY, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-65; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	66	114	121	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18121	18133		10.1074/jbc.M113.478560	http://dx.doi.org/10.1074/jbc.M113.478560			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649631	Green Published, hybrid			2022-12-28	WOS:000320721900018
J	Yang, XH; Li, L; Liang, J; Shi, L; Yang, JG; Yi, X; Zhang, D; Han, X; Yu, N; Shang, YF				Yang, Xiaohan; Li, Lei; Liang, Jing; Shi, Lei; Yang, Jianguo; Yi, Xia; Zhang, Di; Han, Xiao; Yu, Na; Shang, Yongfeng			Histone Acetyltransferase 1 Promotes Homologous Recombination in DNA Repair by Facilitating Histone Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; CHROMATIN REMODELING COMPLEX; SACCHAROMYCES-CEREVISIAE; VARIANT H3.3; IN-VIVO; ACTIVE CHROMATIN; BINDING PROTEIN; DAMAGE RESPONSE; CORE HISTONES; NUCLEOSOME	Faithful repair of DNA double-strand breaks is vital to the maintenance of genome integrity and proper cell functions. Histone modifications, such as reversible acetylation, phosphorylation, methylation, and ubiquitination, which collectively contribute to the establishment of distinct chromatin states, play important roles in the recruitment of repair factors to the sites of double-strand breaks. Here we report that histone acetyltransferase 1 (HAT1), a classical B type histone acetyltransferase responsible for acetylating the N-terminal tail of newly synthesized histone H4 in the cytoplasm, is a key regulator of DNA repair by homologous recombination in the nucleus. We found that HAT1 is required for the incorporation of H4K5/K12-acetylated H3.3 at sites of double-strand breaks through its HIRA-dependent histone turnover activity. Incorporated histones with specific chemical modifications facilitate subsequent recruitment of RAD51, a key repair factor in mammalian cells, to promote efficient homologous recombination. Significantly, depletion of HAT1 sensitized cells to DNA damage compromised the global chromatin structure, inhibited cell proliferation, and induced cell apoptosis. Our experiments uncovered a role for HAT1 in DNA repair in higher eukaryotic organisms and provide a mechanistic insight into the regulation of histone dynamics by HAT1.	[Yang, Xiaohan; Li, Lei; Liang, Jing; Yang, Jianguo; Yi, Xia; Zhang, Di; Han, Xiao; Yu, Na; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China; [Shi, Lei; Shang, Yongfeng] Tianjin Med Univ, Dept Biochem & Mol Biol, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn	Han, Xiao/A-1109-2017; Zhang, Di/AAD-6936-2021; Zhang, Di/AAE-2027-2021	Han, Xiao/0000-0002-5395-4022; Han, Xiao/0000-0002-6024-6286	National Natural Science Foundation of China [91219201, 81130048]; Ministry of Science and Technology of China grants (973 Program) [2011CB504204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China grants (973 Program)	This work was supported by National Natural Science Foundation of China Grants 91219201 and 81130048 (to Y. S.) and by Ministry of Science and Technology of China grants (973 Program: 2011CB504204; to Y. S.).	Adachi N, 2003, J BIOL CHEM, V278, P35897, DOI 10.1074/jbc.M306500200; Adamson B, 2012, NAT CELL BIOL, V14, P318, DOI 10.1038/ncb2426; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Ai X, 2004, MOL CELL, V14, P195, DOI 10.1016/S1097-2765(04)00184-4; ALTHAUS FR, 1992, J CELL SCI, V102, P663; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Barman HK, 2006, BIOCHEM BIOPH RES CO, V345, P1547, DOI 10.1016/j.bbrc.2006.05.079; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Benson LJ, 2007, J BIOL CHEM, V282, P836, DOI 10.1074/jbc.M607464200; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen DY, 2005, J CELL BIOL, V168, P41, DOI 10.1083/jcb.200407182; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Dunlop MH, 2011, J BIOL CHEM, V286, P37328, DOI 10.1074/jbc.M111.290015; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Ge ZQ, 2011, J BIOL CHEM, V286, P16790, DOI 10.1074/jbc.M110.216846; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; He J, 2012, J BIOL CHEM, V287, P31747, DOI 10.1074/jbc.M112.384750; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; HORWITZ SB, 1973, CANCER RES, V33, P2834; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; KLEFF S, 1995, J BIOL CHEM, V270, P24674, DOI 10.1074/jbc.270.42.24674; KLEIMAN NJ, 1990, CURR EYE RES, V9, P1185, DOI 10.3109/02713689009003475; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; LAMOUR V, 1995, HUM MOL GENET, V4, P791, DOI 10.1093/hmg/4.5.791; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lorain S, 1998, MOL CELL BIOL, V18, P5546, DOI 10.1128/MCB.18.9.5546; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; Nociari MM, 1998, J IMMUNOL METHODS, V213, P157, DOI 10.1016/S0022-1759(98)00028-3; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Parthun MR, 2007, ONCOGENE, V26, P5319, DOI 10.1038/sj.onc.1210602; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Qin S, 2006, MOL CELL BIOL, V26, P3649, DOI 10.1128/MCB.26.9.3649-3658.2006; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; SANDALTZOPOULOS R, 1994, NUCLEIC ACIDS RES, V22, P1511, DOI 10.1093/nar/22.8.1511; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Seiden-Long IM, 2006, ONCOGENE, V25, P91, DOI 10.1038/sj.onc.1209005; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Thiriet C, 2005, MOL CELL, V18, P617, DOI 10.1016/j.molcel.2005.05.008; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Tsukuda T, 2005, NATURE, V438, P379, DOI 10.1038/nature04148; Unnikrishnan A, 2010, NAT STRUCT MOL BIOL, V17, P430, DOI 10.1038/nsmb.1780; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Verzijlbergen KF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002284; Vidanes GM, 2005, CELL, V121, P973, DOI 10.1016/j.cell.2005.06.013; Wang HB, 2006, MOL CELL, V22, P383, DOI 10.1016/j.molcel.2006.03.035; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Xiao J, 2001, J BIOL CHEM, V276, P6105, DOI 10.1074/jbc.M008893200; Yang XH, 2011, MOL CELL, V44, P39, DOI 10.1016/j.molcel.2011.07.032; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang Y, 2011, J BIOL CHEM, V286, P42414, DOI 10.1074/jbc.M111.271064	64	67	71	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18271	18282		10.1074/jbc.M113.473199	http://dx.doi.org/10.1074/jbc.M113.473199			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653357	Green Published, hybrid			2022-12-28	WOS:000320721900031
J	Shimizu, N; Nakajima, NI; Tsunematsu, T; Ogawa, I; Kawai, H; Hirayama, R; Fujimori, A; Yamada, A; Okayasu, R; Ishimaru, N; Takata, T; Kudo, Y				Shimizu, Natsumi; Nakajima, Nakako Izumi; Tsunematsu, Takaaki; Ogawa, Ikuko; Kawai, Hidehiko; Hirayama, Ryoichi; Fujimori, Akira; Yamada, Akiko; Okayasu, Ryuichi; Ishimaru, Naozumi; Takata, Takashi; Kudo, Yasusei			Selective Enhancing Effect of Early Mitotic Inhibitor 1 (Emi1) Depletion on the Sensitivity of Doxorubicin or X-ray Treatment in Human Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX/CYCLOSOME; RESISTANT PROSTATE-CANCER; DNA-REPLICATION; GENE-EXPRESSION; AURORA KINASE; UBIQUITIN LIGASE; GEMININ; CYCLE; CARCINOMA; COMPLEX	Chemotherapy and radiation in addition to surgery has proven useful in a number of different cancer types, but the effectiveness in normal tissue cannot be avoided in these therapies. To improve the effectiveness of these therapies selectively in cancer tissue is important for avoiding side effects. Early mitotic inhibitor 1 (Emi1) is known to have the function to inhibit anaphase-promoting complex/cyclosome ubiquitin ligase complex, which ubiquitylates the cell cycle-related proteins. It recently has been shown that Emi1 knockdown prevents transition from S to G(2) phase by down-regulating geminin via anaphase-promoting complex/cyclosome activation. At present, anticancer drugs for targeting DNA synthesis to interfere with rapidly dividing cells commonly are used. As Emi1 depletion interferes with completion of DNA synthesis in cancer cells, we thought that Emi1 knockdown might enhance the sensitivity for anticancer agents. Here, we confirmed that Emi1 siRNA induced polyploidy for preventing transition from S to G(2) phase in several cancer cell lines. Then, we treated Emi1 depleted cells with doxorubicin. Interestingly, increased apoptotic cells were observed after doxorubicin treatment in Emi1 siRNA-treated cancer cells. In addition, Emi1 depletion enhanced the sensitivity of x-ray irradiation in cancer cells. Importantly, synergistic effect of Emi1 knockdown in these combination therapies was not observed in normal cells. These results suggest that Emi1 siRNA can be a useful tool for enhancing of sensitivity of cancer cells to anticancer reagents and radiation.	[Shimizu, Natsumi; Tsunematsu, Takaaki; Takata, Takashi; Kudo, Yasusei] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Oral & Maxillofacial Pathobiol, Hiroshima 7348553, Japan; [Nakajima, Nakako Izumi; Hirayama, Ryoichi; Fujimori, Akira; Okayasu, Ryuichi] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 2638555, Japan; [Nakajima, Nakako Izumi; Hirayama, Ryoichi; Fujimori, Akira; Okayasu, Ryuichi] Natl Inst Radiol Sci, Int Open Lab, Particle Therapy Mol Target Res Unit, Chiba 2638555, Japan; [Ogawa, Ikuko] Hiroshima Univ Hosp, Ctr Oral Clin Examinat, Hiroshima 7348553, Japan; [Kawai, Hidehiko] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Mol Radiobiol, Hiroshima 7348553, Japan; [Yamada, Akiko; Ishimaru, Naozumi; Kudo, Yasusei] Univ Tokushima, Grad Sch, Dept Oral Mol Pathol, Inst Hlth Biosci, Tokushima 7708504, Japan	Hiroshima University; National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; Hiroshima University; Hiroshima University; Tokushima University	Kudo, Y (corresponding author), Univ Tokushima, Grad Sch, Dept Oral Mol Pathol, Inst Hlth Biosci, 3-18-15 Kuramoto, Tokushima 7708504, Japan.	yasusei@tokushima-u.ac.jp	Okayasu, Ryuichi/F-2071-2013	Okayasu, Ryuichi/0000-0001-5091-7210; Kudo, Yasusei/0000-0002-0392-7720; Kawai, Hidehiko/0000-0003-2213-7166	Ministry of Education, Culture, Sports, Science and Technology [23689074, 25670778, 21249088, 23390301, 24249067, 19-9, H23-A-43]; Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science [23-6562]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (23689074 and 25670778 (to Y. K.), 21249088 (to T. Takata), and 23390301 and 24249067 (to R. O.)), Grant-in-aid for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology (19-9, H23-A-43; to R. O.), and a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science (23-6562; to T. Tsunematsu).	Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; French PJ, 2005, CANCER RES, V65, P11335, DOI 10.1158/0008-5472.CAN-05-1886; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Gutgemann I, 2008, MODERN PATHOL, V21, P445, DOI 10.1038/modpathol.3801022; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Lehman NL, 2006, CELL CYCLE, V5, P1569, DOI 10.4161/cc.5.14.2925; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Mihaylov IS, 2002, MOL CELL BIOL, V22, P1868, DOI 10.1128/MCB.22.6.1868-1880.2002; MILAS L, 1994, CANCER RES, V54, P3506; Moretti L, 2011, INT J RADIAT ONCOL, V80, P1189, DOI 10.1016/j.ijrobp.2011.01.060; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Niermann KJ, 2011, RADIAT RES, V175, P444, DOI 10.1667/RR2317.1; Onozuka H, 2011, CANCER SCI, V102, P975, DOI 10.1111/j.1349-7006.2011.01880.x; Pagano M, 2003, CANCER CELL, V4, P251, DOI 10.1016/S1535-6108(03)00243-5; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; POMMIER Y, 1994, CANCER INVEST, V12, P530, DOI 10.3109/07357909409021413; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2001, GENE DEV, V15, P3278, DOI 10.1101/gad.945701; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Takimoto C. H., 2008, PRINCIPLES ONCOLOGIC, P1; Tao Y, 2007, BRIT J CANCER, V97, P1664, DOI 10.1038/sj.bjc.6604083; TERASIMA T, 1963, SCIENCE, V140, P490, DOI 10.1126/science.140.3566.490; TISHLER RB, 1992, CANCER RES, V52, P3495; Verschuren EW, 2007, MOL CELL BIOL, V27, P7955, DOI 10.1128/MCB.00908-07; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yamasaki L, 2004, CURR OPIN CELL BIOL, V16, P623, DOI 10.1016/j.ceb.2004.08.005; Yokoyama K, 2003, INT J ONCOL, V22, P891; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zhang AL, 2007, PROSTATE, V67, P1630, DOI 10.1002/pros.20638; Zhu WG, 2009, CANCER RES, V69, P4870, DOI 10.1158/0008-5472.CAN-08-4559	50	15	15	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17238	17252		10.1074/jbc.M112.446351	http://dx.doi.org/10.1074/jbc.M112.446351			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645673	Green Published, hybrid			2022-12-28	WOS:000320380600020
J	Herrador, A; Leon, S; Haguenauer-Tsapis, R; Vincent, O				Herrador, Antonio; Leon, Sebastien; Haguenauer-Tsapis, Rosine; Vincent, Olivier			A Mechanism for Protein Monoubiquitination Dependent on a trans-Acting Ubiquitin-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; ESCRT-I; RECRUITMENT; COMPLEX; YEAST; RECEPTOR; LIGASE	The length of the ubiquitin chain on a substrate dictates various functional outcomes, yet little is known about its regulation in vivo. The yeast arrestin-related protein Rim8/Art9 is monoubiquitinated in vivo by the Rsp5 ubiquitin ligase. This also requires Vps23, a protein that displays an ubiquitin-E2 variant (UEV) domain. Here, we report that binding of the UEV domain to Rim8 interferes with ubiquitin chain elongation and directs Rim8 monoubiquitination. We propose that Vps23 UEV competes with Rsp5 HECTN-lobe for binding to the first conjugated ubiquitin, thereby preventing polyubiquitination. These findings reveal a novel mechanism to control ubiquitin chain length on substrates in vivo.	[Herrador, Antonio; Vincent, Olivier] CSIC UAM, Inst Invest Biomed, Madrid 28029, Spain; [Leon, Sebastien; Haguenauer-Tsapis, Rosine] Univ Paris Diderot, Inst Jacques Monod, CNRS, UMR 7592,Sorbonne Paris Cite, F-75205 Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Vincent, O (corresponding author), CSIC UAM, Inst Invest Biomed, Arturo Duperier 4, Madrid 28029, Spain.	ovincent@iib.uam.es	vincent, Olivier/H-1620-2015; LEON, Sebastien/A-5441-2008	vincent, Olivier/0000-0003-4355-5367; LEON, Sebastien/0000-0002-2536-8595	Ministerio de Ciencia e Innovacion [BFU2008-02005]; Association pour la Recherche sur le Cancer (ARC) [SFI20101201844]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (BFU2008-02005; to O.V.) and the Association pour la Recherche sur le Cancer (ARC, Grant SFI20101201844; to S.L.).	Burgdorf S, 2004, J BIOL CHEM, V279, P17524, DOI 10.1074/jbc.M313703200; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Erpapazoglou Z, 2012, MOL BIOL CELL, V23, P2170, DOI 10.1091/mbc.E11-10-0891; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Herrador A, 2010, MOL CELL BIOL, V30, P897, DOI 10.1128/MCB.00132-09; Isasa M, 2010, MOL CELL, V38, P733, DOI 10.1016/j.molcel.2010.05.001; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Ren XF, 2011, EMBO J, V30, P2130, DOI 10.1038/emboj.2011.122; Rose MD., 1990, METHODS YEAST GENETI; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Teo H, 2004, J BIOL CHEM, V279, P28689, DOI 10.1074/jbc.M400023200; Wang GL, 1999, MOL CELL BIOL, V19, P342; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484	21	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16206	16211		10.1074/jbc.C113.452250	http://dx.doi.org/10.1074/jbc.C113.452250			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23645667	Green Published, hybrid			2022-12-28	WOS:000320378900001
J	Ostner, G; Lindstrom, V; Christensen, PH; Kozak, M; Abrahamson, M; Grubb, A				Ostner, Gustav; Lindstrom, Veronica; Christensen, Per Hjort; Kozak, Maciej; Abrahamson, Magnus; Grubb, Anders			Stabilization, Characterization, and Selective Removal of Cystatin C Amyloid Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MONOCLONAL-ANTIBODIES; MAMMALIAN LEGUMAIN; COMMON MECHANISM; ION CHANNELS; PROTEIN; FIBRILS; BETA; PATHOGENESIS; TOXICITY	The pathophysiological process in amyloid disorders usually involves the transformation of a functional monomeric protein via potentially toxic oligomers into amyloid fibrils. The structure and properties of the intermediary oligomers have been difficult to study due to their instability and dynamic equilibrium with smaller and larger species. In hereditary cystatin C amyloid angiopathy, a cystatin C variant is deposited in arterial walls and cause brain hemorrhage in young adults. In the present investigation, we use redox experiments of monomeric cystatin C, stabilized against domain swapping by an intramolecular disulfide bond, to generate stable oligomers (dimers, trimers, tetramers, decamers, and high molecular weight oligomers). These oligomers were characterized concerning size by gel filtration, polyacrylamide gel electrophoresis, and mass spectrometry, shape by electron and atomic force microscopy, and, function by assays of their capacity to inhibit proteases. The results showed the oligomers to be highly ordered, domain-swapped assemblies of cystatin C and that the oligomers could not build larger oligomers, or fibrils, without domain swapping. The stabilized oligomers were used to induce antibody formation in rabbits. After immunosorption, using immobilized monomeric cystatin C, and elution from columns with immobilized cystatin C oligomers, oligomer-specific antibodies were obtained. These could be used to selectively remove cystatin C dimers from biological fluids containing both dimers and monomers.	[Ostner, Gustav; Lindstrom, Veronica; Abrahamson, Magnus; Grubb, Anders] Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden; [Christensen, Per Hjort] Dako Denmark AS, DK-2600 Glostrup, Denmark; [Kozak, Maciej] Adam Mickiewicz Univ, Dept Macromol Phys, PL-61614 Poznan, Poland	Lund University; Skane University Hospital; Adam Mickiewicz University	Grubb, A (corresponding author), Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden.	anders.grubb@med.lu.se	Abrahamson, Magnus/CAG-9507-2022; Kozak, Maciej/A-6588-2008	Grubb, Anders/0000-0002-0125-3662; Kozak, Maciej/0000-0003-3312-6518	Swedish Science Research Council [5196]; A. Osterlund Foundation; G. Foundation; J. Kock Foundation; Royal Physiographic Society in Lund, Sweden; National Science Centre, Poland [2012/06/M/ST4/00036]	Swedish Science Research Council; A. Osterlund Foundation; G. Foundation; J. Kock Foundation; Royal Physiographic Society in Lund, Sweden; National Science Centre, Poland(National Science Centre, Poland)	This work was supported in part by the Swedish Science Research Council Project 5196 and by grants from the A. Osterlund, G. and J. Kock Foundations, and the Royal Physiographic Society in Lund, Sweden, and HARMO-NIA3 Project Grant 2012/06/M/ST4/00036 from the National Science Centre, Poland (to M. K. and A. G.)	ABRAHAMSON M, 1994, P NATL ACAD SCI USA, V91, P1416, DOI 10.1073/pnas.91.4.1416; ABRAHAMSON M, 1988, FEBS LETT, V236, P14, DOI 10.1016/0014-5793(88)80276-X; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; BODE W, 1988, EMBO J, V7, P2593, DOI 10.1002/j.1460-2075.1988.tb03109.x; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Fasman G.D., 1989, PRACTICAL HDB BIOCH; Gerhartz B, 1998, BIOCHEMISTRY-US, V37, P17309, DOI 10.1021/bi980873u; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; Guo ZF, 2006, P NATL ACAD SCI USA, V103, P8042, DOI 10.1073/pnas.0602607103; Janowski R, 2005, PROTEINS, V61, P570, DOI 10.1002/prot.20633; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Kagan BL, 2012, PROG MOL BIOL TRANSL, V107, P295, DOI [10.1016/B978-0-12-385883-2.00001-1, 10.1016/B978-0-12-385883-2.00009-6]; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Klapetek P, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/2/025501; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kolodziejczyk R, 2010, FEBS J, V277, P1726, DOI 10.1111/j.1742-4658.2010.07596.x; KYHSEANDERSEN J, 1994, CLIN CHEM, V40, P1921; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Lin H, 2001, FASEB J, V15, P2433, DOI 10.1096/fj.01-0377com; LINDAHL P, 1992, BIOCHEM J, V281, P49, DOI 10.1042/bj2810049; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Nilsson L. A., 1983, SCAND J IMMUNOL S10, V17, P57; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; OLAFSSON I, 1988, SCAND J CLIN LAB INV, V48, P573, DOI 10.3109/00365518809085775; Olafsson I, 2000, AMYLOID, V7, P70, DOI 10.3109/13506120009146827; Ostner G, 2011, SCAND J CLIN LAB INV, V71, P676, DOI 10.3109/00365513.2011.621026; Plakoutsi G, 2005, J MOL BIOL, V351, P910, DOI 10.1016/j.jmb.2005.06.043; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Rasband W, IMAGEJ; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Stroud JC, 2012, P NATL ACAD SCI USA, V109, P7717, DOI 10.1073/pnas.1203193109; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; Yamane T, 2002, BBA-PROTEIN STRUCT M, V1596, P108, DOI 10.1016/S0167-4838(02)00209-1; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394	44	16	16	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16438	16450		10.1074/jbc.M113.469593	http://dx.doi.org/10.1074/jbc.M113.469593			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23629649	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000320378900021
J	Chitalia, V; Shivanna, S; Martorell, J; Meyer, R; Edelman, E; Rahimi, N				Chitalia, Vipul; Shivanna, Sowmya; Martorell, Jordi; Meyer, Rosana; Edelman, Elazer; Rahimi, Nader			c-Cbl, a Ubiquitin E3 Ligase That Targets Active beta-Catenin A NOVEL LAYER OF Wnt SIGNALING REGULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-BOX PROTEIN; GROWTH-FACTOR; TYROSINE PHOSPHORYLATION; CRYSTAL-STRUCTURE; DEGRADATION; ACTIVATION; PATHWAY; COMPLEX; ANGIOGENESIS; ASSOCIATION	Regulation of transcriptionally active nuclear beta-catenin during the Wnt-on phase is crucial to ensure controlled induction of Wnt target genes. Several ubiquitin E3 ligases are known to regulate cytosolic beta-catenin during the Wnt-off phase, but little is known about the fate of active nuclear beta-catenin in the Wnt-on phase. We now describe ubiquitination of active beta-catenin in the Wnt-on phase by a RING finger ubiquitin E3 ligase, Casitas B-lineage lymphoma (c-Cbl) in endothelial cells. c-Cbl binds preferentially to nuclearly active beta-catenin in the Wnt-on phase via the armadillo repeat region. Wild-type c-Cbl suppresses and E3 ligase-deficient c-Cbl-70Z increases Wnt signaling. Wnt induces nuclear translocation of c-Cbl where it ubiquitinates nuclear beta-catenin. Deletion of the c-Cbl UBA domain abrogates its dimerization, binding to beta-catenin, Wnt-induced c-Cbl nuclear translocation, and ubiquitination of nuclear beta-catenin. c-Cbl activity inhibits pro-angiogenic Wnt targets IL-8 and VEGF levels and angiogenesis in a beta-catenin-dependent manner. This study defines for the first time c-Cbl as a ubiquitin E3 ligase that targets nuclearly active beta-catenin in the Wnt-on phase and uncovers a novel layer of regulation of Wnt signaling.	[Chitalia, Vipul; Shivanna, Sowmya] Boston Univ, Sch Med, Boston Med Ctr, Renal Sect,Dept Med, Boston, MA 02118 USA; [Chitalia, Vipul; Shivanna, Sowmya; Martorell, Jordi; Edelman, Elazer] MIT, Dept Biomed Engn, Cambridge, MA 02139 USA; [Meyer, Rosana; Rahimi, Nader] Boston Univ, Dept Pathol, Boston, MA 02118 USA	Boston Medical Center; Boston University; Massachusetts Institute of Technology (MIT); Boston University	Chitalia, V (corresponding author), Boston Univ, Med Ctr, Dept Med, Renal Sect,EBRC, Boston, MA 02118 USA.	vichital@bu.edu; nrahimi@bu.edu	Martorell, Jordi/N-3657-2013	Martorell, Jordi/0000-0002-2043-2762; Chitalia, Vipul/0000-0002-6663-6058; Rahimi, Nader/0000-0002-6745-1725	National Institutes of Health from NIDDK [K08 DK080946, R01 GM-49039, R01 EY017955]; National Kidney Foundation; Generalitat de Catalunya, Spain [FI-DGR 2011]; NATIONAL EYE INSTITUTE [R01EY017955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049039] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; National Kidney Foundation; Generalitat de Catalunya, Spain(Generalitat de Catalunya); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 DK080946, R01 GM-49039 (to E. E.), and R01 EY017955 (to N. R.) from NIDDK. This work was also supported by a Young Investigator Award from the National Kidney Foundation (to V. C.) and Grant FI-DGR 2011 from Generalitat de Catalunya, Spain (to J. M.).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bartkiewicz M, 1999, J BIOL CHEM, V274, P30887, DOI 10.1074/jbc.274.43.30887; Bilechele Travis L., 2008, V468, P99, DOI 10.1007/978-1-59745-249-6_8; BLAKE TJ, 1993, EMBO J, V12, P2017, DOI 10.1002/j.1460-2075.1993.tb05851.x; Chitalia VC, 2008, NAT CELL BIOL, V10, P1208, DOI 10.1038/ncb1781; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Husain D, 2010, INVEST OPHTH VIS SCI, V51, P6803, DOI 10.1167/iovs.10-5255; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kassenbrock CK, 2002, J BIOL CHEM, V277, P24967, DOI 10.1074/jbc.M201026200; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kobayashi S, 2004, FASEB J, V18, P929, DOI 10.1096/fj.03-0767fje; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Liu J, 2002, MOL CELL BIOL, V22, P3599, DOI 10.1128/MCB.22.11.3599-3609.2002; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Lupher ML, 1996, J BIOL CHEM, V271, P24063, DOI 10.1074/jbc.271.39.24063; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Martinelli S, 2010, AM J HUM GENET, V87, P250, DOI 10.1016/j.ajhg.2010.06.015; Masckauchan T. Nestor H., 2005, Angiogenesis, V8, P43, DOI 10.1007/s10456-005-5612-9; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Meyer RD, 2011, ONCOGENE, V30, P2198, DOI 10.1038/onc.2010.597; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nastasi T, 2004, DEV CELL, V6, P269, DOI 10.1016/S1534-5807(04)00020-6; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Rahimi N, 2009, BIOCHEM SOC T, V37, P1189, DOI 10.1042/BST0371189; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Sadot E, 2000, ONCOGENE, V19, P1992, DOI 10.1038/sj.onc.1203519; Sal-Man N, 2005, J BIOL CHEM, V280, P27449, DOI 10.1074/jbc.M503095200; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Singh AJ, 2007, P NATL ACAD SCI USA, V104, P5413, DOI 10.1073/pnas.0700809104; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Thien CBF, 2005, GROWTH FACTORS, V23, P161, DOI 10.1080/08977190500153763; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047; Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3; Zhang XB, 2001, CANCER RES, V61, P6050	40	38	38	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23505	23517		10.1074/jbc.M113.473801	http://dx.doi.org/10.1074/jbc.M113.473801			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23744067	Green Published, hybrid			2022-12-28	WOS:000330598200055
J	Diani-Moore, S; Zhang, S; Ram, P; Rifkind, AB				Diani-Moore, Silvia; Zhang, Sheng; Ram, Payal; Rifkind, Arleen B.			Aryl Hydrocarbon Receptor Activation by Dioxin Targets Phosphoenolpyruvate Carboxykinase (PEPCK) for ADP-ribosylation via 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-inducible Poly(ADP-ribose) Polymerase (TiPARP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADP-ribosylation; Aryl Hydrocarbon Receptor; Dioxin; Liver; Phosphoenolpyruvate Carboxykinase; TiPARP	INDEPENDENT GENE BATTERIES; HEPATIC GLUCONEOGENESIS; HEPATOCYTE CULTURES; MASS-SPECTROMETRY; MOUSE-LIVER; RNA LEVELS; EXPRESSION; TCDD; IDENTIFICATION; MITOCHONDRIAL	Effects of the environmental toxin and carcinogen 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) include a wasting syndrome associated with decreased gluconeogenesis. TCDD is a potent activator of the aryl hydrocarbon receptor (AHR), a ligand activated transcription factor. The relationship between gene activation by the AHR and TCDD toxicities is not well understood. We recently identified a pathway by which the AHR target gene TiPARP (TCDD-inducible poly(ADP-ribose) polymerase) contributes to TCDD suppression of transcription of phosphoenolpyruvate carboxykinase (PEPCK), a key regulator of gluconeogenesis, by consuming NAD(+) and decreasing Sirtuin 1 activation of the peroxisome proliferator-activated receptor coactivator 1 (PGC1), a transcriptional activator of PEPCK. We report here that TCDD-induced TiPARP also targets PEPCK for ADP-ribosylation. Both cytosolic and mitochondrial forms of PEPCK were found to undergo ADP-ribosylation. Unexpectedly, AHR suppression also enhanced ADP-ribosylation and did so by a poly(ADP-ribose) polymerase-independent mechanism. This report 1) identifies ADP-ribosylation as a new posttranslational modification for PEPCK, 2) describes a pathway by which transcriptional induction of TiPARP by the AHR can lead to a downstream posttranslational change in a TCDD target protein (PEPCK), and 3) reveals that the AHR exerts complex, previously unidentified modulatory effects on ADP-ribosylation.	[Diani-Moore, Silvia; Ram, Payal; Rifkind, Arleen B.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Zhang, Sheng] Cornell Univ, Inst Biotechnol & Life Sci Technol, Ithaca, NY 14850 USA	Cornell University; Cornell University	Rifkind, AB (corresponding author), Weill Cornell Med Coll, Dept Pharmacol, 1300 York Ave, New York, NY 10065 USA.	arifkind@med.cornell.edu			National Institutes of Health [ES-03606]; Winston Foundation; Cornell University-Ithaca; Weill Cornell Medical College Faculty; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Winston Foundation; Cornell University-Ithaca; Weill Cornell Medical College Faculty; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES-03606 (to A. B. R.). This work was also supported by a gift from the Winston Foundation (to A. B. R.) and a Seed Grant for Collaborations between Cornell University-Ithaca and Weill Cornell Medical College Faculty.	Adriouch S, 2008, FASEB J, V22, P861, DOI 10.1096/fj.07-9294com; Agca C, 2002, PHYSIOL GENOMICS, V11, P53, DOI 10.1152/physiolgenomics.00108.2001; Asher G, 2010, CELL, V142, P943, DOI 10.1016/j.cell.2010.08.016; Boutros PC, 2009, TOXICOL SCI, V112, P245, DOI 10.1093/toxsci/kfp191; Boutros PC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-419; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Diani-Moore S, 2006, TOXICOL SCI, V90, P96, DOI 10.1093/toxsci/kfj065; Diani-Moore S, 2011, CHEM-BIOL INTERACT, V193, P119, DOI 10.1016/j.cbi.2011.05.010; Diani-Moore S, 2010, J BIOL CHEM, V285, P38801, DOI 10.1074/jbc.M110.131573; Feijs KLH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-5; FernandezSalguero PM, 1996, TOXICOL APPL PHARM, V140, P173, DOI 10.1006/taap.1996.0210; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Goyak KMO, 2008, TOXICOL APPL PHARM, V231, P216, DOI 10.1016/j.taap.2008.04.024; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; HAMADA T, 1984, COMP BIOCHEM PHYS B, V77, P547, DOI 10.1016/0305-0491(84)90273-6; Hanson RW, 2009, J BIOL CHEM, V284, P27021, DOI 10.1074/jbc.R109.040519; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hengel SM, 2009, J AM SOC MASS SPECTR, V20, P477, DOI 10.1016/j.jasms.2008.10.025; Herrero-Yraola A, 2001, EMBO J, V20, P2404, DOI 10.1093/emboj/20.10.2404; HOD Y, 1986, ANN NY ACAD SCI, V478, P31, DOI 10.1111/j.1749-6632.1986.tb15519.x; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Jiang H, 2013, ANAL BIOCHEM, V433, P218, DOI 10.1016/j.ab.2012.10.029; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Kawajiri K, 2007, ARCH BIOCHEM BIOPHYS, V464, P207, DOI 10.1016/j.abb.2007.03.038; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Laing S, 2011, AMINO ACIDS, V41, P257, DOI 10.1007/s00726-010-0676-2; LENTNEK M, 1991, BIOCHEM BIOPH RES CO, V174, P1267, DOI 10.1016/0006-291X(91)91558-T; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; MacPherson L, 2013, NUCLEIC ACIDS RES, V41, P1604, DOI 10.1093/nar/gks1337; Manning GE, 2013, TOXICOL APPL PHARM, V266, P38, DOI 10.1016/j.taap.2012.10.030; Martinez-Zamudio R, 2012, MOL CELL BIOL, V32, P2490, DOI 10.1128/MCB.06667-11; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mendez-Lucas A, 2013, J HEPATOL, V59, P105, DOI 10.1016/j.jhep.2013.02.020; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; Okey AB, 2007, TOXICOL SCI, V98, P5, DOI 10.1093/toxsci/kfm096; Osago H, 2009, ANAL BIOCHEM, V393, P248, DOI 10.1016/j.ab.2009.06.028; Platten M, 2012, ONCOIMMUNOLOGY, V1, P395, DOI 10.4161/onci.19071; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; SAVON S, 1993, BIOL NEONATE, V64, P62; Schwanekamp JA, 2006, BBA-GENE STRUCT EXPR, V1759, P388, DOI 10.1016/j.bbaexp.2006.07.005; STAHL BU, 1993, TOXICOLOGY, V79, P81, DOI 10.1016/0300-483X(93)90207-9; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; UNKILA M, 1994, TOXICOL APPL PHARM, V128, P280, DOI 10.1006/taap.1994.1208; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Walker RP, 2002, PLANT PHYSIOL, V128, P165, DOI 10.1104/pp.010432; WEBER LWD, 1991, ARCH TOXICOL, V65, P119, DOI 10.1007/BF02034937; Yadgary L, 2012, POULTRY SCI, V91, P444, DOI 10.3382/ps.2011-01669; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Yang Y, 2011, J PROTEOME RES, V10, P4647, DOI 10.1021/pr200455s; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	66	22	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21514	21525		10.1074/jbc.M113.458067	http://dx.doi.org/10.1074/jbc.M113.458067			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23770670	hybrid, Green Published			2022-12-28	WOS:000328841900005
J	Ghosh, A; Saminathan, H; Kanthasamy, A; Anantharam, V; Jin, HJ; Sondarva, G; Harischandra, DS; Qian, ZQ; Rana, A; Kanthasamy, AG				Ghosh, Anamitra; Saminathan, Hariharan; Kanthasamy, Arthi; Anantharam, Vellareddy; Jin, Huajun; Sondarva, Gautam; Harischandra, Dilshan S.; Qian, Ziqing; Rana, Ajay; Kanthasamy, Anumantha G.			The Peptidyl-prolyl Isomerase Pin1 Up-regulation and Proapoptotic Function in Dopaminergic Neurons RELEVANCE TO THE PATHOGENESIS OF PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dopamine; Neurobiology; Neurodegenerative Diseases; Neuroprotection; Parkinson Disease; MPTP; Pin1; Caspase-3; Juglone	COUPLED RECEPTOR KINASES; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; CIS/TRANS ISOMERASES; NONMOTOR SYMPTOMS; MOUSE MODEL; CELL-DEATH; SERINE 129; PROTEIN; PHOSPHORYLATION	Parkinson disease (PD) is a chronic neurodegenerative disease characterized by a slow and progressive degeneration of dopaminergic neurons in substantia nigra. The pathophysiological mechanisms underlying PD remain unclear. Pin1, a major peptidyl-prolyl isomerase, has recently been associated with certain diseases. Notably, Ryo et al. (Ryo, A., Togo, T., Nakai, T., Hirai, A., Nishi, M., Yamaguchi, A., Suzuki, K., Hirayasu, Y., Kobayashi, H., Perrem, K., Liou, Y. C., and Aoki, I. (2006) J. Biol. Chem. 281, 4117-4125) implicated Pin1 in PD pathology. Therefore, we sought to systematically characterize the role of Pin1 in PD using cell culture and animal models. To our surprise we observed a dramatic up-regulation of Pin1 mRNA and protein levels in dopaminergic MN9D neuronal cells treated with the parkinsonian toxicant 1-methyl-4-phenylpyridinium (MPP+) as well as in the substantia nigra of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mouse model. Notably, a marked expression of Pin1 was also observed in the substantia nigra of human PD brains along with a high co-localization of Pin1 within dopaminergic neurons. In functional studies, siRNA-mediated knockdown of Pin1 almost completely prevented MPP+-induced caspase-3 activation and DNA fragmentation, indicating that Pin1 plays a proapoptotic role. Interestingly, multiple pharmacological Pin1 inhibitors, including juglone, attenuated MPP+-induced Pin1 up-regulation, -synuclein aggregation, caspase-3 activation, and cell death. Furthermore, juglone treatment in the MPTP mouse model of PD suppressed Pin1 levels and improved locomotor deficits, dopamine depletion, and nigral dopaminergic neuronal loss. Collectively, our findings demonstrate for the first time that Pin1 is up-regulated in PD and has a pathophysiological role in the nigrostriatal dopaminergic system and suggest that modulation of Pin1 levels may be a useful translational therapeutic strategy in PD.	[Harischandra, Dilshan S.; Kanthasamy, Anumantha G.] Iowa State Univ, Dept Biomed Sci, Iowa Ctr Adv Neurotoxicol, Ames, IA 50011 USA; [Sondarva, Gautam; Rana, Ajay] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, Maywood, IL 60153 USA; [Qian, Ziqing] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Rana, Ajay] Hines Vet Affairs Med Ctr, Hines, IL 60141 USA	Iowa State University; Loyola University Chicago; University System of Ohio; Ohio State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Kanthasamy, AG (corresponding author), Iowa State Univ, Dept Biomed Sci, Iowa Ctr Adv Neurotoxicol, Ames, IA 50011 USA.	akanthas@iastate.edu	Ghosh, Anamitra/C-5118-2015; Qian, Ziqing/N-9887-2014; Rana, Ajay/ABE-3739-2020	Qian, Ziqing/0000-0001-9452-1007; Rana, Ajay/0000-0003-0951-2566; Saminathan, Hariharan/0000-0003-0009-7028; Kanthasamy, Arthi/0000-0003-4654-9907; Ghosh, Anamitra/0000-0001-9740-2070; Harischandra, Dilshan/0000-0003-3220-8765; Kanthasamy, Anumantha/0000-0002-6454-4264	National Institutes of Health RO1 [N5074443, NS65167, GM55835]; Veterans Affairs Merit Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065167, R01NS074443] Funding Source: NIH RePORTER	National Institutes of Health RO1(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health RO1 Grants N5074443 (to A. G. K.), NS65167 (to A. K.), and GM55835 (to A. R.).; Recipient of a Veterans Affairs Merit Award.	Ai ZhengHua, 2009, Asian Cardiovasc Thorac Ann, V17, P157, DOI 10.1177/0218492309103297; Akiyama H, 2005, BIOCHEM BIOPH RES CO, V336, P521, DOI 10.1016/j.bbrc.2005.08.130; Anantharam V, 2007, NEUROTOXICOLOGY, V28, P988, DOI 10.1016/j.neuro.2007.08.008; Atchison FW, 2004, FRONT BIOSCI-LANDMRK, V9, P3248, DOI 10.2741/1476; Barone MC, 2008, J NEUROCHEM, V106, P734, DOI 10.1111/j.1471-4159.2008.05427.x; Becker EBE, 2006, NEURON, V49, P655, DOI 10.1016/j.neuron.2006.01.034; Becker EBE, 2007, CELL CYCLE, V6, P1332, DOI 10.4161/cc.6.11.4316; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Butterfield DA, 2006, J NEUROCHEM, V98, P1697, DOI 10.1111/j.1471-4159.2006.03995.x; Castro DS, 2001, J BIOL CHEM, V276, P43277, DOI 10.1074/jbc.M107013200; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Esnault S, 2008, CRIT REV IMMUNOL, V28, P45, DOI 10.1615/CritRevImmunol.v28.i1.30; Esnault S, 2007, J ALLERGY CLIN IMMUN, V120, P1082, DOI 10.1016/j.jaci.2007.06.024; Ghosh A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-241; Ghosh A, 2010, FREE RADICAL BIO MED, V49, P1674, DOI 10.1016/j.freeradbiomed.2010.08.028; Ghosh A, 2009, J NEUROSCI, V29, P13543, DOI 10.1523/JNEUROSCI.4144-09.2009; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hu XM, 2011, J NEUROSCI, V31, P247, DOI 10.1523/JNEUROSCI.4589-10.2011; Hutton M, 2001, TRENDS MOL MED, V7, P467, DOI 10.1016/S1471-4914(01)02123-2; Inglis KJ, 2009, J BIOL CHEM, V284, P2598, DOI 10.1074/jbc.C800206200; Jeong HG, 2009, J IMMUNOL, V183, P6689, DOI 10.4049/jimmunol.0901431; Joseph James D, 2003, Prog Cell Cycle Res, V5, P477; KASTNER A, 1992, J NEUROCHEM, V59, P1080, DOI 10.1111/j.1471-4159.1992.tb08350.x; Kesavapany S, 2007, MOL BIOL CELL, V18, P3645, DOI 10.1091/mbc.E07-03-0237; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lee KY, 2011, MOL CELLS, V32, P107, DOI 10.1007/s10059-011-0074-y; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li HY, 2006, ONCOL REP, V16, P491; Li QM, 2007, J NEUROSCI, V27, P8395, DOI 10.1523/JNEUROSCI.2478-07.2007; Liu T, 2010, J MED CHEM, V53, P2494, DOI 10.1021/jm901778v; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Lu KP, 2003, CANCER CELL, V4, P175, DOI 10.1016/S1535-6108(03)00218-6; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Lv L, 2010, APOPTOSIS, V15, P41, DOI 10.1007/s10495-009-0409-8; Machiya Y, 2010, J BIOL CHEM, V285, P40732, DOI 10.1074/jbc.M110.141952; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; Martinez-Martin P, 2009, NEUROLOGY, V73, P1584, DOI 10.1212/WNL.0b013e3181c0d416; Maruszak A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-115; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; Miyashita H, 2003, ONCOL REP, V10, P455; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Rangasamy V, 2012, P NATL ACAD SCI USA, V109, P8149, DOI 10.1073/pnas.1200804109; Roy A., 2012, PLOS ONE, V7; Rudrabhatla P, 2010, J ALZHEIMERS DIS, V19, P389, DOI 10.3233/JAD-2010-1243; Rudrabhatla P, 2009, J NEUROSCI, V29, P14869, DOI 10.1523/JNEUROSCI.4469-09.2009; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Ryo A, 2002, MOL CELL BIOL, V22, P5281, DOI 10.1128/MCB.22.15.5281-5295.2002; Sakamoto M, 2009, BIOCHEM BIOPH RES CO, V384, P378, DOI 10.1016/j.bbrc.2009.04.130; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Shen ZJ, 2009, NAT IMMUNOL, V10, P257, DOI 10.1038/ni.1697; Song C, 2010, MOL PHARMACOL, V77, P621, DOI 10.1124/mol.109.062174; Sultana R, 2006, NEUROBIOL AGING, V27, P918, DOI 10.1016/j.neurobiolaging.2005.05.005; Sun F, 2005, J PHARMACOL EXP THER, V315, P69, DOI 10.1124/jpet.105.084632; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Wulf GM, 2002, J BIOL CHEM, V277, P47976, DOI 10.1074/jbc.C200538200; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669	66	58	62	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21955	10.1074/jbc.M112.444224	http://dx.doi.org/10.1074/jbc.M112.444224			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23754278	hybrid, Green Published			2022-12-28	WOS:000328841900043
J	Wang, XC; Jin, CY; Tang, Y; Tang, LY; Zhang, YE				Wang, Xiangchun; Jin, Chaoyang; Tang, Yi; Tang, Liu-Ya; Zhang, Ying E.			Ubiquitination of Tumor Necrosis Factor Receptor-associated Factor 4 (TRAF4) by Smad Ubiquitination Regulatory Factor 1 (Smurf1) Regulates Motility of Breast Epithelial and Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Migration; E3 Ubiquitin Ligase; Rac1; Tight Junctions; TRAF; Ubiquitination; Smurf1; TRAF4; Monoubiquitination	LIGASE SMURF2; TRAF4-DEFICIENT MICE; TGF-BETA; DEGRADATION; POLARITY; PATHWAY; MIGRATION; TARGETS; PROTEIN; DIFFERENTIATION	Smad ubiquitin regulatory factors (Smurfs) are HECT-domain ubiquitin E3 ligases that regulate diverse cellular processes, including normal and tumor cell migration. However, the underlying mechanism of the Smurfs' role in cell migration is not fully understood. Here we show that Smurf1 induces ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) at K190. Using the K190R mutant of TRAF4, we demonstrate that Smurf1-induced ubiquitination is required for proper localization of TRAF4 to tight junctions in confluent epithelial cells. We further show that TRAF4 is essential for the migration of both normal mammary epithelial and breast cancer cells. The ability of TRAF4 to promote cell migration is also dependent on Smurf1-mediated ubiquitination, which is associated with Rac1 activation by TRAF4. These results reveal a new regulatory circuit for cell migration, consisting of Smurf1-mediated ubiquitination of TRAF4 and Rac1 activation.	[Wang, Xiangchun; Jin, Chaoyang; Tang, Yi; Tang, Liu-Ya; Zhang, Ying E.] NCI, Lab Cellular & Mol Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhang, YE (corresponding author), NCI, Lab Cellular & Mol Biol, Ctr Canc Res, 37 Convent Dr,Bldg 37,Room 2056B, Bethesda, MD 20892 USA.	zhangyin@mail.nih.gov	Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601	National Institutes of Health, NCI, Center for Cancer Research [ZIA BC 011168]; NATIONAL CANCER INSTITUTE [ZIABC011168] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural research program of the National Institutes of Health, NCI, Center for Cancer Research (ZIA BC 011168).	Birnbaum DJ, 2011, GENE CHROMOSOME CANC, V50, P456, DOI 10.1002/gcc.20870; Blank M, 2012, NAT MED, V18, P227, DOI 10.1038/nm.2596; Cherfils-Vicini J, 2008, IMMUNOLOGY, V124, P562, DOI 10.1111/j.1365-2567.2008.02810.x; Chung JY, 2002, J CELL SCI, V115, P679; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Dai Wen-Bo, 2007, Ai Zheng, V26, P1095; Fukuchi M, 2002, CANCER RES, V62, P7162; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Jin CY, 2009, CANCER RES, V69, P735, DOI 10.1158/0008-5472.CAN-08-1463; Kalkan T, 2009, MOL BIOL CELL, V20, P3436, DOI 10.1091/mbc.E08-03-0325; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kedinger V, 2007, ADV EXP MED BIOL, V597, P60; Kedinger V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003518; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kornegoor R, 2012, BREAST CANCER RES TR, V135, P49, DOI 10.1007/s10549-012-2051-3; Kwei KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023924; Li S, 2010, MOL CELL BIOCHEM, V338, P11, DOI 10.1007/s11010-009-0315-y; Lin X, 2000, J BIOL CHEM, V275, P36818, DOI 10.1074/jbc.C000580200; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Osmundson EC, 2008, J CELL BIOL, V183, P267, DOI 10.1083/jcb.200801049; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Regnier CH, 2002, P NATL ACAD SCI USA, V99, P5585, DOI 10.1073/pnas.052124799; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; TOMASETTO C, 1995, GENOMICS, V28, P367, DOI 10.1006/geno.1995.1163; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Wu RF, 2005, J CELL BIOL, V171, P893, DOI 10.1083/jcb.200507004; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066; Xing LP, 2010, J CELL BIOCHEM, V110, P554, DOI 10.1002/jcb.22586; Yamaguchi K, 2008, BIOL CHEM, V389, P405, DOI 10.1515/BC.2008.036; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202; Ying SX, 2003, J BIOL CHEM, V278, P39029, DOI 10.1074/jbc.M301193200; Zhang H, 2008, J CELL PHYSIOL, V215, P613, DOI 10.1002/jcp.21337; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	44	34	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21784	10.1074/jbc.M113.472704	http://dx.doi.org/10.1074/jbc.M113.472704			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760265	hybrid, Green Published			2022-12-28	WOS:000328841900028
J	Augagneur, Y; Jaubert, L; Schiavoni, M; Pachikara, N; Garg, A; Usmani-Brown, S; Wesolowski, D; Zeller, S; Ghosal, A; Cornillot, E; Said, HM; Kumar, P; Altman, S; Ben Mamoun, C				Augagneur, Yoann; Jaubert, Lise; Schiavoni, Matthieu; Pachikara, Niseema; Garg, Aprajita; Usmani-Brown, Sahar; Wesolowski, Donna; Zeller, Skye; Ghosal, Abhisek; Cornillot, Emmanuel; Said, Hamid M.; Kumar, Priti; Altman, Sidney; Ben Mamoun, Choukri			Identification and Functional Analysis of the Primary Pantothenate Transporter, PfPAT, of the Human Malaria Parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOETHANOLAMINE-METHYLTRANSFERASE; NUCLEOSIDE TRANSPORTER; ENDOPLASMIC-RETICULUM; BIOSYNTHESIS; GROWTH; PFNT1; YEAST; DECARBOXYLASE; LOCALIZATION; VALIDATION	The human malaria parasite Plasmodium falciparum is absolutely dependent on the acquisition of host pantothenate for its development within human erythrocytes. Although the biochemical properties of this transport have been characterized, the molecular identity of the parasite-encoded pantothenate transporter remains unknown. Here we report the identification and functional characterization of the first protozoan pantothenate transporter, PfPAT, from P. falciparum. We show using cell biological, biochemical, and genetic analyses that this transporter is localized to the parasite plasma membrane and plays an essential role in parasite intraerythrocytic development. We have targeted PfPAT to the yeast plasma membrane and showed that the transporter complements the growth defect of the yeast fen2 Delta pantothenate transporter-deficient mutant and mediates the entry of the fungicide drug, fenpropimorph. Our studies in P. falciparum revealed that fenpropimorph inhibits the intraerythrocytic development of both chloroquine-and pyrimethamine-resistant P. falciparum strains with potency equal or better than that of currently available pantothenate analogs. The essential function of PfPAT and its ability to deliver both pantothenate and fenpropimorph makes it an attractive target for the development and delivery of new classes of antimalarial drugs.	[Augagneur, Yoann; Jaubert, Lise; Schiavoni, Matthieu; Pachikara, Niseema; Garg, Aprajita; Usmani-Brown, Sahar; Zeller, Skye; Kumar, Priti; Ben Mamoun, Choukri] Yale Univ, Sch Med, Dept Med, New Haven, CT 06520 USA; [Wesolowski, Donna; Altman, Sidney] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Ghosal, Abhisek; Said, Hamid M.] Univ Calif Irvine, Dept Med, Orange, CA 92668 USA; [Cornillot, Emmanuel] Univ Montpellier I, LBCM, EA4558, F-34095 Montpellier, France	Yale University; Yale University; University of California System; University of California Irvine; Universite de Montpellier	Ben Mamoun, C (corresponding author), Yale Univ, Sch Med, Dept Med, 15 York St,WWW-403D, New Haven, CT 06510 USA.	choukri.benmamoun@yale.edu	augagneur, yoann/L-2000-2015; Cornillot, Emmanuel/P-9656-2017	augagneur, yoann/0000-0002-6816-5931; Cornillot, Emmanuel/0000-0002-1202-1162	National Institutes of Health [AI097218, AI077603]; Burroughs Welcome Fund [1006267]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077603, R01AI097218] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Welcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI097218 and AI077603 (to C. B. M.).; Supported by Burroughs Welcome Fund Grant 1006267.	Augagneur Y, 2012, P NATL ACAD SCI USA, V109, P6235, DOI 10.1073/pnas.1203516109; Baro NK, 2011, BIOCHEMISTRY-US, V50, P6701, DOI 10.1021/bi200922g; Ben Mamoun C, 1999, P NATL ACAD SCI USA, V96, P8716, DOI 10.1073/pnas.96.15.8716; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; Downie MJ, 2008, INT J PARASITOL, V38, P203, DOI 10.1016/j.ijpara.2007.07.005; Downie MJ, 2010, J BIOL CHEM, V285, P20827, DOI 10.1074/jbc.M110.118489; El Bissati K, 2008, MOL BIOCHEM PARASIT, V161, P130, DOI 10.1016/j.molbiopara.2008.06.012; El Bissati K, 2006, P NATL ACAD SCI USA, V103, P9286, DOI 10.1073/pnas.0602590103; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Johnson JD, 2007, ANTIMICROB AGENTS CH, V51, P1926, DOI 10.1128/AAC.01607-06; Kirk K, 2007, CURR DRUG TARGETS, V8, P75, DOI 10.2174/138945007779315560; Marcireau C, 1996, YEAST, V12, P531, DOI 10.1002/(SICI)1097-0061(199605)12:6<531::AID-YEA934>3.3.CO;2-5; Martin RE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r26; Martin RE, 2009, MOL MICROBIOL, V74, P519, DOI 10.1111/j.1365-2958.2009.06863.x; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Pessi G, 2005, J BIOL CHEM, V280, P12461, DOI 10.1074/jbc.M414626200; Rager N, 2001, J BIOL CHEM, V276, P41095, DOI 10.1074/jbc.M107037200; Rason MA, 2008, T ROY SOC TROP MED H, V102, P346, DOI 10.1016/j.trstmh.2008.01.021; Reynolds JM, 2008, J BIOL CHEM, V283, P7894, DOI 10.1074/jbc.M709869200; Saliba KJ, 1998, J BIOL CHEM, V273, P10190, DOI 10.1074/jbc.273.17.10190; Saliba KJ, 2005, MOL BIOCHEM PARASIT, V141, P129, DOI 10.1016/j.molbiopara.2005.02.003; Saliba KJ, 2005, ANTIMICROB AGENTS CH, V49, P632, DOI 10.1128/AAC.49.2.632-637.2005; Saliba KJ, 2001, INT J PARASITOL, V31, P1321, DOI 10.1016/S0020-7519(01)00258-2; Saliba KJ, 2001, J BIOL CHEM, V276, P18115, DOI 10.1074/jbc.M010942200; Santiago TC, 2004, J BIOL CHEM, V279, P9222, DOI 10.1074/jbc.M310502200; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Slavic K, 2010, MOL MICROBIOL, V75, P1402, DOI 10.1111/j.1365-2958.2010.07060.x; Spry C, 2005, ANTIMICROB AGENTS CH, V49, P4649, DOI 10.1128/AAC.49.11.4649-4657.2005; Spry C, 2008, FEMS MICROBIOL REV, V32, P56, DOI 10.1111/j.1574-6976.2007.00093.x; Stolz J, 1999, J BIOL CHEM, V274, P18747, DOI 10.1074/jbc.274.26.18747; Stolz J, 2004, EUKARYOT CELL, V3, P406, DOI 10.1128/EC.3.2.406-412.2004; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Waller KL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-19; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Witola WH, 2006, J BIOL CHEM, V281, P21305, DOI 10.1074/jbc.M603260200; Witola WH, 2008, J BIOL CHEM, V283, P27636, DOI 10.1074/jbc.M804360200; Woodrow CJ, 1999, J BIOL CHEM, V274, P7272, DOI 10.1074/jbc.274.11.7272; Woodrow CJ, 2000, P NATL ACAD SCI USA, V97, P9931, DOI 10.1073/pnas.170153097	43	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20558	20567		10.1074/jbc.M113.482992	http://dx.doi.org/10.1074/jbc.M113.482992			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23729665	Green Published, hybrid			2022-12-28	WOS:000321715100042
J	Garzon, D; Anselmi, C; Bond, PJ; Faraldo-Gomez, JD				Garzon, Diana; Anselmi, Claudio; Bond, Peter J.; Faraldo-Gomez, Jose D.			Dynamics of the Antigen-binding Grooves in CD1 Proteins REVERSIBLE HYDROPHOBIC COLLAPSE IN THE LIPID-FREE STATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; PRESENTING MOLECULES; TAPASIN DEPENDENCE; BOUND LIGANDS; FORCE-FIELD; T-CELLS; SIMULATION; TRAFFICKING; ANGSTROM	CD1 proteins mediate the presentation of endogenous and foreign lipids on the cell surface for recognition by T cell receptors. To sample a diverse antigen pool, CD1 proteins are repeatedly internalized and recycled, assisted, in some cases, by lipid transfer proteins such as saposins. The specificity of each CD1 isoform is, therefore, conferred in part by its intracellular pathway but also by distinct structural features of the antigen-binding domain. Crystal structures of CD1-lipid complexes reveal hydrophobic grooves and pockets within these binding domains that appear to be specialized for different lipids. However, the mechanism of lipid loading and release remains to be characterized. Here we gain insights into this mechanism through a meta-analysis of the five human CD1 isoforms, in the lipid-bound and lipid-free states, using all-atom molecular dynamics simulations. Strikingly, for isoforms CD1b through CD1e, our simulations show the near-complete collapse of the hydrophobic cavities in the absence of the antigen. This event results from the spontaneous closure of the binding domain entrance, flanked by two alpha-helices. Accordingly, we show that the anatomy of the binding cavities is restored if these alpha-helices are repositioned extrinsically, suggesting that helper proteins encountered during recycling facilitate lipid exchange allosterically. By contrast, we show that the binding cavity of CD1a is largely preserved in the unliganded state because of persistent electrostatic interactions that keep the portal alpha-helices at a constant separation. The robustness of this binding groove is consistent with the observation that lipid exchange in CD1a is not dependent on cellular internalization.	[Garzon, Diana; Anselmi, Claudio; Faraldo-Gomez, Jose D.] Max Planck Inst Biophys, Theoret Mol Biophys Grp, D-60438 Frankfurt, Germany; [Bond, Peter J.] Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Cambridge CB2 1EW, England	Max Planck Society; University of Cambridge	Bond, PJ (corresponding author), Univ Cambridge, Dept Chem, Unilever Ctr Mol Sci Informat, Lensfield Rd, Cambridge CB2 1EW, England.	pjb91@cam.ac.uk; jose.faraldo@biophys.mpg.de	Faraldo-Gomez, Jose/H-7127-2016; Anselmi, Claudio/D-6244-2012	Anselmi, Claudio/0000-0002-3017-5085; Bond, Peter/0000-0003-2900-098X	German Research Foundation Cluster of Excellence Grant [EXC115]; IMPReS fellowship of the Max Planck Institute of Biophysics	German Research Foundation Cluster of Excellence Grant; IMPReS fellowship of the Max Planck Institute of Biophysics	This work was supported in part by German Research Foundation Cluster of Excellence Grant EXC115 (to J. D. F. G.) and by an IMPReS fellowship of the Max Planck Institute of Biophysics (to D. G.).	Barral DC, 2007, NAT REV IMMUNOL, V7, P929, DOI 10.1038/nri2191; Bauer A, 1997, EUR J IMMUNOL, V27, P1366, DOI 10.1002/eji.1830270611; Briken V, 2002, EMBO J, V21, P825, DOI 10.1093/emboj/21.4.825; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUTKIEWICZ RR, 1995, J EXP MED, V182, P1913, DOI 10.1084/jem.182.6.1913; Cernadas M, 2010, J IMMUNOL, V184, P1235, DOI 10.4049/jimmunol.0804140; Cheng TY, 2006, EMBO J, V25, P2989, DOI 10.1038/SJ.EMBOJ.7601185; De Libero G, 2005, NAT REV IMMUNOL, V5, P485, DOI 10.1038/nri1631; De Libero G, 2012, TRENDS IMMUNOL, V33, P103, DOI 10.1016/j.it.2012.01.005; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Eswar N., 2006, CURR PROTOC PROT SCI, V50, P291; Feller SE, 1997, BIOPHYS J, V73, P2269, DOI 10.1016/S0006-3495(97)78259-6; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Garcia-Alles LF, 2006, EMBO J, V25, P3684, DOI 10.1038/sj.emboj.7601244; Garcia-Alles LF, 2011, P NATL ACAD SCI USA, V108, P13230, DOI 10.1073/pnas.1105627108; Garstka MA, 2011, FASEB J, V25, P3989, DOI 10.1096/fj.11-190249; Garzon D, 2009, MOL IMMUNOL, V47, P253, DOI 10.1016/j.molimm.2009.09.029; Girardi E, 2010, J IMMUNOL, V185, P376, DOI 10.4049/jimmunol.1000042; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huttinger R, 1999, INT IMMUNOL, V11, P1615, DOI 10.1093/intimm/11.10.1615; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Manolova V, 2006, EUR J IMMUNOL, V36, P1083, DOI 10.1002/eji.200535544; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Moody DB, 2001, IMMUNITY, V15, P861, DOI 10.1016/S1074-7613(01)00250-3; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Porcelli SA, 1998, IMMUNOL TODAY, V19, P362, DOI 10.1016/S0167-5699(98)01289-4; Relloso M, 2008, IMMUNITY, V28, P774, DOI 10.1016/j.immuni.2008.04.017; Salamero J, 2001, J INVEST DERMATOL, V116, P401, DOI 10.1046/j.1523-1747.2001.01264.x; Salio M, 2010, CURR OPIN IMMUNOL, V22, P81, DOI 10.1016/j.coi.2009.12.008; Scharf L, 2010, IMMUNITY, V33, P853, DOI 10.1016/j.immuni.2010.11.026; Sieker F, 2008, MOL IMMUNOL, V45, P3714, DOI 10.1016/j.molimm.2008.06.009; Sieker F, 2007, PROTEIN SCI, V16, P299, DOI 10.1110/ps.062568407; Silk JD, 2008, ANNU REV CELL DEV BI, V24, P369, DOI 10.1146/annurev.cellbio.24.110707.175359; Sugita M, 2000, TRAFFIC, V1, P295, DOI 10.1034/j.1600-0854.2000.010401.x; Sugita M, 1997, J IMMUNOL, V159, P2358; Sugita M, 2004, CURR OPIN IMMUNOL, V16, P90, DOI 10.1016/j.coi.2003.11.014; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104; Zajonc DM, 2007, CURR TOP MICROBIOL, V314, P27; Zajonc DM, 2008, P NATL ACAD SCI USA, V105, P17925, DOI 10.1073/pnas.0809814105; Zajonc DM, 2005, IMMUNITY, V22, P209, DOI 10.1016/j.immuni.2004.12.009; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	51	16	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19528	19536		10.1074/jbc.M113.470179	http://dx.doi.org/10.1074/jbc.M113.470179			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23677998	hybrid, Green Published			2022-12-28	WOS:000321515800019
J	Horlick, RA; Macomber, JL; Bowers, PM; Neben, TY; Tomlinson, GL; Krapf, IP; Dalton, JL; Verdino, P; King, DJ				Horlick, Robert A.; Macomber, John L.; Bowers, Peter M.; Neben, Tamlyn Y.; Tomlinson, Geoffery L.; Krapf, Irina P.; Dalton, Jennifer L.; Verdino, Petra; King, David J.			Simultaneous Surface Display and Secretion of Proteins from Mammalian Cells Facilitate Efficient in Vitro Selection and Maturation of Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOMATIC HYPERMUTATION; MESSENGER-RNAS; 3 ENDS; MEMBRANE; EVOLUTION; VECTORS; CHAINS; DIFFER	A mammalian expression system has been developed that permits simultaneous cell surface display and secretion of the same protein through alternate splicing of pre-mRNA. This enables a flexible system for in vitro protein evolution in mammalian cells where the displayed protein phenotype remains linked to genotype, but with the advantage of soluble protein also being produced without the requirement for any further recloning to allow a wide range of assays, including biophysical and cell-based functional assays, to be used during the selection process. This system has been used for the simultaneous surface presentation and secretion of IgG during antibody discovery and maturation. Presentation and secretion of monomeric Fab can also be achieved to minimize avidity effects. Manipulation of the splice donor site sequence enables control of the relative amounts of cell surface and secreted antibody. Multi-domain proteins may be presented and secreted in different formats to enable flexibility in experimental design, and secreted proteins may be produced with epitope tags to facilitate high-throughput testing. This system is particularly useful in the context of in situ mutagenesis, as in the case of in vitro somatic hypermutation.	[Horlick, Robert A.; Macomber, John L.; Bowers, Peter M.; Neben, Tamlyn Y.; Tomlinson, Geoffery L.; Krapf, Irina P.; Dalton, Jennifer L.; Verdino, Petra; King, David J.] AnaptysBio Inc, San Diego, CA 92121 USA		Horlick, RA (corresponding author), AnaptysBio Inc, Dept Mol Biol, 10421 Pacific Ctr Ct,Ste 200, San Diego, CA 92121 USA.	rhorlick@anaptysbio.com						ALT FW, 1980, CELL, V20, P293, DOI 10.1016/0092-8674(80)90615-7; Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bowers PM, 2011, P NATL ACAD SCI USA, V108, P20455, DOI 10.1073/pnas.1114010108; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Changela A, 2011, J VIROL, V85, P2524, DOI 10.1128/JVI.02335-10; DAMJANOVICH S, 1983, P NATL ACAD SCI-BIOL, V80, P5985, DOI 10.1073/pnas.80.19.5985; Elkina Y, 2011, J CACHEXIA SARCOPENI, V2, P143, DOI 10.1007/s13539-011-0035-5; Gur H, 1999, CELL IMMUNOL, V191, P105, DOI 10.1006/cimm.1998.1417; Horlick RA, 2000, GENE, V243, P187, DOI 10.1016/S0378-1119(99)00561-2; HUANG MTF, 1990, MOL CELL BIOL, V10, P1805, DOI 10.1128/MCB.10.4.1805; KEHRY M, 1980, CELL, V21, P393, DOI 10.1016/0092-8674(80)90476-6; Lipovsek D, 2007, CHEM BIOL, V14, P1176, DOI 10.1016/j.chembiol.2007.09.008; Majors BS, 2012, PROTEIN ENG DES SEL, V25, P27, DOI 10.1093/protein/gzr052; Martin A, 2002, P NATL ACAD SCI USA, V99, P12304, DOI 10.1073/pnas.192442899; McConnell AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049458; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; ROGERS J, 1980, CELL, V20, P303, DOI 10.1016/0092-8674(80)90616-9; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Vendel MC, 2012, ARCH BIOCHEM BIOPHYS, V526, P188, DOI 10.1016/j.abb.2011.12.018; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang L, 2004, P NATL ACAD SCI USA, V101, P16745, DOI 10.1073/pnas.0407752101	22	23	26	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19861	19869		10.1074/jbc.M113.452482	http://dx.doi.org/10.1074/jbc.M113.452482			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689374	Green Published, hybrid			2022-12-28	WOS:000321515800053
J	Rajala, A; Dighe, R; Agbaga, MP; Anderson, RE; Rajala, RVS				Rajala, Ammaji; Dighe, Radhika; Agbaga, Martin-Paul; Anderson, Robert E.; Rajala, Raju V. S.			Insulin Receptor Signaling in Cones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE B-GAMMA; MOLECULAR-CLONING; PROTEIN-KINASE; PHOSPHOINOSITIDE 3-KINASE; RETINAL DEGENERATION; BRAIN INSULIN; PHOTORECEPTOR CELLS; MESSENGER-RNA; MOUSE RETINA; MICE LACKING	In humans, age-related macular degeneration and diabetic retinopathy are the most common disorders affecting cones. In retinitis pigmentosa (RP), cone cell death precedes rod cell death. Systemic administration of insulin delays the death of cones in RP mouse models lacking rods. To date there are no studies on the insulin receptor signaling in cones; however, mRNA levels of IR signaling proteins are significantly higher in cone-dominant neural retina leucine zipper (Nrl) knock-out mouse retinas compared with wild type rod-dominant retinas. We previously reported that conditional deletion of the p85 alpha subunit of phosphoinositide 3-kinase (PI3K) in cones resulted in age-related cone degeneration, and the phenotype was not rescued by healthy rods, raising the question of why cones are not protected by the rod-derived cone survival factors. Interestingly, systemic administration of insulin has been shown to delay the death of cones in mouse models of RP lacking rods. These observations led to the hypothesis that cones may have their own endogenous neuroprotective pathway, or rod-derived cone survival factors may be signaled through cone PI3K. To test this hypothesis we generated p85 alpha(-/-) /Nrl(-/-) double knock-out mice and also rhodopsin mutant mice lacking p85 alpha and examined the effect of the p85 alpha. subunit of PI3K on cone survival. We found that the rate of cone degeneration is significantly faster in both of these models compared with respective mice with competent p85 alpha. These studies suggest that cones may have their own endogenous PI3K-mediated neuroprotective pathway in addition to the cone viability survival signals derived from rods.	Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Anderson, Robert E.; Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Rajala, Ammaji; Dighe, Radhika; Agbaga, Martin-Paul; Anderson, Robert E.; Rajala, Raju V. S.] Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Rajala, RVS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	raju-rajala@ouhsc.edu			National Institutes of Health [EY016507, EY00871, RR17703, EY12190, EY021725]; Research to Prevent Blindness, Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY000871, R01EY016507, P30EY012190, P30EY021725] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY016507, EY00871, RR17703, EY12190, and EY021725. This work was also supported by an unrestricted departmental grant from Research to Prevent Blindness, Inc.	Adler R, 1999, MOL VIS, V5; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Cheng ZY, 2010, TRENDS ENDOCRIN MET, V21, P589, DOI 10.1016/j.tem.2010.06.005; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Cho NC, 2000, ARCH OPHTHALMOL-CHIC, V118, P1393; COFFER PJ, 1991, EUR J BIOCHEM, V201, P475, DOI 10.1111/j.1432-1033.1991.tb16305.x; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; Deng YQ, 2009, AM J PATHOL, V175, P2089, DOI 10.2353/ajpath.2009.090157; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Elias R, 2004, MOL VIS, V10, P672; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Gao YL, 2012, CELL MOL NEUROBIOL, V32, P523, DOI 10.1007/s10571-011-9792-0; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Gomez-Vicente V, 2005, CELL DEATH DIFFER, V12, P796, DOI 10.1038/sj.cdd.4401621; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HEIDENREICH KA, 1993, ANN NY ACAD SCI, V692, P72; Ivanovic I, 2011, INVEST OPHTH VIS SCI, V52, P6355, DOI 10.1167/iovs.10-7138; Ivanovic I, 2011, INVEST OPHTH VIS SCI, V52, P3775, DOI 10.1167/iovs.10-7139; JONES PF, 1991, CELL REGUL, V2, P1001, DOI 10.1091/mbc.2.12.1001; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Kellner U, 1993, Ger J Ophthalmol, V2, P170; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kohl S, 2009, OPHTHALMOLOGE, V106, P109, DOI 10.1007/s00347-008-1864-2; Kryger Z, 1998, VISUAL NEUROSCI, V15, P685, DOI 10.1017/S0952523898154081; Le YZ, 2004, MOL VIS, V10, P1011; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li GY, 2007, J NEUROSCI, V27, P203, DOI 10.1523/JNEUROSCI.0445-06.2007; Li GY, 2008, J NEUROCHEM, V107, P1382, DOI 10.1111/j.1471-4159.2008.05707.x; Linton JD, 2010, P NATL ACAD SCI USA, V107, P8599, DOI 10.1073/pnas.1002471107; Liu Y, 2011, J PATHOL, V225, P54, DOI 10.1002/path.2912; Luo J, 2005, MOL CELL BIOL, V25, P9491, DOI 10.1128/MCB.25.21.9491-9502.2005; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Masure S, 1999, EUR J BIOCHEM, V265, P353, DOI 10.1046/j.1432-1327.1999.00774.x; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Nakatani K, 1999, BIOCHEM BIOPH RES CO, V257, P906, DOI 10.1006/bbrc.1999.0559; Nikonov SS, 2008, NEURON, V59, P462, DOI 10.1016/j.neuron.2008.06.011; Nikonov SS, 2005, J GEN PHYSIOL, V125, P287, DOI 10.1085/jgp.200409208; Nork T M, 2000, Trans Am Ophthalmol Soc, V98, P331; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Punzo C, 2012, J BIOL CHEM, V287, P1642, DOI 10.1074/jbc.R111.304428; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rajala A, 2008, J BIOL CHEM, V283, P19781, DOI 10.1074/jbc.M802374200; Rehen SK, 1999, EUR J NEUROSCI, V11, P4349, DOI 10.1046/j.1460-9568.1999.00868.x; Reiter CEN, 2006, DIABETES, V55, P1148, DOI 10.2337/diabetes.55.04.06.db05-0744; ROBINSON LJ, 1994, ENDOCRINOLOGY, V135, P2568, DOI 10.1210/en.135.6.2568; Sanghera KP, 2011, MOL CELL NEUROSCI, V47, P145, DOI 10.1016/j.mcn.2011.03.010; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Stuck MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032484; Takahashi M, 1996, NEUROSCI LETT, V204, P201, DOI 10.1016/0304-3940(96)12357-0; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Tsang SH, 1996, SCIENCE, V272, P1026, DOI 10.1126/science.272.5264.1026; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Wu XH, 2004, J BIOL CHEM, V279, P9167, DOI 10.1074/jbc.M312397200; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Zhou FT, 2011, J NEUROSCI RES, V89, P1859, DOI 10.1002/jnr.22714; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	76	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19503	19515		10.1074/jbc.M113.469064	http://dx.doi.org/10.1074/jbc.M113.469064			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23673657	Green Published, hybrid			2022-12-28	WOS:000321515800017
J	Bround, MJ; Wambolt, R; Luciani, DS; Kulpa, JE; Rodrigues, B; Brownsey, RW; Allard, MF; Johnson, JD				Bround, Michael J.; Wambolt, Rich; Luciani, Dan S.; Kulpa, Jerzy E.; Rodrigues, Brian; Brownsey, Roger W.; Allard, Michael F.; Johnson, James D.			Cardiomyocyte ATP Production, Metabolic Flexibility, and Survival Require Calcium Flux through Cardiac Ryanodine Receptors in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESSURE-OVERLOAD; ENDOPLASMIC-RETICULUM; MITOCHONDRIAL CA2+; PPAR-ALPHA; HEART; GENE; STRESS; EXPRESSION; ADULT; MICE	Ca2+ fluxes between adjacent organelles are thought to control many cellular processes, including metabolism and cell survival. In vitro evidence has been presented that constitutive Ca2+ flux from intracellular stores into mitochondria is required for basal cellular metabolism, but these observations have not been made in vivo. We report that controlled in vivo depletion of cardiac RYR2, using a conditional gene knock-out strategy (cRyr2KO mice), is sufficient to reduce mitochondrial Ca2+ and oxidative metabolism, and to establish a pseudo-hypoxic state with increased autophagy. Dramatic metabolic reprogramming was evident at the transcriptional level via Sirt1/Foxo1/Pgc1 alpha, Atf3, and Klf15 gene networks. Ryr2 loss also induced a non-apoptotic form of programmed cell death associated with increased calpain-10 but not caspase-3 activation or endoplasmic reticulum stress. Remarkably, cRyr2KO mice rapidly exhibited many of the structural, metabolic, and molecular characteristics of heart failure at a time when RYR2 protein was reduced 50%, a similar degree to that which has been reported in heart failure. RYR2-mediated Ca2+ fluxes are therefore proximal controllers of mitochondrial Ca2+, ATP levels, and a cascade of transcription factors controlling metabolism and survival.	[Bround, Michael J.; Johnson, James D.] Univ British Columbia, Inst Life Sci, Cardiovasc Res Grp, Vancouver, BC V6T 1Z3, Canada; [Bround, Michael J.; Kulpa, Jerzy E.; Brownsey, Roger W.; Johnson, James D.] Univ British Columbia, Inst Life Sci, Diabet Res Grp, Vancouver, BC V6T 1Z3, Canada; [Bround, Michael J.; Johnson, James D.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Bround, Michael J.; Luciani, Dan S.; Johnson, James D.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1Z3, Canada; [Wambolt, Rich; Allard, Michael F.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1Y6, Canada; [Wambolt, Rich; Allard, Michael F.] St Pauls Hosp, James Hogg Res Ctr, Vancouver, BC V6T 1Y6, Canada; [Luciani, Dan S.] Child & Family Res Inst, Vancouver, BC V5Z 4H4, Canada; [Kulpa, Jerzy E.; Brownsey, Roger W.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Rodrigues, Brian] Univ British Columbia, Dept Pharmaceut Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; St. Paul's Hospital; University of Saskatchewan; Child & Family Research Institute; University of British Columbia; University of British Columbia	Johnson, JD (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Cardiovasc Res Grp, 5358 Life Sci Bldg,2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	James.D.Johnson@ubc.ca		Luciani, Dan/0000-0002-4318-4159; Rodrigues, Brian/0000-0002-0129-4261	Canadian Institutes for Health Research; Canadian Diabetes Association; Michael Smith Foundation for Health Research; Carlsberg Foundation	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Carlsberg Foundation(Carlsberg Foundation)	This work was supported by a Canadian Institutes for Health Research operating grant to J. D. J.; Supported by postdoctoral fellowships from the Canadian Diabetes Association, the Michael Smith Foundation for Health Research, and the Carlsberg Foundation.	Agrawal R, 2010, PHARMACOL RES, V61, P269, DOI 10.1016/j.phrs.2009.11.012; ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; ALLY A, 1992, J CHROMATOGR-BIOMED, V575, P19, DOI 10.1016/0378-4347(92)80499-G; Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; Assayag P, 1998, CARDIOVASC RES, V38, P169, DOI 10.1016/S0008-6363(97)00283-6; Belke DD, 1999, AM J PHYSIOL-REG I, V277, pR1210, DOI 10.1152/ajpregu.1999.277.4.R1210; Bidasse KR, 2001, MOL PHARMACOL, V60, P1356, DOI 10.1124/mol.60.6.1356; BRILLANTES AM, 1992, CIRC RES, V71, P18, DOI 10.1161/01.RES.71.1.18; Bround MJ, 2012, CARDIOVASC RES, V96, P372, DOI 10.1093/cvr/cvs260; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Croquelois A, 2008, J EXP MED, V205, P3173, DOI 10.1084/jem.20081427; Crossman DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017901; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; DENTON RM, 1985, AM J PHYSIOL, V249, pE543, DOI 10.1152/ajpendo.1985.249.6.E543; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Dror V, 2008, J BIOL CHEM, V283, P9909, DOI 10.1074/jbc.M710601200; Ferrari R, 2009, CIRC J, V73, P1973, DOI 10.1253/circj.CJ-09-0573; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Igwe EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-408; Johnson JD, 2012, PROTOPLASMA, V249, pS49, DOI 10.1007/s00709-011-0349-3; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Kandilci HB, 2011, J PHYSIOL BIOCHEM, V67, P317, DOI 10.1007/s13105-011-0077-3; Kettlewell S, 2009, J MOL CELL CARDIOL, V46, P891, DOI 10.1016/j.yjmcc.2009.02.016; Khairallah M, 2004, AM J PHYSIOL-HEART C, V286, pH1461, DOI 10.1152/ajpheart.00942.2003; Koh IU, 2010, FEBS J, V277, P2304, DOI 10.1111/j.1742-4658.2010.07646.x; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Liao RL, 2002, CIRCULATION, V106, P2125, DOI 10.1161/01.CIR.0000034049.61181.F3; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Luciani DS, 2009, DIABETES, V58, P422, DOI 10.2337/db07-1762; Lukyanenko V, 2007, J PHYSIOL-LONDON, V583, P251, DOI 10.1113/jphysiol.2007.136549; MATSUI H, 1995, AM J PHYSIOL-CELL PH, V268, pC252, DOI 10.1152/ajpcell.1995.268.1.C252; NAUDIN V, 1991, FEBS LETT, V285, P135, DOI 10.1016/0014-5793(91)80743-M; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Okamoto Y, 2001, AM J PATHOL, V159, P639, DOI 10.1016/S0002-9440(10)61735-X; Pacher P, 2002, P NATL ACAD SCI USA, V99, P2380, DOI 10.1073/pnas.032423699; Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376; Regazzetti C, 2009, DIABETES, V58, P95, DOI 10.2337/db08-0457; Rutter GA, 1996, P NATL ACAD SCI USA, V93, P5489, DOI 10.1073/pnas.93.11.5489; Salnikov V, 2009, J MUSCLE RES CELL M, V30, P161, DOI 10.1007/s10974-009-9186-9; Santiago D. J., 2010, BIOPHYS J; Santiago DJ, 2010, BIOPHYS J, V98, P2111, DOI 10.1016/j.bpj.2010.01.042; Schaeffer PJ, 2004, J BIOL CHEM, V279, P39593, DOI 10.1074/jbc.M403649200; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; Trollinger DR, 1997, BIOCHEM BIOPH RES CO, V236, P738, DOI 10.1006/bbrc.1997.7042; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; WAN B, 1989, J BIOL CHEM, V264, P13430; Yamaguchi N, 2011, AM J PHYSIOL-HEART C, V300, pH2187, DOI 10.1152/ajpheart.00719.2010; Yamamoto K, 2010, BIOCHEM BIOPH RES CO, V400, P175, DOI 10.1016/j.bbrc.2010.08.039; Zou YZ, 2011, HYPERTENSION, V58, P1099, DOI 10.1161/HYPERTENSIONAHA.111.173500	60	58	64	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18975	18986		10.1074/jbc.M112.427062	http://dx.doi.org/10.1074/jbc.M112.427062			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23678000	Green Published, hybrid			2022-12-28	WOS:000321335800034
J	Pang, YH; Kurella, S; Voisset, C; Samanta, D; Banerjee, D; Schabe, A; Das Gupta, C; Galons, H; Blondel, M; Sanyal, S				Pang, Yanhong; Kurella, Sriram; Voisset, Cecile; Samanta, Dibyendu; Banerjee, Debapriya; Schabe, Ariane; Das Gupta, Chanchal; Galons, Herve; Blondel, Marc; Sanyal, Suparna			The Antiprion Compound 6-Aminophenanthridine Inhibits the Protein Folding Activity of the Ribosome by Direct Competition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI RIBOSOME; IN-VITRO; DOMAIN-V; DENATURED PROTEINS; MAMMALIAN PRIONS; 50S SUBUNIT; RNA; DRUGS; GUANABENZ; VIVO	Domain V of the 23S/25S/28S rRNA of the large ribosomal subunit constitutes the active center for the protein folding activity of the ribosome (PFAR). Using in vitro transcribed domain V rRNAs from Escherichia coli and Saccharomyces cerevisiae as the folding modulators and human carbonic anhydrase as a model protein, we demonstrate that PFAR is conserved from prokaryotes to eukaryotes. It was shown previously that 6-aminophenanthridine (6AP), an antiprion compound, inhibits PFAR. Here, using UV cross-linking followed by primer extension, we show that the protein substrates and 6AP interact with a common set of nucleotides on domain V of 23S rRNA. Mutations at the interaction sites decreased PFAR and resulted in loss or change of the binding pattern for both the protein substrates and 6AP. Moreover, kinetic analysis of human carbonic anhydrase refolding showed that 6AP decreased the yield of the refolded protein but did not affect the rate of refolding. Thus, we conclude that 6AP competitively occludes the protein substrates from binding to rRNA and thereby inhibits PFAR. Finally, we propose a scheme clarifying the mechanism by which 6AP inhibits PFAR.	[Pang, Yanhong; Kurella, Sriram; Banerjee, Debapriya; Schabe, Ariane; Sanyal, Suparna] Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; [Voisset, Cecile; Blondel, Marc] Univ Bretagne Occidentale, Ctr Hosp Reg Univ CHRU Brest, Fac Med & Sci Sante,INSERM,UMR 1078, Etab Francais Sang EFS Bretagne,Hop Morvan,Lab Ge, F-29200 Brest, France; [Samanta, Dibyendu; Das Gupta, Chanchal] Univ Calcutta, Dept Biophys Mol Biol & Genet, Kolkata 700009, W Bengal, India; [Galons, Herve] Univ Paris 05, CNRS, UMR 8601, Lab Chim Organ 2, F-75270 Paris 6, France	Uppsala University; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; University of Calcutta; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Sanyal, S (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden.	suparna.sanyal@icm.uu.se	Voisset, Cecile/AAK-1636-2020; Blondel, Marc/AAJ-9049-2020	Blondel, Marc/0000-0003-4897-2995; Pang, Yanhong/0000-0002-5167-4174; Voisset, Cecile/0000-0001-7505-1927	Swedish Research Council (M section); Swedish Research Council (NT section); Swedish Research Council (VR-SIDA); Carl Tryggers Stiftelse; Wenner Gren Stiftelse; Knut and Wallice Wallenberg Foundation; Vinnova/DBT (India); SSF-Dalen (Sweden-France Bilateral Collaboration) Program; Chinese Scholarship Council; INSERM; CRITT Sante Bretagne (Region Bretagne); ANR "Blanche" of the French Government	Swedish Research Council (M section)(Swedish Research Council); Swedish Research Council (NT section)(Swedish Research Council); Swedish Research Council (VR-SIDA)(Swedish Research Council); Carl Tryggers Stiftelse; Wenner Gren Stiftelse; Knut and Wallice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Vinnova/DBT (India); SSF-Dalen (Sweden-France Bilateral Collaboration) Program; Chinese Scholarship Council(China Scholarship Council); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CRITT Sante Bretagne (Region Bretagne); ANR "Blanche" of the French Government(French National Research Agency (ANR))	This work was supported by the Swedish Research Council (individual grants from the M and NT sections, VR-SIDA (Swedish Research Link), and a Linnaeus grant to the Uppsala RNA Research Center); the Carl Tryggers Stiftelse; a postdoctoral stipendium from the Wenner Gren Stiftelse (to D. B.); the Knut and Wallice Wallenberg Foundation (to RiboCORE), Vinnova/DBT (India), and the SSF-Dalen (Sweden-France Bilateral Collaboration) Program (to S. S.); a scholarship from the Chinese Scholarship Council (to Y. P.); and INSERM, CRITT Sante Bretagne (Region Bretagne), and ANR "Blanche" of the French Government (to M. B. and C. V.).	Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; Barbezier N, 2011, EMBO MOL MED, V3, P35, DOI 10.1002/emmm.201000109; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P598, DOI 10.1016/j.bbrc.2007.11.143; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P592, DOI 10.1016/j.bbrc.2007.11.142; BERA AK, 1994, CURR SCI INDIA, V66, P230; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Chattopadhyay S, 1999, BBA-PROTEIN STRUCT M, V1429, P293, DOI 10.1016/S0167-4838(98)00179-4; Chowdhury S, 2002, NUCLEIC ACIDS RES, V30, P1278, DOI 10.1093/nar/30.5.1278; Das A, 2011, J BIOL CHEM, V286, P43771, DOI 10.1074/jbc.M111.263574; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das D, 2012, J BIOL CHEM, V287, P37508, DOI 10.1074/jbc.M112.396127; Das Debasis, 2008, Biotechnology Journal, V3, P999, DOI 10.1002/biot.200800098; Dos Reis S, 2011, BIOCHIMIE, V93, P1047, DOI 10.1016/j.biochi.2011.03.002; Gomes MPB, 2012, WIRES RNA, V3, P415, DOI 10.1002/wrna.118; Gug F, 2010, BIOCONJUGATE CHEM, V21, P279, DOI 10.1021/bc900314n; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; LEWIS ME, 1986, P NATL ACAD SCI USA, V83, P5419, DOI 10.1073/pnas.83.15.5419; Macedo B, 2012, BIOCHEMISTRY-US, V51, P5402, DOI 10.1021/bi300440e; Pal D, 1997, NUCLEIC ACIDS RES, V25, P5047, DOI 10.1093/nar/25.24.5047; Pal S, 1999, J BIOL CHEM, V274, P32771, DOI 10.1074/jbc.274.46.32771; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; Sanyal SC, 2002, NUCLEIC ACIDS RES, V30, P2390, DOI 10.1093/nar/30.11.2390; Silva JL, 2011, METHODS, V53, P306, DOI 10.1016/j.ymeth.2010.12.002; Sulijoadikusumo I, 2001, BIOCHEMISTRY-US, V40, P11559, DOI 10.1021/bi015526q; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002174; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001981; Voisset C, 2011, BIOTECHNOL J, V6, P668, DOI 10.1002/biot.201100021; Voisset Cecile, 2008, Biotechnology Journal, V3, P1033, DOI 10.1002/biot.200800134	29	24	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19081	19089		10.1074/jbc.M113.466748	http://dx.doi.org/10.1074/jbc.M113.466748			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23673663	Green Published, hybrid			2022-12-28	WOS:000321335800043
J	Tanifuji, S; Funakoshi-Tago, M; Ueda, F; Kasahara, T; Mochida, S				Tanifuji, Shota; Funakoshi-Tago, Megumi; Ueda, Fumihito; Kasahara, Tadashi; Mochida, Sumiko			Dynamin Isoforms Decode Action Potential Firing for Synaptic Vesicle Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FROG NEUROMUSCULAR JUNCTION; RAT SYMPATHETIC NEURONS; CA2+ SENSOR PROTEINS; TRANSMITTER RELEASE; CA(V)2.1 CHANNELS; ENDOCYTOSIS; SYNAPSES; EXOCYTOSIS; PLASTICITY; MEMBRANE	Presynaptic nerve terminals must maintain stable neurotransmission via synaptic vesicle membrane recycling despite encountering wide fluctuations in the number and frequency of incoming action potentials (APs). However, the molecular mechanism linking variation in neuronal activity to vesicle trafficking is unknown. Here, we combined genetic knockdown and direct physiological measurements of synaptic transmission from paired neurons to show that three isoforms of dynamin, an essential endocytic protein, work individually to match vesicle reuse pathways, having distinct rate and time constants with physiological AP frequencies. Dynamin 3 resupplied the readily releasable pool with slow kinetics independently of the AP frequency but acted quickly, within 20 ms of the incoming AP. Under high-frequency firing, dynamin 1 regulated recycling to the readily releasable pool with fast kinetics in a slower time window of greater than 50 ms. Dynamin 2 displayed a hybrid response between the other isoforms. Collectively, our findings show how dynamin isoforms select appropriate vesicle reuse pathways associated with specific neuronal firing patterns.	[Tanifuji, Shota; Mochida, Sumiko] Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan; [Tanifuji, Shota; Funakoshi-Tago, Megumi; Ueda, Fumihito; Kasahara, Tadashi] Keio Univ, Dept Biochem, Minato Ku, Tokyo 1058512, Japan	Tokyo Medical University; Keio University	Mochida, S (corresponding author), Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan.	mochida@tokyo-med.ac.jp		Ueda, Fumihito/0000-0003-1241-1643				ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Clayton EL, 2008, J NEUROSCI, V28, P6627, DOI 10.1523/JNEUROSCI.1445-08.2008; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Haucke V, 2011, NAT REV NEUROSCI, V12, P127, DOI 10.1038/nrn2948; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; Leal K, 2012, P NATL ACAD SCI USA, V109, P17069, DOI 10.1073/pnas.1215172109; LIBET B, 1988, BRAIN RES, V473, P271, DOI 10.1016/0006-8993(88)90856-6; Lou XL, 2012, P NATL ACAD SCI USA, V109, pE515, DOI 10.1073/pnas.1121626109; Lu WB, 2009, J BIOL CHEM, V284, P1930, DOI 10.1074/jbc.M803691200; MOCHIDA S, 1994, MICROSC RES TECHNIQ, V29, P94, DOI 10.1002/jemt.1070290206; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Mochida S, 2011, NEUROSCI RES, V70, P16, DOI 10.1016/j.neures.2011.03.005; Park H, 2012, SCIENCE, V335, P1362, DOI 10.1126/science.1216937; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Wenzel EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038188; Wu LG, 2004, TRENDS NEUROSCI, V27, P548, DOI 10.1016/j.tins.2004.07.001; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Ying Y, 2012, FEBS LETT, V586, P3674, DOI 10.1016/j.febslet.2012.08.025; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024	33	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19050	19059		10.1074/jbc.M112.445874	http://dx.doi.org/10.1074/jbc.M112.445874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23687302	Green Published, hybrid			2022-12-28	WOS:000321335800040
J	Jiang, Y; Ding, Q; Xie, XL; Libby, RT; Lefebvre, V; Gan, L				Jiang, Ying; Ding, Qian; Xie, Xiaoling; Libby, Richard T.; Lefebvre, Veronique; Gan, Lin			Transcription Factors SOX4 and SOX11 Function Redundantly to Regulate the Development of Mouse Retinal Ganglion Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN FACTOR BRN-3B; NEURONAL DIFFERENTIATION; SYSTEM DEVELOPMENT; NERVOUS-SYSTEM; VISUAL-SYSTEM; MATH5; MICE; NEUROGENESIS; REQUIREMENT; EXPRESSION	SOX family proteins belong to the high-mobility-group (HMG) domain-containing transcription factors, and function as key players to regulate embryonic development and cell fate determination. The highly related group C Sox genes Sox4 and Sox11 are widely expressed in the development of mouse retina and share a similar expression pattern with each other in this process. Here, to investigate the roles of Sox4 and Sox11 in the retinal development, Sox4, Sox11, and Sox4/Sox11 conditional knock-out (CKO) mice with deletion of Sox4, Sox11, and Sox4/Sox11 in retinas were generated. Our studies demonstrated that targeted disruption of Sox4 or Sox11 in retinas caused a moderate reduction of generation of RGCs. However, a complete loss of RGCs was observed in Sox4/Sox11-null retinas, suggesting the two genes play similar roles in the development of RGCs. Our further analysis confirms that Sox4 and Sox11 function redundantly to regulate the generation of RGCs at early embryonic stages as well as the survival of RGCs at late embryonic stages. In addition, we demonstrated that loss of Math5 impairs the expression of Sox4 and Sox11 in the ganglion cell layer while deletion of Brn3b has no effect on the expression of Sox4 and Sox11. Taken together, these findings elucidate SoxC genes as essential contributors to maintain the survival of RGCs, and imply their intermediate position between Math5 and Brn3b in the genetic hierarchy of RGC development.	[Jiang, Ying; Ding, Qian; Xie, Xiaoling; Libby, Richard T.; Gan, Lin] Univ Rochester, Flaum Eye Inst, Rochester, NY 14642 USA; [Jiang, Ying; Ding, Qian; Xie, Xiaoling; Libby, Richard T.; Gan, Lin] Univ Rochester, Dept Ophthalmol, Rochester, NY 14642 USA; [Jiang, Ying] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Lefebvre, Veronique] Cleveland Clin, Lerner Inst, Cleveland, OH 44195 USA; [Gan, Lin] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou 310036, Zhejiang, Peoples R China	University of Rochester; University of Rochester; University of Rochester; Cleveland Clinic Foundation; Hangzhou Normal University	Gan, L (corresponding author), Univ Rochester, Flaum Eye Inst, 601 Elmwood Ave,Box 659, Rochester, NY 14642 USA.	lin_gan@urmc.rochester.edu		Libby, Richard/0000-0003-2844-7632	National Natural Science Foundation of China [81271006]; Hangzhou City Health Science Foundation [20120633B01]; Research to Prevent Blindness Challenge Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054153] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou City Health Science Foundation; Research to Prevent Blindness Challenge Grant(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Natural Science Foundation of China Grant No. 81271006, and Hangzhou City Health Science Foundation Grant No. 20120633B01, and by a Research to Prevent Blindness Challenge Grant to the Department of Ophthalmology at the University of Rochester.	Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Brown NL, 1998, DEVELOPMENT, V125, P4821; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Cheung M, 2000, MOL BRAIN RES, V79, P180, DOI 10.1016/S0169-328X(00)00109-1; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Farah MH, 2005, J COMP NEUROL, V489, P120, DOI 10.1002/cne.20615; Feng L, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-36; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Hoser M, 2008, MOL CELL BIOL, V28, P4675, DOI 10.1128/MCB.00338-08; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Li YZ, 2012, ACTA BIOCH BIOPH SIN, V44, P660, DOI 10.1093/abbs/gms045; Lin L, 2011, DEV DYNAM, V240, P52, DOI 10.1002/dvdy.22489; Mu LF, 2012, J NEUROSCI, V32, P3067, DOI 10.1523/JNEUROSCI.4679-11.2012; Mu XQ, 2005, DEV BIOL, V280, P467, DOI 10.1016/j.ydbio.2005.01.028; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Nissen-Meyer LSH, 2007, J CELL SCI, V120, P2785, DOI 10.1242/jcs.003855; NIXON RA, 1989, MOL BRAIN RES, V5, P93, DOI 10.1016/0169-328X(89)90001-6; Pan L, 2005, DEVELOPMENT, V132, P703, DOI 10.1242/dev.01646; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Penzo-Mendez A, 2007, GENESIS, V45, P776, DOI 10.1002/dvg.20358; PERRY VH, 1983, J COMP NEUROL, V219, P356, DOI 10.1002/cne.902190309; Potzner MR, 2010, DEVELOPMENT, V137, P775, DOI 10.1242/dev.042101; Sander B, 2011, SEMIN DIAGN PATHOL, V28, P245, DOI 10.1053/j.semdp.2011.02.010; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Thein DC, 2010, J NEUROCHEM, V115, P131, DOI 10.1111/j.1471-4159.2010.06910.x; Usui A, 2013, DEVELOPMENT, V140, P740, DOI 10.1242/dev.090274; Vaney DI, 2002, PROG BRAIN RES, V136, P239; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Wurm A, 2008, EXP EYE RES, V86, P895, DOI 10.1016/j.exer.2008.03.004; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	43	76	77	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18429	18438		10.1074/jbc.M113.478503	http://dx.doi.org/10.1074/jbc.M113.478503			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649630	Green Published, hybrid			2022-12-28	WOS:000320721900045
J	Kim, S; Cipolla, L; Guidetti, G; Okigaki, M; Jin, JG; Torti, M; Kunapuli, SP				Kim, Soochong; Cipolla, Lina; Guidetti, Gianni; Okigaki, Mitsuhiko; Jin, Jianguo; Torti, Mauro; Kunapuli, Satya P.			Distinct Role of Pyk2 in Mediating Thromboxane Generation Downstream of Both G(12/13) and Integrin alpha IIb beta 3 in Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL TYROSINE KINASE; SRC FAMILY KINASES; PROTEIN-KINASE; ADHESION KINASE; MICE LACKING; DIFFERENTIAL REGULATION; THROMBUS FORMATION; 3-KINASE BETA; SHAPE CHANGE; ACTIVATION	Proline-rich tyrosine kinase 2 (Pyk2) is activated by various agonists in platelets. We evaluated the signaling mechanism and the functional role of Pyk2 in platelets by using pharmacological inhibitors and Pyk2-deficient platelets. We found that platelet aggregation and secretion in response to 2-methylthio-ADP (2-MeSADP) and AYPGKF were diminished in the presence of Pyk2 inhibitors or in Pyk2-deficient platelets, suggesting that Pyk2 plays a positive regulatory role in platelet functional responses. It has been shown that ADP-, but not thrombin-induced thromboxane (TxA(2)) generation depends on integrin signaling. Unlike ADP, thrombin activates G(12/13) pathways, and G(12/13) pathways can substitute for integrin signaling for TxA(2) generation. We found that Pyk2 was activated downstream of both G(12/13) and integrin-mediated pathways, and both 2-Me-SADP- and AYPGKF-induced TxA(2) generation was significantly diminished in Pyk2-deficient platelets. In addition, TxA(2) generation induced by co-stimulation of G(i) and G(z) pathways, which is dependent on integrin signaling, was inhibited by blocking Pyk2. Furthermore, inhibition of 2-MeSADP-induced TxA(2) generation by fibrinogen receptor antagonist was not rescued by co-stimulation of G(12/13) pathways in the presence of Pyk2 inhibitor. We conclude that Pyk2 is a common signaling effector downstream of both G(12/13) and integrin alpha IIb beta 3 signaling, which contributes to thromboxane generation.	[Kim, Soochong; Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Kim, Soochong; Jin, Jianguo; Kunapuli, Satya P.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Cipolla, Lina; Guidetti, Gianni; Torti, Mauro] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy; [Okigaki, Mitsuhiko] Kyoto Prefectural Univ Med, Dept Cardiovasc Med, Kyoto 6028566, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pavia; Kyoto Prefectural University of Medicine	Kunapuli, SP (corresponding author), Temple Univ, Sch Med, Dept Physiol, 3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu			National Institutes of Health [HL60683, HL93231]; American Heart Association [12SDG8980013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093231, R01HL060683, R01HL118593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL60683 and HL93231 (to S. P. K.) and American Heart Association Grant 12SDG8980013 (to S. K.).	Astier A, 1997, J BIOL CHEM, V272, P19719, DOI 10.1074/jbc.272.32.19719; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; Bauer M, 1999, BLOOD, V94, P1665, DOI 10.1182/blood.V94.5.1665.417k33_1665_1672; Bhavaraju K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016586; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Canobbio I, 2002, THROMB HAEMOSTASIS, V87, P509, DOI 10.1055/s-0037-1613032; Canobbio I, 2013, BLOOD, V121, P648, DOI 10.1182/blood-2012-06-438762; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; Consonni A, 2012, BLOOD, V119, P847, DOI 10.1182/blood-2011-07-364992; Dorsam RT, 2005, BLOOD, V105, P2749, DOI 10.1182/blood-2004-07-2821; Duan YL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-4; Duan YL, 2010, AM J RESP CELL MOL, V42, P491, DOI 10.1165/rcmb.2008-0469OC; Evangelista V, 2007, BLOOD, V109, P2461, DOI 10.1182/blood-2006-06-029082; Garcia A, 2007, BIOCHEM J, V404, P299, DOI 10.1042/BJ20061584; Garcia A, 2010, BIOCHEM J, V429, P369, DOI 10.1042/BJ20100166; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Hiregowdara D, 1997, J BIOL CHEM, V272, P10804; Hitchcock IS, 2008, BLOOD, V111, P596, DOI 10.1182/blood-2007-05-089680; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Jin JG, 2009, BIOCHEM PHARMACOL, V77, P835, DOI 10.1016/j.bcp.2008.11.017; Keogh RJ, 2002, BIOCHEM BIOPH RES CO, V294, P1001, DOI 10.1016/S0006-291X(02)00568-5; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Koziak K, 2001, BRIT J HAEMATOL, V114, P134, DOI 10.1046/j.1365-2141.2001.02894.x; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lipinski CA, 2010, EXPERT OPIN THER TAR, V14, P95, DOI 10.1517/14728220903473194; MALMSTEN C, 1977, BRIT J HAEMATOL, V35, P511, DOI 10.1111/j.1365-2141.1977.tb00617.x; Murugappan S, 2005, BLOOD, V106, P550, DOI 10.1182/blood-2004-12-4866; Murugappan S, 2009, BIOCHEM J, V417, P113, DOI 10.1042/BJ20080235; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Ohmori T, 2000, BIOCHEM J, V347, P561, DOI 10.1042/0264-6021:3470561; Ohmori T, 1999, THROMB RES, V93, P291, DOI 10.1016/S0049-3848(98)00188-1; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Paul BZS, 1999, J BIOL CHEM, V274, P28293, DOI 10.1074/jbc.274.40.28293; Raja S, 1997, J BIOL CHEM, V272, P10941; Sayed MR, 2000, J CELL PHYSIOL, V183, P314, DOI 10.1002/(SICI)1097-4652(200006)183:3<314::AID-JCP3>3.0.CO;2-J; Schoenwaelder SM, 2010, J BIOL CHEM, V285, P2886, DOI 10.1074/jbc.M109.029132; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Siciliano JC, 1996, J BIOL CHEM, V271, P28942, DOI 10.1074/jbc.271.46.28942; Soltoff SP, 1998, J BIOL CHEM, V273, P2653, DOI 10.1074/jbc.273.5.2653; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Wang L, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-26; Wang ZY, 2001, HYPERTENSION, V37, P148, DOI 10.1161/01.HYP.37.1.148; Woulfe D, 2004, J CLIN INVEST, V113, P441, DOI 10.1172/JCI200420267; Zhu XD, 2008, AM J RESP CELL MOL, V39, P263, DOI 10.1165/rcmb.2008-0047OC	46	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18194	18203		10.1074/jbc.M113.461087	http://dx.doi.org/10.1074/jbc.M113.461087			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23640884	Green Published, hybrid			2022-12-28	WOS:000320721900024
J	Sakaki-Yumoto, M; Liu, JM; Ramalho-Santos, M; Yoshida, N; Derynck, R				Sakaki-Yumoto, Masayo; Liu, Jianming; Ramalho-Santos, Miguel; Yoshida, Nobuaki; Derynck, Rik			Smad2 Is Essential for Maintenance of the Human and Mouse Primed Pluripotent Stem Cell State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN EMBRYONIC STEM; TGF-BETA RECEPTOR; HUMAN ES CELLS; GROWTH-FACTOR; MAINTAINS PLURIPOTENCY; TRANSCRIPTION FACTORS; SELF-RENEWAL; INDUCED DIFFERENTIATION; ENDODERM FORMATION; MH1 DOMAIN	Human embryonic stem cells and mouse epiblast stem cells represent a primed pluripotent stem cell state that requires TGF-beta/activin signaling. TGF-beta and/or activin are commonly thought to regulate transcription through both Smad2 and Smad3. However, the different contributions of these two Smads to primed pluripotency and the downstream events that they may regulate remain poorly understood. We addressed the individual roles of Smad2 and Smad3 in the maintenance of primed pluripotency. We found that Smad2, but not Smad3, is required to maintain the undifferentiated pluripotent state. We defined a Smad2 regulatory circuit in human embryonic stem cells and mouse epiblast stem cells, in which Smad2 acts through binding to regulatory promoter sequences to activate Nanog expression while in parallel repressing autocrine bone morphogenetic protein signaling. Increased autocrine bone morphogenetic protein signaling caused by Smad2 down-regulation leads to cell differentiation toward the trophectoderm, mesoderm, and germ cell lineages. Additionally, induction of Cdx2 expression, as a result of decreased Smad2 expression, leads to repression of Oct4 expression, which, together with the decreased Nanog expression, accelerates the loss of pluripotency. These findings reveal that Smad2 is a unique integrator of transcription and signaling events and is essential for the maintenance of the mouse and human primed pluripotent stem cell state.	[Sakaki-Yumoto, Masayo; Liu, Jianming; Ramalho-Santos, Miguel; Derynck, Rik] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Program Cell Biol, San Francisco, CA 94143 USA; [Sakaki-Yumoto, Masayo; Liu, Jianming; Ramalho-Santos, Miguel; Derynck, Rik] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Program Dev & Stem Cell Biol, San Francisco, CA 94143 USA; [Sakaki-Yumoto, Masayo; Liu, Jianming; Derynck, Rik] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Ramalho-Santos, Miguel] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Yoshida, Nobuaki] Univ Tokyo, Lab Dev Genet, Ctr Expt Med & Syst Biol, Inst Med Sci, Tokyo 1088639, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Tokyo	Derynck, R (corresponding author), Univ Calif San Francisco, Broad Ctr RMB 1027, 35 Med Ctr Way, San Francisco, CA 94143 USA.	rik.derynck@ucsf.edu	Ramalho-Santos, Miguel/L-9092-2018	Ramalho-Santos, Miguel/0000-0003-0177-5556	National Institutes of Health [R21 HL0923494]; CIRM New Stem Cell Lines Grant [RL-100669]; Union Internationale Contre le Cancer; Uehara Foundation; Program in Breakthrough Basic Research at University of California at San Francisco; American Heart Association; University of California at San Francisco; Muscular Dystrophy Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM New Stem Cell Lines Grant; Union Internationale Contre le Cancer; Uehara Foundation(Uehara Memorial Foundation); Program in Breakthrough Basic Research at University of California at San Francisco; American Heart Association(American Heart Association); University of California at San Francisco(University of California System); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 HL0923494 (to R. D.). This work was also supported by CIRM New Stem Cell Lines Grant RL-100669 (to M. R.-S.).; Supported by postdoctoral fellowships from the Union Internationale Contre le Cancer, the Uehara Foundation, and an award from the Program in Breakthrough Basic Research at University of California at San Francisco.; Supported by a postdoctoral fellowship from the American Heart Association, a University of California at San Francisco core exploratory award, and a Muscular Dystrophy Association development grant.	Avery S, 2010, STEM CELLS, V28, P863, DOI 10.1002/stem.409; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Blount AL, 2008, J BIOL CHEM, V283, P7016, DOI 10.1074/jbc.M709502200; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Denissova NG, 2000, P NATL ACAD SCI USA, V97, P6397, DOI 10.1073/pnas.090099297; Dennler S, 1999, ONCOGENE, V18, P1643, DOI 10.1038/sj.onc.1202729; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frankenberg S, 2011, DEV CELL, V21, P1005, DOI 10.1016/j.devcel.2011.10.019; Furtado MB, 2008, GENE DEV, V22, P3037, DOI 10.1101/gad.1682108; Galvin KE, 2010, J BIOL CHEM, V285, P19747, DOI 10.1074/jbc.M109.077347; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Gronroos E, 2012, MOL CELL BIOL, V32, P2904, DOI 10.1128/MCB.00231-12; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179; Liu D, 2001, GENE DEV, V15, P2950, DOI 10.1101/gad.925901; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Messerschmidt DM, 2010, DEV BIOL, V344, P129, DOI 10.1016/j.ydbio.2010.04.020; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Osorno R, 2012, DEVELOPMENT, V139, P2288, DOI 10.1242/dev.078071; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Pereira PNG, 2012, DEVELOPMENT, V139, P3343, DOI 10.1242/dev.075465; Peterson AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036548; Pouponnot C, 1998, J BIOL CHEM, V273, P22865, DOI 10.1074/jbc.273.36.22865; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Topper JN, 1998, P NATL ACAD SCI USA, V95, P9506, DOI 10.1073/pnas.95.16.9506; Tsuneyoshi N, 2012, GENE DEV, V26, P2471, DOI 10.1101/gad.201772.112; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yagi K, 1999, J BIOL CHEM, V274, P703, DOI 10.1074/jbc.274.2.703; Yamamoto M, 2009, J CELL BIOL, V184, P323, DOI 10.1083/jcb.200808044; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zhang PB, 2008, BLOOD, V111, P1933, DOI 10.1182/blood-2007-02-074120	72	61	68	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18546	18560		10.1074/jbc.M112.446591	http://dx.doi.org/10.1074/jbc.M112.446591			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649632	Green Published, hybrid			2022-12-28	WOS:000320721900055
J	Tan, QL; Kerestes, H; Percy, MJ; Pietrofesa, R; Chen, L; Khurana, TS; Christofidou-Solomidou, M; Lappin, TRJ; Lee, FS				Tan, Qiulin; Kerestes, Heddy; Percy, Melanie J.; Pietrofesa, Ralph; Chen, Li; Khurana, Tejvir S.; Christofidou-Solomidou, Melpo; Lappin, Terence R. J.; Lee, Frank S.			Erythrocytosis and Pulmonary Hypertension in a Mouse Model of Human HIF2A Gain of Function Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTERIAL-HYPERTENSION; HYPOXIA; ERYTHROPOIETIN; CELLS; GENE; INACTIVATION; HIF-2-ALPHA; PATHWAY; MICE; POLYCYTHEMIA	The central pathway for oxygen-dependent control of red cell mass is the prolyl hydroxylase domain protein (PHD):hypoxia inducible factor (HIF) pathway. PHD site specifically prolyl hydroxylates the transcription factor HIF-alpha, thereby targeting the latter for degradation. Under hypoxia, this modification is attenuated, allowing stabilized HIF-alpha to activate target genes, including that for erythropoietin (EPO). Studies employing genetically modified mice point to Hif-2 alpha, one of two main Hif-alpha isoforms, as being the critical regulator of Epo in the adult mouse. More recently, erythrocytosis patients with heterozygous point mutations in the HIF2A gene have been identified; whether these mutations were polymorphisms unrelated to the phenotype could not be ruled out. In the present report, we characterize a mouse line bearing a G536W missense mutation in the Hif2a gene that corresponds to the first such human mutation identified (G537W). We obtained mice bearing both heterozygous and homozygous mutations at this locus. We find that these mice display, in a mutation dose-dependent manner, erythrocytosis and pulmonary hypertension with a high degree of penetrance. These findings firmly establish missense mutations in HIF-2 alpha as a cause of erythrocytosis, highlight the importance of this HIF-alpha isoform in erythropoiesis, and point to HIF-alpha consequences of HIF-2 alpha dysregulation.	[Tan, Qiulin; Kerestes, Heddy; Lee, Frank S.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Pietrofesa, Ralph; Christofidou-Solomidou, Melpo] Univ Penn, Perelman Sch Med, Div Pulm Allergy & Crit Care, Dept Med, Philadelphia, PA 19104 USA; [Chen, Li] Univ Penn, Perelman Sch Med, Dept Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA; [Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Khurana, Tejvir S.] Univ Penn, Perelman Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Percy, Melanie J.] Belfast City Hosp, Dept Haematol, Belfast BT9 7AB, Antrim, North Ireland; [Lappin, Terence R. J.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Belfast City Hospital; Queens University Belfast	Lee, FS (corresponding author), Univ Penn, Perelman Sch Med, 605 Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu		Lee, Frank/0000-0003-2511-1834	National Institutes of Health [R01-CA153347, P30-DK19525]; NATIONAL CANCER INSTITUTE [R01CA153347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA153347 (to F. S. L.) and P30-DK19525 (to the Penn Diabetes Endocrine Research Center).	Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Bushuev VI, 2006, HAEMATOLOGICA, V91, P744; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P984, DOI 10.1160/TH08-08-0524; Formenti F, 2011, FASEB J, V25, P2001, DOI 10.1096/fj.10-177378; Furlow PW, 2009, J BIOL CHEM, V284, P9050, DOI 10.1074/jbc.M808737200; Gale DP, 2008, BLOOD, V112, P919, DOI 10.1182/blood-2008-04-153718; Gordeuk VR, 2004, BLOOD, V103, P3924, DOI 10.1182/blood-2003-07-2535; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Kwapiszewska G, 2008, CIRCULATION, V118, P1183, DOI 10.1161/CIRCULATIONAHA.107.761916; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Li XP, 2010, BLOOD CELL MOL DIS, V45, P9, DOI 10.1016/j.bcmd.2010.03.003; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Martini M, 2008, HAEMATOL-HEMATOL J, V93, P1068, DOI 10.3324/haematol.13210; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Nakagawa Y, 2009, BIOCHEM BIOPH RES CO, V382, P183, DOI 10.1016/j.bbrc.2009.03.004; Nemenoff RA, 2008, CIRC RES, V102, P1036, DOI 10.1161/CIRCRESAHA.107.169896; Percy MJ, 2008, BLOOD, V111, P5400, DOI 10.1182/blood-2008-02-137703; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2012, AM J HEMATOL, V87, P439, DOI 10.1002/ajh.23123; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Rankin EB, 2006, CANCER RES, V66, P2576, DOI 10.1158/0008-5472.CAN-05-3241; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Rankin EB, 2009, MOL CELL BIOL, V29, P4527, DOI 10.1128/MCB.00200-09; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Smith TG, 2006, PLOS MED, V3, P1178, DOI 10.1371/journal.pmed.0030290; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Teng XW, 2003, CIRC RES, V92, P1065, DOI 10.1161/01.RES.0000073999.07698.33; van Wijk R, 2010, HAEMATOL-HEMATOL J, V95, P829, DOI 10.3324/haematol.2009.017582; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; Weissmann N, 2005, THROMB HAEMOSTASIS, V94, P630, DOI 10.1160/TH05-02-0104; Wenger RH, 2010, AM J PHYSIOL-RENAL, V298, pF1287, DOI 10.1152/ajprenal.00736.2009; Xu WL, 2004, FASEB J, V18, P1746, DOI 10.1096/fj.04-2317fje; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yamashita T, 2008, BLOOD, V112, P1482, DOI 10.1182/blood-2007-11-122648; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Yoon D, 2011, AM J PHYSIOL-CELL PH, V300, pC1215, DOI 10.1152/ajpcell.00044.2011	52	76	80	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17134	17144		10.1074/jbc.M112.444059	http://dx.doi.org/10.1074/jbc.M112.444059			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640890	Green Published, hybrid			2022-12-28	WOS:000320380600011
J	Mayfield, JA; Hammer, ND; Kurker, RC; Chen, TK; Ojha, S; Skaar, EP; DuBois, JL				Mayfield, Jeffrey A.; Hammer, Neal D.; Kurker, Richard C.; Chen, Thomas K.; Ojha, Sunil; Skaar, Eric P.; DuBois, Jennifer L.			The Chlorite Dismutase (HemQ) from Staphylococcus aureus Has a Redox-sensitive Heme and Is Associated with the Small Colony Variant Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON RESPONSE REGULATOR; ESCHERICHIA-COLI; COPROPORPHYRINOGEN-III; DEGRADING ENZYMES; BACILLUS-SUBTILIS; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; PROTEIN; BINDING; BIOSYNTHESIS	The chlorite dismutases (C-family proteins) are a widespread family of heme-binding proteins for which chemical and biological roles remain unclear. An association of the gene with heme biosynthesis in Gram-positive bacteria was previously demonstrated by experiments involving introduction of genes from two Gram-positive species into heme biosynthesis mutant strains of Escherichia coli, leading to the gene being renamed hemQ. To assess the gene product's biological role more directly, a Staphylococcus aureus strain with an inactivated hemQ gene was generated and shown to be a slow growing small colony variant under aerobic but not anaerobic conditions. The small colony variant phenotype is rescued by the addition of exogenous heme despite an otherwise wild type heme biosynthetic pathway. The Delta hemQ mutant accumulates coproporphyrin specifically under aerobic conditions. Although its sequence is highly similar to functional chlorite dismutases, the HemQ protein has no steady state reactivity with chlorite, very modest reactivity with H2O2 or peracetic acid, and no observable transient intermediates. HemQ's equilibrium affinity for heme is in the low micromolar range. Holo-HemQ reconstituted with heme exhibits heme lysis after <50 turnovers with peroxide and <10 turnovers with chlorite. The heme-free apoprotein aggregates or unfolds over time. IsdG-like proteins and antibiotic biosynthesis monooxygenases are close sequence and structural relatives of HemQ that use heme or porphyrin-like organic molecules as substrates. The genetic and biochemical data suggest a similar substrate role for heme or porphyrin, with possible sensor-regulator functions for the protein. HemQ heme could serve as the means by which S. aureus reversibly adopts an SCV phenotype in response to redox stress.	[Mayfield, Jeffrey A.; Kurker, Richard C.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Hammer, Neal D.; Skaar, Eric P.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Chen, Thomas K.; Ojha, Sunil; DuBois, Jennifer L.] SRI Int, Div Biol Sci, Harrisonburg, VA 22802 USA; [Chen, Thomas K.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59718 USA	University of Notre Dame; Vanderbilt University; SRI International; Montana State University System; Montana State University Bozeman	DuBois, JL (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59718 USA.	jdubois@chemistry.montana.edu		Hammer, Neal/0000-0001-6148-7850	National Institutes of Health [R01GM090260, R01AI069233, R01AI073843]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073843, R01AI069233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM090260 (to J. L. D.) and R01AI069233 and R01AI073843 (to E. P. S.).	Anderson LA, 1997, EUR J BIOCHEM, V246, P119, DOI 10.1111/j.1432-1033.1997.00119.x; Andreoletti P, 2009, BBA-GEN SUBJECTS, V1790, P741, DOI 10.1016/j.bbagen.2009.04.010; Aoki R, 2012, J BIOL CHEM, V287, P13500, DOI 10.1074/jbc.M112.346205; ARNAO MB, 1990, BIOCHIM BIOPHYS ACTA, V1038, P85, DOI 10.1016/0167-4838(90)90014-7; Arnesano F, 2002, BIOCHEMISTRY-US, V41, P13587, DOI 10.1021/bi026362w; Atkinson HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004345; Bab-Dinitz E, 2006, BIOINFORMATICS, V22, P671, DOI 10.1093/bioinformatics/btk043; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Blanc B, 2012, BIOCHEMISTRY-US, V51, P1895, DOI 10.1021/bi2017377; Boynton TO, 2009, BIOCHEMISTRY-US, V48, P6705, DOI 10.1021/bi900850y; Breckau D, 2003, J BIOL CHEM, V278, P46625, DOI 10.1074/jbc.M308553200; Chelikani P, 2004, CELL MOL LIFE SCI, V61, P192, DOI 10.1007/s00018-003-3206-5; Coates JD, 2004, NAT REV MICROBIOL, V2, P569, DOI 10.1038/nrmicro926; Culbertson D. S., 2010, APPL MICROBIOL BIOT, V49, P6051; Dailey TA, 2010, J BIOL CHEM, V285, P25978, DOI 10.1074/jbc.M110.142604; de Geus DC, 2009, J MOL BIOL, V387, P192, DOI 10.1016/j.jmb.2009.01.036; Dunford H. B., 1999, HEME PEROXIDASES; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Ebihara Akio, 2005, Journal of Structural and Functional Genomics, V6, P21, DOI 10.1007/s10969-005-1103-x; EPSTEIN N, 1972, FEBS LETT, V25, P46, DOI 10.1016/0014-5793(72)80450-2; ERMAN JE, 1993, BIOCHEMISTRY-US, V32, P9798, DOI 10.1021/bi00088a035; Faulkner MJ, 2012, J BACTERIOL, V194, P1226, DOI 10.1128/JB.06566-11; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; Goblirsch B, 2011, J MOL BIOL, V408, P379, DOI 10.1016/j.jmb.2011.02.047; Goblirsch BR, 2010, J BIOL INORG CHEM, V15, P879, DOI 10.1007/s00775-010-0651-0; Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b; Hagedoorn PL, 2002, EUR J BIOCHEM, V269, P4905, DOI 10.1046/j.1432-1033.2002.03208.x; HANSSON M, 1994, J BACTERIOL, V176, P5962, DOI 10.1128/jb.176.19.5962-5970.1994; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Hofbauer S, 2012, BBA-PROTEINS PROTEOM, V1824, P1031, DOI 10.1016/j.bbapap.2012.05.012; Kawakami N, 2012, CHEMBIOCHEM, V13, P2045, DOI 10.1002/cbic.201200446; Kohler C, 2008, J BACTERIOL, V190, P6351, DOI 10.1128/JB.00505-08; Kostan J, 2010, J STRUCT BIOL, V172, P331, DOI 10.1016/j.jsb.2010.06.014; Kurker R. C., 2013, THESIS U NOTRE DAME; Lansky IB, 2006, J BIOL CHEM, V281, P13652, DOI 10.1074/jbc.M600824200; Layer G, 2006, J BIOL CHEM, V281, P15727, DOI 10.1074/jbc.M512628200; Lee AQ, 2008, P NATL ACAD SCI USA, V105, P15654, DOI 10.1073/pnas.0804279105; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Letoffe S, 2009, P NATL ACAD SCI USA, V106, P11719, DOI 10.1073/pnas.0903842106; Liu XH, 2011, J BIOL CHEM, V286, P14922, DOI 10.1074/jbc.M110.197780; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Maixner F, 2008, ENVIRON MICROBIOL, V10, P3043, DOI 10.1111/j.1462-2920.2008.01646.x; Marino M, 2000, MICROBIOL-SGM, V146, P97, DOI 10.1099/00221287-146-1-97; Mayfield J. A., 2013, BIOCHEMISTR IN PRESS; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; Mehboob F, 2009, FEMS MICROBIOL LETT, V293, P115, DOI 10.1111/j.1574-6968.2009.01517.x; Mlynek G, 2011, J BACTERIOL, V193, P2408, DOI 10.1128/JB.01262-10; Mobius K, 2010, P NATL ACAD SCI USA, V107, P10436, DOI 10.1073/pnas.1000956107; Olea C, 2010, J AM CHEM SOC, V132, P12794, DOI 10.1021/ja106252b; Olsson U, 2002, J BACTERIOL, V184, P4018, DOI 10.1128/JB.184.14.4018-4024.2002; Panek H, 2002, MICROBIOL-SGM, V148, P2273, DOI 10.1099/00221287-148-8-2273; PROCTOR RA, 1995, CLIN INFECT DIS, V20, P95, DOI 10.1093/clinids/20.1.95; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Rand K, 2010, BIOL CHEM, V391, P55, DOI 10.1515/BC.2010.006; RodriguezLopez JN, 1997, J BIOL CHEM, V272, P5469, DOI 10.1074/jbc.272.9.5469; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Stenklo K, 2001, J BIOL INORG CHEM, V6, P601, DOI 10.1007/s007750100237; Stevens JM, 2003, J BIOL CHEM, V278, P20500, DOI 10.1074/jbc.M212925200; Streit BR, 2008, BIOCHEMISTRY-US, V47, P5271, DOI 10.1021/bi800163x; Streit BR, 2010, J AM CHEM SOC, V132, P5711, DOI 10.1021/ja9082182; Swingle EL, 1935, J BACTERIOL, V29, P467, DOI 10.1128/JB.29.5.467-489.1935; Takayama SJ, 2011, P NATL ACAD SCI USA, V108, P13071, DOI 10.1073/pnas.1101459108; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; VITELLO LB, 1992, BIOCHEMISTRY-US, V31, P11524, DOI 10.1021/bi00161a034; Vlasits J, 2010, ARCH BIOCHEM BIOPHYS, V500, P74, DOI 10.1016/j.abb.2010.04.018; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Wakeman CA, 2012, MOL MICROBIOL, V86, P1376, DOI 10.1111/mmi.12063; WILKS A, 1994, J BIOL CHEM, V269, P29553; Woodward JJ, 2007, NAT METHODS, V4, P43, DOI 10.1038/NMETH984; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; Yang JH, 2005, J BIOL CHEM, V280, P7671, DOI 10.1074/jbc.M411664200; Ye RW, 2000, J BACTERIOL, V182, P4458, DOI 10.1128/JB.182.16.4458-4465.2000; Zubieta C, 2007, PROTEINS, V69, P234, DOI 10.1002/prot.21673	77	43	43	0	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23488	23504		10.1074/jbc.M112.442335	http://dx.doi.org/10.1074/jbc.M112.442335			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23737523	hybrid, Green Published			2022-12-28	WOS:000330598200054
J	Cheepala, SB; Bao, J; Nachagari, D; Sun, DX; Wang, Y; Zhong, T; Naren, AP; Zheng, J; Schuetz, JD				Cheepala, Satish B.; Bao, Ju; Nachagari, Deepa; Sun, Daxi; Wang, Yao; Zhong, Tao; Naren, Anjaparavanda P.; Zheng, Jie; Schuetz, John D.			Crucial Role for Phylogenetically Conserved Cytoplasmic Loop 3 in ABCC4 Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; BINDING CASSETTE TRANSPORTERS; CHLORIDE CHANNEL ACTIVITY; MULTIDRUG-RESISTANCE; SECONDARY STRUCTURE; MOLECULAR-MODEL; MRP4; CFTR; GENE; MUTATIONS	The ABC transporter ABCC4 is recognized as an ATP-dependent exporter of endogenous substances as well as an increasing variety of anionic chemotherapeutics. A loss-of-function variant of zebrafish Abcc4 was identified with a single amino acid substitution in the cytoplasmic loop T804M. Because this substituted amino acid is highly conserved among ABCC4 orthologs and is located in cytoplasmic loop 3 (CL3), we investigated the impact of this mutation on human and zebrafish Abcc4 expression. We demonstrate that zebrafish Abcc4 T804M or human ABCC4 T796M exhibit substantially reduced expression, coupled with impaired plasma membrane localization. To understand the molecular basis for the localization defect, we developed a homology model of zebrafish Abcc4. The homology model suggested that the bulky methionine substitution disrupted side-chain contacts. Molecular dynamic simulations of a fragment of human or zebrafish CL3 containing a methionine substitution indicated altered helicity coupled with reduced thermal stability. Trifluoroethanol challenge coupled with circular dichroism revealed that the methionine substitution disrupted the ability of this fragment of CL3 to readily form an alpha-helix. Furthermore, expression and plasma membrane localization of these mutant ABCC4/Abcc4 proteins are mostly rescued by growing cells at subphysiological temperatures. Because the cystic fibrosis transmembrane conductance regulator (ABCC7) is closely related to ABCC4, we extended this by engineering certain pathogenic CFTR-CL3 mutations, and we showed they destabilized human and zebrafish ABCC4. Altogether, our studies provide the first evidence for a conserved domain in CL3 of ABCC4 that is crucial in ensuring its proper plasma membrane localization.	[Cheepala, Satish B.; Nachagari, Deepa; Sun, Daxi; Wang, Yao; Schuetz, John D.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Bao, Ju; Zheng, Jie] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Zhong, Tao] Vanderbilt Univ, Dept Cardiovasc Biol, Nashville, TN 37235 USA; [Naren, Anjaparavanda P.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center	Schuetz, JD (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	John.Schuetz@stjude.org	Schuetz, John D/N-2692-2018		National Institutes of Health [2R01GM60904, P30CA21745, CA21865, DK080834, DK093045]; ALSAC; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080834, R01DK093045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081492, R01GM100909, R01GM060904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01GM60904, P30CA21745, and CA21865 (to J. D. S.) and DK080834 and DK093045 (to A. P. N.). This work was also supported by ALSAC.	Abla N, 2008, J PHARMACOL EXP THER, V325, P859, DOI 10.1124/jpet.108.136523; Ban H, 2010, J GASTROENTEROL, V45, P1014, DOI 10.1007/s00535-010-0248-y; Banasavadi-Siddegowda YK, 2011, J BIOL CHEM, V286, P43071, DOI 10.1074/jbc.M111.269993; BARBER R, 1980, BIOCHEMISTRY-US, V19, P2560, DOI 10.1021/bi00553a004; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; Bertolucci CM, 2005, PROTEIN SCI, V14, P644, DOI 10.1110/ps.041107205; Borst P, 2007, PFLUG ARCH EUR J PHY, V453, P661, DOI 10.1007/s00424-006-0054-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNTON LL, 1980, J CYCLIC NUCL PROT, V6, P369; Chang C, 2006, EUR J PHARM SCI, V27, P411, DOI 10.1016/j.ejps.2005.09.013; Cheepala S, 2013, ANNU REV PHARMACOL, V53, P231, DOI 10.1146/annurev-pharmtox-010611-134609; CLAUSTRES M, 1993, HUM MOL GENET, V2, P1209, DOI 10.1093/hmg/2.8.1209; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; El Hiani Y, 2012, BIOCHEMISTRY-US, V51, P3971, DOI 10.1021/bi300065z; Fukuda Y, 2011, J BIOL CHEM, V286, P8481, DOI 10.1074/jbc.M110.174516; Hayashi H, 2007, HEPATOLOGY, V45, P1506, DOI 10.1002/hep.21630; Hazai E, 2008, J STRUCT BIOL, V162, P63, DOI 10.1016/j.jsb.2007.12.001; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Janke D, 2008, HUM MUTAT, V29, P659, DOI 10.1002/humu.20694; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Kanki K, 2009, APOPTOSIS, V14, P309, DOI 10.1007/s10495-009-0318-x; Kool M, 1997, CANCER RES, V57, P3537; Krishnamurthy P, 2008, CANCER RES, V68, P4983, DOI 10.1158/0008-5472.CAN-07-6790; Kruh GD, 2007, CANCER METAST REV, V26, P5, DOI 10.1007/s10555-007-9039-1; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Ravna AW, 2008, BIOORG MED CHEM LETT, V18, P3481, DOI 10.1016/j.bmcl.2008.05.047; Ravna AW, 2009, MINI-REV MED CHEM, V9, P186, DOI 10.2174/138955709787316065; Ravna AW, 2008, EUR J MED CHEM, V43, P2557, DOI 10.1016/j.ejmech.2008.01.015; Rosenberg MF, 2011, J BIOL CHEM, V286, P42647, DOI 10.1074/jbc.M111.292268; Sauna ZE, 2004, J BIOL CHEM, V279, P48855, DOI 10.1074/jbc.M408849200; Schuetz JD, 1999, NAT MED, V5, P1048, DOI 10.1038/12487; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; Vardy E, 2004, PROTEIN SCI, V13, P1832, DOI 10.1110/ps.04657704; Walters RFS, 2006, P NATL ACAD SCI USA, V103, P13658, DOI 10.1073/pnas.0605878103; Wielinga PR, 2002, MOL PHARMACOL, V62, P1321, DOI 10.1124/mol.62.6.1321; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22207	22218		10.1074/jbc.M113.476218	http://dx.doi.org/10.1074/jbc.M113.476218			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23766510	Green Published, hybrid			2022-12-28	WOS:000330596300003
J	Glockner, C; Kern, J; Broser, M; Zouni, A; Yachandra, V; Yano, J				Gloeckner, Carina; Kern, Jan; Broser, Matthias; Zouni, Athina; Yachandra, Vittal; Yano, Junko			Structural Changes of the Oxygen-evolving Complex in Photosystem II during the Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-ABSORPTION; PHOTOSYNTHETIC WATER OXIDATION; MN4CA CLUSTER; CRYSTAL-STRUCTURE; MN CLUSTER; MANGANESE COMPLEX; ELECTRONIC-STRUCTURE; S-2 STATES; THERMOSYNECHOCOCCUS-ELONGATUS; ANGSTROM RESOLUTION	The oxygen-evolving complex (OEC) in the membrane-bound protein complex photosystem II (PSII) catalyzes the water oxidation reaction that takes place in oxygenic photosynthetic organisms. We investigated the structural changes of the Mn4CaO5 cluster in the OEC during the S state transitions using x-ray absorption spectroscopy (XAS). Overall structural changes of the Mn4CaO5 cluster, based on the manganese ligand and Mn-Mn distances obtained from this study, were incorporated into the geometry of the Mn4CaO5 cluster in the OEC obtained from a polarized XAS model and the 1.9-angstrom high resolution crystal structure. Additionally, we compared the S-1 state XAS of the dimeric and monomeric form of PSII from Thermosynechococcus elongatus and spinach PSII. Although the basic structures of the OEC are the same for T. elongatus PSII and spinach PSII, minor electronic structural differences that affect the manganese K-edge XAS between T. elongatus PSII and spinach PSII are found and may originate from differences in the second sphere ligand atom geometry.	[Gloeckner, Carina; Broser, Matthias; Zouni, Athina] Tech Univ Berlin, Inst Chem, Max Volmer Lab Biophys Chem, D-10623 Berlin, Germany; [Kern, Jan; Yachandra, Vittal; Yano, Junko] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Technical University of Berlin; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zouni, A (corresponding author), Tech Univ Berlin, Inst Chem, Max Volmer Lab Biophys Chem, Str 17 Juni 135, D-10623 Berlin, Germany.	zouni@mailbox.tu-berlin.de; vkyachandra@lbl.gov; jyano@lbl.gov	Kern, Jan/G-2586-2013	Kern, Jan/0000-0002-7272-1603	National Institutes of Health; NCCR; Department of Energy, Office of Biological and Environmental Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055302, R56GM055302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCR(Swiss National Science Foundation (SNSF)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Prof. Johannes Messinger for many useful discussions, D. DiFiore for technical assistance with sample preparation and the staff at Stanford Synchrotron Radiation Lightsource, Stanford, CA, for support of the EXAFS measurements. Synchrotron facilities were provided by the Stanford Synchrotron Radiation Lightsource operated by the Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Biomedical Technology program is supported by the National Institutes of Health, the NCCR, and the Department of Energy, Office of Biological and Environmental Research.	Ames W, 2011, J AM CHEM SOC, V133, P19743, DOI 10.1021/ja2041805; BALDWIN MJ, 1994, J AM CHEM SOC, V116, P11349, DOI 10.1021/ja00104a014; BOUSSAC A, 1989, BIOCHEMISTRY-US, V28, P8984, DOI 10.1021/bi00449a005; Bricker TM, 2012, BBA-BIOENERGETICS, V1817, P121, DOI 10.1016/j.bbabio.2011.07.006; Broser M, 2010, J BIOL CHEM, V285, P26255, DOI 10.1074/jbc.M110.127589; Chu HA, 2004, BIOCHEMISTRY-US, V43, P3152, DOI 10.1021/bi035915f; Cinco RM, 1999, INORG CHEM, V38, P5988, DOI 10.1021/ic991003j; Cinco RM, 2004, BIOCHEMISTRY-US, V43, P13271, DOI 10.1021/bi036308v; Cinco RM, 1998, J PHYS CHEM B, V102, P8248, DOI 10.1021/jp981658q; Cinco RM, 2002, BIOCHEMISTRY-US, V41, P12928, DOI 10.1021/bi026569p; Cox N, 2013, ACCOUNTS CHEM RES, V46, P1588, DOI 10.1021/ar3003249; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; Dau H, 1997, J PHYS IV, V7, P607, DOI 10.1051/jp4/1997112; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Galstyan A, 2012, J AM CHEM SOC, V134, P7442, DOI 10.1021/ja300254n; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Haddy A, 2007, PHOTOSYNTH RES, V92, P357, DOI 10.1007/s11120-007-9194-9; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Ifuku K, 2011, J PHOTOCH PHOTOBIO B, V104, P158, DOI 10.1016/j.jphotobiol.2011.02.006; Isobe H, 2012, DALTON T, V41, P13727, DOI 10.1039/c2dt31420g; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kanady JS, 2011, SCIENCE, V333, P733, DOI 10.1126/science.1206036; Kern J, 2005, BBA-BIOENERGETICS, V1706, P147, DOI 10.1016/j.bbabio.2004.10.007; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Komenda J, 2012, CURR OPIN PLANT BIOL, V15, P245, DOI 10.1016/j.pbi.2012.01.017; Koua FHM, 2013, P NATL ACAD SCI USA, V110, P3889, DOI 10.1073/pnas.1219922110; Kouril R, 2012, BBA-BIOENERGETICS, V1817, P2, DOI 10.1016/j.bbabio.2011.05.024; Kulik LV, 2007, J AM CHEM SOC, V129, P13421, DOI 10.1021/ja071487f; Kulik LV, 2005, J AM CHEM SOC, V127, P2392, DOI 10.1021/ja043012j; Liang WC, 2000, J AM CHEM SOC, V122, P3399, DOI 10.1021/ja992501u; Lohmiller T, 2012, J BIOL CHEM, V287, P24721, DOI 10.1074/jbc.M112.365288; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Luber S, 2011, BIOCHEMISTRY-US, V50, P6308, DOI 10.1021/bi200681q; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; Miqyass M, 2007, PHOTOSYNTH RES, V92, P275, DOI 10.1007/s11120-006-9124-2; Mukherjee S, 2012, P NATL ACAD SCI USA, V109, P2257, DOI 10.1073/pnas.1115290109; Mukhopadhyay S, 2004, CHEM REV, V104, P3981, DOI 10.1021/cr0206014; Newville M, 2001, J SYNCHROTRON RADIAT, V8, P322, DOI 10.1107/S0909049500016964; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Noguchi T, 2008, COORDIN CHEM REV, V252, P336, DOI 10.1016/j.ccr.2007.05.001; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; ONO T, 1988, FEBS LETT, V227, P147, DOI 10.1016/0014-5793(88)80886-X; Pantazis DA, 2012, ANGEW CHEM INT EDIT, V51, P9935, DOI 10.1002/anie.201204705; Peloquin JM, 2000, J AM CHEM SOC, V122, P10926, DOI 10.1021/ja002104f; Peloquin JM, 2001, BBA-BIOENERGETICS, V1503, P96, DOI 10.1016/S0005-2728(00)00219-X; Pizarro SA, 2004, PHYS CHEM CHEM PHYS, V6, P4864, DOI 10.1039/b407513g; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; Pushkar Y, 2007, J BIOL CHEM, V282, P7198, DOI 10.1074/jbc.M610505200; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Robblee JH, 2002, J AM CHEM SOC, V124, P7459, DOI 10.1021/ja011621a; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Sauer K, 2008, COORDIN CHEM REV, V252, P318, DOI 10.1016/j.ccr.2007.08.009; Siegbahn PEM, 2011, CHEMPHYSCHEM, V12, P3274, DOI 10.1002/cphc.201100475; Siegbahn PEM, 2011, J PHOTOCH PHOTOBIO B, V104, P94, DOI 10.1016/j.jphotobiol.2011.01.014; Siegbahn PEM, 2009, ACCOUNTS CHEM RES, V42, P1871, DOI 10.1021/ar900117k; Sigfridsson KGV, 2013, J BIOL CHEM, V288, P9648, DOI 10.1074/jbc.M112.438796; Su JH, 2011, BBA-BIOENERGETICS, V1807, P829, DOI 10.1016/j.bbabio.2011.03.002; Suzuki H, 2009, J AM CHEM SOC, V131, P7849, DOI 10.1021/ja901696m; Takahashi T, 2009, J BIOL CHEM, V284, P15598, DOI 10.1074/jbc.M109.000372; Teutloff C, 2009, PHYS CHEM CHEM PHYS, V11, P6715, DOI 10.1039/b908093g; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Watanabe M, 2009, PLANT CELL PHYSIOL, V50, P1674, DOI 10.1093/pcp/pcp112; Wydrzynski T, 2005, PHOTOSYSTEM, DOI [10.1007/1-4020-4254-X_6, DOI 10.1007/1-4020-4254-X_6]; Yano J, 2005, J AM CHEM SOC, V127, P14974, DOI 10.1021/ja054873a; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2008, INORG CHEM, V47, P1711, DOI 10.1021/ic7016837; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Yano J, 2011, J BIOL CHEM, V286, P9257, DOI 10.1074/jbc.M110.205740; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	74	125	126	1	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22607	22620		10.1074/jbc.M113.476622	http://dx.doi.org/10.1074/jbc.M113.476622			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23766513	hybrid, Green Published			2022-12-28	WOS:000330596300041
J	Ren, GQ; Li, S; Zhong, HB; Lin, S				Ren, Guiqi; Li, Song; Zhong, Hanbing; Lin, Shuo			Zebrafish Tyrosine Hydroxylase 2 Gene Encodes Tryptophan Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINERGIC NEURON DEVELOPMENT; PARKINSONS-DISEASE; LARVAL ZEBRAFISH; HOMEODOMAIN PROTEIN; PINK1 FUNCTION; DANIO-RERIO; BRAIN; MUTATIONS; SYSTEM; MODEL	The primary pathological hallmark of Parkinson disease (PD) is the profound loss of dopaminergic neurons in the substantia nigra pars compacta. To facilitate the understanding of the underling mechanism of PD, several zebrafish PD models have been generated to recapitulate the characteristics of dopaminergic (DA) neuron loss. In zebrafish studies, tyrosine hydroxylase 1 (th1) has been frequently used as a molecular marker of DA neurons. However, th1 also labels norepinephrine and epinephrine neurons. Recently, a homologue of th1, named tyrosine hydroxylase 2 (th2), was identified based on the sequence homology and subsequently used as a novel marker of DA neurons. In this study, we present evidence that th2 co-localizes with serotonin in the ventral diencephalon and caudal hypothalamus in zebrafish embryos. In addition, knockdown of th2 reduces the level of serotonin in the corresponding th2-positive neurons. This phenotype can be rescued by both zebrafish th2 and mouse tryptophan hydroxylase 1 (Tph1) mRNA as well as by 5-hydroxytryptophan, the product of tryptophan hydroxylase. Moreover, the purified Th2 protein has tryptophan hydroxylase activity comparable with that of the mouse TPH1 protein in vitro. Based on these in vivo and in vitro results, we conclude that th2 is a gene encoding for tryptophan hydroxylase and should be used as a marker gene of serotonergic neurons.	[Ren, Guiqi; Li, Song; Zhong, Hanbing; Lin, Shuo] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen 518055, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	Peking University; University Town of Shenzhen; University of California System; University of California Los Angeles	Lin, S (corresponding author), Life Sci Bldg,621 Charles E Young Dr S, Los Angeles, CA 90095 USA.	shuolin@ucla.edu			Ministry of Science and Technology of China [2009CB941200, 2009CB941300]; Shenzhen Science and Technology Program [JC201104220257A, JC201005270280A, ZYC201006170364A, GJHS20120628101219328]; Guangdong Natural Science Foundation [S2012010009028]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shenzhen Science and Technology Program; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by Ministry of Science and Technology of China Grants 2009CB941200 and 2009CB941300; Shenzhen Science and Technology Program Grants JC201104220257A, JC201005270280A, ZYC201006170364A, and GJHS20120628101219328; and Guangdong Natural Science Foundation Grant S2012010009028.	Anichtchik O, 2008, J NEUROSCI, V28, P8199, DOI 10.1523/JNEUROSCI.0979-08.2008; Bellipanni G, 2002, MECH DEVELOP, V119, pS215, DOI 10.1016/S0925-4773(03)00119-9; Blechman J, 2007, DEVELOPMENT, V134, P4417, DOI 10.1242/dev.011262; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Candy J, 2005, BBA-GENE STRUCT EXPR, V1727, P35, DOI 10.1016/j.bbaexp.2004.11.005; Chen YC, 2012, DEV BIOL, V370, P237, DOI 10.1016/j.ydbio.2012.07.030; Chen YC, 2009, HISTOCHEM CELL BIOL, V132, P375, DOI 10.1007/s00418-009-0619-8; Del Giacco L, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-50; Fett ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011783; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Flinn L, 2009, BRAIN, V132, P1613, DOI 10.1093/brain/awp108; Force A, 1999, GENETICS, V151, P1531; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; Guo S, 1999, DEV BIOL, V208, P473, DOI 10.1006/dbio.1999.9204; HALLIDAY GM, 1990, BRAIN RES, V510, P104, DOI 10.1016/0006-8993(90)90733-R; Hornykiewicz O, 1987, Adv Neurol, V45, P19; Iversen SD, 2007, TRENDS NEUROSCI, V30, P188, DOI 10.1016/j.tins.2007.03.002; Jeong JY, 2006, P NATL ACAD SCI USA, V103, P5143, DOI 10.1073/pnas.0600337103; Kaslin J, 2001, J COMP NEUROL, V440, P342, DOI 10.1002/cne.1390; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee SA, 2003, DEVELOPMENT, V130, P2669, DOI 10.1242/dev.00502; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Lillesaar C, 2011, J CHEM NEUROANAT, V41, P294, DOI 10.1016/j.jchemneu.2011.05.009; Mahler J, 2010, J NEUROSCI, V30, P16621, DOI 10.1523/JNEUROSCI.4769-10.2010; McKinley ET, 2005, MOL BRAIN RES, V141, P128, DOI 10.1016/j.molbrainres.2005.08.014; McLean DL, 2004, J COMP NEUROL, V480, P57, DOI 10.1002/cne.20281; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; Rauch GJ, 2003, ZFIN DIRECT DATA SUB; Ren GQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020630; RIEDERER P, 1976, J NEURAL TRANSM, V38, P277, DOI 10.1007/BF01249445; Rink E, 2002, BRAIN RES BULL, V57, P385, DOI 10.1016/S0361-9230(01)00696-7; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ryu S, 2007, CURR BIOL, V17, P873, DOI 10.1016/j.cub.2007.04.003; Sallinen V, 2010, NEUROBIOL DIS, V40, P93, DOI 10.1016/j.nbd.2010.06.001; Sheng DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000914; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Thisse B, 2004, ZFIN DIRECT DATA SUB; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wen L, 2008, DEV BIOL, V314, P84, DOI 10.1016/j.ydbio.2007.11.012; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Xi YW, 2010, EUR J NEUROSCI, V31, P623, DOI 10.1111/j.1460-9568.2010.07091.x; Yamamoto K, 2011, J COMP NEUROL, V519, P576, DOI 10.1002/cne.22535; Yamamoto K, 2010, MOL CELL NEUROSCI, V43, P394, DOI 10.1016/j.mcn.2010.01.006; Yohrling GJ, 2002, J NEUROCHEM, V82, P1416, DOI 10.1046/j.1471-4159.2002.01084.x	47	28	28	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22451	22459		10.1074/jbc.M113.485227	http://dx.doi.org/10.1074/jbc.M113.485227			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23754283	hybrid, Green Published			2022-12-28	WOS:000330596300026
J	Tran, KD; Rodriguez-Contreras, D; Vieira, DP; Yates, PA; David, L; Beatty, W; Elferich, J; Landfear, SM				Tran, Khoa D.; Rodriguez-Contreras, Dayana; Vieira, Danielle P.; Yates, Phillip A.; David, Larry; Beatty, Wandy; Elferich, Johannes; Landfear, Scott M.			KHARON1 Mediates Flagellar Targeting of a Glucose Transporter in Leishmania mexicana and Is Critical for Viability of Infectious Intracellular Amastigotes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CILIARY MEMBRANE; PRIMARY CILIUM; PROTEIN; GENE; LOCALIZATION; TRAFFICKING; MODULATION; PROTISTS; SEQUENCE; RAFTS	The LmxGT1 glucose transporter is selectively targeted to the flagellum of the kinetoplastid parasite Leishmania mexicana, but the mechanism for targeting this and other flagella-specific membrane proteins among the Kinetoplastida is unknown. To address the mechanism of flagellar targeting, we employed in vivo cross-linking, tandem affinity purification, and mass spectrometry to identify a novel protein, KHARON1 (KH1), which is important for the flagellar trafficking of LmxGT1. Kh1 null mutant parasites are strongly impaired in flagellar targeting of LmxGT1, and trafficking of the permease was arrested in the flagellar pocket. Immunolocalization revealed that KH1 is located at the base of the flagellum, within the flagellar pocket, where it associates with the proximal segment of the flagellar axoneme. We propose that KH1 mediates transit of LmxGT1 from the flagellar pocket into the flagellar membrane via interaction with the proximal portion of the flagellar axoneme. KH1 represents the first component involved in flagellar trafficking of integral membrane proteins among parasitic protozoa. Of considerable interest, Kh1 null mutants are strongly compromised for growth as amastigotes within host macrophages. Thus, KH1 is also important for the disease causing stage of the parasite life cycle.	[Tran, Khoa D.; Rodriguez-Contreras, Dayana; Vieira, Danielle P.; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Yates, Phillip A.; Elferich, Johannes] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [David, Larry] Oregon Hlth & Sci Univ, Dept Prote Shared Resource, Portland, OR 97239 USA; [Beatty, Wandy] Washington Univ, Sch Med, Mol Microbiol Imaging Facil, St Louis, MO 63110 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Washington University (WUSTL)	Landfear, SM (corresponding author), 3181 SW Sam Jackson Pk Rd, Portland, OR USA.	landfear@ohsu.edu	Vieira, Danielle/N-1254-2014	Elferich, Johannes/0000-0002-9911-706X; Landfear, Scott/0000-0002-1643-6664	National Institutes of Health [AI25920, AI023682]; American Heart Association [11POST7440105]; National Institutes of Health NRSA [1F32AI096854]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brasil (CNPq); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025571] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY010572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI096854, R01AI023682, R37AI023682, R01AI025920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI25920 (to S. M. L.) and American Heart Association Postdoctoral Fellowship 11POST7440105 and National Institutes of Health NRSA F32 Fellowship 1F32AI096854 (to K. D. T.).; Supported by a fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-Brasil (CNPq).; Supported by National Institutes of Health Grant AI023682.	Absalon S, 2008, MOL BIOL CELL, V19, P929, DOI 10.1091/mbc.E07-08-0749; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Berbari NF, 2009, CURR BIOL, V19, pR526, DOI 10.1016/j.cub.2009.05.025; Bloodgood RA, 2010, J CELL SCI, V123, P505, DOI 10.1242/jcs.066308; Buchanan KT, 2005, J BIOL CHEM, V280, P40104, DOI 10.1074/jbc.M505777200; Burchmore RJS, 2003, P NATL ACAD SCI USA, V100, P3901, DOI 10.1073/pnas.0630165100; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; CRUZ A, 1990, NATURE, V348, P171, DOI 10.1038/348171a0; Denny PW, 2000, J BIOL CHEM, V275, P11017, DOI 10.1074/jbc.275.15.11017; Denny PW, 2004, MOL MICROBIOL, V53, P725, DOI 10.1111/j.1365-2958.2004.04208.x; Denny PW, 2001, FEBS LETT, V491, P148, DOI 10.1016/S0014-5793(01)02172-X; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Emmer BT, 2010, J CELL SCI, V123, P529, DOI 10.1242/jcs.062968; ENGMAN DM, 1989, J BIOL CHEM, V264, P18627; Figarella K, 2007, MOL MICROBIOL, V65, P1006, DOI 10.1111/j.1365-2958.2007.05845.x; Fridberg A, 2007, PARASITOL RES, V100, P205, DOI 10.1007/s00436-006-0329-2; Fulwiler AL, 2011, MOL BIOCHEM PARASIT, V175, P209, DOI 10.1016/j.molbiopara.2010.10.008; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Ginger ML, 2008, NAT REV MICROBIOL, V6, P838, DOI 10.1038/nrmicro2009; Gluenz E, 2010, FASEB J, V24, P3117, DOI 10.1096/fj.09-151381; Gluenz E, 2010, CURR OPIN MICROBIOL, V13, P473, DOI 10.1016/j.mib.2010.05.008; Godsel LM, 1999, EMBO J, V18, P2057, DOI 10.1093/emboj/18.8.2057; Gourbal B, 2004, J BIOL CHEM, V279, P31010, DOI 10.1074/jbc.M403959200; Gruber M, 2005, NUCLEIC ACIDS RES, V33, pW239, DOI 10.1093/nar/gki405; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Heras SR, 2006, CELL MOL LIFE SCI, V63, P1449, DOI 10.1007/s00018-006-6038-2; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Liu JF, 2003, NUCLEIC ACIDS RES, V31, P3833, DOI 10.1093/nar/gkg515; Mandal G, 2012, MOL MICROBIOL, V85, P1204, DOI 10.1111/j.1365-2958.2012.08169.x; Maric D, 2011, J BIOL CHEM, V286, P33109, DOI 10.1074/jbc.M111.240895; Maric D, 2010, CURR OPIN MICROBIOL, V13, P466, DOI 10.1016/j.mib.2010.06.001; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; McConville MJ, 2002, MICROBIOL MOL BIOL R, V66, P122, DOI 10.1128/MMBR.66.1.122-154.2002; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nasser MIA, 2004, MOL BIOCHEM PARASIT, V135, P89, DOI 10.1016/j.molbiopara.2004.01.009; Oberholzer M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010538; PAINDAVOINE P, 1992, MOL CELL BIOL, V12, P1218, DOI 10.1128/MCB.12.3.1218; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Sacks D L, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1902s28; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tagwerker C, 2006, MOL CELL PROTEOMICS, V5, P737, DOI 10.1074/mcp.M500368-MCP200; Tran KD, 2012, J CELL SCI, V125, P3293, DOI 10.1242/jcs.103028; Tran KD, 2010, DEVELOPMENT, V137, P1421, DOI 10.1242/dev.048678; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Tull D, 2004, MOL BIOL CELL, V15, P4775, DOI 10.1091/mbc.E04-06-0457; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; WHO, 2013, NEGL TROP DIS; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Wittig I, 2008, PROTEOMICS, V8, P3974, DOI 10.1002/pmic.200800017; Zheng ZF, 2004, J BIOL CHEM, V279, P42106, DOI 10.1074/jbc.M403780200	58	17	17	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22721	22733		10.1074/jbc.M113.483461	http://dx.doi.org/10.1074/jbc.M113.483461			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23766511	Green Published, hybrid			2022-12-28	WOS:000330596300050
J	West, L; Lowman, DW; Mora-Montes, HM; Grubb, S; Murdoch, C; Thornhill, MH; Gow, NAR; Williams, D; Haynes, K				West, Lara; Lowman, Douglas W.; Mora-Montes, Hector M.; Grubb, Sarah; Murdoch, Craig; Thornhill, Martin H.; Gow, Neil A. R.; Williams, David; Haynes, Ken			Differential Virulence of Candida glabrata Glycosylation Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Candida albicans; Cell Wall; Fungi; Host-Pathogen Interactions; Virulence Factors	CELL-WALL MANNAN; WILD-TYPE LEVELS; SACCHAROMYCES-CEREVISIAE; GENE FAMILY; PROTEIN GLYCOSYLATION; PATTERN-RECOGNITION; ENDOTHELIAL-CELLS; HYPERTONIC-STRESS; BETA-GLUCAN; SIDE-CHAIN	The fungus Candida glabrata is an important and increasingly common pathogen of humans, particularly in immunocompromised hosts. Despite this, little is known about the attributes that allow this organism to cause disease or its interaction with the host immune system. However, in common with other fungi, the cell wall of C. glabrata is the initial point of contact between the host and pathogen, and as such, it is likely to play an important role in mediating interactions and hence virulence. Here, we show both through genetic complementation and polysaccharide structural analyses that C. glabrata ANP1, MNN2, and MNN11 encode functional orthologues of the respective Saccharomyces cerevisiae mannosyltransferases. Furthermore, we show that deletion of the C. glabrata Anp1, Mnn2, and Mnn11 mannosyltransferases directly affects the structure of the fungal N-linked mannan, in line with their predicted functions, and this has implications for cell wall integrity and consequently virulence. C. glabrata anp1 and mnn2 mutants showed increased virulence, compared with wild-type (and mnn11) cells. This is in contrast to Candida albicans where inactivation of genes involved in mannan biosynthesis has usually been linked to an attenuation of virulence. In the long term, a better understanding of the attributes that allow C. glabrata to cause disease will provide insights that can be adopted for the development of novel therapeutic and diagnostic approaches.	[West, Lara; Haynes, Ken] Univ London Imperial Coll Sci Technol & Med, Dept Microbiol, London SW7 2AZ, England; [Lowman, Douglas W.; Williams, David] E Tennessee State Univ, Dept Surg, Quillen Coll Med, Johnson City, TN 37614 USA; [Lowman, Douglas W.] AppRidge Int LLC, Jonesborough, TN 37659 USA; [Mora-Montes, Hector M.; Gow, Neil A. R.] Univ Aberdeen, Sch Med Sci, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Mora-Montes, Hector M.] Univ Guanajuato, Dept Biol, Div Ciencias Nat & Exactas, Guanajuato 36050, Gto, Mexico; [Grubb, Sarah; Murdoch, Craig; Thornhill, Martin H.] Univ Sheffield, Sch Clin Dent, Sheffield S102TA, S Yorkshire, England; [Haynes, Ken] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England	Imperial College London; East Tennessee State University; University of Aberdeen; Universidad de Guanajuato; University of Sheffield; University of Exeter	Haynes, K (corresponding author), 325 Geoffrey Pope Bldg,Stocker Rd, Exeter EX4 4QD, Devon, England.	k.haynes@exeter.ac.uk	GOW, Neil/AAS-5323-2021; Montes, Hector Manuel Mora/H-1729-2014	GOW, Neil/0000-0002-2776-5850; Montes, Hector Manuel Mora/0000-0001-6973-0595; Murdoch, Craig/0000-0001-9724-122X; Thornhill, Martin/0000-0003-0681-4083	National Institutes of Health from NIGMS [RO1 GM53522]; Biotechnology and Biological Sciences Research Council [BBF005210]; Wellcome Trust [072420 075174, 080088]; National Institutes of Health from NIAID [R21 A1065549-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI065549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053522] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/F005210/2, BB/F005210/1, BBS/B/10331] Funding Source: researchfish; BBSRC [BB/F005210/2, BB/F005210/1] Funding Source: UKRI	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM53522 from NIGMS (to D. L. W.). This work was also supported by Biotechnology and Biological Sciences Research Council Grant BBF005210 (to the Haynes Laboratory), Wellcome Trust Grants 072420 075174, and Wellcome Trust Grant 080088 (to the Gow Laboratory).; Supported by National Institutes of Health Grant R21 A1065549-01A1 from NIAID (to M. H. T.).	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; BALLOU CE, 1990, METHOD ENZYMOL, V185, P440; BALLOU L, 1980, J BIOL CHEM, V255, P5986; Bates S, 2006, J BIOL CHEM, V281, P90, DOI 10.1074/jbc.M510360200; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Brachmann CB, 1998, YEAST, V14, P115; Calcagno AM, 2005, MED MYCOL, V43, P355, DOI 10.1080/13693780400006088; Calcagno AM, 2004, YEAST, V21, P557, DOI 10.1002/yea.1125; Calcagno AM, 2003, MOL MICROBIOL, V50, P1309, DOI 10.1046/j.1365-2958.2003.03755.x; Castano I, 2005, MOL MICROBIOL, V55, P1246, DOI 10.1111/j.1365-2958.2004.04465.x; CHAPMAN RE, 1994, EMBO J, V13, P4896, DOI 10.1002/j.1460-2075.1994.tb06817.x; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Findon H., 2006, THESIS IMPERIAL COLL; Gale CA, 1998, SCIENCE, V279, P1355, DOI 10.1126/science.279.5355.1355; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glee PM, 2001, INFECT IMMUN, V69, P2815, DOI 10.1128/IAI.69.5.2815-2820.2001; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Grubb SEW, 2009, INFECT IMMUN, V77, P3872, DOI 10.1128/IAI.00518-09; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; HAUSLER A, 1992, GLYCOBIOLOGY, V2, P77, DOI 10.1093/glycob/2.1.77; Herscovics A, 1999, BBA-GEN SUBJECTS, V1426, P275, DOI 10.1016/S0304-4165(98)00129-9; HILL K, 1992, GENETICS, V130, P273; Hobson RP, 2004, J BIOL CHEM, V279, P39628, DOI 10.1074/jbc.M405003200; Jawhara S, 2012, J BIOL CHEM, V287, P11313, DOI 10.1074/jbc.M111.329300; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Jungmann J, 1998, EMBO J, V17, P423, DOI 10.1093/emboj/17.2.423; Jungmann J, 1999, J BIOL CHEM, V274, P6579, DOI 10.1074/jbc.274.10.6579; Kamran M, 2004, EUKARYOT CELL, V3, P546, DOI 10.1128/EC.3.2.546-552.2004; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Kitada K, 1996, GENE, V175, P105, DOI 10.1016/0378-1119(96)00132-1; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; KNAUER R, 1994, FEBS LETT, V344, P83, DOI 10.1016/0014-5793(94)00356-4; Kobayashi H, 1998, ARCH MICROBIOL, V169, P188, DOI 10.1007/s002030050559; Kobayashi H, 2003, ARCH MICROBIOL, V180, P76, DOI 10.1007/s00203-003-0550-7; KOBAYASHI H, 1992, ARCH BIOCHEM BIOPHYS, V294, P662, DOI 10.1016/0003-9861(92)90739-J; KOCOUREK J, 1969, J BACTERIOL, V100, P1175, DOI 10.1128/JB.100.3.1175-1181.1969; KWONCHUNG KJ, 1986, INFECT IMMUN, V51, P218, DOI 10.1128/IAI.51.1.218-223.1986; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Levitz SM, 2006, FEMS YEAST RES, V6, P513, DOI 10.1111/j.1567-1364.2006.00071.x; Lizicarova I, 2007, CARBOHYD POLYM, V70, P89, DOI 10.1016/j.carbpol.2007.03.007; Lussier M, 1997, YEAST, V13, P267, DOI 10.1002/(SICI)1097-0061(19970315)13:3<267::AID-YEA72>3.0.CO;2-K; Lussier M, 1997, J BIOL CHEM, V272, P15527, DOI 10.1074/jbc.272.24.15527; Lussier M, 1996, J BIOL CHEM, V271, P11001, DOI 10.1074/jbc.271.18.11001; Lussier M, 1999, BBA-GEN SUBJECTS, V1426, P323, DOI 10.1016/S0304-4165(98)00133-0; MacCallum DM, 2006, INFECT IMMUN, V74, P5244, DOI 10.1128/IAI.00817-06; Mora-Montes HM, 2010, J BIOL CHEM, V285, P12087, DOI 10.1074/jbc.M109.081513; Mora-Montes HM, 2009, FUTURE MICROBIOL, V4, P1167, DOI 10.2217/FMB.09.88; Mueller A, 2000, GLYCOBIOLOGY, V10, P339, DOI 10.1093/glycob/10.4.339; Munro CA, 2005, J BIOL CHEM, V280, P1051, DOI 10.1074/jbc.M411413200; Murciano C, 2011, INFECT IMMUN, V79, P4902, DOI 10.1128/IAI.05591-11; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; OGAWA T, 1981, CARBOHYD RES, V97, P205, DOI 10.1016/S0008-6215(00)80667-9; Okawa Y, 2006, BIOL PHARM BULL, V29, P187, DOI 10.1248/bpb.29.187; Olson GM, 2007, EUKARYOT CELL, V6, P222, DOI 10.1128/EC.00182-06; Rayner JC, 1998, J BIOL CHEM, V273, P26836, DOI 10.1074/jbc.273.41.26836; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Romani Luigina, 2004, Nat Rev Immunol, V4, P1, DOI 10.1038/nri2939; Romero PA, 1997, BIOCHEM J, V321, P289, DOI 10.1042/bj3210289; Ruan SY, 2008, CLIN MICROBIOL INFEC, V14, P136, DOI 10.1111/j.1469-0691.2007.01892.x; Ruiz-Herrera J, 2006, FEMS YEAST RES, V6, P14, DOI 10.1111/j.1567-1364.2005.00017.x; Shibata N, 2003, EUR J BIOCHEM, V270, P2565, DOI 10.1046/j.1432-1033.2003.03622.x; Shibata N, 2007, BIOCHEM J, V404, P365, DOI 10.1042/BJ20070081; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Stead D, 2005, PROTEOMICS, V5, P1838, DOI 10.1002/pmic.200401064; Stead DA, 2010, PROTEOMICS, V10, P212, DOI 10.1002/pmic.200800706; Takahashi S, 2012, FEBS J, V279, P1844, DOI 10.1111/j.1742-4658.2012.08564.x; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Timpel C, 2000, J BACTERIOL, V182, P3063, DOI 10.1128/JB.182.11.3063-3071.2000; Timpel C, 1998, J BIOL CHEM, V273, P20837, DOI 10.1074/jbc.273.33.20837; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; Weig M, 2001, MICROBIOL-SGM, V147, P2007, DOI 10.1099/00221287-147-8-2007; Willger SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006321; Wisplinghoff H, 2003, PEDIATR INFECT DIS J, V22, P686, DOI 10.1097/01.inf.0000078159.53132.40; YIP CL, 1994, P NATL ACAD SCI USA, V91, P2723, DOI 10.1073/pnas.91.7.2723; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0	85	48	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							22006	10.1074/jbc.M113.478743	http://dx.doi.org/10.1074/jbc.M113.478743			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23720756	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000328841900047
J	Yang, XY; Cheyette, BNR				Yang, XiaoYong; Cheyette, Benjamin N. R.			SEC14 and Spectrin Domains 1 (Sestd1) and Dapper Antagonist of Catenin 1 (Dact1) Scaffold Proteins Cooperatively Regulate the Van Gogh-like 2 (Vangl2) Four-pass Transmembrane Protein and Planar Cell Polarity (PCP) Pathway during Embryonic Development in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL-TUBE DEFECTS; BETA-CATENIN; CONVERGENT EXTENSION; WNT; RHO; MUTATIONS; FRODO; HOMOLOG; CELSR1	The planar cell polarity (PCP) pathway is a conserved non-canonical (beta-catenin-independent) branch of Wnt signaling crucial to embryogenesis, during which it regulates cell polarity and polarized cell movements. Disruption of PCP components in mice, including Vangl2 and Dact1, results in defective neural tube closure and other developmental defects. Here, we show that Sestd1 is a novel binding partner of Vangl2 and Dact1. The Sestd1-Dact1 interface is formed by circumscribed regions of Sestd1 (the carboxyl-terminal region) and Dact1 (the amino-terminal region). Remarkably, we show that loss of Sestd1 precisely phenocopies loss of Dact1 during embryogenesis in mice, leading to a spectrum of birth malformations, including neural tube defects, a shortened and/or curly tail, no genital tubercle, blind-ended colons, hydronephrotic kidneys, and no bladder. Moreover, as with Dact1, a knock-out mutation at the Sestd1 locus exhibits reciprocal genetic rescue interactions during development with a semidominant mutation at the Vangl2 locus. Consistent with this, examination of Wnt pathway activities in Sestd1 mutant mouse embryonic tissue reveals disrupted PCP pathway biochemistry similar to that characterized in Dact1 mutant embryos. The Sestd1 protein is a divergent member of the Trio family of GTPase regulatory proteins that lacks a guanine nucleotide exchange factor domain. Nonetheless, in cell-based assays the Sestd1-Dact1 interaction can induce Rho GTPase activation. Together, our data indicate that Sestd1 cooperates with Dact1 in Vangl2 regulation and in the PCP pathway during mammalian embryonic development.	[Yang, XiaoYong; Cheyette, Benjamin N. R.] Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Cheyette, BNR (corresponding author), Univ Calif San Francisco, MC 2611,Rock Hall,Rm 284D,1550 4th St, San Francisco, CA 94158 USA.	bc@ucsf.edu	Cheyette, Benjamin/K-5535-2014	Cheyette, Benjamin/0000-0001-9934-7941	National Institutes of Health [R01HD055300]; National Institute of Mental Health [T32 MH089920]; Department of Psychiatry and the Center for Neurobiology and Psychiatry; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH089920] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Psychiatry and the Center for Neurobiology and Psychiatry; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HD055300 (to B.N.R.C.) and Grant T32 MH089920 from the National Institute of Mental Health (to X.Y.Y.). This work was also supported by the Department of Psychiatry and the Center for Neurobiology and Psychiatry at the University of California San Francisco.	Barrow JR, 2006, SEMIN CELL DEV BIOL, V17, P185, DOI 10.1016/j.semcdb.2006.04.002; Brott BK, 2005, DEV CELL, V8, P703, DOI 10.1016/j.devcel.2005.02.012; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; De Marco P, 2011, BIOFACTORS, V37, P261, DOI 10.1002/biof.170; Detrait ER, 2005, NEUROTOXICOL TERATOL, V27, P515, DOI 10.1016/j.ntt.2004.12.007; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Gao B, 2012, CURR TOP DEV BIOL, V101, P263, DOI 10.1016/B978-0-12-394592-1.00008-9; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Juriloff DM, 2012, BIRTH DEFECTS RES A, V94, P824, DOI 10.1002/bdra.23079; Kibar Z, 2011, CLIN GENET, V80, P76, DOI 10.1111/j.1399-0004.2010.01515.x; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kivimae S, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-33; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lei Y, 2010, NEW ENGL J MED, V362, P2232, DOI 10.1056/NEJMc0910820; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Meng FW, 2008, J CELL SCI, V121, P2904, DOI 10.1242/jcs.032417; Miehe S, 2010, J BIOL CHEM, V285, P12426, DOI 10.1074/jbc.M109.068304; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Okerlund ND, 2010, J NEUROSCI, V30, P4362, DOI 10.1523/JNEUROSCI.0354-10.2010; Park JI, 2006, DEV CELL, V11, P683, DOI 10.1016/j.devcel.2006.09.022; PAULI RM, 1994, AM J MED GENET, V50, P154, DOI 10.1002/ajmg.1320500206; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Robinson A, 2012, HUM MUTAT, V33, P440, DOI 10.1002/humu.21662; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Sato T, 2003, GENOMICS, V82, P218, DOI 10.1016/S0888-7543(03)00071-5; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; Tada M, 2012, CURR TOP DEV BIOL, V101, P77, DOI 10.1016/B978-0-12-394592-1.00004-1; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; Wen J, 2010, J BIOL CHEM, V285, P11023, DOI 10.1074/jbc.M109.085381; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200	47	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20111	20120		10.1074/jbc.M113.465427	http://dx.doi.org/10.1074/jbc.M113.465427			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23696638	Green Published, hybrid			2022-12-28	WOS:000321715100002
J	Javadi, M; Richmond, TD; Huang, K; Barber, DL				Javadi, Mojib; Richmond, Terri D.; Huang, Kai; Barber, Dwayne L.			CBL Linker Region and RING Finger Mutations Lead to Enhanced Granulocyte-Macrophage Colony-stimulating Factor (GM-CSF) Signaling via Elevated Levels of JAK2 and LYN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; PROTEIN-TYROSINE KINASE; COMMON BETA-SUBUNIT; ACQUIRED UNIPARENTAL DISOMY; ACUTE MYELOID-LEUKEMIA; ACTIVATED T-CELLS; C-CBL; PROTOONCOGENE PRODUCT; GROWTH-FACTOR; FACTOR-RECEPTOR	Juvenile myelomonocytic leukemia (JMML) is characterized by hypersensitivity to granulocyte-macrophage colony-stimulating factor (GM-CSF). SHP2, NF-1, KRAS, and NRAS are mutated in JMML patients, leading to aberrant regulation of RAS signaling. A subset of JMML patients harbor CBL mutations associated with 11q acquired uniparental disomy. Many of these mutations are in the linker region and the RING finger of CBL, leading to a loss of E3 ligase activity. We investigated the mechanism by which CBL-Y371H, a linker region mutant, and CBL-C384R, a RING finger mutant, lead to enhanced GM-CSF signaling. Expression of CBL mutants in the TF-1 cell line resulted in enhanced survival in the absence of GM-CSF. Cells expressing CBL mutations displayed increased phosphorylation of GM-CSF receptor beta c subunit in response to stimulation, although expression of total GM-CSFR beta c was lower. This suggested enhanced kinase activity downstream of GM-CSFR. JAK2 and LYN kinase expression is elevated in CBL-Y371H and CBL-C384R mutant cells, resulting in enhanced phosphorylation of CBL and S6 in response to GM-CSF stimulation. Incubation with the JAK2 inhibitor, TG101348, abolished the increased phosphorylation of GM-CSFR beta c in cells expressing CBL mutants, whereas treatment with the SRC kinase inhibitor dasatinib resulted in equalization of GM-CSFR beta c phosphorylation signal between wild type CBL and CBL mutant samples. Dasatinib treatment inhibited the elevated phosphorylation of CBL-Y371H and CBL-C384R mutants. Our study indicates that CBL linker and RING finger mutants lead to enhanced GM-CSF signaling due to elevated kinase expression, which can be blocked using small molecule inhibitors targeting specific downstream pathways.	[Javadi, Mojib; Richmond, Terri D.; Barber, Dwayne L.] Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 2M9, Canada; [Javadi, Mojib; Richmond, Terri D.; Huang, Kai; Barber, Dwayne L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Barber, Dwayne L.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Barber, DL (corresponding author), Ontario Canc Inst, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	dbarber@uhnres.utoronto.ca		Barber, Dwayne/0000-0001-5528-8150	Canadian Institutes of Health Research Grant FRN [42428]	Canadian Institutes of Health Research Grant FRN(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant FRN#42428.	Anderson SM, 1997, J BIOL CHEM, V272, P739, DOI 10.1074/jbc.272.2.739; Andoniou CE, 2000, MOL CELL BIOL, V20, P851, DOI 10.1128/MCB.20.3.851-867.2000; Andoniou CE, 1996, ONCOGENE, V12, P1981; Barber DL, 1997, BLOOD, V89, P3166, DOI 10.1182/blood.V89.9.3166; Barreda DR, 2004, DEV COMP IMMUNOL, V28, P509, DOI 10.1016/j.dci.2003.09.010; Bhattacharyya SP, 2001, IMMUNOL LETT, V75, P131, DOI 10.1016/S0165-2478(00)00289-3; BRIZZI MF, 1994, J BIOL CHEM, V269, P31680; Chan RJ, 2009, LEUKEMIA RES, V33, P355, DOI 10.1016/j.leukres.2008.08.022; COREY S, 1993, EMBO J, V12, P2681, DOI 10.1002/j.1460-2075.1993.tb05929.x; DombroskyFerlan PM, 1997, ONCOGENE, V14, P2019, DOI 10.1038/sj.onc.1201031; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P184, DOI 10.1038/nsmb.2231; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Emanuel PD, 2008, LEUKEMIA, V22, P1335, DOI 10.1038/leu.2008.162; EMANUEL PD, 1991, BLOOD, V77, P925; Fernandes MS, 2010, J BIOL CHEM, V285, P32596, DOI 10.1074/jbc.M110.106161; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; Flotho C, 1999, LEUKEMIA, V13, P32, DOI 10.1038/sj.leu.2401240; FUKAZAWA T, 1995, J BIOL CHEM, V270, P19141, DOI 10.1074/jbc.270.32.19141; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Grishin A, 2000, ONCOGENE, V19, P97, DOI 10.1038/sj.onc.1203254; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; HAYASHIDA K, 1990, P NATL ACAD SCI USA, V87, P9655, DOI 10.1073/pnas.87.24.9655; Hercus TR, 2012, GROWTH FACTORS, V30, P63, DOI 10.3109/08977194.2011.649919; Itoh T, 1998, MOL CELL BIOL, V18, P742, DOI 10.1128/MCB.18.2.742; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kaabeche K, 2004, J BIOL CHEM, V279, P36259, DOI 10.1074/jbc.M402469200; KALRA R, 1994, BLOOD, V84, P3435; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kotecha N, 2008, CANCER CELL, V14, P335, DOI 10.1016/j.ccr.2008.08.014; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Kyo S, 2003, GENES CELLS, V8, P825, DOI 10.1046/j.1365-2443.2003.00679.x; Lei JT, 2011, J BIOL CHEM, V286, P40091, DOI 10.1074/jbc.M111.273482; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LI Y, 1995, J IMMUNOL, V155, P2165; Liu YC, 1997, J BIOL CHEM, V272, P168; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; Marengere LEM, 1997, J IMMUNOL, V159, P70; Martinez-Moczygemba M, 2001, J CLIN INVEST, V108, P1797, DOI 10.1172/JCI200113877; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; Meng FY, 1998, EMBO J, V17, P4391, DOI 10.1093/emboj/17.15.4391; MIYAUCHI J, 1994, BLOOD, V83, P2248; Muramatsu H, 2010, BLOOD, V115, P1969, DOI 10.1182/blood-2009-06-226340; Muto A, 1995, J ALLERGY CLIN IMMUN, V96, P1100, DOI 10.1016/S0091-6749(95)70195-8; Naccache PH, 1997, J LEUKOCYTE BIOL, V62, P901, DOI 10.1002/jlb.62.6.901; Nagao T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027397; Naramura M, 2010, P NATL ACAD SCI USA, V107, P16274, DOI 10.1073/pnas.1007575107; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Nishizumi H, 1998, J EXP MED, V187, P1343, DOI 10.1084/jem.187.8.1343; NOGUCHI T, 1994, MOL CELL BIOL, V14, P6674, DOI 10.1128/MCB.14.10.6674; ODAI H, 1995, J BIOL CHEM, V270, P10800, DOI 10.1074/jbc.270.18.10800; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; PARK LS, 1992, P NATL ACAD SCI USA, V89, P4295, DOI 10.1073/pnas.89.10.4295; Perugini M, 2010, BLOOD, V115, P3346, DOI 10.1182/blood-2009-08-235846; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Rathinam C, 2010, CANCER CELL, V18, P341, DOI 10.1016/j.ccr.2010.09.008; Reedquist KA, 1996, J BIOL CHEM, V271, P8435, DOI 10.1074/jbc.271.14.8435; Reindl C, 2009, CLIN CANCER RES, V15, P2238, DOI 10.1158/1078-0432.CCR-08-1325; SAKAMAKI K, 1992, EMBO J, V11, P3541, DOI 10.1002/j.1460-2075.1992.tb05437.x; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Sargin B, 2007, BLOOD, V110, P1004, DOI 10.1182/blood-2007-01-066076; Saur SJ, 2010, BLOOD, V115, P1254, DOI 10.1182/blood-2009-06-227033; Sawasdikosol S, 1996, J IMMUNOL, V157, P110; Shi ZQ, 2000, MOL CELL BIOL, V20, P1526, DOI 10.1128/MCB.20.5.1526-1536.2000; Side L, 1997, NEW ENGL J MED, V336, P1713, DOI 10.1056/NEJM199706123362404; Side LE, 1998, BLOOD, V92, P267, DOI 10.1182/blood.V92.1.267.413a31_267_272; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tezuka T, 1996, J EXP MED, V183, P675, DOI 10.1084/jem.183.2.675; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thien CBF, 2005, EMBO J, V24, P3807, DOI 10.1038/sj.emboj.7600841; Tsygankov AY, 2001, ONCOGENE, V20, P6382, DOI 10.1038/sj.onc.1204781; Uddin S, 1996, BIOCHEM BIOPH RES CO, V225, P833, DOI 10.1006/bbrc.1996.1259; Wang L, 2002, ONCOGENE, V21, P5346, DOI 10.1038/sj.onc.1205670; Watanabe S, 1996, J ALLERGY CLIN IMMUN, V98, pS183, DOI 10.1016/S0091-6749(96)70065-9; Wei S, 1996, J IMMUNOL, V157, P5155; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Yousefi S, 1996, J EXP MED, V183, P1407, DOI 10.1084/jem.183.4.1407	82	20	20	3	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19459	19470		10.1074/jbc.M113.475087	http://dx.doi.org/10.1074/jbc.M113.475087			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696637	hybrid, Green Published			2022-12-28	WOS:000321515800014
J	Westfall, CS; Muehler, AM; Jez, JM				Westfall, Corey S.; Muehler, Ashley M.; Jez, Joseph M.			Enzyme Action in the Regulation of Plant Hormone Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACID CARBOXYL METHYLTRANSFERASE; CONJUGATES AMINO-ACIDS; BOX PROTEIN TIR1; SALICYLIC-ACID; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; GH3 FAMILY; CYTOKININ BIOSYNTHESIS; INDOLE-3-ACETIC ACIDS; AUXIN BIOSYNTHESIS	Plants synthesize a chemically diverse range of hormones that regulate growth, development, and responses to environmental stresses. The major classes of plant hormones are specialized metabolites with exquisitely tailored perception and signaling systems, but equally important are the enzymes that control the dose and exposure to the bioactive forms of these molecules. Here, we review new insights into the role of enzyme families, including the SABATH methyltransferases, the methylesterases, the GH3 acyl acid-amido synthetases, and the hormone peptidyl hydrolases, in controlling the biosynthesis and modifications of plant hormones and how these enzymes contribute to the network of chemical signals responsible for plant growth, development, and environmental adaptation.	[Westfall, Corey S.; Muehler, Ashley M.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu			National Science Foundation [MCB-1157771]; Div Of Molecular and Cellular Bioscience [1157771] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation Grant MCB-1157771.	An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Bajguz A, 2009, PHYTOCHEMISTRY, V70, P957, DOI 10.1016/j.phytochem.2009.05.006; BARTEL B, 1995, SCIENCE, V268, P1745, DOI 10.1126/science.7792599; Bitto E, 2009, PROTEINS, V74, P61, DOI 10.1002/prot.22124; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Chen F, 2003, PLANT J, V36, P577, DOI 10.1046/j.1365-313X.2003.01902.x; Chen QF, 2010, J BIOL CHEM, V285, P29780, DOI 10.1074/jbc.M110.146431; Chen QF, 2009, ANAL BIOCHEM, V390, P149, DOI 10.1016/j.ab.2009.04.027; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Christ B, 2012, PLANT PHYSIOL, V158, P628, DOI 10.1104/pp.111.188870; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; Daviere JM, 2013, DEVELOPMENT, V140, P1147, DOI 10.1242/dev.087650; Davies RT, 1999, PLANT CELL, V11, P365, DOI 10.1105/tpc.11.3.365; DEMOLE E, 1962, HELV CHIM ACTA, V45, P675, DOI 10.1002/hlca.19620450233; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Forouhar F, 2005, P NATL ACAD SCI USA, V102, P1773, DOI 10.1073/pnas.0409227102; Frebort I, 2011, J EXP BOT, V62, P2431, DOI 10.1093/jxb/err004; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Fujioka S, 2003, ANNU REV PLANT BIOL, V54, P137, DOI 10.1146/annurev.arplant.54.031902.134921; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; HAGEN G, 1985, MOL CELL BIOL, V5, P1197, DOI 10.1128/MCB.5.6.1197; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245; Humphrey AJ, 2006, PHYTOCHEMISTRY, V67, P636, DOI 10.1016/j.phytochem.2005.12.026; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; Khan S, 2007, PLANTA, V226, P21, DOI 10.1007/s00425-006-0462-2; Koo AJK, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00019; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Kumar D, 2003, P NATL ACAD SCI USA, V100, P16101, DOI 10.1073/pnas.0307162100; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; LEE HI, 1995, P NATL ACAD SCI USA, V92, P4076, DOI 10.1073/pnas.92.10.4076; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; McCarthy AA, 2007, PLANT PHYSIOL, V144, P879, DOI 10.1104/pp.106.094854; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Okrent RA, 2011, PLANT MOL BIOL, V76, P489, DOI 10.1007/s11103-011-9776-y; Okrent RA, 2009, J BIOL CHEM, V284, P9742, DOI 10.1074/jbc.M806662200; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peat TS, 2012, PLANT CELL, V24, P4525, DOI 10.1105/tpc.112.102921; Piotrowska A, 2011, PHYTOCHEMISTRY, V72, P2097, DOI 10.1016/j.phytochem.2011.08.012; Pott MB, 2004, PLANT PHYSIOL, V135, P1946, DOI 10.1104/pp.104.041806; Qin GJ, 2005, PLANT CELL, V17, P2693, DOI 10.1105/tpc.105.034959; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ruyter-Spira C, 2013, TRENDS PLANT SCI, V18, P72, DOI 10.1016/j.tplants.2012.10.003; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Seo HS, 2001, P NATL ACAD SCI USA, V98, P4788, DOI 10.1073/pnas.081557298; SERINO L, 1995, MOL GEN GENET, V249, P217, DOI 10.1007/BF00290369; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; SILVERMAN P, 1995, PLANT PHYSIOL, V108, P633, DOI 10.1104/pp.108.2.633; Staswick PE, 2009, PLANT PHYSIOL, V150, P1310, DOI 10.1104/pp.109.138529; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stirnberg P, 2007, PLANT J, V50, P80, DOI 10.1111/j.1365-313X.2007.03032.x; Takase T, 2004, PLANT J, V37, P471, DOI 10.1046/j.1365-313X.2003.01973.x; Tanaka M, 2006, PLANT J, V45, P1028, DOI 10.1111/j.1365-313X.2006.02656.x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Varbanova M, 2007, PLANT CELL, V19, P32, DOI 10.1105/tpc.106.044602; Vlot AC, 2008, PLANT J, V56, P445, DOI 10.1111/j.1365-313X.2008.03618.x; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wasternack C, 2010, ACS CHEM BIOL, V5, P63, DOI 10.1021/cb900269u; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Went F., 1926, P K NED AKAD WETENSC, V30, P10; Westfall CS, 2012, SCIENCE, V336, P1708, DOI 10.1126/science.1221863; Westfall CS, 2010, PLANT SIGNAL BEHAV, V5, P1607, DOI 10.4161/psb.5.12.13941; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008; YALPANI N, 1993, PLANT PHYSIOL, V103, P315, DOI 10.1104/pp.103.2.315; YALPANI N, 1991, PLANT CELL, V3, P809, DOI 10.1105/tpc.3.8.809; Yang Y, 2008, PLANT PHYSIOL, V147, P1034, DOI 10.1104/pp.108.118224; Zhang SW, 2009, PLANT PHYSIOL, V151, P1889, DOI 10.1104/pp.109.146803; Zhao N, 2008, PLANT PHYSIOL, V146, P455, DOI 10.1104/pp.107.110049; Zhao N, 2012, PHYTOCHEMISTRY, V81, P31, DOI 10.1016/j.phytochem.2012.06.011; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042; Zhu JY, 2013, DEVELOPMENT, V140, P1615, DOI 10.1242/dev.060590; Zubieta C, 2003, PLANT CELL, V15, P1704, DOI 10.1105/tpc.014548	99	51	53	1	60	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19304	19311		10.1074/jbc.R113.475160	http://dx.doi.org/10.1074/jbc.R113.475160			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23709222	Green Published, hybrid			2022-12-28	WOS:000321515800001
J	Yu, HJ; Rathore, SS; Shen, JS				Yu, Haijia; Rathore, Shailendra S.; Shen, Jingshi			Synip Arrests Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (SNARE)-dependent Membrane Fusion as a Selective Target Membrane SNARE-binding Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; COMPLEX; EXOCYTOSIS; MUNC18C; MECHANISMS; SECRETION; PHOSPHORYLATION; RECONSTITUTION; IDENTIFICATION; TRAFFICKING	The vesicle fusion reaction in regulated exocytosis requires the concerted action of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) core fusion engine and a group of SNARE-binding regulatory factors. The regulatory mechanisms of vesicle fusion remain poorly understood in most exocytic pathways. Here, we reconstituted the SNARE-dependent vesicle fusion reaction of GLUT4 exocytosis in vitro using purified components. Using this defined fusion system, we discovered that the regulatory factor synip binds to GLUT4 exocytic SNAREs and inhibits the docking, lipid mixing, and content mixing of the fusion reaction. Synip arrests fusion by binding the target membrane SNARE (t-SNARE) complex and preventing the initiation of ternary SNARE complex assembly. Although synip also interacts with the syntaxin-4 monomer, it does not inhibit the pairing of syntaxin-4 with SNAP-23. Interestingly, synip selectively arrests the fusion reactions reconstituted with its cognate SNAREs, suggesting that the defined system recapitulates the biological functions of the vesicle fusion proteins. We further showed that the inhibitory function of synip is dominant over the stimulatory activity of Sec1/Munc18 proteins. Importantly, the inhibitory function of synip is distinct from how other fusion inhibitors arrest SNARE-dependent membrane fusion and therefore likely represents a novel regulatory mechanism of vesicle fusion.	[Yu, Haijia; Rathore, Shailendra S.; Shen, Jingshi] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Shen, JS (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	jingshi.shen@colorado.edu	Yu, Haijia/GXV-5159-2022	Yu, Haijia/0000-0002-7193-8034; YU, HAIJIA/0000-0002-3049-7850; SHEN, JINGSHI/0000-0001-9595-1148	National Institutes of Health [DK080080, DK095367]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK080080, R56DK095367, R01DK095367, R00DK080080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Pathway to Independence Award DK080080 and Grant DK095367 (to J. S.).	Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Blot V, 2008, MOL BIOL CELL, V19, P3477, DOI 10.1091/mbc.E08-03-0236; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Brandie FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004074; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Burgoyne RD, 2007, CURR BIOL, V17, pR255, DOI 10.1016/j.cub.2007.02.006; Burgoyne RD, 2009, ANN NY ACAD SCI, V1152, P76, DOI 10.1111/j.1749-6632.2008.03987.x; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; CHARRON MJ, 1989, P NATL ACAD SCI USA, V86, P2535, DOI 10.1073/pnas.86.8.2535; D'Andrea-Merrins M, 2007, J BIOL CHEM, V282, P16553, DOI 10.1074/jbc.M610818200; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; Jewell JL, 2011, J CELL BIOL, V193, P185, DOI 10.1083/jcb.201007176; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kramer L, 2011, MOL BIOL CELL, V22, P2601, DOI 10.1091/mbc.E11-02-0104; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; LAVAN BE, 1994, BIOCHEM SOC T, V22, P676, DOI 10.1042/bst0220676; Lizunov VA, 2012, AM J PHYSIOL-ENDOC M, V302, pE950, DOI 10.1152/ajpendo.00466.2011; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Rowland AF, 2011, TRAFFIC, V12, P672, DOI 10.1111/j.1600-0854.2011.01178.x; Saito T, 2003, J BIOL CHEM, V278, P36718, DOI 10.1074/jbc.M305114200; Sano H, 2005, BIOCHEM BIOPH RES CO, V332, P880, DOI 10.1016/j.bbrc.2005.05.027; Schekman R., 2004, CELL, V116, pS13, DOI [10.1016/s0092-8674(03)00972-3, DOI 10.1016/S0092-8674(03)00972-3]; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Scott BL, 2003, METHOD ENZYMOL, V372, P274; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Shi L, 2012, SCIENCE, V335, P1355, DOI 10.1126/science.1214984; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Vicogne J, 2006, P NATL ACAD SCI USA, V103, P14761, DOI 10.1073/pnas.0606881103; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yamada E., 2005, J CELL BIOL; Yu HJ, 2013, MOL BIOL CELL, V24, P1176, DOI 10.1091/mbc.E12-11-0810	62	15	15	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18885	18893		10.1074/jbc.M113.465450	http://dx.doi.org/10.1074/jbc.M113.465450			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23665562	hybrid, Green Published			2022-12-28	WOS:000321335800026
J	Modi, KK; Sendtner, M; Pahan, K				Modi, Khushbu K.; Sendtner, Michael; Pahan, Kalipada			Up-regulation of Ciliary Neurotrophic Factor in Astrocytes by Aspirin IMPLICATIONS FOR REMYELINATION IN MULTIPLE SCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; LIPID-LOWERING DRUG; NEUTRAL SPHINGOMYELINASE; CNTF; DISEASE; CELLS; GEMFIBROZIL; NEURONS; KINASE; CAMP	Ciliary neurotrophic factor (CNTF) is a promyelinating trophic factor, and the mechanisms by which CNTF expression could be increased in the brain are poorly understood. Acetylsalicylic acid (aspirin) is one of the most widely used analgesics. Interestingly, aspirin increased mRNA and protein expression of CNTF in primary mouse and human astrocytes in a dose- and time-dependent manner. Aspirin induced the activation of protein kinase A (PKA) but not protein kinase C (PKC). H-89, an inhibitor of PKA, abrogated aspirin-induced expression of CNTF. The activation of cAMP-response element-binding protein (CREB), but not NF-kappa B, by aspirin, the abrogation of aspirin-induced expression of CNTF by siRNA knockdown of CREB, the presence of a consensus cAMP-response element in the promoter of CNTF, and the recruitment of CREB and CREB-binding protein to the CNTF promoter by aspirin suggest that aspirin increases the expression of the Cntf gene via the activation of CREB. Furthermore, we demonstrate that aspirin-induced astroglial CNTF was also functionally active and that supernatants of aspirin-treated astrocytes of wild type, but not Cntf null, mice increased myelin-associated proteins in oligodendrocytes and protected oligodendrocytes from TNF-alpha insult. These results highlight a new and novel myelinogenic property of aspirin, which may be of benefit for multiple sclerosis and other demyelinating disorders.	[Modi, Khushbu K.; Pahan, Kalipada] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Sendtner, Michael] Univ Wurzburg, Inst Clin Neurobiol, D-97078 Wurzburg, Germany; [Pahan, Kalipada] Jesse Brown Vet Affairs Med Ctr, Div Res & Dev, Chicago, IL 60612 USA	Rush University; University of Wurzburg; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Pahan, K (corresponding author), Rush Univ, Med Ctr, Dept Neurol Sci, 1735 West Harrison St,Ste Cohn 320, Chicago, IL 60612 USA.	Kalipada_Pahan@rush.edu	Sendtner, Michael/J-1542-2012; Sendtner, Michael/M-8137-2014	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974	National Institutes of Health [AT6681]; Veteran Affairs Merit Award [I01BX002174]; National Center for Complementary & Integrative Health [R01AT006681] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran Affairs Merit Award; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant AT6681. This work was also supported by Veteran Affairs Merit Award I01BX002174.	Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696; Aubin N, 1998, J NEUROCHEM, V71, P1635, DOI 10.1046/j.1471-4159.1998.71041635.x; Bae MK, 2006, BBA-MOL CELL RES, V1763, P282, DOI 10.1016/j.bbamcr.2006.01.005; BARRES BA, 1993, DEVELOPMENT, V118, P283; Brahmachari S, 2006, J NEUROSCI, V26, P4930, DOI 10.1523/JNEUROSCI.5480-05.2006; Brahmachari S, 2009, J IMMUNOL, V183, P5917, DOI 10.4049/jimmunol.0803336; BUDD JS, 1993, J ROY SOC MED, V86, P261; Corbett GT, 2012, J IMMUNOL, V189, P1002, DOI 10.4049/jimmunol.1102624; Dhaunchak AS, 2011, J NEUROSCI, V31, P14961, DOI 10.1523/JNEUROSCI.2097-11.2011; Emerich DF, 2006, CURR GENE THER, V6, P147, DOI 10.2174/156652306775515547; Ghosh A, 2012, J BIOL CHEM, V287, P38922, DOI 10.1074/jbc.M112.365148; Ghosh A, 2012, J BIOL CHEM, V287, P27189, DOI 10.1074/jbc.M112.346932; Giess R, 2002, ARCH NEUROL-CHICAGO, V59, P407, DOI 10.1001/archneur.59.3.407; HAFLER DA, 1989, IMMUNOL TODAY, V10, P104, DOI 10.1016/0167-5699(89)90236-3; Ito Y, 2006, P NATL ACAD SCI USA, V103, P7871, DOI 10.1073/pnas.0602332103; Jana A, 2007, J NEUROIMMUNE PHARM, V2, P184, DOI 10.1007/s11481-007-9066-2; Jana A, 2010, J NEUROSCI, V30, P12676, DOI 10.1523/JNEUROSCI.1243-10.2010; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Khasnavis S, 2012, J BIOL CHEM, V287, P29529, DOI 10.1074/jbc.M111.338012; Khasnavis S, 2012, J NEUROIMMUNE PHARM, V7, P424, DOI 10.1007/s11481-011-9286-3; Kuhlmann T, 2006, AM J PATHOL, V169, P584, DOI 10.2353/ajpath.2006.051086; LAUDANNO OM, 1987, AM J MED, V83, P43, DOI 10.1016/0002-9343(87)90850-3; Leung FW, 2008, DIGEST DIS SCI, V53, P2604, DOI 10.1007/s10620-007-0178-6; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Linker RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007624; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Lu ZQ, 2009, J NEUROIMMUNOL, V206, P58, DOI 10.1016/j.jneuroim.2008.10.014; Mao LM, 2007, BRAIN RES BULL, V72, P302, DOI 10.1016/j.brainresbull.2007.01.009; MARTIN R, 1992, ANNU REV IMMUNOL, V10, P153, DOI 10.1146/annurev.iy.10.040192.001101; Pahan K, 2010, J NEUROIMMUNE PHARM, V5, P165, DOI 10.1007/s11481-010-9219-6; Riedel W, 2003, MOL CELL BIOCHEM, V247, P83, DOI 10.1023/A:1024142400835; Stankoff B, 2002, J NEUROSCI, V22, P9221; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; STOCKLI KA, 1991, J CELL BIOL, V115, P447, DOI 10.1083/jcb.115.2.447; TAYLOR SS, 1995, FASEB J, V9, P1255, DOI 10.1096/fasebj.9.13.7557015; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Waltereit R, 2003, MOL NEUROBIOL, V27, P99, DOI 10.1385/MN:27:1:99	37	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18533	18545		10.1074/jbc.M112.447268	http://dx.doi.org/10.1074/jbc.M112.447268			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653362	Green Published, hybrid			2022-12-28	WOS:000320721900054
J	Zebda, N; Tian, YF; Tian, XY; Gawlak, G; Higginbotham, K; Reynolds, AB; Birukova, AA; Birukov, KG				Zebda, Noureddine; Tian, Yufeng; Tian, Xinyong; Gawlak, Grzegorz; Higginbotham, Katherine; Reynolds, Albert B.; Birukova, Anna A.; Birukov, Konstantin G.			Interaction of p190RhoGAP with C-terminal Domain of p120-catenin Modulates Endothelial Cytoskeleton and Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-FAMILY GTPASES; CELL-CELL ADHESION; P120 CATENIN; E-CADHERIN; VE-CADHERIN; OXIDIZED PHOSPHOLIPIDS; BARRIER; PHOSPHORYLATION; ACTIVATION; RAC	p120-catenin is a multidomain intracellular protein, which mediates a number of cellular functions, including stabilization of cell-cell transmembrane cadherin complexes as well as regulation of actin dynamics associated with barrier function, lamellipodia formation, and cell migration via modulation of the activities of small GTPAses. One mechanism involves p120 catenin interaction with Rho GTPase activating protein (p190RhoGAP), leading to p190RhoGAP recruitment to cell periphery and local inhibition of Rho activity. In this study, we have identified a stretch of 23 amino acids within the C-terminal domain of p120 catenin as the minimal sequence responsible for the recruitment of p190RhoGAP (herein referred to as CRAD; catenin-RhoGAP association domain). Expression of the p120-catenin truncated mutant lacking the CRAD in endothelial cells attenuated effects of barrier protective oxidized phospholipid, OxPAPC. This effect was accompanied by inhibition of membrane translocation of p190RhoGAP, increased Rho signaling, as well as suppressed activation of Rac1 and its cytoskeletal effectors PAK1 (p21-activated kinase 1) and cortactin. Expression of p120 catenin-truncated mutant lacking CRAD also delayed the recovery process after thrombin-induced endothelial barrier disruption. Concomitantly, RhoA activation and downstream signaling were sustained for a longer period of time, whereas Rac signaling was inhibited. These data demonstrate a critical role for p120-catenin (amino acids 820-843) domain in the p120-cateninp 190RhoGAP signaling complex assembly, membrane targeting, and stimulation of p190RhoGAP activity toward inhibition of the Rho pathway and reciprocal up-regulation of Rac signaling critical for endothelial barrier regulation.	[Zebda, Noureddine; Tian, Yufeng; Tian, Xinyong; Gawlak, Grzegorz; Higginbotham, Katherine; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, Chicago, IL 60637 USA; [Reynolds, Albert B.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA	University of Chicago; Vanderbilt University	Birukov, KG (corresponding author), Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, 5841 S Maryland Ave,Off N-611, Chicago, IL 60637 USA.	kbirukov@medicine.bsd.uchicago.edu	Birukov, Konstantin/FJB-5755-2022		National Institutes of Health [HL087823, HL076259, HL107920, HL089257, CA05724]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089257, R01HL087823, R56HL107920, R01HL107920, R01HL076259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL087823 and HL076259 (to K. G. B.); HL107920 and HL089257 (to A. A. B.); and CA05724 (to A. B. R.).	Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL612, DOI 10.1152/ajplung.90236.2008; Birukova AA, 2012, J CELL PHYSIOL, V227, P3405, DOI 10.1002/jcp.24041; Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011; Birukova AA, 2011, J CELL PHYSIOL, V226, P2052, DOI 10.1002/jcp.22543; Carnahan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015747; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Daniel JM, 1999, MOL CELL BIOL, V19, P3614; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Gentil-dit-Maurin A, 2010, EXP CELL RES, V316, P2587, DOI 10.1016/j.yexcr.2010.06.015; Grosheva I, 2001, J CELL SCI, V114, P695; Hatanaka K, 2011, AM J PHYSIOL-HEART C, V300, pH162, DOI 10.1152/ajpheart.00650.2010; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Konstantoulaki M, 2003, AM J PHYSIOL-LUNG C, V285, pL434, DOI 10.1152/ajplung.00075.2003; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Oas RG, 2010, CIRC RES, V106, P941, DOI 10.1161/CIRCRESAHA.109.207753; Ozaki C, 2010, CELL STRUCT FUNCT, V35, P81, DOI 10.1247/csf.10009; Peifer M, 2003, J CELL BIOL, V163, P437, DOI 10.1083/jcb.200310090; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Reynolds AB, 2007, BBA-MOL CELL RES, V1773, P2, DOI 10.1016/j.bbamcr.2006.09.019; Smalley-Freed WG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019880; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Starosta V, 2012, AM J RESP CELL MOL, V46, P331, DOI 10.1165/rcmb.2011-0153OC; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Wang YL, 2011, J IMMUNOL, V186, P3180, DOI 10.4049/jimmunol.1001252; Wei J, 2005, MOL CELL, V17, P23, DOI 10.1016/j.molcel.2004.11.024; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Xiao K, 2007, BBA-MOL CELL RES, V1773, P8, DOI 10.1016/j.bbamcr.2006.07.005; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Yanagisawa M, 2006, J CELL BIOL, V174, P1087, DOI 10.1083/jcb.200605022	39	50	51	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18290	18299		10.1074/jbc.M112.432757	http://dx.doi.org/10.1074/jbc.M112.432757			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653363	Green Published, hybrid			2022-12-28	WOS:000320721900033
J	Kubota, S; Fukumoto, Y; Aoyama, K; Ishibashi, K; Yuki, R; Morinaga, T; Honda, T; Yamaguchi, N; Kuga, T; Tomonaga, T; Yamaguchi, N				Kubota, Sho; Fukumoto, Yasunori; Aoyama, Kazumasa; Ishibashi, Kenichi; Yuki, Ryuzaburo; Morinaga, Takao; Honda, Takuya; Yamaguchi, Noritaka; Kuga, Takahisa; Tomonaga, Takeshi; Yamaguchi, Naoto			Phosphorylation of KRAB-associated Protein 1 (KAP1) at Tyr-449, Tyr-458, and Tyr-517 by Nuclear Tyrosine Kinases Inhibits the Association of KAP1 and Heterochromatin Protein 1 alpha (HP1 alpha) with Heterochromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; DOUBLE-STRAND BREAKS; SRC-FAMILY KINASES; HP1 PROTEINS; HISTONE H3; C-SRC; SIGNAL-TRANSDUCTION; IONIZING-RADIATION; GROWTH-FACTOR; HUMAN GENOME	Protein tyrosine phosphorylation regulates a wide range of cellular processes at the plasma membrane. Recently, we showed that nuclear tyrosine phosphorylation by Src family kinases (SFKs) induces chromatin structural changes. In this study, we identify KRAB-associated protein 1 (KAP1/TIF1 beta/TRIM28), a component of heterochromatin, as a nuclear tyrosine-phosphorylated protein. Tyrosine phosphorylation of KAP1 is induced by several tyrosine kinases, such as Src, Lyn, Abl, and Brk. Among SFKs, Src strongly induces tyrosine phosphorylation of KAP1. Nucleus-targeted Lyn potentiates tyrosine phosphorylation of KAP1 compared with intact Lyn, but neither intact Fyn nor nucleus-targeted Fyn phosphorylates KAP1. Substitution of the three tyrosine residues Tyr-449/Tyr-458/Tyr517, located close to the HP1 binding-motif, into phenylalanine ablates tyrosine phosphorylation of KAP1. Immunostaining and chromatin fractionation show that Src and Lyn decrease the association of KAP1 with heterochromatin in a kinase activity-dependent manner. KAP1 knockdown impairs the association of HP1 alpha with heterochromatin, because HP1 alpha associates with KAP1 in heterochromatin. Intriguingly, tyrosine phosphorylation of KAP1 decreases the association of HP1 alpha with heterochromatin, which is inhibited by replacement of endogenous KAP1 with its phenylalanine mutant (KAP1-Y449F/Y458F/Y517F, KAP1-3YF). In DNA damage, KAP1-3YF repressed transcription of p21. These results suggest that nucleus-localized tyrosine kinases, including SFKs, phosphorylate KAP1 at Tyr-449/Tyr-458/Tyr-517 and inhibit the association of KAP1 and HP1 alpha with heterochromatin.	[Kubota, Sho; Fukumoto, Yasunori; Aoyama, Kazumasa; Ishibashi, Kenichi; Yuki, Ryuzaburo; Morinaga, Takao; Honda, Takuya; Yamaguchi, Noritaka; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chuo Ku, Chiba 2608675, Japan; [Kuga, Takahisa; Tomonaga, Takeshi] Natl Inst Biomed Innovat, Lab Proteome Res, Osaka 5670085, Japan	Chiba University; National Institute of Health Sciences - Japan	Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	nyama@faculty.chiba-u.jp	Kuga, Takahisa/AAX-9334-2020	Kubota, Sho/0000-0001-6119-1259; Honda, Takuya/0000-0002-7141-0088	Global Center for Education and Research in Immune Regulation and Treatment (G-COE) Program from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Special Funds for Education and Research (Development of SPECT Probes for Pharmaceutical Innovation) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research [24659622, 24790184] Funding Source: KAKEN	Global Center for Education and Research in Immune Regulation and Treatment (G-COE) Program from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Special Funds for Education and Research (Development of SPECT Probes for Pharmaceutical Innovation) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research, the Global Center for Education and Research in Immune Regulation and Treatment (G-COE) Program, and Special Funds for Education and Research (Development of SPECT Probes for Pharmaceutical Innovation) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Amanchy R, 2009, MOL ONCOL, V3, P439, DOI 10.1016/j.molonc.2009.07.001; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; Baldeyron C, 2011, J CELL BIOL, V193, P81, DOI 10.1083/jcb.201101030; Baskaran R, 1997, NATURE, V387, P516, DOI 10.1038/387516a0; BJORGE JD, 1995, J BIOL CHEM, V270, P24222, DOI 10.1074/jbc.270.41.24222; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Cammas F, 2000, DEVELOPMENT, V127, P2955; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Cans C, 2000, BIOCHEM PHARMACOL, V60, P1203, DOI 10.1016/S0006-2952(00)00434-2; Chang CW, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-61; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Delfino FJ, 2006, BIOCHEM J, V399, P141, DOI 10.1042/BJ20060194; Derry JJ, 2000, MOL CELL BIOL, V20, P6114, DOI 10.1128/MCB.20.16.6114-6126.2000; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Herkert B, 2010, J CELL BIOL, V188, P905, DOI 10.1083/jcb.200908103; Hirao A, 1997, EMBO J, V16, P2342, DOI 10.1093/emboj/16.9.2342; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Iwama A, 1996, EMBO J, V15, P5866, DOI 10.1002/j.1460-2075.1996.tb00973.x; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kharbanda S, 1996, CANCER RES, V56, P3617; Kuga T, 2008, EXP CELL RES, V314, P2040, DOI 10.1016/j.yexcr.2008.03.018; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LAW CL, 1994, J BIOL CHEM, V269, P12310; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Lee DH, 2012, EMBO J, V31, P2403, DOI 10.1038/emboj.2012.86; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mera A, 1999, J BIOL CHEM, V274, P15766, DOI 10.1074/jbc.274.22.15766; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nakayama Y, 2005, EXP CELL RES, V304, P570, DOI 10.1016/j.yexcr.2004.11.027; Nakayama Y, 2006, EXP CELL RES, V312, P2252, DOI 10.1016/j.yexcr.2006.03.021; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Noon AT, 2010, NAT CELL BIOL, V12, P177, DOI 10.1038/ncb2017; Obata Y, 2010, J CELL SCI, V123, P2649, DOI 10.1242/jcs.066266; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Taagepera S, 1998, P NATL ACAD SCI USA, V95, P7457, DOI 10.1073/pnas.95.13.7457; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Tamura T, 2000, INT IMMUNOL, V12, P1205, DOI 10.1093/intimm/12.8.1205; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; White D, 2012, MOL CANCER RES, V10, P401, DOI 10.1158/1541-7786.MCR-11-0134; Yamaguchi N, 2001, J CELL SCI, V114, P1631; YAMANASHI Y, 1987, MOL CELL BIOL, V7, P237, DOI 10.1128/MCB.7.1.237; Zeng W, 2010, EPIGENETICS-US, V5, P287, DOI 10.4161/epi.5.4.11683; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	68	34	36	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17871	17883		10.1074/jbc.M112.437756	http://dx.doi.org/10.1074/jbc.M112.437756			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645696	Green Published, hybrid			2022-12-28	WOS:000320380600075
J	Popova, EY; Grigoryev, SA; Fan, YH; Skoultchi, AI; Zhang, SS; Barnstable, CJ				Popova, Evgenya Y.; Grigoryev, Sergei A.; Fan, Yuhong; Skoultchi, Arthur I.; Zhang, Samuel S.; Barnstable, Colin J.			Developmentally Regulated Linker Histone H1c Promotes Heterochromatin Condensation and Mediates Structural Integrity of Rod Photoreceptors in Mouse Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME REPEAT LENGTH; CHROMATIN-STRUCTURE; GENE-EXPRESSION; MYOGENIC DIFFERENTIATION; VARIANT OVEREXPRESSION; CELL-DIFFERENTIATION; CEREBRAL-CORTEX; ACTIVATION; PROTEINS; REVEALS	Mature rod photoreceptor cells contain very small nuclei with tightly condensed heterochromatin. We observed that during mouse rod maturation, the nucleosomal repeat length increases from 190 bp at postnatal day 1 to 206 bp in the adult retina. At the same time, the total level of linker histone H1 increased reaching the ratio of 1.3 molecules of total H1 per nucleosome, mostly via a dramatic increase in H1c. Genetic elimination of the histone H1c gene is functionally compensated by other histone variants. However, retinas in H1c/H1e/H1(0) triple knock-outs have photoreceptors with bigger nuclei, decreased heterochromatin area, and notable morphological changes suggesting that the process of chromatin condensation and rod cell structural integrity are partly impaired. In triple knock-outs, nuclear chromatin exposed several epigenetic histone modification marks masked in the wild type chromatin. Dramatic changes in exposure of a repressive chromatin mark, H3K9me2, indicate that during development linker histone plays a role in establishing the facultative heterochromatin territory and architecture in the nucleus. During retina development, the H1c gene and its promoter acquired epigenetic patterns typical of rod-specific genes. Our data suggest that histone H1c gene expression is developmentally up-regulated to promote facultative heterochromatin in mature rod photoreceptors.	[Popova, Evgenya Y.; Zhang, Samuel S.; Barnstable, Colin J.] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA; [Grigoryev, Sergei A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Fan, Yuhong] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Fan, Yuhong] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Skoultchi, Arthur I.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Zhang, Samuel S.] Singapore Natl Eye Ctr, Singapore Eye Res Inst, Singapore 168751, Singapore	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Yeshiva University; Albert Einstein College of Medicine; National University of Singapore; Singapore National Eye Center	Zhang, SS (corresponding author), Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA.	ssz3@psu.edu; cbarnstable@hmc.psu.edu	Barnstable, Colin/ABB-4822-2021; Barnstable, Colin/GLU-9219-2022	Barnstable, Colin/0000-0002-7011-4068	National Institutes of Health [EY013865, CA079057, GM085261]; Macula Vision Research Foundation; National Science Foundation Grant [MCB-1021681]; NATIONAL CANCER INSTITUTE [R56CA079057, R01CA079057] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macula Vision Research Foundation; National Science Foundation Grant(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY013865 (to C. J. B.), CA079057 (to A. I. S.), and GM085261 (to Y. F.), a grant from the Macula Vision Research Foundation (to C. J. B.), and National Science Foundation Grant MCB-1021681 (to S. A. G.).	Agarwal N, 2007, NUCLEIC ACIDS RES, V35, P5402, DOI 10.1093/nar/gkm599; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; ATHEY BD, 1990, J CELL BIOL, V111, P795, DOI 10.1083/jcb.111.3.795; BATES DL, 1981, NUCLEIC ACIDS RES, V9, P5883, DOI 10.1093/nar/9.22.5883; BERKOWITZ EM, 1983, J NEUROCHEM, V41, P516, DOI 10.1111/j.1471-4159.1983.tb04769.x; Bhattacharjee RN, 2001, MOL CELL BIOL, V21, P5417, DOI 10.1128/MCB.21.16.5417-5425.2001; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Brown DT, 1996, NUCLEIC ACIDS RES, V24, P486, DOI 10.1093/nar/24.3.486; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2004, METHOD ENZYMOL, V377, P85; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Grigoryev SA, 2006, CHROMOSOME RES, V14, P53, DOI 10.1007/s10577-005-1021-6; Grigoryev SA, 2004, J CELL SCI, V117, P6153, DOI 10.1242/cs.01537; Grigoryev SA, 2012, EXP CELL RES, V318, P1448, DOI 10.1016/j.yexcr.2012.02.014; Gunjan A, 1999, J BIOL CHEM, V274, P37950, DOI 10.1074/jbc.274.53.37950; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Helmlinger D, 2006, PLOS BIOL, V4, P432, DOI 10.1371/journal.pbio.0040067; HUANG HC, 1984, J BIOL CHEM, V259, P4237; Istomina NE, 2003, MOL CELL BIOL, V23, P6455, DOI 10.1128/MCB.23.18.6455-6468.2003; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; JAEGER AW, 1982, EMBO J, V1, P811, DOI 10.1002/j.1460-2075.1982.tb01252.x; Jeno L, 1975, Mikroskopie, V31, P1; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kamieniarz K, 2012, GENE DEV, V26, P797, DOI 10.1101/gad.182014.111; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Kizilyaprak C, 2011, NUCLEUS-AUSTIN, V2, P444, DOI 10.4161/nucl.2.5.17843; Kizilyaprak C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011039; Koop R, 2003, EMBO J, V22, P588, DOI 10.1093/emboj/cdg052; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Li JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002879; Lu XW, 2013, SCIENCE, V340, P78, DOI 10.1126/science.1234654; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Medrzycki M., 2012, J VIS EXP, V19, P3577; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Morrow EM, 1998, TRENDS CELL BIOL, V8, P353, DOI 10.1016/S0962-8924(98)01341-5; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Vicent GP, 2011, GENE DEV, V25, P845, DOI 10.1101/gad.621811; PEARSON EC, 1984, EUR J BIOCHEM, V144, P353, DOI 10.1111/j.1432-1033.1984.tb08471.x; Popova EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046867; Popova EY, 2009, CHROMOSOME RES, V17, P47, DOI 10.1007/s10577-008-9005-y; Popova EY, 2006, EXP HEMATOL, V34, P453, DOI 10.1016/j.exphem.2006.01.003; Rawlings JS, 2011, EMBO J, V30, P263, DOI 10.1038/emboj.2010.314; Sekeri-Pataryas KE, 2007, ANN NY ACAD SCI, V1100, P361, DOI 10.1196/annals.1395.039; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; SIROTKIN AM, 1995, P NATL ACAD SCI USA, V92, P6434, DOI 10.1073/pnas.92.14.6434; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; THOMAS JO, 1977, CELL, V10, P633, DOI 10.1016/0092-8674(77)90096-4; WEINTRAUB H, 1978, NUCLEIC ACIDS RES, V5, P1179, DOI 10.1093/nar/5.4.1179; WEINTRAUB H, 1984, CELL, V38, P17, DOI 10.1016/0092-8674(84)90522-1; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Yellajoshyula D, 2006, P NATL ACAD SCI USA, V103, P18568, DOI 10.1073/pnas.0606478103; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215; Zaret KS, 2008, COLD SH Q B, V73, P119, DOI 10.1101/sqb.2008.73.040; Zhang LB, 2011, GENE DEV, V25, P119, DOI 10.1101/gad.1998711; Zhang SSM, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-48; Zhang SSM, 2004, INVEST OPHTH VIS SCI, V45, P2407, DOI 10.1167/iovs.04-0003; Zhang YZ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002691	69	40	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17895	17907		10.1074/jbc.M113.452144	http://dx.doi.org/10.1074/jbc.M113.452144			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645681	Green Published, hybrid			2022-12-28	WOS:000320380600077
J	Rice, SJ; Lai, SC; Wood, LW; Helsley, KR; Runkle, EA; Winslow, MM; Mu, D				Rice, Shawn J.; Lai, Shao-Chiang; Wood, Lauren W.; Helsley, Kaitlin R.; Runkle, E. Aaron; Winslow, Monte M.; Mu, David			MicroRNA-33a Mediates the Regulation of High Mobility Group AT-Hook 2 Gene (HMGA2) by Thyroid Transcription Factor 1 (TTF-1/NKX2-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG-CANCER; TUMOR-SUPPRESSOR; ADENOCARCINOMA; ONCOGENE; LET-7; CHOLESTEROL; EXPRESSION; TARGET; NKX2-1; DIFFERENTIATION	In lung cancers, TTF-1 displays seemingly paradoxical activities. Although TTF-1 is amplified in primary human lung cancers, it inhibits primary lung tumors from metastasizing in a mouse model system. It was reported that the oncogenic proepithelial mesenchymal transition (EMT) high mobility group AT-hook 2 gene (HMGA2) mediates the antimetastatic function of TTF-1. To gain mechanistic insight into the metastasis-critical signaling axis of TTF-1 to HMGA2, we used both reverse and forward strategies and discovered that microRNA-33a (miR-33a) is under direct positive regulation of TTF-1. By chromatin immunoprecipitation, we determined that TTF-1 binds to the promoter of SREBF2, the host gene of miR-33a. The 3'-untranslated region (UTR) of HMGA2 contains three predicted binding sites of miR-33a. We showed that the first two highly conserved sites are conducive to HMGA2 repression by miR-33a, establishing HMGA2 as a genuine target of miR-33a. Functional studies revealed that enforced expression of miR-33a inhibits the motility of lung cancer cells, and this inhibition can be rescued by overexpression of the form of HMGA2 without the 3'-UTR, suggesting that TTF-1 keeps the prometastasis gene HMGA2 in check via up-regulating miR-33a. This study reports the first miRNAs directly regulated by TTF-1 and clarifies how TTF-1 controls HMGA2 expression. Moreover, the documented importance of SREBF2 and miR-33a in regulating cholesterol metabolism suggests that TTF-1 may be a modulator of cholesterol homeostasis in the lung. Future studies will be dedicated to understanding how miRNAs influence the oncogenic activity of TTF-1 and the role of TTF-1 in cholesterol metabolism.	[Rice, Shawn J.] Penn State Univ, Penn State Canc Inst, Hershey, PA 17033 USA; [Lai, Shao-Chiang; Wood, Lauren W.; Helsley, Kaitlin R.; Mu, David] Eastern Virginia Med Sch, Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA 23501 USA; [Lai, Shao-Chiang; Wood, Lauren W.; Helsley, Kaitlin R.; Mu, David] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Runkle, E. Aaron] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Winslow, Monte M.] Stanford Univ Sch Med, Dept Genet, Stanford, CA 94305 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Eastern Virginia Medical School; Eastern Virginia Medical School; University of Pennsylvania; Stanford University	Mu, D (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Leroy T Canoles Jr Canc Res Ctr, Norfolk, VA 23501 USA.	mud@evms.edu	Mu, David/E-8933-2011	Mu, David/0000-0002-7762-0182	National Institutes of Health, NCI [CA127547]; NATIONAL CANCER INSTITUTE [R01CA127547] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA127547 (to D.M.).	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Antonica F, 2012, NATURE, V491, P66, DOI 10.1038/nature11525; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Boggaram V, 2009, CLIN SCI, V116, P27, DOI 10.1042/CS20080068; Bommer GT, 2011, CELL METAB, V13, P241, DOI 10.1016/j.cmet.2011.02.004; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cirera-Salinas D, 2012, CELL CYCLE, V11, P922, DOI 10.4161/cc.11.5.19421; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; DAMANTE G, 1994, NUCLEIC ACIDS RES, V22, P3075, DOI 10.1093/nar/22.15.3075; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; GUAZZI S, 1990, EMBO J, V9, P3631, DOI 10.1002/j.1460-2075.1990.tb07574.x; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hosono Y, 2012, EMBO J, V31, P481, DOI 10.1038/emboj.2011.416; Hsu DS, 2009, P NATL ACAD SCI USA, V106, P5312, DOI 10.1073/pnas.0900827106; Ibrahim AF, 2011, CANCER RES, V71, P5214, DOI 10.1158/0008-5472.CAN-10-4645; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kuo PL, 2013, BBA-GEN SUBJECTS, V1830, P3756, DOI 10.1016/j.bbagen.2013.02.022; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Lize M, 2010, CELL CYCLE, V9, P4579, DOI 10.4161/cc.9.22.13870; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Maeda Y, 2012, J CLIN INVEST, V122, P4388, DOI 10.1172/JCI64048; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Moore KJ, 2011, ANNU REV NUTR, V31, P49, DOI 10.1146/annurev-nutr-081810-160756; Park SM, 2007, CELL CYCLE, V6, P2585, DOI 10.4161/cc.6.21.4845; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Qi Ji, 2012, Front Med, V6, P134, DOI 10.1007/s11684-012-0188-4; Qi J, 2012, CELL CYCLE, V11, P177, DOI 10.4161/cc.11.1.18576; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; REDDEL RR, 1988, CANCER RES, V48, P1904; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Runkle EA, 2012, J BIOL CHEM, V287, P28790, DOI 10.1074/jbc.M112.367987; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Smith B, 2012, CELL REP, V2, P580, DOI 10.1016/j.celrep.2012.08.011; Snyder EL, 2013, MOL CELL, V50, P185, DOI 10.1016/j.molcel.2013.02.018; Sozzi G, 2011, CELL CYCLE, V10, P2045, DOI 10.4161/cc.10.13.15712; Tanaka H, 2007, CANCER RES, V67, P6007, DOI 10.1158/0008-5472.CAN-06-4774; Thomas M, 2012, ONCOGENE, V31, P918, DOI 10.1038/onc.2011.278; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Watanabe H, 2013, GENE DEV, V27, P197, DOI 10.1101/gad.203208.112; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Wu JJ, 2011, CANCER RES, V71, P349, DOI 10.1158/0008-5472.CAN-10-2550; Yamaguchi T, 2012, CANCER CELL, V21, P348, DOI 10.1016/j.ccr.2012.02.008; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang L, 2007, LEUKEMIA, V21, P868, DOI 10.1038/sj.leu.2404624; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008	61	54	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16348	16360		10.1074/jbc.M113.474643	http://dx.doi.org/10.1074/jbc.M113.474643			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625920	hybrid, Green Published			2022-12-28	WOS:000320378900013
J	Sharma, P; Thakran, S; Deng, X; Elam, MB; Park, EA				Sharma, Pragya; Thakran, Shalini; Deng, Xiong; Elam, Marshall B.; Park, Edwards A.			Nuclear Corepressors Mediate the Repression of Phospholipase A(2) Group IIa Gene Transcription by Thyroid Hormone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; SMOOTH-MUSCLE CELLS; KINASE 4 PDK4; CPT-I-ALPHA; NEGATIVE REGULATION; RECEPTOR COREPRESSOR; DIFFERENTIAL REGULATION; HISTONE DEACETYLASE; RESPONSE ELEMENT; HEPG2 CELLS	Secretory phospholipase A(2) group IIa (PLA2g2a) is associated with inflammation, hyperlipidemia, and atherogenesis. Transcription of the PLA2g2a gene is induced by multiple cytokines. Here, we report the surprising observation that thyroid hormone (T-3) inhibited PLA2g2a gene expression in human and rat hepatocytes as well as in rat liver. Moreover, T-3 reduced the cytokine-mediated induction of PLA2g2a, suggesting that the thyroid status may modulate aspects of the inflammatory response. In an effort to dissect the mechanism of repression by T-3, we cloned the PLA2g2a gene and identified a negative T-3 response element in the promoter. This T-3 receptor (TR beta)-binding site differed considerably from consensus T-3 stimulatory elements. Using in vitro and in vivo binding assays, we found that TR beta bound directly to the PLA2g2a promoter as a heterodimer with the retinoid X receptor. Knockdown of nuclear corepressor or silencing mediator for retinoid and thyroid receptors by siRNA blocked the T-3 inhibition of PLA2g2a. Using chromatin immunoprecipitation assays, we showed that nuclear corepressor and silencing mediator for retinoid and thyroid receptors were associated with the PLA2g2a gene in the presence of T-3. In contrast with the established role of T3 to promote coactivator association with TR beta, our experiments demonstrate a novel inverse recruitment mechanism in which liganded TR beta recruits corepressors to inhibit PLA2g2a expression.	[Sharma, Pragya; Thakran, Shalini; Deng, Xiong; Elam, Marshall B.; Park, Edwards A.] Univ Tennessee Hlth Sci Ctr, Dept Pharmacol, Coll Med, Memphis, TN 38163 USA; [Deng, Xiong; Elam, Marshall B.] Dept Vet Affairs Med Ctr, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center	Park, EA (corresponding author), Univ Tennessee Hlth Sci Ctr, Dept Pharmacol, Coll Med, 874 Union Ave, Memphis, TN 38163 USA.	epark@uthsc.edu			National Institutes of Health [DK0059368, DK075504]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075504, R01DK059368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK0059368 (to E. A. P.) and DK075504 (to M. B. E.).	ADAMSON GM, 1994, J BIOCHEM TOXICOL, V9, P181, DOI 10.1002/jbt.2570090403; Angelin B, 2010, CURR OPIN LIPIDOL, V21, P499, DOI 10.1097/MOL.0b013e3283402e9c; Antonio V, 2002, BIOCHEM J, V368, P415, DOI 10.1042/BJ20020658; Arsenault BJ, 2011, EUR HEART J, V32, P923, DOI 10.1093/eurheartj/ehq385; Attia RR, 2011, J BIOL CHEM, V286, P23799, DOI 10.1074/jbc.M111.246389; Attia RR, 2010, J BIOL CHEM, V285, P2375, DOI 10.1074/jbc.M109.039081; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; Berghagen H, 2002, J BIOL CHEM, V277, P49517, DOI 10.1074/jbc.M209546200; Boone LR, 2011, ATHEROSCLEROSIS, V218, P77, DOI 10.1016/j.atherosclerosis.2011.04.028; Cable EE, 2009, HEPATOLOGY, V49, P407, DOI 10.1002/hep.22572; Cappola AR, 2003, J CLIN ENDOCR METAB, V88, P2438, DOI 10.1210/jc.2003-030398; CHATTERJEE VKK, 1989, P NATL ACAD SCI USA, V86, P9114, DOI 10.1073/pnas.86.23.9114; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Collingwood TN, 1998, EMBO J, V17, P4760, DOI 10.1093/emboj/17.16.4760; Cook GA, 2001, J MOL CELL CARDIOL, V33, P317, DOI 10.1006/jmcc.2000.1304; Couturier C, 2000, ARTERIOSCL THROM VAS, V20, P2559, DOI 10.1161/01.ATV.20.12.2559; CROWL RM, 1991, J BIOL CHEM, V266, P2647; Crunkhorn S, 2008, THYROID, V18, P227, DOI 10.1089/thy.2007.0249; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Exeter HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041139; Fan QS, 1997, MOL CELL BIOL, V17, P4238, DOI 10.1128/MCB.17.8.4238; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Flores-Morales A, 2002, MOL ENDOCRINOL, V16, P1257, DOI 10.1210/me.16.6.1257; Fugier C, 2006, J BIOL CHEM, V281, P11553, DOI 10.1074/jbc.M512554200; Furumoto H, 2005, MOL CELL BIOL, V25, P124, DOI 10.1128/MCB.25.1.124-135.2005; Garces F, 2010, OBESITY, V18, P2023, DOI 10.1038/oby.2010.9; Grass DS, 1996, J CLIN INVEST, V97, P2233, DOI 10.1172/JCI118664; Hashimoto K, 2006, ENDOCRINOLOGY, V147, P4292, DOI 10.1210/en.2006-0116; Huggins KW, 2002, AM J PHYSIOL-ENDOC M, V283, pE994, DOI 10.1152/ajpendo.00110.2002; Hui DY, 2009, BRIT J PHARMACOL, V157, P1263, DOI 10.1111/j.1476-5381.2009.00308.x; Ichiki T, 2010, VASC PHARMACOL, V52, P151, DOI 10.1016/j.vph.2009.09.004; Ikegami T, 2005, HEPATOLOGY, V41, P896, DOI 10.1002/hep.20630; Iyer A, 2012, DIABETES, V61, P2320, DOI 10.2337/db11-1179; Jansen MS, 2000, J BIOL CHEM, V275, P34989, DOI 10.1074/jbc.M001752200; Kim SW, 2005, J BIOL CHEM, V280, P14545, DOI 10.1074/jbc.M411517200; Kvetny J, 2004, CLIN ENDOCRINOL, V61, P232, DOI 10.1111/j.1365-2265.2004.02088.x; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; Leitinger N, 1999, ARTERIOSCL THROM VAS, V19, P1291, DOI 10.1161/01.ATV.19.5.1291; Li QL, 2001, AM J PHYSIOL-ENDOC M, V280, pE160, DOI 10.1152/ajpendo.2001.280.1.E160; Lin JZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052407; Lin KH, 2000, ENDOCRINOLOGY, V141, P2540, DOI 10.1210/en.141.7.2540; Liu YY, 2011, ENDOCRINOLOGY, V152, P1143, DOI 10.1210/en.2010-0580; Marimuthu A, 2002, MOL ENDOCRINOL, V16, P271, DOI 10.1210/me.16.2.271; Massaad C, 2000, J BIOL CHEM, V275, P22686, DOI 10.1074/jbc.M001250200; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Murakami M, 2011, J BIOCHEM, V150, P233, DOI 10.1093/jb/mvr088; Murakami M, 2010, BIOCHIMIE, V92, P561, DOI 10.1016/j.biochi.2010.03.015; Nevalainen TJ, 1996, LAB INVEST, V74, P585; Nygard M, 2003, MOL ENDOCRINOL, V17, P79, DOI 10.1210/me.2002-0107; Nygard M, 2006, J MOL ENDOCRINOL, V36, P517, DOI 10.1677/jme.1.01874; Ortiga-Carvalho TM, 2005, J CLIN INVEST, V115, P2517, DOI 10.1172/JCI24109; Putcha BDK, 2009, J BIOL CHEM, V284, P22517, DOI 10.1074/jbc.M109.026682; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sadana P, 2011, ACS CHEM BIOL, V6, P1096, DOI 10.1021/cb200092v; Santos GM, 2006, MOL PHARMACOL, V70, P793, DOI 10.1124/mol.106.025627; Santos GM, 2011, TRENDS ENDOCRIN MET, V22, P87, DOI 10.1016/j.tem.2010.11.004; Sasaki S, 1999, EMBO J, V18, P5389, DOI 10.1093/emboj/18.19.5389; Shibusawa N, 2003, J BIOL CHEM, V278, P732, DOI 10.1074/jbc.M207264200; Thomas G, 2000, J BIOL CHEM, V275, P10876, DOI 10.1074/jbc.275.15.10876; Villa A, 2004, MOL ENDOCRINOL, V18, P863, DOI 10.1210/me.2003-0260; Walker G, 1997, BRIT J PHARMACOL, V121, P787, DOI 10.1038/sj.bjp.0701170; Wang HC, 1996, FASEB J, V10, P1318, DOI 10.1096/fasebj.10.11.8836046; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Weitzel JM, 2001, NUCLEIC ACIDS RES, V29, P5148, DOI 10.1093/nar/29.24.5148; Weitzel JM, 2008, THYROID RES, V1, DOI 10.1186/1756-6614-1-4; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; You SH, 2010, MOL ENDOCRINOL, V24, P1359, DOI 10.1210/me.2009-0501; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhang Y, 2004, J BIOL CHEM, V279, P53963, DOI 10.1074/jbc.M406028200	71	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16321	16333		10.1074/jbc.M112.445569	http://dx.doi.org/10.1074/jbc.M112.445569			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23629656	Green Published, hybrid			2022-12-28	WOS:000320378900011
J	Chen, DQ; Fang, L; Li, HJ; Tang, MS; Jin, CY				Chen, Danqi; Fang, Lei; Li, Hongjie; Tang, Moon-shong; Jin, Chunyuan			Cigarette Smoke Component Acrolein Modulates Chromatin Assembly by Inhibiting Histone Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cigarette Smoke; Epigenetics; Histone Modification; Nucleosome; Transcription; Acrolein; Chromatin Assembly	LUNG-CANCER; TRANSCRIPTIONAL RESPONSES; MUTATIONAL HOTSPOTS; GENE-EXPRESSION; DNA-DAMAGE; CELL-CYCLE; REPLICATION; VARIANTS; BINDING; ACTIVATION	Chromatin structure and gene expression are both regulated by nucleosome assembly. How environmental factors influence histone nuclear import and the nucleosome assembly pathway, leading to changes in chromatin organization and transcription, remains unknown. Acrolein (Acr) is an ,-unsaturated aldehyde, which is abundant in the environment, especially in cigarette smoke. It has recently been implicated as a potential major carcinogen of smoking-related lung cancer. Here we show that Acr forms adducts with histone proteins in vitro and in vivo and preferentially reacts with free histones rather than with nucleosomal histones. Cellular fractionation analyses reveal that Acr exposure specifically inhibits acetylations of N-terminal tails of cytosolic histones H3 and H4, modifications that are important for nuclear import and chromatin assembly. Notably, Acr exposure compromises the delivery of histone H3 into chromatin and increases chromatin accessibility. Moreover, changes in nucleosome occupancy at several genomic loci are correlated with transcriptional responses to Acr exposure. Our data provide new insights into mechanisms whereby environmental factors interact with the genome and influence genome function.	NYU, Sch Med, Dept Environm Med, New York, NY 10987 USA; NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10987 USA	New York University; New York University	Jin, CY (corresponding author), 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	Chunyuan.jin@nyumc.org	Chen, Danqi/AAP-1269-2020; Jin, Chunyuan/GRX-9623-2022	Fang, Lei/0000-0002-2582-4845	National Institutes of Health, NIEHS, Center of Excellence Pilot Project [5 P30 ES000260-47]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS, Center of Excellence Pilot Project; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NIEHS, Center of Excellence Pilot Project Grant 5 P30 ES000260-47 (to C.J.).	Adkins MW, 2004, J BIOL CHEM, V279, P52069, DOI 10.1074/jbc.M406113200; Aldini G, 2011, MOL NUTR FOOD RES, V55, P1301, DOI 10.1002/mnfr.201100182; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Bein K, 2011, MOL NUTR FOOD RES, V55, P1342, DOI 10.1002/mnfr.201100279; Burcham PC, 2008, MINI-REV MED CHEM, V8, P319, DOI 10.2174/138955708783955953; Burcham PC, 2010, CHEM-BIOL INTERACT, V183, P416, DOI 10.1016/j.cbi.2009.12.006; Burcham PC, 2010, ANTIOXID REDOX SIGN, V12, P337, DOI 10.1089/ars.2009.2817; CHUNG FL, 1984, CANCER RES, V44, P990; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Ejlassi-Lassallette A, 2012, BIOCHEM CELL BIOL, V90, P14, DOI [10.1139/o11-044, 10.1139/O11-044]; Ejlassi-Lassallette A, 2011, MOL BIOL CELL, V22, P245, DOI 10.1091/mbc.E10-07-0633; Faroon O, 2008, TOXICOL IND HEALTH, V24, P447, DOI 10.1177/0748233708094188; Faroon O, 2008, TOXICOL IND HEALTH, V24, P543, DOI 10.1177/0748233708098124; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Gossett AJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002771; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Hecht SS, 2006, P NATL ACAD SCI USA, V103, P15725, DOI 10.1073/pnas.0607811103; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; KIM UJ, 1988, EMBO J, V7, P2211, DOI 10.1002/j.1460-2075.1988.tb03060.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li HJ, 2007, J CLIN INVEST, V117, P1314, DOI 10.1172/JCI31222; Li HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002353; Li Q, 2012, BBA-GENE REGUL MECH, V1819, P238, DOI 10.1016/j.bbagrm.2011.06.013; Loyola A, 2006, MOL CELL, V24, P309, DOI 10.1016/j.molcel.2006.08.019; Lu K, 2008, CHEM RES TOXICOL, V21, P1586, DOI 10.1021/tx8000576; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luo J, 2007, AM J PHYSIOL-HEART C, V293, pH3673, DOI 10.1152/ajpheart.00284.2007; Mercado C, 2007, CURR HYPERTENS REP, V9, P66, DOI 10.1007/s11906-007-0012-8; Ning W, 2004, P NATL ACAD SCI USA, V101, P14895, DOI 10.1073/pnas.0401168101; Polo SE, 2006, CURR OPIN GENET DEV, V16, P104, DOI 10.1016/j.gde.2006.02.011; Singh M, 2010, J ALZHEIMERS DIS, V21, P741, DOI 10.3233/JAD-2010-100405; Sithu SD, 2010, TOXICOL APPL PHARM, V248, P100, DOI 10.1016/j.taap.2010.07.013; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Stevens JF, 2011, MOL NUTR FOOD RES, V55, P1275, DOI 10.1002/mnfr.201190034; Tang MS, 2011, MOL NUTR FOOD RES, V55, P1291, DOI 10.1002/mnfr.201100148; Thompson CA, 2008, TOXICOL IN VITRO, V22, P844, DOI 10.1016/j.tiv.2007.12.018; Thompson CA, 2008, CHEM RES TOXICOL, V21, P2245, DOI 10.1021/tx8001934; Tirumalai R, 2002, TOXICOL LETT, V132, P27, DOI 10.1016/S0378-4274(02)00055-3; Valacchi G, 2005, ANTIOXID REDOX SIGN, V7, P25, DOI 10.1089/ars.2005.7.25; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Wang HT, 2013, CARCINOGENESIS, V34, P220, DOI 10.1093/carcin/bgs323; Wang HT, 2012, J BIOL CHEM, V287, P12379, DOI 10.1074/jbc.M111.329623; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Zhang H, 2012, J BIOL CHEM, V287, P6573, DOI 10.1074/jbc.M111.312637; Zhou X, 2009, TOXICOL APPL PHARM, V236, P78, DOI 10.1016/j.taap.2009.01.009; Zhu Y, 2012, BBA-GENE REGUL MECH, V1819, P343, DOI 10.1016/j.bbagrm.2011.07.012	50	54	56	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21678	21687		10.1074/jbc.M113.476630	http://dx.doi.org/10.1074/jbc.M113.476630			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23770671	Green Published, hybrid			2022-12-28	WOS:000328841900020
J	Fernandez, TF; Samal, AB; Bedwell, GJ; Chen, YB; Saad, JS				Fernandez, Timothy F.; Samal, Alexandra B.; Bedwell, Gregory J.; Chen, Yabing; Saad, Jamil S.			Structural and Biophysical Characterization of the Interactions between the Death Domain of Fas Receptor and Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Calmodulin; Fas; NMR; Surface Plasmon Resonance (SPR); Cholangiocarcinoma	SIZE-DISTRIBUTION ANALYSIS; TARGET RECOGNITION; BINDING DOMAIN; ANALYTICAL ULTRACENTRIFUGATION; CHOLANGIOCARCINOMA CELLS; PEPTIDE INTERACTION; MEDIATED APOPTOSIS; NMR-SPECTROSCOPY; EF-HANDS; COMPLEX	The extrinsic apoptotic pathway is initiated by cell surface death receptors such as Fas. Engagement of Fas by Fas ligand triggers a conformational change that allows Fas to interact with adaptor protein Fas-associated death domain (FADD) via the death domain, which recruits downstream signaling proteins to form the death-inducing signaling complex (DISC). Previous studies have shown that calmodulin (CaM) is recruited into the DISC in cholangiocarcinoma cells, suggesting a novel role of CaM in Fas-mediated signaling. CaM antagonists induce apoptosis through a Fas-related mechanism in cholangiocarcinoma and other cancer cell lines possibly by inhibiting Fas-CaM interactions. The structural determinants of Fas-CaM interaction and the underlying molecular mechanisms of inhibition, however, are unknown. Here we employed NMR and biophysical techniques to elucidate these mechanisms. Our data show that CaM binds to the death domain of Fas (FasDD) with an apparent dissociation constant (K-d) of approximate to 2 m and 2:1 CaM:FasDD stoichiometry. The interactions between FasDD and CaM are endothermic and entropically driven, suggesting that hydrophobic contacts are critical for binding. We also show that both the N- and C-terminal lobes of CaM are important for binding. NMR and surface plasmon resonance data show that three CaM antagonists (N-(6-aminohexyl)-5-chloro-1-naphthalene sulfonamide, tamoxifen, and trifluoperazine) greatly inhibit Fas-CaM interactions by blocking the Fas-binding site on CaM. Our findings provide the first structural evidence for Fas-CaM interactions and mechanism of inhibition and provide new insight into the molecular basis for a novel role of CaM in regulating Fas-mediated apoptosis.	[Fernandez, Timothy F.; Samal, Alexandra B.; Bedwell, Gregory J.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Chen, Yabing] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Chen, Yabing] Birmingham Vet Affairs Med Ctr, Res Dept, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Saad, JS (corresponding author), 845 19th St S, Birmingham, AL 35294 USA.	saad@uab.edu		Saad, Jamil/0000-0001-9503-6484	NCI, National Institutes of Health (NIH) [P30CA13148]; NIH [1S10RR026478]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026478] Funding Source: NIH RePORTER	NCI, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank members of our laboratories and Dr. Jay McDonald (University of Alabama at Birmingham) for helpful discussions. We thank Diego Esposito and Paul Driscoll (Medical Research Council National Institute for Medical Research, United Kingdom) for providing NMR signal assignments of FasDD. We thank the University of Alabama Comprehensive Cancer Center X-ray core facility, funded by NCI, National Institutes of Health (NIH) Grant P30CA13148, which houses the Auto-ITC<INF>200</INF>, acquired through NIH Grant 1S10RR026478.	Ahn EY, 2004, J BIOL CHEM, V279, P5661, DOI 10.1074/jbc.M311040200; Ahn EY, 2003, AM J PATHOL, V163, P2053, DOI 10.1016/S0002-9440(10)63563-8; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Chen YB, 2008, J CELL BIOCHEM, V103, P788, DOI 10.1002/jcb.21447; Chen YB, 2006, AM J PATHOL, V169, P1833, DOI 10.2353/ajpath.2006.060234; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chow JYH, 2010, J MOL BIOL, V400, P702, DOI 10.1016/j.jmb.2010.05.022; COOK WJ, 1994, BIOCHEMISTRY-US, V33, P15259, DOI 10.1021/bi00255a006; Daniel PT, 2001, LEUKEMIA, V15, P1022, DOI 10.1038/sj.leu.2402169; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dewhurst LO, 1997, BRIT J CANCER, V75, P860, DOI 10.1038/bjc.1997.153; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Esposito D, 2010, STRUCTURE, V18, P1378, DOI 10.1016/j.str.2010.08.006; Feldkamp MD, 2010, PROTEINS, V78, P2265, DOI 10.1002/prot.22739; Ferguson BJ, 2007, CELL DEATH DIFFER, V14, P1717, DOI 10.1038/sj.cdd.4402191; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; GIETZEN K, 1982, BIOCHEM J, V207, P541, DOI 10.1042/bj2070541; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Huang BH, 1996, NATURE, V384, P638, DOI 10.1038/384638a0; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; ITO H, 1991, ANTICANCER RES, V11, P249; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jing G, 2012, LAB INVEST, V92, P82, DOI 10.1038/labinvest.2011.131; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; Kretsinger RH, 1996, NAT STRUCT BIOL, V3, P12, DOI 10.1038/nsb0196-12; Lafitte D, 1999, EUR J BIOCHEM, V261, P337, DOI 10.1046/j.1432-1327.1999.00284.x; Larsson G, 2005, BIOPHYS J, V89, P1214, DOI 10.1529/biophysj.104.055780; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Majava V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005402; Marsters SA, 1996, CURR BIOL, V6, P1669, DOI 10.1016/S0960-9822(02)70791-4; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Moorthy AK, 2001, J BIOMOL STRUCT DYN, V19, P47, DOI 10.1080/07391102.2001.10506719; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; Pan G, 1999, AM J PATHOL, V155, P193, DOI 10.1016/S0002-9440(10)65113-9; Park WS, 2001, J PATHOL, V193, P162; Pawar P, 2009, CLIN CANCER RES, V15, P1288, DOI 10.1158/1078-0432.CCR-08-1150; Pawar PS, 2008, BIOCHEM J, V412, P459, DOI 10.1042/BJ20071507; Peter M E, 1999, Results Probl Cell Differ, V23, P25; Que FG, 1999, HEPATOLOGY, V30, P1398, DOI 10.1002/hep.510300618; RASMUSSEN CD, 1992, J PHYSIOL-PARIS, V86, P83, DOI 10.1016/S0928-4257(05)80011-7; Samal AB, 2011, J BIOL CHEM, V286, P33533, DOI 10.1074/jbc.M111.273623; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Soini Y, 1998, AM J PATHOL, V153, P1041, DOI 10.1016/S0002-9440(10)65649-0; Stec B, 2012, FEBS LETT, V586, P1675, DOI 10.1016/j.febslet.2012.04.026; Suever JD, 2008, BIOPHYS J, V95, P5913, DOI 10.1529/biophysj.108.130542; Takakuwa T, 2001, CANCER RES, V61, P1382; VANDONSELAAR M, 1994, NAT STRUCT BIOL, V1, P795, DOI 10.1038/nsb1194-795; Vertessy BG, 1998, BIOCHEMISTRY-US, V37, P15300, DOI 10.1021/bi980795a; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Vickers SM, 2002, ANN SURG, V235, P872, DOI 10.1097/00000658-200206000-00016; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEI JW, 1982, CANCER RES, V42, P2571; WU ZN, 1995, J BIOL CHEM, V270, P16045, DOI 10.1074/jbc.270.27.16045; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yuan KY, 2011, J BIOL CHEM, V286, P24776, DOI 10.1074/jbc.M110.202804; Yuan T, 1998, J BIOL CHEM, V273, P30328, DOI 10.1074/jbc.273.46.30328	68	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21898	10.1074/jbc.M113.471821	http://dx.doi.org/10.1074/jbc.M113.471821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760276	hybrid, Green Published			2022-12-28	WOS:000328841900038
J	Shamas-Din, A; Bindner, S; Zhu, WJ; Zaltsman, Y; Campbell, C; Gross, A; Leber, B; Andrews, DW; Fradin, C				Shamas-Din, Aisha; Bindner, Scott; Zhu, Weijia; Zaltsman, Yehudit; Campbell, Clinton; Gross, Atan; Leber, Brian; Andrews, David W.; Fradin, Cecile			tBid Undergoes Multiple Conformational Changes at the Membrane Required for Bax Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bax; Bcl-2 Proteins; Fluorescence Correlation Spectroscopy; Fluorescence Resonance Energy Transfer (FRET); Protein Conformation; Bid; Mtch2; Fluorescence Spectroscopy; tBid	CYTOCHROME-C RELEASE; HOMOLOG 2 MTCH2; OUTER-MEMBRANE; CELL-DEATH; APOPTOSIS; MITOCHONDRIA; BCL-2; PROTEIN; BINDING; SURFACE	Bid is a Bcl-2 family protein that promotes apoptosis by activating Bax and eliciting mitochondrial outer membrane permeabilization (MOMP). Full-length Bid is cleaved in response to apoptotic stimuli into two fragments, p7 and tBid (p15), that are held together by strong hydrophobic interactions until the complex binds to membranes. The detailed mechanism(s) of fragment separation including tBid binding to membranes and release of the p7 fragment to the cytoplasm remain unclear. Using liposomes or isolated mitochondria with fluorescently labeled proteins at physiological concentrations as in vitro models, we report that the two components of the complex quickly separate upon interaction with a membrane. Once tBid binds to the membrane, it undergoes slow structural rearrangements that result in an equilibrium between two major tBid conformations on the membrane. The conformational change of tBid is a prerequisite for interaction with Bax and is, therefore, a novel step that can be modulated to promote or inhibit MOMP. Using automated high-throughput image analysis in cells, we show that down-regulation of Mtch2 causes a significant delay between tBid and Bax relocalization in cells. We propose that by promoting insertion of tBid via a conformational change at the mitochondrial outer membrane, Mtch2 accelerates tBid-mediated Bax activation and MOMP. Thus the interaction of Mtch2 and tBid is a potential target for therapeutic control of Bid initiated cell death.	[Shamas-Din, Aisha; Bindner, Scott; Zhu, Weijia; Campbell, Clinton; Leber, Brian; Andrews, David W.; Fradin, Cecile] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Leber, Brian] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Zaltsman, Yehudit; Gross, Atan] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Fradin, Cecile] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	McMaster University; McMaster University; Weizmann Institute of Science; McMaster University	Fradin, C (corresponding author), McMaster Univ, Dept Phys & Astron, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8S 4M1, Canada.	fradin@physics.mcmaster.ca	Campbell, Clinton/Z-1986-2019; Fradin, Cécile/D-9302-2011; Gross, Atan/ABC-2640-2020	Campbell, Clinton/0000-0002-8896-1134; Fradin, Cécile/0000-0001-8329-4953; Andrews, David/0000-0002-9266-7157; Leber, Brian/0000-0001-5502-1480	Canadian Institute of Health Research [FRN86657, FRN12517]; Ontario Graduate Scholarship in Science and Technology; Natural Sciences and Engineering Council	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship in Science and Technology; Natural Sciences and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Canadian Institute of Health Research Grants FRN86657 (to C. F.) and FRN12517 (to D. W. A. and B. L.).; Recipient of the Ontario Graduate Scholarship in Science and Technology.; Holds a Canada Research Chair funded by the Natural Sciences and Engineering Council. To whom correspondence should be addressed: Dept. of Biochemistry and Biomedical Sciences, Dept. of Physics and Astronomy, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8S 4M1. Tel.: 905-525-9140 (ext. 23181); Fax: 905-546-1252; E-mail: fradin@physics.mcmaster.ca.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Alder NN, 2008, CELL, V134, P439, DOI 10.1016/j.cell.2008.06.007; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Dlugosz PJ, 2006, EMBO J, V25, P2287, DOI 10.1038/sj.emboj.7601126; Gross A, 1999, J BIOL CHEM, V274, P1156, DOI 10.1074/jbc.274.2.1156; Hamilton NA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-110; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Hu X, 2003, APOPTOSIS, V8, P277, DOI 10.1023/A:1023676906857; Katz C, 2012, J BIOL CHEM, V287, P15016, DOI 10.1074/jbc.M111.328377; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim PK, 2004, MOL CELL, V14, P523, DOI 10.1016/S1097-2765(04)00263-1; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Kvansakul M, 2008, CELL DEATH DIFFER, V15, P1564, DOI 10.1038/cdd.2008.83; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Peng J, 2006, J BIOL CHEM, V281, P35802, DOI 10.1074/jbc.M608303200; Polster BM, 2003, J NEUROSCI, V23, P2735; Robinson AJ, 2012, EXP CELL RES, V318, P1316, DOI 10.1016/j.yexcr.2012.01.026; Satsoura D, 2012, BBA-BIOMEMBRANES, V1818, P384, DOI 10.1016/j.bbamem.2011.10.007; Shamas-Din A., 2013, COLD SPRING HARB PER, V5; Shamas-Din A, 2011, BBA-MOL CELL RES, V1813, P508, DOI 10.1016/j.bbamcr.2010.11.024; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tan KO, 1999, J BIOL CHEM, V274, P23687, DOI 10.1074/jbc.274.34.23687; Veresov VG, 2007, EUR BIOPHYS J BIOPHY, V37, P19, DOI 10.1007/s00249-007-0149-z; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Yamaguchi R, 2007, CELL DEATH DIFFER, V14, P616, DOI 10.1038/sj.cdd.4402035; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zaltsman Y, 2010, NAT CELL BIOL, V12, P553, DOI 10.1038/ncb2057; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761	47	68	72	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22111	22127		10.1074/jbc.M113.482109	http://dx.doi.org/10.1074/jbc.M113.482109			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23744079	hybrid, Green Published			2022-12-28	WOS:000328841900055
J	Ganguly, K; Rejmak, E; Mikosz, M; Nikolaev, E; Knapska, E; Kaczmarek, L				Ganguly, Krishnendu; Rejmak, Emilia; Mikosz, Marta; Nikolaev, Evgeni; Knapska, Ewelina; Kaczmarek, Leszek			Matrix Metalloproteinase (MMP) 9 Transcription in Mouse Brain Induced by Fear Learning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; IV COLLAGENASE GENE; MATRIX-METALLOPROTEINASE-9 GENE; SYNAPTIC PLASTICITY; MOLECULAR-BIOLOGY; C-FOS; EXPRESSION; DYSTROGLYCAN; AP-1; MECHANISM	Memory formation requires learning-based molecular and structural changes in neurons, whereas matrix metalloproteinase (MMP) 9 is involved in the synaptic plasticity by cleaving extracellular matrix proteins and, thus, is associated with learning processes in the mammalian brain. Because the mechanisms of MMP-9 transcription in the brain are poorly understood, this study aimed to elucidate regulation of MMP-9 gene expression in the mouse brain after fear learning. We show here that contextual fear conditioning markedly increases MMP-9 transcription, followed by enhanced enzymatic levels in the three major brain structures implicated in fear learning, i.e. the amygdala, hippocampus, and prefrontal cortex. To reveal the role of AP-1 transcription factor in MMP-9 gene expression, we have used reporter gene constructs with specifically mutated AP-1 gene promoter sites. The constructs were introduced into the medial prefrontal cortex of neonatal mouse pups by electroporation, and the regulation of MMP-9 transcription was studied after contextual fear conditioning in the adult animals. Specifically, -42/-50- and -478/-486-bp AP-1 binding motifs of the mouse MMP-9 promoter sequence have been found to play a major role in MMP-9 gene activation. Furthermore, increases in MMP-9 gene promoter binding by the AP-1 transcription factor proteins c-Fos and c-Jun have been demonstrated in all three brain structures under investigation. Hence, our results suggest that AP-1 acts as a positive regulator of MMP-9 transcription in the brain following fear learning.	[Ganguly, Krishnendu; Rejmak, Emilia; Nikolaev, Evgeni; Kaczmarek, Leszek] Nencki Inst, Neurobiol Lab, PL-02093 Warsaw, Poland; [Mikosz, Marta; Knapska, Ewelina] Nencki Inst, Lab Neurobiol Emot, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Polish Academy of Sciences	Ganguly, K (corresponding author), Nencki Inst, Lab Mol Neurobiol, Pasteur 3, PL-02093 Warsaw, Poland.	k.ganguly@nencki.gov.pl; l.kaczmarek@nencki.gov.pl	Knapska, Ewelina/A-9134-2009; Kaczmarek, Leszek/AHA-0076-2022; Kaczmarek, Leszek/B-6171-2008	Knapska, Ewelina/0000-0001-9319-2176; Kaczmarek, Leszek/0000-0002-7207-3490; Kaczmarek, Leszek/0000-0002-7207-3490; GANGULY, KRISHNENDU/0000-0002-9905-4724; Rejmak-Kozicka, Emilia/0000-0003-0522-5316	Foundation for Polish Science Programmes Homing; TEAM Programs	Foundation for Polish Science Programmes Homing; TEAM Programs	This work was supported by the Foundation for Polish Science Programmes Homing (to K.G.) and TEAM (to L.K.) Programs.	Agrawal S, 2006, J EXP MED, V203, P1007, DOI 10.1084/jem.20051342; Asahi M, 2000, J CEREBR BLOOD F MET, V20, P1681, DOI 10.1097/00004647-200012000-00007; Cavaldesi M, 1999, J NEUROCHEM, V72, P1648, DOI 10.1046/j.1471-4159.1999.721648.x; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Crowe David L., 1999, Neoplasia (New York), V1, P368, DOI 10.1038/sj.neo.7900041; Dean KM, 2012, RNA, V18, P2335, DOI 10.1261/rna.035907.112; Deschamps AM, 2006, CARDIOVASC RES, V69, P666, DOI 10.1016/j.cardiores.2005.10.004; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; Dziembowska M, 2012, J NEUROSCI, V32, P14538, DOI 10.1523/JNEUROSCI.6028-11.2012; Eberhardt W, 2002, MOL ENDOCRINOL, V16, P1752, DOI 10.1210/me.2001-0278; Ganguly K, 2012, BIOCHIMIE, V94, P2687, DOI 10.1016/j.biochi.2012.08.004; Gawlak M, 2009, NEUROSCIENCE, V158, P167, DOI 10.1016/j.neuroscience.2008.05.045; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Himelstein BP, 1998, CLIN EXP METASTAS, V16, P169; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Huntley GW, 2012, NAT REV NEUROSCI, V13, P743, DOI 10.1038/nrn3320; Kaczmarek L, 2002, EMBO J, V21, P6643, DOI 10.1093/emboj/cdf676; KACZMAREK L, 1993, J NEUROSCI RES, V34, P377, DOI 10.1002/jnr.490340402; Kaminska B, 1996, J NEUROSCI, V16, P3968; KIM JJ, 1992, BEHAV NEUROSCI, V106, P591, DOI 10.1037/0735-7044.106.4.591; Knapska E, 2006, P NATL ACAD SCI USA, V103, P3858, DOI 10.1073/pnas.0511302103; Knapska E, 2012, P NATL ACAD SCI USA, V109, P17093, DOI 10.1073/pnas.1202087109; Ma ZD, 2004, MOL CELL BIOL, V24, P5496, DOI 10.1128/MCB.24.12.5496-5509.2004; Magid R, 2003, J BIOL CHEM, V278, P32994, DOI 10.1074/jbc.M304799200; Maren S, 2011, NEURON, V70, P830, DOI 10.1016/j.neuron.2011.04.023; Michaluk P, 2007, J BIOL CHEM, V282, P16036, DOI 10.1074/jbc.M700641200; Moon SK, 2004, ARCH BIOCHEM BIOPHYS, V421, P267, DOI 10.1016/j.abb.2003.11.007; Nagy V, 2006, J NEUROSCI, V26, P1923, DOI 10.1523/JNEUROSCI.4359-05.2006; Nair RR, 2006, J BIOL CHEM, V281, P26424, DOI 10.1074/jbc.M602703200; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Ray A, 2005, J IMMUNOL, V175, P4039, DOI 10.4049/jimmunol.175.6.4039; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Rylski M, 2009, MOL CELL NEUROSCI, V40, P98, DOI 10.1016/j.mcn.2008.09.005; SATO H, 1993, J BIOL CHEM, V268, P23460; SATO H, 1993, ONCOGENE, V8, P395; Sivak JM, 2004, MOL CELL BIOL, V24, P245, DOI 10.1128/MCB.24.1.245-257.2004; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Swartz M, 2001, DEV BIOL, V233, P13, DOI 10.1006/dbio.2001.0181; Taheri F, 2007, INVEST OPHTH VIS SCI, V48, P1931, DOI 10.1167/iovs.06-1008; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Wang XB, 2008, P NATL ACAD SCI USA, V105, P19520, DOI 10.1073/pnas.0807248105; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang JQ, 2001, FREE RADICAL BIO MED, V31, P520, DOI 10.1016/S0891-5849(01)00613-X; Zaccaria ML, 2001, NEUROSCIENCE, V104, P311, DOI 10.1016/S0306-4522(01)00092-6; Zhong D, 2006, BIOCHEM BIOPH RES CO, V345, P867, DOI 10.1016/j.bbrc.2006.05.004	49	60	60	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20978	20991		10.1074/jbc.M113.457903	http://dx.doi.org/10.1074/jbc.M113.457903			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23720741	hybrid, Green Published			2022-12-28	WOS:000322014400020
J	Ortega-Roldan, JL; Ossa, F; Schnell, JR				Ortega-Roldan, Jose Luis; Ossa, Felipe; Schnell, Jason R.			Characterization of the Human Sigma-1 Receptor Chaperone Domain Structure and Binding Immunoglobulin Protein (BiP) Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR GRPE; STEROID-BINDING; BENZODIAZEPINE-RECEPTOR; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; SITE; CHOLESTEROL; EXPRESSION; DYNAMICS; SYSTEM	The sigma-1 receptor (S1R) is a ligand-regulated membrane protein chaperone involved in the ER stress response. S1R activity is implicated in diseases of the central nervous system including amnesia, schizophrenia, depression, Alzheimer disease, and addiction. S1R has been shown previously to regulate the Hsp70 binding immunoglobulin protein (BiP) and the inositol triphosphate receptor calcium channel through a C-terminal domain. We have developed methods for bacterial expression and reconstitution of the chaperone domain of human S1R into detergent micelles that enable its study by solution NMR spectroscopy. The chaperone domain is found to contain a helix at the N terminus followed by a largely dynamic region and a structured, helical C-terminal region that encompasses a membrane associated domain containing four helices. The helical region at residues similar to 198-206 is strongly amphipathic and proposed to anchor the chaperone domain to micelles and membranes. Three of the helices in the C-terminal region closely correspond to previously identified cholesterol and drug recognition sites. In addition, it is shown that the chaperone domain interacts with full-length BiP or the isolated nucleotide binding domain of BiP, but not the substrate binding domain, suggesting that the nucleotide binding domain is sufficient for S1R interactions.	[Ortega-Roldan, Jose Luis; Ossa, Felipe; Schnell, Jason R.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Schnell, JR (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	jason.schnell@bioch.ox.ac.uk	Orega-Roldan, Jose/K-4396-2019; Ossa, Felipe/A-9627-2016	Orega-Roldan, Jose/0000-0002-6316-4390; Ossa, Felipe/0000-0002-3968-6447	Wellcome Trust [094872]; Medical Research Council [MR/K018590/1] Funding Source: researchfish; MRC [MR/K018590/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Herwig Schuler (Karolinska Institutet) for providing expression constructs of human BiP and the Wellcome Trust (Grant 094872) for upgrade of the 600 MHz spectrometer used in the studies.	Berardi MJ, 2011, NATURE, V476, P109, DOI 10.1038/nature10257; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Call ME, 2010, NAT IMMUNOL, V11, P1023, DOI 10.1038/ni.1943; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Chen YM, 2007, BIOCHEMISTRY-US, V46, P3532, DOI 10.1021/bi061727o; Csordas G, 2010, MOL CELL, V39, P121, DOI 10.1016/j.molcel.2010.06.029; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fontanilla D, 2008, BIOCHEMISTRY-US, V47, P7205, DOI 10.1021/bi800564j; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Guitart X, 2004, PSYCHOPHARMACOLOGY, V174, P301, DOI 10.1007/s00213-004-1920-9; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kourrich S, 2013, CELL, V152, P236, DOI 10.1016/j.cell.2012.12.004; Lau TL, 2008, BIOCHEMISTRY-US, V47, P4008, DOI 10.1021/bi800107a; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; Pal A, 2012, EUR J PHARMACOL, V682, P12, DOI 10.1016/j.ejphar.2012.01.030; Pal A, 2008, J BIOL CHEM, V283, P19646, DOI 10.1074/jbc.M802192200; Palmer CP, 2007, CANCER RES, V67, P11166, DOI 10.1158/0008-5472.CAN-07-1771; Ramachandran S, 2009, EUR J PHARMACOL, V609, P19, DOI 10.1016/j.ejphar.2009.03.003; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Seth P, 2001, BBA-MOL CELL RES, V1540, P59, DOI 10.1016/S0167-4889(01)00117-3; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sherratt AR, 2009, BBA-BIOMEMBRANES, V1788, P2444, DOI 10.1016/j.bbamem.2009.09.003; Shioda N, 2012, J BIOL CHEM, V287, P23318, DOI 10.1074/jbc.M112.349142; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Stefanski R, 2004, PSYCHOPHARMACOLOGY, V175, P68, DOI 10.1007/s00213-004-1779-9; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Suzuki M, 2007, NAT PROTOC, V2, P1802, DOI 10.1038/nprot.2007.252; Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716; Vasudevan SV, 2010, P NATL ACAD SCI USA, V107, P6847, DOI 10.1073/pnas.0911817107; Walter L, 2005, J BIOENERG BIOMEMBR, V37, P191, DOI 10.1007/s10863-005-6600-x; WEISSMAN AD, 1988, J PHARMACOL EXP THER, V247, P29; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Wu CC, 2012, J BIOL CHEM, V287, P21461, DOI 10.1074/jbc.M112.344358; Wu ZP, 2008, J BIOL CHEM, V283, P28198, DOI 10.1074/jbc.M802099200; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028	50	62	65	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21448	21457		10.1074/jbc.M113.450379	http://dx.doi.org/10.1074/jbc.M113.450379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760505	Green Published, hybrid			2022-12-28	WOS:000322014400062
J	Eliscovich, C; Buxbaum, AR; Katz, ZB; Singer, RH				Eliscovich, Carolina; Buxbaum, Adina R.; Katz, Zachary B.; Singer, Robert H.			mRNA on the Move: The Road to Its Biological Destiny	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ZIPCODE-BINDING-PROTEIN; DROSOPHILA HNRNPA/B HOMOLOG; GROWTH CONE GUIDANCE; BETA-ACTIN SYNTHESIS; IN-VIVO; LIVING CELLS; NUCLEOCYTOPLASMIC TRANSPORT; INTRACELLULAR-LOCALIZATION; CYTOPLASMIC LOCALIZATION; DEPENDENT LOCALIZATION	Cells have evolved to regulate the asymmetric distribution of specific mRNA targets to institute spatial and temporal control over gene expression. Over the last few decades, evidence has mounted as to the importance of localization elements in the mRNA sequence and their respective RNA-binding proteins. Live imaging methodologies have shown mechanistic details of this phenomenon. In this minireview, we focus on the advanced biochemical and cell imaging techniques used to tweeze out the finer aspects of mechanisms of mRNA movement.	[Eliscovich, Carolina; Buxbaum, Adina R.; Katz, Zachary B.; Singer, Robert H.] Yeshiva Univ, Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Singer, Robert H.] Yeshiva Univ, Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Singer, RH (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	robert.singer@einstein.yu.edu		buxbaum, adina/0000-0002-3452-5986	National Institutes of Health [T32 GM007491, GM84364, GM57071, GM86217]; Human Frontier Science Program (HFSP) fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086217, R01GM084364, R01GM057071, T32GM007491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program (HFSP) fellowship(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM007491 (to Z.B.K.) and GM84364, GM57071, and GM86217 (to R.H.S.). This work was also supported by a Human Frontier Science Program (HFSP) fellowship (to C.E.).	Becalska AN, 2009, DEVELOPMENT, V136, P2493, DOI 10.1242/dev.032391; Belaya K, 2011, METHODS MOL BIOL, V714, P265, DOI 10.1007/978-1-61779-005-8_17; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Betley JN, 2004, CURR BIOL, V14, P219, DOI 10.1016/j.cub.2004.01.028; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Bullock SL, 2010, NAT STRUCT MOL BIOL, V17, P703, DOI 10.1038/nsmb.1813; Chao JA, 2010, GENE DEV, V24, P148, DOI 10.1101/gad.1862910; Chartrand P, 1999, CURR BIOL, V9, P333, DOI 10.1016/S0960-9822(99)80144-4; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Condeelis J, 2005, BIOL CELL, V97, P97; Czaplinski K, 2005, DEV CELL, V8, P505, DOI 10.1016/j.devcel.2005.01.012; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Dienstbier M, 2009, GENE DEV, V23, P1546, DOI 10.1101/gad.531009; Doyle M, 2011, EMBO J, V30, P3540, DOI 10.1038/emboj.2011.278; Dynes JL, 2012, J COMP NEUROL, V520, P3105, DOI 10.1002/cne.23073; Dynes JL, 2007, J COMP NEUROL, V500, P433, DOI 10.1002/cne.21189; Eom T, 2003, J NEUROSCI, V23, P10433; Estes PS, 2008, MOL CELL NEUROSCI, V39, P170, DOI 10.1016/j.mcn.2008.06.012; Farina KL, 2003, J CELL BIOL, V160, P77, DOI 10.1083/jcb.200206003; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; Gonzalez I, 1999, CURR BIOL, V9, P337, DOI 10.1016/S0960-9822(99)80145-6; Grunwald D, 2011, NATURE, V475, P333, DOI 10.1038/nature10318; Grunwald D, 2008, METHOD ENZYMOL, V448, P553, DOI 10.1016/S0076-6879(08)02627-X; Grunwald D, 2010, NATURE, V467, P604, DOI 10.1038/nature09438; Gu W, 2002, J CELL BIOL, V156, P41, DOI 10.1083/jcb.200105133; Gu W, 2012, J CELL SCI, V125, P81, DOI 10.1242/jcs.086132; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hocine S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000752; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Jambhekar A, 2007, RNA, V13, P625, DOI 10.1261/rna.262607; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; JEFFERY WR, 1983, DEV BIOL, V99, P408, DOI 10.1016/0012-1606(83)90290-7; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Katz ZB, 2012, GENE DEV, V26, P1885, DOI 10.1101/gad.190413.112; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kress TL, 2004, J CELL BIOL, V165, P203, DOI 10.1083/jcb.200309145; Kruse C, 2002, J CELL BIOL, V159, P971, DOI 10.1083/jcb.200207101; LATHAM VM, 1994, J CELL BIOL, V126, P1211, DOI 10.1083/jcb.126.5.1211; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lionnet T, 2011, NAT METHODS, V8, P165, DOI 10.1038/NMETH.1551; Liu-Yesucevitz L, 2011, J NEUROSCI, V31, P16086, DOI 10.1523/JNEUROSCI.4105-11.2011; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Long RM, 2000, EMBO J, V19, P6592, DOI 10.1093/emboj/19.23.6592; Macdonald PM, 1998, MOL CELL BIOL, V18, P3788, DOI 10.1128/MCB.18.7.3788; Marchand V, 2012, CURR OPIN CELL BIOL, V24, P202, DOI 10.1016/j.ceb.2011.12.014; Medioni C, 2012, DEVELOPMENT, V139, P3263, DOI 10.1242/dev.078626; Messitt TJ, 2008, DEV CELL, V15, P426, DOI 10.1016/j.devcel.2008.06.014; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Pan F, 2007, MOL CELL BIOL, V27, P8340, DOI 10.1128/MCB.00972-07; Park HY, 2012, CELL REPORTS, V1, P179, DOI 10.1016/j.celrep.2011.12.009; Patel VL, 2012, GENE DEV, V26, P43, DOI 10.1101/gad.177428.111; Perycz M, 2011, J NEUROSCI, V31, P5271, DOI 10.1523/JNEUROSCI.2387-10.2011; Racca C, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/neuro.04.005.2010; REBAGLIATI MR, 1985, CELL, V42, P769, DOI 10.1016/0092-8674(85)90273-9; Rodriguez-Navarro S, 2011, CURR OPIN CELL BIOL, V23, P302, DOI 10.1016/j.ceb.2010.12.002; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Ryder Sean P., 2008, V488, P99, DOI 10.1007/978-1-60327-475-3_7; Sasaki Y, 2010, J NEUROSCI, V30, P9349, DOI 10.1523/JNEUROSCI.0499-10.2010; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Siebrasse JP, 2012, P NATL ACAD SCI USA, V109, P9426, DOI 10.1073/pnas.1201781109; Siebrasse JP, 2008, P NATL ACAD SCI USA, V105, P20291, DOI 10.1073/pnas.0810692105; SINGER RH, 1982, P NATL ACAD SCI-BIOL, V79, P7331, DOI 10.1073/pnas.79.23.7331; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Stohr N, 2012, GENE DEV, V26, P176, DOI 10.1101/gad.177642.111; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Tolino M, 2012, EUR J NEUROSCI, V35, P1818, DOI 10.1111/j.1460-9568.2012.08160.x; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Weil TT, 2010, TRENDS CELL BIOL, V20, P380, DOI 10.1016/j.tcb.2010.03.006; Welshhans K, 2011, J NEUROSCI, V31, P9800, DOI 10.1523/JNEUROSCI.0166-11.2011; Wu B, 2012, BIOPHYS J, V102, P2936, DOI 10.1016/j.bpj.2012.05.017; Yamagishi M, 2009, BIOCHEM BIOPH RES CO, V390, P750, DOI 10.1016/j.bbrc.2009.10.043; Yamagishi M, 2009, EXP CELL RES, V315, P1142, DOI 10.1016/j.yexcr.2009.02.009; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7; Yao JQ, 2006, NAT NEUROSCI, V9, P1265, DOI 10.1038/nn1773; Yisraeli JK, 2005, BIOL CELL, V97, P87; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zimyanin VL, 2008, CELL, V134, P843, DOI 10.1016/j.cell.2008.06.053	100	49	61	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20361	20368		10.1074/jbc.R113.452094	http://dx.doi.org/10.1074/jbc.R113.452094			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720759	Green Published, hybrid			2022-12-28	WOS:000321715100024
J	Narayanan, A; Iordanskiy, S; Das, R; Van Duyne, R; Santos, S; Jaworski, E; Guendel, I; Sampey, G; Dalby, E; Iglesias-Ussel, M; Popratiloff, A; Hakami, R; Kehn-Hall, K; Young, M; Subra, C; Gilbert, C; Bailey, C; Romerio, F; Kashanchi, F				Narayanan, Aarthi; Iordanskiy, Sergey; Das, Ravi; Van Duyne, Rachel; Santos, Steven; Jaworski, Elizabeth; Guendel, Irene; Sampey, Gavin; Dalby, Elizabeth; Iglesias-Ussel, Maria; Popratiloff, Anastas; Hakami, Ramin; Kehn-Hall, Kylene; Young, Mary; Subra, Caroline; Gilbert, Caroline; Bailey, Charles; Romerio, Fabio; Kashanchi, Fatah			Exosomes Derived from HIV-1-infected Cells Contain Trans-activation Response Element RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICRORNA BIOGENESIS; INFECTED-CELLS; VIRAL MIRNAS; HIV-1; VIRUS; IDENTIFICATION; NEF; INTERFERENCE; VESICLES; COMPLEXES	Exosomes are nano-sized vesicles produced by healthy and virus-infected cells. Exosomes derived from infected cells have been shown to contain viral microRNAs (miRNAs). HIV-1 encodes its own miRNAs that regulate viral and host gene expression. The most abundant HIV-1-derived miRNA, first reported by us and later by others using deep sequencing, is the trans-activation response element (TAR) miRNA. In this study, we demonstrate the presence of TAR RNA in exosomes from cell culture supernatants of HIV-1-infected cells and patient sera. TAR miRNA was not in Ago2 complexes outside the exosomes but enclosed within the exosomes. We detected the host miRNA machinery proteins Dicer and Drosha in exosomes from infected cells. We report that transport of TAR RNA from the nucleus into exosomes is a CRM1 (chromosome region maintenance 1)-dependent active process. Prior exposure of naive cells to exosomes from infected cells increased susceptibility of the recipient cells to HIV-1 infection. Exosomal TAR RNA down-regulated apoptosis by lowering Bim and Cdk9 proteins in recipient cells. We found 10(4)-10(6) copies/ml TAR RNA in exosomes derived from infected culture supernatants and 10(3) copies/ml TAR RNA in the serum exosomes of highly active antiretroviral therapy-treated patients or long term nonprogressors. Taken together, our experiments demonstrated that HIV-1-infected cells produced exosomes that are uniquely characterized by their proteomic and RNA profiles that may contribute to disease pathology in AIDS.	[Narayanan, Aarthi; Iordanskiy, Sergey; Das, Ravi; Van Duyne, Rachel; Jaworski, Elizabeth; Guendel, Irene; Sampey, Gavin; Dalby, Elizabeth; Hakami, Ramin; Kehn-Hall, Kylene; Bailey, Charles; Kashanchi, Fatah] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [Iordanskiy, Sergey; Van Duyne, Rachel; Santos, Steven; Popratiloff, Anastas] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Iglesias-Ussel, Maria; Romerio, Fabio] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Young, Mary] Georgetown Univ, Med Ctr, Washington Metropolitan Womens Interagency HIV St, Div Infect Dis, Washington, DC 20007 USA; [Subra, Caroline; Gilbert, Caroline] Univ Laval, Ctr Hosp Univ Quebec, Res Ctr, Dept Microbiol Infectiol & Immunol,Med Fac, Quebec City, PQ G1R 2J6, Canada	George Mason University; George Washington University; University System of Maryland; University of Maryland Baltimore; Georgetown University; Laval University	Kashanchi, F (corresponding author), George Mason Univ, Natl Ctr Biodef & Infect Dis, Discovery Hall,Rm 182,10900 Univ Blvd,MS 1H8, Manassas, VA 20110 USA.	fkashanc@gmu.edu	Van Duyne, Rachel/I-7365-2019; Van Duyne, Rachel/ABI-2429-2020; Kehn-Hall, Kylene/I-5752-2013	Van Duyne, Rachel/0000-0003-2914-6874; Gilbert, Caroline/0000-0003-2722-1180; Kehn-Hall, Kylene/0000-0001-8036-7213; Das, Ravi/0000-0002-4301-0642; Subra, Caroline/0000-0001-5272-0972	National Institutes of Health [AI078859, AI074410, AI043894]; NCI; NIDA; NIDCD; NCRR UCSF-CTSI [UL1 RR024131]; District of Columbia Developmental Center for AIDS Research Grant [5P30AI087714-02]; United States Department of Energy [DE-SC0001599]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI087714, R21AI078859, U01AI034989, U01AI031834, U01AI034993, U01AI035004, U01AI042590, R01AI043894, R21AI074410, U01AI034994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS099029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCRR UCSF-CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); District of Columbia Developmental Center for AIDS Research Grant; United States Department of Energy(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI078859, AI074410, and AI043894 (to F. K.), NCI, NIDA, NIDCD, and NCRR UCSF-CTSI Grant UL1 RR024131, and District of Columbia Developmental Center for AIDS Research Grant 5P30AI087714-02 (to S. I.). This work was also supported by United States Department of Energy Grant DE-SC0001599 (to F. K. and C. B.).	Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Ali SA, 2010, AIDS RES HUM RETROV, V26, P173, DOI 10.1089/aid.2009.0068; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Anand Paras K, 2010, Commun Integr Biol, V3, P405, DOI 10.4161/cib.3.5.12474; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth S, 2011, BBA-GENE REGUL MECH, V1809, P631, DOI 10.1016/j.bbagrm.2011.05.010; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Brandano L, 2012, J VIROL, V86, P2347, DOI 10.1128/JVI.06047-11; Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Campbell TD, 2008, ETHN DIS, V18; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Carpio Lawrence, 2010, J RNAi Gene Silencing, V6, pE386; Carpio Lawrence, 2010, J RNAi Gene Silencing, V6, P386; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Coley W, 2010, J BIOL CHEM, V285, P31930, DOI 10.1074/jbc.M110.101709; de Vries W, 2008, INT J BIOCHEM CELL B, V40, P2007, DOI 10.1016/j.biocel.2008.04.015; Denzer K, 2000, J CELL SCI, V113, P3365; Dimov I, 2009, THESCIENTIFICWORLDJO, V9, P1107, DOI 10.1100/tsw.2009.128; Dolken L, 2009, VIRUS GENES, V38, P355, DOI 10.1007/s11262-009-0347-0; Duijvesz D, 2011, EUR UROL, V59, P823, DOI 10.1016/j.eururo.2010.12.031; Easley R, 2010, VIROLOGY, V405, P322, DOI 10.1016/j.virol.2010.06.009; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Furnes C, 2008, ARCH VIROL, V153, P357, DOI 10.1007/s00705-007-1095-x; Gan X, 2011, MOL BIOL CELL, V22, P817, DOI 10.1091/mbc.E10-07-0625; Geanacopoulos Mark, 2005, Science Progress, V88, P49, DOI 10.3184/003685005783238444; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gourzones C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-271; Grishok A, 2005, FEBS LETT, V579, P5932, DOI 10.1016/j.febslet.2005.08.001; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Haasnoot J, 2011, METHODS MOL BIOL, V721, P23, DOI 10.1007/978-1-61779-037-9_2; Klase Z, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-63; Klase Z, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-38; Klase Z, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-18; Lamers SL, 2010, BIOSYSTEMS, V101, P88, DOI 10.1016/j.biosystems.2010.05.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lejeune E, 2011, CURR OPIN CELL BIOL, V23, P258, DOI 10.1016/j.ceb.2011.03.005; Lenassi M, 2010, TRAFFIC, V11, P110, DOI 10.1111/j.1600-0854.2009.01006.x; Lin J, 2007, J VIROL, V81, P12218, DOI 10.1128/JVI.01390-07; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Marini A, 2008, J IMMUNOL, V181, P7713, DOI 10.4049/jimmunol.181.11.7713; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mohammed KD, 2011, J VIROL, V85, P4654, DOI 10.1128/JVI.02374-10; Montgomery Mary K, 2004, Methods Mol Biol, V265, P3; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; Nair V, 2006, TRENDS MICROBIOL, V14, P169, DOI 10.1016/j.tim.2006.02.007; Naqvi AR, 2009, INT J BIOL SCI, V5, P97; Narayanan A, 2011, EXPERT OPIN BIOL TH, V11, P17, DOI 10.1517/14712598.2011.540564; Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44; Ouellet DL, 2008, NUCLEIC ACIDS RES, V36, P2353, DOI 10.1093/nar/gkn076; Paolucci S, 2011, CURR HIV RES, V9, P17, DOI 10.2174/157016211794582641; Pegtel DM, 2011, BBA-GENE REGUL MECH, V1809, P715, DOI 10.1016/j.bbagrm.2011.08.002; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Perron MP, 2008, FRONT BIOSCI-LANDMRK, V13, P2537, DOI 10.2741/2865; Perron Marjorie P., 2009, V487, P369, DOI 10.1007/978-1-60327-547-7_18; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Plaisance-Bonstaff K, 2011, METHODS MOL BIOL, V721, P43, DOI 10.1007/978-1-61779-037-9_3; Poe JA, 2009, J MOL BIOL, V394, P329, DOI 10.1016/j.jmb.2009.09.047; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Rana S, 2011, BIOCHEM SOC T, V39, P559, DOI 10.1042/BST0390559; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Sandonis V, 2009, VIROLOGY, V391, P73, DOI 10.1016/j.virol.2009.05.022; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Schuetz S, 2006, VIROLOGY, V344, P151, DOI 10.1016/j.virol.2005.09.034; Shelton MN, 2012, J VIROL, V86, P406, DOI 10.1128/JVI.05720-11; Shen BY, 2011, J BIOL CHEM, V286, P14383, DOI 10.1074/jbc.M110.208660; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Duyne R, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-21; Van Rij RP, 2006, TRENDS BIOTECHNOL, V24, P186, DOI 10.1016/j.tibtech.2006.02.006; Venkatachari NJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-119; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang SH, 2008, BIOMED ENVIRON SCI, V21, P485, DOI 10.1016/S0895-3988(09)60007-6; Wang Z, 2012, PROTEOMICS, V12, P329, DOI 10.1002/pmic.201100477; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yeung ML, 2009, NUCLEIC ACIDS RES, V37, P6575, DOI 10.1093/nar/gkp707; Yunta M, 2003, CELL SIGNAL, V15, P559, DOI 10.1016/S0898-6568(02)00147-X; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08; Zofall M, 2006, COLD SPRING HARB SYM, V71, P487, DOI 10.1101/sqb.2006.71.059; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339; Zou SP, 2011, J NEUROVIROL, V17, P41, DOI 10.1007/s13365-010-0016-z	93	205	216	3	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20014	20033		10.1074/jbc.M112.438895	http://dx.doi.org/10.1074/jbc.M112.438895			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23661700	Green Published, hybrid			2022-12-28	WOS:000321515800065
J	Lu, D; Insel, PA				Lu, David; Insel, Paul A.			Hydrolysis of Extracellular ATP by Ectonucleoside Triphosphate Diphosphohydrolase (ENTPD) Establishes the Set Point for Fibrotic Activity of Cardiac Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOCARDIAL-INFARCTION; NUCLEOTIDE RECEPTORS; P2Y(2) RECEPTORS; A(2B) RECEPTORS; EXPRESSION; ADENOSINE; INJURY; CD39; ACTIVATION; FIBROSIS	The establishment of set points for cellular activities is essential in regulating homeostasis. Here, we demonstrate key determinants of the fibrogenic set point of cardiac fibroblasts (CFs) by focusing on the pro-fibrotic activity of ATP, which is released by CFs. We tested the hypothesis that the hydrolysis of extracellular ATP by ectonucleoside triphosphate diphosphohydrolases (ENTPDs) regulates pro-fibrotic nucleotide signaling. We detected two ENTPD isoforms, ENTPD-1 and -2, in adult rat ventricular CFs. Partial knockdown of ENTPD-1 and -2 with siRNA increased basal extracellular ATP concentration and enhanced the pro-fibrotic effect of ATP stimulation. Sodium polyoxotungstate-1, an ENTPD inhibitor, not only enhanced the pro-fibrotic effects of exogenously added ATP but also increased basal expression of alpha-smooth muscle actin, plasminogen activator inhibitor-1 and transforming growth factor (TGF)-beta, collagen synthesis, and gel contraction. Furthermore, we found that adenosine, a product of ATP hydrolysis by ENTPD, acts via A2(B) receptors to counterbalance the pro-fibrotic response to ATP. Removal of extracellular adenosine or inhibition of A2(B) receptors enhanced pro-fibrotic ATP signaling. Together, these results demonstrate the contribution of basally released ATP in establishing the set point for fibrotic activity in adult rat CFs and identify a key role for the modulation of this activity by hydrolysis of released ATP by ENTPDs. These findings also imply that cellular homeostasis and fibrotic response involve the integration of signaling that is pro-fibrotic by ATP and anti-fibrotic by adenosine and that is regulated by ENTPDs.	[Lu, David; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr,0636, La Jolla, CA 92093 USA.	pinsel@ucsd.edu			National Institutes of Health [1R01HL091071-01, GM066232, 1F31AG039992-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM066232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG039992] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01HL091071-01 and GM066232 (to P. A. I.) and 1F31AG039992-01 (to D. L.).	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Ayata CK, 2012, GASTROENTEROLOGY, V143, P1620, DOI 10.1053/j.gastro.2012.08.049; Bagatini MD, 2011, CLIN CHIM ACTA, V412, P159, DOI 10.1016/j.cca.2010.09.033; Braun OO, 2010, J MOL CELL CARDIOL, V49, P362, DOI 10.1016/j.yjmcc.2010.05.001; Cai M, 2011, J MOL CELL CARDIOL, V51, P927, DOI 10.1016/j.yjmcc.2011.09.003; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Chen YH, 2004, AM J PHYSIOL-HEART C, V287, pH2478, DOI 10.1152/ajpheart.00217.2004; Clayton A, 2011, J IMMUNOL, V187, P676, DOI 10.4049/jimmunol.1003884; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001; Dobaczewski M, 2010, CIRC RES, V107, P418, DOI 10.1161/CIRCRESAHA.109.216101; Dranoff JA, 2004, AM J PHYSIOL-GASTR L, V287, pG417, DOI 10.1152/ajpgi.00294.2003; Dubey RK, 2001, HYPERTENSION, V37, P716, DOI 10.1161/01.HYP.37.2.716; El-Omar MM, 2005, THROMB RES, V116, P199, DOI 10.1016/j.thromres.2004.11.024; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Epperson SA, 2009, AM J PHYSIOL-CELL PH, V296, pC1171, DOI 10.1152/ajpcell.00290.2008; Fausther M, 2012, AM J PHYSIOL-GASTR L, V302, pG447, DOI [10.1152/ajpgi.00165.2011., 10.1152/ajpgi.00165.2011]; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Goldsmith EC, 2013, AM J PHYSIOL-CELL PH, V304, pC393, DOI 10.1152/ajpcell.00347.2012; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Jhandier MN, 2005, J BIOL CHEM, V280, P22986, DOI 10.1074/jbc.M412371200; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; Kauffenstein G, 2010, CARDIOVASC RES, V85, P204, DOI 10.1093/cvr/cvp265; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lu D, 2012, FASEB J, V26, P2580, DOI 10.1096/fj.12-204677; Maleckar MM, 2009, BIOPHYS J, V97, P2179, DOI [10.1016/j.bpj.2009.07.054, 10.1016/j.bpj.2009.07.0.54]; Marcus AJ, 2003, J PHARMACOL EXP THER, V305, P9, DOI 10.1124/jpet.102.043729; Marcus AJ, 1997, J CLIN INVEST, V99, P1351, DOI 10.1172/JCI119294; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Muller CE, 2006, BIOORG MED CHEM LETT, V16, P5943, DOI 10.1016/j.bmcl.2006.09.003; Neary JT, 2003, J NEUROSCI, V23, P2348, DOI 10.1523/jneurosci.23-06-02348.2003; Nishida M, 2008, EMBO J, V27, P3104, DOI 10.1038/emboj.2008.237; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Takeshita K, 2004, AM J PATHOL, V164, P449, DOI 10.1016/S0002-9440(10)63135-5; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wall MJ, 2008, NEUROPHARMACOLOGY, V55, P1251, DOI 10.1016/j.neuropharm.2008.08.005; Yamamoto K, 2011, J CELL SCI, V124, P3477, DOI 10.1242/jcs.087221; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; Zeisberg EM, 2010, CIRC RES, V107, P1304, DOI 10.1161/CIRCRESAHA.110.231910; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	49	25	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19040	19049		10.1074/jbc.M113.466102	http://dx.doi.org/10.1074/jbc.M113.466102			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23677997	hybrid, Green Published			2022-12-28	WOS:000321335800039
J	Malhi, H; Kropp, EM; Clavo, VF; Kobrossi, CR; Han, J; Mauer, AS; Yong, J; Kaufman, RJ				Malhi, Harmeet; Kropp, Erin M.; Clavo, Vinna F.; Kobrossi, Christina R.; Han, JaeSeok; Mauer, Amy S.; Yong, Jing; Kaufman, Randal J.			C/EBP Homologous Protein-induced Macrophage Apoptosis Protects Mice from Steatohepatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; NONALCOHOLIC STEATOHEPATITIS; OXIDATIVE STRESS; CELL-DEATH; CHOP; EXPRESSION; ROLES; BETA; LIPOAPOPTOSIS	Nonalcoholic fatty liver disease is a heterogeneous disorder characterized by liver steatosis; inflammation and fibrosis are features of the progressive form nonalcoholic steatohepatitis. The endoplasmic reticulum stress response is postulated to play a role in the pathogenesis of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. In particular, C/EBP homologous protein (CHOP) is undetectable under normal conditions but is induced by cellular stress, including endoplasmic reticulum stress. Chop wild type (Chop(+/+)) and knock-out (Chop(-/-)) mice were used in these studies to elucidate the role of CHOP in the pathogenesis of fatty liver disease. Paradoxically, Chop(-/-) mice developed greater liver injury, inflammation, and fibrosis than Chop(+/+) mice, with greater macrophage activation. Primary, bone marrow-derived, and peritoneal macrophages from Chop(+/+) and Chop(-/-) were challenged with palmitic acid, an abundant saturated free fatty acid in plasma and liver lipids. Where palmitic acid treatment activated Chop(+/+) and Chop(-/-) macrophages, Chop(-/-) macrophages were resistant to its lipotoxicity. Chop(-/-) mice were sensitized to liver injury in a second model of dietary steatohepatitis using the methionine-cholinedeficient diet. Analysis of bone marrow chimeras between Chop(-/-) and Chop(+/+) mice demonstrated that Chop in macrophages protects from liver injury and inflammation when fed the methionine-choline-deficient diet. We conclude that Chop deletion has a proinflammatory effect in fatty liver injury apparently due to decreased cell death of activated macrophages, resulting in their net accumulation in the liver. Thus, macrophage CHOP plays a key role in protecting the liver from steatohepatitis likely by limiting macrophage survival during lipotoxicity.	[Malhi, Harmeet; Kropp, Erin M.; Clavo, Vinna F.; Kobrossi, Christina R.; Han, JaeSeok; Kaufman, Randal J.] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA; [Kaufman, Randal J.] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA; [Han, JaeSeok; Yong, Jing; Kaufman, Randal J.] Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Mauer, Amy S.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Sanford Burnham Prebys Medical Discovery Institute; Mayo Clinic	Kaufman, RJ (corresponding author), Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rkaufman@sanfordburnham.org	Han, Jaeseok/AAE-6872-2020	Yong, Jing/0000-0001-8579-1558	National Institutes of Health [K08 DK097178, DK07198]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30DK084567, DK042394, DK088227, DK093074, HL052173, HL057346]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052173, P01HL057346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042394, K08DK097178, R01DK088227, R37DK042394, P30DK084567, R24DK093074, T32DK007198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Cell Signaling in Gastroenterology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 DK097178, DK07198, and a Pilot and Feasibility award from the Mayo Clinic Center for Cell Signaling in Gastroenterology (P30DK084567) (to H. M.) and DK042394, DK088227, DK093074, HL052173, and HL057346 (to R. J. K.).	Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Ariyama Y, 2007, OBESITY, V15, P1647, DOI 10.1038/oby.2007.197; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; FORNACE AJ, 1989, MOL CELL BIOL, V9, P4196, DOI 10.1128/MCB.9.10.4196; Goodall JC, 2010, P NATL ACAD SCI USA, V107, P17698, DOI 10.1073/pnas.1011736107; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Han J, 2013, DIABETOLOGIA, V56, P911, DOI 10.1007/s00125-012-2809-5; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Miao B, 2004, J LIPID RES, V45, P1410, DOI 10.1194/jlr.M300450-JLR200; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; SHERRY B, 1988, J EXP MED, V168, P2251, DOI 10.1084/jem.168.6.2251; Siyan S, 2012, INFLAMM BOWEL DIS, V18, P1735, DOI 10.1002/ibd.22878; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Soon RK, 2010, GASTROENTEROLOGY, V139, P1730, DOI 10.1053/j.gastro.2010.07.046; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Tang QQ, 2004, BIOCHEM BIOPH RES CO, V318, P213, DOI 10.1016/j.bbrc.2004.04.017; VALENTE AJ, 1992, CIRCULATION, V86, P20; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wieckowska A, 2006, HEPATOLOGY, V44, P27, DOI 10.1002/hep.21223; Zhan YT, 2010, WORLD J GASTROENTERO, V16, P4652, DOI 10.3748/wjg.v16.i37.4652; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	37	60	62	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18624	18642		10.1074/jbc.M112.442954	http://dx.doi.org/10.1074/jbc.M112.442954			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23720735	hybrid, Green Published			2022-12-28	WOS:000321335800001
J	Liu, XH; Wu, Y; Yao, S; Levine, AC; Kirschenbaum, A; Collier, L; Bauman, WA; Cardozo, CP				Liu, Xin-Hua; Wu, Yong; Yao, Shen; Levine, Alice C.; Kirschenbaum, Alexander; Collier, Lauren; Bauman, William A.; Cardozo, Christopher P.			Androgens Up-regulate Transcription of the Notch Inhibitor Numb in C2C12 Myoblasts via Wnt/beta-Catenin Signaling to T Cell Factor Elements in the Numb Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; MYOGENIC DIFFERENTIATION; SKELETAL-MUSCLE; WNT; ACTIVATION; RECEPTOR; FATE; STEM; COMPLEX; PROTEIN	Androgen signaling via the androgen receptor is a key pathway that contributes to development, cell fate decisions, and differentiation, including that of myogenic progenitors. Androgens and synthetic steroids have well established anabolic actions on skeletal muscle. Wnt and Notch signaling pathways are also essential to myogenic cell fate decisions during development and tissue repair. However, the interactions among these pathways are largely unknown. Androgenic regulation of Wnt signaling has been reported. Nandrolone, an anabolic steroid, has been shown to inhibit Notch signaling and up-regulate Numb, a Notch inhibitor. To elucidate the mechanisms of interaction between nandrolone and Wnt/Notch signaling, we investigated the effects of nandrolone on Numb expression and Wnt signaling and determined the roles of Wnt signaling in nandrolone-induced Numb expression in C2C12 myoblasts. Nandrolone increased Numb mRNA and protein levels and T cell factor (Tcf) transcriptional activity via inhibition of glycogen synthase kinase 3 beta. Up-regulation of Numb expression by nandrolone was blocked by the Wnt inhibitors, sFRP1 and DKK1, whereas Wnt3a increased Numbm RNA and protein expression. In addition, we observed that the proximal promoter of the Numb gene had functional Tcf binding elements to which beta-catenin was recruited in a manner enhanced by both nandrolone and Wnt3a. Moreover, site-directed mutagenesis indicated that the Tcf binding sites in the Numb promoter are required for the nandrolone-induced Numb transcriptional activation in this cell line. These results reveal a novel molecular mechanism underlying up-regulation of Numb transcription with a critical role for increased canonical Wnt signaling. In addition, the data identify Numb as a novel target gene of the Wnt signaling pathway by which Wnts would be able to inhibit Notch signaling.	[Liu, Xin-Hua; Wu, Yong; Collier, Lauren; Bauman, William A.; Cardozo, Christopher P.] James J Peter Vet Affairs Med Ctr, Natl Ctr Excellence Med Consequences Spinal Cord, Bronx, NY 10468 USA; [Yao, Shen; Levine, Alice C.; Bauman, William A.; Cardozo, Christopher P.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Kirschenbaum, Alexander] Mt Sinai Sch Med, Dept Urol, New York, NY 10029 USA; [Bauman, William A.; Cardozo, Christopher P.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY 10029 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Cardozo, CP (corresponding author), James J Peter Vet Affairs Med Ctr, 130 West Kingsbridge Rd, Bronx, NY 10468 USA.	chris.cardozo@mssm.edu	Cardozo, Christopher/R-6021-2019	Cardozo, Christopher/0000-0003-4013-2537; Levine, Alice/0000-0002-0634-4133	Veterans Health Administration, Rehabilitation Research and Development Service [B4162C, F7756R, F6997R]	Veterans Health Administration, Rehabilitation Research and Development Service(US Department of Veterans Affairs)	This work was supported by the Veterans Health Administration, Rehabilitation Research and Development Service Grants B4162C, F7756R, and F6997R.	Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Carter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-221; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Gregory CM, 2003, SPINAL CORD, V41, P23, DOI 10.1038/sj.sc.3101370; Gulino A, 2010, EXP CELL RES, V316, P900, DOI 10.1016/j.yexcr.2009.11.017; Hayward P, 2008, DEVELOPMENT, V135, P411, DOI 10.1242/dev.000505; Jory A, 2009, STEM CELLS, V27, P2769, DOI 10.1002/stem.220; Katoh M, 2006, INT J MOL MED, V18, P517; Kicman AT, 2008, BRIT J PHARMACOL, V154, P502, DOI 10.1038/bjp.2008.165; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kwon C, 2011, NAT CELL BIOL, V13, P1244, DOI 10.1038/ncb2313; Lange C, 2011, NEUROSCI LETT, V488, P36, DOI 10.1016/j.neulet.2010.10.076; Liu XH, 2007, ANN NY ACAD SCI, V1116, P423, DOI 10.1196/annals.1402.017; Liu XH, 2007, CANCER RES, V67, P5747, DOI 10.1158/0008-5472.CAN-07-0478; Liu XH, 2012, J ANDROL, V33, P1216, DOI 10.2164/jandrol.112.016428; Liu XH, 2011, BIOCHEM BIOPH RES CO, V414, P165, DOI 10.1016/j.bbrc.2011.09.048; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo D, 2005, SEMIN CELL DEV BIOL, V16, P612, DOI 10.1016/j.semcdb.2005.07.002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Munoz-Descalzo S, 2012, BIOESSAYS, V34, P110, DOI 10.1002/bies.201100102; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Pawlowski JE, 2002, J BIOL CHEM, V277, P20702, DOI 10.1074/jbc.M200545200; Shahi P, 2011, STEM CELLS, V29, P678, DOI 10.1002/stem.606; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Singh R, 2003, ENDOCRINOLOGY, V144, P5081, DOI 10.1210/en.2003-0741; Singh R, 2009, ENDOCRINOLOGY, V150, P1259, DOI 10.1210/en.2008-0858; Sinha-Hikim I, 2006, J CLIN ENDOCR METAB, V91, P3024, DOI 10.1210/jc.2006-0357; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Taylor DC, 1999, AM J SPORT MED, V27, P718, DOI 10.1177/03635465990270060601; Truica CI, 2000, CANCER RES, V60, P4709; van Noort M, 2002, EXP CELL RES, V276, P264, DOI 10.1006/excr.2002.5520; Wimalawansa SM, 1999, J APPL PHYSIOL, V86, P1841, DOI 10.1152/jappl.1999.86.6.1841; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Zhao WD, 2008, ENDOCRINOLOGY, V149, P5449, DOI 10.1210/en.2008-0664; Zilian O, 2001, CURR BIOL, V11, P494, DOI 10.1016/S0960-9822(01)00149-X	47	27	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17990	17998		10.1074/jbc.M113.478487	http://dx.doi.org/10.1074/jbc.M113.478487			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649620	hybrid, Green Published			2022-12-28	WOS:000320721900006
J	Sharma, A; Diecke, S; Zhang, WY; Lan, F; He, CJ; Mordwinkin, NM; Chua, KF; Wu, JC				Sharma, Amit; Diecke, Sebastian; Zhang, Wendy Y.; Lan, Feng; He, Chunjiang; Mordwinkin, Nicholas M.; Chua, Katrin F.; Wu, Joseph C.			The Role of SIRT6 Protein in Aging and Reprogramming of Human Induced Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN; DISEASE; STRESS; MICE; AGE; DEACETYLATION; FIBROBLASTS; SENESCENCE; EXPRESSION; CHROMATIN	Aging is known to be the single most important risk factor for multiple diseases. Sirtuin 6, or SIRT6, has recently been identified as a critical regulator of transcription, genome stability, telomere integrity, DNA repair, and metabolic homeostasis. A knockout mouse model of SIRT6 has displayed dramatic phenotypes of accelerated aging. In keeping with its role in aging, we demonstrated that human dermal fibroblasts (HDFs) from older human subjects were more resistant to reprogramming by classic Yamanaka factors than those from younger human subjects, but the addition of SIRT6 during reprogramming improved such efficiency in older HDFs substantially. Despite the importance of SIRT6, little is known about the molecular mechanism of its regulation. We show, for the first, time posttranscriptional regulation of SIRT6 by miR-766 and inverse correlation in the expression of this microRNA in HDFs from different age groups. Our results suggest that SIRT6 regulates miR-766 transcription via a feedback regulatory loop, which has implications for the modulation of SIRT6 expression in reprogramming of aging cells.	[Sharma, Amit; Diecke, Sebastian; Zhang, Wendy Y.; Lan, Feng; He, Chunjiang; Mordwinkin, Nicholas M.; Wu, Joseph C.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Chua, Katrin F.; Wu, Joseph C.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Chua, Katrin F.] Vet Affairs Palo Alto Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Wu, JC (corresponding author), Lorry I Lokey Stem Cell Res Bldg,265 Campus Dr,Rm, Stanford, CA 94305 USA.	joewu@stanford.edu	Lan, Feng/I-2023-2012; Wu, Joseph/H-1067-2013; He, Chunjiang/N-4316-2016	Lan, Feng/0000-0002-9038-4014; Wu, Joseph/0000-0002-6068-8041; Mordwinkin, Nicholas/0000-0002-3019-0170; He, Chunjiang/0000-0002-4868-331X	National Institutes of Health [DP2 OD004437, RC1 HL099117, R01 HL113006, P01 GM099130, UO1 HL099776]; CIRM [RB3-05129]; DFG (German Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL099117, U01HL099776, R01HL113006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099130] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); DFG (German Research Foundation)(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants DP2 OD004437, RC1 HL099117, R01 HL113006, P01 GM099130, UO1 HL099776, and CIRM RB3-05129 (to J. C. W.). This work was also supported by DFG (German Research Foundation) (to S. D.).	Alexiou P, 2010, NUCLEIC ACIDS RES, V38, pD137, DOI 10.1093/nar/gkp888; Alt EU, 2012, STEM CELL RES, V8, P215, DOI 10.1016/j.scr.2011.11.002; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Chen LH, 2010, AGEING RES REV, V9, pS59, DOI 10.1016/j.arr.2010.08.002; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Fernandez-Hernando C, 2011, ARTERIOSCL THROM VAS, V31, P2378, DOI 10.1161/ATVBAHA.111.226688; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gorospe M, 2011, TRENDS GENET, V27, P233, DOI 10.1016/j.tig.2011.03.005; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; HARMAN D, 1991, P NATL ACAD SCI USA, V88, P5360, DOI 10.1073/pnas.88.12.5360; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kawahara TLA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002153; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Lee YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045633; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Tat PA, 2011, CELL REPROGRAM, V13, P331, DOI 10.1089/cell.2011.0002; Tennen RI, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1443; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wilson KD, 2010, CANCER RES, V70, P5539, DOI 10.1158/0008-5472.CAN-09-4238; Wu JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000164; Yamakuchi M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00068; Yoshida Y, 2010, CIRCULATION, V122, P80, DOI 10.1161/CIRCULATIONAHA.109.881433; Yu JM, 2011, AGING CELL, V10, P66, DOI 10.1111/j.1474-9726.2010.00646.x	38	96	105	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18439	18447		10.1074/jbc.M112.405928	http://dx.doi.org/10.1074/jbc.M112.405928			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653361	Green Published, hybrid			2022-12-28	WOS:000320721900046
J	Taouji, S; Higa, A; Delom, F; Palcy, S; Mahon, FX; Pasquet, JM; Bosse, R; Segui, B; Chevet, E				Taouji, Said; Higa, Arisa; Delom, Frederic; Palcy, Sandrine; Mahon, Francois-Xavier; Pasquet, Jean-Max; Bosse, Roger; Segui, Bruno; Chevet, Eric			Phosphorylation of Serine Palmitoyltransferase Long Chain-1 (SPTLC1) on Tyrosine 164 Inhibits Its Activity and Promotes Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC MYELOID-LEUKEMIA; IMATINIB-INDUCED APOPTOSIS; ENDOPLASMIC-RETICULUM; PROTEIN; CERAMIDE; TRAFFICKING; RESISTANCE; KINASE; CANCER; DEATH	In BCR-ABL-expressing cells, sphingolipid metabolism is altered. Because the first step of sphingolipid biosynthesis occurs in the endoplasmic reticulum (ER), our objective was to identify ABL targets in the ER. A phosphoproteomic analysis of canine pancreatic ER microsomes identified 49 high scoring phosphotyrosine-containing peptides. These were then categorized in silico and validated in vitro. We demonstrated that the ER-resident human protein serine palmitoyltransferase long chain-1 (SPTLC1), which is the first enzyme of sphingolipid biosynthesis, is phosphorylated at Tyr(164) by the tyrosine kinase ABL. Inhibition of BCR-ABL using either imatinib or shRNA-mediated silencing led to the activation of SPTLC1 and to increased apoptosis in both K562 and LAMA-84 cells. Finally, we demonstrated that mutation of Tyr(164) to Phe in SPTLC1 increased serine palmitoyltransferase activity. The Y164F mutation also promoted the remodeling of cellular sphingolipid content, thereby sensitizing K562 cells to apoptosis. Our observations provide a mechanistic explanation for imatinib-mediated cell death and a novel avenue for therapeutic strategies.	[Taouji, Said; Higa, Arisa; Chevet, Eric] INSERM, U1053, F-33076 Bordeaux, France; [Taouji, Said; Higa, Arisa; Mahon, Francois-Xavier; Pasquet, Jean-Max; Chevet, Eric] Univ Bordeaux Segalen, F-33076 Bordeaux, France; [Delom, Frederic; Palcy, Sandrine; Chevet, Eric] McGill Univ, Dept Surg, Montreal, PQ H4A 1A1, Canada; [Mahon, Francois-Xavier; Pasquet, Jean-Max] INSERM, U1035, F-33076 Bordeaux, France; [Bosse, Roger] PerkinElmer Biosignal Inc, Montreal, PQ H3J 1R4, Canada; [Segui, Bruno] Ctr Rech Cancerol Toulouse, Equipe 4, INSERM, UMR1037, F-31432 Toulouse 4, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Taouji, S (corresponding author), Univ Bordeaux Segalen, INSERM, U1053, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	said.taouji@inserm.fr; eric.chevet@u-bordeaux2.fr	Ségui, Bruno/O-8957-2014; Delom, Frederic/J-2782-2014; chevet, eric/E-4992-2016; PASQUET, JEAN-MAX/I-9702-2014; PASQUET, JEAN-MAX/T-4906-2019; TAOUJI, Saïd/K-5734-2014	Ségui, Bruno/0000-0002-6119-1889; Delom, Frederic/0000-0002-4600-7633; chevet, eric/0000-0001-5855-4522; PASQUET, JEAN-MAX/0000-0002-1345-3776; TAOUJI, Said/0000-0001-6736-9716	INSERM (Avenir); Institut National du Cancer (INCa); Ligue contre le Cancer; Association de Recherche contre le Cancer; Genome Quebec/Genome Canada; Marie Curie International Reintegration Grant	INSERM (Avenir)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Ligue contre le Cancer(Ligue nationale contre le cancer); Association de Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Genome Quebec/Genome Canada(Genome Canada); Marie Curie International Reintegration Grant(European Commission)	This work was supported by grants from INSERM (Avenir), Institut National du Cancer (INCa), Ligue contre le Cancer, and the Association de Recherche contre le Cancer and a Marie Curie International Reintegration Grant (to E. C.) and a grant from Genome Quebec/Genome Canada (to the Cell Map project at the Montreal Proteomics Network).	Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; Baran Y, 2011, J CANCER RES CLIN, V137, P1535, DOI 10.1007/s00432-011-1016-y; Belloc F, 2009, LEUKEMIA, V23, P679, DOI 10.1038/leu.2008.364; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 1998, NUCLEIC ACIDS RES, V26, P382, DOI 10.1093/nar/26.1.382; Bonhoure E, 2008, LEUKEMIA, V22, P971, DOI 10.1038/leu.2008.95; Burns TA, 2013, J LIPID RES, V54, P794, DOI 10.1194/jlr.M033985; Chevet E, 1999, EMBO J, V18, P3655, DOI 10.1093/emboj/18.13.3655; Dickson RC, 2000, METHOD ENZYMOL, V311, P3; Du YZ, 2006, BLOOD, V107, P1582, DOI 10.1182/blood-2005-06-2318; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hofius D, 2011, CELL DEATH DIFFER, V18, P1257, DOI 10.1038/cdd.2011.43; Ibitayo AI, 1998, AM J PHYSIOL-GASTR L, V275, pG705, DOI 10.1152/ajpgi.1998.275.4.G705; Jenna S, 2005, MOL BIOL CELL, V16, P1629, DOI 10.1091/mbc.E04-08-0760; John AM, 2004, SEMIN CANCER BIOL, V14, P41, DOI 10.1016/j.semcancer.2003.11.006; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Klawitter J, 2009, BRIT J PHARMACOL, V158, P588, DOI 10.1111/j.1476-5381.2009.00345.x; Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902; Liu YF, 2011, CELL RES, V21, P867, DOI 10.1038/cr.2011.75; Lowther J, 2012, BIOCHEM SOC T, V40, P547, DOI 10.1042/BST20110769; Lowther J, 2011, FEBS LETT, V585, P1729, DOI 10.1016/j.febslet.2011.04.013; Manna SK, 2000, J BIOL CHEM, V275, P13297, DOI 10.1074/jbc.275.18.13297; Nakatani H, 2006, INT J MOL MED, V17, P893; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pattacini L, 2004, LEUKEMIA RES, V28, P191, DOI 10.1016/S0145-2126(03)00218-2; Ricci C, 2006, BBA-BIOMEMBRANES, V1758, P2121, DOI 10.1016/j.bbamem.2006.06.016; Rutti MF, 2009, J LIPID RES, V50, P1237, DOI 10.1194/jlr.D900001-JLR200; Ryland LK, 2011, CANCER BIOL THER, V11, P138, DOI 10.4161/cbt.11.2.14624; Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200; Segui B, 2002, BIOCHEM J, V366, P23, DOI 10.1042/BJ20020317; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Tamehiro N, 2009, J BIOL CHEM, V284, P24881, DOI 10.1074/jbc.M109.014365; Tanimura A, 2009, LEUKEMIA RES, V33, P924, DOI 10.1016/j.leukres.2009.01.027; Taouji S, 2009, CURR GENOMICS, V10, P93, DOI 10.2174/138920209787847041	37	13	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17190	17201		10.1074/jbc.M112.409185	http://dx.doi.org/10.1074/jbc.M112.409185			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629659	Green Published, hybrid			2022-12-28	WOS:000320380600016
J	Doshi, R; van Veen, HW				Doshi, Rupak; van Veen, Hendrik W.			Substrate Binding Stabilizes a Pre-translocation Intermediate in the ATP-binding Cassette Transport Protein MsbA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Lipid Transport; Membrane Transport; Multidrug Transporters; Protein Conformation; Substrate-stimulated ATPase	HUMAN P-GLYCOPROTEIN; ABC TRANSPORTER; ALTERNATING ACCESS; DRUG-BINDING; CONFORMATIONAL-CHANGES; MOLECULAR-BASIS; CYCLE; DISSECTION; LMRA	ATP-binding cassette (ABC) transporters belong to one of the largest protein superfamilies that expands from prokaryotes to man. Recent x-ray crystal structures of bacterial and mammalian ABC exporters suggest a common alternating access mechanism of substrate transport, which has also been biochemically substantiated. However, the current model does not yet explain the coupling between substrate binding and ATP hydrolysis that underlies ATP-dependent substrate transport. In our studies on the homodimeric multidrug/lipid A ABC exporter MsbA from Escherichia coli, we performed cysteine cross-linking, fluorescence energy transfer, and cysteine accessibility studies on two reporter positions, near the nucleotide-binding domains and in the membrane domains, for transporter embedded in a biological membrane. Our results suggest for the first time that substrate binding by MsbA stimulates the maximum rate of ATP hydrolysis by facilitating the dimerization of nucleotide-binding domains in a state, which is markedly distinct from the previously described nucleotide-free, inward-facing and nucleotide-bound, outward-facing conformations of ABC exporters and which binds ATP.	[Doshi, Rupak; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	van Veen, HW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008	van Veen, Hendrik W./0000-0002-9658-8077	Biotechnology and Biological Sciences Research Council; Cambridge Commonwealth and Overseas Trust; Charter studentship; BBSRC [BB/I002383/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I002383/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cambridge Commonwealth and Overseas Trust; Charter studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Biotechnology and Biological Sciences Research Council.; Recipient of a Cambridge Commonwealth and Overseas Trust scholarship and a Charter studentship.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Arnaud O, 2010, J MED CHEM, V53, P6720, DOI 10.1021/jm100839w; Booth IR, 2007, NAT REV MICROBIOL, V5, P431, DOI 10.1038/nrmicro1659; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Cooper RS, 2013, J BIOL CHEM, V288, P20785, DOI 10.1074/jbc.M113.477976; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Doshi R, 2013, J BIOL CHEM, V288, P6801, DOI 10.1074/jbc.M112.430074; Doshi R, 2011, BIOCHEM SOC T, V39, P807, DOI 10.1042/BST0390807; Doshi R, 2010, PROTEINS, V78, P2867, DOI 10.1002/prot.22813; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Hellmich UA, 2012, J AM CHEM SOC, V134, P5857, DOI 10.1021/ja211007t; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Infed N, 2011, BBA-BIOMEMBRANES, V1808, P2313, DOI 10.1016/j.bbamem.2011.05.016; Li-Blatter X, 2009, BBA-BIOMEMBRANES, V1788, P2335, DOI 10.1016/j.bbamem.2009.07.010; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; SCARBOROUGH GA, 1995, J BIOENERG BIOMEMBR, V27, P37, DOI 10.1007/BF02110329; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Siarheyeva A, 2009, BIOCHEM J, V419, P317, DOI 10.1042/BJ20081364; Szabo K, 1998, J BIOL CHEM, V273, P10132, DOI 10.1074/jbc.273.17.10132; VanVeen HW, 1996, P NATL ACAD SCI USA, V93, P10668, DOI 10.1073/pnas.93.20.10668; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Wang GC, 1998, EUR J BIOCHEM, V255, P383, DOI 10.1046/j.1432-1327.1998.2550383.x; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Zou P, 2009, J MOL BIOL, V393, P574, DOI 10.1016/j.jmb.2009.08.051; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	36	34	34	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21638	21647		10.1074/jbc.M113.485714	http://dx.doi.org/10.1074/jbc.M113.485714			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23766512	Green Published, hybrid			2022-12-28	WOS:000328841900016
J	Balashov, SP; Petrovskaya, LE; Imasheva, ES; Lukashev, EP; Dioumaev, AK; Wang, JM; Sychev, SV; Dolgikh, DA; Rubin, AB; Kirpichnikov, MP; Lanyi, JK				Balashov, Sergei P.; Petrovskaya, Lada E.; Imasheva, Eleonora S.; Lukashev, Evgeniy P.; Dioumaev, Andrei K.; Wang, Jennifer M.; Sychev, Sergey V.; Dolgikh, Dmitriy A.; Rubin, Andrei B.; Kirpichnikov, Mikhail P.; Lanyi, Janos K.			LYSINE 96 FACILITATES REPROTONATION OF THE SCHIFF BASE IN THE PHOTOCYCLE OF A RETINAL PROTEIN FROM EXIGUOBACTERIUM SIBIRICUM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRIVEN PROTON PUMP; ASPARTIC ACID-96; BACTERIORHODOPSIN MUTANTS; VIBRATIONAL SPECTROSCOPY; STRUCTURAL-CHANGES; RELEASE; PK(A); TRANSLOCATION; WATER; RHODOPSIN	A lysine instead of the usual carboxyl group is in place of the internal proton donor to the retinal Schiff base in the light-driven proton pump of Exiguobacterium sibiricum (ESR). The involvement of this lysine in proton transfer is indicated by the finding that its substitution with alanine or other residues slows reprotonation of the Schiff base (decay of the M intermediate) by more than 2 orders of magnitude. In these mutants, the rate constant of the M decay linearly decreases with a decrease in proton concentration, as expected if reprotonation is limited by the uptake of a proton from the bulk. In wild type ESR, M decay is biphasic, and the rate constants are nearly pH-independent between pH6 and 9. Proton uptake occurs after M formation but before M decay, which is especially evident in D2O and at high pH. Proton uptake is biphasic; the amplitude of the fast phase decreases with a pK(a) of 8.5 +/- 0.3, which reflects the pKa of the donor during proton uptake. Similarly, the fraction of the faster component of M decay decreases and the slower one increases, with a pK(a) of 8.1 +/- 0.2. The data therefore suggest that the reprotonation of the Schiff base in ESR is preceded by transient protonation of an initially unprotonated donor, which is probably the is an element of-amino group of Lys-96 or a water molecule in its vicinity, and it facilitates proton delivery from the bulk to the reaction center of the protein.	[Balashov, Sergei P.; Imasheva, Eleonora S.; Dioumaev, Andrei K.; Wang, Jennifer M.; Lanyi, Janos K.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Petrovskaya, Lada E.; Sychev, Sergey V.; Dolgikh, Dmitriy A.; Kirpichnikov, Mikhail P.] Shemyakin & Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Lukashev, Evgeniy P.; Dolgikh, Dmitriy A.; Rubin, Andrei B.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow 119991, Russia	University of California System; University of California Irvine; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University	Balashov, SP (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	balashov@uci.edu; lpetr65@yahoo.com; jklanyi@uci.edu	Dolgikh, Dmitry A/F-2369-2014; Petrovskaya, Lada/S-1118-2016	Dolgikh, Dmitry/0000-0002-9880-7202; Petrovskaya, Lada/0000-0002-0217-9708; Kirpichnikov, Mikhail/0000-0001-8170-1607	National Institutes of Health [GM29498]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the Department of Energy [DEFG03-86ER13525]; Federal Targeted Program on Scientific and Scientific-Pedagogical Staff of Innovative Russia; Molecular and Cell Biology Program of Russian Academy of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029498, R01GM029498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the Department of Energy; Federal Targeted Program on Scientific and Scientific-Pedagogical Staff of Innovative Russia; Molecular and Cell Biology Program of Russian Academy of Science; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM29498 (to J. K. L. and S. P. B.). This work was also supported by Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the Department of Energy Grant DEFG03-86ER13525 (to J. K. L. and S. P. B.), the Federal Targeted Program on Scientific and Scientific-Pedagogical Staff of Innovative Russia (to L. E. P.), and the Molecular and Cell Biology Program of Russian Academy of Science (to D. A. D.).	AMES JB, 1990, BIOCHEMISTRY-US, V29, P7181, DOI 10.1021/bi00483a005; Balashov SP, 2012, BIOCHEMISTRY-US, V51, P5748, DOI 10.1021/bi300409m; Balashov SP, 2005, SCIENCE, V309, P2061, DOI 10.1126/science.1118046; Balashov SP, 2000, BBA-BIOENERGETICS, V1460, P75, DOI 10.1016/S0005-2728(00)00131-6; Balashov SP, 1999, BIOCHEMISTRY-US, V38, P2026, DOI 10.1021/bi981926a; Balashov SP, 1997, BIOCHEMISTRY-US, V36, P8671, DOI 10.1021/bi970744y; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Bergo VB, 2009, J BIOL CHEM, V284, P2836, DOI 10.1074/jbc.M803792200; BOUSCHE O, 1991, J BIOL CHEM, V266, P11063; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Brown LS, 1996, P NATL ACAD SCI USA, V93, P1731, DOI 10.1073/pnas.93.4.1731; Brown LS, 2000, BIOCHEMISTRY-US, V39, P938, DOI 10.1021/bi9921900; CAO Y, 1993, BIOCHEMISTRY-US, V32, P10239, DOI 10.1021/bi00089a046; CAO Y, 1991, BIOCHEMISTRY-US, V30, P10972, DOI 10.1021/bi00109a023; CAO Y, 1993, BIOCHEMISTRY-US, V32, P1981, DOI 10.1021/bi00059a015; Dioumaev AK, 1997, BIOPHYS CHEM, V67, P1, DOI 10.1016/S0301-4622(96)02268-5; Dioumaev AK, 1998, BIOCHEMISTRY-US, V37, P2496, DOI 10.1021/bi971842m; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Dioumaev AK, 2013, J PHYS CHEM B, V117, P7235, DOI 10.1021/jp402430w; DRACHEV LA, 1987, FEBS LETT, V226, P139, DOI 10.1016/0014-5793(87)80567-7; FAHMY K, 1992, PHOTOCHEM PHOTOBIOL, V56, P1073, DOI 10.1111/j.1751-1097.1992.tb09731.x; Fan Y, 2011, BBA-BIOENERGETICS, V1807, P1457, DOI 10.1016/j.bbabio.2011.07.005; Garczarek F, 2005, P NATL ACAD SCI USA, V102, P3633, DOI 10.1073/pnas.0500421102; GERWERT K, 1989, P NATL ACAD SCI USA, V86, P4943, DOI 10.1073/pnas.86.13.4943; Harms MJ, 2008, PROTEIN SCI, V17, P833, DOI 10.1110/ps.073397708; HEBERLE J, 1992, P NATL ACAD SCI USA, V89, P5996, DOI 10.1073/pnas.89.13.5996; HEGEMANN P, 1985, EMBO J, V4, P2347, DOI 10.1002/j.1460-2075.1985.tb03937.x; Ho MC, 2009, NATURE, V459, P393, DOI 10.1038/nature07938; HOLZ M, 1989, P NATL ACAD SCI USA, V86, P2167, DOI 10.1073/pnas.86.7.2167; Imasheva ES, 2006, PHOTOCHEM PHOTOBIOL, V82, P1406, DOI 10.1562/2006-01-15-RA-776; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Isom DG, 2011, P NATL ACAD SCI USA, V108, P5260, DOI 10.1073/pnas.1010750108; Iverson V, 2012, SCIENCE, V335, P587, DOI 10.1126/science.1212665; KHORANA HG, 1979, P NATL ACAD SCI USA, V76, P5046, DOI 10.1073/pnas.76.10.5046; KHORANA HG, 1993, P NATL ACAD SCI USA, V90, P1166, DOI 10.1073/pnas.90.4.1166; LEWIS A, 1974, P NATL ACAD SCI USA, V71, P4462, DOI 10.1073/pnas.71.11.4462; LOZIER RH, 1976, BIOCHIM BIOPHYS ACTA, V440, P545, DOI 10.1016/0005-2728(76)90041-4; LOZIER RH, 1975, BIOPHYS J, V15, P955, DOI 10.1016/S0006-3495(75)85875-9; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; MILLER A, 1990, BIOCHIM BIOPHYS ACTA, V1020, P57, DOI 10.1016/0005-2728(90)90093-J; Miranda MRM, 2009, BIOPHYS J, V96, P1471, DOI 10.1016/j.bpj.2008.11.026; Misra S, 1997, BIOCHEMISTRY-US, V36, P4875, DOI 10.1021/bi962673t; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; OVCHINNIKOV YA, 1979, FEBS LETT, V100, P219, DOI 10.1016/0014-5793(79)80338-5; Petrovskaya LE, 2010, FEBS LETT, V584, P4193, DOI 10.1016/j.febslet.2010.09.005; Rangarajan R, 2007, BIOCHEMISTRY-US, V46, P12679, DOI 10.1021/bi700955x; Rodrigues DF, 2006, EXTREMOPHILES, V10, P285, DOI 10.1007/s00792-005-0497-5; Schobert B, 2003, J MOL BIOL, V330, P553, DOI 10.1016/S0022-2836(03)00576-X; SUBRAMANIAM S, 1992, J BIOL CHEM, V267, P25730; SZARAZ S, 1994, BIOPHYS J, V67, P1706, DOI 10.1016/S0006-3495(94)80644-7; TITTOR J, 1989, EMBO J, V8, P3477, DOI 10.1002/j.1460-2075.1989.tb08512.x; Vishnivetskaya T, 2000, EXTREMOPHILES, V4, P165, DOI 10.1007/s007920070031; ZIMANYI L, 1993, BIOCHEMISTRY-US, V32, P7669, DOI 10.1021/bi00081a010; Zscherp C, 1999, P NATL ACAD SCI USA, V96, P5498, DOI 10.1073/pnas.96.10.5498	58	28	30	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21254	21265		10.1074/jbc.M113.465138	http://dx.doi.org/10.1074/jbc.M113.465138			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23696649	Green Published, hybrid			2022-12-28	WOS:000322014400046
J	Brash, AR; Boeglin, WE; Stec, DF; Voehler, M; Schneider, C; Cha, JK				Brash, Alan R.; Boeglin, William E.; Stec, Donald F.; Voehler, Markus; Schneider, Claus; Cha, Jin K.			Isolation and Characterization of Two Geometric Allene Oxide Isomers Synthesized from 9S-Hydroperoxylinoleic Acid by Cytochrome P450 CYP74C3 STEREOCHEMICAL ASSIGNMENT OF NATURAL FATTY ACID ALLENE OXIDES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHASE; CORAL; BIOSYNTHESIS; MECHANISM; PRODUCTS; PATHWAY; HYDROPEROXIDE; CONFIGURATION; ARACHIDONATE; METABOLISM	Specialized cytochromes P450 or catalase-related hemoproteins transform fatty acid hydroperoxides to allene oxides, highly reactive epoxides leading to cyclopentenones and other products. The stereochemistry of the natural allene oxides is incompletely defined, as are the structural features required for their cyclization. We investigated the transformation of 9S-hydroperoxylinoleic acid with the allene oxide synthase CYP74C3, a reported reaction that unexpectedly produces an allene oxide-derived cyclopentenone. Using biphasic reaction conditions at 0 degrees C, we isolated the initial products and separated two allene oxide isomers by HPLC at -15 degrees C. One matched previously described allene oxides in its UV spectrum (lambda(max) 236 nm) and NMR spectrum (defining a 9,10-epoxy-octadec-10,12Z-dienoate). The second was a novel stereoisomer (UV lambda(max) 239 nm) with distinctive NMR chemical shifts. Comparison of NOE interactions of the epoxy proton at C9 in the two allene oxides (and the equivalent NOE experiment in 12,13-epoxy allene oxides) allowed assignment at the isomeric C10 epoxy-ene carbon as Z in the new isomer and the E configuration in all previously characterized allene oxides. The novel 10Z isomer spontaneously formed a cis-cyclopentenone at room temperature in hexane. These results explain the origin of the cyclopentenone, provide insights into the mechanisms of allene oxide cyclization, and define the double bond geometry in naturally occurring allene oxides.	[Brash, Alan R.; Boeglin, William E.; Schneider, Claus] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA; [Stec, Donald F.; Voehler, Markus] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Stec, Donald F.; Voehler, Markus] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Nashville, TN 37232 USA; [Cha, Jin K.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Wayne State University	Brash, AR (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA.	alan.brash@vanderbilt.edu			National Institutes of Health Grant [GM-074888]; National Science Foundation (NSF) grant [CHE-1212879]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074888] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF) grant(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-074888 (to A. R. B.). This work was also supported by National Science Foundation (NSF) grant CHE-1212879 (to J. K. C.).	BAERTSCHI SW, 1988, BIOCHEMISTRY-US, V27, P18, DOI 10.1021/bi00401a004; Boeglin WE, 2008, LIPIDS, V43, P979, DOI 10.1007/s11745-008-3230-1; Brash AR, 1996, METHOD ENZYMOL, V272, P250, DOI 10.1016/S0076-6879(96)72030-X; BRASH AR, 1989, J AM CHEM SOC, V111, P1891, DOI 10.1021/ja00187a060; BRASH AR, 1987, J BIOL CHEM, V262, P15829; BRASH AR, 1988, P NATL ACAD SCI USA, V85, P3382, DOI 10.1073/pnas.85.10.3382; Chang ZZ, 2008, ACTA CRYSTALLOGR F, V64, P668, DOI 10.1107/S1744309108017545; COREY EJ, 1987, J AM CHEM SOC, V109, P289, DOI 10.1021/ja00235a053; COREY EJ, 1988, TETRAHEDRON LETT, V29, P2555, DOI 10.1016/S0040-4039(00)86110-9; CROMBIE L, 1991, J CHEM SOC PERK T 1, P577, DOI 10.1039/p19910000577; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Gao BL, 2009, J BIOL CHEM, V284, P22087, DOI 10.1074/jbc.M109.013151; Grechkin AN, 2008, CHEMBIOCHEM, V9, P2498, DOI 10.1002/cbic.200800331; GRECHKIN AN, 1994, BBA-LIPID LIPID MET, V1213, P199, DOI 10.1016/0005-2760(94)90027-2; GRECHKIN AN, 1991, EUR J BIOCHEM, V199, P451, DOI 10.1111/j.1432-1033.1991.tb16143.x; Grechkin AN, 2000, BIOCHEM J, V352, P501, DOI 10.1042/0264-6021:3520501; Hamberg M, 2000, LIPIDS, V35, P353, DOI 10.1007/s11745-000-532-z; HAMBERG M, 1987, BIOCHIM BIOPHYS ACTA, V920, P76, DOI 10.1016/0005-2760(87)90313-4; Havrilla CM, 2000, J AM CHEM SOC, V122, P8042, DOI 10.1021/ja001180f; Hess BA, 1999, J AM CHEM SOC, V121, P5603, DOI 10.1021/ja990728j; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Itoh A, 2002, J BIOL CHEM, V277, P46051, DOI 10.1074/jbc.M207234200; Medvedeva NV, 2005, RUSS J BIOORG CHEM+, V31, P595, DOI 10.1007/s11171-005-0083-8; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; PAN ZQ, 1995, J BIOL CHEM, V270, P8487, DOI 10.1074/jbc.270.15.8487; STOTT K, 1995, J AM CHEM SOC, V117, P4199, DOI 10.1021/ja00119a048; Thomas CP, 2013, CHEM PHYS LIPIDS, V167, P21, DOI 10.1016/j.chemphyslip.2013.01.002; VICK BA, 1983, BIOCHEM BIOPH RES CO, V111, P470, DOI 10.1016/0006-291X(83)90330-3; Watanabe K, 2003, CHEM PHARM BULL, V51, P909; Yu ZY, 2007, LIPIDS, V42, P491, DOI 10.1007/s11745-007-3054-4	30	22	23	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20797	20806		10.1074/jbc.M113.482521	http://dx.doi.org/10.1074/jbc.M113.482521			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23709224	Green Published, hybrid			2022-12-28	WOS:000322014400004
J	Vidal-Laliena, M; Gallastegui, E; Mateo, F; Martinez-Balbas, M; Pujol, MJ; Bachs, O				Vidal-Laliena, Miriam; Gallastegui, Edurne; Mateo, Francesca; Martinez-Balbas, Marian; Jesus Pujol, Maria; Bachs, Oriol			Histone Deacetylase 3 Regulates Cyclin A Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE CHECKPOINT; S-PHASE; COMPLEX; MITOSIS; PHOSPHORYLATION; DESTRUCTION; DEGRADATION; SPECIFICITY; PROTEOLYSIS; PROGRESSION	PCAF and GCN5 acetylate cyclin A at specific lysine residues targeting it for degradation at mitosis. We report here that histone deacetylase 3 (HDAC3) directly interacts with and deacetylates cyclin A. HDAC3 interacts with a domain included in the first 171 aa of cyclin A, a region involved in the regulation of its stability. In cells, overexpression of HDAC3 reduced cyclin A acetylation whereas the knocking down of HDAC3 increased its acetylation. Moreover, reduction of HDAC3 levels induced a decrease of cyclin A that can be reversed by proteasome inhibitors. These results indicate that HDAC3 is able to regulate cyclin A degradation during mitosis via proteasome. Interestingly, HDAC3 is abruptly degraded at mitosis also via proteasome thus facilitating cyclin A acetylation by PCAF/GCN5, which will target cyclin A for degradation. Because cyclin A is crucial for S phase progression and mitosis entry, the knock down of HDAC3 affects cell cycle progression specifically at both, S phase and G2/M transition. In summary we propose here that HDAC3 regulates cyclin A stability by counteracting the action of the acetylases PCAF/GCN5.	[Vidal-Laliena, Miriam; Gallastegui, Edurne; Jesus Pujol, Maria; Bachs, Oriol] Univ Barcelona, Dept Cell Biol Immunol & Neurosci, IDIBAPS, E-08036 Barcelona, Spain; [Mateo, Francesca] CSIC, Dept Cell Biol, Barcelona Inst Mol Biol, E-08028 Barcelona, Spain; [Martinez-Balbas, Marian] CSIC, Dept Mol Biol, Barcelona Inst Mol Biol, E-08028 Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC)	Bachs, O (corresponding author), Univ Barcelona, Dept Cell Biol Immunol & Neurosci, IDIBAPS, E-08036 Barcelona, Spain.	obachs@ub.edu	Mateo, Francesca/K-7746-2015	Mateo, Francesca/0000-0002-2342-7010; Martinez-Balbas, Marian/0000-0003-0173-0964; Gallastegui Calvache, Edurne/0000-0003-0768-8648	Ministerio de Ciencia e Innovacion of Spain [SAF2009-07769]; Istituto de Salud Carlos III [RD06/0020/0010]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Istituto de Salud Carlos III(Instituto de Salud Carlos III)	This work was supported by Grants SAF2009-07769 from the Ministerio de Ciencia e Innovacion of Spain and Reticc RD06/0020/0010 from the Istituto de Salud Carlos III.	Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Canela N, 2006, J BIOL CHEM, V281, P35942, DOI 10.1074/jbc.M603511200; Chae HD, 2011, BMB REP, V44, P553, DOI 10.5483/BMBRep.2011.44.8.553; Chen SA, 2010, NAT CELL BIOL, V12, P1108, DOI 10.1038/ncb2116; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Donzelli M, 2002, EMBO J, V21, P4875, DOI 10.1093/emboj/cdf491; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fung TK, 2005, CELL CYCLE, V4, P1411, DOI 10.4161/cc.4.10.2046; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gong DQ, 2007, CURR BIOL, V17, P85, DOI 10.1016/j.cub.2006.11.066; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Jeyakumar M, 2007, J BIOL CHEM, V282, P9312, DOI 10.1074/jbc.M609009200; Kang DS, 2012, BIOCHEM BIOPH RES CO, V420, P822, DOI 10.1016/j.bbrc.2012.03.081; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Marais A, 2010, J BIOL CHEM, V285, P35728, DOI 10.1074/jbc.M110.154005; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; Mateo F, 2009, NUCLEIC ACIDS RES, V37, P7072, DOI 10.1093/nar/gkp777; Moore NL, 2007, STEROIDS, V72, P202, DOI 10.1016/j.steroids.2006.11.025; Orpinell M, 2010, EMBO J, V29, P2381, DOI 10.1038/emboj.2010.125; PAGANO M, 1991, Progress in Growth Factor Research, V3, P267, DOI 10.1016/0955-2235(91)90004-N; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; RESNITZKY D, 1995, MOL CELL BIOL, V15, P4347; ROSENBERG AR, 1995, ONCOGENE, V10, P1501; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Suryadinata R, 2011, J BIOL CHEM, V286, P5108, DOI 10.1074/jbc.M110.198473; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	36	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21096	21104		10.1074/jbc.M113.458323	http://dx.doi.org/10.1074/jbc.M113.458323			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760262	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000322014400030
J	Saini, V; Marengi, DA; Barry, KJ; Fulzele, KS; Heiden, E; Liu, X; Dedic, C; Maeda, A; Lotinun, S; Baron, R; Pajevic, PD				Saini, Vaibhav; Marengi, Dean A.; Barry, Kevin J.; Fulzele, Keertik S.; Heiden, Erica; Liu, Xiaolong; Dedic, Christopher; Maeda, Akira; Lotinun, Sutada; Baron, Roland; Pajevic, Paola Divieti			Parathyroid Hormone (PTH)/PTH-related Peptide Type 1 Receptor (PPR) Signaling in Osteocytes Regulates Anabolic and Catabolic Skeletal Responses to PTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INCREASES BONE-FORMATION; LINING CELLS; EXPRESSION; SOST; MASS; SCLEROSTIN; PROTEIN; OSTEOBLASTS; ACTIVATION; PREVENTION	Parathyroid hormone (PTH) is the only Food and Drug Administration-approved anabolic agent to treat osteoporosis; however, the cellular targets of PTH action in bone remain controversial. PTH modulates bone turnover by binding to the PTH/PTH-related peptide (PTHrP) type 1 receptor (PPR), a G-protein-coupled receptor highly expressed in bone and kidneys. Osteocytes, the most abundant cells in adult bone, also express PPR. However, the physiological relevance of PPR signaling in osteocytes remains to be elucidated. Toward this goal, we generated mice with PPR deletion in osteocytes (Ocy-PPRKO). Skeletal analysis of these mice revealed a significant increase in bone mineral density and trabecular and cortical bone parameters. Osteoblast activities were reduced in these animals, as demonstrated by decreased collagen type I alpha 1 mRNA and receptor activator of NF-kappa B ligand (RANKL) expression. Importantly, when subjected to an anabolic or catabolic PTH regimen, Ocy-PPRKO animals demonstrated blunted skeletal responses. PTH failed to suppress SOST/Sclerostin or induce RANKL expression in Ocy-PPRKO animals compared with controls. In vitro, osteoclastogenesis was significantly impaired in Ocy-PPRKO upon PTH administration, indicating that osteocytes control osteoclast formation through a PPR-mediated mechanism. Taken together, these data indicate that PPR signaling in osteocytes is required for bone remodeling, and receptor signaling in osteocytes is needed for anabolic and catabolic skeletal responses.	[Saini, Vaibhav; Marengi, Dean A.; Barry, Kevin J.; Fulzele, Keertik S.; Heiden, Erica; Liu, Xiaolong; Dedic, Christopher; Maeda, Akira; Baron, Roland; Pajevic, Paola Divieti] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Boston, MA 02114 USA; [Lotinun, Sutada; Baron, Roland] Harvard Univ, Sch Dent Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard School of Dental Medicine	Pajevic, PD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Thier 1101, Boston, MA 02114 USA.	divieti@helix.mgh.harvard.edu	Pajevic, Paola Divieti/M-3236-2019; Centeno, Patricia Pacios/O-8368-2016	Divieti Pajevic, Paola/0000-0001-9853-9837	National Institutes of Health from the NIDDK [DK079161]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK079161, R01DK079161] Funding Source: NIH RePORTER	National Institutes of Health from the NIDDK; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK079161 from the NIDDK (to P.D.P.).	Baron R, 2007, ENDOCRINOLOGY, V148, P2635, DOI 10.1210/en.2007-0270; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Collette NM, 2012, P NATL ACAD SCI USA, V109, P14092, DOI 10.1073/pnas.1207188109; DOBNIG H, 1995, ENDOCRINOLOGY, V136, P3632, DOI 10.1210/en.136.8.3632; FINKELSTEIN JS, 1994, NEW ENGL J MED, V331, P1618, DOI 10.1056/NEJM199412153312404; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Fulzele K, 2013, BLOOD, V121, P930, DOI 10.1182/blood-2012-06-437160; Genetos DC, 2010, J CELL BIOCHEM, V110, P457, DOI 10.1002/jcb.22559; Huang JC, 2004, J BONE MINER RES, V19, P235, DOI 10.1359/JBMR.0301226; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kim SW, 2012, J BONE MINER RES, V27, P2075, DOI 10.1002/jbmr.1665; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Kramer I, 2012, J BONE MINER RES, V27, P360, DOI 10.1002/jbmr.1492; Leupin O, 2007, J BONE MINER RES, V22, P1957, DOI 10.1359/JBMR.070804; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; O'Brien CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002942; PARFITT AM, 1988, CALCIFIED TISSUE INT, V42, P284, DOI 10.1007/BF02556360; Powell WF, 2011, J ENDOCRINOL, V209, P21, DOI 10.1530/JOE-10-0308; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Riancho JA, 2012, PHARMACOGENOMICS, V13, P815, DOI [10.2217/PGS.12.50, 10.2217/pgs.12.50]; Schaffler MB, 2012, CURR OSTEOPOROS REP, V10, P118, DOI 10.1007/s11914-012-0105-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448	31	106	116	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20122	20134		10.1074/jbc.M112.441360	http://dx.doi.org/10.1074/jbc.M112.441360			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23729679	Green Published, hybrid			2022-12-28	WOS:000321715100003
J	Lin, TH; Lee, SO; Niu, YJ; Xu, DF; Liang, L; Li, L; Yeh, SD; Fujimoto, N; Yeh, SY; Chang, CS				Lin, Tzu-Hua; Lee, Soo Ok; Niu, Yuanjie; Xu, Defeng; Liang, Liang; Li, Lei; Yeh, Shauh-Der; Fujimoto, Naohiro; Yeh, Shuyuan; Chang, Chawnshang			Differential Androgen Deprivation Therapies with Anti-androgens Casodex/Bicalutamide or MDV3100/Enzalutamide versus Anti-androgen Receptor ASC-J9 (R) Lead to Promotion versus Suppression of Prostate Cancer Metastasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SPLICE VARIANT; FULL-LENGTH; TGF-BETA; CASTRATION; CELLS; PROGRESSION; EXPRESSION; SURVIVAL; SMAD3	Despite the fact that androgen deprivation therapy (ADT) can effectively reduce prostate cancer (PCa) size, its effect on PCa metastasis remains unclear. We examined the existing data on PCa patients treated with ADT plus anti-androgens to analyze ADT effects on primary tumor size, prostate-specific antigen (PSA) values, and metastatic incidence. We found that the current ADT with anti-androgens might lead to primary tumor reduction, with PSA decreased yet metastases increased in some PCa patients. Using in vitro and in vivo metastasis models with four human PCa cell lines, we evaluated the effects of the currently used anti-androgens, Casodex/bicalutamide and MDV3100/enzalutamide, and the newly developed anti-AR compounds, ASC-J9 (R) and cryptotanshinone, on PCa cell growth and invasion. In vitro results showed that 10 mu M Casodex or MDV3100 treatments suppressed PCa cell growth and reduced PSA level yet significantly enhanced PCa cell invasion. In vivo mice studies using an orthotopic xenograft mouse model also confirmed these results. In contrast, ASC-J9 (R) led to suppressed PCa cell growth and cell invasion in in vitro and in vivo models. Mechanism dissection indicated these Casodex/MDV3100 treatments enhanced the TGF-beta 1/Smad3/MMP9 pathway, but ASC-J9 (R) and cryptotanshinone showed promising anti-inva-sion effects via down-regulation of MMP9 expression. These findings suggest the potential risks of using anti-androgens and provide a potential new therapy using ASC-J9 (R) to battle PCa metastasis at the castration-resistant stage.	[Lin, Tzu-Hua; Lee, Soo Ok; Niu, Yuanjie; Xu, Defeng; Liang, Liang; Li, Lei; Yeh, Shauh-Der; Fujimoto, Naohiro; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA; [Lin, Tzu-Hua; Lee, Soo Ok; Niu, Yuanjie; Xu, Defeng; Liang, Liang; Li, Lei; Yeh, Shauh-Der; Fujimoto, Naohiro; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA; [Lin, Tzu-Hua; Lee, Soo Ok; Niu, Yuanjie; Xu, Defeng; Liang, Liang; Li, Lei; Yeh, Shauh-Der; Fujimoto, Naohiro; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Radiat Oncol, Rochester, NY 14642 USA; [Lin, Tzu-Hua; Lee, Soo Ok; Niu, Yuanjie; Xu, Defeng; Liang, Liang; Li, Lei; Yeh, Shauh-Der; Fujimoto, Naohiro; Yeh, Shuyuan; Chang, Chawnshang] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA; [Niu, Yuanjie] Tianjin Med Univ, Tianjin Inst Urol, Chawnshang Chang Sex Hormone Res Ctr, Tianjin 300211, Peoples R China; [Chang, Chawnshang] China Med Univ & Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan	University of Rochester; University of Rochester; University of Rochester; University of Rochester; Tianjin Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, CS (corresponding author), Univ Rochester, Med Ctr, Dept Pathol, George Whipple Lab Canc Res, Rochester, NY 14642 USA.	chang@urmc.rochester.edu		Chang, Chawnshang/0000-0001-8510-3516; Lin, Tzuhua/0000-0001-8475-9345	George Whipple Professorship Endowment and Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; National Institutes of Health [CA156700]; NATIONAL CANCER INSTITUTE [R01CA156700] Funding Source: NIH RePORTER	George Whipple Professorship Endowment and Taiwan Department of Health Clinical Trial and Research Center of Excellence; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA156700. This work was also supported by the George Whipple Professorship Endowment and Taiwan Department of Health Clinical Trial and Research Center of Excellence Grant DOH99-TD-B-111-004. ASC-J9 (R) was patented by the University of Rochester, University of North Carolina, and AndroScience and then licensed to AndroScience. Both the University of Rochester and C. Chang own royalties and equity in AndroScience.	Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Gingrich JR, 1997, CANCER RES, V57, P4687; Guo ZY, 2009, CANCER RES, V69, P2305, DOI 10.1158/0008-5472.CAN-08-3795; Hu R, 2012, CANCER RES, V72, P3457, DOI 10.1158/0008-5472.CAN-11-3892; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jennbacken K, 2010, ENDOCR-RELAT CANCER, V17, P469, DOI 10.1677/ERC-10-0015; Kleeberger W, 2007, CANCER RES, V67, P9199, DOI 10.1158/0008-5472.CAN-07-0806; Kolvenbag GJCM, 1998, PROSTATE, V34, P61, DOI 10.1002/(SICI)1097-0045(19980101)34:1<61::AID-PROS8>3.0.CO;2-N; KYPRIANOU N, 1989, MOL ENDOCRINOL, V3, P1515, DOI 10.1210/mend-3-10-1515; Lai JJ, 2009, J CLIN INVEST, V119, P3739, DOI 10.1172/JCI39335; Lai KP, 2013, AM J PATHOL, V182, P460, DOI 10.1016/j.ajpath.2012.10.029; Lee YC, 2010, J PATHOL, V221, P68, DOI 10.1002/path.2687; Levin JI, 2001, BIOORG MED CHEM LETT, V11, P2189, DOI 10.1016/S0960-894X(01)00419-X; Lin HK, 2003, J BIOL CHEM, V278, P50902, DOI 10.1074/jbc.M300676200; Liu XJ, 2006, PHARM RES-DORDR, V23, P82, DOI 10.1007/s11095-005-9043-5; Lu-Yao GL, 2008, JAMA-J AM MED ASSOC, V300, P173, DOI 10.1001/jama.300.2.173; Lupien M, 2009, ENDOCR-RELAT CANCER, V16, P381, DOI 10.1677/ERC-09-0038; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Mulholland DJ, 2011, CANCER CELL, V19, P792, DOI 10.1016/j.ccr.2011.05.006; Murillo H, 2001, ENDOCRINOLOGY, V142, P4795, DOI 10.1210/en.142.11.4795; Nishi N, 1996, PROSTATE, V28, P139; Niu Y, 2010, ONCOGENE, V29, P3593, DOI 10.1038/onc.2010.121; Niu YJ, 2008, P NATL ACAD SCI USA, V105, P12182, DOI 10.1073/pnas.0804700105; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Qi W, 2008, BIOCHEM J, V416, P453, DOI 10.1042/BJ20080651; Ryan CJ, 2011, CLIN CANCER RES, V17, P4854, DOI 10.1158/1078-0432.CCR-11-0815; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Song K, 2010, MOL ENDOCRINOL, V24, P2019, DOI 10.1210/me.2010-0165; Tang Y, 2008, CLIN CANCER RES, V14, P2936, DOI 10.1158/1078-0432.CCR-07-4925; Tyrrell CJ, 1998, EUR UROL, V33, P447, DOI 10.1159/000019634; Virtakoivu R, 2012, MOL BIOL CELL, V23, P3357, DOI 10.1091/mbc.E12-03-0213; VOGES GE, 1995, EUR UROL, V28, P209; VOGES GE, 1994, PROSTATE, P4; Wu CY, 2012, INT J CANCER, V131, P1423, DOI 10.1002/ijc.27343; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Xiang B, 2006, METHOD ENZYMOL, V406, P692, DOI 10.1016/S0076-6879(06)06054-X; Xu DF, 2012, CANCER LETT, V316, P11, DOI 10.1016/j.canlet.2011.10.006; Yamashita S, 2012, NEOPLASIA, V14, P74, DOI 10.1593/neo.111436; Yang ZM, 2007, NAT MED, V13, P348, DOI 10.1038/nm1547	43	93	96	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19359	19369		10.1074/jbc.M113.477216	http://dx.doi.org/10.1074/jbc.M113.477216			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23687298	hybrid, Green Published			2022-12-28	WOS:000321515800006
J	Tashiro, E; Zako, T; Muto, H; Itoo, Y; Sorgjerd, K; Terada, N; Abe, A; Miyazawa, M; Kitamura, A; Kitaura, H; Kubota, H; Maeda, M; Momoi, T; Iguchi-Ariga, SMM; Kinjo, M; Ariga, H				Tashiro, Erika; Zako, Tamotsu; Muto, Hideki; Itoo, Yoshinori; Soergjerd, Karin; Terada, Naofumi; Abe, Akira; Miyazawa, Makoto; Kitamura, Akira; Kitaura, Hirotake; Kubota, Hiroshi; Maeda, Mizuo; Momoi, Takashi; Iguchi-Ariga, Sanae M. M.; Kinjo, Masataka; Ariga, Hiroyoshi			Prefoldin Protects Neuronal Cells from Polyglutamine Toxicity by Preventing Aggregation Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHAPERONE PREFOLDIN; MYC-BINDING PROTEIN; INTRANUCLEAR INCLUSIONS; CYTOSOLIC CHAPERONIN; EUKARYOTIC PREFOLDIN; C-MYC; HUNTINGTONS-DISEASE; EXPANSION PROTEINS; MUTANT HUNTINGTIN; UNFOLDED PROTEINS	Huntington disease is caused by cell death after the expansion of polyglutamine (polyQ) tracts longer than similar to 40 repeats encoded by exon 1 of the huntingtin (HTT) gene. Prefoldin is a molecular chaperone composed of six subunits, PFD1-6, and prevents misfolding of newly synthesized nascent polypeptides. In this study, we found that knockdown of PFD2 and PFD5 disrupted prefoldin formation in HTT-expressing cells, resulting in accumulation of aggregates of a pathogenic form of HTT and in induction of cell death. Dead cells, however, did not contain inclusions of HTT, and analysis by a fluorescence correlation spectroscopy indicated that knockdown of PFD2 and PFD5 also increased the size of soluble oligomers of pathogenic HTT in cells. In vitro single molecule observation demonstrated that prefoldin suppressed HTT aggregation at the small oligomer (dimer to tetramer) stage. These results indicate that prefoldin inhibits elongation of large oligomers of pathogenic Htt, thereby inhibiting subsequent inclusion formation, and suggest that soluble oligomers of polyQ-expanded HTT are more toxic than are inclusion to cells.	[Tashiro, Erika; Abe, Akira; Miyazawa, Makoto; Kitaura, Hirotake; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido 0600812, Japan; [Tashiro, Erika; Abe, Akira; Miyazawa, Makoto] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Zako, Tamotsu; Itoo, Yoshinori; Soergjerd, Karin; Maeda, Mizuo] Riken Inst Phys & Chem Res, Bioengn Lab, Wako, Saitama 3510198, Japan; [Muto, Hideki; Terada, Naofumi; Kitamura, Akira; Kinjo, Masataka] Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido 0010021, Japan; [Itoo, Yoshinori] Univ Tokyo, Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Kubota, Hiroshi] Akita Univ, Grad Sch, Akita 0108502, Japan; [Kubota, Hiroshi] Akita Univ, Fac Engn & Resource Sci, Akita 0108502, Japan; [Momoi, Takashi] Int Univ Hlth & Welf, Med Res Ctr, Otawara, Tochigi 3240011, Japan; [Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University; RIKEN; Hokkaido University; University of Tokyo; Akita University; Akita University; International University of Health & Welfare; Hokkaido University	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp	Maeda, Mizuo/I-3498-2014; Zako, Tamotsu/C-3004-2012; Kinjo, Masataka/F-5267-2011	Kinjo, Masataka/0000-0001-8889-8369	Ministry of Education, Culture, Sports, Science and Technology; New Energy and Industrial Technology Development Organization; RIKEN; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan; Grants-in-Aid for Scientific Research [24570143] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); RIKEN; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology, New Energy and Industrial Technology Development Organization, RIKEN, and the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, Japan.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Cao S, 2008, J IMMUNOL, V181, P476, DOI 10.4049/jimmunol.181.1.476; Cummings CJ, 2001, HUM MOL GENET, V10, P1511, DOI 10.1093/hmg/10.14.1511; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Dong GF, 2012, J BIOL CHEM, V287, P1279, DOI 10.1074/jbc.M111.294280; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Elson EL, 2001, TRAFFIC, V2, P789, DOI 10.1034/j.1600-0854.2001.21107.x; Fujioka Y, 2001, J BIOL CHEM, V276, P45137, DOI 10.1074/jbc.M106127200; Geissler S, 1998, EMBO J, V17, P952, DOI 10.1093/emboj/17.4.952; GELL C, 2006, HDB SINGLE MOL FLUOR; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Iijima M, 1996, ACTA MED OKAYAMA, V50, P73; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Klumpp M, 1997, CELL, V91, P263, DOI 10.1016/S0092-8674(00)80408-0; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Lee Y, 2011, J BIOL CHEM, V286, P726, DOI 10.1074/jbc.M110.177352; Llorca O, 1999, NAT STRUCT BIOL, V6, P639; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Martin-Benito J, 2007, STRUCTURE, V15, P101, DOI 10.1016/j.str.2006.11.006; Miyazawa M, 2011, J BIOL CHEM, V286, P19191, DOI 10.1074/jbc.M110.216259; Mori K, 1998, J BIOL CHEM, V273, P29794, DOI 10.1074/jbc.273.45.29794; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Mousnier A, 2007, P NATL ACAD SCI USA, V104, P13615, DOI 10.1073/pnas.0705162104; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Myung Jae-Kyung, 2004, Proteome Sci, V2, P8, DOI 10.1186/1477-5956-2-8; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Sakono M, 2008, FEBS J, V275, P5982, DOI 10.1111/j.1742-4658.2008.06727.x; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Siegers K, 1999, EMBO J, V18, P75, DOI 10.1093/emboj/18.1.75; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Simons CT, 2004, J BIOL CHEM, V279, P4196, DOI 10.1074/jbc.M306053200; Taguchi H, 2001, NAT BIOTECHNOL, V19, P861, DOI 10.1038/nbt0901-861; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tang B, 2011, NEUROBIOL DIS, V42, P459, DOI 10.1016/j.nbd.2011.02.008; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zako T, 2005, FEBS LETT, V579, P3718, DOI 10.1016/j.febslet.2005.05.061; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	56	36	38	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19958	19972		10.1074/jbc.M113.477984	http://dx.doi.org/10.1074/jbc.M113.477984			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720755	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000321515800061
J	Moore, BS; Mirshahi, UL; Ebersole, TL; Mirshahi, T				Moore, Bryn S.; Mirshahi, Uyenlinh L.; Ebersole, Tonya L.; Mirshahi, Tooraj			A Conserved Mechanism for Gating in an Ionotropic Glutamate Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING CORE; LURCHER MUTATION; TRANSMEMBRANE HELIX; POTASSIUM CHANNELS; MEMBRANE-PROTEINS; K+ CHANNELS; AMPA; DESENSITIZATION; ACTIVATION; CONFORMATION	Ionotropic glutamate receptor (iGluR) channels control synaptic activity. The crystallographic structure of GluA2, the prototypical iGluR, reveals a clamshell-like ligand-binding domain (LBD) that closes in the presence of glutamate to open a gate on the pore lining alpha-helix. How LBD closure leads to gate opening remains unclear. Here, we show that bending the pore helix at a highly conserved alanine residue (Ala-621) below the gate is responsible for channel opening. Substituting Ala-621 with the smaller more flexible glycine resulted in a basally active, nondesensitizing channel with similar to 39-fold increase in glutamate potency without affecting surface expression or binding. On GluA2(A621G), the partial agonist kainate showed efficacy similar to a full agonist, and competitive antagonists CNQX and DNQX acted as a partial agonists. Met-629 in GluA2 sits above the gate and is critical in transmitting LBD closure to the gate. Substituting Met-629 with the flexible glycine resulted in reduced channel activity and glutamate potency. The pore regions in potassium channels are structurally similar to iGluRs. Whereas potassium channels typically use glycines as a hinge for gating, iGluRs use the less flexible alanine as a hinge at a similar position to maintain low basal activity allowing for ligand-mediated gating.	[Moore, Bryn S.; Mirshahi, Uyenlinh L.; Ebersole, Tonya L.; Mirshahi, Tooraj] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA		Mirshahi, T (corresponding author), Weis Ctr Res, Geisinger Clin, 100 North Acad Ave, Danville, PA 17822 USA.	tmirshahi@geisinger.edu		Moore, Bryn/0000-0002-8758-7611	Geisinger Clinic	Geisinger Clinic	This work was supported by funds from the Geisinger Clinic.	Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; BENNETT JA, 1995, NEURON, V14, P373, DOI 10.1016/0896-6273(95)90293-7; Chen GQ, 1998, PROTEIN SCI, V7, P2623, DOI 10.1002/pro.5560071216; Deupi X, 2010, J STRUCT BIOL, V169, P116, DOI 10.1016/j.jsb.2009.09.009; Dong H, 2012, BIOCHEMISTRY-US, V51, P4779, DOI 10.1021/bi300090x; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Eilers M, 2000, P NATL ACAD SCI USA, V97, P5796, DOI 10.1073/pnas.97.11.5796; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; Klein RM, 2004, J NEUROSCI, V24, P4941, DOI 10.1523/JNEUROSCI.0660-04.2004; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Mirshahi T, 2002, J BIOL CHEM, V277, P7348, DOI 10.1074/jbc.M109999200; Rosenhouse-Dantsker A, 2007, CHANNELS, V1, P189, DOI 10.4161/chan.4475; Schlesinger F, 2005, BRIT J PHARMACOL, V145, P656, DOI 10.1038/sj.bjp.0706233; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; Sobolevsky AI, 2003, J NEUROSCI, V23, P7559; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wollmuth LP, 2000, J NEUROSCI, V20, P5973, DOI 10.1523/JNEUROSCI.20-16-05973.2000; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	31	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18842	18852		10.1074/jbc.M113.465187	http://dx.doi.org/10.1074/jbc.M113.465187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671286	Green Published, hybrid			2022-12-28	WOS:000321335800022
J	Hoffmann, DC; Willenborg, S; Koch, M; Zwolanek, D; Muller, S; Becker, AKA; Metzger, S; Ehrbar, M; Kurschat, P; Hellmich, M; Hubbell, JA; Eming, SA				Hoffmann, Daniel C.; Willenborg, Sebastian; Koch, Manuel; Zwolanek, Daniela; Mueller, Stefan; Becker, Ann-Kathrin A.; Metzger, Stephanie; Ehrbar, Martin; Kurschat, Peter; Hellmich, Martin; Hubbell, Jeffrey A.; Eming, Sabine A.			Proteolytic Processing Regulates Placental Growth Factor Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL MIGRATION; HEPARIN-BINDING; VEGF-A; NEUROPILIN-1 BINDS; STRUCTURAL BASIS; TYROSINE KINASE; RECEPTOR; ANGIOGENESIS; INHIBITION; GENE	Placental growth factor (PlGF) is a critical mediator of blood vessel formation, yet mechanisms of its action and regulation are incompletely understood. Here we demonstrate that proteolytic processing regulates the biological activity of PlGF. Specifically, we show that plasmin processing of PlGF-2 yields a protease-resistant core fragment comprising the vascular endothelial growth factor receptor-1 binding site but lacking the carboxyl-terminal domain encoding the heparin-binding domain and an 8-amino acid peptide encoded by exon 7. We have identified plasmin cleavage sites, generated a truncated PlGF118 isoform mimicking plasmin-processed PlGF, and explored its biological function in comparison with that of PlGF-1 and -2. The angiogenic responses induced by the diverse PlGF forms were distinct. Whereas PlGF-2 increased endothelial cell chemotaxis, vascular sprouting, and granulation tissue formation upon skin injury, these activities were abrogated following plasmin digestion. Investigation of PlGF/Neuropilin-1 binding and function suggests a critical role for heparin-binding domain/Neuropilin-1 interaction and its regulation by plasmin processing. Collectively, here we provide new mechanistic insights into the regulation of PlGF-2/Neuropilin-1-mediated tissue vascularization and growth.	[Hoffmann, Daniel C.; Willenborg, Sebastian; Kurschat, Peter; Eming, Sabine A.] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany; [Koch, Manuel; Zwolanek, Daniela; Becker, Ann-Kathrin A.] Univ Cologne, Inst Dent Res & Oral Musculoskeletal Biol, Ctr Biochem, D-50937 Cologne, Germany; [Koch, Manuel; Mueller, Stefan; Eming, Sabine A.] Univ Cologne, Ctr Mol Med Cologne, D-50937 Cologne, Germany; [Hellmich, Martin] Univ Cologne, Inst Med Stat Informat & Epidemiol, D-50937 Cologne, Germany; [Eming, Sabine A.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50937 Cologne, Germany; [Metzger, Stephanie; Ehrbar, Martin] Univ Zurich Hosp, Dept Obstet, CH-8091 Zurich, Switzerland; [Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland	University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Cologne; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Eming, SA (corresponding author), Univ Cologne, Dept Dermatol, Kerpenerstr 62, D-50937 Cologne, Germany.	sabine.eming@uni-koeln.de	Zwolanek, Daniela/AAN-8767-2020; Ehrbar, Martin/O-4130-2019; Koch, Manuel/AAG-9914-2021; Hubbell, Jeffrey A/A-9266-2008; Ehrbar, Martin/F-4578-2012	Ehrbar, Martin/0000-0003-2707-4870; Koch, Manuel/0000-0002-2962-7814; Hubbell, Jeffrey A/0000-0003-0276-5456; Ehrbar, Martin/0000-0003-2707-4870; Hellmich, Martin/0000-0001-5174-928X	European Union [NMP-LA-2008-214402]; Deutsche Forschungsgemeinschaft [SFB 829, SFB 832]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant Angioscaff NMP-LA-2008-214402 (to S. A. E., M. E., and J. A. H.) from the European Union and Deutsche Forschungsgemeinschaft Grants SFB 829 (to S. A. E., P. K., and M. K.) and SFB 832 (to M. K.).	Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Ballmer-Hofer K, 2011, BLOOD, V118, P816, DOI 10.1182/blood-2011-01-328773; Carmeliet P, 2001, NAT MED, V7, P575, DOI 10.1038/87904; Cebe-Suarez S, 2008, FASEB J, V22, P3078, DOI 10.1096/fj.08-107219; Cianfarani F, 2006, AM J PATHOL, V169, P1167, DOI 10.2353/ajpath.2006.051314; DiPalma T, 1996, MAMM GENOME, V7, P6, DOI 10.1007/s003359900003; Eming SA, 2006, J INVEST DERMATOL, V126, P2731, DOI 10.1038/sj.jid.5700474; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; HAUSER S, 1993, GROWTH FACTORS, V9, P259, DOI 10.3109/08977199308991586; Herzog B, 2011, MOL BIOL CELL, V22, P2766, DOI 10.1091/mbc.E09-12-1061; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Iwasaki H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024872; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Lauer G, 2000, J INVEST DERMATOL, V115, P12, DOI 10.1046/j.1523-1747.2000.00036.x; Lee S, 2005, J CELL BIOL, V169, P681, DOI 10.1083/jcb.200409115; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Maes C, 2006, J CLIN INVEST, V116, P1230, DOI 10.1172/JCI26772; MAGLIONE D, 1993, ONCOGENE, V8, P925; Mamluk R, 2002, J BIOL CHEM, V277, P24818, DOI 10.1074/jbc.M200730200; Migdal M, 1998, J BIOL CHEM, V273, P22272, DOI 10.1074/jbc.273.35.22272; Oura H, 2003, BLOOD, V101, P560, DOI 10.1182/blood-2002-05-1516; Palolahti M, 1993, Exp Dermatol, V2, P29, DOI 10.1111/j.1600-0625.1993.tb00196.x; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Parker MW, 2012, J BIOL CHEM, V287, P11082, DOI 10.1074/jbc.M111.331140; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; Roth D, 2006, AM J PATHOL, V168, P670, DOI 10.2353/ajpath.2006.050372; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Sawano A, 1996, CELL GROWTH DIFFER, V7, P213; Shintani Y, 2006, EMBO J, V25, P3045, DOI 10.1038/sj.emboj.7601188; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; Vander Kooi CW, 2007, P NATL ACAD SCI USA, V104, P6152, DOI 10.1073/pnas.0700043104; von Wronski MA, 2006, J BIOL CHEM, V281, P5702, DOI 10.1074/jbc.M511941200; Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694; Zachary IC, 2011, BIOCHEM SOC T, V39, P1583, DOI 10.1042/BST20110697	43	14	15	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17976	17989		10.1074/jbc.M113.451831	http://dx.doi.org/10.1074/jbc.M113.451831			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645683	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000320721900005
J	Gold, MG; Fowler, DM; Means, CK; Pawson, CT; Stephany, JJ; Langeberg, LK; Fields, S; Scott, JD				Gold, Matthew G.; Fowler, Douglas M.; Means, Christopher K.; Pawson, Catherine T.; Stephany, Jason J.; Langeberg, Lorene K.; Fields, Stanley; Scott, John D.			Engineering A-kinase Anchoring Protein (AKAP)-selective Regulatory Subunits of Protein Kinase A (PKA) through Structure-based Phage Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKAP; DYNAMICS; BINDING; SPECIFICITY; NEURONS; COMPLEX; RII	PKA is retained within distinct subcellular environments by the association of its regulatory type II (RII) subunits with A-kinase anchoring proteins (AKAPs). Conventional reagents that universally disrupt PKA anchoring are patterned after a conserved AKAP motif. We introduce a phage selection procedure that exploits high-resolution structural information to engineer RII mutants that are selective for a particular AKAP. Selective RII (R-Select) sequences were obtained for eight AKAPs following competitive selection screening. Biochemical and cell-based experiments validated the efficacy of RSelect proteins for AKAP2 and AKAP18. These engineered proteins represent a new class of reagents that can be used to dissect the contributions of different AKAP-targeted pools of PKA. Molecular modeling and high-throughput sequencing analyses revealed the molecular basis of AKAP-selective interactions and shed new light on native RII-AKAP interactions. We propose that this structure-directed evolution strategy might be generally applicable for the investigation of other protein interaction surfaces.	[Gold, Matthew G.; Fowler, Douglas M.; Means, Christopher K.; Pawson, Catherine T.; Stephany, Jason J.; Langeberg, Lorene K.; Fields, Stanley; Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Gold, Matthew G.; Means, Christopher K.; Pawson, Catherine T.; Langeberg, Lorene K.; Scott, John D.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Fowler, Douglas M.; Stephany, Jason J.; Fields, Stanley] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Fields, Stanley] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gold, MG (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Mortimer St, London WC1E 6BT, England.	m.gold@ucl.ac.uk; scottjdw@uw.edu	Gold, Matthew/AAL-2546-2021	Gold, Matthew/0000-0002-1281-0815	National Institutes of Health [P41 GM103533, F32 GM084699, GM48231]; Experimental Pathology of Cardiovascular Disease Training Grant [T32 HL07312]; Sir Henry Wellcome postdoctoral research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084699, R01GM048231, P41GM103533, R37GM048231] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Experimental Pathology of Cardiovascular Disease Training Grant; Sir Henry Wellcome postdoctoral research fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41 GM103533 (to S. F.), F32 GM084699 (to D. M. F.), and GM48231 (to J. D. S.) and Experimental Pathology of Cardiovascular Disease Training Grant T32 HL07312 (to C. K. M.). This work was also supported by a Sir Henry Wellcome postdoctoral research fellowship (to M. G. G.).	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Brown RL, 2003, BIOCHEM BIOPH RES CO, V306, P394, DOI 10.1016/S0006-291X(03)00982-3; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; CARR DW, 1991, J BIOL CHEM, V266, P14188; Christian F, 2011, J BIOL CHEM, V286, P9079, DOI 10.1074/jbc.M110.160614; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fowler DM, 2011, BIOINFORMATICS, V27, P3430, DOI 10.1093/bioinformatics/btr577; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gold MG, 2006, CURR OPIN STRUC BIOL, V16, P693, DOI 10.1016/j.sbi.2006.10.006; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gold MG, 2012, EMBO MOL MED, V4, P15, DOI 10.1002/emmm.201100184; Gold MG, 2011, P NATL ACAD SCI USA, V108, P6426, DOI 10.1073/pnas.1014400108; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; KEELY SL, 1977, RES COMMUN CHEM PATH, V18, P283; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Knight R, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng030; Lester LB, 1997, P NATL ACAD SCI USA, V94, P14942, DOI 10.1073/pnas.94.26.14942; Li HM, 2012, NAT STRUCT MOL BIOL, V19, P337, DOI 10.1038/nsmb.2238; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Pawson CT, 2010, NAT STRUCT MOL BIOL, V17, P653, DOI 10.1038/nsmb.1843; ROSENMUND C, 1994, NATURE, V368, P853, DOI 10.1038/368853a0; Roy J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2100re9; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; THEURKAUF WE, 1982, J BIOL CHEM, V257, P3284; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Zhong HN, 2009, NEURON, V62, P363, DOI 10.1016/j.neuron.2009.03.013	38	32	32	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17111	17121		10.1074/jbc.M112.447326	http://dx.doi.org/10.1074/jbc.M112.447326			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625929	Green Published, hybrid			2022-12-28	WOS:000320380600009
J	Saito, S; Hosoda, N; Hoshino, S				Saito, Syuhei; Hosoda, Nao; Hoshino, Shin-ichi			The Hbs1-Dom34 Protein Complex Functions in Non-stop mRNA Decay in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NO-GO DECAY; EXON JUNCTION COMPLEX; TERMINATION FACTOR ERF3; E3 UBIQUITIN LIGASE; TRANSLATION TERMINATION; QUALITY-CONTROL; ENDONUCLEOLYTIC CLEAVAGE; STRUCTURAL BASIS; NONSENSE CODONS; RELEASE FACTORS	In yeast, aberrant mRNAs lacking in-frame termination codons are recognized and degraded by the non-stop decay (NSD) pathway. The recognition of non-stop mRNAs involves a member of the eRF3 family of GTP-binding proteins, Ski7. Ski7 is thought to bind the ribosome stalled at the 3'-end of the mRNA poly(A) tail and recruit the exosome to degrade the aberrant message. However, Ski7 is not found in mammalian cells, and even the presence of the NSD mechanism itself has remained enigmatic. Here, we show that unstable non-stop mRNA is degraded in a translation-dependent manner in mammalian cells. The decay requires another eRF3 family member (Hbs1), its binding partner Dom34, and components of the exosome-Ski complex (Ski2/Mtr4 and Dis3). Hbs1-Dom34 binds to form a complex with the exosome-Ski complex. Also, the elimination of aberrant proteins produced from non-stop transcripts requires the RING finger protein listerin. These findings demonstrate that the NSD mechanism exists in mammalian cells and involves Hbs1, Dom34, and the exosome-Ski complex.	[Hoshino, Shin-ichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Nagoya, Aichi 4678603, Japan	Nagoya City University	Hoshino, S (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	hoshino@phar.nagoya-cu.ac.jp		Hoshino, Shinichi/0000-0001-6135-7896	Ministry of Education, Culture, Sports, Science and Technology of Japan [20112005]; Japan Society for the Promotion of Science [21370080]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas "RNA Regulation" 20112005 from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Grant-in-aid for Scientific Research (B) 21370080 from the Japan Society for the Promotion of Science (to S. H.).	Akimitsu N, 2007, EMBO J, V26, P2327, DOI 10.1038/sj.emboj.7601679; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Araki Y, 2001, EMBO J, V20, P4684, DOI 10.1093/emboj/20.17.4684; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Becker T, 2011, NAT STRUCT MOL BIOL, V18, P715, DOI 10.1038/nsmb.2057; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brown JT, 2000, RNA, V6, P449, DOI 10.1017/S1355838200991787; Carr-Schmid A, 2002, MOL CELL BIOL, V22, P2564, DOI 10.1128/MCB.22.8.2564-2574.2002; Chatr-aryamontri A, 2004, HUM MUTAT, V24, P526, DOI 10.1002/humu.20117; Chen LM, 2010, NAT STRUCT MOL BIOL, V17, P1233, DOI 10.1038/nsmb.1922; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Harigaya Y, 2010, WIRES RNA, V1, P132, DOI 10.1002/wrna.17; HENTZE MW, 1988, GENE, V72, P201, DOI 10.1016/0378-1119(88)90145-X; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; Hoshino S, 1999, J BIOL CHEM, V274, P16677, DOI 10.1074/jbc.274.24.16677; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Hosoda N, 2011, EMBO J, V30, P1311, DOI 10.1038/emboj.2011.37; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Klauer AA, 2012, WIRES RNA, V3, P649, DOI 10.1002/wrna.1124; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P17575, DOI 10.1073/pnas.1009598107; Kong J, 2007, NAT STRUCT MOL BIOL, V14, P670, DOI 10.1038/nsmb1256; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Onouchi H, 2005, GENE DEV, V19, P1799, DOI 10.1101/gad.1317105; Passos DO, 2009, MOL BIOL CELL, V20, P3025, DOI 10.1091/mbc.E09-01-0028; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Ruan L, 2010, J BIOL CHEM, V285, P27624, DOI 10.1074/jbc.M110.138867; Schaeffer D, 2011, P NATL ACAD SCI USA, V108, P2366, DOI 10.1073/pnas.1013180108; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; Thermann R, 1998, EMBO J, V17, P3484, DOI 10.1093/emboj/17.12.3484; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Torres-Torronteras J, 2011, HUM MUTAT, V32, pE2061, DOI 10.1002/humu.21447; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; van den Elzen AMG, 2010, NAT STRUCT MOL BIOL, V17, P1446, DOI 10.1038/nsmb.1963; van Hoof A, 2005, GENETICS, V171, P1455, DOI 10.1534/genetics.105.044057; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Wallrapp C, 1998, FEBS LETT, V440, P387, DOI 10.1016/S0014-5793(98)01492-6; Wang LN, 2005, RNA, V11, P1291, DOI 10.1261/rna.2060405; Wilson MA, 2007, GENETICS, V177, P773, DOI 10.1534/genetics.107.073205; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	59	52	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17832	17843		10.1074/jbc.M112.448977	http://dx.doi.org/10.1074/jbc.M112.448977			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23667253	hybrid, Green Published			2022-12-28	WOS:000320380600072
J	Hawkins, BE; Krishnamurthy, S; Castillo-Carranza, DL; Sengupta, U; Prough, DS; Jackson, GR; DeWitt, DS; Kayed, R				Hawkins, Bridget E.; Krishnamurthy, Shashirekha; Castillo-Carranza, Diana L.; Sengupta, Urmi; Prough, Donald S.; Jackson, George R.; DeWitt, Douglas S.; Kayed, Rakez			Rapid Accumulation of Endogenous Tau Oligomers in a Rat Model of Traumatic Brain Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; POSTTRAUMATIC EPILEPSY; PHOSPHORYLATION SITES; NEURONAL LOSS; MOUSE MODEL; HEAD-INJURY; IN-VITRO; TAUOPATHY	Traumatic brain injury (TBI) is a serious problem that affects millions of people in the United States alone. Multiple concussions or even a single moderate to severe TBI can also predispose individuals to develop a pathologically distinct form of tauopathy- related dementia at an early age. No effective treatments are currently available for TBI or TBI-related dementia; moreover, only recently has insight been gained regarding the mechanisms behind their connection. Here, we used antibodies to detect oligomeric and phosphorylated Tau proteins in a non-transgenic rodent model of parasagittal fluid percussion injury. Oligomeric and phosphorylated Tau proteins were detected 4 and 24 h and 2 weeks post-TBI in injured, but not sham control rats. These findings suggest that diagnostic tools and therapeutics that target only toxic forms of Tau may provide earlier detection and safe, more effective treatments for tauopathies associated with repetitive neurotrauma.	[Hawkins, Bridget E.; Jackson, George R.; Kayed, Rakez] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Hawkins, Bridget E.; Prough, Donald S.; DeWitt, Douglas S.] Univ Texas Med Branch, Moody Ctr Traumat Brain & Spinal Cord Injury Res, Galveston, TX 77555 USA; [Hawkins, Bridget E.; Prough, Donald S.; DeWitt, Douglas S.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Krishnamurthy, Shashirekha; Castillo-Carranza, Diana L.; Sengupta, Urmi; Jackson, George R.; Kayed, Rakez] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Krishnamurthy, Shashirekha; Castillo-Carranza, Diana L.; Sengupta, Urmi; Jackson, George R.; Kayed, Rakez] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Krishnamurthy, Shashirekha; Castillo-Carranza, Diana L.; Sengupta, Urmi; Jackson, George R.; Kayed, Rakez] Univ Texas Med Branch, George & Cynthia Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Kayed, R (corresponding author), Univ Texas Med Branch, 301 Univ Blvd, Galveston, TX 77555 USA.	rakayed@utmb.edu	Prough, Donald S/G-5793-2013; Hawkins, Bridget/H-4933-2015	Prough, Donald S/0000-0001-7994-532X; Hawkins, Bridget/0000-0002-1887-3657; Castillo-Carranza, Diana/0000-0003-2511-949X	Cullen Family Trust for Health Care, the Mitchell Center for Neurodegenerative Diseases; Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect	Cullen Family Trust for Health Care, the Mitchell Center for Neurodegenerative Diseases; Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect	This work was supported by the Cullen Family Trust for Health Care, the Mitchell Center for Neurodegenerative Diseases, and the Moody Center for Traumatic Brain & Spinal Cord Injury Research/Mission Connect. R.K. has patent applications on the compositions and methods related to Tau oligomers and antibodies.	Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Behan LA, 2008, J NEUROL NEUROSUR PS, V79, P753, DOI 10.1136/jnnp.2007.132837; Berger Z, 2007, J NEUROSCI, V27, P3650, DOI 10.1523/JNEUROSCI.0587-07.2007; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Castillo-Carranza D. L., 2010, SOC NEUROSCI; Castillo-Carranza Diana L, 2013, Front Biosci (Schol Ed), V5, P426; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Colicos MA, 1996, BRAIN RES, V739, P111, DOI 10.1016/S0006-8993(96)00819-0; Cowan CM, 2012, BIOCHEM SOC T, V40, P693, DOI 10.1042/BST20120135; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GOLDSTEIN LE, 2012, SCI TRANSL MED, V4; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Hall GF, 2012, PRION, V6, P223, DOI 10.4161/pri.19912; Haroutunian V, 2007, NEUROBIOL AGING, V28, P1, DOI 10.1016/j.neurobiolaging.2005.11.001; Hawkins BE, 2012, BRAIN RES, V1432, P28, DOI 10.1016/j.brainres.2011.11.009; Hellmich HL, 2007, BRAIN RES, V1127, P119, DOI 10.1016/j.brainres.2006.09.094; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Henkins KM, 2012, BRAIN PATHOL, V22, P826, DOI 10.1111/j.1750-3639.2012.00598.x; Hoshino S, 1998, NEUROREPORT, V9, P1879, DOI 10.1097/00001756-199806010-00039; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kril JJ, 2002, ACTA NEUROPATHOL, V103, P370, DOI 10.1007/s00401-001-0477-5; Lasagna-Reeves CA, 2011, CURR ALZHEIMER RES, V8, P659; Lasagna-Reeves CA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00700; Lasagna-Reeves CA, 2012, FASEB J, V26, P1946, DOI 10.1096/fj.11-199851; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lasagna-Reeves CA, 2010, BIOCHEMISTRY-US, V49, P10039, DOI 10.1021/bi1016233; Le Meghan N, 2012, Am J Neurodegener Dis, V1, P316; Li Y, 2010, BRAIN RES, V1330, P131, DOI 10.1016/j.brainres.2010.03.034; Liliang PC, 2010, RESUSCITATION, V81, P1205, DOI 10.1016/j.resuscitation.2010.05.016; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Maeda S, 2006, NEUROSCI RES, V54, P197, DOI 10.1016/j.neures.2005.11.009; Magnoni S, 2012, BRAIN, V135, P1268, DOI 10.1093/brain/awr286; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Morsch R, 1999, J NEUROPATH EXP NEUR, V58, P188, DOI 10.1097/00005072-199902000-00008; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Patterson KR, 2011, J BIOL CHEM, V286, P23063, DOI 10.1074/jbc.M111.237974; Pitkanen A, 2006, J NEUROTRAUM, V23, P241, DOI 10.1089/neu.2006.23.241; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Rojo DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023111; Schneider A, 2008, NEUROTHERAPEUTICS, V5, P443, DOI 10.1016/j.nurt.2008.05.006; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Spires TL, 2006, AM J PATHOL, V168, P1598, DOI 10.2353/ajpath.2006.050840; Tai HC, 2012, AM J PATHOL, V181, P1426, DOI 10.1016/j.ajpath.2012.06.033; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Ubhi K, 2011, EXP NEUROL, V230, P157, DOI 10.1016/j.expneurol.2010.10.007; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528	63	99	102	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					17042	17050		10.1074/jbc.M113.472746	http://dx.doi.org/10.1074/jbc.M113.472746			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23632019	Green Published, hybrid			2022-12-28	WOS:000320378900075
J	Sun, ZZ; Smrcka, AV; Chen, SH				Sun, Zhizeng; Smrcka, Alan V.; Chen, Songhai			WDR26 Functions as a Scaffolding Protein to Promote G beta gamma-mediated Phospholipase C beta 2 (PLC beta 2) Activation in Leukocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTIONAL CELL-MIGRATION; SMALL-MOLECULE DISRUPTION; REPEAT PROTEIN; SIGNALING PATHWAY; SUBUNITS; ASSOCIATION; ALPHA; CHEMOTAXIS; PI3K-GAMMA; EFFECTORS	We have recently identified WDR26 as a novel WD40 repeat protein that binds G beta gamma and promotes G beta gamma signaling during leukocyte migration. Here, we have determined the mechanism by which WDR26 enhances G beta gamma-mediated phospholipase C beta 2 (PLC beta 2) activation in leukocytes. We show that WDR26 not only directly bound G beta gamma but also PLC beta 2. The binding sites of WDR26 and PLC beta 2 on G beta(1)gamma(2) were overlapping but not identical. WDR26 used the same domains for binding G beta gamma and PLC beta but still formed a signaling complex with G beta gamma and PLC beta 2 probably due to the fact that WDR26 formed a higher order oligomer through its Lis homology and C-terminal to LisH (LisH-CTLH) and WD40 domains. Additional studies indicated that the formation of higher order oligomers was required for WDR26 to promote PLC beta 2 interaction with and activation by G beta gamma. Moreover, WDR26 was required for PLC beta 2 translocation from the cytosol to the membrane in polarized leukocytes, and the translocation of PLC beta 2 was sufficient to cause partial activation of PLC beta 2. Collectively, our data indicate that WDR26 functions as a scaffolding protein to promote PLC beta 2 membrane translocation and interaction with G beta gamma, thereby enhancing PLC beta 2 activation in leukocytes. These findings have identified a novel mechanism of regulating G beta gamma signaling through a scaffolding protein.	[Sun, Zhizeng; Chen, Songhai] Univ Iowa, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Chen, Songhai] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	University of Iowa; University of Iowa; University of Rochester	Chen, SH (corresponding author), Univ Iowa, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, Bowen Sci Bldg,Rm 2-3452,51 Newton Rd, Iowa City, IA 52242 USA.	songhai-chen@uiowa.edu		Sun, Zhizeng/0000-0002-0033-5885; chen, songhai/0000-0001-7316-7125	National Institutes of Health Grant [GM094255]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094255, R01GM081772] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM094255 (to S. C.).	Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Brock C, 2003, J CELL BIOL, V160, P89, DOI 10.1083/jcb.200210115; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Chen SH, 2005, J BIOL CHEM, V280, P33445, DOI 10.1074/jbc.M505422200; Chen SH, 2004, J BIOL CHEM, V279, P17861, DOI 10.1074/jbc.M313727200; Chen SH, 2008, MOL BIOL CELL, V19, P3909, DOI 10.1091/mbc.E08-04-0433; Chiou WF, 2004, INT IMMUNOPHARMACOL, V4, P1329, DOI 10.1016/j.intimp.2004.05.017; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Feng YS, 2012, FREE RADICAL RES, V46, P777, DOI 10.3109/10715762.2012.678840; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gehrmann J, 2002, AM J PHYSIOL-HEART C, V282, pH445, DOI 10.1152/ajpheart.00565.2001; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Mirshahi Tooraj, 2003, Sci STKE, V2003, pPE32, DOI 10.1126/stke.2003.194.pe32; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Romoser V, 1996, J BIOL CHEM, V271, P25071, DOI 10.1074/jbc.271.41.25071; Runne C, 2013, CELL ADHES MIGR, V7, P214, DOI 10.4161/cam.22940; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Sun ZZ, 2011, J BIOL CHEM, V286, P43902, DOI 10.1074/jbc.M111.301382; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Tang XY, 2011, J BIOL CHEM, V286, P13244, DOI 10.1074/jbc.M110.206615; Tedford HW, 2006, PHARMACOL REV, V58, P837, DOI 10.1124/pr.58.4.11; Wei X, 2010, BIOCHEM BIOPH RES CO, V393, P860, DOI 10.1016/j.bbrc.2010.02.099; WHITEWAY MS, 1995, SCIENCE, V269, P1572, DOI 10.1126/science.7667635; Yoshikawa DM, 2001, J BIOL CHEM, V276, P11246, DOI 10.1074/jbc.M006073200; Yuan CJ, 2007, J BIOL CHEM, V282, P19938, DOI 10.1074/jbc.M700396200; Zhao J, 2009, NEUROSCI LETT, V460, P66, DOI 10.1016/j.neulet.2009.05.024; Zhu Y, 2004, J CELL BIOCHEM, V93, P579, DOI 10.1002/jcb.20175	33	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16715	16725		10.1074/jbc.M113.462564	http://dx.doi.org/10.1074/jbc.M113.462564			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625927	hybrid, Green Published			2022-12-28	WOS:000320378900046
J	Ahuja, S; Jahr, N; Im, SC; Vivekanandan, S; Popovych, N; Le Clair, SV; Huang, R; Soong, R; Xu, JD; Yamamoto, K; Nanga, RP; Bridges, A; Waskell, L; Ramamoorthy, A				Ahuja, Shivani; Jahr, Nicole; Im, Sang-Choul; Vivekanandan, Subramanian; Popovych, Nataliya; Le Clair, Stephanie V.; Huang, Rui; Soong, Ronald; Xu, Jiadi; Yamamoto, Kazutoshi; Nanga, Ravi P.; Bridges, Angela; Waskell, Lucy; Ramamoorthy, Ayyalusamy			A Model of the Membrane-bound Cytochrome b(5)-Cytochrome P450 Complex from NMR and Mutagenesis Data	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytochrome P450; Enzyme Catalysis; Membrane Proteins; NMR; Structural Biology	PROTEIN-PROTEIN ASSOCIATION; TRANSIENT ENCOUNTER COMPLEXES; NADPH-CYTOCHROME-P450 REDUCTASE; ELECTRON-TRANSPORT; BINDING-SITE; B(5); SPECTROSCOPY; STATE; TOOL; PURIFICATION	Microsomal cytochrome b(5) (cytb(5)) is a membrane-bound protein that modulates the catalytic activity of its redox partner, cytochrome P4502B4 (cytP450). Here, we report the first structure of full-length rabbit ferric microsomal cytb(5) (16 kDa), incorporated in two different membrane mimetics (detergent micelles and lipid bicelles). Differential line broadening of the cytb(5) NMR resonances and site-directed mutagenesis data were used to characterize the cytb(5) interaction epitope recognized by ferric microsomal cytP450 (56 kDa). Subsequently, a data-driven docking algorithm, HADDOCK (high ambiguity driven biomolecular docking), was used to generate the structure of the complex between cytP4502B4 and cytb(5) using experimentally derived restraints from NMR, mutagenesis, and the double mutant cycle data obtained on the full-length proteins. Our docking and experimental results point to the formation of a dynamic electron transfer complex between the acidic convex surface of cytb(5) and the concave basic proximal surface of cytP4502B4. The majority of the binding energy for the complex is provided by interactions between residues on the C-helix and -bulge of cytP450 and residues at the end of helix 4 of cytb(5). The structure of the complex allows us to propose an interprotein electron transfer pathway involving the highly conserved Arg-125 on cytP450 serving as a salt bridge between the heme propionates of cytP450 and cytb(5). We have also shown that the addition of a substrate to cytP450 likely strengthens the cytb(5)-cytP450 interaction. This study paves the way to obtaining valuable structural, functional, and dynamic information on membrane-bound complexes.	[Ahuja, Shivani; Jahr, Nicole; Vivekanandan, Subramanian; Popovych, Nataliya; Le Clair, Stephanie V.; Huang, Rui; Soong, Ronald; Xu, Jiadi; Yamamoto, Kazutoshi; Nanga, Ravi P.; Ramamoorthy, Ayyalusamy] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Im, Sang-Choul; Bridges, Angela; Waskell, Lucy] Univ Michigan, Dept Anesthesiol, Ann Arbor, MI 48105 USA; [Im, Sang-Choul; Bridges, Angela; Waskell, Lucy] Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Ramamoorthy, A (corresponding author), Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA.	ramamoor@umich.edu	Huang, Rui/N-4022-2017	Huang, Rui/0000-0002-4064-6397; Xu, Jiadi/0000-0001-9698-5622; Ramamoorthy, Ayyalusamy/0000-0003-1964-1900	National Institutes of Health [GM084018, GM095640, GM094209, GM035533]; Veterans Affairs merit grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084018, R01GM094209, R01GM095640, R01GM035533] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs merit grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM084018 and GM095640 (to A. R.) and GM094209 and GM035533 (to L.W.). This work was also supported by a Veterans Affairs merit grant (to L.W.).	Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Banci L, 2000, EUR J BIOCHEM, V267, P755, DOI 10.1046/j.1432-1327.2000.01054.x; Basaran N, 1999, BIOCHEMISTRY-US, V38, P15245, DOI 10.1021/bi991404a; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; CANOVADAVIS E, 1985, BIOCHEM PHARMACOL, V34, P1907, DOI 10.1016/0006-2952(85)90307-7; CARAVATTI P, 1983, CHEM PHYS LETT, V100, P305, DOI 10.1016/0009-2614(83)80276-0; CHESTER DW, 1992, BIOPHYS J, V61, P1224, DOI 10.1016/S0006-3495(92)81932-X; Chudaev MV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P667, DOI 10.1023/A:1010215516226; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clarke TA, 2004, J BIOL CHEM, V279, P36809, DOI 10.1074/jbc.M406055200; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAILEY HA, 1978, J BIOL CHEM, V253, P8203; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Deep S, 2005, BIOCHEMISTRY-US, V44, P10654, DOI 10.1021/bi050482x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denny JK, 2001, J MAGN RESON, V152, P217, DOI 10.1006/jmre.2001.2405; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Durr UHN, 2012, CHEM REV, V112, P6054, DOI 10.1021/cr300061w; Durr UHN, 2007, J AM CHEM SOC, V129, P6670, DOI 10.1021/ja069028m; Dvinskikh SV, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212939; Estrada DF, 2013, J BIOL CHEM, V288, P17008, DOI 10.1074/jbc.M113.468926; Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200; Frisch C, 1997, J MOL BIOL, V267, P696, DOI 10.1006/jmbi.1997.0892; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; GREENHUT SF, 1993, BIOCHIM BIOPHYS ACTA, V1149, P1, DOI 10.1016/0005-2736(93)90018-U; GRUENKE LD, 1995, J BIOL CHEM, V270, P24707, DOI 10.1074/jbc.270.42.24707; Guengerich FP, 2006, AAPS J, V8, pE101, DOI 10.1208/aapsj080112; Guengerich FP, 2005, BIOCHEM BIOPH RES CO, V338, P465, DOI 10.1016/j.bbrc.2005.08.079; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Halpert JR, 2011, DRUG METAB DISPOS, V39, P1113, DOI 10.1124/dmd.111.039719; Harel M, 2007, J MOL BIOL, V371, P180, DOI 10.1016/j.jmb.2007.05.032; Harris RK, 2002, SOLID STATE NUCL MAG, V22, P458, DOI 10.1006/snmr.2002.0063; HOLLOWAY PW, 1990, BIOCHEMISTRY-US, V29, P9631, DOI 10.1021/bi00493a018; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; KNELLER DG, 1993, J CELL BIOCHEM, P254; Koberova M, 2013, INT J ELECTROCHEM SC, V8, P125; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kurnikov IV., 2000, HARLEM MOL MODELING; LEE KB, 1990, BIOCHEMISTRY-US, V29, P9623, DOI 10.1021/bi00493a017; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; MORGAN ET, 1984, DRUG METAB DISPOS, V12, P358; Mulrooney SB, 2000, PROTEIN EXPRES PURIF, V19, P173, DOI 10.1006/prep.2000.1228; Naffin-Olivos JL, 2006, BIOCHEMISTRY-US, V45, P755, DOI 10.1021/bi051623y; NAKAMURA K, 1994, BBA-PROTEIN STRUCT M, V1207, P40, DOI 10.1016/0167-4838(94)90049-3; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Nevzorov AA, 2003, J MAGN RESON, V160, P33, DOI 10.1016/S1090-7807(02)00138-6; Nguyen KT, 2010, J AM CHEM SOC, V132, P15112, DOI 10.1021/ja106508f; Nunez M, 2010, J BIOMOL NMR, V47, P289, DOI 10.1007/s10858-010-9428-6; O'Donnell A, 2004, BRIT J CANCER, V90, P2317, DOI 10.1038/sj.bjc.6601879; Omura T., 1967, METHOD ENZYMOL, P556, DOI [DOI 10.1016/0076-6879(67)10096-7, 10.1016/0076-6879(67)10096-7.]; Orlando L, 2010, CANCER TREAT REV, V36, pS67, DOI 10.1016/S0305-7372(10)70023-2; Page CC, 2003, CURR OPIN CHEM BIOL, V7, P551, DOI 10.1016/j.cbpa.2003.08.005; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prudencio M, 2004, J MOL RECOGNIT, V17, P524, DOI 10.1002/jmr.686; RODGERS KK, 1988, SCIENCE, V240, P1657, DOI 10.1126/science.2837825; SANDERS CR, 1994, PROG NUCL MAG RES SP, V26, P421, DOI 10.1016/0079-6565(94)80012-X; Saribas AS, 2001, PROTEIN EXPRES PURIF, V21, P303, DOI 10.1006/prep.2000.1377; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; Shao WP, 2003, BIOCHEMISTRY-US, V42, P14774, DOI 10.1021/bi030145t; Shen AL, 2002, J BIOL CHEM, V277, P6536, DOI 10.1074/jbc.M111408200; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; Soong R, 2010, J AM CHEM SOC, V132, P5779, DOI 10.1021/ja910807e; Suh JY, 2007, J AM CHEM SOC, V129, P12954, DOI 10.1021/ja0760978; Sulc M, 2012, NEUROENDOCRINOL LETT, V33, P41; TAMBURINI PP, 1986, ARCH BIOCHEM BIOPHYS, V245, P512, DOI 10.1016/0003-9861(86)90244-4; TAMBURINI PP, 1983, J BIOL CHEM, V258, P3444; TAMBURINI PP, 1987, P NATL ACAD SCI USA, V84, P11, DOI 10.1073/pnas.84.1.11; Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201; Ubbink M, 2009, FEBS LETT, V583, P1060, DOI 10.1016/j.febslet.2009.02.046; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; VERGERES G, 1992, J BIOL CHEM, V267, P12583; Volkov AN, 2010, J BIOMOL NMR, V48, P225, DOI 10.1007/s10858-010-9452-6; Volkov AN, 2005, PROTEIN SCI, V14, P799, DOI 10.1110/ps.041150205; Zamoon J, 2005, P NATL ACAD SCI USA, V102, P4747, DOI 10.1073/pnas.0406039102; Zhang HM, 2008, J BIOL CHEM, V283, P5217, DOI 10.1074/jbc.M709094200; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang Q, 2004, PROTEIN SCI, V13, P2161, DOI 10.1110/ps.04721104; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	83	92	93	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22080	22095		10.1074/jbc.M112.448225	http://dx.doi.org/10.1074/jbc.M112.448225			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23709268	Green Published, hybrid			2022-12-28	WOS:000328841900053
J	Balakrishnan, A; Jordan, F; Nathan, CF				Balakrishnan, Anand; Jordan, Frank; Nathan, Carl F.			Influence of Allosteric Regulators on Individual Steps in the Reaction Catalyzed by Mycobacterium tuberculosis 2-Hyd roxy-3-oxoadipate Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Allosteric Regulation; Bacteria; Metabolism; Mycobacterium tuberculosis; 2-Hydroxy-3-oxoadipate Synthase; Thiamin Diphosphate-dependent Enzymes	GLYOXYLATE CARBOLIGASE ACTIVITY; ALPHA-KETOGLUTARATE; ACETOHYDROXYACID SYNTHASE; THIAMIN DIPHOSPHATE; PYRUVATE-DEHYDROGENASE; RATE CONSTANTS; PROTEIN; IDENTIFICATION; ACID; COMPLEX	Allosteric regulation often controls key branch points in metabolic processes. Mycobacterium tuberculosis 2-hydroxy-3-oxoadipate synthase (HOAS), a thiamin diphosphate (ThDP)-dependent enzyme, produces 2-hydroxy-3-oxoadipate using 2-ketoglutarate and glyoxylate. The proposed chemical mechanism in analogy with other ThDP-dependent carboligases involves multiple ThDP-bound covalent intermediates. Acetyl coenzyme A is an activator, and GarA, a forkhead association domain-containing protein known to regulate glutamate metabolism, is an allosteric inhibitor of HOAS. Steady state kinetics using assays to study the first half and the full catalytic cycle suggested that the regulators act at different steps in the overall mechanism. To explore the modes of regulation and to test the effects on individual catalytic steps, we performed circular dichroism (CD) studies using a non-decarboxylatable 2-ketoglutarate analog and determined the distribution of ThDP-bound covalent intermediates during the steady state of the HOAS reaction using one-dimensional H-1 gradient carbon heteronuclear single quantum coherence NMR. The results suggest that acetyl coenzyme A acts as a mixed V and K type activator and predominantly affects the predecarboxylation steps. GarA does not inhibit the formation of the predecarboxylation analog and does not affect the accumulation of the postdecarboxylation covalent intermediate derived from 2-ketoglutarate; however, it decreases the abundance of the product ThDP adduct in the HOAS pathway. Thus, the two regulators act on different halves of the catalytic cycle in an unusual regulatory regime.	[Balakrishnan, Anand; Nathan, Carl F.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA	Cornell University; Rutgers State University Newark; Rutgers State University New Brunswick	Nathan, CF (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10065 USA.	cnathan@med.cornell.edu		Balakrishnan, Anand/0000-0002-5778-3857	National Institutes of Health [R01 A1064768, GM 050380]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 A1064768 (to C.F.N.) and GM 050380 (to F.J.).	Balakrishnan A, 2012, J AM CHEM SOC, V134, P18644, DOI 10.1021/ja3062375; Balakrishnan A, 2012, J AM CHEM SOC, V134, P3873, DOI 10.1021/ja211139c; Baykal A, 2006, BIOORG CHEM, V34, P380, DOI 10.1016/j.bioorg.2006.09.006; Beigi M, 2013, ORG LETT, V15, P452, DOI 10.1021/ol3031186; Belenky I, 2012, FEBS J, V279, P1967, DOI 10.1111/j.1742-4658.2012.08577.x; Bott M, 2007, TRENDS MICROBIOL, V15, P417, DOI 10.1016/j.tim.2007.08.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brammer LA, 2011, J BIOL CHEM, V286, P36522, DOI 10.1074/jbc.M111.259747; Bunik VI, 2005, BIOCHEMISTRY-US, V44, P10552, DOI 10.1021/bi0503100; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; Chipman D, 1998, BBA-PROTEIN STRUCT M, V1385, P401, DOI 10.1016/S0167-4838(98)00083-1; Choi KJ, 2005, FEBS LETT, V579, P4903, DOI 10.1016/j.febslet.2005.07.055; Cleland W W, 1979, Methods Enzymol, V63, P500; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; de Carvalho LPS, 2010, CHEM BIOL, V17, P323, DOI 10.1016/j.chembiol.2010.03.009; de Souza GA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-316; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Kaplun A, 2008, NAT CHEM BIOL, V4, P113, DOI 10.1038/nchembio.62; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; KLUGER R, 1977, J AM CHEM SOC, V99, P4504, DOI 10.1021/ja00455a052; MENTCH F, 1987, BIOCHEMISTRY-US, V26, P921, DOI 10.1021/bi00377a037; Meyer D, 2011, J AM CHEM SOC, V133, P3609, DOI 10.1021/ja110236w; Nemeria N, 2005, J BIOL CHEM, V280, P21473, DOI 10.1074/jbc.M502691200; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; OFALLON JV, 1977, BIOCHIM BIOPHYS ACTA, V499, P321, DOI 10.1016/0304-4165(77)90063-0; Patel H, 2012, J AM CHEM SOC, V134, P18374, DOI 10.1021/ja307315u; Porat I, 2004, J BACTERIOL, V186, P570, DOI 10.1128/JB.186.2.570-574.2004; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHLOSSB.MA, 1968, BIOCHEMISTRY-US, V7, P333, DOI 10.1021/bi00841a042; Schramm VL, 1998, ANNU REV BIOCHEM, V67, P693, DOI 10.1146/annurev.biochem.67.1.693; Seifert F, 2007, BIOCHEMISTRY-US, V46, P6277, DOI 10.1021/bi700083z; Shim DJ, 2011, BIOCHEMISTRY-US, V50, P7705, DOI 10.1021/bi200936n; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; Tittmann K, 2005, P NATL ACAD SCI USA, V102, P553, DOI 10.1073/pnas.0408210101; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Vinogradov M, 2005, ANAL BIOCHEM, V342, P126, DOI 10.1016/j.ab.2005.03.049; Wagner T, 2011, CHEM BIOL, V18, P1011, DOI 10.1016/j.chembiol.2011.06.004; Werther T, 2008, J BIOL CHEM, V283, P5344, DOI 10.1074/jbc.M706569200; YAMASAKI H, 1971, BIOCHIM BIOPHYS ACTA, V242, P637, DOI 10.1016/0005-2744(71)90156-2; YAMASAKI H, 1970, BIOCHEM BIOPH RES CO, V38, P638, DOI 10.1016/0006-291X(70)90628-5; YAMASAKI H, 1970, BIOCHEM BIOPH RES CO, V39, P790, DOI 10.1016/0006-291X(70)90392-X	44	17	17	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21688	21702		10.1074/jbc.M113.465419	http://dx.doi.org/10.1074/jbc.M113.465419			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760263	Green Published, hybrid			2022-12-28	WOS:000328841900021
J	Sato, T; Fujihashi, M; Miyamoto, Y; Kuwata, K; Kusaka, E; Fujita, H; Miki, K; Atomi, H				Sato, Takaaki; Fujihashi, Masahiro; Miyamoto, Yukika; Kuwata, Keiko; Kusaka, Eriko; Fujita, Haruo; Miki, Kunio; Atomi, Haruyuki			An Uncharacterized Member of the Ribokinase Family in Thermococcus kodakarensis Exhibits myo-Inositol Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRENARCHAEOTE THERMOPROTEUS-TENAX; NON-ALLOSTERIC ENZYME; ADENOSINE KINASE; PHOSPHOTRANSFERASE SYSTEM; ESCHERICHIA-COLI; RIBOSE-1,5-BISPHOSPHATE ISOMERASE; DEPENDENT 6-PHOSPHOFRUCTOKINASE; CARBOHYDRATE-METABOLISM; BIOSYNTHESIS; PHOSPHATE	Here we performed structural and biochemical analyses on the TK2285 gene product, an uncharacterized protein annotated as a member of the ribokinase family, from the hyperthermophilic archaeon Thermococcus kodakarensis. The three-dimensional structure of the TK2285 protein resembled those of previously characterized members of the ribokinase family including ribokinase, adenosine kinase, and phosphofructokinase. Conserved residues characteristic of this protein family were located in a cleft of the TK2285 protein as in other members whose structures have been determined. We thus examined the kinase activity of the TK2285 protein toward various sugars recognized by well characterized ribokinase family members. Although activity with sugar phosphates and nucleosides was not detected, kinase activity was observed toward D-allose, D-lyxose, D-tagatose, D-talose, D-xylose, and D-xylulose. Kinetic analyses with the six sugar substrates revealed high K-m values, suggesting that they were not the true physiological substrates. By examining activity toward amino sugars, sugar alcohols, and disaccharides, we found that the TK2285 protein exhibited prominent kinase activity toward myo-inositol. Kinetic analyses with myo-inositol revealed a greater k(cat) and much lower K-m value than those obtained with the monosaccharides, resulting in over a 2,000-fold increase in k(cat)/K-m values. TK2285 homologs are distributed among members of Thermococcales, and in most species, the gene is positioned close to a myo-inositol monophosphate synthase gene. Our results suggest the presence of a novel subfamily of the ribokinase family whose members are present in Archaea and recognize myo-inositol as a substrate.	[Sato, Takaaki; Kuwata, Keiko; Kusaka, Eriko; Fujita, Haruo; Atomi, Haruyuki] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Fujihashi, Masahiro; Miyamoto, Yukika; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Sakyo Ku, Kyoto 6068502, Japan; [Sato, Takaaki; Fujihashi, Masahiro; Miki, Kunio; Atomi, Haruyuki] Japan Sci & Technol Agcy JST, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Atomi, H (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan.	atomi@sbchem.kyoto-u.ac.jp	Kuwata, Keiko/I-6128-2014	Atomi, Haruyuki/0000-0001-9687-6426	Japan Society for the Promotion of Science KAKENHI Grant [22750150]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Japan Society for the Promotion of Science KAKENHI Grant 22750150 (to T. S.).	Andersson CE, 2002, J MOL BIOL, V315, P409, DOI 10.1006/jmbi.2001.5248; Aono R, 2012, J BACTERIOL, V194, P6847, DOI 10.1128/JB.01335-12; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Borges N, 2010, J BACTERIOL, V192, P191, DOI 10.1128/JB.01115-09; Brouns SJJ, 2008, J MOL BIOL, V379, P357, DOI 10.1016/j.jmb.2008.03.064; Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200; Cabrera R, 2008, J MOL BIOL, V383, P588, DOI 10.1016/j.jmb.2008.08.029; Chen LJ, 1998, J BACTERIOL, V180, P3785, DOI 10.1128/JB.180.15.3785-3792.1998; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fileppi M, 2010, MOL BREEDING, V25, P453, DOI 10.1007/s11032-009-9344-1; Gabor E, 2011, EUR J CELL BIOL, V90, P711, DOI 10.1016/j.ejcb.2011.04.002; Gibbs AC, 2010, J MED CHEM, V53, P7979, DOI 10.1021/jm100677s; Goncalves LG, 2012, ENVIRON MICROBIOL, V14, P691, DOI 10.1111/j.1462-2920.2011.02621.x; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Hansen T, 2004, EXTREMOPHILES, V8, P29, DOI 10.1007/s00792-003-0356-1; Hansen T, 2001, ARCH MICROBIOL, V177, P62, DOI 10.1007/s00203-001-0359-1; Hansen T, 2007, EXTREMOPHILES, V11, P105, DOI 10.1007/s00792-006-0018-1; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Kim SI, 2008, THEOR APPL GENET, V117, P1291, DOI 10.1007/s00122-008-0863-7; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Maj M, 2000, BBA-PROTEIN STRUCT M, V1476, P33, DOI 10.1016/S0167-4838(99)00220-4; Maj MC, 2002, BIOCHEMISTRY-US, V41, P4059, DOI 10.1021/bi0119161; Miallau L, 2007, J BIOL CHEM, V282, P19948, DOI 10.1074/jbc.M701480200; Michell RH, 2011, ADV ENZYME REGUL, V51, P84, DOI 10.1016/j.advenzreg.2010.10.002; MIDDLETON RJ, 1990, BIOCHEM SOC T, V18, P180, DOI 10.1042/bst0180180; Morii H, 2009, J BIOL CHEM, V284, P30766, DOI 10.1074/jbc.M109.034652; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nakamura A, 2012, J BIOL CHEM, V287, P20784, DOI 10.1074/jbc.M112.349423; Nunn CEM, 2010, J BIOL CHEM, V285, P33701, DOI 10.1074/jbc.M110.146332; Orita I, 2006, J BACTERIOL, V188, P4698, DOI 10.1128/JB.00492-06; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALELLA TD, 1980, J BIOL CHEM, V255, P5264; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Park J, 2008, CELL MOL LIFE SCI, V65, P2875, DOI 10.1007/s00018-008-8123-1; Park J, 2007, FEBS LETT, V581, P3211, DOI 10.1016/j.febslet.2007.06.009; Sambrook J., 2001, MOL CLONING LAB MANU, V3; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Schramm A, 2000, J BACTERIOL, V182, P2001, DOI 10.1128/JB.182.7.2001-2009.2000; Schumacher MA, 2000, J MOL BIOL, V298, P875, DOI 10.1006/jmbi.2000.3753; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shi JR, 2005, PLANT J, V42, P708, DOI 10.1111/j.1365-313X.2005.02412.x; Tchieu JH, 2001, J MOL MICROB BIOTECH, V3, P329; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; Verhees CH, 2003, BIOCHEM J, V375, P231, DOI 10.1042/BJ20021472; Xavier KB, 1999, J BACTERIOL, V181, P3358, DOI 10.1128/JB.181.11.3358-3367.1999; Zaparty M, 2008, ARCH MICROBIOL, V190, P231, DOI 10.1007/s00203-008-0375-5	51	9	9	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20856	20867		10.1074/jbc.M113.457259	http://dx.doi.org/10.1074/jbc.M113.457259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23737529	Green Published, hybrid			2022-12-28	WOS:000322014400010
J	Gururaj, C; Federman, R; Chang, A				Gururaj, Charulatha; Federman, Ross; Chang, Amy			Orm Proteins Integrate Multiple Signals to Maintain Sphingolipid Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; YEAST SACCHAROMYCES-CEREVISIAE; GENOME-WIDE ANALYSIS; HEAT-STRESS; SERINE PALMITOYLTRANSFERASE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; KINASE YPK1; MEMBRANE; CALCINEURIN	Sphingolipids are structural components of membranes, and sphingolipid metabolites serve as signaling molecules. The first and rate-limiting step in sphingolipid synthesis is catalyzed by serine palmitoyltransferase (SPT). The recently discovered SPT-associated proteins, Orm1 and Orm2, are critical regulators of sphingolipids. Orm protein phosphorylation mediating feedback regulation of SPT activity occurs in response to multiple sphingolipid intermediates, including long chain base and complex sphingolipids. Both branches of the TOR signaling network, TORC1 and TORC2, participate in regulating sphingolipid synthesis via Orm phosphorylation in response to sphingolipid intermediates as well as nutritional conditions. Moreover, sphingolipid synthesis is regulated in response to endoplasmic reticulum (ER) stress by activation of a calcium-and calcineurin-dependent pathway via transcriptional induction of ORM2. Conversely, the calcium-and calcineurin-dependent pathway signals ER stress response upon lipid dysregulation in the absence of the Orm proteins to restore ER homeostasis.	[Gururaj, Charulatha; Federman, Ross; Chang, Amy] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chang, A (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ, Ann Arbor, MI 48109 USA.	amychang@umich.edu	Chang, Amy/AAS-5491-2020	Chang, Amy/0000-0003-3682-6456	Margaret and Herman Sokol Faculty Award; Elizabeth Crosby Faculty grant from the University of Michigan	Margaret and Herman Sokol Faculty Award; Elizabeth Crosby Faculty grant from the University of Michigan	This work was supported by a Margaret and Herman Sokol Faculty Award and an Elizabeth Crosby Faculty grant from the University of Michigan.	Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05; Cerantola V, 2009, MOL MICROBIOL, V71, P1523, DOI 10.1111/j.1365-2958.2009.06628.x; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; Chang HJ, 2002, GENETICS, V162, P29; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Cyert MS, 2003, BIOCHEM BIOPH RES CO, V311, P1143, DOI 10.1016/S0006-291X(03)01552-3; Daquinag A, 2007, MOL CELL BIOL, V27, P633, DOI 10.1128/MCB.00461-06; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Dudgeon DD, 2008, EUKARYOT CELL, V7, P2037, DOI 10.1128/EC.00291-08; Funato K, 2002, BIOCHEMISTRY-US, V41, P15105, DOI 10.1021/bi026616d; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Hong MP, 2010, J BIOL CHEM, V285, P10951, DOI 10.1074/jbc.M109.056218; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jung US, 2002, MOL MICROBIOL, V46, P781, DOI 10.1046/j.1365-2958.2002.03198.x; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; LOPES JM, 1991, NUCLEIC ACIDS RES, V19, P1687, DOI 10.1093/nar/19.7.1687; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Matmati N, 2008, J LIPID RES, V49, P922, DOI 10.1194/jlr.R800004-JLR200; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Mulet JM, 2006, J BIOL CHEM, V281, P33000, DOI 10.1074/jbc.M604244200; Niles BJ, 2012, P NATL ACAD SCI USA, V109, P1536, DOI 10.1073/pnas.1117563109; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rose M. D., 1990, METHODS YEAST GENETI, P198; Rutkowski DT, 2010, J CELL BIOL, V189, P783, DOI 10.1083/jcb.201003138; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Sato K, 2009, MOL BIOL CELL, V20, P4444, DOI 10.1091/mbc.E09-03-0235; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Shamu CE, 1997, CURR BIOL, V7, pR67, DOI 10.1016/S0960-9822(06)00038-8; Sherman F., 1986, METHODS YEAST GENETI, P523; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Souza CM, 2007, BBA-MOL CELL BIOL L, V1771, P442, DOI 10.1016/j.bbalip.2006.08.006; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Uemura S, 2007, J BIOL CHEM, V282, P8613, DOI 10.1074/jbc.M606649200; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; ZHAO C, 1994, J BIOL CHEM, V269, P21480	52	49	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20453	20463		10.1074/jbc.M113.472860	http://dx.doi.org/10.1074/jbc.M113.472860			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23737533	Green Published, hybrid			2022-12-28	WOS:000321715100033
J	Keown, JR; Griffin, MDW; Mertens, HDT; Pearce, FG				Keown, Jeremy R.; Griffin, Michael D. W.; Mertens, Haydyn D. T.; Pearce, F. Grant			Small Oligomers of Ribulose-bisphosphate Carboxylase/Oxygenase (Rubisco) Activase Are Required for Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT-BINDING INHIBITOR; SEDIMENTATION COEFFICIENT DISTRIBUTIONS; SIZE-DISTRIBUTION ANALYSIS; SCATTERING DATA-ANALYSIS; RIBULOSEBISPHOSPHATE CARBOXYLASE; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; 1,5-BISPHOSPHATE CARBOXYLASE; SLOW INACTIVATION; INTRINSIC FLUORESCENCE; CATALYTIC SITE	Ribulose-bisphosphate carboxylase/oxygenase (Rubisco) activase uses the energy from ATP hydrolysis to remove tight binding inhibitors from Rubisco, thus playing a key role in regulating photosynthesis in plants. Although several structures have recently added much needed structural information for different Rubisco activase enzymes, the arrangement of these subunits in solution remains unclear. In this study, we use a variety of techniques to show that Rubisco activase forms a wide range of structures in solution, ranging from monomers to much higher order species, and that the distribution of these species is highly dependent on protein concentration. The data support a model in which Rubisco activase forms an open spiraling structure rather than a closed hexameric structure. At protein concentrations of 1 mu M, corresponding to the maximal activity of the enzyme, Rubisco activase has an oligomeric state of 2-4 subunits. We propose a model in which Rubisco activase requires at least 1 neighboring subunit for hydrolysis of ATP.	[Keown, Jeremy R.; Pearce, F. Grant] Univ Canterbury, Biomol Interact Ctr, Christchurch 8140, New Zealand; [Keown, Jeremy R.; Pearce, F. Grant] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Griffin, Michael D. W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Mertens, Haydyn D. T.] Australian Synchrotron, Clayton, Vic 3168, Australia	University of Canterbury; University of Canterbury; University of Melbourne	Pearce, FG (corresponding author), Univ Canterbury, Biomol Interact Ctr, Private Bag 4800, Christchurch 8140, New Zealand.	grant.pearce@canterbury.ac.nz	Keown, Jeremy/AAH-4361-2021	Keown, Jeremy/0000-0003-0159-9257; Griffin, Michael/0000-0001-9845-7735; Mertens, Haydyn/0000-0002-5664-744X; Pearce, Frederick/0000-0002-2683-0331	Australian Research Council [DP110103528]; Marsden Fund [UOC0902]	Australian Research Council(Australian Research Council); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	Recipient of an Australian Research Council Postdoctoral Fellowship, Project DP110103528.; Supported by the Marsden Fund Grant UOC0902. To whom correspondence should be addressed. Tel.: 64-3-364-2987 (ext. 45722); Fax: 64-3-364-2590; E-mail: grant.pearce@canterbury.ac.nz.	Andralojc PJ, 2012, BIOCHEM J, V442, P733, DOI 10.1042/BJ20111443; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Barta C, 2010, ARCH BIOCHEM BIOPHYS, V499, P17, DOI 10.1016/j.abb.2010.04.022; BERRY JA, 1987, P NATL ACAD SCI USA, V84, P734, DOI 10.1073/pnas.84.3.734; Blayney MJ, 2011, J AM SOC MASS SPECTR, V22, P1588, DOI 10.1007/s13361-011-0187-8; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Chakraborty M, 2012, BIOPHYS J, V103, P949, DOI 10.1016/j.bpj.2012.07.034; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Dam J, 2004, METHOD ENZYMOL, V384, P185; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1383, DOI 10.1104/pp.93.4.1383; EDMONDSON DL, 1990, FEBS LETT, V260, P62, DOI 10.1016/0014-5793(90)80066-R; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1376, DOI 10.1104/pp.93.4.1376; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1390, DOI 10.1104/pp.93.4.1390; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; GUREVITZ M, 1985, P NATL ACAD SCI USA, V82, P6546, DOI 10.1073/pnas.82.19.6546; GUTTERIDGE S, 1986, NATURE, V324, P274, DOI 10.1038/324274a0; Henderson JN, 2013, BBA-PROTEINS PROTEOM, V1834, P87, DOI 10.1016/j.bbapap.2012.09.006; Henderson JN, 2011, J BIOL CHEM, V286, P35683, DOI 10.1074/jbc.C111.289595; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; KEYS AJ, 1995, J EXP BOT, V46, P1245, DOI 10.1093/jxb/46.special_issue.1245; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kress W, 2007, BIOCHEMISTRY-US, V46, P6183, DOI 10.1021/bi602616t; LAING WA, 1976, BIOCHEM J, V159, P563, DOI 10.1042/bj1590563; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Larson EM, 1997, J BIOL CHEM, V272, P17033, DOI 10.1074/jbc.272.27.17033; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li CH, 2005, J BIOL CHEM, V280, P24864, DOI 10.1074/jbc.M503547200; Li CS, 2006, ARCH BIOCHEM BIOPHYS, V450, P176, DOI 10.1016/j.abb.2006.04.002; Lilley RM, 1997, PLANT PHYSIOL, V114, P605, DOI 10.1104/pp.114.2.605; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ott CM, 2000, J BIOL CHEM, V275, P26241, DOI 10.1074/jbc.M004580200; Paul MJ, 1996, J EXP BOT, V47, P1963, DOI 10.1093/jxb/47.12.1963; Pearce FG, 2006, BIOCHEM J, V399, P525, DOI 10.1042/BJ20060430; Pearce FG, 2003, J BIOL CHEM, V278, P32526, DOI 10.1074/jbc.M305493200; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; PON NG, 1963, BIOCHEM Z, V338, P7; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Portis AR, 2002, PHOTOSYNTH RES, V73, P257, DOI 10.1023/A:1020423802875; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; ROBINSON SP, 1988, PLANT PHYSIOL, V88, P1008, DOI 10.1104/pp.88.4.1008; Sage RF, 2008, J EXP BOT, V59, P1581, DOI 10.1093/jxb/ern053; SALVUCCI ME, 1992, ARCH BIOCHEM BIOPHYS, V298, P688, DOI 10.1016/0003-9861(92)90467-B; Salvucci ME, 1996, PHOTOSYNTH RES, V47, P1, DOI 10.1007/BF00017748; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Stotz M, 2011, NAT STRUCT MOL BIOL, V18, P1366, DOI 10.1038/nsmb.2171; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Wang DF, 2006, PHOTOSYNTH RES, V88, P185, DOI 10.1007/s11120-006-9051-2; WANG ZY, 1993, BIOCHIM BIOPHYS ACTA, V1202, P47, DOI 10.1016/0167-4838(93)90061-U; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Zhu GH, 1998, PHOTOSYNTH RES, V55, P67, DOI 10.1023/A:1005989012003; ZHU GH, 1991, PLANT PHYSIOL, V97, P1354, DOI 10.1104/pp.97.4.1354; ZHU GH, 1991, PLANT PHYSIOL, V97, P1348, DOI 10.1104/pp.97.4.1348	59	25	25	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20607	20615		10.1074/jbc.M113.466383	http://dx.doi.org/10.1074/jbc.M113.466383			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720775	Green Published, hybrid			2022-12-28	WOS:000321715100046
J	Liu, C; Guo, LQ; Menon, S; Jin, D; Pick, E; Wang, XJ; Deng, XW; Wei, N				Liu, Cheng; Guo, Li-Quan; Menon, Suchithra; Jin, Dan; Pick, Elah; Wang, Xuejun; Deng, Xing Wang; Wei, Ning			COP9 Signalosome Subunit Csn8 Is Involved in Maintaining Proper Duration of the G(1) Phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; CELL-CYCLE CONTROL; ARABIDOPSIS COP9; COP9/SIGNALOSOME SUBUNITS; PROLIFERATION; COMPLEX; YEAST; SCF; DIFFERENTIATION; DENEDDYLATION	The COP9 signalosome (CSN) is a conserved protein complex known to be involved in developmental processes of eukaryotic organisms. Genetic disruption of a CSN gene causes arrest during early embryonic development in mice. The Csn8 subunit is the smallest and the least conserved subunit, being absent from the CSN complex of several fungal species. Nevertheless, Csn8 is an integral component of the CSN complex in higher eukaryotes, where it is essential for life. By characterizing the mouse embryonic fibroblasts (MEFs) that express Csn8 at a low level, we found that Csn8 plays an important role in maintaining the proper duration of the G(1) phase of the cell cycle. A decreased level of Csn8, either in Csn8 hypomorphic MEFs or following siRNA-mediated knockdown in HeLa cells, accelerated cell growth rate. Csn8 hypomorphic MEFs exhibited a shortened G1 duration and affected expression of G(1) regulators. In contrast to Csn8, down-regulation of Csn5 impaired cell proliferation. Csn5 proteins were found both as a component of the CSN complex and outside of CSN (Csn5-f), and the amount of Csn5-f relative to CSN was increased in the Csn8 hypomorphic cells. We conclude that CSN harbors both positive and negative regulators of the cell cycle and therefore is poised to influence the fate of a cell at the crossroad of cell division, differentiation, and senescence.	[Liu, Cheng; Guo, Li-Quan; Menon, Suchithra; Jin, Dan; Pick, Elah; Deng, Xing Wang; Wei, Ning] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Wang, Xuejun] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA	Yale University; University of South Dakota	Wei, N (corresponding author), Yale Univ, Dept MCDB, Osborn Mem Labs, Room 451,POB 208104, New Haven, CT 06520 USA.	ning.wei@yale.edu	Wang, Xuejun/K-8874-2013; Deng, Xing Wang/ABF-4107-2020; Wang, Xuejun/AAT-9490-2021; Pick, Elah/G-6137-2018	Wang, Xuejun/0000-0001-9267-1343; Wang, Xuejun/0000-0001-9267-1343; Pick, Elah/0000-0002-6591-2217; Wei, Ning/0000-0001-8827-1320	National Institutes of Health [R01HL085629, GM47850]; National Science Foundation (NSF) [MCB-0929100]; "New Century Excellent Talents" program of Ministry of Education, China [NCET-10-0153]; China Postdoctoral Visiting-Scholar Fellowship [201104519, 20100481042]; China Scholarship Council (CSC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072166, R01HL085629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047850, R01GM047850, R29GM047850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); "New Century Excellent Talents" program of Ministry of Education, China; China Postdoctoral Visiting-Scholar Fellowship; China Scholarship Council (CSC)(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL085629 (to X. J. W. and N. W,) and GM47850 (to X. W. D.). This work was also supported by the National Science Foundation (NSF) 2010 Program MCB-0929100 (to X. W. D.).; Supported by the "New Century Excellent Talents" program of Ministry of Education, China (Grant NCET-10-0153) and China Postdoctoral Visiting-Scholar Fellowship (Grants 201104519 and 20100481042).; Supported by the China Scholarship Council (CSC) of 2011.	Adler AS, 2008, CANCER RES, V68, P506, DOI 10.1158/0008-5472.CAN-07-3060; Busch S, 2007, P NATL ACAD SCI USA, V104, P8089, DOI 10.1073/pnas.0702108104; Choi HH, 2011, ONCOGENE, V30, P4791, DOI 10.1038/onc.2011.192; Cope Gregory A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-1; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Dohmann EMN, 2008, DEVELOPMENT, V135, P2013, DOI 10.1242/dev.020743; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2012, CELL REPORTS, V2, P616, DOI 10.1016/j.celrep.2012.08.019; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Fukumoto A, 2006, FEBS LETT, V580, P5836, DOI 10.1016/j.febslet.2006.09.042; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Lange C, 2009, CELL STEM CELL, V5, P320, DOI 10.1016/j.stem.2009.05.026; Lei D, 2011, CELL DEATH DIFFER, V18, P259, DOI 10.1038/cdd.2010.98; Lim S, 2012, STEM CELLS, V30, P1509, DOI 10.1002/stem.1114; Liu C, 2003, GENE DEV, V17, P1130, DOI 10.1101/gad.1090803; Luke-Glaser S, 2007, MOL CELL BIOL, V27, P4526, DOI 10.1128/MCB.01724-06; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Mori M, 2008, J BIOL CHEM, V283, P29011, DOI 10.1074/jbc.M804539200; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; Oren-Giladi P, 2008, GENES CELLS, V13, P221, DOI 10.1111/j.1365-2443.2008.01164.x; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Oron E, 2002, DEVELOPMENT, V129, P4399; Panattoni M, 2008, J EXP MED, V205, P465, DOI 10.1084/jem.20070725; Peth Andreas, 2007, BMC Biochemistry, V8, P27, DOI 10.1186/1471-2091-8-27; Pick E, 2007, MOL CELL BIOL, V27, P4708, DOI 10.1128/MCB.02432-06; Pick E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043980; Rosel D, 2006, EUR J CELL BIOL, V85, P1023, DOI 10.1016/j.ejcb.2006.04.006; Salomoni P, 2010, TRENDS CELL BIOL, V20, P233, DOI 10.1016/j.tcb.2010.01.006; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Schwechheimer C, 2010, EUR J CELL BIOL, V89, P157, DOI 10.1016/j.ejcb.2009.11.021; Serino G, 2003, PLANT CELL, V15, P719, DOI 10.1105/tpc.009092; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; Su HB, 2011, CIRCULATION, V124, P2117, DOI 10.1161/CIRCULATIONAHA.111.048934; Su HB, 2011, CIRC RES, V108, P40, DOI 10.1161/CIRCRESAHA.110.230607; Su HB, 2009, INT J BIOCHEM CELL B, V41, P615, DOI 10.1016/j.biocel.2008.07.008; Tanguy G, 2008, BBA-MOL CELL RES, V1783, P1189, DOI 10.1016/j.bbamcr.2008.01.010; Tian L, 2010, ONCOGENE, V29, P6125, DOI 10.1038/onc.2010.345; Tomoda K, 2005, BLOOD, V105, P775, DOI 10.1182/blood-2004-04-1242; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Uhle S, 2003, EMBO J, V22, P1302, DOI 10.1093/emboj/cdg127; Wang JY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001232; Wang XP, 2009, PLANT J, V58, P655, DOI 10.1111/j.1365-313X.2009.03805.x; Wee S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-15; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Yang XM, 2002, CURR BIOL, V12, P667, DOI 10.1016/S0960-9822(02)00791-1; Yoneda-Kato N, 2005, EMBO J, V24, P1739, DOI 10.1038/sj.emboj.7600656; Yoshida A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01054; Zhao RY, 2011, J CLIN INVEST, V121, P851, DOI 10.1172/JCI44111; Zhou CS, 2003, MOL CELL, V11, P927, DOI 10.1016/S1097-2765(03)00136-9; Zhou ZP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002712	61	15	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20443	20452		10.1074/jbc.M113.468959	http://dx.doi.org/10.1074/jbc.M113.468959			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23689509	Green Published, hybrid			2022-12-28	WOS:000321715100032
J	Minogue, PJ; Beyer, EC; Berthoud, VM				Minogue, Peter J.; Beyer, Eric C.; Berthoud, Viviana M.			A Connexin50 Mutant, CX50fs, That Causes Cataracts Is Unstable, but Is Rescued by a Proteasomal Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTIONS; CONGENITAL CATARACTS; ATRIAL-FIBRILLATION; LIFE-CYCLE; WILD-TYPE; DEGRADATION; LENS; MUTATIONS; CHANNELS; PATHWAY	The mechanisms by which mutant connexins lead to disease are diverse, including those of connexin50 (CX50) encoded by the GJA8 gene. We investigated the cellular and functional behavior of CX50fs, a mutant CX50 that has a frameshift after amino acid 255 and causes recessive congenital cataracts. Cellular levels of CX50fs were much lower than those of wild type CX50 in stably transfected HeLa cells. Whereas CX50 localized at distinct gap junction plaques and supported extensive intercellular transfer of Neurobiotin, CX50fs gap junctions were rare, and their support of Neurobiotin transfer was reduced by >90%. After inhibition of new protein synthesis with cycloheximide, CX50fs disappeared much more rapidly than CX50, suggesting increased degradation of the mutant. Treatment of cells with epoxomicin (a proteasomal inhibitor) led to a dramatic increase in CX50fs levels and in the abundance of gap junctions. Epoxomicin treatment also rescued intercellular transfer of Neurobiotin to levels similar to those in cells expressing the wild type protein. Treatment with eeyarestatin I (an inhibitor of p97-dependent protein degradation) resulted in many abundant slowly migrating CX50 and CX50fs bands consistent with polyubiquitination of the proteins. These results demonstrate that the CX50fs mutant is rapidly degraded by endoplasmic reticulum-associated degradation in mammalian cells. This accelerated degradation reduces the abundance of gap junctions and the extent of intercellular communication, potentially explaining the pathogenesis of cataracts linked to this mutant. The efficacy of epoxomicin in restoring function suggests that protease inhibition might have therapeutic value for this and other diseases caused by mutants with similar defects.	[Minogue, Peter J.; Beyer, Eric C.; Berthoud, Viviana M.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago	Berthoud, VM (corresponding author), Univ Chicago, Dept Pediat, 900 E 57th St,KCBD 5, Chicago, IL 60637 USA.	vberthou@peds.bsd.uchicago.edu		Beyer, Eric/0000-0001-8044-1356	National Institutes of Health [R01EY08368]; NATIONAL EYE INSTITUTE [R01EY008368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant R01EY08368.	Abrams CK, 2012, BBA-BIOMEMBRANES, V1818, P2030, DOI 10.1016/j.bbamem.2011.08.015; Baruch A, 2001, J BIOL CHEM, V276, P28999, DOI 10.1074/jbc.M103628200; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Berthoud VM, 2003, EUR J CELL BIOL, V82, P209, DOI 10.1078/0171-9335-00316; Chai ZF, 2011, MOL BIOL CELL, V22, P4503, DOI 10.1091/mbc.E11-05-0438; Danilov SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010438; DeRosa AM, 2007, J CELL SCI, V120, P4107, DOI 10.1242/jcs.012237; DeRosa AM, 2006, INVEST OPHTH VIS SCI, V47, P4474, DOI 10.1167/iovs.05-1582; Deuquet J, 2011, EMBO MOL MED, V3, P208, DOI 10.1002/emmm.201100124; Dunn CA, 2012, J BIOL CHEM, V287, P2600, DOI 10.1074/jbc.M111.276261; Eckert R, 2002, PFLUG ARCH EUR J PHY, V443, P843, DOI 10.1007/s00424-001-0760-2; Girao H, 2003, MOL VIS, V9, P24; Gollob MH, 2006, NEW ENGL J MED, V354, P2677, DOI 10.1056/NEJMoa052800; Hejtmancik JF, 2008, SEMIN CELL DEV BIOL, V19, P134, DOI 10.1016/j.semcdb.2007.10.003; Kaffy J, 2013, CURR PHARM DESIGN, V19, P4115, DOI 10.2174/1381612811319220016; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Laing JG, 1998, CARDIOVASC RES, V38, P711, DOI 10.1016/S0008-6363(98)00060-1; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lenk GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002104; Lichtenstein A, 2011, J CELL SCI, V124, P910, DOI 10.1242/jcs.073072; Lichtenstein A, 2009, EXP EYE RES, V88, P600, DOI 10.1016/j.exer.2008.11.024; Lin JS, 1998, EUR J CELL BIOL, V76, P246; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Minogue PJ, 2009, INVEST OPHTH VIS SCI, V50, P5837, DOI 10.1167/iovs.09-3759; Minogue PJ, 2005, J BIOL CHEM, V280, P40788, DOI 10.1074/jbc.M504765200; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; Pal JD, 1999, AM J PHYSIOL-CELL PH, V276, pC1443, DOI 10.1152/ajpcell.1999.276.6.C1443; Pal JD, 2000, AM J PHYSIOL-CELL PH, V279, pC596, DOI 10.1152/ajpcell.2000.279.3.C596; Paznekas WA, 2009, HUM MUTAT, V30, P724, DOI 10.1002/humu.20958; Pereira P, 2003, EXP EYE RES, V76, P623, DOI 10.1016/S0014-4835(03)00020-4; Pfenniger A, 2011, EUR J CLIN INVEST, V41, P103, DOI 10.1111/j.1365-2362.2010.02378.x; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Rong P, 2002, DEVELOPMENT, V129, P167; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Saez JC, 2003, PHYSIOL REV, V83, P1359, DOI 10.1152/physrev.00007.2003; Schmidt W, 2008, MOL VIS, V14, P851; Scott CA, 2011, BIOCHEM J, V438, P245, DOI 10.1042/BJ20110278; Shang F, 1997, J BIOL CHEM, V272, P23086, DOI 10.1074/jbc.272.37.23086; Stergiopoulos K, 1999, CIRC RES, V84, P1144, DOI 10.1161/01.RES.84.10.1144; Thibodeau IL, 2010, CIRCULATION, V122, P236, DOI 10.1161/CIRCULATIONAHA.110.961227; Thomas MA, 2003, J CELL SCI, V116, P2213, DOI 10.1242/jcs.00440; Tong JJ, 2011, AM J PHYSIOL-CELL PH, V300, pC1055, DOI 10.1152/ajpcell.00384.2010; Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933; Voorhees PM, 2003, CLIN CANCER RES, V9, P6316; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; White TW, 1998, J CELL BIOL, V143, P815, DOI 10.1083/jcb.143.3.815; Wilke M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052070; Xu X, 2002, J MEMBRANE BIOL, V186, P101, DOI 10.1007/s00232-001-0139-5; Yin XY, 2008, CELL COMMUN ADHES, V15, P1, DOI 10.1080/15419060802253663	51	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20427	20434		10.1074/jbc.M113.452847	http://dx.doi.org/10.1074/jbc.M113.452847			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720739	Green Published, hybrid			2022-12-28	WOS:000321715100030
J	Wang, T; Cleary, RA; Wang, RP; Tang, DD				Wang, Tao; Cleary, Rachel A.; Wang, Ruping; Tang, Dale D.			Role of the Adapter Protein Abi1 in Actin-associated Signaling and Smooth Muscle Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRK-ASSOCIATED SUBSTRATE; N-WASP ACTIVITY; P21-ACTIVATED KINASE; VIMENTIN NETWORK; TENSION DEVELOPMENT; ABL; POLYMERIZATION; CELLS; PHOSPHORYLATION; STIMULATION	Actin filament polymerization plays a critical role in the regulation of smooth muscle contraction. However, our knowledge regarding modulation of the actin cytoskeleton in smooth muscle just begins to accumulate. In this study, stimulation with acetylcholine (ACh) induced an increase in the association of the adapter protein c-Ab1 interactor 1 (Abi1) with neuronal Wiskott-Aldrich syndrome protein (N-WASP) (an actin-regulatory protein) in smooth muscle cells/tissues. Furthermore, contractile stimulation activated N-WASP in live smooth muscle cells as evidenced by changes in fluorescence resonance energy transfer efficiency of an N-WASP sensor. Abi1 knockdown by lentivirus-mediated RNAi inhibited N-WASP activation, actin polymerization, and contraction in smooth muscle. However, Abi1 silencing did not affect myosin regulatory light chain phosphorylation at Ser-19 in smooth muscle. In addition, c-Ab1 tyrosine kinase and Crk-associated substrate (CAS) have been shown to regulate smooth muscle contraction. The interaction of Abi1 with c-Ab1 and CAS has not been investigated. Here, contractile activation induced formation of a multiprotein complex including c-Ab1, CAS, and Abi1. Knockdown of c-Ab1 and CAS attenuated the activation of Abi1 during contractile activation. More importantly, Abi1 knockdown inhibited c-Ab1 phosphorylation at Tyr-412 and the interaction of c-Ab1 with CAS. These results suggest that Abi1 is an important component of the cellular process that regulates N-WASP activation, actin dynamics, and contraction in smooth muscle. Abi1 is activated by the c-Ab1-CAS pathway, and Abi1 reciprocally controls the activation of its upstream regulator c-Ab1.	[Wang, Tao; Cleary, Rachel A.; Wang, Ruping; Tang, Dale D.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA	Albany Medical College	Tang, DD (corresponding author), 47 New Scotland Ave,MC-8, Albany, NY 12208 USA.	tangd@mail.amc.edu	T, Dale/AAE-9643-2020	T, Dale/0000-0002-7339-9249; Wang, Ruping/0000-0003-4233-7755	National Institutes of Health [HL-110951, HL-113208]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113208, R01HL110951] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-110951 and HL-113208 (to D. D. T.).	Anfinogenova Y, 2007, CIRC RES, V101, P420, DOI 10.1161/CIRCRESAHA.107.156463; Chen S, 2009, AM J PHYSIOL-HEART C, V297, pH533, DOI 10.1152/ajpheart.00237.2009; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Gunst SJ, 2000, EUR RESPIR J, V15, P600, DOI 10.1034/j.1399-3003.2000.15.29.x; Gunst SJ, 2003, RESP PHYSIOL NEUROBI, V137, P151, DOI 10.1016/S1569-9048(03)00144-7; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Herrera AM, 2004, AM J PHYSIOL-LUNG C, V286, pL1161, DOI 10.1152/ajplung.00298.2003; Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Jia L, 2012, AM J PHYSIOL-CELL PH, V302, pC1026, DOI 10.1152/ajpcell.00373.2011; Jia L, 2010, AM J PHYSIOL-CELL PH, V299, pC630, DOI 10.1152/ajpcell.00095.2010; KAMM KE, 1989, ANNU REV PHYSIOL, V51, P299; Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ajpcell.00174.2008; Li QF, 2006, J BIOL CHEM, V281, P34716, DOI 10.1074/jbc.M607715200; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC1424, DOI 10.1152/ajpcell.00324.2009; Li QF, 2009, AM J PHYSIOL-CELL PH, V297, pC299, DOI 10.1152/ajpcell.00037.2009; Lin Y, 2003, AM J PHYSIOL-HEART C, V285, pH710, DOI 10.1152/ajpheart.01127.2002; Lorenz M, 2004, CURR BIOL, V14, P697, DOI 10.1016/j.cub.2004.04.008; Morgan KG, 2008, J CELL MOL MED, V12, P2157, DOI 10.1111/j.1582-4934.2008.00565.x; Ogden K, 2006, AM J PHYSIOL-HEART C, V291, pH2857, DOI 10.1152/ajpheart.00229.2006; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Ryu JR, 2009, MOL CELL BIOL, V29, P1735, DOI 10.1128/MCB.01483-08; SHI YG, 1995, GENE DEV, V9, P2583, DOI 10.1101/gad.9.21.2583; Somlyo AV, 2004, PHILOS T R SOC B, V359, P1921, DOI 10.1098/rstb.2004.1562; Stradal T, 2001, CURR BIOL, V11, P891, DOI 10.1016/S0960-9822(01)00239-1; Tang DD, 2008, J CARDIOVASC PHARM T, V13, P130, DOI 10.1177/1074248407313737; Tang DD, 2005, J BIOL CHEM, V280, P23380, DOI 10.1074/jbc.M413390200; Tang DD, 2005, BIOCHEM J, V388, P773, DOI 10.1042/BJ20050065; Tang DD, 2004, J BIOL CHEM, V279, P51722, DOI 10.1074/jbc.M408351200; Tang DD, 2003, HYPERTENSION, V42, P858, DOI 10.1161/01.HYP.0000085333.76141.33; Tanos BE, 2007, CELL SIGNAL, V19, P1602, DOI 10.1016/j.cellsig.2007.02.008; ten Freyhaus H, 2012, EXPERT OPIN INV DRUG, V21, P119, DOI 10.1517/13543784.2012.632408; Wang JYJ, 2004, NAT CELL BIOL, V6, P3, DOI 10.1038/ncb0104-3; Wang RP, 2007, AM J PHYSIOL-LUNG C, V292, pL240, DOI 10.1152/ajplung.00199.2006; Wang RP, 2006, AM J PHYSIOL-CELL PH, V291, pC483, DOI 10.1152/ajpcell.00097.2006; Wang RP, 2013, AM J RESP CELL MOL, V48, P172, DOI 10.1165/rcmb.2012-0315OC; Ward ME, 2004, P NATL ACAD SCI USA, V101, P970, DOI 10.1073/pnas.0306258101	39	41	41	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20713	20722		10.1074/jbc.M112.439877	http://dx.doi.org/10.1074/jbc.M112.439877			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23740246	hybrid, Green Published			2022-12-28	WOS:000321715100056
J	Dai, C; Shi, DD; Gu, W				Dai, Chao; Shi, Dingding; Gu, Wei			Negative Regulation of the Acetyltransferase TIP60-p53 Interplay by UHRF1 (Ubiquitin-like with PHD and RING Finger Domains 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLTRANSFERASE-1 DNMT1 PROTEIN; HEMI-METHYLATED DNA; CELL-CYCLE ARREST; HISTONE-ACETYLTRANSFERASE; BINDING-PROTEIN; SRA DOMAIN; TRANSCRIPTIONAL REGULATION; CANCER PROGRESSION; COLORECTAL-CANCER; LIGASE ACTIVITY	Numerous studies indicate the importance of acetylation in p53-mediated stress responses upon DNA damage. We and others previously showed that TIP60 (Tat-interacting protein of 60 kDa)-mediated acetylation of p53 at K120 is crucial for p53-dependent apoptotic responses. Nevertheless, it remains unclear how TIP60-mediated effects on p53 are dynamically regulated in vivo. Here, we report that UHRF1 (ubiquitin-like with PHD and RING finger domains 1) interacts with TIP60 both in vitro and in vivo and induces degradation-independent ubiquitination of TIP60. Moreover, UHRF1 expression markedly suppresses the ability of TIP60 to acetylate p53. In contrast, RNAi-mediated knockdown of UHRF1 increases the endogenous levels of p53 acetylation at K120 and p53-mediated apoptosis is significantly enhanced in UHRF1-depleted cells. To elucidate the mechanisms of this regulation, we found that the interaction between TIP60 and p53 is severely inhibited in the presence of UHRF1, suggesting that UHRF1 modulates TIP60-mediated functions in both K120 acetylation-dependent and -independent manners. Consistent with this notion, UHRF1 knockdown promotes activation of p21 and PUMA but not MDM2. These findings demonstrate that UHRF1 is a critical negative regulator of TIP60 and suggest that UHRF1-mediated effects on p53 may contribute, at least in part, to its role in tumorigenesis.	[Dai, Chao; Shi, Dingding; Gu, Wei] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Gu, Wei] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Dai, Chao; Shi, Dingding; Gu, Wei] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Dai, Chao] Columbia Univ, Dept Biol Sci, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, Dept Pathol & Cell Biol, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu			NCI, National Institutes of Health [5R01 CA172023, 5R01 CA085533, 2P01 CA080058]; NATIONAL CANCER INSTITUTE [T32CA009503, P01CA080058, R01CA085533, R01CA172023] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants 5R01 CA172023, 5R01 CA085533, and 2P01 CA080058 (to W. G.).	Achour M, 2009, BIOCHEM BIOPH RES CO, V390, P523, DOI 10.1016/j.bbrc.2009.09.131; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Babbio F, 2012, ONCOGENE, V31, P4878, DOI 10.1038/onc.2011.641; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bhoumik A, 2008, J BIOL CHEM, V283, P17605, DOI 10.1074/jbc.M802030200; Bronner C, 2007, PHARMACOL THERAPEUT, V115, P419, DOI 10.1016/j.pharmthera.2007.06.003; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Charvet C, 2011, MOL CELL, V42, P584, DOI 10.1016/j.molcel.2011.03.033; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Creaven M, 1999, BIOCHEMISTRY-US, V38, P8826, DOI 10.1021/bi9907274; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Dai C, 2011, P NATL ACAD SCI USA, V108, P18937, DOI 10.1073/pnas.1110988108; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Fujimori A, 1998, MAMM GENOME, V9, P1032, DOI 10.1007/s003359900920; Gaughan L, 2002, J BIOL CHEM, V277, P25904, DOI 10.1074/jbc.M203423200; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Guan D., 2012, ONCOGENE; Gupta A., 2012, ONCOGENE, DOI [10.1038/onc.2012.534, DOI 10.1038/0NC.2012.534.[]; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hopfner R, 2000, CANCER RES, V60, P121; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Jenkins Y, 2005, MOL BIOL CELL, V16, P5621, DOI 10.1091/mbc.E05-03-0194; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; Kim JK, 2009, NUCLEIC ACIDS RES, V37, P493, DOI 10.1093/nar/gkn961; Kofunato Y, 2012, ONCOL REP, V28, P1997, DOI 10.3892/or.2012.2064; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lorenzato M, 2005, HUM PATHOL, V36, P1101, DOI 10.1016/j.humpath.2005.07.016; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; Oba-Shinjo SM, 2005, MOL BRAIN RES, V140, P25, DOI 10.1016/j.molbrainres.2005.06.015; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Peng DF, 2005, CANCER SCI, V96, P403, DOI 10.1111/j.1349-7006.2005.00071.x; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Sabatino L, 2012, ONCOGENE, V31, P5061, DOI 10.1038/onc.2012.3; Sawada M, 2007, CANCER LETT, V251, P211, DOI 10.1016/j.canlet.2006.11.023; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Unoki M, 2009, BRIT J CANCER, V101, P98, DOI 10.1038/sj.bjc.6605123; Unoki M, 2011, RECENT PAT ANTI-CANC, V6, P116, DOI 10.2174/157489211793980024; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Weichert W, 2009, CANCER LETT, V280, P168, DOI 10.1016/j.canlet.2008.10.047; Witt O, 2009, CANCER LETT, V280, P123, DOI 10.1016/j.canlet.2009.02.038; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595	57	25	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19581	19592		10.1074/jbc.M113.476606	http://dx.doi.org/10.1074/jbc.M113.476606			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23677994	hybrid, Green Published			2022-12-28	WOS:000321515800024
J	White, EA; Raghuraman, H; Perozo, E; Glotzer, M				White, Erin A.; Raghuraman, Hariharasundaram; Perozo, Eduardo; Glotzer, Michael			Binding of the CYK-4 Subunit of the Centralspindlin Complex Induces a Large Scale Conformational Change in the Kinesin Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAND-OVER-HAND; CULTURED EPITHELIAL-CELLS; CENTRAL SPINDLE; CRYSTAL-STRUCTURE; CLEAVAGE FURROW; DISTANCE MEASUREMENTS; CONTRACTILE RING; CYTOKINESIS; PROTEIN; MICROTUBULES	Centralspindlin is a critical regulator of cytokinesis in animal cells. It is a tetramer consisting of ZEN-4/MKLP1, a kinesin-6 motor, and CYK-4/MgcRacGAP, a Rho GTPase-activating protein. At anaphase, centralspindlin localizes to a narrow region of antiparallel microtubule overlap and initiates central spindle assembly. Central spindle assembly requires complex formation between ZEN-4 and CYK-4. However, the structural consequences of CYK-4 binding to ZEN-4 are unclear as are the mechanisms of microtubule bundling. Here we investigate whether CYK-4 binding induces a conformational change in ZEN-4. Characterization of the structure and conformational dynamics of the minimal interacting regions between ZEN-4 and CYK-4 by continuous wave EPR and double electron-electron resonance (DEER) spectroscopy reveals that CYK-4 binding dramatically stabilizes the relative positions of the neck linker regions of ZEN-4. Additionally, our data indicate that each neck linker is similarly structured in the bound and unbound states. CYK-4 binding decreases the rate of ZEN-4-mediated microtubule gliding. These results constrain models for the molecular organization of centralspindlin.	[White, Erin A.; Perozo, Eduardo] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Raghuraman, Hariharasundaram; Glotzer, Michael] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Glotzer, M (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA.	mglotzer@uchicago.edu		Glotzer, Michael/0000-0002-8723-7232; Raghuraman, H./0000-0001-9106-8278	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074743, R01GM085087, T32GM007183] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074743, R01 GM085087, T32 GM007183] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Alsop GB, 2003, J CELL BIOL, V162, P383, DOI 10.1083/jcb.200301073; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bonaccorsi S, 1998, J CELL BIOL, V142, P751, DOI 10.1083/jcb.142.3.751; Cao LG, 1996, MOL BIOL CELL, V7, P225, DOI 10.1091/mbc.7.2.225; Case RB, 2000, CURR BIOL, V10, P157, DOI 10.1016/S0960-9822(00)00316-X; Eckley DM, 1997, J CELL BIOL, V136, P1169, DOI 10.1083/jcb.136.6.1169; FAIRMAN R, 1995, PROTEIN SCI, V4, P1457, DOI 10.1002/pro.5560040803; FALKE JJ, 1988, J BIOL CHEM, V263, P14850; Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101; Giansanti MG, 1998, GENE DEV, V12, P396, DOI 10.1101/gad.12.3.396; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2006, J MAGN RESON, V180, P137, DOI 10.1016/j.jmr.2006.02.002; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Mori T, 2007, NATURE, V450, P750, DOI 10.1038/nature06346; MUSACCHIO A, 1992, NATURE, V359, P851, DOI 10.1038/359851a0; O'Hara BP, 1999, EMBO J, V18, P5175, DOI 10.1093/emboj/18.19.5175; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pavicic-Kaltenbrunner V, 2007, MOL BIOL CELL, V18, P4992, DOI 10.1091/mbc.E07-05-0468; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simossis VA, 2003, COMPUT BIOL CHEM, V27, P511, DOI 10.1016/j.compbiolchem.2003.09.002; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Toprak E, 2009, P NATL ACAD SCI USA, V106, P12717, DOI 10.1073/pnas.0808396106; Torbeev VY, 2011, P NATL ACAD SCI USA, V108, P20982, DOI 10.1073/pnas.1111202108; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; Wade RH, 2000, NAT STRUCT BIOL, V7, P456, DOI 10.1038/75850; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	43	11	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19785	19795		10.1074/jbc.M113.463695	http://dx.doi.org/10.1074/jbc.M113.463695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720745	Green Published, hybrid			2022-12-28	WOS:000321515800047
J	Hurst, JH; Dohlman, HG				Hurst, Jillian H.; Dohlman, Henrik G.			Dynamic Ubiquitination of the Mitogen-activated Protein Kinase Kinase (MAPKK) Ste7 Determines Mitogen-activated Protein Kinase (MAPK) Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PHEROMONE RESPONSE PATHWAY; SIGNALING SPECIFICITY; DEUBIQUITINATING ENZYMES; FILAMENTOUS-GROWTH; INVASIVE GROWTH; POSTTRANSLATIONAL MODIFICATIONS; FEEDBACK PHOSPHORYLATION; DIFFERENTIAL REGULATION; CAENORHABDITIS-ELEGANS	Ubiquitination is a post-translational modification that tags proteins for proteasomal degradation. In addition, there is a growing appreciation that ubiquitination can influence protein activity and localization. Ste7 is a prototype MAPKK in yeast that participates in both the pheromone signaling and nutrient deprivation/invasive growth pathways. We have shown previously that Ste7 is ubiquitinated upon pheromone stimulation. Here, we show that the Skp1/Cullin/F-box ubiquitin ligase SCFCdc4 and the ubiquitin protease Ubp3 regulate Ste7 ubiquitination and signal specificity. Using purified components, we demonstrate that SCFCdc4 ubiquitinates Ste7 directly. Using gene deletion mutants, we show that SCFCdc4 and Ubp3 have opposing effects on Ste7 ubiquitination. Although SCFCdc4 is necessary for proper activation of the pheromone MAPK Fus3, Ubp3 is needed to limit activation of the invasive growth MAPK Kss1. Finally, we show that Fus3 phosphorylates Ubp3 directly and that phosphorylation of Ubp3 is necessary to limit Kss1 activation. These results reveal a feedback loop wherein one MAPK limits the ubiquitination of an upstream MAPKK and thereby prevents spurious activation of a second competing MAPK.	[Hurst, Jillian H.; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Dohlman, HG (corresponding author), Univ N Carolina, Dept Biochem & Biophys, 3049 Genet Med Bldg,Campus Box 7260, Chapel Hill, NC 27599 USA.	henrik_dohlman@med.unc.edu		Hurst, Jillian/0000-0001-5079-9920; Dohlman, Henrik/0000-0003-2443-0729	National Institutes of Health Ruth L. Kirschstein National Research Service Award [GM096597]; NIGMS [R01-GM059167]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM096597, R01GM059167] Funding Source: NIH RePORTER	National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Ruth L. Kirschstein National Research Service Award GM096597 (to J. H. H.) and Grant R01-GM059167 from NIGMS (to H. G. D.).	Andersson J, 2004, EMBO J, V23, P2564, DOI 10.1038/sj.emboj.7600250; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Bardwell L, 1998, P NATL ACAD SCI USA, V95, P15400, DOI 10.1073/pnas.95.26.15400; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; BARDWELL L, 1994, DEV BIOL, V166, P363, DOI 10.1006/dbio.1994.1323; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Breitkreutz A, 2001, CURR BIOL, V11, P1266, DOI 10.1016/S0960-9822(01)00370-0; Bruckner S, 2004, CURR GENET, V46, P331, DOI 10.1007/s00294-004-0545-1; Cappell SD, 2011, J BIOL CHEM, V286, P14852, DOI 10.1074/jbc.M110.195073; Cappell SD, 2010, MOL CELL, V38, P746, DOI 10.1016/j.molcel.2010.05.026; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chasse SA, 2004, METHOD ENZYMOL, V389, P399; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Cook JG, 1997, NATURE, V390, P85, DOI 10.1038/36355; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; DRISCOLL JJ, 2012, SEMIN HEMATOL, V49, P277, DOI DOI 10.1053/j.seminhematol.2012.04.002; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; Farley FW, 1999, GENETICS, V151, P1425; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Fischer JA, 2002, BIOESSAYS, V24, P13, DOI 10.1002/bies.10030; Gagiano M, 2002, FEMS YEAST RES, V2, P433, DOI 10.1016/S1567-1356(02)00133-2; Garrenton LS, 2006, GENE DEV, V20, P1946, DOI 10.1101/gad.1413706; Garrenton LS, 2010, P NATL ACAD SCI USA, V107, P11805, DOI 10.1073/pnas.1005817107; Garrenton LS, 2009, MOL CELL BIOL, V29, P582, DOI 10.1128/MCB.01019-08; Garrison TR, 1999, J BIOL CHEM, V274, P36387, DOI 10.1074/jbc.274.51.36387; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Hao N, 2007, ONCOGENE, V26, P3254, DOI 10.1038/sj.onc.1210416; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hao N, 2012, MOL BIOL CELL, V23, P3899, DOI 10.1091/mbc.E12-04-0333; Harhaj EW, 2011, CELL RES, V21, P22, DOI 10.1038/cr.2010.166; Henchoz S, 1997, GENE DEV, V11, P3046, DOI 10.1101/gad.11.22.3046; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hubbard EJA, 1997, GENE DEV, V11, P3182, DOI 10.1101/gad.11.23.3182; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Inuzuka H, 2010, ONCOTARGET, V1, P685; Jung YS, 2012, FEBS LETT, V586, P1397, DOI 10.1016/j.febslet.2012.03.052; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; LEVIN DE, 1995, CURR OPIN CELL BIOL, V7, P197, DOI 10.1016/0955-0674(95)80028-X; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Madhani HD, 1997, CELL, V91, P673, DOI 10.1016/S0092-8674(00)80454-7; Maleri S, 2004, MOL CELL BIOL, V24, P9221, DOI 10.1128/MCB.24.20.9221-9238.2004; Mao P, 2010, J BIOL CHEM, V285, P37542, DOI 10.1074/jbc.M110.170175; Maruyama S, 2001, GENOMICS, V78, P214, DOI 10.1006/geno.2001.6658; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Mocciaro A, 2012, J CELL SCI, V125, P255, DOI 10.1242/jcs.091199; Molina M, 2010, YEAST, V27, P503, DOI 10.1002/yea.1791; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Palecek SP, 2002, MICROBIOL-SGM, V148, P893, DOI 10.1099/00221287-148-4-893; Parnell SC, 2005, BIOCHEMISTRY-US, V44, P8159, DOI 10.1021/bi0503091; PELECH SL, 1992, TRENDS BIOCHEM SCI, V17, P233, DOI 10.1016/S0968-0004(00)80005-5; Posas F, 1998, CURR OPIN MICROBIOL, V1, P175, DOI 10.1016/S1369-5274(98)80008-8; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Randles L, 2012, FRONT BIOSCI-LANDMRK, V17, P2140, DOI 10.2741/4042; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Silverman JS, 2012, TRENDS BIOCHEM SCI, V37, P66, DOI 10.1016/j.tibs.2011.10.004; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sole C, 2011, EMBO J, V30, P3274, DOI 10.1038/emboj.2011.227; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Wang GC, 2012, CHIN J CANCER, V31, P169, DOI 10.5732/cjc.011.10319; Wang Y., 2002, J BIOL CHEM; Wang YQ, 2006, J BIOL CHEM, V281, P1964, DOI 10.1074/jbc.M508985200; Wang YQ, 2003, J BIOL CHEM, V278, P22284, DOI 10.1074/jbc.M301272200; Wang YQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007456; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Whelan JT, 2012, J CELL PHYSIOL, V227, P1235, DOI 10.1002/jcp.22899; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wing SS, 2003, INT J BIOCHEM CELL B, V35, P590, DOI 10.1016/S1357-2725(02)00392-8; Winters MJ, 2005, MOL CELL, V20, P21, DOI 10.1016/j.molcel.2005.08.020; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Yang WL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003197; Yang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055833; Yoon S, 2003, J BIOL CHEM, V278, P2131, DOI 10.1074/jbc.M209905200; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200	89	13	13	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18660	18671		10.1074/jbc.M113.475707	http://dx.doi.org/10.1074/jbc.M113.475707			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23645675	hybrid, Green Published			2022-12-28	WOS:000321335800003
J	Chertova, E; Bergamaschi, C; Chertov, O; Sowder, R; Bear, J; Roser, JD; Beach, RK; Lifson, JD; Felber, BK; Pavlakis, GN				Chertova, Elena; Bergamaschi, Cristina; Chertov, Oleg; Sowder, Raymond; Bear, Jenifer; Roser, James D.; Beach, Rachel K.; Lifson, Jeffrey D.; Felber, Barbara K.; Pavlakis, George N.			Characterization and Favorable in Vivo Properties of Heterodimeric Soluble IL-15 center dot IL-15R alpha Cytokine Compared to IL-15 Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD8(+) T-CELLS; RECEPTOR-ALPHA-CHAIN; NATURAL-KILLER-CELLS; SIGNAL PEPTIDE; INTERLEUKIN (IL)-15; ESTABLISHED TUMORS; TRANS PRESENTATION; NONHUMAN-PRIMATES; RHESUS MACAQUES; CD4(+) CELLS	Interleukin-15 (IL-15), a 114-amino acid cytokine related to IL-2, regulates immune homeostasis and the fate of many lymphocyte subsets. We reported that, in the blood of mice and humans, IL-15 is present as a heterodimer associated with soluble IL-15 receptor alpha (sIL-15R alpha). Here, we show efficient production of this noncovalently linked but stable heterodimer in clonal human HEK293 cells and release of the processed IL-15 center dot sIL-15R alpha heterodimer in the medium. Purification of the IL-15 and sIL-15R alpha polypeptides allowed identification of the proteolytic cleavage site of IL-15R alpha and characterization of multiple glycosylation sites. Administration of the IL-15 center dot sIL-15R alpha heterodimer reconstituted from purified subunits resulted in sustained plasma IL-15 levels and in robust expansion of NK and T cells in mice, demonstrating pharmacokinetics and in vivo bioactivity superior to single chain IL-15. These identified properties of heterodimeric IL-15 provide a strong rationale for the evaluation of this molecule for clinical applications.	[Chertova, Elena; Sowder, Raymond; Roser, James D.; Lifson, Jeffrey D.] Frederick Natl Lab, AIDS & Canc Virus Program, Ft Detrick, MD 21702 USA; [Chertov, Oleg] Frederick Natl Lab, Prot Chem Lab, Adv Technol Program, SAIC Frederick Inc, Ft Detrick, MD 21702 USA; [Bergamaschi, Cristina; Beach, Rachel K.; Pavlakis, George N.] NCI, Ctr Canc Res, Vaccine Branch, Human Retrovirus Sect, Frederick, MD 21702 USA; [Bear, Jenifer; Beach, Rachel K.; Felber, Barbara K.] NCI, Ctr Canc Res, Vaccine Branch, Human Retrovirus Pathogenesis Sect, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pavlakis, GN (corresponding author), NCI, Ctr Canc Res, Vaccine Branch, Human Retrovirus Sect, Frederick, MD 21702 USA.	pavlakig@mail.nih.gov			Intramural Research Program, National Cancer Institute, National Institutes of Health (NCI/National Institutes of Health); National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010750, ZIABC010350, ZIABC010334] Funding Source: NIH RePORTER	Intramural Research Program, National Cancer Institute, National Institutes of Health (NCI/National Institutes of Health); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program, National Cancer Institute, National Institutes of Health (NCI/National Institutes of Health) and federal funds from the National Cancer Institute, National Institutes of Health, under contract number HHSN261200800001E.	ANDERSON DM, 1995, J BIOL CHEM, V270, P29862; Bamford RN, 1998, J IMMUNOL, V160, P4418; Beq S, 2009, BLOOD, V114, P816, DOI 10.1182/blood-2008-11-191288; Berard M, 2003, J IMMUNOL, V170, P5018, DOI 10.4049/jimmunol.170.10.5018; Bergamaschi C, 2008, J BIOL CHEM, V283, P4189, DOI 10.1074/jbc.M705725200; Bergamaschi C, 2012, BLOOD, V120, pE1, DOI 10.1182/blood-2011-10-384362; Bergamaschi C, 2009, J IMMUNOL, V183, P3064, DOI 10.4049/jimmunol.0900693; Berger C, 2009, BLOOD, V114, P2417, DOI 10.1182/blood-2008-12-189266; Burkett PR, 2004, J EXP MED, V200, P825, DOI 10.1084/jem.20041389; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Chamorey AL, 2002, EUR CYTOKINE NETW, V13, P154; Cheever MAM, 2008, IMMUNOL REV, V222, P357, DOI 10.1111/j.1600-065X.2008.00604.x; Chirifu M, 2007, NAT IMMUNOL, V8, P1001, DOI 10.1038/ni1492; Croce M, 2012, IMMUNOTHERAPY-UK, V4, P957, DOI [10.2217/IMT.12.92, 10.2217/imt.12.92]; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Dubois S, 1999, J BIOL CHEM, V274, P26978, DOI 10.1074/jbc.274.38.26978; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Duitman EH, 2008, MOL CELL BIOL, V28, P4851, DOI 10.1128/MCB.02178-07; Epardaud M, 2008, CANCER RES, V68, P2972, DOI 10.1158/0008-5472.CAN-08-0045; GIRI JG, 1995, EMBO J, V14, P3654, DOI 10.1002/j.1460-2075.1995.tb00035.x; Gonzalez-Alvaro I, 2003, CLIN EXP RHEUMATOL, V21, P639; GRIBBEN JG, 1990, LANCET, V335, P434, DOI 10.1016/0140-6736(90)90665-R; Han KP, 2011, CYTOKINE, V56, P804, DOI 10.1016/j.cyto.2011.09.028; Jalah R, 2007, DNA CELL BIOL, V26, P827, DOI 10.1089/dna.2007.0645; Karpusas M, 1998, CELL MOL LIFE SCI, V54, P1203, DOI 10.1007/s000180050248; Klebanoff CA, 2004, P NATL ACAD SCI USA, V101, P1969, DOI 10.1073/pnas.0307298101; Kobayashi H, 2005, BLOOD, V105, P721, DOI 10.1182/blood-2003-12-4187; Koka R, 2003, J EXP MED, V197, P977, DOI 10.1084/jem.20021836; Kurys G, 2000, J BIOL CHEM, V275, P30653, DOI 10.1074/jbc.M002373200; Lugli E, 2010, BLOOD, V116, P3238, DOI 10.1182/blood-2010-03-275438; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Mortier E, 2004, J IMMUNOL, V173, P1681, DOI 10.4049/jimmunol.173.3.1681; Mortier E, 2008, J EXP MED, V205, P1213, DOI 10.1084/jem.20071913; Onu A, 1997, J IMMUNOL, V158, P255; Perales MA, 2012, BLOOD, V120, P4882, DOI 10.1182/blood-2012-06-437236; Picker LJ, 2006, J CLIN INVEST, V116, P1514, DOI 10.1172/JCI27564; Querol S, 1999, HAEMATOLOGICA, V84, P493; Rentzos M, 2006, J NEUROL SCI, V241, P25, DOI 10.1016/j.jns.2005.10.003; Ring AM, 2012, NAT IMMUNOL, V13, P1187, DOI 10.1038/ni.2449; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Rubinstein MP, 2002, J IMMUNOL, V169, P4928, DOI 10.4049/jimmunol.169.9.4928; Sandau MM, 2004, J IMMUNOL, V173, P6537, DOI 10.4049/jimmunol.173.11.6537; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sneller MC, 2011, BLOOD, V118, P6845, DOI 10.1182/blood-2011-09-377804; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; TAKEUCHI M, 1991, Glycobiology, V1, P337, DOI 10.1093/glycob/1.4.337; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; Teague RM, 2006, NAT MED, V12, P335, DOI 10.1038/nm1359; Vyas VV, 2012, BIOTECHNOL PROGR, V28, P497, DOI 10.1002/btpr.746; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Waldmann TA, 2011, BLOOD, V117, P4787, DOI 10.1182/blood-2010-10-311456; Zhang ML, 2009, P NATL ACAD SCI USA, V106, P7513, DOI 10.1073/pnas.0902637106; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	60	66	80	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18093	18103		10.1074/jbc.M113.461756	http://dx.doi.org/10.1074/jbc.M113.461756			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649624	Green Published, hybrid			2022-12-28	WOS:000320721900015
J	Xu, Y; Liu, YF; Lee, JG; Ye, YH				Xu, Yue; Liu, Yanfen; Lee, Jin-Gu; Ye, Yihong			A Ubiquitin-like Domain Recruits an Oligomeric Chaperone to a Retrotranslocation Complex in Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; MEMBRANE-PROTEINS; LIGASE; HRD1P; GP78; BAT3; DIMETHYLATION; POLYPEPTIDES; ELIMINATION; INTEGRATION	The Bag6-Ubl4A-Trc35 complex is a multifunctional chaperone that regulates various cellular processes. The diverse functions of Bag6 are supported by its ubiquitous localization to the cytoplasm, the nucleus, and membranes of the endoplasmic reticulum (ER) in cells. In ER-associated degradation (ERAD) pathways, Bag6 can interact with the membrane-associated ubiquitin ligase gp78 via its ubiquitin-like (UBL) domain, but the relative low affinity of this interaction does not reconcile with the fact that a fraction of Bag6 is tightly bound to the membranes. Here, we demonstrate that the UBL domain of Bag6 is required for interaction with the ER membranes. We find that in addition to gp78, the Bag6 UBL domain also binds a UBL-binding motif in UbxD8, an essential component of the gp78 ubiquitinating machinery. Importantly, Bag6 contains a proline-rich (PR) domain termed PDP (Proline rich-DUF3587-Proline rich) that forms homo-oligomer, allowing the UBL domain to form multivalent interactions with gp78 and UbxD8, which are essential for recruitment of Bag6 to the ER membrane. Furthermore, the PR domain comprises largely intrinsically disordered segments, which are sufficient for interaction with an unfolded substrate. We propose that simultaneous association with multiple ERAD factors helps to anchor a disordered chaperone oligomer to the site of retrotranslocation to prevent protein aggregation in ERAD.	[Xu, Yue; Liu, Yanfen; Lee, Jin-Gu; Ye, Yihong] NIH, NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ye, YH (corresponding author), NIH, NIDDK, Mol Biol Lab, 5 Ctr Dr, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov	Xu, Yue/F-8188-2015	Lee, Jin-Gu/0000-0001-9477-6990	NIDDK at the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033008] Funding Source: NIH RePORTER	NIDDK at the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the NIDDK at the National Institutes of Health.	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chartron JW, 2012, CELL REP, V2, P1620, DOI 10.1016/j.celrep.2012.10.010; Chen ZL, 2012, CURR PROTEIN PEPT SC, V13, P414, DOI 10.2174/138920312802430590; Claessen JHL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028542; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Hessa T, 2011, NATURE, V475, P394, DOI 10.1038/nature10181; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Kawahara H, 2013, J BIOCHEM, V153, P147, DOI 10.1093/jb/mvs149; Lee JG, 2013, BIOESSAYS, V35, P377, DOI 10.1002/bies.201200159; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Li LY, 2008, BBA-MOL CELL RES, V1783, P1140, DOI 10.1016/j.bbamcr.2008.01.029; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Minami R, 2010, J CELL BIOL, V190, P637, DOI 10.1083/jcb.200908092; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Soetandyo N, 2010, J CELL SCI, V123, P1031, DOI 10.1242/jcs.059758; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; van der Veen AG, 2012, ANNU REV BIOCHEM, V81, P323, DOI 10.1146/annurev-biochem-093010-153308; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wakeman TP, 2012, EMBO J, V31, P2169, DOI 10.1038/emboj.2012.50; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Xu Y, 2012, CELL REP, V2, P1633, DOI 10.1016/j.celrep.2012.11.010; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	35	48	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18068	18076		10.1074/jbc.M112.449199	http://dx.doi.org/10.1074/jbc.M112.449199			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23665563	Green Published, hybrid			2022-12-28	WOS:000320721900013
J	Sakabe, J; Yamamoto, M; Hirakawa, S; Motoyama, A; Ohta, I; Tatsuno, K; Ito, T; Kabashima, K; Hibino, T; Tokura, Y				Sakabe, Jun-ichi; Yamamoto, Mami; Hirakawa, Satoshi; Motoyama, Akira; Ohta, Isao; Tatsuno, Kazuki; Ito, Taisuke; Kabashima, Kenji; Hibino, Toshihiko; Tokura, Yoshiki			Kallikrein-related Peptidase 5 Functions in Proteolytic Processing of Profilaggrin in Cultured Human Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL BARRIER FUNCTION; HIGH-MOLECULAR-WEIGHT; STRATUM-CORNEUM; SERINE PROTEASES; MOUSE EPIDERMIS; ATOPIC ECZEMA; AMINO-ACIDS; HUMAN SKIN; FILAGGRIN; EXPRESSION	Filaggrin protein is synthesized in the stratum granulosum of the skin and contributes to the formation of the human skin barrier. Profilaggrin is cleaved by proteolytic enzymes and converted to functional filaggrin, but its processing mechanism remains not fully elucidated. Kallikrein-related peptidase 5 (KLK5) is a major serine protease found in the skin, which is secreted from lamellar granules following its expression in the stratum granulosum and activated in the extracellular space of the stratum corneum. Here, we searched for profilaggrin-processing protease(s) by partial purification of epidermal extracts and found KLK5 as a possible candidate. We used high performance liquid chromatography coupled with electrospray tandem mass spectrometry to show that KLK5 cleaves profilaggrin. Furthermore, based on a proximity ligation assay, immunohistochemistry, and immunoelectron microscopy analysis, we reveal that KLK5 and profilaggrin co-localize in the stratum granulosum in human epidermis. KLK5 knockdown in normal cultured human epidermal keratinocytes resulted in higher levels of profilaggrin, indicating that KLK5 potentially functions in profilaggrin cleavage.	[Sakabe, Jun-ichi; Hirakawa, Satoshi; Tatsuno, Kazuki; Ito, Taisuke; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Yamamoto, Mami; Motoyama, Akira; Hibino, Toshihiko] Shiseido Innovat Sci Res & Dev Ctr, Kanazawa Ku, Yokohama, Kanagawa 2388643, Japan; [Yamamoto, Mami] Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, Tokyo 1600023, Japan; [Ohta, Isao] Hamamatsu Univ Sch Med, Dept Lab Med, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Ohta, Isao] Hamamatsu Univ Sch Med, Cent Lab Ultrastruct Res, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, Kyoto 6068507, Japan	Hamamatsu University School of Medicine; Shiseido Company, Limited; Tokyo Medical University; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Kyoto University	Sakabe, J (corresponding author), Hamamatsu Univ Sch Med, Dept Dermatol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	jsakabe@hama-med.ac.jp	Kabashima, Kenji/G-2521-2014	Kabashima, Kenji/0000-0002-0773-0554; Sakabe, Jun-Ichi/0000-0002-8237-0472	Hamamatsu University School of Medicine [101337]; Ministry of Education, Culture, Sports, Science, and Technology [24890082, 24659525]	Hamamatsu University School of Medicine; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research 101337 from the Hamamatsu University School of Medicine (to JS), Grant-in-aid for Research Activity Start-up 24890082 (to J. S.), and Grant-in-aid for Challenging Exploratory Research 24659525 (to Y. T.) from the Ministry of Education, Culture, Sports, Science, and Technology.	BALL RD, 1978, J BIOL CHEM, V253, P5861; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Briot A, 2009, J EXP MED, V206, P1135, DOI 10.1084/jem.20082242; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; DALE BA, 1979, J INVEST DERMATOL, V72, P257, DOI 10.1111/1523-1747.ep12531715; Deraison C, 2007, MOL BIOL CELL, V18, P3607, DOI 10.1091/mbc.E07-02-0124; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Henry J, 2011, FASEB J, V25, P1567, DOI 10.1096/fj.10-168658; Hibino T, 2010, J CELL BIOCHEM, V109, P487, DOI 10.1002/jcb.22425; Ishida-Yamamoto A, 2005, J INVEST DERMATOL, V124, P360, DOI 10.1111/j.0022-202X.2004.23583.x; Kamata Y, 2011, J BIOL CHEM, V286, P8204, DOI 10.1074/jbc.M110.169292; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; LONSDALEECCLES JD, 1984, BIOCHEMISTRY-US, V23, P1239, DOI 10.1021/bi00301a034; Matsui T, 2011, EMBO MOL MED, V3, P320, DOI 10.1002/emmm.201100140; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Nemoto-Hasebe I, 2009, BRIT J DERMATOL, V161, P1387, DOI 10.1111/j.1365-2133.2009.09406.x; RAMSDEN M, 1983, DIFFERENTIATION, V23, P243; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; ROOP DR, 1983, P NATL ACAD SCI-BIOL, V80, P716, DOI 10.1073/pnas.80.3.716; Sandilands A, 2012, J INVEST DERMATOL, V132, P1507, DOI 10.1038/jid.2011.479; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; SCOTT IR, 1981, BIOCHIM BIOPHYS ACTA, V669, P65, DOI 10.1016/0005-2795(81)90224-5; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Takahashi M, 2004, ARCH DERMATOL RES, V295, P448, DOI 10.1007/s00403-003-0448-x; Wu ZH, 2009, J INVEST DERMATOL, V129, P1446, DOI 10.1038/jid.2008.370; Wu ZH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005227; Yamamoto M, 2012, J BIOL CHEM, V287, P32825, DOI 10.1074/jbc.M112.357467	33	46	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17179	17189		10.1074/jbc.M113.476820	http://dx.doi.org/10.1074/jbc.M113.476820			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629652	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000320380600015
J	Silva, PN; Altamentova, SM; Kilkenny, DM; Rocheleau, JV				Silva, Pamuditha N.; Altamentova, Svetlana M.; Kilkenny, Dawn M.; Rocheleau, Jonathan V.			Fibroblast Growth Factor Receptor Like-1 (FGFRL1) Interacts with SHP-1 Phosphatase at Insulin Secretory Granules and Induces Beta-cell ERK1/2 Protein Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL EXPRESSION; FLUORESCENT PROTEIN; DYNAMICS; MOUSE; PROLIFERATION; TRAFFICKING; PATHWAY; PHOGRIN; ATLAS	FGFRL1 is a newly identified member of the fibroblast growth factor receptor (FGFR) family expressed in adult pancreas. Unlike canonical FGFRs that initiate signaling via tyrosine kinase domains, the short intracellular sequence of FGFRL1 consists of a putative Src homology domain-2 (SH2)-binding motif adjacent to a histidine-rich C terminus. As a consequence of nonexistent kinase domains, FGFRL1 has been postulated to act as a decoy receptor to inhibit canonical FGFR ligand-induced signaling. In pancreatic islet beta-cells, canonical FGFR1 signaling affects metabolism and insulin processing. This study determined beta-cell expression of FGFRL1 as well as consequent effects on FGFR1 signaling and biological responses. We confirmed FGFRL1 expression at the plasma membrane and within distinct intracellular granules of both primary beta-cells and beta TC3 cells. Fluorescent protein-tagged FGFRL1 (RL1) induced a significant ligand-independent increase in MAPK signaling. Removal of the histidine-rich domain (RL1-Delta His) or entire intracellular sequence (RL1-Delta C) resulted in greater retention at the plasma membrane and significantly reduced ligand-independent ERK1/2 responses. The SHP-1 phosphatase was identified as an RL1-binding substrate. Point mutation of the SH2-binding motif reduced the ability of FGFRL1 to bind SHP-1 and activate ERK1/2 but did not affect receptor localization to insulin secretory granules. Finally, overexpression of RL1 increased cellular insulin content and matrix adhesion. Overall, these data suggest that FGFRL1 does not function as a decoy receptor in beta-cells, but rather it enhances ERK1/2 signaling through association of SHP-1 with the receptor's intracellular SH2-binding motif.	[Silva, Pamuditha N.; Kilkenny, Dawn M.; Rocheleau, Jonathan V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Altamentova, Svetlana M.; Rocheleau, Jonathan V.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 2M9, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Kilkenny, DM (corresponding author), Univ Toronto, Rosebrugh Bldg,164 Coll St,Rm 407, Toronto, ON M5G 1L7, Canada.	dawn.kilkenny@utoronto.ca; jon.rocheleau@utoronto.ca		Rocheleau, Jonathan/0000-0002-1760-2564	Canadian Institutes of Health Research Bridge Fund Grant [NMD106997]; Natural Sciences and Engineering Research Council of Canada Discovery Grant; Novo-Nordisk student scholarship from the University of Toronto Faculty of Medicine Banting; Novo-Nordisk student scholarship from the University of Toronto Faculty of Medicine Banting and Best Diabetes Centre	Canadian Institutes of Health Research Bridge Fund Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Novo-Nordisk student scholarship from the University of Toronto Faculty of Medicine Banting; Novo-Nordisk student scholarship from the University of Toronto Faculty of Medicine Banting and Best Diabetes Centre	This work was supported by Canadian Institutes of Health Research Bridge Fund Grant NMD106997 (to J. V. R. and D. M. K.), a Natural Sciences and Engineering Research Council of Canada Discovery Grant (to J. V. R.), and a Novo-Nordisk student scholarship from the University of Toronto Faculty of Medicine Banting and Best Diabetes Centre (to P. N. S.). The confocal microscope used in these studies was purchased using a CFI Leaders Opportunity Fund Grant (to J. V. R.).	Aksamitiene E, 2010, CELL SIGNAL, V22, P1369, DOI 10.1016/j.cellsig.2010.05.006; Albrecht DS, 2008, CHEM-BIOL INTERACT, V171, P89, DOI 10.1016/j.cbi.2007.09.001; Arany E, 2000, PEDIATR RES, V48, P389, DOI 10.1203/00006450-200009000-00023; Bapat S, 2001, FEBS LETT, V499, P21, DOI 10.1016/S0014-5793(01)02511-X; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Beazely MA, 2009, J BIOL CHEM, V284, P8054, DOI 10.1074/jbc.M805384200; Burren OS, 2011, NUCLEIC ACIDS RES, V39, pD997, DOI 10.1093/nar/gkq912; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dichmann DS, 2003, DEV DYNAM, V226, P663, DOI 10.1002/dvdy.10270; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Haugsten EM, 2005, J CELL SCI, V118, P3869, DOI 10.1242/jcs.02509; Hiriart M, 2001, ISRAEL MED ASSOC J, V3, P114; Hughes SE, 1997, J HISTOCHEM CYTOCHEM, V45, P1005, DOI 10.1177/002215549704500710; HUTTON JC, 1983, BIOCHEM J, V210, P297, DOI 10.1042/bj2100297; Kilkenny DM, 2008, MOL ENDOCRINOL, V22, P196, DOI 10.1210/me.2007-0241; Kim I, 2001, BBA-GENE STRUCT EXPR, V1518, P152, DOI 10.1016/S0167-4781(00)00282-7; MANDERS EMM, 1992, J CELL SCI, V103, P857; Micou M. K., 2012, LAB COURSE TISSUE EN; Ming AYK, 2012, J BIOL CHEM, V287, P19997, DOI 10.1074/jbc.M111.325670; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pouli AE, 1998, BIOCHEM J, V333, P193, DOI 10.1042/bj3330193; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Rankin MM, 2010, ISLETS, V2, P345, DOI 10.4161/isl.2.6.13376; Rieckmann T, 2008, EXP CELL RES, V314, P1071, DOI 10.1016/j.yexcr.2007.10.029; Rieckmann T, 2009, BBA-MOL BASIS DIS, V1792, P112, DOI 10.1016/j.bbadis.2008.11.006; Rivas-Carrillo JD, 2006, CELL TRANSPLANT, V15, P939, DOI 10.3727/000000006783981323; Seymour PA, 2012, DEVELOPMENT, V139, P3363, DOI 10.1242/dev.078733; Sleeman M, 2001, GENE, V271, P171, DOI 10.1016/S0378-1119(01)00518-2; Steinberg F, 2010, J BIOL CHEM, V285, P2193, DOI 10.1074/jbc.M109.058248; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suckalel J, 2010, TRENDS ENDOCRIN MET, V21, P599, DOI 10.1016/j.tem.2010.06.003; Sun MY, 2012, BIOPHYS J, V103, P2379, DOI 10.1016/j.bpj.2012.10.028; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102; Trueb B, 2003, J BIOL CHEM, V278, P33857, DOI 10.1074/jbc.M300281200; Trueb B, 2011, CELL MOL LIFE SCI, V68, P951, DOI 10.1007/s00018-010-0576-3; Wang W, 2011, J CELL BIOCHEM, V112, P2062, DOI 10.1002/jcb.23125; Wasmeier C, 1996, J BIOL CHEM, V271, P18161, DOI 10.1074/jbc.271.30.18161; Wiedemann M, 2000, GENOMICS, V69, P275, DOI 10.1006/geno.2000.6332; Xu XF, 2011, MECH DEVELOP, V128, P412, DOI 10.1016/j.mod.2011.08.001; Zhen Y, 2007, ONCOGENE, V26, P6372, DOI 10.1038/sj.onc.1210473; Zhuang L, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-33; Zinchuk O, 2004, CELL TISSUE RES, V317, P265, DOI 10.1007/s00441-004-0919-1	45	36	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17859	17870		10.1074/jbc.M112.440677	http://dx.doi.org/10.1074/jbc.M112.440677			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640895	Green Published, hybrid			2022-12-28	WOS:000320380600074
J	Stehle, F; Schulz, K; Fahldieck, C; Kalich, J; Lichtenfels, R; Riemann, D; Seliger, B				Stehle, Franziska; Schulz, Kristin; Fahldieck, Corinna; Kalich, Jana; Lichtenfels, Rudolf; Riemann, Dagmar; Seliger, Barbara			Reduced Immunosuppressive Properties of Axitinib in Comparison with Other Tyrosine Kinase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL-CELL CARCINOMA; REGULATORY T-CELLS; PHASE-I; PERIPHERAL-BLOOD; IMMUNE SUPPRESSION; DOWN-REGULATION; KIDNEY CANCER; SUNITINIB; SORAFENIB; MCL-1	The multikinase inhibitors sunitinib, sorafenib, and axitinib have an impact not only on tumor growth and angiogenesis, but also on the activity and function of immune effector cells. In this study, a comparative analysis of the growth inhibitory properties and apoptosis induction potentials of tyrosine kinase inhibitors on T cells was performed. Tyrosine kinase inhibitor treatment resulted in a dramatic decrease in T cell proliferation along with distinct impacts on the cell cycle progression. This was at least partially associated with an enhanced induction of apoptosis although triggered by distinct apoptotic mechanisms. In contrast to sunitinib and sorafenib, axitinib did not affect the mitochondrial membrane potential (Delta psi(m)) but resulted in an induction or stabilization of the induced myeloid leukemia cell differentiation protein (Mcl-1), leading to an irreversible arrest in the G(2)/M cell cycle phase and delayed apoptosis. Furthermore, the sorafenib-mediated suppression of immune effector cells, in particular the reduction of the CD8(+) T cell subset along with the down-regulation of key immune cell markers such as chemokine CC motif receptor 7 (CCR7), CD26, CD69, CD25, and CXCR3, was not observed in axitinib-treated immune effector cells. Therefore, axitinib rather than sorafenib seems to be suitable for implementation in complex treatment regimens of cancer patients including immunotherapy.	[Stehle, Franziska; Schulz, Kristin; Fahldieck, Corinna; Kalich, Jana; Lichtenfels, Rudolf; Riemann, Dagmar; Seliger, Barbara] Univ Halle Wittenberg, Inst Med Immunol, D-06112 Halle, Saale, Germany	Martin Luther University Halle Wittenberg	Seliger, B (corresponding author), Univ Halle Wittenberg, Inst Med Immunol, Magdeburger Str 2, D-06112 Halle, Saale, Germany.	barbara.seliger@uk-halle.de	Riemann, Dagmar/ABF-1845-2020	Riemann, Dagmar/0000-0002-7989-6262; Seliger, Barbara/0000-0002-5544-4958	Mildred Scheel Foundation; Else Kroener Fresenius Foundation; Sander Foundation	Mildred Scheel Foundation(Deutsche Krebshilfe); Else Kroener Fresenius Foundation; Sander Foundation	This work was supported by the Mildred Scheel, Else Kroener Fresenius, and Sander Foundations.	Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Andersen JL, 2012, NAT CELL BIOL, V14, P563, DOI 10.1038/ncb2511; Awada A, 2005, BRIT J CANCER, V92, P1855, DOI 10.1038/sj.bjc.6602584; Biswas S, 2009, NAT REV CLIN ONCOL, V6, P478, DOI 10.1038/nrclinonc.2009.91; Bose A, 2012, MELANOMA RES, V22, P236, DOI 10.1097/CMR.0b013e3283538293; Bose A, 2011, INT J CANCER, V129, P2158, DOI 10.1002/ijc.25863; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; BUHLING F, 1994, NAT IMMUN, V13, P270; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Chouaib S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00021; Dar WA, 2007, IMMUNOLOGY, V120, P467, DOI 10.1111/j.1365-2567.2006.02534.x; De Meester I, 1999, IMMUNOL TODAY, V20, P367, DOI 10.1016/S0167-5699(99)01486-3; Facciabene A, 2011, NATURE, V475, P226, DOI 10.1038/nature10169; Farsaci B, 2012, INT J CANCER, V130, P1948, DOI 10.1002/ijc.26219; Finke J, 2011, INT IMMUNOPHARMACOL, V11, P856, DOI 10.1016/j.intimp.2011.01.030; Finke JH, 2008, CLIN CANCER RES, V14, P6674, DOI 10.1158/1078-0432.CCR-07-5212; Flanigan Robert C, 2003, Curr Treat Options Oncol, V4, P385, DOI 10.1007/s11864-003-0039-2; Florcken A, 2012, ANTI-CANCER DRUG, V23, P298, DOI 10.1097/CAD.0b013e32834ee2b1; Gouttefangeas C, 2007, CANCER IMMUNOL IMMUN, V56, P117, DOI 10.1007/s00262-006-0172-4; Gua YH, 2010, CLIN IMMUNOL, V135, P55, DOI 10.1016/j.clim.2009.11.013; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hipp MM, 2008, BLOOD, V111, P5610, DOI 10.1182/blood-2007-02-075945; Hutson TE, 2011, ONCOLOGIST, V16, P14, DOI 10.1634/theoncologist.2011-S2-14; HWANG A, 1995, J BIOL CHEM, V270, P28419; Jonasch E, 2010, CANCER-AM CANCER SOC, V116, P57, DOI 10.1002/cncr.24685; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Kujawski M, 2010, CANCER RES, V70, P9599, DOI 10.1158/0008-5472.CAN-10-1293; Leich F, 2007, J BIOL CHEM, V282, P27640, DOI 10.1074/jbc.M702240200; Li B, 2006, CLIN CANCER RES, V12, P6808, DOI 10.1158/1078-0432.CCR-06-1558; Liotta F, 2011, BJU INT, V107, P1500, DOI 10.1111/j.1464-410X.2010.09555.x; Minkin P, 2008, J CHROMATOGR B, V874, P84, DOI 10.1016/j.jchromb.2008.09.007; Mohan K, 2005, EUR J IMMUNOL, V35, P1702, DOI 10.1002/eji.200425885; Naito S, 2000, WORLD J SURG, V24, P1183, DOI 10.1007/s002680010200; Ozao-Choy J, 2009, CANCER RES, V69, P2514, DOI 10.1158/0008-5472.CAN-08-4709; Porta C, 2007, ANTICANCER RES, V27, P165; Porta C, 2011, J CANCER, V2, P333, DOI 10.7150/jca.2.333; Pozarowski Piotr, 2004, Methods Mol Biol, V281, P301; Procopio G, 2011, BRIT J CANCER, V104, P1256, DOI 10.1038/bjc.2011.103; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Rahmani M, 2007, MOL CELL BIOL, V27, P5499, DOI 10.1128/MCB.01080-06; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Rugo HS, 2005, J CLIN ONCOL, V23, P5474, DOI 10.1200/JCO.2005.04.192; Samraj AK, 2007, MOL BIOL CELL, V18, P84, DOI 10.1091/mbc.E06-04-0263; Seliger B, 2010, TRENDS MOL MED, V16, P184, DOI 10.1016/j.molmed.2010.02.001; Sharma S, 2010, ANN ONCOL, V21, P297, DOI 10.1093/annonc/mdp489; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; Thompson RH, 2007, CLIN CANCER RES, V13, P1757, DOI 10.1158/1078-0432.CCR-06-2599; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zhao W, 2008, LEUKEMIA, V22, P1226, DOI 10.1038/leu.2008.58; Zhou XH, 2009, ANAT REC, V292, P1122, DOI 10.1002/ar.20938	54	44	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16334	16347		10.1074/jbc.M112.437962	http://dx.doi.org/10.1074/jbc.M112.437962			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625925	Green Published, hybrid			2022-12-28	WOS:000320378900012
J	Mulepati, S; Bailey, S				Mulepati, Sabin; Bailey, Scott			In Vitro Reconstitution of an Escherichia coli RNA-guided Immune System Reveals Unidirectional, ATP-dependent Degradation of DNA Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRISPR IMMUNITY; CAS3; CASCADE; BINDING; NUCLEASE; PROTEIN; INTERFERENCE; PROKARYOTES; MECHANISM; SEQUENCES	Many prokaryotes utilize small RNA transcribed from clustered, regularly interspaced, short palindromic repeats (CRISPRs) to protect themselves from foreign genetic elements, such as phage and plasmids. In Escherichia coli, this small RNA is packaged into a surveillance complex (Cascade) that uses the RNA sequence to direct binding to invasive DNA. Once bound, Cascade recruits the Cas3 nuclease-helicase, which then proceeds to progressively degrade the invading DNA. Here, using individually purified Cascade and Cas3 from E. coli, we reconstitute CRISPR-mediated plasmid degradation in vitro. Analysis of this reconstituted assay suggests that Cascade recruits Cas3 to a single-stranded region of the DNA target exposed by Cascade binding. Cas3 then nicks the exposed DNA. Recruitment and nicking is stimulated by the presence, but not hydrolysis, of ATP. Following nicking and powered by ATP hydrolysis, the concerted actions of the helicase and nuclease domains of Cas3 proceed to unwind and degrade the entire DNA target in a unidirectional manner.	[Mulepati, Sabin; Bailey, Scott] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bailey, S (corresponding author), Dept Biochem & Mol Biol, 615 N Wolfe St,W8704, Baltimore, MD 21205 USA.	scbailey@jhsph.edu	Bailey, Scott/N-7248-2019		National Institutes of Health [GM097330]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM097330 (to S.B.).	Anjem A, 2009, MOL MICROBIOL, V72, P844, DOI 10.1111/j.1365-2958.2009.06699.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2011, EMBO J, V30, P4616, DOI 10.1038/emboj.2011.377; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Cai LP, 2001, NUCLEIC ACIDS RES, V29, P1389, DOI 10.1093/nar/29.6.1389; Goren MG, 2012, J MOL BIOL, V423, P14, DOI 10.1016/j.jmb.2012.06.037; Graham AI, 2009, J BIOL CHEM, V284, P18377, DOI 10.1074/jbc.M109.001503; Howard JAL, 2011, BIOCHEM J, V439, P85, DOI 10.1042/BJ20110901; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kiianitsa K, 2003, ANAL BIOCHEM, V321, P266, DOI 10.1016/S0003-2697(03)00461-5; Macomber L, 2011, MOL MICROBIOL, V82, P1291, DOI 10.1111/j.1365-2958.2011.07891.x; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2012, J BIOL CHEM, V287, P22445, DOI 10.1074/jbc.C112.379503; Mulepati S, 2011, J BIOL CHEM, V286, P31896, DOI 10.1074/jbc.M111.270017; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Westra ER, 2012, RNA BIOL, V9, P1134, DOI 10.4161/rna.21410; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wigley DB, 2013, NAT REV MICROBIOL, V11, P9, DOI 10.1038/nrmicro2917; Yosef I, 2011, P NATL ACAD SCI USA, V108, P20136, DOI 10.1073/pnas.1113519108	27	130	132	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22184	22192		10.1074/jbc.M113.472233	http://dx.doi.org/10.1074/jbc.M113.472233			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23760266	Green Published, hybrid			2022-12-28	WOS:000330596300001
J	Iguchi, M; Kujuro, Y; Okatsu, K; Koyano, F; Kosako, H; Kimura, M; Suzuki, N; Uchiyama, S; Tanaka, K; Matsuda, N				Iguchi, Masahiro; Kujuro, Yuki; Okatsu, Kei; Koyano, Fumika; Kosako, Hidetaka; Kimura, Mayumi; Suzuki, Norihiro; Uchiyama, Shinichiro; Tanaka, Keiji; Matsuda, Noriyuki			Parkin-catalyzed Ubiquitin-Ester Transfer Is Triggered by PINK1-dependent Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Parkin; Pink1; Ubiquitin; Ubiquitin Ligase; RING Finger	MITOCHONDRIAL TRANSLOCATION; PROTEIN LIGASE; OXIDATIVE STRESS; RING DOMAIN; CELL-DEATH; PINK1; DEGRADATION; MUTATIONS; DYSFUNCTION; MECHANISMS	PINK1 and PARKIN are causal genes for autosomal recessive familial Parkinsonism. PINK1 is a mitochondrial Ser/Thr kinase, whereas Parkin functions as an E3 ubiquitin ligase. Under steady-state conditions, Parkin localizes to the cytoplasm where its E3 activity is repressed. A decrease in mitochondrial membrane potential triggers Parkin E3 activity and recruits it to depolarized mitochondria for ubiquitylation of mitochondrial substrates. The molecular basis for how the E3 activity of Parkin is re-established by mitochondrial damage has yet to be determined. Here we provide in vitro biochemical evidence for ubiquitin-thioester formation on Cys-431 of recombinant Parkin. We also report that Parkin forms a ubiquitin-ester following a decrease in mitochondrial membrane potential in cells, and that this event is essential for substrate ubiquitylation. Importantly, the Parkin RING2 domain acts as a transthiolation or acyl-transferring domain rather than an E2-recruiting domain. Furthermore, formation of the ubiquitin-ester depends on PINK1 phosphorylation of Parkin Ser-65. A phosphorylation-deficient mutation completely inhibited formation of the Parkin ubiquitin-ester intermediate, whereas phosphorylation mimics, such as Ser to Glu substitution, enabled partial formation of the intermediate irrespective of Ser-65 phosphorylation. We propose that PINK1-dependent phosphorylation of Parkin leads to the ubiquitin-ester transfer reaction of the RING2 domain, and that this is an essential step in Parkin activation.	[Iguchi, Masahiro; Kujuro, Yuki; Okatsu, Kei; Koyano, Fumika; Kimura, Mayumi; Tanaka, Keiji; Matsuda, Noriyuki] Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan; [Iguchi, Masahiro; Uchiyama, Shinichiro] Tokyo Womens Med Univ, Dept Neurol, Sch Med, Shinjuku Ku, Tokyo 1628666, Japan; [Kujuro, Yuki; Suzuki, Norihiro] Keio Univ, Dept Neurol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Okatsu, Kei; Koyano, Fumika] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan; [Kosako, Hidetaka] Univ Tokushima, Div Dis Prote, Inst Enzyme Res, Tokushima 7708503, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Women's Medical University; Keio University; University of Tokyo; Tokushima University	Tanaka, K (corresponding author), Tokyo Metropolitan Inst Med Sci, Lab Prot Metab, Setagaya Ku, Tokyo 1568506, Japan.	tanaka-kj@igakuken.or.jp	Suzuki, Norihiro/J-5125-2013; Matsuda, Noriyuki/AAI-3156-2020	Suzuki, Norihiro/0000-0002-0399-6590; Matsuda, Noriyuki/0000-0001-8199-952X; Iguchi, Masahiro/0000-0001-6989-0687; Okatsu, Kei/0000-0001-8949-3750	Japan Society for the Promotion of Science (JSPS)/Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI [23-6061, 23791001, 21000012, 23687018, 24111557, 25112522]; Tomizawa Jun-ichi and Keiko Fund for Young Scientist; Takeda Science Foundation; Tomizawa Jun-ichi and Keiko Fund of Molecular Biology Society of Japan for Young Scientist	Japan Society for the Promotion of Science (JSPS)/Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI; Tomizawa Jun-ichi and Keiko Fund for Young Scientist; Takeda Science Foundation(Takeda Science Foundation (TSF)); Tomizawa Jun-ichi and Keiko Fund of Molecular Biology Society of Japan for Young Scientist	This work was supported in part by Japan Society for the Promotion of Science (JSPS)/Ministry of Education, Culture, Sports, Science and Technology (MEXT) KAKENHI Grants 23-6061 (to K. O.), 23791001 (to Y. K.), 21000012 (to K. T.), and 23687018, 24111557, and 25112522 (to N. M.); the Tomizawa Jun-ichi and Keiko Fund for Young Scientist (to N. M.); and the Takeda Science Foundation (to H. K., N. M., and K. T.). Supported by Tomizawa Jun-ichi and Keiko Fund of Molecular Biology Society of Japan for Young Scientist.	Avraham E, 2007, J BIOL CHEM, V282, P12842, DOI 10.1074/jbc.M608243200; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Chew KCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019720; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Denison SR, 2003, ONCOGENE, V22, P8370, DOI 10.1038/sj.onc.1207072; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Exner N, 2012, EMBO J, V31, P3038, DOI 10.1038/emboj.2012.170; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Greene AW, 2012, EMBO REP, V13, P378, DOI 10.1038/embor.2012.14; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hemelaar J, 2004, MOL CELL BIOL, V24, P84, DOI 10.1128/MCB.24.1.84-95.2004; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imaizumi Y, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-35; Jin SM, 2010, J CELL BIOL, V191, P933, DOI 10.1083/jcb.201008084; Joselin AP, 2012, HUM MOL GENET, V21, P4888, DOI 10.1093/hmg/dds325; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2012, PROTEOMICS, V12, P192, DOI 10.1002/pmic.201100524; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Koh H, 2010, ANAT CELL BIOL, V43, P179, DOI 10.5115/acb.2010.43.3.179; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Love KR, 2009, ACS CHEM BIOL, V4, P275, DOI 10.1021/cb9000348; Matsuda N, 2006, J BIOL CHEM, V281, P3204, DOI 10.1074/jbc.M510393200; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Narendra D, 2012, COLD SPRING HARB PER, V4; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2012, BIOCHEM BIOPH RES CO, V428, P197, DOI 10.1016/j.bbrc.2012.10.041; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pawlyk AC, 2003, J BIOL CHEM, V278, P48120, DOI 10.1074/jbc.M306889200; Pogson JH, 2011, CURR NEUROL NEUROSCI, V11, P283, DOI 10.1007/s11910-011-0187-x; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Rankin Carolyn A, 2011, Open Biochem J, V5, P9, DOI 10.2174/1874091X01105010009; Riley BE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2982; Rubio de la Torre E, 2009, HUM MOL GENET, V18, P809, DOI 10.1093/hmg/ddn407; Sha D, 2010, HUM MOL GENET, V19, P352, DOI 10.1093/hmg/ddp501; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Spratt DE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2983; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Trempe JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00038; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456; Vives-Bauza C, 2011, TRENDS MOL MED, V17, P158, DOI 10.1016/j.molmed.2010.11.002; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang XN, 2011, CELL, V147, P893, DOI 10.1016/j.cell.2011.10.018; Wauer T, 2013, EMBO J; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Yacobi-Sharon K, 2013, DEV CELL, V25, P29, DOI 10.1016/j.devcel.2013.02.002; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	75	150	156	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							22019	10.1074/jbc.M113.467530	http://dx.doi.org/10.1074/jbc.M113.467530			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23754282	Green Published, hybrid			2022-12-28	WOS:000328841900048
J	Li, XY; Zhang, JY; Jia, R; Cheng, V; Xu, X; Qiao, WT; Guo, F; Liang, C; Cen, S				Li, Xiaoyu; Zhang, Jianyong; Jia, Rui; Cheng, Vicky; Xu, Xin; Qiao, Wentao; Guo, Fei; Liang, Chen; Cen, Shan			The MOV10 Helicase Inhibits LINE-1 Mobility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOBEC3 CYTIDINE DEAMINASES; L1 RETROTRANSPOSITION; LTR RETROTRANSPOSONS; RNA; METHYLATION; PROTEINS; IDENTIFICATION; EXPRESSION; FAMILY; RETROVIRUSES	LINE-1 (long interspersed element 1) is an autonomous non-long terminal repeat retrotransposon. Its replication often causes mutation and rearrangement of host genomic DNA. Accordingly, host cells have evolved mechanisms to control LINE-1 mobility. Here, we report that a helicase named MOV10 effectively suppresses LINE-1 transposition. Mutating the helicase motifs impairs this function of MOV10, suggesting that MOV10 requires its helicase activity to suppress LINE-1 replication. Further studies show that MOV10 post-transcriptionally diminishes the level of LINE-1 RNA. The association of MOV10 with both LINE-1 RNA and ORF1 suggests that MOV10 interacts with LINE-1 RNP and consequently causes its RNA degradation. These data demonstrate collectively that MOV10 contributes to the cellular control of LINE-1 replication.	[Li, Xiaoyu; Liang, Chen; Cen, Shan] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China; [Xu, Xin; Guo, Fei] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100050, Peoples R China; [Zhang, Jianyong; Cheng, Vicky] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Zhang, Jianyong; Liang, Chen] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Cheng, Vicky; Liang, Chen] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Jia, Rui; Xu, Xin; Qiao, Wentao] Nankai Univ, Tianjin 300071, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Lady Davis Institute; McGill University; McGill University; McGill University; Nankai University	Liang, C (corresponding author), Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China.	chen.liang@mcgill.ca; shancen@imb.pumc.edu.cn	ZHANG, Jianyong/L-5934-2015	Jia, Rui/0000-0002-1797-4069; Guo, Fei/0000-0003-3500-1006	Canadian Institutes of Health Research 973 Program [2012CB911102]; National Natural Science Foundation of China [31270210]	Canadian Institutes of Health Research 973 Program(Canadian Institutes of Health Research (CIHR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Canadian Institutes of Health Research 973 Program Grant 2012CB911102 and National Natural Science Foundation of China Grant 31270210.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Arjan-Odedra S, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-53; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Burdick R, 2010, J VIROL, V84, P10241, DOI 10.1128/JVI.00585-10; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Chen JM, 2005, HUM GENET, V117, P411, DOI 10.1007/s00439-005-1321-0; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; Doucet AJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001150; Esnault C, 2006, NUCLEIC ACIDS RES, V34, P1522, DOI 10.1093/nar/gkl054; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Esnault C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-75; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Frost RJA, 2010, P NATL ACAD SCI USA, V107, P11847, DOI 10.1073/pnas.1007158107; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Goodier JL, 2007, MOL CELL BIOL, V27, P6469, DOI 10.1128/MCB.00332-07; Goodier JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002941; Goodier JL, 2010, HUM MOL GENET, V19, P1712, DOI 10.1093/hmg/ddq048; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Haussecker D, 2008, NAT STRUCT MOL BIOL, V15, P714, DOI 10.1038/nsmb.1440; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lu CY, 2012, J VIROL, V86, P10517, DOI 10.1128/JVI.00868-12; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; MOOSLEHNER K, 1991, MOL CELL BIOL, V11, P886, DOI 10.1128/MCB.11.2.886; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Renard M, 2010, J MOL BIOL, V400, P323, DOI 10.1016/j.jmb.2010.05.029; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang XJ, 2010, J BIOL CHEM, V285, P14346, DOI 10.1074/jbc.M110.109314; Wissing S, 2011, J BIOL CHEM, V286, P36427, DOI 10.1074/jbc.M111.251058; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zamudio N, 2010, HEREDITY, V105, P92, DOI 10.1038/hdy.2010.53; Zheng K, 2010, P NATL ACAD SCI USA, V107, P11841, DOI 10.1073/pnas.1003953107; Zhou YD, 2008, VIROLOGY, V372, P97, DOI 10.1016/j.virol.2007.10.027	58	68	70	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21148	21160		10.1074/jbc.M113.465856	http://dx.doi.org/10.1074/jbc.M113.465856			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754279	Green Published, hybrid			2022-12-28	WOS:000322014400035
J	van der Deen, M; Taipaleenmaki, H; Zhang, Y; Teplyuk, NM; Gupta, A; Cinghu, S; Shogren, K; Maran, A; Yaszemski, MJ; Ling, L; Cool, SM; Leong, DT; Dierkes, C; Zustin, J; Salto-Tellez, M; Ito, Y; Bae, SC; Zielenska, M; Squire, JA; Lian, JB; Stein, JL; Zambetti, GP; Jones, SN; Galindo, M; Hesse, E; Stein, GS; van Wijnen, AJ				van der Deen, Margaretha; Taipaleenmaeki, Hanna; Zhang, Ying; Teplyuk, Nadiya M.; Gupta, Anurag; Cinghu, Senthilkumar; Shogren, Kristen; Maran, Avudaiappan; Yaszemski, Michael J.; Ling, Ling; Cool, Simon M.; Leong, David T.; Dierkes, Christian; Zustin, Jozef; Salto-Tellez, Manuel; Ito, Yoshiaki; Bae, Suk-Chul; Zielenska, Maria; Squire, Jeremy A.; Lian, Jane B.; Stein, Janet L.; Zambetti, Gerard P.; Jones, Stephen N.; Galindo, Mario; Hesse, Eric; Stein, Gary S.; van Wijnen, Andre J.			MicroRNA-34c Inversely Couples the Biological Functions of the Runt-related Transcription Factor RUNX2 and the Tumor Suppressor p53 in Osteosarcoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; TARGETED DISRUPTION; GENE-EXPRESSION; GROWTH; MOUSE; PROLIFERATION; PATHOGENESIS; PROGRESSION; OCCUPANCY; INTERACTS	Osteosarcoma (OS) is a primary bone tumor that is most prevalent during adolescence. RUNX2, which stimulates differentiation and suppresses proliferation of osteoblasts, is deregulated in OS. Here, we define pathological roles of RUNX2 in the etiology of OS and mechanisms by which RUNX2 expression is stimulated. RUNX2 is often highly expressed in human OS biopsies and cell lines. Small interference RNA-mediated depletion of RUNX2 inhibits growth of U2OS OS cells. RUNX2 levels are inversely linked to loss of p53 (which predisposes to OS) in distinct OS cell lines and osteoblasts. RUNX2 protein levels decrease upon stabilization of p53 with the MDM2 inhibitor Nutlin-3. Elevated RUNX2 protein expression is post-transcriptionally regulated and directly linked to diminished expression of several validated RUNX2 targeting microRNAs in human OS cells compared with mesenchymal progenitor cells. The p53-dependent miR-34c is the most significantly down-regulated RUNX2 targeting microRNAs in OS. Exogenous supplementation of miR-34c markedly decreases RUNX2 protein levels, whereas 3'-UTR reporter assays establish RUNX2 as a direct target of miR-34c in OS cells. Importantly, Nutlin-3-mediated stabilization of p53 increases expression of miR-34c and decreases RUNX2. Thus, a novel p53-miR-34c-RUNX2 network controls cell growth of osseous cells and is compromised in OS.	[van der Deen, Margaretha; Taipaleenmaeki, Hanna; Zhang, Ying; Teplyuk, Nadiya M.; Gupta, Anurag; Cinghu, Senthilkumar; Lian, Jane B.; Stein, Janet L.; Jones, Stephen N.; Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [van der Deen, Margaretha; Taipaleenmaeki, Hanna; Zhang, Ying; Teplyuk, Nadiya M.; Gupta, Anurag; Cinghu, Senthilkumar; Lian, Jane B.; Stein, Janet L.; Jones, Stephen N.; Stein, Gary S.; van Wijnen, Andre J.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; [Taipaleenmaeki, Hanna; Hesse, Eric] Univ Med Ctr Hamburg Eppendorf, Dept Trauma Hand & Reconstruct Surg, Heisenberg Grp Mol Skeletal Biol, D-20246 Hamburg, Germany; [Shogren, Kristen; Maran, Avudaiappan; Yaszemski, Michael J.; van Wijnen, Andre J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Shogren, Kristen; Maran, Avudaiappan; Yaszemski, Michael J.; van Wijnen, Andre J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Ling, Ling; Cool, Simon M.; van Wijnen, Andre J.] Agcy Sci Technol & Res, Inst Med Biol, Singapore 138648, Singapore; [Cool, Simon M.; van Wijnen, Andre J.] Natl Univ Singapore Hosp, Dept Orthopaed Surg, Singapore 119228, Singapore; [Leong, David T.] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore 117576, Singapore; [Dierkes, Christian] Med Care Unit Histol Cytol & Mol Diagnost, D-54296 Trier, Germany; [Zustin, Jozef] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, D-20246 Hamburg, Germany; [Salto-Tellez, Manuel] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland; [Salto-Tellez, Manuel; Ito, Yoshiaki] Natl Univ Singapore, Ctr Translat Med, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Bae, Suk-Chul] Chungbuk Natl Univ, Sch Med, Dept Biochem, Cheongju 361763, South Korea; [Zielenska, Maria] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada; [Squire, Jeremy A.] Queens Univ, Kingston Gen Hosp, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada; [Lian, Jane B.; Stein, Janet L.; Stein, Gary S.] Univ Vermont, Sch Med, Dept Biochem, Vermont Canc Ctr Basic & Translat Res, Burlington, VT 05405 USA; [Zambetti, Gerard P.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Galindo, Mario] Univ Chile, Fac Med, Millennium Inst Immunol & Immunotherapy, Santiago 7, Chile; [Galindo, Mario] Univ Chile, Fac Med, Inst Biomed Sci, Program Cellular & Mol Biol, Santiago 7, Chile	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Hamburg; University Medical Center Hamburg-Eppendorf; Mayo Clinic; Mayo Clinic; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; National University of Singapore; University of Hamburg; University Medical Center Hamburg-Eppendorf; Queens University Belfast; National University of Singapore; Chungbuk National University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; Queens University - Canada; University of Vermont; St Jude Children's Research Hospital; Universidad de Chile; Universidad de Chile	Stein, GS (corresponding author), Univ Vermont, Sch Med, Dept Biochem, Vermont Canc Ctr Basic & Translat Res, HSRF 326, Burlington, VT 05405 USA.	gary.stein@uvm.edu; vanwijnen.andre@mayo.edu	Zambetti, Gerard/N-8093-2018; Taipaleennmäki, Hanna/GRX-7143-2022; van Wijnen, Andre J./AAG-3578-2019; Leong, David/AAE-5620-2019; Squire, Jeremy A/A-9352-2012; Cool, Simon/W-1257-2018; Leong, David/G-1056-2012; Cool, Simon McKenzie/AAG-4346-2021	Zambetti, Gerard/0000-0002-0929-5007; van Wijnen, Andre J./0000-0002-4458-0946; Leong, David/0000-0001-8539-9062; Squire, Jeremy A/0000-0002-9863-468X; Cool, Simon/0000-0001-8543-3056; Leong, David/0000-0001-8539-9062; Taipaleenmaki, Hanna/0000-0002-8254-9333; Salto-Tellez, Manuel/0000-0001-8586-282X	National Institutes of Health [AR49069, CA082834]; Iniciativa Cientifico Milenio [P09/016-F]; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1095234]; Deutsche Forschungsgemeinschaft [HE 5208/2-1]; EMBO postdoctoral fellowship; NATIONAL CANCER INSTITUTE [R01CA077735, P01CA082834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039588, R01AR049069] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iniciativa Cientifico Milenio; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EMBO postdoctoral fellowship(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR49069 (to A. v- W.) and CA082834 (to G. S. S.). This work was also supported by grant sponsors Iniciativa Cientifico Milenio P09/016-F (to M. G.), Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) 1095234 (to M. G.), and Deutsche Forschungsgemeinschaft Grant HE 5208/2-1 (to E. H.).; Recipient of an EMBO postdoctoral fellowship.	Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Chi XZ, 2009, CANCER RES, V69, P8111, DOI 10.1158/0008-5472.CAN-09-1057; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Das K, 2008, PATHOLOGY, V40, P441, DOI 10.1080/00313020802198101; Das K, 2009, EUR J CANCER, V45, P2239, DOI 10.1016/j.ejca.2009.06.021; Fuchs B, 2002, CLIN ORTHOP RELAT R, P40; Galindo M, 2005, J BIOL CHEM, V280, P20274, DOI 10.1074/jbc.M413665200; HANSEN MF, 1991, CLIN ORTHOP RELAT R, P237; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Jensen ED, 2010, BIOFACTORS, V36, P25, DOI 10.1002/biof.72; Jones KB, 2012, CANCER RES, V72, P1865, DOI 10.1158/0008-5472.CAN-11-2663; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Liu JC, 2011, J BIOL CHEM, V286, P30057, DOI 10.1074/jbc.M111.241505; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030; Martin J. W., 2011, Sarcoma, V2011, P282745, DOI 10.1155/2011/282745; Martin JW, 2010, CYTOGENET GENOME RES, V128, P199, DOI 10.1159/000308353; Nathan SS, 2009, MOL BIOL REP, V36, P153, DOI 10.1007/s11033-008-9378-1; Ong CW, 2010, HISTOPATHOLOGY, V56, P523, DOI 10.1111/j.1365-2559.2010.03496.x; Pereira BP, 2009, J CELL PHYSIOL, V221, P778, DOI 10.1002/jcp.21921; Pratap J, 2003, CANCER RES, V63, P5357; Pratap J, 2011, BONE, V48, P30, DOI 10.1016/j.bone.2010.05.035; Sadikovic B, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-202; San Martin IA, 2009, J CELL PHYSIOL, V221, P560, DOI 10.1002/jcp.21894; Stott FJ, 1998, EMBO J, V17, P5001, DOI 10.1093/emboj/17.17.5001; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; van der Deen M, 2012, J BIOL CHEM, V287, P4503, DOI 10.1074/jbc.M111.287771; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Wang XY, 2006, J CELL BIOL, V172, P115, DOI 10.1083/jcb.200507106; Wei JW, 2012, J CELL BIOL, V197, P509, DOI 10.1083/jcb.201201057; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Young DW, 2007, NATURE, V445, P442, DOI 10.1038/nature05473; Zaidi SK, 2007, P NATL ACAD SCI USA, V104, P19861, DOI 10.1073/pnas.0709650104; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P9863, DOI 10.1073/pnas.1018493108; Zhang Y, 2009, J BIOL CHEM, V284, P3125, DOI 10.1074/jbc.M807466200	45	89	89	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21307	21319		10.1074/jbc.M112.445890	http://dx.doi.org/10.1074/jbc.M112.445890			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23720736	Green Published, hybrid			2022-12-28	WOS:000322014400050
J	Zamanian-Daryoush, M; Lindner, D; Tallant, TC; Wang, ZN; Buffa, J; Klipfell, E; Parker, Y; Hatala, D; Parsons-Wingerter, P; Rayman, P; Yusufishaq, MSS; Fisher, EA; Smith, JD; Finke, J; DiDonato, JA; Hazen, SL				Zamanian-Daryoush, Maryam; Lindner, Daniel; Tallant, Thomas C.; Wang, Zeneng; Buffa, Jennifer; Klipfell, Elizabeth; Parker, Yvonne; Hatala, Denise; Parsons-Wingerter, Patricia; Rayman, Pat; Yusufishaq, Mohamed Sharif S.; Fisher, Edward A.; Smith, Jonathan D.; Finke, Jim; DiDonato, Joseph A.; Hazen, Stanley L.			The Cardioprotective Protein Apolipoprotein A1 Promotes Potent Anti-tumorigenic Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; APOA-I; MATRIX METALLOPROTEINASES; CORONARY ATHEROSCLEROSIS; OXIDATIVE STRESS; HDL; INFLAMMATION; CANCER; CELLS; CHOLESTEROL	Here, we show that apolipoprotein A1 (apoA1), the major protein component of high density lipoprotein (HDL), through both innate and adaptive immune processes, potently suppresses tumor growth and metastasis in multiple animal tumor models, including the aggressive B16F10L murine malignant melanoma model. Mice expressing the human apoA1 transgene (A1Tg) exhibited increased infiltration of CD11b(+) F4/80(+) macrophages with M1, anti-tumor phenotype, reduced tumor burden and metastasis, and enhanced survival. In contrast, apoA1-deficient (A1KO) mice showed markedly heightened tumor growth and reduced survival. Injection of human apoA1 into A1KO mice inoculated with tumor cells remarkably reduced both tumor growth and metastasis, enhanced survival, and promoted regression of both tumor and metastasis burden when administered following palpable tumor formation and metastasis development. Studies with apolipoprotein A2 revealed the anti-cancer therapeutic effect was specific to apoA1. In vitro studies ruled out substantial direct suppressive effects by apoA1 or HDL on tumor cells. Animal models defective in different aspects of immunity revealed both innate and adaptive arms of immunity contribute to complete apoA1 anti-tumor activity. This study reveals a potent immunomodulatory role for apoA1 in the tumor microenvironment, altering tumor-associated macrophages from a pro-tumor M2 to an anti-tumor M1 phenotype. Use of apoA1 to redirect in vivo elicited tumor-infiltrating macrophages toward tumor rejection may hold benefit as a potential cancer therapeutic.	[Zamanian-Daryoush, Maryam; Tallant, Thomas C.; Wang, Zeneng; Buffa, Jennifer; Klipfell, Elizabeth; Yusufishaq, Mohamed Sharif S.; Smith, Jonathan D.; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Zamanian-Daryoush, Maryam; Tallant, Thomas C.; Wang, Zeneng; Buffa, Jennifer; Klipfell, Elizabeth; DiDonato, Joseph A.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Lindner, Daniel; Parker, Yvonne] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44195 USA; [Hatala, Denise] Cleveland Clin, Imaging Core, Cleveland, OH 44195 USA; [Rayman, Pat; Finke, Jim] Cleveland Clin, Dept Immunol, Cleveland, OH 44195 USA; [Smith, Jonathan D.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Parsons-Wingerter, Patricia] NASA, John H Glenn Res Ctr, Cleveland, OH 44135 USA; [Fisher, Edward A.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Fisher, Edward A.; Hazen, Stanley L.] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 10016 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; National Aeronautics & Space Administration (NASA); New York University; New York University	Hazen, SL (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Wang, Zeneng/AAK-6119-2021; Lindner, Daniel/ABB-5440-2020; Fisher, Edward/ABE-7469-2020; Hazen, Stanley L/ABD-5845-2021; Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X; Fisher, Edward/0000-0001-9802-143X	National Institutes of Health [P01HL098055, P01HL076491, HL094525]; LeDucq Fondation; Abbott; Cleveland Heart Lab; Esperion; Lilly; Liposcience Inc.; Merck Co., Inc.; Pfizer Inc.; NATIONAL CANCER INSTITUTE [R01CA150959] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055, R01HL094525, P01HL076491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LeDucq Fondation; Abbott(Abbott Laboratories); Cleveland Heart Lab; Esperion; Lilly(Eli Lilly); Liposcience Inc.; Merck Co., Inc.(Merck & Company); Pfizer Inc.(Pfizer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL098055, P01HL076491, and HL094525. This work was also supported in part by a grant from the LeDucq Fondation. Drs. Zamanian-Daryoush, DiDonato, and Hazen report being listed as co-inventors on pending and issued patents held by the Cleveland Clinic. Dr. Hazen reports having been paid as a consultant for the following companies: Abbott, Cleveland Heart Lab, Esperion, Lilly, Liposcience Inc., Merck & Co., Inc., and Pfizer Inc. and receiving research funds from Abbott, Cleveland Heart Lab, Liposcience Inc., and Pfizer Inc.	Bauvois B, 2012, BBA-REV CANCER, V1825, P29, DOI 10.1016/j.bbcan.2011.10.001; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Camont L, 2011, TRENDS MOL MED, V17, P594, DOI 10.1016/j.molmed.2011.05.013; Chen W, 2012, CHINESE MED J-PEKING, V125, P481, DOI 10.3760/cma.j.issn.0366-6999.2012.03.015; Clemente CG, 1996, CANCER, V77, P1303, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1303::AID-CNCR12>3.0.CO;2-5; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; de Souza JA, 2010, J CELL MOL MED, V14, P608, DOI 10.1111/j.1582-4934.2009.00713.x; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; Fuhrman B, 2010, ATHEROSCLEROSIS, V211, P61, DOI 10.1016/j.atherosclerosis.2010.01.025; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gao F, 2011, INTEGR BIOL-UK, V3, P479, DOI 10.1039/c0ib00147c; Godar DE, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/858425; Gordon SM, 2011, TRENDS ENDOCRIN MET, V22, P9, DOI 10.1016/j.tem.2010.10.001; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Grunfeld C, 1999, J LIPID RES, V40, P245; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hofmann UB, 2005, BIOCHIMIE, V87, P307, DOI 10.1016/j.biochi.2005.01.013; Jafri H, 2010, J AM COLL CARDIOL, V55, P2846, DOI 10.1016/j.jacc.2009.12.069; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kim KD, 2005, BIOCHEM BIOPH RES CO, V338, P1126, DOI 10.1016/j.bbrc.2005.10.065; Kim S, 2011, ANN NY ACAD SCI, V1217, P191, DOI 10.1111/j.1749-6632.2010.05882.x; Kujawski M, 2008, J CLIN INVEST, V118, P3367, DOI 10.1172/JCI35213; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Mckenzie JA, 2012, ANTICANCER RES, V32, P397; Murph M, 2007, METHOD ENZYMOL, V433, P1, DOI 10.1016/S0076-6879(07)33001-2; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Murphy AJ, 2011, ARTERIOSCL THROM VAS, V31, P1333, DOI 10.1161/ATVBAHA.111.226258; Navarini-Meury AA, 2009, SEMIN CANCER BIOL, V19, P84, DOI 10.1016/j.semcancer.2008.10.012; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; OSBORNE JC, 1986, METHOD ENZYMOL, V128, P213; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Piras F, 2007, HISTOPATHOLOGY, V50, P835, DOI 10.1111/j.1365-2559.2007.02695.x; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Rye KA, 2009, J LIPID RES, V50, pS195, DOI 10.1194/jlr.R800034-JLR200; Sacks FM, 2009, J LIPID RES, V50, P894, DOI 10.1194/jlr.M800622-JLR200; Sarov-Blat L, 2007, ARTERIOSCL THROM VAS, V27, P1115, DOI 10.1161/ATVBAHA.106.138990; Shahzad MMK, 2011, NEOPLASIA, V13, P309, DOI 10.1593/neo.101372; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Singh IP, 1999, ANTIVIR RES, V42, P211, DOI 10.1016/S0166-3542(99)00032-7; SRINIVAS RV, 1991, J CELL BIOCHEM, V45, P224, DOI 10.1002/jcb.240450214; Su F, 2010, P NATL ACAD SCI USA, V107, P19997, DOI 10.1073/pnas.1009010107; TADA N, 1993, MOL CELL BIOCHEM, V119, P171, DOI 10.1007/BF00926868; Tannenbaum CS, 1998, J IMMUNOL, V161, P927; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang SH, 2012, ATHEROSCLEROSIS, V225, P105, DOI 10.1016/j.atherosclerosis.2012.07.029; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Wilhelm AJ, 2010, J BIOL CHEM, V285, P36158, DOI 10.1074/jbc.M110.134130; Yang L, 2004, CANCER CELL, V6, P409, DOI 10.1016/j.ccr.2004.08.031; Yang SO, 2013, P NATL ACAD SCI USA, V110, P2511, DOI 10.1073/pnas.1213657110; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	65	155	162	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21237	21252		10.1074/jbc.M113.468967	http://dx.doi.org/10.1074/jbc.M113.468967			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23720750	Green Published, hybrid			2022-12-28	WOS:000322014400045
J	De Zutter, JK; Levine, KB; Deng, D; Carruthers, A				De Zutter, Julie K.; Levine, Kara B.; Deng, Di; Carruthers, Anthony			Sequence Determinants of GLUT1 Oligomerization ANALYSIS BY HOMOLOGY-SCANNING MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE GLUCOSE-TRANSPORTER; ESCHERICHIA-COLI; SUGAR-TRANSPORT; OUTER HELIX; STRUCTURAL BASIS; LIGAND-BINDING; CYTOCHALASIN-B; AMINO-ACID; PROTEINS; SITES	The human blood-brain barrier glucose transport protein (GLUT1) forms homodimers and homotetramers in detergent micelles and in cell membranes, where the GLUT1 oligomeric state determines GLUT1 transport behavior. GLUT1 and the neuronal glucose transporter GLUT3 do not form heterocomplexes in human embryonic kidney 293 (HEK293) cells as judged by co-immunoprecipitation assays. Using homology-scanning mutagenesis in which GLUT1 domains are substituted with equivalent GLUT3 domains and vice versa, we show that GLUT1 transmembrane helix 9 (TM9) is necessary for optimal association of GLUT1-GLUT3 chimeras with parental GLUT1 in HEK cells. GLUT1 TMs 2, 5, 8, and 11 also contribute to a less abundant heterocomplex. Cell surface GLUT1 and GLUT3 containing GLUT1 TM9 are 4-fold more catalytically active than GLUT3 and GLUT1 containing GLUT3 TM9. GLUT1 and GLUT3 display allosteric transport behavior. Size exclusion chromatography of detergent solubilized, purified GLUT1 resolves GLUT1/lipid/detergent micelles as 6- and 10-nm Stokes radius particles, which correspond to GLUT1 dimers and tetramers, respectively. Studies with GLUTs expressed in and solubilized from HEK cells show that HEK cell GLUT1 resolves as 6- and 10-nm Stokes radius particles, whereas GLUT3 resolves as a 6-nm particle. Substitution of GLUT3 TM9 with GLUT1 TM9 causes chimeric GLUT3 to resolve as 6- and 10-nm Stokes radius particles. Substitution of GLUT1 TM9 with GLUT3 TM9 causes chimeric GLUT1 to resolve as a mixture of 6- and 4-nm particles. We discuss these findings in the context of determinants of GLUT oligomeric structure and transport function.	[De Zutter, Julie K.; Levine, Kara B.; Deng, Di; Carruthers, Anthony] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), 364 Plantat St,LRB Rm 926, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu			National Institutes of Health [DK 36081, DK 44888]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK036081, R01DK036081, R01DK044888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 36081 and DK 44888.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; ALVAREZ J, 1987, J BIOL CHEM, V262, P3502; APPLEMAN JR, 1985, J BIOL CHEM, V260, P4575; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; Blodgett DM, 2008, J BIOL CHEM, V283, P36416, DOI 10.1074/jbc.M804802200; BURANT CF, 1992, BIOCHEMISTRY-US, V31, P10414, DOI 10.1021/bi00157a032; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3907, DOI 10.1021/bi00230a015; Carruthers A., 1996, TRANSPORT PROCESSES, P311; CASEY JR, 1991, J BIOL CHEM, V266, P15726; CHIN JJ, 1987, P NATL ACAD SCI USA, V84, P4113, DOI 10.1073/pnas.84.12.4113; Cloherty EK, 2001, BIOCHEMISTRY-US, V40, P15549, DOI 10.1021/bi015586w; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Cura AJ, 2012, AM J PHYSIOL-CELL PH, V303, pC806, DOI 10.1152/ajpcell.00437.2011; Cura AJ, 2010, J BIOL CHEM, V285, P15430, DOI 10.1074/jbc.M110.110593; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; GORGA FR, 1981, BIOCHEMISTRY-US, V20, P5108, DOI 10.1021/bi00521a003; Hamill S, 1999, BIOCHEMISTRY-US, V38, P16974, DOI 10.1021/bi9918792; HEBERT DN, 1991, BIOCHEMISTRY-US, V30, P4654, DOI 10.1021/bi00233a003; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; HELGERSON AL, 1987, J BIOL CHEM, V262, P5464; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; HRESKO RC, 1994, J BIOL CHEM, V269, P20482; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jiang JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055408; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; JUNG CY, 1980, J BIOL CHEM, V255, P361; Leeds JA, 2001, J MOL BIOL, V313, P181, DOI 10.1006/jmbi.2001.5007; Levine KB, 2005, BIOCHEMISTRY-US, V44, P5606, DOI 10.1021/bi0477541; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; LIEB WR, 1974, BIOCHIM BIOPHYS ACTA, V373, P178, DOI 10.1016/0005-2736(74)90144-8; Lis M, 2006, BIOCHEM BIOPH RES CO, V339, P321, DOI 10.1016/j.bbrc.2005.11.022; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; Mueckler M, 2004, J BIOL CHEM, V279, P46876, DOI 10.1074/jbc.M408632200; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2008, J BIOL CHEM, V283, P11550, DOI 10.1074/jbc.M708896200; Mueckler M, 2006, J BIOL CHEM, V281, P36993, DOI 10.1074/jbc.M608158200; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Olczak M, 2006, BBA-MOL CELL RES, V1763, P82, DOI 10.1016/j.bbamcr.2005.12.006; PESSINO A, 1991, J BIOL CHEM, V266, P20213; Robertson JL, 2010, NATURE, V468, P844, DOI 10.1038/nature09556; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Shi YH, 2012, PROTEIN SCI, V21, P1197, DOI 10.1002/pro.2107; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Vollers SS, 2012, J BIOL CHEM, V287, P42533, DOI 10.1074/jbc.M112.369587; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	51	39	39	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20734	20744		10.1074/jbc.M113.469023	http://dx.doi.org/10.1074/jbc.M113.469023			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720776	Green Published, hybrid			2022-12-28	WOS:000321715100058
J	He, C; Ryan, AJ; Murthy, S; Carter, AB				He, Chao; Ryan, Alan J.; Murthy, Shubha; Carter, A. Brent			Accelerated Development of Pulmonary Fibrosis via Cu, Zn-superoxide Dismutase-induced Alternative Activation of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GENE-EXPRESSION; ALVEOLAR MACROPHAGES; MITOCHONDRIAL SUPEROXIDE; SCHISTOSOMA-MANSONI; HYDROGEN-PEROXIDE; TH2 CELLS; GENERATION; MECHANISM; PROTEINS	Macrophages not only initiate and accentuate inflammation after tissue injury, but they are also involved in resolution and repair. This difference in macrophage activity is the result of a differentiation process to either M1 or M2 phenotypes. M1 macrophages are pro-inflammatory and have microbicidal and tumoricidal activity, whereas the M2 macrophages are involved in tumor progression and tissue remodeling and can be profibrotic in certain conditions. Because mitochondrial Cu, Zn-superoxide dismutase (Cu, Zn-SOD)-mediated H2O2 is crucial for development of pulmonary fibrosis, we hypothesized that Cu, Zn-SOD modulated the macrophage phenotype. In this study, we demonstrate that Cu, Zn-SOD polarized macrophages to an M2 phenotype, and Cu, Zn-SOD-mediated H2O2 levels modulated M2 gene expression at the transcriptional level by redox regulation of a critical cysteine in STAT6. Furthermore, overexpression of Cu, Zn-SOD in mice resulted in a profibrotic environment and accelerated the development of pulmonary fibrosis, whereas polarization of macrophages to the M1 phenotype attenuated pulmonary fibrosis. Taken together, these observations provide a novel mechanism of Cu, Zn-SOD-mediated and Th2-independent M2 polarization and provide a potential therapeutic target for attenuating the accelerated development of pulmonary fibrosis.	[Ryan, Alan J.; Murthy, Shubha; Carter, A. Brent] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [He, Chao; Carter, A. Brent] Univ Iowa, Dept Radiat Oncol, Carver Coll Med, Iowa City, IA 52242 USA; [He, Chao; Carter, A. Brent] Univ Iowa, Grad Program Free Rad & Radiat Biol, Carver Coll Med, Iowa City, IA 52242 USA; [Carter, A. Brent] Univ Iowa, Coll Publ Hlth, Dept Human Toxicol, Iowa City, IA 52242 USA; [Carter, A. Brent] Iowa City Vet Adm Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa	Carter, AB (corresponding author), Univ Iowa, Carver Coll Med, C33 GH, Iowa City, IA 52242 USA.	brent-carter@uiowa.edu			National Institutes of Health [2R01ES015981-06, R01ES014871]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Grant [1BX001135-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605, R01ES015981, R01ES014871] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Grant(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants 2R01ES015981-06 and R01ES014871. This work was also supported by a Merit Review from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Grant 1BX001135-01.	BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Buettner GR, 2006, FREE RADICAL BIO MED, V41, P1338, DOI 10.1016/j.freeradbiomed.2006.07.015; Carter AB, 1998, AM J RESP CELL MOL, V18, P384, DOI 10.1165/ajrcmb.18.3.2972; Carter KB, 2000, J BIOL CHEM, V275, P27858; Chang SC, 2001, FREE RADICAL BIO MED, V31, P1084, DOI 10.1016/S0891-5849(01)00691-8; Chensue SW, 1997, J IMMUNOL, V159, P3565; Chiaramonte MG, 1999, J CLIN INVEST, V104, P777, DOI 10.1172/JCI7325; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Daniel C, 2000, J BIOL CHEM, V275, P14255, DOI 10.1074/jbc.C000129200; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; FRIDOVICH I, 1986, ANNU REV PHYSIOL, V48, P693; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Hirakawa S, 2011, J IMMUNOL, V186, P4762, DOI 10.4049/jimmunol.1000791; Kaplan MH, 1998, J IMMUNOL, V160, P1850; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Mandal D, 2010, CELL SIGNAL, V22, P1485, DOI 10.1016/j.cellsig.2010.05.017; Marikovsky M, 2003, J IMMUNOL, V170, P2993, DOI 10.4049/jimmunol.170.6.2993; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Pearce EJ, 1996, INT IMMUNOL, V8, P435, DOI 10.1093/intimm/8.4.435; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; PONNAPPA BC, 1981, AM J PHYSIOL, V240, pG122, DOI 10.1152/ajpgi.1981.240.2.G122; POSTLETHWAITE AE, 1992, J CLIN INVEST, V90, P1479, DOI 10.1172/JCI116015; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; REMBISH SJ, 1994, FREE RADICAL BIO MED, V17, P117, DOI 10.1016/0891-5849(94)90109-0; Saito A, 2001, STROKE, V32, P1652, DOI 10.1161/01.STR.32.7.1652; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Tephly LA, 2007, AM J PHYSIOL-LUNG C, V293, pL1143, DOI 10.1152/ajplung.00114.2007; Tephly LA, 2007, AM J RESP CELL MOL, V37, P366, DOI 10.1165/rcmb.2006-0268OC; TREDE NS, 1995, J IMMUNOL, V155, P902; Vaknin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026921; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Venkatachalam P, 2008, ONCOGENE, V27, P20, DOI 10.1038/sj.onc.1210634; Wakisaka Y, 2010, STROKE, V41, P790, DOI 10.1161/STROKEAHA.109.569616; Zhang LF, 2009, J PROTEOME RES, V8, P1631, DOI 10.1021/pr800685h	46	78	86	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20745	20757		10.1074/jbc.M112.410720	http://dx.doi.org/10.1074/jbc.M112.410720			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720777	hybrid, Green Published			2022-12-28	WOS:000321715100059
J	Gerken, TA; Revoredo, L; Thome, JJC; Tabak, LA; Vester-Christensen, MB; Clausen, H; Gahlay, GK; Jarvis, DL; Johnson, RW; Moniz, HA; Moremen, K				Gerken, Thomas A.; Revoredo, Leslie; Thome, Joseph J. C.; Tabak, Lawrence A.; Vester-Christensen, Malene Bech; Clausen, Henrik; Gahlay, Gagandeep K.; Jarvis, Donald L.; Johnson, Roy W.; Moniz, Heather A.; Moremen, Kelley			Family of Glycosyltransferases (ppGalNAc Ts) Acts as a Switch Directing Glycopeptide Substrate Glycosylation in an N- or C-terminal Direction, Further Controlling Mucin Type O-Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; ACETYL-D-GALACTOSAMINE; NEIGHBORING RESIDUE GLYCOSYLATION; TRANSFERASE GENE FAMILY; UDP-GALNAC; LECTIN DOMAINS; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE-1; ACETYLGALACTOSAMINYLTRANSFERASES T1; TUMORAL CALCINOSIS; SUGAR RECOGNITION	Mucin type O-glycosylation is initiated by a large family of polypeptide GalNAc transferases (ppGalNAc Ts) that add alpha-GalNAc to the Ser and Thr residues of peptides. Of the 20 human isoforms, all but one are composed of two globular domains linked by a short flexible linker: a catalytic domain and a ricin-like lectin carbohydrate binding domain. Presently, the roles of the catalytic and lectin domains in peptide and glycopeptide recognition and specificity remain unclear. To systematically study the role of the lectin domain in ppGalNAc T glycopeptide substrate utilization, we have developed a series of novel random glycopeptide substrates containing a single GalNAc-O-Thr residue placed near either the N or C terminus of the glycopeptide substrate. Our results reveal that the presence and N- or C-terminal placement of the GalNAc-O-Thr can be important determinants of overall catalytic activity and specificity that differ between transferase isoforms. For example, ppGalNAc T1, T2, and T14 prefer C-terminally placed GalNAc-O-Thr, whereas ppGalNAc T3 and T6 prefer N-terminally placed GalNAc-O-Thr. Several transferase isoforms, ppGalNAc T5, T13, and T16, display equally enhanced N- or C-terminal activities relative to the nonglycosylated control peptides. This N-and/or C-terminal selectivity is presumably due to weak glycopeptide binding to the lectin domain, whose orientation relative to the catalytic domain is dynamic and isoform-dependent. Such N-or C-terminal glycopeptide selectivity provides an additional level of control or fidelity for the O-glycosylation of biologically significant sites and suggests that O-glycosylation may in some instances be exquisitely controlled.	[Gerken, Thomas A.; Thome, Joseph J. C.] Case Western Reserve Univ, Dept Pediat, WA Bernbaum Ctr Cyst Fibrosis Res, Cleveland, OH 44106 USA; [Gerken, Thomas A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Gerken, Thomas A.; Revoredo, Leslie] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Tabak, Lawrence A.] NIDCR, Sect Biol Chem, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Vester-Christensen, Malene Bech; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, CCG, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Vester-Christensen, Malene Bech; Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, CCG, Dept Dent, DK-2200 Copenhagen N, Denmark; [Gahlay, Gagandeep K.; Jarvis, Donald L.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA; [Johnson, Roy W.; Moniz, Heather A.; Moremen, Kelley] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Copenhagen; University of Copenhagen; University of Wyoming; University System of Georgia; University of Georgia	Gerken, TA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pediat, BRB 823,2109 Adelbert Rd, Cleveland, OH 44104 USA.	txg2@cwru.edu	Gahlay, Gagandeep/F-3975-2010; Moremen, Kelley/AAD-4661-2019; clausen, henrik/AAD-8016-2021; Gahlay, Gagandeep/AAO-7928-2020	Gahlay, Gagandeep/0000-0002-0058-2827; Clausen, Henrik/0000-0002-0915-5055; Jarvis, Donald/0000-0002-8104-7155	National Institutes of Health [R01-CA78834, P41-GM103390, P41-RR005351]; National Institutes of Health; NIDCR; Danish National Research Foundation Grant [DNRF107]; NATIONAL CANCER INSTITUTE [R01CA078834] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390, U01GM113534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Danish National Research Foundation Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA78834 (to T. A. G.) and P41-GM103390 and P41-RR005351 (to James Prestegard (Complex Carbohydrate Center, University of Georgia) and K. M. and D. L. J.) and a National Institutes of Health, NIDCR, intramural program grant (to L. A. T.). This work was also supported by Danish National Research Foundation Grant DNRF107 (to H. C.).	Alfalah M, 1999, CURR BIOL, V9, P593, DOI 10.1016/S0960-9822(99)80263-2; Bennett EP, 1999, J BIOL CHEM, V274, P25362, DOI 10.1074/jbc.274.36.25362; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Berois N, 2006, J HISTOCHEM CYTOCHEM, V54, P317, DOI 10.1369/jhc.5A6783.2005; Berois N, 2013, CLIN CHEM, V59, P225, DOI 10.1373/clinchem.2012.192328; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Carmon A, 2007, GENETICS, V176, P309, DOI 10.1534/genetics.106.060897; Cheng LM, 2002, FEBS LETT, V531, P115, DOI 10.1016/S0014-5793(02)03399-9; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Fritz TA, 2006, J BIOL CHEM, V281, P8613, DOI 10.1074/jbc.M513590200; Fritz TA, 2004, P NATL ACAD SCI USA, V101, P15307, DOI 10.1073/pnas.0405657101; Fujimoto Z, 2000, J MOL BIOL, V300, P575, DOI 10.1006/jmbi.2000.3877; Garringer HJ, 2006, J CLIN ENDOCR METAB, V91, P4037, DOI 10.1210/jc.2006-0305; Gaziel-Sovran A, 2011, CANCER CELL, V20, P104, DOI 10.1016/j.ccr.2011.05.027; Gerken TA, 2004, BIOCHEMISTRY-US, V43, P9888, DOI 10.1021/bi049178e; Gerken TA, 2002, J BIOL CHEM, V277, P49850, DOI 10.1074/jbc.M205851200; Gerken TA, 2002, J BIOL CHEM, V277, P7736, DOI 10.1074/jbc.M111690200; Gerken TA, 2006, J BIOL CHEM, V281, P32403, DOI 10.1074/jbc.M605149200; Gerken TA, 2011, J BIOL CHEM, V286, P14493, DOI 10.1074/jbc.M111.218701; Gerken TA, 2008, GLYCOBIOLOGY, V18, P861, DOI 10.1093/glycob/cwn073; Gill DJ, 2011, TRENDS CELL BIOL, V21, P149, DOI 10.1016/j.tcb.2010.11.004; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Hagen KGT, 2009, GLYCOBIOLOGY, V19, P102, DOI 10.1093/glycob/cwn096; Hanisch FG, 2001, GLYCOBIOLOGY, V11, P731, DOI 10.1093/glycob/11.9.731; Hassan H, 2000, J BIOL CHEM, V275, P38197, DOI 10.1074/jbc.M005783200; Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805; Herr P, 2008, DEVELOPMENT, V135, P1813, DOI 10.1242/dev.019323; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Holleboom AG, 2011, CELL METAB, V14, P811, DOI 10.1016/j.cmet.2011.11.005; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Imberty A, 1997, PROTEIN ENG, V10, P1353, DOI 10.1093/protein/10.12.1353; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kinlough CL, 2011, J BIOL CHEM, V286, P39072, DOI 10.1074/jbc.M111.289504; Kubota T, 2006, J MOL BIOL, V359, P708, DOI 10.1016/j.jmb.2006.03.061; Lang TA, 2007, P NATL ACAD SCI USA, V104, P16209, DOI 10.1073/pnas.0705984104; Lee SH, 2010, J BIOL CHEM, V285, P37683, DOI 10.1074/jbc.M110.162735; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Maveyraud L, 2009, PROTEINS, V75, P89, DOI 10.1002/prot.22222; Nakayama Y, 2012, J BIOL CHEM, V287, P32222, DOI 10.1074/jbc.M112.370932; Park JH, 2011, NEOPLASIA, V13, P320, DOI 10.1593/neo.101440; Pedersen JW, 2011, J BIOL CHEM, V286, P32684, DOI 10.1074/jbc.M111.273722; Perrine CL, 2009, J BIOL CHEM, V284, P20387, DOI 10.1074/jbc.M109.017236; Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005; RAJU TS, 1994, BIOCHEM BIOPH RES CO, V205, P402, DOI 10.1006/bbrc.1994.2679; Raman J, 2008, J BIOL CHEM, V283, P22942, DOI 10.1074/jbc.M803387200; Raman J, 2012, GLYCOBIOLOGY, V22, P768, DOI 10.1093/glycob/cwr183; Schjoldager KTBG, 2012, BBA-GEN SUBJECTS, V1820, P2079, DOI 10.1016/j.bbagen.2012.09.014; Schjoldager KTBG, 2010, J BIOL CHEM, V285, P36293, DOI 10.1074/jbc.M110.156950; Schjoldager KTBG, 2012, P NATL ACAD SCI USA, V109, P9893, DOI 10.1073/pnas.1203563109; Schjoldager KTBG, 2011, J BIOL CHEM, V286, P40122, DOI 10.1074/jbc.M111.287912; Simmons AD, 1999, HUM MOL GENET, V8, P2155, DOI 10.1093/hmg/8.12.2155; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Tabak LA, 2010, SEMIN CELL DEV BIOL, V21, P616, DOI 10.1016/j.semcdb.2010.02.001; Tani M, 2003, J BIOL CHEM, V278, P10523, DOI 10.1074/jbc.M207932200; Taniuchi K, 2011, ONCOGENE, V30, P4843, DOI 10.1038/onc.2011.194; Tenno M, 2002, J BIOL CHEM, V277, P47088, DOI 10.1074/jbc.M207369200; Tenno M, 2002, BIOCHEM BIOPH RES CO, V298, P755, DOI 10.1016/S0006-291X(02)02549-4; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Tian E, 2009, GLYCOCONJUGATE J, V26, P325, DOI 10.1007/s10719-008-9162-4; Tran DT, 2013, J BIOL CHEM, V288, P6921, DOI 10.1074/jbc.R112.418558; Tran DT, 2012, J BIOL CHEM, V287, P5243, DOI 10.1074/jbc.M111.306159; Vakhrushev S. Y., 2013, MOL CELL PR IN PRESS; Vester-Christensen M. B., 2013, METHODS MOL IN PRESS; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Wakinaka T, 2013, GLYCOBIOLOGY, V23, P232, DOI 10.1093/glycob/cws142; Wandall HH, 2007, GLYCOBIOLOGY, V17, P374, DOI 10.1093/glycob/cwl082; Wopereis S, 2006, CLIN CHEM, V52, P574, DOI 10.1373/clinchem.2005.063040; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Yoshimura Y, 2012, GLYCOBIOLOGY, V22, P429, DOI 10.1093/glycob/cwr159; Young WW, 2003, GLYCOBIOLOGY, V13, P549, DOI 10.1093/glycob/cwg062; Zhang Y, 2003, J BIOL CHEM, V278, P573, DOI 10.1074/jbc.M203094200	75	60	63	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19900	19914		10.1074/jbc.M113.477877	http://dx.doi.org/10.1074/jbc.M113.477877			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689369	hybrid, Green Published			2022-12-28	WOS:000321515800056
J	Schonbrun, M; Kolesnikov, M; Kupiec, M; Weisman, R				Schonbrun, Miriam; Kolesnikov, Masha; Kupiec, Martin; Weisman, Ronit			TORC2 Is Required to Maintain Genome Stability during S Phase in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; NITROGEN STARVATION; DNA-DAMAGE; SEXUAL DEVELOPMENT; CELL-DIVISION; REPLICATION; REPAIR; GENE; PATHWAY; GROWTH	DNA damage can occur due to environmental insults or intrinsic metabolic processes and is a major threat to genome stability. The DNA damage response is composed of a series of well coordinated cellular processes that include activation of the DNA damage checkpoint, transient cell cycle arrest, DNA damage repair, and reentry into the cell cycle. Here we demonstrate that mutant cells defective for TOR complex 2 (TORC2) or the downstream AGC-like kinase, Gad8, are highly sensitive to chronic replication stress but are insensitive to ionizing radiation. We show that in response to replication stress, TORC2 is dispensable for Chk1-mediated cell cycle arrest but is required for the return to cell cycle progression. Rad52 is a DNA repair and recombination protein that forms foci at DNA damage sites and stalled replication forks. TORC2 mutant cells show increased spontaneous nuclear Rad52 foci, particularly during S phase, suggesting that TORC2 protects cells from DNA damage that occurs during normal DNA replication. Consistently, the viability of TORC2-Gad8 mutant cells is dependent on the presence of the homologous recombination pathway and other proteins that are required for replication restart following fork replication stalling. Our findings indicate that TORC2 is required for genome integrity. This may be relevant for the growing amount of evidence implicating TORC2 in cancer development.	[Schonbrun, Miriam; Kolesnikov, Masha; Kupiec, Martin; Weisman, Ronit] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Weisman, Ronit] Open Univ Israel, Dept Nat & Life Sci, Raanana, Israel	Tel Aviv University; Open University Israel	Weisman, R (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, Green Bldg,Rm 211, IL-69978 Tel Aviv, Israel.	ronitt@post.tau.ac.il	weisman, ronit/D-3741-2016; weisman, ronit/R-6969-2016		Association of International Cancer Research [11-0281]; Open University of Israel Research Fund [37076]	Association of International Cancer Research; Open University of Israel Research Fund	This work was supported by Association of International Cancer Research Grant 11-0281 and Open University of Israel Research Fund Grant 37076 (to R. W.).	Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Aspuria PJ, 2007, CELL CYCLE, V6, P1692, DOI 10.4161/cc.6.14.4478; Bass KL, 2012, J CELL SCI, V125, P2753, DOI 10.1242/jcs.103119; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Carr AM, 2002, DNA REPAIR, V1, P983, DOI 10.1016/S1568-7864(02)00165-9; Cavero S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001138; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; den Elzen NR, 2004, EMBO J, V23, P908, DOI 10.1038/sj.emboj.7600105; Dovey CL, 2007, GENETICS, V177, P47, DOI 10.1534/genetics.107.077255; Dovey CL, 2009, DNA REPAIR, V8, P1390, DOI 10.1016/j.dnarep.2009.09.008; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; HSIANG YH, 1989, CANCER RES, V49, P5077; Humphrey T, 2000, MUTAT RES-FUND MOL M, V451, P211, DOI 10.1016/S0027-5107(00)00051-8; Ikai N, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110007; Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245; JIMENEZ G, 1992, P NATL ACAD SCI USA, V89, P4952, DOI 10.1073/pnas.89.11.4952; Kawai M, 2001, CURR GENET, V39, P166; Kominami K, 1998, EMBO J, V17, P5388, DOI 10.1093/emboj/17.18.5388; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moynihan EB, 1999, MOL BIOL CELL, V10, P245, DOI 10.1091/mbc.10.2.245; Muris DFR, 1996, J CELL SCI, V109, P73; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; NIWA O, 1989, EMBO J, V8, P3045, DOI 10.1002/j.1460-2075.1989.tb08455.x; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Osman F, 2000, CURR GENET, V38, P113, DOI 10.1007/s002940000145; OSTERMANN K, 1993, NUCLEIC ACIDS RES, V21, P5940, DOI 10.1093/nar/21.25.5940; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Raji H, 2006, YEAST, V23, P963, DOI 10.1002/yea.1414; Rhind N, 1998, GENETICS, V149, P1729; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schonbrun M, 2009, MOL CELL BIOL, V29, P4584, DOI 10.1128/MCB.01879-08; Sheedy DM, 2005, GENETICS, V171, P457, DOI 10.1534/genetics.105.044966; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Stolz J, 2004, EUKARYOT CELL, V3, P406, DOI 10.1128/EC.3.2.406-412.2004; Takahara T, 2012, GENES CELLS, V17, P698, DOI 10.1111/j.1365-2443.2012.01618.x; Tatebe Hisashi, 2010, Small GTPases, V1, P180, DOI 10.4161/sgtp.1.3.14936; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; van Slegtenhorst M, 2004, J BIOL CHEM, V279, P12706, DOI 10.1074/jbc.M313874200; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2001, J BIOL CHEM, V276, P24736, DOI 10.1074/jbc.M102090200; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Win TZ, 2005, J CELL SCI, V118, P5777, DOI 10.1242/jcs.02694; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yuasa T, 2004, GENES CELLS, V9, P1069, DOI 10.1111/j.1365-2443.2004.00790.x; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	70	24	24	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19649	19660		10.1074/jbc.M113.464974	http://dx.doi.org/10.1074/jbc.M113.464974			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23703609	Green Published, hybrid			2022-12-28	WOS:000321515800036
J	Sweeney, NL; Shadrick, WR; Mukherjee, S; Li, KL; Frankowski, KJ; Schoenen, FJ; Frick, DN				Sweeney, Noreena L.; Shadrick, William R.; Mukherjee, Sourav; Li, Kelin; Frankowski, Kevin J.; Schoenen, Frank J.; Frick, David N.			Primuline Derivatives That Mimic RNA to Stimulate Hepatitis C Virus NS3 Helicase-catalyzed ATP Hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEST-NILE-VIRUS; EXPANDED FAT NUCLEOSIDE; NUCLEOTIDE ANALOGS; KINETIC-ANALYSIS; CDNA-CLONE; INHIBITORS; TRANSLOCATION; IDENTIFICATION; TRANSCRIPTS; MECHANISM	ATP hydrolysis fuels the ability of helicases and related proteins to translocate on nucleic acids and separate base pairs. As a consequence, nucleic acid binding stimulates the rate at which a helicase catalyzes ATP hydrolysis. In this study, we searched a library of small molecule helicase inhibitors for compounds that stimulate ATP hydrolysis catalyzed by the hepatitis C virus (HCV) NS3 helicase, which is an important antiviral drug target. Two compounds were found that stimulate HCV helicase-catalyzed ATP hydrolysis, both of which are amide derivatives synthesized from the main component of the yellow dye primuline. Both compounds possess a terminal pyridine moiety, which was critical for stimulation. Analogs lacking a terminal pyridine inhibited HCV helicase catalyzed ATP hydrolysis. Unlike other HCV helicase inhibitors, the stimulatory compounds differentiate between helicases isolated from various HCV genotypes and related viruses. The compounds only stimulated ATP hydrolysis catalyzed by NS3 purified from HCV genotype 1b. They inhibited helicases from other HCV genotypes (e.g. 1a and 2a) or related flaviviruses (e.g. Dengue virus). The stimulatory compounds interacted with HCV helicase in the absence of ATP with dissociation constants of about 2 mu M. Molecular modeling and site-directed mutagenesis studies suggest that the stimulatory compounds bind in the HCV helicase RNA-binding cleft near key residues Arg-393, Glu-493, and Ser-231.	[Sweeney, Noreena L.; Shadrick, William R.; Mukherjee, Sourav; Frick, David N.] Univ Wisconsin, Dept Chem & Biochem, Milwaukee, WI 53211 USA; [Li, Kelin; Frankowski, Kevin J.; Schoenen, Frank J.] Univ Kansas, Specialized Chem Ctr, Lawrence, KS 66047 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Kansas	Frick, DN (corresponding author), Univ Wisconsin, Dept Chem & Biochem, 3210 N Cramer St, Milwaukee, WI 53211 USA.	frickd@uwm.edu		Frick, David/0000-0002-2434-7223; Schoenen, Frank/0000-0003-2711-1117	National Institutes of Health [R01 AI088001, U54 HG005031]; UWM Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UWM Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI088001 and U54 HG005031, and a Research Growth Initiative Award from the UWM Research Foundation.	Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Belon CA, 2010, BIOCHEMISTRY-US, V49, P1822, DOI 10.1021/bi901974a; Belon CA, 2008, BIOTECHNIQUES, V45, P433, DOI 10.2144/000112834; Beran RKF, 2006, J MOL BIOL, V358, P974, DOI 10.1016/j.jmb.2006.02.078; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; Borowski P, 2001, J VIROL, V75, P3220, DOI 10.1128/JVI.75.7.3220-3229.2001; Chao L, 1999, J VIROL, V73, P8798, DOI 10.1128/JVI.73.10.8798-8807.1999; Chen CS, 2009, J MED CHEM, V52, P2716, DOI 10.1021/jm8011905; Frick DN, 2007, J MOL BIOL, V365, P1017, DOI 10.1016/j.jmb.2006.10.023; Frick DN, 2010, METHODS MOL BIOL, V587, P223, DOI 10.1007/978-1-60327-355-8_16; Frick DN, 2004, NUCLEIC ACIDS RES, V32, P5519, DOI 10.1093/nar/gkh891; Gemma S, 2011, BIOORG MED CHEM LETT, V21, P2776, DOI 10.1016/j.bmcl.2010.09.002; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Hanson AM, 2012, METHOD ENZYMOL, V511, P463, DOI 10.1016/B978-0-12-396546-2.00021-8; Heck JA, 2008, ANTIMICROB AGENTS CH, V52, P1901, DOI 10.1128/AAC.01496-07; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Kim JW, 2003, J VIROL, V77, P571, DOI 10.1128/JVI.77.1.571-582.2003; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200; Lam AMI, 2003, J VIROL, V77, P3950, DOI 10.1128/JVI.77.7.3950-3961.2003; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Li KL, 2012, J MED CHEM, V55, P3319, DOI 10.1021/jm300021v; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Moustakas DT, 2006, J COMPUT AID MOL DES, V20, P601, DOI 10.1007/s10822-006-9060-4; Mukherjee S, 2012, NUCLEIC ACIDS RES, V40, P8607, DOI 10.1093/nar/gks623; Najda-Bernatowicz A, 2010, BIOORGAN MED CHEM, V18, P5129, DOI 10.1016/j.bmc.2010.05.066; Ndjomou J, 2012, ANTIVIR RES, V96, P245, DOI 10.1016/j.antiviral.2012.08.006; Neumann-Haefelin C, 2008, J VIROL, V82, P3438, DOI 10.1128/JVI.01700-07; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Preugschat F, 2000, BIOCHEMISTRY-US, V39, P5174, DOI 10.1021/bi9923860; Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449; Tackett AJ, 2001, NUCLEIC ACIDS RES, V29, P565, DOI 10.1093/nar/29.2.565; Thibeault D, 2004, J VIROL, V78, P7352, DOI 10.1128/JVI.78.14.7352-7359.2004; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Yanagi M, 1998, VIROLOGY, V244, P161, DOI 10.1006/viro.1998.9092; Yanagi M, 1999, VIROLOGY, V262, P250, DOI 10.1006/viro.1999.9889; Yanagi M, 1997, P NATL ACAD SCI USA, V94, P8738, DOI 10.1073/pnas.94.16.8738; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zhang N, 2003, J MED CHEM, V46, P4149, DOI 10.1021/jm030842j; Zhang N, 2003, J MED CHEM, V46, P4776, DOI 10.1021/jm030277k	42	7	7	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19949	19957		10.1074/jbc.M113.463166	http://dx.doi.org/10.1074/jbc.M113.463166			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23703611	hybrid, Green Published			2022-12-28	WOS:000321515800060
J	Wei, Q; Li, JH; Liu, T; Tong, XM; Ye, X				Wei, Qian; Li, Junhui; Liu, Ting; Tong, Xiaomei; Ye, Xin			Phosphorylation of Minichromosome Maintenance Protein 7 (MCM7) by Cyclin/Cyclin-dependent Kinase Affects Its Function in Cell Cycle Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; HELICASE ACTIVITY; CHECKPOINT; INITIATION; PATHWAY; CDK	MCM7 is one of the subunits of the MCM2-7 complex that plays a critical role in DNA replication initiation and cell proliferation of eukaryotic cells. After forming the pre-replication complex (pre-RC) with other components, the MCM2-7 complex is activated by DDK/cyclin-dependent kinase to initiate DNA replication. Each subunit of the MCM2-7 complex functions differently under regulation of various kinases on the specific site, which needs to be investigated in detail. In this study, we demonstrated that MCM7 is a substrate of cyclin E/Cdk2 and can be phosphorylated on Ser-121. We found that the distribution of MCM7-S121A is different from wild-type MCM7 and that the MCM7-S121A mutant is much less efficient to form a pre-RC complex with MCM3/MCM5/cdc45 compared with wild-type MCM7. By using the Tet-On inducible HeLa cell line, we revealed that overexpression of wild-type MCM7 but not MCM7-S121A can block S phase entry, suggesting that an excess of the pre-RC complex may activate the cell cycle checkpoint. Further analysis indicates that the Chk1 pathway is activated in MCM7-overexpressed cells in a p53-dependent manner. We performed experiments with the human normal cell line HL-7702 and also observed that overexpression of MCM7 can cause S phase block through checkpoint activation. In addition, we found that MCM7 could also be phosphorylated by cyclin B/Cdk1 on Ser-121 both in vitro and in vivo. Furthermore, overexpression of MCM7-S121A causes an obvious M phase exit delay, which suggests that phosphorylation of MCM7 on Ser-121 in M phase is very important for a proper mitotic exit. These data suggest that the phosphorylation of MCM7 on Ser-121 by cyclin/Cdks is involved in preventing DNA rereplication as well as in regulation of the mitotic exit.	[Wei, Qian; Li, Junhui; Liu, Ting; Tong, Xiaomei; Ye, Xin] Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, Beijing 100101, Peoples R China; [Wei, Qian; Li, Junhui; Liu, Ting] Univ Chinese Acad Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, X (corresponding author), Chinese Acad Sci, Key Lab Pathogen Microbiol & Immunol, Inst Microbiol, 1 Beichen West Rd, Beijing 100101, Peoples R China.	yex@im.ac.cn			National Natural Science Foundation of China [81272272]; Ministry of Science and Technology of China [2013ZX10004611, 2012CB519003, 2011CB504705]; Chinese Academy of Sciences [KSCX2-EW-J-6]; Innovative Research Group of the National Natural Science Foundation of China [81021003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Innovative Research Group of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grant 81272272; by Ministry of Science and Technology of China Grants 2013ZX10004611, 2012CB519003, and 2011CB504705; by Chinese Academy of Sciences Innovation Project Grant KSCX2-EW-J-6; and by Innovative Research Group of the National Natural Science Foundation of China Grant 81021003 (to X. Y.).	Abe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040129; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Deng M, 2009, J BIOL CHEM, V284, P7875, DOI 10.1074/jbc.M807827200; Ferguson RL, 2008, J CELL SCI, V121, P3224, DOI 10.1242/jcs.034702; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ishimi Y, 2000, J BIOL CHEM, V275, P16235, DOI 10.1074/jbc.M909040199; Ishimi Y, 2001, J BIOL CHEM, V276, P34428, DOI 10.1074/jbc.M104480200; Lei M, 2001, J CELL SCI, V114, P1447; Li JH, 2011, J BIOL CHEM, V286, P39776, DOI 10.1074/jbc.M111.226464; Lin DI, 2008, P NATL ACAD SCI USA, V105, P8079, DOI 10.1073/pnas.0800077105; Liu YZ, 2012, LUNG CANCER, V77, P176, DOI 10.1016/j.lungcan.2012.03.001; Maiorano D, 2006, CURR OPIN CELL BIOL, V18, P130, DOI 10.1016/j.ceb.2006.02.006; Nitani N, 2006, GENETICS, V174, P155, DOI 10.1534/genetics.106.060053; Padmanabhan V, 2004, J CLIN PATHOL, V57, P1057, DOI 10.1136/jcp.2004.016436; Porter ACG, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-3; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shohet JM, 2002, CANCER RES, V62, P1123; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Tanaka S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-16; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; You ZY, 2002, J BIOL CHEM, V277, P42471, DOI 10.1074/jbc.M205769200; Yun HJ, 2012, MOL CELL BIOCHEM, V363, P281, DOI 10.1007/s11010-011-1180-z	27	25	26	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19715	19725		10.1074/jbc.M112.449652	http://dx.doi.org/10.1074/jbc.M112.449652			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720738	hybrid, Green Published			2022-12-28	WOS:000321515800041
J	Reithinger, JH; Kim, JEH; Kim, H				Reithinger, Johannes H.; Kim, Ji Eun Hani; Kim, Hyun			Sec62 Protein Mediates Membrane Insertion and Orientation of Moderately Hydrophobic Signal Anchor Proteins in the Endoplasmic Reticulum (ER)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREPRO-ALPHA-FACTOR; SEQUENCE ORIENTATION; TARGETING PATHWAY; MOLECULAR CODE; YEAST; TRANSPORT; COMPLEX; TRANSLOCATION; RECOGNITION; DOMAIN	Nascent chains are known to be targeted to the endoplasmic reticulum membrane either by a signal recognition particle (SRP)-dependent co-translational or by an SRP-independent post-translational translocation route depending on signal sequences. Using a set of model and cellular proteins carrying an N-terminal signal anchor sequence of controlled hydrophobicity and yeast mutant strains defective in SRP or Sec62 function, the hydrophobicity-dependent targeting efficiency and targeting pathway preference were systematically evaluated. Our results suggest that an SRP-dependent co-translational and an SRP-independent post-translational translocation are not mutually exclusive for signal anchor proteins and that moderately hydrophobic ones require both SRP and Sec62 for proper targeting and translocation to the endoplasmic reticulum. Further, defect in Sec62 selectively reduced signal sequences inserted in an N-in-C-out (type II) membrane topology, implying an undiscovered role of Sec62 in regulating the orientation of the signal sequence in an early stage of translocation.	[Reithinger, Johannes H.; Kim, Ji Eun Hani; Kim, Hyun] Seoul Natl Univ, Sch Biol Sci, Seoul 151747, South Korea; [Reithinger, Johannes H.] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden	Seoul National University (SNU); Stockholm University	Kim, H (corresponding author), Seoul Natl Univ, Sch Biol Sci, Bldg 504-421, Seoul 151747, South Korea.	joy@snu.ac.kr			National Research Foundation of Korea [2012-0001935, C00048]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by Basic Research Grant 2012-0001935 and Global Research Network Grant C00048 from the National Research Foundation of Korea (to H. K.).	Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Devaraneni PK, 2011, CELL, V146, P134, DOI 10.1016/j.cell.2011.06.004; Eusebio A, 1998, EXP CELL RES, V241, P181, DOI 10.1006/excr.1998.4042; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Kocik L, 2012, J MOL BIOL, V424, P368, DOI 10.1016/j.jmb.2012.10.010; Lakkaraju AKK, 2012, MOL BIOL CELL, V23, P2712, DOI 10.1091/mbc.E12-03-0228; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; Lee H, 2012, BIOCHEM BIOPH RES CO, V427, P780, DOI 10.1016/j.bbrc.2012.09.138; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; Matlack KES, 1999, CELL, V97, P553, DOI 10.1016/S0092-8674(00)80767-9; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Muller L, 2010, MOL BIOL CELL, V21, P691, DOI 10.1091/mbc.E09-08-0730; Mutka SC, 2001, MOL BIOL CELL, V12, P577, DOI 10.1091/mbc.12.3.577; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rosch K, 2000, J BIOL CHEM, V275, P14916, DOI 10.1074/jbc.M000456200; SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16; SHAW AS, 1988, P NATL ACAD SCI USA, V85, P7592, DOI 10.1073/pnas.85.20.7592; SPIESS M, 1995, FEBS LETT, V369, P76, DOI 10.1016/0014-5793(95)00551-J; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Tyedmers J, 2000, P NATL ACAD SCI USA, V97, P7214, DOI 10.1073/pnas.97.13.7214; Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555; Wilkinson BM, 2001, DEV CELL, V1, P401, DOI 10.1016/S1534-5807(01)00043-0; Wittke S, 2000, MOL BIOL CELL, V11, P3859, DOI 10.1091/mbc.11.11.3859	35	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18058	18067		10.1074/jbc.M113.473009	http://dx.doi.org/10.1074/jbc.M113.473009			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23632075	hybrid, Green Published			2022-12-28	WOS:000320721900012
J	Chai, L; Romero, D; Kayatekin, C; Akabayov, B; Vlamakis, H; Losick, R; Kolter, R				Chai, Liraz; Romero, Diego; Kayatekin, Can; Akabayov, Barak; Vlamakis, Hera; Losick, Richard; Kolter, Roberto			Isolation, Characterization, and Aggregation of a Structured Bacterial Matrix Precursor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS BIOFILMS; AMYLOID FIBERS; IN-VITRO; PROTEIN; BIOGENESIS; OLIGOMERS; SURFACE; PSEUDOMONAS; MONOLAYERS; DIVERSITY	Biofilms are surface-associated groups of microbial cells that are embedded in an extracellular matrix (ECM). The ECM is a network of biopolymers, mainly polysaccharides, proteins, and nucleic acids. ECM proteins serve a variety of structural roles and often form amyloid-like fibers. Despite the extensive study of the formation of amyloid fibers from their constituent subunits in humans, much less is known about the assembly of bacterial functional amyloid-like precursors into fibers. Using dynamic light scattering, atomic force microscopy, circular dichroism, and infrared spectroscopy, we show that our unique purification method of a Bacillus subtilis major matrix protein component results in stable oligomers that retain their native alpha-helical structure. The stability of these oligomers enabled us to control the external conditions that triggered their aggregation. In particular, we show that stretched fibers are formed on a hydrophobic surface, whereas plaque-like aggregates are formed in solution under acidic pH conditions. TasA is also shown to change conformation upon aggregation and gain some beta-sheet structure. Our studies of the aggregation of a bacterial matrix protein from its subunits shed new light on assembly processes of the ECM within bacterial biofilms.	[Chai, Liraz; Romero, Diego; Vlamakis, Hera; Kolter, Roberto] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Kayatekin, Can] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Akabayov, Barak] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Losick, Richard] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Harvard University	Kolter, R (corresponding author), 77 Louis Pasteur Ave, Boston, MA 02115 USA.	rkolter@hms.harvard.edu	Romero, Diego/D-3849-2013; Kayatekin, Can/B-6618-2009; Akabayov, Barak/Y-5786-2019	Romero, Diego/0000-0002-2052-6515; Akabayov, Barak/0000-0002-3882-2742; Kayatekin, Can/0000-0002-4367-9645	National Institutes of Health [GM58213, GM18546]; BASF (Badische Anilin- und Soda-Fabrik) Advanced Research Initiative at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058213, R01GM018568, F31GM018546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BASF (Badische Anilin- und Soda-Fabrik) Advanced Research Initiative at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM58213 (to R. K.) and GM18546 (to R. L.). This work was also supported by grants from the BASF (Badische Anilin- und Soda-Fabrik) Advanced Research Initiative at Harvard University (to R. L. and R. K.).	Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006; Chang WS, 2007, J BACTERIOL, V189, P8290, DOI 10.1128/JB.00727-07; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Dueholm MS, 2011, BIOCHEMISTRY-US, V50, P8281, DOI 10.1021/bi200967c; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; Epstein EA, 2008, CELL MICROBIOL, V10, P1413, DOI 10.1111/j.1462-5822.2008.01148.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Flory PJ., 1953, PRINCIPLES POLYM CHE, V672; FRASER PE, 1991, BIOPHYS J, V60, P1190, DOI 10.1016/S0006-3495(91)82154-3; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kearns DB, 2005, MOL MICROBIOL, V55, P739, DOI 10.1111/j.1365-2958.2004.04440.x; Keller A, 2011, ACS NANO, V5, P2770, DOI 10.1021/nn1031998; Kobayashi K, 2012, MOL MICROBIOL, V85, P51, DOI 10.1111/j.1365-2958.2012.08094.x; Magdassi S., 1996, SURFACE ACTIVITIES P; MAOZ R, 1988, J CHIM PHYS PCB, V85, P1059, DOI 10.1051/jcp/1988851059; McGlinchey RP, 2011, J BIOL CHEM, V286, P8385, DOI 10.1074/jbc.M110.197152; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; PARRISH JR, 1972, BIOPOLYMERS, V11, P1001, DOI 10.1002/bip.1972.360110506; Pfefferkorn CM, 2010, P NATL ACAD SCI USA, V107, P21447, DOI 10.1073/pnas.1006424107; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Rubinstein SM, 2012, MOL MICROBIOL, V86, P426, DOI 10.1111/j.1365-2958.2012.08201.x; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shahnawaz M, 2012, J BIOL CHEM, V287, P11665, DOI 10.1074/jbc.M111.282533; Shu Q, 2012, P NATL ACAD SCI USA, V109, P6502, DOI 10.1073/pnas.1204161109; SINGH BR, 2000, ACS S SERIES, V750; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Stover AG, 1999, J BACTERIOL, V181, P1664; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Wang X, 2007, J BIOL CHEM, V282, P3713, DOI 10.1074/jbc.M609228200; WASSERMAN SR, 1989, LANGMUIR, V5, P1074, DOI 10.1021/la00088a035; Wilking JN, 2011, MRS BULL, V36, P385, DOI 10.1557/mrs.2011.71; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; YAMADA M, 1987, J NEUROL, V234, P371, DOI 10.1007/BF00314080; Zurdo J, 2001, J MOL BIOL, V311, P325, DOI 10.1006/jmbi.2001.4858	47	50	50	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17559	17568		10.1074/jbc.M113.453605	http://dx.doi.org/10.1074/jbc.M113.453605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632024	Green Published, hybrid			2022-12-28	WOS:000320380600047
J	Kovalenko, OV; Olland, A; Piche-Nicholas, N; Godbole, A; King, D; Svenson, K; Calabro, V; Muller, MR; Barelle, CJ; Somers, W; Gill, DS; Mosyak, L; Tchistiakova, L				Kovalenko, Oleg V.; Olland, Andrea; Piche-Nicholas, Nicole; Godbole, Adarsh; King, Daniel; Svenson, Kristine; Calabro, Valerie; Mueller, Mischa R.; Barelle, Caroline J.; Somers, William; Gill, Davinder S.; Mosyak, Lidia; Tchistiakova, Lioudmila			Atypical Antigen Recognition Mode of a Shark Immunoglobulin New Antigen Receptor (IgNAR) Variable Domain Characterized by Humanization and Structural Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEINS; ANTIBODIES; COMPLEX; MATURATION; SELECTION; DESIGN; SYSTEM; ENZYME; VHH	The immunoglobulin new antigen receptors (IgNARs) are a class of Ig-like molecules of the shark immune system that exist as heavy chain-only homodimers and bind antigens by their single domain variable regions (V-NARs). Following shark immunization and/or in vitro selection, V-NARs can be generated as soluble, stable, and specific high affinity monomeric binding proteins of similar to 12 kDa. We have previously isolated a V-NAR from an immunized spiny dogfish shark, named E06, that binds specifically and with high affinity to human, mouse, and rat serum albumins. Humanization of E06 was carried out by converting over 60% of non-complementarity-determining region residues to those of a human germ line V kappa 1 sequence, DPK9. The resulting huE06 molecules have largely retained the specificity and affinity of antigen binding of the parental V-NAR. Crystal structures of the shark E06 and its humanized variant (huE06 v1.1) in complex with human serum albumin (HSA) were determined at 3- and 2.3-angstrom resolution, respectively. The huE06 v1.1 molecule retained all but one amino acid residues involved in the binding site for HSA. Structural analysis of these V-NARs has revealed an unusual variable domain-antigen interaction. E06 interacts with HSA in an atypical mode that utilizes extensive framework contacts in addition to complementarity-determining regions that has not been seen previously in V-NARs. On the basis of the structure, the roles of various elements of the molecule are described with respect to antigen binding and V-NAR stability. This information broadens the general understanding of antigen recognition and provides a framework for further design and humanization of shark IgNARs.	[Kovalenko, Oleg V.; Olland, Andrea; Piche-Nicholas, Nicole; Godbole, Adarsh; King, Daniel; Svenson, Kristine; Calabro, Valerie; Somers, William; Gill, Davinder S.; Mosyak, Lidia; Tchistiakova, Lioudmila] Pfizer Res & Dev, Global Biotherapeut Technol, Cambridge, MA 02140 USA; [Mueller, Mischa R.] Pfizer, Aberdeen AB25 2ZS, Scotland; [Barelle, Caroline J.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	Pfizer; Pfizer; University of Aberdeen	Kovalenko, OV (corresponding author), Pfizer Inc, 87 Cambridge Pk Dr, Cambridge, MA 02140 USA.	oleg.kovalenko@pfizer.com	Piche-Nicholas, Nicole/AAH-5536-2021	Piche-Nicholas, Nicole/0000-0003-0695-7965				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barelle C, 2009, ADV EXP MED BIOL, V655, P49, DOI 10.1007/978-1-4419-1132-2_6; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Bricogne G, 2009, BUSTER VERSION 2 8 0; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Conrath K, 2005, J MOL BIOL, V350, P112, DOI 10.1016/j.jmb.2005.04.050; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Dooley H, 2003, MOL IMMUNOL, V40, P25, DOI 10.1016/S0161-5890(03)00084-1; Dooley H, 2006, P NATL ACAD SCI USA, V103, P1846, DOI 10.1073/pnas.0508341103; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; Fennell BJ, 2010, J MOL BIOL, V400, P155, DOI 10.1016/j.jmb.2010.04.061; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Hwang WYK, 2005, METHODS, V36, P35, DOI 10.1016/j.ymeth.2005.01.004; JANIN J, 1990, J BIOL CHEM, V265, P16027; Koide A, 2002, P NATL ACAD SCI USA, V99, P1253, DOI 10.1073/pnas.032665299; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Liu JL, 2007, MOL IMMUNOL, V44, P1775, DOI 10.1016/j.molimm.2006.07.299; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller MR, 2012, MABS-AUSTIN, V4, P673, DOI 10.4161/mabs.22242; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Roux KH, 1998, P NATL ACAD SCI USA, V95, P11804, DOI 10.1073/pnas.95.20.11804; Simmons DP, 2006, J IMMUNOL METHODS, V315, P171, DOI 10.1016/j.jim.2006.07.019; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; Stanfield RL, 2007, J MOL BIOL, V367, P358, DOI 10.1016/j.jmb.2006.12.045; Streltsov VA, 2004, P NATL ACAD SCI USA, V101, P12444, DOI 10.1073/pnas.0403509101; Transue TR, 1998, PROTEINS, V32, P515, DOI 10.1002/(SICI)1097-0134(19980901)32:4<515::AID-PROT9>3.0.CO;2-E; Tsurushita N, 2005, METHODS, V36, P69, DOI 10.1016/j.ymeth.2005.01.007; Vincke C, 2009, J BIOL CHEM, V284, P3273, DOI 10.1074/jbc.M806889200; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	37	52	67	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17408	17419		10.1074/jbc.M112.435289	http://dx.doi.org/10.1074/jbc.M112.435289			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632026	Green Published, hybrid			2022-12-28	WOS:000320380600033
J	Zhang, QC; Schenauer, MR; McCarter, JD; Flynn, GC				Zhang, Qingchun; Schenauer, Matthew R.; McCarter, John D.; Flynn, Gregory C.			IgG1 Thioether Bond Formation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODY; BETA-ELIMINATION; CROSS-LINKS; DISULFIDE BONDS; LANTHIONINE; PROTEIN; ALKALI; SUSCEPTIBILITY; RACEMIZATION; DEGRADATION	During either production or storage, the LC214-HC220 disulfide in therapeutic antibodies can convert to a thioether bond. Here we report that a thioether forms at the same position on antibodies in vivo. An IgG1 kappa therapeutic antibody dosed in humans formed a thioether at this position at a rate of about 0.1%/day while circulating in blood. Thioether modifications were also found at this position in endogenous antibodies isolated from healthy human subjects, at levels consistent with this conversion rate. For both endogenous antibodies and recombinant antibodies studied in vivo, thioether conversion rates were faster for IgG1 antibodies containing lambda light chains than those containing kappa light chains. These light chain reaction rate differences were replicated in vitro. Additional mechanistic studies showed that base-catalyzed thioether formation through the light chain dehydrogenation was more preferred on antibodies with lambda light chains, which may help explain the observed reaction rate differences.	Amgen Inc, Dept Proc & Prod Dev, Thousand Oaks, CA 91320 USA; [McCarter, John D.] Amgen Inc, Dept Therapeut Discovery, Thousand Oaks, CA 91320 USA	Amgen; Amgen	Flynn, GC (corresponding author), Amgen Inc, Mail Stop 30E-1-C,Amgen Ctr Dr, Thousand Oaks, CA 91320 USA.	gflynn@amgen.com						Amano M, 2011, ANAL CHEM, V83, P3857, DOI 10.1021/ac200321v; BESSEMS GJH, 1987, EXP EYE RES, V44, P691, DOI 10.1016/S0014-4835(87)80139-2; Cohen SL, 2007, J AM CHEM SOC, V129, P6976, DOI 10.1021/ja0705994; Datola A, 2007, CHEMMEDCHEM, V2, P1181, DOI 10.1002/cmdc.200700042; EARLAND C, 1961, NATURE, V191, P384, DOI 10.1038/191384a0; FLORENCE TM, 1980, BIOCHEM J, V189, P507, DOI 10.1042/bj1890507; Flynn GC, 2010, MOL IMMUNOL, V47, P2074, DOI 10.1016/j.molimm.2010.04.006; Friedman M, 1999, J AGR FOOD CHEM, V47, P1295, DOI 10.1021/jf981000+; Goetze AM, 2011, GLYCOBIOLOGY, V21, P949, DOI 10.1093/glycob/cwr027; Goetze AM, 2010, MABS-AUSTIN, V2, P500, DOI 10.4161/mabs.2.5.12897; Gu S, 2010, ANAL BIOCHEM, V400, P89, DOI 10.1016/j.ab.2010.01.019; HAN Y, 1991, POULTRY SCI, V70, P812, DOI 10.3382/ps.0700812; HORN M. J., 1941, Journal of Biological Chemistry, V139, P473; Horn MJ, 1942, J BIOL CHEM, V144, P87; Horn MJ, 1941, J BIOL CHEM, V138, P141; Huang LH, 2010, ANAL CHEM, V82, P6363, DOI 10.1021/ac101348w; Lagrain B, 2010, J AGR FOOD CHEM, V58, P10761, DOI 10.1021/jf102575r; Linetsky M, 2004, EXP EYE RES, V79, P499, DOI 10.1016/j.exer.2004.06.026; Lispi M, 2009, J PHARM SCI-US, V98, P4511, DOI 10.1002/jps.21774; Liu HC, 2008, J PHARM SCI-US, V97, P2426, DOI 10.1002/jps.21180; Liu HC, 2011, ANAL BIOCHEM, V408, P277, DOI 10.1016/j.ab.2010.09.025; Liu HC, 2010, ANAL CHEM, V82, P5219, DOI 10.1021/ac100575n; Liu YD, 2008, J BIOL CHEM, V283, P29266, DOI 10.1074/jbc.M804787200; Liu YD, 2009, BIOLOGICALS, V37, P313, DOI 10.1016/j.biologicals.2009.06.001; Maggon K, 2007, CURR MED CHEM, V14, P1978; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Mozziconacci O, 2010, CHEM RES TOXICOL, V23, P1310, DOI 10.1021/tx100193b; NASHEF AS, 1977, J AGR FOOD CHEM, V25, P245, DOI 10.1021/jf60210a020; Pan H, 2009, ANAL BIOCHEM, V388, P273, DOI 10.1016/j.ab.2009.02.037; Pristatsky P, 2009, ANAL CHEM, V81, P6148, DOI 10.1021/ac9006254; Rathore AS, 2009, TRENDS BIOTECHNOL, V27, P546, DOI 10.1016/j.tibtech.2009.06.006; Rombouts I, 2010, J CEREAL SCI, V52, P362, DOI 10.1016/j.jcs.2010.06.006; Tou JS, 2009, PROTEIN J, V28, P87, DOI 10.1007/s10930-009-9167-2; Tous GI, 2005, ANAL CHEM, V77, P2675, DOI 10.1021/ac0500582; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Yin S, 2013, PHARM RES-DORDR, V30, P167, DOI 10.1007/s11095-012-0860-z	36	35	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16371	16382		10.1074/jbc.M113.468397	http://dx.doi.org/10.1074/jbc.M113.468397			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625924	hybrid, Green Published			2022-12-28	WOS:000320378900015
J	Mujtaba, S; Winer, BY; Jaganathan, A; Patel, J; Sgobba, M; Schuch, R; Gupta, YK; Haider, S; Wang, R; Fischetti, VA				Mujtaba, Shiraz; Winer, Benjamin Y.; Jaganathan, Anbalagan; Patel, Jigneshkumar; Sgobba, Miriam; Schuch, Raymond; Gupta, Yogesh K.; Haider, Shozeb; Wang, Rong; Fischetti, Vincent A.			Anthrax SET Protein A POTENTIAL VIRULENCE DETERMINANT THAT EPIGENETICALLY REPRESSES NF-kappa B ACTIVATION IN INFECTED MACROPHAGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-ANTHRACIS; HISTONE METHYLATION; LYSINE METHYLATION; STRUCTURAL BASIS; KINASE-KINASE; LETHAL FACTOR; TRANSCRIPTION; BACTERIAL; GERMINATION; GENES	Toxins play a major role in the pathogenesis of Bacillus anthracis by subverting the host defenses. However, besides toxins, B. anthracis expresses effector proteins, whose role in pathogenesis are yet to be investigated. Here we present that suppressor-of-variegation, enhancer-of-zeste, trithorax protein from B. anthracis (BaSET) methylates human histone H1, resulting in repression of NF-kappa B functions. Notably, BaSET is secreted and undergoes nuclear translocation to enhance H1 methylation in B. anthracis-infected macrophages. Compared with wild type Sterne, delayed growth kinetics and altered septum formation were observed in the BaSET knock-out (Ba Delta SET) bacilli. Uncontrolled BaSET expression during complementation of the BaSET gene in Ba Delta SET partially restored growth during stationary phase but resulted in substantially shorter bacilli throughout the growth cycle. Importantly, in contrast to Sterne, the Ba Delta SET B. anthracis is avirulent in a lethal murine bacteremia model of infection. Collectively, BaSET is required for repression of host transcription as well as proper B. anthracis growth, making it a potentially unique virulence determinant.	[Mujtaba, Shiraz; Jaganathan, Anbalagan; Patel, Jigneshkumar; Gupta, Yogesh K.] Mt Sinai Sch Med, Dept Struct & Chem, New York, NY 10029 USA; [Wang, Rong] Mt Sinai Sch Med, Dept Genet & Genom Biol, New York, NY 10029 USA; [Winer, Benjamin Y.; Schuch, Raymond; Fischetti, Vincent A.] Rockefeller Univ, Lab Bacterial Pathogenesis & Immunol, New York, NY 10065 USA; [Sgobba, Miriam; Haider, Shozeb] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast BT9 7BL, Antrim, North Ireland	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Rockefeller University; Queens University Belfast	Mujtaba, S (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem, New York, NY 10029 USA.	shiraz.mujtaba@mssm.edu; vaf@mail.rockefeller.edu	Gupta, Yogesh K/B-6949-2009; Haider, Shozeb M/B-3452-2015; Haider, Shozeb/Q-1599-2019; Gupta, Yogesh/AFH-5204-2022; Wang, Rong/A-8721-2009	Gupta, Yogesh K/0000-0001-6372-5007; Haider, Shozeb M/0000-0003-2650-2925; Haider, Shozeb/0000-0003-2650-2925; Gupta, Yogesh/0000-0001-6372-5007; Winer, Benjamin/0000-0001-7895-2544	National Institutes of Health [5R01AI057472, 5R01CA143662-02]; Centre for Cancer Research and Cell Biology startup funds; NATIONAL CANCER INSTITUTE [R01CA143662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre for Cancer Research and Cell Biology startup funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01AI057472 (USPHS; to V. A. F.) and 5R01CA143662-02 (to S. M.). This work was also supported by Centre for Cancer Research and Cell Biology startup funds (to S. H.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Venegas R, 2007, MOL BIOL EVOL, V24, P482, DOI 10.1093/molbev/msl184; Aravind L, 2003, CELL CYCLE, V2, P369, DOI 10.4161/cc.2.4.419; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Barua S, 2009, INFECT IMMUN, V77, P23, DOI 10.1128/IAI.00801-08; Borah JC, 2011, CHEM BIOL, V18, P531, DOI 10.1016/j.chembiol.2010.12.021; Couture JF, 2006, J BIOL CHEM, V281, P19280, DOI 10.1074/jbc.M602257200; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Dodatko T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006398; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Ezzell JW, 1999, J APPL MICROBIOL, V87, P250, DOI 10.1046/j.1365-2672.1999.00881.x; Fazzini MM, 2010, J BACTERIOL, V192, P4012, DOI 10.1128/JB.00197-10; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Giebel JD, 2009, J BACTERIOL, V191, P5569, DOI 10.1128/JB.00408-09; Giles RH, 1998, TRENDS GENET, V14, P178, DOI 10.1016/S0168-9525(98)01438-3; Goodman RH, 2000, GENE DEV, V14, P1553; Gut IM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-46; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Imhof A, 1997, CURR BIOL, V7, P689, DOI 10.1016/S0960-9822(06)00296-X; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; Koehler TM, 2009, MOL ASPECTS MED, V30, P386, DOI 10.1016/j.mam.2009.07.004; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Ling BMT, 2012, MOL BIOL CELL, V23, P4778, DOI 10.1091/mbc.E12-04-0311; Ling BMT, 2012, P NATL ACAD SCI USA, V109, P841, DOI 10.1073/pnas.1111628109; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; McGillivray SM, 2009, J INNATE IMMUN, V1, P494, DOI 10.1159/000225955; Meinzer U, 2012, CELL HOST MICROBE, V11, P337, DOI 10.1016/j.chom.2012.02.009; Mogridge J, 2004, LANCET, V364, P393, DOI 10.1016/S0140-6736(04)16779-2; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Mujtaba S, 2008, NAT CELL BIOL, V10, P1114, DOI 10.1038/ncb1772; Mujtaba S, 2011, METHODS, V53, P97, DOI 10.1016/j.ymeth.2010.09.001; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Pellizzari R, 2000, INT J MED MICROBIOL, V290, P421; Qadri I, 1996, P NATL ACAD SCI USA, V93, P10578, DOI 10.1073/pnas.93.20.10578; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Tournier JN, 2009, EXPERT REV ANTI-INFE, V7, P219, DOI 10.1586/14787210.7.2.219; Turnbull PCB, 2002, CURR TOP MICROBIOL, V271, P1; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wang S, 2005, MOL MICROBIOL, V58, P791, DOI 10.1111/j.1365-2958.2005.04864.x; Weiss T, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-7; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	59	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23458	23472		10.1074/jbc.M113.467696	http://dx.doi.org/10.1074/jbc.M113.467696			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23720780	Green Published, hybrid			2022-12-28	WOS:000330598200052
J	Appolaire, A; Rosenbaum, E; Dura, MA; Colombo, M; Marty, V; Savoye, MN; Godfroy, A; Schoehn, G; Girard, E; Gabel, F; Franzetti, B				Appolaire, Alexandre; Rosenbaum, Eva; Dura, M. Asuncion; Colombo, Matteo; Marty, Vincent; Savoye, Marjolaine Noirclerc; Godfroy, Anne; Schoehn, Guy; Girard, Eric; Gabel, Frank; Franzetti, Bruno			Pyrococcus horikoshii TET2 Peptidase Assembling Process and Associated Functional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; LEUCINE AMINOPEPTIDASE; SUBSTRATE-SPECIFICITY; BLEOMYCIN HYDROLASE; PROTEIN-DEGRADATION; TRICORN PROTEASE; REVEALS; COMPLEX; MACROMOLECULES; SCATTERING	Tetrahedral (TET) aminopeptidases are large polypeptide destruction machines present in prokaryotes and eukaryotes. Here, the rules governing their assembly into hollow 12-subunit tetrahedrons are addressed by using TET2 from Pyrococcus horikoshii (PhTET2) as a model. Point mutations allowed the capture of a stable, catalytically active precursor. Small angle x- ray scattering revealed that it is a dimer whose architecture in solution is identical to that determined by x- ray crystallography within the fully assembled TET particle. Small angle x- ray scattering also showed that the reconstituted PhTET2 dodecameric particle displayed the same quaternary structure and thermal stability as the wild-type complex. The PhTET2 assembly intermediates were characterized by analytical ultracentrifugation, native gel electrophoresis, and electron microscopy. They revealed that PhTET2 assembling is a highly ordered process in which hexamers represent the main intermediate. Peptide degradation assays demonstrated that oligomerization triggers the activity of the TET enzyme toward large polypeptidic substrates. Fractionation experiments in Pyrococcus and Halobacterium cells revealed that, in vivo, the dimeric precursor co-exists together with assembled TET complexes. Taken together, our observations explain the biological significance of TET oligomerization and suggest the existence of a functional regulation of the dimer-dodecamer equilibrium in vivo.	[Appolaire, Alexandre; Rosenbaum, Eva; Dura, M. Asuncion; Colombo, Matteo; Marty, Vincent; Savoye, Marjolaine Noirclerc; Schoehn, Guy; Girard, Eric; Gabel, Frank; Franzetti, Bruno] CNRS, Inst Biol Struct, UMR5075, F-38027 Grenoble, France; [Appolaire, Alexandre; Rosenbaum, Eva; Dura, M. Asuncion; Colombo, Matteo; Marty, Vincent; Savoye, Marjolaine Noirclerc; Schoehn, Guy; Girard, Eric; Gabel, Frank; Franzetti, Bruno] CEA Grenoble, F-38054 Grenoble, France; [Appolaire, Alexandre; Rosenbaum, Eva; Dura, M. Asuncion; Colombo, Matteo; Marty, Vincent; Savoye, Marjolaine Noirclerc; Schoehn, Guy; Girard, Eric; Gabel, Frank; Franzetti, Bruno] Univ Grenoble 1, F-38027 Grenoble, France; [Godfroy, Anne] IFREMER, UMR6197, Lab Microbiol Environm Extremes, F-29280 Plouzane, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Universite de Bretagne Occidentale	Franzetti, B (corresponding author), Inst Biol Struct, 41 Rue J Horowitz, F-38027 Grenoble 1, France.	franzetti@ibs.fr	Anne, Godfroy/J-9897-2017; Godfroy, Anne/X-1992-2018	Anne, Godfroy/0000-0003-0483-4160; Godfroy, Anne/0000-0003-0483-4160; Schoehn, Guy/0000-0002-1459-3201; Noirclerc-Savoye, Marjolaine/0000-0002-5481-6561; Girard, Eric/0000-0002-5758-6095; Gabel, Frank/0000-0003-3446-2601	Agence Nationale de la Recherche ["MacroTET"-BLAN-07-3204002, "Archelyse" ANR-12-BSV8-0019-01]; GRD Ecchis; French Ministry for Research and Technology; French National Research Agency	Agence Nationale de la Recherche(French National Research Agency (ANR)); GRD Ecchis; French Ministry for Research and Technology; French National Research Agency(French National Research Agency (ANR))	This work was supported in part by the Agence Nationale de la Recherche Grants "MacroTET"-BLAN-07-3204002 and "Archelyse" ANR-12-BSV8-0019-01 and the GRD Ecchis.; Supported by a Ph.D. scholarship from the French Ministry for Research and Technology.; Supported by a French National Research Agency postdoctoral fellowship.	Ando S, 1999, FEBS LETT, V447, P25, DOI 10.1016/S0014-5793(99)00257-4; Borissenko L, 2005, J MOL BIOL, V346, P1207, DOI 10.1016/j.jmb.2004.12.056; Brandstetter H, 2001, NATURE, V414, P466, DOI 10.1038/35106609; BURLEY SK, 1990, P NATL ACAD SCI USA, V87, P6878, DOI 10.1073/pnas.87.17.6878; BURLEY SK, 1992, J MOL BIOL, V224, P113, DOI 10.1016/0022-2836(92)90580-D; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chaikuad A, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-14; Chamieh H, 2008, BIOCHEM J, V411, P387, DOI 10.1042/BJ20071502; Chen YY, 2012, J BIOL CHEM, V287, P13356, DOI 10.1074/jbc.M112.347518; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Clantin B, 2001, EUR J BIOCHEM, V268, P3937, DOI 10.1046/j.1432-1327.2001.02302.x; Debela M, 2006, J MOL BIOL, V362, P1094, DOI 10.1016/j.jmb.2006.08.003; Delfosse V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004712; Du XL, 2000, P NATL ACAD SCI USA, V97, P14079, DOI 10.1073/pnas.260503597; Dura MA, 2009, MOL MICROBIOL, V72, P26, DOI 10.1111/j.1365-2958.2009.06600.x; Dura MA, 2005, BIOCHEMISTRY-US, V44, P3477, DOI 10.1021/bi047736j; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; GINZBURG M, 1970, Journal of General Physiology, V55, P187, DOI 10.1085/jgp.55.2.187; Glatter O, 2002, N-HOLLAND D, P73; Godfroy A, 2000, FEMS MICROBIOL LETT, V186, P127, DOI 10.1111/j.1574-6968.2000.tb09093.x; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gonzales T, 1996, FEMS MICROBIOL REV, V18, P319, DOI 10.1111/j.1574-6976.1996.tb00247.x; Gonzalez JM, 1998, EXTREMOPHILES, V2, P123, DOI 10.1007/s007920050051; Guzman-Rojas L, 2012, P NATL ACAD SCI USA, V109, P1637, DOI 10.1073/pnas.1120790109; Holz RC, 2003, CURR OPIN CHEM BIOL, V7, P197, DOI 10.1016/S1367-5931(03)00033-4; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; JOSHUATOR L, 1995, SCIENCE, V269, P945, DOI 10.1126/science.7638617; Kim D, 2010, BIOCHEM BIOPH RES CO, V391, P431, DOI 10.1016/j.bbrc.2009.11.075; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P399, DOI 10.1016/S0968-0004(97)01117-1; Marquardt U, 2002, J MOL BIOL, V321, P491, DOI 10.1016/S0022-2836(02)00625-3; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; O'Farrell PA, 1999, STRUCT FOLD DES, V7, P619, DOI 10.1016/S0969-2126(99)80083-5; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Remaut H, 2001, NAT STRUCT BIOL, V8, P674, DOI 10.1038/90380; Rosenbaum E, 2011, BBA-PROTEINS PROTEOM, V1814, P1289, DOI 10.1016/j.bbapap.2010.11.008; Russo S, 2004, J BIOL CHEM, V279, P51275, DOI 10.1074/jbc.M409455200; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Schoehn G, 2006, J BIOL CHEM, V281, P36327, DOI 10.1074/jbc.M604417200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Svedberg T, 1940, THE ULTRACENTRIFUGE; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Talon R, 2011, J SYNCHROTRON RADIAT, V18, P74, DOI 10.1107/S0909049510036824; Tamura T, 1996, SCIENCE, V274, P1385, DOI 10.1126/science.274.5291.1385; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; TAYLOR A, 1993, TRENDS BIOCHEM SCI, V18, P167; Thompson MW, 1998, EUR J BIOCHEM, V258, P923, DOI 10.1046/j.1432-1327.1998.2580923.x; van Endert P, 2011, CELL MOL LIFE SCI, V68, P1553, DOI 10.1007/s00018-011-0662-1; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wriggers Willy, 2010, Biophys Rev, V2, P21, DOI 10.1007/s12551-009-0026-3	55	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22542	22554		10.1074/jbc.M113.450189	http://dx.doi.org/10.1074/jbc.M113.450189			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23696647	Green Published, hybrid			2022-12-28	WOS:000330596300034
J	Brunner, R; Ng, CL; Aissaoui, H; Akabas, MH; Boss, C; Brun, R; Callaghan, PS; Corminboeuf, O; Fidock, DA; Frame, IJ; Heidmann, B; Le Bihan, A; Jeno, P; Mattheis, C; Moes, S; Muller, IB; Paguio, M; Roepe, PD; Siegrist, R; Voss, T; Welford, RWD; Wittlin, S; Binkert, C				Brunner, Ralf; Ng, Caroline L.; Aissaoui, Hamed; Akabas, Myles H.; Boss, Christoph; Brun, Reto; Callaghan, Paul S.; Corminboeuf, Olivier; Fidock, David A.; Frame, Ithiel J.; Heidmann, Bibia; Le Bihan, Amelie; Jenoe, Paul; Mattheis, Corinna; Moes, Suzette; Mueller, Ingrid B.; Paguio, Michelle; Roepe, Paul D.; Siegrist, Romain; Voss, Till; Welford, Richard W. D.; Wittlin, Sergio; Binkert, Christoph			UV-triggered Affinity Capture Identifies Interactions between the Plasmodium falciparum Multidrug Resistance Protein 1 (PfMDR1) and Antimalarial Agents in Live Parasitized Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROOROTATE DEHYDROGENASE; ARTEMISININ RESISTANCE; MALARIA; TARGET; MEFLOQUINE; TRANSPORTER; SENSITIVITY; INHIBITORS; QUININE; GENE	A representative of a new class of potent antimalarials with an unknown mode of action was recently described. To identify the molecular target of this class of antimalarials, we employed a photo-reactive affinity capture method to find parasite proteins specifically interacting with the capture compound in living parasitized cells. The capture reagent retained the antimalarial properties of the parent molecule (ACT-213615) and accumulated within parasites. We identified several proteins interacting with the capture compound and established a functional interaction between ACT-213615 and PfMDR1. We surmise that PfMDR1 may play a role in the antimalarial activity of the piperazine-containing compound ACT-213615.	[Brunner, Ralf; Brun, Reto; Voss, Till; Wittlin, Sergio] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Brunner, Ralf; Brun, Reto; Voss, Till; Wittlin, Sergio] Univ Basel, CH-4003 Basel, Switzerland; [Ng, Caroline L.; Fidock, David A.; Mattheis, Corinna] Columbia Univ, Med Ctr, Hammer Hlth Sci Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Aissaoui, Hamed; Boss, Christoph; Corminboeuf, Olivier; Heidmann, Bibia; Le Bihan, Amelie; Siegrist, Romain; Welford, Richard W. D.; Binkert, Christoph] Actel Pharmaceut Ltd, Drug Discovery Biol, CH-4123 Allschwil, Switzerland; [Akabas, Myles H.; Frame, Ithiel J.] Yeshiva Univ, Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Callaghan, Paul S.; Paguio, Michelle; Roepe, Paul D.] Georgetown Univ, Dept Chem Biochem & Cellular & Mol Biol, Washington, DC 20057 USA; [Jenoe, Paul; Moes, Suzette] Univ Basel, Biozentrum, Prote Core Facil, CH-4056 Basel, Switzerland; [Mueller, Ingrid B.] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Columbia University; Actelion Pharmaceuticals Ltd; Yeshiva University; Albert Einstein College of Medicine; Georgetown University; University of Basel; Bernhard Nocht Institut fur Tropenmedizin	Binkert, C (corresponding author), Actel Pharmaceut Ltd, Drug Discovery Biol, CH-4123 Allschwil, Switzerland.	christoph.binkert@ext.actelion.com		Frame, I.J./0000-0002-7560-7427; Akabas, Myles/0000-0001-8781-7846; Fidock, David/0000-0001-6753-8938	National Institutes of Health [R01 AI079709, RO1 AI056312, T32-GM007288]; Medicines for Malaria Venture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056312, R01AI079709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medicines for Malaria Venture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 AI079709 (to D. A. F.) and RO1 AI056312 (to P. D. R.). I. J. F. was supported in part by National Institutes of Health Grant T32-GM007288. This work was also supported by the Medicines for Malaria Venture (to D. A. F.). H. Aissaoui, C. Binkert, C. Boss, O. Corminboeuf, B. Heidmann, A. Le Bihan, R. Siegrist, and R. Welford are or were Actelion employees.	Baldwin SA, 2007, CURR PHARM DESIGN, V13, P569, DOI 10.2174/138161207780162845; Booker ML, 2010, J BIOL CHEM, V285, P33054, DOI 10.1074/jbc.M110.162081; Brunner R, 2012, J INFECT DIS, V206, P735, DOI 10.1093/infdis/jis418; Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683; Charman SA, 2011, P NATL ACAD SCI USA, V108, P4400, DOI 10.1073/pnas.1015762108; Coteron JM, 2011, J MED CHEM, V54, P5540, DOI 10.1021/jm200592f; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Duraisingh MT, 2005, ACTA TROP, V94, P181, DOI 10.1016/j.actatropica.2005.04.008; Durdagi S, 2011, CURR MED CHEM, V18, P2601, DOI 10.2174/092986711795933641; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferreira PE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023875; Frame IJ, 2012, BIOCHEM J, V446, P179, DOI 10.1042/BJ20112220; Hofer S, 2008, J ANTIMICROB CHEMOTH, V62, P1061, DOI 10.1093/jac/dkn315; Koster H, 2007, ASSAY DRUG DEV TECHN, V5, P381, DOI 10.1089/adt.2006.039; LIBBY PR, 1978, J BIOL CHEM, V253, P233; Mahaut-Smith MP, 2008, TRENDS PHARMACOL SCI, V29, P421, DOI 10.1016/j.tips.2008.05.007; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Muller IB, 2010, CELL MICROBIOL, V12, P677, DOI 10.1111/j.1462-5822.2010.01426.x; Parker MD, 2000, BIOCHEM J, V349, P67, DOI 10.1042/0264-6021:3490067; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Pleeter P, 2010, MOL BIOCHEM PARASIT, V173, P158, DOI 10.1016/j.molbiopara.2010.05.012; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Sanchez CP, 2008, MOL MICROBIOL, V70, P786, DOI 10.1111/j.1365-2958.2008.06413.x; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; Terstappen GC, 2007, NAT REV DRUG DISCOV, V6, P891, DOI 10.1038/nrd2410; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; White NJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P301; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601	35	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22576	22583		10.1074/jbc.M113.453159	http://dx.doi.org/10.1074/jbc.M113.453159			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23754276	Green Published, hybrid			2022-12-28	WOS:000330596300038
J	Billet, A; Luo, YS; Balghi, H; Hanrahan, JW				Billet, Arnaud; Luo, Yishan; Balghi, Haouaria; Hanrahan, John W.			Role of Tyrosine Phosphorylation in the Muscarinic Activation of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CFTR; G Protein-coupled Receptors (GPCR); PP2A; Src; Tyrosine Protein Kinase (Tyrosine Kinase); Muscarinic 3 Receptor	PROTEIN-KINASE-A; TRACHEAL SUBMUCOSAL GLANDS; CHLORIDE CHANNEL; CL-CHANNEL; CELLS; FLUID; SECRETION; CALCIUM; GENE; IDENTIFICATION	Cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride (Cl-) channel, which plays an important role in physiological anion and fluid secretion, and is defective in several diseases. Although its activation by PKA and PKC has been studied extensively, its regulation by receptors is less well understood. To study signaling involved in CFTR activation, we measured whole-cell Cl- currents in BHK cells cotransfected with GPCRs and CFTR. In cells expressing the M3 muscarinic acetylcholine receptor, the agonist carbachol (Cch) caused strong activation of CFTR through two pathways; the canonical PKA-dependent mechanism and a second mechanism that involves tyrosine phosphorylation. The role of PKA was suggested by partial inhibition of cholinergic stimulation by the specific PKA inhibitor Rp-cAMPS. The role of tyrosine kinases was suggested by Cch stimulation of 15SA-CFTR and 9CA-CFTR, mutants that lack 15 PKA or 9 PKC consensus sequences and are unresponsive to PKA or PKC stimulation, respectively. Moreover the residual Cch response was sensitive to inhibitors of the Pyk2 and Src tyrosine kinase family. Our results suggest that tyrosine phosphorylation acts on CFTR directly and through inhibition of the phosphatase PP2A. Results suggest that PKA and tyrosine kinases contribute to CFTR regulation by GPCRs that are expressed at the apical membrane of intestinal and airway epithelia.	McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Res Inst, Ctr Hosp, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University	Billet, A (corresponding author), McIntyre Med Sci, Dept Physiol, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	arnaud.billet@mcgill.ca	billet, arnaud/P-9503-2016; Hanrahan, John/AGG-1926-2022; Billet, Arnaud/AAZ-3834-2020	Hanrahan, John/0000-0001-9080-2039; 	Canada Foundation for Innovation; Canadian Institutes for Health Research; Groupe d'Etude des Proteines Membranaire (GEPROM); Groupe de Recherche Axe sur la Structure des Proteines (GRASP); CIHR Program in Chemical Biology at McGill; Cystic Fibrosis Canada	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Groupe d'Etude des Proteines Membranaire (GEPROM); Groupe de Recherche Axe sur la Structure des Proteines (GRASP); CIHR Program in Chemical Biology at McGill(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada	This research was supported by the Canada Foundation for Innovation and Canadian Institutes for Health Research.; Supported by fellowships from the Groupe d'Etude des Proteines Membranaire (GEPROM), the Groupe de Recherche Axe sur la Structure des Proteines (GRASP), and the CIHR Program in Chemical Biology at McGill.; Supported by the CIHR Program in Chemical Biology at McGill and by Cystic Fibrosis Canada.	ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; BEAR CE, 1992, CELL, V68, P809, DOI 10.1016/0092-8674(92)90155-6; BERGER HA, 1993, J BIOL CHEM, V268, P2037; BERGER HA, 1991, J CLIN INVEST, V88, P1422, DOI 10.1172/JCI115450; Brinson AE, 1998, J BIOL CHEM, V273, P1711, DOI 10.1074/jbc.273.3.1711; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; CORRALES RJ, 1984, J APPL PHYSIOL, V56, P1076, DOI 10.1152/jappl.1984.56.4.1076; FIELD M, 1972, J CLIN INVEST, V51, P796, DOI 10.1172/JCI106874; Fischer H, 1996, BIOPHYS J, V71, P3073, DOI 10.1016/S0006-3495(96)79501-2; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Halls ML, 2011, COLD SPRING HARB PER, V3; Hirst R. A., 1993, BIOCHEM SOC T, V21, p431S; Jia YL, 1997, J BIOL CHEM, V272, P4978, DOI 10.1074/jbc.272.8.4978; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; KARTNER N, 1991, CELL, V64, P681, DOI 10.1016/0092-8674(91)90498-N; Kerem E, 2006, PAEDIATR RESPIR REV, V7, pS144, DOI 10.1016/j.prrv.2006.04.219; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Li HY, 2012, AM J PHYSIOL-RENAL, V303, pF1176, DOI 10.1152/ajprenal.00130.2012; Li X, 1998, J BIOL CHEM, V273, P9361, DOI 10.1074/jbc.273.16.9361; Liang LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021991; Liang L, 2009, AM J PHYSIOL-CELL PH, V296, pC131, DOI 10.1152/ajpcell.00346.2008; Luo JX, 1998, AM J PHYSIOL-CELL PH, V274, pC1397, DOI 10.1152/ajpcell.1998.274.5.C1397; Luo Y, 2009, BIOCHEM J, V419, P211, DOI 10.1042/BJ20081869; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Luz S, 2011, MOL CELL BIOL, V31, P4392, DOI 10.1128/MCB.05517-11; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Park S., 2013, GASTROENTEROLOGY, V13; Park S, 2012, PHYSIOLOGY, V27, P291, DOI 10.1152/physiol.00028.2012; Reddy MM, 2001, AM J PHYSIOL-CELL PH, V280, pC604, DOI 10.1152/ajpcell.2001.280.3.C604; RIORDAN JR, 1989, SCIENCE, V245, P1066; Salinas D, 2004, FASEB J, V18, P431, DOI 10.1096/fj.04-2879fje; Schultheiss G, 2005, J MEMBRANE BIOL, V204, P117, DOI 10.1007/s00232-005-0757-4; Seibert FS, 1999, BBA-BIOMEMBRANES, V1461, P275, DOI 10.1016/S0005-2736(99)00163-7; SUIDAN HS, 1991, CELL REGUL, V2, P13, DOI 10.1091/mbc.2.1.13; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; TABCHARANI JA, 1991, NATURE, V352, P628, DOI 10.1038/352628a0; Thelin WR, 2005, J BIOL CHEM, V280, P41512, DOI 10.1074/jbc.M507308200; Watcharasit P, 2001, NEUROCHEM RES, V26, P809, DOI 10.1023/A:1011612118779; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40	44	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21815	10.1074/jbc.M113.479360	http://dx.doi.org/10.1074/jbc.M113.479360			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760269	hybrid, Green Published			2022-12-28	WOS:000328841900031
J	Kundumani-Sridharan, V; Singh, NK; Kumar, S; Gadepalli, R; Rao, GN				Kundumani-Sridharan, Venkatesh; Singh, Nikhlesh K.; Kumar, Sanjay; Gadepalli, Ravisekhar; Rao, Gadiparthi N.			Nuclear Factor of Activated T Cells cl Mediates p21-activated Kinase 1 Activation in the Modulation of Chemokine-induced Human Aortic Smooth Muscle Cell F-actin Stress Fiber Formation, Migration, and Proliferation and Injury-induced Vascular Wall Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclin-dependent Kinase (CDK); Cell Growth; Cell Migration; NFAT Transcription Factor; Vascular Smooth Muscle Cells	COUPLED RECEPTOR AGONIST; INDUCED NEOINTIMA FORMATION; MONOCYTE CHEMOATTRACTANT; TYROSINE KINASE; CYCLIN D1; SIGNAL TRANSDUCER; IN-VIVO; PROTEIN; BINDING; NFATC1	Recent literature suggests that cyclin-dependent kinases (CDKs) mediate cell migration. However, the mechanisms were not known. Therefore, the objective of this study is to test whether cyclin/CDKs activate Pak1, an effector of Rac1, whose involvement in the modulation of cell migration and proliferation is well established. Monocyte chemotactic protein 1 (MCP1) induced Pak1 phosphorylation/activation in human aortic smooth muscle cells (HASMCs) in a delayed time-dependent manner. MCP1 also stimulated F-actin stress fiber formation in a delayed manner in HASMCs, as well as the migration and proliferation of these cells. Inhibition of Pak1 suppressed MCP1-induced HASMC F-actin stress fiber formation, migration, and proliferation. MCP1 induced cyclin D1 expression as well as CDK6 and CDK4 activities, and these effects were dependent on activation of NFATc1. Depletion of NFATc1, cyclin D1, CDK6, or CDK4 levels attenuated MCP1-induced Pak1 phosphorylation/activation and resulted in decreased HASMC F-actin stress fiber formation, migration, and proliferation. CDK4, which appeared to be activated downstream of CDK6, formed a complex with Pak1 in response to MCP1. MCP1 also activated Rac1 in a time-dependent manner, and depletion/inhibition of its levels/activation abrogated MCP1-induced NFATc1-cyclin D1-CDK6-CDK4-Pak1 signaling and, thereby, decreased HASMC F-actin stress fiber formation, migration, and proliferation. In addition, smooth muscle-specific deletion of NFATc1 led to decreased cyclin D1 expression and CDK6, CDK4, and Pak1 activities, resulting in reduced neointima formation in response to injury. Thus, these observations reveal that Pak1 is a downstream effector of CDK4 and Rac1-dependent, NFATc1-mediated cyclin D1 expression and CDK6 activity mediate this effect. In addition, smooth muscle-specific deletion of NFATc1 prevented the capacity of vascular smooth muscle cells for MCP-1-induced activation of the cyclin D1-CDK6-CDK4-Pak1 signaling axis, affecting their migration and proliferation in vitro and injury-induced neointima formation in vivo.	[Kundumani-Sridharan, Venkatesh; Singh, Nikhlesh K.; Kumar, Sanjay; Gadepalli, Ravisekhar; Rao, Gadiparthi N.] Univ Tennessee, Hlth Sci Ctr, Dept Physiol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Rao, GN (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	rgadipar@uthsc.edu	Kundumani-Sridharan, Venkatesh/I-4799-2016; Singh, Nikhlesh/AAA-4253-2020; Gadepalli, Ravisekhar/AAU-2636-2020; Kundumani-Sridharan, Venkatesh/ABD-9613-2021; Kundumani-Sridharan, Venkatesh/AAB-4535-2020	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Singh, Nikhlesh/0000-0002-3665-6023; kumar, sanjay/0000-0002-2678-3387	NHBLI, National Institutes of Health [HL069908, HL103575]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069908, R01HL103575] Funding Source: NIH RePORTER	NHBLI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHBLI, National Institutes of Health Grants HL069908 and HL103575 (to G. N. R.).	Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Chow CW, 2000, MOL CELL BIOL, V20, P5227, DOI 10.1128/MCB.20.14.5227-5234.2000; Doi H, 2005, ARTERIOSCL THROM VAS, V25, P2328, DOI 10.1161/01.ATV.0000185829.47163.32; Dronadula N, 2006, J LIPID RES, V47, P767, DOI 10.1194/jlr.M500369-JLR200; Fujii T, 2005, J BIOL CHEM, V280, P23041, DOI 10.1074/jbc.M409397200; Furukawa Y, 1999, CIRC RES, V84, P306, DOI 10.1161/01.RES.84.3.306; Glaven JA, 1999, J BIOL CHEM, V274, P2279, DOI 10.1074/jbc.274.4.2279; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Karpurapu M, 2008, J BIOL CHEM, V283, P26577, DOI 10.1074/jbc.M800423200; Karpurapu M, 2010, J BIOL CHEM, V285, P3510, DOI 10.1074/jbc.M109.063727; Kumar AHS, 2010, FASEB J, V24, P81, DOI 10.1096/fj.09-132225; Kundumani-Sridharan V, 2007, AM J PATHOL, V171, P1381, DOI 10.2353/ajpath.2007.061258; Kundumani-Sridharan V, 2012, J BIOL CHEM, V287, P22463, DOI 10.1074/jbc.M112.362996; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Modha R, 2008, J BIOL CHEM, V283, P1492, DOI 10.1074/jbc.M706760200; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Ortega-Perez I, 2005, J BIOL CHEM, V280, P20867, DOI 10.1074/jbc.M501898200; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Schober A, 2004, CIRC RES, V95, P1125, DOI 10.1161/01.RES.0000149518.86865.3e; SCHWARTZ SM, 1995, CIRC RES, V77, P445, DOI 10.1161/01.RES.77.3.445; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Shutes A, 2007, J BIOL CHEM, V282, P35666, DOI 10.1074/jbc.M703571200; Singh NK, 2012, J BIOL CHEM, V287, P36291, DOI 10.1074/jbc.M112.361220; Singh NK, 2011, J BIOL CHEM, V286, P22478, DOI 10.1074/jbc.M111.225060; Soni R, 2000, BIOCHEM BIOPH RES CO, V275, P877, DOI 10.1006/bbrc.2000.3349; Subramanian P, 2010, CIRC RES, V107, P96, DOI 10.1161/CIRCRESAHA.109.212647; Teramoto H, 1996, J BIOL CHEM, V271, P27225, DOI 10.1074/jbc.271.44.27225; Wang D, 2009, CIRC RES, V104, P1066, DOI 10.1161/CIRCRESAHA.109.196691; Weber DS, 2004, CIRC RES, V94, P1219, DOI 10.1161/01.RES.0000126848.54740.4A; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; Yellaturu CR, 2002, BIOCHEM J, V368, P183, DOI 10.1042/BJ20020347; Yoshida K, 2003, CIRCULATION, V108, P1746, DOI 10.1161/01.CIR.0000089374.35455.F3; Zhao TQ, 2009, J LIPID RES, V50, P521, DOI 10.1194/jlr.M800388-JLR200; Zhong ZJ, 2010, CANCER RES, V70, P2105, DOI 10.1158/0008-5472.CAN-08-1108	50	30	32	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22150	22162		10.1074/jbc.M113.454082	http://dx.doi.org/10.1074/jbc.M113.454082			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23737530	Green Published, hybrid			2022-12-28	WOS:000328841900058
J	Zirkin, S; Davidovich, A; Don, J				Zirkin, Shahar; Davidovich, Ateret; Don, Jeremy			The PIM-2 Kinase Is an Essential Component of the Ultraviolet Damage Response That Acts Upstream to E2F-1 and ATM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Base Excision Repair; Cancer Biology; Cell Signaling; DNA Damage Response; ATM; E2F-1; PIM-2	NUCLEOTIDE EXCISION-REPAIR; HISTONE H2AX PHOSPHORYLATION; INDUCED DNA-DAMAGE; DOUBLE-STRAND BREAKS; CELL-CYCLE PHASE; DEPENDENT PHOSPHORYLATION; INDUCED APOPTOSIS; LYMPHOID TUMORS; UV-IRRADIATION; ACTIVATES ATM	The oncogenic nature ascribed to the PIM-2 kinase relies mostly on phosphorylation of substrates that act as pro-survival/anti-apoptotic factors. Nevertheless, pro-survival effects can also result from activating DNA repair mechanisms following damage. In this study, we addressed the possibility that PIM-2 plays a role in the cellular response to UV damage, an issue that has never been addressed before. We found that in U2OS cells, PIM-2 expression and activity increased upon exposure to UVC radiation (2-50 mJ/cm(2)), and Pim-2-silenced cells were significantly more sensitive to UV radiation. Overexpression of PIM-2 accelerated removal of UV-induced DNA lesions over time, reduced gamma H2AX accumulation in damaged cells, and rendered these cells significantly more viable following UV radiation. The protective effect of PIM-2 was mediated by increased E2F-1 and activated ATM levels. Silencing E2F-1 reduced the protective effect of PIM-2, whereas inhibiting ATM activity abrogated this protective effect, irrespective of E2F-1 levels. The results obtained in this study place PIM-2 upstream to E2F-1 and ATM in the UV-induced DNA damage response.	[Zirkin, Shahar; Davidovich, Ateret; Don, Jeremy] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel	Bar Ilan University	Don, J (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel.	jeremy.don@biu.ac.il	Don, Jeremy/AAS-1240-2021		Weinkselbaum family medical research fund [3-00000-5049]	Weinkselbaum family medical research fund	This study was supported by Grant 3-00000-5049 from the Weinkselbaum family medical research fund administered by the Israeli Ministry of Health Chief Scientist Research Fund.	Alarcon-Vargas D, 2002, ONCOGENE, V21, P4384, DOI 10.1038/sj.onc.1205543; Allen JD, 1996, SEMIN CANCER BIOL, V7, P299, DOI 10.1006/scbi.1996.0038; Allen JD, 1997, ONCOGENE, V15, P1133, DOI 10.1038/sj.onc.1201288; AMSON R, 1989, P NATL ACAD SCI USA, V86, P8857, DOI 10.1073/pnas.86.22.8857; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001; Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8; Berton TR, 2005, ONCOGENE, V24, P2449, DOI 10.1038/sj.onc.1208462; Claudio JO, 2002, BLOOD, V100, P2175, DOI 10.1182/blood-2002-01-0008; Cohen AM, 2004, LEUKEMIA LYMPHOMA, V45, P951, DOI 10.1080/10428190310001641251; Dai H, 2005, PROSTATE, V65, P276, DOI 10.1002/pros.20294; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Downs JA, 2005, CELL CYCLE, V4, P1373, DOI 10.4161/cc.4.10.2108; Dunkern TR, 2002, MOL BIOL CELL, V13, P348, DOI 10.1091/mbc.01-05-0225; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Furuta T, 2003, J BIOL CHEM, V278, P20303, DOI 10.1074/jbc.M300198200; Guo RF, 2010, J BIOL CHEM, V285, P19308, DOI 10.1074/jbc.M110.121939; Halicka HD, 2005, CELL CYCLE, V4, P339; Hammerman PS, 2004, CANCER RES, V64, P8341, DOI 10.1158/0008-5472.CAN-04-2284; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Hsu JL, 2012, CANCER LETT, V319, P214, DOI 10.1016/j.canlet.2012.01.004; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Lavin MF, 2007, ONCOGENE, V26, P7749, DOI 10.1038/sj.onc.1210880; Levy D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034736; Lin WC, 2001, GENE DEV, V15, P1833; Luo L. Z., 2012, PLOS ONE, V7; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; MOROY T, 1991, ONCOGENE, V6, P1941; Nawijn MC, 2011, NAT REV CANCER, V11, P23, DOI 10.1038/nrc2986; Oh KS, 2011, DNA REPAIR, V10, P5, DOI 10.1016/j.dnarep.2010.09.004; Paull TT, 2005, CELL CYCLE, V4, P737, DOI 10.4161/cc.4.6.1715; Potter AJ, 2002, CARCINOGENESIS, V23, P389, DOI 10.1093/carcin/23.3.389; Powers JT, 2004, MOL CANCER RES, V2, P203; Pustisek N, 2011, COLLEGIUM ANTROPOL, V35, P339; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Ren K, 2010, PATHOL ONCOL RES, V16, P229, DOI 10.1007/s12253-009-9215-4; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; SMITH ML, 1995, ONCOGENE, V10, P1053; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Thyagarajan B, 2007, MUTAGENESIS, V22, P147, DOI 10.1093/mutage/gel071; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Wang Z, 2001, J Vet Sci, V2, P167; Wang ZP, 2010, INT J BIOCHEM CELL B, V42, P1030, DOI 10.1016/j.biocel.2010.03.012; Xiaofei E., 2011, PLOS PATHOG, V7; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; Yajima H, 2009, J MOL BIOL, V385, P800, DOI 10.1016/j.jmb.2008.11.036; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Yoshida S, 1999, ONCOGENE, V18, P7994, DOI 10.1038/sj.onc.1203293; Zhang Y, 2008, ONCOGENE, V27, P4809, DOI 10.1038/onc.2008.123; Zhao H, 2010, CYTOM PART A, V77A, P285, DOI 10.1002/cyto.a.20839; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	57	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21770	10.1074/jbc.M113.458851	http://dx.doi.org/10.1074/jbc.M113.458851			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760264	Green Published, hybrid			2022-12-28	WOS:000328841900027
J	Li, YK; Xie, JJ; Xu, XP; Liu, L; Wan, YS; Liu, YL; Zhu, CL; Zhu, Y				Li, Yongkui; Xie, Jiajia; Xu, Xiupeng; Liu, Li; Wan, Yushun; Liu, Yingle; Zhu, Chengliang; Zhu, Ying			Inducible Interleukin 32 (IL-32) Exerts Extensive Antiviral Function via Selective Stimulation of Interferon lambda 1 (IFN-lambda 1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-B-VIRUS; BLOOD MONONUCLEAR-CELLS; NF-KAPPA-B; IFN-LAMBDA; SURFACE-ANTIGEN; PROINFLAMMATORY CYTOKINE; HBV REPLICATION; PROTEIN; EXPRESSION; TRANSCRIPTION	Interleukin (IL)-32 has been recognized as a proinflammatory cytokine that participates in responses to viral infection. However, little is known about how IL-32 is induced in response to viral infection and the mechanisms of IL-32-mediated antiviral activities. We discovered that IL-32 is elevated by hepatitis B virus (HBV) infection both in vitro and in vivo and that HBV induced IL-32 expression at the level of both transcription and post-transcription. Furthermore, microRNA-29b was found to be a key factor in HBV-regulated IL-32 expression by directly targeting the mRNA 3'-untranslated region of IL-32. Antiviral analysis showed that IL-32 was not sufficient to alter HBV replication in HepG2.2.15 cells. To mimic the viremic phase of viral infection, freshly isolated peripheral blood mononuclear cells were treated with IL-32 gamma, the secretory isoform, and the supernatants were used for antiviral assays. Surprisingly, these supernatants exhibited extensive antiviral activity against multiplex viruses besides HBV. Thus, we speculated that the IL-32 gamma-treated peripheral blood mononuclear cells produced and secreted an unknown antiviral factor. Using antibody neutralization assays, we identified the factor as interferon (IFN)-lambda 1 and not IFN-alpha. Further studies indicated that IL-32 gamma effectively inhibited HBV replication in a hydrodynamic injection mouse model. Clinical data showed that elevated levels of IFN-lambda 1 both in serum and liver tissue of HBV patients were positively correlated to the increased levels of IL-32. Our results demonstrate that elevated IL-32 levels during viral infection mediate antiviral effects by stimulating the expression of IFN-lambda 1.	[Li, Yongkui; Xie, Jiajia; Xu, Xiupeng; Liu, Li; Wan, Yushun; Liu, Yingle; Zhu, Chengliang; Zhu, Ying] Wuhan Univ, State Key Lab Virol, Zhongnan Hosp, Coll Life Sci, Wuhan 430072, Peoples R China; [Li, Yongkui; Xie, Jiajia; Xu, Xiupeng; Liu, Li; Wan, Yushun; Liu, Yingle; Zhu, Chengliang; Zhu, Ying] Wuhan Univ, Chinese French Liver Dis Res Inst, Zhongnan Hosp, Wuhan 430072, Peoples R China; [Li, Yongkui] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Res Ctr Tissue Engn & Regenerat Med, Wuhan 430022, Peoples R China	Wuhan University; Wuhan University; Huazhong University of Science & Technology	Zhu, Y (corresponding author), Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China.	yingzhu@whu.edu.cn	Li, Yongkui/GSI-9600-2022; Wan, Yushun/AFS-1315-2022; Li, Hongpu/B-7707-2014; Wan, Yushun/AFT-0087-2022	Wan, Yushun/0000-0003-0496-6315; Li, Hongpu/0000-0003-2323-6107; Li, Yongkui/0000-0002-1532-4855	Major State Basic Research Development Program of China [2009CB522506, 2013CB911102]; National Natural Science Foundation of China [81271821]; National Mega Project on Major Infectious Diseases Prevention [2012ZX10004503-004]	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Mega Project on Major Infectious Diseases Prevention	This work was supported by Major State Basic Research Development Program of China Grants 2009CB522506 and 2013CB911102, National Natural Science Foundation of China Grant 81271821, and National Mega Project on Major Infectious Diseases Prevention Grant 2012ZX10004503-004.	Andoh A, 2008, WORLD J GASTROENTERO, V14, P5154, DOI 10.3748/wjg.14.5154; Ank N, 2006, J VIROL, V80, P4501, DOI 10.1128/JVI.80.9.4501-4509.2006; Bandi P, 2010, J INTERF CYTOK RES, V30, P123, DOI 10.1089/jir.2009.0049; BENN J, 1995, P NATL ACAD SCI USA, V92, P11215, DOI 10.1073/pnas.92.24.11215; Benn J, 1996, J VIROL, V70, P4978, DOI 10.1128/JVI.70.8.4978-4985.1996; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Choi HJ, 2001, J INFECT DIS, V184, P560, DOI 10.1086/322805; Almeida GMD, 2008, ANTIVIR RES, V80, P302, DOI 10.1016/j.antiviral.2008.06.016; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Gottwein JM, 2007, GASTROENTEROLOGY, V133, P1614, DOI 10.1053/j.gastro.2007.08.005; Hong SH, 2007, VIRUS RES, V126, P245, DOI 10.1016/j.virusres.2007.03.006; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Joosten LAB, 2006, P NATL ACAD SCI USA, V103, P3298, DOI 10.1073/pnas.0511233103; JUNG MC, 1991, HEPATOLOGY, V13, P637, DOI 10.1002/hep.1840130405; Keller SA, 2000, BLOOD, V96, P2537; Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Lee S, 2010, HYBRIDOMA, V29, P501, DOI 10.1089/hyb.2010.0059; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001985; LOBBIANI A, 1990, J MED VIROL, V31, P190, DOI 10.1002/jmv.1890310304; Maher SG, 2008, CANCER BIOL THER, V7, P1109, DOI 10.4161/cbt.7.7.6192; Marukian S, 2011, HEPATOLOGY, V54, P1913, DOI 10.1002/hep.24580; Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Moschen AR, 2011, HEPATOLOGY, V53, P1819, DOI 10.1002/hep.24285; Netea MG, 2005, P NATL ACAD SCI USA, V102, P16309, DOI 10.1073/pnas.0508237102; Netea MG, 2006, PLOS MED, V3, P1310, DOI 10.1371/journal.pmed.0030277; Nold MF, 2008, J IMMUNOL, V181, P557, DOI 10.4049/jimmunol.181.1.557; Pan Y, 2007, BIOCHEM BIOPH RES CO, V359, P70, DOI 10.1016/j.bbrc.2007.05.052; PASQUINELLI C, 1986, J HEPATOL, V3, P95, DOI 10.1016/S0168-8278(86)80152-0; Rasool ST, 2008, IMMUNOL LETT, V117, P161, DOI 10.1016/j.imlet.2008.01.007; Robek MD, 2005, J VIROL, V79, P3851, DOI 10.1128/JVI.79.6.3851-3854.2005; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; StollBecker S, 1997, J VIROL, V71, P5399, DOI 10.1128/JVI.71.7.5399-5407.1997; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; Thomson SJP, 2009, P NATL ACAD SCI USA, V106, P11564, DOI 10.1073/pnas.0904477106; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Wu CC, 2012, J VIROL, V86, P4658, DOI 10.1128/JVI.06353-11; Wu KL, 2007, ANTIVIR RES, V74, P142, DOI 10.1016/j.antiviral.2006.11.004; Yan XH, 2006, INT J BIOCHEM CELL B, V38, P1417, DOI 10.1016/j.biocel.2006.02.003; Yang PL, 2002, P NATL ACAD SCI USA, V99, P13825, DOI 10.1073/pnas.202398599; Zepp JA, 2011, J IMMUNOL, V186, P4110, DOI 10.4049/jimmunol.1000081	47	37	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20927	20941		10.1074/jbc.M112.440115	http://dx.doi.org/10.1074/jbc.M112.440115			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23729669	Green Published, hybrid			2022-12-28	WOS:000322014400016
J	Lim, EK; Mitchell, PJ; Brown, N; Drummond, RA; Brown, GD; Kaye, PM; Bowles, DJ				Lim, Eng-Kiat; Mitchell, Paul J.; Brown, Najmeeyah; Drummond, Rebecca A.; Brown, Gordon D.; Kaye, Paul M.; Bowles, Dianna J.			Regiospecific Methylation of a Dietary Flavonoid Scaffold Selectively Enhances IL-1 beta Production following Toll-like Receptor 2 Stimulation in THP-1 Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTOZOAN NEGLECTED DISEASES; ACTIVATED PROTEIN-KINASES; RAW 264.7 CELLS; SECONDARY METABOLITES; INFLAMMATORY RESPONSE; INNATE IMMUNITY; QUERCETIN; PLANTS; POLYMORPHISM	It is now recognized that innate immunity to intestinal microflora plays a significant role in mediating immune health, and modulation of microbial sensing may underpin the impact of plant natural products in the diet or when used as nutraceuticals. In this context, we have examined five classes of plant-derived flavonoids (flavonols, flavones, flavanones, catechins, and cyanidin) for their ability to regulate cytokine release induced by the Toll-like receptor 2 (TLR2) agonist Pam3CSK4. We found that the flavonols selectively co-stimulated IL-1 beta secretion but had no impact on the secretion of IL-6. Importantly, this costimulation of TLR2-induced cytokine secretion was dependent on regiospecific methylation of the flavonol scaffold with a rank order of quercetin-3,4'-dimethylether > quercetin-3-methylether > casticin. The mechanism underpinning this costimulation did not involve enhanced inflammasome activation. In contrast, the methylated flavonols enhanced IL-1 beta gene expression through transcriptional regulation, involving mechanisms that operate downstream of the initial NF-kappa B and STAT1 activation events. These studies demonstrate an exquisite level of control of scaffold bioactivity by regiospecific methylation, with important implications for understanding how natural products affect innate immunity and for their development as novel immunomodulators for clinical use.	[Lim, Eng-Kiat; Mitchell, Paul J.; Brown, Najmeeyah; Kaye, Paul M.] Univ York, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Lim, Eng-Kiat; Mitchell, Paul J.; Brown, Najmeeyah; Kaye, Paul M.; Bowles, Dianna J.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Drummond, Rebecca A.; Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	University of Hull; University of York - UK; University of York - UK; University of Aberdeen	Kaye, PM (corresponding author), Univ York, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England.	paul.kaye@york.ac.uk; dianna.bowles@york.ac.uk	Drummond, Rebecca/I-3155-2019	Drummond, Rebecca/0000-0001-5424-7074; brown, gordon/0000-0002-0287-5383; Kaye, Paul/0000-0002-8796-4755	Wellcome Trust; Leverhulme Trust; Medical Research Council [G1000230] Funding Source: researchfish; MRC [G1000230] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a Wellcome Trust project grant (to P. M. K., D. J. B., and E.-K. L.) and a Leverhulme Trust Senior Research Fellowship (to D. J. B.).	Albert EJ, 2008, J LEUKOCYTE BIOL, V83, P833, DOI 10.1189/jlb.0807557; Bhaskar S, 2011, IMMUNOBIOLOGY, V216, P367, DOI 10.1016/j.imbio.2010.07.011; Boesch-Saadatmandi C, 2010, J PHYSIOL PHARMACOL, V61, P99; Byun EH, 2011, FEBS LETT, V585, P814, DOI 10.1016/j.febslet.2011.02.010; Choi HJ, 2008, EUR J PHARMACOL, V601, P171, DOI 10.1016/j.ejphar.2008.09.032; Chu X, 2012, J AGR FOOD CHEM, V60, P3947, DOI 10.1021/jf2051587; Cohen-Poradosu R, 2011, J INFECT DIS, V204, P363, DOI 10.1093/infdis/jir277; Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a; de Oliveira JG, 2012, WORLD J GASTROENTERO, V18, P1235, DOI 10.3748/wjg.v18.i11.1235; De Santi C, 2002, INT J CLIN PHARM TH, V40, P207; Del Rio D, 2010, BRIT J NUTR, V104, pS67, DOI 10.1017/S0007114510003958; Dong L, 2012, J GASTROEN HEPATOL, V27, P110, DOI 10.1111/j.1440-1746.2011.06839.x; FENTON MJ, 1987, J IMMUNOL, V138, P3972; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Han JM, 2010, BIOL PHARM BULL, V33, P1019, DOI 10.1248/bpb.33.1019; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Hemaiswarya S, 2008, PHYTOMEDICINE, V15, P639, DOI 10.1016/j.phymed.2008.06.008; Huo MX, 2012, INT IMMUNOPHARMACOL, V12, P241, DOI 10.1016/j.intimp.2011.11.017; Jelavic TB, 2006, CLIN GENET, V70, P156, DOI 10.1111/j.1399-0004.2006.00651.x; Jones DJL, 2004, BRIT J CANCER, V91, P1213, DOI 10.1038/sj.bjc.6602091; Kim DH, 2012, BIOORG MED CHEM LETT, V22, P700, DOI 10.1016/j.bmcl.2011.10.067; Kim YJ, 2010, INT IMMUNOPHARMACOL, V10, P1127, DOI 10.1016/j.intimp.2010.06.017; Krenn L, 2009, FITOTERAPIA, V80, P267, DOI 10.1016/j.fitote.2009.03.001; Lee JK, 2009, BIOCHEM PHARMACOL, V77, P1391, DOI 10.1016/j.bcp.2009.01.009; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Marques R, 2011, CELL MOL LIFE SCI, V68, P3661, DOI 10.1007/s00018-011-0829-9; Martin C, 2011, PLANT CELL, V23, P1685, DOI 10.1105/tpc.111.083279; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Messlik A, 2009, J PROTEOME RES, V8, P4406, DOI 10.1021/pr9000465; Modolo LV, 2009, PLANT-DERIVED NATURAL PRODUCTS: SYNTHESIS, FUNCTION, AND APPLICATION, P143, DOI 10.1007/978-0-387-85498-4_6; Morimoto M, 2009, J GASTROEN HEPATOL, V24, P1123, DOI 10.1111/j.1440-1746.2008.05714.x; Nicholas C, 2007, J IMMUNOL, V179, P7121, DOI 10.4049/jimmunol.179.10.7121; Park HY, 2012, INT J MOL MED, V29, P1146, DOI 10.3892/ijmm.2012.935; Park SE, 2011, BRIT J PHARMACOL, V164, P1008, DOI 10.1111/j.1476-5381.2011.01389.x; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Rhee SH, 2003, J BIOL CHEM, V278, P22506, DOI 10.1074/jbc.M208633200; Rios JL, 2009, CURR PHARM DESIGN, V15, P1212, DOI 10.2174/138161209787846874; Rubio S, 2006, EUR J PHARMACOL, V548, P9, DOI 10.1016/j.ejphar.2006.07.020; Schmidt TJ, 2012, CURR MED CHEM, V19, P2128; Schmidt TJ, 2012, CURR MED CHEM, V19, P2176; Shen JK, 2009, ANN HEMATOL, V88, P743, DOI 10.1007/s00277-008-0677-3; Soromou LW, 2012, MOLECULES, V17, P3574, DOI 10.3390/molecules17033574; Soromou LW, 2012, BIOCHEM BIOPH RES CO, V419, P256, DOI 10.1016/j.bbrc.2012.02.005; Tahara T, 2008, DIGEST DIS SCI, V53, P919, DOI 10.1007/s10620-007-9950-x; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Torres F, 2011, MOL CARCINOGEN, V50, P113, DOI 10.1002/mc.20693; Torres F, 2010, MOL CARCINOGEN, V49, P464, DOI 10.1002/mc.20619; Zhang Y, 2008, J IMMUNOL, V181, P503, DOI 10.4049/jimmunol.181.1.503; Zheng LT, 2008, INT IMMUNOPHARMACOL, V8, P484, DOI 10.1016/j.intimp.2007.12.012	51	12	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21126	21135		10.1074/jbc.M113.453514	http://dx.doi.org/10.1074/jbc.M113.453514			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760261	hybrid, Green Published			2022-12-28	WOS:000322014400033
J	Loo, TW; Bartlett, MC; Clarke, DM				Loo, Tip W.; Bartlett, M. Claire; Clarke, David M.			Human P-glycoprotein Contains a Greasy Ball-and-Socket Joint at the Second Transmission Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-BINDING SITES; NUCLEOTIDE-BINDING; TRANSMEMBRANE SEGMENT-11; MULTIDRUG TRANSPORTER; PROMOTE MATURATION; CYTOPLASMIC LOOPS; ABC TRANSPORTERS; ATPASE ACTIVITY; MUTANTS; RESISTANCE	The P-glycoprotein drug pump protects us from toxins. Drug-binding sites in the transmembrane (TM) domains (TMDs) are connected to the nucleotide-binding domains (NBDs) by intracellular helices (IHs). TMD-NBD cross-talk is a key step in the transport mechanism because drug binding stimulates ATP hydrolysis followed by drug efflux. Here, we tested whether the IHs are critical for maturation and TMD-NBD coupling by characterizing the effects of mutations to the IH1 and IH2 interfaces. Although IH1 mutations had little effect, most mutations at the IH2-NBD2 interface inhibited maturation or activity. For example, the F1086A mutation at the IH2-NBD2 interface abolished drug-stimulated ATPase activity. The mutant F1086A, however, retained the ability to bind ATP and drug substrates. The mutant was defective in mediating ATP-dependent conformational changes in the TMDs because binding of ATP no longer promoted cross-linking between cysteines located at the extracellular ends of TM segments 6 and 12. Replacement of Phe-1086 (in NBD2) with hydrophobic but not charged residues yielded active mutants. The activity of the F1086A mutant could be restored when the nearby residue Ala-266 (in IH2) was replaced with aromatic residues. These results suggest that Ala266/Phe-1086 lies in a hydrophobic IH2-NBD2 "ball-and-socket" joint.	[Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	Canadian Institutes of Health Research; Canadian Cancer Society	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by grants from the Canadian Institutes of Health Research and the Canadian Cancer Society.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kaminski WE, 2006, BBA-MOL BASIS DIS, V1762, P510, DOI 10.1016/j.bbadis.2006.01.011; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2013, BIOCHEMISTRY-US, V52, P3194, DOI 10.1021/bi400425k; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; LOO TW, 1994, J BIOL CHEM, V269, P7243; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200; Ravna AW, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-33; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Taylor AM, 2001, BRIT J PHARMACOL, V134, P1609, DOI 10.1038/sj.bjp.0704400; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Wise JG, 2012, BIOCHEMISTRY-US, V51, P5125, DOI 10.1021/bi300299z	42	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20326	20333		10.1074/jbc.M113.484550	http://dx.doi.org/10.1074/jbc.M113.484550			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23733192	Green Published, hybrid			2022-12-28	WOS:000321715100021
J	Misiewicz, M; Dery, MA; Foveau, B; Jodoin, J; Ruths, D; LeBlanc, AC				Misiewicz, Michael; Dery, Marc-Andre; Foveau, Benedicte; Jodoin, Julie; Ruths, Derek; LeBlanc, Andrea C.			Identification of a Novel Endoplasmic Reticulum Stress Response Element Regulated by XBP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRION PROTEIN GENE; CELLULAR PRION; MESSENGER-RNA; FUNCTIONAL-CHARACTERIZATION; OXIDATIVE STRESS; EXPRESSION; PRNP; FAMILY; MICE; PRP	Understanding the regulatory mechanisms mediating PRNP gene expression is highly relevant to elucidating normal cellular prion protein (PrP) function(s) and the transmissibility of prion protein neurodegenerative diseases. Here, luciferase reporter assays showed that an endoplasmic reticulum stress element (ERSE)-like element, CCAAT-N26-CCACG in the human PRNP promoter, is regulated by ER stress and X-box-binding protein 1 (XBP1) but not by activating transcription factor 6 alpha (ATF6 alpha). Bioinformatics identified the ERSE-26 motif in 37 other human genes in the absence of canonical ERSE sites except for three genes. Several of these genes are associated with a synaptic function or are involved in oxidative stress. Brefeldin A, tunicamycin, and thapsigargin ER stressors induced gene expression of PRNP and four randomly chosen ERSE-26-containing genes, ERLEC1, GADD45B, SESN2, and SLC38A5, in primary human neuron cultures or in the breast carcinoma MCF-7 cell line, although the level of the response depends on the gene analyzed, the genetic background of the cells, the cell type, and the ER stressor. Overexpression of XBP1 increased, whereas siRNA knockdown of XBP1 considerably reduced, PRNP and ERLEC1 mRNA levels in MCF-7 cells. Taken together, these results identify a novel ER stress regulator, which implicates the ER stress response in previously unrecognized cellular functions.	[Misiewicz, Michael; LeBlanc, Andrea C.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3T 1E2, Canada; [Misiewicz, Michael; Dery, Marc-Andre; Foveau, Benedicte; Jodoin, Julie; LeBlanc, Andrea C.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Ruths, Derek] McGill Univ, Sch Comp Sci, Montreal, PQ H3T 1E2, Canada; [Dery, Marc-Andre; Foveau, Benedicte; LeBlanc, Andrea C.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3T 1E2, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; McGill University	LeBlanc, AC (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, 3755 Ch Cote St Catherine, Montreal, PQ H3T 1E2, Canada.	andrea.leblanc@mcgill.ca			Canadian Institutes of Health Research [MOP89376, MOP102738]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grants MOP89376 and MOP102738 (to A. C. L).	Bauer MF, 1999, J MOL BIOL, V289, P69, DOI 10.1006/jmbi.1999.2751; Bellingham SA, 2009, J BIOL CHEM, V284, P1291, DOI 10.1074/jbc.M804755200; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Budanou AV, 2010, EMBO MOL MED, V2, P388, DOI 10.1002/emmm.201000097; Budanov AV, 2011, ANTIOXID REDOX SIGN, V15, P1679, DOI 10.1089/ars.2010.3530; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Cabral ALB, 2002, J BIOL CHEM, V277, P5675, DOI 10.1074/jbc.M104815200; Catalano RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019209; CHESEBRO B, 1985, NATURE, V315, P331, DOI 10.1038/315331a0; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Cocco M, 2012, J IMMUNOL, V189, P5773, DOI 10.4049/jimmunol.1103720; Dery MA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3398; Engelmann A, 2008, ONCOGENE, V27, P1429, DOI 10.1038/sj.onc.1210772; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jeong JK, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.037; Kelley KD, 2010, CANCER RES, V70, P3566, DOI 10.1158/0008-5472.CAN-09-3219; Kercher L, 2004, AM J PATHOL, V165, P2055, DOI 10.1016/S0002-9440(10)63256-7; Kikuchi Y, 2008, FEBS J, V275, P2965, DOI 10.1111/j.1742-4658.2008.06452.x; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; LeBlanc A, 1995, J NEUROSCI, V15, P7837; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Liu K, 2001, J IMMUNOL, V166, P7335, DOI 10.4049/jimmunol.166.12.7335; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Mahal SP, 2001, GENE, V268, P105, DOI 10.1016/S0378-1119(01)00424-3; Makrinou E, 2002, MAMM GENOME, V13, P696, DOI 10.1007/s00335-002-3043-0; MANSON J, 1992, DEVELOPMENT, V115, P117; McCormack JE, 2002, GENE, V288, P139, DOI 10.1016/S0378-1119(02)00466-3; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Mitteregger G, 2007, BRAIN PATHOL, V17, P174, DOI 10.1111/j.1750-3639.2007.00061.x; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; Morimura N, 2006, GENE, V380, P72, DOI 10.1016/j.gene.2006.05.014; Moro F, 1999, EMBO J, V18, P3667, DOI 10.1093/emboj/18.13.3667; MULLER WEG, 1992, BIOCHIM BIOPHYS ACTA, V1139, P32, DOI 10.1016/0925-4439(92)90079-3; Nakanishi T, 2001, AM J PHYSIOL-CELL PH, V281, pC1757, DOI 10.1152/ajpcell.2001.281.6.C1757; Nishida N, 1999, LAB INVEST, V79, P689; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Perraud AL, 2003, J BIOL CHEM, V278, P1794, DOI 10.1074/jbc.M205601200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; PUCKETT C, 1991, AM J HUM GENET, V49, P320; Qin KF, 2009, J BIOL CHEM, V284, P4582, DOI 10.1074/jbc.M808410200; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; ROBAKIS NK, 1986, P NATL ACAD SCI USA, V83, P6377, DOI 10.1073/pnas.83.17.6377; Sanchez-Juan P, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-73; Sander P, 2005, J BIOL CHEM, V280, P37408, DOI 10.1074/jbc.M506361200; Sander P, 2004, NEUROGENETICS, V5, P19, DOI 10.1007/s10048-003-0171-y; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schjerling P, 1996, NUCLEIC ACIDS RES, V24, P4599, DOI 10.1093/nar/24.23.4599; Shyu WC, 2004, CELL MOL NEUROBIOL, V24, P257, DOI 10.1023/B:CEMN.0000018620.41913.d2; Shyu WC, 2002, MOL NEUROBIOL, V26, P1, DOI 10.1385/MN:26:1:001; SUTRAVE P, 1994, GENE, V146, P209, DOI 10.1016/0378-1119(94)90294-1; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Vincent B, 2009, J NEUROSCI, V29, P6752, DOI 10.1523/JNEUROSCI.0789-09.2009; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Weise J, 2004, NEUROSCI LETT, V372, P146, DOI 10.1016/j.neulet.2004.09.030; Wong BS, 2001, J NEUROCHEM, V76, P565, DOI 10.1046/j.1471-4159.2001.00028.x; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yanagisawa K, 2010, CANCER RES, V70, P9949, DOI 10.1158/0008-5472.CAN-10-1055; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741	74	30	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20378	20391		10.1074/jbc.M113.457242	http://dx.doi.org/10.1074/jbc.M113.457242			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23737521	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000321715100026
J	Pan, XY; Munshi, MK; Iqbal, J; Queiroz, J; Sirwi, AA; Shah, S; Younus, A; Hussain, MM				Pan, Xiaoyue; Munshi, Mohamed Khalid; Iqbal, Jahangir; Queiroz, Joyce; Sirwi, Alaa Ahmed; Shah, Shrenik; Younus, Abdullah; Hussain, M. Mahmood			Circadian Regulation of Intestinal Lipid Absorption by Apolipoprotein AIV Involves Forkhead Transcription Factors A2 and O1 and Microsomal Triglyceride Transfer Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATED CACO-2 CELLS; EPITHELIAL-CELLS; LIPOPROTEIN SYNTHESIS; GENE-TRANSCRIPTION; DIURNAL REGULATION; FEEDING-BEHAVIOR; FOOD-INTAKE; FATTY-ACID; IV; SECRETION	We have shown previously that Clock, microsomal triglyceride transfer protein (MTP), and nocturnin are involved in the circadian regulation of intestinal lipid absorption. Here, we clarified the role of apolipoprotein AIV (apoAIV) in the diurnal regulation of plasma lipids and intestinal lipid absorption in mice. Plasma triglyceride in apoAIV(-/-) mice showed diurnal variations similar to apoAIV(+/+) mice; however, the increases in plasma triglyceride at night were significantly lower in these mice. ApoAIV(-/-) mice absorbed fewer lipids at night and showed blunted response to daytime feeding. To explain reasons for these lower responses, we measured MTP expression; intestinal MTP was low at night, and its induction after food entrainment was less in apoAIV(-/-) mice. Conversely, apoAIV overexpression increased MTP mRNA in hepatoma cells, indicating transcriptional regulation. Mechanistic studies revealed that sequences between -204/-775 bp in the MTP promoter respond to apoAIV and that apoAIV enhances expression of FoxA2 and FoxO1 transcription factors and their binding to the identified cis elements in the MTP promoter at night. Knockdown of FoxA2 and FoxO1 abolished apoAIV-mediated MTP induction. Similarly, knockdown of apoAIV in differentiated Caco-2 cells reduced MTP, FoxA2, and FoxO1 mRNA levels, cellular MTP activity, and media apoB. Moreover, FoxA2 and FoxO1 expression showed diurnal variations, and their expression was significantly lower in apoAIV(-/-) mice. These data indicate that apoAIV modulates diurnal changes in lipid absorption by regulating forkhead transcription factors and MTP and that inhibition of apoAIV expression might reduce plasma lipids.	[Pan, Xiaoyue] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Pan, XY (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	xiaoyue.pan@downstate.edu; mahmood.hussain@downstate.edu	Sirwi, Alaa A/K-2240-2018; Iqbal, Jahangir/B-3903-2014	Sirwi, Alaa A/0000-0001-7823-1210; Iqbal, Jahangir/0000-0002-9021-2271	National Institutes of Health [DK46900, DK81879]; American Heart Association [2300158]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081879, R01DK046900, R29DK046900, R56DK046900] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK46900 and DK81879 (to M. M. H.). This work was also supported by Scientist Development Grant 2300158 (to X. P.) from the American Heart Association.	AALTOSETALA K, 1994, J CLIN INVEST, V93, P1776, DOI 10.1172/JCI117163; Anwar K, 2006, J LIPID RES, V47, P1261, DOI 10.1194/jlr.M500523-JLR200; APFELBAUM TF, 1987, AM J PHYSIOL, V252, pG662, DOI 10.1152/ajpgi.1987.252.5.G662; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bakillah A, 1997, LIPIDS, V32, P1113, DOI 10.1007/s11745-997-0143-8; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Berriot-Varoqueaux N, 2000, ANNU REV NUTR, V20, P663, DOI 10.1146/annurev.nutr.20.1.663; BISGAIER CL, 1985, J LIPID RES, V26, P11; Black DD, 2007, AM J PHYSIOL-GASTR L, V293, pG519, DOI 10.1152/ajpgi.00189.2007; Carriere V, 2005, J BIOL CHEM, V280, P5406, DOI 10.1074/jbc.M408002200; Cohen RD, 1997, J CLIN INVEST, V99, P1906, DOI 10.1172/JCI119358; Dai K, 2012, J LIPID RES, V53, P901, DOI 10.1194/jlr.M025130; Dai KZ, 2010, ARTERIOSCL THROM VAS, V30, P568, DOI 10.1161/ATVBAHA.109.198135; Douris N, 2011, CURR BIOL, V21, P1347, DOI 10.1016/j.cub.2011.07.018; Duverger N, 1996, SCIENCE, V273, P966, DOI 10.1126/science.273.5277.966; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P8242, DOI 10.1073/pnas.82.23.8242; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; FUJIMOTO K, 1992, AM J PHYSIOL, V262, pG1002, DOI 10.1152/ajpgi.1992.262.6.G1002; FUKAGAWA K, 1994, AM J PHYSIOL-REG I, V267, pR1385, DOI 10.1152/ajpregu.1994.267.5.R1385; GORDON DA, 1995, TRENDS CELL BIOL, V5, P317, DOI 10.1016/S0962-8924(00)89054-6; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; GREEN PHR, 1979, J CLIN INVEST, V64, P233, DOI 10.1172/JCI109444; HAGAN DL, 1994, J BIOL CHEM, V269, P28737; HUGHES TE, 1987, J BIOL CHEM, V262, P3762; Hussain MM, 2011, CLIN LIPIDOL, V6, P293, DOI 10.2217/CLP.11.21; Hussain MM, 2009, TRENDS ENDOCRIN MET, V20, P177, DOI 10.1016/j.tem.2009.01.001; Hussain MM, 2005, CURR OPIN LIPIDOL, V16, P281, DOI 10.1097/01.mol.0000169347.53568.5a; Hussain MM, 1996, BBA-LIPID LIPID MET, V1300, P151, DOI 10.1016/0005-2760(96)00041-0; HUSSAIN MM, 1995, ARTERIOSCL THROM VAS, V15, P485, DOI 10.1161/01.ATV.15.4.485; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Iqbal J, 2009, AM J PHYSIOL-ENDOC M, V296, pE1183, DOI 10.1152/ajpendo.90899.2008; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kitamura T, 2007, ENDOCR J, V54, P507, DOI 10.1507/endocrj.KR-109; Kumar NS, 1999, AM J PHYSIOL-GASTR L, V276, pG378, DOI 10.1152/ajpgi.1999.276.2.G378; Leng SY, 2007, AM J PHYSIOL-GASTR L, V293, pG475, DOI 10.1152/ajpgi.00072.2007; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200; Lu S, 2002, J BIOL CHEM, V277, P31929, DOI 10.1074/jbc.M201418200; Luchoomun J, 1999, J BIOL CHEM, V274, P19565, DOI 10.1074/jbc.274.28.19565; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Pan X., 2012, BIOCHIM BIOPHYS ACTA, V1821, P725; Pan XY, 2007, J BIOL CHEM, V282, P24707, DOI 10.1074/jbc.M701305200; Pan XY, 2007, J BIOL CHEM, V282, P17078, DOI 10.1074/jbc.M701742200; Pan XY, 2010, CELL METAB, V12, P174, DOI 10.1016/j.cmet.2010.05.014; Pan XY, 2009, J LIPID RES, V50, P1800, DOI 10.1194/jlr.M900085-JLR200; Qin XF, 2005, CURR DRUG TARGETS, V6, P145, DOI 10.2174/1389450053174541; Rava P, 2005, J LIPID RES, V46, P1779, DOI 10.1194/jlr.D400043-JLR200; Shen L, 2005, AM J PHYSIOL-GASTR L, V288, pG48, DOI 10.1152/ajpgi.00064.2004; Simon T, 2011, J LIPID RES, V52, P1984, DOI 10.1194/jlr.M017418; Stan S, 2003, BBA-MOL CELL BIOL L, V1631, P177, DOI 10.1016/S1388-1981(03)00004-0; Sun H, 2008, EXPERT OPIN DRUG MET, V4, P395, DOI 10.1517/17425255.4.4.395 ; Tso P, 2004, AM J PHYSIOL-GASTR L, V286, pG885, DOI 10.1152/ajpgi.00511.2003; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Wang HY, 2005, TRENDS MOL MED, V11, P262, DOI 10.1016/j.molmed.2005.04.003; WEINBERG RB, 1990, GASTROENTEROLOGY, V98, P17, DOI 10.1016/0016-5085(90)91285-E; Weinberg RB, 2002, CURR OPIN LIPIDOL, V13, P125, DOI 10.1097/00041433-200204000-00003; Weinberg RB, 2000, J LIPID RES, V41, P1419; Weinstock PH, 1997, J LIPID RES, V38, P1782; WEISER MM, 1973, J BIOL CHEM, V248, P2536; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Yao Y, 2011, AM J PHYSIOL-GASTR L, V300, pG357, DOI 10.1152/ajpgi.00353.2010; YAO ZM, 1993, ARTERIOSCLER THROMB, V13, P1476, DOI 10.1161/01.ATV.13.10.1476	63	23	24	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20464	20476		10.1074/jbc.M113.473454	http://dx.doi.org/10.1074/jbc.M113.473454			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23729668	Green Published, hybrid			2022-12-28	WOS:000321715100034
J	Sogaard, R; Borre, L; Braunstein, TH; Madsen, KL; MacAulay, N				Sogaard, Rikke; Borre, Lars; Braunstein, Thomas H.; Madsen, Kenneth L.; MacAulay, Nanna			Functional Modulation of the Glutamate Transporter Variant GLT1b by the PDZ Domain Protein PICK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; AMINO-ACID TRANSPORTERS; LONG-TERM DEPRESSION; DIFFERENTIAL REGULATION; SPLICE VARIANTS; NERVOUS-SYSTEM; ION FLUXES; RAT-BRAIN; GLT-1; LOCALIZATION	The dominant glutamate transporter isoform in the mammalian brain, GLT1, exists as at least three splice variants, GLT1a, GLT1b, and GLT1c. GLT1b interacts with the scaffold protein PICK1 (protein interacting with kinase C1), which is implicated in glutamatergic neurotransmission via its regulatory effect on trafficking of AMPA-type glutamate receptors. The 11 extreme C-terminal residues specific for the GLT1b variant are essential for its specific interaction with the PICK1 PDZ domain, but a functional consequence of this interaction has remained unresolved. To identify a functional effect of PICK1 on GLT1a or GLT1b separately, we employed the Xenopus laevis expression system. GLT1a and GLT1b displayed similar electrophysiological properties and EC50 for glutamate. Co-expressed PICK1 localized efficiently to the plasma membrane and resulted in a 5-fold enhancement of the leak current in GLT1b-expressing oocytes with only a minor effect on [H-3] glutamate uptake. Three different GLT1 substrates all caused a slow TBOA-sensitive decay in the membrane current upon prolonged application, which provides support for the leak current being mediated by GLT1b itself. Leak and glutamate-evoked currents in GLT1a-expressing oocytes were unaffected by PICK1 co-expression. PKC activation down-regulated GLT1a and GLT1b activity to a similar extent, which was not affected by co-expression of PICK1. In conclusion, PICK1 may not only affect glutamatergic neurotransmission by its regulatory effect on glutamate receptors but may also affect neuronal excitability via an increased GLT1b-mediated leak current. This may be particularly relevant in pathological conditions such as amyotrophic lateral sclerosis and cerebral hypoxia, which are associated with neuronal GLT1b up-regulation.	[Sogaard, Rikke; MacAulay, Nanna] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Borre, Lars; Madsen, Kenneth L.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Braunstein, Thomas H.] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	MacAulay, N (corresponding author), Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark.	macaulay@sund.ku.dk	Madsen, Kenneth/C-7778-2012; MacAulay, Nanna/AER-7709-2022; Braunstein, Thomas Hartig/B-8064-2008	Madsen, Kenneth/0000-0001-9274-6691; MacAulay, Nanna/0000-0002-7800-6600; Braunstein, Thomas Hartig/0000-0001-6632-7960	Lundbeck Foundation; Dagmar Marshall grant	Lundbeck Foundation(Lundbeckfonden); Dagmar Marshall grant	This work was supported by a grant from the Lundbeck Foundation and a Dagmar Marshall grant (to R.S.).	ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Baron A, 2002, J BIOL CHEM, V277, P50463, DOI 10.1074/jbc.M208848200; Bassan M, 2008, EUR J NEUROSCI, V27, P66, DOI 10.1111/j.1460-9568.2007.05986.x; Bergles DE, 2002, J NEUROSCI, V22, P10153; Billups B, 1996, NATURE, V379, P171, DOI 10.1038/379171a0; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Chen WZ, 2002, J NEUROSCI, V22, P2142, DOI 10.1523/JNEUROSCI.22-06-02142.2002; Chen YM, 2003, J NEUROCHEM, V84, P1332, DOI 10.1046/j.1471-4159.2003.01630.x; D'Amico A, 2010, TRAFFIC, V11, P1455, DOI 10.1111/j.1600-0854.2010.01110.x; Danbolt NC, 1998, METHOD ENZYMOL, V296, P388; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dev KK, 2000, J NEUROSCI, V20, P7252; Focant MC, 2013, NEUROPATH APPL NEURO, V39, P231, DOI 10.1111/j.1365-2990.2012.01282.x; Gebhardt FM, 2010, J BIOL CHEM, V285, P31313, DOI 10.1074/jbc.M110.153494; Gonzalez-Gonzalez IM, 2008, J NEUROCHEM, V105, P1834, DOI 10.1111/j.1471-4159.2008.05281.x; Gonzalez-Gonzalez IM, 2008, GLIA, V56, P963, DOI 10.1002/glia.20670; Grewer C, 2005, J MEMBRANE BIOL, V203, P1, DOI 10.1007/s00232-004-0731-6; Guillet BA, 2005, NEUROCHEM INT, V46, P337, DOI 10.1016/j.neuint.2004.10.006; Holmseth S, 2009, NEUROSCIENCE, V162, P1055, DOI 10.1016/j.neuroscience.2009.03.048; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Jansen AM, 2009, J COMP NEUROL, V517, P313, DOI 10.1002/cne.22155; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kalandadze A, 2002, J BIOL CHEM, V277, P45741, DOI 10.1074/jbc.M203771200; KANAI Y, 1995, J BIOL CHEM, V270, P16561, DOI 10.1074/jbc.270.28.16561; Karatas-Wulf U, 2009, NEUROSCIENCE, V161, P794, DOI 10.1016/j.neuroscience.2009.04.017; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Madsen KL, 2008, TRAFFIC, V9, P1327, DOI 10.1111/j.1600-0854.2008.00761.x; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; Moeller HB, 2009, AM J PHYSIOL-RENAL, V296, pF649, DOI 10.1152/ajprenal.90682.2008; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Otis TS, 2000, J NEUROSCI, V20, P2749; Otis TS, 1998, J NEUROSCI, V18, P7099; Pow DV, 2004, DEV BRAIN RES, V153, P1, DOI 10.1016/j.devbrainres.2004.06.019; Rauen T, 2004, NEUROCHEM INT, V45, P1095, DOI 10.1016/j.neuint.2004.04.006; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Schmitt A, 2002, NEUROSCIENCE, V109, P45, DOI 10.1016/S0306-4522(01)00451-1; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shigeri Y, 2001, J NEUROCHEM, V79, P297, DOI 10.1046/j.1471-4159.2001.00588.x; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Sogaard R, 2012, AM J PHYSIOL-CELL PH, V302, pC880, DOI 10.1152/ajpcell.00238.2011; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Sullivan R, 2004, GLIA, V45, P155, DOI 10.1002/glia.10317; Susarla BTS, 2008, NEUROCHEM INT, V52, P709, DOI 10.1016/j.neuint.2007.08.020; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; Volk L, 2010, P NATL ACAD SCI USA, V107, P21784, DOI 10.1073/pnas.1016103107; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Watzke N, 2001, FEBS LETT, V503, P121, DOI 10.1016/S0014-5793(01)02715-6; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004	55	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20195	20207		10.1074/jbc.M113.471128	http://dx.doi.org/10.1074/jbc.M113.471128			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23697999	hybrid, Green Published			2022-12-28	WOS:000321715100009
J	Newhart, A; Rafalska-Metcalf, IU; Yang, T; Joo, LM; Powers, SL; Kossenkov, AV; Lopez-Jones, M; Singer, RH; Showe, LC; Skordalakes, E; Janicki, SM				Newhart, Alyshia; Rafalska-Metcalf, Ilona U.; Yang, Tian; Joo, Lucy M.; Powers, Sara Lawrence; Kossenkov, Andrew V.; Lopez-Jones, Melissa; Singer, Robert H.; Showe, Louise C.; Skordalakes, Emmanuel; Janicki, Susan M.			Single Cell Analysis of RNA-mediated Histone H3.3 Recruitment to a Cytomegalovirus Promoter-regulated Transcription Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-INDEPENDENT DEPOSITION; REPEAT-CONTAINING RNA; SIMPLEX-VIRUS TYPE-1; GENOME-WIDE ANALYSIS; VARIANT H3.3; MOLECULAR DISSECTION; CHROMATIN; HETEROCHROMATIN; CHAPERONE; DAXX	Unlike the core histones, which are incorporated into nucleosomes concomitant with DNA replication, histone H3.3 is synthesized throughout the cell cycle and utilized for replication-independent (RI) chromatin assembly. The RI incorporation of H3.3 into nucleosomes is highly conserved and occurs at both euchromatin and heterochromatin. However, neither the mechanism of H3.3 recruitment nor its essential function is well understood. Several different chaperones regulate H3.3 assembly at distinct sites. The H3.3 chaperone, Daxx, and the chromatin-remodeling factor, ATRX, are required for H3.3 incorporation and heterochromatic silencing at telomeres, pericentromeres, and the cytomegalovirus (CMV) promoter. By evaluating H3.3 dynamics at a CMV promoter-regulated transcription site in a genetic background in which RI chromatin assembly is blocked, we have been able to decipher the regulatory events upstream of RI nucleosomal deposition. We find that at the activated transcription site, H3.3 accumulates with sense and antisense RNA, suggesting that it is recruited through an RNA-mediated mechanism. Sense and antisense transcription also increases after H3.3 knockdown, suggesting that the RNA signal is amplified when chromatin assembly is blocked and attenuated by nucleosomal deposition. Additionally, we find that H3.3 is still recruited after Daxx knockdown, supporting a chaperone-independent recruitment mechanism. Sequences in the H3.3 N-terminal tail and alpha N helix mediate both its recruitment to RNA at the activated transcription site and its interaction with double-stranded RNA in vitro. Interestingly, the H3.3 gain-of-function pediatric glioblastoma mutations, G34R and K27M, differentially affect H3.3 affinity in these assays, suggesting that disruption of an RNA-mediated regulatory event could drive malignant transformation.	[Newhart, Alyshia; Rafalska-Metcalf, Ilona U.; Joo, Lucy M.; Powers, Sara Lawrence; Kossenkov, Andrew V.; Showe, Louise C.; Janicki, Susan M.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Skordalakes, Emmanuel] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA; [Yang, Tian] Univ Penn, Roy & Diana Vagelos Scholars Program Mol Life Sci, Philadelphia, PA 19104 USA; [Lopez-Jones, Melissa; Singer, Robert H.] Yeshiva Univ Albert Einstein Coll Med, Dept Anat, Bronx, NY 10461 USA; [Lopez-Jones, Melissa; Singer, Robert H.] Yeshiva Univ Albert Einstein Coll Med, Dept Biol Struct, Bronx, NY 10461 USA	The Wistar Institute; The Wistar Institute; University of Pennsylvania; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Janicki, SM (corresponding author), Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA.	sjanicki@wistar.org	Skordalakes, Emmanuel/H-7071-2019	Skordalakes, Emmanuel/0000-0002-7600-2833	National Institutes of Health [R01 GM 093000-02, P30 CA10815]; Wistar Institute; Arnold and Mabel Beckman Foundation; Mallinckrodt Foundation; Emerald Foundation; March of Dimes Basil O'Connor Award; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088332, R01GM093000] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wistar Institute; Arnold and Mabel Beckman Foundation; Mallinckrodt Foundation; Emerald Foundation; March of Dimes Basil O'Connor Award(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM 093000-02 and P30 CA10815 (Wistar Cancer Center Core Grant Facilities: Genomics, Bioinformatics, Protein Expression and Library Screening, Imaging, and Research Supply). This work was also supported by start-up funding from the Wistar Institute and grants from the Arnold and Mabel Beckman Foundation, the Mallinckrodt Foundation, and the Emerald Foundation, the March of Dimes Basil O'Connor Award.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2002, P NATL ACAD SCI USA, V99, P16477, DOI 10.1073/pnas.172403699; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Bonnefoy E, 2007, PLOS GENET, V3, P1991, DOI 10.1371/journal.pgen.0030182; Bower K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050062; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Campos EI, 2010, GENE DEV, V24, P1334, DOI 10.1101/gad.1946810; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; Choi ES, 2005, NUCLEIC ACIDS RES, V33, P7102, DOI 10.1093/nar/gki1011; Cui BW, 2006, MOL CELL BIOL, V26, P7719, DOI 10.1128/MCB.01139-06; Delbarre E, 2013, GENOME RES, V23, P440, DOI 10.1101/gr.142703.112; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Elsaesser SJ, 2010, COLD SH Q B, V75, P27, DOI 10.1101/sqb.2010.75.008; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Everett RD, 2008, J VIROL, V82, P2661, DOI 10.1128/JVI.02308-07; Eymery A, 2009, INT J DEV BIOL, V53, P259, DOI 10.1387/ijdb.082673ae; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Femino AM, 2003, METHOD ENZYMOL, V361, P245; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Govin J, 2010, GENE DEV, V24, P1772, DOI 10.1101/gad.1954910; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Harada A, 2012, EMBO J, V31, P2994, DOI 10.1038/emboj.2012.136; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; HUANG RCC, 1965, P NATL ACAD SCI USA, V54, P960, DOI 10.1073/pnas.54.3.960; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jullien J, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-17; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kapranov P, 2010, NATURE, V466, P642, DOI 10.1038/nature09190; Kim HD, 2008, NAT STRUCT MOL BIOL, V15, P1192, DOI 10.1038/nsmb.1500; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Lin LJ, 2010, MOL CELL BIOL, V30, P1116, DOI 10.1128/MCB.01229-09; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lukashchuk V, 2010, J VIROL, V84, P4026, DOI 10.1128/JVI.02597-09; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; NELSON T, 1981, BIOCHEMISTRY-US, V20, P2594, DOI 10.1021/bi00512a035; Newhart A, 2013, MOL BIOL CELL, V24, P1454, DOI 10.1091/mbc.E12-09-0669; Newhart A, 2012, J CELL SCI, V125, P5489, DOI 10.1242/jcs.110148; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Ooi SL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1090; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; Porro A, 2010, MOL CELL BIOL, V30, P4808, DOI 10.1128/MCB.00460-10; PROUDFOOT NJ, 1989, TRENDS BIOCHEM SCI, V14, P105, DOI 10.1016/0968-0004(89)90132-1; Rafalska-Metcalf IU, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010272; Rai TS, 2011, MOL CELL BIOL, V31, P4107, DOI 10.1128/MCB.05546-11; Raitskin O, 2001, P NATL ACAD SCI USA, V98, P6571, DOI 10.1073/pnas.111153798; ROHRBAUGH ML, 1985, MOL CELL BIOL, V5, P147, DOI 10.1128/MCB.5.1.147; Sakai A, 2009, CURR BIOL, V19, P1816, DOI 10.1016/j.cub.2009.09.021; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Santenard A, 2010, NAT CELL BIOL, V12, P853, DOI 10.1038/ncb2089; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sioud M, 2007, ADV DRUG DELIVER REV, V59, P153, DOI 10.1016/j.addr.2007.03.006; Stroud H, 2012, P NATL ACAD SCI USA, V109, P5370, DOI 10.1073/pnas.1203145109; Szenker E, 2011, CELL RES, V21, P421, DOI 10.1038/cr.2011.14; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tamura T, 2009, J BIOL CHEM, V284, P12217, DOI 10.1074/jbc.M805651200; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; van der Heijden GW, 2007, NAT GENET, V39, P251, DOI 10.1038/ng1949; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; WAGNER RW, 1988, MOL CELL BIOL, V8, P770, DOI 10.1128/MCB.8.2.770; Waterborg JH, 2012, BIOCHEM CELL BIOL, V90, P79, DOI [10.1139/O11-036, 10.1139/o11-036]; Wirbelauer C, 2005, GENE DEV, V19, P1761, DOI 10.1101/gad.347705; Wollmann H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002658; Wu B, 2010, J MOL BIOL, V398, P633, DOI 10.1016/j.jmb.2010.03.038; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501; Zaslavsky E, 2010, J IMMUNOL, V184, P2908, DOI 10.4049/jimmunol.0903453; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06; Zhu YS, 2004, MOL BIOL CELL, V15, P81, DOI 10.1091/mbc.E03-07-0525; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	90	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19882	19899		10.1074/jbc.M113.473181	http://dx.doi.org/10.1074/jbc.M113.473181			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689370	Green Published, hybrid			2022-12-28	WOS:000321515800055
J	Cushman, I; Cushman, SM; Potter, PM; Casey, PJ				Cushman, Ian; Cushman, Stephanie M.; Potter, Philip M.; Casey, Patrick J.			Control of RhoA Methylation by Carboxylesterase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; ISOPRENYLCYSTEINE CARBOXYLMETHYLTRANSFERASE; PROTEIN PRENYLATION; CANCER-CELLS; METHYLTRANSFERASE; RAS; GTPASES; LOCALIZATION; ACTIVATION; ESTERASE	A number of proteins that play key roles in cell signaling are post-translationally modified by the prenylation pathway. The final step in this pathway is methylation of the carboxyl terminus of the prenylated protein by isoprenylcysteine carboxylmethyltransferase. Due to the impact of methylation on Rho function, we sought to determine if the process was reversible and hence could control Rho function in a dynamic fashion. Elevating isoprenylcysteine carboxylmethyltransferase activity in cells has profound effects on MDA-MB-231 cell morphology, implying the presence of a pool of unmethylated prenyl proteins in these cells under normal conditions. Using a knockdown approach, we identified a specific esterase, carboxylesterase 1, whose function had a clear impact not only on the methylation status of RhoA but also RhoA activation and cell morphology. These data provide compelling evidence that C-terminal modification of prenyl proteins, rather than being purely a constitutive process, can serve as a point of regulation of function for this important class of protein.	[Cushman, Ian; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Cushman, Stephanie M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Potter, Philip M.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Cushman, Ian; Casey, Patrick J.] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore 169857, Singapore	Duke University; Duke University; St Jude Children's Research Hospital; National University of Singapore	Casey, PJ (corresponding author), Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, 8 Coll Rd, Singapore 169857, Singapore.	patrick.casey@duke-nus.edu.sg	; Potter, Philip/J-4515-2013	Casey, Patrick/0000-0002-7366-9309; Potter, Philip/0000-0001-8922-8535	American Lebanese and Syrian Associated Charities; St. Jude Children's Research Hospital	American Lebanese and Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); St. Jude Children's Research Hospital	This work was supported by the by the American Lebanese and Syrian Associated Charities and the St. Jude Children's Research Hospital.	Ashby MN, 1998, CURR OPIN LIPIDOL, V9, P99, DOI 10.1097/00041433-199804000-00004; Backlund PS, 1997, J BIOL CHEM, V272, P33175, DOI 10.1074/jbc.272.52.33175; Baron RA, 2007, BIOCHEMISTRY-US, V46, P554, DOI 10.1021/bi060344n; Baron Rudi A., 2004, BMC Biochemistry, V5, P19, DOI 10.1186/1471-2091-5-19; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; Bergo MO, 2001, J BIOL CHEM, V276, P5841, DOI 10.1074/jbc.C000831200; Brusehaber E, 2009, BIOORGAN MED CHEM, V17, P7878, DOI 10.1016/j.bmc.2009.10.033; Casey PJ, 1996, J BIOL CHEM, V271, P5289, DOI 10.1074/jbc.271.10.5289; Cushman I, 2011, CELL ADHES MIGR, V5, P11, DOI 10.4161/cam.5.1.13196; Cushman I, 2009, J BIOL CHEM, V284, P27964, DOI 10.1074/jbc.M109.025296; Deem AK, 2006, GENE, V380, P159, DOI 10.1016/j.gene.2006.05.023; Doll RJ, 2004, CURR OPIN DRUG DISC, V7, P478; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Gelb MH, 2006, NAT CHEM BIOL, V2, P518, DOI 10.1038/nchembio818; GLOMSET JA, 1994, ANNU REV CELL BIOL, V10, P181, DOI 10.1146/annurev.cellbio.10.1.181; Harrington EO, 2004, AM J PHYSIOL-LUNG C, V287, pL1091, DOI 10.1152/ajplung.00421.2003; Holmes RS, 2010, MAMM GENOME, V21, P427, DOI 10.1007/s00335-010-9284-4; Jayaram B, 2011, ISLETS, V3, P48, DOI 10.4161/isl.3.2.15016; Lu Q, 2004, CIRC RES, V94, P306, DOI 10.1161/01.RES.0000113923.85084.C1; Meigs T. E., 2005, J BIOL CHEM; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Morton CL, 2000, MOL BIOTECHNOL, V16, P193, DOI 10.1385/MB:16:3:193; Oboh OT, 2008, J BIOCHEM MOL TOXIC, V22, P51, DOI 10.1002/jbt.20214; Otto JC, 1999, J BIOL CHEM, V274, P8379, DOI 10.1074/jbc.274.13.8379; Ross MK, 2007, J BIOCHEM MOL TOXIC, V21, P187, DOI 10.1002/jbt.20178; Rounds S., 2008, T AM CLIN CLIMAT ASS, V119, P167; Rounds Sharon, 2008, Trans Am Clin Climatol Assoc, V119, P155; Wahlstrom AM, 2008, BLOOD, V112, P1357, DOI 10.1182/blood-2007-06-094060; Wang M, 2008, J BIOL CHEM, V283, P18678, DOI 10.1074/jbc.M801855200; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Winter-Vann AM, 2005, P NATL ACAD SCI USA, V102, P4336, DOI 10.1073/pnas.0408107102; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Young S. G., 2001, ENZYMES, V21, P156; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	34	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19177	19183		10.1074/jbc.M113.467407	http://dx.doi.org/10.1074/jbc.M113.467407			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658012	Green Published, hybrid			2022-12-28	WOS:000321335800051
J	Hassan, BH; Lindsey-Boltz, LA; Kemp, MG; Sancar, A				Hassan, Bachar H.; Lindsey-Boltz, Laura A.; Kemp, Michael G.; Sancar, Aziz			Direct Role for the Replication Protein Treslin (Ticrr) in the ATR Kinase-mediated Checkpoint Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; C-TERMINAL TAIL; TOPBP1; PHOSPHORYLATION; INITIATION; RECONSTITUTION; ACTIVATION; CLASPIN; COMPLEX; DOMAIN	TopBP1 (topoisomerase II beta-binding protein 1) is a dual replication/checkpoint protein. Treslin/Ticrr, an essential replication protein, was discovered as a binding partner for TopBP1 and also in a genetic screen for checkpoint regulators in zebrafish. Treslin is phosphorylated by CDK2/cyclin E in a cell cycle-dependent manner, and its phosphorylation state dictates its interaction with TopBP1. The role of Treslin in the initiation of DNA replication has been partially elucidated; however, its role in the checkpoint response remained elusive. In this study, we show that Treslin stimulates ATR phosphorylation of Chk1 both in vitro and in vivo in a TopBP1-dependent manner. Moreover, we show that the phosphorylation state of Treslin at Ser-1000 is important for its checkpoint activity. Overall, our results indicate that, like TopBP1, Treslin is a dual replication/checkpoint protein that directly participates in ATR-mediated checkpoint signaling.	[Hassan, Bachar H.; Lindsey-Boltz, Laura A.; Kemp, Michael G.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Kemp, Michael G./AAT-1545-2021; Lindsey-Boltz, Laura/A-3121-2010	Kemp, Michael G./0000-0001-8203-0745; Lindsey-Boltz, Laura/0000-0001-6493-8194	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32833.	Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Bartek J, 2004, NAT REV MOL CELL BIO, V5, P792, DOI 10.1038/nrm1493; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Boos D, 2011, CURR BIOL, V21, P1152, DOI 10.1016/j.cub.2011.05.057; Canman CE, 2001, CURR BIOL, V11, pR121, DOI 10.1016/S0960-9822(01)00057-4; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2010, P NATL ACAD SCI USA, V107, P13660, DOI 10.1073/pnas.1007856107; Choi JH, 2009, METHODS, V48, P3, DOI 10.1016/j.ymeth.2009.02.006; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Diffley JFX, 2011, PHILOS T R SOC B, V366, P3545, DOI 10.1098/rstb.2011.0073; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Kubota Y, 2003, GENE DEV, V17, P1141, DOI 10.1101/gad.1070003; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lin SJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002801; Lindsey-Boltz LA, 2011, J BIOL CHEM, V286, P19229, DOI 10.1074/jbc.M111.237958; Lindsey-Boltz LA, 2009, J BIOL CHEM, V284, P33107, DOI 10.1074/jbc.M109.064485; Lopez-Mosqueda J, 2010, NATURE, V467, P479, DOI 10.1038/nature09377; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2011, J BIOL CHEM, V286, P40999, DOI 10.1074/jbc.M111.283994; Navadgi-Patil VM, 2009, MOL CELL, V36, P743, DOI 10.1016/j.molcel.2009.10.014; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076	31	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18903	18910		10.1074/jbc.M113.475517	http://dx.doi.org/10.1074/jbc.M113.475517			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23696651	Green Published, hybrid			2022-12-28	WOS:000321335800028
J	Li, C; Wei, J; Li, Y; He, X; Zhou, Q; Yan, J; Zhang, J; Liu, Y; Liu, Y; Shu, HB				Li, Chao; Wei, Jin; Li, Ying; He, Xiao; Zhou, Qian; Yan, Jie; Zhang, Jing; Liu, Ying; Liu, Yu; Shu, Hong-Bing			Transmembrane Protein 214 (TMEM214) Mediates Endoplasmic Reticulum Stress-induced Caspase 4 Enzyme Activation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER; INVOLVEMENT; MECHANISMS; PATHWAY; CELLS; CRMA; CHOP	Endoplasmic reticulum (ER) stress caused by excessive aggregation of misfolded proteins induces apoptosis. Although ER stress-induced apoptosis has been implicated in many diseases, the detailed mechanisms are not well understood. Here, we identified human transmembrane protein 214 (TMEM214) as a critical mediator of ER stress-induced apoptosis. Overexpression of TMEM214 induced apoptosis, whereas knockdown of TMEM214 inhibited ER stress-induced apoptosis. TMEM214 was localized on the outer membrane of the ER and constitutively associated with procaspase 4, which was also critical for ER stress induced apoptosis. TMEM214-induced apoptosis was abolished by a dominant negative mutant of procaspase 4, whereas caspase 4-induced apoptosis was inhibited by knockdown of TMEM214. Furthermore, knockdown of TMEM214 inhibited the activation and cleavage of procaspase 4 by impairing its recruitment to the ER. Our findings suggest that TMEM214 is essential for ER stress-induced apoptosis by acting as an anchor for recruitment of procaspase 4 to the ER and its subsequent activation.	[Li, Chao; Wei, Jin; Li, Ying; He, Xiao; Zhou, Qian; Yan, Jie; Zhang, Jing; Liu, Ying; Liu, Yu; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn	WEI, JIN/ABE-6512-2021	Wei, Jin/0000-0002-2832-1610; Liu, Ying/0000-0001-7915-7294; ZHOU, Qian/0000-0002-2249-0739	Chinese Ministry of Science and Technology [2012CB910201]; National Science Foundation of China [91029302, 31130020, 31221061]; Chinese 111 Project Grant [B06018]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 111 Project Grant	This work was supported by Chinese Ministry of Science and Technology Grant 2012CB910201, by National Science Foundation of China Grants 91029302, 31130020, and 31221061, and by Chinese 111 Project Grant B06018.	Bian ZM, 2009, INVEST OPHTH VIS SCI, V50, P6006, DOI 10.1167/iovs.09-3628; Fischer H, 2002, BIOCHEM BIOPH RES CO, V293, P722, DOI 10.1016/S0006-291X(02)00289-9; Han KJ, 2004, J BIOL CHEM, V279, P15652, DOI 10.1074/jbc.M311629200; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Kamada S, 1997, CELL DEATH DIFFER, V4, P473, DOI 10.1038/sj.cdd.4400268; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Li B, 2011, CELL SIGNAL, V23, P35, DOI 10.1016/j.cellsig.2010.07.019; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Moon DO, 2011, BIOCHEM PHARMACOL, V82, P1641, DOI 10.1016/j.bcp.2011.08.019; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Nakagawa T, 2000, J CELL BIOL, V150, P887, DOI 10.1083/jcb.150.4.887; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamamuro A, 2011, J PHARMACOL SCI, V115, P239, DOI 10.1254/jphs.10217SC; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	24	47	52	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17908	17917		10.1074/jbc.M113.458836	http://dx.doi.org/10.1074/jbc.M113.458836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23661706	hybrid, Green Published			2022-12-28	WOS:000320380600078
J	Creager-Allen, RL; Silversmith, RE; Bourret, RB				Creager-Allen, Rachel L.; Silversmith, Ruth E.; Bourret, Robert B.			A Link between Dimerization and Autophosphorylation of the Response Regulator PhoB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Signal Transduction; Cooperativity; Enzyme Kinetics; Protein Phosphorylation; Protein-Protein Interactions; Dimerization; PhoB; Phosphoramidate; Response Regulator; Two-component System	2-COMPONENT SIGNAL-TRANSDUCTION; SMALL-MOLECULE PHOSPHODONORS; ESCHERICHIA-COLI; BACTERIAL CHEMOTAXIS; KINETIC CHARACTERIZATION; CHEY PHOSPHORYLATION; CRYSTAL-STRUCTURE; ACETYL PHOSPHATE; RECEIVER DOMAIN; IN-VITRO	Response regulator proteins within two-component signal transduction systems are activated by phosphorylation and can catalyze their own covalent phosphorylation using small molecule phosphodonors. To date, comprehensive kinetic characterization of response regulator autophosphorylation is limited to CheY, which follows a simple model of phosphodonor binding followed by phosphorylation. We characterized autophosphorylation of the response regulator PhoB, known to dimerize upon phosphorylation. In contrast to CheY, PhoB time traces exhibited an initial lag phase and gave apparent pseudo-first order rate constants that increased with protein concentration. Furthermore, plots of the apparent autophosphorylation rate constant versus phosphodonor concentration were sigmoidal, as were PhoB binding isotherms for the phosphoryl group analog BeF3-. Successful mathematical modeling of the kinetic data necessitated inclusion of the formation of a PhoB heterodimer (one phosphorylated and one unphosphorylated monomer) with an enhanced rate of phosphorylation. Specifically, dimerization constants for the PhoB heterodimer and homodimer ( two phosphorylated monomers) were similar, but the rate constant for heterodimer phosphorylation was similar to 10-fold higher than for the monomer. In a test of the model, disruption of the known PhoB(N) dimerization interface by mutation led to markedly slower and noncooperative autophosphorylation kinetics. Furthermore, phosphotransfer from the sensor kinase PhoR was enhanced by dimer formation. Phosphorylation-mediated dimerization allows many response regulators to bind to tandem DNA-binding sites and regulate transcription. Our data challenge the notion that response regulator dimers primarily form between two phosphorylated monomers and raise the possibility that response regulator heterodimers containing one phosphoryl group may participate in gene regulation.	[Creager-Allen, Rachel L.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Silversmith, Ruth E.; Bourret, Robert B.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bourret, RB (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	bourret@med.unc.edu	Bourret, Robert/X-3606-2019	Bourret, Robert/0000-0002-6666-9220	National Institutes of Health from NIGMS [R01GM050860]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050860] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM050860 from NIGMS.	Ames SK, 1999, P NATL ACAD SCI USA, V96, P11792, DOI 10.1073/pnas.96.21.11792; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; Barbieri CM, 2010, J BIOL CHEM, V285, P32325, DOI 10.1074/jbc.M110.157164; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P142, DOI 10.1016/j.mib.2010.01.015; Bourret RB, 2010, METHOD ENZYMOL, V471, P89, DOI 10.1016/S0076-6879(10)71006-5; Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039; Da Re SS, 1999, FEBS LETT, V457, P323, DOI 10.1016/S0014-5793(99)01057-1; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Decker KB, 2012, MICROBIOL-SGM, V158, P1665, DOI 10.1099/mic.0.058941-0; Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06; FIEDLER U, 1995, EMBO J, V14, P3696, DOI 10.1002/j.1460-2075.1995.tb00039.x; Fisher SL, 1996, BIOCHEMISTRY-US, V35, P4732, DOI 10.1021/bi9525435; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gao R, 2008, MOL MICROBIOL, V69, P1358, DOI 10.1111/j.1365-2958.2008.06355.x; Gao R, 2013, P NATL ACAD SCI USA, V110, P672, DOI 10.1073/pnas.1214587110; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; GILLESGONZALEZ MA, 1993, J BIOL CHEM, V268, P16293; Goulian M, 2010, CURR OPIN MICROBIOL, V13, P184, DOI 10.1016/j.mib.2010.01.009; Head CG, 1998, J MOL BIOL, V281, P857, DOI 10.1006/jmbi.1998.1985; HESS JF, 1988, COLD SPRING HARB SYM, V53, P41, DOI 10.1101/SQB.1988.053.01.008; HIRATSU K, 1995, GENE, V161, P7, DOI 10.1016/0378-1119(95)00259-9; Hung DCI, 2012, J BACTERIOL, V194, P1127, DOI 10.1128/JB.06565-11; JANIN J, 1990, J BIOL CHEM, V265, P16027; Kierzek AM, 2010, MOL BIOSYST, V6, P531, DOI 10.1039/b906951h; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; LUKAT GS, 1990, BIOCHEMISTRY-US, V29, P5436, DOI 10.1021/bi00475a004; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; Magasanik B., 1996, ESCHERICHIA COLI SAL, P1344; MAKINO K, 1988, J MOL BIOL, V203, P85, DOI 10.1016/0022-2836(88)90093-9; MARTIN RB, 1988, BIOCHEM BIOPH RES CO, V155, P1194; Mayover TL, 1999, BIOCHEMISTRY-US, V38, P2259, DOI 10.1021/bi981707p; McCleary WR, 1996, MOL MICROBIOL, V20, P1155, DOI 10.1111/j.1365-2958.1996.tb02636.x; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; MCCLEARY WR, 1990, J BACTERIOL, V172, P6661, DOI 10.1128/jb.172.12.6661-6668.1990; Psakis G, 2011, BIOCHEMISTRY-US, V50, P6178, DOI 10.1021/bi200612d; Schuster M, 2001, P NATL ACAD SCI USA, V98, P6003, DOI 10.1073/pnas.101571298; Sheridan R. C., 2007, INORG SYN, P23; SHINAGAWA H, 1983, J MOL BIOL, V168, P477, DOI 10.1016/S0022-2836(83)80297-6; Silversmith RE, 1997, BIOCHEMISTRY-US, V36, P14965, DOI 10.1021/bi9715573; Silversmith RE, 2005, BIOCHEMISTRY-US, V44, P7768, DOI 10.1021/bi0501636; Silversmith RE, 2010, CURR OPIN MICROBIOL, V13, P177, DOI 10.1016/j.mib.2010.01.004; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Sola M, 1999, J MOL BIOL, V285, P675, DOI 10.1006/jmbi.1998.2326; Sola M, 2006, ACTA CRYSTALLOGR D, V62, P1046, DOI 10.1107/S0907444906024541; STOCK AM, 1993, BIOCHEMISTRY-US, V32, P13375, DOI 10.1021/bi00212a001; Thomas SA, 2013, BIOCHEMISTRY-US, V52, P2262, DOI 10.1021/bi301654m; Huynh TN, 2011, MOL MICROBIOL, V82, P275, DOI 10.1111/j.1365-2958.2011.07829.x; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Yan D, 1999, P NATL ACAD SCI USA, V96, P14789, DOI 10.1073/pnas.96.26.14789; Zapf JW, 1996, BIOCHEMISTRY-US, V35, P2926, DOI 10.1021/bi9519361; Zhou L., 2005, J INTEGR BIOINFORM, V2, P11; Zundel CJ, 1998, FEBS LETT, V441, P242, DOI 10.1016/S0014-5793(98)01556-7	60	31	31	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21755	10.1074/jbc.M113.471763	http://dx.doi.org/10.1074/jbc.M113.471763			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760278	Green Published, hybrid			2022-12-28	WOS:000328841900026
J	Shi, FT; Kim, H; Lu, WS; He, QY; Liu, D; Goodell, MA; Wan, M; Zhou, SY				Shi, Feng-Tao; Kim, Hyeung; Lu, Weisi; He, Quanyuan; Liu, Dan; Goodell, Margaret A.; Wan, Ma; Zhou Songyang			Ten-Eleven Translocation 1 (Tet1) Is Regulated by O-Linked N-Acetylglucosamine Transferase (Ogt) for Target Gene Repression in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLCNAC TRANSFERASE; TRANSCRIPTIONAL REPRESSION; PLURIPOTENCY NETWORK; DNA METHYLATION; 5-HYDROXYMETHYLCYTOSINE; PROTEIN; COMPLEX; 5-METHYLCYTOSINE; GLCNACYLATION; EXPRESSION	As a member of the Tet (Ten-eleven translocation) family proteins that can convert 5-methylcytosine (5mC) to 5-hydroxylmethylcytosine (5hmC), Tet1 has been implicated in regulating global DNA demethylation and gene expression. Tet1 is highly expressed in embryonic stem (ES) cells and appears primarily to repress developmental genes for maintaining pluripotency. To understand how Tet1 may regulate gene expression, we conducted large scale immunoprecipitation followed by mass spectrometry of endogenous Tet1 in mouse ES cells. We found that Tet1 could interact with multiple chromatin regulators, including Sin3A and NuRD complexes. In addition, we showed that Tet1 could also interact with the O-GlcNAc transferase (Ogt) and be O-GlcNAcylated. Depletion of Ogt led to reduced Tet1 and 5hmC levels on Tet1-target genes, whereas ectopic expression of wild-type but not enzymatically inactive Ogt increased Tet1 levels. Mutation of the putative O-GlcNAcylation site on Tet1 led to decreased O-GlcNAcylation and level of the Tet1 protein. Our results suggest that O-GlcNAcylation can positively regulate Tet1 protein concentration and indicate that Tet1-mediated 5hmC modification and target repression is controlled by Ogt.	[Lu, Weisi; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, Minist Educ, Key Lab Gene Engn, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Weisi; Zhou Songyang] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Shi, Feng-Tao; Kim, Hyeung; He, Quanyuan; Liu, Dan; Wan, Ma; Zhou Songyang] Baylor Coll Med, Verna & Marrs Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA	Sun Yat Sen University; Sun Yat Sen University; Baylor College of Medicine; Baylor College of Medicine	Wan, M (corresponding author), Baylor Coll Med, Verna & Marrs Dept Biochem & Mol Biol, Houston, TX 77030 USA.	mw6@bcm.edu; songyang@bcm.edu		Goodell, Margaret A./0000-0003-1111-2932	National Institutes of Health Grants through the NCI [CA133249]; National Institutes of Health Grants through the NIGMS [GM081627, GM095599]; National Basic Research Program (973 Program) [2012CB911201, 2010CB945401]; National Natural Science Foundation [91019020, 91213302]; Specialized Research Fund for the Doctoral Program of Higher Education Grant [20100171110028]; Introduced Innovative R&D Team of Guangdong Province Grant [201001Y0104687244]; Welch Foundation Grant [Q-1673]; Genome-wide RNAi Screens Cores Shared Resource at the Dan L. Duncan Cancer Center Grant [P30CA125123]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [5P30HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA133249, P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095599, P01GM081627] Funding Source: NIH RePORTER	National Institutes of Health Grants through the NCI; National Institutes of Health Grants through the NIGMS; National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education Grant; Introduced Innovative R&D Team of Guangdong Province Grant; Welch Foundation Grant(The Welch Foundation); Genome-wide RNAi Screens Cores Shared Resource at the Dan L. Duncan Cancer Center Grant; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported, in whole or in part, by the National Institutes of Health Grants CA133249 through the NCI and GM081627 and GM095599 through the NIGMS. This work was also supported by National Basic Research Program (973 Program) Grants 2012CB911201 and 2010CB945401; National Natural Science Foundation Grants 91019020 and 91213302; Specialized Research Fund for the Doctoral Program of Higher Education Grant 20100171110028; Introduced Innovative R&D Team of Guangdong Province Grant 201001Y0104687244; the Welch Foundation Grant Q-1673; and the Genome-wide RNAi Screens Cores Shared Resource at the Dan L. Duncan Cancer Center Grant P30CA125123. This work was also supported in part by Baylor College of Medicine Intellectual and Developmental Disabilities Research Center (BCM IDDRC) Grant 5P30HD024064 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Callige Mathilde, 2006, Nucl Recept Signal, V4, pe004; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Freudenberg JM, 2012, NUCLEIC ACIDS RES, V40, P3364, DOI 10.1093/nar/gkr1253; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; INGHAM PW, 1984, CELL, V37, P815, DOI 10.1016/0092-8674(84)90416-1; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jang H, 2012, CELL STEM CELL, V11, P62, DOI 10.1016/j.stem.2012.03.001; Ko M, 2011, BLOOD, V118, P4501, DOI 10.1182/blood-2011-08-373357; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Vella P, 2013, MOL CELL, V49, P645, DOI 10.1016/j.molcel.2012.12.019; Vervoorts J, 2006, J BIOL CHEM, V281, P34725, DOI 10.1074/jbc.R600017200; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamaguchi S, 2012, NATURE, V492, P443, DOI 10.1038/nature11709; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang HK, 2010, CELL RES, V20, P1390, DOI 10.1038/cr.2010.156	46	109	112	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20776	20784		10.1074/jbc.M113.460386	http://dx.doi.org/10.1074/jbc.M113.460386			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23729667	Green Published, hybrid			2022-12-28	WOS:000322014400002
J	Millon-Fremillon, A; Brunner, M; Abed, N; Collomb, E; Ribba, AS; Block, MR; Albiges-Rizo, C; Bouvard, D				Millon-Fremillon, Angelique; Brunner, Molly; Abed, Nadia; Collomb, Elodie; Ribba, Anne-Sophie; Block, Marc R.; Albiges-Rizo, Corinne; Bouvard, Daniel			Calcium and Calmodulin-dependent Serine/Threonine Protein Kinase Type II (CaMKII)-mediated Intramolecular Opening of Integrin Cytoplasmic Domain-associated Protein-1 (ICAP-1 alpha) Negatively Regulates beta 1 Integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-LIKE DOMAIN; SMOOTH-MUSCLE; ALPHA(5)BETA(1) INTEGRIN; BETA(1) INTEGRIN; CELL-MIGRATION; TAIL DOMAINS; ADHESION; TALIN; ACTIVATION; ALPHA(V)BETA(3)	Focal adhesion turnover during cell migration is an integrated cyclic process requiring tight regulation of integrin function. Interaction of integrin with its ligand depends on its activation state, which is regulated by the direct recruitment of proteins onto the beta integrin chain cytoplasmic domain. We previously reported that ICAP-1 alpha, a specific cytoplasmic partner of beta 1A integrins, limits both talin and kindlin interaction with beta 1 integrin, thereby restraining focal adhesion assembly. Here we provide evidence that the calcium and calmodulin-dependent serine/threonine protein kinase type II (CaMKII) is an important regulator of ICAP-1 alpha for controlling focal adhesion dynamics. CaMKII directly phosphorylates ICAP-1 alpha and disrupts an intramolecular interaction between the N- and the C-terminal domains of ICAP-1 alpha, unmasking the PTB domain, thereby permitting ICAP-1 alpha binding onto the beta 1 integrin tail. ICAP-1 alpha direct interaction with the beta 1 integrin tail and the modulation of beta 1 integrin affinity state are required for down-regulating focal adhesion assembly. Our results point to a molecular mechanism for the phosphorylation-dependent control of ICAP-1 alpha function by CaMKII, allowing the dynamic control of beta 1 integrin activation and cell adhesion.	[Millon-Fremillon, Angelique; Brunner, Molly; Abed, Nadia; Collomb, Elodie; Ribba, Anne-Sophie; Block, Marc R.; Albiges-Rizo, Corinne; Bouvard, Daniel] INSERM, Inst Albert Bonniot U823, F-38042 Grenoble, France; [Millon-Fremillon, Angelique; Brunner, Molly; Abed, Nadia; Collomb, Elodie; Ribba, Anne-Sophie; Block, Marc R.; Albiges-Rizo, Corinne; Bouvard, Daniel] CNRS, Inst Albert Bonniot ERL5224, F-38042 Grenoble, France; [Millon-Fremillon, Angelique; Brunner, Molly; Abed, Nadia; Collomb, Elodie; Ribba, Anne-Sophie; Block, Marc R.; Albiges-Rizo, Corinne; Bouvard, Daniel] Univ Grenoble Alpes, Inst Albert Bonniot U823, F-38042 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Albiges-Rizo, C (corresponding author), Univ Grenoble 1, ERL CNRS 5284, INSERM U823, Inst Albert Bonniot, Site Sante,BP170 La Tronche, F-38042 Grenoble 9, France.	Corinne.albiges-rizo@ujf-grenoble.fr; daniel.bouvard@ujf-grenoble.fr	ribba, anne-sophie/N-3109-2013; Bouvard, Daniel/M-2727-2013; Block, Marc R/M-2740-2013; Bouvard, Daniel/B-1260-2017; Albiges-Rizo, Corinne/M-2568-2013	Block, Marc R/0000-0003-2214-9706; Bouvard, Daniel/0000-0002-0845-6681; ALBIGES-RIZO, Corinne/0000-0002-6333-4150; Ribba, Anne-Sophie/0000-0001-5342-8455	Pro-INSERM grant, Ligue contre le Cancer, and INCa; Ligue contre le Cancer; ARC fellowship; Ministere de la Recherche	Pro-INSERM grant, Ligue contre le Cancer, and INCa; Ligue contre le Cancer(Ligue nationale contre le cancer); ARC fellowship(Australian Research Council); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	This work was supported by a Pro-INSERM grant, Ligue contre le Cancer, and INCa (to D.B.) and Ligue contre le Cancer (equipe labelise 2010) (to C.A.-R.).; 1 Supported by an ARC fellowship. Present address: Wellcome Trust Centre for Cell-Matrix Research, Manchester University, Oxford Road, M13 9PT, United Kingdom.; 2 Supported by a fellowship from the Ministere de la Recherche.	Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Bejar R, 2002, J NEUROSCI, V22, P5719; Bilato C, 1997, J CLIN INVEST, V100, P693, DOI 10.1172/JCI119582; Blystone SD, 1999, J CELL BIOL, V145, P889, DOI 10.1083/jcb.145.4.889; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Bouvard D, 2006, EUR J CELL BIOL, V85, P275, DOI 10.1016/j.ejcb.2005.10.005; Bouvard D, 1998, J CELL SCI, V111, P657; Bouvard D, 2003, J BIOL CHEM, V278, P6567, DOI 10.1074/jbc.M211258200; Bouvard D, 1998, BIOCHEM BIOPH RES CO, V252, P46, DOI 10.1006/bbrc.1998.9592; Bouvard D, 2007, DEVELOPMENT, V134, P2615, DOI 10.1242/dev.000877; Bretscher A, 1995, BIOCHEMISTRY-US, V34, P16830, DOI 10.1021/bi00051a034; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chang DD, 1997, J CELL BIOL, V138, P1149, DOI 10.1083/jcb.138.5.1149; Chang DD, 2002, J BIOL CHEM, V277, P8140, DOI 10.1074/jbc.M109031200; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Degani S, 2002, J CELL BIOL, V156, P377, DOI 10.1083/jcb.200108030; Easley CA, 2008, CELL MOTIL CYTOSKEL, V65, P662, DOI 10.1002/cm.20294; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Fournier HN, 2002, J BIOL CHEM, V277, P20895, DOI 10.1074/jbc.M200200200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JOHNSON RP, 1995, NATURE, V373, P261, DOI 10.1038/373261a0; JOHNSON RP, 1994, J BIOL CHEM, V269, P12611; Kim J, 2011, J CELL SCI, V124, P3929, DOI 10.1242/jcs.095471; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liu WZ, 2013, MOL CELL, V49, P719, DOI 10.1016/j.molcel.2012.12.005; Lundberg MS, 1998, J MOL CELL CARDIOL, V30, P2377, DOI 10.1006/jmcc.1998.0795; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; MARTIN M, 1995, J CELL BIOL, V128, P1081, DOI 10.1083/jcb.128.6.1081; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Mould AP, 2004, CURR OPIN CELL BIOL, V16, P544, DOI 10.1016/j.ceb.2004.07.003; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Rotenberg A, 1996, CELL, V87, P1351, DOI 10.1016/S0092-8674(00)81829-2; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Sjaastad MD, 1996, MOL BIOL CELL, V7, P1025, DOI 10.1091/mbc.7.7.1025; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Worth DC, 2010, J CELL BIOL, V189, P369, DOI 10.1083/jcb.200912014; Wu X, 1998, J CELL BIOL, V143, P241, DOI 10.1083/jcb.143.1.241; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Zhang XA, 1999, J BIOL CHEM, V274, P11, DOI 10.1074/jbc.274.1.11	50	15	15	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20248	20260		10.1074/jbc.M113.455956	http://dx.doi.org/10.1074/jbc.M113.455956			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720740	hybrid, Green Published			2022-12-28	WOS:000321715100014
J	Poulsen, N; Scheffel, A; Sheppard, VC; Chesley, PM; Kroger, N				Poulsen, Nicole; Scheffel, Andre; Sheppard, Vonda C.; Chesley, Patrick M.; Kroeger, Nils			Pentalysine Clusters Mediate Silica Targeting of Silaffins in Thalassiosira pseudonana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL; VALVE MORPHOGENESIS; MATRIX VESICLES; DIATOM; BIOMINERALIZATION; BACILLARIOPHYCEAE; BIOGENESIS; BIOSILICA; PROTEINS; IDENTIFICATION	The biological formation of inorganic materials (biomineralization) often occurs in specialized intracellular vesicles. Prominent examples are diatoms, a group of single-celled eukaryotic microalgae that produce their SiO2 (silica)-based cell walls within intracellular silica deposition vesicles (SDVs). SDVs contain protein-based organic matrices that control silica formation, resulting in species specifically nanopatterned biosilica, an organic-inorganic composite material. So far no information is available regarding the molecular mechanisms of SDV biogenesis. Here we have investigated by fluorescence microscopy and subcellular membrane fractionation the intracellular transport of silaffin Sil3. Silaffins are a group of phosphoproteins constituting the main components of the organic matrix of diatom biosilica. We demonstrate that the N-terminal signal peptide of Sil3 mediates import into a specific subregion of the endoplasmic reticulum. Additional segments from the mature part of Sil3 are required to reach post-endoplasmic reticulum compartments. Further transport of Sil3 and incorporation into the biosilica (silica targeting) require protein segments that contain a high density of modified lysine residues and phosphoserines. Silica targeting of Sil3 is not dependent on a particular peptide sequence, yet a lysine-rich 12-14-amino acid peptide motif (pentalysine cluster), which is conserved in all silaffins, strongly promotes silica targeting. The results of the present work provide the first insight into the molecular mechanisms for biogenesis of mineral-forming vesicles from an eukaryotic organism.	[Poulsen, Nicole; Kroeger, Nils] Tech Univ Dresden, B CUBE, D-01307 Dresden, Germany; [Kroeger, Nils] Tech Univ Dresden, Dept Chem & Food Chem, D-01062 Dresden, Germany; [Poulsen, Nicole; Scheffel, Andre; Sheppard, Vonda C.; Chesley, Patrick M.; Kroeger, Nils] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Kroeger, Nils] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA	Technische Universitat Dresden; Technische Universitat Dresden; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Kroger, N (corresponding author), Tech Univ Dresden, B CUBE, Arnoldstr. 18, D-01307 Dresden, Germany.	kroeger@bcube-dresden.de			Deutsche Forschungsgemeinschaft (DFG) [KR1853/3-1]; United States Department of Energy (DOE) Office of Basic Energy Sciences [SCHE1637/1-1, DE-SC0002245]; National Science Foundation (NSF) [DMR-0845939]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); United States Department of Energy (DOE) Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) through Grant KR1853/3-1 (to N.K.) and Postdoctoral Fellowship SCHE1637/1-1 (to A.S.), by the United States Department of Energy (DOE) Office of Basic Energy Sciences through Grant DE-SC0002245 (to N.K.), and by the National Science Foundation (NSF) through Grant DMR-0845939 (to N.K.).	ALI SY, 1970, P NATL ACAD SCI USA, V67, P1513, DOI 10.1073/pnas.67.3.1513; Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Bauerlein E, 2003, ANGEW CHEM INT EDIT, V42, P614, DOI 10.1002/anie.200390176; Brunner E, 2009, ANGEW CHEM INT EDIT, V48, P9724, DOI 10.1002/anie.200905028; DEAN AM, 1990, SCIENCE, V249, P1044, DOI 10.1126/science.2204110; Descles J, 2008, NEW PHYTOL, V177, P822, DOI 10.1111/j.1469-8137.2007.02303.x; Felsner G, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-223; Fischer H, 1999, J PHYCOL, V35, P113, DOI 10.1046/j.1529-8817.1999.3510113.x; Frigeri LG, 2006, MOL CELL PROTEOMICS, V5, P182, DOI 10.1074/mcp.M500174-MCP200; Gould SB, 2006, J MOL EVOL, V62, P674, DOI 10.1007/s00239-005-0099-y; Graham T. R., 2002, PROTEIN TARGETING TR, P322; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Hildebrand M, 2003, PROG MOLEC, V33, P11; Hildebrand M, 2007, J PHYCOL, V43, P730, DOI 10.1111/j.1529-8817.2007.00361.x; Jogler C, 2009, ANNU REV MICROBIOL, V63, P501, DOI 10.1146/annurev.micro.62.081307.162908; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2002, SCIENCE, V298, P584, DOI 10.1126/science.1076221; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Pickett-Heaps J., 1990, PROGR PHYCOLOGICAL R, V7, P1; Poulsen N, 2004, J BIOL CHEM, V279, P42993, DOI 10.1074/jbc.M407734200; Poulsen N, 2003, P NATL ACAD SCI USA, V100, P12075, DOI 10.1073/pnas.2035131100; Poulsen N, 2007, ANGEW CHEM INT EDIT, V46, P1843, DOI 10.1002/anie.200603928; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Round F. E., 1990, DIATOMS BIOL MORPHOL; Scheffel A, 2011, P NATL ACAD SCI USA, V108, P3175, DOI 10.1073/pnas.1012842108; SCHMID AMM, 1994, PROTOPLASMA, V181, P43, DOI 10.1007/BF01666388; Sheppard V, 2010, J BIOL CHEM, V285, P1166, DOI 10.1074/jbc.M109.039529; Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764; Sumper M, 2007, ANGEW CHEM INT EDIT, V46, P8405, DOI 10.1002/anie.200702413; Tesson B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014300; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Van de Meene AML, 2004, EUR J PHYCOL, V39, P93, DOI 10.1080/09670260310001646522; van de Meene AML, 2002, J PHYCOL, V38, P351, DOI 10.1046/j.1529-8817.2002.01124.x; Varki A., 2009, ESSENTIALS GLYCOBIOL, P37; Vrieling EG, 1999, J PHYCOL, V35, P548, DOI 10.1046/j.1529-8817.1999.3530548.x; Wang XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020523; Ward DM, 2005, MOL B INT U, P111; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; Wenzl S, 2008, ANGEW CHEM INT EDIT, V47, P1729, DOI 10.1002/anie.200704994; Wilt FH, 2008, EXP CELL RES, V314, P1744, DOI 10.1016/j.yexcr.2008.01.036	43	45	45	3	76	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20100	20109		10.1074/jbc.M113.469379	http://dx.doi.org/10.1074/jbc.M113.469379			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720751	hybrid, Green Published			2022-12-28	WOS:000321715100001
J	Ryan, L; Lamarre, B; Diu, T; Ravi, J; Judge, PJ; Temple, A; Carr, M; Cerasoli, E; Su, B; Jenkinson, HF; Martyna, G; Crain, J; Watts, A; Ryadnov, MG				Ryan, Lloyd; Lamarre, Baptiste; Diu, Ting; Ravi, Jascindra; Judge, Peter J.; Temple, Adam; Carr, Matthew; Cerasoli, Eleonora; Su, Bo; Jenkinson, Howard F.; Martyna, Glenn; Crain, Jason; Watts, Anthony; Ryadnov, Maxim G.			Anti-antimicrobial Peptides FOLDING-MEDIATED HOST DEFENSE ANTAGONISTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COILED-COIL; PROTEIN INTERACTIONS; MEMBRANE-PROTEINS; RESISTANCE; DOMAINS; BINDING; DESIGN; ALPHA; HINGE	Antimicrobial or host defense peptides are innate immune regulators found in all multicellular organisms. Many of them fold into membrane-bound alpha-helices and function by causing cell wall disruption in microorganisms. Herein we probe the possibility and functional implications of antimicrobial antagonism mediated by complementary coiled-coil interactions between antimicrobial peptides and de novo designed antagonists: anti-antimicrobial peptides. Using sequences from native helical families such as cathelicidins, cecropins, and magainins we demonstrate that designed antagonists can co-fold with antimicrobial peptides into functionally inert helical oligomers. The properties and function of the resulting assemblies were studied in solution, membrane environments, and in bacterial culture by a combination of chiroptical and solid-state NMR spectroscopies, microscopy, bioassays, and molecular dynamics simulations. The findings offer a molecular rationale for anti-antimicrobial responses with potential implications for antimicrobial resistance.	[Ryan, Lloyd; Lamarre, Baptiste; Diu, Ting; Ravi, Jascindra; Cerasoli, Eleonora; Ryadnov, Maxim G.] Natl Phys Lab, Teddington TW11 0LW, Middx, England; [Ryan, Lloyd] St Georges Univ London, Div Biomed Sci, London SW17 0RE, England; [Diu, Ting; Su, Bo; Jenkinson, Howard F.] Univ Bristol, Sch Oral & Dent Sci, Bristol BS1 2LY, Avon, England; [Judge, Peter J.; Watts, Anthony] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Temple, Adam; Carr, Matthew; Crain, Jason; Ryadnov, Maxim G.] Univ Edinburgh, Sch Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland; [Martyna, Glenn] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA	National Physical Laboratory - UK; St Georges University London; University of Bristol; University of Oxford; University of Edinburgh; International Business Machines (IBM)	Ryadnov, MG (corresponding author), Natl Phys Lab, Teddington TW11 0LW, Middx, England.	max.ryadnov@npl.co.uk	Jenkinson, Howard/AAD-9282-2022; Judge, Peter J/AAU-3776-2021; Jenkinson, Howard/ABI-1842-2020	Judge, Peter J/0000-0003-0609-0900; Jenkinson, Howard/0000-0002-9195-7945; Su, Bo/0000-0003-1063-8182	United Kingdom Department of Business, Innovation and Skills; European Metrology Research Programme [HLT10]; Strategic Research Programme of the National Physical Laboratory; Scottish Universities Physics Alliance, IBM Research, and Engineering and Physical Sciences Research Council [EP/I029443/1, EP/I029516/1]; EPSRC [EP/I029443/1, EP/I029516/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I029516/1, EP/I029443/1] Funding Source: researchfish	United Kingdom Department of Business, Innovation and Skills; European Metrology Research Programme; Strategic Research Programme of the National Physical Laboratory; Scottish Universities Physics Alliance, IBM Research, and Engineering and Physical Sciences Research Council; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the United Kingdom Department of Business, Innovation and Skills, European Metrology Research Programme Grant HLT10, the Strategic Research Programme of the National Physical Laboratory, the Scottish Universities Physics Alliance, IBM Research, and Engineering and Physical Sciences Research Council Grants EP/I029443/1 (to J.C.) and EP/I029516/1 (to A.W. and P.J.J.).	Afacan NJ, 2012, CURR PHARM DESIGN, V18, P807, DOI 10.2174/138161212799277617; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Bonev BB, 2000, BIOCHEMISTRY-US, V39, P11425, DOI 10.1021/bi0001170; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Bulheller BM, 2009, J AM CHEM SOC, V131, P13305, DOI 10.1021/ja902662e; Cerasoli E, 2012, PHYS CHEM CHEM PHYS, V14, P1277, DOI 10.1039/c1cp23155c; De Crescenzo G, 2003, BIOCHEMISTRY-US, V42, P1754, DOI 10.1021/bi0268450; De Matteis MA, 2000, J CELL SCI, V113, P2331; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; GAZIT E, 1994, BIOCHEMISTRY-US, V33, P10681, DOI 10.1021/bi00201a016; Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200; Gourley DG, 2001, NAT STRUCT BIOL, V8, P521, DOI 10.1038/88584; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Hicks MR, 2010, CHEM SOC REV, V39, P3380, DOI 10.1039/b912917k; ISONO F, 1989, J ANTIBIOT, V42, P674, DOI 10.7164/antibiotics.42.674; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Knodler LA, 2011, CELL MICROBIOL, V13, P1497, DOI 10.1111/j.1462-5822.2011.01635.x; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MORRISETT JD, 1977, BIOCHIM BIOPHYS ACTA, V472, P93, DOI 10.1016/0304-4157(77)90015-6; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Naider F, 2009, CURR OPIN STRUC BIOL, V19, P473, DOI 10.1016/j.sbi.2009.07.003; Oh D, 2000, BIOCHEMISTRY-US, V39, P11855, DOI 10.1021/bi000453g; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Rose A, 2004, CELL MOL LIFE SCI, V61, P1996, DOI 10.1007/s00018-004-4039-6; ROZZELLE JE, 1994, PROTEIN SCI, V3, P345; Ryadnov MG, 2009, J AM CHEM SOC, V131, P13240, DOI 10.1021/ja905539h; Ryadnov MG, 2003, J AM CHEM SOC, V125, P9388, DOI 10.1021/ja0352045; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Sharma AK, 2008, J BIOL CHEM, V283, P32860, DOI 10.1074/jbc.M804916200; Simmaco M, 2009, BBA-BIOMEMBRANES, V1788, P1551, DOI 10.1016/j.bbamem.2009.01.004; Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866; Veit G, 2006, J BIOL CHEM, V281, P3494, DOI 10.1074/jbc.M509333200; Yang ST, 2006, BIOCHEMISTRY-US, V45, P1775, DOI 10.1021/bi051524k; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yoder NC, 2006, J AM CHEM SOC, V128, P188, DOI 10.1021/ja055494k; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147	38	26	26	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20162	20172		10.1074/jbc.M113.459560	http://dx.doi.org/10.1074/jbc.M113.459560			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23737519	Green Published, hybrid			2022-12-28	WOS:000321715100006
J	Benod, C; Carlsson, J; Uthayaruban, R; Hwang, P; Irwin, JJ; Doak, AK; Shoichet, BK; Sablin, EP; Fletterick, RJ				Benod, Cindy; Carlsson, Jens; Uthayaruban, Rubatharshini; Hwang, Peter; Irwin, John J.; Doak, Allison K.; Shoichet, Brian K.; Sablin, Elena P.; Fletterick, Robert J.			Structure-based Discovery of Antagonists of Nuclear Receptor LRH-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNALING PATHWAYS; MOLECULAR DOCKING; ESTROGEN-RECEPTOR; BETA-CATENIN; CANCER-CELLS; FORCE-FIELD; HOMOLOG-1; EXPRESSION; GENE; INHIBITORS	Liver receptor homolog 1 (nuclear receptor LRH-1, NR5A2) is an essential regulator of gene transcription, critical for maintenance of cell pluripotency in early development and imperative for the proper functions of the liver, pancreas, and intestines during the adult life. Although physiological hormones of LRH-1 have not yet been identified, crystallographic and biochemical studies demonstrated that LRH-1 could bind regulatory ligands and suggested phosphatidylinositols as potential hormone candidates for this receptor. No synthetic antagonists of LRH-1 are known to date. Here, we identify the first small molecule antagonists of LRH-1 activity. Our search for LRH-1 modulators was empowered by screening of 5.2 million commercially available compounds via molecular docking followed by verification of the top-ranked molecules using in vitro direct binding and transcriptional assays. Experimental evaluation of the predicted ligands identified two compounds that inhibit the transcriptional activity of LRH-1 and diminish the expression of the receptor's target genes. Among the affected transcriptional targets are co-repressor SHP (small heterodimer partner) as well as cyclin E1 (CCNE1) and G0S2 genes that are known to regulate cell growth and proliferation. Treatments of human pancreatic (AsPC-1), colon (HT29), and breast adenocarcinoma cells T47D and MDA-MB-468 with the LRH-1 antagonists resulted in the receptor-mediated inhibition of cancer cell proliferation. Our data suggest that specific antagonists of LRH-1 could be used as specific molecular probes for elucidating the roles of the receptor in different types of malignancies.	[Benod, Cindy; Uthayaruban, Rubatharshini; Hwang, Peter; Sablin, Elena P.; Fletterick, Robert J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Carlsson, Jens; Irwin, John J.; Doak, Allison K.; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fletterick, RJ (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St,GH S412E, San Francisco, CA 94158 USA.	Robert.Fletterick@ucsf.edu		Irwin, John/0000-0002-1195-6417; Carlsson, Jens/0000-0003-4623-2977	National Institutes of Health [GM59957, R01 DK078075, R21 CA140751]; Department of Defense Grant [W81XWH-12-1-0396]; California Breast Cancer Research Program; Knut and Alice Wallenberg Foundation; NATIONAL CANCER INSTITUTE [R21CA140751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071630, U01GM094614, R01GM059957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Grant(United States Department of Defense); California Breast Cancer Research Program; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM59957 (to B. K. S.) and R01 DK078075 and R21 CA140751 (to R. J. F.). This work was also supported by Department of Defense Grant W81XWH-12-1-0396 (to R. J. F.), by a fellowship from the California Breast Cancer Research Program (to C. B.), and a fellowship from the Knut and Alice Wallenberg Foundation (to J. C.).	Annicotte JS, 2005, ONCOGENE, V24, P8167, DOI 10.1038/sj.onc.1208950; Benod C, 2011, P NATL ACAD SCI USA, V108, P16927, DOI 10.1073/pnas.1112047108; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Carlsson J, 2010, J MED CHEM, V53, P3748, DOI 10.1021/jm100240h; Chand AL, 2010, ENDOCR-RELAT CANCER, V17, P965, DOI 10.1677/ERC-10-0179; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clyne CD, 2004, MOL CELL ENDOCRINOL, V215, P39, DOI 10.1016/j.mce.2003.11.001; Coan KED, 2008, J AM CHEM SOC, V130, P9606, DOI 10.1021/ja802977h; di Magliano MP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001155; Doak AK, 2010, J MED CHEM, V53, P4259, DOI 10.1021/jm100254w; Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w; Dube C, 2009, CANCER LETT, V275, P127, DOI 10.1016/j.canlet.2008.10.008; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Fayard E, 2003, J BIOL CHEM, V278, P35725, DOI 10.1074/jbc.M302370200; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Huang DZ, 2006, J AM CHEM SOC, V128, P5436, DOI 10.1021/ja0573108; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Kim JW, 2004, J CLIN ENDOCR METAB, V89, P3042, DOI 10.1210/jc.2003-031599; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Lee MB, 2005, MOL CELL BIOL, V25, P1879, DOI 10.1128/MCB.25.5.1879-1890.2005; Lee YK, 2006, J BIOL CHEM, V281, P7850, DOI 10.1074/jbc.M509115200; Li JB, 1998, J PHYS CHEM A, V102, P1820, DOI 10.1021/jp972682r; Lorber DM, 2005, CURR TOP MED CHEM, V5, P739, DOI 10.2174/1568026054637683; Lorber DM, 1998, PROTEIN SCI, V7, P938; Mataki C, 2007, MOL CELL BIOL, V27, P8330, DOI 10.1128/MCB.00852-07; Musille PM, 2012, NAT STRUCT MOL BIOL, V19, P532, DOI 10.1038/nsmb.2279; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Pike ACW, 2001, STRUCTURE, V9, P145, DOI 10.1016/S0969-2126(01)00568-8; Powers RA, 2002, STRUCTURE, V10, P1013, DOI 10.1016/S0969-2126(02)00799-2; Qin J, 2004, MOL ENDOCRINOL, V18, P2424, DOI 10.1210/me.2004-0009; Rey J, 2012, CHEMMEDCHEM, V7, P1909, DOI 10.1002/cmdc.201200307; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; Saif MW, 2010, CANCER J, V16, P196, DOI 10.1097/PPO.0b013e3181e076af; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; Schoonjans K, 2005, P NATL ACAD SCI USA, V102, P2058, DOI 10.1073/pnas.0409756102; Sheela SG, 2005, DEV BIOL, V286, P377, DOI 10.1016/j.ydbio.2005.06.023; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Sidler D, 2011, ONCOGENE, V30, P2411, DOI 10.1038/onc.2010.629; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Thiruchelvam PTR, 2011, BREAST CANCER RES TR, V127, P385, DOI 10.1007/s10549-010-0994-9; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang SL, 2008, MOL CELL BIOCHEM, V308, P93, DOI 10.1007/s11010-007-9616-1; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; WEINER SJ, 1986, J COMPUT CHEM, V7, P230, DOI 10.1002/jcc.540070216; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Whitby RJ, 2011, J MED CHEM, V54, P2266, DOI 10.1021/jm1014296; Wilkinson JM, 2008, J BIOMOL SCREEN, V13, P755, DOI 10.1177/1087057108322155; Wu YL, 2005, MOL CELL, V18, P413, DOI 10.1016/j.molcel.2005.04.014; Yumoto F, 2012, P NATL ACAD SCI USA, V109, P143, DOI 10.1073/pnas.1117036108	58	68	69	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19830	19844		10.1074/jbc.M112.411686	http://dx.doi.org/10.1074/jbc.M112.411686			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23667258	Green Published, hybrid			2022-12-28	WOS:000321515800051
J	McCallum, M; Shaw, GS; Creuzenet, C				McCallum, Matthew; Shaw, Gary S.; Creuzenet, Carole			Comparison of Predicted Epimerases and Reductases of the Campylobacter jejuni D-altro- and L-gluco-Heptose Synthesis Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-L-FUCOSE; HELICOBACTER-PYLORI; ESCHERICHIA-COLI; ACTIVE-SITE; GDP-4-KETO-6-DEOXY-D-MANNOSE EPIMERASE/REDUCTASE; O-ANTIGEN; BIOSYNTHESIS; POLYSACCHARIDE; MECHANISM; LIPOPOLYSACCHARIDES	Uniquely modified heptoses found in surface carbohydrates of bacterial pathogens are potential therapeutic targets against such pathogens. Our recent biochemical characterization of the GDP-6-deoxy-D-manno- and GDP-6-deoxy-D-altro-heptose biosynthesis pathways has provided the foundation for elucidation of the more complex L-gluco-heptose synthesis pathway of Campylobacter jejuni strain NCTC 11168. In this work we use GDP-4-keto, 6-deoxy-D-lyxo-heptose as a surrogate substrate to characterize three enzymes predicted to be involved in this pathway: WcaG(NCTC) (also known as Cj1427), MlghB (Cj1430), and MlghC (Cj1428). We compare them with homologues involved in D-altro-heptose production: WcaG(81176) (formerly WcaG), DdahB (Cjj1430), and DdahC (Cjj1427). We show that despite high levels of similarity, the enzymes have pathway-specific catalytic activities and substrate specificities. MlghB forms three products via C3 and C5 epimerization activities, whereas its DdahB homologue only had C3 epimerase activity along its cognate pathway. MlghC is specific for the double C3/C5 epimer generated by MlghB and produces L-gluco-heptose via stereospecific C4 reductase activity. In contrast, its homologue DdahC only uses the C3 epimer to yield D-altro-heptose via C4 reduction. Finally, we show that WcaG(NCTC) is not necessary for L-gluco-heptose synthesis and does not affect its production by MlghB and MlghC, in contrast to its homologue WcaG(81176), that has regulatory activity on D-altro-heptose synthesis. These studies expand our fundamental understanding of heptose modification, provide new glycobiology tools to synthesize novel heptose derivatives with biomedical applications, and provide a foundation for the structure function analysis of these enzymes.	[McCallum, Matthew; Creuzenet, Carole] Univ Western Ontario, Dept Microbiol & Immunol, Infect Dis Res Grp, London, ON N6A 5C1, Canada; [Shaw, Gary S.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Creuzenet, C (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Infect Dis Res Grp, DSB 3031, London, ON N6A 5C1, Canada.	ccreuzen@uwo.ca	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625	Natural Sciences and Engineering Research Council (NSERC) of Canada [RGPIN 240762-2010]; Canadian Institutes of Health Research [MOP 93520]; Canada Research Chairs program	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs program(Canada Research Chairs)	This work was supported through operating grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada (RGPIN 240762-2010]; to C. C.) and the Canadian Institutes of Health Research (MOP 93520) and the Canada Research Chairs program (to G. S.).	Angulo Frederick J, 2004, Semin Pediatr Infect Dis, V15, P78, DOI 10.1053/j.spid.2004.01.010; ASPINALL GO, 1992, CARBOHYD RES, V231, P13, DOI 10.1016/0008-6215(92)84003-B; Ayukawa T, 2012, P NATL ACAD SCI USA, V109, P15318, DOI 10.1073/pnas.1202369109; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; Bohaychuk VM, 2009, CAN VET J, V50, P173; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Butty FD, 2009, BIOCHEMISTRY-US, V48, P7764, DOI 10.1021/bi901065t; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Deckert A, 2010, J FOOD PROTECT, V73, P1317, DOI 10.4315/0362-028X-73.7.1317; Dong C, 2007, J MOL BIOL, V365, P146, DOI 10.1016/j.jmb.2006.09.063; Guerry P, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00007; Ho N, 2008, MOL MICROBIOL, V68, P424, DOI 10.1111/j.1365-2958.2008.06163.x; Jarvinen N, 2001, EUR J BIOCHEM, V268, P6458, DOI 10.1046/j.0014-2956.2001.02601.x; JOHN BK, 1993, J MAGN RESON SER A, V101, P113, DOI 10.1006/jmra.1993.1019; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; King JD, 2007, J MOL BIOL, V374, P749, DOI 10.1016/j.jmb.2007.09.055; Kirkpatrick BD, 2011, CURR OPIN GASTROEN, V27, P1, DOI 10.1097/MOG.0b013e3283413763; Lau STB, 2008, J AM CHEM SOC, V130, P17593, DOI 10.1021/ja807799k; Llull D, 2001, J BIOL CHEM, V276, P21053, DOI 10.1074/jbc.M010287200; Logan SM, 2005, GLYCOBIOLOGY, V15, P721, DOI 10.1093/glycob/cwi057; Major LL, 2005, J AM CHEM SOC, V127, P18309, DOI 10.1021/ja056490i; Maue AC, 2013, INFECT IMMUN, V81, P665, DOI 10.1128/IAI.01008-12; McCallum M, 2012, J BIOL CHEM, V287, P29776, DOI 10.1074/jbc.M112.390492; McCallum M, 2011, BIOCHEM J, V439, P235, DOI 10.1042/BJ20110890; Menon S, 1999, J BIOL CHEM, V274, P26743, DOI 10.1074/jbc.274.38.26743; Moran AP, 2001, J AUTOIMMUN, V16, P241, DOI 10.1006/jaut.2000.0490; Newton DT, 1999, BIOCHEM J, V339, P63, DOI 10.1042/0264-6021:3390063; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Rahim R, 2000, MICROBIOL-UK, V146, P2803, DOI 10.1099/00221287-146-11-2803; Rasko DA, 2001, J INFECT DIS, V184, P315, DOI 10.1086/322025; Reeves PR, 1996, TRENDS MICROBIOL, V4, P495, DOI 10.1016/S0966-842X(97)82912-5; Rizzi M, 1998, STRUCTURE, V6, P1453, DOI 10.1016/S0969-2126(98)00144-0; Rosano C, 2000, J MOL BIOL, V303, P77, DOI 10.1006/jmbi.2000.4106; Shashkov AS, 2001, CARBOHYD RES, V330, P289, DOI 10.1016/S0008-6215(00)00309-8; St Michael F, 2002, EUR J BIOCHEM, V269, P5119, DOI 10.1046/j.1432-1033.2002.03201.x; Stern RJ, 1999, MICROBIOL-UK, V145, P663, DOI 10.1099/13500872-145-3-663; Sternberg MJE, 2013, J MOL BIOL, V425, P186, DOI 10.1016/j.jmb.2012.10.014; Wu BY, 2001, BIOCHEM BIOPH RES CO, V285, P364, DOI 10.1006/bbrc.2001.5137; XIANG SH, 1993, J BACTERIOL, V175, P4877, DOI 10.1128/JB.175.15.4877-4884.1993; YAO ZJ, 1994, J BACTERIOL, V176, P4133, DOI 10.1128/JB.176.13.4133-4143.1994	41	18	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19569	19580		10.1074/jbc.M113.468066	http://dx.doi.org/10.1074/jbc.M113.468066			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689373	Green Published, hybrid			2022-12-28	WOS:000321515800023
J	Mendes-Pinto, MM; Galzerano, D; Telfer, A; Pascal, AA; Robert, B; Ilioaia, C				Mendes-Pinto, Maria M.; Galzerano, Denise; Telfer, Alison; Pascal, Andrew A.; Robert, Bruno; Ilioaia, Cristian			Mechanisms Underlying Carotenoid Absorption in Oxygenic Photosynthetic Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; PHOTOSYSTEM-II; BETA-CAROTENE; ELECTRONIC ABSORPTION; CRYSTAL-STRUCTURE; TRIPLET-STATES; SPECTRA; XANTHOPHYLLS; IDENTIFICATION; INSIGHTS	The electronic properties of carotenoid molecules underlie their multiple functions throughout biology, and tuning of these properties by their in vivo locus is of vital importance in a number of cases. This is exemplified by photosynthetic carotenoids, which perform both light-harvesting and photoprotective roles essential to the photosynthetic process. However, despite a large number of scientific studies performed in this field, the mechanism( s) used to modulate the electronic properties of carotenoids remain elusive. We have chosen two specific cases, the two beta-carotene molecules in photosystem II reaction centers and the two luteins in the major photosystem II light-harvesting complex, to investigate how such a tuning of their electronic structure may occur. Indeed, in each case, identical molecular species in the same protein are seen to exhibit different electronic properties (most notably, shifted absorption peaks). We assess which molecular parameters are responsible for this in vivo tuning process and attempt to assign it to specific molecular events imposed by their binding pockets.	[Mendes-Pinto, Maria M.; Galzerano, Denise; Pascal, Andrew A.; Robert, Bruno; Ilioaia, Cristian] Univ Paris 11, Inst Biol & Technol Saclay, CNRS, UMR 8221, F-91191 Gif Sur Yvette, France; [Telfer, Alison] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, London SW7 2AZ, England	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Imperial College London	Robert, B (corresponding author), Univ Paris 11, Inst Biol & Technol Saclay, CNRS, UMR 8221, F-91191 Gif Sur Yvette, France.	bruno.robert@cea.fr	Robert, Bruno/D-1264-2012; Pinto, Maria Manuela Mendes/M-2804-2013; pascal, andrew a/B-6186-2014	Robert, Bruno/0000-0001-5999-4538; pascal, andrew a/0000-0002-1844-6065; Mendes Pinto, Maria Manuela/0000-0001-7541-7335; ILIOAIA, Cristian/0000-0001-7505-1900	European Union program Marie Curie FP7 Initial Training Network HARVEST; European Research Council project PHOTPROT; French National Research Agency project Cyanoprotect; Commissariat a l'Energie Atomique-EUROTALENS program [PCOFUND-GA-2008-228664]	European Union program Marie Curie FP7 Initial Training Network HARVEST; European Research Council project PHOTPROT; French National Research Agency project Cyanoprotect(French National Research Agency (ANR)); Commissariat a l'Energie Atomique-EUROTALENS program	This work was supported by European Union program Marie Curie FP7 Initial Training Network HARVEST, by the European Research Council project PHOTPROT, and by the French National Research Agency project Cyanoprotect.; Supported by a Commissariat a l'Energie Atomique-EUROTALENS program under European Contract PCOFUND-GA-2008-228664.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; ANDERSSON PO, 1991, PHOTOCHEM PHOTOBIOL, V54, P353, DOI 10.1111/j.1751-1097.1991.tb02027.x; Andreeva A, 2011, SPECTROCHIM ACTA A, V78, P1261, DOI 10.1016/j.saa.2010.12.071; ARAKI G, 1952, PROG THEOR PHYS, V8, P639, DOI 10.1143/PTP.8.639; Britton G., 2008, CAROTENOIDS; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Cerezo J, 2012, J PHYS CHEM A, V116, P3498, DOI 10.1021/jp301485k; Chen ZG, 2006, J PHYS CHEM A, V110, P11291, DOI 10.1021/jp0643247; Christensen RL, 2004, ARCH BIOCHEM BIOPHYS, V430, P30, DOI 10.1016/j.abb.2004.02.026; COGDELL RJ, 1994, PURE APPL CHEM, V66, P1041; DALE J, 1954, ACTA CHEM SCAND, V8, P1235, DOI 10.3891/acta.chem.scand.08-1235; DURRANT JR, 1990, BIOCHIM BIOPHYS ACTA, V1017, P167, DOI 10.1016/0005-2728(90)90148-W; Foote C.S, 1976, FREE RADICALS BIOL, P85, DOI DOI 10.1016/B978-0-12-566502-5.50010-X; Gall A, 1999, BIOCHEMISTRY-US, V38, P5185, DOI 10.1021/bi982486q; Golibrzuch K, 2011, PHYS CHEM CHEM PHYS, V13, P6340, DOI 10.1039/c0cp02525a; HEMLEY R, 1977, BIOPHYS J, V20, P377, DOI 10.1016/S0006-3495(77)85556-2; HIRAYAMA K, 1955, J AM CHEM SOC, V77, P379, DOI 10.1021/ja01607a042; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ilioaia C, 2011, J BIOL CHEM, V286, P27247, DOI 10.1074/jbc.M111.234617; KUKI M, 1994, PHOTOCHEM PHOTOBIOL, V59, P116; KWA SLS, 1992, BIOCHIM BIOPHYS ACTA, V1099, P193; LEROSEN AL, 1952, J CHEM PHYS, V20, P233, DOI 10.1063/1.1700384; Liu WL, 2012, CHINESE J CHEM, V30, P2573, DOI 10.1002/cjoc.201200661; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Mendes-Pinto MM, 2013, J PHYS CHEM B, V117, P11015, DOI 10.1021/jp309908r; MERLIN JC, 1985, PURE APPL CHEM, V57, P785, DOI 10.1351/pac198557050785; MIMURO M, 1995, BBA-BIOENERGETICS, V1232, P81, DOI 10.1016/0005-2728(95)00116-2; Niyogi KK, 1997, P NATL ACAD SCI USA, V94, P14162, DOI 10.1073/pnas.94.25.14162; Papagiannakis E, 2002, P NATL ACAD SCI USA, V99, P6017, DOI 10.1073/pnas.092626599; Phillip D, 1996, P NATL ACAD SCI USA, V93, P1492, DOI 10.1073/pnas.93.4.1492; Polivka T, 2010, ACCOUNTS CHEM RES, V43, P1125, DOI 10.1021/ar100030m; Renge I, 2011, J PHOTOCH PHOTOBIO A, V218, P156, DOI 10.1016/j.jphotochem.2010.12.015; Robert B, 2004, TRENDS PLANT SCI, V9, P385, DOI 10.1016/j.tplants.2004.06.006; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 2000, FEBS LETT, V477, P181, DOI 10.1016/S0014-5793(00)01799-3; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; Standfuss R, 2005, EMBO J, V24, P919, DOI 10.1038/sj.emboj.7600585; SUZUKI H, 1964, J PHYS SOC JPN, V19, P724, DOI 10.1143/JPSJ.19.724; TAKAHASHI Y, 1987, BIOCHIM BIOPHYS ACTA, V893, P49, DOI 10.1016/0005-2728(87)90147-2; Tomo T, 1997, BBA-BIOENERGETICS, V1321, P21, DOI 10.1016/S0005-2728(97)00037-6; TRUSCOTT TG, 1973, PHOTOCHEM PHOTOBIOL, V17, P43, DOI 10.1111/j.1751-1097.1973.tb06329.x; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANDORSSEN RJ, 1987, BIOCHIM BIOPHYS ACTA, V893, P267, DOI 10.1016/0005-2728(87)90048-X; Wang P, 2005, CHEM PHYS LETT, V410, P108, DOI 10.1016/j.cplett.2005.05.037; Wilson A, 2008, P NATL ACAD SCI USA, V105, P12075, DOI 10.1073/pnas.0804636105; Wirtz AC, 2007, BIOPHYS J, V93, P981, DOI 10.1529/biophysj.106.103473; Yan HC, 2007, BIOCHEM BIOPH RES CO, V355, P457, DOI 10.1016/j.bbrc.2007.01.172	48	33	33	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18758	18765		10.1074/jbc.M112.423681	http://dx.doi.org/10.1074/jbc.M112.423681			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23720734	hybrid, Green Published			2022-12-28	WOS:000321335800011
J	Yi, TF; Papadopoulos, E; Hagner, PR; Wagner, G				Yi, Tingfang; Papadopoulos, Evangelos; Hagner, Patrick R.; Wagner, Gerhard			Hypoxia-inducible Factor-1 alpha (HIF-1 alpha) Promotes Cap-dependent Translation of Selective mRNAs through Up-regulating Initiation Factor eIF4E1 in Breast Cancer Cells under Hypoxia Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; TUMOR-GROWTH; STEM-CELLS; PROTEIN-SYNTHESIS; FACTOR EIF-4E; FACTOR 4E; OVEREXPRESSION; ANGIOGENESIS; PHOSPHORYLATION	Hypoxia promotes tumor evolution and metastasis, and hypoxia-inducible factor-1 alpha (HIF-1 alpha) is a key regulator of hypoxia-related cellular processes in cancer. The eIF4E translation initiation factors, eIF4E1, eIF4E2, and eIF4E3, are essential for translation initiation. However, whether and how HIF-1 alpha affects cap-dependent translation through eIF4Es in hypoxic cancer cells has been unknown. Here, we report that HIF-1 alpha promoted cap-dependent translation of selective mRNAs through up-regulation of eIF4E1 in hypoxic breast cancer cells. Hypoxia-promoted breast cancer tumorsphere growth was HIF-1 alpha-dependent. We found that eIF4E1, not eIF4E2 or eIF4E3, is the dominant eIF4E family member in breast cancer cells under both normoxia and hypoxia conditions. eIF4E3 expression was largely sequestered in breast cancer cells at normoxia and hypoxia. Hypoxia up-regulated the expression of eIF4E1 and eIF4E2, but only eIF4E1 expression was HIF-1 alpha-dependent. In hypoxic cancer cells, HIF-1 alpha-up-regulated eIF4E1 enhanced cap-dependent translation of a subset of mRNAs encoding proteins important for breast cancer cell mammosphere growth. In searching for correlations, we discovered that human eIF4E1 promoter harbors multiple potential hypoxia response elements. Furthermore, using chromatin immunoprecipitation (ChIP) and luciferase and point mutation assays, we found that HIF-1 alpha utilized hypoxia response elements in the human eIF4E1 proximal promoter region to activate eIF4E1 expression. Our study suggests that HIF-1 alpha promotes cap-dependent translation of selective mRNAs through up-regulating eIF4E1, which contributes to tumorsphere growth of breast cancer cells at hypoxia. The data shown provide new insights into protein synthesis mechanisms in cancer cells at low oxygen levels.	[Yi, Tingfang; Papadopoulos, Evangelos; Hagner, Patrick R.; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	Gerhard_Wagner@hms.harvard.edu			National Institutes of Health [RO1 CA068262]; NATIONAL CANCER INSTITUTE [R01CA068262] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 CA068262 (to G. W.).	Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bauer C, 2002, INT J CANCER, V98, P181, DOI 10.1002/ijc.10180; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Bolat F, 2010, PATHOL RES PRACT, V206, P19, DOI 10.1016/j.prp.2009.07.017; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chung J, 2006, ONCOGENE, V25, P3079, DOI 10.1038/sj.onc.1209328; Coleman LJ, 2009, BRIT J CANCER, V100, P1393, DOI 10.1038/sj.bjc.6605044; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Elson DA, 2000, CANCER RES, V60, P6189; Fan SQ, 2009, CANCER BIOL THER, V8, P1463, DOI 10.4161/cbt.8.15.8960; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FREDERICKSON RM, 1991, MOL CELL BIOL, V11, P2896, DOI 10.1128/MCB.11.5.2896; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Guo P, 2003, CANCER RES, V63, P4684; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Hoskin PJ, 2003, BRIT J CANCER, V89, P1290, DOI 10.1038/sj.bjc.6601260; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Jiang BH, 1997, CANCER RES, V57, P5328; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Knaup KX, 2009, MOL CANCER RES, V7, P88, DOI 10.1158/1541-7786.MCR-08-0288; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Liu NA, 2011, P NATL ACAD SCI USA, V108, P8414, DOI 10.1073/pnas.1018091108; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Mathupala SP, 2001, J BIOL CHEM, V276, P43407, DOI 10.1074/jbc.M108181200; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; MIYAGI Y, 1995, CANCER LETT, V91, P247, DOI 10.1016/0304-3835(95)03737-H; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Noske A, 2008, ONCOL REP, V20, P1409, DOI 10.3892/or_00000160; Osborne MJ, 2013, P NATL ACAD SCI USA, V110, P3877, DOI 10.1073/pnas.1216862110; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Salehi Z, 2006, CLIN BIOCHEM, V39, P404, DOI 10.1016/j.clinbiochem.2005.11.007; Scarpino S, 2004, J PATHOL, V202, P352, DOI 10.1002/path.1522; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Tanaka H, 2006, CANCER RES, V66, P11263, DOI 10.1158/0008-5472.CAN-06-1699; Tejada S, 2009, J HISTOCHEM CYTOCHEM, V57, P503, DOI 10.1369/jhc.2009.952929; Thomas JD, 2008, RNA, V14, P771, DOI 10.1261/rna.857308; Thumma SC, 2007, CANCER LETT, V258, P1, DOI 10.1016/j.canlet.2007.08.022; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Yi TF, 2010, J BIOL CHEM, V285, P17811, DOI 10.1074/jbc.M110.130740; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Young RM, 2008, J BIOL CHEM, V283, P16309, DOI 10.1074/jbc.M710079200; Zhang HJ, 2012, BLOOD, V119, P2595, DOI 10.1182/blood-2011-10-387381; Zhong H, 1999, CANCER RES, V59, P5830; Zhu KY, 2009, CANCER RES, V69, P1836, DOI 10.1158/0008-5472.CAN-08-4103	64	45	47	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18732	18742		10.1074/jbc.M113.471466	http://dx.doi.org/10.1074/jbc.M113.471466			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23667251	hybrid, Green Published			2022-12-28	WOS:000321335800009
J	Chandler, JD; Nichols, DP; Nick, JA; Hondal, RJ; Day, BJ				Chandler, Joshua D.; Nichols, David P.; Nick, Jerry A.; Hondal, Robert J.; Day, Brian J.			Selective Metabolism of Hypothiocyanous Acid by Mammalian Thioredoxin Reductase Promotes Lung Innate Immunity and Antioxidant Defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; LACTOPEROXIDASE-THIOCYANATE; CYSTIC-FIBROSIS; MYELOPEROXIDASE; INHIBITION; SYSTEM; OXIDATION; GLUTATHIONE; SALIVA; CHLORINATION	The endogenously produced oxidant hypothiocyanous acid (HOSCN) inhibits and kills pathogens but paradoxically is well tolerated by mammalian host tissue. Mammalian high molecular weight thioredoxin reductase (H-TrxR) is evolutionarily divergent from bacterial low molecular weight thioredoxin reductase (L-TrxR). Notably, mammalian H-TrxR contains a selenocysteine (Sec) and has wider substrate reactivity than L-TrxR. Recombinant rat cytosolic H-TrxR1, mouse mitochondrial H-TrxR2, and a purified mixture of both from rat selectively turned over HOSCN (k(cat) = 357 +/- 16 min(-1); K-m = 31.9 +/- 10.3 mu M) but were inactive against the related oxidant hypochlorous acid. Replacing Sec with Cys or deleting the final eight C-terminal peptides decreased affinity and turnover of HOSCN by H-TrxR. Similarly, glutathione reductase (an H-TrxR homologue lacking Sec) was less effective at HOSCN turnover. In contrast to H-TrxR and glutathione reductase, recombinant Escherichia coli L-TrxR was potently inhibited by HOSCN (IC50 = 2.75 mu M). Similarly, human bronchial epithelial cell (16HBE) lysates metabolized HOSCN, but E. coli and Pseudomonas aeruginosa lysates had little or no activity. HOSCN selectively produced toxicity in bacteria, whereas hypochlorous acid was nonselectively toxic to both bacteria and 16HBE. Treatment with the H-TrxR inhibitor auranofin inhibited HOSCN metabolism in 16HBE lysates and significantly increased HOSCN-mediated cytotoxicity. These findings demonstrate both the metabolism of HOSCN by mammalian H-TrxR resulting in resistance to HOSCN in mammalian cells and the potent inhibition of bacterial L-TrxR resulting in cytotoxicity in bacteria. These data support a novel selective mechanism of host defense in mammals wherein HOSCN formation simultaneously inhibits pathogens while sparing host tissue.	[Chandler, Joshua D.; Day, Brian J.] Univ Colorado Denver, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Chandler, Joshua D.; Nichols, David P.; Nick, Jerry A.; Day, Brian J.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Nichols, David P.; Nick, Jerry A.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Hondal, Robert J.] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; National Jewish Health; University of Vermont	Day, BJ (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St, Denver, CO 80206 USA.	dayb@njhealth.org		Nichols, David/0000-0001-8611-7960	National Institutes of Health [HL084469]; Cystic Fibrosis Foundation; CCTSI KL2 Scholars Grant [TR000156]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001080, KL2TR000156, UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); CCTSI KL2 Scholars Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL084469 (to B. J. D.). This work was also supported by a Cystic Fibrosis Foundation research grant (to B. J. D. and D. P. N.) and CCTSI KL2 Scholars Grant TR000156 (to D. P. N.).	Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; [Anonymous], BIOCH PHARM, V84, P1381; Arlandson M, 2001, J BIOL CHEM, V276, P215, DOI 10.1074/jbc.M004881200; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Chapman ALP, 2002, J BIOL CHEM, V277, P9757, DOI 10.1074/jbc.M106134200; Courtois P, 1996, BIOCHEM MOL MED, V57, P134, DOI 10.1006/bmme.1996.0019; DAS D, 1995, BIOCHEM J, V305, P59, DOI 10.1042/bj3050059; Eckenroth B, 2006, BIOCHEMISTRY-US, V45, P5158, DOI 10.1021/bi0517887; Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Fenoll-Palomares C, 2004, REV ESP ENFERM DIG, V96, P773; Fragoso MA, 2004, J PHYSIOL-LONDON, V561, P183, DOI 10.1113/jphysiol.2004.071548; Gould NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-119; Hilliard Jay B, 2002, Methods Mol Med, V70, P409; Hirt RP, 2002, TRENDS PARASITOL, V18, P302, DOI 10.1016/S1471-4922(02)02293-6; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Hondal RJ, 2011, AMINO ACIDS, V41, P73, DOI 10.1007/s00726-010-0494-6; Kariya C, 2008, INFECT IMMUN, V76, P4455, DOI 10.1128/IAI.00136-08; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kostikas K, 2002, AM J RESP CRIT CARE, V165, P1364, DOI 10.1164/rccm.200111-068OC; LENANDERLUMIKARI M, 1992, ORAL MICROBIOL IMMUN, V7, P315, DOI 10.1111/j.1399-302X.1992.tb00595.x; Lorentzen D, 2011, FREE RADICAL BIO MED, V50, P1144, DOI 10.1016/j.freeradbiomed.2011.02.013; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Lu J, 2013, FASEB J, V27, P1394, DOI 10.1096/fj.12-223305; Marzano C, 2007, FREE RADICAL BIO MED, V42, P872, DOI 10.1016/j.freeradbiomed.2006.12.021; MIKOLA H, 1995, ANTIVIR RES, V26, P161, DOI 10.1016/0166-3542(94)00073-H; Minarowski L, 2008, FOLIA HISTOCHEM CYTO, V46, P245, DOI 10.2478/v10042-008-0037-0; Nagy P, 2006, BIOCHEMISTRY-US, V45, P12610, DOI 10.1021/bi061015y; Nagy P, 2009, CHEM RES TOXICOL, V22, P1833, DOI 10.1021/tx900249d; ORAM JD, 1966, BIOCHEM J, V100, P373, DOI 10.1042/bj1000373; REITER B, 1976, INFECT IMMUN, V13, P800, DOI 10.1128/IAI.13.3.800-807.1976; Senthilmohan R, 2006, ARCH BIOCHEM BIOPHYS, V445, P235, DOI 10.1016/j.abb.2005.07.005; Skaff O, 2012, BIOCHEM J, V441, P305, DOI 10.1042/BJ20101762; Souza CEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027641; Stacey MM, 2012, ANTIOXID REDOX SIGN, V17, P411, DOI 10.1089/ars.2011.4348; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; TENOVUO J, 1985, ANTIMICROB AGENTS CH, V27, P96, DOI 10.1128/AAC.27.1.96; TENOVUO J, 1982, J DENT RES, V61, P982, DOI 10.1177/00220345820610081301; vanDalen CJ, 1997, BIOCHEM J, V327, P487; Wang JG, 2006, J IMMUNOL, V177, P8714, DOI 10.4049/jimmunol.177.12.8714; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Wu WJ, 1999, J BIOL CHEM, V274, P25933, DOI 10.1074/jbc.274.36.25933; Xu YP, 2009, P NATL ACAD SCI USA, V106, P20515, DOI 10.1073/pnas.0911412106; Xulu BA, 2010, BIOCHEMISTRY-US, V49, P2068, DOI 10.1021/bi902089w; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637; ZIEGENHORN J, 1976, CLIN CHEM, V22, P151	47	45	46	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18421	18428		10.1074/jbc.M113.468090	http://dx.doi.org/10.1074/jbc.M113.468090			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23629660	hybrid, Green Published			2022-12-28	WOS:000320721900044
J	Liu, Z; Ioerger, TR; Wang, F; Sacchettini, JC				Liu, Zhen; Ioerger, Thomas R.; Wang, Feng; Sacchettini, James C.			Structures of Mycobacterium tuberculosis FadD10 Protein Reveal a New Type of Adenylate-forming Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC GENE-CLUSTER; ACYL-COA SYNTHETASE; NONRIBOSOMAL PEPTIDE SYNTHETASE; CRYSTAL-STRUCTURE; COENZYME; IDENTIFICATION; CLONING; OVEREXPRESSION; PURIFICATION; MYCOSUBTILIN	Mycobacterium tuberculosis has a group of 34 FadD proteins that belong to the adenylate-forming superfamily. They are classified as either fatty acyl-AMP ligases (FAALs) or fatty acyl-CoA ligases based on sequence analysis. FadD10, involved in the synthesis of a virulence-related lipopeptide, was mis-annotated as a fatty acyl-CoA ligase; however, it is in fact a FAAL that transfers fatty acids to an acyl carrier protein (Rv0100). In this study, we have determined the structures of FadD10 in both the apo-form and the complexed form with dodecanoyl-AMP, where we see for the first time an adenylate-forming enzyme that does not adopt a closed conformation for catalysis. Indeed, this novel conformation of FadD10, facilitated by its unique inter-domain and intermolecular interactions, is critical for the enzyme to carry out the acyl transfer onto Rv0100 rather than coenzyme A. This contradicts the existing model of FAALs that rely on an insertion motif for the acyltransferase specificity and thus makes FadD10 a new type of FAAL. We have also characterized the fatty acid preference of FadD10 through biological and structural analyses, and the data indicate long chain saturated fatty acids as the biological substrates of the enzyme.	[Liu, Zhen; Sacchettini, James C.] Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA; [Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA; [Wang, Feng] Calif Inst Biomed Res, La Jolla, CA 92037 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Sacchettini, JC (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77842 USA.	sacchett@tamu.edu		Wang, Feng/0000-0003-2980-4646	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Li-Wei Hung at the Advanced Light Source for collecting the diffraction data of the apo-FadD10. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231. We thank Amir Safi and Tracey Musa for editing the manuscript and Dr. Inna Krieger, Anup Aggarwal, and Mallikarjun Lalgondar for helpful comments on the manuscript.	Abe T, 2008, J BIOL CHEM, V283, P11312, DOI 10.1074/jbc.M709654200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersson CS, 2012, STRUCTURE, V20, P1062, DOI 10.1016/j.str.2012.03.012; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; Baltz RH, 2006, J IND MICROBIOL BIOT, V33, P66, DOI 10.1007/s10295-005-0030-y; Billman-Jacobe H, 1999, MOL MICROBIOL, V33, P1244, DOI 10.1046/j.1365-2958.1999.01572.x; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Casabon I, 2013, MOL MICROBIOL, V87, P269, DOI 10.1111/mmi.12095; Chhabra A, 2012, P NATL ACAD SCI USA, V109, P5681, DOI 10.1073/pnas.1118680109; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Duckworth BP, 2012, CURR TOP MED CHEM, V12, P766; Duitman EH, 1999, P NATL ACAD SCI USA, V96, P13294, DOI 10.1073/pnas.96.23.13294; Dunphy KY, 2010, J INFECT DIS, V201, P1232, DOI 10.1086/651452; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fraga H, 2004, CHEMBIOCHEM, V5, P110, DOI 10.1002/cbic.200300735; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Goyal A, 2012, J MOL BIOL, V416, P221, DOI 10.1016/j.jmb.2011.12.031; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Hansen DB, 2007, J AM CHEM SOC, V129, P6366, DOI 10.1021/ja070890j; Heinzelmann E, 2005, MICROBIOL-SGM, V151, P1963, DOI 10.1099/mic.0.27844-0; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Hotter GS, 2005, J BACTERIOL, V187, P2267, DOI 10.1128/JB.187.7.2267-2277.2005; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Linne U, 2007, FEBS LETT, V581, P905, DOI 10.1016/j.febslet.2007.01.066; Luft T, 2005, ARCH MICROBIOL, V183, P277, DOI 10.1007/s00203-005-0770-0; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Miao V, 2005, MICROBIOL-SGM, V151, P1507, DOI 10.1099/mic.0.27757-0; Miao V, 2006, J IND MICROBIOL BIOT, V33, P129, DOI 10.1007/s10295-005-0028-5; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Mohanty D, 2011, TUBERCULOSIS, V91, P448, DOI 10.1016/j.tube.2011.04.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pojer F, 2002, MICROBIOL-SGM, V148, P3901, DOI 10.1099/00221287-148-12-3901; Raman S, 2006, J BACTERIOL, V188, P8460, DOI 10.1128/JB.01212-06; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rindi L, 2004, MICROBIOLOGICA, V27, P125; Rottig M, 2011, NUCLEIC ACIDS RES, V39, pW362, DOI 10.1093/nar/gkr323; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; Schmutz E, 2003, EUR J BIOCHEM, V270, P4413, DOI 10.1046/j.1432-1033.2003.03830.x; Shah MB, 2009, PROTEINS, V77, P685, DOI 10.1002/prot.22482; Simeone R, 2010, FEBS J, V277, P2715, DOI [10.1111/j.1742-4658.2010.07688.x, 10.1111/j.1742-464X.2010.07688.x]; Steffensky M, 2000, J BIOL CHEM, V275, P21754, DOI 10.1074/jbc.M003066200; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wang F, 2007, CHEM BIOL, V14, P543, DOI 10.1016/j.chembiol.2007.04.005; Zhang ZN, 2011, J MOL BIOL, V406, P313, DOI 10.1016/j.jmb.2010.12.011	53	26	26	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18473	18483		10.1074/jbc.M113.466912	http://dx.doi.org/10.1074/jbc.M113.466912			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23625916	Green Published, hybrid			2022-12-28	WOS:000320721900049
J	Wang, N; Zimmerman, K; Raab, RW; McKown, RL; Hutnik, CML; Talla, V; Tyler, MF; Lee, JK; Laurie, GW				Wang, Ningning; Zimmerman, Keith; Raab, Ronald W.; McKown, Robert L.; Hutnik, Cindy M. L.; Talla, Venu; Tyler, Milton F.; Lee, Jae K.; Laurie, Gordon W.			Lacritin Rescues Stressed Epithelia via Rapid Forkhead Box O3 (FOXO3)-associated Autophagy That Restores Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSECRETORY MITOGEN LACRITIN; DRY EYE; NEGATIVE REGULATOR; PROTEOMIC ANALYSES; SIGNALING PATHWAY; BINDING-PROTEIN; LACRIMAL GLAND; CELLS; DEGRADATION; DISEASE	Homeostasis is essential for cell survival. However, homeostatic regulation of surface epithelia is poorly understood. The eye surface, lacking the cornified barrier of skin, provides an excellent model. Tears cover the surface of the eye and are deficient in dry eye, the most common eye disease affecting at least 5% of the world's population. Only a tiny fraction of the tear proteome appears to be affected, including lacritin, an epithelium-selective mitogen that promotes basal tearing when topically applied to rabbit eyes. Here we show that homeostasis of cultured corneal epithelia is entirely lacritin-dependent and elucidate the mechanism as a rapid autophagic flux to promptly restore cellular metabolism and mitochondrial fusion in keeping with the short residence time of lacritin on the eye. Accelerated flux appears to be derived from lacritin-stimulated acetylation of FOXO3 as a novel ligand for ATG101 and coupling of stress-acetylated FOXO1 with ATG7(which remains uncoupled without lacritin) and be sufficient to selectively divert huntingtin mutant Htt103Q aggregates largely without affecting non-aggregated Htt25Q. This is in keeping with stress as a prerequisite for lacritin-stimulated autophagy. Lacritin targets the cell surface proteoglycan syndecan-1 via its C-terminal amino acids Leu(108)-Leu(109)-Phe(112) and is also available in saliva, plasma, and lung lavage. Thus, lacritin may promote epithelial homeostasis widely.	[Wang, Ningning; Zimmerman, Keith; Talla, Venu; Tyler, Milton F.; Laurie, Gordon W.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; [Lee, Jae K.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Lee, Jae K.] Univ Virginia, Dept Syst & Informat Engn, Charlottesville, VA 22908 USA; [Laurie, Gordon W.] Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22908 USA; [Raab, Ronald W.; McKown, Robert L.] James Madison Univ, Dept Integrated Sci & Technol, Harrisonburg, VA 22807 USA; [Hutnik, Cindy M. L.] Univ Western Ontario, Dept Ophthalmol, London, ON N6A 4V2, Canada	University of Virginia; University of Virginia; University of Virginia; University of Virginia; James Madison University; Western University (University of Western Ontario)	Laurie, GW (corresponding author), Univ Virginia, Dept Cell Biol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	glaurie@virginia.edu	Laurie, Gordon W/A-5244-2008	Laurie, Gordon W/0000-0002-5311-2650; Talla, Venu/0000-0002-5695-7536; Tyler IV, Milton/0000-0002-9870-0755	National Institutes of Health [RO1 EY013143, EY018222]; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013143, R01EY018222] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 EY013143 and EY018222 (to G. W. L.).	Barabino S, 2012, PROG RETIN EYE RES, V31, P271, DOI 10.1016/j.preteyeres.2012.02.003; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Campesan S, 2011, CURR BIOL, V21, P961, DOI 10.1016/j.cub.2011.04.028; Chen LY, 2011, J PROTEOME RES, V10, P4876, DOI 10.1021/pr2004874; Ciani B, 2003, J BIOL CHEM, V278, P37409, DOI 10.1074/jbc.M307416200; Duran A, 2011, MOL CELL, V44, P134, DOI 10.1016/j.molcel.2011.06.038; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fleiszig SMJ, 2003, INFECT IMMUN, V71, P3866, DOI 10.1128/IAI.71.7.3866-3874.2003; Green-Church KB, 2008, MOL VIS, V14, P291; Grzelkowska-Kowalczyk K, 2010, CELL MOL BIOL LETT, V15, P13, DOI 10.2478/s11658-009-0033-1; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Herok GH, 2009, CURR EYE RES, V34, P589, DOI 10.1080/02713680902972366; Hosokawa N, 2009, AUTOPHAGY, V5, P973, DOI 10.4161/auto.5.7.9296; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Kakazu A, 2004, INVEST OPHTH VIS SCI, V45, P3485, DOI 10.1167/iovs.04-0372; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; Koo BS, 2005, J PROTEOME RES, V4, P719, DOI 10.1021/pr0498133; Lam H, 2009, AM J OPHTHALMOL, V147, P198, DOI 10.1016/j.ajo.2008.08.032; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Landgraf P, 2008, J BIOL CHEM, V283, P25036, DOI 10.1074/jbc.M800963200; Lara-Pezzi E, 2007, J CELL BIOL, V179, P1205, DOI 10.1083/jcb.200704179; Laurie GW, 2008, OPTOMETRY VISION SCI, V85, P643, DOI 10.1097/OPX.0b013e318181ae73; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; LOHMANDER LS, 1979, J BIOL CHEM, V254, P551; Ma PS, 2008, EXP EYE RES, V86, P457, DOI 10.1016/j.exer.2007.01.025; Ma PS, 2006, J CELL BIOL, V174, P1097, DOI 10.1083/jcb.200511134; Malik SA, 2011, CELL CYCLE, V10, P2917, DOI 10.4161/cc.10.17.17067; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; McKown RL, 2009, EXP EYE RES, V88, P848, DOI 10.1016/j.exer.2008.09.002; Mercer CA, 2009, AUTOPHAGY, V5, P649, DOI 10.4161/auto.5.5.8249; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nichols JJ, 2009, CORNEA, V28, P1109, DOI 10.1097/ICO.0b013e3181a2ad81; Ozyildirim AM, 2005, INVEST OPHTH VIS SCI, V46, P1572, DOI 10.1167/iovs.04-1380; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; Qi H, 2008, EXP EYE RES, V87, P580, DOI 10.1016/j.exer.2008.09.012; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; RIGGS TR, 1948, J BIOL CHEM, V172, P539; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schenk S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-41; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Seifert K, 2012, INVEST OPHTH VIS SCI, V53, P6610, DOI 10.1167/iovs.11-8729; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Sinha RA, 2012, J CLIN INVEST, V122, P2428, DOI 10.1172/JCI60580; Srinivasan S, 2012, INVEST OPHTH VIS SCI, V53, P5052, DOI 10.1167/iovs.11-9022; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; van Grevenynghe J, 2008, NAT MED, V14, P266, DOI 10.1038/nm1728; Velez VF, 2013, INVEST OPHTH VIS SCI, V54, P2123, DOI 10.1167/iovs.12-11488; Wang JH, 2006, J CELL BIOL, V174, P689, DOI 10.1083/jcb.200605140; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Wu ZH, 2007, J BIOL CHEM, V282, P22414, DOI 10.1074/jbc.M702321200; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yoon K, 2008, CELL DEATH DIFFER, V15, P730, DOI 10.1038/sj.cdd.4402304; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang YH, 2013, J BIOL CHEM, V288, P12090, DOI 10.1074/jbc.M112.422717; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069; Zheng XF, 2010, CORNEA, V29, P1048, DOI 10.1097/ICO.0b013e3181cf98ff; Zhou L, 2009, J PROTEOME RES, V8, P4889, DOI 10.1021/pr900686s	72	36	38	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18146	18161		10.1074/jbc.M112.436584	http://dx.doi.org/10.1074/jbc.M112.436584			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23640897	hybrid, Green Published			2022-12-28	WOS:000320721900020
J	Xu, XM; Kobayashi, S; Chen, K; Timm, D; Volden, P; Huang, Y; Gulick, J; Yue, ZY; Robbins, J; Epstein, PN; Liang, QR				Xu, Xianmin; Kobayashi, Satoru; Chen, Kai; Timm, Derek; Volden, Paul; Huang, Yuan; Gulick, James; Yue, Zhenyu; Robbins, Jeffrey; Epstein, Paul N.; Liang, Qiangrong			Diminished Autophagy Limits Cardiac Injury in Mouse Models of Type 1 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED CARDIOMYOCYTE INJURY; HIGH-RISK PATIENTS; VITAMIN-E; CARDIOVASCULAR EVENTS; OXIDATIVE STRESS; HEMODYNAMIC STRESS; PATHOGENIC ROLE; HEART-FAILURE; DEATH PLAYS	Cardiac autophagy is inhibited in type 1 diabetes. However, it remains unknown if the reduced autophagy contributes to the pathogenesis of diabetic cardiomyopathy. We addressed this question using mouse models with gain-and loss-of-autophagy. Autophagic flux was inhibited in diabetic hearts when measured at multiple time points after diabetes induction by streptozotocin as assessed by protein levels of microtubule-associated protein light chain 3 form 2 (LC3-II) or GFP-LC3 puncta in the absence and presence of the lysosome inhibitor bafilomycin A1. Autophagy in diabetic hearts was further reduced in beclin 1- or Atg16-deficient mice but was restored partially or completely by overexpression of beclin 1 to different levels. Surprisingly, diabetes-induced cardiac damage was substantially attenuated in beclin 1- and Atg16-deficient mice as shown by improved cardiac function as well as reduced levels of oxidative stress, interstitial fibrosis, and myocyte apoptosis. In contrast, diabetic cardiac damage was dose-dependently exacerbated by beclin 1 overexpression. The cardioprotective effects of autophagy deficiency were reproduced in OVE26 diabetic mice. These effects were associated with partially restored mitophagy and increased expression and mitochondrial localization of Rab9, an essential regulator of a non-canonical alternative autophagic pathway. Together, these findings demonstrate that the diminished autophagy is an adaptive response that limits cardiac dysfunction in type 1 diabetes, presumably through up-regulation of alternative autophagy and mitophagy.	[Xu, Xianmin; Kobayashi, Satoru; Chen, Kai; Timm, Derek; Volden, Paul; Huang, Yuan; Liang, Qiangrong] Univ S Dakota, Sanford Sch Med, Cardiovasc Hlth Res Ctr, Dept Internal Med, Sioux Falls, SD 57104 USA; [Robbins, Jeffrey] Cincinnati Childrens Hosp Med Ctr, Div Mol Cardiovasc Biol, Cincinnati, OH 45229 USA; [Yue, Zhenyu] Mt Sinai Sch Med, Dept Neurol & Neurosci, New York, NY 10029 USA; [Epstein, Paul N.] Univ Louisville, Dept Pediat & Pharmacol, Louisville, KY 40202 USA; [Epstein, Paul N.] Univ Louisville, Dept Toxicol, Louisville, KY 40202 USA	University of South Dakota; Cincinnati Children's Hospital Medical Center; Icahn School of Medicine at Mount Sinai; University of Louisville; University of Louisville	Liang, QR (corresponding author), NY Inst Technol, Dept Biomed Sci, Coll Osteopath Med, Old Westbury, NY 11568 USA.	qliang03@nyit.edu		Epstein, Paul/0000-0002-7006-8954	American Diabetes Association [1-09-CD-09]; Juvenile Diabetes Research Foundation; National Institutes of Health National Center for Research Resources [5P20RR017662-10]; NIGMS [8 P20 GM103455-10]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017662] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103455] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Career Development Grant 1-09-CD-09) from the American Diabetes Association. Parts of this study were presented at the 71st and 72nd Scientific Sessions of the American Diabetes Association, San Diego, California, June 24-28, 2011 and in Philadelphia, PA, June 8-12, 2012.; Supported by an Advanced Postdoctoral Fellowship from the Juvenile Diabetes Research Foundation.; We thank Dr. Herbert W. Virgin from the Washington University School of Medicine for generous donation of the ATG16L1-HM mice and Dr. Noboru Mizushima from Tokyo Medical and Dental University for the GFP-LC3 mice. We are grateful to the Physiology Core Facility at the Sanford Research/USD for performing echocardiographic and hemodynamic measurements. We also thank the Imaging Core Facility for assistance with confocal microscopy. These core facilities are supported by National Institutes of Health National Center for Research Resources Grant 5P20RR017662-10 and NIGMS Grant 8 P20 GM103455-10.	Akazawa H, 2004, J BIOL CHEM, V279, P41095, DOI 10.1074/jbc.M313084200; BELL DSH, 1995, DIABETES CARE, V18, P708, DOI 10.2337/diacare.18.5.708; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Bugger H, 2010, CARDIOVASC RES, V88, P229, DOI 10.1093/cvr/cvq239; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Codogno P, 2012, NAT REV MOL CELL BIO, V13, P7, DOI 10.1038/nrm3249; Cuervo AM, 2005, AUTOPHAGY, V1, P131, DOI 10.4161/auto.1.3.2017; Fiordaliso F, 2004, J MOL CELL CARDIOL, V37, P959, DOI 10.1016/j.yjmcc.2004.07.008; Fujimoto K, 2009, J BIOL CHEM, V284, P27664, DOI 10.1074/jbc.M109.041616; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hamacher-Brady A, 2006, CARDIOVASC DRUG THER, V20, P445, DOI 10.1007/s10557-006-0583-7; Hur KY, 2010, DIABETES OBES METAB, V12, P20, DOI 10.1111/j.1463-1326.2010.01278.x; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Johansen JS, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-5; Juenemann K, 2012, INT J CELL BIOL; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kobayashi S, 2007, J BIOL CHEM, V282, P21945, DOI 10.1074/jbc.M703048200; Kobayashi S, 2012, AUTOPHAGY, V8, P577, DOI 10.4161/auto.18980; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Liang QR, 2002, DIABETES, V51, P174, DOI 10.2337/diabetes.51.1.174; Lonn E, 2002, DIABETES CARE, V25, P1919, DOI 10.2337/diacare.25.11.1919; Lonn E, 2005, JAMA-J AM MED ASSOC, V293, P1338, DOI 10.1001/jama.293.11.1338; Lu LH, 2009, INT J CARDIOL, V134, P82, DOI 10.1016/j.ijcard.2008.01.043; Maloyan A, 2009, CIRC RES, V104, P1021, DOI 10.1161/CIRCRESAHA.108.193516; Martinet W, 2007, TRENDS MOL MED, V13, P482, DOI 10.1016/j.molmed.2007.08.004; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Meijer AJ, 2007, AUTOPHAGY, V3, P523; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Mizushima N, 2005, CELL DEATH DIFFER, V12, P1535, DOI 10.1038/sj.cdd.4401728; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Reznick RM, 2006, J PHYSIOL-LONDON, V574, P33, DOI 10.1113/jphysiol.2006.109512; Sacco M, 2003, DIABETES CARE, V26, P3264, DOI 10.2337/diacare.26.12.3264; Saeedi R, 2008, AM J PHYSIOL-HEART C, V294, pH2497, DOI 10.1152/ajpheart.00873.2007; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Scarlatti F, 2008, CELL DEATH DIFFER, V15, P1318, DOI 10.1038/cdd.2008.51; Takagi H, 2007, ANTIOXID REDOX SIGN, V9, P1373, DOI 10.1089/ars.2007.1689; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Terman A, 2005, CARDIOVASC RES, V68, P355, DOI 10.1016/j.cardiores.2005.08.014; Thomson DM, 2009, J PHYSIOL-LONDON, V587, P2077, DOI 10.1113/jphysiol.2008.166512; Wold LE, 2005, ACTA PHARMACOL SIN, V26, P908, DOI 10.1111/j.1745-7254.2005.00146.x; Xie ZL, 2011, DIABETES, V60, P1770, DOI 10.2337/db10-0351; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Ye G, 2004, DIABETES, V53, P1336, DOI 10.2337/diabetes.53.5.1336; Ye G, 2003, DIABETES, V52, P777, DOI 10.2337/diabetes.52.3.777; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Yusuf S, 2000, NEW ENGL J MED, V342, P154, DOI 10.1056/NEJM200001203420302; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	57	175	193	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18077	18092		10.1074/jbc.M113.474650	http://dx.doi.org/10.1074/jbc.M113.474650			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23658055	Green Published, hybrid			2022-12-28	WOS:000320721900014
J	Guengerich, FP				Guengerich, F. Peter			New Trends in Cytochrome P450 Research at the Half-Century Mark	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							MONOXIDE-BINDING PIGMENT; LIVER MICROSOMES; SUPERFAMILY	Cytochrome P450 enzymes have major roles in the metabolism of steroids, drugs, carcinogens, eicosanoids, and numerous other chemicals. The P450s are collectively considered the most diverse catalysts known in biochemistry, although they operate from a basic structural fold and catalytic mechanism. The four minireviews in this thematic series deal with the unusual aspects of catalytic reactions and electron transfer pathway organization, the structural diversity of P450s, and the expanding roles of P450s in disease and medicine.	[Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA090426] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		GARFINKEL D, 1958, ARCH BIOCHEM BIOPHYS, V77, P493, DOI 10.1016/0003-9861(58)90095-X; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2013, J BIOL CHEM, V288, P17065, DOI 10.1074/jbc.R113.462275; Guengerich FP, 2011, PHARMACOL REV, V63, P684, DOI 10.1124/pr.110.003525; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; KATAGIRI M, 1968, J BIOL CHEM, V243, P3543; KLINGENBERG M, 1958, ARCH BIOCHEM BIOPHYS, V75, P376, DOI 10.1016/0003-9861(58)90436-3; Krest CM, 2013, J BIOL CHEM, V288, P17074, DOI 10.1074/jbc.R113.473108; MUELLER GC, 1948, J BIOL CHEM, V176, P535; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; OMURA T, 1964, J BIOL CHEM, V239, P2379; OMURA T, 1964, J BIOL CHEM, V239, P2370; OMURA T, 1962, J BIOL CHEM, V237, P1375; Pikuleva IA, 2013, J BIOL CHEM, V288, P17091, DOI 10.1074/jbc.R112.431916; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; RYAN KJ, 1958, BIOCHIM BIOPHYS ACTA, V27, P658, DOI 10.1016/0006-3002(58)90408-6; Sato R., 1987, CYT P 450 NEW TRENDS; Williams RT, 1947, DETOXICATION MECH, V1	18	18	19	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17063	17064		10.1074/jbc.R113.466821	http://dx.doi.org/10.1074/jbc.R113.466821			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632015	Green Published, hybrid			2022-12-28	WOS:000320380600003
J	Guengerich, FP; Munro, AW				Guengerich, F. Peter; Munro, Andrew W.			Unusual Cytochrome P450 Enzymes and Reactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SELF-SUFFICIENT CYTOCHROME-P450; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; P450-CATALYZED HYDROXYLATION; MOLECULAR-CLONING; ELECTRON-TRANSFER; FUSION PROTEIN; MECHANISM; ACID; P450	Cytochrome P450 enzymes primarily catalyze mixed-function oxidation reactions, plus some reductions and rearrangements of oxygenated species, e.g. prostaglandins. Most of these reactions can be rationalized in a paradigm involving Compound I, a high-valent iron-oxygen complex (FeO3+), to explain seemingly unusual reactions, including ring couplings, ring expansion and contraction, and fusion of substrates. Most P450s interact with flavoenzymes or iron-sulfur proteins to receive electrons from NAD(P)H. In some cases, P450s are fused to protein partners. Other P450s catalyze non-redox isomerization reactions. A number of permutations on the P450 theme reveal the diversity of cytochrome P450 form and function.	[Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA; [Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England	Vanderbilt University; Vanderbilt University; University of Manchester	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	Munro, Andrew/G-5639-2019	Munro, Andrew/0000-0002-4642-180X	National Institutes of Health [R37 CA090426, P30 ES000267]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/K001884/1, BB/H006265/1, BB/F00883X/1, BB/F002521/1, BB/G014329/1, BB/I019227/1] Funding Source: researchfish; BBSRC [BB/I019227/1, BB/G014329/1, BB/H006265/1, BB/F002521/1, BB/F00883X/1, BB/K001884/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426 and P30 ES000267. This is the first article in the Thematic Minireview Series on Cytochrome P450.	Auclair K, 2002, J AM CHEM SOC, V124, P6020, DOI 10.1021/ja025608h; Austin RN, 2006, ANGEW CHEM INT EDIT, V45, P8192, DOI 10.1002/anie.200603282; Bajpai P, 2013, J BIOL CHEM, V288, P4436, DOI 10.1074/jbc.M112.402123; Barry SM, 2012, NAT CHEM BIOL, V8, P814, DOI 10.1038/nchembio.1048; BONDON A, 1989, J BIOL CHEM, V264, P1988; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; Cai HL, 1999, J AM CHEM SOC, V121, P11656, DOI 10.1021/ja9914240; Cheng QA, 2010, J AM CHEM SOC, V132, P15173, DOI 10.1021/ja107801v; Chowdhary PK, 2007, BIOCHEMISTRY-US, V46, P14429, DOI 10.1021/bi701945j; Coelho PS, 2013, SCIENCE, V339, P307, DOI 10.1126/science.1231434; Cooper HLR, 2011, ARCH BIOCHEM BIOPHYS, V507, P111, DOI 10.1016/j.abb.2010.11.001; CULBERSON CF, 1992, EXP MYCOL, V16, P52, DOI 10.1016/0147-5975(92)90041-O; Dalber A, 2005, J INORG BIOCHEM, V99, P185, DOI 10.1016/j.jinorgbio.2004.09.018; De Mot R, 2002, TRENDS MICROBIOL, V10, P502, DOI 10.1016/S0966-842X(02)02458-7; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Frey PA, 1997, CURR OPIN CHEM BIOL, V1, P347, DOI 10.1016/S1367-5931(97)80072-5; Fujishiro T, 2011, J BIOL CHEM, V286, P29941, DOI 10.1074/jbc.M111.245225; Gesell A, 2009, J BIOL CHEM, V284, P24432, DOI 10.1074/jbc.M109.033373; Girvan HM, 2011, ARCH BIOCHEM BIOPHYS, V507, P75, DOI 10.1016/j.abb.2010.09.014; Glieder A, 2002, NAT BIOTECHNOL, V20, P1135, DOI 10.1038/nbt744; Grobe N, 2009, J BIOL CHEM, V284, P24425, DOI 10.1074/jbc.M109.011320; Guengerich F. P., 2014, HDB METABOL IN PRESS, V1; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; GUENGERICH FP, 1989, J BIOL CHEM, V264, P17198; GUROFF G, 1967, SCIENCE, V157, P1524, DOI 10.1126/science.157.3796.1524; GUSTAFSSON JA, 1979, BIOCHEMISTRY-US, V18, P865, DOI 10.1021/bi00572a020; Gustafsson MCU, 2004, BIOCHEMISTRY-US, V43, P5474, DOI 10.1021/bi035904m; HADDOCK RE, 1984, XENOBIOTICA, V14, P327, DOI 10.3109/00498258409151419; Hansen BG, 2012, APPL ENVIRON MICROB, V78, P4908, DOI 10.1128/AEM.07955-11; Hawkes DB, 2010, CHEMBIOCHEM, V11, P1107, DOI 10.1002/cbic.201000119; He X, 2005, J BIOL CHEM, V280, P22697, DOI 10.1074/jbc.M502632200; HECKER M, 1989, J BIOL CHEM, V264, P141; Hong HZ, 2011, CHEM RES TOXICOL, V24, P125, DOI 10.1021/tx100337s; Humphreys WG, 2008, DRUG METABOLISM IN DRUG DESIGN AND DEVELOPMENT: BASIC CONCEPTS AND PRACTICE, P239; Ikezawa N, 2009, PLANT CELL REP, V28, P123, DOI 10.1007/s00299-008-0624-8; Ikezawa N, 2008, J BIOL CHEM, V283, P8810, DOI 10.1074/jbc.M705082200; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Itoh A, 2001, J BIOL CHEM, V276, P3620, DOI 10.1074/jbc.M008964200; Jackson CJ, 2002, J BIOL CHEM, V277, P46959, DOI 10.1074/jbc.M203523200; Kawakami N, 2011, ANGEW CHEM INT EDIT, V50, P5315, DOI 10.1002/anie.201007975; KEDDERIS GL, 1983, MOL PHARMACOL, V23, P758; Kille S, 2011, NAT CHEM, V3, P738, DOI [10.1038/nchem.1113, 10.1038/NCHEM.1113]; Kitazume T, 2000, J BIOL CHEM, V275, P39734, DOI 10.1074/jbc.M005617200; Kitazume T, 2007, BIOCHEMISTRY-US, V46, P11892, DOI 10.1021/bi701031r; Kolvenbach B, 2007, APPL ENVIRON MICROB, V73, P4776, DOI 10.1128/AEM.00329-07; Krest CM, 2013, J BIOL CHEM, V288, P17074, DOI 10.1074/jbc.R113.473108; Lamb DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0434; Lamb DC, 2009, J VIROL, V83, P8266, DOI 10.1128/JVI.00289-09; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12390, DOI 10.1021/bi049131t; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; LIEBLER DC, 1983, BIOCHEMISTRY-US, V22, P5482, DOI 10.1021/bi00293a005; Liu L, 2006, APPL MICROBIOL BIOT, V72, P876, DOI 10.1007/s00253-006-0355-0; Feo ML, 2013, ENVIRON HEALTH PERSP, V121, P440, DOI 10.1289/ehp.1205446; MACDONALD TL, 1982, J AM CHEM SOC, V104, P2050, DOI 10.1021/ja00371a056; Matsui K, 1996, FEBS LETT, V394, P21, DOI 10.1016/0014-5793(96)00924-6; Meharenna YT, 2004, BIOCHEMISTRY-US, V43, P9487, DOI 10.1021/bi049293p; MILLER RE, 1982, BIOCHEMISTRY-US, V21, P1090, DOI 10.1021/bi00534a041; Moncrieffe MC, 2012, J MOL BIOL, V415, P92, DOI 10.1016/j.jmb.2011.10.036; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Munro AW, 1996, MOL MICROBIOL, V20, P1115, DOI 10.1111/j.1365-2958.1996.tb02632.x; NAGY I, 1995, J BACTERIOL, V177, P676, DOI 10.1128/jb.177.3.676-687.1995; NARHI LO, 1987, J BIOL CHEM, V262, P6683; Neeli R, 2005, FEBS LETT, V579, P5582, DOI 10.1016/j.febslet.2005.09.023; Nishida CR, 2010, MOL PHARMACOL, V78, P497, DOI 10.1124/mol.110.065045; Noble MA, 1999, BIOCHEM J, V339, P371, DOI 10.1042/0264-6021:3390371; OKAZAKI O, 1993, J BIOL CHEM, V268, P1546; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; Oshima R, 2004, J MOL BIOL, V342, P207, DOI 10.1016/j.jmb.2004.07.009; Reilly CA, 2013, CHEM RES TOXICOL, V26, P55, DOI 10.1021/tx300366k; Rendic S, 2012, CHEM RES TOXICOL, V25, P1316, DOI 10.1021/tx300132k; RETTIE AE, 1987, SCIENCE, V235, P890, DOI 10.1126/science.3101178; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Roberts GA, 2003, J BIOL CHEM, V278, P48914, DOI 10.1074/jbc.M309630200; Rontein D, 2008, J BIOL CHEM, V283, P6067, DOI 10.1074/jbc.M708950200; ROSS D, 1983, LIFE SCI, V32, P597, DOI 10.1016/0024-3205(83)90204-7; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; Rylott EL, 2011, BBA-PROTEINS PROTEOM, V1814, P230, DOI 10.1016/j.bbapap.2010.07.004; Schuckel J, 2012, CHEMBIOCHEM, V13, P2758, DOI 10.1002/cbic.201200572; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; SHEA JP, 1982, BIOCHEM BIOPH RES CO, V109, P231, DOI 10.1016/0006-291X(82)91589-3; Shinkyo R, 2011, J BIOL CHEM, V286, P33021, DOI 10.1074/jbc.M111.282434; Sivaramakrishnan S, 2012, J AM CHEM SOC, V134, P6673, DOI 10.1021/ja211499q; SONG WC, 1991, SCIENCE, V253, P781, DOI 10.1126/science.1876834; SUGIURA M, 1980, CANCER RES, V40, P2910; Toy PH, 1998, J AM CHEM SOC, V120, P7719, DOI 10.1021/ja981157i; Turpeinen M, 2009, DRUG METAB DISPOS, V37, P1017, DOI 10.1124/dmd.108.025700; Wang K, 2012, CHEM RES TOXICOL, V25, P1740, DOI 10.1021/tx3001994; Warman AJ, 2012, FEBS J, V279, P1675, DOI 10.1111/j.1742-4658.2012.08543.x; Xiao Y, 2011, DRUG METAB DISPOS, V39, P944, DOI 10.1124/dmd.111.039321; YAMAZAKI H, 1995, BIOCHEMISTRY-US, V34, P8380, DOI 10.1021/bi00026a020; Yun CH, 1999, ARCH BIOCHEM BIOPHYS, V367, P81, DOI 10.1006/abbi.1999.1254; Zhao B, 2005, J BIOL CHEM, V280, P11599, DOI 10.1074/jbc.M410933200; Zhao B, 2009, J BIOL CHEM, V284, P36711, DOI 10.1074/jbc.M109.064683; Zilly FE, 2011, ANGEW CHEM INT EDIT, V50, P2720, DOI 10.1002/anie.201006587	99	216	229	2	208	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17065	17073		10.1074/jbc.R113.462275	http://dx.doi.org/10.1074/jbc.R113.462275			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632016	Green Published, hybrid			2022-12-28	WOS:000320380600004
J	Sakuma, M; Imada, K; Okumura, Y; Uchiya, K; Yamashita, N; Ogawa, K; Hijikata, A; Shirai, T; Homma, M; Nikai, T				Sakuma, Mayuko; Imada, Katsumi; Okumura, Yoshiyuki; Uchiya, Kei-ichi; Yamashita, Nobuo; Ogawa, Kenji; Hijikata, Atsushi; Shirai, Tsuyoshi; Homma, Michio; Nikai, Toshiaki			X-ray Structure Analysis and Characterization of AFUEI, an Elastase Inhibitor from Aspergillus fumigatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGLIN-C; MOLECULAR-STRUCTURE; PROTEINASE; PURIFICATION; STABILITY; PROTEASES; ALIGNMENT; SOFTWARE; CRYSTAL; COMPLEX	Elastase from Aspergillus sp. is an important factor for aspergillosis. AFUEI is an inhibitor of the elastase derived from Aspergillus fumigatus. AFUEI is a member of the I78 inhibitor family and has a high inhibitory activity against elastases of Aspergillus fumigatus and Aspergillus flavus, human neutrophil elastase and bovine chymotrypsin, but does not inhibit bovine trypsin. Here we report the crystal structure of AFUEI in two crystal forms. AFUEI is a wedge-shaped protein composed of an extended loop and a scaffold protein core. The structure of AFUEI shows remarkable similarity to serine protease inhibitors of the potato inhibitor I family, although they are classified into different inhibitor families. A structural comparison with the potato I family inhibitors suggests that the extended loop of AFUEI corresponds to the binding loop of the potato inhibitor I family, and AFUEI inhibits its cognate proteases through the same mechanism as the potato I family inhibitors.	[Sakuma, Mayuko; Homma, Michio] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Imada, Katsumi] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Toyonaka, Osaka 5600043, Japan; [Okumura, Yoshiyuki; Uchiya, Kei-ichi; Nikai, Toshiaki] Meijo Univ, Fac Pharm, Dept Microbiol, Tempaku Ku, Nagoya, Aichi 4688503, Japan; [Yamashita, Nobuo] Hakutsuru Sake Brewing Co Ltd, Higashinada Ku, Kobe, Hyogo 6580041, Japan; [Ogawa, Kenji] Higashi Nagoya Natl Hosp, Dept Pulm Med, Meito Ku, Nagoya, Aichi 4658620, Japan; [Hijikata, Atsushi; Shirai, Tsuyoshi] Nagahama Inst Biosci & Technol, Fac Biosci, Nagahama 5260829, Japan	Nagoya University; Osaka University; Meijo University	Homma, M (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	g44416a@cc.nagoya-u.ac.jp		Imada, Katsumi/0000-0003-1342-8885; Hijikata, Atsushi/0000-0003-4297-8368; Shirai, Tsuyoshi/0000-0002-2506-5738	Ministry of Education, Science, and Culture of Japan; Japan Science and Technology Corporation; Specially Promoted Research of Meijo University Research Institute; Yakult Co. Ltd.; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [24590164] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Specially Promoted Research of Meijo University Research Institute; Yakult Co. Ltd.; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Science, and Culture of Japan and from the Japan Science and Technology Corporation (to M. H.) and for Specially Promoted Research of Meijo University Research Institute and from the Yakult Co. Ltd. (to T. N.). This work was also supported by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to A. H. and T. S.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alp S, 2008, J BASIC MICROB, V48, P331, DOI 10.1002/jobm.200700349; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BETZEL C, 1993, FEBS LETT, V317, P185, DOI 10.1016/0014-5793(93)81273-3; BOUCHARA JP, 1995, TRENDS MICROBIOL, V3, P327, DOI 10.1016/S0966-842X(00)88965-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ML, 2002, BIOCHEMISTRY-US, V41, P9572, DOI 10.1021/bi0258952; Cierpicki T, 2000, J MOL BIOL, V302, P1179, DOI 10.1006/jmbi.2000.4116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEINSTEIN G, 1973, BIOCHIM BIOPHYS ACTA, V309, P196, DOI 10.1016/0005-2744(73)90331-8; FRIGERIO F, 1992, J MOL BIOL, V225, P107, DOI 10.1016/0022-2836(92)91029-O; GERTLER A, 1971, BIOCHIM BIOPHYS ACTA, V235, P378, DOI 10.1016/0005-2744(71)90217-8; Hijikata A, 2011, PROTEINS, V79, P1868, DOI 10.1002/prot.23011; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; Huma Habib, 2007, Biotechnology and Molecular Biology Reviews, V2, P068; JACKSON SE, 1994, BIOCHEMISTRY-US, V33, P13880, DOI 10.1021/bi00250a042; Koizumi M, 2008, J SYNCHROTRON RADIAT, V15, P308, DOI 10.1107/S0909049507060670; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Leslie A. G. W., 1992, CRYSTALLOGRAPHY, V26, P27; MCPHALEN CA, 1987, BIOCHEMISTRY-US, V26, P261, DOI 10.1021/bi00375a036; MCPHALEN CA, 1988, BIOCHEMISTRY-US, V27, P6582, DOI 10.1021/bi00417a058; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Morya VK, 2012, APPL BIOCHEM BIOTECH, V166, P243, DOI 10.1007/s12010-011-9420-y; NIKAI T, 1977, YAKUGAKU ZASSHI, V97, P507, DOI 10.1248/yakushi1947.97.5_507; Okumura Yoshiyuki, 2008, Nihon Ishinkin Gakkai Zasshi, V49, P87, DOI 10.3314/jjmm.49.87; Okumura Yoshiyuki, 2006, Nihon Ishinkin Gakkai Zasshi, V47, P219; Okumura Y, 2008, J MED MICROBIOL, V57, P803, DOI 10.1099/jmm.0.47789-0; Okumura Yoshiyuki, 2007, Nihon Ishinkin Gakkai Zasshi, V48, P13, DOI 10.3314/jjmm.48.13; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rawlings ND, 2010, BIOCHIMIE, V92, P1463, DOI 10.1016/j.biochi.2010.04.013; Taguchi S, 1997, J MOL EVOL, V44, P542, DOI 10.1007/PL00006178; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang LF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020950; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wojtaszek J, 2006, COMP BIOCHEM PHYS B, V143, P465, DOI 10.1016/j.cbpb.2005.12.023; Yamashita N, 2011, J BIOSCI BIOENG, V112, P114, DOI 10.1016/j.jbiosc.2011.03.020; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	40	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17451	17459		10.1074/jbc.M112.433987	http://dx.doi.org/10.1074/jbc.M112.433987			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640894	Green Published, hybrid			2022-12-28	WOS:000320380600037
J	Euden, J; Mason, SA; Viero, C; Thomas, NL; Williams, AJ				Euden, Joanne; Mason, Sammy A.; Viero, Cedric; Thomas, N. Lowri; Williams, Alan J.			Investigations of the Contribution of a Putative Glycine Hinge to Ryanodine Receptor Channel Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RELEASE CHANNEL; TRANSMEMBRANE SEQUENCE; CA2+-RELEASE CHANNEL; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; CALCIUM-RELEASE; ACTIVATION; MUTATION; CATIONS; FAMILY	Ryanodine receptor channels (RyR) are key components of striated muscle excitation-contraction coupling, and alterations in their function underlie both inherited and acquired disease. A full understanding of the disease process will require a detailed knowledge of the mechanisms and structures involved in RyR function. Unfortunately, high-resolution structural data, such as exist for K+-selective channels, are not available for RyR. In the absence of these data, we have used modeling to identify similarities in the structural elements of K+ channel pore-forming regions and postulated equivalent regions of RyR. This has identified a sequence of residues in the cytosolic cavity-lining transmembrane helix of RyR (G(4864)LIIDA(4869) in RyR2) analogous to the glycine hinge motif present in many K+ channels. Gating in these K+ channels can be disrupted by substitution of residues for the hinge glycine. We investigated the involvement of glycine 4864 in RyR2 gating by monitoring properties of recombinant human RyR2 channels in which this glycine is replaced by residues that alter gating in K+ channels. Our data demonstrate that introducing alanine at position 4864 produces no significant change in RyR2 function. In contrast, function is altered when glycine 4864 is replaced by either valine or proline, the former preventing channel opening and the latter modifying both ion translocation and gating. Our studies reveal novel information on the structural basis of RyR gating, identifying both similarities with, and differences from, K+ channels. Glycine 4864 is not absolutely required for channel gating, but some flexibility at this point in the cavity-lining transmembrane helix is necessary for normal RyR function.	[Euden, Joanne; Mason, Sammy A.; Viero, Cedric; Thomas, N. Lowri; Williams, Alan J.] Cardiff Univ, Inst Mol & Expt Med, Cardiff CF14 4XN, S Glam, Wales	Cardiff University	Williams, AJ (corresponding author), Cardiff Univ, Inst Mol & Expt Med, Cardiff CF14 4XN, S Glam, Wales.	williamsaj9@cardiff.ac.uk		Williams, Alan/0000-0002-3770-8761; Thomas, Nia Lowri/0000-0001-8822-8576; Viero, Cedric/0000-0001-5291-1234; euden, joanne/0000-0002-2844-6878	British Heart Foundation [RG/09/009/28069]	British Heart Foundation(British Heart Foundation)	The work was supported by British Heart Foundation Programme Grant RG/09/009/28069.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; George CH, 2003, CIRC RES, V93, P531, DOI 10.1161/01.RES.0000091335.07574.86; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Mason SA, 2012, J GEN PHYSIOL, V140, P325, DOI 10.1085/jgp.201210851; Mead-Savery FC, 2009, BIOPHYS J, V96, P1374, DOI 10.1016/j.bpj.2008.10.054; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Ramachandran S, 2013, J BIOL CHEM, V288, P6154, DOI 10.1074/jbc.M112.433789; Ramachandran S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000367; Ranatunga KM, 2007, MOL MEMBR BIOL, V24, P185, DOI 10.1080/09687860601076522; Ranatunga KM, 2005, MOL PHARMACOL, V68, P840, DOI 10.1124/mol.105.012807; Rosenhouse-Dantsker A, 2007, CHANNELS, V1, P189, DOI 10.4161/chan.4475; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Shang L, 2008, EUR BIOPHYS J BIOPHY, V37, P165, DOI 10.1007/s00249-007-0206-7; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; SITSAPESAN R, 1994, BIOPHYS J, V67, P1484, DOI 10.1016/S0006-3495(94)80622-8; Thomas LN, 2004, CARDIOVASC RES, V64, P52, DOI 10.1016/j.cardiores.2004.06.009; Thomas NL, 2012, WILEY INTERDISCIP RE, V1, P383, DOI DOI 10.1002/WMTS.34; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Welch W, 2004, BIOPHYS J, V87, P2335, DOI 10.1529/biophysj.104.044180; Williams A. J., 1995, ION CHANNELS PRACTIC, P43; Williams AJ, 2001, Q REV BIOPHYS, V34, P61, DOI 10.1017/S0033583501003675; ZORZATO F, 1990, J BIOL CHEM, V265, P2244	34	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16671	16679		10.1074/jbc.M113.465310	http://dx.doi.org/10.1074/jbc.M113.465310			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23632022	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000320378900042
J	Itoh, S; Yokoyama, R; Kamoshida, G; Fujiwara, T; Okada, H; Takii, T; Tsuji, T; Fujii, S; Hashizume, H; Onozaki, K				Itoh, Saotomo; Yokoyama, Ryosuke; Kamoshida, Go; Fujiwara, Toshinobu; Okada, Hiromi; Takii, Takemasa; Tsuji, Tsutomu; Fujii, Satoshi; Hashizume, Hideki; Onozaki, Kikuo			Staphylococcal Superantigen-like Protein 10 (SSL10) Inhibits Blood Coagulation by Binding to Prothrombin and Factor Xa via Their gamma-Carboxyglutamic Acid (Gla) Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Toxins; Blood Coagulation Factors; Coagulation Factors; Prothrombin; Staphylococcus aureus; Staphylococcal Superantigen-like Protein	AUREUS; RECEPTOR; ACTIVATION; EVASION; GENOME; ALPHA; GENE	The staphylococcal superantigen-like protein (SSL) family is composed of 14 exoproteins sharing structural similarity with superantigens but no superantigenic activity. Target proteins of four SSLs have been identified to be involved in host immune responses. However, the counterparts of other SSLs have been functionally uncharacterized. In this study, we have identified porcine plasma prothrombin as SSL10-binding protein by affinity purification using SSL10-conjugated Sepharose. The resin recovered the prodomain of prothrombin (fragment 1 + 2) as well as factor Xa in pull-down analysis. The equilibrium dissociation constant between SSL10 and prothrombin was 1.36 x 10(-7) m in surface plasmon resonance analysis. On the other hand, the resin failed to recover -carboxyglutamic acid (Gla) domain-less coagulation factors and prothrombin from warfarin-treated mice, suggesting that the Gla domain of the coagulation factors is essential for the interaction. SSL10 prolonged plasma clotting induced by the addition of Ca2+ and factor Xa. SSL10 did not affect the protease activity of thrombin but inhibited the generation of thrombin activity in recalcified plasma. S. aureus produces coagulase that non-enzymatically activates prothrombin. SSL10 attenuated clotting induced by coagulase, but the inhibitory effect was weaker than that on physiological clotting, and SSL10 did not inhibit protease activity of staphylothrombin, the complex of prothrombin with coagulase. These results indicate that SSL10 inhibits blood coagulation by interfering with activation of coagulation cascade via binding to the Gla domain of coagulation factor but not by directly inhibiting thrombin activity. This is the first finding that the bacterial protein inhibits blood coagulation via targeting the Gla domain of coagulation factors.	[Itoh, Saotomo; Yokoyama, Ryosuke; Fujiwara, Toshinobu; Takii, Takemasa; Onozaki, Kikuo] Nagoya City Univ, Dept Mol Hlth Sci, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Itoh, Saotomo; Kamoshida, Go; Tsuji, Tsutomu] Hoshi Univ, Dept Microbiol, Sch Pharm & Pharmaceut Sci, Shinagawa Ku, Tokyo 1428501, Japan; [Okada, Hiromi; Fujii, Satoshi] Nagoya City Univ, Dept Mol & Cellular Pathobiol & Therapeut, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan; [Hashizume, Hideki] Inst Microbial Chem, Lab Dis Biol, Shinagawa Ku, Tokyo 1410021, Japan	Nagoya City University; Hoshi University; Nagoya City University	Itoh, S (corresponding author), Nagoya City Univ, Dept Mol Hlth Sci, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	s-itoh@phar.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ohyama Health Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ohyama Health Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan; the Ohyama Health Foundation; and the Takeda Science Foundation.	Al-Shangiti AM, 2004, INFECT IMMUN, V72, P4261, DOI 10.1128/IAI.72.7.4261-4270.2004; Arcus VL, 2002, J BIOL CHEM, V277, P32274, DOI 10.1074/jbc.M203914200; Bardoel BW, 2012, J MOL MED, V90, P1109, DOI 10.1007/s00109-012-0926-8; Bestebroer J, 2007, BLOOD, V109, P2936, DOI 10.1182/blood-2006-06-015461; Bestebroer J, 2010, CELL MICROBIOL, V12, P1506, DOI 10.1111/j.1462-5822.2010.01486.x; Bestebroer J, 2009, BLOOD, V113, P328, DOI 10.1182/blood-2008-04-153882; De Haas CJC, 2009, J THROMB HAEMOST, V7, P1867, DOI 10.1111/j.1538-7836.2009.03564.x; DODE C, 1980, BIOCHEM BIOPH RES CO, V94, P660, DOI 10.1016/0006-291X(80)91283-8; Fitzgerald JR, 2003, INFECT IMMUN, V71, P2827, DOI 10.1128/IAI.71.5.2827-2838.2003; Itoh S, 2012, MICROBIOL IMMUNOL, V56, P363, DOI 10.1111/j.1348-0421.2012.00452.x; Itoh S, 2010, INFECT IMMUN, V78, P3298, DOI 10.1128/IAI.00178-10; Itoh S, 2010, MOL IMMUNOL, V47, P932, DOI 10.1016/j.molimm.2009.09.027; KAWABATA S, 1985, J BIOCHEM, V98, P1603, DOI 10.1093/oxfordjournals.jbchem.a135430; Kroh HK, 2009, P NATL ACAD SCI USA, V106, P7786, DOI 10.1073/pnas.0811750106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Langley R, 2005, J IMMUNOL, V174, P2926, DOI 10.4049/jimmunol.174.5.2926; LIJNEN HR, 1991, J BIOL CHEM, V266, P11826; McAdow M, 2012, J INNATE IMMUN, V4, P141, DOI 10.1159/000333447; Patel D, 2010, J IMMUNOL, V184, P6283, DOI 10.4049/jimmunol.0903311; Postma B, 2004, J IMMUNOL, V172, P6994, DOI 10.4049/jimmunol.172.11.6994; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016; Walenkamp AME, 2009, NEOPLASIA, V11, P333, DOI 10.1593/neo.81508; Williams RJ, 2000, INFECT IMMUN, V68, P4407, DOI 10.1128/IAI.68.8.4407-4415.2000; Yokoyama R, 2012, INFECT IMMUN, V80, P2816, DOI 10.1128/IAI.00399-12	24	30	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21569	21580		10.1074/jbc.M113.451419	http://dx.doi.org/10.1074/jbc.M113.451419			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23754290	Green Published, hybrid			2022-12-28	WOS:000328841900010
J	Pustylnik, S; Fiorino, C; Nabavi, N; Zappitelli, T; da Silva, R; Aubin, JE; Harrison, RE				Pustylnik, Sofia; Fiorino, Cara; Nabavi, Noushin; Zappitelli, Tanya; da Silva, Rosa; Aubin, Jane E.; Harrison, Rene E.			EB1 Levels Are Elevated in Ascorbic Acid (AA)-stimulated Osteoblasts and Mediate Cell-Cell Adhesion-induced Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta-Catenin; Cell Biology; E-cadherin; Microtubules; Osteoblasts; EB1; Cell Contacts	MICROTUBULE PLUS-END; BETA-CATENIN; E-CADHERIN; N-CADHERIN; BONE-CELLS; SIGNALING PATHWAYS; ADHERENS JUNCTIONS; WNT; PROTEIN; GROWTH	Osteoblasts are differentiated mesenchymal cells that function as the major bone-producing cells of the body. Differentiation cues including ascorbic acid (AA) stimulation provoke intracellular changes in osteoblasts leading to the synthesis of the organic portion of the bone, which includes collagen type I 1, proteoglycans, and matrix proteins, such as osteocalcin. During our microarray analysis of AA-stimulated osteoblasts, we observed a significant up-regulation of the microtubule (MT) plus-end binding protein, EB1, compared with undifferentiated osteoblasts. EB1 knockdown significantly impaired AA-induced osteoblast differentiation, as detected by reduced expression of osteoblast differentiation marker genes. Intracellular examination of AA-stimulated osteoblasts treated with EB1 siRNA revealed a reduction in MT stability with a concomitant loss of -catenin distribution at the cell cortex and within the nucleus. Diminished -catenin levels in EB1 siRNA-treated osteoblasts paralleled an increase in phospho--catenin and active glycogen synthase kinase 3, a kinase known to target -catenin to the proteasome. EB1 siRNA treatment also reduced the expression of the -catenin gene targets, cyclin D1 and Runx2. Live immunofluorescent imaging of differentiated osteoblasts revealed a cortical association of EB1-mcherry with -catenin-GFP. Immunoprecipitation analysis confirmed an interaction between EB1 and -catenin. We also determined that cell-cell contacts and cortically associated EB1/-catenin interactions are necessary for osteoblast differentiation. Finally, using functional blocking antibodies, we identified E-cadherin as a major contributor to the cell-cell contact-induced osteoblast differentiation.	[Pustylnik, Sofia; Fiorino, Cara; da Silva, Rosa; Harrison, Rene E.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada; [Nabavi, Noushin] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Zappitelli, Tanya; Aubin, Jane E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Aubin, Jane E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Scarborough; University of California System; University of California Berkeley; University of Toronto; University of Toronto	Harrison, RE (corresponding author), Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON M1C 1A4, Canada.	harrison@utsc.utoronto.ca		Aubin, Jane E./0000-0002-7268-5235; Nabavi, Noushin/0000-0002-5471-6229	Natural Science and Engineering Research Council (NSERC) [RGPIN 298538-09]; General Motors Women in Sciences and Mathematics scholarship; NSERC-Canada Graduate Scholarship; Ontario Early Researcher Award; Canadian Institutes of Health Research New Investigator Award	Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); General Motors Women in Sciences and Mathematics scholarship; NSERC-Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR))	This work was supported in part by Natural Science and Engineering Research Council (NSERC) Grant RGPIN 298538-09 (to R. E. H.); Recipient of a General Motors Women in Sciences and Mathematics scholarship and an NSERC-Canada Graduate Scholarship.; Recipient of an Ontario Early Researcher Award and a Canadian Institutes of Health Research New Investigator Award. To whom correspondence should be addressed. Tel.: 416-287-7377; Fax: 416-287-7676; E-mail: harrison@utsc.utoronto.ca.	Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; AUBIN JE, 1982, J CELL BIOL, V92, P452, DOI 10.1083/jcb.92.2.452; Bahmanyar S, 2010, J CELL SCI, V123, P3125, DOI 10.1242/jcs.064782; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Bellett G, 2009, CELL MOTIL CYTOSKEL, V66, P893, DOI 10.1002/cm.20393; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Binker MG, 2007, J IMMUNOL, V179, P3780, DOI 10.4049/jimmunol.179.6.3780; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brocardo M, 2008, TRENDS CELL BIOL, V18, P587, DOI 10.1016/j.tcb.2008.09.002; BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; Canalis E, 2007, NEW ENGL J MED, V357, P905, DOI 10.1056/NEJMra067395; Cawthorn WP, 2012, BONE, V50, P477, DOI 10.1016/j.bone.2011.08.010; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Cheng SL, 1998, J BONE MINER RES, V13, P633, DOI 10.1359/jbmr.1998.13.4.633; Cheng SL, 2000, J BONE MINER RES, V15, P2362, DOI 10.1359/jbmr.2000.15.12.2362; Chigita S, 2012, INT J ONCOL, V41, P2021, DOI 10.3892/ijo.2012.1671; COLLARESBUZATO CB, 1994, BBA-MOL CELL RES, V1222, P147, DOI 10.1016/0167-4889(94)90163-5; COLLARESBUZATO CB, 1994, HISTOCHEMISTRY, V101, P185, DOI 10.1007/BF00269543; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Di Benedetto A, 2010, J CELL SCI, V123, P2640, DOI 10.1242/jcs.067777; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Edwards JR, 2012, DISCOV MED, V13, P201; El-Rifai W, 2001, INT J CANCER, V92, P832, DOI 10.1002/ijc.1264; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Ferrari SL, 2000, J BONE MINER RES, V15, P198, DOI 10.1359/jbmr.2000.15.2.198; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; Friedman MS, 2009, J BIOL CHEM, V284, P14117, DOI 10.1074/jbc.M808337200; Fujii K, 2005, PROTEOMICS, V5, P1411, DOI 10.1002/pmic.200401004; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Goichberg P, 2001, J CELL SCI, V114, P1309; Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006; Goshima Y, 1997, J NEUROBIOL, V33, P316, DOI 10.1002/(SICI)1097-4695(199709)33:3<316::AID-NEU9>3.0.CO;2-4; Goshima Y, 2002, J CLIN INVEST, V109, P993, DOI 10.1172/JCI200215467; Guntur AR, 2012, BONE, V50, P54, DOI 10.1016/j.bone.2011.09.036; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Hida T, 2012, J NEUROSCI, V32, P11905, DOI 10.1523/JNEUROSCI.6139-11.2012; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoeppner LH, 2009, EXPERT OPIN THER TAR, V13, P485, DOI [10.1517/14728220902841961, 10.1517/14728220902841961 ]; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Ishiyama Noboru, 2012, Subcell Biochem, V60, P39, DOI 10.1007/978-94-007-4186-7_3; Javed A, 2010, ORAL MAXIL SURG CLIN, V22, P283, DOI 10.1016/j.coms.2010.05.001; JOU TS, 1995, P NATL ACAD SCI USA, V92, P5067, DOI 10.1073/pnas.92.11.5067; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LEBLOND CP, 1989, ANAT REC, V224, P123, DOI 10.1002/ar.1092240204; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Lemonnier J, 2001, J BONE MINER RES, V16, P832, DOI 10.1359/jbmr.2001.16.5.832; Ligon LA, 2007, TRAFFIC, V8, P808, DOI 10.1111/j.1600-0854.2007.00574.x; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mbalaviele G, 2005, J CELL BIOCHEM, V94, P403, DOI 10.1002/jcb.20253; Mbalaviele G, 2006, J BONE MINER RES, V21, P1821, DOI 10.1359/JBMR.060811; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Nabavi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046265; Nabavi N, 2008, J BIOL CHEM, V283, P19678, DOI 10.1074/jbc.M802517200; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nishigaki R, 2005, PROTEOMICS, V5, P3205, DOI 10.1002/pmic.200401307; Orsulic S, 1999, J CELL SCI, V112, P1237; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Qiang YW, 2009, BLOOD, V113, P4319, DOI 10.1182/blood-2008-08-174300; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Sadot E, 2002, J CELL SCI, V115, P2771; Salazar VS, 2008, J CELL BIOCHEM, V104, P942, DOI 10.1002/jcb.21679; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; SCHERFT JP, 1975, CELL TISSUE RES, V157, P353; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Sinha K. M., J CELL BIOCH, V114, P975; Soltanoff CS, 2009, CRIT REV EUKAR GENE, V19, P1; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; SU LK, 1995, CANCER RES, V55, P2972; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tirnauer JS, 2000, J CELL BIOL, V149, P761, DOI 10.1083/jcb.149.4.761; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Wang Y, 2012, TUMOR BIOL, V33, P1871, DOI 10.1007/s13277-012-0447-7; Wang YH, 2005, ONCOGENE, V24, P6637, DOI 10.1038/sj.onc.1208819; Wen YD, 2004, KENYON REV, V26, P1; WHITSON SW, 1992, J BONE MINER RES, V7, P727; WHITSON SW, 1984, J CELL BIOL, V99, P607, DOI 10.1083/jcb.99.2.607; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Zhang RR, 2013, BONE, V52, P145, DOI 10.1016/j.bone.2012.09.029; Zhang T, 2009, J CELL SCI, V122, P1401, DOI 10.1242/jcs.039255	97	14	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22096	22110		10.1074/jbc.M113.481515	http://dx.doi.org/10.1074/jbc.M113.481515			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23740245	hybrid, Green Published			2022-12-28	WOS:000328841900054
J	Gee, EPS; Yuksel, D; Stultz, CM; Ingber, DE				Gee, Elaine P. S.; Yueksel, Deniz; Stultz, Collin M.; Ingber, Donald E.			SLLISWD Sequence in the 10FNIII Domain Initiates Fibronectin Fibrillogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-BINDING DOMAIN; EXTRACELLULAR-MATRIX; INTEGRIN ACTIVATION; PLASMA FIBRONECTIN; SYNERGY SITE; III DOMAINS; ANGIOGENESIS; FRAGMENT; ADHESION; PROTEINS	Fibronectin (FN) assembly into extracellular matrix is tightly regulated and essential to embryogenesis and wound healing. FN fibrillogenesis is initiated by cytoskeleton-derived tensional forces transmitted across transmembrane integrins onto RGD binding sequences within the tenth FN type III (10FNIII) domains. These forces unfold 10FNIII to expose cryptic FN assembly sites; however, a specific sequence has not been identified in 10FNIII. Our past steered molecular dynamics simulations modeling 10FNIII unfolding by force at its RGD loop predicted a mechanical intermediate with a solvent-exposed N terminus spanning the A and B beta-strands. Here, we experimentally confirm that the predicted 23-residue cryptic peptide 1 (CP1) initiates FN multimerization, which is mediated by interactions with 10FNIII that expose hydrophobic surfaces that support 8-anilino-1-napthalenesulfonic acid binding. Localization of multimerization activity to the C terminus led to the discovery of a minimal 7-amino acid "multimerization sequence" (SLLISWD), which induces polymerization of FN and the clotting protein fibrinogen in addition to enhancing FN fibrillogenesis in fibroblasts. A point mutation at Trp-6 that reduces exposure of hydrophobic sites for 8-anilino-1-napthalenesulfonic acid binding and beta-structure formation inhibits FN multimerization and prevents physiological cell-based FN assembly in culture. We propose a model for cell-mediated fibrillogenesis whereby cell traction force initiates a cascade of intermolecular exchange starting with the unfolding of 10FNIII to expose the multimerization sequence, which interacts with strandBof another 10FNIII domain via a Trp-mediated beta-strand exchange to stabilize a partially unfolded intermediate that propagates FN self-assembly.	[Gee, Elaine P. S.; Yueksel, Deniz; Ingber, Donald E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Yueksel, Deniz; Ingber, Donald E.] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Yueksel, Deniz; Ingber, Donald E.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Yueksel, Deniz; Ingber, Donald E.] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Yueksel, Deniz; Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Stultz, Collin M.] MIT, Dept Elect Engn & Comp Sci, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Stultz, Collin M.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, 3 Blackfan Circle,CLSB 5th Floor, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Ingber, Donald E/AAC-5894-2019		National Institutes of Health [PO1 CA045548]; United States Department of Defense Breast Cancer Innovator Award [BC074986]; Wyss Institute for Biologically Inspired Engineering at Harvard University; NATIONAL CANCER INSTITUTE [P01CA045548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Defense Breast Cancer Innovator Award(United States Department of Defense); Wyss Institute for Biologically Inspired Engineering at Harvard University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 CA045548, by United States Department of Defense Breast Cancer Innovator Award BC074986, and a grant from the Wyss Institute for Biologically Inspired Engineering at Harvard University (to D. E. I.).	Akerman ME, 2005, P NATL ACAD SCI USA, V102, P2040, DOI 10.1073/pnas.0409844102; AOTA S, 1994, J BIOL CHEM, V269, P24756; Azzi A, 1974, Methods Enzymol, V32, P234; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; Carr PA, 1997, STRUCTURE, V5, P949, DOI 10.1016/S0969-2126(97)00248-7; Chen F, 1996, J BIOL CHEM, V271, P9084, DOI 10.1074/jbc.271.15.9084; Cota E, 2000, PROTEIN SCI, V9, P112; Cota E, 2000, J MOL BIOL, V302, P713, DOI 10.1006/jmbi.2000.4053; Craig D, 2004, STRUCTURE, V12, P21, DOI 10.1016/j.str.2003.11.024; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; Dutta S, 2008, J MOL BIOL, V382, P721, DOI 10.1016/j.jmb.2008.07.036; Feaver RE, 2010, CIRC RES, V106, P1703, DOI 10.1161/CIRCRESAHA.109.216283; FOGERTY FJ, 1990, J CELL BIOL, V111, P699, DOI 10.1083/jcb.111.2.699; Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Gee EPS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002373; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Grant RP, 1997, J BIOL CHEM, V272, P6159, DOI 10.1074/jbc.272.10.6159; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hocking DC, 1996, J CELL BIOL, V133, P431, DOI 10.1083/jcb.133.2.431; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; HYNES RO, 1973, P NATL ACAD SCI USA, V70, P3170, DOI 10.1073/pnas.70.11.3170; Johansson Staffan, 1997, Frontiers in Bioscience (online), V2, pD126; Knowles LM, 2012, ANGIOGENESIS, V15, P115, DOI 10.1007/s10456-011-9247-8; Lemmon CA, 2011, J BIOL CHEM, V286, P26375, DOI 10.1074/jbc.M111.240028; Little WC, 2009, NANO LETT, V9, P4158, DOI 10.1021/nl902365z; Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863; LITVINOVICH SV, 1995, J MOL BIOL, V248, P611, DOI 10.1006/jmbi.1995.0246; Marsden M, 2001, DEVELOPMENT, V128, P3635; MCDONALD JA, 1987, J BIOL CHEM, V262, P2957; MCKEOWNLONGO PJ, 1983, J CELL BIOL, V97, P466, DOI 10.1083/jcb.97.2.466; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; MOSHER DF, 1975, J BIOL CHEM, V250, P6614; NAGAI T, 1991, J CELL BIOL, V114, P1295, DOI 10.1083/jcb.114.6.1295; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Ohashi T, 2009, BIOCHEMISTRY-US, V48, P4189, DOI 10.1021/bi900001g; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Otzen DE, 2000, P NATL ACAD SCI USA, V97, P9907, DOI 10.1073/pnas.160086297; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Pereira M, 2002, J CELL SCI, V115, P609; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Prabhakaran S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005412; Sechler JL, 1997, MOL BIOL CELL, V8, P2563, DOI 10.1091/mbc.8.12.2563; Sid B, 2004, CRIT REV ONCOL HEMAT, V49, P245, DOI 10.1016/j.critrevonc.2003.09.009; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Wall J, 1999, METHOD ENZYMOL, V309, P204; Wang RX, 2005, J BIOL CHEM, V280, P28803, DOI 10.1074/jbc.M501421200; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167; Yakovlev S, 2000, BIOCHEMISTRY-US, V39, P15721, DOI 10.1021/bi001836h; YAMADA KM, 1980, J BIOL CHEM, V255, P6055; Yi M, 2001, P NATL ACAD SCI USA, V98, P620, DOI 10.1073/pnas.98.2.620; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	60	18	18	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21329	21340		10.1074/jbc.M113.462077	http://dx.doi.org/10.1074/jbc.M113.462077			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23740248	Green Published, hybrid			2022-12-28	WOS:000322014400052
J	Naito, T; Kuma, A; Mizushima, N				Naito, Takako; Kuma, Akiko; Mizushima, Noboru			Differential Contribution of Insulin and Amino Acids to the mTORC1-Autophagy Pathway in the Liver and Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TARGET; PROTEIN-SYNTHESIS; SKELETAL-MUSCLE; RAT-LIVER; AUTOPHAGY; RAPAMYCIN; GROWTH; MTORC1; DEPRIVATION	Autophagy is a highly inducible intracellular degradation process. It is generally induced by nutrient starvation and suppressed by food intake. Mammalian (or mechanistic) target of rapamycin complex 1 (mTORC1) is considered to be the major regulator of autophagy, but the precise mechanism of in vivo regulation remains to be fully characterized. Here, we examined the autophagy-suppressive effect of glucose, insulin, and amino acids in the liver and muscle in mice starved for 1 day. Refeeding after starvation with a standard mouse chow rapidly suppressed autophagy in both tissues, and this suppression was inhibited by rapamycin administration almost completely in the liver and partially in muscle, confirming that mTORC1 is indeed a crucial regulator in vivo. As glucose administration showed no major suppressive effect on autophagy, we examined the role of insulin and amino acids using hyperinsulinemic-euglycemic clamp and intravenous amino acid infusion techniques. Insulin administration showed a clear effect on the mTORC1-autophagy pathway in muscle, but had only a very weak effect in the liver. By contrast, amino acids were able to regulate the mTORC1-autophagy pathway in the liver, but less effectively in muscle. These results suggest that autophagy is differentially regulated by insulin and amino acids in a tissue-dependent manner.	[Naito, Takako; Kuma, Akiko; Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Naito, Takako; Kuma, Akiko; Mizushima, Noboru] Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo 1130033, Japan; [Naito, Takako; Kuma, Akiko; Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo 1130033, Japan; [Kuma, Akiko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Tokyo 1020076, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST)	Mizushima, N (corresponding author), Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nmizu@m.u-tokyo.ac.jp	Mizushima, Noboru/C-3635-2009	Mizushima, Noboru/0000-0002-6258-6444	Ministry of Education, Culture, Sports, Science and Technology, Japan; Funding Program for Next Generation World-Leading Researchers; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Funding Program for Next Generation World-Leading Researchers, and the Takeda Science Foundation (to N.M.).	Baum JI, 2009, AM J PHYSIOL-ENDOC M, V297, pE410, DOI 10.1152/ajpendo.00042.2009; Davis TA, 2002, AM J PHYSIOL-ENDOC M, V282, pE880, DOI 10.1152/ajpendo.00517.2001; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; Dennis MD, 2011, J BIOL CHEM, V286, P8287, DOI 10.1074/jbc.M110.209171; Efeyan A, 2013, NATURE, V493, P679, DOI 10.1038/nature11745; FAFOURNOUX P, 1990, AM J PHYSIOL, V259, pE614, DOI 10.1152/ajpendo.1990.259.5.E614; Holst JJ, 2004, AM J PHYSIOL-ENDOC M, V287, pE199, DOI 10.1152/ajpendo.00545.2003; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kubota N, 2006, J BIOL CHEM, V281, P8748, DOI 10.1074/jbc.M505649200; Kuma A, 2010, SEMIN CELL DEV BIOL, V21, P683, DOI 10.1016/j.semcdb.2010.03.002; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LENK SE, 1992, AM J PHYSIOL, V263, pE856, DOI 10.1152/ajpendo.1992.263.5.E856; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005; O'Connor PMJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE994, DOI 10.1152/ajpendo.00391.2003; PALOU A, 1981, HORM METAB RES, V13, P326, DOI 10.1055/s-2007-1019258; PFEIFER U, 1981, J MOL CELL CARDIOL, V13, P37, DOI 10.1016/0022-2828(81)90227-3; Pfeifer U., 1987, LYSOSOMES THEIR ROLE, P3; Quy PN, 2013, J BIOL CHEM, V288, P1125, DOI 10.1074/jbc.M112.399949; Reggiori Fulvio, 2012, Int J Cell Biol, V2012, P219625, DOI 10.1155/2012/219625; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	40	60	62	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21074	21081		10.1074/jbc.M113.456228	http://dx.doi.org/10.1074/jbc.M113.456228			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23744068	Green Published, hybrid			2022-12-28	WOS:000322014400028
J	Song, TJ; Yang, LX; Kabra, N; Chen, LH; Koomen, J; Haura, EB; Chen, JD				Song, Tanjing; Yang, Leixiang; Kabra, Neha; Chen, Lihong; Koomen, John; Haura, Eric B.; Chen, Jiandong			The NAD(+) Synthesis Enzyme Nicotinamide Mononucleotide Adenylyltransferase (NMNAT1) Regulates Ribosomal RNA Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; POLYMERASE-I TRANSCRIPTION; REMODELING COMPLEX NORC; WALLERIAN DEGENERATION; HETEROCHROMATIN FORMATION; SIRT1; MUTATIONS; PATHWAY; PROTEIN; BIOSYNTHESIS	The chromosomal region encoding the nuclear NAD(+) synthesis enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT1) is frequently deleted in human cancer. We describe evidence that NMNAT1 interacts with the nucleolar repressor protein nucleomethylin and is involved in regulating rRNA transcription. NMNAT1 binds to nucleomethylin and is recruited into a ternary complex containing the NAD(+)-dependent deacetylase SirT1. NMNAT1 expression stimulates the deacetylase function of SirT1. Knockdown of NMNAT1 enhances rRNA transcription and promotes cell death after nutrient deprivation. Furthermore, NMNAT1 expression is induced by DNA damage and plays a role in preventing cell death after damage. Heterozygous deletion of NMNAT1 in lung tumor cell lines correlates with low expression level and increased sensitivity to DNA damage. These results suggest that NMNAT1 deletion in tumors may contribute to transformation by increasing rRNA synthesis, but may also increase sensitivity to nutrient stress and DNA damage.	[Song, Tanjing; Yang, Leixiang; Kabra, Neha; Chen, Lihong; Koomen, John; Chen, Jiandong] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Haura, Eric B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Chen, JD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	jiandong.chen@moffitt.org	song, tanjing/N-7539-2013		United States Army Medical Research and Materiel Command [DAMD 17-02-2-0051, W81XWH-08-2-0101]; National Functional Genomics Center; National Cancer Institute [P30-CA076292]; Moffitt Foundation; NATIONAL CANCER INSTITUTE [R01CA121291, R01CA141244, P30CA076292] Funding Source: NIH RePORTER	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Functional Genomics Center; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Moffitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Junn Yanagisawa for the NML construct, the Moffitt Molecular Genomics Core for DNA sequence analyses, and the Moffitt Proteomics Core for protein mass spectrometric analyses. The Moffitt Proteomics Core Facility is supported by the United States Army Medical Research and Materiel Command under Award DAMD 17-02-2-0051, continuing as W81XWH-08-2-0101, for a National Functional Genomics Center, the National Cancer Institute under Award P30-CA076292 as a Cancer Center Support grant, and the Moffitt Foundation.	Ali YO, 2011, J BIOL CHEM, V286, P19089, DOI 10.1074/jbc.M111.219295; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Ayrault O, 2006, ONCOGENE, V25, P7577, DOI 10.1038/sj.onc.1209743; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Berger F, 2007, P NATL ACAD SCI USA, V104, P3765, DOI 10.1073/pnas.0609211104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Chiang PW, 2012, NAT GENET, V44, P972, DOI 10.1038/ng.2370; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361; Garavaglia S, 2002, J BIOL CHEM, V277, P8524, DOI 10.1074/jbc.M111589200; Grummt I, 2003, NAT REV MOL CELL BIO, V4, P641, DOI 10.1038/nrm1171; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2011, FEBS LETT, V585, P1657, DOI 10.1016/j.febslet.2011.04.060; Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Miles EW, 1999, J BIOL CHEM, V274, P12193, DOI 10.1074/jbc.274.18.12193; Murayama A, 2008, CELL, V133, P627, DOI 10.1016/j.cell.2008.03.030; Perrault I, 2012, NAT GENET, V44, P975, DOI 10.1038/ng.2357; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Santoro R, 2002, NAT GENET, V32, P393, DOI 10.1038/ng1010; Solimini NL, 2012, SCIENCE, V337, P104, DOI 10.1126/science.1219580; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Voit R, 1997, MOL CELL BIOL, V17, P4230, DOI 10.1128/MCB.17.8.4230; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhang T, 2009, J BIOL CHEM, V284, P20408, DOI 10.1074/jbc.M109.016469; Zhou YG, 2009, NAT CELL BIOL, V11, P1010, DOI 10.1038/ncb1914	33	27	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20908	20917		10.1074/jbc.M113.470302	http://dx.doi.org/10.1074/jbc.M113.470302			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23737528	Green Published, hybrid			2022-12-28	WOS:000322014400014
J	Kim, GW; Li, L; Gorbani, M; You, LY; Yang, XJ				Kim, Go-Woon; Li, Lin; Gorbani, Mohammad; You, Linya; Yang, Xiang-Jiao			Mice Lacking alpha-Tubulin Acetyltransferase 1 Are Viable but Display alpha-Tubulin Acetylation Deficiency and Dentate Gyrus Distortion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; LONG-TERM POTENTIATION; LYSINE ACETYLATION; POSTTRANSLATIONAL MODIFICATIONS; HISTONE DEACETYLASES; STABILIZATION; DOUBLECORTIN; SENSITIVITY; INDUCTION; MEC-17	alpha-Tubulin acetylation at Lys-40, located on the luminal side of microtubules, has been widely studied and used as a marker for stable microtubules in the cilia and other subcellular structures, but the functional consequences remain perplexing. Recent studies have shown that Mec-17 and its paralog are responsible for alpha-tubulin acetylation in Caenorhabditis elegans. There is one such protein known as Atat1 (alpha-tubulin acetyltransferase 1) per higher organism. Zebrafish Atat1 appears to govern embryo development, raising the intriguing possibility that Atat1 is also critical for development in mammals. In addition to Atat1, three other mammalian acetyltransferases, ARD1-NAT1, ELP3, and GCN5, have been shown to acetylate alpha-tubulin in vitro, so an important question is how these four enzymes contribute to the acetylation in vivo. We demonstrate here that Atat1 is a major alpha-tubulin acetyltransferase in mice. It is widely expressed in mouse embryos and tissues. Although Atat1-null animals display no overt phenotypes, alpha-tubulin acetylation is lost in sperm flagella and the dentate gyrus is slightly deformed. Furthermore, human ATAT1 colocalizes on bundled microtubules with doublecortin. These results thus suggest that mouse Atat1 may regulate advanced functions such as learning and memory, thereby shedding novel light on the physiological roles of alpha-tubulin acetylation in mammals.	[Kim, Go-Woon; Li, Lin; Gorbani, Mohammad; You, Linya; Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Kim, Go-Woon; Yang, Xiang-Jiao] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 1A3, Canada; [Li, Lin; Gorbani, Mohammad; You, Linya; Yang, Xiang-Jiao] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A3, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Yang, XJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca		You, Linya/0000-0002-2569-0269	Canadian Institutes of Health Research; Canadian Cancer Society; Canada Foundation for Innovation; Ministere du Developpement Economique, Innovation, et Exportation du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ministere du Developpement Economique, Innovation, et Exportation du Quebec	This work was supported by research grants from the Canadian Institutes of Health Research, the Canadian Cancer Society, the Canada Foundation for Innovation, and the Ministere du Developpement Economique, Innovation, et Exportation du Quebec (to X.J.Y.).	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; BAAS PW, 1990, J CELL BIOL, V111, P495, DOI 10.1083/jcb.111.2.495; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Cueva JG, 2012, CURR BIOL, V22, P1066, DOI 10.1016/j.cub.2012.05.012; des Portes V, 1998, CELL, V92, P51; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Dong H.W., 2008, ALLEN REFERENCE ATLA; Duffy SK, 2012, CELL, V149, P936, DOI 10.1016/j.cell.2012.02.064; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; Friedmann DR, 2012, P NATL ACAD SCI USA, V109, P19655, DOI 10.1073/pnas.1209357109; Fukada M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030924; Fukushige T, 1999, J CELL SCI, V112, P395; Fukushima N, 2009, J NEUROCHEM, V109, P683, DOI 10.1111/j.1471-4159.2009.06013.x; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kalebic N, 2013, MOL CELL BIOL, V33, P1114, DOI 10.1128/MCB.01044-12; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; Kormendi V, 2012, J BIOL CHEM, V287, P41569, DOI 10.1074/jbc.C112.421222; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KOZMINSKI KG, 1993, CELL MOTIL CYTOSKEL, V25, P158, DOI 10.1002/cm.970250205; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; LEDIZET M, 1986, J CELL BIOL, V103, P13, DOI 10.1083/jcb.103.1.13; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Li L, 2012, J NEUROSCI, V32, P12673, DOI 10.1523/JNEUROSCI.0016-12.2012; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Nagy A., 2003, MANIPULATING MOUSE E; Nam HJ, 2010, J BIOL CHEM, V285, P32888, DOI 10.1074/jbc.M110.162743; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Ohkawa N, 2008, GENES CELLS, V13, P1171, DOI 10.1111/j.1365-2443.2008.01235.x; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Paxinos G., 2008, MOUSE BRAIN STEREOTA; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Sadoul K, 2012, BLOOD, V120, P4215, DOI 10.1182/blood-2012-05-428011; Sengottuvel Vetrivel, 2011, Commun Integr Biol, V4, P391, DOI 10.4161/cib.4.4.15552; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; SMITH CL, 1994, J CELL BIOL, V127, P1407, DOI 10.1083/jcb.127.5.1407; Solinger JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000820; Soppina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048204; Steczkiewicz K, 2006, CELL CYCLE, V5, P2927, DOI 10.4161/cc.5.24.3572; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sudo H, 2010, J NEUROSCI, V30, P7215, DOI 10.1523/JNEUROSCI.0048-10.2010; Tahmasebi S, 2013, J BIOL CHEM, V288, P12791, DOI 10.1074/jbc.M113.465443; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Taschner M, 2012, P NATL ACAD SCI USA, V109, P19649, DOI 10.1073/pnas.1209343109; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Walkinshaw DR, 2013, J BIOL CHEM, V288, P5591, DOI 10.1074/jbc.M112.445668; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Xiong X, 2013, J INTEGR PLANT BIOL, V55, P209, DOI 10.1111/jipb.12003; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zilberman Y, 2009, J CELL SCI, V122, P3531, DOI 10.1242/jcs.046813	87	84	85	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20334	20350		10.1074/jbc.M113.464792	http://dx.doi.org/10.1074/jbc.M113.464792			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720746	Green Published, hybrid			2022-12-28	WOS:000321715100022
J	Lapointe, CP; Wickens, M				Lapointe, Christopher P.; Wickens, Marvin			The Nucleic Acid-binding Domain and Translational Repression Activity of a Xenopus Terminal Uridylyl Transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONCANONICAL POLY(A) POLYMERASES; HISTONE MESSENGER-RNAS; NUCLEOTIDYL TRANSFERASES; CAENORHABDITIS-ELEGANS; 3' URIDYLATION; PRE-MICRORNA; ALPHA-HELIX; REV PROTEIN; STEM-LOOP; I-TASSER	Terminal uridylyl transferases (TUTs) catalyze the addition of uridines to the 3' ends of RNAs and are implicated in the regulation of both messenger RNAs and microRNAs. To better understand how TUTs add uridines to RNAs, we focused on a putative TUT from Xenopus laevis, XTUT7. We determined that XTUT7 catalyzed the addition of uridines to RNAs. Mutational analysis revealed that a truncated XTUT7 enzyme, which contained solely the nucleotidyl transferase and poly(A) polymerase-associated domains, was sufficient for catalytic activity. XTUT7 activity decreased upon removal of the CCHC zinc finger domains and a short segment of basic amino acids (the basic region). This basic region bound nucleic acids in vitro. We also demonstrated that XTUT7 repressed translation of a polyadenylated RNA, to which it added a distinct number of uridines. We generated a predicted structure of the XTUT7 catalytic core that indicated histidine 1269 was likely important for uridine specificity. Indeed, mutation of histidine 1269 broadened the nucleotide specificity of XTUT7 and abolished XTUT7-dependent translational repression. Our data reveal key aspects of how XTUT7 adds uridines to RNAs, highlight the role of the basic region, illustrate that XTUT7 can repress translation, and identify an amino acid important for uridine specificity.	[Lapointe, Christopher P.; Wickens, Marvin] Univ Wisconsin, Integrated Program Biochem, Madison, WI 53706 USA; [Wickens, Marvin] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Wickens, M (corresponding author), Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	wickens@biochem.wisc.edu		Lapointe, Christopher/0000-0002-0406-105X	National Institutes of Health [GM31892, GM50942]; Wisconsin Alumni Research Foundation; Genentech; Wharton Predoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031892, R37GM031892, R01GM050942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Alumni Research Foundation; Genentech(Roche HoldingGenentech); Wharton Predoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31892 and GM50942 (to M. W.).; Supported by Wisconsin Alumni Research Foundation, Genentech, and Wharton Predoctoral Fellowships.	Aphasizhev R, 2005, CELL MOL LIFE SCI, V62, P2194, DOI 10.1007/s00018-005-5198-9; Baltz AG, 2012, MOL CELL, V46, P674, DOI 10.1016/j.molcel.2012.05.021; Battiste JL, 1996, SCIENCE, V273, P1547, DOI 10.1126/science.273.5281.1547; Bayer TS, 2005, RNA, V11, P1848, DOI 10.1261/rna.2167605; Berndt H, 2012, RNA, V18, P958, DOI 10.1261/rna.032292.112; Blahna MT, 2011, J BIOL CHEM, V286, P42381, DOI 10.1074/jbc.M111.259689; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Chritton JJ, 2010, RNA, V16, P1217, DOI 10.1261/rna.2070110; Cooke A, 2011, P NATL ACAD SCI USA, V108, P15870, DOI 10.1073/pnas.1105151108; Cooke A, 2010, J BIOL CHEM, V285, P28506, DOI 10.1074/jbc.M110.150763; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DALY TJ, 1989, NATURE, V342, P816, DOI 10.1038/342816a0; Daugherty MD, 2010, NAT STRUCT MOL BIOL, V17, P1337, DOI 10.1038/nsmb.1902; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2012, CELL, V151, P521, DOI 10.1016/j.cell.2012.09.022; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hoefig KP, 2013, NAT STRUCT MOL BIOL, V20, P73, DOI 10.1038/nsmb.2450; Hook BA, 2007, J BIOL CHEM, V282, P15430, DOI 10.1074/jbc.M611253200; Ibrahim F, 2010, P NATL ACAD SCI USA, V107, P3906, DOI 10.1073/pnas.0912632107; Jones M, 2012, DANCING TIMES, V102, P11; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Kim YK, 2010, CELL, V143, P703, DOI 10.1016/j.cell.2010.11.018; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101; LAZINSKI D, 1989, CELL, V59, P207, DOI 10.1016/0092-8674(89)90882-9; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Lunde BM, 2012, NUCLEIC ACIDS RES, V40, P9815, DOI 10.1093/nar/gks740; Martin G, 2008, BBA-GENE REGUL MECH, V1779, P206, DOI 10.1016/j.bbagrm.2007.12.003; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; Minshall N, 2001, RNA, V7, P1728, DOI 10.1017/S135583820101158X; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Munoz-Tello P, 2012, STRUCTURE, V20, P977, DOI 10.1016/j.str.2012.04.006; Newman MA, 2011, RNA, V17, P1795, DOI 10.1261/rna.2713611; Norbury CJ, 2010, BIOCHEM SOC T, V38, P1150, DOI 10.1042/BST0381150; OLSEN HS, 1990, SCIENCE, V247, P845, DOI 10.1126/science.2406903; Rammelt C, 2011, RNA, V17, P1737, DOI 10.1261/rna.2787011; Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799; Ren GD, 2012, CURR BIOL, V22, P695, DOI 10.1016/j.cub.2012.02.052; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Rissland OS, 2009, NAT STRUCT MOL BIOL, V16, P616, DOI 10.1038/nsmb.1601; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schmidt MJ, 2010, WIRES RNA, V1, P142, DOI 10.1002/wrna.16; Schmidt MJ, 2011, RNA, V17, P39, DOI 10.1261/rna.2252511; Song MG, 2007, RNA, V13, P2356, DOI 10.1261/rna.765807; Su W, 2013, RNA, V19, P1, DOI 10.1261/rna.034470.112; TAN RY, 1993, CELL, V73, P1031, DOI 10.1016/0092-8674(93)90280-4; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; WEEKS KM, 1990, SCIENCE, V249, P1281, DOI 10.1126/science.2205002; Weiss MA, 1998, BIOPOLYMERS, V48, P167, DOI 10.1002/(SICI)1097-0282(1998)48:2<167::AID-BIP6>3.0.CO;2-8; Wickens M, 2008, SCIENCE, V319, P1344, DOI 10.1126/science.1154946; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Yates LA, 2012, NAT STRUCT MOL BIOL, V19, P782, DOI 10.1038/nsmb.2329; Yeom KH, 2011, EMBO REP, V12, P690, DOI 10.1038/embor.2011.100; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhao YY, 2012, CURR BIOL, V22, P689, DOI 10.1016/j.cub.2012.02.051	69	19	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20723	20733		10.1074/jbc.M113.455451	http://dx.doi.org/10.1074/jbc.M113.455451			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23709223	hybrid, Green Published			2022-12-28	WOS:000321715100057
J	Yamasaki, K; Daiho, T; Danko, S; Suzuki, H				Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi			Roles of Long-range Electrostatic Domain Interactions and K+ in Phosphoenzyme Transition of Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; ADP-INSENSITIVE PHOSPHOENZYME; STABLE STRUCTURAL ANALOG; 1ST TRANSMEMBRANE HELIX; CALCIUM-PUMP; SENSITIVE PHOSPHOENZYME; CRYSTAL-STRUCTURE; OCCLUDED CA2+; INTERMEDIATE; BINDING	Sarcoplasmic reticulum Ca2+-ATPase couples the motions and rearrangements of three cytoplasmic domains (A, P, and N) with Ca2+ transport. We explored the role of electrostatic force in the domain dynamics in a rate-limiting phosphoenzyme (EP) transition by a systematic approach combining electrostatic screening with salts, computer analysis of electric fields in crystal structures, and mutations. Low KCl concentration activated and increasing salt above 0.1 M inhibited the EP transition. A plot of the logarithm of the transition rate versus the square of the mean activity coefficient of the protein gave a linear relationship allowing division of the activation energy into an electrostatic component and a non-electrostatic component in which the screenable electrostatic forces are shielded by salt. Results show that the structural change in the transition is sterically restricted, but that strong electrostatic forces, when K+ is specifically bound at the P domain, come into play to accelerate the reaction. Electric field analysis revealed long-range electrostatic interactions between the N and P domains around their hinge. Mutations of the residues directly involved and other charged residues at the hinge disrupted in parallel the electric field and the structural transition. Favorable electrostatics evidently provides a low energy path for the critical N domain motion toward the P domain, overcoming steric restriction. The systematic approach employed here is, in general, a powerful tool for understanding the structural mechanisms of enzymes.	[Yamasaki, Kazuo; Daiho, Takashi; Danko, Stefania; Suzuki, Hiroshi] Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan	Asahikawa Medical College	Yamasaki, K (corresponding author), Asahikawa Med Univ, Dept Biochem, Asahikawa, Hokkaido 0788510, Japan.	kyamasak@asahikawa-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [23370058] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (C) (to K. Y.) and (B) (to H. S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bronsted JN, 1922, J AM CHEM SOC, V44, P877, DOI 10.1021/ja01426a001; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Daiho T, 2003, J BIOL CHEM, V278, P39197, DOI 10.1074/jbc.M305200200; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Daiho T, 2010, J BIOL CHEM, V285, P24538, DOI 10.1074/jbc.M110.144535; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2009, J BIOL CHEM, V284, P22722, DOI 10.1074/jbc.M109.029702; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; GUGGENHEIM EA, 1955, T FARADAY SOC, V51, P747, DOI 10.1039/tf9555100747; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; Liu XY, 2009, J BIOL CHEM, V284, P25190, DOI 10.1074/jbc.M109.034140; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Ma HL, 2005, BIOCHEMISTRY-US, V44, P8090, DOI 10.1021/bi050332m; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PUNZENGRUBER C, 1978, EUR J BIOCHEM, V92, P349, DOI 10.1111/j.1432-1033.1978.tb12754.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scatchard G, 1936, CHEM REV, V19, P309, DOI 10.1021/cr60064a008; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; SHIGEKAWA M, 1976, J BIOL CHEM, V251, P6947; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Sorensen TLM, 2004, J BIOL CHEM, V279, P46355, DOI 10.1074/jbc.C400414200; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2009, BBA-MOL CELL RES, V1793, P941, DOI 10.1016/j.bbamcr.2008.10.008; WAKABAYASHI S, 1984, J BIOL CHEM, V259, P4427; Wang GL, 2005, J BIOL CHEM, V280, P26508, DOI 10.1074/jbc.M503789200; WEBER K, 1969, J BIOL CHEM, V244, P4406; Yamasaki K, 2008, J BIOL CHEM, V283, P29144, DOI 10.1074/jbc.M804596200; Yamasaki K, 2010, J BIOL CHEM, V285, P38674, DOI 10.1074/jbc.M110.183343	38	6	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20646	20657		10.1074/jbc.M113.482711	http://dx.doi.org/10.1074/jbc.M113.482711			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23737524	Green Published, hybrid			2022-12-28	WOS:000321715100050
J	Matsushita, Y; Sakamoto, K; Tamamura, Y; Shibata, Y; Minamizato, T; Kihara, T; Ito, M; Katsube, K; Hiraoka, S; Koseki, H; Harada, K; Yamaguchi, A				Matsushita, Yuki; Sakamoto, Kei; Tamamura, Yoshihiro; Shibata, Yasuaki; Minamizato, Tokutaro; Kihara, Tasuku; Ito, Masako; Katsube, Ken-ichi; Hiraoka, Shuichi; Koseki, Haruhiko; Harada, Kiyoshi; Yamaguchi, Akira			CCN3 Protein Participates in Bone Regeneration as an Inhibitory Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRILL-HOLE INJURY; MORPHOGENETIC PROTEINS; OSTEOBLAST DIFFERENTIATION; NOV CCN3; SIGNALING PATHWAYS; CAUSES OSTEOPENIA; HUMAN FRACTURES; WILMS-TUMORS; IN-VITRO; EXPRESSION	CCN3, a member of the CCN protein family, inhibits osteoblast differentiation in vitro. However, the role of CCN3 in bone regeneration has not been well elucidated. In this study, we investigated the role of CCN3 in bone regeneration. We identified the Ccn3 gene by microarray analysis as a highly expressed gene at the early phase of bone regeneration in a mouse bone regeneration model. We confirmed the up-regulation of Ccn3 at the early phase of bone regeneration by RT-PCR, Western blot, and immunofluorescence analyses. Ccn3 transgenic mice, in which Ccn3 expression was driven by 2.3-kb Col1a1 promoter, showed osteopenia compared with wild-type mice, but Ccn3 knock-out mice showed no skeletal changes compared with wild-type mice. We analyzed the bone regeneration process in Ccn3 transgenic mice and Ccn3 knock-out mice by microcomputed tomography and histological analyses. Bone regeneration in Ccn3 knock-out mice was accelerated compared with that in wild-type mice. The mRNA expression levels of osteoblast-related genes (Runx2, Sp7, Col1a1, Alpl, and Bglap) in Ccn3 knock-out mice were up-regulated earlier than those in wildtype mice, as demonstrated by RT-PCR. Bone regeneration in Ccn3 transgenic mice showed no significant changes compared with that in wild-type mice. Phosphorylation of Smad1/5 was highly up-regulated at bone regeneration sites in Ccn3 KO mice compared with wild-type mice. These results indicate that CCN3 is up-regulated in the early phase of bone regeneration and acts as a negative regulator for bone regeneration. This study may contribute to the development of new strategies for bone regeneration therapy.	[Matsushita, Yuki; Sakamoto, Kei; Tamamura, Yoshihiro; Katsube, Ken-ichi; Yamaguchi, Akira] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Oral Pathol, Tokyo 1138549, Japan; [Matsushita, Yuki; Kihara, Tasuku; Harada, Kiyoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Sect Maxillofacial Surg, Tokyo 1138549, Japan; [Matsushita, Yuki; Yamaguchi, Akira] Tokyo Med & Dent Univ, Global Ctr Excellence Program, Int Res Ctr Mol Sci Tooth & Bone Dis, Tokyo 1138549, Japan; [Tamamura, Yoshihiro] Mukogawa Womens Univ, Dept Hlth & Sports Sci, Nishinomiya, Hyogo 6638137, Japan; [Shibata, Yasuaki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Oral Pathol, Nagasaki 8528588, Japan; [Minamizato, Tokutaro] Nagasaki Univ, Grad Sch Biomed Sci, Dept Regenerat Oral Surg, Nagasaki 8528588, Japan; [Ito, Masako] Nagasaki Univ Hosp, Med Work Life Balance Ctr, Nagasaki 8528588, Japan; [Hiraoka, Shuichi] Natl Res Inst Child Hlth & Dev, Dept Allergy & Immunol, Tokyo 200045, Japan; [Koseki, Haruhiko] RIKEN Res Ctr Allergy & Immunol, Lab Dev Genet, Yokohama, Kanagawa 1578535, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Mukogawa Women's University; Nagasaki University; Nagasaki University; Nagasaki University; National Center for Child Health & Development - Japan; RIKEN	Yamaguchi, A (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Sect Oral Pathol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	akira.mpa@tmd.ac.jp	Koseki, Haruhiko/I-3825-2014; Matsushita, Yuki/H-3188-2015; Yamaguchi, Akira/AAX-9286-2020	Koseki, Haruhiko/0000-0001-8424-5854; Matsushita, Yuki/0000-0001-9577-3249; 	Japan Society for the Promotion of Science [21659420, 22249061, 23659854]; Ministry of Health, Labor, and Welfare [21040101]; Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research [23592696] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical and Dental University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research 21659420, 22249061, and 23659854 from the Japan Society for the Promotion of Science and Health and Labor Sciences Research Grant 21040101 from the Ministry of Health, Labor, and Welfare (to A. Y.) and by the Global Center of Excellence Program, International Research Center for Molecular Science in Tooth and Bone Diseases, Tokyo Medical and Dental University.	BOSTROM MPG, 1995, J ORTHOPAED RES, V13, P357, DOI 10.1002/jor.1100130309; Burren CP, 1999, J CLIN ENDOCR METAB, V84, P1096; Canalis E, 2010, ENDOCRINOLOGY, V151, P221, DOI 10.1210/en.2009-0574; Chevalier G, 1998, AM J PATHOL, V152, P1563; Dean DB, 2010, J ANAT, V216, P625, DOI 10.1111/j.1469-7580.2010.01214.x; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Ellis PD, 2000, ARTERIOSCL THROM VAS, V20, P1912, DOI 10.1161/01.ATV.20.8.1912; Gazzerro E, 1998, J CLIN INVEST, V102, P2106, DOI 10.1172/JCI3459; Gupta R, 2007, SCIENCE, V316, P590, DOI 10.1126/science.1136031; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Haque T, 2008, BONE, V42, P1144, DOI 10.1016/j.bone.2008.01.028; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Ito M, 2005, J BONE MINER RES, V20, P1828, DOI 10.1359/JBMR.050610; Janune D, 2011, FEBS LETT, V585, P3033, DOI 10.1016/j.febslet.2011.08.024; Katae Y, 2009, J ORTHOP RES, V27, P1652, DOI 10.1002/jor.20920; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katsube K, 2001, Brain Res Gene Expr Patterns, V1, P61; Katsube K, 2009, J CELL COMMUN SIGNAL, V3, P135, DOI 10.1007/s12079-009-0059-1; Katsuki Y, 2008, BIOCHEM BIOPH RES CO, V368, P808, DOI 10.1016/j.bbrc.2008.02.010; Kawaki H, 2011, BONE, V49, P975, DOI 10.1016/j.bone.2011.06.033; Kloen P, 2012, BONE, V51, P59, DOI 10.1016/j.bone.2012.03.032; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; KREBSBACH PH, 1993, MOL CELL BIOL, V13, P5168, DOI 10.1128/MCB.13.9.5168; Kubota S, 2012, JPN DENT SCI REV, V48, P101, DOI 10.1016/j.jdsr.2012.02.002; Kwong FNK, 2009, INT ORTHOP, V33, P281, DOI 10.1007/s00264-008-0691-z; Lafont J, 2005, J BONE MINER RES, V20, P2213, DOI 10.1359/JBMR.050818; Lin CG, 2005, J BIOL CHEM, V280, P8229, DOI 10.1074/jbc.M404903200; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Macsai CE, 2012, BONE, V50, P1081, DOI 10.1016/j.bone.2012.02.013; Minamizato T, 2007, BIOCHEM BIOPH RES CO, V354, P567, DOI 10.1016/j.bbrc.2007.01.029; Monfoulet L, 2010, CALCIFIED TISSUE INT, V86, P72, DOI 10.1007/s00223-009-9314-y; Nakase T, 2006, J BONE MINER METAB, V24, P425, DOI 10.1007/s00774-006-0718-8; Natarajan D, 2000, DEV DYNAM, V219, P417, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1058>3.0.CO;2-2; Ouellet V, 2012, J CELL COMMUN SIGNAL, V6, P73, DOI 10.1007/s12079-012-0161-7; Ouellet V, 2011, AM J PATHOL, V178, P2377, DOI 10.1016/j.ajpath.2011.01.033; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Pereira RC, 2000, ENDOCRINOLOGY, V141, P4558, DOI 10.1210/en.141.12.4558; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Shimoyama T, 2010, ARTERIOSCL THROM VAS, V30, P675, DOI 10.1161/ATVBAHA.110.203356; SORET J, 1989, J VIROL, V63, P1803, DOI 10.1128/JVI.63.4.1803-1807.1989; Su BY, 1998, CR ACAD SCI III-VIE, V321, P883, DOI 10.1016/S0764-4469(99)80002-X; Subramaniam MM, 2008, VIRCHOWS ARCH, V452, P33, DOI 10.1007/s00428-007-0523-3; Tanaka K, 2010, BONE, V47, P1006, DOI 10.1016/j.bone.2010.08.016; Uchida S, 2000, BONE, V27, P81, DOI 10.1016/S8756-3282(00)00293-3; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Yamaguchi A, 2008, JPN DENT SCI REV, V44, P48, DOI 10.1016/j.jdsr.2007.11.003; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6; Yoshimura Y, 2001, J BONE MINER RES, V16, P876, DOI 10.1359/jbmr.2001.16.5.876	50	35	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19973	19985		10.1074/jbc.M113.454652	http://dx.doi.org/10.1074/jbc.M113.454652			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23653360	hybrid, Green Published			2022-12-28	WOS:000321515800062
J	Shirodkar, P; Fenton, AL; Meng, L; Koch, CA				Shirodkar, Purnata; Fenton, Amanda L.; Meng, Li; Koch, C. Anne			Identification and Functional Characterization of a Ku-binding Motif in Aprataxin Polynucleotide Kinase/Phosphatase-like Factor (APLF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNER-SYNDROME PROTEIN; DNA-DAMAGE RESPONSE; STRAND BREAK REPAIR; END; C2ORF13; TRANSLOCATION; TRANSPORT; DYNAMICS; COMPLEX; KINASE	Aprataxin polynucleotide kinase/phosphatase-like factor (APLF) facilitates nonhomologous end joining (NHEJ) and associates with the core NHEJ components XRCC4-DNA ligase IV and Ku. The APLF forkhead-associated (FHA) domain directs interactions with XRCC4, but the APLF-Ku interaction has not been well characterized. Here we describe an evolutionarily conserved amino acid motif within APLF that is required for mediating the physical interaction between APLF and Ku. This APLF Ku-binding motif possesses a similarity to regions identified in other NHEJ factors, WRN and XLF, which also direct interactions with Ku. Indeed, peptides derived from the Ku-binding region of APLF, WRN, or XLF were sufficient to reconstitute the interaction with Ku in vitro. Although APLF is localized predominantly to the nucleus, it does not possess a nuclear localization signal (NLS). Interestingly, the disruption of the APLF-Ku interaction by substituting key residues in the APLF Ku-binding motif was associated with increased relocalization of APLF to the cytoplasm and reduced association with XRCC4, which was rescued by the introduction of an NLS onto APLF. When human cells stably depleted of APLF were reconstituted with APLF Ku-binding mutants, or with an APLF FHA mutant that is known to disrupt interactions with XRCC4, APLF-dependent NHEJ and the retention of APLF at sites of laser-generated DNA damage were impaired. These data suggest functional requirements for Ku and XRCC4 in APLF-dependent NHEJ and a unique role for Ku as a factor required to facilitate the nuclear retention of APLF.	[Shirodkar, Purnata; Fenton, Amanda L.; Meng, Li; Koch, C. Anne] Univ Hlth Network, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Shirodkar, Purnata; Fenton, Amanda L.; Koch, C. Anne] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Koch, C. Anne] Univ Hlth Network, Radiat Med Program, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Koch, CA (corresponding author), Univ Hlth Network, Radiat Med Program, Princess Margaret Canc Ctr, 610 Univ Ave, Toronto, ON M5G 2M9, Canada.	anne.koch@rmp.uhn.on.ca			Canadian Institutes of Health Research (CIHR) [MOP-102691]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grant MOP-102691 (to C. A. K.).	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Bekker-Jensen S, 2006, J CELL BIOL, V173, P195, DOI 10.1083/jcb.200510130; Bekker-Jensen S, 2007, J BIOL CHEM, V282, P19638, DOI 10.1074/jbc.C700060200; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Caldecott KW, 2003, CELL, V112, P7, DOI 10.1016/S0092-8674(02)01247-3; Chen L, 2000, J BIOL CHEM, V275, P26196, DOI 10.1074/jbc.M000491200; Comai L, 2004, MECH AGEING DEV, V125, P521, DOI 10.1016/j.mad.2004.06.004; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; Grundy GJ, 2013, EMBO J, V32, P112, DOI 10.1038/emboj.2012.304; Iles N, 2007, MOL CELL BIOL, V27, P3793, DOI 10.1128/MCB.02269-06; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Karmakar P, 2002, NUCLEIC ACIDS RES, V30, P3583, DOI 10.1093/nar/gkf482; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Knudsen NO, 2009, DNA REPAIR, V8, P682, DOI 10.1016/j.dnarep.2009.03.005; Koch CA, 2004, EMBO J, V23, P3874, DOI 10.1038/sj.emboj.7600375; Koike M, 2002, J RADIAT RES, V43, P223, DOI 10.1269/jrr.43.223; Li BM, 2002, NUCLEIC ACIDS RES, V30, P3653, DOI 10.1093/nar/gkf488; Li BM, 2001, J BIOL CHEM, V276, P9896, DOI 10.1074/jbc.M008575200; Li GY, 2010, P NATL ACAD SCI USA, V107, P9129, DOI 10.1073/pnas.1000556107; Macrae CJ, 2008, DNA REPAIR, V7, P292, DOI 10.1016/j.dnarep.2007.10.008; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Rulten SL, 2008, MOL CELL BIOL, V28, P4620, DOI 10.1128/MCB.02243-07; Rulten SL, 2011, MOL CELL, V41, P33, DOI 10.1016/j.molcel.2010.12.006; Santagati F, 2001, NUCLEIC ACIDS RES, V29, P1574, DOI 10.1093/nar/29.7.1574; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003; Weterings E, 2009, MOL CELL BIOL, V29, P1134, DOI 10.1128/MCB.00971-08; Wu XT, 1996, MOL CELL BIOL, V16, P5186; Yannone SM, 2001, J BIOL CHEM, V276, P38242; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yano K, 2011, FEBS LETT, V585, P841, DOI 10.1016/j.febslet.2011.02.020	38	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19604	19613		10.1074/jbc.M112.440388	http://dx.doi.org/10.1074/jbc.M112.440388			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689425	Green Published, hybrid			2022-12-28	WOS:000321515800026
J	Artyukhin, AB; Yim, JJ; Srinivasan, J; Izrayelit, Y; Bose, N; von Reuss, SH; Jo, Y; Jordan, JM; Baugh, LR; Cheong, M; Sternberg, PW; Avery, L; Schroeder, FC				Artyukhin, Alexander B.; Yim, Joshua J.; Srinivasan, Jagan; Izrayelit, Yevgeniy; Bose, Neelanjan; von Reuss, Stephan H.; Jo, Yeara; Jordan, James M.; Baugh, L. Ryan; Cheong, Micheong; Sternberg, Paul W.; Avery, Leon; Schroeder, Frank C.			Succinylated Octopamine Ascarosides and a New Pathway of Biogenic Amine Metabolism in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHEROMONE; BIOSYNTHESIS; SEROTONIN; BEHAVIOR; REVEALS	The ascarosides, small-molecule signals derived from combinatorial assembly of primary metabolism-derived building blocks, play a central role in Caenorhabditis elegans biology and regulate many aspects of development and behavior in this model organism as well as in other nematodes. Using HPLC-MS/MS-based targeted metabolomics, we identified novel ascarosides incorporating a side chain derived from succinylation of the neurotransmitter octopamine. These compounds, named osas#2, osas#9, and osas#10, are produced predominantly by L1 larvae, where they serve as part of a dispersal signal, whereas these ascarosides are largely absent from the metabolomes of other life stages. Investigating the biogenesis of these octopamine-derived ascarosides, we found that succinylation represents a previously unrecognized pathway of biogenic amine metabolism. At physiological concentrations, the neurotransmitters serotonin, dopamine, and octopamine are converted to a large extent into the corresponding succinates, in addition to the previously described acetates. Chemically, bimodal deactivation of biogenic amines via acetylation and succinylation parallels posttranslational modification of proteins via acetylation and succinylation of L-lysine. Our results reveal a small-molecule connection between neurotransmitter signaling and interorganismal regulation of behavior and suggest that ascaroside biosynthesis is based in part on co-option of degradative biochemical pathways.	[Artyukhin, Alexander B.; Yim, Joshua J.; Izrayelit, Yevgeniy; Bose, Neelanjan; von Reuss, Stephan H.; Schroeder, Frank C.] Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA; [Artyukhin, Alexander B.; Yim, Joshua J.; Izrayelit, Yevgeniy; Bose, Neelanjan; von Reuss, Stephan H.; Schroeder, Frank C.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Artyukhin, Alexander B.; Avery, Leon] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Srinivasan, Jagan; Jo, Yeara; Sternberg, Paul W.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Srinivasan, Jagan; Jo, Yeara; Sternberg, Paul W.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jordan, James M.; Baugh, L. Ryan] Duke Univ, Duke Ctr Syst Biol, Dept Biol, Durham, NC 27708 USA	Cornell University; Boyce Thompson Institute for Plant Research; Cornell University; Virginia Commonwealth University; California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Duke University	Schroeder, FC (corresponding author), Cornell Univ, Boyce Thompson Inst, Ithaca, NY 14853 USA.	schroeder@cornell.edu	Baugh, L. Ryan/GRS-0507-2022; Srinivasan, Jagan/B-6215-2015; Bose, Neelanjan/B-8054-2017	Baugh, L. Ryan/0000-0003-2148-5492; Bose, Neelanjan/0000-0002-3817-4757; Jordan, James/0000-0002-7620-462X; Schroeder, Frank/0000-0002-4420-0237; Yim, Joshua/0000-0002-9999-1566; Srinivasan, Jagan/0000-0001-5449-7938; von Reuss, Stephan/0000-0003-4325-5495; Cheong, Mi Cheong/0000-0002-7604-6203; Jo, Yeara/0000-0002-1340-1968	National Institutes of Health [GM088290, GM008500, DK83593, GM085285]; National Science Foundation [IOS1120206]; Vassar College Mary Landon Sague Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008500, R01GM085285, R01GM088290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Vassar College Mary Landon Sague Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM088290 (to F. C. S.), GM008500 (to Y. I.), DK83593 (to L. A.), and GM085285 (to F. C. S. and P. W. S.), and National Science Foundation Grant IOS1120206 (to L. R. B.), as well as the Vassar College Mary Landon Sague Fellowship (to Y. I.).	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Bose N, 2012, ANGEW CHEM INT EDIT, V51, P12438, DOI 10.1002/anie.201206797; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Butcher RA, 2009, P NATL ACAD SCI USA, V106, P1875, DOI 10.1073/pnas.0810338106; Chase Daniel L, 2007, WormBook, P1; Cho BT, 2002, TETRAHEDRON-ASYMMETR, V13, P1209; Choe A, 2012, P NATL ACAD SCI USA, V109, P20949, DOI 10.1073/pnas.1218302109; Choe A, 2012, CURR BIOL, V22, P772, DOI 10.1016/j.cub.2012.03.024; Deyrup ST, 2011, P NATL ACAD SCI USA, V108, P9753, DOI 10.1073/pnas.1107020108; ERSPAMER V, 1952, NATURE, V169, P375, DOI 10.1038/169375b0; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Harris G, 2010, J NEUROSCI, V30, P7889, DOI 10.1523/JNEUROSCI.0497-10.2010; Hilliard MA, 2002, CURR BIOL, V12, P730, DOI 10.1016/S0960-9822(02)00813-8; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Isaac RE, 1996, PARASITOLOGY, V113, pS157, DOI 10.1017/S0031182000077957; ISAAC RE, 1990, MOL BIOCHEM PARASIT, V43, P193, DOI 10.1016/0166-6851(90)90144-B; Izrayelit Y, 2013, ACS CHEM BIOL, V8, P314, DOI 10.1021/cb3004644; Izrayelit Y, 2012, ACS CHEM BIOL, V7, P1321, DOI 10.1021/cb300169c; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Joo HJ, 2009, BIOCHEM J, V422, P61, DOI 10.1042/BJ20090513; Kaplan F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038735; Lee BH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000213; Lee I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044720; Lin HN, 2012, ACS CHEM BIOL, V7, P947, DOI 10.1021/cb3001793; Ludewig AH, 2013, P NATL ACAD SCI USA, V110, P5522, DOI 10.1073/pnas.1214467110; Ludewig Andreas H, 2013, WormBook, P1, DOI 10.1895/wormbook.1.155.1; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Pungaliya C, 2009, P NATL ACAD SCI USA, V106, P7708, DOI 10.1073/pnas.0811918106; Roeder T, 1999, PROG NEUROBIOL, V59, P533, DOI 10.1016/S0301-0082(99)00016-7; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Srinivasan J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001237	33	51	51	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18778	18783		10.1074/jbc.C113.477000	http://dx.doi.org/10.1074/jbc.C113.477000			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23689506	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000321335800015
J	Jacobi, CLJ; Rudigier, LJ; Scholz, H; Kirschner, KM				Jacobi, Charlotte L. J.; Rudigier, Lucas J.; Scholz, Holger; Kirschner, Karin M.			Transcriptional Regulation by the Wilms Tumor Protein, Wt1, Suggests a Role of the Metalloproteinase Adamts16 in Murine Genitourinary Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRKB NEUROTROPHIN RECEPTOR; SEX DETERMINATION; GENE-PRODUCT; MOUSE OVARY; THROMBOSPONDIN MOTIFS; SUPPRESSOR PROTEIN; KIDNEY DEVELOPMENT; PROGENITOR CELLS; GROWTH-FACTOR; IMMATURE RAT	ADAMTS16 (a disintegrin and metalloproteinase with thrombospondin motifs) is a secreted mammalian metalloproteinase with unknown function. We report here that murine Adamts16 is co-expressed with the Wilms tumor protein, Wt1, in the developing glomeruli of embryonic kidneys. Adamts16 mRNA levels were significantly reduced upon transfection of embryonic murine kidney explants with Wt1 antisense vivo-morpholinos. Antisense knockdown of Adamts16 inhibited branching morphogenesis in kidney organ cultures. Adamts16 was detected by in situ mRNA hybridization and/or immunohistochemistry also in embryonic gonads and in spermatids and granulosa cells of adult testes and ovaries, respectively. Silencing of Wt1 by transfection with antisense vivo-morpholinos significantly increased Adamts16 mRNA in cultured embryonic XY gonads (11.5 and 12.5 days postconception), and reduced Adamts16 transcripts in XX gonads (12.5 and 13.5 days postconception). Three predicted Wt1 consensus motifs could be identified in the promoter and the 5'-untranslated region of the murine Adamts16 gene. Binding of Wt1 protein to these elements was verified by EMSA and ChIP. A firefly luciferase reporter gene under control of the Adamts16 promoter was activated similar to 8-fold by transient co-transfection of human granulosa cells with a Wt1 expression construct. Gradual shortening of the 5'-flanking sequence successively reduced and eventually abrogated Adamts16 promoter activation by Wt1. These findings demonstrate that Wt1 differentially regulates the Adamts16 gene in XX and XY embryonic gonads. It is suggested that Adamts16 acts immediately downstream of Wt1 during murine urogenital development. We propose that Adamts16 is involved in branching morphogenesis of the kidneys in mice.	[Jacobi, Charlotte L. J.; Rudigier, Lucas J.; Scholz, Holger; Kirschner, Karin M.] Charite, Inst Vegetat Physiol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Scholz, H (corresponding author), Charite, Inst Vegetat Physiol, Charitepl 1, D-10117 Berlin, Germany.	holger.scholz@charite.de		Kirschner, Karin/0000-0003-0226-8636; Jacobi, Charlotte/0000-0001-6398-2812	Deutsche Forschungsgemeinschaft [Scho634/8-1]; Sonnenfeld-Stiftung; FAZIT-STIFTUNG	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonnenfeld-Stiftung; FAZIT-STIFTUNG	This work was supported in part by Deutsche Forschungsgemeinschaft Grant Scho634/8-1.; Recipient of fellowships from the Sonnenfeld-Stiftung and the FAZIT-STIFTUNG.	Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; Bor YC, 2006, GENE DEV, V20, P1597, DOI 10.1101/gad.1402306; BYSKOV AG, 1978, BIOL REPROD, V19, P720, DOI 10.1095/biolreprod19.4.720; Cal S, 2002, GENE, V283, P49, DOI 10.1016/S0378-1119(01)00861-7; Clapcote SJ, 2005, BIOTECHNIQUES, V38, P702, DOI 10.2144/05385BM05; Clark ME, 2000, GENOMICS, V67, P343, DOI 10.1006/geno.2000.6246; COLIGE A, 1995, J BIOL CHEM, V270, P16724, DOI 10.1074/jbc.270.28.16724; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; Dame C, 2006, BLOOD, V107, P4282, DOI 10.1182/blood-2005-07-2889; Davies JA, 2004, HUM MOL GENET, V13, P235, DOI 10.1093/hmg/ddh015; ENGLERT C, 1995, EMBO J, V14, P4662, DOI 10.1002/j.1460-2075.1995.tb00148.x; Espey LL, 2000, BIOL REPROD, V62, P1090, DOI 10.1095/biolreprod62.4.1090; Fernandes RJ, 2001, J BIOL CHEM, V276, P31502, DOI 10.1074/jbc.M103466200; Gao S, 2007, MOL HUM REPROD, V13, P465, DOI 10.1093/molehr/gam037; GONDOS B, 1975, AM J PATHOL, V81, P303; Gopalakrishnan K, 2012, P NATL ACAD SCI USA, V109, P20555, DOI 10.1073/pnas.1211290109; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618; HAMILTON TB, 1995, NUCLEIC ACIDS RES, V23, P277, DOI 10.1093/nar/23.2.277; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; Hossain A, 2001, J BIOL CHEM, V276, P16817, DOI 10.1074/jbc.M009056200; Hurskainen TL, 1999, J BIOL CHEM, V274, P25555, DOI 10.1074/jbc.274.36.25555; Joe B, 2009, HUM MOL GENET, V18, P2825, DOI 10.1093/hmg/ddp218; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; Kim JH, 2005, J VASC INTERV RADIOL, V16, P543, DOI 10.1097/01.RVI.0000150033.13928.D4; Kirschner KM, 2008, FASEB J, V22, P2690, DOI 10.1096/fj.07-097576; Klattig J, 2007, MOL CELL BIOL, V27, P4355, DOI 10.1128/MCB.01780-06; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Kuno K, 1998, J BIOL CHEM, V273, P13912, DOI 10.1074/jbc.273.22.13912; Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932; LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Madan P, 2003, BIOL REPROD, V69, P1506, DOI 10.1095/biolreprod.102.013714; MADDEN SL, 1991, SCIENCE, V253, P1550, DOI 10.1126/science.1654597; Martens LK, 2007, J BIOL CHEM, V282, P14379, DOI 10.1074/jbc.M609857200; Martinez-Estrada OM, 2010, NAT GENET, V42, P89, DOI 10.1038/ng.494; Michos O, 2009, CURR OPIN GENET DEV, V19, P484, DOI 10.1016/j.gde.2009.09.003; Miller-Hodges E, 2012, J PATHOL, V226, P229, DOI 10.1002/path.2977; Mittaz L, 2004, BIOL REPROD, V70, P1096, DOI 10.1095/biolreprod.103.023911; MORRIS JF, 1991, ONCOGENE, V6, P2339; Niaudet P, 2006, PEDIATR NEPHROL, V21, P1653, DOI 10.1007/s00467-006-0208-1; PELLETIER J, 1991, CELL, V67, P437, DOI 10.1016/0092-8674(91)90194-4; PETERS H, 1967, FERTIL STERIL, V18, P309; Pohl M, 2000, AM J PHYSIOL-RENAL, V279, pF891, DOI 10.1152/ajprenal.2000.279.5.F891; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; Richards JS, 2005, BIOL REPROD, V72, P1241, DOI 10.1095/biolreprod.104.038083; Roberts SGE, 2006, BIOCHEM SOC SYMP, V73, P191; Robker RL, 2000, P NATL ACAD SCI USA, V97, P4689, DOI 10.1073/pnas.080073497; Roh J, 2009, FERTIL STERIL, V91, P1451, DOI 10.1016/j.fertnstert.2008.07.012; Sakamoto N, 2010, CANCER SCI, V101, P1038, DOI 10.1111/j.1349-7006.2009.01477.x; Sawyer HR, 2002, BIOL REPROD, V66, P1134, DOI 10.1095/biolreprod66.4.1134; Schumacher V, 1998, KIDNEY INT, V53, P1594, DOI 10.1046/j.1523-1755.1998.00948.x; Sciesielski LK, 2010, FEBS LETT, V584, P4665, DOI 10.1016/j.febslet.2010.10.045; Shimamura R, 1997, CLIN CANCER RES, V3, P2571; Stricker S, 2006, DEV DYNAM, V235, P3456, DOI 10.1002/dvdy.20993; Surridge AK, 2009, MATRIX BIOL, V28, P416, DOI 10.1016/j.matbio.2009.07.001; Swain A, 1999, GENE DEV, V13, P755, DOI 10.1101/gad.13.7.755; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349; Wagner KD, 2001, J AM SOC NEPHROL, V12, P1188, DOI 10.1681/ASN.V1261188; Wagner N, 2005, GENE DEV, V19, P2631, DOI 10.1101/gad.346405; Warburg O, 1942, BIOCHEM Z, V310, P384; Worley JR, 2003, J BIOL CHEM, V278, P51340, DOI 10.1074/jbc.M310865200; Yoon O, 2012, MOL REPROD DEV, V79, P368, DOI 10.1002/mrd.22036	66	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18811	18824		10.1074/jbc.M113.464644	http://dx.doi.org/10.1074/jbc.M113.464644			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23661704	hybrid, Green Published			2022-12-28	WOS:000321335800019
J	Guo, L; Ai, JT; Zheng, Z; Howatt, DA; Daugherty, A; Huang, B; Li, XA				Guo, Ling; Ai, Junting; Zheng, Zhong; Howatt, Deborah A.; Daugherty, Alan; Huang, Bin; Li, Xiang-An			High Density Lipoprotein Protects against Polymicrobe-induced Sepsis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-A-I; NECROSIS-FACTOR RELEASE; SCAVENGER RECEPTOR; SR-BI; CECAL LIGATION; UNITED-STATES; ENDOTOXIN; HDL; LIPOPOLYSACCHARIDE; CHYLOMICRONS	HDL has been considered to be a protective factor in sepsis; however, most contributing studies were conducted using the endotoxic animal model, and evidence from clinically relevant septic animal models remains limited and controversial. Furthermore, little is known about the roles of HDL in sepsis other than LPS neutralization. In this study, we employed cecal ligation and puncture (CLP), a clinically relevant septic animal model, and utilized apoA-I knock-out (KO) and transgenic mice to elucidate the roles of HDL in sepsis. ApoA-I-KO mice were more susceptible to CLP-induced septic death as shown by the 47.1% survival of apoA-I-KO mice versus the 76.7% survival of C57BL/6J (B6) mice (p = 0.038). ApoA-I-KO mice had exacerbated inflammatory cytokine production during sepsis compared with B6 mice. Further study indicated that serum from apoA-I-KO mice displayed less capacity for LPS neutralization compared with serum from B6 mice. In addition, apoA-I-KO mice had less LPS clearance, reduced corticosterone generation, and impaired leukocyte recruitment in sepsis. In contrast to apoA-I-KO mice, apoA-I transgenic mice were moderately resistant to CLP-induced septic death compared with B6 mice. In conclusion, our findings reveal multiple protective roles of HDL in CLP-induced sepsis. In addition to its well established role in neutralization of LPS, HDL exerts its protection against sepsis through promoting LPS clearance and modulating corticosterone production and leukocyte recruitment. Our study supports efforts to raise HDL levels as a therapeutic approach for sepsis.	[Guo, Ling; Ai, Junting; Zheng, Zhong; Li, Xiang-An] Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA; [Ai, Junting; Zheng, Zhong; Li, Xiang-An] Univ Kentucky, Coll Med, Grad Ctr Nutr Sci, Lexington, KY 40536 USA; [Howatt, Deborah A.; Daugherty, Alan; Li, Xiang-An] Univ Kentucky, Coll Med, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Huang, Bin] Univ Kentucky, Coll Med, Kentucky Canc Registry, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Li, XA (corresponding author), Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY 40536 USA.	xli2@email.uky.edu	Daugherty, Alan/C-8282-2009	Daugherty, Alan/0000-0003-2093-3775	National Institutes of Health from NIGMS [R01 GM085231, R01 GM085231-2S1, R01 GM085231-5S1]; Children's Miracle Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085231] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Children's Miracle Network; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM085231, R01 GM085231-2S1, and R01 GM085231-5S1 from NIGMS (to X.-A. L.). This work was also supported by a grant from the Children's Miracle Network.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; Cai L, 2008, J CLIN INVEST, V118, P364, DOI 10.1172/JCI31539; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; CUE JI, 1994, ARCH SURG-CHICAGO, V129, P193; Dai LJ, 2010, J LIPID RES, V51, P2695, DOI 10.1194/jlr.M008086; Echtenacher B, 2001, INFECT IMMUN, V69, P7271, DOI 10.1128/IAI.69.12.7172-7276.2001; EISENBERG S, 1984, J LIPID RES, V25, P1017; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; Feng H, 2010, J BIOL CHEM, V285, P25154, DOI 10.1074/jbc.M110.116897; Guo L, 2009, J BIOL CHEM, V284, P19826, DOI 10.1074/jbc.M109.020933; HARRIS HW, 1993, J CLIN INVEST, V91, P1028, DOI 10.1172/JCI116259; HARRIS HW, 1990, J CLIN INVEST, V86, P696, DOI 10.1172/JCI114765; Hoekstra M, 2008, J LIPID RES, V49, P738, DOI 10.1194/jlr.M700475-JLR200; HUBSCH AP, 1993, CIRC SHOCK, V40, P14; Ji AL, 2012, J LIPID RES, V53, P446, DOI 10.1194/jlr.M017079; Lee RP, 2007, RES NURS HEALTH, V30, P250, DOI 10.1002/nur.20187; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; Munford RS, 2005, J ENDOTOXIN RES, V11, P69, DOI 10.1179/096805105X35161; Murch O, 2007, INTENS CARE MED, V33, P13, DOI 10.1007/s00134-006-0432-y; Ocuin LM, 2011, J LEUKOCYTE BIOL, V89, P423, DOI 10.1189/jlb.0810479; Pajkrt D, 1996, J EXP MED, V184, P1601, DOI 10.1084/jem.184.5.1601; PARKER TS, 1995, INFECT IMMUN, V63, P253, DOI 10.1128/IAI.63.1.253-258.1995; Pavlou E., 2008, CRIT CARE, DOI [10.1186/cc6422, DOI 10.1186/CC6422]; Plump AS, 1996, J CLIN INVEST, V97, P2660, DOI 10.1172/JCI118716; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; QUEZADO ZMN, 1995, J PHARMACOL EXP THER, V272, P604; READ TE, 1993, INFECT IMMUN, V61, P3496, DOI 10.1128/IAI.61.8.3496-3502.1993; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; RUBIN EM, 1991, P NATL ACAD SCI USA, V88, P434, DOI 10.1073/pnas.88.2.434; Sessler Curtis N, 2004, Curr Opin Crit Care, V10, P354, DOI 10.1097/01.ccx.0000139363.76068.7b; Sorci-Thomas MG, 2012, BBA-MOL CELL BIOL L, V1821, P502, DOI 10.1016/j.bbalip.2011.08.019; Suzuki M, 2010, CIRCULATION, V122, P1919, DOI 10.1161/CIRCULATIONAHA.110.961193; Tsai MH, 2009, J HEPATOL, V50, P906, DOI 10.1016/j.jhep.2008.12.024; ULEVITCH RJ, 1981, J CLIN INVEST, V67, P827, DOI 10.1172/JCI110100; ULEVITCH RJ, 1979, J CLIN INVEST, V64, P1516, DOI 10.1172/JCI109610; van Leeuwen HJ, 2003, CRIT CARE MED, V31, P1359, DOI 10.1097/01.CCM.0000059724.08290.51; Vishnyakova TG, 2003, J BIOL CHEM, V278, P22771, DOI 10.1074/jbc.M211032200; Wang L, 2010, CYTOKINE, V49, P194, DOI 10.1016/j.cyto.2009.08.008; Wilhelm AJ, 2009, ARTERIOSCL THROM VAS, V29, P843, DOI 10.1161/ATVBAHA.108.183442; WILLIAMSON R, 1992, P NATL ACAD SCI USA, V89, P7134, DOI 10.1073/pnas.89.15.7134; Yurdakul P, 2011, AM J PATHOL, V179, P23, DOI 10.1016/j.ajpath.2011.03.009; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhang ZH, 2009, AM J PHYSIOL-HEART C, V297, pH866, DOI 10.1152/ajpheart.01232.2008	49	85	90	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17947	17953		10.1074/jbc.M112.442699	http://dx.doi.org/10.1074/jbc.M112.442699			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23658016	Green Published, hybrid			2022-12-28	WOS:000320721900002
J	Tsai, CJ; Chu, G				Tsai, Chun J.; Chu, Gilbert			Cooperative Assembly of a Protein-DNA Filament for Nonhomologous End Joining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; LIGASE-IV COMPLEX; V(D)J RECOMBINATION; GEL-ELECTROPHORESIS; CRYSTAL-STRUCTURE; MAMMALIAN-CELLS; XRCC4 PROTEIN; CERNUNNOS-XLF; KU; LIGATION	Nonhomologous end joining repairs DNA double-strand breaks created by ionizing radiation and V(D)J recombination. Ku, XRCC4/Ligase IV (XL), and XLF have a remarkable mismatched end (MEnd) ligase activity, particularly for ends with mismatched 3' overhangs, but the mechanism has remained obscure. Here, we showed XL required Ku to bind DNA, whereas XLF required both Ku and XL to bind DNA. We detected cooperative assembly of one or two Ku molecules and up to five molecules each of XL and XLF into a Ku-XL-XLF-DNA (MEnd ligase-DNA) complex. XLF mutations that disrupted its interactions with XRCC4 or DNA also disrupted complex assembly and end joining. Together with published co-crystal structures of truncated XRCC4 and XLF proteins, our data with full-length Ku, XL, and XLF bound to DNA indicate assembly of a filament containing Ku plus alternating XL and XLF molecules. By contrast, in the absence of XLF, we detected cooperative assembly of up to six molecules each of Ku and XL into a Ku-XL-DNA complex, consistent with a filament containing alternating Ku and XL molecules. Despite a lower molecular mass, MEnd ligase-DNA had a lower electrophoretic mobility than Ku-XL-DNA. The anomalous difference in mobility and difference in XL to Ku molar ratio suggests that MEnd ligase-DNA has a distinct structure that successfully aligns mismatched DNA ends for ligation.	[Chu, Gilbert] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University	Chu, G (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	chu@stanford.edu			National Institutes of Health [R01-GM086579]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM086579 (to G. C.).	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Andres SN, 2011, ACTA CRYSTALLOGR F, V67, P1399, DOI 10.1107/S1744309111033549; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Budman J, 2005, EMBO J, V24, P849, DOI 10.1038/sj.emboj.7600563; Budman J, 2007, J BIOL CHEM, V282, P11950, DOI 10.1074/jbc.M610058200; CROTHERS DM, 1992, METHOD ENZYMOL, V212, P46; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; FRIED MG, 1989, ELECTROPHORESIS, V10, P366, DOI 10.1002/elps.1150100515; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gu JF, 2007, NUCLEIC ACIDS RES, V35, P5755, DOI 10.1093/nar/gkm579; Hammarsten O, 1998, P NATL ACAD SCI USA, V95, P525, DOI 10.1073/pnas.95.2.525; Hammel M, 2011, J BIOL CHEM, V286, P32638, DOI 10.1074/jbc.M111.272641; Hammel M, 2010, STRUCTURE, V18, P1431, DOI 10.1016/j.str.2010.09.009; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Li G, 2008, MOL CELL, V31, P631, DOI 10.1016/j.molcel.2008.07.017; LIEBER MR, 1987, GENE DEV, V1, P751, DOI 10.1101/gad.1.8.751; Malivert L, 2010, J BIOL CHEM, V285, P26475, DOI 10.1074/jbc.M110.138156; Mani RS, 2010, J BIOL CHEM, V285, P37619, DOI 10.1074/jbc.M109.058719; Meek K, 2008, ADV IMMUNOL, V99, P33, DOI 10.1016/S0065-2776(08)00602-0; RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741; Ropars V, 2011, P NATL ACAD SCI USA, V108, P12663, DOI 10.1073/pnas.1100758108; Slater GW, 1996, METHOD ENZYMOL, V270, P272; SMIDER V, 1994, SCIENCE, V266, P288, DOI 10.1126/science.7939667; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wu PY, 2007, J BIOL CHEM, V282, P31937, DOI 10.1074/jbc.M704554200; Wu Q, 2011, BIOCHEM SOC T, V39, P1387, DOI 10.1042/BST0391387; Yano K, 2008, CELL CYCLE, V7, P1321, DOI 10.4161/cc.7.10.5898; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Yano K, 2011, FEBS LETT, V585, P841, DOI 10.1016/j.febslet.2011.02.020; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679; Zha S, 2007, P NATL ACAD SCI USA, V104, P4518, DOI 10.1073/pnas.0611734104; Zha S, 2011, NATURE, V469, P250, DOI 10.1038/nature09604	40	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18110	18120		10.1074/jbc.M113.464115	http://dx.doi.org/10.1074/jbc.M113.464115			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23620595	Green Published, hybrid			2022-12-28	WOS:000320721900017
J	Becker, T; Horvath, SE; Bottinger, L; Gebert, N; Daum, G; Pfanner, N				Becker, Thomas; Horvath, Susanne E.; Boettinger, Lena; Gebert, Natalia; Daum, Guenther; Pfanner, Nikolaus			Role of Phosphatidylethanolamine in the Biogenesis of Mitochondrial Outer Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; RESPIRATORY-CHAIN SUPERCOMPLEXES; SYNTHETIC LETHAL INTERACTION; TAIL-ANCHORED PROTEINS; BETA-BARREL PROTEINS; PHOSPHATIDYLSERINE DECARBOXYLASE; IMPORT CHANNEL; INTERMEMBRANE SPACE; TOM COMPLEX; PRESEQUENCE TRANSLOCASE	The mitochondrial outer membrane contains proteinaceous machineries for the import and assembly of proteins, including TOM (translocase of the outer membrane) and SAM (sorting and assembly machinery). It has been shown that the dimeric phospholipid cardiolipin is required for the stability of TOM and SAM complexes and thus for the efficient import and assembly of beta-barrel proteins and some alpha-helical proteins of the outer membrane. Here, we report that mitochondria deficient in phosphatidylethanolamine (PE), the second non-bilayer-forming phospholipid, are impaired in the biogenesis of beta -barrel proteins, but not of alpha-helical outer membrane proteins. The stability of TOM and SAM complexes is not disturbed by the lack of PE. By dissecting the import steps of beta-barrel proteins, we show that an early import stage involving translocation through the TOM complex is affected. In PE-depleted mitochondria, the TOM complex binds precursor proteins with reduced efficiency. We conclude that PE is required for the proper function of the TOM complex.	[Becker, Thomas; Horvath, Susanne E.; Boettinger, Lena; Gebert, Natalia; Pfanner, Nikolaus] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Becker, Thomas; Pfanner, Nikolaus] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Boettinger, Lena] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Horvath, Susanne E.; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria	University of Freiburg; University of Freiburg; University of Freiburg; Graz University of Technology	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at; nikolaus.pfanner@biochemie.uni-freiburg.de	Pfanner, Nikolaus/AAV-7878-2021; Becker, Thomas/AAS-9404-2020		Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 746]; Excellence Initiative of the German Federal and State Governments (Spemann Graduate School) [EXC 294 BIOSS, GSC-4]; Bundesministerium fur Bildung und Forschung; Austrian Science Fund FWF Project [21429]; DK Molecular Enzymology Grant [W901-B05]; Austrian Science Fund (FWF) [P 21429, W 901] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments (Spemann Graduate School); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Austrian Science Fund FWF Project(Austrian Science Fund (FWF)); DK Molecular Enzymology Grant(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Deutsche Forschungsgemeinschaft Sonderforschungsbereich 746, Excellence Initiative of the German Federal and State Governments Grants EXC 294 BIOSS and GSC-4 (Spemann Graduate School), the Bundesministerium fur Bildung und Forschung, and Austrian Science Fund FWF Project 21429 and DK Molecular Enzymology Grant W901-B05 (to G. D.).	Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Becker T, 2011, J CELL BIOL, V194, P387, DOI 10.1083/jcb.201102044; Becker T, 2011, J MOL BIOL, V405, P113, DOI 10.1016/j.jmb.2010.11.002; Becker T, 2010, MOL BIOL CELL, V21, P3106, DOI 10.1091/mbc.E10-06-0518; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Bogdanov M, 1999, J BIOL CHEM, V274, P12339, DOI 10.1074/jbc.274.18.12339; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Colombini M, 2012, BBA-BIOMEMBRANES, V1818, P1457, DOI 10.1016/j.bbamem.2011.12.026; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dimmer KS, 2012, J CELL SCI, V125, P3464, DOI 10.1242/jcs.103804; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Dukanovic J, 2009, MOL CELL BIOL, V29, P5975, DOI 10.1128/MCB.00069-09; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; Gallas MR, 2006, MOL BIOL CELL, V17, P4051, DOI 10.1091/mbc.E06-04-0366; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gonzalvez F, 2008, J CELL BIOL, V183, P681, DOI 10.1083/jcb.200803129; Habib SJ, 2005, J BIOL CHEM, V280, P6434, DOI 10.1074/jbc.M411510200; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Horvath SE, 2012, J BIOL CHEM, V287, P36744, DOI 10.1074/jbc.M112.398107; Horvath SE, 2011, BBA-MOL CELL BIOL L, V1811, P1030, DOI 10.1016/j.bbalip.2011.08.007; Hulett JM, 2008, J MOL BIOL, V376, P694, DOI 10.1016/j.jmb.2007.12.021; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; Krumpe K, 2012, MOL BIOL CELL, V23, P3927, DOI 10.1091/mbc.E11-12-0994; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lackey SWK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025650; Meineke B, 2008, FEBS LETT, V582, P855, DOI 10.1016/j.febslet.2008.02.009; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2006, J BIOL CHEM, V281, P22819, DOI 10.1074/jbc.M602679200; Merklinger E, 2012, BIOCHEM J, V442, P381, DOI 10.1042/BJ20111363; Mihara K, 2000, BIOESSAYS, V22, P364, DOI 10.1002/(SICI)1521-1878(200004)22:4<364::AID-BIES6>3.0.CO;2-N; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nguyen TT, 2012, TRAFFIC, V13, P880, DOI 10.1111/j.1600-0854.2012.01352.x; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; Papic D, 2011, J CELL BIOL, V194, P397, DOI 10.1083/jcb.201102041; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Popov-Celeketic J, 2008, J MOL BIOL, V376, P671, DOI 10.1016/j.jmb.2007.12.006; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; SPERKAGOTTLIEB CDM, 1988, BIOCHIM BIOPHYS ACTA, V946, P227, DOI 10.1016/0005-2736(88)90397-5; Stojanovski D, 2007, J CELL BIOL, V179, P881, DOI 10.1083/jcb.200706043; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; van der Does C, 2000, J BIOL CHEM, V275, P2472, DOI 10.1074/jbc.275.4.2472; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Wideman JG, 2010, MOL BIOL CELL, V21, P1725, DOI 10.1091/mbc.E09-10-0844; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Yamano K, 2010, J BIOL CHEM, V285, P41222, DOI 10.1074/jbc.M110.163238; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	98	41	41	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16451	16459		10.1074/jbc.M112.442392	http://dx.doi.org/10.1074/jbc.M112.442392			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23625917	Green Published, hybrid			2022-12-28	WOS:000320378900022
J	Galaleldeen, A; Taylor, AB; Chen, D; Schuermann, JP; Holloway, SP; Hou, SP; Gong, SQ; Zhong, GM; Hart, PJ				Galaleldeen, Ahmad; Taylor, Alexander B.; Chen, Ding; Schuermann, Jonathan P.; Holloway, Stephen P.; Hou, Shuping; Gong, Siqi; Zhong, Guangming; Hart, P. John			Structure of the Chlamydia trachomatis Immunodominant Antigen Pgp3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Pathogenesis; Chlamydia; Immunology; Tumor Necrosis Factor (TNF); X-ray Crystallography; Beta-Helix; Beta-Propeller; Helical Coiled-coil; Pgp3; Sexually Transmitted Disease	SEGMENTED COILED-COIL; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL REGULATOR; BACTERIOPHAGE-T4 FIBRITIN; TERMINAL DOMAIN; PROTEIN; PLASMID; RESOLUTION; REVEALS; ALPHA	Chlamydia trachomatis infection is the most common sexually transmitted bacterial disease. Left untreated, it can lead to ectopic pregnancy, pelvic inflammatory disease, and infertility. Here we present the structure of the secreted C. trachomatis protein Pgp3, an immunodominant antigen and putative virulence factor. The approximate to 84-kDa Pgp3 homotrimer, encoded on a cryptic plasmid, consists of globular N- and C-terminal assemblies connected by a triple-helical coiled-coil. The C-terminal domains possess folds similar to members of the TNF family of cytokines. The closest Pgp3 C-terminal domain structural homologs include a lectin from Burkholderia cenocepacia, the C1q component of complement, and a portion of the Bacillus anthracis spore surface protein BclA, all of which play roles in bioadhesion. The N-terminal domain consists of a concatenation of structural motifs typically found in trimeric viral proteins. The central parallel triple-helical coiled-coil contains an unusual alternating pattern of apolar and polar residue pairs that generate a rare right-handed superhelical twist. The unique architecture of Pgp3 provides the basis for understanding its role in chlamydial pathogenesis and serves as the platform for its optimization as a potential vaccine antigen candidate.	[Galaleldeen, Ahmad; Taylor, Alexander B.; Holloway, Stephen P.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Chen, Ding; Hou, Shuping; Gong, Siqi; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Taylor, Alexander B.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Xray Crystallog Core Lab, San Antonio, TX 78229 USA; [Galaleldeen, Ahmad] St Marys Univ, Dept Biol Sci, San Antonio, TX 78228 USA; [Schuermann, Jonathan P.] Cornell Univ, Dept Chem & Chem Biol, Northeastern Collaborat Access Team, Ithaca, NY 14853 USA; [Hart, P. John] South Texas Vet Hlth Care Syst, Dept Vet Affairs, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cornell University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Zhong, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol, San Antonio, TX 78229 USA.	zhongg@uthscsa.edu; pjhart@biochem.uthscsa.edu	Gong, Siqi/ABD-9207-2020; Gong, Siqi/AAM-1568-2021	Gong, Siqi/0000-0002-1111-6039; Taylor, Alexander/0000-0003-3517-6033; Galaleldeen, Ahmad/0000-0003-1160-6908	National Institutes of Health [AI47997, AI64537]; Robert A. Welch Foundation [AQ-1399]; National Center for Research Resources at the National Institute of Health [RR-15301]; U.S. Department of Energy, Office of Basic Energy Sciences [W-31-109-ENG-38]; Cancer Therapy & Research Center Cancer Center [NCI P30CA054174]; United States Department of Defense to the UTSA/UTHSCSA Center for Excellence in Genomics Research [W911NF-11-1-0136]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047997, R01AI064537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); National Center for Research Resources at the National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Cancer Therapy & Research Center Cancer Center; United States Department of Defense to the UTSA/UTHSCSA Center for Excellence in Genomics Research(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI47997 and AI64537 (to G.Z.). This work was also supported by Robert A. Welch Foundation Grant AQ-1399 (to P.J.H.). This work is partially the result of research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, supported by Award RR-15301 from the National Center for Research Resources at the National Institute of Health. Use of the Advanced Photon Source is supported by the U.S. Department of Energy, Office of Basic Energy Sciences under Contract W-31-109-ENG-38. This work was also supported in part by Cancer Therapy & Research Center Cancer Center Support Grant NCI P30CA054174 and Contract Number W911NF-11-1-0136 from the United States Department of Defense to the UTSA/UTHSCSA Center for Excellence in Genomics Research.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; Boudko SP, 2002, EUR J BIOCHEM, V269, P833, DOI 10.1046/j.1432-1033.2002.02734.x; Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Budrys NM, 2012, OBSTET GYNECOL, V119, P1009, DOI 10.1097/AOG.0b013e3182519326; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; CASPAR DLD, 1988, NATURE, V332, P659, DOI 10.1038/332659a0; Cha SS, 1999, IMMUNITY, V11, P253, DOI 10.1016/S1074-7613(00)80100-4; Chen CKM, 2011, TRENDS BIOCHEM SCI, V36, P553, DOI 10.1016/j.tibs.2011.07.004; Chen DJ, 2010, WIRELESSHART: REAL-TIME MESH NETWORK FOR INDUSTRIAL AUTOMATION, P3, DOI 10.1007/978-1-4419-6047-4_1; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; COMANDUCCI M, 1993, J GEN MICROBIOL, V139, P1083, DOI 10.1099/00221287-139-5-1083; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; Coulibaly F, 2010, J VIROL, V84, P1792, DOI 10.1128/JVI.01536-09; Da Ros CT, 2008, ASIAN J ANDROL, V10, P110, DOI 10.1111/j.1745-7262.2008.00367.x; den Hartog JE, 2006, HUM REPROD UPDATE, V12, P719, DOI 10.1093/humupd/dml030; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donati M, 2003, VACCINE, V21, P1089, DOI 10.1016/S0264-410X(02)00631-X; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel J, 2004, P NATL ACAD SCI USA, V101, P9947, DOI 10.1073/pnas.0403633101; Ghebrehiwet B, 2004, MOL IMMUNOL, V41, P173, DOI 10.1016/j.molimm.2004.03.014; Ghebrehiwet B, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00052; Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hybiske K, 2007, P NATL ACAD SCI USA, V104, P11430, DOI 10.1073/pnas.0703218104; Hymowitz SG, 2003, STRUCTURE, V11, P1513, DOI 10.1016/j.str.2003.11.009; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Kari L, 2011, J EXP MED, V208, P2217, DOI 10.1084/jem.20111266; KING J, 1971, J MOL BIOL, V62, P465, DOI 10.1016/0022-2836(71)90148-3; Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1; Lamzin V. S., 2001, INT TABLES CRYSTALLO, VF, P720; Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817; Li ZY, 2008, INFECT IMMUN, V76, P3415, DOI 10.1128/IAI.01377-07; Liu CQ, 2008, BIOTECHNOL BIOENG, V99, P774, DOI 10.1002/bit.21637; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Lu CX, 2012, INVEST OPHTH VIS SCI, V53, P2551, DOI 10.1167/iovs.11-9212; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A., 1999, CRYSTALLIZATION BIOL; Merckel MC, 2005, MOL CELL, V18, P161, DOI 10.1016/j.molcel.2005.03.019; Mitraki A, 2002, J STRUCT BIOL, V137, P236, DOI 10.1006/jsbi.2002.4447; Mitraki A, 1999, EUR J BIOCHEM, V264, P599, DOI 10.1046/j.1432-1327.1999.00683.x; MURZIN AG, 1992, PROTEINS, V14, P191, DOI 10.1002/prot.340140206; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Peters J, 1996, J MOL BIOL, V257, P1031, DOI 10.1006/jmbi.1996.0221; Reiter DM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002166; Rety S, 2005, J BIOL CHEM, V280, P43073, DOI 10.1074/jbc.M510087200; Seetharaman SV, 2010, ARCH BIOCHEM BIOPHYS, V503, P183, DOI 10.1016/j.abb.2010.08.014; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Song LH, 2013, INFECT IMMUN, V81, P636, DOI 10.1128/IAI.01305-12; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Sulak O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002238; Sulak O, 2010, STRUCTURE, V18, P59, DOI 10.1016/j.str.2009.10.021; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas NS, 1997, MICROBIOL-SGM, V143, P1847, DOI 10.1099/00221287-143-6-1847; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; van Raaij MJ, 2001, J MOL BIOL, V314, P1137, DOI 10.1006/jmbi.2000.5204; van Raaij MJ, 1999, NATURE, V401, P935, DOI 10.1038/44880; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	76	27	32	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22068	22079		10.1074/jbc.M113.475012	http://dx.doi.org/10.1074/jbc.M113.475012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23703617	Green Published, hybrid			2022-12-28	WOS:000328841900052
J	Cruz-Gallardo, I; Diaz-Moreno, I; Diaz-Quintana, A; Donaire, A; Velazquez-Campoy, A; Curd, RD; Rangachari, K; Birdsall, B; Ramos, A; Holder, AA; De la Rosa, MA				Cruz-Gallardo, Isabel; Diaz-Moreno, Irene; Diaz-Quintana, Antonio; Donaire, Antonio; Velazquez-Campoy, Adrian; Curd, Rachel D.; Rangachari, Kaveri; Birdsall, Berry; Ramos, Andres; Holder, Anthony A.; De la Rosa, Miguel A.			Antimalarial Activity of Cupredoxins THE INTERACTION OF PLASMODIUM MEROZOITE SURFACE PROTEIN 1(19) (MSP1(19)) AND RUSTICYANIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARASITE-INHIBITORY ANTIBODIES; CYTOCHROME-F; THIOBACILLUS-FERROOXIDANS; HYDROPHOBIC INTERACTIONS; TRANSIENT COMPLEX; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; MALARIA; FALCIPARUM; PLASTOCYANIN	The discovery of effective new antimalarial agents is urgently needed. One of the most frequently studied molecules anchored to the parasite surface is the merozoite surface protein-1 (MSP1). At red blood cell invasion MSP1 is proteolytically processed, and the 19-kDa C-terminal fragment (MSP1(19)) remains on the surface and is taken into the red blood cell, where it is transferred to the food vacuole and persists until the end of the intracellular cycle. Because a number of specific antibodies inhibit erythrocyte invasion and parasite growth, MSP1(19) is therefore a promising target against malaria. Given the structural homology of cupredoxins with the Fab domain of monoclonal antibodies, an approach combining NMR and isothermal titration calorimetry (ITC) measurements with docking calculations based on BiGGER is employed on MSP1(19)-cupredoxin complexes. Among the cupredoxins tested, rusticyanin forms a well defined complex with MSP1(19) at a site that overlaps with the surface recognized by the inhibitory antibodies. The addition of holo-rusticyanin to infected cells results in parasitemia inhibition, but negligible effects on parasite growth can be observed for apo-rusticyanin and other proteins of the cupredoxin family. These findings point to rusticyanin as an excellent therapeutic tool for malaria treatment and provide valuable information for drug design.	[Cruz-Gallardo, Isabel; Diaz-Moreno, Irene; Diaz-Quintana, Antonio; De la Rosa, Miguel A.] Univ Seville, CSIC, CicCartuja, IBVF, Seville 41092, Spain; [Donaire, Antonio] Univ Murcia, Dept Quim Inorgan, Fac Quim, Murcia 30100, Spain; [Velazquez-Campoy, Adrian] Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza 50018, Spain; [Curd, Rachel D.; Rangachari, Kaveri; Holder, Anthony A.] Natl Inst Med Res, MRC, Div Parasitol, London W7 1AA, England; [Birdsall, Berry; Ramos, Andres] Natl Inst Med Res, MRC, Mol Struct Div, London W7 1AA, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-JA-USE - Centro de Investigaciones Cientificas Isla de La Cartuja (CICIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); University of Murcia; University of Zaragoza; MRC National Institute for Medical Research; MRC National Institute for Medical Research	De la Rosa, MA (corresponding author), Univ Seville, CSIC, CicCartuja, IBVF, Ave Americo Vespucio 49, Seville 41092, Spain.	marosa@us.es	Cruz-Gallardo, Isabel/J-7042-2014; Díaz-Moreno, Irene/E-7181-2010; Donaire, Antonio/K-7782-2014; Díaz-Quintana, Antonio/A-1946-2011; De la Rosa, Miguel/B-2545-2014; Velazquez-Campoy, Adrian/E-7946-2012; Holder, Anthony A/A-7554-2013	Cruz-Gallardo, Isabel/0000-0002-5936-2749; Díaz-Moreno, Irene/0000-0002-5318-7644; Donaire, Antonio/0000-0002-1456-2085; Díaz-Quintana, Antonio/0000-0001-8973-8009; De la Rosa, Miguel/0000-0003-1187-5737; Velazquez-Campoy, Adrian/0000-0001-5702-4538; Holder, Anthony A/0000-0002-8490-6058	Junta de Andalucia (Spain) [P08-CVI-3876, BIO198]; European Social Fund-ERDF; Junta de Andalucia [P08-CVI-3876]; Ministerio de Economia y Competitividad [SAF2011-26611]; Fundacion Seneca de la Region de Murcia (Spain) [15354/PI/10]; Ministerio de Ciencia e Innovacion (Spain) [BFU2010-19451]; Medical Research Council [U117574558, U117532067]; European Union FP7 Network of Excellence EviMalar; MRC [MC_U117532067, MC_U117533887, MC_U117574558, MC_PC_13051] Funding Source: UKRI; Medical Research Council [MC_U117533887, MC_U117574558, MC_U117532067, MC_PC_13051] Funding Source: researchfish	Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission); European Social Fund-ERDF; Junta de Andalucia(Junta de Andalucia); Ministerio de Economia y Competitividad(Spanish Government); Fundacion Seneca de la Region de Murcia (Spain)(Fundacion Seneca); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union FP7 Network of Excellence EviMalar; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Junta de Andalucia Grants P08-CVI-3876 and BIO198 (Spain) and European Social Fund-ERDF 2007-2013.; Supported by Junta de Andalucia Ph.D. Grant P08-CVI-3876 and GERMN bursaries for short term stays (Spain).; Supported by Ministerio de Economia y Competitividad Grant SAF2011-26611 and Fundacion Seneca de la Region de Murcia Grant 15354/PI/10 (Spain).; Supported by Ministerio de Ciencia e Innovacion Grant BFU2010-19451 (Spain).; Supported by Medical Research Council Grant U117574558.; Laboratory work supported by Medical Research Council Grant U117532067 and the European Union FP7 Network of Excellence EviMalar.	Alcaraz LA, 2005, FEBS LETT, V579, P5223, DOI 10.1016/j.febslet.2005.08.048; Autore F, 2007, PROTEINS, V66, P513, DOI 10.1002/prot.21212; Babon JJ, 2007, MOL BIOCHEM PARASIT, V153, P31, DOI 10.1016/j.molbiopara.2007.01.015; Badsberg U, 1996, BIOCHEMISTRY-US, V35, P7021, DOI 10.1021/bi960621y; Benjamin PA, 1999, MOL BIOCHEM PARASIT, V104, P147, DOI 10.1016/S0166-6851(99)00142-5; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; BLAKE RC, 1987, J BIOL CHEM, V262, P14983; Chakrabarty A. M., 2006, U.S. Patent, Patent No. [WO 2006/127477 A3, 2006127477]; Chaudhari A, 2006, CELL CYCLE, V5, P1642, DOI 10.4161/cc.5.15.2992; Chitarra V, 1999, MOL CELL, V3, P457, DOI 10.1016/S1097-2765(00)80473-6; Crane BR, 2001, J AM CHEM SOC, V123, P11623, DOI 10.1021/ja0115870; Crowley PB, 2001, J AM CHEM SOC, V123, P10444, DOI 10.1021/ja0112700; Cruz-Gallardo I, 2012, FEBS LETT, V586, P646, DOI 10.1016/j.febslet.2011.08.035; Diaz-Moreno I, 2005, J BIOL CHEM, V280, P18908, DOI 10.1074/jbc.M413298200; Fleck SL, 2003, J BIOL CHEM, V278, P47670, DOI 10.1074/jbc.M306603200; Garman SC, 2003, J BIOL CHEM, V278, P7264, DOI 10.1074/jbc.M210716200; Goddard T. D., 2006, SPARKY 3; Hall JF, 1996, FEMS MICROBIOL LETT, V137, P85, DOI 10.1111/j.1574-6968.1996.tb08087.x; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; Hobbs Charlotte, 2011, F1000 Biol Rep, V3, P24, DOI 10.3410/B3-24; Holder AA, 2009, PARASITOLOGY, V136, P1445, DOI 10.1017/S0031182009990515; HOLDER AA, 1994, PARASITOL TODAY, V10, P182, DOI 10.1016/0169-4758(94)90025-6; Holder AA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000638; Jimenez B, 2003, BIOCHEMISTRY-US, V42, P10396, DOI 10.1021/bi034692q; Lange C, 2005, BBA-BIOENERGETICS, V1707, P179, DOI 10.1016/j.bbabio.2004.12.002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lazarou M, 2009, INFECT IMMUN, V77, P5659, DOI 10.1128/IAI.00167-09; LING IT, 1994, PARASITE IMMUNOL, V16, P63, DOI 10.1111/j.1365-3024.1994.tb00324.x; Morgan WD, 2000, J BIOMOL NMR, V17, P337, DOI 10.1023/A:1008313530207; Morgan WD, 1999, J MOL BIOL, V289, P113, DOI 10.1006/jmbi.1999.2753; Morgan WD, 2005, BIOCHEMISTRY-US, V44, P518, DOI 10.1021/bi0482957; Moss DK, 2012, INFECT IMMUN, V80, P1280, DOI 10.1128/IAI.05887-11; O'Donnell RA, 2000, NAT MED, V6, P91, DOI 10.1038/71595; Opar A, 2011, NAT REV DRUG DISCOV, V10, P887, DOI 10.1038/nrd3611; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; Pizarro JC, 2003, J MOL BIOL, V328, P1091, DOI 10.1016/S0022-2836(03)00376-0; Valero LMS, 1998, INFECT IMMUN, V66, P3925, DOI 10.1128/IAI.66.8.3925-3930.1998; VANDEKAMP M, 1990, BIOCHIM BIOPHYS ACTA, V1019, P283, DOI 10.1016/0005-2728(90)90206-J; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; Yamada T, 2004, CELL CYCLE, V3, P1182; Yamada T, 2002, INFECT IMMUN, V70, P7054, DOI 10.1128/IAI.70.12.7054-7062.2002; Zaballa ME, 2012, P NATL ACAD SCI USA, V109, P9254, DOI 10.1073/pnas.1119460109; Zhao D, 1998, BIOPHYS J, V74, pA233	46	9	9	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20896	20907		10.1074/jbc.M113.460162	http://dx.doi.org/10.1074/jbc.M113.460162			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23749994	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000322014400013
J	Fan, C; Li, Z; Yin, HY; Xiang, S				Fan, Chen; Li, Zi; Yin, Huiyong; Xiang, Song			Structure and Function of Allophanate Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYS CATALYTIC TRIAD; UREA CARBOXYLASE; ADENOSINE-TRIPHOSPHATE; PROVIDES INSIGHTS; CRYSTAL-STRUCTURE; IDENTIFICATION; AMIDOLYASE; ENZYME; CYCLOTRANSFERASE; PURIFICATION	Allophanate hydrolase converts allophanate to ammonium and carbon dioxide. It is conserved in many organisms and is essential for their utilization of urea as a nitrogen source. It also has important functions in a newly discovered eukaryotic pyrimidine nucleic acid precursor degradation pathway, the yeast-hypha transition that several pathogens utilize to escape the host defense, and an s-triazine herbicide degradation pathway recently emerged in many soil bacteria. We have determined the crystal structure of the Kluyveromyces lactis allophanate hydrolase. Together with structure-directed functional studies, we demonstrate that its N and C domains catalyze a two-step reaction and contribute to maintaining a dimeric form of the enzyme required for their optimal activities. Our studies also provide molecular insights into their catalytic mechanism. Interestingly, we found that the C domain probably catalyzes a novel form of decarboxylation reaction that might expand the knowledge of this common reaction in biological systems.	[Fan, Chen; Li, Zi; Yin, Huiyong; Xiang, Song] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Xiang, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai 200031, Peoples R China.	sxiang@sibs.ac.cn	Xiang, Song/AAF-6422-2019	Xiang, Song/0000-0001-9314-4684; yin, hui yong/0000-0001-7049-1560	Ministry of Science and Technology of China (973 Program) [2011CB910500, 2010CB912502]; One Hundred Talents Program of the Chinese Academy of Sciences	Ministry of Science and Technology of China (973 Program)(Ministry of Science and Technology, ChinaNational Basic Research Program of China); One Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by grants from the Ministry of Science and Technology of China (973 Program Grants 2011CB910500 and 2010CB912502) and the One Hundred Talents Program of the Chinese Academy of Sciences.	Andersen G, 2008, J MOL BIOL, V380, P656, DOI 10.1016/j.jmb.2008.05.029; ARTHUR H, 1976, J BACTERIOL, V128, P56, DOI 10.1128/JB.128.1.56-68.1976; Blaise M, 2010, EMBO J, V29, P3118, DOI 10.1038/emboj.2010.192; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Canfield DE, 2010, SCIENCE, V330, P192, DOI 10.1126/science.1186120; Doublie S, 1996, FEBS LETT, V384, P219, DOI 10.1016/0014-5793(96)00316-X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan C, 2012, J BIOL CHEM, V287, P9389, DOI 10.1074/jbc.M111.319475; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ito T, 2010, NATURE, V467, P612, DOI 10.1038/nature09411; Jacques DA, 2011, ACTA CRYSTALLOGR D, V67, P105, DOI 10.1107/S0907444910051127; Jacques DA, 2011, J MOL BIOL, V405, P214, DOI 10.1016/j.jmb.2010.10.047; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanamori T, 2005, FEMS MICROBIOL LETT, V245, P61, DOI 10.1016/j.femsle.2005.02.023; Kanamori T, 2004, J BACTERIOL, V186, P2532, DOI 10.1128/JB.186.9.2532-2539.2004; Labahn J, 2002, J MOL BIOL, V322, P1053, DOI 10.1016/S0022-2836(02)00886-0; LEFTLEY JW, 1973, J GEN MICROBIOL, V77, P109, DOI 10.1099/00221287-77-1-109; Li TF, 2012, BIOORG CHEM, V43, P2, DOI 10.1016/j.bioorg.2012.03.001; Lin Y, 2013, BIOCHEMISTRY-US, V52, P690, DOI 10.1021/bi301242m; MOBLEY HLT, 1995, MICROBIOL REV, V59, P451, DOI 10.1128/MMBR.59.3.451-480.1995; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Nakamura A, 2006, SCIENCE, V312, P1954, DOI 10.1126/science.1127156; Navarathna DHMLP, 2010, FEMS YEAST RES, V10, P209, DOI 10.1111/j.1567-1364.2010.00602.x; Oakley AJ, 2008, J BIOL CHEM, V283, P22031, DOI 10.1074/jbc.M803623200; Oakley AJ, 2010, J BIOL CHEM, V285, P9642, DOI 10.1074/jbc.M109.082099; Ohtaki A, 2010, BBA-PROTEINS PROTEOM, V1804, P184, DOI 10.1016/j.bbapap.2009.10.001; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; ROON RJ, 1968, J BIOL CHEM, V243, P5213; Shapir N, 2006, APPL ENVIRON MICROB, V72, P2491, DOI 10.1128/AEM.72.4.2491-2495.2006; Shapir N, 2005, J BACTERIOL, V187, P3731, DOI 10.1128/JB.187.11.3731-3738.2005; Shin S, 2002, EMBO J, V21, P2509, DOI 10.1093/emboj/21.11.2509; Shin S, 2003, J BIOL CHEM, V278, P24937, DOI 10.1074/jbc.M302156200; Sirko A, 2000, ACTA BIOCHIM POL, V47, P1189, DOI 10.18388/abp.2000_3972; Sterner R. W., 2002, ECOLOGICAL STOICHIOM, P44; Strope PK, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-80; Takahashi S., 1959, NIPPON KAGAKU ZASSHI, V80, P92; Vylkova S, 2011, MBIO, V2, DOI 10.1128/mBio.00055-11; WHITNEY PA, 1972, J BIOL CHEM, V247, P1349; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu J, 2009, J MOL BIOL, V391, P703, DOI 10.1016/j.jmb.2009.06.014; Yasuhira K, 2010, J BIOL CHEM, V285, P1239, DOI 10.1074/jbc.M109.041285	43	19	19	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21422	21432		10.1074/jbc.M113.453837	http://dx.doi.org/10.1074/jbc.M113.453837			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754281	hybrid, Green Published			2022-12-28	WOS:000322014400060
J	Feldman-Salit, A; Hering, S; Messiha, HL; Veith, N; Cojocaru, V; Sieg, A; Westerhoff, HV; Kreikemeyer, B; Wade, RC; Fiedler, T				Feldman-Salit, Anna; Hering, Silvio; Messiha, Hanan L.; Veith, Nadine; Cojocaru, Vlad; Sieg, Antje; Westerhoff, Hans V.; Kreikemeyer, Bernd; Wade, Rebecca C.; Fiedler, Tomas			Regulation of the Activity of Lactate Dehydrogenases from Four Lactic Acid Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-STEAROTHERMOPHILUS; LACTOBACILLUS-PLANTARUM; KINETIC-PARAMETERS; GENOME SEQUENCE; BINDING; SUBSTITUTION; PATHOGENESIS; METABOLISM; MECHANISM; EVOLUTION	Despite high similarity in sequence and catalytic properties, the L-lactate dehydrogenases (LDHs) in lactic acid bacteria (LAB) display differences in their regulation that may arise from their adaptation to different habitats. We combined experimental and computational approaches to investigate the effects of fructose 1,6-bisphosphate (FBP), phosphate (P-i), and ionic strength (NaCl concentration) on six LDHs from four LABs studied at pH 6 and pH 7. We found that 1) the extent of activation by FBP (K-act) differs. Lactobacillus plantarum LDH is not regulated by FBP, but the other LDHs are activated with increasing sensitivity in the following order: Enterococcus faecalis LDH2 <= Lactococcus lactis LDH2 < E. faecalis LDH1 < L. lactis LDH1 <= Streptococcus pyogenes LDH. This trend reflects the electrostatic properties in the allosteric binding site of the LDH enzymes. 2) For L. plantarum, S. pyogenes, and E. faecalis, the effects of Pi are distinguishable from the effect of changing ionic strength by adding NaCl. 3) Addition of Pi inhibits E. faecalis LDH2, whereas in the absence of FBP, Pi is an activator of S. pyogenes LDH, E. faecalis LDH1, and L. lactis LDH1 and LDH2 at pH 6. These effects can be interpreted by considering the computed binding affinities of Pi to the catalytic and allosteric binding sites of the enzymes modeled in protonation states corresponding to pH 6 and pH 7. Overall, the results show a subtle interplay among the effects of P-i, FBP, and pH that results in different regulatory effects on the LDHs of different LABs.	[Feldman-Salit, Anna; Veith, Nadine; Cojocaru, Vlad; Wade, Rebecca C.] Heidelberg Inst Theoret Studies, Mol & Cellular Modeling Grp, D-69118 Heidelberg, Germany; [Feldman-Salit, Anna; Veith, Nadine] Heidelberg Univ, BioQuant, D-69120 Heidelberg, Germany; [Wade, Rebecca C.] Heidelberg Univ, Ctr Mol Biol, D-69120 Heidelberg, Germany; [Hering, Silvio; Sieg, Antje; Kreikemeyer, Bernd; Fiedler, Tomas] Univ Med Rostock, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany; [Messiha, Hanan L.; Westerhoff, Hans V.] Univ Manchester, MIB, Manchester Ctr Integrat Syst Biol, Manchester M1 7DN, Lancs, England; [Westerhoff, Hans V.] Univ Amsterdam, SILS, NL-1018 HV Amsterdam, Netherlands; [Westerhoff, Hans V.] Vrije Univ Amsterdam, Netherlands Inst Syst Biol, FALW, NL-1018 HV Amsterdam, Netherlands	Heidelberg Institute for Theoretical Studies; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Rostock; University of Manchester; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Wade, RC (corresponding author), Heidelberg Inst Theoret Studies, Mol & Cellular Modeling Grp, D-69118 Heidelberg, Germany.	rebecca.wade@h-its.org; tomas.fiedler@med.uni-rostock.de	Cojocaru, Vlad/GZA-7475-2022; Wade, Rebecca/L-1489-2019; Westerhoff, Hans V/I-5762-2012	Cojocaru, Vlad/0000-0003-0886-3401; Wade, Rebecca/0000-0001-5951-8670; Westerhoff, Hans V/0000-0002-0443-6114; Fiedler, Tomas/0000-0001-6717-1865; Kreikemeyer, Bernd/0000-0001-9527-5098	Systems Biology of Microorganisms Network (SysMO) SysMO-LAB project; Systems Biology of Microorganisms Network (SysMO) SysMO-LAB2 project; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung); Klaus Tschira Foundation; BIOMS Center for Modeling and Simulation in the Biosciences, Heidelberg; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Manchester Centre for Integrative Systems Biology [BB/C008219/1, G530225/1, I017186/1, I004696/1, F003552/1]; EU-FP7; NWO; BBSRC [BB/I004696/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C008219/1, BB/I004696/1] Funding Source: researchfish	Systems Biology of Microorganisms Network (SysMO) SysMO-LAB project; Systems Biology of Microorganisms Network (SysMO) SysMO-LAB2 project; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); Klaus Tschira Foundation; BIOMS Center for Modeling and Simulation in the Biosciences, Heidelberg; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Manchester Centre for Integrative Systems Biology; EU-FP7(European Commission); NWO(Netherlands Organization for Scientific Research (NWO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Systems Biology of Microorganisms Network (SysMO) SysMO-LAB and SysMO-LAB2 projects with funding from the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung), the Klaus Tschira Foundation (to A. F.-S., V. C., and R. C. W.), the BIOMS Center for Modeling and Simulation in the Biosciences, Heidelberg (to A. F.-S.), and Biotechnology and Biological Sciences Research Council and Engineering and Physical Sciences Research Council funding also of the Manchester Centre for Integrative Systems Biology (to H. M. and H. W.; Grants BB/C008219/1, G530225/1, I017186/1, I004696/1, F003552/1), EU-FP7, and NWO.	CAMERON AD, 1994, J MOL BIOL, V238, P615, DOI 10.1006/jmbi.1994.1318; CLARKE AR, 1987, BIOCHIM BIOPHYS ACTA, V913, P72, DOI 10.1016/0167-4838(87)90234-2; CLARKE AR, 1985, BIOCHIM BIOPHYS ACTA, V829, P387, DOI 10.1016/0167-4838(85)90249-3; CROW VL, 1977, J BACTERIOL, V131, P82, DOI 10.1128/JB.131.1.82-91.1977; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Enderton H., 2001, MATH INTRO LOGIC; Fiedler T, 2011, APPL ENVIRON MICROB, V77, P612, DOI 10.1128/AEM.01838-10; Fiedler T, 2010, FUTURE MICROBIOL, V5, P1675, DOI [10.2217/fmb.10.128, 10.2217/FMB.10.128]; Fisher K, 2009, BRIT J BIOMED SCI, V66, P180, DOI 10.1080/09674845.2009.11730270; Gabdoulline RR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-373; Gaspar P, 2007, FEBS J, V274, P5924, DOI 10.1111/j.1742-4658.2007.06115.x; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; HODGKIN EE, 1987, INT J QUANTUM CHEM, P105; IWATA S, 1994, NAT STRUCT BIOL, V1, P176, DOI 10.1038/nsb0394-176; Jonsson M, 2009, APPL ENVIRON MICROB, V75, P4901, DOI 10.1128/AEM.00344-09; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Levering J, 2012, FEBS J, V279, P1274, DOI 10.1111/j.1742-4658.2012.08523.x; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Mainardi JL, 2008, FEMS MICROBIOL REV, V32, P386, DOI 10.1111/j.1574-6976.2007.00097.x; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; Messiha HL, 2011, METHOD ENZYMOL, V500, P215, DOI 10.1016/B978-0-12-385118-5.00012-8; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Price CE, 2012, FEMS MICROBIOL REV, V36, P949, DOI 10.1111/j.1574-6976.2011.00323.x; ROSSMANN MG, 1973, J MOL BIOL, V76, P533, DOI 10.1016/0022-2836(73)90491-9; Sanchez R, 2000, METH MOL B, V143, P97; Siezen RJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S3; Swainston N, 2010, FEBS J, V277, P3769, DOI 10.1111/j.1742-4658.2010.07778.x; TAGUCHI H, 1992, EUR J BIOCHEM, V209, P993, DOI 10.1111/j.1432-1033.1992.tb17373.x; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204; WIGLEY DB, 1992, J MOL BIOL, V223, P317, DOI 10.1016/0022-2836(92)90733-Z	32	34	34	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21295	21306		10.1074/jbc.M113.458265	http://dx.doi.org/10.1074/jbc.M113.458265			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23720742	Green Published, hybrid			2022-12-28	WOS:000322014400049
J	Perrett, RM; Fowkes, RC; Caunt, CJ; Tsaneva-Atanasova, K; Bowsher, CG; McArdle, CA				Perrett, Rebecca M.; Fowkes, Robert C.; Caunt, Christopher J.; Tsaneva-Atanasova, Krasimira; Bowsher, Clive G.; McArdle, Craig A.			Signaling to Extracellular Signal-regulated Kinase from ErbB1 Kinase and Protein Kinase C FEEDBACK, HETEROGENEITY, AND GATING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; ERK MAP KINASE; NEGATIVE FEEDBACK; SPATIOTEMPORAL REGULATION; NUCLEAR TRANSLOCATION; RECEPTOR; PHOSPHORYLATION; LOCALIZATION; SPECIFICITY; ACTIVATION	Many extracellular signals act via the Raf/MEK/ERK cascade in which kinetics, cell-cell variability, and sensitivity of the ERK response can all influence cell fate. Here we used automated microscopy to explore the effects of ERK-mediated negative feedback on these attributes in cells expressing endogenous ERK or ERK2-GFP reporters. We studied acute rather than chronic stimulation with either epidermal growth factor (ErbB1 activation) or phorbol 12,13-dibutyrate (PKC activation). In unstimulated cells, ERK-mediated negative feedback reduced the population-average and cell-cell variability of the level of activated ppERK and increased its robustness to changes in ERK expression. In stimulated cells, negative feedback (evident between 5 min and 4 h) also reduced average levels and variability of phosphorylated ERK (ppERK) without altering the "gradedness" or sensitivity of the response. Binning cells according to total ERK expression revealed, strikingly, that maximal ppERK responses initially occur at submaximal ERK levels and that this non-monotonic relationship changes to an increasing, monotonic one within 15 min. These phenomena occur in HeLa cells and MCF7 breast cancer cells and in the presence and absence of ERK-mediated negative feedback. They were best modeled assuming distributive (rather than processive) activation. Thus, we have uncovered a novel, time-dependent change in the relationship between total ERK and ppERK levels that persists without negative feedback. This change makes acute response kinetics dependent on ERK level and provides a "gating" or control mechanism in which the interplay between stimulus duration and the distribution of ERK expression across cells could modulate the proportion of cells that respond to stimulation.	[McArdle, Craig A.] Univ Bristol, Sch Clin Sci, Labs Integrat Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England; [Fowkes, Robert C.] Univ London Royal Vet Coll, Endocrine Signaling Grp, London NW1 0TU, England; [Caunt, Christopher J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Tsaneva-Atanasova, Krasimira] Univ Bristol, Dept Engn Math, Bristol Ctr Appl Nonlinear Math, Bristol BS8 1TR, Avon, England; [Bowsher, Clive G.] Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England	University of Bristol; University of London; University of London Royal Veterinary College; University of Bath; University of Bristol; University of Bristol	McArdle, CA (corresponding author), Univ Bristol, Sch Clin Sci, Labs Integrat Neurosci & Endocrinol, Whitson St, Bristol BS1 3NY, Avon, England.	craig.mcardle@bristol.ac.uk	Fowkes, Robert/HHT-0664-2022; McArdle, Craig/AAQ-5660-2021; Tsaneva-Atanasova, Krasimira T/AAG-6766-2019; Fowkes, Robert/AAI-4756-2020	McArdle, Craig/0000-0003-4836-5351; Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Fowkes, Robert/0000-0002-2222-2056	Medical Research Council [MRC G0901763]; Medical Research Council Biomedical Informatics Fellowship; EPSRC [EP/D063485/1] Funding Source: UKRI; MRC [G0701772, G0901763] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D063485/1] Funding Source: researchfish; Medical Research Council [G0901763, G0701772] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council Biomedical Informatics Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Medical Research Council Project Grant MRC G0901763 (to C. A. M. and R. C. F).; Supported by a Medical Research Council Biomedical Informatics Fellowship.	AHARONOV A, 1978, J BIOL CHEM, V253, P3970; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; Armstrong SP, 2010, J BIOL CHEM, V285, P24360, DOI 10.1074/jbc.M110.115964; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Birtwistle MR, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-109; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Burack WR, 1997, BIOCHEMISTRY-US, V36, P5929, DOI 10.1021/bi970535d; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Caunt CJ, 2010, J CELL SCI, V123, P4310, DOI 10.1242/jcs.076349; Caunt CJ, 2010, METHODS MOL BIOL, V661, P507, DOI 10.1007/978-1-60761-795-2_32; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P308, DOI 10.1016/j.tem.2006.08.001; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; Cohen DM, 1996, J BIOL CHEM, V271, P12903, DOI 10.1074/jbc.271.22.12903; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Finch AR, 2012, CELL SIGNAL, V24, P1002, DOI 10.1016/j.cellsig.2011.12.021; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Gunawardena J, 2005, P NATL ACAD SCI USA, V102, P14617, DOI 10.1073/pnas.0507322102; Harding A, 2005, CURR BIOL, V15, P869, DOI 10.1016/j.cub.2005.04.020; Kholodenko BN, 2010, NAT REV MOL CELL BIO, V11, P414, DOI 10.1038/nrm2901; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Kupzig S, 2005, P NATL ACAD SCI USA, V102, P7577, DOI 10.1073/pnas.0409611102; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lidke DS, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.064972; Lin J, 2009, MOL CELL BIOL, V29, P2082, DOI 10.1128/MCB.01634-08; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Ory S, 2003, CURR BIOL, V13, P1356, DOI 10.1016/S0960-9822(03)00535-9; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ruf F, 2007, BIOPHYS J, V93, P4474, DOI 10.1529/biophysj.107.115170; Ruf F, 2006, J BIOL CHEM, V281, P30967, DOI 10.1074/jbc.M606486200; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Shankaran H, 2010, CURR OPIN GENET DEV, V20, P650, DOI 10.1016/j.gde.2010.08.002; Sturm OE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001212; Takahashi K, 2010, P NATL ACAD SCI USA, V107, P2473, DOI 10.1073/pnas.0906885107; Takahashi S, 2008, CURR BIOL, V18, P1184, DOI 10.1016/j.cub.2008.07.050; Walker SA, 2003, FEBS LETT, V546, P6, DOI 10.1016/S0014-5793(03)00412-5; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513	49	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21001	21014		10.1074/jbc.M113.455345	http://dx.doi.org/10.1074/jbc.M113.455345			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754287	Green Published, hybrid			2022-12-28	WOS:000322014400022
J	Zhang, HT; Ghai, P; Wu, H; Wang, CH; Field, J; Zhou, GL				Zhang, Haitao; Ghai, Pooja; Wu, Huhehasi; Wang, Changhui; Field, Jeffrey; Zhou, Guo-Lei			Mammalian Adenylyl Cyclase-associated Protein 1 (CAP1) Regulates Cofilin Function, the Actin Cytoskeleton, and Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIM-KINASE 1; SACCHAROMYCES-CEREVISIAE; BINDING; ACTIVATION; DYNAMICS; PHOSPHORYLATION; ADF/COFILIN; INTEGRINS; MOTILITY; HOMOLOG	CAP (adenylyl cyclase-associated protein) was first identified in yeast as a protein that regulates both the actin cytoskeleton and the Ras/cAMP pathway. Although the role in Ras signaling does not extend beyond yeast, evidence supports that CAP regulates the actin cytoskeleton in all eukaryotes including mammals. In vitro actin polymerization assays show that both mammalian and yeast CAP homologues facilitate cofilin-driven actin filament turnover. We generated HeLa cells with stable CAP1 knockdown using RNA interference. Depletion of CAP1 led to larger cell size and remarkably developed lamellipodia as well as accumulation of filamentous actin (F-actin). Moreover, we found that CAP1 depletion also led to changes in cofilin phosphorylation and localization as well as activation of focal adhesion kinase (FAK) and enhanced cell spreading. CAP1 forms complexes with the adhesion molecules FAK and Talin, which likely underlie the cell adhesion phenotypes through inside-out activation of integrin signaling. CAP1-depleted HeLa cells also had substantially elevated cell motility as well as invasion through Matrigel. In summary, in addition to generating in vitro and in vivo evidence further establishing the role of mammalian CAP1 in actin dynamics, we identified a novel cellular function for CAP1 in regulating cell adhesion.	[Zhang, Haitao; Ghai, Pooja; Wu, Huhehasi; Zhou, Guo-Lei] Arkansas State Univ, Dept Biol Sci, State Univ, AR 72467 USA; [Zhang, Haitao; Ghai, Pooja; Zhou, Guo-Lei] Arkansas State Univ, Mol Biosci Program, State Univ, AR 72467 USA; [Wang, Changhui] Tongji Univ, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Field, Jeffrey] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	Arkansas State University; Arkansas State University; Tongji University; University of Pennsylvania; Pennsylvania Medicine	Field, J (corresponding author), Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA.	jfield@upenn.edu; gzhou@astate.edu	Ghai, Pooja/ABD-5648-2021	Ghai, Pooja/0000-0001-5078-5844	Arkansas Biosciences Institute and Arkansas State University; National Scientist Development Grant from the American Heart Association [NSDG 0630394N]; National Institutes of Health [R01 GM48241]; Arkansas Breast Cancer Research Program; University of Arkansas for Medical Sciences Translational Research Institute (CSTA) [UL1TR000039]; Institutional Development Award (IDeA) from National Institutes of Health through the NIGMS [P20GM12345]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103429, R01GM048241] Funding Source: NIH RePORTER	Arkansas Biosciences Institute and Arkansas State University; National Scientist Development Grant from the American Heart Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arkansas Breast Cancer Research Program; University of Arkansas for Medical Sciences Translational Research Institute (CSTA); Institutional Development Award (IDeA) from National Institutes of Health through the NIGMS; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by startup funds from the Arkansas Biosciences Institute and Arkansas State University, as well as National Scientist Development Grant NSDG 0630394N from the American Heart Association (to G. L. Z.).; Supported by National Institutes of Health Grant R01 GM48241.; Supported by a grant from Arkansas Breast Cancer Research Program and the University of Arkansas for Medical Sciences Translational Research Institute (CSTA Grant Award UL1TR000039), and an Institutional Development Award (IDeA) from National Institutes of Health Grant P20GM12345 through the NIGMS.	Bamburg JR, 2009, CELL MOTIL CYTOSKEL, V66, P635, DOI 10.1002/cm.20388; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; Bernstein BW, 2006, AM J PHYSIOL-CELL PH, V291, pC828, DOI 10.1152/ajpcell.00066.2006; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Carlier MF, 2007, J BIOL CHEM, V282, P23005, DOI 10.1074/jbc.R700020200; Cascio S, 2011, J BIOL CHEM, V286, P42248, DOI 10.1074/jbc.M111.297630; Chaudhry F, 2010, CYTOSKELETON, V67, P120, DOI 10.1002/cm.20429; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; DesMarais V, 2005, J CELL SCI, V118, P19, DOI 10.1242/jcs.01631; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fairley EAL, 1999, J CELL SCI, V112, P2571; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; Freeman NL, 2000, CELL MOTIL CYTOSKEL, V45, P106, DOI 10.1002/(SICI)1097-0169(200002)45:2<106::AID-CM3>3.0.CO;2-3; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; Hall A, 2009, CANC METASTASIS REV, V28, P5; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; He Jianbo, 2011, Int J Proteomics, V2011, P896476, DOI 10.1155/2011/896476; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Ishikawa-Ankerhold HC, 2010, CYTOSKELETON, V67, P442, DOI 10.1002/cm.20456; KAWAMUKAI M, 1992, MOL BIOL CELL, V3, P167, DOI 10.1091/mbc.3.2.167; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; MINTZER KA, 1994, CELL SIGNAL, V6, P681, DOI 10.1016/0898-6568(94)90050-7; Mitake Shigehisa, 1997, Kaohsiung Journal of Medical Sciences, V13, P10; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moriyama K, 2002, J CELL SCI, V115, P1591; Noegel AA, 1999, J CELL SCI, V112, P3195; O'Neill KE, 1996, THESIS COLUMBIA U; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Olson MF, 2009, CLIN EXP METASTAS, V26, P273, DOI 10.1007/s10585-008-9174-2; Peche V, 2007, CELL MOL LIFE SCI, V64, P2702, DOI 10.1007/s00018-007-7316-3; Peche VS, 2013, CELL MOL LIFE SCI, V70, P527, DOI 10.1007/s00018-012-1142-y; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Quintero-Monzon O, 2009, J BIOL CHEM, V284, P10923, DOI 10.1074/jbc.M808760200; Ren XD, 2000, J CELL SCI, V113, P3673; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shibata R, 2006, CLIN CANCER RES, V12, P5363, DOI 10.1158/1078-0432.CCR-05-2245; Subramanian C, 2013, MOL CANCER RES, V11, P173, DOI 10.1158/1541-7786.MCR-12-0065; Vezina CM, 2004, ENVIRON HEALTH PERSP, V112, P1636, DOI 10.1289/txg.7253; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; VOJTEK AB, 1993, J CELL SCI, V105, P777; Wang CH, 2008, J CELL SCI, V121, P2913, DOI 10.1242/jcs.023911; WANG J, 1993, MOL CELL BIOL, V13, P4087, DOI 10.1128/MCB.13.7.4087; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Yamazaki K, 2009, LAB INVEST, V89, P425, DOI 10.1038/labinvest.2009.5; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; YU G, 1994, J CELL SCI, V107, P1671; Zhou GL, 2003, MOL CELL BIOL, V23, P8058, DOI 10.1128/MCB.23.22.8058-8069.2003; Zhou GL, 2006, J BIOL CHEM, V281, P36443, DOI 10.1074/jbc.M600788200; Zucchi I, 2004, P NATL ACAD SCI USA, V101, P18147, DOI 10.1073/pnas.0408260101	61	63	68	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20966	20977		10.1074/jbc.M113.484535	http://dx.doi.org/10.1074/jbc.M113.484535			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23737525	hybrid, Green Published			2022-12-28	WOS:000322014400019
J	Regulski, K; Courtin, P; Kulakauskas, S; Chapot-Chartier, MP				Regulski, Krzysztof; Courtin, Pascal; Kulakauskas, Saulius; Chapot-Chartier, Marie-Pierre			A Novel Type of Peptidoglycan-binding Domain Highly Specific for Amidated D-Asp Cross-bridge, Identified in Lactobacillus casei Bacteriophage Endolysins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTIC-ACID BACTERIA; LACTOCOCCUS-LACTIS; STAPHYLOCOCCUS-AUREUS; MUREIN HYDROLASES; SURFACE DISPLAY; HIGH-AFFINITY; CELL-SURFACE; WALL; PROTEINS; LYSINS	Peptidoglycan hydrolases (PGHs) are responsible for bacterial cell lysis. Most PGHs have a modular structure comprising a catalytic domain and a cell wall-binding domain (CWBD). PGHs of bacteriophage origin, called endolysins, are involved in bacterial lysis at the end of the infection cycle. We have characterized two endolysins, Lc-Lys and Lc-Lys-2, identified in prophages present in the genome of Lactobacillus casei BL23. These two enzymes have different catalytic domains but similar putative C-terminal CWBDs. By analyzing purified peptidoglycan (PG) degradation products, we showed that Lc-Lys is an N-acetylmuramoyl-L-alanine amidase, whereas Lc-Lys-2 is a gamma-D-glutamyl-L-lysyl endopeptidase. Remarkably, both lysins were able to lyse only Gram-positive bacterial strains that possess PG with D-Ala(4)-> D-Asx-L-Lys(3) in their cross-bridge, such as Lactococcus casei, Lactococcus lactis, and Enterococcus faecium. By testing a panel of L. lactis cell wall mutants, we observed that Lc-Lys and Lc-Lys-2 were not able to lyse mutants with a modified PG cross-bridge, constituting D-Ala(4)-> L-Ala-(L-Ala/L-Ser)-L-Lys(3); moreover, they do not lyse the L. lactis mutant containing only the nonamidated D-Asp cross-bridge, i.e. D-Ala(4)-> D-Asp-L-Lys(3). In contrast, Lc-Lys could lyse the ampicillin-resistant E. faecium mutant with 3 -> 3 L-Lys(3)-D-Asn-L-Lys(3) bridges replacing the wild-type 4 -> 3 D-Ala(4)-D-Asn-L-Lys(3) bridges. We showed that the C-terminal CWBD of Lc-Lys binds PG containing mainly D-Asn but not PG with only the nonamidated D-Asp-containing cross-bridge, indicating that the CWBD confers to Lc-Lys its narrow specificity. In conclusion, the CWBD characterized in this study is a novel type of PG-binding domain targeting specifically the D-Asn interpeptide bridge of PG.	[Regulski, Krzysztof; Courtin, Pascal; Kulakauskas, Saulius; Chapot-Chartier, Marie-Pierre] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Regulski, Krzysztof; Courtin, Pascal; Kulakauskas, Saulius; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, F-78352 Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Chapot-Chartier, MP (corresponding author), INRA, Micalis, Batiment 222, F-78352 Jouy En Josas, France.	Marie-Pierre.Chapot@jouy.inra.fr		Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	INRA; Region Ile de France; Marie Curie FP7 Initial Training Network Cross Talk [21553-2]	INRA; Region Ile de France(Region Ile-de-France); Marie Curie FP7 Initial Training Network Cross Talk	This work was supported in part by INRA and Region Ile de France and was an associated project from the Marie Curie FP7 Initial Training Network Cross Talk (Grant Agreement 21553-2).	Acedo-Felix E, 2003, INT J SYST EVOL MICR, V53, P67, DOI 10.1099/ijs.0.02325-0; Bermudez-Humaran LG, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S4; Bosma T, 2006, APPL ENVIRON MICROB, V72, P880, DOI 10.1128/AEM.72.1.880-889.2006; Bustamante N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046654; Bustamante N, 2010, J BIOL CHEM, V285, P33184, DOI 10.1074/jbc.M110.154559; Chapot-Chartier MP, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P383, DOI 10.1007/978-3-642-05062-6_13; Chapot-Chartier MP, 2010, J BIOL CHEM, V285, P10464, DOI 10.1074/jbc.M109.082958; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Eugster MR, 2012, J BACTERIOL, V194, P6498, DOI 10.1128/JB.00808-12; Eugster MR, 2011, MOL MICROBIOL, V81, P1419, DOI 10.1111/j.1365-2958.2011.07774.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Frankel MB, 2012, J BIOL CHEM, V287, P10460, DOI 10.1074/jbc.M111.336404; GARCIA E, 1988, P NATL ACAD SCI USA, V85, P914, DOI 10.1073/pnas.85.3.914; Garneau JE, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S20; Gasson MJ, 1996, ANTON LEEUW INT J G, V70, P147, DOI 10.1007/BF00395931; GASSON MJ, 1983, J BACTERIOL, V154, P1; Grundling A, 2006, J BACTERIOL, V188, P2463, DOI 10.1128/JB.188.7.2463-2472.2006; Hermoso JA, 2007, CURR OPIN MICROBIOL, V10, P461, DOI 10.1016/j.mib.2007.08.002; Hu SM, 2010, APPL ENVIRON MICROB, V76, P2410, DOI 10.1128/AEM.01752-09; Huard C, 2003, MICROBIOL-SGM, V149, P695, DOI 10.1099/mic.0.25875-0; Kashige N, 2000, ARCH VIROL, V145, P1521, DOI 10.1007/s007050070073; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Leenhouts K, 1999, ANTON LEEUW INT J G, V76, P367, DOI 10.1023/A:1002095802571; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Lortal S, 2005, INT DAIRY J, V15, P857, DOI 10.1016/j.idairyj.2004.08.024; Lu JZQ, 2006, J BIOL CHEM, V281, P549, DOI 10.1074/jbc.M509691200; Mainardi JL, 2000, J BIOL CHEM, V275, P16490, DOI 10.1074/jbc.M909877199; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Mo KF, 2012, J AM CHEM SOC, V134, P15556, DOI 10.1021/ja3069962; Nilsen T, 2003, APPL ENVIRON MICROB, V69, P2975, DOI 10.1128/AEM.69.5.2975-2984.2003; O'Flaherty S, 2009, FEMS MICROBIOL REV, V33, P801, DOI 10.1111/j.1574-6976.2009.00176.x; Pritchard DG, 2007, APPL ENVIRON MICROB, V73, P7150, DOI 10.1128/AEM.01783-07; Regulski K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032301; Ribelles P, 2013, APPL MICROBIOL BIOT, V97, P1231, DOI 10.1007/s00253-012-4575-1; Ribelles P, 2012, APPL MICROBIOL BIOT, V94, P101, DOI 10.1007/s00253-011-3588-5; Roces C, 2012, APPL ENVIRON MICROB, V78, P4157, DOI 10.1128/AEM.00795-12; Sambrook J., 2002, MOL CLONING LAB MANU; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schmelcher M, 2010, APPL ENVIRON MICROB, V76, P5745, DOI 10.1128/AEM.00801-10; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Veiga P, 2006, MOL MICROBIOL, V62, P1713, DOI 10.1111/j.1365-2958.2006.05474.x; Veiga P, 2009, J BACTERIOL, V191, P3752, DOI 10.1128/JB.00126-09; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799	49	22	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20416	20426		10.1074/jbc.M112.446344	http://dx.doi.org/10.1074/jbc.M112.446344			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23733182	Green Published, hybrid			2022-12-28	WOS:000321715100029
J	Lietzan, AD; St Maurice, M				Lietzan, Adam D.; St Maurice, Martin			A Substrate-induced Biotin Binding Pocket in the Carboxyltransferase Domain of Pyruvate Carboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFERASE DOMAIN; CRYSTAL-STRUCTURE; MECHANISM; ROLES; C-13; TLS; DECARBOXYLATION; IDENTIFICATION; ACETOACETATE; OXALACETATE	Biotin-dependent enzymes catalyze carboxyl transfer reactions by efficiently coordinating multiple reactions between spatially distinct active sites. Pyruvate carboxylase (PC), a multifunctional biotin-dependent enzyme, catalyzes the bicarbonate- and MgATP-dependent carboxylation of pyruvate to oxaloacetate, an important anaplerotic reaction in mammalian tissues. To complete the overall reaction, the tethered biotin prosthetic group must first gain access to the biotin carboxylase domain and become carboxylated and then translocate to the carboxyltransferase domain, where the carboxyl group is transferred from biotin to pyruvate. Here, we report structural and kinetic evidence for the formation of a substrate-induced biotin binding pocket in the carboxyltransferase domain of PC from Rhizobium etli. Structures of the carboxyltransferase domain reveal that R. etli PC occupies a symmetrical conformation in the absence of the biotin carboxylase domain and that the carboxyltransferase domain active site is conformationally rearranged upon pyruvate binding. This conformational change is stabilized by the interaction of the conserved residues Asp(590) and Tyr(628) and results in the formation of the biotin binding pocket. Site-directed mutations at these residues reduce the rate of biotin-dependent reactions but have no effect on the rate of biotin-independent oxaloacetate decarboxylation. Given the conservation with carboxyltransferase domains in oxaloacetate decarboxylase and transcarboxylase, the structure-based mechanism described for PC may be applicable to the larger family of biotin-dependent enzymes.	[Lietzan, Adam D.; St Maurice, Martin] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	St Maurice, M (corresponding author), Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA.	martin.stmaurice@marquette.edu	St. Maurice, Martin/AGJ-6319-2022; Lietzan, Adam/AAT-4163-2021; St.Maurice, Martin/AAL-5054-2021	St. Maurice, Martin/0000-0002-6507-9528; Lietzan, Adam/0000-0001-6388-2491; 	National Institutes of Health [GM070455]; National Science Foundation [DBI-959442]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070455] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0959442] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant GM070455 (to W. W. Cleland, J. C. Wallace, P. V. Attwood, and M. St. Maurice). This work was also supported in part through instrumentation funded by the National Science Foundation through grant DBI-959442. Use of the Advanced Photon Source was supported by United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor for the support of this research program (Grant 085P1000817).	Adina-Zada A, 2012, BIOCHEMISTRY-US, V51, P8208, DOI 10.1021/bi301060d; ATTWOOD PV, 1986, BIOCHEMISTRY-US, V25, P8191, DOI 10.1021/bi00373a011; ATTWOOD PV, 1991, BIOCHEM J, V273, P443, DOI 10.1042/bj2730443; ATTWOOD PV, 1986, BIOCHEMISTRY-US, V25, P8197, DOI 10.1021/bi00373a012; ATTWOOD PV, 1995, INT J BIOCHEM CELL B, V27, P231, DOI 10.1016/1357-2725(94)00087-R; Benton BM, 2004, J BACTERIOL, V186, P8478, DOI 10.1128/JB.186.24.8478-8489.2004; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Duangpan S, 2010, BIOCHEMISTRY-US, V49, P3296, DOI 10.1021/bi901894t; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Gamberino WC, 1997, J NEUROCHEM, V69, P2312; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GOODALL GJ, 1981, BIOCHEM J, V199, P603, DOI 10.1042/bj1990603; Granjon T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010935; Han J, 2010, J ENDOCRINOL, V204, P143, DOI 10.1677/JOE-09-0391; Hazen SA, 1997, DEV NEUROSCI-BASEL, V19, P162, DOI 10.1159/000111202; Jitrapakdee S, 2006, CELL MOL LIFE SCI, V63, P843, DOI 10.1007/s00018-005-5410-y; Jitrapakdee S, 2010, DIABETOLOGIA, V53, P1019, DOI 10.1007/s00125-010-1685-0; Large V, 1999, DIABETES, V48, P1251, DOI 10.2337/diabetes.48.6.1251; Lasso G, 2010, STRUCTURE, V18, P1300, DOI 10.1016/j.str.2010.07.008; Lietzan AD, 2011, BIOCHEMISTRY-US, V50, P9708, DOI 10.1021/bi201277j; LIU KJM, 1991, BIOCHEM BIOPH RES CO, V179, P366, DOI 10.1016/0006-291X(91)91379-Q; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; Marlier JF, 2013, BIOCHEMISTRY-US, V52, P2888, DOI 10.1021/bi400075t; Maveyraud L, 1996, J AM CHEM SOC, V118, P7435, DOI 10.1021/ja9609718; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REID KSC, 1985, FEBS LETT, V190, P209, DOI 10.1016/0014-5793(85)81285-0; Schar J, 2010, J BACTERIOL, V192, P1774, DOI 10.1128/JB.01132-09; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Studer R, 2007, J MOL BIOL, V367, P547, DOI 10.1016/j.jmb.2006.12.035; Tong L, 2013, CELL MOL LIFE SCI, V70, P863, DOI 10.1007/s00018-012-1096-0; Waldrop GL, 2012, PROTEIN SCI, V21, P1597, DOI 10.1002/pro.2156; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wolfenden R, 2011, J AM CHEM SOC, V133, P5683, DOI 10.1021/ja111457h; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Yongbiao J, 2004, BIOCHEMISTRY-US, V43, P5912, DOI 10.1021/bi035783q; Yu LPC, 2009, STRUCTURE, V17, P823, DOI 10.1016/j.str.2009.04.008; Zauhar RJ, 2000, BIOPOLYMERS, V53, P233, DOI 10.1002/(SICI)1097-0282(200003)53:3<233::AID-BIP3>3.3.CO;2-W; Zeczycki Tonya N, 2010, Open Enzym Inhib J, V3, P8; Zeczycki TN, 2011, BIOCHEMISTRY-US, V50, P9724, DOI 10.1021/bi2012788; Zeczycki TN, 2011, BIOCHEMISTRY-US, V50, P9694, DOI 10.1021/bi201276r; Zeczycki TN, 2009, BIOCHEMISTRY-US, V48, P4305, DOI 10.1021/bi9003759; Zucker F, 2010, ACTA CRYSTALLOGR D, V66, P889, DOI 10.1107/S0907444910020421	46	18	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19915	19925		10.1074/jbc.M113.477828	http://dx.doi.org/10.1074/jbc.M113.477828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23698000	hybrid, Green Published			2022-12-28	WOS:000321515800057
J	Sommer, LAM; Schaad, M; Dames, SA				Sommer, Lisa A. M.; Schaad, Martin; Dames, Sonja A.			NMR- and Circular Dichroism-monitored Lipid Binding Studies Suggest a General Role for the FATC Domain as Membrane Anchor of Phosphatidylinositol 3-Kinase-related Kinases (PIKK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; DNA-PKCS; PHOSPHATIDIC-ACID; OXIDATIVE STRESS; PLASMA-MEMBRANE; HISTONE ACETYLTRANSFERASE; 3-DIMENSIONAL STRUCTURE; SIGNAL-TRANSDUCTION; MAMMALIAN TARGET	The FATC domain is shared by all members of the family of phosphatidylinositol-3 kinase-related kinases (PIKKs). It has been shown that the FATC domain plays an important role for the regulation of each PIKK. However, other than an involvement in protein-protein interactions, a common principle for the action of the FATC domain has not been detected. A detailed characterization of the structure and lipid binding properties of the FATC domain of the Ser/Thr kinase target of rapamycin (TOR) revealed that it contains a redox-sensitive membrane anchor in its C terminus. Because the C-terminal regions of the FATC domains of all known PIKKs are rather hydrophobic and especially rich in aromatic residues, we examined whether the ability to interact with lipids and membranes might be a general property. Here, we present the characterization of the interactions with lipids and different membrane mimetics for the FATC domains of human DNA-PKcs, human ATM, human ATR, human SMG-1, and human TRRAP by NMR and CD spectroscopy. The data indicate that all of these can interact with different membrane mimetics and may have different preferences only for membrane properties such as surface charge, curvature, and lipid packing. The oxidized form of the TOR FATC domain is well structured overall and forms an alpha-helix that is followed by a disulfide-bonded loop. In contrast, the FATC domains of the other PIKKs are rather unstructured in the isolated form and only significantly populate alpha-helical secondary structure upon interaction with membrane mimetics.	[Sommer, Lisa A. M.; Schaad, Martin; Dames, Sonja A.] Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, D-85747 Garching, Germany	Technical University of Munich	Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Chair Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.	sonja.dames@tum.de		Dames, Sonja/0000-0001-7495-6943	German Research Foundation [DA 1195/3-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by Grant DA 1195/3-1 from the German Research Foundation (to S. A. D.).	Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Camargo DCR, 2012, BIOCHEMISTRY-US, V51, P4909, DOI 10.1021/bi3002133; Chen BPC, 2012, CANCER LETT, V327, P103, DOI 10.1016/j.canlet.2011.12.004; Chen RQ, 2009, J BIOL CHEM, V284, P16752, DOI 10.1074/jbc.M109.014316; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; Dames SA, 2011, J BIOL CHEM, V286, P36907, DOI 10.1074/jbc.M111.225052; Dames SA, 2010, J BIOL CHEM, V285, P7766, DOI 10.1074/jbc.M109.058404; Dazert E, 2011, CURR OPIN CELL BIOL, V23, P744, DOI 10.1016/j.ceb.2011.09.003; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Farrow NA, 1997, BIOCHEMISTRY-US, V36, P2390, DOI 10.1021/bi962548h; Flynn RL, 2011, TRENDS BIOCHEM SCI, V36, P133, DOI 10.1016/j.tibs.2010.09.005; Foster DA, 2009, BBA-MOL CELL BIOL L, V1791, P949, DOI 10.1016/j.bbalip.2009.02.009; Gonzalez-Estevez C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002619; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grdzka I., 2013, BIOCHIM BIOPHYS ACTA, V1830, P2233; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Herceg Z, 2005, CELL CYCLE, V4, P383, DOI 10.4161/cc.4.3.1546; Hoke SMT, 2010, CURR GENET, V56, P447, DOI 10.1007/s00294-010-0313-3; Huth JR, 1997, PROTEIN SCI, V6, P2359; Jiang XF, 2006, J BIOL CHEM, V281, P15741, DOI 10.1074/jbc.M513172200; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Ju JH, 2010, J BIOL CHEM, V285, P41152, DOI 10.1074/jbc.M110.158352; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; Knutson BA, 2010, J STRUCT BIOL, V170, P354, DOI 10.1016/j.jsb.2010.01.002; Koenig BW, 2003, J BIOMOL NMR, V26, P193, DOI 10.1023/A:1023887412387; Kong XM, 2011, CELL SIGNAL, V23, P1273, DOI 10.1016/j.cellsig.2011.04.005; Kruger A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001959; Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200; Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200; Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lazaridis T, 2005, J PHYS CHEM B, V109, P15098, DOI 10.1021/jp0516801; Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281; Liu W, 2006, BIOCHEMISTRY-US, V45, P11713, DOI 10.1021/bi0608414; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Lucero H, 2003, J BIOL CHEM, V278, P22136, DOI 10.1074/jbc.M301579200; Masse I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003354; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Morita T, 2007, J BIOL CHEM, V282, P7799, DOI 10.1074/jbc.M610159200; Myers GA, 2012, J AM CHEM SOC, V134, P19652, DOI 10.1021/ja306074k; Nakada D, 2005, MOL BIOL CELL, V16, P5227, DOI 10.1091/mbc.E05-05-0405; Oliveira V, 2008, J BIOL CHEM, V283, P13174, DOI 10.1074/jbc.M708008200; Pan Y, 2012, GERONTOLOGY, V58, P524, DOI 10.1159/000342204; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; Robert F, 2006, MOL CELL BIOL, V26, P402, DOI 10.1128/MCB.26.2.402-412.2006; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177; Sommer LAM, 2012, PROTEIN SCI, V21, P1566, DOI 10.1002/pro.2127; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Sun H, 2008, J BIOL CHEM, V283, P22233, DOI 10.1074/jbc.M802074200; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x; Tausk R. J., 1974, BIOPHYS CHEM, V1, P184, DOI DOI 10.1016/0301-4622(74)80005-0; TAUSK RJM, 1974, BIOPHYS CHEM, V2, P175, DOI 10.1016/0301-4622(74)80004-9; Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f; Toulany M, 2012, MOL CANCER RES, V10, P945, DOI 10.1158/1541-7786.MCR-11-0592; Unno A, 2005, BIOCHEM BIOPH RES CO, V327, P933, DOI 10.1016/j.bbrc.2004.12.095; Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Walsh JD, 2010, BIOPHYS J, V99, P2636, DOI 10.1016/j.bpj.2010.08.036; Watters D, 1997, ONCOGENE, V14, P1911, DOI 10.1038/sj.onc.1201037; Weschayanwiwat P, 2005, J SURFACTANTS DETERG, V8, P65, DOI 10.1007/s11743-005-0332-8; Whiles JA, 2002, BIOORG CHEM, V30, P431, DOI 10.1016/S0045-2068(02)00527-8; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yan J, 2000, INT J RADIAT BIOL, V76, P1025, DOI 10.1080/09553000050111497; Zhang LQ, 2006, CELL SIGNAL, V18, P1386, DOI 10.1016/j.cellsig.2005.10.017; Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200; Zinzalla V, 2011, CELL, V144, P757, DOI 10.1016/j.cell.2011.02.014	83	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					20046	20063		10.1074/jbc.M113.467233	http://dx.doi.org/10.1074/jbc.M113.467233			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23671275	Green Published, hybrid			2022-12-28	WOS:000321515800067
J	Tzarum, N; Komornik, N; Ben Chetrit, D; Engelberg, D; Livnah, O				Tzarum, Netanel; Komornik, Nadav; Ben Chetrit, Dorin; Engelberg, David; Livnah, Oded			DEF Pocket in p38 alpha Facilitates Substrate Selectivity and Mediates Autophosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE MUTANTS; DOCKING SITES; MAP KINASES; PROTEIN-KINASES; C-JUN; ACTIVATION; P38-ALPHA; ERK2; PHOSPHORYLATION; MOTIF	Signaling processes are primarily promoted by molecular recognition and corresponding protein-protein interactions. One of the key eukaryotic signaling pathways is the MAP kinase cascade involved in vital cellular processes such as cell proliferation, differentiation, apoptosis, and stress response. The principle recognition site of MAP kinases, the common docking (CD) region, forms selective interactions with substrates, upstream activators, and phosphatases. A second docking site, defined as the DEF site interaction pocket (DEF pocket), is formed subsequent to ERK2 and p38 alpha activation. Both crystal structures of p38 alpha in its dually phosphorylated form and of intrinsically active mutants showed the DEF pocket, giving motivation for studying its role in substrate activation and selectivity. Mutating selected DEF pocket residues significantly decreased the phosphorylation levels of three p38 alpha substrates (ATFII, Elk-1, and MBP) with no apparent effect on the phosphorylation of MK2 kinase. Conversely, mutating the CD region gave the opposite effect, suggesting p38 alpha substrates can be classified into DEF-dependent and DEF-independent substrates. In addition, mutating DEF pocket residues decreased the autophosphorylation capability of intrinsically active p38 alpha mutants, suggesting DEF-mediated trans-autophosphorylation in p38 alpha. These results could contribute to understanding substrate selectivity of p38 alpha and serve as a platform for designing p38 alpha-selective DEF site blockers, which partially inhibit p38 alpha binding DEF-dependent substrates, whereas maintaining its other functions intact. In this context, preliminary results using synthetic peptides reveal significant inhibition of substrate phosphorylation by activated p38 alpha.	[Tzarum, Netanel; Komornik, Nadav; Ben Chetrit, Dorin; Engelberg, David; Livnah, Oded] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silverman Inst Life Sci, IL-91904 Jerusalem, Israel; [Tzarum, Netanel; Komornik, Nadav; Ben Chetrit, Dorin; Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Livnah, O (corresponding author), Hebrew Univ Jerusalem, Edmond J Safra Campus, IL-91904 Jerusalem, Israel.	oded.livnah@huji.ac.il		Tzarum, Netanel/0000-0001-6401-1356	ISF Research Center of Excellence [180/09]	ISF Research Center of Excellence	This work was supported by ISF Research Center of Excellence 180/09 awarded (to O. L. and D. E.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Avitzour M, 2007, FEBS J, V274, P963, DOI 10.1111/j.1742-4658.2007.05644.x; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bardwell L, 1996, TRENDS BIOCHEM SCI, V21, P373, DOI 10.1016/S0968-0004(96)30032-7; Bell M, 2001, J BIOL CHEM, V276, P25351, DOI 10.1074/jbc.M101818200; BENLEVY R, 1995, EMBO J, V14, P5920, DOI 10.1002/j.1460-2075.1995.tb00280.x; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BOTT CM, 1994, FEBS LETT, V352, P201, DOI 10.1016/0014-5793(94)00958-9; Callaway KA, 2006, BIOCHEMISTRY-US, V45, P13719, DOI 10.1021/bi0610451; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Enslen H, 2000, EMBO J, V19, P1301, DOI 10.1093/emboj/19.6.1301; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gills JJ, 2007, J BIOL CHEM, V282, P27020, DOI 10.1074/jbc.M701108200; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Levin-Salomon V, 2008, J BIOL CHEM, V283, P34500, DOI 10.1074/jbc.M806443200; Mittelstadt PR, 2009, J BIOL CHEM, V284, P15469, DOI 10.1074/jbc.M901004200; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rainey MA, 2005, J AM CHEM SOC, V127, P10494, DOI 10.1021/ja052915p; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; SMITH JA, 1993, MOL CELL BIOCHEM, V128, P51, DOI 10.1007/BF01076757; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tzarum N, 2012, J MOL BIOL, V424, P339, DOI 10.1016/j.jmb.2012.10.007; Tzarum N, 2011, J MOL BIOL, V405, P1154, DOI 10.1016/j.jmb.2010.11.023; Vinciguerra M, 2004, J BIOL CHEM, V279, P9634, DOI 10.1074/jbc.M308721200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang YY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.203786	44	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19537	19547		10.1074/jbc.M113.464511	http://dx.doi.org/10.1074/jbc.M113.464511			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23671282	hybrid, Green Published			2022-12-28	WOS:000321515800020
J	Papp-Wallace, KM; Taracila, MA; Gatta, JA; Ohuchi, N; Bonomo, RA; Nukaga, M				Papp-Wallace, Krisztina M.; Taracila, Magdalena A.; Gatta, Julian A.; Ohuchi, Nozomi; Bonomo, Robert A.; Nukaga, Michiyoshi			Insights into beta-Lactamases from Burkholderia Species, Two Phylogenetically Related yet Distinct Resistance Determinants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM INFECTION; SITE OMEGA LOOP; PSEUDOMONAS-AERUGINOSA; NOSOCOMIAL OUTBREAK; ESCHERICHIA-COLI; CEPACIA; PSEUDOMALLEI; KPC-2; MELIOIDOSIS; CEFTAZIDIME	Burkholderia cepacia complex and Burkholderia pseudomallei are opportunistic human pathogens. Resistance to beta-lactams among Burkholderia spp. is attributable to expression of beta-lactamases (e. g. PenA in B. cepacia complex and PenI in B. pseudomallei). Phylogenetic comparisons reveal that PenA and PenI are highly related. However, the analyses presented here reveal that PenA is an inhibitor-resistant carbapenemase, most similar to KPC-2 (the most clinically significant serine carbapenemase), whereas PenI is an extended spectrum beta-lactamase. PenA hydrolyzes beta-lactams with k(cat) values ranging from 0.38 +/- 0.04 to 460 +/- 46 s(-1) and possesses high k(cat)/k(inact) values of 2000, 1500, and 75 for beta-lactamase inhibitors. PenI demonstrates the highest k(cat) value for cefotaxime of 9.0 +/- 0.9 s(-1). Crystal structure determination of PenA and PenI reveals important differences that aid in understanding their contrasting phenotypes. Changes in the positioning of conserved catalytic residues (e.g. Lys-73, Ser-130, and Tyr-105) as well as altered anchoring and decreased occupancy of the deacylation water explain the lower k(cat) values of PenI. The crystal structure of PenA with imipenem docked into the active site suggests why this carbapenem is hydrolyzed and the important role of Arg220, which was functionally confirmed by mutagenesis and biochemical characterization. Conversely, the conformation of Tyr-105 hindered docking of imipenem into the active site of PenI. The structural and biochemical analyses of PenA and PenI provide key insights into the hydrolytic mechanisms of beta-lactamases, which can lead to the rational design of novel agents against these pathogens.	[Papp-Wallace, Krisztina M.; Taracila, Magdalena A.; Gatta, Julian A.; Bonomo, Robert A.] Louis Stokes Cleveland Dept Vet Affairs, Res Serv, Cleveland, OH 44106 USA; [Papp-Wallace, Krisztina M.; Taracila, Magdalena A.; Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Ohuchi, Nozomi; Nukaga, Michiyoshi] Josai Int Univ, Togane City, Chiba 2838555, Japan	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Bonomo, RA (corresponding author), 10701 East Blvd, Cleveland, OH 44106 USA.	robert.bonomo@med.va.gov	Papp-Wallace, Krisztina/L-2923-2019	Papp-Wallace, Krisztina/0000-0002-9976-7898	National Institutes of Health, NIAID [R01 AI100560, R01 AI063517]; Veterans Affairs Career Development Program; Cleveland Department of Veterans Affairs; Veterans Affairs Merit Review Program; Geriatric Research Education and Clinical Center [VISN 10]; Japan Society for the Promotion of Science (KAKENHI) [22590401]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063517, R01AI100560] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs Career Development Program; Cleveland Department of Veterans Affairs; Veterans Affairs Merit Review Program(US Department of Veterans Affairs); Geriatric Research Education and Clinical Center; Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI100560 and R01 AI063517 from NIAID (to R. A. B.). This work was also supported by the Veterans Affairs Career Development Program (to K. M. P.-W.), by funds and/or facilities provided by the Cleveland Department of Veterans Affairs, the Veterans Affairs Merit Review Program, Geriatric Research Education and Clinical Center Grant VISN 10 (to R. A. B.), and Japan Society for the Promotion of Science Grant-in-aid for Scientific Research (KAKENHI) Grant 22590401 (to M. N.). This work has been performed under the approval of the Photon Factory Program Advisory Committee (Proposal No. 2010G584).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Aldhous P, 2005, NATURE, V434, P692, DOI 10.1038/434692a; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Avgeri SG, 2009, INT J ANTIMICROB AG, V33, P394, DOI 10.1016/j.ijantimicag.2008.09.010; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chantratita N, 2011, P NATL ACAD SCI USA, V108, P17165, DOI 10.1073/pnas.1111020108; CHARNAS RL, 1981, BIOCHEMISTRY-US, V20, P2732, DOI 10.1021/bi00513a005; Cheung TKM, 2002, ANTIMICROB AGENTS CH, V46, P1132, DOI 10.1128/AAC.46.4.1132-1135.2002; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; Clinical Laboratory Standards Institute, 2006, M07A7 CLSI; da Silva RM, 2012, EXPERT OPIN BIOL TH, V12, P663, DOI 10.1517/14712598.2012.681369; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Diller DJ, 2003, J MED CHEM, V46, P4638, DOI 10.1021/jm020503a; Diller DJ, 2001, PROTEINS, V43, P113, DOI 10.1002/1097-0134(20010501)43:2<113::AID-PROT1023>3.0.CO;2-T; Dolan SA, 2011, INFECT CONT HOSP EP, V32, P804, DOI 10.1086/660876; Douce RW, 2008, INFECT CONT HOSP EP, V29, P364, DOI 10.1086/533543; Drawz SM, 2011, PROTEIN SCI, V20, P941, DOI 10.1002/pro.612; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; EASTON CJ, 1982, BIOCHEMISTRY-US, V21, P2857, DOI 10.1021/bi00541a008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Falade OO, 2008, NEW ENGL J MED, V359, P628, DOI 10.1056/NEJMcps0708803; Frase H, 2009, J BIOL CHEM, V284, P29509, DOI 10.1074/jbc.M109.011262; Girlich D, 2010, ANTIMICROB AGENTS CH, V54, P328, DOI 10.1128/AAC.00961-09; GODFREY AJ, 1991, ANTIMICROB AGENTS CH, V35, P1635, DOI 10.1128/AAC.35.8.1635; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Henriques I, 2004, ANTIMICROB AGENTS CH, V48, P2321, DOI 10.1128/AAC.48.6.2321-2324.2004; Heo ST, 2008, J HOSP INFECT, V70, P241, DOI 10.1016/j.jhin.2008.07.019; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Holmes A, 1998, EMERG INFECT DIS, V4, P221, DOI 10.3201/eid0402.980209; Kattan JN, 2008, CLIN MICROBIOL INFEC, V14, P1102, DOI 10.1111/j.1469-0691.2008.02101.x; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; KOPONEN MA, 1991, ARCH INTERN MED, V151, P605, DOI 10.1001/archinte.151.3.605; Lee CS, 2008, J HOSP INFECT, V68, P280, DOI 10.1016/j.jhin.2008.01.002; Lin S, 1998, BIOCHEM J, V333, P395, DOI 10.1042/bj3330395; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2005, Chron Respir Dis, V2, P209, DOI 10.1191/1479972305cd053ra; Martin M, 2012, ANAESTHESIST, V61, P25, DOI 10.1007/s00101-011-1954-4; Martin M, 2011, J HOSP INFECT, V77, P267, DOI 10.1016/j.jhin.2010.10.004; Martins IS, 2010, INFECT CONT HOSP EP, V31, P516, DOI 10.1086/651667; Memish ZA, 2009, AM J INFECT CONTROL, V37, P431, DOI 10.1016/j.ajic.2006.10.002; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; Molina-Cabrillana J, 2006, INFECT CONT HOSP EP, V27, P1281, DOI 10.1086/508845; Moreira BM, 2005, J HOSP INFECT, V60, P51, DOI 10.1016/j.jhin.2004.09.036; Nukaga M, 2003, J MOL BIOL, V328, P289, DOI 10.1016/S0022-2836(03)00210-9; Nukaga M, 2008, J AM CHEM SOC, V130, P12656, DOI 10.1021/ja7111146; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALZKILL T, 1994, MOL MICROBIOL, V12, P217, DOI 10.1111/j.1365-2958.1994.tb01011.x; Papp-Wallace KM, 2012, ANTIMICROB AGENTS CH, V56, P4428, DOI 10.1128/AAC.05769-11; Papp-Wallace KM, 2010, PROTEIN SCI, V19, P1714, DOI 10.1002/pro.454; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P2867, DOI 10.1128/AAC.00197-10; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P890, DOI 10.1128/AAC.00693-09; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Petrosino JF, 1996, J BACTERIOL, V178, P1821, DOI 10.1128/jb.178.7.1821-1828.1996; Poirel L, 2001, ANTIMICROB AGENTS CH, V45, P2598, DOI 10.1128/AAC.45.9.2598-2603.2001; Poirel L, 2009, ANTIMICROB AGENTS CH, V53, P876, DOI 10.1128/AAC.00946-08; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Rao SN, 2007, J CHEM INF MODEL, V47, P2159, DOI 10.1021/ci6004299; Rholl DA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00139; Rosengarten D, 2010, INFECT CONT HOSP EP, V31, P769, DOI 10.1086/653611; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Sturenburg E, 2004, J ANTIMICROB CHEMOTH, V54, P406, DOI 10.1093/jac/dkh334; Suarez-Moreno ZR, 2012, MICROB ECOL, V63, P249, DOI 10.1007/s00248-011-9929-1; Sunenshine R, 2009, CLIN INFECT DIS, V48, P1580, DOI 10.1086/598938; Trepanier S, 1997, ANTIMICROB AGENTS CH, V41, P2399, DOI 10.1128/AAC.41.11.2399; Tribuddharat C, 2003, ANTIMICROB AGENTS CH, V47, P2082, DOI 10.1128/AAC.47.7.2082-2087.2003; Vandamme P, 2011, SYST APPL MICROBIOL, V34, P87, DOI 10.1016/j.syapm.2010.10.002; Winkler ML, 2013, J MED CHEM, V56, P1084, DOI 10.1021/jm301490d; Wooten MD, 2001, JCR-J CLIN RHEUMATOL, V7, P242, DOI 10.1097/00124743-200108000-00010; Wuthiekanun Vanaporn, 2006, Expert Rev Anti Infect Ther, V4, P445, DOI 10.1586/14787210.4.3.445; Yang CJ, 2008, J HOSP INFECT, V69, P398, DOI 10.1016/j.jhin.2008.03.011; ZAFARALLA G, 1992, BIOCHEMISTRY-US, V31, P3847, DOI 10.1021/bi00130a016	77	46	46	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19090	19102		10.1074/jbc.M113.458315	http://dx.doi.org/10.1074/jbc.M113.458315			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658015	Green Published, hybrid			2022-12-28	WOS:000321335800044
J	Simon, P; Baumner, S; Busch, O; Rohrich, R; Kaese, M; Richterich, P; Wehrend, A; Muller, K; Gerardy-Schahn, R; Muhlenhoff, M; Geyer, H; Geyer, R; Middendorff, R; Galuska, SP				Simon, Peter; Baeumner, Soeren; Busch, Oliver; Roehrich, Rene; Kaese, Miriam; Richterich, Peter; Wehrend, Axel; Mueller, Karin; Gerardy-Schahn, Rita; Muehlenhoff, Martina; Geyer, Hildegard; Geyer, Rudolf; Middendorff, Ralf; Galuska, Sebastian P.			Polysialic Acid Is Present in Mammalian Semen as a Post-translational Modification of the Neural Cell Adhesion Molecule NCAM and the Polysialyltransferase ST8SiaII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL EXTRACELLULAR TRAPS; ULTRASENSITIVE CHEMICAL METHOD; FERTILITY-ASSOCIATED ANTIGEN; HUMAN DENDRITIC CELLS; HUMAN UTERINE CERVIX; IN-VIVO; N-CAM; LEUKOCYTIC REACTION; MOUSE-BRAIN; POLYSIALYLATION	Fertilization in animals is a complex sequence of several biochemical events beginning with the insemination into the female reproductive tract and, finally, leading to embryogenesis. Studies by Kitajima and co-workers (Miyata, S., Sato, C., and Kitajima, K. (2007) Trends Glycosci. Glyc, 19, 85-98) demonstrated the presence of polysialic acid (polySia) on sea urchin sperm. Based on these results, we became interested in the potential involvement of sialic acid polymers in mammalian fertilization. Therefore, we isolated human sperm and performed analyses, including Western blotting and mild 1,2-diamino-4,5-methylenedioxybenzene-HPLC, that revealed the presence alpha 2,8-linked polySia chains. Further analysis by a glyco-proteomics approach led to the identification of two polySia carriers. Interestingly, besides the neural cell adhesion molecule, the polysialyltransferase ST8SiaII has also been found to be a target for polysialylation. Further analysis of testis and epididymis tissue sections demonstrated that only epithelial cells of the caput were polySia-positive. During the epididymal transit, polySia carriers were partially integrated into the sperm membrane of the postacrosomal region. Because polySia is known to counteract histone as well as neutrophil extracellular trap-mediated cytotoxicity against host cells, which plays a role after insemination, we propose that polySia in semen represents a cytoprotective element to increase the number of vital sperm.	[Simon, Peter; Baeumner, Soeren; Busch, Oliver; Roehrich, Rene; Kaese, Miriam; Geyer, Hildegard; Geyer, Rudolf; Galuska, Sebastian P.] Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany; [Richterich, Peter; Wehrend, Axel] Univ Giessen, Clin Obstet Gynecol & Androl Small & Large Anim, D-35392 Giessen, Germany; [Mueller, Karin] Leibniz Inst Zoo & Wildlife Res, D-10315 Berlin, Germany; [Gerardy-Schahn, Rita; Muehlenhoff, Martina] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Middendorff, Ralf] Univ Giessen, Fac Med, Inst Anat & Cell Biol, D-35385 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Leibniz Institut fur Zoo und Wildtierforschung; Hannover Medical School; Justus Liebig University Giessen	Galuska, SP (corresponding author), Univ Giessen, Fac Med, Inst Biochem, D-35392 Giessen, Germany.	sebastian.galuska@biochemie.med.uni-giessen.de			Deutsche Forschungsgemeinschaft [GA 1755/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GA 1755/1-1 (to S. P. G.).	Aitken RJ, 2007, ASIAN J ANDROL, V9, P554, DOI 10.1111/j.1745-7262.2007.00280.x; Alghamdi AS, 2005, BIOL REPROD, V73, P1174, DOI 10.1095/biolreprod.105.045666; Angata K, 1998, J BIOL CHEM, V273, P28524, DOI 10.1074/jbc.273.43.28524; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; Bellin ME, 1998, J ANIM SCI, V76, P2032; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Brinkmann V, 2007, NAT REV MICROBIOL, V5, P577, DOI 10.1038/nrmicro1710; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Close BE, 2001, GLYCOBIOLOGY, V11, P997, DOI 10.1093/glycob/11.11.997; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; Drake PM, 2008, J IMMUNOL, V181, P6850, DOI 10.4049/jimmunol.181.10.6850; Drake PM, 2009, P NATL ACAD SCI USA, V106, P11995, DOI 10.1073/pnas.0905188106; Drobnis E Z, 1992, Oxf Rev Reprod Biol, V14, P1; FINNE J, 1982, J BIOL CHEM, V257, P1966; FROSCH M, 1985, P NATL ACAD SCI USA, V82, P1194, DOI 10.1073/pnas.82.4.1194; Fujimoto I, 2001, J BIOL CHEM, V276, P31745, DOI 10.1074/jbc.M104525200; Galuska SP, 2008, J BIOL CHEM, V283, P17, DOI 10.1074/jbc.M707024200; Galuska SP, 2006, J BIOL CHEM, V281, P31605, DOI 10.1074/jbc.M606516200; Galuska SP, 2012, J PROTEOMICS, V75, P5266, DOI 10.1016/j.jprot.2012.06.011; Galuska SP, 2010, P NATL ACAD SCI USA, V107, P10250, DOI 10.1073/pnas.0912103107; Gatti JL, 2004, ANIM REPROD SCI, V82-3, P321, DOI 10.1016/j.anireprosci.2004.05.011; GERARDYSCHAHN R, 1994, INT J CANCER, P27; Haselhorst T, 2006, CHEMBIOCHEM, V7, P1875, DOI 10.1002/cbic.200600252; Inoue S, 2000, J BIOL CHEM, V275, P29968, DOI 10.1074/jbc.M004150200; Inoue S, 2001, BIOCHIMIE, V83, P605, DOI 10.1016/S0300-9084(01)01307-4; Inoue S, 2001, J BIOL CHEM, V276, P31863, DOI 10.1074/jbc.M103336200; Inoue S, 2001, GLYCOBIOLOGY, V11, P759, DOI 10.1093/glycob/11.9.759; LACKIE PM, 1994, DIFFERENTIATION, V57, P119, DOI 10.1046/j.1432-0436.1994.5720119.x; LACKIE PM, 1990, DEVELOPMENT, V110, P933; Liedtke S, 2001, GLYCOBIOLOGY, V11, P373, DOI 10.1093/glycob/11.5.373; Marengo SR, 2008, ANIM REPROD SCI, V105, P52, DOI 10.1016/j.anireprosci.2007.11.018; McCauley TC, 1999, MOL REPROD DEV, V54, P145, DOI 10.1002/(SICI)1098-2795(199910)54:2&lt;145::AID-MRD6&gt;3.0.CO;2-6; Miyata S, 2007, TRENDS GLYCOSCI GLYC, V19, P85, DOI 10.4052/tigg.19.85; Miyata S, 2006, GLYCOBIOLOGY, V16, P1229, DOI 10.1093/glycob/cwl036; MOOLENAAR CECK, 1990, CANCER RES, V50, P1102; Muhlenhoff M, 2001, J BIOL CHEM, V276, P34066, DOI 10.1074/jbc.M101022200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Nakata D, 2005, J BIOL CHEM, V280, P38305, DOI 10.1074/jbc.M508762200; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; PANDYA IJ, 1985, FERTIL STERIL, V43, P417; Pang PC, 2007, J BIOL CHEM, V282, P36593, DOI 10.1074/jbc.M705134200; Rey-Gallardo A, 2011, GLYCOBIOLOGY, V21, P655, DOI 10.1093/glycob/cwq216; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Rolland M, 2013, HUM REPROD, V28, P462, DOI 10.1093/humrep/des415; Rutishauser U, 1996, CURR OPIN CELL BIOL, V8, P679, DOI 10.1016/S0955-0674(96)80109-8; Rutishauser U., 1992, DEVELOPMENT S, V116, P99; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Saez F, 2003, J ANDROL, V24, P149; Saffarzadeh M, 2013, CURR OPIN HEMATOL, V20, P3, DOI 10.1097/MOH.0b013e32835a0025; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Sato C, 1998, ANAL BIOCHEM, V261, P191, DOI 10.1006/abio.1998.2718; Stummeyer K, 2005, NAT STRUCT MOL BIOL, V12, P90, DOI 10.1038/nsmb874; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055; TANG J, 1992, NEURON, V8, P1031, DOI 10.1016/0896-6273(92)90125-W; Thimon V, 2008, HUM REPROD, V23, P1698, DOI 10.1093/humrep/den181; THOMPSON LA, 1992, AM J REPROD IMMUNOL, V28, P85, DOI 10.1111/j.1600-0897.1992.tb00765.x; TROY FA, 1992, GLYCOBIOLOGY, V2, P5, DOI 10.1093/glycob/2.1.5; Ulm C., 2013, CELL MOL LI IN PRESS; von der Ohe M, 2002, GLYCOBIOLOGY, V12, P47, DOI 10.1093/glycob/12.1.47; Wang Y, 2010, J NEUROSCI, V30, P3482, DOI 10.1523/JNEUROSCI.3940-09.2010; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; ZUBER C, 1992, J BIOL CHEM, V267, P9965	67	43	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18825	18833		10.1074/jbc.M113.451112	http://dx.doi.org/10.1074/jbc.M113.451112			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671285	Green Published, hybrid			2022-12-28	WOS:000321335800020
J	Buck, TM; Plavchak, L; Roy, A; Donnelly, BF; Kashlan, OB; Kleyman, TR; Subramanya, AR; Brodsky, JL				Buck, Teresa M.; Plavchak, Lindsay; Roy, Ankita; Donnelly, Bridget F.; Kashlan, Ossama B.; Kleyman, Thomas R.; Subramanya, Arohan R.; Brodsky, Jeffrey L.			The Lhs1/GRP170 Chaperones Facilitate the Endoplasmic Reticulum-associated Degradation of the Epithelial Sodium Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-EXCHANGE FACTOR; HEAT-SHOCK PROTEINS; NA+ CHANNEL; MOLECULAR CHAPERONES; MISFOLDED GLYCOPROTEINS; HSP70 CHAPERONES; QUALITY-CONTROL; MECHANISTICALLY DISTINCT	The epithelial sodium channel, ENaC, plays a critical role in maintaining salt and water homeostasis, and not surprisingly defects in ENaC function are associated with disease. Like many other membrane-spanning proteins, this trimeric protein complex folds and assembles inefficiently in the endoplasmic reticulum (ER), which results in a substantial percentage of the channel being targeted for ER-associated degradation (ERAD). Because the spectrum of factors that facilitates the degradation of ENaC is incomplete, we developed yeast expression systems for each ENaC subunit. We discovered that a conserved Hsp70-like chaperone, Lhs1, is required for maximal turnover of the ENaC alpha subunit. By expressing Lhs1 ATP binding mutants, we also found that the nucleotide exchange properties of this chaperone are dispensable for ENaC degradation. Consistent with the precipitation of an Lhs1-alpha ENaC complex, Lhs1 holdase activity was instead most likely required to support the ERAD of alpha ENaC. Moreover, a complex containing the mammalian Lhs1 homolog GRP170 and alpha ENaC co-precipitated, and GRP170 also facilitated ENaC degradation in human, HEK293 cells, and in a Xenopus oocyte expression system. In both yeast and higher cell types, the effect of Lhs1 on the ERAD of alpha ENaC was selective for the unglycosylated form of the protein. These data establish the first evidence that Lhs1/Grp170 chaperones can act as mediators of ERAD substrate selection.	[Buck, Teresa M.; Plavchak, Lindsay; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Roy, Ankita; Donnelly, Bridget F.; Kashlan, Ossama B.; Kleyman, Thomas R.; Subramanya, Arohan R.] Univ Pittsburgh, Renal Electrolyte Div, Dept Med, Pittsburgh, PA 15261 USA; [Subramanya, Arohan R.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, A320 Langley Hall,4249 5th Ave, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu	Subramanya, Arohan R./AAN-5217-2020	Subramanya, Arohan R./0000-0002-2609-7643; Buck, Teresa/0000-0002-9013-9756; ROY, ANKITA/0000-0002-3032-6365	National Institutes of Health [K01DK090195, DK65161, GM75061, DK79307]; United States Department of Veterans Affairs; University of Pittsburgh George O'Brien Kidney Research Center; American Heart Association [10BGIA3890010]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK065161, P30DK079307, R01DK065161, K01DK090195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs(US Department of Veterans Affairs); University of Pittsburgh George O'Brien Kidney Research Center; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants K01DK090195 (to T. M. B.), DK65161 (to T. K.), GM75061 (to J. L. B.), and DK79307 (to the University of Pittsburgh George O'Brien Kidney Research Center).; Supported by a Mid-level Career Development Award from the United States Department of Veterans Affairs, pilot funds from the University of Pittsburgh George O'Brien Kidney Research Center, and by James A. Shaver Fund of the American Heart Association Grant 10BGIA3890010.	Adams A., 1998, METHODS YEAST GENETI, V1997; Adams CM, 1997, J BIOL CHEM, V272, P27295, DOI 10.1074/jbc.272.43.27295; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Ahner A, 2007, MOL BIOL CELL, V18, P806, DOI 10.1091/mbc.E06-05-0458; Andreasson C, 2010, J BIOL CHEM, V285, P12445, DOI 10.1074/jbc.M109.096735; Asher C, 1996, AM J PHYSIOL-CELL PH, V271, pC605, DOI 10.1152/ajpcell.1996.271.2.C605; Baxter BK, 1996, MOL CELL BIOL, V16, P6444; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Buck TM, 2007, SEMIN CELL DEV BIOL, V18, P751, DOI 10.1016/j.semcdb.2007.09.001; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CANESSA CM, 1994, AM J PHYSIOL-CELL PH, V267, pC1682, DOI 10.1152/ajpcell.1994.267.6.C1682; Chanoux RA, 2012, J BIOL CHEM, V287, P19255, DOI 10.1074/jbc.M112.357756; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Craven RA, 1996, EMBO J, V15, P2640, DOI 10.1002/j.1460-2075.1996.tb00624.x; de Keyzer J, 2009, J BIOL CHEM, V284, P31564, DOI 10.1074/jbc.M109.055160; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Gelling CL, 2012, GENETICS, V192, P889, DOI 10.1534/genetics.112.143487; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Grubb S, 2012, MOL BIOL CELL, V23, P520, DOI 10.1091/mbc.E11-08-0704; Grunder S, 1997, EMBO J, V16, P899, DOI 10.1093/emboj/16.5.899; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Gusarova V, 2001, J BIOL CHEM, V276, P24891, DOI 10.1074/jbc.M100633200; Hale SJ, 2010, J BIOL CHEM, V285, P21600, DOI 10.1074/jbc.M110.111211; Han S, 2007, J BIOL CHEM, V282, P26140, DOI 10.1074/jbc.M701969200; Hebert DN, 2012, TRENDS BIOCHEM SCI, V37, P404, DOI 10.1016/j.tibs.2012.07.005; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hill K, 2000, EMBO J, V19, P550, DOI 10.1093/emboj/19.4.550; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Hutt DM, 2012, J BIOL CHEM, V287, P21914, DOI 10.1074/jbc.M112.339788; Ismail N, 2006, CELL, V126, P237, DOI 10.1016/j.cell.2006.07.001; JORDAN R, 1995, J BIOL CHEM, V270, P4563, DOI 10.1074/jbc.270.9.4563; Kabani M, 2002, FEBS LETT, V531, P339, DOI 10.1016/S0014-5793(02)03570-6; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kashlan OB, 2007, J BIOL CHEM, V282, P28149, DOI 10.1074/jbc.M703409200; Kashlan OB, 2012, EXP CELL RES, V318, P1011, DOI 10.1016/j.yexcr.2012.02.024; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; LIBEREK K, 1995, P NATL ACAD SCI USA, V92, P6224, DOI 10.1073/pnas.92.14.6224; LIN HY, 1993, MOL BIOL CELL, V4, P1109, DOI 10.1091/mbc.4.11.1109; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Malik B, 2001, J BIOL CHEM, V276, P12903, DOI 10.1074/jbc.M010626200; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller GM, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M707339200; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Park J, 2003, BIOCHEMISTRY-US, V42, P14893, DOI 10.1021/bi030122e; Park JE, 2006, CANCER RES, V66, P1161, DOI 10.1158/0008-5472.CAN-05-2609; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Prince LS, 1999, AM J PHYSIOL-CELL PH, V276, pC1346, DOI 10.1152/ajpcell.1999.276.6.C1346; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Qu DF, 1996, J BIOL CHEM, V271, P22791, DOI 10.1074/jbc.271.37.22791; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; RASMUSSEN SW, 1994, YEAST, V10, pS69, DOI 10.1002/yea.320100009; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Rutkevich LA, 2011, CURR OPIN CELL BIOL, V23, P157, DOI 10.1016/j.ceb.2010.10.011; Saris N, 1997, J CELL BIOL, V137, P813, DOI 10.1083/jcb.137.4.813; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Scott CM, 2007, MOL BIOL CELL, V18, P3776, DOI 10.1091/mbc.E07-01-0034; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shen Y, 2005, MOL BIOL CELL, V16, P40, DOI 10.1091/mbc.E04-05-0434; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; SIMONS JF, 1995, J CELL BIOL, V130, P41, DOI 10.1083/jcb.130.1.41; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; SNYDER PM, 1994, J BIOL CHEM, V269, P24379; Snyder PM, 1998, J BIOL CHEM, V273, P681, DOI 10.1074/jbc.273.2.681; Soundararajan R, 2012, MOL CELL ENDOCRINOL, V350, P242, DOI 10.1016/j.mce.2011.11.003; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Tams JW, 1999, BBA-PROTEIN STRUCT M, V1432, P214, DOI 10.1016/S0167-4838(99)00103-X; Taylor M, 2010, J BIOL CHEM, V285, P31261, DOI 10.1074/jbc.M110.148981; Teckman JH, 1996, J BIOL CHEM, V271, P13215, DOI 10.1074/jbc.271.22.13215; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Trueman SF, 2012, J CELL BIOL, V199, P907, DOI 10.1083/jcb.201207163; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200; Weitzmann A, 2006, FEBS LETT, V580, P5237, DOI 10.1016/j.febslet.2006.08.055; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Wolf DH, 2005, CURR TOP MICROBIOL, V300, P41; Yan M, 2011, BIOCHEM J, V438, P447, DOI 10.1042/BJ20110500; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zhang Yimao, 2002, Methods Mol Med, V70, P257; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	116	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18366	18380		10.1074/jbc.M113.469882	http://dx.doi.org/10.1074/jbc.M113.469882			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645669	Green Published, hybrid			2022-12-28	WOS:000320721900040
J	Hong, F; Liu, B; Chiosis, G; Gewirth, DT; Li, ZH				Hong, Feng; Liu, Bei; Chiosis, Gabriela; Gewirth, Daniel T.; Li, Zihai			alpha 7 Helix Region of alpha I Domain Is Crucial for Integrin Binding to Endoplasmic Reticulum Chaperone gp96 A POTENTIAL THERAPEUTIC TARGET FOR CANCER METASTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; SHOCK-PROTEIN GP96; CLINICAL-SIGNIFICANCE; MONOCLONAL-ANTIBODY; MALIGNANT-MELANOMA; MASTER CHAPERONE; CELL-LINES; EXPRESSION; TUMOR; ADHESION	Integrins play important roles in regulating a diverse array of cellular functions crucial to the initiation, progression, and metastasis of tumors. Previous studies have shown that a majority of integrins are folded by the endoplasmic reticulum chaperone gp96. Here, we demonstrate that the dimerization of integrin alpha L and beta 2 is highly dependent on gp96. The alpha I domain (AID), a ligand binding domain shared by seven integrin alpha-subunits, is a critical region for integrin binding to gp96. Deletion of AID significantly reduced the interaction between integrin alpha L and gp96. Overexpression of AID intracellularly decreased surface expression of gp96 clients (integrins and Toll-like receptors) and cancer cell invasion. The alpha 7 helix region is crucial for AID binding to gp96. A cell-permeable alpha 7 helix peptide competitively inhibited the interaction between gp96 and integrins and blocked cell invasion. Thus, targeting the binding site of alpha 7 helix of AID on gp96 is potentially a new strategy for treatment of cancer metastasis.	[Hong, Feng; Liu, Bei; Li, Zihai] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Chiosis, Gabriela] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Gewirth, Daniel T.] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10065 USA	Medical University of South Carolina; Hauptman Woodward Medical Research Institute; Memorial Sloan Kettering Cancer Center	Li, ZH (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	zihai@musc.edu			National Institutes of Health [AI070603, AI077283]; Flow Cytometry Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; SmartState Endowed Chair Program of South Carolina; NATIONAL CANCER INSTITUTE [R01CA172546, R01CA095130, R21CA158609, P30CA008748, P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070603, U01AI125859, R01AI077283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flow Cytometry Shared Resource, Hollings Cancer Center, Medical University of South Carolina; SmartState Endowed Chair Program of South Carolina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI070603 and AI077283 (to Z. L.) and by the Flow Cytometry Shared Resource, Hollings Cancer Center, Medical University of South Carolina Grant P30 CA138313.; Abney Chair Remembering Sally Abney Rose in Stem Cell Biology & Therapy and supported by the SmartState Endowed Chair Program of South Carolina.	ALBELDA SM, 1990, CANCER RES, V50, P6757; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bolli N, 2009, LEUKEMIA, V23, P501, DOI 10.1038/leu.2008.326; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Burkhart DJ, 2004, MOL CANCER THER, V3, P1593; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dingemans AMC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-152; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Fujisaki T, 1999, CANCER RES, V59, P4427; Guo WJ, 2006, CELL, V126, P489, DOI 10.1016/j.cell.2006.05.047; Gutheil JC, 2000, CLIN CANCER RES, V6, P3056; He HZ, 2006, J MED CHEM, V49, P381, DOI 10.1021/jm0508078; Heike M, 2000, INT J CANCER, V86, P489, DOI 10.1002/(SICI)1097-0215(20000515)86:4<489::AID-IJC7>3.3.CO;2-4; Hodorova I, 2008, NEOPLASMA, V55, P31; Li XM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-8; Lin CY, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-136; Liu B, 2008, BLOOD, V112, P1223, DOI 10.1182/blood-2008-03-143107; Liu B, 2013, P NATL ACAD SCI USA, V110, P6877, DOI 10.1073/pnas.1302933110; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039442; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; Matos DM, 2006, BRAZ J MED BIOL RES, V39, P1349, DOI 10.1590/S0100-879X2006001000011; McNeel DG, 2005, CLIN CANCER RES, V11, P7851, DOI 10.1158/1078-0432.CCR-05-0262; Missotten GS, 2003, INVEST OPHTH VIS SCI, V44, P3059, DOI 10.1167/iovs.02-1038; Morales C, 2009, J IMMUNOL, V183, P5121, DOI 10.4049/jimmunol.0900811; Natali PG, 1997, CANCER RES, V57, P1554; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Pontier SM, 2009, J CELL SCI, V122, P207, DOI 10.1242/jcs.040394; Raguse JD, 2004, ORAL ONCOL, V40, P228, DOI 10.1016/j.oraloncology.2003.08.003; Shen CY, 2002, LUNG CANCER, V38, P235, DOI 10.1016/S0169-5002(02)00300-8; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Staron M, 2010, BLOOD, V115, P2380, DOI 10.1182/blood-2009-07-233031; Taldone T, 2009, CURR TOP MED CHEM, V9, P1436, DOI 10.2174/156802609789895737; Usmani SZ, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-40; Vincent AM, 1996, BLOOD, V87, P4780, DOI 10.1182/blood.V87.11.4780.bloodjournal87114780; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wu MFF, 2007, PROTEOMICS, V7, P1973, DOI 10.1002/pmic.200600643; Wu S, 2012, J BIOL CHEM, V287, P6735, DOI 10.1074/jbc.M111.309526; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zhao M, 2004, MED RES REV, V24, P1, DOI 10.1002/med.10056; Zheng HC, 2008, HUM PATHOL, V39, P1042, DOI 10.1016/j.humpath.2007.11.009	42	23	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18243	18248		10.1074/jbc.M113.468850	http://dx.doi.org/10.1074/jbc.M113.468850			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23671277	Green Published, hybrid			2022-12-28	WOS:000320721900028
J	Esposito, G; Garvey, M; Alverdi, V; Pettirossi, F; Corazza, A; Fogolari, F; Polano, M; Mangione, PP; Giorgetti, S; Stoppini, M; Rekas, A; Bellotti, V; Heck, AJR; Carver, JA				Esposito, Gennaro; Garvey, Megan; Alverdi, Vera; Pettirossi, Fabio; Corazza, Alessandra; Fogolari, Federico; Polano, Maurizio; Mangione, P. Patrizia; Giorgetti, Sofia; Stoppini, Monica; Rekas, Agata; Bellotti, Vittorio; Heck, Albert J. R.; Carver, John A.			Monitoring the Interaction between beta(2)-Microglobulin and the Molecular Chaperone alpha B-crystallin by NMR and Mass Spectrometry alpha B-CRYSTALLIN DISSOCIATES beta(2)-MICROGLOBULIN OLIGOMERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID FIBRIL FORMATION; HEAT-SHOCK PROTEINS; SOLVENT PERTURBATION; COMMON MECHANISM; IN-VITRO; AGGREGATION; BETA-2-MICROGLOBULIN; SPECTROSCOPY; EXTENSION; BINDING	The interaction at neutral pH between wild-type and a variant form (R3A) of the amyloid fibril-forming protein beta(2)-microglobulin (beta 2m) and the molecular chaperone alpha B-crystallin was investigated by thioflavin T fluorescence, NMR spectroscopy, and mass spectrometry. Fibril formation of R3A beta 2m was potently prevented by alpha B-crystallin. alpha B-crystallin also prevented the unfolding and nonfibrillar aggregation of R3A beta 2m. From analysis of the NMR spectra collected at various R3A beta 2m to alpha B-crystallin molar subunit ratios, it is concluded that the structured beta-sheet core and the apical loops of R3A beta 2m interact in a nonspecific manner with the alpha B-crystallin. Complementary information was derived from NMR diffusion coefficient measurements of wild-type beta 2m at a 100-fold concentration excess with respect to alpha B-crystallin. Mass spectrometry acquired in the native state showed that the onset of wild-type beta 2m oligomerization was effectively reduced by alpha B-crystallin. Furthermore, and most importantly, alpha B-crystallin reversibly dissociated beta 2m oligomers formed spontaneously in aged samples. These results, coupled with our previous studies, highlight the potent effectiveness of alpha B-crystallin in preventing beta 2m aggregation at the various stages of its aggregation pathway. Our findings are highly relevant to the emerging view that molecular chaperone action is intimately involved in the prevention of in vivo amyloid fibril formation.	[Esposito, Gennaro; Alverdi, Vera; Pettirossi, Fabio; Corazza, Alessandra; Fogolari, Federico; Polano, Maurizio] Univ Udine, Dept Sci Med & Biol, I-33100 Udine, Italy; [Garvey, Megan; Carver, John A.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Mangione, P. Patrizia; Giorgetti, Sofia; Stoppini, Monica; Bellotti, Vittorio] Univ Pavia, Ist Biochim, Dipartimento Med Mol, I-27100 Pavia, Italy; [Mangione, P. Patrizia; Bellotti, Vittorio] UCL, Div Med, Ctr Amyloidosis & Acute Phase Prot, Wolfson Drug Discovery Unit, London NW3 2PF, England; [Rekas, Agata] Australian Nucl Sci & Technol Org, Natl Deuterat Facil, Lucas Heights, NSW 2522, Australia; [Heck, Albert J. R.] Univ Utrecht, Dept Biomol Mass Spectrometry & Prote, Bijvoet Ctr Biomol Res, NL-3584 CA Utrecht, Netherlands; [Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands	University of Udine; University of Adelaide; University of Pavia; University of London; University College London; Australian Nuclear Science & Technology Organisation; Utrecht University; Utrecht University	Esposito, G (corresponding author), Univ Udine, Dept Sci Med & Biol, Ple Kolbe 4, I-33100 Udine, Italy.	rino.esposito@uniud.it	Garvey, Megan/J-9334-2013; Giorgetti, Sofia/AAD-4341-2019; Garvey, Megan/C-9137-2015; Polano, Maurizio/AAB-9679-2020; Bellotti, Vittorio/A-6201-2014; Heck, Albert/D-7098-2011; Carver, John Adrian/J-3825-2014; Corazza, Alessandra/AGB-1457-2022	Giorgetti, Sofia/0000-0001-9438-6511; Polano, Maurizio/0000-0002-6101-1382; Bellotti, Vittorio/0000-0001-8678-662X; Heck, Albert/0000-0002-2405-4404; Carver, John Adrian/0000-0002-2441-8108; Corazza, Alessandra/0000-0003-2272-1928; Mangione, Palma/0000-0003-0260-1400; Fogolari, Federico/0000-0001-9862-250X	Italian Ministry of Education (MIUR) [PRIN N. 20083ERXWS, FIRB N. RBRN07BMCT, FIRB N. RBFR109EOS]; Fondazione Cariplo Project [2011-2096, MR/K000187/1]; European Union Grant [LSHM-CT-2006-037525-EURAMY]; National Health and Medical Research Council of Australia; Australian Research Council; MRC [MR/K000187/1] Funding Source: UKRI; Medical Research Council [MR/K000187/1] Funding Source: researchfish	Italian Ministry of Education (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fondazione Cariplo Project(Fondazione Cariplo); European Union Grant; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Italian Ministry of Education (MIUR) Grants PRIN N. 20083ERXWS, FIRB N. RBRN07BMCT, and FIRB N. RBFR109EOS, Fondazione Cariplo Project 2011-2096, Strategic Award MR/K000187/1, European Union Grant LSHM-CT-2006-037525-EURAMY, the National Health and Medical Research Council of Australia, and the Australian Research Council.	Bagneris C, 2009, J MOL BIOL, V392, P1242, DOI 10.1016/j.jmb.2009.07.069; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bellotti V, 1998, EUR J BIOCHEM, V258, P61, DOI 10.1046/j.1432-1327.1998.2580061.x; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Binger KJ, 2013, FASEB J, V27, P1214, DOI 10.1096/fj.12-220657; Bova MP, 1997, J BIOL CHEM, V272, P29511, DOI 10.1074/jbc.272.47.29511; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; CARVER JA, 1992, FEBS LETT, V311, P143, DOI 10.1016/0014-5793(92)81386-Z; Carver JA, 1999, PROG RETIN EYE RES, V18, P431, DOI 10.1016/S1350-9462(98)00027-5; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; Carver JA, 1998, INT J BIOL MACROMOL, V22, P197, DOI 10.1016/S0141-8130(98)00017-8; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Corazza A, 2004, J BIOL CHEM, V279, P9176, DOI 10.1074/jbc.M310779200; Dehle FC, 2010, CELL STRESS CHAPERON, V15, P1013, DOI 10.1007/s12192-010-0212-z; Devlin GL, 2003, J BIOL CHEM, V278, P48644, DOI 10.1074/jbc.M308376200; Eakin CM, 2002, BIOCHEMISTRY-US, V41, P10646, DOI 10.1021/bi025944a; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Ecroyd H, 2008, FEBS J, V275, P935, DOI 10.1111/j.1742-4658.2008.06257.x; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Esposito G, 2000, PROTEIN SCI, V9, P831, DOI 10.1110/ps.9.5.831; ESPOSITO G, 1992, J MOL BIOL, V224, P659, DOI 10.1016/0022-2836(92)90551-T; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; Floege J, 2001, KIDNEY INT, V59, pS164, DOI 10.1046/j.1523-1755.2001.59780164.x; Garvey M, 2013, BIOCHEM BIOPH RES CO, V433, P276, DOI 10.1016/j.bbrc.2013.02.073; Garvey M, 2011, BIOPOLYMERS, V95, P376, DOI 10.1002/bip.21584; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jehle S, 2009, J MOL BIOL, V385, P1481, DOI 10.1016/j.jmb.2008.10.097; Jerschow A, 1998, J MAGN RESON, V132, P13, DOI 10.1006/jmre.1998.1400; Kad NM, 2003, J MOL BIOL, V330, P785, DOI 10.1016/S0022-2836(03)00583-7; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kudva YC, 1997, FEBS LETT, V416, P117, DOI 10.1016/S0014-5793(97)01180-0; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; Meehan S, 2007, J MOL BIOL, V372, P470, DOI 10.1016/j.jmb.2007.06.060; Molinari H, 1997, BIOPHYS J, V73, P382, DOI 10.1016/S0006-3495(97)78078-0; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Rekas A, 2007, FEBS J, V274, P6290, DOI 10.1111/j.1742-4658.2007.06144.x; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Sun TX, 1998, J BIOL CHEM, V273, P286, DOI 10.1074/jbc.273.1.286; Treweek TM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001046; Treweek TM, 2003, AUST J CHEM, V56, P357, DOI 10.1071/CH03031; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; van Duijn E, 2005, NAT METHODS, V2, P371, DOI 10.1038/nmeth753; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Villanueva J, 2004, PROTEIN SCI, V13, P797, DOI 10.1110/ps.03445704; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yamamoto S, 2005, BBA-PROTEINS PROTEOM, V1753, P4, DOI 10.1016/j.bbapap.2005.09.006; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	71	29	29	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17844	17858		10.1074/jbc.M112.448639	http://dx.doi.org/10.1074/jbc.M112.448639			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645685	Green Published, hybrid			2022-12-28	WOS:000320380600073
J	Leidgens, S; Bullough, KZ; Shi, HF; Li, FM; Shakoury-Elizeh, M; Yabe, T; Subramanian, P; Hsu, E; Natarajan, N; Nandal, A; Stemmler, TL; Philpott, CC				Leidgens, Sebastien; Bullough, Kimberly Z.; Shi, Haifeng; Li, Fengmin; Shakoury-Elizeh, Minoo; Yabe, Toshiki; Subramanian, Poorna; Hsu, Emory; Natarajan, Navin; Nandal, Anjali; Stemmler, Timothy L.; Philpott, Caroline C.			Each Member of the Poly-r(C)-binding Protein 1 (PCBP) Family Exhibits Iron Chaperone Activity toward Ferritin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; BINDING-PROTEIN; SACCHAROMYCES-CEREVISIAE; HOMEOSTASIS; GENE; HYDROXYLASE; PATHWAY; YEAST	The mechanisms through which iron-dependent enzymes receive their metal cofactors are largely unknown. Poly r(C)-binding protein 1 (PCBP1) is an iron chaperone for ferritin; both PCBP1 and its paralog PCBP2 are required for iron delivery to the prolyl hydroxylase that regulates HIF1. Here we show that PCBP2 is also an iron chaperone for ferritin. Co-expression of PCBP2 and human ferritins in yeast activated the iron deficiency response and increased iron deposition into ferritin. Depletion of PCBP2 in Huh7 cells diminished iron incorporation into ferritin. Both PCBP1 and PCBP2 were co-immunoprecipitated with ferritin in HEK293 cells, and expression of both PCBPs was required for ferritin complex formation in cells. PCBP1 and -2 exhibited high affinity binding to ferritin in vitro. Mammalian genomes encode 4 PCBPs, including the minimally expressed PCBPs 3 and 4. Expression of PCBP3 and -4 in yeast activated the iron deficiency response, but only PCBP3 exhibited strong interactions with ferritin. Expression of PCBP1 and ferritin in an iron-sensitive, ccc1 yeast strain intensified the toxic effects of iron, whereas expression of PCBP4 protected the cells from iron toxicity. Thus, PCBP1 and -2 form a complex for iron delivery to ferritin, and all PCBPs may share iron chaperone activity.	[Leidgens, Sebastien; Bullough, Kimberly Z.; Shi, Haifeng; Li, Fengmin; Shakoury-Elizeh, Minoo; Yabe, Toshiki; Hsu, Emory; Natarajan, Navin; Nandal, Anjali; Philpott, Caroline C.] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Subramanian, Poorna; Stemmler, Timothy L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Hsu, Emory] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wayne State University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Philpott, CC (corresponding author), NIDDK, Genet & Metab Sect, Liver Dis Branch, NIH, Bldg 10,Rm 9B-16,10 Ctr Dr, Bethesda, MD 20892 USA.	carolinep@intra.niddk.nih.gov	Li, Fengmin/K-8740-2012; Nandal, Anjali/A-5376-2013; LI, feng/HIR-1703-2022; Yabe-Wada, Toshiki/D-2420-2013; Li, Fengmin/J-5721-2013	Li, Fengmin/0000-0002-2144-3498; Yabe-Wada, Toshiki/0000-0002-6208-0590; Stemmler, Timothy/0000-0002-6298-088X	Intramural Research Program of the NIDDK, National Institutes of Health; National Institutes of Health [DK068139]; Grants-in-Aid for Scientific Research [25870851] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054510, R01DK068139] Funding Source: NIH RePORTER	Intramural Research Program of the NIDDK, National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Program of the NIDDK, National Institutes of Health.; Supported by the National Institutes of Health Grant DK068139.	Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Bou-Abdallah F, 2002, BIOCHEMISTRY-US, V41, P11184, DOI 10.1021/bi020215g; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chkheidze AN, 1999, MOL CELL BIOL, V19, P4572; Choi HS, 2007, FASEB J, V21, P3963, DOI 10.1096/fj.07-8561com; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li YJ, 2012, CELL METAB, V15, P895, DOI 10.1016/j.cmet.2012.04.021; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Rang DH, 2012, GENE, V501, P33, DOI 10.1016/j.gene.2012.04.001; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Scoumanne A, 2011, NUCLEIC ACIDS RES, V39, P213, DOI 10.1093/nar/gkq778; Shakoury-Elizeh M, 2004, MOL BIOL CELL, V15, P1233, DOI 10.1091/mbc.E03-09-0642; SHERMAN F, 1991, P3; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Zhu JH, 2000, MOL CELL BIOL, V20, P5602, DOI 10.1128/MCB.20.15.5602-5618.2000	28	115	118	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17791	17802		10.1074/jbc.M113.460253	http://dx.doi.org/10.1074/jbc.M113.460253			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640898	Green Published, hybrid			2022-12-28	WOS:000320380600068
J	Kwon, HS; Johnson, TV; Tomarev, SI				Kwon, Heung Sun; Johnson, Thomas V.; Tomarev, Stanislav I.			Myocilin Stimulates Osteogenic Differentiation of Mesenchymal Stem Cells through Mitogen-activated Protein Kinase Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPEN-ANGLE GLAUCOMA; HUMAN TRABECULAR MESHWORK; OSTEOBLAST DIFFERENTIATION; OSTERIX EXPRESSION; GENE-EXPRESSION; TRANSGENIC MICE; MUTATED MOUSE; MAPK PATHWAY; BONE-MARROW; ER STRESS	Myocilin is a secreted glycoprotein that is expressed in ocular and non-ocular tissues. Mutations in the MYOCILIN gene may lead to juvenile-and adult-onset primary open-angle glaucoma. Here we report that myocilin is expressed in bone marrow-derived mesenchymal stem cells (MSCs) and plays a role in their differentiation into osteoblasts in vitro and in osteogenesis in vivo. Expression of myocilin was detected in MSCs derived from mouse, rat, and human bone marrow, with human MSCs exhibiting the highest level of myocilin expression. Expression of myocilin rose during the course of human MSC differentiation into osteoblasts but not into adipocytes, and treatment with exogenous myocilin further enhanced osteogenesis. MSCs derived from Myoc-null mice had a reduced ability to differentiate into the osteoblastic lineage, which was partially rescued by exogenous extracellular myocilin treatment. Myocilin also stimulated osteogenic differentiation of wild-type MSCs, which was associated with activation of the p38, Erk1/2, and JNK MAP kinase signaling pathways as well as up-regulated expression of the osteogenic transcription factors Runx2 and Dlx5. Finally, cortical bone thickness and trabecular volume, as well as the expression level of osteopontin, a known factor of bone remodeling and osteoblast differentiation, were reduced dramatically in the femurs of Myoc-null mice compared with wild-type mice. These data suggest that myocilin should be considered as a target for improving the bone regenerative potential of MSCs and may identify a new role for myocilin in bone formation and/or maintenance in vivo.	[Kwon, Heung Sun; Johnson, Thomas V.; Tomarev, Stanislav I.] NEI, SRGCB, LRCMB, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Tomarev, SI (corresponding author), NEI, SRGCB, LRCMB, NIH, Bldg 6,Room 212,6 Ctr Dr, Bethesda, MD 20892 USA.	tomarevs@nei.nih.gov	Johnson, Thomas V/C-9351-2011	Johnson, Thomas V/0000-0002-5372-5457	National Institutes of Health; National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, National Eye Institute.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bogoyevitch MA, 2008, BBA-PROTEINS PROTEOM, V1784, P76, DOI 10.1016/j.bbapap.2007.09.013; Borras T, 2009, EXP EYE RES, V88, P738, DOI 10.1016/j.exer.2008.11.027; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Celil AB, 2005, J BIOL CHEM, V280, P31353, DOI 10.1074/jbc.M503845200; Choi ST, 2008, RHEUMATOLOGY, V47, P1775, DOI 10.1093/rheumatology/ken385; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Delany AM, 2009, J CELL COMMUN SIGNAL, V3, P227, DOI 10.1007/s12079-009-0076-0; English K, 2010, CELL STEM CELL, V7, P431, DOI 10.1016/j.stem.2010.09.009; Fingert JH, 2002, SURV OPHTHALMOL, V47, P547, DOI 10.1016/S0039-6257(02)00353-3; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Gonzalez P, 2000, INVEST OPHTH VIS SCI, V41, P3678; Gordeladze JO, 2008, EXP CELL RES, V314, P1495, DOI 10.1016/j.yexcr.2007.12.023; Gould DB, 2006, MOL CELL BIOL, V26, P8427, DOI 10.1128/MCB.01127-06; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Griffin M, 2011, J BONE JOINT SURG BR, V93B, P427, DOI 10.1302/0301-620X.93B4.25249; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Joe MK, 2012, J BIOL CHEM, V287, P13216, DOI 10.1074/jbc.M111.224063; Joe MK, 2010, AM J PATHOL, V176, P2880, DOI 10.2353/ajpath.2010.090853; Johnson TV, 2010, INVEST OPHTH VIS SCI, V51, P2051, DOI 10.1167/iovs.09-4509; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee MH, 2003, BIOCHEM BIOPH RES CO, V309, P689, DOI 10.1016/j.bbrc.2003.08.058; Lemonnier J, 2004, J BIOL CHEM, V279, P259, DOI 10.1074/jbc.M308665200; Lin GL, 2011, J CELL BIOCHEM, V112, P3491, DOI 10.1002/jcb.23287; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Malyukova I, 2006, INVEST OPHTH VIS SCI, V47, P206, DOI 10.1167/iovs.05-0220; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; O'Brien ET, 2000, INVEST OPHTH VIS SCI, V41, P3842; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Peters DM, 2005, EXP CELL RES, V303, P218, DOI 10.1016/j.yexcr.2004.09.026; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Senatorov V, 2006, J NEUROSCI, V26, P11903, DOI 10.1523/JNEUROSCI.3020-06.2006; Shepard AR, 2001, INVEST OPHTH VIS SCI, V42, P3173; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Stebbins JL, 2008, P NATL ACAD SCI USA, V105, P16809, DOI 10.1073/pnas.0805677105; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385; Tomarev SI, 2003, INVEST OPHTH VIS SCI, V44, P2588, DOI 10.1167/iovs.02-1099; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V245, P887, DOI 10.1006/bbrc.1998.8541; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Yi CQ, 2010, ACS NANO, V4, P6439, DOI 10.1021/nn101373r; Zhou Y, 2008, INVEST OPHTH VIS SCI, V49, P1932, DOI 10.1167/iovs.07-1339; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	57	28	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16882	16894		10.1074/jbc.M112.422972	http://dx.doi.org/10.1074/jbc.M112.422972			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23629661	Green Published, hybrid			2022-12-28	WOS:000320378900061
J	Humphreys, JM; Piala, AT; Akella, R; He, HX; Goldsmith, EJ				Humphreys, John M.; Piala, Alexander T.; Akella, Radha; He, Haixia; Goldsmith, Elizabeth J.			Precisely Ordered Phosphorylation Reactions in the p38 Mitogen-activated Protein (MAP) Kinase Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE-2; DUAL PHOSPHORYLATION; TRANSCRIPTION FACTOR; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; SPECIFICITY; P38-ALPHA; SWITCH; JNK; IDENTIFICATION	The MAP kinase cascades, composed of a MAP3K, a MAP2K, and a MAPK, control switch responses to extracellular stimuli and stress in eukaryotes. The most important feature of these modules is thought to be the two double phosphorylation reactions catalyzed by MAP3Ks and MAP2Ks. We addressed whether the reactions are sequential or random in the p38 MAP kinase module. Mass spectrometry was used to track the phosphorylation of the MAP2K MEK6 by two MAP3Ks, TAO2 and ASK1, and the subsequent phosphorylation of p38 alpha by MEK6/S*T* (where S (Ser) and T (Thr) are the two phosphorylation sites and * denotes phosphorylation). Both double phosphorylation reactions are precisely ordered. MEK6 is phosphorylated first on Thr-211 and then on Ser-207 by both MAP3Ks. This is the first demonstration of a precise reaction order for a MAP2K. p38 alpha is phosphorylated first on Tyr-182 and then on Thr-180, the same reaction order observed previously in ERK2. Thus, intermediates were MEK6/ST* and p38 alpha/TY*. Similarly, the phosphorylation of the p38 alpha transcription factor substrate ATF2 occurs in a precise sequence. Progress curves for the appearance of intermediates were fit to kinetic models. The models confirmed the reaction order, revealed processivity in the phosphorylation of MEK6 by ASK1, and suggested that the order of phosphorylation is dictated by both binding and catalysis rates.	[Humphreys, John M.; Piala, Alexander T.; Akella, Radha; He, Haixia; Goldsmith, Elizabeth J.] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Goldsmith, EJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biophys, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Elizabeth.Goldsmith@UTSouthwestern.edu			National Institutes of Health [DK46993]; Welch Foundation [I1128]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46993 (to E. J. G.). This work was also supported by Welch Foundation Grant I1128.	AHN NG, 1991, J BIOL CHEM, V266, P4220; Akella R, 2010, STRUCTURE, V18, P1571, DOI 10.1016/j.str.2010.09.015; ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Aokia K, 2011, P NATL ACAD SCI USA, V108, P12675, DOI 10.1073/pnas.1104030108; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Baan B, 2009, MOL CELL ENDOCRINOL, V311, P94, DOI 10.1016/j.mce.2009.07.023; Bagowski CP, 2003, CURR BIOL, V13, P315, DOI 10.1016/S0960-9822(03)00083-6; Bell M, 2003, J BIOL CHEM, V278, P14603, DOI 10.1074/jbc.C300006200; Bukhtiyarova M, 2004, PROTEIN EXPRES PURIF, V37, P154, DOI 10.1016/j.pep.2004.05.017; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Cheng M, 1996, J BIOL CHEM, V271, P12057, DOI 10.1074/jbc.271.20.12057; Choi MY, 2008, MOL CELLS, V26, P200; Cirit M, 2010, J BIOL CHEM, V285, P36736, DOI 10.1074/jbc.M110.148759; Deininger SO, 2011, ANAL BIOANAL CHEM, V401, P167, DOI 10.1007/s00216-011-4929-z; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Ferrell JE, 1997, J BIOL CHEM, V272, P19008, DOI 10.1074/jbc.272.30.19008; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Furdui CM, 2006, MOL CELL, V21, P711, DOI 10.1016/j.molcel.2006.01.022; Goldsmith EJ, 2010, METHODS MOL BIOL, V661, P223, DOI 10.1007/978-1-60761-795-2_13; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAYSTEAD TAJ, 1992, FEBS LETT, V306, P17, DOI 10.1016/0014-5793(92)80828-5; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuzmic P, 2009, ANAL BIOCHEM, V394, P287, DOI 10.1016/j.ab.2009.06.040; Kuzmic P, 2009, METHOD ENZYMOL, V467, P247, DOI 10.1016/S0076-6879(09)67010-5; Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000; Lawrence MC, 2008, CELL RES, V18, P436, DOI 10.1038/cr.2008.37; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Malleshaiah MK, 2010, NATURE, V465, P101, DOI 10.1038/nature08946; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Min XS, 2009, STRUCTURE, V17, P96, DOI 10.1016/j.str.2008.11.007; O'Shaughnessy EC, 2011, CELL, V144, P119, DOI 10.1016/j.cell.2010.12.014; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; ROBBINS DJ, 1993, J AM SOC NEPHROL, V4, P1104; Salazar C, 2007, FEBS J, V274, P1046, DOI 10.1111/j.1742-4658.2007.05653.x; Van Slyke DD, 1914, J BIOL CHEM, V19, P141; Waas WF, 2001, J BIOL CHEM, V276, P5676, DOI 10.1074/jbc.M008787200; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Whitehurst A, 2004, MOL CELL BIOL, V24, P10145, DOI 10.1128/MCB.24.23.10145-10150.2004; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhao Y, 2001, J BIOL CHEM, V276, P32382, DOI 10.1074/jbc.M103369200; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zhou TJ, 2004, STRUCTURE, V12, P1891, DOI 10.1016/j.str.2004.07.021	56	23	23	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 9	2013	288	32					23322	23330		10.1074/jbc.M113.462101	http://dx.doi.org/10.1074/jbc.M113.462101			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302IN	23744074	hybrid, Green Published			2022-12-28	WOS:000330598200037
J	Kurasawa, JH; Shestopal, SA; Karnaukhova, E; Struble, EB; Lee, TK; Sarafanov, AG				Kurasawa, James H.; Shestopal, Svetlana A.; Karnaukhova, Elena; Struble, Evi B.; Lee, Timothy K.; Sarafanov, Andrey G.			Mapping the Binding Region on the Low Density Lipoprotein Receptor for Blood Coagulation Factor VIII	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood Coagulation Factors; Factor VIII; Lipoprotein Receptor; Receptor Structure-Function; Recombinant Protein Expression; Hemophilia A	CONSERVED ACIDIC RESIDUE; CORONARY-ARTERY-DISEASE; NMR SOLUTION STRUCTURE; CYSTEINE-RICH REPEATS; VON-WILLEBRAND-FACTOR; LIGAND-BINDING; LDL RECEPTOR; ALPHA-2-MACROGLOBULIN RECEPTOR; FACTOR IXA; STRUCTURAL REQUIREMENTS	Low density lipoprotein receptor (LDLR) was shown to mediate clearance of blood coagulation factor VIII (FVIII) from the circulation. To elucidate the mechanism of interaction of LDLR and FVIII, our objective was to identify the region of the receptor necessary for binding FVIII. Using surface plasmon resonance, we found that LDLR exodomain and its cluster of complement-type repeats (CRs) bind FVIII in the same mode. This indicated that the LDLR site for FVIII is located within the LDLR cluster. Similar results were obtained for another ligand of LDLR, -2-macroglobulin receptor-associated protein (RAP), a common ligand of receptors from the LDLR family. We further generated a set of recombinant fragments of the LDLR cluster and assessed their structural integrity by binding to RAP and by circular dichroism. A number of fragments overlapping CR.2-5 of the cluster were positive for binding RAP and FVIII. The specificity of these interactions was tested by site-directed mutagenesis of conserved tryptophans within the LDLR fragments. For FVIII, the specificity was also tested using a single-chain variable antibody fragment directed against the FVIII light chain as a competitor. Both cases resulted in decreased binding, thus confirming its specificity. The mutagenic study also showed an importance of the conserved tryptophans in LDLR for both ligands, and the competitive binding results showed an involvement of the light chain of FVIII in its interaction with LDLR. In conclusion, the region of CR.2-5 of LDLR was defined as the binding site for FVIII and RAP.	[Kurasawa, James H.; Shestopal, Svetlana A.; Karnaukhova, Elena; Struble, Evi B.; Lee, Timothy K.; Sarafanov, Andrey G.] US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA	US Food & Drug Administration (FDA)	Sarafanov, AG (corresponding author), US FDA, Div Hematol, Off Blood Res & Review, Ctr Biol Evaluat & Res, 1401 Rockville Pike HFM-340, Rockville, MD 20852 USA.	andrey.sarafanov@fda.hhs.gov		Shestopal, Svetlana/0000-0003-0725-5885; Sarafanov, Andrey/0000-0001-6124-9713	Center for Biologics Evaluation and Research (CBER) of the United States Food and Drug Administration (FDA); Research Participation Program at the CBER	Center for Biologics Evaluation and Research (CBER) of the United States Food and Drug Administration (FDA); Research Participation Program at the CBER	This work was supported by funds from the Center for Biologics Evaluation and Research (CBER) of the United States Food and Drug Administration (FDA) and also by the Research Participation Program at the CBER administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the United States Department of Energy and the United States Food and Drug Administration. This work was initially presented at the 54th American Society of Hematology Annual Meeting, December 8-11,2012, in Atlanta, GA.	Ananyeva NM, 2008, BLOOD COAGUL FIBRIN, V19, P543, DOI 10.1097/MBC.0b013e3283068859; Ananyeva NM, 2008, BLOOD COAGUL FIBRIN, V19, P166, DOI 10.1097/MBC.0b013e3282f5457b; Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Andersen OM, 2001, BIOCHEM J, V357, P289, DOI 10.1042/0264-6021:3570289; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; BATTEY FD, 1994, J BIOL CHEM, V269, P23268; Beglova N, 2001, BIOCHEMISTRY-US, V40, P2808, DOI 10.1021/bi0027276; Bieri S, 1998, BIOCHEMISTRY-US, V37, P10994, DOI 10.1021/bi980452c; Bovenschen N, 2006, J THROMB HAEMOST, V4, P1487, DOI 10.1111/j.1538-7836.2006.01965.x; Bovenschen N, 2005, BLOOD, V106, P906, DOI 10.1182/blood-2004-11-4230; Bovenschen N, 2004, BRIT J HAEMATOL, V126, P722, DOI 10.1111/j.1365-2141.2004.05093.x; Bovenschen N, 2003, J BIOL CHEM, V278, P9370, DOI 10.1074/jbc.M212053200; Bovenschen N, 2003, BLOOD, V101, P3933, DOI 10.1182/blood-2002-07-2081; Butenas S, 2009, HAEMOPHILIA, V15, P63, DOI 10.1111/j.1365-2516.2008.01826.x; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; Christiansen MLS, 2010, HAEMOPHILIA, V16, P878, DOI 10.1111/j.1365-2516.2010.02333.x; Croy JE, 2004, BIOCHEMISTRY-US, V43, P7328, DOI 10.1021/bi036208p; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; Dolmer K, 2000, J BIOL CHEM, V275, P3264, DOI 10.1074/jbc.275.5.3264; Dolmer K, 2006, J BIOL CHEM, V281, P34189, DOI 10.1074/jbc.M604389200; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fay PJ, 2006, INT J HEMATOL, V83, P103, DOI 10.1532/IJH97.05113; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Guo Y, 2004, J BIOL CHEM, V279, P16629, DOI 10.1074/jbc.M400157200; Guttman M, 2011, BIOCHEMISTRY-US, V50, P11001, DOI 10.1021/bi2014486; Huang W, 1999, J BIOL CHEM, V274, P14130, DOI 10.1074/jbc.274.20.14130; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; Kurasawa JH, 2013, PROTEIN EXPRES PURIF, V88, P201, DOI 10.1016/j.pep.2012.12.008; Lazic A, 2003, BIOCHEMISTRY-US, V42, P14913, DOI 10.1021/bi035779e; Lenting PJ, 1999, J BIOL CHEM, V274, P23734, DOI 10.1074/jbc.274.34.23734; LENTING PJ, 1994, J BIOL CHEM, V269, P7150; Lin Y, 2004, HAEMOPHILIA, V10, P459, DOI 10.1111/j.1365-2516.2004.00957.x; Martinelli N, 2010, BLOOD, V116, P5688, DOI 10.1182/blood-2010-03-277079; MEDH JD, 1995, J BIOL CHEM, V270, P536, DOI 10.1074/jbc.270.2.536; Meems H, 2011, INT J BIOCHEM CELL B, V43, P1114, DOI 10.1016/j.biocel.2011.03.014; Meems H, 2009, BLOOD, V114, P3938, DOI 10.1182/blood-2009-01-197707; Meijer A., 2007, J THROMB HAEMOST S2, V5; Meijer A., 2005, J THROMB HAEMOST S1, V3, pOR162; Meijer AB, 2007, BBA-PROTEINS PROTEOM, V1774, P714, DOI 10.1016/j.bbapap.2007.04.003; Mello TBT, 2008, THROMB RES, V121, P625, DOI 10.1016/j.thromres.2007.08.002; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; Ofosu FA, 2012, HAEMOPHILIA, V18, P917, DOI 10.1111/j.1365-2516.2012.02861.x; Orlando RA, 1997, P NATL ACAD SCI USA, V94, P2368, DOI 10.1073/pnas.94.6.2368; Pahl S, 2013, HAEMOPHILIA, V19, P392, DOI 10.1111/hae.12076; Pocathikorn A, 2003, ATHEROSCLEROSIS, V168, P115, DOI 10.1016/S0021-9150(03)00087-X; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Saenko EL, 1999, J BIOL CHEM, V274, P37685, DOI 10.1074/jbc.274.53.37685; Saenko EL, 1996, J BIOL CHEM, V271, P27424, DOI 10.1074/jbc.271.44.27424; Sarafanov A, 2004, ANAL BIOCHEM, V328, P98, DOI 10.1016/j.ab.2003.11.028; Sarafanov AG, 2001, J BIOL CHEM, V276, P11970, DOI 10.1074/jbc.M008046200; Sarafanov AG, 2007, THROMB HAEMOSTASIS, V98, P1170, DOI 10.1160/TH07-05-0353; Sato A, 1999, BIOCHEM J, V341, P377, DOI 10.1042/0264-6021:3410377; Simonovic M, 2001, BIOCHEMISTRY-US, V40, P15127, DOI 10.1021/bi015688m; Strickland DK, 2003, J THROMB HAEMOST, V1, P1663, DOI 10.1046/j.1538-7836.2003.00330.x; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; van den Biggelaar M, 2011, J THROMB HAEMOST, V9, P821; van den Brink EN, 2001, BLOOD, V97, P966, DOI 10.1182/blood.V97.4.966; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; Vormittag R, 2007, J THROMB HAEMOST, V5, P497, DOI 10.1111/j.1538-7836.2007.02337.x; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105	69	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							22033	10.1074/jbc.M113.468108	http://dx.doi.org/10.1074/jbc.M113.468108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23754288	Green Published, hybrid			2022-12-28	WOS:000328841900049
J	Maszczak-Seneczko, D; Sosicka, P; Olczak, T; Jakimowicz, P; Majkowski, M; Olczak, M				Maszczak-Seneczko, Dorota; Sosicka, Paulina; Olczak, Teresa; Jakimowicz, Piotr; Majkowski, Michal; Olczak, Mariusz			UDP-N-acetylglucosamine Transporter (SLC35A3) Regulates Biosynthesis of Highly Branched N-Glycans and Keratan Sulfate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycosylation; Glycosyltransferases; Golgi; Keratan; Proteoglycan; UDP-N-Acetylglucosamine Transporter; Branched N-Glycans	NUCLEOTIDE-SUGAR TRANSPORTER; GDP-MANNOSE TRANSPORTER; GALACTOSE TRANSPORTER; MOLECULAR-CLONING; GOLGI MEMBRANE; SIALIC-ACID; ACETYLGALACTOSAMINE TRANSPORTER; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; GAL TRANSPORTER	SLC35A3 is considered the main UDP-N-acetylglucosamine transporter (NGT) in mammals. Detailed analysis of NGT is restricted because mammalian mutant cells defective in this activity have not been isolated. Therefore, using the siRNA approach, we developed and characterized several NGT-deficient mammalian cell lines. CHO, CHO-Lec8, and HeLa cells deficient in NGT activity displayed a decrease in the amount of highly branched tri- and tetraantennary N-glycans, whereas monoantennary and diantennary ones remained unchanged or even were accumulated. Silencing the expression of NGT in Madin-Darby canine kidney II cells resulted in a dramatic decrease in the keratan sulfate content, whereas no changes in biosynthesis of heparan sulfate were observed. We also demonstrated for the first time close proximity between NGT and mannosyl (-1,6-)-glycoprotein -1,6-N-acetylglucosaminyltransferase (Mgat5) in the Golgi membrane. We conclude that NGT may be important for the biosynthesis of highly branched, multiantennary complex N-glycans and keratan sulfate. We hypothesize that NGT may specifically supply -1,3-N-acetylglucosaminyl-transferase 7 (3GnT7), Mgat5, and possibly mannosyl (-1,3-)-glycoprotein -1,4-N-acetylglucosaminyltransferase (Mgat4) with UDP-GlcNAc.	[Maszczak-Seneczko, Dorota; Sosicka, Paulina; Olczak, Teresa; Olczak, Mariusz] Univ Wroclaw, Lab Biochem, Fac Biotechnol, PL-50137 Wroclaw, Poland; [Jakimowicz, Piotr] Univ Wroclaw, Lab Biotechnol, Fac Biotechnol, PL-50137 Wroclaw, Poland; [Majkowski, Michal] Univ Wroclaw, Lab Cytobiochem, Fac Biotechnol, PL-51148 Wroclaw, Poland	University of Wroclaw; University of Wroclaw; University of Wroclaw	Olczak, M (corresponding author), Univ Wroclaw, Lab Biochem, Fac Biotechnol, 2 Tamka St, PL-50137 Wroclaw, Poland.	Mariusz.Olczak@biotech.uni.wroc.pl			National Science Center (NCN), Krakow, Poland [2011/03/B/NZ1/02084]	National Science Center (NCN), Krakow, Poland	This work was supported by Grant 2011/03/B/NZ1/02084 from the National Science Center (NCN), Krakow, Poland.	BRANDLI AW, 1988, J BIOL CHEM, V263, P16283; BRILES EB, 1977, J BIOL CHEM, V252, P1107; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; COATES SW, 1980, J BIOL CHEM, V255, P9225; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; Gao XD, 2000, J BIOL CHEM, V275, P17718, DOI 10.1074/jbc.M909946199; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Guillen E, 1998, P NATL ACAD SCI USA, V95, P7888, DOI 10.1073/pnas.95.14.7888; HARA T, 1989, J BIOCHEM-TOKYO, V106, P236, DOI 10.1093/oxfordjournals.jbchem.a122838; Hong KJ, 2000, BIOCHEMISTRY-US, V39, P2013, DOI 10.1021/bi992363l; Ishida N, 1996, J BIOCHEM, V120, P1074; Ishida N, 1999, J BIOCHEM, V126, P1107, DOI 10.1093/oxfordjournals.jbchem.a022556; Ishida N, 2005, GENOMICS, V85, P106, DOI 10.1016/j.ygeno.2004.09.010; Ishida N, 1999, J BIOCHEM, V126, P68, DOI 10.1093/oxfordjournals.jbchem.a022437; Kitayama K, 2007, J BIOL CHEM, V282, P30085, DOI 10.1074/jbc.M703695200; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Liu L, 2010, SEMIN CELL DEV BIOL, V21, P600, DOI 10.1016/j.semcdb.2010.02.002; Martinez-Duncker I, 2003, BIOCHIMIE, V85, P245, DOI 10.1016/S0300-9084(03)00046-4; Maszczak-Seneczko D, 2012, FEBS LETT, V586, P4082, DOI 10.1016/j.febslet.2012.10.016; Maszczak-Seneczko D, 2011, ACTA BIOCHIM POL, V58, P413; Maszczak-Seneczko D, 2011, GLYCOCONJUGATE J, V28, P481, DOI 10.1007/s10719-011-9348-z; Maszczak-Seneczko D, 2011, FEBS LETT, V585, P3090, DOI 10.1016/j.febslet.2011.08.038; Miera N, 1996, J BIOCHEM-TOKYO, V120, P236; Munster AK, 1998, P NATL ACAD SCI USA, V95, P9140, DOI 10.1073/pnas.95.16.9140; Muraoka M, 2001, FEBS LETT, V495, P87, DOI 10.1016/S0014-5793(01)02358-4; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Olczak M, 2006, BBA-MOL CELL RES, V1763, P82, DOI 10.1016/j.bbamcr.2005.12.006; Olczak M, 2002, BIOCHEM BIOPH RES CO, V293, P213, DOI 10.1016/S0006-291X(02)00201-2; Olczak M, 2013, BIOCHEM BIOPH RES CO, V434, P473, DOI 10.1016/j.bbrc.2013.03.098; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; Puglielli L, 1999, J BIOL CHEM, V274, P4474, DOI 10.1074/jbc.274.7.4474; Sprong H, 2003, MOL BIOL CELL, V14, DOI 10.1091/mbc.E03-03-0130; STANLEY P, 1983, SOMAT CELL GENET, V9, P593, DOI 10.1007/BF01574260; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Toma L, 1996, J BIOL CHEM, V271, P3897; Yoshioka S, 1997, J BIOCHEM, V122, P691	38	38	38	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21850	10.1074/jbc.M113.460543	http://dx.doi.org/10.1074/jbc.M113.460543			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23766508	Green Published, hybrid			2022-12-28	WOS:000328841900034
J	Owens, CP; Chim, N; Graves, AB; Harmston, CA; Iniguez, A; Contreras, H; Liptak, MD; Goulding, CW				Owens, Cedric P.; Chim, Nicholas; Graves, Amanda B.; Harmston, Christine A.; Iniguez, Angelina; Contreras, Heidi; Liptak, Matthew D.; Goulding, Celia W.			The Mycobacterium tuberculosis Secreted Protein Rv0203 Transfers Heme to Membrane Proteins MmpL3 and MmpL11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heme; Iron; Kinetics; Mycobacterium tuberculosis; Protein Domains; Transport; Heme Uptake Pathway; Iron Acquisition	MAGNETIC CIRCULAR-DICHROISM; METAL EFFLUX COMPLEX; STAPHYLOCOCCUS-AUREUS; BINDING PROTEIN; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; SULFOLIPID-1 BIOSYNTHESIS; SECONDARY STRUCTURE; ACQUISITION-SYSTEM; CELL-WALL	Mycobacterium tuberculosis is the causative agent of tuberculosis, which is becoming an increasingly global public health problem due to the rise of drug-resistant strains. While residing in the human host, M. tuberculosis needs to acquire iron for its survival. M. tuberculosis has two iron uptake mechanisms, one that utilizes non-heme iron and another that taps into the vast host heme-iron pool. To date, proteins known to be involved in mycobacterial heme uptake are Rv0203, MmpL3, and MmpL11. Whereas Rv0203 transports heme across the bacterial periplasm or scavenges heme from host heme proteins, MmpL3 and MmpL11 are thought to transport heme across the membrane. In this work, we characterize the heme-binding properties of the predicted extracellular soluble E1 domains of both MmpL3 and MmpL11 utilizing absorption, electron paramagnetic resonance, and magnetic circular dichroism spectroscopic methods. Furthermore, we demonstrate that Rv0203 transfers heme to both MmpL3-E1 and MmpL11-E1 domains at a rate faster than passive heme dissociation from Rv0203. This work elucidates a key step in the mycobacterial uptake of heme, and it may be useful in the development of anti-tuberculosis drugs targeting this pathway.	[Owens, Cedric P.; Chim, Nicholas; Harmston, Christine A.; Iniguez, Angelina; Contreras, Heidi; Goulding, Celia W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Goulding, Celia W.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Graves, Amanda B.; Liptak, Matthew D.] Univ Vermont, Dept Chem, Burlington, VT 05405 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Vermont	Goulding, CW (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	celia.goulding@uci.edu	Liptak, Matthew/AAJ-2533-2021	Liptak, Matthew/0000-0002-4951-6636; Owens, Cedric/0000-0002-8102-8181	National Institutes of Health [AI081161, GM101945]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081161] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM101945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI081161 (to C. W. G.) and GM101945 (to H. C.).	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Aranda R, 2007, J MOL BIOL, V374, P374, DOI 10.1016/j.jmb.2007.08.058; Bartsch R. G., 1971, METHODS ENZYMOL, V23, P344, DOI [10.1016/S0076-6879(71)23110-4, DOI 10.1016/S0076-6879(71)23110-4]; BARTSCH RG, 1971, J BIOL CHEM, V246, P4489; Bhakta MN, 2006, BIOCHEMISTRY-US, V45, P11642, DOI 10.1021/bi060980l; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Block DR, 2007, BIOCHEMISTRY-US, V46, P14391, DOI 10.1021/bi701509n; Cescau S, 2007, BIOMETALS, V20, P603, DOI 10.1007/s10534-006-9050-y; Chan ACK, 2006, J MOL BIOL, V362, P1108, DOI 10.1016/j.jmb.2006.08.001; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Chim N, 2010, J MOL BIOL, V395, P595, DOI 10.1016/j.jmb.2009.11.025; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Converse SE, 2005, J BACTERIOL, V187, P1238, DOI 10.1128/JB.187.4.1238-1245.2005; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Critchton R. R., 2009, IRON METABOLISM MOL, P170; Dawson R. M. C., 1986, DATA BIOCH RES, P230; Desuzinges-Mandon E, 2010, J BIOL CHEM, V285, P33123, DOI 10.1074/jbc.M110.139170; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Du J, 2011, COORDIN CHEM REV, V255, P700, DOI 10.1016/j.ccr.2011.01.029; Ekworomadu MT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002559; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2010, J BIOL CHEM, V285, P34579, DOI 10.1074/jbc.M110.172924; Grigg JC, 2010, J INORG BIOCHEM, V104, P341, DOI 10.1016/j.jinorgbio.2009.09.012; Grzegorzewicz AE, 2012, NAT CHEM BIOL, V8, P334, DOI [10.1038/NCHEMBIO.794, 10.1038/nchembio.794]; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11310, DOI 10.1021/bi9603736; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Hawkins BK, 1996, BBA-PROTEIN STRUCT M, V1295, P165, DOI 10.1016/0167-4838(96)00031-3; Hopkinson BM, 2008, APPL ENVIRON MICROB, V74, P6263, DOI 10.1128/AEM.00964-08; Izadi N, 1997, BIOCHEMISTRY-US, V36, P7050, DOI 10.1021/bi962577s; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Jones CM, 2011, J BACTERIOL, V193, P1767, DOI 10.1128/JB.01312-10; KAWAMURAKONISHI Y, 1988, EUR J BIOCHEM, V170, P589, DOI 10.1111/j.1432-1033.1988.tb13738.x; Kim EH, 2011, J BACTERIOL, V193, P2381, DOI 10.1128/JB.01323-10; La Rosa V, 2012, ANTIMICROB AGENTS CH, V56, P324, DOI 10.1128/AAC.05270-11; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Lei BF, 2003, INFECT IMMUN, V71, P5962, DOI 10.1128/IAI.71.10.5962-5969.2003; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; Long F, 2012, PHILOS T R SOC B, V367, P1047, DOI 10.1098/rstb.2011.0203; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Masuda T, 1999, J BIOL CHEM, V274, P33594, DOI 10.1074/jbc.274.47.33594; Mattle D, 2010, J MOL BIOL, V404, P220, DOI 10.1016/j.jmb.2010.09.005; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Moller JKS, 2007, MEAT SCI, V75, P203, DOI 10.1016/j.meatsci.2006.07.005; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Nikaido Hiroshi, 2011, Adv Enzymol Relat Areas Mol Biol, V77, P1; Nygaard TK, 2006, J BIOL CHEM, V281, P20761, DOI 10.1074/jbc.M601832200; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Perera R, 2011, ARCH BIOCHEM BIOPHYS, V507, P119, DOI 10.1016/j.abb.2010.12.010; Pond AE, 1999, BIOCHEMISTRY-US, V38, P7601, DOI 10.1021/bi9825448; Scherman MS, 2012, BIOORGAN MED CHEM, V20, P3255, DOI 10.1016/j.bmc.2012.03.058; Seeliger JC, 2012, J BIOL CHEM, V287, P7990, DOI 10.1074/jbc.M111.315473; Sennhauser G, 2009, J MOL BIOL, V389, P134, DOI 10.1016/j.jmb.2009.04.001; Singleton C, 2010, J BIOL CHEM, V285, P16023, DOI 10.1074/jbc.M109.067215; Su CC, 2011, NATURE, V470, P558, DOI 10.1038/nature09743; Tahlan K, 2012, ANTIMICROB AGENTS CH, V56, P1797, DOI 10.1128/AAC.05708-11; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; Tullius MV, 2011, P NATL ACAD SCI USA, V108, P5051, DOI 10.1073/pnas.1009516108; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; VICKERY L, 1976, J AM CHEM SOC, V98, P343, DOI 10.1021/ja00418a005; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; White GF, 2011, FEBS J, V278, P2011, DOI 10.1111/j.1742-4658.2011.08117.x; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	76	66	70	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21714	21728		10.1074/jbc.M113.453076	http://dx.doi.org/10.1074/jbc.M113.453076			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760277	Green Published, hybrid			2022-12-28	WOS:000328841900023
J	Chen, PC; Olson, EM; Zhou, Q; Kryukova, Y; Sampson, HM; Thomas, DY; Shyng, SL				Chen, Pei-Chun; Olson, Erik M.; Zhou, Qing; Kryukova, Yelena; Sampson, Heidi M.; Thomas, David Y.; Shyng, Show-Ling			Carbamazepine as a Novel Small Molecule Corrector of Trafficking-impaired ATP-sensitive Potassium Channels Identified in Congenital Hyperinsulinism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFONYLUREA RECEPTOR; CYSTIC-FIBROSIS; INSULIN-SECRETION; F508DEL-CFTR TRAFFICKING; INTRACELLULAR-TRANSPORT; DEFECTIVE TRAFFICKING; QUALITY-CONTROL; HUMAN-DISEASES; PROTEIN; AUTOPHAGY	ATP-sensitive potassium (K-ATP) channels consisting of sulfonylurea receptor 1 (SUR1) and the potassium channel Kir6.2 play a key role in insulin secretion by coupling metabolic signals to beta-cell membrane potential. Mutations in SUR1 and Kir6.2 that impair channel trafficking to the cell surface lead to loss of channel function and congenital hyperinsulinism. We report that carbamazepine, an anticonvulsant, corrects the trafficking defects of mutant K-ATP channels previously identified in congenital hyperinsulinism. Strikingly, of the 19 SUR1 mutations examined, only those located in the first transmembrane domain of SUR1 responded to the drug. We show that unlike that reported for several other protein misfolding diseases, carbamazepine did not correct K-ATP channel trafficking defects by activating autophagy; rather, it directly improved the biogenesis efficiency of mutant channels along the secretory pathway. In addition to its effect on channel trafficking, carbamazepine also inhibited K-ATP channel activity. Upon subsequent removal of carbamazepine, however, the function of rescued channels was recovered. Importantly, combination of the K-ATP channel opener diazoxide and carbamazepine led to enhanced mutant channel function without carbamazepine washout. The corrector effect of carbamazepine on mutant K-ATP channels was also demonstrated in rat and human beta-cells with an accompanying increase in channel activity. Our findings identify carbamazepine as a novel small molecule corrector that may be used to restore K-ATP channel expression and function in a subset of congenital hyperinsulinism patients.	[Chen, Pei-Chun; Olson, Erik M.; Zhou, Qing; Kryukova, Yelena; Shyng, Show-Ling] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Sampson, Heidi M.; Thomas, David Y.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	Oregon Health & Science University; McGill University	Shyng, SL (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	shyngs@ohsu.edu	Thomas, David/M-7661-2017	Thomas, David/0000-0002-8854-762X; Chen, Pei-Chun/0000-0002-2550-6556	National Institutes of Health [T32 DK007680, DK57699]; March of Dimes Foundation [1-2001-707]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066485, R01DK057699, T32DK007680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 DK007680 (to Richard H. Goodman; in support of P.-C. C.) and DK57699 (to S.-L. S.). This work was also supported by March of Dimes Foundation Research Grant 1-2001-707 (to S.-L. S.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Ambrosio AF, 2002, NEUROCHEM RES, V27, P121, DOI 10.1023/A:1014814924965; Ambrosio AF, 1999, NEUROPHARMACOLOGY, V38, P1349, DOI 10.1016/S0028-3908(99)00058-1; ANDERSON MP, 1992, SCIENCE, V257, P1701, DOI 10.1126/science.1382316; Aridor M, 2002, TRAFFIC, V3, P781, DOI 10.1034/j.1600-0854.2002.31103.x; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Carlile GW, 2007, CHEMBIOCHEM, V8, P1012, DOI 10.1002/cbic.200700027; Cartier EA, 2001, P NATL ACAD SCI USA, V98, P2882, DOI 10.1073/pnas.051499698; Chan KW, 2003, EMBO J, V22, P3833, DOI 10.1093/emboj/cdg376; Chen PC, 2011, AM J PHYSIOL-CELL PH, V300, pC506, DOI 10.1152/ajpcell.00429.2010; Chen Y, 2005, HUM MOL GENET, V14, P2559, DOI 10.1093/hmg/ddi259; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Conti LR, 2001, J BIOL CHEM, V276, P41270, DOI 10.1074/jbc.M106555200; Crane A, 2004, J BIOL CHEM, V279, P9080, DOI 10.1074/jbc.M311079200; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Glaser B, 1998, J PEDIATR-US, V133, P801, DOI 10.1016/S0022-3476(98)70160-X; Gloyn AL, 2006, HUM MUTAT, V27, P220, DOI 10.1002/humu.20292; GRANGER P, 1995, MOL PHARMACOL, V47, P1189; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Higgins CF, 2001, SCIENCE, V293, P1782, DOI 10.1126/science.1065588; Hohmeier HE, 1997, DIABETES, V46, P968, DOI 10.2337/diabetes.46.6.968; Huopio H, 2002, AM J PHYSIOL-ENDOC M, V283, pE207, DOI 10.1152/ajpendo.00047.2002; Kapturczak M, 2002, MOL THER, V5, P154, DOI 10.1006/mthe.2002.0522; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Luna B, 2001, AM FAM PHYSICIAN, V63, P1747; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; MacMullen CM, 2011, DIABETES, V60, P1797, DOI 10.2337/db10-1631; Mousavi SA, 2003, BIOCHEM J, V372, P861, DOI 10.1042/BJ20021136; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Otonkoski T, 1999, DIABETES, V48, P408, DOI 10.2337/diabetes.48.2.408; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Qu BH, 1997, J BIOENERG BIOMEMBR, V29, P483, DOI 10.1023/A:1022439108101; Raab-Graham KF, 1999, J BIOL CHEM, V274, P29122, DOI 10.1074/jbc.274.41.29122; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Renna M, 2010, J BIOL CHEM, V285, P11061, DOI 10.1074/jbc.R109.072181; Ringe Dagmar, 2009, J Biol, V8, P80, DOI 10.1186/jbiol186; Robert R, 2008, MOL PHARMACOL, V73, P478, DOI 10.1124/mol.107.040725; Robert R, 2010, MOL PHARMACOL, V77, P922, DOI 10.1124/mol.109.062679; Sampson HM, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-11; Sampson HM, 2011, CHEM BIOL, V18, P231, DOI 10.1016/j.chembiol.2010.11.016; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Schwartz TB, 2004, PERSPECT BIOL MED, V47, P564, DOI 10.1353/pbm.2004.0071; Skach William R, 2007, Biochem J, V406, pe1; Snider KE, 2013, J CLIN ENDOCR METAB, V98, pE355, DOI 10.1210/jc.2012-2169; Stanley CA, 2002, J CLIN ENDOCR METAB, V87, P4857, DOI 10.1210/jc.2002-021403; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Taschenberger G, 2002, J BIOL CHEM, V277, P17139, DOI 10.1074/jbc.M200363200; Verkman AS, 2006, CURR PHARM DESIGN, V12, P2235, DOI 10.2174/138161206777585148; Wang F, 2012, J BIOL CHEM, V287, P10482, DOI 10.1074/jbc.M111.312223; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yan FF, 2006, J BIOL CHEM, V281, P33403, DOI 10.1074/jbc.M605195200; Yan FF, 2010, MOL BIOL CELL, V21, P1945, DOI 10.1091/mbc.E10-02-0116; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Yan FF, 2004, J BIOL CHEM, V279, P11096, DOI 10.1074/jbc.M312810200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	68	45	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20942	20954		10.1074/jbc.M113.470948	http://dx.doi.org/10.1074/jbc.M113.470948			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23744072	Green Published, hybrid			2022-12-28	WOS:000322014400017
J	Hubbi, ME; Hu, HX; Kshitiz; Gilkes, DM; Semenza, GL				Hubbi, Maimon E.; Hu, Hongxia; Kshitiz; Gilkes, Daniele M.; Semenza, Gregg L.			Sirtuin-7 Inhibits the Activity of Hypoxia-inducible Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-1-ALPHA HIF-1-ALPHA; TRANSCRIPTIONAL ACTIVITY; FACTOR 1-ALPHA; HIF-ALPHA; DEGRADATION; BINDING; TRANSACTIVATION; RESPONSES; SIRT7; VHL	Hypoxia-inducible factor (HIF) 1 and HIF-2 are heterodimeric proteins composed of an oxygen-regulated HIF-1 alpha or HIF-2 alpha subunit, respectively, and a constitutively expressed HIF-1 beta subunit, which mediate adaptive transcriptional responses to hypoxia. Here, we report that Sirt7 (sirtuin-7) negatively regulates HIF-1 alpha and HIF-2 alpha protein levels by a mechanism that is independent of prolyl hydroxylation and that does not involve proteasomal or lysosomal degradation. The effect of Sirt7 was maintained in the presence of the sirtuin inhibitor nicotinamide and upon deletion or mutation of its deacetylase domain, indicating a non-catalytic function. Knockdown of Sirt7 led to an increase in HIF-1 alpha and HIF-2 alpha protein levels and an increase in HIF-1 and HIF-2 transcriptional activity. Thus, we identify a novel molecular function of Sirt7 as a negative regulator of HIF signaling.	[Hubbi, Maimon E.; Hu, Hongxia; Kshitiz; Gilkes, Daniele M.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Vasc Program, Baltimore, MD 21205 USA; [Hubbi, Maimon E.; Hu, Hongxia; Gilkes, Daniele M.; Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Hu, Hongxia] Johns Hopkins Univ, Sch Med, Predoctoral Training Program Human Genet, Baltimore, MD 21205 USA; [Kshitiz] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Semenza, GL (corresponding author), Johns Hopkins Univ, Sch Med, Miller Res Bldg,Suite 671,733 N Broadway, Baltimore, MD 21205 USA.	gsemenza@jhmi.edu	Kz, Kshitiz/B-9143-2013; Kz, Kshitiz/I-3657-2013; Gilkes, Daniele M/AAI-8133-2020; Hu, Hongxia/Q-7765-2016	Kz, Kshitiz/0000-0003-4241-9427; Kz, Kshitiz/0000-0003-4241-9427; Gilkes, Daniele M/0000-0003-3984-9338; Hubbi, Maimon/0000-0001-9763-287X	United States Public Health Service [N01-HV28180, HHS-N268201000032c]; Johns Hopkins Institute for Cell Engineering; American Heart Association [10PRE4160120]; Komen Foundation [KG111254];  [T32-HL007525]; NATIONAL CANCER INSTITUTE [K99CA181352] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Johns Hopkins Institute for Cell Engineering; American Heart Association(American Heart Association); Komen Foundation(Susan G. Komen Breast Cancer Foundation); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Contracts N01-HV28180 and HHS-N268201000032c from the United States Public Health Service and Postdoctoral Training Grant T32-HL007525 (to M. E. H.). This work was also supported by the Johns Hopkins Institute for Cell Engineering, American Heart Association Predoctoral Fellowship 10PRE4160120 (to K.), and Komen Foundation Postdoctoral Fellowship KG111254 (to D. M. G.).	Baek JH, 2007, J BIOL CHEM, V282, P33358, DOI 10.1074/jbc.M705627200; Baek JH, 2007, J BIOL CHEM, V282, P23572, DOI 10.1074/jbc.M703504200; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Chen R, 2012, J BIOL CHEM, V287, P30800, DOI 10.1074/jbc.M111.244780; Chiang WC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002948; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Foxler DE, 2012, NAT CELL BIOL, V14, P201, DOI 10.1038/ncb2424; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Grob A, 2009, J CELL SCI, V122, P489, DOI 10.1242/jcs.042382; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Hubbi ME, 2013, J BIOL CHEM, V288, P10703, DOI 10.1074/jbc.M112.414771; Hubbi ME, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003417; Hubbi ME, 2012, J BIOL CHEM, V287, P6139, DOI 10.1074/jbc.M111.278630; Hubbi ME, 2011, MOL CELL, V42, P700, DOI 10.1016/j.molcel.2011.03.029; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, J BIOL CHEM, V272, P19253, DOI 10.1074/jbc.272.31.19253; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Laemmle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033433; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin J, 2012, IUBMB LIFE, V64, P921, DOI 10.1002/iub.1089; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Tsai YC, 2012, MOL CELL PROTEOMICS, V11, P60, DOI 10.1074/mcp.A111.015156; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	39	101	108	2	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20768	20775		10.1074/jbc.M113.476903	http://dx.doi.org/10.1074/jbc.M113.476903			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23750001	Green Published, hybrid			2022-12-28	WOS:000322014400001
J	Ouberai, MM; Wang, J; Swann, MJ; Galvagnion, C; Guilliams, T; Dobson, CM; Welland, ME				Ouberai, Myriam M.; Wang, Juan; Swann, Marcus J.; Galvagnion, Celine; Guilliams, Tim; Dobson, Christopher M.; Welland, Mark E.			alpha-Synuclein Senses Lipid Packing Defects and Induces Lateral Expansion of Lipids Leading to Membrane Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; PHOSPHOLIPID-BINDING; REAL-TIME; CURVATURE; PROTEIN; CONFORMATION; MECHANISMS; ADSORPTION	There is increasing evidence for the involvement of lipid membranes in both the functional and pathological properties of alpha-synuclein (alpha-Syn). Despite many investigations to characterize the binding of alpha-Syn to membranes, there is still a lack of understanding of the binding mode linking the properties of lipid membranes to alpha-Syn insertion into these dynamic structures. Using a combination of an optical biosensing technique and in situ atomic force microscopy, we show that the binding strength of alpha-Syn is related to the specificity of the lipid environment (the lipid chemistry and steric properties within a bilayer structure) and to the ability of the membranes to accommodate and remodel upon the interaction of alpha-Syn with lipid membranes. We show that this interaction results in the insertion of alpha-Syn into the region of the headgroups, inducing a lateral expansion of lipid molecules that can progress to further bilayer remodeling, such as membrane thinning and expansion of lipids out of the membrane plane. We provide new insights into the affinity of alpha-Syn for lipid packing defects found in vesicles of high curvature and in planar membranes with cone-shaped lipids and suggest a comprehensive model of the interaction between alpha-Syn and lipid bilayers. The ability of alpha-Syn to sense lipid packing defects and to remodel membrane structure supports its proposed role in vesicle trafficking.	[Ouberai, Myriam M.; Welland, Mark E.] Univ Cambridge, Dept Engn, Nanosci Ctr, Cambridge CB3 0FF, England; [Wang, Juan; Swann, Marcus J.] Farfield Grp Ltd, Biolin Sci, Manchester M90 3DQ, Lancs, England; [Galvagnion, Celine; Guilliams, Tim; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Cambridge; University of Cambridge	Ouberai, MM (corresponding author), Univ Cambridge, Dept Engn, Nanosci Ctr, Cambridge CB3 0FF, England.	mmo25@cam.ac.uk	Galvagnion, Celine/K-7940-2018	Galvagnion, Celine/0000-0001-9753-3310	Biotechnology and Biological Sciences Research Council [BB/H003843/1]; European Union (EU) training network project NEURASYNC; EU FP6 project ASMENA; Elan plc; Parkinson's UK [H-0903]; Parkinson&quot;s UK [H-0903] Funding Source: researchfish; BBSRC [BB/H003843/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU) training network project NEURASYNC; EU FP6 project ASMENA; Elan plc; Parkinson's UK(Parkinson's UK); Parkinson&quot;s UK(Parkinson&apos;s UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/H003843/1, European Union (EU) training network project NEURASYNC, EU FP6 project ASMENA, Elan plc, and Parkinson's UK Grant H-0903.	Antonny B, 1997, J BIOL CHEM, V272, P30848, DOI 10.1074/jbc.272.49.30848; Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Auluck PK, 2010, ANNU REV CELL DEV BI, V26, P211, DOI 10.1146/annurev.cellbio.042308.113313; Bodner CR, 2010, BIOCHEMISTRY-US, V49, P862, DOI 10.1021/bi901723p; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Branden M, 2008, CHEMPHYSCHEM, V9, P2480, DOI 10.1002/cphc.200800614; Canale C, 2006, BIOPHYS J, V91, P4575, DOI 10.1529/biophysj.106.089482; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Coan KED, 2012, ANAL CHEM, V84, P1586, DOI 10.1021/ac202844e; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Domanov YA, 2006, BIOPHYS J, V91, P4427, DOI 10.1529/biophysj.106.091702; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Fortin DL, 2004, J NEUROSCI, V24, P6715, DOI 10.1523/JNEUROSCI.1594-04.2004; Freeman NJ, 2004, J PHYS-CONDENS MAT, V16, pS2493, DOI 10.1088/0953-8984/16/26/023; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Graneli A, 2004, CHEMPHYSCHEM, V5, P729, DOI 10.1002/cphc.200301061; HAUSER H, 1981, BIOCHIM BIOPHYS ACTA, V650, P21, DOI 10.1016/0304-4157(81)90007-1; Heller WT, 2000, BIOCHEMISTRY-US, V39, P139, DOI 10.1021/bi991892m; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Jao CC, 2008, P NATL ACAD SCI USA, V105, P19666, DOI 10.1073/pnas.0807826105; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kim HY, 2009, J AM CHEM SOC, V131, P17482, DOI 10.1021/ja9077599; Kranenburg M, 2004, BIOPHYS J, V87, P1596, DOI 10.1529/biophysj.104.045005; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lee TH, 2010, BBA-BIOMEMBRANES, V1798, P544, DOI 10.1016/j.bbamem.2010.01.014; Ly HV, 2004, BIOPHYS J, V87, P1013, DOI 10.1529/biophysj.103.034280; Machan R, 2010, CHEM PHYS LIPIDS, V163, P200, DOI 10.1016/j.chemphyslip.2009.11.005; Martinez Z, 2007, BIOCHEMISTRY-US, V46, P1868, DOI 10.1021/bi061749a; Mashaghi A, 2008, ANAL CHEM, V80, P3666, DOI 10.1021/ac800027s; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mecke A, 2005, BIOPHYS J, V89, P4043, DOI 10.1529/biophysj.105.062596; Middleton ER, 2010, BIOPHYS J, V99, P2279, DOI 10.1016/j.bpj.2010.07.056; Mizuno N, 2012, J BIOL CHEM, V287, P29301, DOI 10.1074/jbc.M112.365817; Nielsen SB, 2010, J COLLOID INTERF SCI, V345, P248, DOI 10.1016/j.jcis.2010.01.065; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Singh S, 2012, BBA-BIOMEMBRANES, V1818, P2244, DOI 10.1016/j.bbamem.2012.03.017; SLATER JL, 1988, PROG LIPID RES, V27, P325, DOI 10.1016/0163-7827(88)90010-0; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; van Rooijen BD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014292; Varkey J, 2013, J BIOL CHEM, V288, P17620, DOI 10.1074/jbc.M113.476697; Varkey J, 2010, J BIOL CHEM, V285, P32486, DOI 10.1074/jbc.M110.139576; Westphal CH, 2013, J BIOL CHEM, V288, P1829, DOI 10.1074/jbc.M112.418871; Xu KR, 2013, BIOMATERIALS, V34, P1461, DOI 10.1016/j.biomaterials.2012.10.078; Zakharov SD, 2007, BIOCHEMISTRY-US, V46, P14369, DOI 10.1021/bi701275p; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	58	143	145	0	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20883	20895		10.1074/jbc.M113.478297	http://dx.doi.org/10.1074/jbc.M113.478297			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23740253	Green Published, hybrid			2022-12-28	WOS:000322014400012
J	Nagpal, L; Haque, MM; Saha, A; Mukherjee, N; Ghosh, A; Ranu, BC; Stuehr, DJ; Panda, K				Nagpal, Latika; Haque, Mohammad M.; Saha, Amit; Mukherjee, Nirmalya; Ghosh, Arnab; Ranu, Brindaban C.; Stuehr, Dennis J.; Panda, Koustubh			Mechanism of Inducible Nitric-oxide Synthase Dimerization Inhibition by Novel Pyrimidine Imidazoles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAHYDROBIOPTERIN INTERACTION; SUBUNIT DIMERIZATION; ESCHERICHIA-COLI; OXYGENASE DOMAIN; NO SYNTHASE; DIMER; HEME; CALMODULIN; EXPRESSION; SUBSTRATE	Overproduction of nitric oxide (NO) by inducible nitric-oxide synthase (iNOS) has been etiologically linked to several inflammatory, immunological, and neurodegenerative diseases. As dimerization of NOS is required for its activity, several dimerization inhibitors, including pyrimidine imidazoles, are being evaluated for therapeutic inhibition of iNOS. However, the precise mechanism of their action is still unclear. Here, we examined the mechanism of iNOS inhibition by a pyrimidine imidazole core compound and its derivative (PID), having low cellular toxicity and high affinity for iNOS, using rapid stopped-flow kinetic, gel filtration, and spectrophotometric analysis. PID bound to iNOS heme to generate an irreversible PID-iNOS monomer complex that could not be converted to active dimers by tetrahydrobiopterin (H4B) and L-arginine (Arg). We utilized the iNOS oxygenase domain (iNOSoxy) and two monomeric mutants whose dimerization could be induced (K82AiNOSoxy) or not induced (D92AiNOSoxy) with H4B to elucidate the kinetics of PID binding to the iNOS monomer and dimer. We observed that the apparent PID affinity for the monomer was 11 times higher than the dimer. PID binding rate was also sensitive to H4B and Arg site occupancy. PID could also interact with nascent iNOS monomers in iNOS-synthesizing RAW cells, to prevent their post-translational dimerization, and it also caused irreversible monomerization of active iNOS dimers thereby accomplishing complete physiological inhibition of iNOS. Thus, our study establishes PID as a versatile iNOS inhibitor and therefore a potential in vivo tool for examining the causal role of iNOS in diseases associated with its overexpression as well as therapeutic control of such diseases.	[Nagpal, Latika; Panda, Koustubh] Univ Calcutta, Dept Biotechnol, Kolkata 700019, India; [Nagpal, Latika; Panda, Koustubh] Univ Calcutta, Guha Ctr Genet Engn & Biotechnol, Kolkata 700019, India; [Haque, Mohammad M.; Ghosh, Arnab; Stuehr, Dennis J.] Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Saha, Amit; Mukherjee, Nirmalya; Ranu, Brindaban C.] Indian Assoc Cultivat Sci, Dept Organ Chem, Kolkata 700032, India	University of Calcutta; University of Calcutta; Cleveland Clinic Foundation; Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Stuehr, DJ (corresponding author), Cleveland Clin, Dept Pathobiol, Lerner Res Inst, Cleveland, OH 44195 USA.	stuehrd@ccf.org; kpbcg@caluniv.ac.in	Saha, Amit/Z-5717-2019; Panda, Koustubh/E-5273-2017	Nagpal, Latika/0000-0003-0510-7299; GHOSH, ARNAB/0000-0002-7498-1994; Panda, Koustubh/0000-0002-4783-2221; MUKHERJEE, NIRMALYA/0000-0002-6755-2235; HAQUE, MOHAMMAD/0000-0003-0852-6368	UGC UPE; National Institute of Health [GM51491, CA53914, HL58883]; INSPIRE-DST Fellowship, Government of India; Fulbright-Nehru Doctoral and Professional Research Fellowship; NATIONAL CANCER INSTITUTE [R01CA053914, R29CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058883, P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	UGC UPE(University Grants Commission, India); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSPIRE-DST Fellowship, Government of India; Fulbright-Nehru Doctoral and Professional Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by UGC UPE (Modern Biology) research grant (to K. P.) and by National Institute of Health Grants GM51491, CA53914, and HL58883 (to D. J. S.) and INSPIRE-DST Fellowship, Government of India, and Fulbright-Nehru Doctoral and Professional Research Fellowship (to L. N.).	Adak S, 1999, J BIOL CHEM, V274, P22313, DOI 10.1074/jbc.274.32.22313; Albakri QA, 1996, J BIOL CHEM, V271, P5414, DOI 10.1074/jbc.271.10.5414; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; BAEK KJ, 1993, J BIOL CHEM, V268, P21120; Bienkowska-Haba M, 2006, ARCH IMMUNOL THER EX, V54, P201, DOI 10.1007/s00005-006-0025-z; Blasko E, 2002, J BIOL CHEM, V277, P295, DOI 10.1074/jbc.M105691200; BOULLERNE AI, 1995, J NEUROIMMUNOL, V60, P117, DOI 10.1016/0165-5728(95)00061-6; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Burnstock G., 1997, NITRIC OXIDE HLTH DI, P1; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; Davey DD, 2007, J MED CHEM, V50, P1146, DOI 10.1021/jm061319i; Enkhbaatar P, 2003, AM J PHYSIOL-HEART C, V285, pH2430, DOI 10.1152/ajpheart.00055.2003; Fedorov R, 2004, P NATL ACAD SCI USA, V101, P5892, DOI 10.1073/pnas.0306588101; Gahman TC, 2011, BIOORG MED CHEM LETT, V21, P6888, DOI 10.1016/j.bmcl.2011.08.112; Ghosh DK, 1999, EMBO J, V18, P6260, DOI 10.1093/emboj/18.22.6260; Ghosh DK, 1997, BIOCHEMISTRY-US, V36, P10609, DOI 10.1021/bi9702290; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Ichinose F, 2003, AM J PHYSIOL-HEART C, V285, pH2524, DOI 10.1152/ajpheart.00530.2003; KLATT P, 1995, EMBO J, V14, P3687, DOI 10.1002/j.1460-2075.1995.tb00038.x; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; KRONCKE KD, 1995, BIOL CHEM H-S, V376, P327; Li HY, 2005, J INORG BIOCHEM, V99, P293, DOI 10.1016/j.jinorgbio.2004.10.016; MARTIN W, 1986, J PHARMACOL EXP THER, V237, P529; McMillan K, 2000, P NATL ACAD SCI USA, V97, P1506, DOI 10.1073/pnas.97.4.1506; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; MILSTIEN S, 1994, J NEUROCHEM, V63, P1178; NAKANE M, 1993, FEBS LETT, V316, P175, DOI 10.1016/0014-5793(93)81210-Q; ODELL TJ, 1994, SCIENCE, V265, P542, DOI 10.1126/science.7518615; Panda K, 2005, P NATL ACAD SCI USA, V102, P10117, DOI 10.1073/pnas.0408972102; Panda K, 2003, J BIOL CHEM, V278, P37122, DOI 10.1074/jbc.M304456200; Panda K, 2002, J BIOL CHEM, V277, P31020, DOI 10.1074/jbc.M203749200; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; RADOMSKI MW, 1990, P NATL ACAD SCI USA, V87, P10043, DOI 10.1073/pnas.87.24.10043; RodriguezCrespo I, 1997, BIOCHEMISTRY-US, V36, P8530, DOI 10.1021/bi970192j; RodriguezCrespo I, 1996, J BIOL CHEM, V271, P11462, DOI 10.1074/jbc.271.19.11462; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Sennequier N, 1999, J BIOL CHEM, V274, P930, DOI 10.1074/jbc.274.2.930; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; STUEHR DJ, 1987, CANCER RES, V47, P5590; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Wu CQ, 1996, BIOCHEM BIOPH RES CO, V222, P439, DOI 10.1006/bbrc.1996.0763	45	23	23	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19685	19697		10.1074/jbc.M112.446542	http://dx.doi.org/10.1074/jbc.M112.446542			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696643	hybrid, Green Published			2022-12-28	WOS:000321515800039
J	Sharma, P; Wollenberg, K; Sellers, M; Zainabadi, K; Galinsky, K; Moss, E; Nguitragool, W; Neafsey, D; Desai, SA				Sharma, Paresh; Wollenberg, Kurt; Sellers, Morgan; Zainabadi, Kayvan; Galinsky, Kevin; Moss, Eli; Nguitragool, Wang; Neafsey, Daniel; Desai, Sanjay A.			An Epigenetic Antimalarial Resistance Mechanism Involving Parasite Genes Linked to Nutrient Uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE ANION CHANNEL; PLASMODIUM-FALCIPARUM; MALARIA PARASITES; RHOPTRY PROTEIN; CHLOROQUINE RESISTANCE; ANTIGENIC VARIATION; FUNCTIONAL-ANALYSIS; MULTIGENE FAMILY; PFMDR1 GENE; ERYTHROCYTE	Acquired antimalarial drug resistance produces treatment failures and has led to periods of global disease resurgence. In Plasmodium falciparum, resistance is known to arise through genome-level changes such as mutations and gene duplications. We now report an epigenetic resistance mechanism involving genes responsible for the plasmodial surface anion channel, a nutrient channel that also transports ions and antimalarial compounds at the host erythrocyte membrane. Two blasticidin S-resistant lines exhibited markedly reduced expression of clag genes linked to channel activity, but had no genome-level changes. Silencing aborted production of the channel protein and was directly responsible for reduced uptake. Silencing affected clag paralogs on two chromosomes and was mediated by specific histone modifications, allowing a rapidly reversible drug resistance phenotype advantageous to the parasite. These findings implicate a novel epigenetic resistance mechanism that involves reduced host cell uptake and is a worrisome liability for water-soluble antimalarial drugs.	[Sharma, Paresh; Sellers, Morgan; Zainabadi, Kayvan; Nguitragool, Wang; Desai, Sanjay A.] NIAID, Lab Malaria & Vector Res, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20852 USA; [Wollenberg, Kurt] NIAID, Bioinformat & Computat Biosci Branch, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20852 USA; [Galinsky, Kevin; Moss, Eli; Neafsey, Daniel] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Desai, SA (corresponding author), NIAID, Lab Malaria & Vector Res, Off Cyber Infrastruct & Computat Biol, NIH, Bethesda, MD 20852 USA.	sdesai@niaid.nih.gov		Sellers, Morgan/0000-0003-2539-9903; Nguitragool, Wang/0000-0002-5484-7130; Desai, Sanjay/0000-0003-2150-2483; Galinsky, Kevin/0000-0003-0311-4938	National Institutes of Health Intramural Research Program; Bill and Melinda Gates Foundation; NIAID; NATIONAL CANCER INSTITUTE [T32CA009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000882] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program, NIAID, and by a Global Health Program grant from the Bill and Melinda Gates Foundation.	Alexandre Jean S.F., 2011, Tropical Medicine and Health, V39, P77, DOI 10.2149/tmh.2011-12; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Balu B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-83; Bhat PJ, 2009, J BIOSCIENCES, V34, P513, DOI 10.1007/s12038-009-0070-y; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; Comeaux CA, 2011, MOL MICROBIOL, V80, P378, DOI 10.1111/j.1365-2958.2011.07572.x; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Crowley VM, 2011, MOL MICROBIOL, V80, P391, DOI 10.1111/j.1365-2958.2011.07574.x; Desai SA, 2012, CELL MICROBIOL, V14, P1003, DOI 10.1111/j.1462-5822.2012.01790.x; Duraisingh MT, 2005, ACTA TROP, V94, P181, DOI 10.1016/j.actatropica.2005.04.008; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037; Goel S, 2010, P NATL ACAD SCI USA, V107, P16643, DOI 10.1073/pnas.1002568107; Greenwood Brian, 2009, Trans R Soc Trop Med Hyg, V103 Suppl 1, pS2, DOI 10.1016/j.trstmh.2008.10.027; Gregson A, 2005, PHARMACOL REV, V57, P117, DOI 10.1124/pr.57.1.4; Haynes RK, 2006, CURR TOP MED CHEM, V6, P509, DOI 10.2174/156802606776743129; Hill DA, 2007, P NATL ACAD SCI USA, V104, P1063, DOI 10.1073/pnas.0610353104; Iriko H, 2008, MOL BIOCHEM PARASIT, V158, P11, DOI 10.1016/j.molbiopara.2007.11.004; Jiang LB, 2010, P NATL ACAD SCI USA, V107, P2224, DOI 10.1073/pnas.0913396107; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaneko O, 2001, MOL BIOCHEM PARASIT, V118, P223, DOI 10.1016/S0166-6851(01)00391-7; Kaneko O, 2007, PARASITOL INT, V56, P255, DOI 10.1016/j.parint.2007.05.003; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Kyes S, 2002, MOL BIOCHEM PARASIT, V123, P79, DOI 10.1016/S0166-6851(02)00135-4; Ling IT, 2004, MOL MICROBIOL, V52, P107, DOI 10.1111/j.1365-2958.2003.03969.x; Lisk G, 2008, ANTIMICROB AGENTS CH, V52, P2346, DOI 10.1128/AAC.00057-08; Lisk G, 2007, MOL PHARMACOL, V71, P1241, DOI 10.1124/mol.106.030734; Lisk G, 2010, BBA-BIOMEMBRANES, V1798, P1679, DOI 10.1016/j.bbamem.2010.04.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Lyko B, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-124; Malmquist NA, 2012, P NATL ACAD SCI USA, V109, P16708, DOI 10.1073/pnas.1205414109; Martinez A, 2009, J BIOL INORG CHEM, V14, P863, DOI 10.1007/s00775-009-0498-4; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Pillai AD, 2013, MOL MICROBIOL, V88, P20, DOI 10.1111/mmi.12159; Pillai AD, 2012, MOL PHARMACOL, V82, P1104, DOI 10.1124/mol.112.081224; Pillai AD, 2010, MOL PHARMACOL, V77, P724, DOI 10.1124/mol.109.062711; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Ralph SA, 2005, CURR OPIN MICROBIOL, V8, P434, DOI 10.1016/j.mib.2005.06.007; Rasti N, 2004, FEMS IMMUNOL MED MIC, V41, P9, DOI 10.1016/j.femsim.2004.01.010; Ritchie TJ, 2011, DRUG DISCOV TODAY, V16, P164, DOI 10.1016/j.drudis.2010.11.014; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Staines HM, 2000, BBA-BIOMEMBRANES, V1463, P88, DOI 10.1016/S0005-2736(99)00187-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Trenholme KR, 2000, P NATL ACAD SCI USA, V97, P4029, DOI 10.1073/pnas.040561197; Vincensini L, 2008, MOL BIOCHEM PARASIT, V160, P81, DOI 10.1016/j.molbiopara.2008.04.002; Wagner MA, 2003, BIOPHYS J, V84, P116, DOI 10.1016/S0006-3495(03)74836-X; Wanamaker CP, 2003, ANN NY ACAD SCI, V998, P66, DOI 10.1196/annals.1254.009; Wickham ME, 2003, MOL BIOCHEM PARASIT, V129, P147, DOI 10.1016/S0166-6851(03)00118-X; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	58	57	57	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19429	19440		10.1074/jbc.M113.468371	http://dx.doi.org/10.1074/jbc.M113.468371			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720749	hybrid, Green Published			2022-12-28	WOS:000321515800011
J	DeLucia, M; Mehrens, J; Wu, Y; Ahn, J				DeLucia, Maria; Mehrens, Jennifer; Wu, Ying; Ahn, Jinwoo			HIV-2 and SIVmac Accessory Virulence Factor Vpx Down-regulates SAMHD1 Enzyme Catalysis Prior to Proteasome-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION FACTOR SAMHD1; AICARDI-GOUTIERES SYNDROME; UBIQUITIN LIGASE; PROTEIN; REPLICATION; INFECTION; LYMPHOCYTES; INHIBITION; INTERPLAY; GENE	SAMHD1, a dGTP-regulated deoxyribonucleoside triphosphate (dNTP) triphosphohydrolase, down-regulates dNTP pools in terminally differentiated and quiescent cells, thereby inhibiting HIV-1 infection at the reverse transcription step. HIV-2 and simian immunodeficiency virus (SIV) counteract this restriction via a virion-associated virulence accessory factor, Vpx (Vpr in some SIVs), which loads SAMHD1 onto CRL4-DCAF1 E3 ubiquitin ligase for polyubiquitination, programming it for proteasome-dependent degradation. However, the detailed molecular mechanisms of SAMHD1 recruitment to the E3 ligase have not been defined. Further, whether divergent, orthologous Vpx proteins, encoded by distinct HIV/SIV strains, bind SAMHD1 in a similar manner, at a molecular level, is not known. We applied surface plasmon resonance analysis to assess the requirements for and kinetics of binding between various primate SAMHD1 proteins and Vpx proteins from SIV or HIV-2 strains. Our data indicate that Vpx proteins, bound to DCAF1, interface with the C terminus of primate SAMHD1 proteins with nanomolar affinity, manifested by rapid association and slow dissociation. Further, we provide evidence that Vpx binding to SAMHD1 inhibits its catalytic activity and induces disassembly of a dGTP-dependent oligomer. Our studies reveal a previously unrecognized biochemical mechanism of Vpx-mediated SAMHD1 inhibition: direct down-modulation of its catalytic activity, mediated by the same binding event that leads to SAMHD1 recruitment to the E3 ubiquitin ligase for proteasome-dependent degradation.	[DeLucia, Maria; Mehrens, Jennifer; Wu, Ying; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [DeLucia, Maria; Mehrens, Jennifer; Wu, Ying; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahn, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	jahn@structbio.pitt.edu			National Institutes of Health [P50GM082251]; University of Pittsburgh School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh School of Medicine(University of Pittsburgh); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50GM082251. This work was also supported by funds from the University of Pittsburgh School of Medicine.	Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Britan-Rosich E, 2011, J MOL BIOL, V410, P1065, DOI 10.1016/j.jmb.2011.03.058; Chen RX, 2004, J BIOL CHEM, V279, P28419, DOI 10.1074/jbc.M403875200; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goncalves A, 2012, HUM MUTAT, V33, P1116, DOI 10.1002/humu.22087; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Hofmann H, 2012, J VIROL, V86, P12552, DOI 10.1128/JVI.01657-12; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; KAWAMURA M, 1994, MICROBIOL IMMUNOL, V38, P871, DOI 10.1111/j.1348-0421.1994.tb02140.x; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Planelles V, 2012, CELL HOST MICROBE, V11, P103, DOI 10.1016/j.chom.2012.02.001; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Puigdomenech I, 2013, J VIROL, V87, P2846, DOI 10.1128/JVI.02514-12; Santa-Marta M, 2005, J BIOL CHEM, V280, P8765, DOI 10.1074/jbc.M409309200; Santa-Marta M, 2007, MOL IMMUNOL, V44, P583, DOI 10.1016/j.molimm.2006.02.005; Schaller T, 2012, SCIENCE, V335, P1313, DOI 10.1126/science.1221057; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; St Gelais C, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-105; Vorontsov II, 2011, J BIOL CHEM, V286, P33158, DOI 10.1074/jbc.M111.250456; Wei W, 2012, CELL MICROBIOL, V14, P1745, DOI 10.1111/j.1462-5822.2012.01835.x; White TE, 2013, VIROLOGY, V436, P81, DOI 10.1016/j.virol.2012.10.029; Wu L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-88; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Yan N, 2012, NAT MED, V18, P1611, DOI 10.1038/nm.2980; Yu HX, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-27; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991; Zhang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037477	44	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19116	19126		10.1074/jbc.M113.469007	http://dx.doi.org/10.1074/jbc.M113.469007			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23677995	hybrid, Green Published			2022-12-28	WOS:000321335800046
J	Wen, PC; Verhalen, B; Wilkens, S; Mchaourab, HS; Tajkhorshid, E				Wen, Po-Chao; Verhalen, Brandy; Wilkens, Stephan; Mchaourab, Hassane S.; Tajkhorshid, Emad			On the Origin of Large Flexibility of P-glycoprotein in the Inward-facing State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; BACTERIAL ABC TRANSPORTER; NUCLEOTIDE-BINDING DOMAIN; ATP-BINDING; MULTIDRUG TRANSPORTER; TRANSMEMBRANE DOMAINS; MALTOSE TRANSPORTER; ALTERNATING ACCESS; GATING HINGE; DRUG-BINDING	P-glycoprotein (Pgp) is one of the most biomedically relevant transporters in the ATP binding cassette (ABC) superfamily due to its involvement in developing multidrug resistance in cancer cells. Employing molecular dynamics simulations and double electron-electron resonance spectroscopy, we have investigated the structural dynamics of membrane-bound Pgp in the inward-facing state and found that Pgp adopts an unexpectedly wide range of conformations, highlighted by the degree of separation between the two nucleotide-binding domains (NBDs). The distance between the two NBDs in the equilibrium simulations covers a range of at least 20 angstrom, including, both, more open and more closed NBD configurations than the crystal structure. The double electron-electron resonance measurements on spin-labeled Pgp mutants also show wide distributions covering both longer and shorter distances than those observed in the crystal structure. Based on structural and sequence analyses, we propose that the transmembrane domains of Pgp might be more flexible than other structurally known ABC exporters. The structural flexibility of Pgp demonstrated here is not only in close agreement with, but also helps rationalize, the reported high NBD fluctuations in several ABC exporters and possibly represents a fundamental difference in the transport mechanism between ABC exporters and ABC importers. In addition, during the simulations we have captured partial entrance of a lipid molecule from the bilayer into the lumen of Pgp, reaching the putative drug binding site. The location of the protruding lipid suggests a putative pathway for direct drug recruitment from the membrane.	[Wen, Po-Chao; Tajkhorshid, Emad] Univ Illinois, Coll Med, Dept Biochem, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Wen, Po-Chao; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Verhalen, Brandy; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA; [Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Vanderbilt University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Mchaourab, HS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Med Ctr, Nashville, TN 37232 USA.	hassane.mchaourab@vanderbilt.edu; emad@life.illinois.edu	Tajkhorshid, Emad/AAN-8323-2021; Wen, Po-Chao/I-5031-2014; Wen, Po-Chao/Q-5293-2019	Wen, Po-Chao/0000-0002-6049-6904; Wen, Po-Chao/0000-0002-6049-6904; Tajkhorshid, Emad/0000-0001-8434-1010	National Institutes of Health [U54-GM087519, R01-CA100246, R01-GM086749, P41-GM104601, 5T32NS007491-12]; NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086749, R01GM058600, P41GM104601, U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants U54-GM087519 (to H. S. M. and E. T.), R01-CA100246 (to W. S.), R01-GM086749 (to E. T.), P41-GM104601 (to E. T.), and 5T32NS007491-12 (to B. V.).	Abraham I, 2010, BIOCHEM PHARMACOL, V80, P1497, DOI 10.1016/j.bcp.2010.08.001; Abulrob ANG, 1999, BIOCHEM BIOPH RES CO, V262, P121, DOI 10.1006/bbrc.1999.1120; Aittoniemi J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000762; Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Al-Shawi MK, 2005, J BIOENERG BIOMEMBR, V37, P489, DOI 10.1007/s10863-005-9497-5; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Becker JP, 2010, J PHYS CHEM B, V114, P15948, DOI 10.1021/jp1038392; Becker JP, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-3; Bessadok A, 2011, J BIOL CHEM, V286, P3552, DOI 10.1074/jbc.M110.155200; Bikadi Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025815; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Bosch I, 1997, BIOCHEMISTRY-US, V36, P5685, DOI 10.1021/bi962728r; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen ZS, 2011, FEBS J, V278, P3226, DOI 10.1111/j.1742-4658.2011.08235.x; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Di Ianni ME, 2012, J CHEM INF MODEL, V52, P3325, DOI 10.1021/ci300423q; Ding SH, 2005, J GEN PHYSIOL, V126, P213, DOI 10.1085/jgp.200509287; Dolghih E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002083; Eckford PDW, 2005, BIOCHEM J, V389, P517, DOI 10.1042/BJ20050047; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Gualdesi MS, 2012, EUR J PHARM SCI, V47, P965, DOI 10.1016/j.ejps.2012.10.002; Gyimesi G, 2011, BBA-BIOMEMBRANES, V1808, P2954, DOI 10.1016/j.bbamem.2011.07.038; Ho BK, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-14; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Holland I. B., 2003, ABC PROTEINS BACTERI; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Ivetac A, 2008, EUR BIOPHYS J BIOPHY, V37, P403, DOI 10.1007/s00249-007-0225-4; Ivetac A, 2007, BIOCHEMISTRY-US, V46, P2767, DOI 10.1021/bi0622571; Jabeen I, 2012, J MED CHEM, V55, P3261, DOI 10.1021/jm201705f; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jones PM, 2012, J PHYS CHEM A, V116, P3004, DOI 10.1021/jp211139s; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Kandt C, 2010, PROTEINS, V78, P738, DOI 10.1002/prot.22606; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Klepsch F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002036; Korkhov VM, 2012, FEBS LETT, V586, P972, DOI 10.1016/j.febslet.2012.02.042; Liu M, 2013, J BIOMOL STRUCT DYN, V31, P612, DOI 10.1080/07391102.2012.706079; Liu RH, 2000, BIOCHEMISTRY-US, V39, P14927, DOI 10.1021/bi0018786; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Magidovich E, 2004, BIOCHEMISTRY-US, V43, P13242, DOI 10.1021/bi048377v; Mehmood S, 2012, P NATL ACAD SCI USA, V109, P10832, DOI 10.1073/pnas.1204067109; O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Oliveira ASF, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002128; Oloo EO, 2004, J BIOL CHEM, V279, P45013, DOI 10.1074/jbc.M405084200; Omote H, 2004, BIOCHEMISTRY-US, V43, P3917, DOI 10.1021/bi035365l; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Pajeva IK, 2009, FEBS J, V276, P7016, DOI 10.1111/j.1742-4658.2009.07415.x; Palmeira A, 2012, BIOCHEM PHARMACOL, V83, P57, DOI 10.1016/j.bcp.2011.10.004; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Qu Q, 2001, BIOCHEMISTRY-US, V40, P1413, DOI 10.1021/bi002035h; Ravna AW, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-33; Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456; Rosenberg MF, 2003, J BIOL CHEM, V278, P8294, DOI 10.1074/jbc.M211758200; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Siarheyeva A, 2007, BIOCHEMISTRY-US, V46, P3075, DOI 10.1021/bi062109a; Singh DV, 2013, J MOL MODEL, V19, P227, DOI 10.1007/s00894-012-1535-8; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Oliveira AS, 2011, PROTEINS, V79, P1977, DOI 10.1002/prot.23023; Sonne J, 2007, BIOPHYS J, V92, P2727, DOI 10.1529/biophysj.106.097972; St-Pierre JF, 2012, J PHYS CHEM B, V116, P2934, DOI 10.1021/jp209126c; Storm J, 2007, BIOCHEMISTRY-US, V46, P9899, DOI 10.1021/bi700447p; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tombline G, 2006, ARCH BIOCHEM BIOPHYS, V445, P124, DOI 10.1016/j.abb.2005.11.004; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Verhalen B, 2012, J BIOL CHEM, V287, P1112, DOI 10.1074/jbc.M111.301192; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Wen PC, 2011, BIOPHYS J, V101, P680, DOI 10.1016/j.bpj.2011.06.031; Wise JG, 2012, BIOCHEMISTRY-US, V51, P5125, DOI 10.1021/bi300299z; Yamaguchi H, 2012, BIOINFORMATION, V8, P1066, DOI 10.6026/97320630081066; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhao XQ, 2012, MOL PHARMACOL, V82, P47, DOI 10.1124/mol.111.076299; Zhao Y, 2004, NEURON, V41, P859, DOI 10.1016/S0896-6273(04)00116-3; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	84	94	96	0	30	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19211	19220		10.1074/jbc.M113.450114	http://dx.doi.org/10.1074/jbc.M113.450114			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23658020	hybrid, Green Published			2022-12-28	WOS:000321335800054
J	Williamson, DM; Elferich, J; Ramakrishnan, P; Thomas, G; Shinde, U				Williamson, Danielle M.; Elferich, Johannes; Ramakrishnan, Parvathy; Thomas, Gary; Shinde, Ujwal			The Mechanism by Which a Propeptide-encoded pH Sensor Regulates Spatiotemporal Activation of Furin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; PROPROTEIN CONVERTASE 1/3; INTRAMOLECULAR CHAPERONE; CIRCULAR-DICHROISM; ENDOPLASMIC-RETICULUM; ENZYME ACTIVATION; PRO-DOMAIN; CLEAVAGE; STABILITY; PEPTIDES	The proprotein convertase furin requires the pH gradient of the secretory pathway to regulate its multistep, compartment-specific autocatalytic activation. Although His-69 within the furin prodomain serves as the pH sensor that detects transport of the propeptide-enzyme complex to the trans-Golgi network, where it promotes cleavage and release of the inhibitory propeptide, a mechanistic understanding of how His-69 protonation mediates furin activation remains unclear. Here we employ biophysical, biochemical, and computational approaches to elucidate the mechanism underlying the pH-dependent activation of furin. Structural analyses and binding experiments comparing the wild-type furin propeptide with a nonprotonatable His-69 -> Leu mutant that blocks furin activation in vivo revealed protonation of His-69 reduces both the thermodynamic stability of the propeptide as well as its affinity for furin at pH 6.0. Structural modeling combined with mathematical modeling and molecular dynamic simulations suggested that His-69 does not directly contribute to the propeptide-enzyme interface but, rather, triggers movement of a loop region in the propeptide that modulates access to the cleavage site and, thus, allows for the tight pH regulation of furin activation. Our work establishes a mechanism by which His-69 functions as a pH sensor that regulates compartment-specific furin activation and provides insights into how other convertases and proteases may regulate their precise spatiotemporal activation.	[Williamson, Danielle M.; Elferich, Johannes; Ramakrishnan, Parvathy; Shinde, Ujwal] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Thomas, Gary] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shinde, U (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	shindeu@ohsu.edu		Elferich, Johannes/0000-0002-9911-706X	National Institutes of Health [CA151564]; National Science Foundation [MCB0746589]; American Heart Foundation; American Heart Association [12PRE11470005]; Div Of Molecular and Cellular Bioscience [0746589] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA151564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK096752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Foundation(American Heart Association); American Heart Association(American Heart Association); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health training grant (to D. M. W.) and National Institutes of Health Grant CA151564 (to G. T.). This work was also supported by National Science Foundation CAREER Award MCB0746589 and a grant in aid from the American Heart Foundation (to U. S.) and by American Heart Association Predoctoral Training Grant 12PRE11470005 (to J. E.).	Anderson ED, 1997, EMBO J, V16, P1508, DOI 10.1093/emboj/16.7.1508; Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Artenstein AW, 2011, NEW ENGL J MED, V365, P2507, DOI 10.1056/NEJMra1106700; Basak A, 2003, BIOCHEM J, V373, P231, DOI 10.1042/BJ20030120; BASAK A, 1994, INT J PEPT PROT RES, V44, P253; Bhattacharjya S, 2001, PROTEIN SCI, V10, P934, DOI 10.1110/ps.41301; Bhattacharjya S, 2007, BIOPOLYMERS, V86, P329, DOI 10.1002/bip.20748; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS CL, 1992, J MOL BIOL, V227, P375, DOI 10.1016/0022-2836(92)90893-O; CREEMERS JWM, 1995, J BIOL CHEM, V270, P2695, DOI 10.1074/jbc.270.6.2695; DAGGETT V, 1992, P NATL ACAD SCI USA, V89, P5142, DOI 10.1073/pnas.89.11.5142; DAGGETT V, 1993, J MOL BIOL, V232, P600, DOI 10.1006/jmbi.1993.1414; Day R, 1998, J BIOL CHEM, V273, P829, DOI 10.1074/jbc.273.2.829; Dhar P, 2004, BIOINFORMATICS, V20, P1319, DOI 10.1093/bioinformatics/bth067; Dillon SL, 2012, J MOL BIOL, V423, P47, DOI 10.1016/j.jmb.2012.06.023; Dufour EK, 2005, PROTEIN SCI, V14, P303, DOI 10.1110/ps.04843305; Elferich J., 2013, FASEB J IN PRESS; Feliciangeli SF, 2006, J BIOL CHEM, V281, P16108, DOI 10.1074/jbc.M600760200; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2733, DOI 10.1038/nprot.2006.229; Greenfield NJ, 2006, NAT PROTOC, V1, P2891, DOI 10.1038/nprot.2006.244; JEAN F, 1993, BIOCHEM J, V292, P891, DOI 10.1042/bj2920891; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kim WJ, 2012, MOL CELL BIOL, V32, P3382, DOI 10.1128/MCB.06331-11; LAKOWICZ JR, 1983, BIOCHEMISTRY-US, V22, P1741, DOI 10.1021/bi00277a001; LEDUC R, 1992, J BIOL CHEM, V267, P14304; Marie-Claire C, 2001, J MOL BIOL, V305, P151, DOI 10.1006/jmbi.2000.4233; Nair SK, 2005, J MOL ENDOCRINOL, V35, P211, DOI 10.1677/jme.1.01830; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; REHEMTULLA A, 1992, P NATL ACAD SCI USA, V89, P8235, DOI 10.1073/pnas.89.17.8235; Salimi NL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000689; SAWICKI CA, 1976, J BIOL CHEM, V251, P1533; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2011, METHODS MOL BIOL, V768, P23, DOI 10.1007/978-1-61779-204-5_3; Seidah NG, 2011, ANN NY ACAD SCI, V1220, P149, DOI 10.1111/j.1749-6632.2010.05883.x; SHINDE U, 1993, P NATL ACAD SCI USA, V90, P6924, DOI 10.1073/pnas.90.15.6924; Shinde U, 2000, SEMIN CELL DEV BIOL, V11, P35, DOI 10.1006/scdb.1999.0349; SHINDE U, 1993, TRENDS BIOCHEM SCI, V18, P442, DOI 10.1016/0968-0004(93)90146-E; Shinde U, 2011, METHODS MOL BIOL, V768, P59, DOI 10.1007/978-1-61779-204-5_4; Subbian E, 2005, J MOL BIOL, V347, P367, DOI 10.1016/j.jmb.2005.01.028; Subbian E, 2004, BIOCHEMISTRY-US, V43, P14348, DOI 10.1021/bi048397x; Tanco S, 2010, J BIOL CHEM, V285, P18385, DOI 10.1074/jbc.M109.060350; Tangrea MA, 2002, J MOL BIOL, V320, P801, DOI 10.1016/S0022-2836(02)00543-0; Tangrea MA, 2001, BIOCHEMISTRY-US, V40, P5488, DOI 10.1021/bi0026472; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829	47	16	16	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19154	19165		10.1074/jbc.M112.442681	http://dx.doi.org/10.1074/jbc.M112.442681			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23653353	Green Published, hybrid			2022-12-28	WOS:000321335800049
J	Baba, K; Morimoto, H; Imaoka, S				Baba, Kazunobu; Morimoto, Haruka; Imaoka, Susumu			Seven in Absentia Homolog 2 (Siah2) Protein Is a Regulator of NF-E2-related Factor 2 (Nrf2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; E3 LIGASE SIAH2; OXIDATIVE STRESS; UBIQUITIN LIGASE; RESPONSE ELEMENT; GENE-EXPRESSION; PROLYL-HYDROXYLASES; SIGNALING PATHWAYS; NITRIC-OXIDE; INDUCTION	Under pathological conditions such as ischemia-reperfusion, Nrf2 acts as a key regulator of cellular oxidative response. Provided that Nrf2 is sensitive to hypoxia during ischemia, Nrf2 may affect reactive oxygen species metabolism during reoxygenation. In this study, hypoxia suppressed Nrf2 protein, and its hypoxic suppression was not recovered with knockdown of the Nrf2 repressor Keap1. Moreover, an Nrf2 mutant lacking the Keap1 binding domain was suppressed under hypoxia, suggesting that Keap1 does not contribute to hypoxic Nrf2 suppression. HIF-1 alpha and Siah2 are both key regulators of hypoxic responses. Hypoxia induced the Siah2 protein. Although inhibition or knockdown of Siah2 prevented the suppression of Nrf2, knockdown of HIF-1 alpha did not. Moreover, Siah2 interacted with Nrf2 through a binding motif, suggesting that Siah2 contributes to the suppression of Nrf2. Some cytosolic kinases also play important roles in Nrf2 regulation. In this study, PKC phosphorylates serine residues of Nrf2 during hypoxia. Knockdown of Siah2 rescued hypoxic decreases in an Nrf2 mutant that mimicked phosphorylation at serine 40 or lacked this phosphorylation site, suggesting that Siah2 contributes to the degradation of Nrf2 irrespective of its phosphorylation status. Moreover, knockdown of Siah2 attenuated ubiquitination of the Nrf2 mutant, suggesting that association of Siah2 with Nrf2 causes proteasome-mediated degradation of Nrf2.	[Imaoka, Susumu] Kwansei Gakuin Univ, Sch Sci & Technol, Res Ctr Environm Biosci, Sanda, Hyogo 6691337, Japan; Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biosci, Sanda, Hyogo 6691337, Japan	Kwansei Gakuin University; Kwansei Gakuin University	Imaoka, S (corresponding author), Kwansei Gakuin Univ, Sch Sci & Technol, Res Ctr Environm Biosci, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	imaoka@kwansei.ac.jp			Japan Society for the Promotion of Science; Hyogo Science and Technology Association; Ministry of Education, Culture, Sports, Science and Technology; Kwansei Gakuin University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hyogo Science and Technology Association; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kwansei Gakuin University(Kwansei Gakuin University)	This work was supported in part by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science, a grant-in aid from the Hyogo Science and Technology Association, the Support Project to Assist Private Universities in Developing Bases from the Ministry of Education, Culture, Sports, Science and Technology, and by a grant-in-aid from Kwansei Gakuin University.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Bauer CE, 1999, ANNU REV MICROBIOL, V53, P495, DOI 10.1146/annurev.micro.53.1.495; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chen CW, 2009, IEEE T CIRC SYST VID, V19, P1, DOI 10.1109/TCSVT.2009.2012413; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Dalton TD, 1999, ANNU REV PHARMACOL, V39, P67, DOI 10.1146/annurev.pharmtox.39.1.67; Devling TWP, 2005, P NATL ACAD SCI USA, V102, P7280, DOI 10.1073/pnas.0501475102; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Jansen MPHM, 2009, BREAST CANCER RES TR, V116, P263, DOI 10.1007/s10549-008-0125-z; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Kang KW, 2002, NITRIC OXIDE-BIOL CH, V7, P244, DOI 10.1016/S1089-8603(02)00117-9; Kaur C, 2008, CLIN OPHTHALMOL, V2, P879, DOI 10.2147/opth.s3361; Khurana A, 2006, J BIOL CHEM, V281, P35316, DOI 10.1074/jbc.M606568200; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Kubo T, 2004, BIOCHEM BIOPH RES CO, V318, P1006, DOI 10.1016/j.bbrc.2004.04.125; Maxwell PH, 2001, ADV EXP MED BIOL, V502, P365; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Mo C, 2012, J BIOL CHEM, V287, P19242, DOI 10.1074/jbc.M112.349936; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537; Osada M, 2002, J BIOL CHEM, V277, P23367, DOI 10.1074/jbc.M112413200; Ristoiu V, 2011, PAIN, V152, P936, DOI 10.1016/j.pain.2011.02.024; RUSHMORE TH, 1990, J BIOL CHEM, V265, P14648; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shah M, 2009, PIGM CELL MELANOMA R, V22, P799, DOI 10.1111/j.1755-148X.2009.00628.x; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Ueda K, 2008, FEBS LETT, V582, P2357, DOI 10.1016/j.febslet.2008.05.040; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Yu R, 1999, J BIOL CHEM, V274, P27545, DOI 10.1074/jbc.274.39.27545; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	36	36	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18393	18405		10.1074/jbc.M112.438762	http://dx.doi.org/10.1074/jbc.M112.438762			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645672	Green Published, hybrid			2022-12-28	WOS:000320721900042
J	Rauhala, L; Hamalainen, L; Salonen, P; Bart, G; Tammi, M; Pasonen-Seppanen, S; Tammi, R				Rauhala, Leena; Hamalainen, Lasse; Salonen, Pauliina; Bart, Genevieve; Tammi, Markku; Pasonen-Seppanen, Sanna; Tammi, Raija			Low Dose Ultraviolet B Irradiation Increases Hyaluronan Synthesis in Epidermal Keratinocytes via Sequential Induction of Hyaluronan Synthases Has1-3 Mediated by p38 and Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN SKIN; PERMEABILITY BARRIER; ORGANOTYPIC CULTURES; DERMAL COMPARTMENTS; MOUSE EPIDERMIS; CELL CARCINOMA; RETINOIC ACID; UP-REGULATION; TGF-BETA	Hyaluronan, a major epidermal extracellular matrix component, responds strongly to different kinds of injuries. This also occurs by UV radiation, but the mechanisms involved are poorly understood. The effects of a single ultraviolet B (UVB) exposure on hyaluronan content and molecular mass, and expression of genes involved in hyaluronan metabolism were defined in monolayer and differentiated, organotypic three-dimensional cultures of rat epidermal keratinocytes. The signals regulating the response were characterized using specific inhibitors and Western blotting. In monolayer cultures, UVB increased hyaluronan synthase Has1 mRNA already 4 h postexposure, with a return to control level by 24 h. In contrast, Has2 and Has3 were persistently elevated from 8 h onward. Silencing of Has2 and especially Has3 decreased the UVB-induced accumulation of hyaluronan. p38 and Ca2+/calmodulin-dependent protein kinase II pathways were found to be involved in the UVB-induced up-regulation of Has2 and Has3 expression, respectively, and their inhibition reduced hyaluronan deposition. However, the expressions of the hyaluronan-degrading enzymes Hyal1 and Hyal2 and the hyaluronan receptor Cd44 were also up-regulated by UVB. In organotypic cultures, UVB treatment also resulted in increased expression of both Has and Hyal genes and shifted hyaluronan toward a smaller size range. Histochemical stainings indicated localized losses of hyaluronan in the epidermis. The data show that exposure of keratinocytes to acute, low dose UVB increases hyaluronan synthesis via up-regulation of Has2 and Has3. The simultaneously enhanced catabolism of hyaluronan demonstrates the complexity of the UVB-induced changes. Nevertheless, enhanced hyaluronan metabolism is an important part of the adaptation of keratinocytes to radiation injury.	[Rauhala, Leena; Hamalainen, Lasse; Salonen, Pauliina; Bart, Genevieve; Tammi, Markku; Pasonen-Seppanen, Sanna; Tammi, Raija] Univ Eastern Finland, Sch Med, Inst Biomed Anat, Kuopio 70211, Finland	University of Eastern Finland	Rauhala, L (corresponding author), Univ Eastern Finland, Sch Med, Inst Biomed Anat, Kuopio Campus,Yliopistonranta 1 E,POB 1627, Kuopio 70211, Finland.	leena.rauhala@uef.fi	Tammi, Markku/AAQ-7878-2021	Bart, Genevieve/0000-0001-9809-150X; Hamalainen, Lasse/0000-0003-1649-1150	Tekes; Cancer Center of the University of Eastern Finland; Juselius Foundation	Tekes(Finnish Funding Agency for Technology & Innovation (TEKES)); Cancer Center of the University of Eastern Finland; Juselius Foundation	This work was supported by grants from Tekes (to R. T.), the Cancer Center of the University of Eastern Finland (to R. T. and M. T.), and the Juselius Foundation (to R. T. and M. T.).	Adler V, 1996, CARCINOGENESIS, V17, P2073, DOI 10.1093/carcin/17.9.2073; Agren UM, 1997, FREE RADICAL BIO MED, V23, P996, DOI 10.1016/S0891-5849(97)00098-1; Ajani G, 2007, EXP CELL RES, V313, P3005, DOI 10.1016/j.yexcr.2007.04.021; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Averbeck M, 2007, J INVEST DERMATOL, V127, P687, DOI 10.1038/sj.jid.5700614; BADEN HP, 1983, J INVEST DERMATOL, V80, P124, DOI 10.1111/1523-1747.ep12532899; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Bito T, 2010, EXP DERMATOL, V19, P654, DOI 10.1111/j.1600-0625.2010.01084.x; Bourguignon LYW, 2006, J BIOL CHEM, V281, P14026, DOI 10.1074/jbc.M507734200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenner M, 2005, BRIT J DERMATOL, V153, P733, DOI 10.1111/j.1365-2133.2005.06780.x; Calikoglu E, 2006, PHOTOCHEM PHOTOBIOL, V82, P1342, DOI 10.1562/2006-02-10-RA-801; Caskey RC, 2013, CELL TISSUE RES, V351, P117, DOI 10.1007/s00441-012-1504-7; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Dai G, 2007, AM J PATHOL, V171, P1451, DOI 10.2353/ajpath.2007.070136; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Ducale AE, 2005, AM J PHYSIOL-GASTR L, V289, pG462, DOI 10.1152/ajpgi.00494.2004; Esser PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041340; Hasova M, 2011, ARCH DERMATOL RES, V303, P277, DOI 10.1007/s00403-011-1146-8; Heck DE, 2003, J BIOL CHEM, V278, P22432, DOI 10.1074/jbc.C300048200; Heldin P, 2008, CONNECT TISSUE RES, V49, P215, DOI 10.1080/03008200802143323; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; Hong SP, 2008, J INVEST DERMATOL, V128, P2880, DOI 10.1038/jid.2008.169; Hwang YP, 2011, J DERMATOL SCI, V63, P93, DOI 10.1016/j.jdermsci.2011.04.008; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 2008, SEMIN CANCER BIOL, V18, P268, DOI 10.1016/j.semcancer.2008.03.006; Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439; Jost M, 2000, EUR J DERMATOL, V10, P505; Kakizaki I, 2008, ARCH BIOCHEM BIOPHYS, V471, P85, DOI 10.1016/j.abb.2007.12.004; Karvinen S, 2003, J BIOL CHEM, V278, P49495, DOI 10.1074/jbc.M310445200; Karvinen S, 2003, BRIT J DERMATOL, V148, P86, DOI 10.1046/j.1365-2133.2003.05028.x; Kim DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010290; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Lee SE, 2010, CLIN EXP DERMATOL, V35, P650, DOI 10.1111/j.1365-2230.2009.03699.x; Li YH, 2006, INT J MOL MED, V18, P713; Mack JA, 2012, J INVEST DERMATOL, V132, P198, DOI 10.1038/jid.2011.248; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Masaki H, 2009, J INVEST DERM SYMP P, V14, P50, DOI 10.1038/jidsymp.2009.12; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Maytin EV, 2004, AM J PATHOL, V165, P1331, DOI 10.1016/S0002-9440(10)63391-3; Monslow J, 2009, J INVEST DERMATOL, V129, P2046, DOI 10.1038/jid.2009.9; Monzon ME, 2010, J BIOL CHEM, V285, P26126, DOI 10.1074/jbc.M110.135194; Mouchet N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010776; Nitzki F, 2010, CANCER RES, V70, P2739, DOI 10.1158/0008-5472.CAN-09-3743; Oikari S, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P39; Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x; Pasonen-Seppanen S, 2001, HISTOCHEM CELL BIOL, V116, P287, DOI 10.1007/s004180100312; Pasonen-Seppanen S, 2012, HISTOCHEM CELL BIOL, V137, P107, DOI 10.1007/s00418-011-0883-2; Pasonen-Seppanen SM, 2008, J INVEST DERMATOL, V128, P797, DOI 10.1038/sj.jid.5701098; Passi A, 2004, EXP CELL RES, V296, P123, DOI 10.1016/j.yexer.2004.01.031; Pauloin T, 2009, MOL VIS, V15, P577; Peus D, 1999, J INVEST DERMATOL, V112, P751, DOI 10.1046/j.1523-1747.1999.00584.x; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramamurthi A, 2003, J BIOMED MATER RES A, V66A, P317, DOI 10.1002/jbm.a.10588; REED RK, 1988, ACTA PHYSIOL SCAND, V134, P405, DOI 10.1111/j.1748-1716.1988.tb08508.x; Rezvani HR, 2007, J BIOL CHEM, V282, P16413, DOI 10.1074/jbc.M611397200; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Rilla K, 2013, J BIOL CHEM, V288, P5973, DOI 10.1074/jbc.M112.443879; Rock K, 2011, J BIOL CHEM, V286, P18268, DOI 10.1074/jbc.M110.201665; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Schindler EM, 2009, CANCER RES, V69, P4648, DOI 10.1158/0008-5472.CAN-08-4455; Schulz T, 2007, J BIOL CHEM, V282, P20999, DOI 10.1074/jbc.M700915200; Siiskonen H, 2011, J HISTOCHEM CYTOCHEM, V59, P908, DOI 10.1369/0022155411417874; Spicer Andrew P, 2004, Birth Defects Res C Embryo Today, V72, P89, DOI 10.1002/bdrc.20006; Stern R, 2008, CLIN DERMATOL, V26, P106, DOI 10.1016/j.clindermatol.2007.09.013; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; Suhonen TM, 2003, EUR J PHARM SCI, V20, P107, DOI 10.1016/S0928-0987(03)00176-3; TAKAHASHI Y, 1995, J DERMATOL SCI, V10, P139, DOI 10.1016/0923-1811(95)00396-A; TAMMI R, 1991, J INVEST DERMATOL, V97, P126, DOI 10.1111/1523-1747.ep12478553; Tammi R, 1998, J BIOL CHEM, V273, P28878, DOI 10.1074/jbc.273.44.28878; Tammi R, 2005, J INVEST DERMATOL, V124, P898, DOI 10.1111/j.0022-202X.2005.23697.x; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; TAMMI R, 1988, J INVEST DERMATOL, V90, P412, DOI 10.1111/1523-1747.ep12456530; Tammi R, 2001, J BIOL CHEM, V276, P35111, DOI 10.1074/jbc.M103481200; Tammi RH, 2000, HISTOCHEM CELL BIOL, V113, P265, DOI 10.1007/s004180000128; Tanimoto K, 2001, CONNECT TISSUE RES, V42, P187, DOI 10.3109/03008200109005649; Tobiishi M, 2011, J DERMATOL SCI, V64, P31, DOI 10.1016/j.jdermsci.2011.06.006; Tuhkanen AL, 1997, J INVEST DERMATOL, V109, P213, DOI 10.1111/1523-1747.ep12319402; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Van Laethem A, 2009, PHOTOCH PHOTOBIO SCI, V8, P299, DOI 10.1039/b813346h; WANG C, 1992, HISTOCHEMISTRY, V98, P105, DOI 10.1007/BF00717001; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Wright SC, 1997, FASEB J, V11, P843, DOI 10.1096/fasebj.11.11.9285482; Xu YR, 2006, AM J PATHOL, V169, P823, DOI 10.2353/ajpath.2006.050449; Xu YR, 2009, J CELL BIOCHEM, V107, P873, DOI 10.1002/jcb.22195; YANAGISHITA M, 1989, METHOD ENZYMOL, V179, P435; Yasul H, 2006, BIOCHEM BIOPH RES CO, V347, P83, DOI 10.1016/j.bbrc.2006.06.046; Zhang QS, 2001, INT J ONCOL, V19, P1057; Zhong JL, 2011, PHOTOCHEM PHOTOBIOL, V87, P1092, DOI 10.1111/j.1751-1097.2011.00963.x	91	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17999	18012		10.1074/jbc.M113.472530	http://dx.doi.org/10.1074/jbc.M113.472530			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645665	hybrid, Green Published			2022-12-28	WOS:000320721900007
J	Erat, MC; Sladek, B; Campbell, ID; Vakonakis, I				Erat, Michele C.; Sladek, Barbara; Campbell, Iain D.; Vakonakis, Ioannis			Structural Analysis of Collagen Type I Interactions with Human Fibronectin Reveals a Cooperative Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GELATIN-BINDING; CRYSTAL-STRUCTURE; CRYSTALLOGRAPHIC STRUCTURE; (6)F1(1)F2(2)F2 FRAGMENT; 6 MODULES; DOMAIN; SITES; SCATTERING; IDENTIFICATION; COMPLEXES	Despite its biological importance, the interaction between fibronectin (FN) and collagen, two abundant and crucial tissue components, has not been well characterized on a structural level. Here, we analyzed the four interactions formed between epitopes of collagen type I and the collagen-binding fragment (gelatin-binding domain (GBD)) of human FN using solution NMR, fluorescence, and small angle x-ray scattering methods. Collagen association with FN modules (8-9)FnI occurs through a conserved structural mechanism but exhibits a 400-fold disparity in affinity between collagen sites. This disparity is reduced in the full-length GBD, as (6)FnI(1-2)FnII(7)FnI binds a specific collagen epitope next to the weakest (8-9)FnI-binding site. The cooperative engagement of all GBD modules with collagen results in four broadly equipotent FN-collagen interaction sites. Collagen association stabilizes a distinct monomeric GBD conformation in solution, giving further evidence to the view that FN fragments form well defined functional and structural units.	[Erat, Michele C.; Sladek, Barbara; Campbell, Iain D.; Vakonakis, Ioannis] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Vakonakis, I (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ioannis.vakonakis@bioch.ox.ac.uk			Marie Curie Fellowship under European Commission Framework Programme 7 [235532]; Royal Society research grant [RG100227]; BBSRC [BB/J008265/1];  [088497/Z/09/Z]; Biotechnology and Biological Sciences Research Council [BB/J008265/1] Funding Source: researchfish; Medical Research Council [G0900052] Funding Source: researchfish; MRC [G0900052] Funding Source: UKRI	Marie Curie Fellowship under European Commission Framework Programme 7; Royal Society research grant(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by Marie Curie Fellowship 235532 under European Commission Framework Programme 7 and by Royal Society research grant RG100227.; Wellcome Trust Research Career Development Fellow supported by Grant 088497/Z/09/Z and BBSRC Project Grant BB/J008265/1. To whom correspondence should be addressed: Dept. of Biochemistry, University of Oxford, South Parks Rd., Oxford OX1 3QU, United Kingdom. Tel.: 44-1865-613362; Fax: 44-1865-613201; E-mail: ioannis.vakonakis@bioch.ox.ac.uk.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Atkin KE, 2010, J BIOL CHEM, V285, P36977, DOI 10.1074/jbc.M110.156935; BALIAN G, 1980, J BIOL CHEM, V255, P3234; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BLUMENSTOCK FA, 1993, J LEUKOCYTE BIOL, V54, P56, DOI 10.1002/jlb.54.1.56; Campbell ID, 1998, NAT STRUCT BIOL, V5, P496, DOI 10.1038/733; DESSAU W, 1978, BIOCHEM J, V169, P55, DOI 10.1042/bj1690055; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Erat MC, 2010, J BIOL CHEM, V285, P33764, DOI 10.1074/jbc.M110.139394; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; ERICKSON HP, 1981, J CELL BIOL, V91, P673, DOI 10.1083/jcb.91.3.673; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Graille M, 2010, STRUCTURE, V18, P710, DOI 10.1016/j.str.2010.03.012; Holmes DF, 2010, J MOL BIOL, V399, P9, DOI 10.1016/j.jmb.2010.04.008; HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cb.01.110185.000435; Hynes RO, 1990, FIBRONECTINS; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; KLEINMAN HK, 1976, BIOCHEM BIOPH RES CO, V72, P426, DOI 10.1016/S0006-291X(76)80060-5; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LACELLE P, 1990, BLOOD, V75, P470; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LITVINOVICH SV, 1991, J MOL BIOL, V217, P563, DOI 10.1016/0022-2836(91)90758-X; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; Millard CJ, 2005, FEBS LETT, V579, P4529, DOI 10.1016/j.febslet.2005.05.082; Pagett A, 2005, BIOCHEMISTRY-US, V44, P14682, DOI 10.1021/bi050937i; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Sharma A, 1999, EMBO J, V18, P1468, DOI 10.1093/emboj/18.6.1468; Stultz CM, 2002, J MOL BIOL, V319, P997, DOI 10.1016/S0022-2836(02)00421-7; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	49	52	52	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17441	17450		10.1074/jbc.M113.469841	http://dx.doi.org/10.1074/jbc.M113.469841			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23653354	Green Published, hybrid			2022-12-28	WOS:000320380600036
J	McCarthy, RC; Kosman, DJ				McCarthy, Ryan C.; Kosman, Daniel J.			Ferroportin and Exocytoplasmic Ferroxidase Activity Are Required for Brain Microvascular Endothelial Cell Iron Efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED CERULOPLASMIN; CENTRAL-NERVOUS-SYSTEM; EXPRESSION; HEPHAESTIN; ASTROCYTES; COPPER; OLIGODENDROCYTES; ACCUMULATION; METABOLISM; STABILITY	The mechanism(s) of iron flux across the brain microvasculature endothelial cells (BMVEC) of the blood-brain barrier remains unknown. Although both hephaestin (Hp) and the ferrous iron permease ferroportin (Fpn) have been identified in BMVEC, their roles in iron efflux have not been examined. Using a human BMVEC line (hBMVEC), we have demonstrated that these proteins are required for iron efflux from these cells. Expression of both Hp and Fpn protein was confirmed in hBMVEC by immunoblot and indirect immunofluorescence; we show that hBMVEC express soluble ceruloplasmin (Cp) transcript as well. Depletion of endogenous Hp and Cp via copper chelation leads to the reduction of hBMVEC Fpn protein levels as well as a complete inhibition of Fe-59 efflux. Both hBMVEC Fpn protein and Fe-59 efflux activity are restored upon incubation with 6.6 nM soluble plasma Cp. These results are independent of the source of cell iron, whether delivered as transferrinor non-transferrin-bound Fe-59. Our results demonstrate that iron efflux from hBMVEC Fpn requires the action of an exocytoplasmic ferroxidase, which can be either endogenous Hp or extracellular Cp.	[McCarthy, Ryan C.; Kosman, Daniel J.] SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Kosman, DJ (corresponding author), SUNY Buffalo, Dept Biochem, Farber Hall Rm 140,3435 Main St,Bldg 26, Buffalo, NY 14214 USA.	camkos@buffalo.edu			National Institutes of Health [DK053820]; American Heart Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053820, R56DK053820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grant DK053820 from the National Institutes of Health (to D. J. K.) and a predoctoral fellowship from the American Heart Association (to R. C. M.).	Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Anderson GJ, 2009, CELL MOL LIFE SCI, V66, P3241, DOI 10.1007/s00018-009-0051-1; Chen HJ, 2009, J CELL BIOCHEM, V107, P803, DOI 10.1002/jcb.22178; Chung B, 2009, J NUTR, V139, P1457, DOI 10.3945/jn.108.102905; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Dringen R, 2007, NEUROCHEM RES, V32, P1884, DOI 10.1007/s11064-007-9375-0; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Ganz T, 2005, CELL METAB, V1, P155, DOI 10.1016/j.cmet.2005.02.005; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Greenough MA, 2013, NEUROCHEM INT, V62, P540, DOI 10.1016/j.neuint.2012.08.014; Han O, 2007, J CELL BIOCHEM, V101, P1000, DOI 10.1002/jcb.21392; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Klomp LWJ, 1996, HUM MOL GENET, V5, P1989, DOI 10.1093/hmg/5.12.1989; Klomp LWJ, 1996, J CLIN INVEST, V98, P207, DOI 10.1172/JCI118768; Kono S, 2010, BBA-MOL BASIS DIS, V1802, P968, DOI 10.1016/j.bbadis.2010.07.011; Leipuviene R, 2007, CELL MOL LIFE SCI, V64, P2945, DOI 10.1007/s00018-007-7198-4; Marques L, 2012, BLOOD CELL MOL DIS, V48, P110, DOI 10.1016/j.bcmd.2011.11.005; McCarthy RC, 2012, BIOMETALS, V25, P665, DOI 10.1007/s10534-012-9538-6; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Nittis T, 2004, J BIOL CHEM, V279, P25696, DOI 10.1074/jbc.M401151200; Patel BN, 2000, J BIOL CHEM, V275, P4305, DOI 10.1074/jbc.275.6.4305; Patel BN, 1997, J BIOL CHEM, V272, P20185, DOI 10.1074/jbc.272.32.20185; Prohaska JR, 2005, J NEUROCHEM, V93, P698, DOI 10.1111/j.1471-4159.2005.03091.x; Qian ZM, 2007, J CELL BIOCHEM, V102, P1225, DOI 10.1002/jcb.21352; Qiao B, 2012, CELL METAB, V15, P918, DOI 10.1016/j.cmet.2012.03.018; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Salvador GA, 2010, BIOFACTORS, V36, P103, DOI 10.1002/biof.80; Schulz K, 2011, J NEUROSCI, V31, P13301, DOI 10.1523/JNEUROSCI.2838-11.2011; Sedlak E, 2008, BIOPHYS J, V94, P1384, DOI 10.1529/biophysj.107.113696; Skjorringe T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00169; Slany A, 2010, J PROTEOME RES, V9, P6, DOI 10.1021/pr900057t; Thomas C, 2004, GUT, V53, P44, DOI 10.1136/gut.53.1.44; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Wang J, 2007, EUR J NEUROSCI, V25, P2766, DOI 10.1111/j.1460-9568.2007.05515.x; Wolkow N, 2012, AM J PATHOL, V180, P1614, DOI 10.1016/j.ajpath.2011.12.041; Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066; Yang WM, 2011, CELL MOL NEUROBIOL, V31, P93, DOI 10.1007/s10571-010-9558-0	40	53	54	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17932	17940		10.1074/jbc.M113.455428	http://dx.doi.org/10.1074/jbc.M113.455428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640881	hybrid, Green Published			2022-12-28	WOS:000320380600080
J	Pikuleva, IA; Waterman, MR				Pikuleva, Irina A.; Waterman, Michael R.			Cytochromes P450: Roles in Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							VITAMIN-D 25-HYDROXYLASE; CHAIN CLEAVAGE ENZYME; D-3 1-ALPHA-HYDROXYLASE GENE; BILE-ACID SYNTHESIS; 46,XY SEX REVERSAL; CEREBROTENDINOUS-XANTHOMATOSIS; CHOLESTEROL 24-HYDROXYLASE; ALDOSTERONE SYNTHASE; STEROL 27-HYDROXYLASE; ADRENAL INSUFFICIENCY	The cytochrome P450 superfamily consists of a large number of heme-containing monooxygenases. Many human P450s metabolize drugs used to treat human diseases. Others are necessary for synthesis of endogenous compounds essential for human physiology. In some instances, alterations in specific P450s affect the biological processes that they mediate and lead to a disease. In this minireview, we describe medically significant human P450s (from families 2, 4, 7, 11, 17, 19, 21, 24, 27, 46, and 51) and the diseases associated with these P450s.	[Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Waterman, Michael R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Case Western Reserve University; Vanderbilt University	Pikuleva, IA (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA.	iap8@case.edu		Pikuleva, Irina/0000-0001-9742-6232	National Institutes of Health from the United States Public Health Service [GM62882, GM67871]; Research to Prevent Blindness; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067871, R01GM062882] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM62882 (to I. A. P) and GM67871 (to M. R. W) from the United States Public Health Service. This is the fourth article in the Thematic Minireview Series on Cytochrome P450.; Recipient of a Jules and Doris Stein professorship from the Research to Prevent Blindness. To whom correspondence should be addressed. E-mail: iap8@case.edu.	Adams JS, 2012, ARCH BIOCHEM BIOPHYS, V523, P95, DOI 10.1016/j.abb.2012.02.016; AKIBA T, 1980, BIOCHEM BIOPH RES CO, V94, P313, DOI 10.1016/S0006-291X(80)80222-1; al Kandari Hessa, 2006, J Clin Endocrinol Metab, V91, P2821, DOI 10.1210/jc.2005-2230; Al Mutair AN, 2012, J CLIN ENDOCR METAB, V97, pE2022, DOI 10.1210/jc.2012-1340; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; Biancheri R, 2009, NEUROMUSCULAR DISORD, V19, P62, DOI 10.1016/j.nmd.2008.10.009; Bjorkhem I, 1997, J BIOL CHEM, V272, P30178, DOI 10.1074/jbc.272.48.30178; Bjorkhem I., 1995, METABOLIC MOL BASES, P2073; Brown J, 2004, J BIOL CHEM, V279, P34674, DOI 10.1074/jbc.M402324200; Buzdar AU, 2002, CANCER, V95, P2006, DOI 10.1002/cncr.10908; CALI JJ, 1991, J BIOL CHEM, V266, P7774; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Capdevila JH, 2007, KIDNEY INT, V72, P683, DOI 10.1038/sj.ki.5002394; Capidevila JH, 2007, CURR OPIN NEPHROL HY, V16, P465, DOI 10.1097/MNH.0b013e32827ab48c; Charlesworth Jac C, 2009, BMC Proc, V3 Suppl 7, pS92; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Cheng JB, 2003, J BIOL CHEM, V278, P38084, DOI 10.1074/jbc.M307028200; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Cui NY, 2012, BONE, V51, P563, DOI 10.1016/j.bone.2012.05.006; Dauber A, 2012, J CLIN ENDOCR METAB, V97, pE268, DOI 10.1210/jc.2011-1972; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Dong Q, 2004, MOL GENET METAB, V83, P197, DOI 10.1016/j.ymgme.2004.07.006; Famer D, 2007, BIOCHEM BIOPH RES CO, V359, P46, DOI 10.1016/j.bbrc.2007.05.033; Fourgeux C, 2009, INVEST OPHTH VIS SCI, V50, P5712, DOI 10.1167/iovs.09-3655; Fu GK, 1997, MOL ENDOCRINOL, V11, P1961, DOI 10.1210/me.11.13.1961; Gainer JV, 2008, J AM SOC NEPHROL, V19, P1606, DOI 10.1681/ASN.2008010063; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; Gallus GN, 2006, NEUROL SCI, V27, P143, DOI 10.1007/s10072-006-0618-7; Gallus GN, 2010, EUR J NEUROL, V17, P1259, DOI 10.1111/j.1468-1331.2010.03002.x; Geller DH, 1997, NAT GENET, V17, P201, DOI 10.1038/ng1097-201; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Goizet C, 2009, BRAIN, V132, P1589, DOI 10.1093/brain/awp073; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Guengerich F. R., 2012, METABOLISM DRUGS OTH, P27, DOI [10.1002/9783527630905.ch2, DOI 10.1002/9783527630905.CH2]; Hampf M, 2001, J CLIN ENDOCR METAB, V86, P4445, DOI 10.1210/jc.86.9.4445; Hiort O, 2005, J CLIN ENDOCR METAB, V90, P538, DOI 10.1210/jc.2004-1059; Hiratsuka M, 2006, MUTAT RES-FUND MOL M, V599, P98, DOI 10.1016/j.mrfmmm.2006.02.008; Jones MEE, 2007, NAT CLIN PRACT ENDOC, V3, P414, DOI 10.1038/ncpendmet0477; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Katsumata N, 2002, J CLIN ENDOCR METAB, V87, P3808, DOI 10.1210/jc.87.8.3808; Keber R, 2011, J BIOL CHEM, V286, P29086, DOI 10.1074/jbc.M111.253245; Kim CJ, 2008, J CLIN ENDOCR METAB, V93, P696, DOI 10.1210/jc.2007-2330; Kitanaka S, 1999, J CLIN ENDOCR METAB, V84, P4111, DOI 10.1210/jc.84.11.4111; Kitanaka S, 1998, NEW ENGL J MED, V338, P653, DOI 10.1056/NEJM199803053381004; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; Levine MA, 2007, BONE, V40, pS60, DOI 10.1016/j.bone.2007.04.079; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16543, DOI 10.1074/jbc.M001810200; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; Lorincz MT, 2005, ARCH NEUROL-CHICAGO, V62, P1459, DOI 10.1001/archneur.62.9.1459; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; Martin KO, 1997, J LIPID RES, V38, P1053; Mast N, 2011, J BIOL CHEM, V286, P5607, DOI 10.1074/jbc.M110.188433; Miller WL, 2011, J LIPID RES, V52, P2111, DOI 10.1194/jlr.R016675; Mossbock G, 2011, MOL VIS, V17, P616; Nguyen HH, 2010, MOL GENET METAB, V100, P357, DOI 10.1016/j.ymgme.2010.04.016; Omoto Y, 2005, P NATL ACAD SCI USA, V102, P2814, DOI 10.1073/pnas.0500198102; Parajes S, 2010, J CLIN ENDOCR METAB, V95, P779, DOI 10.1210/jc.2009-0651; Peter M, 1999, HORM RES, V51, P211, DOI 10.1159/000023374; Pikuleva IA, 2008, EXPERT OPIN DRUG MET, V4, P1403, DOI 10.1517/17425255.4.11.1403 ; Pilo-de-la-Fuente B, 2011, EUR J NEUROL, V18, P1203, DOI 10.1111/j.1468-1331.2011.03439.x; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; Rose K, 2001, J BIOL CHEM, V276, P23937, DOI 10.1074/jbc.M011564200; Rose KA, 1997, P NATL ACAD SCI USA, V94, P4925, DOI 10.1073/pnas.94.10.4925; Rubtsov P, 2009, J CLIN ENDOCR METAB, V94, P936, DOI 10.1210/jc.2008-1118; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Sahakitrungruang T, 2011, J CLIN ENDOCR METAB, V96, P792, DOI 10.1210/jc.2010-1828; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; Schule R, 2009, NEUROGENETICS, V10, P97, DOI 10.1007/s10048-008-0158-9; Schuster I, 2011, BBA-PROTEINS PROTEOM, V1814, P186, DOI 10.1016/j.bbapap.2010.06.022; Schwarz M, 2001, J LIPID RES, V42, P1594; Schwarz M, 1997, J BIOL CHEM, V272, P23995, DOI 10.1074/jbc.272.38.23995; Setchell KDR, 1998, J CLIN INVEST, V102, P1690, DOI 10.1172/JCI2962; Simpson ER, 2011, EXPERT REV ENDOCRINO, V6, P383, DOI [10.1586/eem.11.35, 10.1586/EEM.11.35]; STAPLETON G, 1995, J BIOL CHEM, V270, P29739, DOI 10.1074/jbc.270.50.29739; Stiles AR, 2009, J BIOL CHEM, V284, P28485, DOI 10.1074/jbc.R109.042168; Streeten EA, 2011, NEW ENGL J MED, V365, P1741, DOI 10.1056/NEJMc1110226; Strushkevich N, 2008, J MOL BIOL, V380, P95, DOI 10.1016/j.jmb.2008.03.065; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Tajima T, 2001, J CLIN ENDOCR METAB, V86, P3820, DOI 10.1210/jc.86.8.3820; Tebben PJ, 2012, J CLIN ENDOCR METAB, V97, pE423, DOI 10.1210/jc.2011-1935; Tsaousidou MK, 2008, AM J HUM GENET, V82, P510, DOI 10.1016/j.ajhg.2007.10.001; Ueki I, 2008, J PEDIATR GASTR NUTR, V46, P465, DOI 10.1097/MPG.0b013e31815a9911; Vasaitis TS, 2011, J STEROID BIOCHEM, V125, P23, DOI 10.1016/j.jsbmb.2010.11.005; Wang JT, 1998, AM J HUM GENET, V63, P1694, DOI 10.1086/302156; Wang XM, 2002, J CLIN ENDOCR METAB, V87, P2424, DOI 10.1210/jc.87.6.2424; Weihua Z, 2002, P NATL ACAD SCI USA, V99, P13589, DOI 10.1073/pnas.162477299; White PC, 2000, ENDOCR REV, V21, P245, DOI 10.1210/er.21.3.245; WHITE PC, 1994, ENDOCR REV, V15, P421, DOI 10.1210/er.15.4.421; WHITE PC, 1986, HUM IMMUNOL, V15, P404, DOI 10.1016/0198-8859(86)90018-2; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P449, DOI 10.1016/j.coph.2008.06.004; Zhao B, 2012, J BIOL CHEM, V287, P10613, DOI 10.1074/jbc.M111.323501; Zhu JG, 2012, ARCH BIOCHEM BIOPHYS, V523, P30, DOI 10.1016/j.abb.2012.01.013	95	60	64	1	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17091	17098		10.1074/jbc.R112.431916	http://dx.doi.org/10.1074/jbc.R112.431916			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632021	Green Published, hybrid			2022-12-28	WOS:000320380600007
J	Dauden, MI; Martin-Benito, J; Sanchez-Ferrero, JC; Pulido-Cid, M; Valpuesta, JM; Carrascosa, JL				Dauden, Maria I.; Martin-Benito, Jaime; Sanchez-Ferrero, Juan C.; Pulido-Cid, Mar; Valpuesta, Jose M.; Carrascosa, Jose L.			Large Terminase Conformational Change Induced by Connector Binding in Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA PACKAGING MOTOR; PARTICLE ELECTRON CRYOMICROSCOPY; SITE-DIRECTED MUTAGENESIS; IMAGE-PROCESSING PACKAGE; DEFINED INVITRO SYSTEM; IN-VITRO SYSTEM; ATPASE ACTIVITY; FUNCTIONAL DOMAINS; PORTAL PROTEIN; LARGE SUBUNIT	Background: The complex formed by the terminase and the connector provides the structural framework and the chemical energy for DNA packaging during bacteriophage morphogenesis. Results: The terminase builds a pentamer that presents two conformational topologies. Conclusion: The conformational change of the terminase might be coupled to DNA packaging. Significance: Terminase function might be based on concerted intersubunit movement within the connector-terminase complex.	[Dauden, Maria I.; Martin-Benito, Jaime; Pulido-Cid, Mar; Valpuesta, Jose M.; Carrascosa, Jose L.] CSIC, Dept Macromol Struct, Madrid 28049, Spain; [Sanchez-Ferrero, Juan C.] CSIC, Ctr Nacl Biotecnol, Computat Syst Biol Grp, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Carrascosa, JL (corresponding author), CSIC, Dept Macromol Struct, Madrid 28049, Spain.	jlcarras@cnb.csic.es	Valpuesta, Jose M/AAA-6002-2019; Dauden, Maria I./AAA-4248-2021; Valpuesta, José M/T-1977-2017	Dauden, Maria I./0000-0003-2129-3941; Valpuesta, José M/0000-0001-7468-8053; Martin-Benito Romero, Jaime/0000-0002-8541-4709	BFU [2011-29038]; Ministerio de Ciencia e Innovacion (MICINN) [S2009/Mat 1507]; Comunidad de Madrid [2011-25090/BMC]; MICINN	BFU; Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by Grants BFU 2011-29038 of Ministerio de Ciencia e Innovacion (MICINN) and S2009/Mat 1507 from Comunidad de Madrid (to J.L.C.) and BFU 2011-25090/BMC of MICINN (to J.M.-B.).	Aathavan K, 2009, NATURE, V461, P669, DOI 10.1038/nature08443; Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Agirrezabala X, 2005, J MOL BIOL, V347, P895, DOI 10.1016/j.jmb.2005.02.005; Agirrezabala X, 2007, STRUCTURE, V15, P461, DOI 10.1016/j.str.2007.03.004; Bamford DH, 2005, CURR OPIN STRUC BIOL, V15, P655, DOI 10.1016/j.sbi.2005.10.012; Baumann RG, 2006, MOL MICROBIOL, V61, P16, DOI 10.1111/j.1365-2958.2006.05203.x; Buttner CR, 2012, P NATL ACAD SCI USA, V109, P811, DOI 10.1073/pnas.1110270109; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Cerritelli ME, 2003, ADV PROTEIN CHEM, V64, P301; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Cuervo A., 2012, ELS, DOI [10.1002/9780470015902.A0024053, DOI 10.1002/9780470015902.A0024053]; Cuervo A, 2012, CURR OPIN BIOTECH, V23, P529, DOI 10.1016/j.copbio.2011.11.029; DAVIS RW, 1971, J MOL BIOL, V62, P287, DOI 10.1016/0022-2836(71)90428-1; de Beer T, 2002, MOL CELL, V9, P981, DOI 10.1016/S1097-2765(02)00537-3; Draper B, 2007, J MOL BIOL, V369, P79, DOI 10.1016/j.jmb.2007.03.019; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FUJISAWA H, 1991, VIROLOGY, V185, P788, DOI 10.1016/0042-6822(91)90550-U; Fuller DN, 2007, J MOL BIOL, V373, P1113, DOI 10.1016/j.jmb.2007.09.011; Fuller DN, 2007, P NATL ACAD SCI USA, V104, P16868, DOI 10.1073/pnas.0704008104; Goetzinger KR, 2003, J MOL BIOL, V331, P139, DOI 10.1016/S0022-2836(03)00636-3; Gual A, 2000, J BIOL CHEM, V275, P35311, DOI 10.1074/jbc.M004309200; Guasch A, 2002, J MOL BIOL, V315, P663, DOI 10.1006/jmbi.2001.5278; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; HAMADA K, 1986, VIROLOGY, V151, P110, DOI 10.1016/0042-6822(86)90108-X; HAMADA K, 1987, VIROLOGY, V159, P244, DOI 10.1016/0042-6822(87)90461-2; HAMADA K, 1986, VIROLOGY, V151, P119, DOI 10.1016/0042-6822(86)90109-1; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hegde S, 2012, J VIROL, V86, P4046, DOI 10.1128/JVI.07197-11; HENDRIX RW, 1978, P NATL ACAD SCI USA, V75, P4779, DOI 10.1073/pnas.75.10.4779; Hugel T, 2007, PLOS BIOL, V5, P558, DOI 10.1371/journal.pbio.0050059; Hwang Y, 1996, J MOL BIOL, V261, P524, DOI 10.1006/jmbi.1996.0480; Ionel A, 2011, J BIOL CHEM, V286, P234, DOI 10.1074/jbc.M110.187211; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; KIMURA M, 1991, VIROLOGY, V180, P709, DOI 10.1016/0042-6822(91)90084-O; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Leffers G, 2000, J BIOL CHEM, V275, P37127, DOI 10.1074/jbc.M003357200; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; MANNE V, 1982, J BIOL CHEM, V257, P13223; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Mertens J, 2012, SENSOR ACTUAT B-CHEM, V171, P263, DOI 10.1016/j.snb.2012.03.062; Mertens J, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/1/015501; Mettenleiter TC, 2006, CURR OPIN MICROBIOL, V9, P423, DOI 10.1016/j.mib.2006.06.013; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; MORITA M, 1995, VIROLOGY, V211, P516, DOI 10.1006/viro.1995.1433; MORITA M, 1995, J MOL BIOL, V245, P635, DOI 10.1006/jmbi.1994.0052; MORITA M, 1994, J MOL BIOL, V235, P248, DOI 10.1016/S0022-2836(05)80031-2; MORITA M, 1993, VIROLOGY, V193, P748, DOI 10.1006/viro.1993.1183; Nadal M, 2010, P NATL ACAD SCI USA, V107, P16078, DOI 10.1073/pnas.1007144107; Nemecek D, 2008, J MOL BIOL, V383, P494, DOI 10.1016/j.jmb.2008.08.050; Nemecek D, 2007, J MOL BIOL, V374, P817, DOI 10.1016/j.jmb.2007.08.070; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Oliveira L, 2006, J BIOL CHEM, V281, P21914, DOI 10.1074/jbc.M603314200; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Orlova EV, 1999, NAT STRUCT BIOL, V6, P842; Oster G, 2000, BBA-BIOENERGETICS, V1458, P482, DOI 10.1016/S0005-2728(00)00096-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; Roy A, 2012, STRUCTURE, V20, P1403, DOI 10.1016/j.str.2012.05.014; Roy A, 2012, J BIOL CHEM, V287, P28196, DOI 10.1074/jbc.M112.349894; Scheres SHW, 2005, BIOINFORMATICS, V21, P243, DOI 10.1093/bioinformatics/bti1140; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; SHIBATA H, 1987, J MOL BIOL, V196, P845, DOI 10.1016/0022-2836(87)90409-8; SHIBATA H, 1987, VIROLOGY, V159, P250, DOI 10.1016/0042-6822(87)90462-4; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Smits C, 2009, EMBO REP, V10, P592, DOI 10.1038/embor.2009.53; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Sun S, 2012, P NATL ACAD SCI USA, V109, P817, DOI 10.1073/pnas.1110224109; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; Trus BL, 2004, J VIROL, V78, P12668, DOI 10.1128/JVI.78.22.12668-12671.2004; Valpuesta JM, 2000, J STRUCT BIOL, V131, P146, DOI 10.1006/jsbi.2000.4281; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510; Vlieghe D, 1999, ACTA CRYSTALLOGR D, V55, P1495, DOI 10.1107/S0907444999007933; Wang HY, 1998, NATURE, V396, P279, DOI 10.1038/24409; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; Zhao HY, 2012, J MOL BIOL, V423, P413, DOI 10.1016/j.jmb.2012.07.016	86	26	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 7	2013	288	23					16998	17007		10.1074/jbc.M112.448951	http://dx.doi.org/10.1074/jbc.M112.448951			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	163ZU	23632014	Green Published, hybrid			2022-12-28	WOS:000320378900071
J	Fujieda, N; Yabuta, S; Ikeda, T; Oyama, T; Muraki, N; Kurisu, G; Itoh, S				Fujieda, Nobutaka; Yabuta, Shintaro; Ikeda, Takuya; Oyama, Takuji; Muraki, Norifumi; Kurisu, Genji; Itoh, Shinobu			Crystal Structures of Copper-depleted and Copper-bound Fungal Pro-tyrosinase INSIGHTS INTO ENDOGENOUS CYSTEINE-DEPENDENT COPPER INCORPORATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Copper; Copper Transport; Post-translational Modification; Protein Cross-linking; Tyrosinase; Copper Chaperone; Protein-derived Cofactor; Zymogen	MECHANISM; RECOGNITION; PROTEIN; CLONING; OXIDASE; GENE	Tyrosinase, a dinuclear copper monooxygenase/oxidase, plays a crucial role in the melanin pigment biosynthesis. The structure and functions of tyrosinase have so far been studied extensively, but the post-translational maturation process from the pro-form to the active form has been less explored. In this study, we provide the crystal structures of Aspergillus oryzae full-length pro-tyrosinase in the holo- and the apo-forms at 1.39 and 2.05 resolution, respectively, revealing that Phe(513) on the C-terminal domain is accommodated in the substrate-binding site as a substrate analog to protect the dicopper active site from substrate access (proteolytic cleavage of the C-terminal domain or deformation of the C-terminal domain by acid treatment transforms the pro-tyrosinase to the active enzyme (Fujieda, N., Murata, M., Yabuta, S., Ikeda, T., Shimokawa, C., Nakamura, Y., Hata, Y., and Itoh, S. (2012) ChemBioChem. 13, 193-201 and Fujieda, N., Murata, M., Yabuta, S., Ikeda, T., Shimokawa, C., Nakamura, Y., Hata, Yl, and Itoh, S. (2013) J. Biol. Inorg. Chem. 18, 19-26). Detailed crystallographic analysis and structure-based mutational studies have shown that the copper incorporation into the active site is governed by three cysteines as follows: Cys(92), which is covalently bound to His(94) via an unusual thioether linkage in the holo-form, and Cys(522) and Cys(525) of the CXXC motif located on the C-terminal domain. Molecular mechanisms of the maturation processes of fungal tyrosinase involving the accommodation of the dinuclear copper unit, the post-translational His-Cys thioether cross-linkage formation, and the proteolytic C-terminal cleavage to produce the active tyrosinase have been discussed on the basis of the detailed structural information.	[Fujieda, Nobutaka; Yabuta, Shintaro; Ikeda, Takuya; Itoh, Shinobu] Osaka Univ, Grad Sch Engn, Div Adv Sci & Biotechnol, Dept Mat & Life Sci, Suita, Osaka 5650871, Japan; [Oyama, Takuji; Muraki, Norifumi; Kurisu, Genji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kurisu, G (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamada Oka, Suita, Osaka 5650871, Japan.	gkurisu@protein.osaka-u.ac.jp; shinobu@mls.eng.osaka-u.ac.jp	Fujieda, Nobutaka/AED-3193-2022; Itoh, Shinobu/AAF-4038-2020; KURISU, GENJI/ABA-5960-2020; Muraki, Norifumi/AAW-2540-2020; KURISU, GENJI/AAD-7109-2022	Fujieda, Nobutaka/0000-0003-1045-6063; KURISU, GENJI/0000-0002-5354-0807; Muraki, Norifumi/0000-0003-4112-2955; KURISU, GENJI/0000-0002-5354-0807; Oyama, Takuji/0000-0002-3411-7608	Ministry of Education, Culture, Sports, Science and Technology. Japan [22105007, 20038784]; Grants-in-Aid for Scientific Research [22105007] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology. Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid for Scientific Research on Innovative Areas (Molecular Activation Directed toward Straightforward Synthesis) 22105007 (to S. I.) and Grant-in-aid for Challenging Exploratory Research 20038784 from the Ministry of Education, Culture, Sports, Science and Technology. Japan (to N. F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; Davis AV, 2008, NAT CHEM BIOL, V4, P148, DOI 10.1038/nchembio0308-148; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flurkey WH, 2008, J INORG BIOCHEM, V102, P2160, DOI 10.1016/j.jinorgbio.2008.08.007; Fujieda N, 2012, CHEMBIOCHEM, V13, P193, DOI 10.1002/cbic.201100609; Fujieda N, 2011, J AM CHEM SOC, V133, P1180, DOI 10.1021/ja108280w; Gaetke LM, 2003, TOXICOLOGY, V189, P147, DOI 10.1016/S0300-483X(03)00159-8; Halaouli S, 2006, APPL MICROBIOL BIOT, V70, P580, DOI 10.1007/s00253-005-0109-4; HAZES B, 1993, PROTEIN SCI, V2, P597; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ismaya WT, 2011, BIOCHEMISTRY-US, V50, P5477, DOI 10.1021/bi200395t; ITOH S, 2004, COMPREHENSIVE COORDI, V8, P369; Itoh S, 2007, ACCOUNTS CHEM RES, V40, P592, DOI 10.1021/ar6000395; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KARLIN KD, 1993, SCIENCE, V261, P701, DOI 10.1126/science.7688141; Kawamura-Konishi Y, 2007, BIOSCI BIOTECH BIOCH, V71, P1752, DOI 10.1271/bbb.70171; Klabunde T, 1998, NAT STRUCT BIOL, V5, P1084, DOI 10.1038/4193; KUPPER U, 1989, J BIOL CHEM, V264, P17250; Li YC, 2009, P NATL ACAD SCI USA, V106, P17002, DOI 10.1073/pnas.0906095106; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Matoba Y, 2011, J BIOL CHEM, V286, P30219, DOI 10.1074/jbc.M111.256818; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Robinson NJ, 2010, ANNU REV BIOCHEM, V79, P537, DOI 10.1146/annurev-biochem-030409-143539; Sendovski M, 2011, J MOL BIOL, V405, P227, DOI 10.1016/j.jmb.2010.10.048; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yike I, 2011, MYCOPATHOLOGIA, V171, P299, DOI 10.1007/s11046-010-9386-2	32	54	54	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22128	22140		10.1074/jbc.M113.477612	http://dx.doi.org/10.1074/jbc.M113.477612			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23749993	hybrid, Green Published			2022-12-28	WOS:000328841900056
J	Lloyd, SJA; Raychaudhuri, S; Espenshade, PJ				Lloyd, S. Julie-Ann; Raychaudhuri, Sumana; Espenshade, Peter J.			Subunit Architecture of the Golgi Dsc E3 Ligase Required for Sterol Regulatory Element-binding Protein (SREBP) Cleavage in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNSATURATED FATTY-ACIDS; UBIQUITIN; DISLOCATION; CDC48; UBXD8; DEGRADATION; MACHINERY; DERLIN-1; REVEALS; DOMAINS	The membrane-bound sterol regulatory element-binding protein (SREBP) transcription factors regulate lipogenesis in mammalian cells and are activated through sequential cleavage by the Golgi-localized Site-1 and Site-2 proteases. The mechanism of fission yeast SREBP cleavage is less well defined and, in contrast, requires the Golgi-localized Dsc E3 ligase complex. The Dsc E3 ligase consists of five integral membrane subunits, Dsc1 through Dsc5, and resembles membrane E3 ligases that function in endoplasmic reticulum-associated degradation. Using immunoprecipitation assays and blue native electrophoresis, we determined the subunit architecture for the complex of Dsc1 through Dsc5, showing that the Dsc proteins form sub-complexes and display defined connectivity. Dsc2 is a rhomboid pseudoprotease family member homologous to mammalian UBAC2 and a central component of the Dsc E3 ligase. We identified conservation in the architecture of the Dsc E3 ligase and the multisubunit E3 ligase gp78 in mammals. Specifically, Dsc1-Dsc2-Dsc5 forms a complex resembling gp78-UBAC2-UBXD8. Further characterization of Dsc2 revealed that its C-terminal UBA domain can bind to ubiquitin chains but that the Dsc2 UBA domain is not essential for yeast SREBP cleavage. Based on the ability of rhomboid superfamily members to bind transmembrane proteins, we speculate that Dsc2 functions in SREBP recognition and binding. Homologs of Dsc1 through Dsc4 are required for SREBP cleavage and virulence in the human opportunistic pathogen Aspergillus fumigatus. Thus, these studies advance our organizational understanding of multisubunit E3 ligases involved in endoplasmic reticulum-associated degradation and fungal pathogenesis.	[Lloyd, S. Julie-Ann; Raychaudhuri, Sumana; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu		Raychaudhuri, Sumana/0000-0002-3164-0057	National Institutes of Health [R01 HL077588, F31 HL097668]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588, F31HL097668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL077588 (to P. J. E.) and F31 HL097668 (S. J. L.).	Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gordon C, 1996, J BIOL CHEM, V271, P5704, DOI 10.1074/jbc.271.10.5704; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lee JN, 2010, P NATL ACAD SCI USA, V107, P21424, DOI 10.1073/pnas.1011859107; Lee JN, 2008, J BIOL CHEM, V283, P33772, DOI 10.1074/jbc.M806108200; Lemberg MK, 2013, TRENDS CELL BIOL, V23, P210, DOI 10.1016/j.tcb.2013.01.002; Matta-Camacho E, 2009, J MOL BIOL, V386, P569, DOI 10.1016/j.jmb.2008.09.086; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Olzmann JA, 2012, COLD SPRING HARB PER, V5, DOI DOI 10.1101/CSHPERSPECT.A013185; Olzmann JA, 2013, P NATL ACAD SCI USA, V110, P1345, DOI 10.1073/pnas.1213738110; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Porter JR, 2010, J BIOL CHEM, V285, P41051, DOI 10.1074/jbc.M110.144337; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Reggiori F, 2002, NAT CELL BIOL, V4, P117, DOI 10.1038/ncb743; Ryan CJ, 2012, MOL CELL, V46, P691, DOI 10.1016/j.molcel.2012.05.028; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Suzuki M, 2012, MOL BIOL CELL, V23, P800, DOI 10.1091/mbc.E11-11-0950; Todd BL, 2006, MOL CELL BIOL, V26, P2817, DOI 10.1128/MCB.26.7.2817-2831.2006; Tse MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028511; Willger SD, 2012, EUKARYOT CELL, V11, P1557, DOI 10.1128/EC.00252-12; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200; Zettl M, 2011, CELL, V145, P79, DOI 10.1016/j.cell.2011.02.047; Ziegler FD, 1999, GLYCOBIOLOGY, V9, P497, DOI 10.1093/glycob/9.5.497; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031	42	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21043	21054		10.1074/jbc.M113.468215	http://dx.doi.org/10.1074/jbc.M113.468215			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23760507	hybrid, Green Published			2022-12-28	WOS:000322014400025
J	Ngo, KV; Molzberger, ET; Chitteni-Pattu, S; Cox, MM				Ngo, Khanh V.; Molzberger, Eileen T.; Chitteni-Pattu, Sindhu; Cox, Michael M.			Regulation of Deinococcus radiodurans RecA Protein Function via Modulation of Active and Inactive Nucleoprotein Filament States	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; DEPENDENT ATPASE ACTIVITY; ESCHERICHIA-COLI; BINDING-PROTEIN; IONIZING-RADIATION; KINETIC MECHANISM; DUPLEX DNA; CONFORMATIONAL-CHANGES; QUANTITATIVE-ANALYSIS; CRYSTAL-STRUCTURE	The RecA protein of Deinococcus radiodurans (DrRecA) has a central role in genome reconstitution after exposure to extreme levels of ionizing radiation. When bound to DNA, filaments of DrRecA protein exhibit active and inactive states that are readily interconverted in response to several sets of stimuli and conditions. At 30 degrees C, the optimal growth temperature, and at physio-logical pH 7.5, DrRecA protein binds to double-stranded DNA (dsDNA) and forms extended helical filaments in the presence of ATP. However, the ATP is not hydrolyzed. ATP hydrolysis of the DrRecA-dsDNA filament is activated by addition of single-stranded DNA, with or without the single-stranded DNA-binding protein. The ATPase function of DrRecA nucleoprotein filaments thus exists in an inactive default state under some conditions. ATPase activity is thus not a reliable indicator of DNA binding for all bacterial RecA proteins. Activation is effected by situations in which the DNA substrates needed to initiate recombinational DNA repair are present. The inactive state can also be activated by decreasing the pH (protonation of multiple ionizable groups is required) or by addition of volume exclusion agents. Single-stranded DNA-binding protein plays a much more central role in DNA pairing and strand exchange catalyzed by DrRecA than is the case for the cognate proteins in Escherichia coli. The data suggest a mechanism to enhance the efficiency of recombinational DNA repair in the context of severe genomic degradation in D. radiodurans.	[Ngo, Khanh V.; Molzberger, Eileen T.; Chitteni-Pattu, Sindhu; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	cox@biochem.wisc.edu			National Institutes of Health Grant from the NIGMS [GM32335]; Advanced Opportunity Fellowship from the University of Wisconsin College of Agricultural and Life Sciences; Genentech predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335, U01GM032335] Funding Source: NIH RePORTER	National Institutes of Health Grant from the NIGMS; Advanced Opportunity Fellowship from the University of Wisconsin College of Agricultural and Life Sciences; Genentech predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32335 from the NIGMS (to M. M. C.). This work was also supported by an Advanced Opportunity Fellowship from the University of Wisconsin College of Agricultural and Life Sciences and a Genentech predoctoral fellowship (both to K. V. N.). Michael M. Cox is a board member and shareholder of Recombitech, Inc., which is applying recombinational DNA repair to problems in medical diagnostics. His relationship to the company is managed by the University of Wisconsin-Madison in accordance with its conflict of interest policies.	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Baitin DM, 2008, J BACTERIOL, V190, P3036, DOI 10.1128/JB.01006-07; Bedale WA, 1996, J BIOL CHEM, V271, P5725, DOI 10.1074/jbc.271.10.5725; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Bevilacqua PC, 2003, BIOCHEMISTRY-US, V42, P2259, DOI 10.1021/bi027273m; Bork JM, 2001, J BIOL CHEM, V276, P45740, DOI 10.1074/jbc.M109247200; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Carroll JD, 1996, J BACTERIOL, V178, P130, DOI 10.1128/jb.178.1.130-135.1996; Cox JM, 2006, J BIOL CHEM, V281, P12968, DOI 10.1074/jbc.M513736200; Cox JM, 2005, PLOS BIOL, V3, P231, DOI 10.1371/journal.pbio.0030052; Cox JM, 2008, J BIOL CHEM, V283, P24909, DOI 10.1074/jbc.M803934200; Cox M.M., 2007, TOPICS CURRENT GENET, P53; Cox Michael M., 2005, P369; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; Cox MM, 2001, P NATL ACAD SCI USA, V98, P8173, DOI 10.1073/pnas.131004998; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; DICAPUA E, 1982, J MOL BIOL, V157, P87, DOI 10.1016/0022-2836(82)90514-9; Dittrich M, 2007, TOP CURR CHEM, V268, P319, DOI 10.1007/128_2006_086; Drees JC, 2004, J BIOL CHEM, V279, P52991, DOI 10.1074/jbc.M409050200; Duany YD, 2011, PHYS CHEM CHEM PHYS, V13, P10009, DOI 10.1039/c0cp02859b; Earl AM, 2002, J BACTERIOL, V184, P6216, DOI 10.1128/JB.184.22.6216-6224.2002; EGELMAN EH, 1993, MICRON, V24, P309, DOI 10.1016/0968-4328(93)90056-7; EGELMAN EH, 1986, J MOL BIOL, V191, P677, DOI 10.1016/0022-2836(86)90453-5; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Eggler AL, 2002, J BIOL CHEM, V277, P39280, DOI 10.1074/jbc.M204328200; Fonville NC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000865; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; Frenkiel-Krispin D, 2006, J STRUCT BIOL, V156, P311, DOI 10.1016/j.jsb.2006.05.014; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Hsieh J, 1999, J MOL BIOL, V288, P255, DOI 10.1006/jmbi.1999.2666; Hsu HF, 2011, BIOCHEMISTRY-US, V50, P8270, DOI 10.1021/bi200423t; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; IYPE LE, 1995, J BIOL CHEM, V270, P19473, DOI 10.1074/jbc.270.33.19473; IYPE LE, 1994, J BIOL CHEM, V269, P24967; Jezewska MJ, 1996, J BIOL CHEM, V271, P4261; Kim JI, 2002, P NATL ACAD SCI USA, V99, P7917, DOI 10.1073/pnas.122218499; Kim JI, 2002, J BACTERIOL, V184, P1649, DOI 10.1128/JB.184.6.1649-1660.2002; Knowles DB, 2011, P NATL ACAD SCI USA, V108, P12699, DOI 10.1073/pnas.1103382108; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1987, P NATL ACAD SCI USA, V84, P3127, DOI 10.1073/pnas.84.10.3127; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P8266, DOI 10.1021/bi100920w; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8461, DOI 10.1073/pnas.151260698; LAVERY PE, 1992, J BIOL CHEM, V267, P9315; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Lewis R, 2008, NUCLEIC ACIDS RES, V36, P1881, DOI 10.1093/nar/gkn040; LINDSLEY JE, 1989, J MOL BIOL, V205, P695, DOI 10.1016/0022-2836(89)90315-X; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16381, DOI 10.1074/jbc.M212916200; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; McGrew DA, 2003, CRIT REV BIOCHEM MOL, V38, P385, DOI 10.1080/10409230390242489; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; Michel B, 2005, PLOS BIOL, V3, P1174, DOI 10.1371/journal.pbio.0030255; Minsky A, 2003, MOL MICROBIOL, V50, P367, DOI 10.1046/j.1365-2958.2003.03705.x; Minton KW, 1996, MUTAT RES-DNA REPAIR, V363, P1, DOI 10.1016/0921-8777(95)00014-3; MOORE KJM, 1994, BIOCHEMISTRY-US, V33, P14550, DOI 10.1021/bi00252a023; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; NORDEN B, 1992, J MOL BIOL, V226, P1175, DOI 10.1016/0022-2836(92)91060-3; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; Rainey FA, 2005, APPL ENVIRON MICROB, V71, P5225, DOI 10.1128/AEM.71.9.5225-5235.2005; Rajan R, 2004, J MOL BIOL, V344, P951, DOI 10.1016/j.jmb.2004.09.087; Rajendran S, 2000, J MOL BIOL, V303, P773, DOI 10.1006/jmbi.2000.4124; REGISTER JC, 1986, P NATL ACAD SCI USA, V83, P624, DOI 10.1073/pnas.83.3.624; Sakai A, 2009, J BIOL CHEM, V284, P3264, DOI 10.1074/jbc.M807220200; Sattin BD, 2004, BIOPHYS J, V87, P3430, DOI 10.1529/biophysj.104.045567; SCHUTTE BC, 1988, BIOCHEMISTRY-US, V27, P7886, DOI 10.1021/bi00420a046; SCHUTTE BC, 1987, BIOCHEMISTRY-US, V26, P5616, DOI 10.1021/bi00392a006; Segel I. H., 1975, ENZYME KINETICS, P884; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Shan Q, 1997, J BIOL CHEM, V272, P11063; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shan Q, 1996, J MOL BIOL, V257, P756, DOI 10.1006/jmbi.1996.0200; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Soustelle C, 2002, GENETICS, V161, P535; Steffen SE, 2002, J BIOL CHEM, V277, P14493, DOI 10.1074/jbc.M112444200; Sugiyama T, 1997, J BIOL CHEM, V272, P7940, DOI 10.1074/jbc.272.12.7940; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zaitsev EN, 2000, GENE DEV, V14, P740	100	23	25	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21351	21366		10.1074/jbc.M113.459230	http://dx.doi.org/10.1074/jbc.M113.459230			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23729671	Green Published, hybrid			2022-12-28	WOS:000322014400054
J	Tsutsui, T; Fukasawa, R; Shinmyouzu, K; Nakagawa, R; Tobe, K; Tanaka, A; Ohkuma, Y				Tsutsui, Taiki; Fukasawa, Rikiya; Shinmyouzu, Kaori; Nakagawa, Reiko; Tobe, Kazuyuki; Tanaka, Aki; Ohkuma, Yoshiaki			Mediator Complex Recruits Epigenetic Regulators via Its Two Cyclin-dependent Kinase Subunits to Repress Transcription of Immune Response Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; BINDING PROTEIN-BETA; REPEAT DOMAIN; CDK8; C/EBP; EXPRESSION; METHYLATION; ACTIVATION; RECEPTOR; PRMT5	The Mediator complex (Mediator) plays pivotal roles in activating transcription by RNA polymerase II, but relatively little is known about its roles in repression. Here, we identified the histone arginine methyltransferase PRMT5 and WD repeat protein 77/methylosome protein 50 (WDR77/MEP50) as Mediator cyclin-dependent kinase (CDK)-interacting proteins and studied the roles of PRMT5 in the transcriptional regulation of CCAAT enhancer-binding protein (C/EBP) beta target genes. First, we purified CDK8- and CDK19-containing complexes from HeLa nuclear extracts and subjected these purified complexes to mass spectrometric analyses. These experiments revealed that two Mediator CDKs, CDK8 and CDK19, individually interact with PRMT5 and WDR77, and their interactions with PRMT5 cause transcriptional repression of C/EBP beta target genes by regulating symmetric dimethylation of histone H4 arginine 3 (H4R3me2s) in the promoter regions of those genes. Furthermore, the recruitment of the DNA methyltransferase DNMT3A correlated with H4R3 dimethylation potentially leading to DNA methylation at the promoter proximal region and tight inhibition of preinitiation complex formation. In vertebrates, C/EBP beta regulates many genes involved in immune responses and cell differentiation. These findings shed light on the molecular mechanisms of the repressive roles of Mediator CDKs in transcription of C/EBP beta target genes and might provide clues that enable future studies of the functional associations between Mediators and epigenetic regulation.	[Tsutsui, Taiki; Fukasawa, Rikiya; Tanaka, Aki; Ohkuma, Yoshiaki] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Gene Regulat, Toyama 9300194, Japan; [Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Toyama 9300194, Japan; [Shinmyouzu, Kaori; Nakagawa, Reiko] RIKEN Ctr Dev Biol, Mass Spectrometry Anal Unit, Chuo Ku, Kobe, Hyogo 6500047, Japan	University of Toyama; University of Toyama; RIKEN	Ohkuma, Y (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Lab Gene Regulat, 2630 Sugitani, Toyama 9300194, Japan.	ohkumay@pha.u-toyama.ac.jp	Nakagawa, Reiko/C-4214-2017	Nakagawa, Reiko/0000-0002-6178-2945; Tsutsui, Taiki/0000-0002-9793-4402	National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science	National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants from the National Project on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science and Technology (to Y.O.) and from the Japan Society for the Promotion of Science through "Research Fellowships for Young Scientists" (to T.T.).	Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Bourbon HM, 2004, MOL CELL, V14, P553, DOI 10.1016/j.molcel.2004.05.011; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Furumoto T, 2007, GENES CELLS, V12, P119, DOI 10.1111/j.1365-2443.2007.01036.x; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kim YK, 2006, EMBO J, V25, P3596, DOI 10.1038/sj.emboj.7601248; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kowenz-Leutz E, 2010, EMBO J, V29, P1105, DOI 10.1038/emboj.2010.3; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li H, 2008, J BIOL CHEM, V283, P13077, DOI 10.1074/jbc.M800604200; Lin JJ, 2011, GENE DEV, V25, P2198, DOI 10.1101/gad.17554711; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Meyer KD, 2008, EMBO J, V27, P1447, DOI 10.1038/emboj.2008.78; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Mo XM, 2004, MOL CELL, V13, P241, DOI 10.1016/S1097-2765(03)00521-5; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nerlov C, 2007, TRENDS CELL BIOL, V17, P318, DOI 10.1016/j.tcb.2007.07.004; NONET ML, 1989, GENETICS, V123, P715; Pavri R, 2005, MOL CELL, V18, P83, DOI 10.1016/j.molcel.2005.02.034; Rachez C, 1998, GENE DEV, V12, P1787, DOI 10.1101/gad.12.12.1787; Roesler WJ, 2001, ANNU REV NUTR, V21, P141, DOI 10.1146/annurev.nutr.21.1.141; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Tsutsui T, 2008, GENES CELLS, V13, P817, DOI 10.1111/j.1365-2443.2008.01208.x; Tsutsui T, 2011, GENES CELLS, V16, P1208, DOI 10.1111/j.1365-2443.2011.01565.x; Uematsu S, 2007, J IMMUNOL, V179, P5378, DOI 10.4049/jimmunol.179.8.5378; Westerling T, 2007, MOL CELL BIOL, V27, P6177, DOI 10.1128/MCB.01302-06; Xu XJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-396; Zahnow CA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001033	59	54	66	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					20955	20965		10.1074/jbc.M113.486746	http://dx.doi.org/10.1074/jbc.M113.486746			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23749998	hybrid, Green Published			2022-12-28	WOS:000322014400018
J	Cotter, DG; Ercal, B; d'Avignon, DA; Dietzen, DJ; Crawford, PA				Cotter, David G.; Ercal, Baris; d'Avignon, D. Andre; Dietzen, Dennis J.; Crawford, Peter A.			Impact of Peripheral Ketolytic Deficiency on Hepatic Ketogenesis and Gluconeogenesis during the Transition to Birth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA-TRANSFERASE DEFICIENCY; RAT-LIVER MITOCHONDRIA; KETONE-BODY METABOLISM; FATTY-ACID-METABOLISM; PYRUVATE-DEHYDROGENASE; SUCCINYL-COA; PHOSPHOENOLPYRUVATE CARBOXYKINASE; NEONATAL HYPOGLYCEMIA; MAGNETIC-RESONANCE; MAMMALIAN-TISSUES	Preservation of bioenergetic homeostasis during the transition from the carbohydrate-laden fetal diet to the high fat, low carbohydrate neonatal diet requires inductions of hepatic fatty acid oxidation, gluconeogenesis, and ketogenesis. Mice with loss-of-function mutation in the extrahepatic mitochondrial enzyme CoA transferase (succinyl-CoA: 3-oxoacid CoA transferase, SCOT, encoded by nuclear Oxct1) cannot terminally oxidize ketone bodies and develop lethal hyperketonemic hypoglycemia within 48 h of birth. Here we use this model to demonstrate that loss of ketone body oxidation, an exclusively extrahepatic process, disrupts hepatic intermediary metabolic homeostasis after high fat mother's milk is ingested. Livers of SCOT-knock-out (SCOT-KO) neonates induce the expression of the genes encoding peroxisome proliferator-activated receptor gamma co-activator-1a (PGC-1 alpha), phosphoenolpyruvate carboxykinase (PEPCK), pyruvate carboxylase, and glucose-6-phosphatase, and the neonate's pools of gluconeogenic alanine and lactate are each diminished by 50%. NMR-based quantitative fate mapping of C-13-labeled substrates revealed that livers of SCOT-KO newborn mice synthesize glucose from exogenously administered pyruvate. However, the contribution of exogenous pyruvate to the tricarboxylic acid cycle as acetyl-CoA is increased in SCOT-KO livers and is associated with diminished terminal oxidation of fatty acids. After mother's milk provokes hyperketonemia, livers of SCOT-KO mice diminish de novo hepatic beta-hydroxybutyrate synthesis by 90%. Disruption of beta-hydroxybutyrate production increases hepatic NAD(+)/NADH ratios 3-fold, oxidizing redox potential in liver but not skeletal muscle. Together, these results indicate that peripheral ketone body oxidation prevents hypoglycemia and supports hepatic metabolic homeostasis, which is critical for the maintenance of glycemia during the adaptation to birth.	[Cotter, David G.; Ercal, Baris; Crawford, Peter A.] Washington Univ, Dept Med, Ctr Cardiovasc Res, St Louis, MO 63110 USA; [Cotter, David G.; Dietzen, Dennis J.] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [d'Avignon, D. Andre] Washington Univ, Dept Chem, St Louis, MO 63110 USA; [Crawford, Peter A.] Washington Univ, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Crawford, PA (corresponding author), Washington Univ, Dept Med, Div Cardiol, Sch Med, Campus Box 8086,660 S Euclid Ave, St Louis, MO 63110 USA.	pcrawford@wustl.edu		Crawford, Peter/0000-0001-8597-4426	National Institutes of Health [DK091538, HL007873]; March of Dimes; Children's Discovery Institute through St. Louis Children's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK020579, R01DK091538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Children's Discovery Institute through St. Louis Children's Hospital; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK091538 (to P. A. C.) and Training Grant HL007873 (to D. G. C.). This work was also supported by the March of Dimes and the Children's Discovery Institute through St. Louis Children's Hospital (to P. A. C.).	Aledo R, 2001, HUM GENET, V109, P19, DOI 10.1007/s004390100554; Andrews MT, 2009, AM J PHYSIOL-REG I, V296, pR383, DOI 10.1152/ajpregu.90795.2008; BATENBURG JJ, 1976, J BIOL CHEM, V251, P1364; Berry GT, 2001, J INHERIT METAB DIS, V24, P587, DOI 10.1023/A:1012419911789; BOCK HG, 1975, J BIOL CHEM, V250, P5774; BOUGNERES PF, 1986, J CLIN INVEST, V77, P42, DOI 10.1172/JCI112299; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cotter DG, 2013, AM J PHYSIOL-HEART C, V304, pH1060, DOI 10.1152/ajpheart.00646.2012; Cotter DG, 2013, AM J PHYSIOL-ENDOC M, V304, pE363, DOI 10.1152/ajpendo.00547.2012; Cotter DG, 2011, J BIOL CHEM, V286, P6902, DOI 10.1074/jbc.M110.192369; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Cunnane SC, 2003, COMP BIOCHEM PHYS A, V136, P17, DOI 10.1016/S1095-6433(03)00048-5; Dietzen DJ, 2008, RAPID COMMUN MASS SP, V22, P3481, DOI 10.1002/rcm.3754; Fukao T, 1997, PEDIATR RES, V42, P498, DOI 10.1203/00006450-199710000-00013; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Harris DL, 2012, J PEDIATR-US, V161, P787, DOI 10.1016/j.jpeds.2012.05.022; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Huidekoper HH, 2008, EUR J PEDIATR, V167, P859, DOI 10.1007/s00431-007-0598-5; Jones JG, 1997, ANAL BIOCHEM, V249, P201, DOI 10.1006/abio.1997.2172; KassovskaBratinova S, 1996, AM J HUM GENET, V59, P519; LEHNINGER AL, 1960, J BIOL CHEM, V235, P2450; LINCOLN BC, 1987, ARCH BIOCHEM BIOPHYS, V259, P149, DOI 10.1016/0003-9861(87)90480-2; MAGNUSSON I, 1991, J BIOL CHEM, V266, P6975; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Merritt ME, 2011, P NATL ACAD SCI USA, V108, P19084, DOI 10.1073/pnas.1111247108; Minino A. M., 2010, CDC CONTROL PREVENTI, V59, P1; Mitchell GA, 2000, ONLINE METABOLIC MOL, P12; NiezenKoning KE, 1997, EUR J PEDIATR, V156, P870, DOI 10.1007/s004310050733; Orii KE, 2008, TOHOKU J EXP MED, V215, P227, DOI 10.1620/tjem.215.227; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Platt MW, 2005, SEMIN FETAL NEONAT M, V10, P341, DOI 10.1016/j.siny.2005.04.001; PREUVENEERS MJ, 1973, BIOCHEM J, V133, P159, DOI 10.1042/bj1330159; Pryce JW, 2011, J CLIN PATHOL, V64, P1005, DOI 10.1136/jclinpath-2011-200218; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Satapati S, 2012, J LIPID RES, V53, P1080, DOI 10.1194/jlr.M023382; SCOFIELD RF, 1982, ARCH BIOCHEM BIOPHYS, V214, P268, DOI 10.1016/0003-9861(82)90030-3; STERN JR, 1956, J BIOL CHEM, V221, P15; Sunny NE, 2010, AM J PHYSIOL-ENDOC M, V298, pE1226, DOI 10.1152/ajpendo.00033.2010; TAYLOR SI, 1975, J BIOL CHEM, V250, P2028; TILDON JT, 1972, J CLIN INVEST, V51, P493, DOI 10.1172/JCI106837; Wentz AE, 2010, J BIOL CHEM, V285, P24447, DOI 10.1074/jbc.M110.100651; WILLIAMS.DH, 1971, BIOCHEM J, V121, P41, DOI 10.1042/bj1210041; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; YANG SY, 1987, J BIOL CHEM, V262, P13027; Ziegler A, 2002, NMR BIOMED, V15, P222, DOI 10.1002/nbm.764	49	13	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19739	19749		10.1074/jbc.M113.454868	http://dx.doi.org/10.1074/jbc.M113.454868			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23689508	Green Published, hybrid			2022-12-28	WOS:000321515800043
J	Hu, XL; Bardhan, K; Paschall, AV; Yang, DF; Waller, JL; Park, MA; Nayak-Kapoor, A; Samuel, TA; Abrams, SI; Liu, KB				Hu, Xiaolin; Bardhan, Kankana; Paschall, Amy V.; Yang, Dafeng; Waller, Jennifer L.; Park, Mary Anne; Nayak-Kapoor, Asha; Samuel, Thomas A.; Abrams, Scott I.; Liu, Kebin			Deregulation of Apoptotic Factors Bcl-xL and Bax Confers Apoptotic Resistance to Myeloid-derived Suppressor Cells and Contributes to Their Persistence in Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; IMMUNE SUPPRESSION; TUMOR MICROENVIRONMENT; IN-VITRO; DEATH; EXPRESSION; FAS; DIFFERENTIATION; INHIBITION; ACCUMULATION	Myeloid-derived suppressor cells (MDSCs) are heterogeneous immature myeloid cells that accumulate in response to tumor progression. Compelling data from mouse models and human cancer patients showed that tumor-induced inflammatory mediators induce MDSC differentiation. However, the mechanisms underlying MDSC persistence is largely unknown. Here, we demonstrated that tumor-induced MDSCs exhibit significantly decreased spontaneous apoptosis as compared with myeloid cells with the same phenotypes from tumor-free mice. Consistent with the decreased apoptosis, cell surface Fas receptor decreased significantly in tumor-induced MDSCs. Screening for changes of key apoptosis mediators downstream the Fas receptor revealed that expression levels of IRF8 and Bax are diminished, whereas expression of Bcl-xL is increased in tumor-induced MDSCs. We further determined that IRF8 binds directly to Bax and Bcl-x promoter in primary myeloid cells in vivo, and IRF8-deficient MDSC-like cells also exhibit increased Bcl-xL and decreased Bax expression. Analysis of CD69 and CD25 levels revealed that cytotoxic T lymphocytes (CTLs) are partially activated in tumor-bearing hosts. Strikingly, FasL but not perforin and granzymes were selectively activated in CTLs in the tumor-bearing host. ABT-737 significantly increased the sensitivity of MDSCs to Fas-mediated apoptosis in vitro. More importantly, ABT-737 therapy increased MDSC spontaneous apoptosis and decreased MDSC accumulation in tumor-bearing mice. Our data thus determined that MDSCs use down-regulation of IRF8 to alter Bax and Bcl-xL expression to deregulate the Fas-mediated apoptosis pathway to evade elimination by host CTLs. Therefore, targeting Bcl-xL is potentially effective in suppression of MDSC persistence in cancer therapy.	[Hu, Xiaolin; Bardhan, Kankana; Paschall, Amy V.; Yang, Dafeng; Liu, Kebin] Georgia Regents Univ, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Waller, Jennifer L.] Georgia Regents Univ, Dept Biostat & Epidemiol, Augusta, GA 30912 USA; [Park, Mary Anne] Georgia Regents Univ, Dept Surg, Augusta, GA 30912 USA; [Nayak-Kapoor, Asha; Samuel, Thomas A.] Georgia Regents Univ, Dept Hematol & Oncol, Med Coll Georgia, Augusta, GA 30912 USA; [Nayak-Kapoor, Asha; Samuel, Thomas A.; Liu, Kebin] Georgia Regents Univ, Ctr Canc, Augusta, GA 30912 USA; [Abrams, Scott I.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Roswell Park Cancer Institute	Liu, KB (corresponding author), Georgia Regents Univ, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.	Kliu@gru.edu		Liu, Kebin/0000-0003-1965-7240	National Institutes of Health [CA133085, CA168512-DRP1, CA140622]; American Cancer Society [RSG-09209]; NATIONAL CANCER INSTITUTE [R01CA140622, U54CA168512, R01CA133085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA133085, CA168512-DRP1 (to K. L.), and CA140622 (to S. I. A.). This work was also supported by American Cancer Society Grant RSG-09209 (to K. L.).	Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Burchert A, 2004, BLOOD, V103, P3480, DOI 10.1182/blood-2003-08-2970; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Corzo CA, 2010, J EXP MED, V207, P2439, DOI 10.1084/jem.20100587; Fortin C, 2012, J IMMUNOL, V189, P1843, DOI 10.4049/jimmunol.1200584; Fricke I, 2007, CLIN CANCER RES, V13, P4840, DOI 10.1158/1078-0432.CCR-07-0409; Gabriele L, 1999, J EXP MED, V190, P411, DOI 10.1084/jem.190.3.411; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Haile LA, 2010, J IMMUNOL, V185, P203, DOI 10.4049/jimmunol.0903573; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; Ikner A, 2011, J BIOL CHEM, V286, P21546, DOI 10.1074/jbc.M110.203745; Jayaraman P, 2012, J IMMUNOL, V188, P5365, DOI 10.4049/jimmunol.1103553; Kilinc MO, 2009, J IMMUNOL, V183, P7656, DOI 10.4049/jimmunol.0902625; Kim PKM, 2001, DRUG RESIST UPDATE, V4, P293, DOI 10.1054/drup.2001.0223; Kober AMM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.93; Koenigsmann J, 2009, LEUKEMIA LYMPHOMA, V50, P2078, DOI 10.3109/10428190903296913; Kusmartsev S, 2003, CANCER RES, V63, P4441; Kusmartsev S, 2008, J IMMUNOL, V181, P346, DOI 10.4049/jimmunol.181.1.346; Lavrik IN, 2012, CELL DEATH DIFFER, V19, P36, DOI 10.1038/cdd.2011.155; Lavrik IN, 2008, J BIOL CHEM, V283, P26401, DOI 10.1074/jbc.M800823200; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Lenardo M. J., 2010, ALPS 10 LESSONS INT; Liu K, 2010, WORLD J GASTRO ONCOL, V2, P399, DOI 10.4251/wjgo.v2.i11.399; Mace TA, 2013, CANCER RES, V73, P3007, DOI 10.1158/0008-5472.CAN-12-4601; Melani C, 2007, CANCER RES, V67, P11438, DOI 10.1158/0008-5472.CAN-07-1882; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Meng XW, 2011, J BIOL CHEM, V286, P35823, DOI 10.1074/jbc.M111.240432; Mohr A, 2005, ONCOGENE, V24, P2421, DOI 10.1038/sj.onc.1208432; Mundy-Bosse BL, 2011, CANCER RES, V71, P5101, DOI 10.1158/0008-5472.CAN-10-2670; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Nikolov NP, 2010, BLOOD, V116, P740, DOI 10.1182/blood-2009-08-237560; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Ozao-Choy J, 2009, CANCER RES, V69, P2514, DOI 10.1158/0008-5472.CAN-08-4709; Pilon-Thomas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027729; Qu P, 2011, J IMMUNOL, V187, P3854, DOI 10.4049/jimmunol.1003358; Ramachandran IR, 2013, J IMMUNOL, V190, P3815, DOI 10.4049/jimmunol.1203373; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Rooswinkel RW, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.109; Ryzhov S, 2011, J IMMUNOL, V187, P6120, DOI 10.4049/jimmunol.1101225; Saleem SJ, 2012, J IMMUNOL, V189, P511, DOI 10.4049/jimmunol.1200647; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Serafini P, 2006, J EXP MED, V203, P2691, DOI 10.1084/jem.20061104; Sharp DA, 2005, J BIOL CHEM, V280, P19401, DOI 10.1074/jbc.M413962200; Shoemaker AR, 2006, CANCER RES, V66, P8731, DOI 10.1158/0008-5472.CAN-06-0367; Sinha P, 2008, J IMMUNOL, V181, P4666, DOI 10.4049/jimmunol.181.7.4666; Sinha P, 2011, BLOOD, V117, P5381, DOI 10.1182/blood-2010-11-321752; Solito S, 2011, BLOOD, V118, P2254, DOI 10.1182/blood-2010-12-325753; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Srivastava MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040677; Srivastava MK, 2012, IMMUNOTHERAPY-UK, V4, P291, DOI [10.2217/IMT.11.178, 10.2217/imt.11.178]; Stewart TJ, 2009, J CELL MOL MED, V13, P3939, DOI 10.1111/j.1582-4934.2009.00685.x; Stewart TJ, 2009, J IMMUNOL, V183, P117, DOI 10.4049/jimmunol.0804132; Straus SE, 2001, BLOOD, V98, P194, DOI 10.1182/blood.V98.1.194; Suzuki E, 2005, CLIN CANCER RES, V11, P6713, DOI 10.1158/1078-0432.CCR-05-0883; Toivonen HT, 2011, J BIOL CHEM, V286, P18375, DOI 10.1074/jbc.M110.177097; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Waight JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027690; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812; Yang DF, 2007, J IMMUNOL, V179, P4775, DOI 10.4049/jimmunol.179.7.4775; Yang DF, 2012, J IMMUNOL, V188, P4441, DOI 10.4049/jimmunol.1103035; Yang DF, 2009, CANCER RES, V69, P1080, DOI 10.1158/0008-5472.CAN-08-2520; Yang JN, 2011, J IMMUNOL, V187, P4426, DOI 10.4049/jimmunol.1101034; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004	75	53	55	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19103	19115		10.1074/jbc.M112.434530	http://dx.doi.org/10.1074/jbc.M112.434530			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23677993	Green Published, hybrid			2022-12-28	WOS:000321335800045
J	Bouillon, A; Giganti, D; Benedet, C; Gorgette, O; Petres, S; Crublet, E; Girard-Blanc, C; Witkowski, B; Menard, D; Nilges, M; Mercereau-Puijalon, O; Stoven, V; Barale, JC				Bouillon, Anthony; Giganti, David; Benedet, Christophe; Gorgette, Olivier; Petres, Stephane; Crublet, Elodie; Girard-Blanc, Christine; Witkowski, Benoit; Menard, Didier; Nilges, Michael; Mercereau-Puijalon, Odile; Stoven, Veronique; Barale, Jean-Christophe			In Silico Screening on the Three-dimensional Model of the Plasmodium vivax SUB1 Protease Leads to the Validation of a Novel Anti-parasite Compound	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILISIN-LIKE PROTEASE-1; ANTIMALARIAL-DRUG DISCOVERY; MALARIA PARASITE; FLEXIBLE DOCKING; ACTIVE-SITE; PROTEINS; INHIBITORS; BINDING; EGRESS; ENERGY	Widespread drug resistance calls for the urgent development of new antimalarials that target novel steps in the life cycle of Plasmodium falciparum and Plasmodium vivax. The essential subtilisin-like serine protease SUB1 of Plasmodium merozoites plays a dual role in egress from and invasion into host erythrocytes. It belongs to a new generation of attractive drug targets against which specific potent inhibitors are actively searched. We characterize here the P. vivax SUB1 enzyme and show that it displays a typical auto-processing pattern and apical localization in P. vivax merozoites. To search for small PvSUB1 inhibitors, we took advantage of the similarity of SUB1 with bacterial subtilisins and generated P. vivax SUB1 three-dimensional models. The structure-based virtual screening of a large commercial chemical compounds library identified 306 virtual best hits, of which 37 were experimentally confirmed inhibitors and 5 had K-i values of <50 mu M for PvSUB1. Interestingly, they belong to different chemical families. The most promising competitive inhibitor of PvSUB1(compound 2) was equally active on PfSUB1 and displayed anti-P. falciparum and Plasmodium berghei activity in vitro and in vivo, respectively. Compound 2 inhibited the endogenous PfSUB1 as illustrated by the inhibited maturation of its natural substrate PfSERA5 and inhibited parasite egress and subsequent erythrocyte invasion. These data indicate that the strategy of in silico screening of three-dimensional models to select for virtual inhibitors combined with stringent biological validation successfully identified several inhibitors of the PvSUB1 enzyme. The most promising hit proved to be a potent cross-inhibitor of PlasmodiumSUB1, laying the groundwork for the development of a globally active small compound antimalarial.	[Bouillon, Anthony; Gorgette, Olivier; Mercereau-Puijalon, Odile; Barale, Jean-Christophe] Inst Pasteur, Unite Immunol Mol Parasites, Dept Parasitol & Mycol, F-75015 Paris, France; [Bouillon, Anthony; Gorgette, Olivier; Mercereau-Puijalon, Odile] CNRS, URA2581, F-75015 Paris, France; [Giganti, David; Nilges, Michael] Inst Pasteur, Unite Bioinformat Struct, Dept Biol Struct & Chim, F-75015 Paris, France; [Giganti, David; Nilges, Michael] CNRS, UMR3258, F-75015 Paris, France; [Benedet, Christophe; Witkowski, Benoit; Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Petres, Stephane; Crublet, Elodie; Girard-Blanc, Christine] Inst Pasteur, Dept Biol Struct & Chim, F-75015 Paris, France; [Stoven, Veronique; Barale, Jean-Christophe] Mines ParisTech, Ctr Computat Biol, F-77300 Fontainebleau, France; [Stoven, Veronique] Inst Curie, INSERM, U900, F-75248 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Barale, JC (corresponding author), Inst Pasteur, Unite Immunol Mol Parasites, URA CNRS 2581, Dept Parasitol & Mycol, 28 Rue Dr Roux, F-75724 Paris 15, France.	jean-christophe.barale@pasteur.fr	Menard, Didier/O-3294-2013; Mercereau-Puijalon, Odile/AAA-2242-2020; Nilges, Michael/E-4803-2011; Witkowski, Benoit/T-1118-2019	Menard, Didier/0000-0003-1357-4495; Nilges, Michael/0000-0002-1451-8092; petres, stephane/0000-0002-4716-565X	"Fond Dedie: Combattre les Maladies Parasitaires" from Sanofi-Aventis; French Ministry of Research; Institut Carnot-Pasteur Maladies Infectieuses; Carnot grant program of the "Institut Carnot-Pasteur Maladies Infectieuses"	"Fond Dedie: Combattre les Maladies Parasitaires" from Sanofi-Aventis; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut Carnot-Pasteur Maladies Infectieuses; Carnot grant program of the "Institut Carnot-Pasteur Maladies Infectieuses"	This work was supported in part by the "Fond Dedie: Combattre les Maladies Parasitaires" from Sanofi-Aventis and the French Ministry of Research and a grant from the Institut Carnot-Pasteur Maladies Infectieuses.; Ph.D. Fellow of the "Direction Generale pour l'Armement" from the French Ministry of Defense and supported by the Carnot grant program of the "Institut Carnot-Pasteur Maladies Infectieuses."	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ang KKH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001023; [Anonymous], 1999, HDB ANIMAL MODELS IN; Barale JC, 1999, P NATL ACAD SCI USA, V96, P6445, DOI 10.1073/pnas.96.11.6445; Bastianelli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021812; BERGER A, 1970, PHILOS T R SOC B, V257, P249, DOI 10.1098/rstb.1970.0024; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Blackman MJ, 1998, J BIOL CHEM, V273, P23398, DOI 10.1074/jbc.273.36.23398; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Bouillon A., 2013, METHODS MOL BIOL MAL, P523; Dalton JAR, 2007, BIOINFORMATICS, V23, P1901, DOI 10.1093/bioinformatics/btm262; Dechamps S, 2010, INT J PARASITOL, V40, P1347, DOI 10.1016/j.ijpara.2010.05.008; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Dowse Timothy J., 2008, V47, P121; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gemma S, 2012, BIOORG MED CHEM LETT, V22, P5317, DOI 10.1016/j.bmcl.2012.06.023; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; GRON H, 1992, BIOCHEMISTRY-US, V31, P6011, DOI 10.1021/bi00141a008; GROS P, 1992, PROTEINS, V12, P63, DOI 10.1002/prot.340120108; Grunberg R, 2007, BIOINFORMATICS, V23, P769, DOI 10.1093/bioinformatics/btl655; Grum-Tokars V, 2008, VIRUS RES, V133, P63, DOI 10.1016/j.virusres.2007.02.015; Guiguemde WA, 2012, CHEM BIOL, V19, P116, DOI 10.1016/j.chembiol.2012.01.004; Hindle SA, 2002, J COMPUT AID MOL DES, V16, P129, DOI 10.1023/A:1016399411208; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jean L, 2005, MOL BIOCHEM PARASIT, V144, P187, DOI 10.1016/j.molbiopara.2005.07.008; Klibanov OM, 2011, PHARMACOTHERAPY, V31, P951, DOI 10.1592/phco.31.10.951; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Larsson P, 2008, PROTEIN SCI, V17, P990, DOI 10.1110/ps.073344908; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li QG, 2007, CYTOM PART A, V71A, P297, DOI 10.1002/cyto.a.20380; *MALERA CONS GROUP, 2011, PLOS MED, V0008; McGovern SL, 2003, J MED CHEM, V46, P2895, DOI 10.1021/jm0300330; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Meyers MJ, 2012, CURR TOP MED CHEM, V12, P445; Nicola G, 2008, J COMPUT BIOL, V15, P231, DOI 10.1089/cmb.2007.0178; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Rosenthal PJ, 2011, ADV EXP MED BIOL, V712, P30, DOI 10.1007/978-1-4419-8414-2_3; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Sadowski J, 1997, J COMPUT AID MOL DES, V11, P53, DOI 10.1023/A:1008023427310; Safeukui I, 2004, BIOCHEM PHARMACOL, V68, P1903, DOI 10.1016/j.bcp.2004.05.049; Saify ZS, 2012, BIOORG MED CHEM LETT, V22, P1282, DOI 10.1016/j.bmcl.2011.10.018; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Schapira M, 1999, J MOL RECOGNIT, V12, P177, DOI 10.1002/(SICI)1099-1352(199905/06)12:3<177::AID-JMR451>3.0.CO;2-Z; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Totrov M, 1997, PROTEINS, P215; Withers-Martinez C, 2002, J BIOL CHEM, V277, P29698, DOI 10.1074/jbc.M203088200; Withers-Martinez C, 2012, INT J PARASITOL, V42, P597, DOI 10.1016/j.ijpara.2012.04.005; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	53	17	17	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18561	18573		10.1074/jbc.M113.456764	http://dx.doi.org/10.1074/jbc.M113.456764			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653352	hybrid, Green Published			2022-12-28	WOS:000320721900056
J	Chiluiza, D; Krishna, S; Schumacher, VA; Schlondorff, J				Chiluiza, David; Krishna, Sneha; Schumacher, Valerie A.; Schloendorff, Johannes			Gain-of-function Mutations in Transient Receptor Potential C6 (TRPC6) Activate Extracellular Signal-regulated Kinases 1/2 (ERK1/2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; EXPERIMENTAL MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS; HYPOXIC PULMONARY VASOCONSTRICTION; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; GLOMERULAR MESANGIAL CELLS; HUMAN DIABETIC-NEPHROPATHY; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE; ANGIOTENSIN-II; CA2+ ENTRY	Gain-of-function mutations in the canonical transient receptor potential 6 (TRPC6) gene are a cause of autosomal dominant focal segmental glomerulosclerosis (FSGS). The mechanisms whereby abnormal TRPC6 activity results in proteinuria remain unknown. The ERK1/2 MAPKs are activated in glomeruli and podocytes in several proteinuric disease models. We therefore examined whether FSGS-associated mutations in TRPC6 result in activation of these kinases. In 293T cells and cultured podocytes, overexpression of gain-of-function TRPC6 mutants resulted in increased ERK1/2 phosphorylation, an effect dependent upon channel function. Pharmacologic inhibitor studies implicated several signaling mediators, including calmodulin and calcineurin, supporting the importance of TRPC6-mediated calcium influx in this process. Through medium transfer experiments, we uncovered two distinct mechanisms for ERK activation by mutant TRPC6, a cell-autonomous, EGF receptor-independent mechanism and a non-cell-autonomous mechanism involving metalloprotease-mediated release of a presumed EGF receptor ligand. The inhibitors KN-92 and H89 were able to block both pathways in mutant TRPC6 expressing cells as well as the prolonged elevation of intracellular calcium levels upon carbachol stimulation seen in these cells. However, these effects appear to be independent of their effects on calcium/calmodulin-dependent protein kinase II and PKA, respectively. Phosphorylation of Thr-70, Ser-282, and Tyr-31/285 were not necessary for ERK activation by mutant TRPC6, although a phosphomimetic TRPC6 S282E mutant was capable of ERK activation. Taken together, these results identify two pathways downstream of mutant TRPC6 leading to ERK activation that may play a role in the development of FSGS.	[Chiluiza, David; Krishna, Sneha; Schloendorff, Johannes] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Chiluiza, David; Schumacher, Valerie A.; Schloendorff, Johannes] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Schumacher, Valerie A.] Boston Childrens Hosp, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Schlondorff, J (corresponding author), Div Nephrol, RN304B,99 Brookline Ave, Boston, MA 02215 USA.	jschlond@bidmc.harvard.edu		Schlondorff, Johannes/0000-0002-9973-9731	National Institutes of Health, NIDDK [K08DK80947]; American Society of Nephrology; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080947] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Society of Nephrology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grant K08DK80947. This work was also supported by a Carl W. Gottschalk Research Grant from the American Society of Nephrology.	Aouadi M, 2006, BIOCHIMIE, V88, P1091, DOI 10.1016/j.biochi.2006.06.003; Awazu M, 1999, J AM SOC NEPHROL, V10, P738; Bijian K, 2005, AM J PHYSIOL-RENAL, V289, pF1313, DOI 10.1152/ajprenal.00106.2005; Bijian K, 2004, AM J PHYSIOL-RENAL, V286, pF255, DOI 10.1152/ajprenal.00259.2003; Bokemeyer D, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017576.50319.AC; Bokemeyer D, 2000, J AM SOC NEPHROL, V11, P232, DOI 10.1681/ASN.V112232; Bokemeyer D, 1997, J CLIN INVEST, V100, P582, DOI 10.1172/JCI119568; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Brinkkoetter PT, 2009, J CLIN INVEST, V119, P3089, DOI 10.1172/JCI37978; Carlson SM, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002010; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Chen CA, 2012, EXP BIOL MED, V237, P777, DOI 10.1258/ebm.2012.011157; Chen J, 2009, AM J PHYSIOL-HEART C, V297, pH417, DOI 10.1152/ajpheart.01130.2008; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cybulsky AV, 2005, AM J PHYSIOL-RENAL, V289, pF593, DOI 10.1152/ajprenal.00066.2005; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Davis J, 2012, DEV CELL, V23, P705, DOI 10.1016/j.devcel.2012.08.017; Dietrich A, 2005, MOL CELL BIOL, V25, P6980, DOI 10.1128/MCB.25.16.6980-6989.2005; Doublier S, 2011, KIDNEY INT, V79, P404, DOI 10.1038/ki.2010.398; Eckel J, 2011, J AM SOC NEPHROL, V22, P526, DOI 10.1681/ASN.2010050522; Emerling BM, 2007, FEBS LETT, V581, P5727, DOI 10.1016/j.febslet.2007.11.038; Engh RA, 1996, J BIOL CHEM, V271, P26157, DOI 10.1074/jbc.271.42.26157; Espinosa EVP, 2012, BIOCHEM BIOPH RES CO, V417, P853, DOI 10.1016/j.bbrc.2011.12.058; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Flannery PJ, 2006, NEPHRON EXP NEPHROL, V103, pE109, DOI 10.1159/000092196; Fuchs B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-20; Fukazawa R, 2003, J MOL CELL CARDIOL, V35, P1473, DOI 10.1016/j.yjmcc.2003.09.012; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Gorin Y, 2004, BIOCHEM J, V381, P231, DOI 10.1042/BJ20031614; Gottlieb P, 2008, PFLUG ARCH EUR J PHY, V455, P1097, DOI 10.1007/s00424-007-0359-3; Hamaguchi A, 2000, J AM SOC NEPHROL, V11, P39, DOI 10.1681/ASN.V11139; Hamaguchi A, 1998, J AM SOC NEPHROL, V9, P372; Harada M, 2012, CIRCULATION, V126, P2051, DOI 10.1161/CIRCULATIONAHA.112.121830; Hassock SR, 2002, BLOOD, V100, P2801, DOI 10.1182/blood-2002-03-0723; Heeringa SF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007771; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Horinouchi T, 2012, J PHARMACOL EXP THER, V340, P143, DOI 10.1124/jpet.111.187500; Jiang LN, 2011, EXP BIOL MED, V236, P184, DOI 10.1258/ebm.2010.010237; Kanda S, 2011, MOL BIOL CELL, V22, P1824, DOI 10.1091/mbc.E10-12-0929; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Koitabashi N, 2010, J MOL CELL CARDIOL, V48, P713, DOI 10.1016/j.yjmcc.2009.11.015; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Krall P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012859; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Kwan HY, 2004, P NATL ACAD SCI USA, V101, P2625, DOI 10.1073/pnas.0304471101; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lemos VS, 2007, BIOCHEM BIOPH RES CO, V352, P130, DOI 10.1016/j.bbrc.2006.10.160; Leuner K, 2010, MOL PHARMACOL, V77, P368, DOI 10.1124/mol.109.057513; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Li XC, 2006, BIOCHEM PHARMACOL, V71, P1711, DOI 10.1016/j.bcp.2006.03.018; Li Y, 2005, NATURE, V434, P894, DOI 10.1038/nature03477; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Liu SF, 2010, MOL BIOL REP, V37, P2477, DOI 10.1007/s11033-009-9761-6; Loot AE, 2011, J CARDIOVASC PHARM, V57, P140, DOI 10.1097/FJC.0b013e3181ed088d; Moeller CC, 2007, J AM SOC NEPHROL, V18, P29, DOI 10.1681/ASN.2006091010; Murshid A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013830; Nijenhuis T, 2011, AM J PATHOL, V179, P1719, DOI 10.1016/j.ajpath.2011.06.033; Nishida M, 2007, J BIOL CHEM, V282, P23117, DOI 10.1074/jbc.M611780200; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; Nishioka K, 2011, ARTERIOSCL THROM VAS, V31, P2278, DOI 10.1161/ATVBAHA.110.221010; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Onohara N, 2006, EMBO J, V25, P5305, DOI 10.1038/sj.emboj.7601417; Park SJ, 2004, BIOCHEM BIOPH RES CO, V323, P1, DOI 10.1016/j.bbrc.2004.08.047; Pippin JW, 2003, J CLIN INVEST, V111, P877, DOI 10.1172/JCI200315645; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Rosker C, 2004, J BIOL CHEM, V279, P13696, DOI 10.1074/jbc.M308108200; Roskoski R, 2012, PHARMACOL RES, V66, P105, DOI 10.1016/j.phrs.2012.04.005; Rubinfeld Hadara, 2004, Methods Mol Biol, V250, P1; Sakai N, 2005, AM J KIDNEY DIS, V45, P54, DOI 10.1053/j.ajkd.2004.08.039; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Samapati R, 2012, AM J RESP CRIT CARE, V185, P160, DOI 10.1164/rccm.201104-0717OC; Schlondorff J, 2009, AM J PHYSIOL-CELL PH, V296, pC558, DOI 10.1152/ajpcell.00077.2008; Schumacher VA, 2011, J AM SOC NEPHROL, V22, P1286, DOI 10.1681/ASN.2010080860; Shen B, 2011, J BIOL CHEM, V286, P19439, DOI 10.1074/jbc.M110.210294; Singh I, 2007, J BIOL CHEM, V282, P7833, DOI 10.1074/jbc.M608288200; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P16586, DOI 10.1073/pnas.0606894103; Sung TS, 2011, AM J PHYSIOL-CELL PH, V301, pC823, DOI 10.1152/ajpcell.00351.2010; Tajeddine N, 2012, J BIOL CHEM, V287, P16146, DOI 10.1074/jbc.M112.340034; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Tamouza H, 2012, KIDNEY INT, V82, P1284, DOI 10.1038/ki.2012.192; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Tian DQ, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001200; TOMBES RM, 1995, CELL GROWTH DIFFER, V6, P1063; Tomic M, 2011, AM J PHYSIOL-ENDOC M, V301, pE370, DOI 10.1152/ajpendo.00130.2011; Toyoda M, 2004, KIDNEY INT, V66, P1107, DOI 10.1111/j.1523-1755.2004.00798.x; Wada T, 2008, NEPHRON EXP NEPHROL, V109, pE8, DOI 10.1159/000131892; Wang LM, 2012, KIDNEY INT, V81, P1075, DOI 10.1038/ki.2011.472; Wang YQ, 2010, J AM SOC NEPHROL, V21, P1657, DOI 10.1681/ASN.2009121253; Wang YL, 2012, J AM SOC NEPHROL, V23, P1977, DOI 10.1681/ASN.2012040383; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Weissmann N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1660; Werry TD, 2005, TRENDS ENDOCRIN MET, V16, P26, DOI 10.1016/j.tem.2004.11.008; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Yao H, 2009, CELL DEATH DIFFER, V16, P1681, DOI 10.1038/cdd.2009.108; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang H, 2009, EXP BIOL MED, V234, P1029, DOI 10.3181/0901-RM-11; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhu B, 2009, MUTAT RES-FUND MOL M, V664, P84, DOI 10.1016/j.mrfmmm.2008.11.021; Zhu L, 2011, J AM SOC NEPHROL, V22, P1621, DOI 10.1681/ASN.2010111146	108	42	44	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18407	18420		10.1074/jbc.M113.463059	http://dx.doi.org/10.1074/jbc.M113.463059			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645677	Green Published, hybrid			2022-12-28	WOS:000320721900043
J	Ferluga, S; Hantgan, R; Goldgur, Y; Himanen, JP; Nikolov, DB; Debinski, W				Ferluga, Sara; Hantgan, Roy; Goldgur, Yehuda; Himanen, Juha P.; Nikolov, Dimitar B.; Debinski, Waldemar			Biological and Structural Characterization of Glycosylation on Ephrin-A1, a Preferred Ligand for EphA2 Receptor Tyrosine Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING DOMAIN; CANCER-THERAPY; TUMOR-CELLS; GLYCOPROTEINS; RECOGNITION; ECTODOMAIN; COMPLEX; FAMILY	The EphA2 receptor tyrosine kinase is overexpressed in a number of malignancies and is activated by ephrin ligands, most commonly by ephrin-A1. The crystal structure of the ligand-receptor complex revealed a glycosylation on the Asn-26 of ephrin-A1. Here we report for the first time the significance of the glycosylation in the biology of EphA2 and ephrin-A1. Ephrin-A1 was enzymatically deglycosylated, and its activity was evaluated in several assays using glioblastoma (GBM) cells and recombinant EphA2. We found that deglycosylated ephrin-A1 does not efficiently induce EphA2 receptor internalization and degradation, and does not activate the downstream signaling pathways involved in cell migration and proliferation. Data obtained by surface plasmon resonance confirms that deglycosylated ephrin-A1 does not bind EphA2 with high affinity. Mutations in the glycosylation site on ephrin-A1 result in protein aggregation and mislocalization. Analysis of Eph/ephrin crystal structures reveals an interaction between the ligand's carbohydrates and two residues of EphA2:Asp-78 and Lys-136. These findings suggest that the glycosylation on ephrin-A1 plays a critical role in the binding and activation of the EphA2 receptor.	[Ferluga, Sara; Debinski, Waldemar] Wake Forest Univ, Dept Neurosurg, Brain Tumor Ctr Excellence, Ctr Comprehens Canc, Winston Salem, NC 27157 USA; [Hantgan, Roy] Wake Forest Univ, Wake Forest Sch Med, Dept Biochem & Mol Med, Winston Salem, NC 27157 USA; [Goldgur, Yehuda; Himanen, Juha P.; Nikolov, Dimitar B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Wake Forest University; Wake Forest University; Memorial Sloan Kettering Cancer Center	Debinski, W (corresponding author), Wake Forest Sch Med, Brain Tumor Ctr Excellence, Thomas K Hearn Brain Tumor Res Ctr, Med Ctr Blvd, Winston Salem, NC 27157 USA.	debinski@wakehealth.edu		Ferluga, Sara/0000-0002-6151-5492	National Institutes of Health [NCI R01 CA139099, CA74145, NS38486]; NATIONAL CANCER INSTITUTE [R01CA074145, P30CA012197, R01CA139099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038486] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NCI R01 CA139099 and CA74145 (to W. D.) and NS38486 (to D. B. N.).	Beauchamp A, 2012, MOL CELL BIOL, V32, P3253, DOI 10.1128/MCB.06791-11; Beauchamp A, 2012, SEMIN CELL DEV BIOL, V23, P109, DOI 10.1016/j.semcdb.2011.10.019; Cantor, 1980, BIOPHYS CHEM; Drickamer K., 2006, INTRO GLYCOBIOLOGY; ELBEIN AD, 1981, TRENDS BIOCHEM SCI, V6, P219, DOI 10.1016/0968-0004(81)90080-3; Flanagan JG, 1997, CELL, V90, P403; Gobin AM, 2008, INT J NANOMED, V3, P351; Himanen JP, 1998, NATURE, V396, P486, DOI 10.1038/24904; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Kalo MS, 1999, CELL TISSUE RES, V298, P1, DOI 10.1007/PL00008807; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lee HY, 2011, J PHARM PHARMACOL, V63, P1401, DOI 10.1111/j.2042-7158.2011.01306.x; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Nikolov DB, 2005, BIOCHEMISTRY-US, V44, P10947, DOI 10.1021/bi050789w; NISHIKAWA Y, 1980, BIOCHEM BIOPH RES CO, V97, P1296, DOI 10.1016/S0006-291X(80)80007-6; Parri M, 2007, J BIOL CHEM, V282, P19619, DOI 10.1074/jbc.M701319200; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; ROBBINS PW, 1984, J BIOL CHEM, V259, P7577; Roth J, 2010, MOL CELLS, V30, P497, DOI 10.1007/s10059-010-0159-z; Singla N, 2010, BIOCHEM BIOPH RES CO, V399, P555, DOI 10.1016/j.bbrc.2010.07.109; Sun XL, 2011, CANCER LETT, V312, P168, DOI 10.1016/j.canlet.2011.07.035; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Tome CML, 2012, J BIOL CHEM, V287, P14012, DOI 10.1074/jbc.M111.311670; Toth J, 2001, DEV CELL, V1, P83, DOI 10.1016/S1534-5807(01)00002-8; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Wykosky J, 2005, MOL CANCER RES, V3, P541, DOI 10.1158/1541-7786.MCR-05-0056; Wykosky J, 2008, ONCOGENE, V27, P7260, DOI 10.1038/onc.2008.328; Wykosky J, 2007, MOL CANCER THER, V6, P3208, DOI 10.1158/1535-7163.MCT-07-0200; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Xi HQ, 2012, J CELL MOL MED, V16, P2894, DOI 10.1111/j.1582-4934.2012.01612.x	37	23	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18448	18457		10.1074/jbc.M113.464008	http://dx.doi.org/10.1074/jbc.M113.464008			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23661698	hybrid, Green Published			2022-12-28	WOS:000320721900047
J	Ejlerskov, P; Rasmussen, I; Nielsen, TT; Bergstrom, AL; Tohyama, Y; Jensen, PH; Vilhardt, F				Ejlerskov, Patrick; Rasmussen, Izabela; Nielsen, Troels Tolstrup; Bergstrom, Ann-Louise; Tohyama, Yumi; Jensen, Poul Henning; Vilhardt, Frederik			Tubulin Polymerization-promoting Protein (TPPP/p25 alpha) Promotes Unconventional Secretion of alpha-Synuclein through Exophagy by Impairing Autophagosome-Lysosome Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT HUNTINGTIN; QUALITY-CONTROL; CELL-DEATH; MACROAUTOPHAGY; BODY; NEURODEGENERATION; DEGRADATION; PATHOLOGY; DISEASE; RAB7	Aggregation of alpha-synuclein can be promoted by the tubulin polymerization-promoting protein/p25 alpha, which we have used here as a tool to study the role of autophagy in the clearance of alpha-synuclein. In NGF-differentiated PC12 catecholaminergic nerve cells, we show that de novo expressed p25 alpha co-localizes with alpha-synuclein and causes its aggregation and distribution into autophagosomes. However, p25 alpha also lowered the mobility of autophagosomes and hindered the final maturation of autophagosomes by preventing their fusion with lysosomes for the final degradation of alpha-synuclein. Instead, p25 alpha caused a 4-fold increase in the basal level of alpha-synuclein secreted into the medium. Secretion was strictly dependent on autophagy and could be up-regulated (trehalose and Rab1A) or down-regulated (3-methyladenine and ATG5 shRNA) by enhancers or inhibitors of autophagy or by modulating minus-end-directed (HDAC6 shRNA) or plus-end-directed (Rab8) trafficking of autophagosomes along microtubules. Finally, we show in the absence of tubulin polymerization-promoting protein/p25 alpha that alpha-synuclein release was modulated by dominant mutants of Rab27A, known to regulate exocytosis of late endosomal (and amphisomal) elements, and that both lysosomal fusion block and secretion of alpha-synuclein could be replicated by knockdown of the p25 alpha target, HDAC6, the predominant cytosolic deacetylase in neurons. Our data indicate that unconventional secretion of alpha-synuclein can be mediated through exophagy and that factors, which increase the pool of autophagosomes/amphisomes (e.g. lysosomal disturbance) or alter the polarity of vesicular transport of autophagosomes on microtubules, can result in an increased release of alpha-synuclein monomer and aggregates to the surroundings.	[Ejlerskov, Patrick; Rasmussen, Izabela; Nielsen, Troels Tolstrup; Vilhardt, Frederik] Univ Copenhagen, Dept Cellular & Mol Med, Panum Inst, DK-2200 Copenhagen N, Denmark; [Ejlerskov, Patrick] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2200 Copenhagen N, Denmark; [Nielsen, Troels Tolstrup] Copenhagen Univ Hosp, Rigshosp, Dept Neurol, Danish Dementia Res Ctr, DK-2100 Copenhagen, Denmark; [Bergstrom, Ann-Louise] Lundbeck AS, DK-2500 Valby, Denmark; [Tohyama, Yumi] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Div Biochem, Himeji, Hyogo 6708524, Japan; [Jensen, Poul Henning] Aarhus Univ, Dept Biomed, DK-8000 Aarhus, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Lundbeck Corporation; Himeji Dokkyo University; Aarhus University	Vilhardt, F (corresponding author), Univ Copenhagen, Dept Cellular & Mol Med, Fac Hlth Sci, Panum Inst, 18-4,Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	vilhardt@sund.ku.dk	Vilhardt, Frederik/AAX-4766-2021; Nielsen, Troels Tolstrup/AAP-8330-2021	Nielsen, Troels Tolstrup/0000-0002-3292-1846; Ejlerskov, Patrick/0000-0002-2514-3185; Vilhardt, Frederik/0000-0001-8604-7165; Jensen, Poul Henning/0000-0002-4439-9020	Danish Parkinson Foundation; JASCHA Foundation; Warwara-Larsen Foundation; Danish Research Council; Aase and Ejnar Danielsens Foundation; NOVO Nordisk Foundation; Lundbeck Foundation; Grants-in-Aid for Scientific Research [23590374] Funding Source: KAKEN	Danish Parkinson Foundation; JASCHA Foundation; Warwara-Larsen Foundation; Danish Research Council(Det Frie Forskningsrad (DFF)); Aase and Ejnar Danielsens Foundation; NOVO Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Danish Parkinson Foundation (to F. V. and P. E.), The JASCHA Foundation, The Warwara-Larsen Foundation, The Danish Research Council, Aase and Ejnar Danielsens Foundation, NOVO Nordisk Foundation (to F. V.), and the Lundbeck Foundation (to P. H. J.).	Acevedo K, 2007, EXP CELL RES, V313, P4091, DOI 10.1016/j.yexcr.2007.08.012; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Denzer K, 2000, J CELL SCI, V113, P3365; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Duran JM, 2010, J CELL BIOL, V188, P527, DOI 10.1083/jcb.200911154; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goldbaum O, 2008, GLIA, V56, P1736, DOI 10.1002/glia.20720; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hasegawa T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029460; Hasholt L, 2003, J GENE MED, V5, P528, DOI 10.1002/jgm.378; Hattula K, 2006, J CELL SCI, V119, P4866, DOI 10.1242/jcs.03275; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Koles K, 2012, J BIOL CHEM, V287, P16820, DOI 10.1074/jbc.M112.342667; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kragh CL, 2009, J BIOL CHEM, V284, P10211, DOI 10.1074/jbc.M809671200; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Ryo A, 2006, J BIOL CHEM, V281, P4117, DOI 10.1074/jbc.M507026200; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Schneider A, 2013, CELL TISSUE RES, V352, P33, DOI 10.1007/s00441-012-1428-2; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Tooze SA, 2010, NAT CELL BIOL, V12, P831, DOI 10.1038/ncb0910-831; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Vilhardt F, 1999, MOL BIOL CELL, V10, P179, DOI 10.1091/mbc.10.1.179; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xie YY, 2010, FASEB J, V24, P196, DOI 10.1096/fj.09-133082; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yeger-Lotem E, 2009, NAT GENET, V41, P316, DOI 10.1038/ng.337; Yokoyama K, 2011, J BIOL CHEM, V286, P5375, DOI 10.1074/jbc.M110.171702; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhang W, 2007, GLIA, V55, P1178, DOI 10.1002/glia.20532	66	154	156	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17313	17335		10.1074/jbc.M112.401174	http://dx.doi.org/10.1074/jbc.M112.401174			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629650	hybrid, Green Published			2022-12-28	WOS:000320380600026
J	Land, AM; Law, EK; Carpenter, MA; Lackey, L; Brown, WL; Harris, RS				Land, Allison M.; Law, Emily K.; Carpenter, Michael A.; Lackey, Lela; Brown, William L.; Harris, Reuben S.			Endogenous APOBEC3A DNA Cytosine Deaminase Is Cytoplasmic and Nongenotoxic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBIT LINE-1 RETROTRANSPOSITION; ACTIVATION-INDUCED DEAMINASE; CYTIDINE DEAMINASES; DAMAGE RESPONSE; HUMAN-CELLS; ALU RETROTRANSPOSITION; SOMATIC HYPERMUTATION; ANTIVIRAL ACTIVITY; NUCLEAR IMPORT; H2AX PROTEIN	APOBEC3A (A3A) is a myeloid lineage-specific DNA cytosine deaminase with a role in innate immunity to foreign DNA. Previous studies have shown that heterologously expressed A3A is genotoxic, suggesting that monocytes may have a mechanism to regulate this enzyme. Indeed, we observed no significant cytotoxicity when interferon was used to induce the expression of endogenous A3A in CD14(+)-enriched primary cells or the monocytic cell line THP-1. In contrast, doxycycline-induced A3A in HEK293 cells caused major cytotoxicity at protein levels lower than those observed when CD14(+) cells were stimulated with interferon. Immunofluorescent microscopy of interferon-stimulated CD14(+) and THP-1 cells revealed that endogenous A3A is cytoplasmic, in stark contrast to stably or transiently transfected A3A, which has a cell-wide localization. A3A constructs engineered to be cytoplasmic are also nontoxic in HEK293 cells. These data combine to suggest that monocytic cells use a cytoplasmic retention mechanism to control A3A and avert genotoxicity during innate immune responses.	Univ Minnesota, Dept Biochem Mol Biol & Biophys, Inst Mol Virol, Masonic Canc Ctr, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Harris, RS (corresponding author), 321 Church St SE,6-155 Jackson Hall, Minneapolis, MN 55455 USA.	rsh@umn.edu	Brown, William/GXN-2777-2022	Lackey, Lela/0000-0003-2163-4005; Carpenter, Michael/0000-0001-9524-5323	National Institutes of Health [R01 AI064046, P01 GM091743, T32 DE07288, F32 GM095219]; Canadian Institutes for Health Research (CIHR) Postdoctoral Fellowship; National Science Foundation (NSF) Predoctoral Fellowship; National Institutes of Health Molecular Virology Training [T32 AI083196]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064046, T32AI083196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM095219, P01GM091743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research (CIHR) Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); National Science Foundation (NSF) Predoctoral Fellowship(National Science Foundation (NSF)); National Institutes of Health Molecular Virology Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI064046 and P01 GM091743 (to R. S. H.).; Supported by a Canadian Institutes for Health Research (CIHR) Postdoctoral Fellowship.; Supported by National Institutes of Health Grants T32 DE07288 and F32 GM095219.; Supported in part by a National Science Foundation (NSF) Predoctoral Fellowship and National Institutes of Health Molecular Virology Training Grant T32 AI083196.	Aynaud MM, 2012, J BIOL CHEM, V287, P39182, DOI 10.1074/jbc.M112.372722; Bennett RP, 2008, J BIOL CHEM, V283, P7320, DOI 10.1074/jbc.M708567200; Bennett RP, 2006, BIOCHEM BIOPH RES CO, V350, P214, DOI 10.1016/j.bbrc.2006.09.032; Berger A, 2010, J BIOL CHEM, V285, P12248, DOI 10.1074/jbc.M109.090977; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chen WT, 2013, MOL CELL BIOL, V33, P111, DOI 10.1128/MCB.01024-12; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Goila-Gaur R, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-61; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Koning FA, 2011, J VIROL, V85, P13448, DOI 10.1128/JVI.00775-11; Lackey L, 2012, J MOL BIOL, V419, P301, DOI 10.1016/j.jmb.2012.03.011; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Larue RS, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-104; Li MMH, 2011, J VIROL, V85, P8197, DOI 10.1128/JVI.00624-11; Lovsin N, 2009, ANN NY ACAD SCI, V1178, P268, DOI 10.1111/j.1749-6632.2009.05006.x; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2008, J VIROL, V82, P987, DOI 10.1128/JVI.01078-07; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nabel CS, 2012, NAT CHEM BIOL, V8, P751, DOI [10.1038/NCHEMBIO.1042, 10.1038/nchembio.1042]; Narvaiza I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000439; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; Ooms M, 2012, J VIROL, V86, P6097, DOI 10.1128/JVI.06570-11; Ord D, 2003, EXP CELL RES, V286, P308, DOI 10.1016/S0014-4827(03)00070-3; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Shinohara M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00806; Stenglein MD, 2008, J VIROL, V82, P9591, DOI 10.1128/JVI.02471-07; Stenglein MD, 2006, J BIOL CHEM, V281, P16837, DOI 10.1074/jbc.M602367200; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Wijesinghe P, 2012, NUCLEIC ACIDS RES, V40, P9206, DOI 10.1093/nar/gks685; Wu CY, 2011, J BIOL CHEM, V286, P30806, DOI 10.1074/jbc.M111.257469; Wu M, 2003, J BIOL CHEM, V278, P27072, DOI 10.1074/jbc.M209814200	55	57	59	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17253	17260		10.1074/jbc.M113.458661	http://dx.doi.org/10.1074/jbc.M113.458661			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640892	Green Published, hybrid			2022-12-28	WOS:000320380600021
J	Oguariri, RM; Dai, L; Adelsberger, JW; Rupert, A; Stevens, R; Yang, J; Huang, DW; Lempicki, RA; Zhou, M; Baseler, MW; Lane, HC; Imamichi, T				Oguariri, Raphael M.; Dai, Lue; Adelsberger, Joseph W.; Rupert, Adam; Stevens, Randy; Yang, Jun; Huang, Dawei; Lempicki, Richard A.; Zhou, Ming; Baseler, Michael W.; Lane, H. Clifford; Imamichi, Tomozumi			Interleukin-2 Inhibits HIV-1 Replication in Some Human T Cell Lymphotrophic Virus-1-infected Cell Lines via the Induction and Incorporation of APOBEC3G into the Virion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS FACTOR-ALPHA; GAMMA-CHAIN; ANTIVIRAL ACTIVITY; IN-VIVO; FUNCTIONAL COMPONENT; CYTIDINE DEAMINATION; HUMAN MACROPHAGES; CUTTING EDGE; VIF PROTEIN	IL-2 has been used in culture of primary T cells to maintain cell proliferation. We have previously reported that IL-27 inhibits HIV-1 replication in primary T cells in the presence of IL-2. To gain a better understanding of the mechanisms involved in this inhibitory effect, we attempted to investigate in detail the effects of IL-27 and IL-2 using several cell lines. Unexpectedly, IL-27 did not inhibit HIV-1 in T cell lines, whereas IL-2 inhibited HIV-1 replication in the human T cell lymphotrophic virus (HTLV)- 1-transformed T cell lines, MT-2, MT-4, SLB-1, and ATL-2. No effects were seen in HTLV-1-negative cell lines. Utilizing MT-2 cells, we demonstrated that IL-2 treatment inhibited HIV-1 syncytia-inducing ability and dose-dependently decreased supernatant p24 antigen levels by >90%. Using real time PCR and Western blot analysis, we observed that IL-2 treatment induced the host restriction factor, APOBEC3G with accumulation into the lower molecular mass active form as characterized by FPLC. Further analysis revealed that the virus recovered from IL-2-treated MT-2 cells had impaired replication competency. This was found to be due to incorporation of APOBEC3G into the virion despite the presence of Vif. These findings demonstrate a novel role for IL-2 in regulating production of infectious HIV-1 virions in HTLV-1-infected cells through the induction of APOBEC3G.	[Oguariri, Raphael M.; Dai, Lue; Imamichi, Tomozumi] Frederick Natl Lab Canc Res, Lab Human Retrovirol, Frederick, MD 21702 USA; [Adelsberger, Joseph W.; Rupert, Adam; Stevens, Randy; Baseler, Michael W.] Frederick Natl Lab Canc Res, AIDS Monitoring Lab, Frederick, MD 21702 USA; [Yang, Jun; Huang, Dawei; Lempicki, Richard A.] Frederick Natl Lab Canc Res, Lab Immunopathogenesis & Bioinformat, Frederick, MD 21702 USA; [Oguariri, Raphael M.; Dai, Lue; Adelsberger, Joseph W.; Rupert, Adam; Stevens, Randy; Yang, Jun; Huang, Dawei; Lempicki, Richard A.; Baseler, Michael W.; Imamichi, Tomozumi] Frederick Natl Lab Canc Res, Clin Serv Program, Appl & Dev Directorate, Frederick, MD 21702 USA; [Zhou, Ming] Frederick Natl Lab Canc Res, Lab Prote & Analyt Technol, Adv Technol Program Directorate, Sci Applicat Int Corp,Frederick Inc, Frederick, MD 21702 USA; [Lane, H. Clifford] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Imamichi, T (corresponding author), Frederick Natl Lab Canc Res, Lab Human Retrovirol, Appl & Dev Directorate, Sci Applicat Int Corp,Frederick Inc, Bldg 550,Rm 126,1050 Boyles St, Frederick, MD 21702 USA.	timamichi@mail.nih.gov	Lempicki, Richard A/E-1844-2012	Lempicki, Richard A/0000-0002-7059-409X; Imamichi, Tomozumi/0000-0002-1474-1796	National Institutes of Health [HHSN261200800001E]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by a National Institutes of Health Grant under Contract HHSN261200800001E. This work was also supported in part by the National Institute of Allergy and Infectious Diseases.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; BOHNLEIN E, 1989, J VIROL, V63, P1578; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Casoli C, 2007, AIDS REV, V9, P140; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059194; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; Dai L, 2013, J EXP MED, V210, P517, DOI 10.1084/jem.20120572; DiSanto JP, 1995, IMMUNOL REV, V148, P19; Fakruddin JM, 2007, BLOOD, V109, P1841, DOI 10.1182/blood-2006-02-001578; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; FOLI BA, 1995, BLOOD, V85, P2114, DOI 10.1182/blood.V85.8.2114.bloodjournal8582114; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; GIRI JG, 1994, EMBO J, V13, P2822, DOI 10.1002/j.1460-2075.1994.tb06576.x; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Greenwell-Wild T, 2009, BLOOD, V114, P1864, DOI 10.1182/blood-2009-03-211540; HAERTLE T, 1988, J BIOL CHEM, V263, P5870; HARADA S, 1985, SCIENCE, V229, P563, DOI 10.1126/science.2992081; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hatzakis A, 2000, LANCET, V355, P599, DOI 10.1016/S0140-6736(99)10311-8; Holmes RK, 2007, J BIOL CHEM, V282, P2587, DOI 10.1074/jbc.M607298200; Hou W, 2009, J VIROL, V83, P3834, DOI 10.1128/JVI.01773-08; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Imamichi T, 2003, J VIROL, V77, P1011, DOI 10.1128/JVI.77.2.1011-1020.2003; Imamichi T, 2000, J VIROL, V74, P10958, DOI 10.1128/JVI.74.23.10958-10964.2000; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; KALTER DC, 1991, J IMMUNOL, V146, P298; Kamata M., 2009, PLOS PATHOG, V5; Kao S, 2003, J VIROL, V77, P11398, DOI 10.1128/JVI.77.21.11398-11407.2003; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Liddament MT, 2004, CURR BIOL, V14, P1385, DOI 10.1016/j.cub.2004.06.050; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; McNees AL, 2005, J CLIN VIROL, V34, P52, DOI 10.1016/j.jcv.2004.12.018; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Moriuchi H, 1998, J EXP MED, V187, P1689, DOI 10.1084/jem.187.10.1689; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; Oguariri RM, 2007, J BIOL CHEM, V282, P3594, DOI 10.1074/jbc.M608150200; PAUWELS R, 1987, J VIROL METHODS, V16, P171, DOI 10.1016/0166-0934(87)90002-4; PERNO CF, 1992, BLOOD, V80, P995; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; Poli G, 1993, Semin Immunol, V5, P165, DOI 10.1006/smim.1993.1020; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; Saifuddin M, 2000, J IMMUNOL, V164, P3941, DOI 10.4049/jimmunol.164.8.3941; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Soros VB, 2007, PLOS PATHOG, V3, P152, DOI 10.1371/journal.ppat.0030015; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Swaminathan S, 2013, BIOCHEM BIOPH RES CO, V434, P228, DOI 10.1016/j.bbrc.2013.03.046; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xiang JH, 2004, LANCET, V363, P2040, DOI 10.1016/S0140-6736(04)16453-2; Xu HZ, 2004, P NATL ACAD SCI USA, V101, P5652, DOI 10.1073/pnas.0400830101; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	67	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17812	17822		10.1074/jbc.M113.468975	http://dx.doi.org/10.1074/jbc.M113.468975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640893	Green Published, hybrid			2022-12-28	WOS:000320380600070
J	Oliver, MB; Jones, C; Larson, TR; Calix, JJ; Zartler, ER; Yother, J; Nahm, MH				Oliver, Melissa B.; Jones, Chris; Larson, Thomas R.; Calix, Juan J.; Zartler, Edward R.; Yother, Janet; Nahm, Moon H.			Streptococcus pneumoniae Serotype 11D Has a Bispecific Glycosyltransferase and Expresses Two Different Capsular Polysaccharide Repeating Units	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Enzyme Mutation; Molecular Evolution; NMR; Polysaccharide; Streptococcus pneumoniae; WcrL; Bispecific Transferase; Capsular Polysaccharide Structure; Serotype 11D	GUILLAIN-BARRE-SYNDROME; HEPARAN-SULFATE; NEISSERIA-MENINGITIDIS; CLINICAL-FEATURES; GENE POLYMORPHISM; BIOSYNTHETIC LOCI; AMINO-ACID; SPECIFICITIES; ANTIBODY; NMR	Streptococcus pneumoniae (pneumococcus) expresses a capsular polysaccharide (CPS) that protects against host immunity and is synthesized by enzymes in the capsular polysaccharide synthesis (cps) locus. Serogroup 11 has six members (11A to -E) and the CPS structure of all members has been solved, except for serotype 11D. The cps loci of 11A and 11D differ by one codon (N112S) in wcrL, which putatively encodes a glycosyltransferase that adds the fourth sugar of the CPS repeating unit (RU). Gas chromatography and nuclear magnetic resonance analysis revealed that 11A and 11D PSs contain identical CPS RUs that contain Glc as the fourth sugar. However, approximate to 25% of 11D CPS RUs contain instead GlcNAc as the fourth sugar, suggesting that 11D wcrL encodes a bispecific glycosyltransferase. To test the hypothesis that codon 112 of WcrL determines enzyme specificity, and therefore the fourth sugar in the RU, we generated three isogenic pneumococcal strains with 11A cps loci containing wcrL encoding Ser-112 (MBO128) or Ala-112 (MBO130). MBO128 was serologically and biochemically identical to serotype 11D. MBO130 has a unique serologic profile; has as much GlcNAc as 11F, 11B, and 11C CPS do; and may represent a new serotype. These findings demonstrate how pneumococci alter their CPS structure and their immunologic properties with a minimal genetic change.	[Larson, Thomas R.; Calix, Juan J.; Nahm, Moon H.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Oliver, Melissa B.; Yother, Janet; Nahm, Moon H.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Jones, Chris] Natl Inst Biol Stand & Controls, Mol Struct Lab, S Mimms EN6 3QG, Herts, England; [Zartler, Edward R.] Quantum Tessera Consulting LLC, Collegeville, PA 19426 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institute for Biological Standards & Control	Nahm, MH (corresponding author), Univ Alabama Birmingham, Dept Pathol, BBRB 614,1720 2nd Ave S, Birmingham, AL 35294 USA.	nahm@uab.edu	Jones, Chris/AAF-4063-2021	Jones, Chris/0000-0001-7109-492X; Nahm, Moon/0000-0002-6922-1042	National Institutes of Health [F31 AI-093103, R01 AI-28457, R01 AI-31473]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031473, F31AI093103, R01AI028457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants F31 AI-093103 (to J. J. C.), R01 AI-28457 (to J. Y.), and R01 AI-31473 (to M. H. N.). The University of Alabama at Birmingham has intellectual property rights for some of the reagents used in this study. M. B. Oliver, T. R. Larson, J. J. Calix, J. Yother, and M. H. Nahm are University of Alabama at Birmingham employees. We thank Dr. S. Kornfeld for encouragement and Dr. P. Qasba for careful reading of the manuscript.	Aanensen DM, 2007, J BACTERIOL, V189, P7856, DOI 10.1128/JB.00837-07; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bhushan R, 1998, INFECT IMMUN, V66, P5848, DOI 10.1128/IAI.66.12.5848-5853.1998; Bratcher PE, 2009, MICROBIOL-SGM, V155, P576, DOI 10.1099/mic.0.024521-0; BROWN EJ, 1982, J CLIN INVEST, V69, P85, DOI 10.1172/JCI110444; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Calix JJ, 2011, J BACTERIOL, V193, P5271, DOI 10.1128/JB.05034-11; Calix JJ, 2010, J INFECT DIS, V202, P29, DOI 10.1086/653123; Camilli R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-25; Cartee RT, 2005, J BACTERIOL, V187, P7425, DOI 10.1128/JB.187.21.7425-7433.2005; Claus H, 2009, MOL MICROBIOL, V71, P960, DOI 10.1111/j.1365-2958.2008.06580.x; Draing C, 2006, J BIOL CHEM, V281, P33849, DOI 10.1074/jbc.M602676200; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14; Lin JS, 2006, J CLIN MICROBIOL, V44, P383, DOI 10.1128/JCM.44.2.383-388.2006; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; Okada M, 2010, BIOCHEM J, V428, P463, DOI 10.1042/BJ20100101; Pedersen LC, 2003, J BIOL CHEM, V278, P14420, DOI 10.1074/jbc.M210532200; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Qasba PK, 2008, CURR DRUG TARGETS, V9, P292, DOI 10.2174/138945008783954943; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; Ramakrishnan B, 2007, J MOL BIOL, V365, P570, DOI 10.1016/j.jmb.2006.10.034; Trzcinski K, 2003, APPL ENVIRON MICROB, V69, P7364, DOI 10.1128/AEM.69.12.7364-7370.2003; Tsang RSW, 2008, CAN J MICROBIOL, V54, P229, DOI 10.1139/w07-132; van Selm S, 2003, INFECT IMMUN, V71, P6192, DOI 10.1128/IAI.71.11.6192-6198.2003; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Viel S, 2003, BIOMACROMOLECULES, V4, P1843, DOI 10.1021/bm0342638; Xayarath B, 2007, J BACTERIOL, V189, P3369, DOI 10.1128/JB.01938-06; Yother J, 2011, ANNU REV MICROBIOL, V65, P563, DOI 10.1146/annurev.micro.62.081307.162944; Yu J, 2008, J MED MICROBIOL, V57, P171, DOI 10.1099/jmm.0.47549-0; Yuki N, 2007, J NEUROCHEM, V103, P150, DOI 10.1111/j.1471-4159.2007.04707.x; Zartler ER, 2011, J BIOMOL NMR, V51, P357, DOI 10.1007/s10858-011-9563-8; Zartler ER, 2009, J BIOL CHEM, V284, P7318, DOI 10.1074/jbc.M807952200	34	20	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21945	10.1074/jbc.M113.488528	http://dx.doi.org/10.1074/jbc.M113.488528			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23737526	hybrid, Green Published			2022-12-28	WOS:000328841900042
J	Zhang, Y; Zhao, HF; Wang, J; Ge, JP; Li, Y; Gu, JK; Li, P; Feng, Y; Yang, MJ				Zhang, Yi; Zhao, Haifeng; Wang, Jia; Ge, Jingpeng; Li, Yang; Gu, Jinke; Li, Peng; Feng, Yue; Yang, Maojun			Structural Insight into Caenorhabditis elegans Sex-determining Protein FEM-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; Protein Phosphatase; Protein Structure; Structural Biology; X-ray Crystallography; FEM-2; Novel Fold; Sex Determination; Substrate	C-ELEGANS; PHOSPHATASES; SPECIFICITY; MECHANISM; SOFTWARE; DOMAIN; MODEL; PP2C	In the nematode Caenorhabditis elegans, fem-1, fem-2, and fem-3 play crucial roles in male sexual development. Among these three genes, fem-2 encodes a PP2C (serine/threonine phosphatase type 2C)-like protein, whose activity promotes the development of masculinity. Different from the canonical PP2Cs, FEM-2 consists of an additional N-terminal domain (NTD) apart from its C-terminal catalytic domain. Interestingly, genetic studies have indicated indispensable roles for both of these two domains of FEM-2 in promoting male development, but the underlying mechanism remains unknown. In the present study, we solved the crystal structure of full-length FEM-2, which revealed a novel structural fold formed by its NTD. Structural and functional analyses demonstrated that the NTD did not directly regulate the in vitro dephosphorylation activity of FEM-2, but instead functioned as a scaffold domain in the assembly of the FEM-1/2/3 complex, the executioner in the final step of the sex determination pathway. Biochemical studies further identified the regions in the NTD involved in FEM-1 and FEM-3 interactions. Our results not only identified a novel fold formed by the extra domain of a noncanonical PP2C enzyme, but also provided important insights into the molecular mechanism of how the NTD works in mediating the sex-determining role of FEM-1/2/3 complex.	[Zhang, Yi; Zhao, Haifeng; Wang, Jia; Ge, Jingpeng; Li, Yang; Gu, Jinke; Li, Peng; Feng, Yue; Yang, Maojun] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, Minist Educ MOE,Key Lab Prot Sci, Beijing 100084, Peoples R China; [Feng, Yue] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing 100029, Peoples R China	Tsinghua University; Beijing University of Chemical Technology	Yang, MJ (corresponding author), Tsinghua Univ, Med Bldg C232, Beijing 100084, Peoples R China.	maojunyang@tsinghua.edu.cn	Gai, Jingpeng/AAT-9369-2021; Feng, Yue/HGE-4589-2022; Ge, Jingpeng/AGG-3471-2022	Gai, Jingpeng/0000-0001-6164-1221; Feng, Yue/0000-0002-1576-1385; Gu, Jinke/0000-0001-5942-480X; Yang, Maojun/0000-0002-6798-3094	Ministry of Science and Technology [31030020, 2012CB911101, 2011CB910502, 31170679]; National Natural Science Foundation of China	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 31030020, 2012CB911101, and 2011CB910502 and Grant 31170679 from the Ministry of Science and Technology and the National Natural Science Foundation of China.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ChinSang ID, 1996, GENE DEV, V10, P2314, DOI 10.1101/gad.10.18.2314; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hansen D, 1998, GENETICS, V149, P1353; HODGKIN J, 1986, GENETICS, V114, P15; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lum DH, 2000, GENE DEV, V14, P3153; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehra A, 1999, GENE DEV, V13, P1453, DOI 10.1101/gad.13.11.1453; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PILGRIM D, 1995, MOL BIOL CELL, V6, P1159, DOI 10.1091/mbc.6.9.1159; Reiner DJ, 1999, NATURE, V402, P199, DOI 10.1038/46072; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; SERGIENKO EA, 1994, ANAL BIOCHEM, V221, P348, DOI 10.1006/abio.1994.1424; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Starostina NG, 2007, DEV CELL, V13, P127, DOI 10.1016/j.devcel.2007.05.008; Tan KML, 2001, J BIOL CHEM, V276, P44193, DOI 10.1074/jbc.M105880200; Wang Q, 2002, J NEUROSCI, V22, P2274, DOI 10.1523/JNEUROSCI.22-06-02274.2002; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Zarkower D, 2006, WORMBOOK, V1, P1, DOI DOI 10.1895/WORMBOOK.1.84.1; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	27	10	18	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22058	22066		10.1074/jbc.M113.464339	http://dx.doi.org/10.1074/jbc.M113.464339			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760267	Green Published, hybrid			2022-12-28	WOS:000328841900051
J	Vater, A; Sell, S; Kaczmarek, P; Maasch, C; Buchner, K; Pruszynska-Oszmalek, E; Kolodziejski, P; Purschke, WG; Nowak, KW; Strowski, MZ; Klussmann, S				Vater, Axel; Sell, Simone; Kaczmarek, Przemyslaw; Maasch, Christian; Buchner, Klaus; Pruszynska-Oszmalek, Ewa; Kolodziejski, Pawel; Purschke, Werner G.; Nowak, Krzysztof W.; Strowski, Mathias Z.; Klussmann, Sven			A Mixed Mirror-image DNA/RNA Aptamer Inhibits Glucagon and Acutely Improves Glucose Tolerance in Models of Type 1 and Type 2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOGENOUS GLUCAGON; RANDOM MUTAGENESIS; MOUSE MODELS; IN-VIVO; INSULIN; HYPERGLYCEMIA; SPIEGELMER; RNA; IMMUNONEUTRALIZATION; FLEXIBILITY	Excessive secretion of glucagon, a functional insulin antagonist, significantly contributes to hyperglycemia in type 1 and type 2 diabetes. Accordingly, immunoneutralization of glucagon or genetic deletion of the glucagon receptor improved glucose homeostasis in animal models of diabetes. Despite this strong evidence, agents that selectively interfere with endogenous glucagon have not been implemented in clinical practice yet. We report the discovery of mirror-image DNA-aptamers (Spiegelmer (R)) that bind and inhibit glucagon. The affinity of the best binding DNA oligonucleotide was remarkably increased (>25-fold) by the introduction of oxygen atoms at selected 2'-positions through deoxyribo- to ribonucleotide exchanges resulting in a mixed DNA/RNA-Spiegelmer (NOX-G15) that binds glucagon with a K-d of 3 nM. NOX-G15 shows no cross-reactivity with related peptides such as glucagon-like peptide-1, glucagon-like peptide-2, gastric-inhibitory peptide, and prepro-vasoactive intestinal peptide. In vitro, NOX-G15 inhibits glucagon-stimulated cAMP production in CHO cells overexpressing the human glucagon receptor with an IC50 of 3.4 nM. A single injection of NOX-G15 ameliorated glucose excursions in intraperitoneal glucose tolerance tests in mice with streptozotocin-induced (type 1) diabetes and in a non-genetic mouse model of type 2 diabetes. In conclusion, the data suggest NOX-G15 as a therapeutic candidate with the potential to acutely attenuate hyperglycemia in type 1 and type 2 diabetes.	[Vater, Axel; Sell, Simone; Maasch, Christian; Buchner, Klaus; Purschke, Werner G.; Klussmann, Sven] NOXXON Pharma AG, D-10589 Berlin, Germany; [Kaczmarek, Przemyslaw; Pruszynska-Oszmalek, Ewa; Kolodziejski, Pawel; Nowak, Krzysztof W.] Poznan Univ Life Sci, Dept Anim Physiol & Biochem, PL-60637 Poznan, Poland; [Strowski, Mathias Z.] Charite, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany; [Strowski, Mathias Z.] Charite, Interdisciplinary Ctr Metab Endocrinol Diabet & M, D-13353 Berlin, Germany	NOXXON Pharma; Poznan University of Life Sciences; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klussmann, S (corresponding author), NOXXON Pharma AG, Max Dohrn Str 8-10, D-10589 Berlin, Germany.	sklussmann@noxxon.com	Pruszynska-Oszmalek, Ewa/C-8761-2011; Kolodziejski, Pawel A/O-8296-2019; Nowak, Krzysztof W./C-3435-2009; Kaczmarek, Przemyslaw/D-1031-2011	Pruszynska-Oszmalek, Ewa/0000-0002-7182-6905; Kolodziejski, Pawel A/0000-0003-0715-0223; Nowak, Krzysztof W./0000-0002-1948-6544; Vater, Axel/0000-0003-4166-982X	Deutsche Forschungsgemeinschaft (DFG) [STR558/6-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported in part by a Deutsche Forschungsgemeinschaft (DFG) Grant STR558/6-1 (to M. Z. S.). A. V., S. S., C. M., K. B., W. G. P., and S. K. are employees of NOXXON Pharma AG, a company that has a commercial interest in Spiegelmers.	Bansal P, 2008, AM J PHYSIOL-ENDOC M, V295, pE751, DOI 10.1152/ajpendo.90295.2008; Baribault H, 2010, METHODS MOL BIOL, V602, P135, DOI 10.1007/978-1-60761-058-8_9; BRAND CL, 1994, DIABETOLOGIA, V37, P985, DOI 10.1007/BF00400461; CUMMINS LL, 1995, NUCLEIC ACIDS RES, V23, P2019, DOI 10.1093/nar/23.11.2019; Dallas-Yang Q, 2004, EUR J PHARMACOL, V501, P225, DOI 10.1016/j.ejphar.2004.08.023; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265; Hagerman PJ, 1997, ANNU REV BIOPH BIOM, V26, P139, DOI 10.1146/annurev.biophys.26.1.139; Isis, 2011, IS IN PHAS 1 STUD IS; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kim RM, 2008, BIOORG MED CHEM LETT, V18, P3701, DOI 10.1016/j.bmcl.2008.05.072; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kulkarni O, 2007, J AM SOC NEPHROL, V18, P2350, DOI 10.1681/ASN.2006121348; Lee Y, 2012, P NATL ACAD SCI USA, V109, P14972, DOI 10.1073/pnas.1205983109; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; Luo J, 1998, METABOLISM, V47, P663, DOI 10.1016/S0026-0495(98)90027-0; Mang Y, 2004, DIABETES, V53, P410; Pocai A, 2012, J ENDOCRINOL, V215, P335, DOI 10.1530/JOE-12-0368; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Schwoebel F, 2013, BLOOD, V121, P2311, DOI 10.1182/blood-2012-09-456756; Shafer RH, 2001, BIOPOLYMERS, V56, P209, DOI 10.1002/1097-0282(2000/2001)56:3<209::AID-BIP10018>3.0.CO;2-Y; Shah P, 2000, J CLIN ENDOCR METAB, V85, P4053, DOI 10.1210/jc.85.11.4053; Shearman LP, 2006, ENDOCRINOLOGY, V147, P1517, DOI 10.1210/en.2005-0993; Sorensen H, 2006, DIABETES, V55, P2843, DOI 10.2337/db06-0222; STAUB A., 1955, JOUR BIOL CHEM, V214, P619; Strowski MZ, 2004, ENDOCRINOLOGY, V145, P5259, DOI 10.1210/en.2004-0610; Tang CF, 2006, J AM CHEM SOC, V128, P5966, DOI 10.1021/ja0603958; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; UNGER RH, 1971, NEW ENGL J MED, V285, P443; UNGER RH, 1975, LANCET, V1, P14; UNSON CG, 1989, PEPTIDES, V10, P1171, DOI 10.1016/0196-9781(89)90010-7; Vater A, 2003, CURR OPIN DRUG DI DE, V6, P253; WILLIAMS KP, 1995, NUCLEIC ACIDS RES, V23, P4220, DOI 10.1093/nar/23.20.4220; Wlotzka B, 2002, P NATL ACAD SCI USA, V99, P8898, DOI 10.1073/pnas.132067399; WYATT JR, 1989, NUCLEIC ACIDS RES, V17, P7833, DOI 10.1093/nar/17.19.7833; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009; Zaccolo M, 1996, J MOL BIOL, V255, P589, DOI 10.1006/jmbi.1996.0049	39	45	46	5	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21136	21147		10.1074/jbc.M112.444414	http://dx.doi.org/10.1074/jbc.M112.444414			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23744070	Green Published, hybrid			2022-12-28	WOS:000322014400034
J	Schmidt, C; Athenstaedt, K; Koch, B; Ploier, B; Daum, G				Schmidt, Claudia; Athenstaedt, Karin; Koch, Barbara; Ploier, Birgit; Daum, Guenther			Regulation of the Yeast Triacylglycerol Lipase Tgl3p by Formation of Nonpolar Lipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; NEUTRAL LIPIDS; PARTICLES; ACYLTRANSFERASE; PROTEINS; DROPLETS; STORAGE; CELLS; ESTERIFICATION	Tgl3p, the major triacylglycerol lipase of the yeast Saccharomyces cerevisiae, is a component of lipid droplets but is also present in the endoplasmic reticulum in a minor amount. Recently, it was shown that this enzyme can also serve as a lysophospholipid acyltransferase (Rajakumari, S., and Daum, G. (2010) Mol. Biol. Cell 21, 501-510). Here, we describe the effects of the presence/absence of triacylglycerols and lipid droplets on the functionality of Tgl3p. In a dga1 Delta lro1 Delta are1 Delta are2 Delta quadruple mutant lacking all four triacylglycerol- and steryl ester-synthesizing acyltransferases and consequently the lipid droplets, the gene expression of TGL3 was only slightly altered. In contrast, protein level and stability of Tgl3p were markedly reduced in the absence of lipid droplets. Under these conditions, the enzyme was localized to the endoplasmic reticulum. Even the lack of the substrate, triacylglycerol, affected stability and localization of Tgl3p to some extent. Interestingly, Tgl3p present in the endoplasmic reticulum seems to lack lipolytic as well as acyltransferase activity as shown by enzymatic analysis and lipid profiling. Thus, we propose that the activity of Tgl3p is restricted to lipid droplets, whereas the endoplasmic reticulum may serve as a parking lot for this enzyme.	[Schmidt, Claudia; Athenstaedt, Karin; Koch, Barbara; Ploier, Birgit; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Athenstaedt, Karin] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	Graz University of Technology; University of Graz	Daum, G (corresponding author), Graz Univ Technol, Inst Biochem, Petersgasse 12-2, A-8010 Graz, Austria.	guenther.daum@tugraz.at		Athenstaedt, Karin/0000-0001-7198-3989	Austrian Science Fund [W901 DK]; Molecular Enzymology [P23029, P21251]; Austrian Science Fund (FWF) [P 21251, P 23029, W 901] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Molecular Enzymology; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund Projects W901 DK Molecular Enzymology and P23029 (to G. D.) and P21251 (to K. A.).	Athenstaedt K, 2006, CELL MOL LIFE SCI, V63, P1355, DOI 10.1007/s00018-006-6016-8; Athenstaedt K, 2005, J BIOL CHEM, V280, P37301, DOI 10.1074/jbc.M507261200; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Athenstaedt K, 1999, J BACTERIOL, V181, P6441, DOI 10.1128/JB.181.20.6441-6448.1999; Athenstaedt K, 2011, BBA-MOL CELL BIOL L, V1811, P587, DOI 10.1016/j.bbalip.2011.07.004; Brasaemle DL, 2012, J BIOL CHEM, V287, P2273, DOI 10.1074/jbc.R111.309088; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Czabany T, 2008, J BIOL CHEM, V283, P17065, DOI 10.1074/jbc.M800401200; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; FOLCH J, 1957, J BIOL CHEM, V226, P497; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Grillitsch K, 2011, BBA-MOL CELL BIOL L, V1811, P1165, DOI 10.1016/j.bbalip.2011.07.015; HAID A, 1983, METHOD ENZYMOL, V96, P192; Horvath SE, 2011, BBA-MOL CELL BIOL L, V1811, P1030, DOI 10.1016/j.bbalip.2011.08.007; Jacquier N, 2011, J CELL SCI, V124, P2424, DOI 10.1242/jcs.076836; Kalantari F, 2010, MOL MEMBR BIOL, V27, P462, DOI 10.3109/09687688.2010.538936; Kohlwein SD, 2013, GENETICS, V193, P1, DOI 10.1534/genetics.112.143362; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leber R, 1998, MOL BIOL CELL, V9, P375, DOI 10.1091/mbc.9.2.375; LEBER R, 1994, YEAST, V10, P1421, DOI 10.1002/yea.320101105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Oelkers P, 2000, J BIOL CHEM, V275, P15609, DOI 10.1074/jbc.C000144200; Oelkers P, 2002, J BIOL CHEM, V277, P8877, DOI 10.1074/jbc.M111646200; Rajakumari S, 2010, BBA-MOL CELL BIOL L, V1801, P1314, DOI 10.1016/j.bbalip.2010.08.004; Rajakumari S, 2010, J BIOL CHEM, V285, P15769, DOI 10.1074/jbc.M109.076331; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602; Zweytick D, 2000, EUR J BIOCHEM, V267, P1075, DOI 10.1046/j.1432-1327.2000.01103.x; Zweytick D, 2000, BBA-REV BIOMEMBRANES, V1469, P101, DOI 10.1016/S0005-2736(00)00294-7	39	22	24	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19939	19948		10.1074/jbc.M113.459610	http://dx.doi.org/10.1074/jbc.M113.459610			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23673660	Green Published, hybrid			2022-12-28	WOS:000321515800059
J	Bettaieb, A; Bakke, J; Nagata, N; Matsuo, K; Xi, YN; Liu, SM; AbouBechara, D; Melhem, R; Stanhope, K; Cummings, B; Graham, J; Bremer, A; Zhang, S; Lyssiotis, CA; Zhang, ZY; Cantley, LC; Havel, PJ; Haj, FG				Bettaieb, Ahmed; Bakke, Jesse; Nagata, Naoto; Matsuo, Kosuke; Xi, Yannan; Liu, Siming; AbouBechara, Daniel; Melhem, Ramzi; Stanhope, Kimber; Cummings, Bethany; Graham, James; Bremer, Andrew; Zhang, Sheng; Lyssiotis, Costas A.; Zhang, Zhong-Yin; Cantley, Lewis C.; Havel, Peter J.; Haj, Fawaz G.			Protein Tyrosine Phosphatase 1B Regulates Pyruvate Kinase M2 Tyrosine Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN SENSITIVITY; ENDOPLASMIC-RETICULUM; GLUCOSE-HOMEOSTASIS; METABOLIC SYNDROME; BODY-WEIGHT; PTP1B; ADIPOSITY; BINDING; PKM2; INHIBITORS	Protein-tyrosine phosphatase 1B (PTP1B) is a physiological regulator of glucose homeostasis and adiposity and is a drug target for the treatment of obesity and diabetes. Here we identify pyruvate kinase M2 (PKM2) as a novel PTP1B substrate in adipocytes. PTP1B deficiency leads to increased PKM2 total tyrosine and Tyr(105) phosphorylation in cultured adipocytes and in vivo. Substrate trapping and mutagenesis studies identify PKM2 Tyr-(105) and Tyr-148 as key sites that mediate PTP1B-PKM2 interaction. In addition, in vitro analyses illustrate a direct effect of Tyr-(105) phosphorylation on PKM2 activity in adipocytes. Importantly, PTP1B pharmacological inhibition increased PKM2 Tyr-(105) phosphorylation and decreased PKM2 activity. Moreover, PKM2 Tyr-(105) phosphorylation is regulated nutritionally, decreasing in adipose tissue depots after high-fat feeding. Further, decreased PKM2 Tyr-(105) phosphorylation correlates with the development of glucose intolerance and insulin resistance in rodents, non-human primates, and humans. Together, these findings identify PKM2 as a novel substrate of PTP1B and provide new insights into the regulation of adipose PKM2 activity.	[Bettaieb, Ahmed; Bakke, Jesse; Nagata, Naoto; Matsuo, Kosuke; Xi, Yannan; Liu, Siming; AbouBechara, Daniel; Melhem, Ramzi; Stanhope, Kimber; Cummings, Bethany; Graham, James; Havel, Peter J.; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Stanhope, Kimber; Cummings, Bethany; Graham, James; Havel, Peter J.] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA; [Bremer, Andrew] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Zhang, Sheng; Zhang, Zhong-Yin] Indiana Univ, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Lyssiotis, Costas A.; Cantley, Lewis C.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Lyssiotis, Costas A.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Internal Med, Sacramento, CA 95817 USA; [Haj, Fawaz G.] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; Vanderbilt University; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Davis; University of California System; University of California Davis	Haj, FG (corresponding author), Univ Calif Davis, Dept Nutr, 3135 Meyer Hall, Davis, CA 95616 USA.	fghaj@ucdavis.edu	Lyssiotis, Costas A/AAI-1923-2019; Cantley, Lewis C/D-1800-2014; NAGATA, Naoto/D-9261-2012	Lyssiotis, Costas A/0000-0001-9309-6141; Cantley, Lewis C/0000-0002-1298-7653; NAGATA, Naoto/0000-0002-2389-2334; Graham, James/0000-0001-6507-8149; Havel, Peter/0000-0003-3652-8301; Bakke, Jesse/0000-0003-0305-5165	National Institutes of Health [R56DK084317, R01DK090492, AT-003645, HL-075675, HL-091333, DK-087307, CA-69202]; NCI; Juvenile Diabetes Research Foundation Research Foundation Research [1-2009-337]; Training Program in Biomolecular Technology Fellowship [T32-GM008799]; American Diastases Association; University of California, Office of the President; Damon Runyon Cancer Research Foundation Amgen Fellowship [DRG-2056-10]; Agios Pharmaceuticals; NATIONAL CANCER INSTITUTE [R01CA069202] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT003645] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091333, R01HL075675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090492, R00DK100736, U24DK092993, RC1DK087307, R56DK084317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203, T32GM008799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Juvenile Diabetes Research Foundation Research Foundation Research; Training Program in Biomolecular Technology Fellowship; American Diastases Association; University of California, Office of the President(University of California System); Damon Runyon Cancer Research Foundation Amgen Fellowship; Agios Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R56DK084317 and R01DK090492 (to F. G. H.); AT-003645, HL-075675, HL-091333, and DK-087307 (to P. J. H.); CA-69202 (to Z. Y. Z.); and NCI and National Institutes of Health grants (to L. C. C.). This work was also supported by Juvenile Diabetes Research Foundation Research Grant 1-2009-337) (to F. G. H.), by a Training Program in Biomolecular Technology Fellowship T32-GM008799 (to J. B.), by an American Diastases Association and multicampus award from the University of California, Office of the President (to P. J. H.), and by Damon Runyon Cancer Research Foundation Amgen Fellowship DRG-2056-10 (to C. A. L.). Dr. Cantley owns equity in and receives compensation from Agios Pharmaceuticals and serves on the Board of Directors and Scientific Advisory Board of Agios Pharmaceuticals. Agios Pharmaceuticals is identifying metabolic pathways of cancer cells and developing drugs to inhibit such enzymes to disrupt tumor cell growth and survival.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bettaieb A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034412; Bettaieb A, 2011, J BIOL CHEM, V286, P9225, DOI 10.1074/jbc.M110.186148; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; Breitkopf Susanne B, 2012, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1819s98; Bremer AA, 2011, CTS-CLIN TRANSL SCI, V4, P243, DOI 10.1111/j.1752-8062.2011.00298.x; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Cummings BP, 2011, P NATL ACAD SCI USA, V108, P14670, DOI 10.1073/pnas.1107163108; Cummings BP, 2008, AM J PHYSIOL-REG I, V295, pR1782, DOI 10.1152/ajpregu.90635.2008; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Goldberg MS, 2012, J EXP MED, V209, P217, DOI 10.1084/jem.20111487; Haj FG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036633; Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hoshino A, 2007, J BIOL CHEM, V282, P17706, DOI 10.1074/jbc.M700094200; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Jiang JK, 2010, BIOORG MED CHEM LETT, V20, P3387, DOI 10.1016/j.bmcl.2010.04.015; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; KAYNE FJ, 1973, ARCH BIOCHEM BIOPHYS, V159, P292, DOI 10.1016/0003-9861(73)90455-4; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Lee JW, 2008, INT J BIOCHEM CELL B, V40, P1043, DOI 10.1016/j.biocel.2007.11.009; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Macintyre AN, 2011, MOL CELL, V42, P713, DOI 10.1016/j.molcel.2011.06.003; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Mann JI, 2002, LANCET, V360, P783, DOI 10.1016/S0140-6736(02)09901-4; Matsuo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016446; Miranda S, 2010, CELL SIGNAL, V22, P645, DOI 10.1016/j.cellsig.2009.11.019; Muthusamy VS, 2008, CHEM-BIOL INTERACT, V174, P69, DOI 10.1016/j.cbi.2008.04.016; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Owen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032700; Ramachandran C, 2003, CURR TOP MED CHEM, V3, P749, DOI 10.2174/1568026033452276; Rondinone CM, 2002, DIABETES, V51, P2405, DOI 10.2337/diabetes.51.8.2405; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Spoden GA, 2008, INT J CANCER, V123, P312, DOI 10.1002/ijc.23512; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Stuible M, 2008, J BIOL CHEM, V283, P15740, DOI 10.1074/jbc.M710534200; Swarbrick MM, 2009, ENDOCRINOLOGY, V150, P1670, DOI 10.1210/en.2008-0885; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Urs S, 2006, TRANSGENIC RES, V15, P647, DOI 10.1007/s11248-006-9000-z; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Xie LP, 2003, BIOCHEMISTRY-US, V42, P12792, DOI 10.1021/bi035238p; Yamada E, 1999, BIOCHEM BIOPH RES CO, V256, P257, DOI 10.1006/bbrc.1999.0228; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	62	41	42	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17360	17371		10.1074/jbc.M112.441469	http://dx.doi.org/10.1074/jbc.M112.441469			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640882	Green Published, hybrid			2022-12-28	WOS:000320380600029
J	Bergeron, D; Lapointe, C; Bissonnette, C; Tremblay, G; Motard, J; Roucou, X				Bergeron, Danny; Lapointe, Catherine; Bissonnette, Cyntia; Tremblay, Guillaume; Motard, Julie; Roucou, Xavier			An Out-of-frame Overlapping Reading Frame in the Ataxin-1 Coding Sequence Encodes a Novel Ataxin-1 Interacting Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ataxia; Gene Expression; Nucleus; RNA-Binding Protein; Translation; Alternative Translation Initiation; Spinocerebellar Ataxia Type 1; Dual Coding Gene; Overlapping Reading Frame	POLYGLUTAMINE-INDUCED DISEASE; NUCLEAR-LOCALIZATION; SHUTTLING SEQUENCE; MESSENGER-RNA; CAG REPEAT; GENE; TRANSCRIPTION; IMPORT; STRESS; IDENTIFICATION	Spinocerebellar ataxia type 1 is an autosomal dominant cerebellar ataxia associated with the expansion of a polyglutamine tract within the ataxin-1 (ATXN1) protein. Recent studies suggest that understanding the normal function of ATXN1 in cellular processes is essential to decipher the pathogenesis mechanisms in spinocerebellar ataxia type 1. We found an alternative translation initiation ATG codon in the +3 reading frame of human ATXN1 starting 30 nucleotides downstream of the initiation codon for ATXN1 and ending at nucleotide 587. This novel overlapping open reading frame (ORF) encodes a 21-kDa polypeptide termed Alt-ATXN1 (Alternative ATXN1) with a completely different amino acid sequence from ATXN1. We introduced a hemagglutinin tag in-frame with Alt-ATXN1 in ATXN1 cDNA and showed in cell culture the co-expression of both ATXN1 and Alt-ATXN1. Remarkably, Alt-ATXN1 colocalized and interacted with ATXN1 in nuclear inclusions. In contrast, in the absence of ATXN1 expression, Alt-ATXN1 displays a homogenous nucleoplasmic distribution. Alt-ATXN1 interacts with poly(A)(+) RNA, and its nuclear localization is dependent on RNA transcription. Polyclonal antibodies raised against Alt-ATXN1 confirmed the expression of Alt-ATXN1 in human cerebellum expressing ATXN1. These results demonstrate that human ATXN1 gene is a dual coding sequence and that ATXN1 interacts with and controls the subcellular distribution of Alt-ATXN1.	[Bergeron, Danny; Lapointe, Catherine; Bissonnette, Cyntia; Tremblay, Guillaume; Motard, Julie; Roucou, Xavier] Univ Sherbrooke, Dept Biochem, Fac Med & Sci Sante, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Roucou, X (corresponding author), Univ Sherbrooke, Dept Biochim Z8 2001, Fac Med & Sci Sante, 3201 Jean Mignault, Sherbrooke, PQ J1E 4K8, Canada.	xavier.roucou@usherbrooke.ca			Canadian Institutes for Health Research [MOP-89881]; Natural Sciences and Engineering Research Council of Canada; Fonds de la Recherche en sante du Quebec	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds de la Recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes for Health Research (MOP-89881; to X. R.).; Recipient of a postgraduate scholarship from the Natural Sciences and Engineering Research Council of Canada and from the Fonds de la Recherche en sante du Quebec.	Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Beaudoin S, 2009, BBA-MOL CELL RES, V1793, P335, DOI 10.1016/j.bbamcr.2008.10.009; Cansizoglu AE, 2007, NAT STRUCT MOL BIOL, V14, P452, DOI 10.1038/nsmb1229; CHUNG MY, 1993, NAT GENET, V5, P254, DOI 10.1038/ng1193-254; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; Cummings CJ, 1999, NEURON, V24, P879, DOI 10.1016/S0896-6273(00)81035-1; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Cvetanovic M, 2007, EMBO REP, V8, P671, DOI 10.1038/sj.embor.7400983; Cvetanovic M, 2012, NEUROBIOL DIS, V48, P526, DOI 10.1016/j.nbd.2012.07.024; DUNCAN RF, 1987, ARCH BIOCHEM BIOPHYS, V256, P651, DOI 10.1016/0003-9861(87)90622-9; Emamian ES, 2003, NEURON, V38, P375, DOI 10.1016/S0896-6273(03)00258-7; Fan XHC, 1998, P NATL ACAD SCI USA, V95, P15293, DOI 10.1073/pnas.95.26.15293; Goggin K, 2008, BBA-MOL CELL RES, V1783, P479, DOI 10.1016/j.bbamcr.2007.10.008; Grenier C, 2006, J NEUROCHEM, V97, P1456, DOI 10.1111/j.1471-4159.2006.03837.x; Ho O, 2006, J IMMUNOL, V177, P8283, DOI 10.4049/jimmunol.177.12.8283; Ito T, 2010, BIOCHEM BIOPH RES CO, V403, P161, DOI 10.1016/j.bbrc.2010.10.036; Kang S, 2009, MOL CELLS, V27, P621, DOI 10.1007/s10059-009-0095-y; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee S, 1999, MOL CELL BIOL, V19, P1486; Lee Y, 2011, DEV CELL, V21, P746, DOI 10.1016/j.devcel.2011.08.017; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lin YT, 2006, RNA, V12, P1486, DOI 10.1261/rna.42206; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Michael WM, 1995, COLD SPRING HARB SYM, V60, P663, DOI 10.1101/SQB.1995.060.01.071; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PINOLROMA S, 1991, SCIENCE, V253, P312, DOI 10.1126/science.1857966; Pollard VW, 1996, CELL, V86, P985, DOI 10.1016/S0092-8674(00)80173-7; QUELLE DE, 1995, CELL, V83, P993; Riley BE, 2006, GENE DEV, V20, P2183, DOI 10.1101/gad.1436506; Rosenberg SA, 2002, J IMMUNOL, V168, P2402, DOI 10.4049/jimmunol.168.5.2402; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Smith D.B., 2001, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.MB1607S28, DOI 10.1002/0471142727.MB1607S28]; Tong X, 2011, EMBO REP, V12, P428, DOI 10.1038/embor.2011.49; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Vanderperre B, 2011, FASEB J, V25, P2373, DOI 10.1096/fj.10-173815; Wang RF, 1996, J EXP MED, V183, P1131, DOI 10.1084/jem.183.3.1131; Wu J, 1999, J BIOL CHEM, V274, P29202, DOI 10.1074/jbc.274.41.29202; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang C, 2010, J BIOL CHEM, V285, P8515, DOI 10.1074/jbc.M109.079079; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	49	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21824	10.1074/jbc.M113.472654	http://dx.doi.org/10.1074/jbc.M113.472654			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760502	hybrid, Green Published			2022-12-28	WOS:000328841900032
J	Musille, PM; Pathak, M; Lauer, JL; Griffin, PR; Ortlund, EA				Musille, Paul M.; Pathak, Manish; Lauer, Janelle L.; Griffin, Patrick R.; Ortlund, Eric A.			Divergent Sequence Tunes Ligand Sensitivity in Phospholipid-regulated Hormone Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEROIDOGENIC FACTOR-I; CRYSTAL-STRUCTURE; LRH-1; GENE; EXPRESSION; BINDING; PROTEIN; TRANSCRIPTION; ACTIVATION; REPRESSES	The members of the NR5A subfamily of nuclear receptors (NRs) are important regulators of pluripotency, lipid and glucose homeostasis, and steroidogenesis. Liver receptor homologue 1 (LRH-1; NR5A2) and steroidogenic factor 1 (SF-1; NR5A1) have therapeutic potential for the treatment of metabolic and neoplastic disease; however, a poor understanding of their ligand regulation has hampered the pursuit of these proteins as pharmaceutical targets. In this study, we dissect how sequence variation among LRH-1 orthologs affects phospholipid (PL) binding and regulation. Both human LRH-1 (hLRH-1) and mouse LRH-1 (mLRH-1) respond to newly discovered medium chain PL agonists to modulate lipid and glucose homeostasis. These PLs activate hLRH-1 by altering receptor dynamics in a newly identified alternate activation function region. Mouse and Drosophila orthologs contain divergent sequences in this region potentially altering PL-driven activation. Structural evidence suggests that these sequence differences in mLRH-1 and Drosophila FTZ-f1 (dmFTZ-f1) confer at least partial ligand independence, making them poor models for hLRH-1 studies; however, the mechanisms of ligand independence remain untested. We show using structural and biochemical methods that the recent evolutionary divergence of the mLRH-1 stabilizes the active conformation in the absence of ligand, yet does not abrogate PL-dependent activation. We also show by mass spectrometry and biochemical assays that FTZ-f1 is incapable of PL binding. This work provides a structural mechanism for the differential tuning of PL sensitivity in NR5A orthologs and supports the use of mice as viable therapeutic models for LRH-1-dependent diseases.	[Musille, Paul M.; Pathak, Manish; Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Lauer, Janelle L.; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA	Emory University; Scripps Research Institute	Ortlund, EA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	eortlun@emory.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NIDDK [RO1DK095750]; NIGMS [R01GM084041]; Emory-NIEHS Graduate and Postdoctoral Training in Toxicology Grant [T32ES012870]; American Heart Association (AHA) [12PRE12060583]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES012870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Emory-NIEHS Graduate and Postdoctoral Training in Toxicology Grant; American Heart Association (AHA)(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Data were collected at SE Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract Number W-31-109-Eng-38.; This work was supported, in whole or in part, by National Institutes of Health Grants RO1DK095750 from the NIDDK (to E. A. O.), R01GM084041 from the NIGMS (to P. R. G.), and Emory-NIEHS Graduate and Postdoctoral Training in Toxicology Grant T32ES012870 (to P. M. M.). This work was also supported by American Heart Association (AHA) Predoctoral Grant 12PRE12060583 (to P. M. M.).	Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bridgham JT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000497; Chalmers MJ, 2006, ANAL CHEM, V78, P1005, DOI 10.1021/ac051294f; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clyne CD, 2004, MOL CELL ENDOCRINOL, V215, P39, DOI 10.1016/j.mce.2003.11.001; Clyne CD, 2002, J BIOL CHEM, V277, P20591, DOI 10.1074/jbc.M201117200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Fernandez-Marcos PJ, 2011, BBA-MOL BASIS DIS, V1812, P947, DOI 10.1016/j.bbadis.2010.12.010; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Hammer GD, 1999, FRONT NEUROENDOCRIN, V20, P199, DOI 10.1006/frne.1999.0182; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Kelly VR, 2011, MOL CELL ENDOCRINOL, V332, P116, DOI 10.1016/j.mce.2010.10.003; Kelly VR, 2010, MOL ENDOCRINOL, V24, P2281, DOI 10.1210/me.2010-0133; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Mullaney BC, 2010, CELL METAB, V12, P398, DOI 10.1016/j.cmet.2010.08.013; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Musille PM, 2013, FEBS LETT, V587, P1238, DOI 10.1016/j.febslet.2013.01.004; Musille PM, 2012, NAT STRUCT MOL BIOL, V19, P532, DOI 10.1038/nsmb.2279; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pare JF, 2004, J BIOL CHEM, V279, P21206, DOI 10.1074/jbc.M401523200; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Raaijmakers HCA, 2009, J BIOL CHEM, V284, P19572, DOI 10.1074/jbc.M109.007872; Sablin EP, 2009, MOL ENDOCRINOL, V23, P25, DOI 10.1210/me.2007-0508; Sablin EP, 2003, MOL CELL, V11, P1575, DOI 10.1016/S1097-2765(03)00236-3; Schoch GA, 2010, J MOL BIOL, V395, P568, DOI 10.1016/j.jmb.2009.11.011; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; UEDA H, 1990, GENE DEV, V4, P624, DOI 10.1101/gad.4.4.624; Urs AN, 2007, MOL CELL ENDOCRINOL, V265, P174, DOI 10.1016/j.mce.2006.12.016; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Whitby RJ, 2011, J MED CHEM, V54, P2266, DOI 10.1021/jm1014296; Xu PL, 2003, ACTA BIOCH BIOPH SIN, V35, P897; Yoo J, 2011, J BIOL CHEM, V286, P31225, DOI 10.1074/jbc.M111.252916; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	46	11	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20702	20712		10.1074/jbc.M113.472837	http://dx.doi.org/10.1074/jbc.M113.472837			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23737522	hybrid, Green Published			2022-12-28	WOS:000321715100055
J	Hankins, JL; Ward, KE; Linton, SS; Barth, BM; Stahelin, RV; Fox, TE; Kester, M				Hankins, Jody L.; Ward, Katherine E.; Linton, Sam S.; Barth, Brian M.; Stahelin, Robert V.; Fox, Todd E.; Kester, Mark			Ceramide 1-Phosphate Mediates Endothelial Cell Invasion via the Annexin a2-p11 Heterotetrameric Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); TISSUE-PLASMINOGEN ACTIVATOR; TNF-ALPHA; A2 HETEROTETRAMER; BIOACTIVE LIPIDS; II TETRAMER; RECEPTOR; CERAMIDE-1-PHOSPHATE; PROLIFERATION; MOBILIZATION	The bioactive sphingolipid, ceramide 1-phosphate (C-1-P), has been implicated as an extracellular chemotactic agent directing cellular migration in hematopoietic stem/progenitor cells and macrophages. However, interacting proteins that could mediate these actions of C-1-P have, thus far, eluded identification. We have now identified and characterized interactions between ceramide 1-phosphate and the annexin a2-p11 heterotetramer constituents. This C-1-P-receptor complex is capable of facilitating cellular invasion. Herein, we demonstrate in both coronary artery macrovascular endothelial cells and retinal microvascular endothelial cells that C-1-P induces invasion through an extracellular matrix barrier. By employing surface plasmon resonance, lipid-binding ELISA, and mass spectrometry technologies, we have demonstrated that the heterotetramer constituents bind to C-1-P. Although the annexin a2-p11 heterotetramer constituents do not bind the lipid C-1-P exclusively, other structurally similar lipids, such as phosphatidylserine, sphingosine 1-phosphate, and phosphatidic acid, could not elicit the potent chemotactic stimulation observed with C-1-P. Further, we show that siRNA-mediated knockdown of either annexin a2 or p11 protein significantly inhibits C-1-P-directed invasion, indicating that the heterotetrameric complex is required for C-1-P-mediated chemotaxis. These results imply that extracellular C-1-P, acting through the extracellular annexin a2-p11 heterotetrameric protein, can mediate vascular endothelial cell invasion.	[Hankins, Jody L.; Linton, Sam S.; Fox, Todd E.; Kester, Mark] Penn State Univ, Dept Pharmacol, Coll Med, Hershey, PA 17033 USA; [Barth, Brian M.] Penn State Univ, Dept Med, Coll Med, Hershey, PA 17033 USA; [Ward, Katherine E.; Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Notre Dame; Indiana University System; Indiana University South Bend	Kester, M (corresponding author), Penn State Coll Med, Dept Pharmacol, R130, Hershey, PA 17033 USA.	mkester@psu.edu	Stahelin, Robert/L-3567-2019; Kester, Mark/ABG-4615-2020	Linton, Samuel/0000-0003-2419-0673; Barth, Brian/0000-0002-3542-1804; Stahelin, Robert/0000-0001-5443-7863	National Institutes of Health [R01HL076789, EY018336]; American Diabetes Association Research Award; Pennsylvania Department of Health using Tobacco Settlement Funds; American Heart Association [GRNT12080254, 11PRE7640028]; National Institutes of Health Chemistry-Biochemistry-Biology Interface Training Fellowship [T32GM075762]; NATIONAL EYE INSTITUTE [R01EY018336] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM075762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Research Award(American Diabetes Association); Pennsylvania Department of Health using Tobacco Settlement Funds; American Heart Association(American Heart Association); National Institutes of Health Chemistry-Biochemistry-Biology Interface Training Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL076789 and EY018336 (to M. K.). This work has also been supported by an American Diabetes Association Research Award (to M. K.). Core Facility services and instruments (ABI 4000 QTrap, 5600 TripleTOF) used in this project were funded, in part, under a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds. Additional support for these studies came from American Heart Association Grant GRNT12080254 (to R. V. S.). Penn State Research Foundation has previously licensed ceramide-based delivery systems and nanotechnologies to Keystone Nano Inc. (State College, PA). M. Kester is Chief Medical Officer of Keystone Nano Inc.; Supported by American Heart Association Predoctoral Fellowship 11PRE7640028 and National Institutes of Health Chemistry-Biochemistry-Biology Interface Training Fellowship T32GM075762.	BLACKWOOD RA, 1990, BIOCHEM J, V266, P195, DOI 10.1042/bj2660195; Boath A, 2008, J BIOL CHEM, V283, P8517, DOI 10.1074/jbc.M707107200; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Brindley DN, 2002, BBA-MOL CELL BIOL L, V1582, P33, DOI 10.1016/S1388-1981(02)00135-X; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V131, P554, DOI 10.1111/j.1365-2141.2005.05806.x; Cesarman-Maus G, 2005, BRIT J HAEMATOL, V129, P307, DOI 10.1111/j.1365-2141.2005.05444.x; Deora AB, 2004, J BIOL CHEM, V279, P43411, DOI 10.1074/jbc.M408078200; Eichner A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002617; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Gangoiti P, 2008, CELL SIGNAL, V20, P726, DOI 10.1016/j.cellsig.2007.12.008; Gangoiti P, 2012, BIOCHIMIE, V94, P597, DOI 10.1016/j.biochi.2011.09.009; GERKE V, 1985, EMBO J, V4, P2917, DOI 10.1002/j.1460-2075.1985.tb04023.x; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Golan K, 2012, BLOOD, V119, P2478, DOI 10.1182/blood-2011-06-358614; GomezMunoz A, 1997, BIOCHEM J, V325, P435, DOI 10.1042/bj3250435; GOMEZMUNOZ A, 1995, MOL PHARMACOL, V47, P883; Granado MH, 2009, CELL SIGNAL, V21, P405, DOI 10.1016/j.cellsig.2008.11.003; HAJJAR KA, 1994, J BIOL CHEM, V269, P21191; Hajjar KA, 1996, J BIOL CHEM, V271, P21652, DOI 10.1074/jbc.271.35.21652; Hankins JL, 2011, J BIOL CHEM, V286, P44357, DOI 10.1074/jbc.M111.264010; HE CS, 1989, P NATL ACAD SCI USA, V86, P2632, DOI 10.1073/pnas.86.8.2632; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Hou YC, 2008, CANCER INVEST, V26, P809, DOI 10.1080/07357900801898664; Jozefowski S, 2010, J IMMUNOL, V185, P6960, DOI 10.4049/jimmunol.0902926; Juarez JG, 2012, BLOOD, V119, P707, DOI 10.1182/blood-2011-04-348904; Kassam G, 1998, BIOCHEMISTRY-US, V37, P16958, DOI 10.1021/bi981713l; Kim CH, 2012, LEUKEMIA, V26, P106, DOI 10.1038/leu.2011.185; Kim TJ, 2011, EXP CELL RES, V317, P2041, DOI 10.1016/j.yexcr.2011.05.011; Kooijman EE, 2008, BIOPHYS J, V94, P4320, DOI 10.1529/biophysj.107.121046; Kooijman EE, 2009, BIOPHYS J, V96, P2204, DOI 10.1016/j.bpj.2008.11.062; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; KRISTOFFERSEN EK, 1994, SCAND J IMMUNOL, V40, P237, DOI 10.1111/j.1365-3083.1994.tb03456.x; Kwon MJ, 2005, FRONT BIOSCI-LANDMRK, V10, P300, DOI 10.2741/1529; Lambert O, 1997, J MOL BIOL, V272, P42, DOI 10.1006/jmbi.1997.1183; Lamour NF, 2011, J BIOL CHEM, V286, P42808, DOI 10.1074/jbc.M111.310169; Lamour NF, 2009, J BIOL CHEM, V284, P26897, DOI 10.1074/jbc.M109.001677; Laumonnier Y, 2006, BLOOD, V107, P3342, DOI 10.1182/blood-2005-07-2840; Lijnen HR, 1998, THROMB HAEMOSTASIS, V79, P1171; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; MacLeod TJ, 2003, J BIOL CHEM, V278, P25577, DOI 10.1074/jbc.M301017200; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; McElwain MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026993; Menke M, 2004, CHEMBIOCHEM, V5, P1003, DOI 10.1002/cbic.200400004; Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742; Mitra P, 2007, FEBS LETT, V581, P735, DOI 10.1016/j.febslet.2007.01.041; O'Neill Sean M, 2008, Vasc Dis Prev, V5, P200, DOI 10.2174/156727008785133809; Puisieux A, 1996, BIOCHEM J, V313, P51, DOI 10.1042/bj3130051; Ratajczak MZ, 2012, LEUKEMIA, V26, P63, DOI 10.1038/leu.2011.242; Ratajczak MZ, 2012, ADV EXP MED BIOL, V946, P37, DOI 10.1007/978-1-4614-0106-3_3; Ross M, 2003, BIOCHEMISTRY-US, V42, P3131, DOI 10.1021/bi027069z; Rozenova KA, 2010, J BIOL CHEM, V285, P21103, DOI 10.1074/jbc.M109.080671; SATO Y, 1993, EXP CELL RES, V204, P223, DOI 10.1006/excr.1993.1028; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stock RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036003; Su SC, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M110.157271; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Subramanian P, 2007, J LIPID RES, V48, P2701, DOI 10.1194/jlr.M700356-JLR200; Surette AP, 2011, BLOOD, V118, P3172, DOI 10.1182/blood-2011-05-353482; Waisman DM, 2005, BRIT J HAEMATOL, V131, P553, DOI 10.1111/j.1365-2141.2005.05805.x; WAISMAN DM, 1995, MOL CELL BIOCHEM, V149, P301, DOI 10.1007/BF01076592; Ward KE, 2013, J LIPID RES, V54, P636, DOI 10.1194/jlr.M031088; WERB Z, 1977, NEW ENGL J MED, V296, P1017, DOI 10.1056/NEJM197705052961801; Zobiack N, 2003, MOL BIOL CELL, V14, P4896, DOI 10.1091/mbc.E03-06-0387	65	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19726	19738		10.1074/jbc.M113.481622	http://dx.doi.org/10.1074/jbc.M113.481622			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23696646	hybrid, Green Published			2022-12-28	WOS:000321515800042
J	Oku, S; Takahashi, N; Fukata, Y; Fukata, M				Oku, Shinichiro; Takahashi, Naoki; Fukata, Yuko; Fukata, Masaki			In Silico Screening for Palmitoyl Substrates Reveals a Role for DHHC1/3/10 (zDHHC1/3/11)-mediated Neurochondrin Palmitoylation in Its Targeting to Rab5-positive Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN PALMITOYLATION; DIFFERENTIAL REGULATION; NEURONAL DEVELOPMENT; SYNAPTIC PLASTICITY; AUXILIARY SUBUNITS; MEMBRANE-PROTEINS; AMPA RECEPTORS; IDENTIFICATION; TRAFFICKING	Protein palmitoylation, a common post-translational lipid modification, plays an important role in protein trafficking and functions. Recently developed palmitoyl-proteomic methods identified many novel substrates. However, the whole picture of palmitoyl substrates has not been clarified. Here, we performed global in silico screening using the CSS-Palm 2.0 program, free software for prediction of palmitoylation sites, and selected 17 candidates as novel palmitoyl substrates. Of the 17 candidates, 10 proteins, including 6 synaptic proteins (Syd-1, transmembrane AMPA receptor regulatory protein (TARP) gamma-2, TARP gamma-8, cornichon-2, Ca2+/calmodulin-dependent protein kinase II alpha, and neurochondrin (Ncdn)/norbin), one focal adhesion protein (zyxin), two ion channels (TRPM8 and TRPC1), and one G-protein-coupled receptor (orexin 2 receptor), were palmitoylated. Using the DHHC palmitoylating enzyme library, we found that all tested substrates were palmitoylated by the Golgi-localized DHHC3/7 subfamily. Ncdn, a regulator for neurite outgrowth and synaptic plasticity, was robustly palmitoylated by the DHHC1/10 (zDHHC1/11; z1/11) subfamily, whose substrate has not yet been reported. As predicted by CSS-Palm 2.0, Cys-3 and Cys-4 are the palmitoylation sites for Ncdn. Ncdn was specifically localized in somato-dendritic regions, not in the axon of rat cultured neurons. Stimulated emission depletion microscopy revealed that Ncdn was localized to Rab5-positive early endosomes in a palmitoylation-dependent manner, where DHHC1/10 (z1/11) were also distributed. Knockdown of DHHC1, -3, or -10 (z11) resulted in the loss of Ncdn from Rab5-positive endosomes. Thus, through in silico screening, we demonstrate that Ncdn and the DHHC1/10 (z1/11) and DHHC3/7 subfamilies are novel palmitoyl substrate-enzyme pairs and that Ncdn palmitoylation plays an essential role in its specific endosomal targeting.	[Oku, Shinichiro; Takahashi, Naoki; Fukata, Yuko; Fukata, Masaki] Natl Inst Nat Sci, Div Membrane Physiol, Dept Cell Physiol, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan; [Oku, Shinichiro; Fukata, Yuko; Fukata, Masaki] Grad Univ Adv Studies SOKENDAI, Dept Physiol Sci, Sch Life Sci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Fukata, M (corresponding author), Natl Inst Physiol Sci, Div Membrane Physiol, Dept Cell Physiol, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.	mfukata@nips.ac.jp	Fukata, Masaki/AAZ-2476-2021	Fukata, Masaki/0000-0001-5200-9806; Fukata, Yuko/0000-0001-7724-8643	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21680029, 23110520, 20670005]; Funding Program for Next Generation World-Leading Researchers [LS123]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported, in whole or in part, by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants 21680029 and 23110520 (to Y. F.) and 20670005 (to M. F.) and by the Funding Program for Next Generation World-Leading Researchers (LS123; to M. F.).	Apweiler R, 2004, CURR OPIN CHEM BIOL, V8, P76, DOI 10.1016/j.cbpa.2003.12.004; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Dateki M, 2005, J BIOL CHEM, V280, P20503, DOI 10.1074/jbc.M414033200; DeSouza S, 2002, J NEUROSCI, V22, P3493; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; El-Husseini AE, 2000, J BIOL CHEM, V275, P23904, DOI 10.1074/jbc.M909919199; El-Husseini AED, 2002, NAT REV NEUROSCI, V3, P791, DOI 10.1038/nrn940; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kato AS, 2010, NEURON, V68, P1082, DOI 10.1016/j.neuron.2010.11.026; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mirza SP, 2007, PHYSIOL GENOMICS, V30, P89, DOI 10.1152/physiolgenomics.00279.2006; Mochizuki R, 2003, BIOCHEM BIOPH RES CO, V310, P1219, DOI 10.1016/j.bbrc.2003.09.153; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Ogasawara O, 2006, NUCLEIC ACIDS RES, V34, pD628, DOI 10.1093/nar/gkj137; Ohno Y, 2012, MOL BIOL CELL, V23, P4543, DOI 10.1091/mbc.E12-05-0336; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Schwaibold EMC, 2008, BIOCHEM BIOPH RES CO, V373, P366, DOI 10.1016/j.bbrc.2008.06.042; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shinozaki K, 1997, BIOCHEM BIOPH RES CO, V240, P766, DOI 10.1006/bbrc.1997.7660; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; Van Itallie CM, 2005, J CELL SCI, V118, P1427, DOI 10.1242/jcs.01735; Wang Hong, 2010, Commun Integr Biol, V3, P487, DOI 10.4161/cib.3.6.12844; Wang H, 2009, SCIENCE, V326, P1554, DOI 10.1126/science.1178496; WYLLIE DJA, 1994, NEURON, V13, P635, DOI 10.1016/0896-6273(94)90031-0; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhao LH, 2002, J BIOL CHEM, V277, P49352, DOI 10.1074/jbc.M209760200	51	31	32	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19816	19829		10.1074/jbc.M112.431676	http://dx.doi.org/10.1074/jbc.M112.431676			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23687301	Green Published, hybrid			2022-12-28	WOS:000321515800050
J	Hu, YL; Hung, AC; Cui, H; Dawkins, E; Bolos, M; Foa, L; Young, KM; Small, DH				Hu, Yanling; Hung, Amos C.; Cui, Hao; Dawkins, Edgar; Bolos, Marta; Foa, Lisa; Young, Kaylene M.; Small, David H.			Role of Cystatin C in Amyloid Precursor Protein-induced Proliferation of Neural Stem/Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; BETA; APP; DIFFERENTIATION; NEUROGENESIS; EXPRESSION; GENERATION; ASSOCIATION; ASTROCYTES; DEPOSITION	The amyloid precursor protein (APP) is well studied for its role in Alzheimer disease. However, little is known about its normal function. In this study, we examined the role of APP in neural stem/progenitor cell (NSPC) proliferation. NSPCs derived from APP-overexpressing Tg2576 transgenic mice proliferated more rapidly than NSPCs from the corresponding background strain (C57Bl/6xSJL) wild-type mice. In contrast, NSPCs from APP knock-out (APP-KO) mice had reduced proliferation rates when compared with NSPCs from the corresponding background strain (C57Bl/6). A secreted factor, identified as cystatin C, was found to be responsible for this effect. Levels of cystatin C were higher in the Tg2576 conditioned medium and lower in the APP-KO conditioned medium. Furthermore, immunodepletion of cystatin C from the conditioned medium completely removed the ability of the conditioned medium to increase NSPC proliferation. The results demonstrate that APP expression stimulates NSPC proliferation and that this effect is mediated via an increase in cystatin C secretion.	[Hu, Yanling; Hung, Amos C.; Cui, Hao; Dawkins, Edgar; Bolos, Marta; Foa, Lisa; Young, Kaylene M.; Small, David H.] Menzies Res Inst Tasmania, Hobart, Tas 7001, Australia; [Cui, Hao] Univ Tasmania, Sch Pharm, Hobart, Tas 7001, Australia; [Foa, Lisa] Univ Tasmania, Sch Med, Hobart, Tas 7001, Australia	University of Tasmania; Menzies Institute for Medical Research; University of Tasmania; University of Tasmania	Small, DH (corresponding author), Univ Tasmania, Private Bag 23, Hobart, Tas 7001, Australia.	d.h.small@menzies.utas.edu.au	Foa, Lisa/J-7781-2014; Bolos Jurado, Marta/J-7620-2014; Dawkins, Edgar/L-1720-2013	Foa, Lisa/0000-0003-4131-8341; Bolos Jurado, Marta/0000-0003-2652-8607; Dawkins, Edgar/0000-0003-1737-9435; Young, Kaylene/0000-0002-1686-3463; Hung, Chun-Tao/0000-0001-7572-8897	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by project grants from the National Health and Medical Research Council of Australia.	BLUMBERGS PC, 1995, J NEUROTRAUM, V12, P565, DOI 10.1089/neu.1995.12.565; Chasseigneaux S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016301; CLARRIS HJ, 1995, DEV BRAIN RES, V88, P87, DOI 10.1016/0165-3806(95)00083-P; COCHRAN E, 1991, AM J PATHOL, V139, P485; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; Cui P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023219; Freude KK, 2011, J BIOL CHEM, V286, P24264, DOI 10.1074/jbc.M111.227421; Gakhar-Koppole N, 2008, EUR J NEUROSCI, V28, P871, DOI 10.1111/j.1460-9568.2008.06398.x; GENTLEMAN SM, 1993, PROG BRAIN RES, V96, P237; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; HAYASHI Y, 1994, BIOCHEM BIOPH RES CO, V205, P936, DOI 10.1006/bbrc.1994.2755; Hornsten A, 2007, P NATL ACAD SCI USA, V104, P1971, DOI 10.1073/pnas.0603997104; Hua Y, 2012, INT J NEUROSCI, V122, P431, DOI 10.3109/00207454.2012.672502; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Joshi P, 2009, DEV BIOL, V335, P1, DOI 10.1016/j.ydbio.2009.07.041; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Kato T, 2006, P NATL ACAD SCI USA, V103, P6019, DOI 10.1073/pnas.0509789103; Kaur G, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00079; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Kwak YD, 2006, STEM CELLS DEV, V15, P381, DOI 10.1089/scd.2006.15.381; Lazarov O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00081; Lee HW, 2008, NEUROSCI LETT, V436, P245, DOI 10.1016/j.neulet.2008.03.038; Lee JA, 2007, ZEBRAFISH, V4, P277, DOI 10.1089/zeb.2007.0516; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; MATTSON MP, 1994, J NEUROBIOL, V25, P439, DOI 10.1002/neu.480250409; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Millet P, 2005, NEUROBIOL DIS, V19, P57, DOI 10.1016/j.nbd.2004.11.006; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Moyse E, 2008, CURR STEM CELL RES T, V3, P163, DOI 10.2174/157488808785740334; MUCKE L, 1994, BRAIN RES, V666, P151, DOI 10.1016/0006-8993(94)90767-6; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Nunan J, 2000, FEBS LETT, V483, P6, DOI 10.1016/S0014-5793(00)02076-7; Pardossi-Piquard R, 2012, J NEUROCHEM, V120, P109, DOI 10.1111/j.1471-4159.2011.07475.x; PATTERSON D, 1988, P NATL ACAD SCI USA, V85, P8266, DOI 10.1073/pnas.85.21.8266; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Rodgers SP, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-28; SMALL DH, 1994, J NEUROSCI, V14, P2117; SMALL DH, 1992, J NEUROSCI, V12, P4143; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Steinhoff T, 2001, NEUROBIOL DIS, V8, P647, DOI 10.1006/nbdi.2001.0412; TABATON M, 1992, BRAIN RES, V593, P299, DOI 10.1016/0006-8993(92)91323-7; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zhou ZD, 2011, CELL ADHES MIGR, V5, P280, DOI 10.4161/cam.5.4.16986	47	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18853	18862		10.1074/jbc.M112.443671	http://dx.doi.org/10.1074/jbc.M112.443671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671283	hybrid, Green Published			2022-12-28	WOS:000321335800023
J	Mediouni, S; Darque, A; Ravaux, I; Baillat, G; Devaux, C; Loret, EP				Mediouni, Sonia; Darque, Albert; Ravaux, Isabelle; Baillat, Gilbert; Devaux, Christian; Loret, Erwann P.			Identification of a Highly Conserved Surface on Tat Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 TAT; CIRCULAR-DICHROISM; STRUCTURAL CHARACTERIZATION; HOMONUCLEAR H-1-NMR; PROTEIN; VIRUS; ANTIBODY; TRANSACTIVATION; CONFORMATION; ASSIGNMENT	Extracellular Tat is suspected to protect HIV-1-infected cells from cellular immunity. Seropositive patients are unable to produce neutralizing antibodies against Tat, and Tat is still secreted under antiviral treatment. In mice, the Tat OYI vaccine candidate generates neutralizing antibodies such as the mAb 7G12. A peptide called MIMOOX was designed from fragments of Tat OYI identified as the possible binding site for mAb 7G12. MIMOOX was chemically synthesized, and its structure was stabilized with a disulfide bridge. Circular dichroism spectra showed that MIMOOX had mainly beta turns but no alpha helix as Tat OYI. MIMOOX was recognized by mAb 7G12 in ELISA only in reduced conditions. Moreover, a competitive recognition assay with mAb 7G12 between MIMOOX and Tat variants showed that MIMOOX mimics a highly conserved surface in Tat variants. Rat immunizations with MIMOOX induce antibodies recognizing Tat variants from the main HIV-1 subtypes and confirm the Tat OYI vaccine approach.	[Mediouni, Sonia; Darque, Albert; Ravaux, Isabelle; Baillat, Gilbert; Loret, Erwann P.] Aix Marseille Univ, Equipe Technol Rech Appl VIH ETRAV 1, Fac Pharm, UMR 5236,CNRS, F-13385 Marseille 5, France; [Devaux, Christian] UM2, UM1, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, UMR 5236,CNRS, F-34293 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Loret, EP (corresponding author), Aix Marseille Univ, Equipe Technol Rech Appl VIH ETRAV 1, Fac Pharm, UMR 5236,CNRS, 27 BD Jean Moulin, F-13385 Marseille 5, France.	erwann.loret@univ-amu.fr			BIOSANTECH (Sofia Antipolis, France); MIMETICS (Lausanne, Switzerland)	BIOSANTECH (Sofia Antipolis, France); MIMETICS (Lausanne, Switzerland)	This work was supported by BIOSANTECH (Sofia Antipolis, France) and MIMETICS (Lausanne, Switzerland).	Bachler BC, 2013, J VIROL, V87, P4403, DOI 10.1128/JVI.02888-12; BAYER P, 1995, J MOL BIOL, V247, P529, DOI 10.1016/S0022-2836(05)80133-0; Bomsel M, 2011, IMMUNITY, V34, P269, DOI 10.1016/j.immuni.2011.01.015; Campbell GR, 2007, VACCINE, V25, P8441, DOI 10.1016/j.vaccine.2007.09.070; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Caselli E, 1999, J IMMUNOL, V162, P5631; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Ensoli B, 2008, AIDS, V22, P2207, DOI 10.1097/QAD.0b013e32831392d4; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Ensoli B, 2009, VACCINE, V28, P371, DOI 10.1016/j.vaccine.2009.10.038; Feinberg MB, 2002, NAT MED, V8, P207, DOI 10.1038/nm0302-207; FURLINI MCRG, 1995, J ACQ IMMUN DEF SYND, V10, P408, DOI 10.1097/00042560-199512000-00003; Goldstein G, 2012, HUM VACC IMMUNOTHER, V8, P1425, DOI 10.4161/hv.21616; Gregoire C, 2001, BIOPOLYMERS, V62, P324, DOI 10.1002/bip.10000; Guillon C, 2007, VACCINE, V25, P7491, DOI 10.1016/j.vaccine.2007.08.060; Hardy F, 1997, J IMMUNOL METHODS, V200, P155, DOI 10.1016/S0022-1759(96)00201-3; HUET T, 1989, AIDS, V3, P707, DOI 10.1097/00002030-198911000-00004; KOKEN SEC, 1994, J BIOL CHEM, V269, P8366; Lakhashe SK, 2011, VACCINE, V29, P5611, DOI 10.1016/j.vaccine.2011.06.017; Lecoq A, 2008, VACCINE, V26, P2615, DOI 10.1016/j.vaccine.2008.02.057; Liao WT, 2012, VACCINE, V30, P2453, DOI 10.1016/j.vaccine.2012.01.055; Longo O, 2009, VACCINE, V27, P3306, DOI 10.1016/j.vaccine.2009.01.090; LORET EP, 1992, P NATL ACAD SCI USA, V89, P9734, DOI 10.1073/pnas.89.20.9734; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Mayol K, 2007, VACCINE, V25, P6047, DOI 10.1016/j.vaccine.2007.05.048; Mediouni S, 2012, J BIOL CHEM, V287, P11942, DOI 10.1074/jbc.M111.319863; Mediouni Sonia, 2012, Infectious Disorders - Drug Targets, V12, P81; Mediouni Sonia, 2011, Infectious Disorders - Drug Targets, V11, P57; Moreau E, 2004, J VIROL, V78, P3792, DOI 10.1128/JVI.78.7.3792-3796.2004; Opi S, 2002, J BIOL CHEM, V277, P35915, DOI 10.1074/jbc.M204393200; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; Pfeiffer B, 2003, ANGEW CHEM INT EDIT, V42, P2368, DOI 10.1002/anie.200250348; Reynell L, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13535; Rodman TC, 2001, EXP HEMATOL, V29, P1004, DOI 10.1016/S0301-472X(01)00678-6; Senkaali D, 2008, AIDS RES HUM RETROV, V24, P587, DOI 10.1089/aid.2007.0171; Serriere J, 2011, J MOL BIOL, V405, P33, DOI 10.1016/j.jmb.2010.10.033; Shojania S, 2006, J BIOL CHEM, V281, P8347, DOI 10.1074/jbc.M510748200; STEINAA L, 1994, ARCH VIROL, V139, P263, DOI 10.1007/BF01310790; Tahirov TH, 2010, NATURE, V465, P747, DOI 10.1038/nature09131; Valvatne H, 1996, AIDS RES HUM RETROV, V12, P611, DOI 10.1089/aid.1996.12.611; Watkins JD, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-8; Watkins JD, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-83; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WONGSTAAL F, 1985, NATURE, V317, P395, DOI 10.1038/317395a0	44	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19072	19080		10.1074/jbc.M113.466011	http://dx.doi.org/10.1074/jbc.M113.466011			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23678001	Green Published, hybrid			2022-12-28	WOS:000321335800042
J	Motizuki, M; Isogaya, K; Miyake, K; Ikushima, H; Kubota, T; Miyazono, K; Saitoh, M; Miyazawa, K				Motizuki, Mitsuyoshi; Isogaya, Kazunobu; Miyake, Kunio; Ikushima, Hiroaki; Kubota, Takeo; Miyazono, Kohei; Saitoh, Masao; Miyazawa, Keiji			Oligodendrocyte Transcription Factor 1 (Olig1) Is a Smad Cofactor Involved in Cell Motility Induced by Transforming Growth Factor-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; SIGNAL-TRANSDUCTION; SYNEXPRESSION GROUP; INITIATING CELLS; I RECEPTORS; C-SKI; CANCER; PROTEINS; PIN1	Transforming growth factor (TGF)-beta plays crucial roles in embryonic development and adult tissue homeostasis by eliciting various cellular responses in target cells. TGF-beta signaling is principally mediated through receptor-activated Smad proteins, which regulate expression of target genes in cooperation with other DNA-binding transcription factors (Smad cofactors). In this study, we found that the basic helix-loop-helix transcription factor Olig1 is a Smad cofactor involved in TGF-beta-induced cell motility. Knockdown of Olig1 attenuated TGF-beta-induced cell motility in chamber migration and wound healing assays. In contrast, Olig1 knockdown had no effect on bone morphogenetic protein-induced cell motility, TGF-beta-induced cytostasis, or epithelial-mesenchymal transition. Furthermore, we observed that cooperation of Smad2/3 with Olig1 is regulated by a peptidyl-prolyl cis/trans-isomerase, Pin1. TGF-beta-induced cell motility, induction of Olig1-regulated genes, and physical interaction between Smad2/3 and Olig1 were all inhibited after knockdown of Pin1, indicating a novel mode of regulation of Smad signaling. We also found that Olig1 interacts with the L3 loop of Smad3. Using a synthetic peptide corresponding to the L3 loop of Smad3, we succeeded in selectively inhibiting TGF-beta-induced cell motility. These findings may lead to a new strategy for selective regulation of TGF-beta-induced cellular responses.	[Motizuki, Mitsuyoshi; Saitoh, Masao; Miyazawa, Keiji] Univ Yamanashi, Dept Biochem, Interdisciplinary Grad Sch Med & Engn, Tamaho, Yamanashi 4093898, Japan; [Miyake, Kunio; Kubota, Takeo] Univ Yamanashi, Dept Epigenet Med, Interdisciplinary Grad Sch Med & Engn, Tamaho, Yamanashi 4093898, Japan; [Isogaya, Kazunobu; Ikushima, Hiroaki; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan	University of Yamanashi; University of Yamanashi; University of Tokyo	Miyazawa, K (corresponding author), Univ Yamanashi, Dept Biochem, Interdisciplinary Grad Sch Med & Engn, Tamaho, Yamanashi 4093898, Japan.	keiji-miyazawa@umin.ac.jp	MIYAZAWA, KEIJI/I-9713-2014		Japan Society for the Promotion of Science (JSPS) KAKENHI [40209896]; JSPS; Fugaku Memorial Foundation; Grants-in-Aid for Scientific Research [22112002] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Fugaku Memorial Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant 40209896, JSPS Core-to-Core Program "Cooperative International Framework in TGF-beta Family Signaling" and the Fugaku Memorial Foundation.	Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Chen YG, 1998, GENE DEV, V12, P2144, DOI 10.1101/gad.12.14.2144; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Cui QQ, 2005, ONCOGENE, V24, P3864, DOI 10.1038/sj.onc.1208556; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ehata S, 2011, ONCOGENE, V30, P1693, DOI 10.1038/onc.2010.546; Ekman M, 2012, MOL BIOL CELL, V23, P2109, DOI 10.1091/mbc.E10-12-1000; Germain S, 2000, GENE DEV, V14, P435; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Goto K, 2007, J BIOL CHEM, V282, P20603, DOI 10.1074/jbc.M702100200; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Ikushima H, 2010, CANCER SCI, V101, P306, DOI 10.1111/j.1349-7006.2009.01441.x; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Ishii R, 2012, EMBO J, V31, P2541, DOI 10.1038/emboj.2012.77; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lo RS, 1998, EMBO J, V17, P996, DOI 10.1093/emboj/17.4.996; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuura I, 2010, J BIOL CHEM, V285, P1754, DOI 10.1074/jbc.M109.063826; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Mizuide M, 2003, J BIOL CHEM, V278, P531, DOI 10.1074/jbc.C200596200; Nagano Y, 2010, J BIOCHEM, V147, P545, DOI 10.1093/jb/mvp202; Naka K, 2010, NATURE, V463, P676, DOI 10.1038/nature08734; Nakano A, 2009, J BIOL CHEM, V284, P6109, DOI 10.1074/jbc.M804659200; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Saitoh M, 2012, J BIOCHEM, V151, P563, DOI 10.1093/jb/mvs040; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Tang B, 2007, CANCER RES, V67, P8643, DOI 10.1158/0008-5472.CAN-07-0982; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Vasilaki E, 2010, FASEB J, V24, P891, DOI 10.1096/fj.09-134742; Yoshimura A, 2010, J BIOCHEM, V147, P781, DOI 10.1093/jb/mvq043; Zhang Y, 1998, NATURE, V394, P909, DOI 10.1038/29814	40	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18911	18922		10.1074/jbc.M113.480996	http://dx.doi.org/10.1074/jbc.M113.480996			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23720758	Green Published, hybrid			2022-12-28	WOS:000321335800029
J	Scaglione, KM; Basrur, V; Ashraf, NS; Konen, JR; Elenitoba-Johnson, KSJ; Todi, SV; Paulson, HL				Scaglione, Kenneth Matthew; Basrur, Venkatesha; Ashraf, Naila S.; Konen, John R.; Elenitoba-Johnson, Kojo S. J.; Todi, Sokol V.; Paulson, Henry L.			The Ubiquitin-conjugating Enzyme (E2) Ube2w Ubiquitinates the N Terminus of Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 LIGASE; MHC-I; DEGRADATION; LYSINE; RESIDUES; UBIQUITYLATION; MECHANISM; ATAXIN-3; CYSTEINE; REVEALS	Attachment of ubiquitin to substrate is typically thought to occur via formation of an isopeptide bond between the C-terminal glycine residue of ubiquitin and a lysine residue in the substrate. In vitro, Ube2w is nonreactive with free lysine yet readily ubiquitinates substrate. Ube2w also contains novel residues within its active site that are important for its ability to ubiquitinate substrate. To identify the site of modification, we analyzed ubiquitinated substrates by mass spectrometry and found the N-terminal -NH2 group as the site of conjugation. To confirm N-terminal ubiquitination, we generated lysine-less and N-terminally blocked versions of one substrate, the polyglutamine disease protein ataxin-3, and showed that Ube2w can ubiquitinate a lysine-less, but not N-terminally blocked, ataxin-3. This was confirmed with a second substrate, the neurodegenerative disease protein Tau. Finally, we directly sequenced the N terminus of unmodified and ubiquitinated ataxin-3, demonstrating that Ube2w attaches ubiquitin to the N terminus of its substrates. Together these data demonstrate that Ube2w has novel enzymatic properties that direct ubiquitination of the N terminus of substrates.	[Scaglione, Kenneth Matthew; Ashraf, Naila S.; Konen, John R.; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Basrur, Venkatesha; Elenitoba-Johnson, Kojo S. J.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Todi, Sokol V.] Wayne State Univ, Dept Pharmacol, Detroit, MI 48201 USA; [Todi, Sokol V.] Wayne State Univ, Dept Neurol, Detroit, MI 48201 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wayne State University; Wayne State University	Scaglione, KM (corresponding author), Univ Michigan, Sch Med, Dept Neurol, 109 Zina Pitcher Pl,4001 BSRB, Ann Arbor, MI 48109 USA.	kscaglio@umich.edu; henryp@umich.edu		Scaglione, Kenneth/0000-0002-3858-9418; TODI, SOKOL/0000-0003-4399-5549; Elenitoba-Johnson, Kojo/0000-0002-1082-1545	National Institutes of Health [K99 NS073936, R00 NS064097, R01 AG034228, R01 NS038712]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS073936, R01NS038712, R00NS064097, R00NS073936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants K99 NS073936 (to K. M. S.), R00 NS064097 (to S. V. T.), and R01 AG034228 and R01 NS038712 (to H. L. P.).	Aviel S, 2000, J BIOL CHEM, V275, P23491, DOI 10.1074/jbc.M002052200; Barghorn Stefan, 2004, V299, P35; Ben-Saadon R, 2004, J BIOL CHEM, V279, P41414, DOI 10.1074/jbc.M407201200; Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; Choi YS, 2010, J BIOL CHEM, V285, P17754, DOI 10.1074/jbc.M109.090621; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fajerman I, 2004, BIOCHEM BIOPH RES CO, V314, P505, DOI 10.1016/j.bbrc.2003.12.116; Herr RA, 2009, TRAFFIC, V10, P1301, DOI 10.1111/j.1600-0854.2009.00946.x; Ikeda M, 2002, VIROLOGY, V300, P153, DOI 10.1006/viro.2002.1562; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Noy T, 2012, BIOCHEM BIOPH RES CO, V418, P408, DOI 10.1016/j.bbrc.2012.01.045; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Reinstein E, 2000, ONCOGENE, V19, P5944, DOI 10.1038/sj.onc.1203989; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tatham MH, 2013, BIOCHEM J, V453, P137, DOI 10.1042/BJ20130244; Todi SV, 2010, J BIOL CHEM, V285, P39303, DOI 10.1074/jbc.M110.181610; Tokunaga F, 2012, ENDOCR J, V59, P641, DOI 10.1507/endocrj.EJ12-0148; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Trausch-Azar J, 2010, J BIOL CHEM, V285, P40192, DOI 10.1074/jbc.M110.131615; Vosper JMD, 2009, J BIOL CHEM, V284, P15458, DOI 10.1074/jbc.M809366200; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2009, J CELL BIOL, V187, P655, DOI 10.1083/jcb.200908036; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	36	66	69	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18784	18788		10.1074/jbc.C113.477596	http://dx.doi.org/10.1074/jbc.C113.477596			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23696636	hybrid, Green Published			2022-12-28	WOS:000321335800016
J	Wang, YL; Jiang, L; Ji, X; Yang, B; Zhang, Y; Fu, XD				Wang, Yanling; Jiang, Li; Ji, Xiong; Yang, Bo; Zhang, Yi; Fu, Xiang-Dong			Hepatitis B Viral RNA Directly Mediates Down-regulation of the Tumor Suppressor MicroRNA miR-15a/miR-16-1 in Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-X PROTEIN; HEPATOCELLULAR-CARCINOMA; LIVER; GENE; REPLICATION; EXPRESSION; TARGET; REPRESSION; ROLES	Hepatitis B virus (HBV) is a key risk factor for the development of hepatocellular carcinoma (HCC). Recent work suggests a functional link between HCC and microRNA expression, but the mechanism underlying the functional interaction between microRNA and HBV infection has remained largely elusive. Here we present evidence that the microRNA machinery serves as a defense system against HBV infection, which, in turn, reprograms the expression of specific microRNAs. We demonstrate a critical role of miR-15a/miR-16-1 in this functional interplay between microRNA and HBV infection, but in contrast to various indirect mechanisms mediated by viral proteins, we unexpectedly found that the HBx transcript directly triggers the down-regulation of miR-15a/miR-16-1 via the microRNA targeting sequences in the viral RNA. Because miR-15a and miR-16-1 are well known tumor suppressor microRNAs in multiple human cancers, our findings raise the intriguing possibility that viral RNA-mediated down-regulation of specific tumor suppressor microRNAs may contribute to HCC development in HBV-infected cells.	[Wang, Yanling; Jiang, Li; Ji, Xiong; Yang, Bo; Zhang, Yi; Fu, Xiang-Dong] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China; [Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Wuhan University; University of California System; University of California San Diego	Fu, XD (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	xdfu@ucsd.edu		Zhang, Yi/0000-0003-1035-6134	National Institutes of Health [GM049369, GM052872]; China 973 Program [2011CB811300, 2012CB910800]; Chinese 111 Program [B06018]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052872, R01GM049369] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China 973 Program(National Basic Research Program of China); Chinese 111 Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM049369 and GM052872. This work was also supported by China 973 Program Grants 2011CB811300 and 2012CB910800) and by Chinese 111 Program Grant B06018.	Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Arbuthnot P, 2000, J GASTROEN HEPATOL, V15, P357, DOI 10.1046/j.1440-1746.2000.02069.x; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Bouchard MJ, 2004, J VIROL, V78, P12725, DOI 10.1128/JVI.78.23.12725-12734.2004; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Cougot D, 2007, J BIOL CHEM, V282, P4277, DOI 10.1074/jbc.M606774200; Ebert MS, 2010, CURR BIOL, V20, pR858, DOI 10.1016/j.cub.2010.08.052; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Gramantieri L, 2008, J CELL MOL MED, V12, P2189, DOI 10.1111/j.1582-4934.2008.00533.x; Hayes CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047490; Henke JI, 2008, EMBO J, V27, P3300, DOI 10.1038/emboj.2008.244; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kremsdorf D, 2006, ONCOGENE, V25, P3823, DOI 10.1038/sj.onc.1209559; Lee SG, 2000, ONCOGENE, V19, P468, DOI 10.1038/sj.onc.1203312; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li CF, 2013, J VIROL, V87, P2193, DOI 10.1128/JVI.02831-12; Liu WH, 2011, BBA-GENE REGUL MECH, V1809, P678, DOI 10.1016/j.bbagrm.2011.04.008; Loeb GB, 2012, MOL CELL, V48, P760, DOI 10.1016/j.molcel.2012.10.002; Melegari M, 1998, J VIROL, V72, P1737, DOI 10.1128/JVI.72.3.1737-1743.1998; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Tang H, 2006, CANCER SCI, V97, P977, DOI 10.1111/j.1349-7006.2006.00299.x; TIOLLAIS P, 1985, NATURE, V317, P489, DOI 10.1038/317489a0; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wang Y, 2010, J HEPATOL, V53, P57, DOI 10.1016/j.jhep.2009.12.043; Wong CM, 2002, CLIN CANCER RES, V8, P2266; Wu G, 2011, BRIT J CANCER, V105, P146, DOI 10.1038/bjc.2011.190; Yang LA, 2010, CANCER BIOL THER, V9, P803, DOI 10.4161/cbt.9.10.11440; Yoshikawa T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00637; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195	38	85	92	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18484	18493		10.1074/jbc.M113.458158	http://dx.doi.org/10.1074/jbc.M113.458158			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649629	Green Published, hybrid			2022-12-28	WOS:000320721900050
J	Campbell, KN; Wong, JS; Gupta, R; Asanuma, K; Sudol, M; He, JC; Mundel, P				Campbell, Kirk N.; Wong, Jenny S.; Gupta, Ritu; Asanuma, Katsuhiko; Sudol, Marius; He, John Cijiang; Mundel, Peter			Yes-associated Protein (YAP) Promotes Cell Survival by Inhibiting Proapoptotic Dendrin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING PROTEIN; WW DOMAIN; INDUCED APOPTOSIS; RAT-BRAIN; HIPPO; PODOCYTES; PATHWAY; KIBRA; DROSOPHILA; GENE	Kidney podocytes are highly specialized terminally differentiated cells that form the final barrier to urinary protein loss. Podocytes are a target for injury by metabolic, autoimmune, hereditary, inflammatory, and other stressors. Persistence of podocyte injury leads to podocyte death and loss, which results in progressive kidney damage and ultimately kidney failure. Dendrin is a dual compartment protein with proapoptotic signaling properties. Nuclear relocation of dendrin in response to glomerular injury promotes podocyte apoptosis. Here we show that Yes-associated protein (YAP), a downstream target of Hippo kinases and an inhibitor of apoptosis, is expressed in the nucleus of podocytes. The WW domains of YAP mediate the interaction with the PPXY motifs of dendrin. This interaction is functionally relevant because YAP binding to dendrin reduces dendrin-dependent, staurosporine-induced apoptosis in co-transfected HEK293 cells. Moreover gene silencing of YAP in podocytes increases adriamycin-induced podocyte apoptosis. It also increases staurosporine-induced caspase-3/7 activity, which is rescued by dendrin depletion in YAP knockdown cells. Our findings elucidate YAP binding to dendrin as a prosurvival mechanism. The antiapoptotic signaling properties of YAP in podocytes could hold significance in the quest for targeted therapeutics aimed at preventing podocyte loss.	[Campbell, Kirk N.; Wong, Jenny S.; Sudol, Marius; He, John Cijiang] Mt Sinai Sch Med, Div Nephrol, New York, NY 10029 USA; [Gupta, Ritu] Yale New Haven Med Ctr, Dept Med, New Haven, CT 06511 USA; [Asanuma, Katsuhiko] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Lab Kidney Res,TMK Project, Kyoto 6068501, Japan; [Sudol, Marius] Weis Ctr Res, Danville, PA 17822 USA; [Mundel, Peter] Massachusetts Gen Hosp, Dept Med, Boston, MA 02129 USA; [Mundel, Peter] Harvard Univ, Sch Med, Boston, MA 02129 USA	Icahn School of Medicine at Mount Sinai; Yale University; Kyoto University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Campbell, KN (corresponding author), Mt Sinai Sch Med, Div Nephrol, Box 1243,1 Gustave L Levy Pl, New York, NY 10029 USA.	kirk.campbell@mssm.edu; mundel.peter@mgh.harvard.edu			National Institutes of Health [DK57683, DK062472, DK09368201, DK081617]; NephCure Young Investigator grant; PA Breast Cancer Coalition [60707, 920093]; Geisinger Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057683, K08DK081617, R01DK062472] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NephCure Young Investigator grant; PA Breast Cancer Coalition; Geisinger Clinic; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57683, DK062472, and DK09368201 (to P. M.), National Institutes of Health Grant DK081617 (to K. N. C.). This work was also supported by a NephCure Young Investigator grant (to K. N. C.) and by PA Breast Cancer Coalition Grants 60707 and 920093 and by a grant from the Geisinger Clinic (to M. S.).	Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Asanuma K, 2011, AM J NEPHROL, V33, P537, DOI 10.1159/000327995; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Biswas S, 2006, NEUROSCIENCE, V142, P315, DOI 10.1016/j.neuroscience.2006.06.026; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Csibi A, 2012, NAT CELL BIOL, V14, P1244, DOI 10.1038/ncb2634; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Gaffney CJ, 2012, GENE, V509, P215, DOI 10.1016/j.gene.2012.08.025; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011288; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Johansson AC, 2003, CELL DEATH DIFFER, V10, P1253, DOI 10.1038/sj.cdd.4401290; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Kriz W, 2005, KIDNEY INT, V67, P404, DOI 10.1111/j.1523-1755.2005.67097.x; Moleirinho S, 2013, ONCOGENE, V32, P1821, DOI 10.1038/onc.2012.196; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; MUNDLOS S, 1993, DEVELOPMENT, V119, P1329; NeunerJehle M, 1996, J NEUROSCI RES, V46, P138, DOI 10.1002/(SICI)1097-4547(19961015)46:2<138::AID-JNR2>3.0.CO;2-I; PABST R, 1983, KIDNEY INT, V24, P626, DOI 10.1038/ki.1983.203; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Schiffer M, 2004, J BIOL CHEM, V279, P37004, DOI 10.1074/jbc.M403534200; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; SUDOL M, 1994, ONCOGENE, V9, P2145; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.1.225; Tharaux PL, 2012, SEMIN NEPHROL, V32, P394, DOI 10.1016/j.semnephrol.2012.06.011; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Yue TL, 1998, J MOL CELL CARDIOL, V30, P495, DOI 10.1006/jmcc.1997.0614; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, J CELL SCI, V123, P4001, DOI 10.1242/jcs.069070	38	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17057	17062		10.1074/jbc.C113.457390	http://dx.doi.org/10.1074/jbc.C113.457390			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23667252	Green Published, hybrid			2022-12-28	WOS:000320380600002
J	Krokowski, D; Han, J; Saikia, M; Majumder, M; Yuan, CL; Guan, BJ; Bevilacqua, E; Bussolati, O; Broer, S; Arvan, P; Tchorzewski, M; Snider, MD; Puchowicz, M; Croniger, CM; Kimball, SR; Pan, T; Koromilas, AE; Kaufman, RJ; Hatzoglou, M				Krokowski, Dawid; Han, Jaeseok; Saikia, Mridusmita; Majumder, Mithu; Yuan, Celvie L.; Guan, Bo-Jhih; Bevilacqua, Elena; Bussolati, Ovidio; Broeer, Stefan; Arvan, Peter; Tchorzewski, Marek; Snider, Martin D.; Puchowicz, Michelle; Croniger, Colleen M.; Kimball, Scot R.; Pan, Tao; Koromilas, Antonis E.; Kaufman, Randal J.; Hatzoglou, Maria			A Self-defeating Anabolic Program Leads to beta-Cell Apoptosis in Endoplasmic Reticulum Stress-induced Diabetes via Regulation of Amino Acid Flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; OXIDATIVE STRESS; PHOSPHORYLATION; TRANSPORTER; INSULIN; CHOP; DEPHOSPHORYLATION; TRANSLATION; INHIBITION; ACTIVATION	Endoplasmic reticulum (ER) stress-induced responses are associated with the loss of insulin-producing beta-cells in type 2 diabetes mellitus. beta-Cell survival during ER stress is believed to depend on decreased protein synthesis rates that are mediated via phosphorylation of the translation initiation factor eIF2 alpha. It is reported here that chronic ER stress correlated with increased islet protein synthesis and apoptosis in beta-cells in vivo. Paradoxically, chronic ER stress in beta-cells induced an anabolic transcription program to overcome translational repression by eIF2 alpha phosphorylation. This program included expression of amino acid transporter and aminoacyl-tRNA synthetase genes downstream of the stress-induced ATF4-mediated transcription program. The anabolic response was associated with increased amino acid flux and charging of tRNAs for branched chain and aromatic amino acids (e.g. leucine and tryptophan), the levels of which are early serum indicators of diabetes. We conclude that regulation of amino acid transport in beta-cells during ER stress involves responses leading to increased protein synthesis, which can be protective during acute stress but can lead to apoptosis during chronic stress. These studies suggest that the increased expression of amino acid transporters in islets can serve as early diagnostic biomarkers for the development of diabetes.	[Krokowski, Dawid; Saikia, Mridusmita; Majumder, Mithu; Yuan, Celvie L.; Guan, Bo-Jhih; Bevilacqua, Elena; Puchowicz, Michelle; Croniger, Colleen M.; Hatzoglou, Maria] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Snider, Martin D.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Han, Jaeseok; Kaufman, Randal J.] Sanford Burnham Med Res Inst, Ctr Neurosci Aging & Stem Cell Res, La Jolla, CA 92037 USA; [Bussolati, Ovidio] Univ Parma, Dept Biomed Biotechnol & Translat Sci, I-43100 Parma, Italy; [Broeer, Stefan] Australian Natl Univ, Res Sch Biol, Canberra, Acton 0200, Australia; [Arvan, Peter] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Tchorzewski, Marek] Marie Curie Sklodowska Univ, Dept Mol Biol, PL-02031 Lublin, Poland; [Kimball, Scot R.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Koromilas, Antonis E.] McGill Univ, Dept Oncol, Montreal, PQ H3A 0G4, Canada	Case Western Reserve University; Case Western Reserve University; Sanford Burnham Prebys Medical Discovery Institute; University of Parma; Australian National University; University of Michigan System; University of Michigan; Maria Curie-Sklodowska University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Chicago; McGill University	Krokowski, D (corresponding author), Case Western Reserve Univ, Dept Nutr, 10900 Euclid Ave, Cleveland, OH 44106 USA.	krokud@gmail.com; mxh8@case.edu	Broer, Stefan/A-1286-2008; Han, Jaeseok/AAE-6872-2020; Bussolati, Ovidio/B-7589-2013	Broer, Stefan/0000-0002-8040-1634; Bussolati, Ovidio/0000-0002-4301-2939; Tchorzewski, Marek/0000-0002-0718-4223; Saikia, Mridusmita/0000-0002-5848-3303	National Institutes of Health [R37-DK60596, R01-DK53307, DK48280, R37DK042394, R01DK088227, DK15658]; MMPC [U24 DK76174]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK042394, R01DK088227, R01DK015658, R01DK060596, P30DK020572, R01DK048280, U24DK076174, R37DK060596, R01DK053307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MMPC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK60596 and R01-DK53307 (to M. H.), DK48280 (to P. A.), R37DK042394 and R01DK088227 (to R. J. K.), DK15658 (to S. K.), and MMPC U24 DK76174 (to Case Western Reserve University).	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Franchi-Gazzola R, 2006, ACTA PHYSIOL, V187, P273, DOI 10.1111/j.1748-1716.2006.01552.x; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Huang C., 2013, CURR TOP ME IN PRESS; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Karunakaran S, 2008, BIOCHEM J, V414, P343, DOI 10.1042/BJ20080622; Kaufman RJ, 2010, DIABETES OBES METAB, V12, P99, DOI 10.1111/j.1463-1326.2010.01281.x; Kaufman RJ, 2011, NEW ENGL J MED, V365, P1931, DOI 10.1056/NEJMcibr1109442; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Ku GM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002449; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li G, 2009, J CELL BIOL, V186, P783, DOI 10.1083/jcb.200904060; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Majumder M, 2012, MOL CELL BIOL, V32, P992, DOI 10.1128/MCB.06665-11; Malmberg SE, 2008, J BIOL CHEM, V283, P19229, DOI 10.1074/jbc.M801331200; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martin L, 2010, J BIOL CHEM, V285, P31944, DOI 10.1074/jbc.M110.153148; McGirr R, 2011, MOL IMAGING BIOL, V13, P962, DOI 10.1007/s11307-010-0435-5; Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580; Melnik BC, 2012, WORLD J DIABETES, V3, P38, DOI 10.4239/wjd.v3.i3.38; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Oslowski CM, 2011, CURR OPIN CELL BIOL, V23, P207, DOI 10.1016/j.ceb.2010.11.005; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Papa FR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007666; PATHAK VK, 1988, MOL CELL BIOL, V8, P993, DOI 10.1128/MCB.8.2.993; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Shennan DB, 2008, ONCOL REP, V20, P885, DOI 10.3892/or_00000087; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tomi M, 2005, INVEST OPHTH VIS SCI, V46, P2522, DOI 10.1167/iovs.04-1175; Tuckow AP, 2010, AM J PHYSIOL-ENDOC M, V299, pE241, DOI 10.1152/ajpendo.00151.2010; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Yuan CL, 2008, AM J PHYSIOL-ENDOC M, V295, pE216, DOI 10.1152/ajpendo.00545.2007; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877	53	80	82	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17202	17213		10.1074/jbc.M113.466920	http://dx.doi.org/10.1074/jbc.M113.466920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23645676	hybrid, Green Published			2022-12-28	WOS:000320380600017
J	Mallick, J; Whiteway, M				Mallick, Jaideep; Whiteway, Malcolm			The Evolutionary Rewiring of the Ribosomal Protein Transcription Pathway Modifies the Interaction of Transcription Factor Heteromer Ifh1-Fhl1 (Interacts with Forkhead 1-Forkhead-like 1) with the DNA-binding Specificity Element	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-ALBICANS; GENE-EXPRESSION; YEAST; GROWTH; IDENTIFICATION; PROMOTERS; DOMAINS; RAP1	The genes encoding the ribosomal proteins of fungi form a regulon whose expression is enhanced under good growth conditions and down-regulated under starvation conditions. The fungal pathogen Candida albicans contains an evolutionarily ancient control circuit for this regulon where a heteromer made up of the transcription regulators Ifh1 (interacts with Forkhead 1) and Fhl1 (Forkhead-like 1) is targeted to the ribosomal protein genes by the DNA binding factor Tbf1. In the more recently evolved circuit in the model yeast Saccharomyces cerevisiae (Sc), the generalist repressor-activator protein Rap1 now directs the Ifh1-Fhl1 module to the ribosomal protein genes. Even though overall sequence similarity is low for the respective Fhl1 and Ifh1 subunits, in both species, the Ifh1 protein links to the Forkhead-associated domain of Fhl1 through its FHB domain. Intriguingly, correlated with the transition to the Rap1-regulated circuit, the Sc-Ifh1 contains a Rap1 binding domain that is not present in the C. albicans protein. Because no extensive common sequences are found in Tbf1 and Rap1, it appears that these targeting proteins must connect to the Ifh1-Fhl1 module in distinct ways. Two-hybrid and co-immunoprecipitation analysis has been used to show that in C. albicans Tbf1 is linked to the heterodimer through direct association with Fhl1. By contrast, in S. cerevisiae, the linkage of the heteromer to Rap1 occurs through Ifh1. Thus, in the ascomycetes, the Ifh1-Fhl1 heterodimer has reconfigured its protein associations to remain connected to the ribosomal protein regulon despite rewiring of the targeting transcription factor from Tbf1 to Rap1.	[Whiteway, Malcolm] Concordia Univ, Dept Biol, Ctr Struct & Funct Genom, Montreal, PQ H4B 1R6, Canada; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	Concordia University - Canada; McGill University	Whiteway, M (corresponding author), Concordia Univ, Dept Biol, Ctr Struct & Funct Genom, 7141 Sherbrooke St W, Montreal, PQ H4B 1R6, Canada.	malcolm.whiteway@concordia.ca			Canadian Institute for Health Research Grant [MOP-42516]	Canadian Institute for Health Research Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institute for Health Research Grant MOP-42516 (to M. W.).	Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Bilaud T, 1996, NUCLEIC ACIDS RES, V24, P1294, DOI 10.1093/nar/24.7.1294; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; BRIGATI C, 1993, MOL CELL BIOL, V13, P1306, DOI 10.1128/MCB.13.2.1306; Bruckner A, 2009, INT J MOL SCI, V10, P2763, DOI 10.3390/ijms10062763; Cote P, 2011, MBIO, V2, DOI 10.1128/mBio.00230-10; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Gasch AP, 2004, PLOS BIOL, V2, P2202, DOI 10.1371/journal.pbio.0020398; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Habib N, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.50; Hall DB, 2006, MOL CELL BIOL, V26, P3672, DOI 10.1128/MCB.26.9.3672-3679.2006; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hogues H, 2008, MOL CELL, V29, P552, DOI 10.1016/j.molcel.2008.02.006; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Lavoie H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000329; Lavoie H, 2009, CURR OPIN MICROBIOL, V12, P655, DOI 10.1016/j.mib.2009.09.015; Lavoie H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-578; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li H, 2010, CURR BIOL, V20, pR746, DOI 10.1016/j.cub.2010.06.056; Martchenko M, 2007, EUKARYOT CELL, V6, P291, DOI 10.1128/EC.00183-06; Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Powers T, 2003, CURR TOP MICROBIOL, V279, P39; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Preti M, 2010, MOL CELL, V38, P614, DOI 10.1016/j.molcel.2010.04.016; Ribaud V, 2012, EMBO J, V31, P138, DOI 10.1038/emboj.2011.349; Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553; Rudra D, 2004, GENE DEV, V18, P2431, DOI 10.1101/gad.1256704; Rudra D, 2007, MOL CELL BIOL, V27, P4815, DOI 10.1128/MCB.02062-06; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; UEMURA H, 1990, MOL CELL BIOL, V10, P6389, DOI 10.1128/MCB.10.12.6389; Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wu CL, 2006, GENE DEV, V20, P734, DOI 10.1101/gad.1375706; Zhao Y, 2006, MOL CELL BIOL, V26, P4853, DOI 10.1128/MCB.02367-05; Zhu L, 2011, METHODS MOL BIOL, V754, P167, DOI 10.1007/978-1-61779-154-3_9; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383	47	18	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17508	17519		10.1074/jbc.M112.436683	http://dx.doi.org/10.1074/jbc.M112.436683			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625919	Green Published, hybrid			2022-12-28	WOS:000320380600042
J	Wessel, SR; Marceau, AH; Massoni, SC; Zhou, RB; Ha, T; Sandler, SJ; Keck, JL				Wessel, Sarah R.; Marceau, Aimee H.; Massoni, Shawn C.; Zhou, Ruobo; Ha, Taekjip; Sandler, Steven J.; Keck, James L.			PriC-mediated DNA Replication Restart Requires PriC Complex Formation with the Single-stranded DNA-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; EXONUCLEASE-I; STRUCTURAL BASIS; 2 MODES; SSB; FORKS; RECOMBINATION; PRIMOSOME; HELICASE; INITIATION	Frequent collisions between cellular DNA replication complexes (replisomes) and obstacles such as damaged DNA or frozen protein complexes make DNA replication fork progression surprisingly sporadic. These collisions can lead to the ejection of replisomes prior to completion of replication, which, if left unrepaired, results in bacterial cell death. As such, bacteria have evolved DNA replication restart mechanisms that function to reload replisomes onto abandoned DNA replication forks. Here, we define a direct interaction between PriC, a key Escherichia coli DNA replication restart protein, and the single-stranded DNA-binding protein (SSB), a protein that is ubiquitously associated with DNA replication forks. PriC/SSB complex formation requires evolutionarily conserved residues from both proteins, including a pair of Arg residues from PriC and the C terminus of SSB. In vitro, disruption of the PriC/SSB interface by sequence changes in either protein blocks the first step of DNA replication restart, reloading of the replicative DnaB helicase onto an abandoned replication fork. Consistent with the critical role of PriC/SSB complex formation in DNA replication restart, PriC variants that cannot bind SSB are non-functional in vivo. Single-molecule experiments demonstrate that PriC binding to SSB alters SSB/DNA complexes, exposing single-stranded DNA and creating a platform for other proteins to bind. These data lead to a model in which PriC interaction with SSB remodels SSB/DNA structures at abandoned DNA replication forks to create a DNA structure that is competent for DnaB loading.	[Wessel, Sarah R.; Marceau, Aimee H.; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA; [Massoni, Shawn C.; Sandler, Steven J.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Zhou, Ruobo; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Zhou, Ruobo; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA	University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Amherst; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Keck, JL (corresponding author), 1135 Biochem Sci Bldg,420 Henry Mall, Madison, WI 53706 USA.	jlkeck@wisc.edu	Ha, Taekjip/B-9506-2009	Ha, Taekjip/0000-0003-2195-6258; Keck, James/0000-0002-5961-0220; Zhou, Ruobo/0000-0001-8628-0282	National Institutes of Health [GM098885, GM065367]; National Science Foundation [0822613]; National Institutes of Health in Molecular Biosciences [GM07215]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098885, R01GM065367, T32GM007215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health in Molecular Biosciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM098885 (to J. L. K. and S. J. S.) and GM065367 (to T. H.), National Science Foundation Grant 0822613 (to T. H). T. H. is an employee of the Howard Hughes Medical Institute. J. L. K. is cofounder of Replisoma, Inc.; Supported in part by National Institutes of Health Training Grant GM07215 in Molecular Biosciences.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Atkinson J, 2009, NUCLEIC ACIDS RES, V37, P3475, DOI 10.1093/nar/gkp244; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; CHASE JW, 1984, J BIOL CHEM, V259, P805; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Genschel J, 2000, BIOL CHEM, V381, P183, DOI 10.1515/BC.2000.025; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2005, J BIOL CHEM, V280, P34143, DOI 10.1074/jbc.M507224200; Heller RC, 2007, DNA REPAIR, V6, P945, DOI 10.1016/j.dnarep.2007.02.014; Inoue J, 2011, J BIOL CHEM, V286, P6720, DOI 10.1074/jbc.M110.164210; James P, 1996, GENETICS, V144, P1425; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Jones JM, 1999, J MOL BIOL, V289, P503, DOI 10.1006/jmbi.1999.2783; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kozlov AG, 2010, BIOCHEMISTRY-US, V49, P3555, DOI 10.1021/bi100069s; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; Liu J, 1999, J BIOL CHEM, V274, P25033, DOI 10.1074/jbc.274.35.25033; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Manhart CM, 2013, J BIOL CHEM, V288, P3989, DOI 10.1074/jbc.M112.435966; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; McCool JD, 2004, GENETICS, V167, P569, DOI 10.1534/genetics.103.025296; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; Mott ML, 2007, NAT REV MICROBIOL, V5, P343, DOI 10.1038/nrmicro1640; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Nurse P, 1999, J BIOL CHEM, V274, P25026, DOI 10.1074/jbc.274.35.25026; Reams AB, 2010, GENETICS, V184, P1077, DOI 10.1534/genetics.109.111963; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; Ryzhikov M, 2011, NUCLEIC ACIDS RES, V39, P6305, DOI 10.1093/nar/gkr199; Sandigursky M, 1996, RADIAT RES, V145, P619, DOI 10.2307/3579281; Sandler SJ, 2000, GENETICS, V155, P487; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Tanaka T, 2007, J BIOL CHEM, V282, P19917, DOI 10.1074/jbc.M701848200; WANG TCV, 1982, J BACTERIOL, V151, P186, DOI 10.1128/JB.151.1.186-192.1982; WILLETTS NS, 1969, J BACTERIOL, V97, P244, DOI 10.1128/JB.97.1.244-249.1969; Yeeles JTP, 2010, DNA REPAIR, V9, P276, DOI 10.1016/j.dnarep.2009.12.016; Zhou RB, 2011, CELL, V146, P222, DOI 10.1016/j.cell.2011.06.036	47	34	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17569	17578		10.1074/jbc.M113.478156	http://dx.doi.org/10.1074/jbc.M113.478156			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629733	Green Published, hybrid			2022-12-28	WOS:000320380600048
J	Li, JH; Zhuo, M; Pei, L; Yu, ASL				Li, Jiahua; Zhuo, Min; Pei, Lei; Yu, Alan S. L.			Conserved Aromatic Residue Confers Cation Selectivity in Claudin-2 and Claudin-10b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIGHT JUNCTION; PARACELLULAR PORES; POTASSIUM CHANNEL; AQUEOUS-SOLUTIONS; MOLECULAR-BASIS; FORMS; LOCALIZATION; BINDING; KIDNEY; SITE	In tight junctions, both claudin-2 and claudin-10b form paracellular cation-selective pores by the interaction of the first ECL 1 with permeating ions. We hypothesized that a highly conserved aromatic residue near the pore selectivity filter of claudins contributes to cation selectivity by cation-pi interaction with the permeating cation. To test this, we generated MDCK I Tet-off cells stably transfected with claudin-2 Tyr(67) mutants. The Y67L mutant showed reduced cation selectivity compared with wild-type claudin-2 due to a decrease in Na+ permeability, without affecting the Cl- permeability. The Y67A mutant enlarged the pore size and further decreased the charge selectivity due to an increase in Cl- permeability. The Y67F mutant restored the Na+ permeability, Cl- permeability, and pore size back to wild-type. The accessibility of Y67C to methanethiosulfonate modification indicated that its side chain faces the lumen of the pore. In claudin-10b, the F66L mutant reduced cation selectivity, and the F66A mutant lost pore conductance. We conclude that the conserved aromatic residue near the cation pore domain of claudins contributes to cation selectivity by a dual role of cation-pi interaction and a luminal steric effect. Our findings provide new insight into how ion selectivity is achieved in the paracellular pore.	[Li, Jiahua; Zhuo, Min; Pei, Lei; Yu, Alan S. L.] Univ Kansas, Med Ctr, Div Nephrol & Hypertens, Kansas City, KS 66160 USA; [Li, Jiahua; Zhuo, Min; Pei, Lei; Yu, Alan S. L.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA; [Pei, Lei; Yu, Alan S. L.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Yu, ASL (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, 3901 Rainbow Blvd,Mail Stop 3018, Kansas City, KS 66160 USA.	ayu@kumc.edu	Yu, Alan/AID-7467-2022	Yu, Alan/0000-0002-1776-2533	National Institutes of Health [9P20GM104936]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936, U01GM094627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Confocal Imaging Core at the University of Kansas Medical Center was supported by National Institutes of Health Grant 9P20GM104936 (to Dale Abrahamson).	Angelow S, 2009, J BIOL CHEM, V284, P29205, DOI 10.1074/jbc.M109.043752; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gunzel D, 2009, J CELL SCI, V122, P1507, DOI 10.1242/jcs.040113; Guidoni L, 2002, J RECEPT SIGNAL TR R, V22, P315, DOI 10.1081/RRS-120014604; Hou JH, 2008, J CLIN INVEST, V118, P619, DOI 10.1172/JCI33970; Hou JH, 2010, P NATL ACAD SCI USA, V107, P18010, DOI 10.1073/pnas.1009399107; Kielland J, 1937, J AM CHEM SOC, V59, P1675, DOI 10.1021/ja01288a032; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Koneshan S, 1998, J PHYS CHEM B, V102, P4193, DOI 10.1021/jp980642x; Krug SM, 2012, CELL MOL LIFE SCI, V69, P2765, DOI 10.1007/s00018-012-0949-x; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Tamura A, 2011, GASTROENTEROLOGY, V140, P913, DOI 10.1053/j.gastro.2010.08.006; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2006, AM J PHYSIOL-RENAL, V291, pF1288, DOI 10.1152/ajprenal.00138.2006; Wulfsberg G, 2000, INORG CHEM, P57; Yu ASL, 2011, METHODS MOL BIOL, V762, P27, DOI 10.1007/978-1-61779-185-7_3; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088	22	20	20	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22790	22797		10.1074/jbc.M113.484238	http://dx.doi.org/10.1074/jbc.M113.484238			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23760508	Green Published, hybrid			2022-12-28	WOS:000330596300056
J	Lund, J; Olsen, OH; Sorensen, ES; Stennicke, HR; Petersen, HH; Overgaard, MT				Lund, Jacob; Olsen, Ole H.; Sorensen, Esben S.; Stennicke, Henning R.; Petersen, Helle H.; Overgaard, Michael T.			ADAMDEC1 Is a Metzincin Metalloprotease with Dampened Proteolytic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-BINDING SITE; STREPTOMYCES-CAESPITOSUS; INTRACELLULAR MATURATION; CANDIDATE GENES; FAMILY; DISINTEGRIN; ALPHA; EXPRESSION; DECYSIN; PROPROTEIN	ADAMDEC1 (Decysin-1) is a putative ADAM (a disintegrin and metalloprotease)-like metalloprotease with an unknown physiological role, selectively expressed in mature dendritic cells and macrophages. When compared with other members of the ADAM family, ADAMDEC1 displays some unusual features. It lacks the auxiliary cysteine-rich, EGF, and transmembrane domains, as well as the cytoplasmic tail. The active site of ADAMDEC1 is unique by being the only mammalian ADAM protease with a non-histidine zinc ligand, having an aspartic acid residue instead. Here we demonstrate that ADAMDEC1, despite these unique features, functions as an active metalloprotease. Thus, ADAMDEC1 is secreted as a mature, glycosylated, and proteolytically active metalloprotease, capable of cleaving macromolecular substrates. In the recombinant form, three of the four potential N-linked glycosylation sites are modified by carbohydrate attachment. Substitution of basic residues at the predicted proprotein convertase cleavage site blocks proprotein processing, revealing both specific ADAMDEC1-dependent and specific ADAMDEC1-independent cleavage of the prodomain. The pro-form of ADAMDEC1 does not have proteolytic activity, demonstrating that the prodomain of ADAMDEC1, like in other members of the ADAM family, confers catalytic latency. Interestingly, the proteolytic activity of mature ADAMDEC1 can be significantly enhanced when a canonical ADAM active site with three zinc-coordinating histidine residues is introduced.	[Lund, Jacob; Overgaard, Michael T.] Aalborg Univ, Dept Chem & Biotechnol, DK-9000 Aalborg, Denmark; [Lund, Jacob; Olsen, Ole H.; Stennicke, Henning R.; Petersen, Helle H.] Novo Nordisk AS, Dept Haemophilia Biochem, DK-2760 Malov, Denmark; [Sorensen, Esben S.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark	Aalborg University; Novo Nordisk; Aarhus University	Overgaard, MT (corresponding author), Aalborg Univ, Dept Chem & Biotechnol, Sohngaardsholmsvej 49, DK-9000 Aalborg, Denmark.	mto@bio.aau.dk	Lund, Jacob/G-9885-2013; Overgaard, Michael Toft/E-1354-2011	Lund, Jacob/0000-0001-8627-7382; Overgaard, Michael Toft/0000-0002-1423-2481; Sorensen, Esben Skipper/0000-0002-7050-3354				Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Baran N, 2003, BIOL REPROD, V68, P1787, DOI 10.1095/biolreprod.102.009761; Bates EEM, 2002, IMMUNOGENETICS, V54, P96, DOI 10.1007/s00251-002-0430-3; BODE W, 1993, FEBS LETT, V331, P134, DOI 10.1016/0014-5793(93)80312-I; Crouser ED, 2009, AM J RESP CRIT CARE, V179, P929, DOI 10.1164/rccm.200803-490OC; Dommels YEM, 2007, GENES NUTR, V2, P209, DOI 10.1007/s12263-007-0051-4; Endres K, 2003, EUR J BIOCHEM, V270, P2386, DOI 10.1046/j.1432-1033.2003.03606.x; Fritsche J, 2003, IMMUNOLOGY, V110, P450, DOI 10.1111/j.1365-2567.2003.01754.x; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; HARPEL PC, 1973, J EXP MED, V138, P508, DOI 10.1084/jem.138.3.508; HARPEL PC, 1979, J BIOL CHEM, V254, P8669; Howard L, 2000, BIOCHEM J, V348, P21, DOI 10.1042/0264-6021:3480021; IPPOLITO JA, 1994, BIOCHEMISTRY-US, V33, P15241, DOI 10.1021/bi00255a004; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kang TB, 2002, J BIOL CHEM, V277, P25583, DOI 10.1074/jbc.M203532200; KESTER WR, 1977, BIOCHEMISTRY-US, V16, P2506, DOI 10.1021/bi00630a030; KIEFER LL, 1993, J AM CHEM SOC, V115, P12581, DOI 10.1021/ja00079a046; Klein T, 2011, J PROTEOME RES, V10, P17, DOI 10.1021/pr100556z; Kurisu G, 1997, J FERMENT BIOENG, V83, P590, DOI 10.1016/S0922-338X(97)81142-7; Kurisu G, 2000, J INORG BIOCHEM, V82, P225, DOI 10.1016/S0162-0134(00)00136-7; LAMPEL JS, 1992, J BACTERIOL, V174, P2797, DOI 10.1128/JB.174.9.2797-2808.1992; Loechel F, 1999, J BIOL CHEM, V274, P13427, DOI 10.1074/jbc.274.19.13427; Loechel F, 1998, J BIOL CHEM, V273, P16993, DOI 10.1074/jbc.273.27.16993; Long JY, 2012, GENE, V507, P36, DOI 10.1016/j.gene.2012.07.016; Lum L, 1998, J BIOL CHEM, V273, P26236, DOI 10.1074/jbc.273.40.26236; Macartney-Coxson DP, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-187; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Mueller CGF, 1997, J EXP MED, V186, P655, DOI 10.1084/jem.186.5.655; Mueller CGF, 2001, J IMMUNOL, V167, P5052, DOI 10.4049/jimmunol.167.9.5052; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Roghani M, 1999, J BIOL CHEM, V274, P3531, DOI 10.1074/jbc.274.6.3531; Schlomann U, 2002, J BIOL CHEM, V277, P48210, DOI 10.1074/jbc.M203355200; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; SHAKINESHLEMAN SH, 1993, BIOCHEMISTRY-US, V32, P9465, DOI 10.1021/bi00087a026; SOTTRUPJENSEN L, 1990, J BIOL CHEM, V265, P17727; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Tortorella MD, 2004, J BIOL CHEM, V279, P17554, DOI 10.1074/jbc.M313041200; Gomis-Ruth FX, 2009, J BIOL CHEM, V284, P15353, DOI 10.1074/jbc.R800069200; Xu JG, 2012, NEUROL RES, V34, P701, DOI 10.1179/1743132812Y.0000000067; Zhou WH, 2009, BLOOD, V113, P929, DOI 10.1182/blood-2008-07-167775	45	18	21	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21367	21375		10.1074/jbc.M113.474536	http://dx.doi.org/10.1074/jbc.M113.474536			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23754285	hybrid, Green Published			2022-12-28	WOS:000322014400055
J	de la Roche, J; Eberhardt, MJ; Klinger, AB; Stanslowsky, N; Wegner, F; Koppert, W; Reeh, PW; Lampert, A; Fischer, MJM; Leffler, A				de la Roche, Jeanne; Eberhardt, Mirjam J.; Klinger, Alexandra B.; Stanslowsky, Nancy; Wegner, Florian; Koppert, Wolfgang; Reeh, Peter W.; Lampert, Angelika; Fischer, Michael J. M.; Leffler, Andreas			The Molecular Basis for Species-specific Activation of Human TRPA1 Protein by Protons Involves Poorly Conserved Residues within Transmembrane Domains 5 and 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; VANILLOID RECEPTOR TRPV1; ROOT GANGLION NEURONS; CAPSAICIN RECEPTOR; COVALENT MODIFICATION; SENSORY NEURONS; PAIN SENSATION; NITRIC-OXIDE; ACID; NOCICEPTORS	The surveillance of acid-base homeostasis is concerted by diverse mechanisms, including an activation of sensory afferents. Proton-evoked activation of rodent sensory neurons is mainly mediated by the capsaicin receptor TRPV1 and acid-sensing ion channels. In this study, we demonstrate that extracellular acidosis activates and sensitizes the human irritant receptor TRPA1 (hTRPA1). Proton-evoked membrane currents and calcium influx through hTRPA1 occurred at physiological acidic pH values, were concentration-dependent, and were blocked by the selective TRPA1 antagonist HC030031. Both rodent and rhesus monkey TRPA1 failed to respond to extracellular acidosis, and protons even inhibited rodent TRPA1. Accordingly, mouse dorsal root ganglion neurons lacking TRPV1 only responded to protons when hTRPA1 was expressed heterologously. This species-specific activation of hTRPA1 by protons was reversed in both mouse and rhesus monkey TRPA1 by exchange of distinct residues within transmembrane domains 5 and 6. Furthermore, protons seem to interact with an extracellular interaction site to gate TRPA1 and not via a modification of intracellular N-terminal cysteines known as important interaction sites for electrophilic TRPA1 agonists. Our data suggest that hTRPA1 acts as a sensor for extracellular acidosis in human sensory neurons and should thus be taken into account as a yet unrecognized transduction molecule for proton-evoked pain and inflammation. The species specificity of this property is unique among known endogenous TRPA1 agonists, possibly indicating that evolutionary pressure enforced TRPA1 to inherit the role as an acid sensor in human sensory neurons.	[de la Roche, Jeanne; Eberhardt, Mirjam J.; Koppert, Wolfgang; Leffler, Andreas] Hannover Med Sch, Dept Anesthesia & Crit Care Med, D-30625 Hannover, Germany; [Stanslowsky, Nancy; Wegner, Florian] Hannover Med Sch, Dept Neurol, D-30625 Hannover, Germany; [Eberhardt, Mirjam J.; Klinger, Alexandra B.; Reeh, Peter W.; Lampert, Angelika; Fischer, Michael J. M.] Univ Erlangen Nurnberg, Inst Physiol & Pathophysiol, D-91054 Erlangen, Germany	Hannover Medical School; Hannover Medical School; University of Erlangen Nuremberg	de la Roche, J (corresponding author), Hannover Med Sch, Clin Anesthesia & Crit Care Med, Carl Neuberg Str 1, D-30625 Hannover, Germany.	delaroche.jeanne@mh-hannover.de; leffler.andreas@mh-hannover.de	Reeh, Peter W./J-8981-2012; Lampert, Angelika/F-7198-2010; Fischer, Michael J.M./P-8715-2014	Reeh, Peter W./0000-0002-4367-094X; Lampert, Angelika/0000-0001-6319-6272; Fischer, Michael J.M./0000-0002-3811-7066	Hannover Medical School; German Research Association [LA2740/2-1]	Hannover Medical School; German Research Association(German Research Foundation (DFG))	This study was supported by an internal grant of the Hannover Medical School (to J.d.I.R.) and by German Research Association Grant LA2740/2-1 (to A.L.).	Andersson DA, 2004, J NEUROSCI, V24, P5364, DOI 10.1523/JNEUROSCI.0890-04.2004; Banke TG, 2011, BRAIN RES, V1381, P21, DOI 10.1016/j.brainres.2011.01.021; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Baumann TK, 1996, PAIN, V65, P31, DOI 10.1016/0304-3959(95)00145-X; Baumann TK, 2004, EUR J NEUROSCI, V19, P1343, DOI 10.1111/j.1460-9568.2004.03097.x; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; Bianchi BR, 2012, J PHARMACOL EXP THER, V341, P360, DOI 10.1124/jpet.111.189902; Birdsong WT, 2010, NEURON, V68, P739, DOI 10.1016/j.neuron.2010.09.029; Cadiou H, 2007, J NEUROSCI, V27, P13251, DOI 10.1523/JNEUROSCI.2135-07.2007; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chen J, 2008, J NEUROSCI, V28, P5063, DOI 10.1523/JNEUROSCI.0047-08.2008; Chen J, 2009, J GEN PHYSIOL, V133, P623, DOI 10.1085/jgp.200910246; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Delaunay A, 2012, P NATL ACAD SCI USA, V109, P13124, DOI 10.1073/pnas.1120350109; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Deval E, 2010, PHARMACOL THERAPEUT, V128, P549, DOI 10.1016/j.pharmthera.2010.08.006; Eberhardt MJ, 2012, J BIOL CHEM, V287, P28291, DOI 10.1074/jbc.M111.328674; Fischer MJM, 2010, J BIOL CHEM, V285, P34781, DOI 10.1074/jbc.M110.143958; Fujita F, 2008, J CLIN INVEST, V118, P4049, DOI 10.1172/JCI35957; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Holzer Peter, 2009, Handb Exp Pharmacol, P283, DOI 10.1007/978-3-540-79090-7_9; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jones NG, 2004, J NEUROSCI, V24, P10974, DOI 10.1523/JNEUROSCI.2619-04.2004; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; KRISHTAL OA, 1981, BRAIN RES, V214, P150, DOI 10.1016/0006-8993(81)90446-7; Lambert S, 2005, J PHYSIOL-LONDON, V567, P191, DOI 10.1113/jphysiol.2005.089888; Leffler A, 2006, NEUROSCIENCE, V139, P699, DOI 10.1016/j.neuroscience.2005.12.020; Leffler A, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-62; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Miyamoto T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007596; Mohapatra DP, 2003, MOL CELL NEUROSCI, V23, P314, DOI 10.1016/S1044-7431(03)00054-X; Nilius B, 2011, J PHYSIOL-LONDON, V589, P1543, DOI 10.1113/jphysiol.2010.200717; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Reeh P W, 2001, Curr Opin Pharmacol, V1, P45, DOI 10.1016/S1471-4892(01)00014-5; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Samad A, 2011, BIOCHEM J, V433, P197, DOI 10.1042/BJ20101256; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; STEEN KH, 1995, NEUROSCI LETT, V199, P29, DOI 10.1016/0304-3940(95)12002-L; STEEN KH, 1992, J NEUROSCI, V12, P86; Steen KH, 1999, EUR J NEUROSCI, V11, P2783, DOI 10.1046/j.1460-9568.1999.00695.x; Takahashi N, 2008, CHANNELS, V2, P287, DOI 10.4161/chan.2.4.6745; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Wang S, 2010, J BIOL CHEM, V285, P11547, DOI 10.1074/jbc.M109.058727; Wang YY, 2008, J BIOL CHEM, V283, P32691, DOI 10.1074/jbc.M803568200; Wang YYY, 2011, J GEN PHYSIOL, V137, P493, DOI 10.1085/jgp.201110615; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c	52	73	74	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20280	20292		10.1074/jbc.M113.479337	http://dx.doi.org/10.1074/jbc.M113.479337			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23709225	Green Published, hybrid			2022-12-28	WOS:000321715100017
J	Gauss, GH; Kleven, MD; Sendamarai, AK; Fleming, MD; Lawrence, CM				Gauss, George H.; Kleven, Mark D.; Sendamarai, Anoop K.; Fleming, Mark D.; Lawrence, C. Martin			The Crystal Structure of Six-transmembrane Epithelial Antigen of the Prostate 4 (Steap4), a Ferri/Cuprireductase, Suggests a Novel Interdomain Flavin-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-RELATED PROTEIN; 6 TRANSMEMBRANE PROTEIN; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; METABOLIC SYNDROME; PHOSPHOPROTEOMIC ANALYSIS; ACTIVATED MACROPHAGES; POSITIVE REGULATOR; MOLECULAR-CLONING; ESCHERICHIA-COLI	Steap4 is a cell surface metalloreductase linked to obesity-associated insulin resistance. Initial characterization of its cell surface metalloreductase activity has been reported, but thorough biochemical characterization of this activity is lacking. Here, we report detailed kinetic analysis of the Steap4 cell surface metalloreductase activities. Steap4 shows physiologically relevant K-m values for both Fe3+ and Cu2+ and retains activity at acidic pH, suggesting it may also function within intracellular organelles to reduce these metals. Flavin-dependent NADPH oxidase activity that was much greater than the equivalent Steap3 construct was observed for the isolated N-terminal oxidoreductase domain. The crystal structure of the Steap4 oxidoreductase domain was determined, providing a structural explanation for these differing activities. Structure-function work also suggested Steap4 utilizes an interdomain flavin-binding site to shuttle electrons between the oxidoreductase and transmembrane domains, and it showed that the disordered N-terminal residues do not contribute to enzymatic activity.	[Gauss, George H.; Kleven, Mark D.; Sendamarai, Anoop K.; Lawrence, C. Martin] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Fleming, Mark D.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Fleming, Mark D.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Montana State University System; Montana State University Bozeman; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Lawrence, CM (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	lawrence@chemistry.montana.edu	Lawrence, C. Martin/AAH-3420-2020	Lawrence, C. Martin/0000-0002-5398-466X; Fleming, Mark/0000-0003-0948-4024; Sendamarai, Anoop/0000-0002-0476-5428; Kleven, Mark/0000-0003-1204-6658	Department of Energy, Office of Biological and Environmental Research; National Institutes of Health; NCCR Biomedical Technology Program; NIGMS; Murdock Foundation; National Science Foundation-Major Research Instrumentation Program; M. J. Murdock Charitable Trust; National Institutes of Health Grant [RO1 GM084326]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084326] Funding Source: NIH RePORTER	Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCR Biomedical Technology Program; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Murdock Foundation; National Science Foundation-Major Research Instrumentation Program(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); M. J. Murdock Charitable Trust; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, National Institutes of Health, NCCR Biomedical Technology Program and NIGMS. The Macromolecular Diffraction Laboratory at Montana State University was supported, in part, by a grant from the Murdock Foundation. The Montana State University confocal microscope was purchased with funding from the National Science Foundation-Major Research Instrumentation Program and the M. J. Murdock Charitable Trust.; This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM084326 (to C. M. L. and M. D. F.). Portions of this work were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences.	Aliverti A, 1999, METH MOL B, V131, P9; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Arner P, 2008, J CLIN ENDOCR METAB, V93, P2249, DOI 10.1210/jc.2008-0206; BABIOR BM, 1981, J BIOL CHEM, V256, P2321; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen XH, 2010, INT J MOL MED, V25, P361, DOI 10.3892/ijmm_00000353; Cheng R, 2011, MOL MED REP, V4, P519, DOI 10.3892/mmr.2011.443; Christensen GL, 2010, MOL CELL PROTEOMICS, V9, P1540, DOI 10.1074/mcp.M900550-MCP200; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Fasshauer M, 2004, FEBS LETT, V560, P153, DOI 10.1016/S0014-5793(04)00096-1; Fieschi F, 1995, J BIOL CHEM, V270, P30392, DOI 10.1074/jbc.270.51.30392; Fischer M, 2002, EUR J BIOCHEM, V269, P519, DOI 10.1046/j.0014-2956.2001.02674.x; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; FONTECAVE M, 1987, J BIOL CHEM, V262, P12325; Gomes IM, 2012, MOL CANCER RES, V10, P573, DOI 10.1158/1541-7786.MCR-11-0281; Goswami T, 2012, PROTEOMICS, V12, P2185, DOI 10.1002/pmic.201200003; Grandchamp B, 2011, BLOOD, V118, P6660, DOI 10.1182/blood-2011-01-329011; Grunewald TGP, 2012, BIOL CELL, V104, P641, DOI 10.1111/boc.201200027; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Guo Yan-ying, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P299, DOI 10.3881/j.issn.1000-503X.2011.03.018; Guo YY, 2011, CHINESE MED J-PEKING, V124, P2096, DOI 10.3760/cma.j.issn.0366-6999.2011.14.003; Guo Yan-ying, 2011, Zhonghua Yixue Yichuanxue Zazhi, V28, P78, DOI 10.3760/cma.j.issn.1003-9406.2011.01.018; HINKSON JW, 1968, BIOCHEMISTRY-US, V7, P2666, DOI 10.1021/bi00847a033; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; Kidane TZ, 2012, BIOMETALS, V25, P697, DOI 10.1007/s10534-012-9528-8; Konstantopoulos N, 2011, PHYSIOL GENOMICS, V43, P110, DOI 10.1152/physiolgenomics.00115.2010; Korkmaz CG, 2005, ONCOGENE, V24, P4934, DOI 10.1038/sj.onc.1208677; Korkmaz KS, 2002, J BIOL CHEM, V277, P36689, DOI 10.1074/jbc.M202414200; Kralisch S, 2009, FEBS LETT, V583, P1196, DOI 10.1016/j.febslet.2009.03.015; KUNOW J, 1993, ARCH MICROBIOL, V160, P199; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Li L, 2010, P NATL ACAD SCI USA, V107, P3505, DOI 10.1073/pnas.0913192107; Li NF, 2010, ARCH MED RES, V41, P449, DOI 10.1016/j.arcmed.2010.08.006; Moreno-Navarrete JM, 2011, J NUTR BIOCHEM, V22, P1143, DOI 10.1016/j.jnutbio.2010.09.015; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Miot A, 2010, J CLIN ENDOCR METAB, V95, P2942, DOI 10.1210/jc.2010-0026; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan C, 2008, PROTEOMICS, V8, P4534, DOI 10.1002/pmic.200800105; PARKINSON JF, 1988, J BIOL CHEM, V263, P8859; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Qiu J, 2007, BIOCHEM BIOPH RES CO, V352, P469, DOI 10.1016/j.bbrc.2006.11.049; Ramadoss P, 2010, J BIOL CHEM, V285, P16453, DOI 10.1074/jbc.M109.066936; Raymond C, 2011, METHODS, V55, P44, DOI 10.1016/j.ymeth.2011.04.002; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sanchez-Pulido L, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-98; Schrodinger L., 2011, PYMOL MOL GRAPHICS S; Sendamarai AK, 2008, P NATL ACAD SCI USA, V105, P7410, DOI 10.1073/pnas.0801318105; Sparna T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-226; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Su D, 2006, FEBS J, V273, P3722, DOI 10.1111/j.1742-4658.2006.05381.x; ten Freyhaus H, 2012, CELL METAB, V16, P81, DOI 10.1016/j.cmet.2012.05.009; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; Vignozzi L, 2012, J ENDOCRINOL, V212, P71, DOI 10.1530/JOE-11-0289; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang C. Y., 2013, HEPATOLOGY IN PRESS; Wang CY, 2012, J BIOL CHEM, V287, P34032, DOI 10.1074/jbc.M112.367284; Wang YF, 2011, ADV NUTR, V2, P129, DOI 10.3945/an.110.000273; Warkentin E, 2005, ACTA CRYSTALLOGR D, V61, P198, DOI 10.1107/S0907444904030732; Weintz G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.29; Wellen KE, 2007, CELL, V129, P537, DOI 10.1016/j.cell.2007.02.049; Wisniewski JR, 2010, J PROTEOME RES, V9, P3280, DOI 10.1021/pr1002214; Wyman S, 2008, FEBS LETT, V582, P1901, DOI 10.1016/j.febslet.2008.05.010; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n; Zhang CM, 2008, ACTA PHARMACOL SIN, V29, P587, DOI 10.1111/j.1745-7254.2008.00793.x; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058126; Zhao NN, 2010, J BIOL CHEM, V285, P32141, DOI 10.1074/jbc.M110.143248	79	28	29	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20668	20682		10.1074/jbc.M113.479154	http://dx.doi.org/10.1074/jbc.M113.479154			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23733181	Green Published, hybrid			2022-12-28	WOS:000321715100052
J	Han, BK; Emr, SD				Han, Bong-Kwan; Emr, Scott D.			The Phosphatidylinositol 3,5-Bisphosphate (PI(3,5)P-2)-dependent Tup1 Conversion (PIPTC) Regulates Metabolic Reprogramming from Glycolysis to Gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REPRESSION; COMPLEX FUNCTIONS; DOMAIN PROTEIN; IN-VIVO; GENES; SAGA; ACTIVATOR; STRESS; COACTIVATOR	Glucose/carbon metabolism is a fundamental cellular process in living cells. In response to varying environments, eukaryotic cells reprogram their glucose/carbon metabolism between aerobic or anaerobic glycolysis, oxidative phosphorylation, and/or gluconeogenesis. The distinct type of glucose/carbon metabolism that a cell carries out has significant effects on the cell's proliferation and differentiation. However, it is poorly understood how the reprogramming of glucose/carbon metabolism is regulated. Here, we report a novel endosomal PI(3,5)P-2 lipid-dependent regulatory mechanism that is required for metabolic reprogramming from glycolysis to gluconeogenesis in Saccharomyces cerevisiae. Certain gluconeogenesis genes, such as FBP1 (encoding fructose-1,6-bisphosphatase 1) and ICL1 (encoding isocitrate lyase 1) are under control of the Mig1 repressor and Cyc8-Tup1 corepressor complex. We previously identified the PI(3,5)P-2-dependent Tup1 conversion (PIPTC), a mechanism to convert Cyc8-Tup1 corepressor to Cti6-Cyc8-Tup1 coactivator. We demonstrate that the PIPTC plays a critical role for transcriptional activation of FBP1 and ICL1. Furthermore, without the PIPTC, the Cat8 and Sip4 transcriptional activators cannot be efficiently recruited to the promoters of FBP1 and ICL1, suggesting a key role for the PIPTC in remodulating the chromatin architecture at the promoters. Our findings expand our understanding of the regulatory mechanisms for metabolic reprogramming in eukaryotes to include key regulation steps outside the nucleus. Given that Tup1 and the metabolic enzymes that control PI(3,5)P-2 are highly conserved among eukaryotes, our findings may provide important insights toward understanding glucose/carbon metabolic reprogramming in other eukaryotes, including humans.	[Han, Bong-Kwan; Emr, Scott D.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Han, Bong-Kwan; Emr, Scott D.] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Emr, SD (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	sde26@cornell.edu			Cornell University	Cornell University	This work was supported by funds from a Cornell University Research Grant (to S. D. E.).	Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Biddick RK, 2008, J BIOL CHEM, V283, P33101, DOI 10.1074/jbc.M805258200; Bojunga N, 1999, MOL GEN GENET, V262, P869, DOI 10.1007/s004380051152; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; ENTIAN KD, 1992, TRENDS BIOCHEM SCI, V17, P506, DOI 10.1016/0968-0004(92)90341-6; Fleming AB, 2001, EMBO J, V20, P5219, DOI 10.1093/emboj/20.18.5219; Fraenkel D. G., 2011, YEAST INTERMEDIARY M; Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65; Genereaux J, 2012, GENETICS, V191, P765, DOI 10.1534/genetics.112.140459; Goldfarb Tamara, 2004, Methods Mol Biol, V262, P223; Han BK, 2011, GENE DEV, V25, P984, DOI 10.1101/gad.1998611; Hedbacker K, 2008, FRONT BIOSCI-LANDMRK, V13, P2408, DOI 10.2741/2854; HEDGES D, 1995, MOL CELL BIOL, V15, P1915; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoke SMT, 2008, J MOL BIOL, V384, P743, DOI 10.1016/j.jmb.2008.09.088; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kim J, 2013, SCIENCE, V340, P558, DOI 10.1126/science.1238523; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; LUNDIN M, 1994, MOL CELL BIOL, V14, P1979, DOI 10.1128/MCB.14.3.1979; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; NEHLIN JO, 1991, EMBO J, V10, P3373, DOI 10.1002/j.1460-2075.1991.tb04901.x; Orian A, 2007, P NATL ACAD SCI USA, V104, P15771, DOI 10.1073/pnas.0707418104; Papamichos-Chronakis M, 2002, MOL CELL, V9, P1297, DOI 10.1016/S1097-2765(02)00545-2; RACKER E, 1974, MOL CELL BIOCHEM, V5, P17, DOI 10.1007/BF01874168; Rahner A, 1999, MOL MICROBIOL, V34, P146, DOI 10.1046/j.1365-2958.1999.01588.x; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; SCHOLER A, 1993, CURR GENET, V23, P375, DOI 10.1007/BF00312621; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Vincent O, 1998, EMBO J, V17, P7002, DOI 10.1093/emboj/17.23.7002; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Wang JCW, 2000, J BIOL CHEM, V275, P18418, DOI 10.1074/jbc.M910211199; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; Wong KH, 2011, GENE DEV, V25, P2525, DOI 10.1101/gad.179275.111; Zaragoza O, 2001, BIOCHEM J, V359, P193, DOI 10.1042/0264-6021:3590193	52	9	10	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20633	20645		10.1074/jbc.M113.452813	http://dx.doi.org/10.1074/jbc.M113.452813			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23733183	Green Published, hybrid			2022-12-28	WOS:000321715100049
J	Humbert, MV; Rasia, RM; Checa, SK; Soncini, FC				Humbert, Maria V.; Rasia, Rodolfo M.; Checa, Susana K.; Soncini, Fernando C.			Protein Signatures That Promote Operator Selectivity among Paralog MerR Monovalent Metal Ion Regulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; DNA; COPPER; RESISTANCE; GOLD; METALLOREGULATOR; MECHANISM; OPERON; FAMILY	Two paralog transcriptional regulators of the MerR family, CueR and GolS, are responsible for monovalent metal ion sensing and resistance in Salmonella enterica. Although similar in sequence and also in their target binding sites, these proteins differ in signal detection and in the set of target genes they control. Recently, we demonstrated that selective promoter recognition depends on the presence of specific bases located at positions 3' and 3 within the operators they interact with. Here, we identify the amino acid residues within the N-terminal DNA-binding domain of these sensor proteins that are directly involved in operator discrimination. We demonstrate that a methionine residue at position 16 of GolS, absolutely conserved among GolS-like proteins but absent in all CueR-like xenologs, is the key to selectively recognize operators that harbor the distinctive GolS-operator signature, whereas the residue at position 19 finely tunes the regulator/operator interaction. Furthermore, swapping these residues switches the set of genes recognized by these transcription factors. These results indicate that co-evolution of a regulator and its cognate operators within the bacterial cell provides the conditions to avoid cross-recognition and guarantees the proper response to metal injury.	[Humbert, Maria V.; Rasia, Rodolfo M.; Checa, Susana K.; Soncini, Fernando C.] Univ Nacl Rosario, Consejo Nacl Invest Cient & Tecn Ocampo & Esmeral, Inst Biol Mol & Celular Rosario IBR, CONICET UNR, RA-2000 Rosario, Argentina; [Humbert, Maria V.; Checa, Susana K.; Soncini, Fernando C.] Univ Nacl Rosario, Dept Microbiol, RA-2000 Rosario, Argentina; [Rasia, Rodolfo M.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Dept Quim Biol, RA-2000 Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; National University of Rosario	Soncini, FC (corresponding author), Inst Biol Mol & Celular Rosario IBR CONICET, Fac Ciencias Bioquim & Farmaceut UNR, Dept Microbiol Ocampo & Esmeralda, RA-2000 Rosario, Argentina.	soncini@ibr-conicet.gov.ar	Checa, S/AAG-6180-2019	Rasia, Rodolfo/0000-0003-3940-067X; Checa, Susana/0000-0003-1629-2848; Soncini, Fernando/0000-0002-8925-7763	Agencia Nacional de Promocion Cientifica y Tecnologica; National Research Council, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); National Research Council, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	This work was supported by grants from the Agencia Nacional de Promocion Cientifica y Tecnologica and from the National Research Council, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) (to S. K. C. and F. C. S.).	Aiyar A, 1996, Methods Mol Biol, V57, P177; Andoy NM, 2009, BIOPHYS J, V97, P844, DOI 10.1016/j.bpj.2009.05.027; ANSARI AZ, 1995, NATURE, V374, P371; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Changela A, 2003, SCIENCE, V301, P1383, DOI 10.1126/science.1085950; Checa SK, 2007, MOL MICROBIOL, V63, P1307, DOI 10.1111/j.1365-2958.2007.05590.x; Checa SK, 2011, BIOMETALS, V24, P419, DOI 10.1007/s10534-010-9393-2; Chen P, 2010, NAT PROD REP, V27, P757, DOI 10.1039/b906691h; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Espariz M, 2007, MICROBIOL-SGM, V153, P2989, DOI 10.1099/mic.0.2007/006536-0; Heldwein EEZ, 2001, NATURE, V409, P378, DOI 10.1038/35053138; Jian X, 2009, J AM CHEM SOC, V131, P10869, DOI 10.1021/ja904279n; Kim JS, 2002, FEMS MICROBIOL LETT, V210, P99, DOI 10.1111/j.1574-6968.2002.tb11166.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Martinez-Nunez MA, 2010, MICROBIOL-SGM, V156, P14, DOI 10.1099/mic.0.033266-0; Newberry KJ, 2004, J BIOL CHEM, V279, P20356, DOI 10.1074/jbc.M400960200; Audero MEP, 2010, MOL MICROBIOL, V78, P853, DOI 10.1111/j.1365-2958.2010.07370.x; Pontel LB, 2007, MOL MICROBIOL, V66, P814, DOI 10.1111/j.1365-2958.2007.05963.x; Pontel LB, 2009, MOL MICROBIOL, V73, P212, DOI 10.1111/j.1365-2958.2009.06763.x; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Stoyanov JV, 2003, J BIOL CHEM, V278, P1407, DOI 10.1074/jbc.C200580200; Summers AO, 2009, CURR OPIN MICROBIOL, V12, P138, DOI 10.1016/j.mib.2009.02.003; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Watanabe S, 2008, P NATL ACAD SCI USA, V105, P4121, DOI 10.1073/pnas.0709188105	28	14	14	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20510	20519		10.1074/jbc.M113.452797	http://dx.doi.org/10.1074/jbc.M113.452797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23733186	Green Published, hybrid			2022-12-28	WOS:000321715100038
J	Zhang, J; Nakatsu, Y; Shinjo, T; Guo, Y; Sakoda, H; Yamamotoya, T; Otani, Y; Okubo, H; Kushiyama, A; Fujishiro, M; Fukushima, T; Tsuchiya, Y; Kamata, H; Iwashita, M; Nishimura, F; Katagiri, H; Takahashi, S; Kurihara, H; Uchida, T; Asano, T				Zhang, Jun; Nakatsu, Yusuke; Shinjo, Takanori; Guo, Ying; Sakoda, Hideyuki; Yamamotoya, Takeshi; Otani, Yuichiro; Okubo, Hirofumi; Kushiyama, Akifumi; Fujishiro, Midori; Fukushima, Toshiaki; Tsuchiya, Yoshihiro; Kamata, Hideaki; Iwashita, Misaki; Nishimura, Fusanori; Katagiri, Hideki; Takahashi, Shin-ichiro; Kurihara, Hiroki; Uchida, Takafumi; Asano, Tomoichiro			Par14 Protein Associates with Insulin Receptor Substrate 1 (IRS-1), Thereby Enhancing Insulin-induced IRS-1 Phosphorylation and Metabolic Actions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL-PROLYL ISOMERASE; PRERIBOSOMAL RIBONUCLEOPROTEIN COMPLEXES; IMMUNOSUPPRESSANT FK506; CIS/TRANS ISOMERASE; BINDING-PROTEIN; PIN1; RESISTANCE; KINASE; IDENTIFICATION; CYCLOPHILIN	Pin1 and Par14 are parvulin-type peptidyl-prolyl cis/trans isomerases. Although numerous proteins have been identified as Pin1 substrates, the target proteins of Par14 remain largely unknown. Par14 expression levels are increased in the livers and embryonic fibroblasts of Pin1KO mice, suggesting a compensatory relationship between the functions of Pin1 and Par14. In this study, the association of Par14 with insulin receptor substrate 1 (IRS-1) was demonstrated in HepG2 cells overexpressing both as well as endogenously in the mouse liver. The analysis using deletion-mutated Par14 and IRS-1 constructs revealed the N-terminal portion containing the basic domain of Par14 and the two relatively C-terminal portions of IRS-1 to be involved in these associations, in contrast to the WW domain of Pin1 and the SAIN domain of IRS-1. Par14 overexpression in HepG2 markedly enhanced insulin-induced IRS-1 phosphorylation and its downstream events, PI3K binding with IRS-1 and Akt phosphorylation. In contrast, treating HepG2 cells with Par14 siRNA suppressed these events. In addition, overexpression of Par14 in the insulin-resistant ob/ob mouse liver by adenoviral transfer significantly improved hyperglycemia with normalization of hepatic PEPCK and G6Pase mRNA levels, and gene suppression of Par14 using shRNA adenovirus significantly exacerbated the glucose intolerance in Pin1 KO mice. Therefore, although Pin1 and Par14 associate with different portions of IRS-1, the prolyl cis/trans isomerization in multiple sites of IRS-1 by these isomerases appears to be critical for efficient insulin receptor-induced IRS-1 phosphorylation. This process is likely to be one of the major mechanisms regulating insulin sensitivity and also constitutes a potential therapeutic target for novel insulin-sensitizing agents.	[Zhang, Jun; Nakatsu, Yusuke; Guo, Ying; Otani, Yuichiro; Okubo, Hirofumi; Fukushima, Toshiaki; Tsuchiya, Yoshihiro; Kamata, Hideaki; Asano, Tomoichiro] Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, Hiroshima 7348553, Japan; [Shinjo, Takanori; Iwashita, Misaki; Nishimura, Fusanori] Hiroshima Univ, Grad Sch Biomed Sci, Dept Dent Sci Hlth Promot, Hiroshima 7348553, Japan; [Sakoda, Hideyuki; Yamamotoya, Takeshi; Fujishiro, Midori] Univ Tokyo, Dept Internal Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Kushiyama, Akifumi] Asahi Life Fdn, Inst Adult Dis, Div Diabet & Metab, Chiyoda Ku, Tokyo 1000006, Japan; [Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Takahashi, Shin-ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Kurihara, Hiroki] Univ Tokyo, Grad Sch Med, Dept Physiol Chem & Metab, Bunkyo Ku, Tokyo 7348553, Japan; [Uchida, Takafumi] Tohoku Univ, Grad Sch Agr Sci, Dept Mol Cell Biol, Sendai, Miyagi 9818555, Japan	Hiroshima University; Hiroshima University; University of Tokyo; Asahi Life Foundation; Tohoku University; University of Tokyo; University of Tokyo; Tohoku University	Asano, T (corresponding author), Hiroshima Univ, Grad Sch Med, Dept Med Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	asano-tky@umin.ac.jp	Kushiyama, Akifumi/A-6386-2011; 祐介, 中津/AAP-8396-2020; Kushiyama, Akifumi/W-5988-2019; Kamata, Hideaki/N-3907-2017	Kushiyama, Akifumi/0000-0003-1385-7487; Kushiyama, Akifumi/0000-0003-1385-7487; Okubo, Hirofumi/0000-0002-9220-9084; Nakatsu, Yusuke/0000-0003-3279-1276; Kurihara, Hiroki/0000-0002-6476-5593; Takahashi, Shin-Ichiro/0000-0002-2323-2010; Shinjo, Takanori/0000-0002-8269-2826; Uchida, Takafumi/0000-0003-3665-4906; Iwashita, Misaki/0000-0002-8557-346X				Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fujimori F, 1999, BIOCHEM BIOPH RES CO, V265, P658, DOI 10.1006/bbrc.1999.1736; Fujiyama S, 2002, J BIOL CHEM, V277, P23773, DOI 10.1074/jbc.M201181200; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Greene MW, 2002, BIOCHEMISTRY-US, V41, P7082, DOI 10.1021/bi015992f; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Le Roith D, 2001, DIABETES CARE, V24, P588, DOI 10.2337/diacare.24.3.588; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Luo ML, 2007, ENDOCRINOLOGY, V148, P4895, DOI 10.1210/en.2007-0049; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nakatsu Y, 2011, J BIOL CHEM, V286, P20812, DOI 10.1074/jbc.M110.206904; Nakatsu Y, 2010, J BIOL CHEM, V285, P33018, DOI 10.1074/jbc.M110.137836; Oliveira AG, 2011, DIABETES, V60, P784, DOI 10.2337/db09-1907; Ono H, 2003, DIABETES, V52, P2905, DOI 10.2337/diabetes.52.12.2905; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Qiao LY, 2002, J BIOL CHEM, V277, P26530, DOI 10.1074/jbc.M201494200; Rulten S, 1999, BIOCHEM BIOPH RES CO, V259, P557, DOI 10.1006/bbrc.1999.0828; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; Surmacz TA, 2002, J MOL BIOL, V321, P235, DOI 10.1016/S0022-2836(02)00615-0; Takahashi N, 2003, MASS SPECTROM REV, V22, P287, DOI 10.1002/mas.10057; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Uchida T, 1999, FEBS LETT, V446, P278, DOI 10.1016/S0014-5793(99)00239-2; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Wang XDJ, 2006, BIOPOLYMERS, V84, P125, DOI 10.1002/bip.20240; WHITE MF, 1994, J BIOL CHEM, V269, P1; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	36	17	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20692	20701		10.1074/jbc.M113.485730	http://dx.doi.org/10.1074/jbc.M113.485730			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720771	Green Published, hybrid			2022-12-28	WOS:000321715100054
J	Hou, YA; Chen, XQ; Tolmachova, T; Ernst, SA; Williams, JA				Hou, Yanan; Chen, Xuequn; Tolmachova, Tatyana; Ernst, Stephen A.; Williams, John A.			EPI64B Acts as a GTPase-activating Protein for Rab27B in Pancreatic Acinar Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATES AMYLASE RELEASE; GRISCELLI-SYNDROME; GDP/GTP EXCHANGE; RAB3 SUBFAMILY; SECRETION; MELANOCYTES; EXOCYTOSIS; MEMBRANE; GRANULES; MUTANTS	The small GTPase Rab27B localizes to the zymogen granule membranes and plays an important role in regulating protein secretion by pancreatic acinar cells, as does Rab3D. A common guanine nucleotide exchange factor (GEF) for Rab3 and Rab27 has been reported; however, the GTPase-activating protein (GAP) specific for Rab27B has not been identified. In this study, the expression in mouse pancreatic acini of two candidate Tre-2/Bub2/Cdc16 (TBC) domain-containing proteins, EPI64 (TBC1D10A) and EPI64B (TBC1D10B), was first demonstrated. Their GAP activity on digestive enzyme secretion was examined by adenovirus-mediated overexpression of EPI64 and EPI64B in isolated pancreatic acini. EPI64B almost completely abolished the GTP-bound form of Rab27B, without affecting GTP-Rab3D. Overexpression of EPI64B also enhanced amylase release. This enhanced release was independent of Rab27A, but dependent on Rab27B, as shown using acini from genetically modified mice. EPI64 had a mild effect on both GTP-Rab27B and amylase release. Co-overexpression of EPI64B with Rab27B can reverse the inhibitory effect of Rab27B on amylase release. Mutations that block the GAP activity decreased the inhibitory effect of EPI64B on the GTP-bound state of Rab27B and abolished the enhancing effect of EPI64B on the amylase release. These data suggest that EPI64B can serve as a potential physiological GAP for Rab27B and thereby participate in the regulation of exocytosis in pancreatic acinar cells.	[Hou, Yanan; Chen, Xuequn; Williams, John A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Ernst, Stephen A.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Williams, John A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Tolmachova, Tatyana] Univ London Imperial Coll Sci Technol & Med, Mol Med Sect, Natl Heart & Lung Inst, London SW7 2AZ, England	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Imperial College London	Hou, YA (corresponding author), Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.	ynhou@umich.edu; xchen@med.wayne.edu; jawillms@umich.edu		Williams, John/0000-0002-6063-7615	National Institutes of Health [R37DK041122]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK041122, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R37DK041122 (to J. A. W.).	Albert S, 1999, EMBO J, V18, P5216, DOI 10.1093/emboj/18.19.5216; [Anonymous], 2010, PANCREAPEDIA EXOCRIN, DOI DOI 10.3998/PANC.2010.18; [Anonymous], 2012, PHYSL GASTROINTESTIN; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bi Y, 2005, AM J PHYSIOL-GASTR L, V289, pG561, DOI 10.1152/ajpgi.00508.2004; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chen D, 1997, BIOCHEM MOL MED, V60, P27, DOI 10.1006/bmme.1996.2559; Chen XW, 2011, MOL BIOL CELL, V22, P141, DOI 10.1091/mbc.E10-08-0665; Chen XQ, 2002, J BIOL CHEM, V277, P18002, DOI 10.1074/jbc.M201248200; Chen XQ, 2006, MOL CELL PROTEOMICS, V5, P306, DOI 10.1074/mcp.M500172-MCP200; Chen XQ, 2004, BIOCHEM BIOPH RES CO, V323, P1157, DOI 10.1016/j.bbrc.2004.08.212; Chen XQ, 2003, J BIOL CHEM, V278, P50053, DOI 10.1074/jbc.M309910200; Chen XQ, 2008, MOL CELL PROTEOMICS, V7, P2323, DOI 10.1074/mcp.M700575-MCP200; Chen YR, 2003, P NATL ACAD SCI USA, V100, P14012, DOI 10.1073/pnas.2436350100; Chen YR, 2002, J INVEST DERMATOL, V118, P933, DOI 10.1046/j.1523-1747.2002.01754.x; Chiang LL, 2011, AM J PHYSIOL-CELL PH, V301, pC507, DOI 10.1152/ajpcell.00355.2010; Figueiredo AC, 2008, J BIOL CHEM, V283, P23209, DOI 10.1074/jbc.M804134200; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Fuchs E, 2007, J CELL BIOL, V177, P1133, DOI 10.1083/jcb.200612068; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; Hokanson DE, 2012, MOL BIOL CELL, V23, P701, DOI 10.1091/mbc.E11-06-0521; Hsu C, 2010, J CELL BIOL, V189, P223, DOI 10.1083/jcb.200911018; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Imai A, 2011, J BIOL CHEM, V286, P33854, DOI 10.1074/jbc.M111.281394; Imai A, 2009, EUR J ORAL SCI, V117, P224, DOI 10.1111/j.1600-0722.2009.00618.x; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; Kondo H, 2006, J BIOL CHEM, V281, P28657, DOI 10.1074/jbc.M603227200; Lam AD, 2010, BIOPHYS J, V99, P1311, DOI 10.1016/j.bpj.2010.06.014; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Merrins MJ, 2008, J PHYSIOL-LONDON, V586, P5367, DOI 10.1113/jphysiol.2008.158477; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Saegusa C, 2008, ARCH BIOCHEM BIOPHYS, V475, P87, DOI 10.1016/j.abb.2008.04.031; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Suda J, 2011, GASTROENTEROLOGY, V140, P868, DOI 10.1053/j.gastro.2010.09.044; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Vincent S, 1998, P NATL ACAD SCI USA, V95, P2210, DOI 10.1073/pnas.95.5.2210; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; Westbroek W, 2004, PIGM CELL RES, V17, P498, DOI 10.1111/j.1600-0749.2004.00173.x; WILLIAMS JA, 1978, AM J PHYSIOL, V235, pE517, DOI 10.1152/ajpendo.1978.235.5.E517; Williams JA, 2009, AM J PHYSIOL-ENDOC M, V296, pE405, DOI 10.1152/ajpendo.90874.2008; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Zhao SL, 2002, ENDOCRINOLOGY, V143, P1817, DOI 10.1210/en.143.5.1817	50	11	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19548	19557		10.1074/jbc.M113.472134	http://dx.doi.org/10.1074/jbc.M113.472134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23671284	hybrid, Green Published			2022-12-28	WOS:000321515800021
J	Huang, YT; Liu, TH; Lin, SM; Chen, YW; Pan, YJ; Lee, CH; Sun, YJ; Tseng, FG; Pan, RL				Huang, Yun-Tzu; Liu, Tseng-Huang; Lin, Shih-Ming; Chen, Yen-Wei; Pan, Yih-Jiuan; Lee, Ching-Hung; Sun, Yuh-Ju; Tseng, Fan-Gang; Pan, Rong-Long			Squeezing at Entrance of Proton Transport Pathway in Proton-translocating Pyrophosphatase upon Substrate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-PYROPHOSPHATASE; RESIDUES; PROTEIN; MEMBRANE; DOMAINS	Homodimeric proton-translocating pyrophosphatase (H+- PPase; EC 3.6.1.1) is indispensable for many organisms in maintaining organellar pH homeostasis. This unique proton pump couples the hydrolysis of PPi to proton translocation across the membrane. H+-PPase consists of 14-16 relatively hydrophobic transmembrane domains presumably for proton translocation and hydrophilic loops primarily embedding a catalytic site. Several highly conserved polar residues located at or near the entrance of the transport pathway in H+-PPase are essential for proton pumping activity. In this investigation single molecule FRET was employed to dissect the action at the pathway entrance in homodimeric Clostridium tetani H+-PPase upon ligand binding. The presence of the substrate analog, imidodiphosphate mediated two sites at the pathway entrance moving toward each other. Moreover, single molecule FRET analyses after the mutation at the first proton-carrying residue (Arg-169) demonstrated that conformational changes at the entrance are conceivably essential for the initial step of H+-PPase proton translocation. Aworking model is accordingly proposed to illustrate the squeeze at the entrance of the transport pathway in H+-PPase upon substrate binding.	[Huang, Yun-Tzu; Liu, Tseng-Huang; Lin, Shih-Ming; Chen, Yen-Wei; Pan, Yih-Jiuan; Lee, Ching-Hung; Sun, Yuh-Ju; Pan, Rong-Long] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan; [Huang, Yun-Tzu; Liu, Tseng-Huang; Lin, Shih-Ming; Chen, Yen-Wei; Pan, Yih-Jiuan; Lee, Ching-Hung; Sun, Yuh-Ju; Pan, Rong-Long] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Tseng, Fan-Gang] Natl Tsing Hua Univ, Dept Engn & Syst Sci, Hsinchu 30013, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Pan, RL (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 30013, Taiwan.	rlpan@life.nthu.edu.tw		Tseng, Fan-Gang/0000-0001-7654-6905	National Science Council, Republic of China [NSC 101-2627-M-007-008, NSC 100-2627-M-007-012, 100-2311-B-007-001-MY3, NSC 101-2627-M-007-003, NSC 1002120-M-007-006, NSC 099-2811-B-007-012]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council, Republic of China Grants NSC 101-2627-M-007-008, NSC 100-2627-M-007-012, and 100-2311-B-007-001-MY3 (to R.-L. P.), NSC 101-2627-M-007-003 and NSC 1002120-M-007-006 (to F.-G. T.), and NSC 099-2811-B-007-012 (to Y.-T. H.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BALTSCHEFFSKY M, 1967, NATURE, V216, P241, DOI 10.1038/216241a0; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Ginsburg H, 2002, TRENDS PARASITOL, V18, P483, DOI 10.1016/S1471-4922(02)02350-4; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Hirono M, 2007, BBA-BIOENERGETICS, V1767, P930, DOI 10.1016/j.bbabio.2007.03.014; Hsiao YY, 2007, BBA-BIOENERGETICS, V1767, P965, DOI 10.1016/j.bbabio.2007.04.007; Huang YT, 2010, J BIOL CHEM, V285, P23655, DOI 10.1074/jbc.M110.134916; Ishii Y, 1999, CHEM PHYS, V247, P163, DOI 10.1016/S0301-0104(99)00174-3; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Lee CH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.190215; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Lidke KA, 2005, IEEE T IMAGE PROCESS, V14, P1237, DOI 10.1109/TIP.2005.852458; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; Maeshima M, 2001, ANNU REV PLANT PHYS, V52, P469, DOI 10.1146/annurev.arplant.52.1.469; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Nomura SIM, 2008, J BIOTECHNOL, V133, P190, DOI 10.1016/j.jbiotec.2007.08.023; Pan YJ, 2011, BBA-BIOENERGETICS, V1807, P59, DOI 10.1016/j.bbabio.2010.10.006; REA PA, 1992, TRENDS BIOCHEM SCI, V17, P348, DOI 10.1016/0968-0004(92)90313-X; SATO MH, 1994, J BIOL CHEM, V269, P6725; Schultz A, 2003, BBA-BIOENERGETICS, V1607, P141, DOI 10.1016/j.bbabio.2003.09.003; Schumacher K, 2006, CURR OPIN PLANT BIOL, V9, P595, DOI 10.1016/j.pbi.2006.09.001; Tzeng CM, 1996, BIOCHEM J, V316, P143, DOI 10.1042/bj3160143; Van RC, 2005, BBA-BIOENERGETICS, V1709, P84, DOI 10.1016/j.bbabio.2005.05.011; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340	32	8	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19312	19320		10.1074/jbc.M113.469353	http://dx.doi.org/10.1074/jbc.M113.469353			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720778	Green Published, hybrid			2022-12-28	WOS:000321515800002
J	Yu, N; Huangyang, PW; Yang, XH; Han, X; Yan, RR; Jia, HT; Shang, YF; Sun, LY				Yu, Na; Huangyang, Peiwei; Yang, Xiaohan; Han, Xiao; Yan, Ruorong; Jia, Hongti; Shang, Yongfeng; Sun, Luyang			microRNA-7 Suppresses the Invasive Potential of Breast Cancer Cells and Sensitizes Cells to DNA Damages by Targeting Histone Methyltransferase SET8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH; METHYLATION; REPAIR; MONOMETHYLATION; RECOGNITION; PR-SET7; GENE; OVEREXPRESSION; REPRESSION; 53BP1	SET8 (SET domain containing 8) is a histone H4 lysine 20 (H4K20)-specific monomethyltransferase in higher eukaryotes that exerts diverse functions in transcription regulation, DNA repair, tumor metastasis, and genome integrity. The activity of SET8 is tightly controlled during cell cycle through post-translational modifications, including ubiquitination, phosphorylation, and sumoylation. However, how the expression of SET8 is regulated is not fully understood. Here, we report that microRNA-7 is a negative regulator of SET8. We demonstrated that microRNA-7 inhibits H4K20 monomethylation and suppresses epithelial-mesenchymal transition and the invasive potential of breast cancer cells. We showed that microRNA-7 promotes spontaneous DNA damages and sensitizes cells to induced DNA damages. Our experiments provide a molecular mechanism for the regulation of SET8 and extend the biological function of microRNA-7 to DNA damage response, supporting the pursuit of microRNA-7 as a potential target for breast cancer intervention.	[Yu, Na; Huangyang, Peiwei; Yang, Xiaohan; Han, Xiao; Yan, Ruorong; Jia, Hongti; Shang, Yongfeng; Sun, Luyang] Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Shang, Yongfeng] Tianjin Med Univ, Tianjin Key Lab Med Epigenet, Tianjin 300070, Peoples R China	Peking University; Tianjin Medical University	Sun, LY (corresponding author), Peking Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	Luyang_sun@hsc.pku.edu.cn	Han, Xiao/A-1109-2017; HUANG, YANGPEIWEI/AAS-7683-2021; Huangyang, Peiwei/AAS-8905-2021	Han, Xiao/0000-0002-5395-4022; HUANG, YANGPEIWEI/0000-0002-9131-3891; Han, Xiao/0000-0002-6024-6286	National Natural Science Foundation of China [81071673, 91219201, 81130048]; Beijing Natural Science Foundation [5112017, 5132020]; Ministry of Science and Technology of China [2011CB504204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Grants 81071673 (to L. S.) and 91219201 and 81130048 (to Y. S.) from the National Natural Science Foundation of China, Grants 5112017 and 5132020 (to L. S.) from Beijing Natural Science Foundation, and Grant 973 Program 2011CB504204 (to Y. S.) from the Ministry of Science and Technology of China.	Asangani IA, 2013, MOL CELL, V49, P80, DOI 10.1016/j.molcel.2012.10.008; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Cantone I, 2013, NAT STRUCT MOL BIOL, V20, P282, DOI 10.1038/nsmb.2489; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Cochrane Dawn R., 2010, Hormones & Cancer, V1, P306, DOI 10.1007/s12672-010-0043-5; Congdon LM, 2010, J CELL BIOCHEM, V110, P609, DOI 10.1002/jcb.22570; Driskell I, 2012, EMBO J, V31, P616, DOI 10.1038/emboj.2011.421; Fedoriw A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008136; Giovannetti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049145; Havens CG, 2012, J BIOL CHEM, V287, P11410, DOI 10.1074/jbc.M111.337683; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kalinowski FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047067; Kong D, 2012, ONCOGENE, V31, P3949, DOI 10.1038/onc.2011.558; Kong XB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041523, 10.1371/journal.pone.0033381]; Kredo-Russo S, 2012, EXP DIABETES RES, DOI 10.1155/2012/695214; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Mansour WY, 2013, RADIOTHER ONCOL, V106, P147, DOI 10.1016/j.radonc.2012.10.020; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Munoz MC, 2012, J BIOL CHEM, V287, P40618, DOI 10.1074/jbc.M112.410951; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Park JH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-82; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Rai K, 2011, MOL CANCER THER, V10, P1720, DOI 10.1158/1535-7163.MCT-11-0220; Reddy SDN, 2008, CANCER RES, V68, P8195, DOI 10.1158/0008-5472.CAN-08-2103; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Skalsky RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024248; Solomon DA, 2004, J CELL BIOL, V166, P455, DOI 10.1083/jcb.200312048; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Webster RJ, 2009, J BIOL CHEM, V284, P5731, DOI 10.1074/jbc.M804280200; Wu SM, 2011, CELL CYCLE, V10, P68, DOI 10.4161/cc.10.1.14363; Xiong SD, 2011, INT J BIOL SCI, V7, P805, DOI 10.7150/ijbs.7.805; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; Zhang N, 2013, ONCOGENE, V32, P5078, DOI 10.1038/onc.2012.526; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156	51	38	45	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19633	19642		10.1074/jbc.M113.475657	http://dx.doi.org/10.1074/jbc.M113.475657			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23720754	Green Published, hybrid			2022-12-28	WOS:000321515800029
J	Dong, YY; Gu, Y; Huan, YJ; Wang, YJ; Liu, Y; Liu, M; Ding, F; Gu, XS; Wang, YJ				Dong, Yingying; Gu, Yun; Huan, Youjuan; Wang, Yingjie; Liu, Yan; Liu, Mei; Ding, Fei; Gu, Xiaosong; Wang, Yongjun			HMGB1 Protein Does Not Mediate the Inflammatory Response in Spontaneous Spinal Cord Regeneration A HINT FOR CNS REGENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; MOBILITY GROUP BOX-1; TOLL-LIKE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; NEURITE OUTGROWTH; IMMUNE-RESPONSES; PATTERN-RECOGNITION; PRIMARY CULTURES; GEKKO-JAPONICUS; PLASMA-MEMBRANE	Uncontrolled, excessive inflammation contributes to the secondary tissue damage of traumatic spinal cord, and HMGB1 is highlighted for initiation of a vicious self-propagating inflammatory circle by release from necrotic cells or immune cells. Several regenerative-competent vertebrates have evolved to circumvent the second damages during the spontaneous spinal cord regeneration with an unknown HMGB1 regulatory mechanism. By genomic surveys, we have revealed that two paralogs of HMGB1 are broadly retained from fish in the phylogeny. However, their spatial-temporal expression and effects, as shown in lowest amniote gecko, were tightly controlled in order that limited inflammation was produced in spontaneous regeneration. Two paralogs from gecko HMGB1 (gHMGB1) yielded distinct injury and infectious responses, with gHMGB1b significantly up-regulated in the injured cord. The intracellular gHMGB1b induced less release of inflammatory cytokines than gHMGB1a in macrophages, and the effects could be shifted by exchanging one amino acid in the inflammatory domain. Both intracellular proteins were able to mediate neuronal programmed apoptosis, which has been indicated to produce negligible inflammatory responses. In vivo studies demonstrated that the extracellular proteins could not trigger a cascade of the inflammatory cytokines in the injured spinal cord. Signal transduction analysis found that gHMGB1 proteins could not bind with cell surface receptors TLR2 and TLR4 to activate inflammatory signaling pathway. However, they were able to interact with the receptor for advanced glycation end products to potentiate oligodendrocyte migration by activation of both NF kappa B and Rac1/Cdc42 signaling. Our results reveal that HMGB1 does not mediate the inflammatory response in spontaneous spinal cord regeneration, but it promotes CNS regeneration.	[Dong, Yingying; Gu, Yun; Huan, Youjuan; Wang, Yingjie; Liu, Yan; Liu, Mei; Ding, Fei; Gu, Xiaosong; Wang, Yongjun] Nantong Univ, Key Lab Neuroregenerat, Nantong 226007, Peoples R China	Nantong University	Gu, XS (corresponding author), Nantong Univ, Key Lab Neuroregenerat, 19 Qixiu Rd, Nantong 226007, Peoples R China.	neurongu@public.nt.js.cn; wyjbs@ntu.edu.cn		Wang, Yongjun/0000-0001-5040-8926	National Natural Science Foundation of China [31071874, 31171405]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Basic Research Program of Jiangsu Education Department [10KJA180041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Basic Research Program of Jiangsu Education Department	This work was supported by National Natural Science Foundation of China Grants 31071874 and 31171405, the Priority Academic Program Development of Jiangsu Higher Education Institutions, and Basic Research Program of Jiangsu Education Department Grant 10KJA180041.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Andersson U, 2010, BBA-GENE REGUL MECH, V1799, P141, DOI 10.1016/j.bbagrm.2009.11.003; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi ME, 2000, EMBO REP, V1, P109, DOI 10.1093/embo-reports/kvd030; Bianchi ME, 1998, AM J HUM GENET, V63, P1573, DOI 10.1086/302170; Blight A R, 1985, Cent Nerv Syst Trauma, V2, P299; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Chen KB, 2011, SPINE, V36, P2122, DOI 10.1097/BRS.0b013e318203941c; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; DASTON MM, 1994, J NEUROCYTOL, V23, P323, DOI 10.1007/BF01188500; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Ding YM, 2004, J NEUROCHEM, V89, P776, DOI 10.1111/j.1471-4159.2004.02415.x; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Escobar HM, 2003, CYTOGENET GENOME RES, V101, P33, DOI 10.1159/000073415; Fages C, 2000, J CELL SCI, V113, P611; Fang P, 2012, MOL NEUROBIOL, V45, P499, DOI 10.1007/s12035-012-8264-y; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Ferretti P, 2003, DEV DYNAM, V226, P245, DOI 10.1002/dvdy.10226; Fitch MT, 1999, J NEUROSCI, V19, P8182; Fleming JC, 2006, BRAIN, V129, P3249, DOI 10.1093/brain/awl296; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Gensel JC, 2012, CELL TISSUE RES, V349, P201, DOI 10.1007/s00441-012-1425-5; Gong HJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S10; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Hasegawa A, 2011, J SURG RES, V169, P85, DOI 10.1016/j.jss.2009.10.015; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hoffmann FG, 2012, MOL BIOL EVOL, V29, P303, DOI 10.1093/molbev/msr207; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Johansson JU, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000278; Kawabata H, 2010, SPINE, V35, P1109, DOI 10.1097/BRS.0b013e3181bd14b6; Kiba T, 2002, DIGESTION, V66, P79, DOI 10.1159/000065594; Kigerl KA, 2009, CURR TOP MICROBIOL, V336, P121, DOI 10.1007/978-3-642-00549-7_7; Kim JB, 2006, J NEUROSCI, V26, P6413, DOI 10.1523/JNEUROSCI.3815-05.2006; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Kuniyasu H, 2003, ONCOL REP, V10, P445; Kvarnhammar AM, 2012, IMMUNOLOGY, V136, P11, DOI 10.1111/j.1365-2567.2012.03556.x; Li GL, 1996, J NEUROPATH EXP NEUR, V55, P280, DOI 10.1097/00005072-199603000-00003; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Liu K, 2007, FASEB J, V21, P3904, DOI 10.1096/fj.07-8770com; Liu M, 2010, CELL BIOL INT, V34, P153, DOI 10.1042/CBI20090015; Liu Y, 2006, J MOL NEUROSCI, V29, P21, DOI 10.1385/JMN:29:1:21; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Mazet F, 2002, CURR OPIN GENET DEV, V12, P393, DOI 10.1016/S0959-437X(02)00315-5; McLean KE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-50; Mekhail M, 2012, PROG NEUROBIOL, V96, P322, DOI 10.1016/j.pneurobio.2012.01.008; MERENMIES J, 1991, J BIOL CHEM, V266, P16722; Moleri S, 2011, GENE EXPR PATTERNS, V11, P3, DOI 10.1016/j.gep.2010.08.006; Nesic O, 2001, J NEUROTRAUM, V18, P947, DOI 10.1089/089771501750451857; Orlova VV, 2007, EMBO J, V26, P1129, DOI 10.1038/sj.emboj.7601552; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pasheva E, 2004, BIOCHEMISTRY-US, V43, P2935, DOI 10.1021/bi035615y; Popovich PG, 2008, NAT REV NEUROSCI, V9, P481, DOI 10.1038/nrn2398; Probert L, 2000, BRAIN, V123, P2005, DOI 10.1093/brain/123.10.2005; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Qin JD, 2008, J NEUROSCI RES, V86, P2414, DOI 10.1002/jnr.21692; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; RAUVALA H, 1987, J BIOL CHEM, V262, P16625; Rauvala H, 2007, CURR MOL MED, V7, P725, DOI 10.2174/156652407783220750; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; Rehm BHA, 2001, APPL MICROBIOL BIOT, V57, P579, DOI 10.1007/s00253-001-0844-0; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schwartz M, 2004, TRENDS PHARMACOL SCI, V25, P407, DOI 10.1016/j.tips.2004.06.010; Sessa L, 2007, GENE, V387, P133, DOI 10.1016/j.gene.2006.08.034; Sirbulescu RF, 2011, BRAIN RES REV, V67, P73, DOI 10.1016/j.brainresrev.2010.11.001; Sorci G, 2013, BBA-MOL CELL RES, V1833, P101, DOI 10.1016/j.bbamcr.2012.10.021; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tian L, 2009, TRENDS IMMUNOL, V30, P91, DOI 10.1016/j.it.2008.11.002; Tseng AS, 2007, DEV BIOL, V301, P62, DOI 10.1016/j.ydbio.2006.10.048; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wang YJ, 2012, INT J BIOCHEM CELL B, V44, P2288, DOI 10.1016/j.biocel.2012.09.011; Wang YJ, 2012, J CELL BIOCHEM, V113, P1842, DOI 10.1002/jcb.24053; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017878; Wijburg OLC, 1997, IMMUNOLOGY, V92, P252, DOI 10.1046/j.1365-2567.1997.00340.x; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750	95	32	33	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18204	18218		10.1074/jbc.M113.463810	http://dx.doi.org/10.1074/jbc.M113.463810			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23649623	Green Published, hybrid			2022-12-28	WOS:000320721900025
J	Molitor, B; Stassen, M; Modi, A; El-Mashtoly, SF; Laurich, C; Lubitz, W; Dawson, JH; Rother, M; Frankenberg-Dinkel, N				Molitor, Bastian; Stassen, Marc; Modi, Anuja; El-Mashtoly, Samir F.; Laurich, Christoph; Lubitz, Wolfgang; Dawson, John H.; Rother, Michael; Frankenberg-Dinkel, Nicole			A Heme-based Redox Sensor in the Methanogenic Archaeon Methanosarcina acetivorans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DESULFOVIBRIO-VULGARIS HILDENBOROUGH; RESONANCE RAMAN-SPECTRA; IN-VITRO FORMATION; C-TYPE CYTOCHROME; COLI EC DOS; ESCHERICHIA-COLI; LIGAND-BINDING; OXYGEN SENSOR; AUTOCATALYTIC FORMATION; SIGNAL-TRANSDUCTION	Based on a bioinformatics study, the protein MA4561 from the methanogenic archaeon Methanosarcina acetivorans was originally predicted to be a multidomain phytochrome-like photosensory kinase possibly binding open-chain tetrapyrroles. Although we were able to show that recombinantly produced and purified protein does not bind any known phytochrome chromophores, UV-visible spectroscopy revealed the presence of a heme tetrapyrrole cofactor. In contrast to many other known cytoplasmic heme-containing proteins, the heme was covalently attached via one vinyl side chain to cysteine 656 in the second GAF domain. This GAF domain by itself is sufficient for covalent attachment. Resonance Raman and magnetic circular dichroism data support a model of a six-coordinate heme species with additional features of a five-coordination structure. The heme cofactor is redox-active and able to coordinate various ligands like imidazole, dimethyl sulfide, and carbon monoxide depending on the redox state. Interestingly, the redox state of the heme cofactor has a substantial influence on autophosphorylation activity. Although reduced protein does not autophosphorylate, oxidized protein gives a strong autophosphorylation signal independent from bound external ligands. Based on its genomic localization, MA4561 is most likely a sensor kinase of a two-component system effecting regulation of the Mts system, a set of three homologous corrinoid/methyltransferase fusion protein isoforms involved in methyl sulfide metabolism. Consistent with this prediction, an M. acetivorans mutant devoid of MA4561 constitutively synthesized MtsF. On the basis of our results, we postulate a heme-based redox/dimethyl sulfide sensory function of MA4561 and propose to designate it MsmS (methyl sulfide methyltransferase-associated sensor).	[Molitor, Bastian; El-Mashtoly, Samir F.; Frankenberg-Dinkel, Nicole] Ruhr Univ Bochum, Fac Biol & Biotechnol, D-44780 Bochum, Germany; [Stassen, Marc; Rother, Michael] Goethe Univ Frankfurt, Inst Mol Biosci, D-60438 Frankfurt, Germany; [Modi, Anuja; Dawson, John H.] Univ S Carolina, Dept Chem & Biochem, Columbia, SC 29208 USA; [Laurich, Christoph; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Rother, Michael] Tech Univ Dresden, Inst Microbiol, D-01217 Dresden, Germany	Ruhr University Bochum; Goethe University Frankfurt; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Max Planck Society; Technische Universitat Dresden	Frankenberg-Dinkel, N (corresponding author), Ruhr Univ Bochum, Fac Biol & Biotechnol, Univ Str 150, D-44780 Bochum, Germany.	nicole.frankenberg@rub.de	El-Mashtoly, Samir/C-8761-2014; Molitor, Bastian/GNP-4969-2022; Modi, Anuja/R-3788-2017; Frankenberg-Dinkel, Nicole/C-1058-2011; Molitor, Bastian/A-9684-2018; Dawson, John/HDM-6702-2022	El-Mashtoly, Samir/0000-0001-6087-8817; Molitor, Bastian/0000-0002-0776-1668; Frankenberg-Dinkel, Nicole/0000-0002-7757-6839; Molitor, Bastian/0000-0002-0776-1668; Rother, Michael/0000-0002-2306-8783; Dawson, John H/0000-0002-4902-4295	Ruhr University Bochum Research School scholarship; National Institutes of Health [GM26730]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026730] Funding Source: NIH RePORTER	Ruhr University Bochum Research School scholarship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Ruhr University Bochum Research School scholarship (to B. M.) and National Institutes of Health Grant GM26730 (to J. H. D.).	ABE M, 1978, J CHEM PHYS, V69, P4526, DOI 10.1063/1.436450; Aono S, 1996, BIOCHEM BIOPH RES CO, V228, P752, DOI 10.1006/bbrc.1996.1727; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; Ashby Mark K., 2006, Archaea, V2, P11, DOI 10.1155/2006/562404; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Boccazzi P, 2000, J BACTERIOL, V182, P2611, DOI 10.1128/JB.182.9.2611-2618.2000; Boon EM, 2005, J INORG BIOCHEM, V99, P892, DOI 10.1016/j.jinorgbio.2004.12.016; Bose A, 2008, MOL MICROBIOL, V67, P649, DOI 10.1111/j.1365-2958.2007.06075.x; Bose A, 2009, MOL MICROBIOL, V74, P227, DOI 10.1111/j.1365-2958.2009.06864.x; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Cheek J, 1999, J BIOL INORG CHEM, V4, P64, DOI 10.1007/s007750050290; Daltrop O, 2003, J BIOL CHEM, V278, P24308, DOI 10.1074/jbc.M301967200; Daltrop O, 2002, P NATL ACAD SCI USA, V99, P7872, DOI 10.1073/pnas.132259099; DAWSON JH, 1992, J INORG BIOCHEM, V45, P179, DOI 10.1016/0162-0134(92)80043-U; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; DOLLA A, 1992, J BACTERIOL, V174, P1726, DOI 10.1128/jb.174.6.1726-1733.1992; Du J, 2011, J PORPHYR PHTHALOCYA, V15, P29, DOI 10.1142/S1088424610002872; Duff SMG, 1997, J BIOL CHEM, V272, P16746, DOI 10.1074/jbc.272.27.16746; El-Mashtoly SF, 2008, J RAMAN SPECTROSC, V39, P1614, DOI 10.1002/jrs.2035; FU RD, 1994, J BACTERIOL, V176, P344, DOI 10.1128/JB.176.2.344-350.1994; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gilles-Gonzalez MA, 2004, J APPL PHYSIOL, V96, P774, DOI 10.1152/japplphysiol.00941.2003; GILLESGONZALEZ MA, 1994, BIOCHEMISTRY-US, V33, P8067, DOI 10.1021/bi00192a011; GILLESGONZALEZ MA, 1993, J BIOL CHEM, V268, P16293; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Guss Adam M., 2008, Archaea, V2, P193, DOI 10.1155/2008/534081; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; HUFF AM, 1993, INORG CHEM, V32, P1460, DOI 10.1021/ic00060a023; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitanishi K, 2011, J BIOL CHEM, V286, P35522, DOI 10.1074/jbc.M111.274811; Kitanishi K, 2010, BIOCHEMISTRY-US, V49, P10381, DOI 10.1021/bi100733q; Koretke KK, 2000, MOL BIOL EVOL, V17, P1956, DOI 10.1093/oxfordjournals.molbev.a026297; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Kuzelova K, 1997, BBA-GEN SUBJECTS, V1336, P497, DOI 10.1016/S0304-4165(97)00062-7; LI XY, 1988, J AM CHEM SOC, V110, P6024, DOI 10.1021/ja00226a017; Masuda S, 2002, CELL, V110, P613, DOI 10.1016/S0092-8674(02)00876-0; Metcalf WW, 1997, P NATL ACAD SCI USA, V94, P2626, DOI 10.1073/pnas.94.6.2626; Metcalf WW, 1996, J BACTERIOL, V178, P5797, DOI 10.1128/jb.178.19.5797-5802.1996; Moran JJ, 2008, APPL ENVIRON MICROB, V74, P540, DOI 10.1128/AEM.01750-07; Moran James J., 2005, Archaea, V1, P303, DOI 10.1155/2005/650670; Moskvin OV, 2007, J BIOL CHEM, V282, P28740, DOI 10.1074/jbc.M703261200; Oelgeschlager E, 2009, MOL MICROBIOL, V72, P1260, DOI 10.1111/j.1365-2958.2009.06723.x; Pipirou Z, 2007, BIOCHEMISTRY-US, V46, P13269, DOI 10.1021/bi7015316; Pipirou Z, 2007, BIOCHEMISTRY-US, V46, P2174, DOI 10.1021/bi062274q; Poulos TL, 2006, CURR OPIN STRUC BIOL, V16, P736, DOI 10.1016/j.sbi.2006.09.006; Pritchett MA, 2004, APPL ENVIRON MICROB, V70, P1425, DOI 10.1128/AEM.70.3.1425-1433.2004; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Shelver D, 1997, P NATL ACAD SCI USA, V94, P11216, DOI 10.1073/pnas.94.21.11216; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; SPIRO TG, 1979, J AM CHEM SOC, V101, P2648, DOI 10.1021/ja00504a027; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tanaka A, 2007, J BIOL CHEM, V282, P21301, DOI 10.1074/jbc.M701920200; Tanaka A, 2008, BIOCHEMISTRY-US, V47, P13438, DOI 10.1021/bi8012017; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Thony-Meyer L, 2002, BIOCHEM SOC T, V30, P633; Tietze M, 2003, CHEMBIOCHEM, V4, P333, DOI 10.1002/cbic.200390053; Tomlinson EJ, 2000, J BIOL CHEM, V275, P32530, DOI 10.1074/jbc.M004022200; Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Yoshioka S, 2005, BIOCHEMISTRY-US, V44, P15406, DOI 10.1021/bi0513352	67	15	16	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18458	18472		10.1074/jbc.M113.476267	http://dx.doi.org/10.1074/jbc.M113.476267			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23661702	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000320721900048
J	Zhang, SF; Schones, DE; Malicet, C; Rochman, M; Zhou, M; Foisner, R; Bustin, M				Zhang, Shaofei; Schones, Dustin E.; Malicet, Cedric; Rochman, Mark; Zhou, Ming; Foisner, Roland; Bustin, Michael			High Mobility Group Protein N5 (HMGN5) and Lamina-associated Polypeptide 2 alpha (LAP2 alpha) Interact and Reciprocally Affect Their Genome-wide Chromatin Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL-PROTEINS; LINKER HISTONE; RNA-SEQ; DIFFERENTIATION; H1; NUCLEOSOMES; COMPLEXES	The interactions of nuclear lamins with the chromatin fiber play an important role in regulating nuclear architecture and chromatin function; however, the full spectrum of these interactions is not known. We report that the N-terminal domain of the nucleosome-binding protein HMGN5 interacts with the C-terminal domain of the lamin-binding protein LAP2 alpha and that these proteins reciprocally alter their interaction with chromatin. Chromatin immunoprecipitation analysis of cells lacking either HMGN5 or LAP2 alpha reveals that loss of either protein affects the genome-wide distribution of the remaining partner. Our study identifies a new functional link between chromatin-binding and lamin-binding proteins.	[Zhang, Shaofei; Malicet, Cedric; Rochman, Mark; Bustin, Michael] NCI, NIH, Prot Sect, Lab Metab,Ctr Canc Res, Bethesda, MD 20892 USA; [Schones, Dustin E.] Beckman Res Inst City Hope, Dept Canc Biol, Duarte, CA 91010 USA; [Zhou, Ming] NCI Frederick, SAIC Frederick Inc, Adv Technol Program, Lab Prote & Analyt Technol, Frederick, MD 21702 USA; [Foisner, Roland] Med Univ Vienna, Max Perutz Labs, A-1030 Vienna, Austria	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); City of Hope; Beckman Research Institute of City of Hope; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Bustin, M (corresponding author), NCI, NIH, Prot Sect, Lab Metab,Ctr Canc Res, Bethesda, MD 20892 USA.	Bustin@helix.nih.gov	Foisner, Roland/AAD-1833-2019; Bustin, Michael/G-6155-2015; Zhang, Shaofei/J-5273-2017	Bustin, Michael/0000-0002-5147-7242; Foisner, Roland/0000-0003-4734-4647; Rochman, Mark/0000-0002-0818-927X	Center for Cancer Research, Intramural Program of the NCI, National Institutes of Health; United States-Israel Binational Science Foundation (BSF) [2009236]; NCI [K22 HL101950]; Austrian Research Fund (FWF) [P22043-B12]; Austrian Science Fund (FWF) [P 22043] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC004496, ZIABC011154] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL101950] Funding Source: NIH RePORTER	Center for Cancer Research, Intramural Program of the NCI, National Institutes of Health; United States-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Austrian Research Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by the Center for Cancer Research, Intramural Program of the NCI, National Institutes of Health (to M. B.). This work was also supported by United States-Israel Binational Science Foundation (BSF) Grants 2009236 (to M. B.) and NCI Grant K22 HL101950 (to D. E. S.) and by Grant P22043-B12 of the Austrian Research Fund (FWF) (to R. F.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bianchi ME, 2005, CURR OPIN GENET DEV, V15, P496, DOI 10.1016/j.gde.2005.08.007; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; Catez F, 2002, EMBO REP, V3, P760, DOI 10.1093/embo-reports/kvf156; Cuddapah S, 2011, MOL CELL BIOL, V31, P700, DOI 10.1128/MCB.00740-10; Dechat T, 2000, J CELL SCI, V113, P3473; Dechat T, 2010, COLD SH Q B, V75, P533, DOI 10.1101/sqb.2010.75.018; Dechat T, 2009, ADV ENZYME REGUL, V49, P157, DOI 10.1016/j.advenzreg.2008.12.003; Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lim JH, 2002, J BIOL CHEM, V277, P20774, DOI 10.1074/jbc.M200404200; Malicet C, 2011, MOL CELL BIOL, V31, P2742, DOI 10.1128/MCB.05216-11; Naetar N, 2008, NAT CELL BIOL, V10, P1341, DOI 10.1038/ncb1793; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Postnikov Y, 2010, BBA-GENE REGUL MECH, V1799, P62, DOI 10.1016/j.bbagrm.2009.11.016; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Rochman M, 2009, MOL CELL, V35, P642, DOI 10.1016/j.molcel.2009.07.002; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ueda T, 2008, MOL CELL BIOL, V28, P2872, DOI 10.1128/MCB.02181-07; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	27	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18104	18109		10.1074/jbc.C113.469544	http://dx.doi.org/10.1074/jbc.C113.469544			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23673662	hybrid, Green Published			2022-12-28	WOS:000320721900016
J	Tsai, CC; Lin, CR; Tsai, HY; Chen, CJ; Li, WT; Yu, HM; Ke, YY; Hsieh, WY; Chang, CY; Wu, CY; Chen, ST; Wong, CH				Tsai, Chia-Che; Lin, Chih-Ru; Tsai, Hsien-Yu; Chen, Chia-Jung; Li, Wen-Tai; Yu, Hui-Ming; Ke, Yi-Yu; Hsieh, Wei-Ying; Chang, Cheng-Yen; Wu, Chung-Yi; Chen, Shui-Tein; Wong, Chi-Huey			The Immunologically Active Oligosaccharides Isolated from Wheatgrass Modulate Monocytes via Toll-like Receptor-2 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GLUCAN; IMMUNE-SYSTEM; POLYSACCHARIDES; INNATE; INTERLEUKIN-12; MACROPHAGES; GANODERMA; DECTIN-1; DIETARY; TLR2	Wheatgrass is one of the most widely used health foods, but its functional components and mechanisms remain unexplored. Herein, wheatgrass-derived oligosaccharides (WG-PS3) were isolated and found to induce CD69 and Th1 cytokine expression in human peripheral blood mononuclear cells. In particular, WG-PS3 directly activated the purified monocytes by inducing the expression of CD69, CD80, CD86, IL-12, and TNF-alpha but affected NK and T cells only in the presence of monocytes. After further purification and structural analysis, maltoheptaose was identified from WG-PS3 as an immunomodulator. Maltoheptaose activated monocytes via Toll-like receptor 2 (TLR-2) signaling, as discovered by pretreatment of blocking antibodies against Toll-like receptors (TLRs) and also determined by click chemistry. This study is the first to reveal the immunostimulatory component of wheatgrass with well defined molecular structures and mechanisms.	[Tsai, Chia-Che; Lin, Chih-Ru; Tsai, Hsien-Yu; Chen, Chia-Jung; Li, Wen-Tai; Hsieh, Wei-Ying; Chang, Cheng-Yen; Chen, Shui-Tein; Wong, Chi-Huey] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan; [Yu, Hui-Ming; Ke, Yi-Yu; Wu, Chung-Yi; Chen, Shui-Tein; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lin, Chih-Ru; Chen, Shui-Tein; Wong, Chi-Huey] Natl Taiwan Univ, Coll Life Sci, Inst Biochem Sci, Taipei 106, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Chen, ST (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan.	bcchen@gate.sinica.edu.tw	Wu, Chung-Yi/K-8334-2018	Tsai, Hsien-Yu/0000-0003-2842-1133	National Science Council, Development Program of Industrialization for Agricultural Biotechnology Grant [098S0030049-AI]	National Science Council, Development Program of Industrialization for Agricultural Biotechnology Grant	This work was supported by the National Science Council, Development Program of Industrialization for Agricultural Biotechnology Grant 098S0030049-AI.	Abdelsadik A, 2011, HUM IMMUNOL, V72, P1188, DOI 10.1016/j.humimm.2011.08.015; Ahmad A, 2012, CRIT REV FOOD SCI, V52, P201, DOI 10.1080/10408398.2010.499806; Alitheen NB, 2011, PAK J PHARM SCI, V24, P243; Arpaia N, 2011, CURR OPIN VIROL, V1, P447, DOI 10.1016/j.coviro.2011.10.006; Ben-Arye E, 2002, SCAND J GASTROENTERO, V37, P444, DOI 10.1080/003655202317316088; Bland EJ, 2004, CARBOHYD RES, V339, P1673, DOI 10.1016/j.carres.2004.05.009; Chang R, 2002, J ALTERN COMPLEM MED, V8, P559, DOI 10.1089/107555302320825066; Crozat K, 2009, IMMUNOL REV, V227, P129, DOI 10.1111/j.1600-065X.2008.00736.x; Das A, 2012, INT J FOOD SCI NUTR, V63, P718, DOI 10.3109/09637486.2011.644769; Figueiredo RT, 2012, CARBOHYD RES, V356, P260, DOI 10.1016/j.carres.2012.02.028; Kankkunen P, 2010, J IMMUNOL, V184, P6335, DOI 10.4049/jimmunol.0903019; Keystone EC, 2010, J RHEUMATOL, V37, P27, DOI 10.3899/jrheum.091463; Kirschning CJ, 2002, CURR TOP MICROBIOL, V270, P121; Lee SM, 1998, LEUKEMIA LYMPHOMA, V29, P427, DOI 10.3109/10428199809050903; Liu JJ, 2009, RECENT PAT ANTI-CANC, V4, P101, DOI 10.2174/157489209788452858; Lucey DR, 1996, CLIN MICROBIOL REV, V9, P532, DOI 10.1128/CMR.9.4.532; Murphy EA, 2010, CURR OPIN CLIN NUTR, V13, P656, DOI 10.1097/MCO.0b013e32833f1afb; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Pietrocola G, 2011, INT J ARTIF ORGANS, V34, P799, DOI 10.5301/ijao.5000030; Ramberg JE, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-54; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Shao BM, 2004, BIOCHEM BIOPH RES CO, V323, P133, DOI 10.1016/j.bbrc.2004.08.069; SHERMER M, 2008, SCI AM, V299, P42; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; Sletmoen M, 2008, BIOPOLYMERS, V89, P310, DOI 10.1002/bip.20920; Trinchieri G, 1996, J LEUKOCYTE BIOL, V59, P505, DOI 10.1002/jlb.59.4.505; Tsai CC, 2008, COMB CHEM HIGH T SCR, V11, P834, DOI 10.2174/138620708786734307; Volman JJ, 2010, NUTR RES, V30, P40, DOI 10.1016/j.nutres.2009.10.023; Wu ML, 2010, BIOTECHNOL PROGR, V26, P1391, DOI 10.1002/btpr.429; Yoshikai Yasunobu, 2006, Nihon Rinsho, V64, P1223; Zheng Z, 1998, Chin J Biotechnol, V14, P93	33	30	32	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17689	17697		10.1074/jbc.M112.448381	http://dx.doi.org/10.1074/jbc.M112.448381			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23629653	Green Published, hybrid			2022-12-28	WOS:000320380600059
J	Vaidyanathan, R; Vega, AL; Song, CH; Zhou, Q; Tan, BH; Berger, S; Makielski, JC; Eckhardt, LL				Vaidyanathan, Ravi; Vega, Amanda L.; Song, Chunhua; Zhou, Qing; Tan, Bihua; Berger, Stuart; Makielski, Jonathan C.; Eckhardt, Lee L.			The Interaction of Caveolin 3 Protein with the Potassium Inward Rectifier Channel Kir2.1 PHYSIOLOGY AND PATHOLOGY RELATED TO LONG QT SYNDROME 9 (LQT9)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; HEART-FAILURE; MACROMOLECULAR COMPLEX; KCNJ2 MUTATIONS; MUSCLE-CELLS; TRAFFICKING; EXPRESSION; ARRHYTHMIA; SKELETAL; SODIUM	Mutations in CAV3 cause LQT syndrome 9 (LQT9). A previously reported LQT9 patient had prominent U waves on ECG, a feature that has been correlated with Kir2.1 loss of function. Our objective was to determine whether caveolin 3 (Cav3) associates with Kir2.1 and whether LQT9-associated CAV3 mutations affect the biophysical properties of Kir2.1. Kir2.1 current (I-K1) density was measured using the whole-cell voltage clamp technique. WT-Cav3 did not affect I-K1. However, F97C-Cav3 and T78M-Cav3 decreased I-K1 density significantly by similar to 60%, and P104L-Cav3 decreased I-K1 density significantly by similar to 30% at -60 mV. Immunostained rat heart cryosections and HEK293 cells cotransfected with Kir2.1 and WT-Cav3 both demonstrated colocalization of Kir2.1 and WT-Cav3 by confocal imaging. Cav3 coimmunoprecipitated with Kir2.1 in human ventricular myocytes and in heterologous expression systems. Additionally, FRET efficiency was highly specific, with a molecular distance of 5.6 +/- 0.4 nm, indicating close protein location. Colocalization experiments found that Cav3 and Kir2.1 accumulated in the Golgi compartment. On-cell Western blot analysis showed decreased Kir2.1 cell surface expression by 60% when expressed with F97C-Cav3 and by 20% when expressed with P104L-Cav3 compared with WT-Cav3. This is the first report of an association between Cav3 and Kir2.1. The Cav3 mutations F97C-Cav3, P104L-Cav3, and T78M-Cav3 decreased I-K1 density significantly. This effect was related to a reduced cell surface expression of Kir2.1. Kir2.1 loss of function is additive to the increase described previously in late I-Na, prolonging repolarization and leading to arrhythmia generation in Cav3-mediated LQT9.	[Makielski, Jonathan C.; Eckhardt, Lee L.] Univ Wisconsin, Dept Med, Div Cardiovasc Med, Madison, WI 53792 USA; [Makielski, Jonathan C.; Eckhardt, Lee L.] Univ Wisconsin, Cellular & Mol Arrhythmia Res Program, Madison, WI 53792 USA; [Berger, Stuart] Med Coll Wisconsin, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin	Eckhardt, LL (corresponding author), 600 Highland Ave,CSC H4-522, Madison, WI 53792 USA.	lle@medicine.wisc.edu	song, chunhua/K-7882-2016; song, chunhua/K-7882-2016	song, chunhua/0000-0001-7563-0339; song, chunhua/0000-0002-4081-2543; Eckhardt, Lee/0000-0001-5792-064X	University of Wisconsin Cellular and Molecular Arrhythmia Research Program; American Heart Association National Scientist Development [11SDG5000003]; University of Wisconsin School of Medicine and Public Health	University of Wisconsin Cellular and Molecular Arrhythmia Research Program; American Heart Association National Scientist Development(American Heart Association); University of Wisconsin School of Medicine and Public Health	This work was supported by the University of Wisconsin Cellular and Molecular Arrhythmia Research Program, by American Heart Association National Scientist Development Grant 11SDG5000003 (to L. E.), and by the University of Wisconsin School of Medicine and Public Health.	Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; Balijepalli RC, 2008, PROG BIOPHYS MOL BIO, V98, P149, DOI 10.1016/j.pbiomolbio.2009.01.012; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Cheng J., 2013, J MOL CELL IN PRESS; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Couchoux H, 2007, J PHYSIOL-LONDON, V580, P745, DOI 10.1113/jphysiol.2006.124198; Cui S, 2010, J BIOL CHEM, V285, P41732, DOI 10.1074/jbc.M110.153312; Delisle BP, 2003, J BIOL CHEM, V278, P35749, DOI 10.1074/jbc.M305787200; Eckhardt LL, 2007, HEART RHYTHM, V4, P323, DOI 10.1016/j.hrthm.2006.10.025; Galbiati F, 1999, J BIOL CHEM, V274, P25632, DOI 10.1074/jbc.274.36.25632; Gomez R, 2009, CIRC RES, V105, P383, DOI 10.1161/CIRCRESAHA.109.197558; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hare JM, 2000, CIRC RES, V86, P1085, DOI 10.1161/01.RES.86.10.1085; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Leonoudakis D, 2001, J CELL SCI, V114, P987; Miake J, 2003, J CLIN INVEST, V111, P1529, DOI 10.1172/JCI200317959; Milstein ML, 2012, P NATL ACAD SCI USA, V109, pE2134, DOI 10.1073/pnas.1109370109; Petitprez S, 2011, CIRC RES, V108, P294, DOI 10.1161/CIRCRESAHA.110.228312; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Pu JL, 2008, J MOL CELL CARDIOL, V44, P188, DOI 10.1016/j.yjmcc.2007.09.010; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Schwartz PJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P868, DOI 10.1161/CIRCEP.111.962019; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Tomaselli GF, 2004, CIRC RES, V95, P754, DOI 10.1161/01.RES.0000145047.14691.db; Tristani-Firouzi M, 2002, J CLIN INVEST, V110, P381, DOI 10.1172/JCI200215183; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Vaidyanathan R, 2010, J BIOL CHEM, V285, P28000, DOI 10.1074/jbc.M110.110858; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Wang ZG, 1998, CIRCULATION, V98, P2422, DOI 10.1161/01.CIR.98.22.2422	31	40	42	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17472	17480		10.1074/jbc.M112.435370	http://dx.doi.org/10.1074/jbc.M112.435370			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640888	Green Published, hybrid			2022-12-28	WOS:000320380600039
J	Zhang, L; He, ZG				Zhang, Lei; He, Zheng-Guo			Radiation-sensitive Gene A (RadA) Targets DisA, DNA Integrity Scanning Protein A, to Negatively Affect Cyclic Di-AMP Synthesis Activity in Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; REGULATES EXPRESSION; CHECKPOINT PROTEIN; BIOFILM FORMATION; ESCHERICHIA-COLI; CYTOSOLIC DNA; GMP-AMP; RECOMBINATION; TRANSFORMATION; 2ND-MESSENGER	Cyclic di-AMP has been recognized as a ubiquitous second messenger involved in the regulation of bacterial signal transduction. However, little is known about the control of its synthesis and its physiological role in bacteria. In this study, we report a novel mechanism of control of c-di-AMP synthesis and its effects on bacterial growth in Mycobacterium smegmatis. We identified a DisA homolog in M. smegmatis, MsDisA, as an enzyme involved in c-di-AMP synthesis. Furthermore, MsRadA, a RadA homolog in M. smegmatis was found to act as an antagonist of the MsDisA protein. MsRadA can physically interact with MsDisA and inhibit the c-di-AMP synthesis activity of MsDisA. Overexpression of MsdisA in M. smegmatis led to cell expansion and bacterial aggregation as well as loss of motility. However, co-expression of MsradA and MsdisA rescued these abnormal phenotypes. Furthermore, we show that the interaction between RadA and DisA and its role in inhibiting c-di-AMP synthesis may be conserved in bacteria. Our findings enhance our understanding of the control of c-di-AMP synthesis and its physiological roles in bacteria.	[Zhang, Lei; He, Zheng-Guo] Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Ctr Prote Res, Natl Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014; Zhang, Lei/M-6146-2013	Zhang, Lei/0000-0002-8566-6068	National Natural Science Foundation of China [31025002, 30930003]; Fundamental Research Funds for the Central Universities [2011PY140]; Creative Research Groups of Hubei; Hubei Chutian Scholar Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Creative Research Groups of Hubei; Hubei Chutian Scholar Program	This work was supported by the National Natural Science Foundation of China Grants 31025002 and 30930003, Fundamental Research Funds for the Central Universities Grant 2011PY140, the Creative Research Groups of Hubei, and the Hubei Chutian Scholar Program (to Z.-G. H.).	Bai Y., 2012, PLOS ONE, V7, DOI DOI 10.1371/J0URNAL.P0NE; Beam CE, 2002, J BACTERIOL, V184, P6836, DOI 10.1128/JB.184.24.6836-6844.2002; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Burghout P, 2007, J BACTERIOL, V189, P6540, DOI 10.1128/JB.00573-07; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gopalaswamy R, 2008, FEMS MICROBIOL LETT, V278, P121, DOI 10.1111/j.1574-6968.2007.00989.x; Huang F, 2010, NUCLEIC ACIDS RES, V38, P8219, DOI 10.1093/nar/gkq737; Jani C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-327; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Rao MD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.383604; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Song YH, 1996, J BACTERIOL, V178, P5045, DOI 10.1128/jb.178.16.5045-5048.1996; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010672; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zhang L, 2009, P NATL ACAD SCI USA, V106, P7792, DOI 10.1073/pnas.0813056106	35	42	54	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22426	22436		10.1074/jbc.M113.464883	http://dx.doi.org/10.1074/jbc.M113.464883			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23760274	Green Published, hybrid			2022-12-28	WOS:000330596300024
J	Bastin, G; Heximer, SP				Bastin, Guillaume; Heximer, Scott P.			Rab Family Proteins Regulate the Endosomal Trafficking and Function of RGS4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Endocytosis; G-protein-coupled Receptors (GPCR); G-proteins; RGS Proteins; Signaling	MUSCARINIC ACETYLCHOLINE-RECEPTORS; GTPASE-ACTIVATING PROTEINS; END RULE PATHWAY; PLASMA-MEMBRANE; SIGNALING 4; IN-VIVO; SUBCELLULAR-LOCALIZATION; LYSOSOMAL DEGRADATION; RETROGRADE TRANSPORT; ALZHEIMERS-DISEASE	RGS4, a heterotrimeric G-protein inhibitor, localizes to plasma membrane (PM) and endosomal compartments. Here, we examined Rab-mediated control of RGS4 internalization and recycling. Wild type and constitutively active Rab5 decreased RGS4 PM levels while increasing its endosomal targeting. Rab5, however, did not appreciably affect the PM localization or function of the M1 muscarinic receptor (M1R)/G(q) signaling cascade. RGS4-containing endosomes co-localized with subsets of Rab5-, transferrin receptor-, and Lamp1/Lysotracker-marked compartments suggesting RGS4 traffics through PM recycling or acidified endosome pathways. Rab7 activity promoted TGN association, whereas Rab7(dominant negative) trapped RGS4 in late endosomes. Furthermore, RGS4 was found to co-localize with an endosomal pool marked by Rab11, the protein that mediates recycling/sorting of proteins to the PM. The Cys-12 residue in RGS4 appeared important for its Rab11-mediated trafficking to the PM. Rab11(dominant negative) decreased RGS4 PM levels and increased the number of RGS4-containing endosomes. Inhibition of Rab11 activity decreased RGS4 function as an inhibitor of M1R activity without affecting localization and function of the M1R/G(q) signaling complex. Thus, both Rab5 activation and Rab11 inhibition decreased RGS4 function in a manner that is independent from their effects on the localization and function of the M1R/G(q) signaling complex. This is the first study to implicate Rab GTPases in the intracellular trafficking of an RGS protein. Thus, Rab GTPases may be novel molecular targets for the selective regulation of M1R-mediated signaling via their specific effects on RGS4 trafficking and function.	[Bastin, Guillaume; Heximer, Scott P.] Univ Toronto, Dept Physiol Heart & Stroke, Richard Lewar Ctr Excellence Cardiovasc Res, Toronto, ON M5S 1A8, Canada; [Bastin, Guillaume] Univ Lille 1, USR CNRS 3290, F-59655 Villeneuve Dascq, France	University of Toronto; Universite de Lille - ISITE; Universite de Lille	Heximer, SP (corresponding author), Univ Toronto, Dept Physiol Heart & Stroke, Richard Lewar Ctr Excellence Cardiovasc Res, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	scott.heximer@utoronto.ca			Canadian Institutes of Health Research Operating Grants Program [MOP-106670]	Canadian Institutes of Health Research Operating Grants Program(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grants Program Grant MOP-106670 (to S. P. H.).	Anborgh PH, 2000, MOL ENDOCRINOL, V14, P2040, DOI 10.1210/me.14.12.2040; Baetz NW, 2013, MOL BIOL CELL, V24, P643, DOI 10.1091/mbc.E12-09-0659; Bastin G, 2012, J BIOL CHEM, V287, P28966, DOI 10.1074/jbc.M112.345629; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bernstein LS, 2000, J BIOL CHEM, V275, P18520, DOI 10.1074/jbc.M000618200; Borroni V, 2011, J BIOL CHEM, V286, P17122, DOI 10.1074/jbc.M110.211870; Bose A, 2001, MOL CELL BIOL, V21, P5262, DOI 10.1128/MCB.21.15.5262-5275.2001; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; Bouley R, 2005, AM J PHYSIOL-CELL PH, V288, pC1390, DOI 10.1152/ajpcell.00353.2004; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Burd CG, 2011, TRAFFIC, V12, P948, DOI 10.1111/j.1600-0854.2011.01188.x; Cavalli V, 2001, FEBS LETT, V498, P190, DOI 10.1016/S0014-5793(01)02484-X; Chatterjee TK, 2003, J BIOL CHEM, V278, P30261, DOI 10.1074/jbc.M212687200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen YJ, 2012, J NEUROSCI, V32, P2683, DOI 10.1523/JNEUROSCI.4125-11.2011; Chia PZC, 2011, J CELL SCI, V124, P2401, DOI 10.1242/jcs.083782; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cifelli C, 2008, CIRC RES, V103, P527, DOI 10.1161/CIRCRESAHA.108.180984; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Dale LB, 2004, J BIOL CHEM, V279, P13110, DOI 10.1074/jbc.M313333200; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; de Azua IR, 2011, TRENDS ENDOCRIN MET, V22, P74, DOI 10.1016/j.tem.2010.10.004; de Azua IR, 2010, P NATL ACAD SCI USA, V107, P7999, DOI 10.1073/pnas.1003655107; Delaney KA, 2002, J BIOL CHEM, V277, P33439, DOI 10.1074/jbc.M205293200; Ding L, 2009, BIOL PSYCHIAT, V65, P541, DOI 10.1016/j.biopsych.2008.10.026; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Emilsson L, 2006, SYNAPSE, V59, P173, DOI 10.1002/SYN.20226; Esseltine JL, 2011, MOL PHARMACOL, V79, P175, DOI 10.1124/mol.110.068379; Fan GH, 2003, BLOOD, V101, P2115, DOI 10.1182/blood-2002-07-1965; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fielding AB, 2005, EMBO J, V24, P3389, DOI 10.1038/sj.emboj.7600803; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gidon A, 2012, TRAFFIC, V13, P815, DOI 10.1111/j.1600-0854.2012.01354.x; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; Grimsey NL, 2011, BBA-MOL CELL RES, V1813, P1554, DOI 10.1016/j.bbamcr.2011.05.010; Gu S, 2007, J BIOL CHEM, V282, P33064, DOI 10.1074/jbc.M702685200; Hagiwara M, 2009, BIOCHEM BIOPH RES CO, V378, P73, DOI 10.1016/j.bbrc.2008.10.172; Harris IS, 2004, DIABETES, V53, P3082, DOI 10.2337/diabetes.53.12.3082; Hinkle PM, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00180; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Horgan CP, 2011, BIOCHEM SOC T, V39, P1202, DOI 10.1042/BST0391202; Huang J, 2009, PROG MOL BIOL TRANSL, V86, P115, DOI 10.1016/S1877-1173(09)86005-5; Hubbard VM, 2010, J IMMUNOL, V185, P7349, DOI 10.4049/jimmunol.1000576; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hurst JH, 2009, CELL MOL BIOL LETT, V14, P153, DOI 10.2478/s11658-008-0040-7; IOANNOU YA, 1992, J CELL BIOL, V119, P1137, DOI 10.1083/jcb.119.5.1137; Ishida M, 2012, J CELL SCI, V125, P5177, DOI 10.1242/jcs.109314; Jaen C, 2006, J BIOL CHEM, V281, P34549, DOI 10.1074/jbc.M603177200; Jing JA, 2010, MOL BIOL CELL, V21, P3041, DOI 10.1091/mbc.E10-04-0313; Kanamarlapudi V., 2012, PLOS ONE, V7; Kantamneni S, 2009, NEUROSCI LETT, V452, P106, DOI 10.1016/j.neulet.2009.01.011; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Laroche G, 2007, MOL CELL BIOCHEM, V306, P141, DOI 10.1007/s11010-007-9564-9; Lau AW, 2008, J CELL SCI, V121, P4008, DOI 10.1242/jcs.033522; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Lerner TN, 2012, NEURON, V73, P347, DOI 10.1016/j.neuron.2011.11.015; Luzio JP, 2010, BIOCHEM SOC T, V38, P1413, DOI 10.1042/BST0381413; Macia E, 2012, J CELL SCI, V125, P4026, DOI 10.1242/jcs.102343; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Mittmann C, 2002, CARDIOVASC RES, V55, P778, DOI 10.1016/S0008-6363(02)00459-5; Moreau K, 2012, J CELL BIOL, V196, P483, DOI 10.1083/jcb.201110114; Muma NA, 2003, SYNAPSE, V47, P58, DOI 10.1002/syn.10153; Ng EL, 2012, CELL BIOCHEM FUNCT, V30, P515, DOI 10.1002/cbf.2827; Pacey LKK, 2009, MOL PHARMACOL, V76, P18, DOI 10.1124/mol.109.056127; Paspalas CD, 2009, CEREB CORTEX, V19, P2145, DOI 10.1093/cercor/bhn235; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Prigent M, 2003, J CELL BIOL, V163, P1111, DOI 10.1083/jcb.200305029; Reiner C, 2008, LIFE SCI, V82, P718, DOI 10.1016/j.lfs.2008.01.013; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Schwendt M, 2012, PSYCHOPHARMACOLOGY, V221, P621, DOI 10.1007/s00213-011-2606-8; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Smith DC, 2006, TRAFFIC, V7, P379, DOI 10.1111/j.1600-0854.2006.00391.x; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Stokes L, 2013, PURINERG SIGNAL, V9, P113, DOI 10.1007/s11302-012-9336-1; Sullivan BM, 2000, MOL BIOL CELL, V11, P3155, DOI 10.1091/mbc.11.9.3155; Svensson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038517; Takahashi S, 2012, J CELL SCI, V125, P4049, DOI 10.1242/jcs.102913; Takata K, 2006, CELL MOL BIOL, V52, P34, DOI 10.1170/T747; Tanabe K, 2005, MOL BIOL CELL, V16, P1617, DOI 10.1091/mbc.E04-08-0683; Tatenhorst L, 2004, J NEUROPATH EXP NEUR, V63, P210, DOI 10.1093/jnen/63.3.210; Tsutsumi R, 2009, MOL CELL BIOL, V29, P435, DOI 10.1128/MCB.01144-08; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; Wang Q, 2011, J BIOL CHEM, V286, P7854, DOI 10.1074/jbc.M110.160911; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Xie Y, 2009, CANCER RES, V69, P5743, DOI 10.1158/0008-5472.CAN-08-3564; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zhang QL, 2002, J PHYSIOL-LONDON, V545, P355, DOI 10.1113/jphysiol.2002.032151	95	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21836	10.1074/jbc.M113.466888	http://dx.doi.org/10.1074/jbc.M113.466888			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23733193	Green Published, hybrid			2022-12-28	WOS:000328841900033
J	Gadd, MS; Jacques, DA; Nisevic, I; Craig, VJ; Kwan, AH; Guss, JM; Matthews, JM				Gadd, Morgan S.; Jacques, David A.; Nisevic, Ivan; Craig, Vanessa J.; Kwan, Ann H.; Guss, J. Mitchell; Matthews, Jacqueline M.			A Structural Basis for the Regulation of the LIM-Homeodomain Protein Islet 1 (Isl1) by Intra- and Intermolecular Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein-Nucleic Acid Interaction; Protein-Protein Interactions; Structural Biology; Tissue-specific Transcription Factors; Transcription Regulation; Competitive Binding; LIM-Homeodomain Transcription Factors	THERMAL SHIFT ASSAYS; MOTOR-NEURON; TRANSCRIPTION FACTORS; LMO4-LDB1 COMPLEX; NMR-SPECTROSCOPY; DRUG DISCOVERY; BINDING; DOMAINS; CRYSTALLIZATION; DIFFERENTIATION	Islet 1 (Isl1) is a transcription factor of the LIM-homeodomain (LIM-HD) protein family and is essential for many developmental processes. LIM-HD proteins all contain two protein-interacting LIM domains, a DNA-binding homeodomain (HD), and a C-terminal region. In Isl1, the C-terminal region also contains the LIM homeobox 3 (Lhx3)-binding domain (LBD), which interacts with the LIM domains of Lhx3. The LIM domains of Isl1 have been implicated in inhibition of DNA binding potentially through an intramolecular interaction with or close to the HD. Here we investigate the LBD as a candidate intramolecular interaction domain. Competitive yeast-two hybrid experiments indicate that the LIM domains and LBD from Isl1 can interact with apparently low affinity, consistent with no detection of an intermolecular interaction in the same system. Nuclear magnetic resonance studies show that the interaction is specific, whereas substitution of the LBD with peptides of the same amino acid composition but different sequence is not specific. We solved the crystal structure of a similar but higher affinity complex between the LIM domains of Isl1 and the LIM interaction domain from the LIM-HD cofactor protein LIM domain-binding protein 1 (Ldb1) and used these coordinates to generate a homology model of the intramolecular interaction that indicates poorer complementarity for the weak intramolecular interaction. The intramolecular interaction in Isl1 may provide protection against aggregation, minimize unproductive DNA binding, and facilitate cofactor exchange within the cell.	[Gadd, Morgan S.; Jacques, David A.; Nisevic, Ivan; Craig, Vanessa J.; Kwan, Ann H.; Guss, J. Mitchell; Matthews, Jacqueline M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Matthews, JM (corresponding author), Univ Sydney, Sch Mol Biosci, Bldg G08, Sydney, NSW 2006, Australia.	jacqui.matthews@sydney.edu.au	Guss, Jules Mitchell/N-1387-2019	Guss, Jules Mitchell/0000-0003-4259-6079; Gadd, Morgan/0000-0001-6124-0858; Matthews, Jacqueline/0000-0001-8518-3472; Jacques, David/0000-0002-6426-4510; Kwan, Ann/0000-0002-1506-2226	Australian Research Council; Australian Postgraduate Awards; Senior Research Fellowship from the National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); Australian Postgraduate Awards(Australian Government); Senior Research Fellowship from the National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by a grant from the Australian Research Council.; Supported by Australian Postgraduate Awards.; Supported by a Senior Research Fellowship from the National Health and Medical Research Council of Australia.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Bachy I, 2002, NEUROREPORT, V13, pA23, DOI 10.1097/00001756-200202110-00002; Bachy I, 2001, J NEUROSCI, V21, P7620, DOI 10.1523/JNEUROSCI.21-19-07620.2001; Bhati M, 2008, EMBO J, V27, P2018, DOI 10.1038/emboj.2008.123; Bhati M, 2008, ACTA CRYSTALLOGR F, V64, P297, DOI 10.1107/S174430910800691X; Bhati M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040719; Bridwell JL, 2001, GENE, V277, P239, DOI 10.1016/S0378-1119(01)00704-1; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cross AJ, 2010, J MOL BIOL, V399, P133, DOI 10.1016/j.jmb.2010.04.006; Dawid IB, 1998, TRENDS GENET, V14, P480, DOI 10.1016/S0168-9525(98)01615-1; DAWID IB, 1995, CR ACAD SCI III-VIE, V318, P295; Deane JE, 2004, EMBO J, V23, P3589, DOI 10.1038/sj.emboj.7600376; Deane JE, 2003, ACTA CRYSTALLOGR D, V59, P1484, DOI 10.1107/S0907444903011843; Deane JE, 2003, EMBO J, V22, P2224, DOI 10.1093/emboj/cdg196; Deane JE, 2001, PROTEIN ENG, V14, P493, DOI 10.1093/protein/14.7.493; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; El Omari K, 2011, BLOOD, V117, P2146, DOI 10.1182/blood-2010-07-293357; Elshatory Y, 2007, J NEUROSCI, V27, P12707, DOI 10.1523/JNEUROSCI.3951-07.2007; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gadd MS, 2012, ACTA CRYSTALLOGR F, V68, P1398, DOI 10.1107/S1744309112040031; Gadd MS, 2011, J BIOL CHEM, V286, P42971, DOI 10.1074/jbc.M111.248559; Gadd MS, 2009, ACTA CRYSTALLOGR F, V65, P151, DOI 10.1107/S1744309108043431; Jeffries CM, 2006, PROTEIN SCI, V15, P2612, DOI 10.1110/ps.062377006; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Jurata LW, 1997, MOL CELL BIOL, V17, P5688, DOI 10.1128/MCB.17.10.5688; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwan AH, 2011, FEBS J, V278, P687, DOI 10.1111/j.1742-4658.2011.08004.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee C, 2005, J BIOMOL NMR, V33, P198, DOI 10.1007/s10858-005-3209-7; Lee S, 2008, DEV CELL, V14, P877, DOI 10.1016/j.devcel.2008.03.021; Lee SK, 2003, NEURON, V38, P731, DOI 10.1016/S0896-6273(03)00296-4; Liew CK, 2008, PROTEIN SCI, V17, P1630, DOI 10.1110/ps.034983.108; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; LUMSDEN A, 1995, CURR BIOL, V5, P491, DOI 10.1016/S0960-9822(95)00100-X; Matthews JM, 2013, FEBS LETT, V587, P1164, DOI 10.1016/j.febslet.2013.01.002; Matthews JM, 2003, EMBO REP, V4, P1132, DOI 10.1038/sj.embor.7400030; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Radde-Gallwitz K, 2004, J COMP NEUROL, V477, P412, DOI 10.1002/cne.20257; Ryan DP, 2006, J MOL BIOL, V359, P66, DOI 10.1016/j.jmb.2006.02.074; SANCHEZGARCIA I, 1993, EMBO J, V12, P4243, DOI 10.1002/j.1460-2075.1993.tb06108.x; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; Takuma N, 1998, DEVELOPMENT, V125, P4835; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wissmueller S, 2011, PROTEINS, V79, P2365, DOI 10.1002/prot.23068; XUE D, 1993, SCIENCE, V261, P1324, DOI 10.1126/science.8103239	64	18	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21924	10.1074/jbc.M113.478586	http://dx.doi.org/10.1074/jbc.M113.478586			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23750000	Green Published, hybrid			2022-12-28	WOS:000328841900040
J	Nakajima, C; Kulik, A; Frotscher, M; Herz, J; Schafer, M; Bock, HH; May, P				Nakajima, Chikako; Kulik, Akos; Frotscher, Michael; Herz, Joachim; Schaefer, Michael; Bock, Hans H.; May, Petra			Low Density Lipoprotein Receptor-related Protein 1 (LRP1) Modulates N-Methyl-D-aspartate (NMDA) Receptor-dependent Intracellular Signaling and NMDA-induced Regulation of Postsynaptic Protein Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamate Receptors; Lipoprotein Receptor; Secretases; Signaling; Synapses	GAMMA-SECRETASE; NERVOUS-SYSTEM; HUMAN BRAIN; RAT-BRAIN; GENE; NEURONS; MICE; LOCALIZATION; DISRUPTION; ACTIVATION	The lipoprotein receptor LRP1 is essential in neurons of the central nervous system, as was revealed by the analysis of conditional Lrp1-deficient mouse models. The molecular basis of its neuronal functions, however, is still incompletely understood. Here we show by immunocytochemistry, electron microscopy, and postsynaptic density preparation that LRP1 is located postsynaptically. Basal and NMDA-induced phosphorylation of the transcription factor cAMP-response element-binding protein (CREB) as well as NMDA target gene transcription are reduced in LRP1-deficient neurons. In control neurons, NMDA promotes -secretase-dependent release of the LRP1 intracellular domain (LRP1-ICD). However, pull-down and chromatin immunoprecipitation (ChIP) assays showed no direct interaction between the LRP1-ICD and either CREB or target gene promoters. On the other hand, NMDA-induced degradation of the postsynaptic scaffold protein PSD-95 was impaired in the absence of LRP1, whereas its ubiquitination was increased, indicating that LRP1 influences the composition of postsynaptic protein complexes. Accordingly, NMDA-induced internalization of the AMPA receptor subunit GluA1 was impaired in LRP1-deficient neurons. These results show a role of LRP1 in the regulation and turnover of synaptic proteins, which may contribute to the reduced dendritic branching and to the neurological phenotype observed in the absence of LRP1.	[Nakajima, Chikako; Bock, Hans H.; May, Petra] Univ Hosp, Dept Med 2, D-79104 Freiburg, Germany; [Nakajima, Chikako; Frotscher, Michael; Herz, Joachim; Schaefer, Michael; Bock, Hans H.; May, Petra] Univ Hosp, Ctr Neurosci, D-79104 Freiburg, Germany; [Nakajima, Chikako; Frotscher, Michael; Herz, Joachim; Schaefer, Michael; Bock, Hans H.; May, Petra] Univ Freiburg, D-79104 Freiburg, Germany; [Kulik, Akos] Univ Freiburg, Inst Physiol 2, D-79104 Freiburg, Germany; [Nakajima, Chikako; May, Petra] Univ Hosp, Dept Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany; [Nakajima, Chikako; May, Petra] Univ Dusseldorf, D-40225 Dusseldorf, Germany; [Frotscher, Michael] Univ Hamburg, Inst Struct Neurobiol, Ctr Mol Neurobiol Hamburg ZMNH, D-20251 Hamburg, Germany; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Neurotherapeut, Dallas, TX 75390 USA; [Kulik, Akos] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany; [Schaefer, Michael] Univ Med Ctr, Dept Anesthesiol, D-55131 Mainz, Germany; [Schaefer, Michael] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, D-55131 Mainz, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Heinrich Heine University Dusseldorf; University of Hamburg; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Freiburg; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	May, P (corresponding author), Univ Hosp Dusseldorf, Dept Gastroenterol Hepatol & Infectiol, Bldg 13-54-00-81,Moorenstr 5, D-40225 Dusseldorf, Germany.	Petra.May@med.uni-duesseldorf.de	Bock, Hans/AAF-2635-2021; Schaefer, Michael K.E./S-1715-2019	Schaefer, Michael K.E./0000-0001-6055-6244; Nakajima, Chikako/0000-0003-3071-8585	Deutsche Forschungsgemeinschaft [MA 2410/1-3, MA 2410/1-4, SFB 780/TP5, BO1806/3-1]; Wolfgang Paul Award by the Humboldt Foundation; National Institutes of Health; Ted Nash Longlife Foundation; BrightFocus Foundation; Consortium for Frontotemporal Dementia Research;  [BIOSS-2 (TP6)]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wolfgang Paul Award by the Humboldt Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ted Nash Longlife Foundation; BrightFocus Foundation(BrightFocus Foundation); Consortium for Frontotemporal Dementia Research; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Deutsche Forschungsgemeinschaft Grants MA 2410/1-3 and 1-4 (to P. M.), SFB 780/TP5 (to J. H., H. B., and M. F.) and BO1806/3-1 (to H. B.).; Recipient of a grant in BIOSS-2 (TP6).; The recipient of a Wolfgang Paul Award by the Humboldt Foundation. Supported by grants from the National Institutes of Health, the Ted Nash Longlife Foundation, the BrightFocus Foundation, and the Consortium for Frontotemporal Dementia Research.	Bacskai BJ, 2000, P NATL ACAD SCI USA, V97, P11551, DOI 10.1073/pnas.200238297; Bianchetta MJ, 2011, J NEUROSCI, V31, P12029, DOI 10.1523/JNEUROSCI.2388-11.2011; Bock HH, 2003, CURR BIOL, V13, P18, DOI 10.1016/S0960-9822(02)01403-3; BU GJ, 1994, J BIOL CHEM, V269, P18521; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; FRYKMAN PK, 1995, P NATL ACAD SCI USA, V92, P8453, DOI 10.1073/pnas.92.18.8453; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; HERZ J, 1988, EMBO J, V7, P4119, DOI 10.1002/j.1460-2075.1988.tb03306.x; KALB RG, 1994, DEVELOPMENT, V120, P3063; Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Liu QA, 2010, J NEUROSCI, V30, P17068, DOI 10.1523/JNEUROSCI.4067-10.2010; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Martin AM, 2008, J BIOL CHEM, V283, P12004, DOI 10.1074/jbc.M707607200; May P, 2002, J BIOL CHEM, V277, P18736, DOI 10.1074/jbc.M201979200; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Qiu ZH, 2002, J BIOL CHEM, V277, P14458, DOI 10.1074/jbc.M112066200; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Rohlmann A, 1996, NAT BIOTECHNOL, V14, P1562, DOI 10.1038/nbt1196-1562; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; TOOYAMA I, 1995, BRAIN RES, V691, P235, DOI 10.1016/0006-8993(95)00735-9; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; WOLF BB, 1992, AM J PATHOL, V141, P37; Zhang C, 2009, AM J PATHOL, V174, P586, DOI 10.2353/ajpath.2009.080661; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	32	52	52	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30							21909	10.1074/jbc.M112.444364	http://dx.doi.org/10.1074/jbc.M112.444364			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760271	Green Published, hybrid			2022-12-28	WOS:000328841900039
J	Eckhard, U; Schonauer, E; Brandstetter, H				Eckhard, Ulrich; Schoenauer, Esther; Brandstetter, Hans			Structural Basis for Activity Regulation and Substrate Preference of Clostridial Collagenases G, H, and T	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I; PROTEIN-STRUCTURE; HISTOLYTICUM; PROTEASES; DOMAINS; ASTACIN; ENZYMES	Clostridial collagenases are among the most efficient enzymes to degrade by far the most predominant protein in the biosphere. Here we present crystal structures of the peptidases of three clostridial collagenase isoforms (ColG, ColH, and ColT). The comparison of unliganded and liganded structures reveals a quaternary subdomain dynamics. In the unliganded ColH structure, this globular dynamics is modulated by an aspartate switch motion that binds to the catalytic zinc. We further identified a calcium binding site in proximity to the catalytic zinc. Both ions are required for full activity, explaining why calcium critically affects the enzymatic activity of clostridial collagenases. Our studies further reveal that loops close to the active site thus serve as characteristic substrate selectivity filter. These elements explain the distinct peptidolytic and collagenolytic activities of these enzymes and provide a rational framework to engineer collagenases with customized substrate specificity as well as for inhibitor design.	[Eckhard, Ulrich; Schoenauer, Esther; Brandstetter, Hans] Salzburg Univ, Dept Mol Biol, Div Struct Biol, A-5020 Salzburg, Austria	Salzburg University	Brandstetter, H (corresponding author), Salzburg Univ, Dept Mol Biol, Div Struct Biol, Billrothstr 11, A-5020 Salzburg, Austria.	hans.brandstetter@sbg.ac.at	Eckhard, Ulrich/L-3733-2016; Brandstetter, Hans/E-6754-2011	Eckhard, Ulrich/0000-0001-5863-4514; Brandstetter, Hans/0000-0002-6089-3045; Schonauer, Esther/0000-0002-2625-9446	Priority Program Biosciences and Health of the University of Salzburg; Land Salzburg; Austrian Science Fund (FWF) [P20582-B03]; Austrian Science Fund (FWF) [P 20582] Funding Source: researchfish	Priority Program Biosciences and Health of the University of Salzburg; Land Salzburg; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Priority Program Biosciences and Health of the University of Salzburg, the Land Salzburg, and the Austrian Science Fund (FWF Project P20582-B03).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bond CS, 2003, BIOINFORMATICS, V19, P311, DOI 10.1093/bioinformatics/19.2.311; BOND MD, 1984, BIOCHEMISTRY-US, V23, P3085, DOI 10.1021/bi00308a036; Brandhorst H, 2010, TRANSPLANTATION, V90, P334, DOI 10.1097/TP.0b013e3181e49bd7; Breite AG, 2011, TRANSPL P, V43, P3171, DOI 10.1016/j.transproceed.2011.09.059; Briers Y, 2007, J BIOCHEM BIOPH METH, V70, P531, DOI 10.1016/j.jbbm.2006.10.009; Bruggemann H, 2004, ANAEROBE, V10, P53, DOI 10.1016/j.anaerobe.2003.08.001; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Desai SS, 2011, J HAND SURG-AM, V36A, P936, DOI 10.1016/j.jhsa.2011.03.002; Ducka P, 2009, APPL MICROBIOL BIOT, V83, P1055, DOI 10.1007/s00253-009-1953-4; Eckhard U, 2008, ACTA CRYSTALLOGR F, V64, P419, DOI 10.1107/S1744309108010476; Eckhard U, 2011, NAT STRUCT MOL BIOL, V18, P1109, DOI 10.1038/nsmb.2127; Eckhard U, 2011, BIOL CHEM, V392, P1039, DOI 10.1515/BC.2011.099; Eckhard U, 2009, BIOL CHEM, V390, P11, DOI 10.1515/BC.2009.004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; FRENCH MF, 1992, J PROTEIN CHEM, V11, P83, DOI 10.1007/BF01025095; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Guevara T, 2010, J BIOL CHEM, V285, P13958, DOI 10.1074/jbc.M109.097436; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; Matsushita O, 2001, TOXICON, V39, P1769, DOI 10.1016/S0041-0101(01)00163-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOOKHTIAR KA, 1985, BIOCHEMISTRY-US, V24, P6527, DOI 10.1021/bi00344a033; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagase H, 2011, BIOL EXTRACELL MATR, P95, DOI 10.1007/978-3-642-16861-1_5; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Ravanti L, 2000, INT J MOL MED, V6, P391; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Shi L, 2009, J WOUND OSTOMY CONT, V36, pS12, DOI 10.1097/WON.0b013e3181bfdd1a; STOCKER W, 1993, EUR J BIOCHEM, V214, P215, DOI 10.1111/j.1432-1033.1993.tb17915.x; Tallant C, 2010, J BIOL CHEM, V285, P13951, DOI 10.1074/jbc.M109.083378; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; VANWART HE, 1981, ANAL BIOCHEM, V113, P356, DOI 10.1016/0003-2697(81)90089-0; VANWART HE, 1985, BIOCHEMISTRY-US, V24, P6520, DOI 10.1021/bi00344a032; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; Weichenberger CX, 2007, NUCLEIC ACIDS RES, V35, pW403, DOI 10.1093/nar/gkm263; Wilson JJ, 2003, EMBO J, V22, P1743, DOI 10.1093/emboj/cdg172; Zhang P, 2009, NEW ENGL J MED, V361, P2578, DOI 10.1056/NEJMc0909497	47	48	56	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20184	20194		10.1074/jbc.M112.448548	http://dx.doi.org/10.1074/jbc.M112.448548			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23703618	hybrid, Green Published			2022-12-28	WOS:000321715100008
J	Pinakoulaki, E; Daskalakis, V; Ohta, T; Richter, OMH; Budiman, K; Kitagawa, T; Ludwig, B; Varotsis, C				Pinakoulaki, Eftychia; Daskalakis, Vangelis; Ohta, Takehiro; Richter, Oliver-Matthias H.; Budiman, Kerstin; Kitagawa, Teizo; Ludwig, Bernd; Varotsis, Constantinos			The Protein Effect in the Structure of Two Ferryl-Oxo Intermediates at the Same Oxidation Level in the Heme Copper Binuclear Center of Cytochrome c Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRETCHING RAMAN BAND; OXYGEN ACTIVATION; ELECTRON-TRANSFER; DIOXYGEN ACTIVATION; BOND-CLEAVAGE; REDUCTION; RESOLUTION; MECHANISM; SPECTRA; ENERGY	Identification of the intermediates and determination of their structures in the reduction of dioxygen to water by cytochrome c oxidase (CcO) are particularly important to understanding both O-2 activation and proton pumping by the enzyme. In this work, we report the products of the rapid reaction of O-2 with the mixed valence form (Cu-A(2+), heme a(3+), heme a(3)(2+)-Cu-B(1+)) of the enzyme. The resonance Raman results show the formation of two ferryl-oxo species with characteristic Fe(IV)=O stretching modes at 790 and 804 cm(-1) at the peroxy oxidation level (P-M). Density functional theory calculations show that the protein environment of the proximal H-bonded His-411 determines the strength of the distal Fe(IV)=O bond. In contrast to previous proposals, the P-M intermediate is also formed in the reaction of Y167F with O-2. These results suggest that in the fully reduced enzyme, the proton pumping nu(Fe(IV)=O) = 804 cm(-1) to nu(Fe(IV)=O) = 790 cm(-1) transition (P -> F, where P is peroxy and F is ferryl) is triggered not only by electron transfer from heme a to heme a(3) but also by the formation of the H-bonded form of the His-411-Fe(IV)=O conformer in the proximal site of heme a(3). The implications of these results with respect to the role of an O=Fe(IV)His-411-H-bonded form to the ring A propionate of heme a(3)-Asp-399-H2O site and, thus, to the exit/output proton channel (H2O) pool during the proton pumping P -> F transition are discussed. We propose that the environment proximal to the heme a(3) controls the spectroscopic properties of the ferryl intermediates in cytochrome oxidases.	[Pinakoulaki, Eftychia] Univ Cyprus, Dept Chem, CY-1678 Nicosia, Cyprus; [Daskalakis, Vangelis; Varotsis, Constantinos] Cyprus Univ Technol, Dept Environm Sci & Technol, CY-3603 Lemesos, Cyprus; [Ohta, Takehiro] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 8128581, Japan; [Ohta, Takehiro] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 8128581, Japan; [Richter, Oliver-Matthias H.; Ludwig, Bernd] Goethe Univ Frankfurt, Biozentrum, Inst Biochem, D-60439 Frankfurt, Germany; [Budiman, Kerstin] Max Planck Inst Biophys, D-60439 Frankfurt, Germany; [Kitagawa, Teizo] Univ Hyogo, Grad Sch Life Sci, Picobiol Inst, Hyogo 6781297, Japan	University of Cyprus; Cyprus University of Technology; Kyushu University; Kyushu University; Goethe University Frankfurt; Max Planck Society; University of Hyogo	Varotsis, C (corresponding author), Cyprus Univ Technol, Dept Environm Sci & Technol, POB 50329, CY-3603 Lemesos, Cyprus.	c.varotsis@cut.ac.cy	Daskalakis, Vangelis/G-9890-2018	Daskalakis, Vangelis/0000-0001-8870-0850; Pinakoulaki, Eftychia/0000-0003-3320-6112; Varotsis, Constantinos/0000-0003-2771-8891	Cyprus Research Promotion Foundation [TEXNOLOGIA/THEPIS/0609(BE)/05]; Minister of Science, Sports and Culture, Japan [14001004]; Deutsche Forschungsgemeinschaft (DFG) [SFB472]; Japan Society for the Promotion of Science (JSPS)	Cyprus Research Promotion Foundation; Minister of Science, Sports and Culture, Japan; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by funds from the Cyprus Research Promotion Foundation (to C.V.) (TEXNOLOGIA/THEPIS/0609(BE)/05), the Minister of Science, Sports and Culture, Japan (Grant 14001004) (to T.K.), and Deutsche Forschungsgemeinschaft (DFG) (Grant SFB472) (to B.L.).; 1 Recipient of a research fellowship from the Japan Society for the Promotion of Science (JSPS).	BABCOCK GT, 1992, NATURE, V356, P301, DOI 10.1038/356301a0; BECKE AD, 1988, J CHEM PHYS, V88, P2547, DOI 10.1063/1.454033; Blomberg MRA, 2003, INORG CHEM, V42, P5231, DOI 10.1021/ic034060s; Budiman K, 2004, BIOCHEMISTRY-US, V43, P11709, DOI 10.1021/bi048898i; Daskalakis V, 2008, J AM CHEM SOC, V130, P12385, DOI 10.1021/ja801840y; Daskalakis V, 2010, J PHYS CHEM B, V114, P1136, DOI 10.1021/jp910006k; Dey A, 2002, J AM CHEM SOC, V124, P3206, DOI 10.1021/ja012402s; FergusonMiller S, 1996, CHEM REV, V96, P2889, DOI 10.1021/cr950051s; Gennis RB, 1998, BBA-BIOENERGETICS, V1365, P241, DOI 10.1016/S0005-2728(98)00075-9; HAN S, 1990, P NATL ACAD SCI USA, V87, P8408, DOI 10.1073/pnas.87.21.8408; Han S, 2000, J BIOL CHEM, V275, P1910, DOI 10.1074/jbc.275.3.1910; HAN SW, 1990, NATURE, V348, P89, DOI 10.1038/348089a0; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Kim Y, 2001, J AM CHEM SOC, V123, P757, DOI 10.1021/ja0027867; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lyons JA, 2012, NATURE, V487, P514, DOI 10.1038/nature11182; Michel H, 1998, P NATL ACAD SCI USA, V95, P12819, DOI 10.1073/pnas.95.22.12819; Michel H, 1998, ANNU REV BIOPH BIOM, V27, P329, DOI 10.1146/annurev.biophys.27.1.329; OGURA T, 1990, J AM CHEM SOC, V112, P5630, DOI 10.1021/ja00170a032; Ogura T, 1996, J AM CHEM SOC, V118, P5443, DOI 10.1021/ja951922i; OGURA T, 1993, J AM CHEM SOC, V115, P8527, DOI 10.1021/ja00072a002; OGURA T, 1990, J BIOL CHEM, V265, P14721; Pinakoulaki E, 2003, J BIOL CHEM, V278, P18761, DOI 10.1074/jbc.M211925200; Pinakoulaki E, 2002, J BIOL CHEM, V277, P13563, DOI 10.1074/jbc.M112200200; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; Proshlyakov DA, 1996, BIOCHEMISTRY-US, V35, P76, DOI 10.1021/bi9511705; PROSHLYAKOV DA, 1994, J BIOL CHEM, V269, P29385; Proshlyakov DA, 1998, P NATL ACAD SCI USA, V95, P8020, DOI 10.1073/pnas.95.14.8020; Takahashi T, 2005, J AM CHEM SOC, V127, P9970, DOI 10.1021/ja051761a; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TURBOMOLE GMbH, 2005, TURBOMOLE VERS 5 8 0; VAROTSIS C, 1993, P NATL ACAD SCI USA, V90, P237, DOI 10.1073/pnas.90.1.237; VAROTSIS C, 1990, BIOCHEMISTRY-US, V29, P7357, DOI 10.1021/bi00484a001; VAROTSIS C, 1989, J AM CHEM SOC, V111, P6439, DOI 10.1021/ja00198a075; VAROTSIS C, 1990, J BIOL CHEM, V265, P11131; VAROTSIS CA, 1995, J AM CHEM SOC, V117, P11260, DOI 10.1021/ja00150a025; Wiertz FGM, 2004, FEBS LETT, V575, P127, DOI 10.1016/j.febslet.2004.08.048; WIKSTROM M, 1989, NATURE, V338, P776, DOI 10.1038/338776a0; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723	39	19	20	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20261	20266		10.1074/jbc.M113.468488	http://dx.doi.org/10.1074/jbc.M113.468488			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23723073	hybrid, Green Published			2022-12-28	WOS:000321715100015
J	Baid, R; Upadhyay, AK; Shinohara, T; Kompella, UB				Baid, Rinku; Upadhyay, Arun K.; Shinohara, Toshimichi; Kompella, Uday B.			Biosynthesis, Characterization, and Efficacy in Retinal Degenerative Diseases of Lens Epithelium-derived Growth Factor Fragment (LEDGF(1-326)), a Novel Therapeutic Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; ENDOPLASMIC-RETICULUM STRESS; VITAMIN-A SUPPLEMENTATION; MACULAR DEGENERATION; HIV-1 INTEGRASE; RHODOPSIN GENE; SURVIVAL; LEDGF; RPE; PREVALENCE	For vision-threatening retinitis pigmentosa and dry age-related macular degeneration, there are no United States Food and Drug Administration (FDA)-approved treatments. We identified, biosynthesized, purified, and characterized lens epithelium-derived growth factor fragment (LEDGF(1-326)) as a novel protein therapeutic. LEDGF(1-326) was produced at about 20 mg/liter of culture when expressed in the Escherichia coli system, with about 95% purity and aggregate-free homogeneous population with a mean hydrodynamic diameter of 9 +/- 1 nm. The free energy of unfolding of LEDGF(1-326) was 3.3 +/- 0.5 kcal mol(-1), and melting temperature was 44.8 +/- 0.2 degrees C. LEDGF(1-326) increased human retinal pigment epithelial cell viability from 48.3 +/- 5.6 to 119.3 +/- 21.1% in the presence of P23H mutant rhodopsin-mediated aggregation stress. LEDGF(1-326) also increased retinal pigment epithelial cell FluoSphere uptake to 140 +/- 10%. Eight weeks after single intravitreal injection in Royal College of Surgeons (RCS) rats, LEDGF(1-326) increased the b-wave amplitude significantly from 9.4 +/- 4.6 to 57.6 +/- 8.8 mu V for scotopic electroretinogram and from 10.9 +/- 5.6 to 45.8 +/- 15.2 mu V for photopic electroretinogram. LEDGF(1-326) significantly increased the retinal outer nuclear layer thickness from 6.34 +/- 1.6 to 11.7 +/- 0.7 mu m. LEDGF(1-326) is a potential new therapeutic agent for treating retinal degenerative diseases.	[Baid, Rinku; Upadhyay, Arun K.; Kompella, Uday B.] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA; [Kompella, Uday B.] Univ Colorado, Dept Ophthalmol, Aurora, CO 80045 USA; [Shinohara, Toshimichi] Univ Nebraska Med Ctr, Dept Ophthalmol, Omaha, NE 68198 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Nebraska System; University of Nebraska Medical Center	Kompella, UB (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Anschutz Med Campus,12850 E Montview Blvd,C238-V2, Aurora, CO 80045 USA.	uday.kompella@ucdenver.edu	Upadhyay, Arun/D-4510-2014	Shinohara, Toshimichi/0000-0002-7197-9039	National Institutes of Health [EY018940, RC1 EY020361, R21EY17360]; NATIONAL EYE INSTITUTE [RC1EY020361, R01EY018940, R21EY017360] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018940, RC1 EY020361, and R21EY17360 (to U. B. K.).	Albanes D, 1996, J NATL CANCER I, V88, P1560, DOI 10.1093/jnci/88.21.1560; Baid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024616; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P1456, DOI 10.1001/archopht.1993.01090110014001; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Cangemi Francis E, 2007, BMC Ophthalmol, V7, P3, DOI 10.1186/1471-2415-7-3; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Delyfer MN, 2004, BIOL CELL, V96, P261, DOI 10.1016/j.biolcel.2004.01.006; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; Fatma N, 2000, INVEST OPHTH VIS SCI, V41, P2648; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gokce I, 2005, J AM CHEM SOC, V127, P9700, DOI 10.1021/ja052632x; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Kuehn BM, 2005, JAMA-J AM MED ASSOC, V293, P1841, DOI 10.1001/jama.293.15.1841; LAVAIL MM, 1975, J HERED, V66, P242, DOI 10.1093/oxfordjournals.jhered.a108621; Li TS, 1998, P NATL ACAD SCI USA, V95, P11933, DOI 10.1073/pnas.95.20.11933; Libby RT, 2010, ADV EXP MED BIOL, V664, P403, DOI 10.1007/978-1-4419-1399-9_46; Machida S, 2001, INVEST OPHTH VIS SCI, V42, P1087; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Matsui H, 2001, INVEST OPHTH VIS SCI, V42, P2935; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Nakamura M, 2000, INVEST OPHTH VIS SCI, V41, P1168; Nishikawa S, 1998, EXP EYE RES, V67, P509, DOI 10.1006/exer.1998.0538; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Nowak Jerzy Z, 2007, Postepy Hig Med Dosw (Online), V61, P83; Ohguro Hiroshi, 2002, Nippon Ganka Gakkai Zasshi, V106, P461; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Scholtz JM, 2009, METHOD ENZYMOL, V466, P549, DOI 10.1016/S0076-6879(09)66023-7; Sibulesky L, 1999, AM J CLIN NUTR, V69, P656; Singh DP, 1999, INVEST OPHTH VIS SCI, V40, P1444; Singh DP, 2006, J MOL BIOL, V355, P379, DOI 10.1016/j.jmb.2005.10.054; Stuen C, 2003, GENERATIONS, V27, P8; Vets S, 2012, MOL THER, V20, P908, DOI 10.1038/mt.2012.6; WYSZYNSKI RE, 1989, INVEST OPHTH VIS SCI, V30, P2341	43	3	4	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17372	17383		10.1074/jbc.M112.441618	http://dx.doi.org/10.1074/jbc.M112.441618			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23640891	Green Published, hybrid			2022-12-28	WOS:000320380600030
J	Zaffagnini, M; Morisse, S; Bedhomme, M; Marchand, CH; Festa, M; Rouhier, N; Lemaire, SD; Trost, P				Zaffagnini, Mirko; Morisse, Samuel; Bedhomme, Mariette; Marchand, Christophe H.; Festa, Margherita; Rouhier, Nicolas; Lemaire, Stephane D.; Trost, Paolo			Mechanisms of Nitrosylation and Denitrosylation of Cytoplasmic Glyceraldehyde-3-phosphate Dehydrogenase from Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN S-NITROSYLATION; NITRIC-OXIDE; THIOREDOXIN REDUCTASE; PROTEOMIC ANALYSIS; GLUTAREDOXIN S12; CELL-DEATH; NITROSATION; GLUTATHIONYLATION; NITROSOTHIOLS; GAPDH	Nitrosylation is a reversible post-translational modification of protein cysteines playing a major role in cellular regulation and signaling in many organisms, including plants where it has been implicated in the regulation of immunity and cell death. The extent of nitrosylation of a given cysteine residue is governed by the equilibrium between nitrosylation and denitrosylation reactions. The mechanisms of these reactions remain poorly studied in plants. In this study, we have employed glycolytic GAPDH from Arabidopsis thaliana as a tool to investigate the molecular mechanisms of nitrosylation and denitrosylation using a combination of approaches, including activity assays, the biotin switch technique, site-directed mutagenesis, and mass spectrometry. Arabidopsis GAPDH activity was reversibly inhibited by nitrosylation of catalytic Cys-149 mediated either chemically with a strong NO donor or by trans-nitrosylation with GSNO. GSNO was found to trigger both GAPDH nitrosylation and glutathionylation, although nitrosylation was widely prominent. Arabidopsis GAPDH was found to be denitrosylated by GSH but not by plant cytoplasmic thioredoxins. GSH fully converted nitrosylated GAPDH to the reduced, active enzyme, without forming any glutathionylated GAPDH. Thus, we found that nitrosylation of GAPDH is not a step toward formation of the more stable glutathionylated enzyme. GSH-dependent denitrosylation of GAPC1 was found to be linked to the [GSH]/[GSNO] ratio and to be independent of the [GSH]/[GSSG] ratio. The possible importance of these biochemical properties for the regulation of Arabidopsis GAPDH functions in vivo is discussed.	[Zaffagnini, Mirko; Festa, Margherita; Trost, Paolo] Univ Bologna, Dept Pharm & Biotechnol, Lab Plant Redox Biol, I-40126 Bologna, Italy; [Zaffagnini, Mirko; Morisse, Samuel; Bedhomme, Mariette; Marchand, Christophe H.; Lemaire, Stephane D.] Univ Paris 06, Lab Biol Mol & Cellulaire Eucaryotes, CNRS FRE3354, Inst Biol Physicochim, F-75005 Paris, France; [Rouhier, Nicolas] Univ Lorraine, Inst Natl Rech Agronom, IFR 110, Interact Arbres Microorganismes UMR1136, F-54506 Vandoeuvre Les Nancy, France	University of Bologna; UDICE-French Research Universities; Sorbonne Universite; INRAE; Universite de Lorraine	Lemaire, SD (corresponding author), Univ Paris 06, Lab Biol Mol & Cellulaire Eucaryotes, CNRS FRE3354, Inst Biol Physicochim, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	stephane.lemaire@ibpc.fr; paolo.trost@unibo.it	Lemaire, Stéphane D/A-3530-2008; MARCHAND, Christophe H/B-5854-2008; Festa, Margherita/AAE-4539-2019	Lemaire, Stéphane D/0000-0001-6442-0547; MARCHAND, Christophe H/0000-0002-0729-3841; Festa, Margherita/0000-0003-4990-7554; Trost, Paolo/0000-0002-6347-8701; Zaffagnini, Mirko/0000-0001-5115-0859; Rouhier, Nicolas/0000-0002-2036-7884	PRIN; ANR [12-BSV5-0019 REDPRO2]; Ville de Paris; LABEX DYNAMO [ANR-11-0011]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); ANR(French National Research Agency (ANR)); Ville de Paris; LABEX DYNAMO	This work was supported in part by Grants PRIN 2008 (to P. T.) and PRIN 2009 (to M. Z.), ANR Grant 12-BSV5-0019 REDPRO2 (to C. H. M. and S. D. L.), a "Research in Paris" fellowship from Ville de Paris (to M. Z.), and by LABEX DYNAMO ANR-11-0011.	Abat JK, 2008, FEBS J, V275, P2862, DOI 10.1111/j.1742-4658.2008.06425.x; Airaki M, 2011, PLANT CELL PHYSIOL, V52, P2006, DOI 10.1093/pcp/pcr133; Akhtar Mohd Waseem, 2012, Int J Cell Biol, V2012, P463756, DOI 10.1155/2012/463756; Anand P, 2012, J MOL MED, V90, P233, DOI 10.1007/s00109-012-0878-z; Anderson LE, 2004, PROTOPLASMA, V223, P33, DOI 10.1007/s00709-003-0030-6; Astier J, 2012, BIOCHEM J, V447, P249, DOI 10.1042/BJ20120257; Astier J, 2011, PLANT SCI, V181, P527, DOI 10.1016/j.plantsci.2011.02.011; Bedhomme M, 2012, BIOCHEM J, V445, P337, DOI 10.1042/BJ20120505; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2010, BIOCHEMISTRY-US, V49, P6963, DOI 10.1021/bi100619k; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; BIESECKER G, 1977, NATURE, V266, P328, DOI 10.1038/266328a0; Broniowska KA, 2013, BBA-GEN SUBJECTS, V1830, P3173, DOI 10.1016/j.bbagen.2013.02.004; Castello PR, 2008, P NATL ACAD SCI USA, V105, P8203, DOI 10.1073/pnas.0709461105; Chakravarti R, 2012, J BIOL CHEM, V287, P16179, DOI 10.1074/jbc.M112.342758; Coles SJ, 2009, BIOCHEMISTRY-US, V48, P645, DOI 10.1021/bi801805h; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Dietz KJ, 2008, PHYSIOL PLANTARUM, V133, P459, DOI 10.1111/j.1399-3054.2008.01120.x; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Fermani S, 2007, P NATL ACAD SCI USA, V104, P11109, DOI 10.1073/pnas.0611636104; Fermani S, 2012, J BIOL CHEM, V287, P21372, DOI 10.1074/jbc.M112.350355; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Forrester MT, 2009, FREE RADICAL BIO MED, V46, P119, DOI 10.1016/j.freeradbiomed.2008.09.034; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Foster MW, 2009, BIOCHEMISTRY-US, V48, P792, DOI 10.1021/bi801813n; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gao XH, 2010, FEBS LETT, V584, P2242, DOI 10.1016/j.febslet.2010.04.034; Gelhaye E, 2003, FEBS LETT, V555, P443, DOI 10.1016/S0014-5793(03)01301-2; Gelhaye E, 2002, PHYSIOL PLANTARUM, V114, P165, DOI 10.1034/j.1399-3054.2002.1140202.x; Giustarini D, 2005, ANTIOXID REDOX SIGN, V7, P930, DOI 10.1089/ars.2005.7.930; Giustarini D, 2009, CRIT REV CL LAB SCI, V46, P241, DOI 10.3109/10408360903142326; Goyer A, 1999, FEBS LETT, V444, P165, DOI 10.1016/S0014-5793(99)00051-4; Hancock JT, 2009, MOL BIOTECHNOL, V43, P162, DOI 10.1007/s12033-009-9189-1; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hogg N, 2002, ANNU REV PHARMACOL, V42, P585, DOI 10.1146/annurev.pharmtox.42.092501.104328; Holtgrefe S, 2008, PHYSIOL PLANTARUM, V133, P211, DOI 10.1111/j.1399-3054.2008.01066.x; JACQUOT JP, 1994, J MOL BIOL, V235, P1357, DOI 10.1006/jmbi.1994.1091; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Kaneko R, 2003, J MASS SPECTROM, V38, P526, DOI 10.1002/jms.466; Konorev EA, 2000, FREE RADICAL BIO MED, V28, P1671, DOI 10.1016/S0891-5849(00)00281-1; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Lindermayr C, 2009, J PROTEOMICS, V73, P1, DOI 10.1016/j.jprot.2009.07.002; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2000, P NATL ACAD SCI USA, V97, P4672, DOI 10.1073/pnas.090083597; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Marri L, 2009, MOL PLANT, V2, P259, DOI 10.1093/mp/ssn061; Mazzola JL, 2003, J NEUROSCI RES, V71, P279, DOI 10.1002/jnr.10484; Mitchell DA, 2005, NAT CHEM BIOL, V1, P154, DOI 10.1038/nchembio720; Mitchell DA, 2007, P NATL ACAD SCI USA, V104, P11609, DOI 10.1073/pnas.0704898104; Mohr S, 1999, J BIOL CHEM, V274, P9427, DOI 10.1074/jbc.274.14.9427; Moreau M, 2010, PHYSIOL PLANTARUM, V138, P372, DOI 10.1111/j.1399-3054.2009.01308.x; Nakamura T, 2010, MOL CELL, V39, P184, DOI 10.1016/j.molcel.2010.07.002; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; Paige JS, 2008, CHEM BIOL, V15, P1307, DOI 10.1016/j.chembiol.2008.10.013; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Qu J, 2011, P NATL ACAD SCI USA, V108, P14330, DOI 10.1073/pnas.1105172108; Romero JM, 2009, J NEUROSCI RES, V87, P701, DOI 10.1002/jnr.21897; Romero-Puertas MC, 2008, PROTEOMICS, V8, P1459, DOI 10.1002/pmic.200700536; Rouhier N, 2007, P NATL ACAD SCI USA, V104, P7379, DOI 10.1073/pnas.0702268104; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Sengupta R, 2013, ANTIOXID REDOX SIGN, V18, P259, DOI 10.1089/ars.2012.4716; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; Sicard-Roselli C, 2004, EUR J BIOCHEM, V271, P3481, DOI 10.1111/j.1432-1033.2004.04279.x; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Sliskovic I, 2005, J BIOL CHEM, V280, P8733, DOI 10.1074/jbc.M408080200; Spadaro D, 2010, PHYSIOL PLANTARUM, V138, P360, DOI 10.1111/j.1399-3054.2009.01307.x; Srinivasan U, 1997, BIOCHEMISTRY-US, V36, P3199, DOI 10.1021/bi962017t; Starke DW, 1997, FREE RADICAL BIO MED, V23, P373, DOI 10.1016/S0891-5849(97)00009-9; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Sun JH, 2010, CIRC RES, V106, P285, DOI 10.1161/CIRCRESAHA.109.209452; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Talfournier F, 1998, EUR J BIOCHEM, V252, P447, DOI 10.1046/j.1432-1327.1998.2520447.x; Tanou G, 2012, PLANT J, V72, P585, DOI 10.1111/j.1365-313X.2012.05100.x; Tanou G, 2009, PLANT J, V60, P795, DOI 10.1111/j.1365-313X.2009.04000.x; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Vescovi M, 2013, PLANT PHYSIOL, V162, P333, DOI 10.1104/pp.113.215194; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Wang XW, 1999, ARCH BIOCHEM BIOPHYS, V367, P348, DOI 10.1006/abbi.1999.1261; Wang YQ, 2009, J BIOL CHEM, V284, P2131, DOI 10.1074/jbc.M806782200; Wawer I, 2010, BIOCHEM J, V429, P73, DOI 10.1042/BJ20100492; Wu CG, 2011, J PROTEOMICS, V74, P2498, DOI 10.1016/j.jprot.2011.06.001; Wu C, 2010, MOL CELL PROTEOMICS, V9, P2262, DOI 10.1074/mcp.M110.000034; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540; Yu MD, 2012, CURR OPIN PLANT BIOL, V15, P424, DOI 10.1016/j.pbi.2012.03.005; Yun BW, 2011, NATURE, V478, P264, DOI 10.1038/nature10427; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x; Zaffagnini M, 2012, ANTIOXID REDOX SIGN, V16, P17, DOI 10.1089/ars.2011.3933	94	83	84	2	40	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 2	2013	288	31					22777	22789		10.1074/jbc.M113.475467	http://dx.doi.org/10.1074/jbc.M113.475467			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	302HY	23749990	Green Published, hybrid			2022-12-28	WOS:000330596300055
J	Antinone, SE; Ghadge, GD; Lam, TT; Wang, LJ; Roos, RP; Green, WN				Antinone, Sarah E.; Ghadge, Ghanashyam D.; Lam, Tukiet T.; Wang, Lijun; Roos, Raymond P.; Green, William N.			Palmitoylation of Superoxide Dismutase 1 (SOD1) Is Increased for Familial Amyotrophic Lateral Sclerosis-linked SOD1 Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (Lou Gehrig Disease); Neurodegenerative Diseases; Post-translational Modification; Protein Palmitoylation; Superoxide Dismutase (SOD)	WILD-TYPE SOD1; UNFOLDED PROTEIN RESPONSE; MOTOR-NEURONS; SPINAL-CORD; ER STRESS; CU,ZN-SUPEROXIDE DISMUTASE; MAMMALIAN-CELLS; TRANSGENIC MICE; DISULFIDE BOND; FREE CYSTEINES	Mutations in Cu,Zn-superoxide dismutase (mtSOD1) cause familial amyotrophic lateral sclerosis (FALS), a neurodegenerative disease resulting from motor neuron degeneration. Here, we demonstrate that wild type SOD1 (wtSOD1) undergoes palmitoylation, a reversible post-translational modification that can regulate protein structure, function, and localization. SOD1 palmitoylation was confirmed by multiple techniques, including acyl-biotin exchange, click chemistry, cysteine mutagenesis, and mass spectrometry. Mass spectrometry and cysteine mutagenesis demonstrated that cysteine residue 6 was the primary site of palmitoylation. The palmitoylation of FALS-linked mtSOD1s (A4V and G93A) was significantly increased relative to that of wtSOD1 expressed in HEK cells and a motor neuron cell line. The palmitoylation of FALS-linked mtSOD1s (G93A and G85R) was also increased relative to that of wtSOD1 when assayed from transgenic mouse spinal cords. We found that the level of SOD1 palmitoylation correlated with the level of membrane-associated SOD1, suggesting a role for palmitoylation in targeting SOD1 to membranes. We further observed that palmitoylation occurred predominantly on disulfide-reduced as opposed to disulfide-bonded SOD1, suggesting that immature SOD1 is the primarily palmitoylated species. Increases in SOD1 disulfide bonding and maturation with increased copper chaperone for SOD1 expression caused a decrease in wtSOD1 palmitoylation. Copper chaperone for SOD1 overexpression decreased A4V palmitoylation less than wtSOD1 and had little effect on G93A mtSOD1 palmitoylation. These findings suggest that SOD1 palmitoylation occurs prior to disulfide bonding during SOD1 maturation and that palmitoylation is increased when disulfide bonding is delayed or decreased as observed for several mtSOD1s.	[Antinone, Sarah E.; Green, William N.] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Ghadge, Ghanashyam D.; Wang, Lijun; Roos, Raymond P.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Lam, Tukiet T.] Yale Univ, WM Keck Biotechnol Resource Lab, New Haven, CT 06511 USA	University of Chicago; University of Chicago; Yale University	Roos, RP (corresponding author), Univ Chicago, Dept Neurol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	rroos@neurology.bsd.uchicago.edu; wgreen@bsd.uchicago.edu			National Institutes of Health [NS043782, DA019695, MH081251, F32NS077609]; Yale University/NIDA Neuroproteomics Center [P30DA018343]; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH081251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS077609, R56NS043782, R01NS043782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035430, P30DA018343, P01DA019695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale University/NIDA Neuroproteomics Center; Epilepsy Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants NS043782, DA019695, and MH081251 and by the Yale University/NIDA Neuroproteomics Center Grant P30DA018343 (to W. N. G.).; Supported by National Institutes of Health Grant F32NS077609 and by the Epilepsy Foundation.	ABERNETHY JL, 1974, J BIOL CHEM, V249, P7339; Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2013, NAT CHEM BIOL, V9, P297, DOI [10.1038/NCHEMBIO.1202, 10.1038/nchembio.1202]; Banci L, 2009, P NATL ACAD SCI USA, V106, P6980, DOI 10.1073/pnas.0809845106; Bianchetta MJ, 2011, J NEUROSCI, V31, P12029, DOI 10.1523/JNEUROSCI.2388-11.2011; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brotherton T, 2011, AMYOTROPH LATERAL SC, V12, P215, DOI 10.3109/17482968.2010.531279; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruns CK, 2007, EMBO J, V26, P855, DOI 10.1038/sj.emboj.7601528; Caruano-Yzermans AL, 2006, J BIOL CHEM, V281, P13581, DOI 10.1074/jbc.M601580200; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; CHANG LY, 1988, J CELL BIOL, V107, P2169, DOI 10.1083/jcb.107.6.2169; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Cozzolino M, 2008, J BIOL CHEM, V283, P866, DOI 10.1074/jbc.M705657200; Cozzolino M, 2012, PROG NEUROBIOL, V97, P54, DOI 10.1016/j.pneurobio.2011.06.003; De Vos KJ, 2007, HUM MOL GENET, V16, P2720, DOI 10.1093/hmg/ddm226; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; Fujisawa T, 2012, ANN NEUROL, V72, P739, DOI 10.1002/ana.23668; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Ghadge GD, 2006, NEUROBIOL DIS, V21, P194, DOI 10.1016/j.nbd.2005.07.006; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hang HC, 2007, J AM CHEM SOC, V129, P2744, DOI 10.1021/ja0685001; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kawamata H, 2008, HUM MOL GENET, V17, P3303, DOI 10.1093/hmg/ddn226; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Lelie HL, 2011, J BIOL CHEM, V286, P2795, DOI 10.1074/jbc.M110.186999; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; Li QA, 2010, P NATL ACAD SCI USA, V107, P21146, DOI 10.1073/pnas.1014862107; Magrane J, 2012, J NEUROSCI, V32, P229, DOI 10.1523/JNEUROSCI.1233-11.2012; Marin EP, 2012, CIRC RES, V110, P1336, DOI 10.1161/CIRCRESAHA.112.269514; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Morita M, 1996, NEUROSCI LETT, V205, P79, DOI 10.1016/0304-3940(96)12378-8; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Oh YK, 2008, J NEUROCHEM, V104, P993, DOI 10.1111/j.1471-4159.2007.05053.x; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Proescher JB, 2008, HUM MOL GENET, V17, P1728, DOI 10.1093/hmg/ddn063; Prudencio M, 2012, J NEUROCHEM, V121, P475, DOI 10.1111/j.1471-4159.2012.07690.x; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Tobisawa S, 2003, BIOCHEM BIOPH RES CO, V303, P496, DOI 10.1016/S0006-291X(03)00353-X; Urushitani M, 2008, FASEB J, V22, P2476, DOI 10.1096/fj.07-092783; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang LJ, 2011, HUM MOL GENET, V20, P1008, DOI 10.1093/hmg/ddq546; Wang LJ, 2009, NEUROBIOL DIS, V35, P234, DOI 10.1016/j.nbd.2009.05.002; Wang LJ, 2009, HUM MOL GENET, V18, P1642, DOI 10.1093/hmg/ddp085; Watanabe S, 2007, FREE RADICAL BIO MED, V42, P1534, DOI 10.1016/j.freeradbiomed.2007.02.004; Wilcox KC, 2009, J BIOL CHEM, V284, P13940, DOI 10.1074/jbc.M809687200; Young FB, 2012, PROG NEUROBIOL, V97, P220, DOI 10.1016/j.pneurobio.2011.11.002; Zhao WH, 2010, GLIA, V58, P231, DOI 10.1002/glia.20919	74	30	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					21606	21617		10.1074/jbc.M113.487231	http://dx.doi.org/10.1074/jbc.M113.487231			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23760509	hybrid, Green Published			2022-12-28	WOS:000328841900013
J	Wang, C; Chang, JYF; Yang, CF; Huang, YQ; Liu, JC; You, P; McKeehan, WL; Wang, F; Li, XK				Wang, Cong; Chang, Julia Yu Fong; Yang, Chaofeng; Huang, Yanqing; Liu, Junchen; You, Pan; McKeehan, Wallace L.; Wang, Fen; Li, Xiaokun			Type 1 Fibroblast Growth Factor Receptor in Cranial Neural Crest Cell-derived Mesenchyme Is Required for Palatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Craniofacial Development; Fibroblast Growth Factor (FGF); Fibroblast Growth Factor Receptor (FGFR); Transgenic Mice; Tyrosinase	ABNORMAL TONGUE DEVELOPMENT; CAUSES CLEFT-PALATE; CRANIOFACIAL DEVELOPMENT; HYPOGONADOTROPIC HYPOGONADISM; MOUSE EMBRYOS; MUTANT MICE; LIP; FGFR1; FUSION; TRANSFORMATION	Cleft palate is a common congenital birth defect. The fibroblast growth factor (FGF) family has been shown to be important for palatogenesis, which elicits the regulatory functions by activating the FGF receptor tyrosine kinase. Mutations in Fgf or Fgfr are associated with cleft palate. To date, most mechanistic studies on FGF signaling in palate development have focused on FGFR2 in the epithelium. Although Fgfr1 is expressed in the cranial neural crest (CNC)-derived palate mesenchyme and Fgfr1 mutations are associated with palate defects, how FGFR1 in palate mesenchyme regulates palatogenesis is not well understood. Here, we reported that by using Wnt1(Cre) to delete Fgfr1 in neural crest cells led to cleft palate, cleft lip, and other severe craniofacial defects. Detailed analyses revealed that loss-of-function mutations in Fgfr1 did not abrogate patterning of CNC cells in palate shelves. However, it upset cell signaling in the frontofacial areas, delayed cell proliferation in both epithelial and mesenchymal compartments, prevented palate shelf elevation, and compromised palate shelf fusion. This is the first report revealing how FGF signaling in CNC cells regulates palatogenesis.	[Wang, Cong; Li, Xiaokun] Wenzhou Med Coll, Coll Pharm, Wenzhou 325000, Zhejiang, Peoples R China; [Wang, Cong; Chang, Julia Yu Fong; Yang, Chaofeng; Huang, Yanqing; Liu, Junchen; You, Pan; McKeehan, Wallace L.; Wang, Fen] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA	Wenzhou Medical University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Wang, F (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Canc & Stem Cell Biol, Houston, TX 77030 USA.	fwang@ibt.tamhsc.edu; xiaokunli@163.net		CHANG, JULIA YU-FONG/0000-0002-3880-3787; Liu, Junchen/0000-0003-2765-9780	National Institutes of Health [K08DE020883]; USPHS [CA96824, CA140388]; Natural Science Foundation of Zhejiang Province of China [Y2110492]; J. S. Dunn Research Foundation; Cancer Prevention and Research Institution of Texas [CPRIT110555]; National Natural Science Foundation of China [81101712, 81270761]; NATIONAL CANCER INSTITUTE [R56CA096824, R01CA096824, P50CA140388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE020883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); J. S. Dunn Research Foundation; Cancer Prevention and Research Institution of Texas; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant K08DE020883 (to J. Y. C.) and Grants CA96824 and CA140388 from USPHS (to F. W.). This work was also supported by the Natural Science Foundation of Zhejiang Province of China Grant Y2110492 (to C. W.), the J. S. Dunn Research Foundation (to W. L. M.), and Grant CPRIT110555 from the Cancer Prevention and Research Institution of Texas (to F. W. and W. L. M.), and the National Natural Science Foundation of China Grants 81101712 and 81270761 (to X. L.).	Alappat S, 2003, CELL RES, V13, P429, DOI 10.1038/sj.cr.7290185; Alappat SR, 2005, DEV BIOL, V277, P102, DOI 10.1016/j.ydbio.2004.09.010; Barrow JR, 1999, DEVELOPMENT, V126, P5011; Bjork BC, 2010, HUM MOL GENET, V19, P774, DOI 10.1093/hmg/ddp543; Casey LM, 2006, DEV DYNAM, V235, P1830, DOI 10.1002/dvdy.20821; Chai Y, 1998, INT J DEV BIOL, V42, P87; Charoenchaikorn K, 2009, DEV BIOL, V326, P392, DOI 10.1016/j.ydbio.2008.10.018; Cobourne MT, 2009, DEV BIOL, V331, P38, DOI 10.1016/j.ydbio.2009.04.021; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; GENDRONMAGUIRE M, 1993, CELL, V75, P1317, DOI 10.1016/0092-8674(93)90619-2; He FL, 2011, DEV BIOL, V350, P511, DOI 10.1016/j.ydbio.2010.12.021; He FL, 2010, DEV BIOL, V347, P109, DOI 10.1016/j.ydbio.2010.08.014; Hosokawa R, 2009, J EXP ZOOL PART B, V312B, P343, DOI 10.1002/jez.b.21274; Huang X, 2008, DEV DYNAM, V237, P3079, DOI 10.1002/dvdy.21714; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Jiang RL, 2006, DEV DYNAM, V235, P1152, DOI 10.1002/dvdy.20646; Jin YR, 2012, DEVELOPMENT, V139, P1821, DOI 10.1242/dev.075796; Kaartinen V, 1997, DEV DYNAM, V209, P255, DOI 10.1002/(SICI)1097-0177(199707)209:3<255::AID-AJA1>3.0.CO;2-H; Kanda T, 2003, ARCH ORAL BIOL, V48, P213, DOI 10.1016/S0003-9969(02)00204-2; KHRAPUNOV SM, 1975, UKR BIOKHIM ZH+, V47, P284; Kim HG, 2005, J MED GENET, V42, P666, DOI 10.1136/jmg.2004.026989; Lee JM, 2008, DEV BIOL, V314, P341, DOI 10.1016/j.ydbio.2007.11.033; Lee S, 2001, PLAST RECONSTR SURG, V107, P1776, DOI 10.1097/00006534-200106000-00021; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Martinez-Abadias N, 2013, DIS MODEL MECH, V6, P768, DOI 10.1242/dmm.010397; Matsumura K, 2011, BIOCHEM BIOPH RES CO, V404, P1076, DOI 10.1016/j.bbrc.2010.12.116; MCKEEHAN WL, 2009, HDB CELL SIGNALING, P253; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Minowada G, 1999, DEVELOPMENT, V126, P4465; Murray SA, 2007, DEVELOPMENT, V134, P1789, DOI 10.1242/dev.02837; Nie XG, 2006, ORAL DIS, V12, P102, DOI 10.1111/j.1601-0825.2005.01176.x; Pitteloud N, 2006, P NATL ACAD SCI USA, V103, P6281, DOI 10.1073/pnas.0600962103; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Ricks JE, 2002, TERATOLOGY, V65, P116, DOI 10.1002/tera.10022; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Sato N, 2004, J CLIN ENDOCR METAB, V89, P1079, DOI 10.1210/jc.2003-030476; Shimabukuro Y, 2008, MATRIX BIOL, V27, P232, DOI 10.1016/j.matbio.2007.10.005; SHIOTA K, 1990, ACTA ANAT, V137, P59; SHULER CF, 1995, CRIT REV ORAL BIOL M, V6, P202, DOI 10.1177/10454411950060030301; Snyder-Warwick AK, 2012, J CRANIOFAC SURG, V23, P397, DOI 10.1097/SCS.0b013e318240fed7; Snyder-Warwick AK, 2010, P NATL ACAD SCI USA, V107, P2515, DOI 10.1073/pnas.0913985107; Song ZC, 2013, J BIOL CHEM, V288, P10440, DOI 10.1074/jbc.M112.432286; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takamori K, 2008, J DENT RES, V87, P238, DOI 10.1177/154405910808700307; TRAINOR PA, 1994, DEVELOPMENT, V120, P2397; Trokovic N, 2003, GENE DEV, V17, P141, DOI 10.1101/gad.250703; Trokovic R, 2003, EMBO J, V22, P1811, DOI 10.1093/emboj/cdg169; Welsh IC, 2007, MECH DEVELOP, V124, P746, DOI 10.1016/j.mod.2007.06.007; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601; Zhang ZY, 2002, DEVELOPMENT, V129, P4135	51	48	50	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 26	2013	288	30					22174	22183		10.1074/jbc.M113.463620	http://dx.doi.org/10.1074/jbc.M113.463620			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	277TJ	23754280	Green Published, hybrid			2022-12-28	WOS:000328841900060
J	Nakamura, I; Fernandez-Barrena, MG; Ortiz-Ruiz, MC; Almada, LL; Hu, CL; Elsawa, SF; Mills, LD; Romecin, PA; Gulaid, KH; Moser, CD; Han, JJ; Vrabel, A; Hanse, EA; Akogyeram, NA; Albrecht, JH; Monga, SPS; Sanderson, SO; Prieto, J; Roberts, LR; Fernandez-Zapico, ME				Nakamura, Ikuo; Fernandez-Barrena, Maite G.; Ortiz-Ruiz, Maria C.; Almada, Luciana L.; Hu, Chunling; Elsawa, Sherine F.; Mills, Lisa D.; Romecin, Paola A.; Gulaid, Kadra H.; Moser, Catherine D.; Han, Jing-Jing; Vrabel, Anne; Hanse, Eric A.; Akogyeram, Nicholas A.; Albrecht, Jeffrey H.; Monga, Satdarshan P. S.; Sanderson, Schuyler O.; Prieto, Jesus; Roberts, Lewis R.; Fernandez-Zapico, Martin E.			Activation of the Transcription Factor GLI1 by WNT Signaling Underlies the Role of SULFATASE 2 as a Regulator of Tissue Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE; LIVER-REGENERATION; HEDGEHOG; CANCER; EXPRESSION; GROWTH; 6-O-ENDOSULFATASES; RESTORATION; HEPATOCYTES; SURVIVAL	Tissue regeneration requires the activation of a set of specific growth signaling pathways. The identity of these cascades and their biological roles are known; however, the molecular mechanisms regulating the interplay between these pathways remain poorly understood. Here, we define a new role for SULFATASE 2 (SULF2) in regulating tissue regeneration and define the WNT-GLI1 axis as a novel downstream effector for this sulfatase in a liver model of tissue regeneration. SULF2 is a heparan sulfate 6-O-endosulfatase, which releases growth factors from extracellular storage sites turning active multiple signaling pathways. We demonstrate that SULF2-KO mice display delayed regeneration after partial hepatectomy (PH). Mechanistic analysis of the SULF2-KO phenotype showed a decrease in WNT signaling pathway activity in vivo. In isolated hepatocytes, SULF2 deficiency blocked WNT-induced beta-CATENIN nuclear translocation, TCF activation, and proliferation. Furthermore, we identified the transcription factor GLI1 as a novel target of the SULF2-WNT cascade. WNT induces GLI1 expression in a SULF2-and beta-CATENIN-dependent manner. GLI1-KO mice phenocopied the SULF2-KO, showing delayed regeneration and decreased hepatocyte proliferation. Moreover, we identified CYCLIN D1, a key mediator of cell growth during tissue regeneration, as a GLI1 transcriptional target. GLI1 binds to the cyclin d1 promoter and regulates its activity and expression. Finally, restoring GLI1 expression in the liver of SULF2-KO mice after PH rescues CYCLIN D1 expression and hepatocyte proliferation to wild-type levels. Thus, together these findings define a novel pathway in which SULF2 regulates tissue regeneration in part via the activation of a novel WNT-GLI1-CYCLIN D1 pathway.	[Nakamura, Ikuo; Hu, Chunling; Gulaid, Kadra H.; Moser, Catherine D.; Akogyeram, Nicholas A.; Roberts, Lewis R.; Fernandez-Zapico, Martin E.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Nakamura, Ikuo; Hu, Chunling; Gulaid, Kadra H.; Moser, Catherine D.; Akogyeram, Nicholas A.; Roberts, Lewis R.; Fernandez-Zapico, Martin E.] Mayo Clin Canc Ctr, Rochester, MN 55905 USA; [Fernandez-Barrena, Maite G.; Almada, Luciana L.; Mills, Lisa D.; Han, Jing-Jing; Vrabel, Anne; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Sanderson, Schuyler O.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Ortiz-Ruiz, Maria C.; Romecin, Paola A.] Univ Murcia, Fac Med, Dept Fisiol, E-30100 Murcia, Spain; [Elsawa, Sherine F.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Hanse, Eric A.; Albrecht, Jeffrey H.] Hennepin Cty Med Ctr, Div Gastroenterol, Minneapolis, MN 55404 USA; [Monga, Satdarshan P. S.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15216 USA; [Monga, Satdarshan P. S.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15216 USA; [Prieto, Jesus] Ctr Invest Med Aplicada, Pamplona 31008, Spain	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Murcia; Northern Illinois University; Hennepin County Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roberts, LR (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	roberts.lewis@mayo.edu; fernandezzapico.martin@mayo.edu	ORTIZ, MARÍA CLARA/AAB-8660-2020; Fernandez-Barrena, Maite G/J-8040-2014; Romecin, Paola A/AAA-5432-2019	ORTIZ, MARÍA CLARA/0000-0001-9430-6550; Fernandez-Barrena, Maite G/0000-0003-0375-6236; Monga, Satdarshan/0000-0002-8437-3378; Roberts, Lewis/0000-0001-7885-8574; Hanse, Eric/0000-0002-1234-0198; Romecin Duran, Paola Alejandra/0000-0001-6890-5883; Hu, Chunling/0000-0002-6814-4639	National Institutes of Health [CA100882, CA128633, CA165076]; Mayo Clinic Center for Cell Signaling in Gastroenterology [NIDDK P30DK084567]; Mayo Clinic Cancer Center [CA15083]; Mayo Clinic Center for Translational Science Activities (National Institutes of Health/NCRR CTSA Grant) [KL2 RR024151]; American Gastroenterological Association Foundation for Digestive Health and Nutrition Bridging Grant; NATIONAL CANCER INSTITUTE [R56CA100882, R01CA165076, R01CA100882, R21CA128633, P30CA015083] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK054921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Cell Signaling in Gastroenterology; Mayo Clinic Cancer Center; Mayo Clinic Center for Translational Science Activities (National Institutes of Health/NCRR CTSA Grant); American Gastroenterological Association Foundation for Digestive Health and Nutrition Bridging Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA100882 and CA128633 (to L. R. R.) and CA165076 (to L. R. R. and M. E. F.-Z.); the Mayo Clinic Center for Cell Signaling in Gastroenterology (NIDDK P30DK084567) (to M. E. F.-Z.); the Mayo Clinic Cancer Center (CA15083), the Mayo Clinic Center for Translational Science Activities (National Institutes of Health/NCRR CTSA Grant KL2 RR024151), and an American Gastroenterological Association Foundation for Digestive Health and Nutrition Bridging Grant (to L. R. R.).	Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Bertrand FE, 2012, CELL CYCLE, V11, P4344, DOI 10.4161/cc.22134; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; DELAHUNTY TJ, 1970, J LIPID RES, V11, P536; Elsawa SF, 2011, J BIOL CHEM, V286, P21524, DOI 10.1074/jbc.M111.234146; Epps CW., 2012, ISSUES ECOL FAL, V2012, P1; Farooqi AA, 2011, CELL PROLIFERAT, V44, P508, DOI 10.1111/j.1365-2184.2011.00784.x; Frese MA, 2009, J BIOL CHEM, V284, P28033, DOI 10.1074/jbc.M109.035808; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; GUMUCIO JJ, 1986, HEPATOLOGY, V6, P932, DOI 10.1002/hep.1840060521; Hanse EA, 2012, CELL CYCLE, V11, P2681, DOI 10.4161/cc.21019; Hanse EA, 2009, CELL CYCLE, V8, P2802, DOI 10.4161/cc.8.17.9465; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2010, HEPATOLOGY, V52, P1680, DOI 10.1002/hep.23848; Lamanna WC, 2006, BIOCHEM J, V400, P63, DOI 10.1042/BJ20060848; Lemjabbar-Alaoui H, 2010, ONCOGENE, V29, P635, DOI 10.1038/onc.2009.365; Liang KW, 2004, GENE THER, V11, P901, DOI 10.1038/sj.gt.3302239; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; MICHALOPOULOS G, 1982, CANCER RES, V42, P4673; Monga SPS, 2001, HEPATOLOGY, V33, P1098, DOI 10.1053/jhep.2001.23786; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Nejak-Bowen Kari, 2008, Organogenesis, V4, P92; Nejak-Bowen KN, 2010, HEPATOLOGY, V51, P1603, DOI 10.1002/hep.23538; Ochoa B, 2010, HEPATOLOGY, V51, P1712, DOI 10.1002/hep.23525; Park HL, 2000, DEVELOPMENT, V127, P1593; Sekine S, 2007, HEPATOLOGY, V45, P361, DOI 10.1002/hep.21523; Shteyer E, 2004, HEPATOLOGY, V40, P1322, DOI 10.1002/hep.20462; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Wilson NH, 2012, VITAM HORM, V88, P173, DOI 10.1016/B978-0-12-394622-5.00008-0; Yu M, 2009, J BIOL CHEM, V284, P5620, DOI 10.1074/jbc.M809172200; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200	37	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 19	2013	288	29					21389	21398		10.1074/jbc.M112.443440	http://dx.doi.org/10.1074/jbc.M112.443440			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	186AU	23740243	Green Published, hybrid			2022-12-28	WOS:000322014400057
J	Sudo, Y; Okazaki, A; Ono, H; Yagasaki, J; Sugo, S; Kamiya, M; Reissig, L; Inoue, K; Ihara, K; Kandori, H; Takagi, S; Hayashi, S				Sudo, Yuki; Okazaki, Ayako; Ono, Hikaru; Yagasaki, Jin; Sugo, Seiya; Kamiya, Motoshi; Reissig, Louisa; Inoue, Keiichi; Ihara, Kunio; Kandori, Hideki; Takagi, Shin; Hayashi, Shigehiko			A Blue-shifted Light-driven Proton Pump for Neural Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSORY RHODOPSIN-II; PHARAONIS PHOBORHODOPSIN; RETINAL PROTEINS; NATRONOBACTERIUM-PHARAONIS; WAVELENGTH REGULATION; VISUAL PIGMENTS; OPSIN SHIFT; BACTERIORHODOPSIN; BINDING; CHROMOPHORE	Ion-transporting rhodopsins are widely utilized as optogenetic tools both for light-induced neural activation and silencing. The most studied representative is Bacteriorhodopsin (BR), which absorbs green/red light (similar to 570 nm) and functions as a proton pump. Upon photoexcitation, BR induces a hyperpolarization across the membrane, which, if incorporated into a nerve cell, results in its neural silencing. In this study, we show that several residues around the retinal chromophore, which are completely conserved among BR homologs from the archaea, are involved in the spectral tuning in a BR homolog (HwBR) and that the combination mutation causes a large spectral blue shift (lambda(max) = 498 nm) while preserving the robust pumping activity. Quantum mechanics/molecular mechanics calculations revealed that, compared with the wild type, the beta-ionone ring of the chromophore in the mutant is rotated similar to 130 degrees because of the lack of steric hindrance between the methyl groups of the retinal and the mutated residues, resulting in the breakage of the pi conjugation system on the polyene chain of the retinal. By the same mutations, similar spectral blue shifts are also observed in another BR homolog, archearhodopsin-3 (also called Arch). The color variant of archearhodopsin-3 could be successfully expressed in the neural cells of Caenorhabditis elegans, and illumination with blue light (500 nm) led to the effective locomotory paralysis of the worms. Thus, we successfully produced a blue-shifted proton pump for neural silencing.	[Sudo, Yuki; Okazaki, Ayako; Yagasaki, Jin; Reissig, Louisa; Takagi, Shin] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Ihara, Kunio] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Sudo, Yuki; Inoue, Keiichi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Sudo, Yuki] Inst Mol Sci, Dept Life & Coordinat Complex Mol Sci, Okazaki, Aichi 4448585, Japan; [Ono, Hikaru; Inoue, Keiichi; Kandori, Hideki] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Sugo, Seiya; Kamiya, Motoshi; Hayashi, Shigehiko] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Nagoya Institute of Technology; Kyoto University	Sudo, Y (corresponding author), Nagoya Univ, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648602, Japan.	z47867a@cc.nagoya-u.ac.jp	Sudo, Yuki/AGY-0493-2022; Inoue, Keiichi/AEO-3337-2022; IHARA, Kunio/D-1952-2011	Sudo, Yuki/0000-0001-8155-9356; Inoue, Keiichi/0000-0002-6898-4347; 	Japanese Ministry of Education, Culture, Sports, Science, and Technology [22018010, 23687019, 23657100, 24115508, 24655009, 23107717, 23700580]; Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research [22300126, 23657100] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by Grants 22018010, 23687019, and 23657100 (to Y. S.), 24115508 and 24655009 (to K. I.), and 23107717 and 23700580 (to S. H.) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology and by funds from the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (to S. H.).	Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; BLATZ PE, 1972, BIOCHEMISTRY-US, V11, P848, DOI 10.1021/bi00755a026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cembran A, 2005, J PHYS CHEM A, V109, P6597, DOI 10.1021/jp052068c; Chizhov I, 1998, BIOPHYS J, V75, P999, DOI 10.1016/S0006-3495(98)77588-5; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Fujimoto K, 2007, J CHEM THEORY COMPUT, V3, P605, DOI 10.1021/ct6002687; GREENHALGH DA, 1993, J BIOL CHEM, V268, P20305; Hayashi S, 2001, J PHYS CHEM B, V105, P10124, DOI 10.1021/jp011362b; HONIG B, 1979, J AM CHEM SOC, V101, P7084, DOI 10.1021/ja00517a060; HU JG, 1994, P NATL ACAD SCI USA, V91, P8880, DOI 10.1073/pnas.91.19.8880; Kitajima-Ihara T, 2008, J BIOL CHEM, V283, P23533, DOI 10.1074/jbc.M802990200; Kosugi T, 2012, J CHEM THEORY COMPUT, V8, P322, DOI 10.1021/ct2005837; Kouyama T, 2010, PHOTOCH PHOTOBIO SCI, V9, P1458, DOI 10.1039/c0pp00236d; Losi A, 2012, ANNU REV PLANT BIOL, V63, P49, DOI 10.1146/annurev-arplant-042811-105538; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Nielsen MB, 2009, CHEM SOC REV, V38, P913, DOI 10.1039/b802068j; Okazaki A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035370; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pastrana E, 2011, NAT METHODS, V8, P447, DOI 10.1038/nmeth0611-447; Rajamani R, 2002, J COMPUT CHEM, V23, P96, DOI 10.1002/jcc.1159; Sasaki J, 2008, PHOTOCHEM PHOTOBIOL, V84, P863, DOI 10.1111/j.1751-1097.2008.00314.x; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 2001, BBA-BIOMEMBRANES, V1515, P92, DOI 10.1016/S0005-2736(01)00394-7; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; Sudo Y, 2002, BIOPHYS J, V83, P427, DOI 10.1016/S0006-3495(02)75180-1; Sudo Y, 2001, PHOTOCHEM PHOTOBIOL, V74, P489, DOI 10.1562/0031-8655(2001)074<0489:PPBTIC>2.0.CO;2; Sudo Y., 2012, CRC HDB ORGANIC PHOT, P1173; Sudo Y, 2006, P NATL ACAD SCI USA, V103, P16129, DOI 10.1073/pnas.0607467103; Sudo Y, 2011, J BIOL CHEM, V286, P11328, DOI 10.1074/jbc.M110.187948; Sudo Y, 2011, J BIOL CHEM, V286, P5967, DOI 10.1074/jbc.M110.190058; Sudo Y, 2009, BIOCHEMISTRY-US, V48, P10136, DOI 10.1021/bi901338d; Suzuki D, 2009, J MOL BIOL, V392, P48, DOI 10.1016/j.jmb.2009.06.050; Wanko M, 2005, J PHYS CHEM B, V109, P3606, DOI 10.1021/jp0463060; YAN B, 1995, J BIOL CHEM, V270, P29668; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004	39	53	55	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 12	2013	288	28					20624	20632		10.1074/jbc.M113.475533	http://dx.doi.org/10.1074/jbc.M113.475533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	182BI	23720753	Green Published, hybrid			2022-12-28	WOS:000321715100048
J	Uranga, RM; Katz, S; Salvador, GA				Maria Uranga, Romina; Katz, Sebastian; Alejandra Salvador, Gabriela			Enhanced Phosphatidylinositol 3-kinase (PI3K)/Akt Signaling Has Pleiotropic Targets in Hippocampal Neurons Exposed to Iron-induced Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REGULATION; NUCLEAR TRANSLOCATION; SUPEROXIDE-DISMUTASE; AKT PHOSPHORYLATION; SYNAPTIC ENDINGS; CELL-DEATH; NEURODEGENERATION; PATHWAY; BRAIN; ACTIVATION	The PI3K/Akt pathway is a key component in synaptic plasticity and neuronal survival. The aim of this work was to investigate the participation of the PI3K/Akt pathway and its outcome on different molecular targets such as glycogen synthase kinase 3 beta (GSK3 beta) and Forkhead box-O (FoxO) transcription factors during mild oxidative stress triggered by iron overload. The exposure of mouse hippocampal neurons (HT22) to different concentrations of Fe2+ (25-200 mu M) for 24 h led us to define a mild oxidative injury status (50 mu M Fe2+) in which cell morphology showed changes typical of neuronal damage with increased lipid peroxidation and cellular oxidant levels but no alteration of cellular viability. There was a simultaneous increase in both Akt and GSK3 beta phosphorylation. Levels of phospho-FoxO3a (inactive form) increased in the cytosolic fraction of cells treated with iron in a PI3K-dependent manner. Moreover, PI3K and Akt translocated to the nucleus in response to oxidative stress. Iron-overloaded cells harboring a constitutively active form of Akt showed decreased oxidants levels. Indeed, GSH synthesis under oxidative stress conditions was regulated by activated Akt. Our results show that activation of the PI3K/Akt pathway during iron-induced neurotoxicity regulates multiple targets such as GSK3 beta, FoxO transcriptional activity, and glutathione metabolism, thus modulating the neuronal response to oxidative stress.	[Maria Uranga, Romina; Alejandra Salvador, Gabriela] Inst Invest Bioquim Bahia Blanca, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Maria Uranga, Romina; Katz, Sebastian; Alejandra Salvador, Gabriela] Univ Nacl Sur, RA-8000 Bahia Blanca, Buenos Aires, Argentina; [Maria Uranga, Romina; Katz, Sebastian; Alejandra Salvador, Gabriela] Consejo Nacl Invest Cient & Tecn, RA-8000 Bahia Blanca, Buenos Aires, Argentina	National University of the South; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Salvador, GA (corresponding author), Inst Invest Bioquim Bahia Blanca, La Carrindanga Km 7, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	salvador@criba.edu.ar	Uranga, Romina M/A-7660-2011; Salvador, Gabriela/GOJ-7718-2022	Uranga, Romina Maria/0000-0002-8113-4646	Universidad Nacional del Sur [PGI 24/B179]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT-2010-0936]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 11220090100687]; Fundacion Florencio Fiorini	Universidad Nacional del Sur; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Florencio Fiorini	This work was supported by Universidad Nacional del Sur Grant PGI 24/B179), by Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) Grant PICT-2010-0936), by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grant PIP 11220090100687), and by the Fundacion Florencio Fiorini.	Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Ayton S, 2013, FREE RADICAL BIO MED, V62, P76, DOI 10.1016/j.freeradbiomed.2012.10.558; Badve S, 2010, AM J PATHOL, V176, P2139, DOI 10.2353/ajpath.2010.090477; Bartzokis G, 2004, ANN NY ACAD SCI, V1012, P224, DOI 10.1196/annals.1306.019; Berg Daniela, 2006, Top Magn Reson Imaging, V17, P5, DOI 10.1097/01.rmr.0000245461.90406.ad; Bijur GN, 2001, J BIOL CHEM, V276, P37436, DOI 10.1074/jbc.M105725200; Boehme KA, 2008, P NATL ACAD SCI USA, V105, P7785, DOI 10.1073/pnas.0703423105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castellani RJ, 2007, NEUROCHEM RES, V32, P1640, DOI 10.1007/s11064-007-9360-7; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Choi H, 2012, NEUROTOXICOLOGY, V33, P85, DOI 10.1016/j.neuro.2011.12.005; CONNOR JR, 1992, ANN NEUROL, V32, pS51, DOI 10.1002/ana.410320710; Dai YX, 2007, J PSYCHIATR NEUROSCI, V32, P323; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Fan CD, 2013, J BIOL CHEM, V288, P1674, DOI 10.1074/jbc.M112.416339; Farina M, 2013, NEUROCHEM INT, V62, P575, DOI 10.1016/j.neuint.2012.12.006; Fukunaga K, 2005, J PHARMACOL SCI, V98, P205, DOI 10.1254/jphs.FMJ05001X3; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Joseph JA, 2005, NEUROCHEM RES, V30, P927, DOI 10.1007/s11064-005-6967-4; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Lee YJ, 2009, J NEUROCHEM, V111, P90, DOI 10.1111/j.1471-4159.2009.06297.x; Lijnen PJ, 2010, AM J HYPERTENS, V23, P1128, DOI 10.1038/ajh.2010.128; Los M, 2009, BIOESSAYS, V31, P492, DOI 10.1002/bies.200900005; Lu Q, 2013, EXP PHYSIOL, V98, P934, DOI 10.1113/expphysiol.2012.068361; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Mancuso C, 2007, FRONT BIOSCI-LANDMRK, V12, P1107, DOI 10.2741/2130; Uranga RM, 2009, TOXICOL SCI, V111, P331, DOI 10.1093/toxsci/kfp152; Mateos MV, 2012, BBA-MOL CELL RES, V1823, P2136, DOI 10.1016/j.bbamcr.2012.09.005; Mateos MV, 2008, NEUROCHEM INT, V53, P199, DOI 10.1016/j.neuint.2008.07.005; Meares GP, 2007, J BIOL CHEM, V282, P16989, DOI 10.1074/jbc.M700610200; Medina Miguel, 2011, Int J Alzheimers Dis, V2011, P479249, DOI 10.4061/2011/479249; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Min YK, 2007, EXP CELL RES, V313, P312, DOI 10.1016/j.yexcr.2006.10.013; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Nguyen TLX, 2006, BIOCHEM BIOPH RES CO, V349, P789, DOI 10.1016/j.bbrc.2006.08.120; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Diez GR, 2012, NEUROCHEM INT, V61, P749, DOI 10.1016/j.neuint.2012.06.012; Ryder J, 2004, CELL SIGNAL, V16, P187, DOI 10.1016/j.cellsig.2003.07.004; Salvador Gabriela A, 2010, Int J Alzheimers Dis, V2011, P720658, DOI 10.4061/2011/720658; Salvador GA, 2010, BIOFACTORS, V36, P103, DOI 10.1002/biof.80; Schneider SA, 2009, J NEUROL NEUROSUR PS, V80, P589, DOI 10.1136/jnnp.2008.169953; Schneider SA, 2013, J NEURAL TRANSM, V120, P695, DOI 10.1007/s00702-012-0922-8; Shi QL, 2007, ALZ DIS ASSOC DIS, V21, P276, DOI 10.1097/WAD.0b013e31815721c3; Su B, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-32; Toker A, 2000, MOL PHARMACOL, V57, P652, DOI 10.1124/mol.57.4.652; Toker Alex, 2012, Adv Biol Regul, V52, P78; Uranga RM, 2010, NEUROSCIENCE, V170, P381, DOI 10.1016/j.neuroscience.2010.07.044; Uranga RM, 2007, J NEUROSCI RES, V85, P2924, DOI 10.1002/jnr.21406; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Wang SH, 2012, CURR NEUROVASC RES, V9, P20, DOI 10.2174/156720212799297137; Webster KA, 2004, CIRC RES, V94, P856, DOI 10.1161/01.RES.0000126699.49835.5D; WINTERBOURN CC, 1994, ARCH BIOCHEM BIOPHYS, V314, P284, DOI 10.1006/abbi.1994.1444	60	77	79	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 5	2013	288	27					19773	19784		10.1074/jbc.M113.457622	http://dx.doi.org/10.1074/jbc.M113.457622			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	179JG	23687303	hybrid, Green Published			2022-12-28	WOS:000321515800046
J	Mandal, P; Verma, N; Chauhan, S; Tomar, RS				Mandal, Papita; Verma, Naveen; Chauhan, Sakshi; Tomar, Raghuvir S.			Unexpected Histone H3 Tail-clipping Activity of Glutamate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLTRANSFERASE COMPLEXES; REGULATED EVENT; CHROMATIN; CLEAVAGE; TRANSCRIPTION; PROTEOLYSIS; PROTEINS; BINDING; WATER	Clipping of histone tails has been reported in several organisms. However, the significance and regulation of histone tail clipping largely remains unclear. According to recent discoveries H3 clipping has been found to be involved in regulation of gene expression and chromatin dynamics. Earlier we had provided evidence of tissue-specific proteolytic processing of histone H3 in White Leghorn chicken liver nuclei. In this study we identify a novel activity of glutamate dehydrogenase (GDH) as a histone H3-specific protease in chicken liver tissue. This protease activity is regulated by divalent ions and thiol-disulfide conversion in vitro. GDH specifically clips H3 in its free as well as chromatin-bound form. Furthermore, we have found an inhibitor that inhibits the H3-clipping activity of GDH. Like previously reported proteases, GDH too may have the potential to regulate/modulate post-translational modifications of histone H3 by removing the N-terminal residues of the histone. In short, our findings identify an unexpected proteolytic activity of GDH specific to histone H3 that is regulated by redox state, ionic concentrations, and a cellular inhibitor in vitro.	[Mandal, Papita; Verma, Naveen; Chauhan, Sakshi; Tomar, Raghuvir S.] Indian Inst Sci Educ & Res Bhopal, Lab Chromatin Biol, Dept Biol Sci, Bhopal 462023, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Tomar, RS (corresponding author), Indian Inst Sci Educ & Res Bhopal, Lab Chromatin Biol, Transit Campus,ITI Gas Rahat Bldg, Bhopal 462023, Madhya Pradesh, India.	rst@iiserb.ac.in	Verma, Naveen/AGI-5147-2022	Verma, Naveen/0000-0003-4211-579X	Department of Biotechnology, Council of Scientific and Industrial Research, Government of India; Indian Institute of Science Education and Research Bhopal; University Grants Commission	Department of Biotechnology, Council of Scientific and Industrial Research, Government of India; Indian Institute of Science Education and Research Bhopal; University Grants Commission(University Grants Commission, India)	This work was supported by grants from the Department of Biotechnology, Council of Scientific and Industrial Research, Government of India and Indian Institute of Science Education and Research Bhopal (to R. S. T.).; Recipient of a fellowship from the University Grants Commission.	ALLIS CD, 1984, J CELL BIOL, V99, P1669, DOI 10.1083/jcb.99.5.1669; ALLIS CD, 1984, EXP CELL RES, V153, P287, DOI 10.1016/0014-4827(84)90601-3; ALLIS CD, 1980, CELL, V20, P55; An WJ, 2003, J BIOL CHEM, V278, P1504, DOI 10.1074/jbc.M209355200; BAKER PJ, 1992, PROTEINS, V12, P75, DOI 10.1002/prot.340120109; Belsham GJ, 2000, J VIROL, V74, P272, DOI 10.1128/JVI.74.1.272-280.2000; Bertin A, 2004, BIOCHEMISTRY-US, V43, P4773, DOI 10.1021/bi036210g; Chandy M, 2006, EUKARYOT CELL, V5, P1738, DOI 10.1128/EC.00165-06; Chodaparambil JV, 2006, E SCHERING RES FDN W, V57, P29; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Depken M, 2009, BIOPHYS J, V96, P777, DOI 10.1016/j.bpj.2008.09.055; EICKBUSH TH, 1976, CELL, V9, P785, DOI 10.1016/0092-8674(76)90141-0; ELIA MC, 1988, J BIOL CHEM, V263, P9958; FALK MM, 1990, J VIROL, V64, P748, DOI 10.1128/JVI.64.2.748-756.1990; Grillo C, 2002, BIOCHEM BIOPH RES CO, V295, P67, DOI 10.1016/S0006-291X(02)00634-4; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Kaul R, 1997, J BACTERIOL, V179, P5928, DOI 10.1128/jb.179.18.5928-5934.1997; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee MK, 2002, EXTREMOPHILES, V6, P151, DOI 10.1007/s007920100238; Lee WK, 2000, J CELL BIOCHEM, V76, P244; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mandal P, 2012, BIOCHEM BIOPH RES CO, V421, P261, DOI 10.1016/j.bbrc.2012.03.149; Pattenden Samantha G, 2005, Genome Biol, V6, P355, DOI 10.1186/gb-2005-6-11-355; Peterson CL, 2002, EMBO REP, V3, P319, DOI 10.1093/embo-reports/kvf075; Santos-Rosa H, 2009, NAT STRUCT MOL BIOL, V16, P17, DOI 10.1038/nsmb.1534; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STILLMAN TJ, 1993, J MOL BIOL, V234, P1131, DOI 10.1006/jmbi.1993.1665; SUROWY CS, 1983, P NATL ACAD SCI-BIOL, V80, P5510, DOI 10.1073/pnas.80.18.5510; TESAR M, 1990, VIROLOGY, V174, P364, DOI 10.1016/0042-6822(90)90090-E; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wysocka J, 2006, METHODS, V40, P339, DOI 10.1016/j.ymeth.2006.05.028	31	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18743	18757		10.1074/jbc.M113.462531	http://dx.doi.org/10.1074/jbc.M113.462531			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23673664	Green Published, hybrid			2022-12-28	WOS:000321335800010
J	Mizuno, K; Boudko, S; Engel, J; Bachinger, HP				Mizuno, Kazunori; Boudko, Sergei; Engel, Juergen; Baechinger, Hans Peter			Vascular Ehlers-Danlos Syndrome Mutations in Type III Collagen Differently Stall the Triple Helical Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; OSTEOGENESIS IMPERFECTA; TRIMERIZATION DOMAIN; CONNECTIVE-TISSUE; NC2 DOMAIN; CHAIN; DISORDER; FIBRILS; PEPTIDE; HAPLOINSUFFICIENCY	Vascular Ehlers-Danlos syndrome (EDS) type IV is the most severe form of EDS. In many cases the disease is caused by a point mutation of Gly in type III collagen. Aslower folding of the collagen helix is a potential cause for over-modifications. However, little is known about the rate of folding of type III collagen in patients with EDS. To understand the molecular mechanism of the effect of mutations, a system was developed for bacterial production of homotrimeric model polypeptides. The C-terminal quarter, 252 residues, of the natural human type III collagen was attached to (GPP)(7) with the type XIX collagen trimerization domain (NC2). The natural collagen domain forms a triple helical structure without 4-hydroxylation of proline at a low temperature. At 33 degrees C, the natural collagenous part is denatured, but the C-terminal (GPP)(7)-NC2 remains intact. Switching to a low temperature triggers the folding of the type III collagen domain in a zipper-like fashion that resembles the natural process. We used this system for the two known EDS mutations (Gly-to-Val) in the middle at Gly-910 and at the C terminus at Gly-1018. In addition, wild-type and Gly-to-Ala mutants were made. The mutations significantly slow down the overall rate of triple helix formation. The effect of the Gly-to-Val mutation is much more severe compared with Gly-to-Ala. This is the first report on the folding of collagen with EDS mutations, which demonstrates local delays in the triple helix propagation around the mutated residue.	[Mizuno, Kazunori; Boudko, Sergei; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland Res Ctr, Portland, OR 97239 USA; [Boudko, Sergei; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland	Oregon Health & Science University; Oregon Health & Science University; University of Basel	Bachinger, HP (corresponding author), Shriners Hosp Children, Portland Res Ctr, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	hpb@shcc.org	Mizuno, Kazunori/AAY-7613-2021	Mizuno, Kazunori/0000-0003-3354-6264; Boudko, Sergei/0000-0003-3856-4859	Shriners Hospitals for Children	Shriners Hospitals for Children	This work was supported by a grant from Shriners Hospitals for Children (to H. P. B.).	Aebi U., 2006, CELL BIOL LAB HDB, P241; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; Bachinger HP, 2005, PROTEIN FOLDING HANDBOOK, P1059; Baumann M, 2012, AM J HUM GENET, V90, P201, DOI 10.1016/j.ajhg.2011.12.004; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439; Boudko S. P., 2012, INT J BIOCH CELL BIO, V44; Boudko SP, 2008, J BIOL CHEM, V283, P32580, DOI 10.1074/jbc.M805394200; Boudko SP, 2012, J BIOL CHEM, V287, P44536, DOI 10.1074/jbc.M112.417543; Boudko SP, 2010, J BIOL CHEM, V285, P23721, DOI 10.1074/jbc.M110.128405; Boudko SP, 2009, J MOL BIOL, V392, P787, DOI 10.1016/j.jmb.2009.07.057; Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200; Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; Colige A, 2004, J INVEST DERMATOL, V123, P656, DOI 10.1111/j.0022-202X.2004.23406.x; Colige A, 2005, J BIOL CHEM, V280, P34397, DOI 10.1074/jbc.M506458200; Cooper TK, 2010, VET PATHOL, V47, P1028, DOI 10.1177/0300985810374842; Dalgleish R, 1998, NUCLEIC ACIDS RES, V26, P253, DOI 10.1093/nar/26.1.253; Dalgleish R, 1997, NUCLEIC ACIDS RES, V25, P181, DOI 10.1093/nar/25.1.181; De Paepe A, 2012, CLIN GENET, V82, P1, DOI 10.1111/j.1399-0004.2012.01858.x; DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x; FLEISCHMAJER R, 1990, J STRUCT BIOL, V105, P162, DOI 10.1016/1047-8477(90)90110-X; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; KEENE DR, 1991, J HISTOCHEM CYTOCHEM, V39, P59, DOI 10.1177/39.1.1983874; KEENE DR, 1987, J CELL BIOL, V105, P2393, DOI 10.1083/jcb.105.5.2393; Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852; Malfait F, 2005, AM J MED GENET C, V139C, P17, DOI 10.1002/ajmg.c.30070; Mizuno K, 2010, BIOPHYS J, V98, P3004, DOI 10.1016/j.bpj.2010.03.019; MORRIS NP, 1986, J BIOL CHEM, V261, P5638; Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381; Okuyama K, 2009, ACTA CRYSTALLOGR D, V65, P1007, DOI 10.1107/S0907444909023051; PINNELL SR, 1972, NEW ENGL J MED, V286, P1013, DOI 10.1056/NEJM197205112861901; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; RICHARDS AJ, 1991, J MED GENET, V28, P458, DOI 10.1136/jmg.28.7.458; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Schmid FX, 2002, ADV PROTEIN CHEM, V59, P243; Schwarze U, 2001, AM J HUM GENET, V69, P989, DOI 10.1086/324123; Smith LB, 2011, CARDIOVASC RES, V90, P182, DOI 10.1093/cvr/cvq356; Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Vranka JA, 2010, J BIOL CHEM, V285, P17253, DOI 10.1074/jbc.M110.102228; Wang WM, 2003, J BIOL CHEM, V278, P19549, DOI 10.1074/jbc.M300767200; Wirz JA, 2011, MATRIX BIOL, V30, P9, DOI 10.1016/j.matbio.2010.09.005; Wu JJ, 2010, J BIOL CHEM, V285, P18537, DOI 10.1074/jbc.M110.112904; Yoshizumi A, 2011, J BIOL CHEM, V286, P17512, DOI 10.1074/jbc.M110.217364; Yu ZX, 2010, PROTEIN SCI, V19, P775, DOI 10.1002/pro.356	50	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					19166	19176		10.1074/jbc.M113.462002	http://dx.doi.org/10.1074/jbc.M113.462002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23645670	Green Published, hybrid			2022-12-28	WOS:000321335800050
J	Nielsen, MJ; Andersen, CBF; Moestrup, SK				Nielsen, Marianne Jensby; Andersen, Christian Brix Folsted; Moestrup, Soren Kragh			CD163 Binding to Haptoglobin-Hemoglobin Complexes Involves a Dual-point Electrostatic Receptor-Ligand Pairing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; SCAVENGER; RECOGNITION; LIPOPROTEIN; REVEALS; PROTEIN; CHAIN; MICE	Formation of the haptoglobin (Hp)-hemoglobin (Hb) complex in human plasma leads to a high affinity recognition by the endocytic macrophage receptor CD163. A fast segregation of Hp-Hb from CD163 occurs at endosomal conditions (pH <6.5). The ligand binding site of CD163 has previously been shown to involve the scavenger receptor cysteine-rich (SRCR) domain 3. This domain and the adjacent SRCR domain 2 of CD163 contain a consensus motif for a calcium-coordinated acidic amino acid triad cluster as originally identified in the SRCR domain of the scavenger receptor MARCO. Here we show that site-directed mutagenesis in each of these acidic triads of SRCR domains 2 and 3 abrogates the high affinity binding of recombinant CD163 to Hp-Hb. In the ligand, Hp Arg-252 and Lys-262, both present in a previously identified CD163 binding loop of Hp, were revealed as essential residues for the high affinity receptor binding. These findings are in accordance with pairing of the calcium-coordinated acidic clusters in SRCR domains 2 and 3 with the two basic Arg/Lys residues in the Hp loop. Such a two-point electrostatic pairing is mechanistically similar to the pH-sensitive pairings disclosed in crystal structures of ligands in complex with tandem LDL receptor repeats or tandem CUB domains in other endocytic receptors.	[Nielsen, Marianne Jensby; Andersen, Christian Brix Folsted; Moestrup, Soren Kragh] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Moestrup, Soren Kragh] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Moestrup, SK (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle,Bldg 1170, DK-8000 Aarhus C, Denmark.	skm@biokemi.au.dk	Moestrup, Søren Kragh/A-1403-2014; Moestrup, Søren Kragh/AAD-1735-2019	Moestrup, Søren Kragh/0000-0003-3862-2107; 	Danish Council for Independent Research (Medical Sciences); Novo Nordisk Foundation; Foundation for the Advancement of Medical Science; European Research Council; Lundbeck Foundation [R54-2010-5637] Funding Source: researchfish	Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Foundation for the Advancement of Medical Science; European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden)	This work was supported by The Danish Council for Independent Research (Medical Sciences), The Novo Nordisk Foundation, The Foundation for the Advancement of Medical Science, and The European Research Council (to the TROJA project).	Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Andersen CBF, 2010, NATURE, V464, P445, DOI 10.1038/nature08874; BENSI G, 1985, EMBO J, V4, P119, DOI 10.1002/j.1460-2075.1985.tb02325.x; Buehler PW, 2009, BLOOD, V113, P2578, DOI 10.1182/blood-2008-08-174466; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2254, DOI 10.1089/ars.2012.4605; Fabriek BO, 2007, BLOOD, V109, P5223, DOI 10.1182/blood-2006-08-036467; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Martinez VG, 2011, PHARMACOL REV, V63, P967, DOI 10.1124/pr.111.004523; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; GREER J, 1980, P NATL ACAD SCI-BIOL, V77, P3393, DOI 10.1073/pnas.77.6.3393; Gronlund J, 2000, J IMMUNOL, V165, P6406, DOI 10.4049/jimmunol.165.11.6406; HWANG PK, 1980, J BIOL CHEM, V255, P3038; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; KUROSKY A, 1974, BIOCHEM GENET, V11, P279, DOI 10.1007/BF00485995; KUROSKY A, 1980, P NATL ACAD SCI-BIOL, V77, P3388, DOI 10.1073/pnas.77.6.3388; LAW SKA, 1993, EUR J IMMUNOL, V23, P2320, DOI 10.1002/eji.1830230940; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Madsen M, 2004, J BIOL CHEM, V279, P51561, DOI 10.1074/jbc.M409629200; MAEDA N, 1985, J BIOL CHEM, V260, P6698; MAEDA N, 1984, NATURE, V309, P131, DOI 10.1038/309131a0; Moeller JB, 2012, J IMMUNOL, V188, P2399, DOI 10.4049/jimmunol.1103150; Moller HJ, 2010, IMMUNOBIOLOGY, V215, P406, DOI 10.1016/j.imbio.2009.05.003; Nielsen M. J., 2007, BLOOD, V282, P1072; Nielsen MJ, 2006, FUTURE LIPIDOL, V1, P729, DOI 10.2217/17460875.1.6.729; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Nielsen MJ, 2010, ANTIOXID REDOX SIGN, V12, P261, DOI 10.1089/ars.2009.2792; Nielsen MJ, 2009, BLOOD, V114, P764, DOI 10.1182/blood-2009-01-198309; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; SADRZADEH SMH, 1984, J BIOL CHEM, V259, P4354; Van Gorp H, 2010, MOL IMMUNOL, V47, P1650, DOI 10.1016/j.molimm.2010.02.008	31	39	40	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18834	18841		10.1074/jbc.M113.471060	http://dx.doi.org/10.1074/jbc.M113.471060			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23671278	Green Published, hybrid			2022-12-28	WOS:000321335800021
J	Vannier, C; Mock, K; Brabletz, T; Driever, W				Vannier, Corinne; Mock, Kerstin; Brabletz, Thomas; Driever, Wolfgang			Zeb1 Regulates E-cadherin and Epcam (Epithelial Cell Adhesion Molecule) Expression to Control Cell Behavior in Early Zebrafish Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL TRANSITION; ZINC-FINGER; TRANSCRIPTION FACTOR; GASTRULATION MOVEMENTS; MOUSE EMBRYO; CANCER-CELLS; GENE; DELTA-EF1; FAMILY; METASTASIS	The ZEB1 transcription factor is best known as an inducer of epithelial-mesenchymal transitions (EMT) in cancer metastasis, acting through transcriptional repression of CDH1 (encoding E-cadherin) and the EMT-suppressing microRNA-200s (miR-200s). Here we analyze roles of the ZEB1 zebrafish orthologs, Zeb1a and Zeb1b, and of miR-200s in control of cell adhesion and morphogenesis during gastrulation and segmentation stages. Loss and gain of function analyses revealed that Zeb1 represses cdh1 expression to fine-tune adhesiveness of migrating deep blastodermal cells. Furthermore, Zeb1 acts as a repressor of epcam in the deep cells of the blastoderm and may contribute to control of epithelial integrity of enveloping layer cells, the outermost cells of the blastoderm. We found a similar ZEB1-dependent repression of EPCAM expression in human pancreatic and breast cancer cell lines, mediated through direct binding of ZEB1 to the EPCAM promoter. Thus, Zeb1 proteins employ several evolutionary conserved mechanisms to regulate cell-cell adhesion during development and cancer.	[Vannier, Corinne; Mock, Kerstin; Driever, Wolfgang] Univ Freiburg, Inst Biol 1, Fac Biol, D-79104 Freiburg, Germany; [Vannier, Corinne; Mock, Kerstin; Brabletz, Thomas] Univ Freiburg, Dept Visceral Surg, D-79106 Freiburg, Germany; [Brabletz, Thomas; Driever, Wolfgang] BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg	Driever, W (corresponding author), Univ Freiburg, Inst Biol 1, Hauptstr 1, D-79104 Freiburg, Germany.	driever@biologie.uni-freiburg.de		Driever, Wolfgang/0000-0002-9551-9141	Deutsche Forschungsgemeinschaft DFG [SFB850A1, SFB850B2]; Deutsche Krebshilfe [109430]; Excellence Initiative of the German Federal Government [EXC 294]; Excellence Initiative of the German State Government [EXC 294]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government	This work was supported by Deutsche Forschungsgemeinschaft DFG Grants SFB850A1 (to W. D.) and SFB850B2 (to T. B.), Deutsche Krebshilfe Grant 109430 (to T. B.), and by the Excellence Initiative of the German Federal and State Governments (EXC 294; to W. D. and T. B.).	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Aigner K, 2007, FEBS LETT, V581, P1617, DOI 10.1016/j.febslet.2007.03.026; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Babb SG, 2004, DEV DYNAM, V230, P263, DOI 10.1002/dvdy.20057; Babb SG, 2001, DEV DYNAM, V221, P231, DOI 10.1002/dvdy.1132; Blanco MJ, 2007, DEVELOPMENT, V134, P4073, DOI 10.1242/dev.006858; Brabletz T, 2012, NAT REV CANCER, V12, P425, DOI 10.1038/nrc3265; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cha YI, 2006, GENE DEV, V20, P77, DOI 10.1101/gad.1374506; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Drake JM, 2010, J BIOL CHEM, V285, P33940, DOI 10.1074/jbc.M110.136044; FUNAHASHI J, 1993, DEVELOPMENT, V119, P433; Gemmill RM, 2011, CANCER LETT, V300, P66, DOI 10.1016/j.canlet.2010.09.007; Goudarzi M, 2012, DEV CELL, V23, P210, DOI 10.1016/j.devcel.2012.05.007; Hajra KM, 2002, CANCER RES, V62, P1613; Hammerschmidt M, 2008, DEVELOPMENT, V135, P3625, DOI 10.1242/dev.015701; Harrington MJ, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-130; Horio M, 2012, ANN SURG ONCOL, V19, pS634, DOI 10.1245/s10434-011-2142-0; Kane DA, 2005, DEVELOPMENT, V132, P1105, DOI 10.1242/dev.01668; Kawahara Atsuo, 2002, Gene Expression Patterns, V2, P201, DOI 10.1016/S1567-133X(02)00062-5; KRAUSS S, 1991, DEVELOPMENT, V113, P1193; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Lin F, 2009, J CELL BIOL, V184, P909, DOI 10.1083/jcb.200805148; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Maghzal N, 2010, J CELL BIOL, V191, P645, DOI 10.1083/jcb.201004074; Malaga-Trillo E, 2009, PRION, V3, P129, DOI 10.4161/pri.3.3.9651; McFarland KN, 2005, DEV DYNAM, V233, P390, DOI 10.1002/dvdy.20325; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Montero JA, 2005, DEVELOPMENT, V132, P1187, DOI 10.1242/dev.01667; Muraoka O, 2000, DEV BIOL, V228, P29, DOI 10.1006/dbio.2000.9909; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P843; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; Shestopalov IA, 2012, NAT CHEM BIOL, V8, P270, DOI [10.1038/nchembio.772, 10.1038/NCHEMBIO.772]; Shimizu T, 2005, MECH DEVELOP, V122, P747, DOI 10.1016/j.mod.2005.03.008; Shin JO, 2012, HISTOCHEM CELL BIOL, V137, P459, DOI 10.1007/s00418-012-0915-6; Slanchev K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000563; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Song SM, 2013, DEV CELL, V24, P486, DOI 10.1016/j.devcel.2013.01.016; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Speirs CK, 2010, DEVELOPMENT, V137, P1327, DOI 10.1242/dev.045971; Takagi T, 1998, DEVELOPMENT, V125, P21; TAM PPL, 1993, MICROSC RES TECHNIQ, V26, P301, DOI 10.1002/jemt.1070260405; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Van Grunsven LA, 2006, DEV DYNAM, V235, P1491, DOI 10.1002/dvdy.20727; Villablanca EJ, 2006, DEV DYNAM, V235, P1578, DOI 10.1002/dvdy.20743; Warga RM, 2007, DEV BIOL, V310, P211, DOI 10.1016/j.ydbio.2007.06.023; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yamashita S, 2004, NATURE, V429, P298, DOI 10.1038/nature02545	62	57	57	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 28	2013	288	26					18643	18659		10.1074/jbc.M113.467787	http://dx.doi.org/10.1074/jbc.M113.467787			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	176WB	23667256	Green Published, hybrid			2022-12-28	WOS:000321335800002
J	Allmann, S; Morand, P; Ebikeme, C; Gales, L; Biran, M; Hubert, J; Brennand, A; Mazet, M; Franconi, JM; Michels, PAM; Portais, JC; Boshart, M; Bringaud, F				Allmann, Stefan; Morand, Pauline; Ebikeme, Charles; Gales, Lara; Biran, Marc; Hubert, Jane; Brennand, Ana; Mazet, Muriel; Franconi, Jean-Michel; Michels, Paul A. M.; Portais, Jean-Charles; Boshart, Michael; Bringaud, Frederic			Cytosolic NADPH Homeostasis in Glucose-starved Procyclic Trypanosoma brucei Relies on Malic Enzyme and the Pentose Phosphate Pathway Fed by Gluconeogenic Flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON REGULATORY PROTEIN-1; MOLECULAR CHARACTERIZATION; PARASITIC PROTOZOA; OXIDATIVE STRESS; PLASMODIUM-FALCIPARUM; AFRICAN TRYPANOSOMES; PROLINE METABOLISM; HYDROGEN-PEROXIDE; TRYPANOTHIONE; LEISHMANIA	All living organisms depend on NADPH production to feed essential biosyntheses and for oxidative stress defense. Protozoan parasites such as the sleeping sickness pathogen Trypanosoma brucei adapt to different host environments, carbon sources, and oxidative stresses during their infectious life cycle. The procyclic stage develops in the midgut of the tsetse insect vector, where they rely on proline as carbon source, although they prefer glucose when grown in rich media. Here, we investigate the flexible and carbon source-dependent use of NADPH synthesis pathways in the cytosol of the procyclic stage. The T. brucei genome encodes two cytosolic NADPH-producing pathways, the pentose phosphate pathway (PPP) and the NADP-dependent malic enzyme (MEc). Reverse genetic blocking of those pathways and a specific inhibitor (dehydroepiandrosterone) of glucose-6-phosphate dehydrogenase together established redundancy with respect to H2O2 stress management and parasite growth. Blocking both pathways resulted in similar to 10-fold increase of susceptibility to H2O2 stress and cell death. Unexpectedly, the same pathway redundancy was observed in glucose-rich and glucose-depleted conditions, suggesting that gluconeogenesis can feed the PPP to provide NADPH. This was confirmed by (i) a lethal phenotype of RNAi-mediated depletion of glucose-6-phosphate isomerase (PGI) in the glucose-depleted Delta mec/Delta mec null background, (ii) an similar to 10-fold increase of susceptibility to H2O2 stress observed for the Delta mec/Delta mec/(RNAi)PGI double mutant when compared with the single mutants, and (iii) the C-13 enrichment of glycolytic and PPP intermediates from cells incubated with [U-C-13] proline, in the absence of glucose. Gluconeogenesis-supported NADPH supply may also be important for nucleotide and glycoconjugate syntheses in the insect host.	[Allmann, Stefan; Brennand, Ana; Boshart, Michael] Univ Munich, Biozentrum, Fac Biol, Genet Sect, D-82152 Martinsried, Germany; [Morand, Pauline; Ebikeme, Charles; Biran, Marc; Mazet, Muriel; Franconi, Jean-Michel; Bringaud, Frederic] Univ Bordeaux Segalen, Ctr Resonance Magnet Syst Biol RMSB, CNRS, UMR5536, F-33076 Bordeaux, France; [Gales, Lara; Hubert, Jane; Portais, Jean-Charles] Univ Toulouse, INSA, UPS, INP,LISBP, F-31077 Toulouse, France; [Gales, Lara; Hubert, Jane; Portais, Jean-Charles] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Gales, Lara; Hubert, Jane; Portais, Jean-Charles] CNRS, UMR5504, F-31400 Toulouse, France; [Michels, Paul A. M.] Catholic Univ Louvain, de Duve Inst, Trop Dis Res Unit, B-1200 Brussels, Belgium; [Michels, Paul A. M.] Catholic Univ Louvain, Biochem Lab, B-1200 Brussels, Belgium	University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Catholique Louvain; Universite Catholique Louvain	Boshart, M (corresponding author), Univ Munich, Biozentrum, Fac Biol, Genet Sect, Grosshadernerstr 2-4, D-82152 Martinsried, Germany.	boshart@lmu.de; bringaud@rmsb.u-bordeaux2.fr	Boshart, Michael/A-2700-2011; Michels, Paul A/A-5637-2009	Boshart, Michael/0000-0002-5070-2663; Michels, Paul A/0000-0003-3726-6104; Portais, Jean-Charles/0000-0002-3480-0933; Ebikeme, Charles/0000-0002-9989-6489	Region Midi-Pyrenees; European Regional Development Fund (ERDF); INRA; CNRS	Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European Regional Development Fund (ERDF)(European Commission); INRA; CNRS(Centre National de la Recherche Scientifique (CNRS))	We are grateful to Larissa Ivanova (Ludwig-Maximilians Universitat Munich) and Nicolas Plazolle (Universite Bordeaux Segalen) for invaluable technical support. We thank Artur Cordeiro for providing DHEA. The mass spectrometry equipment and nuclear magnetic resonance equipment used in this study are part of the MetaToul platform (Toulouse, France) that is funded by the Region Midi-Pyrenees, the European Regional Development Fund (ERDF), the INRA, and the CNRS, which are gratefully acknowledged.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; Akerman SE, 2005, J BIOL CHEM, V280, P564, DOI 10.1074/jbc.M406367200; ARRICK BA, 1981, J EXP MED, V153, P720, DOI 10.1084/jem.153.3.720; Azema L, 2004, BIOCHEM PHARMACOL, V67, P459, DOI 10.1016/j.bcp.2003.09.005; Barrett Michael P., 2002, Current Topics in Medicinal Chemistry, V2, P471, DOI 10.2174/1568026024607427; Barrett MP, 1997, PARASITOL TODAY, V13, P11, DOI 10.1016/S0169-4758(96)10075-2; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Birkholtz LM, 2011, BIOCHEM J, V438, P229, DOI 10.1042/BJ20110362; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; BOVERIS A, 1980, BIOCHEM J, V188, P643, DOI 10.1042/bj1880643; Bringaud F, 2000, MOL BIOCHEM PARASIT, V111, P283, DOI 10.1016/S0166-6851(00)00319-4; Bringaud F, 1998, P NATL ACAD SCI USA, V95, P7963, DOI 10.1073/pnas.95.14.7963; Bringaud F, 2012, FRONT BIOSCI-LANDMRK, V17, P349, DOI 10.2741/3931; BRUN R, 1979, ACTA TROP, V36, P289; Bursell E., 1981, P135; CANNATA JJB, 1979, BIOCHEM J, V184, P409, DOI 10.1042/bj1840409; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; Cordeiro AT, 2009, BIOORGAN MED CHEM, V17, P2483, DOI 10.1016/j.bmc.2009.01.068; Coustou V, 2005, J BIOL CHEM, V280, P16559, DOI 10.1074/jbc.M500343200; Coustou V, 2008, J BIOL CHEM, V283, P16342, DOI 10.1074/jbc.M709592200; Coustou V, 2006, J BIOL CHEM, V281, P26832, DOI 10.1074/jbc.M601377200; Creek DJ, 2012, ANAL CHEM, V84, P8442, DOI 10.1021/ac3018795; CRONIN CN, 1989, FEBS LETT, V244, P26, DOI 10.1016/0014-5793(89)81154-8; Duffieux F, 2000, J BIOL CHEM, V275, P27559; Ebikeme C, 2010, J BIOL CHEM, V285, P32312, DOI 10.1074/jbc.M110.124917; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Garami A, 2001, EMBO J, V20, P3657, DOI 10.1093/emboj/20.14.3657; Ghozlane Amine, 2012, Advances in Bioinformatics, V2012, P159423, DOI 10.1155/2012/159423; Gupta S, 2011, MOL BIOCHEM PARASIT, V176, P112, DOI 10.1016/j.molbiopara.2010.12.006; Hannaert V, 2003, P NATL ACAD SCI USA, V100, P1067, DOI 10.1073/pnas.0335769100; Hao ZG, 2003, INSECT BIOCHEM MOLEC, V33, P1155, DOI 10.1016/j.ibmb.2003.07.001; Harlow E, 1988, ANTIBODIES LABORATOR, P471; He SS, 2012, ANTIMICROB AGENTS CH, V56, P2428, DOI 10.1128/AAC.06386-11; Heise N, 1999, MOL BIOCHEM PARASIT, V99, P21, DOI 10.1016/S0166-6851(98)00176-5; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Igoillo-Esteve M, 2007, AN ACAD BRAS CIENC, V79, P649, DOI 10.1590/S0001-37652007000400007; Ingram AK, 2000, MOL BIOCHEM PARASIT, V111, P309, DOI 10.1016/S0166-6851(00)00322-4; Jiang P, 2013, NATURE, V493, P689, DOI 10.1038/nature11776; Kiefer P, 2007, ANAL BIOCHEM, V360, P182, DOI 10.1016/j.ab.2006.06.032; KLEIN RA, 1975, PARASITOLOGY, V71, P93, DOI 10.1017/S003118200005318X; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Leroux AE, 2011, FEMS MICROBIOL LETT, V314, P25, DOI 10.1111/j.1574-6968.2010.02142.x; Luscher A, 2007, CURR PHARM DESIGN, V13, P555, DOI 10.2174/138161207780162809; Mannaert A, 2012, TRENDS PARASITOL, V28, P370, DOI 10.1016/j.pt.2012.06.003; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Muller IB, 2008, MOL BIOCHEM PARASIT, V160, P1, DOI 10.1016/j.molbiopara.2008.03.008; Mueller S, 2000, FREE RADICAL BIO MED, V29, P410, DOI 10.1016/S0891-5849(00)00261-6; Muller S, 2004, MOL MICROBIOL, V53, P1291, DOI 10.1111/j.1365-2958.2004.04257.x; Naderer T, 2006, P NATL ACAD SCI USA, V103, P5502, DOI 10.1073/pnas.0509196103; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; ORELLANO E, 1981, MOL BIOCHEM PARASIT, V3, P1, DOI 10.1016/0166-6851(81)90072-4; Pantopoulos K, 1997, J BIOL CHEM, V272, P9802; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Riviere L, 2004, J BIOL CHEM, V279, P45337, DOI 10.1074/jbc.M407513200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Suga H, 2013, APPL MICROBIOL BIOT, V97, P1669, DOI 10.1007/s00253-012-4298-3; Sureda A, 2005, FREE RADICAL RES, V39, P817, DOI 10.1080/10715760500164045; Tetaud E, 2001, MOL BIOCHEM PARASIT, V116, P171, DOI 10.1016/S0166-6851(01)00320-6; van Weelden SWH, 2003, J BIOL CHEM, V278, P12854, DOI 10.1074/jbc.M213190200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	66	49	50	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18494	18505		10.1074/jbc.M113.462978	http://dx.doi.org/10.1074/jbc.M113.462978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23665470	Green Published, hybrid			2022-12-28	WOS:000320721900051
J	Guerriero, CJ; Weiberth, KF; Brodsky, JL				Guerriero, Christopher J.; Weiberth, Kurt F.; Brodsky, Jeffrey L.			Hsp70 Targets a Cytoplasmic Quality Control Substrate to the San1p Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; ER-ASSOCIATED DEGRADATION; A-FACTOR TRANSPORTER; TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; PROTEIN-DEGRADATION; MISFOLDED PROTEINS; MOLECULAR CHAPERONES; AAA-ATPASE	Accumulation of misfolded proteins in cellular compartments can result in stress-induced cell death. In the endoplasmic reticulum (ER), ER-associated degradation clears aberrant proteins from the secretory pathway. In the cytoplasm and nucleus, this job is left to the cytoplasmic quality control (CytoQC) machinery. Both processes utilize chaperones and the ubiquitin-proteasome system to aid in protein elimination. Previous studies in yeast have drawn comparisons between these processes using data from structurally and topologically different substrates. We sought to draw a direct comparison between ERAD and CytoQC by studying the elimination of a single misfolded domain that, depending on its residence, is disposed by either of these pathways. The truncated, second nucleotide binding domain (NBD2*) from a yeast ERAD substrate, Ste6p*, resides at the cytoplasmic face of the ER. We show that a soluble form of NBD2* is cytoplasmic and unlike wild-type NBD2 is targeted for proteasome-mediated degradation. In contrast to Ste6p*, which employs the ER-localized Doa10p ubiquitin ligase, NBD2* is ubiquitinated by a nuclear E3 ligase San1p, a factor that is also required for its degradation. Although the yeast cytoplasmic Hsp70 chaperone, Ssa1p, has been thought to facilitate the nuclear import or to maintain the solubility of most CytoQC substrates, we discovered that Ssa1p facilitates the interaction between San1p and NBD2*, demonstrating that chaperones can aid in substrate recognition and San1p-dependent protein degradation. These results emphasize the diverse action of molecular chaperones during CytoQC.	[Guerriero, Christopher J.; Weiberth, Kurt F.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, A320 Langley Hall, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu		Guerriero, Christopher/0000-0002-1046-2300	National Institutes of Health National Research Service [1F32GM090364, GM75061, DK79307]; American Heart Association [09POST2140058]; Beckman Scholars award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061, F32GM090364] Funding Source: NIH RePORTER	National Institutes of Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Beckman Scholars award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health National Research Service Award 1F32GM090364 (to C. J. G.) and Grants GM75061 and DK79307 (University of Pittsburgh George O'Brien Kidney Research Center) (to J. L. B.). This work was also supported by American Heart Association Grant 09POST2140058 (to C. J. G.) and a Beckman Scholars award (to K. F. W.).	ADAMS A, 1997, METHODS YEAST GENETI, P145; Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Amberg D. C., 2005, METHODS YEAST GENETI, P149; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Becker J, 1996, MOL CELL BIOL, V16, P4378; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; BERKOWER C, 1991, EMBO J, V10, P3777, DOI 10.1002/j.1460-2075.1991.tb04947.x; BERKOWER C, 1994, MOL BIOL CELL, V5, P1185, DOI 10.1091/mbc.5.11.1185; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; BRODSKY JL, 1993, J CELL BIOL, V123, P1355, DOI 10.1083/jcb.123.6.1355; Carmichael J, 2000, P NATL ACAD SCI USA, V97, P9701, DOI 10.1073/pnas.170280697; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Feige MJ, 2011, CURR OPIN CELL BIOL, V23, P167, DOI 10.1016/j.ceb.2010.10.012; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fredrickson EK, 2013, J BIOL CHEM, V288, P6130, DOI 10.1074/jbc.M112.406710; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Gaczynska Maria, 2005, V301, P3; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hagiwara M, 2012, ANTIOXID REDOX SIGN, V16, P1119, DOI 10.1089/ars.2011.4495; Hampton RY, 2012, CURR OPIN CELL BIOL, V24, P460, DOI 10.1016/j.ceb.2012.05.010; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; JONES EW, 1984, ANNU REV GENET, V18, P233, DOI 10.1146/annurev.ge.18.120184.001313; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052; Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; KUCHLER K, 1989, EMBO J, V8, P3973, DOI 10.1002/j.1460-2075.1989.tb08580.x; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Lee DH, 1996, MOL CELL BIOL, V16, P4773; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lee DH, 2010, BIOCHEM BIOPH RES CO, V391, P1056, DOI 10.1016/j.bbrc.2009.12.018; Lipson C, 2008, J BIOL CHEM, V283, P7166, DOI 10.1074/jbc.M705893200; Loayza D, 1998, MOL CELL BIOL, V18, P779, DOI 10.1128/MCB.18.2.779; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; McClellan AJ, 2005, CELL, V121, P739, DOI 10.1016/j.cell.2005.03.024; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; MIZUNAGA T, 1990, J BIOCHEM, V108, P846, DOI 10.1093/oxfordjournals.jbchem.a123291; MOIR D, 1982, GENETICS, V100, P547; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Park SY, 2010, BIOCHEM BIOPH RES CO, V391, P1449, DOI 10.1016/j.bbrc.2009.12.090; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Prasad R, 2012, BIOCHEM BIOPH RES CO, V425, P689, DOI 10.1016/j.bbrc.2012.07.080; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; SANDERS SL, 1992, CELL, V69, P353, DOI 10.1016/0092-8674(92)90415-9; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Sullivan ML, 2003, J HISTOCHEM CYTOCHEM, V51, P545, DOI 10.1177/002215540305100417; Summers DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052099; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Varshavsky AV, 2006, PROTEIN SCI, V15, P647, DOI 10.1110/ps.052012306; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Wang SY, 2011, J BIOL CHEM, V286, P29376, DOI 10.1074/jbc.M111.233346; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Zhang Yimao, 2002, Methods Mol Med, V70, P257	99	61	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18506	18520		10.1074/jbc.M113.475905	http://dx.doi.org/10.1074/jbc.M113.475905			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23653356	hybrid, Green Published			2022-12-28	WOS:000320721900052
J	Knyazev, DG; Lents, A; Krause, E; Ollinger, N; Siligan, C; Papinski, D; Winter, L; Horner, A; Pohl, P				Knyazev, Denis G.; Lents, Alexander; Krause, Eberhard; Ollinger, Nicole; Siligan, Christine; Papinski, Daniel; Winter, Lukas; Horner, Andreas; Pohl, Peter			The Bacterial Translocon SecYEG Opens upon Ribosome Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-CONDUCTING CHANNEL; PLANAR LIPID BILAYERS; ENDOPLASMIC-RETICULUM MEMBRANE; ESCHERICHIA-COLI; WATER PERMEABILITY; POLYPEPTIDE-CHAIN; SMALL MOLECULES; PLUG DOMAIN; COMPLEX; PURIFICATION	In co-translational translocation, the ribosome funnel and the channel of the protein translocation complex SecYEG are aligned. For the nascent chain to enter the channel immediately after synthesis, a yet unidentified signal triggers displacement of the SecYEG sealing plug from the pore. Here, we show that ribosome binding to the resting SecYEG channel triggers this conformational transition. The purified and reconstituted SecYEG channel opens to form a large ion-conducting channel, which has the conductivity of the plug deletion mutant. The number of ion-conducting channels inserted into the planar bilayer per fusion event roughly equals the number of SecYEG channels counted by fluorescence correlation spectroscopy in a single proteoliposome. Thus, the open probability of the channel must be close to unity. To prevent the otherwise lethal proton leak, a closed post-translational conformation of the SecYEG complex bound to a ribosome must exist.	[Knyazev, Denis G.; Lents, Alexander; Ollinger, Nicole; Siligan, Christine; Papinski, Daniel; Winter, Lukas; Horner, Andreas; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4020 Linz, Austria; [Krause, Eberhard] Leibniz Inst Mol Pharmacol FMP, D-13125 Berlin, Germany	Johannes Kepler University Linz; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Pohl, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40, A-4020 Linz, Austria.	peter.pohl@jku.at	Horner, Andreas/F-6427-2013; Knyazev, Denis G/E-5045-2019; Pohl, Peter/A-5361-2008	Horner, Andreas/0000-0002-5328-1745; Knyazev, Denis G/0000-0003-3197-1849; Pohl, Peter/0000-0002-1792-2314; Ollinger, Nicole/0000-0003-2659-6968	Austrian Science Fund (FWF) [P20872]; Austrian Science Fund (FWF) [P 20872] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Grant P20872 (to P. P.).	Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; BORGESE N, 1974, J MOL BIOL, V88, P559, DOI 10.1016/0022-2836(74)90408-2; Bostina M, 2005, J MOL BIOL, V352, P1035, DOI 10.1016/j.jmb.2005.08.005; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; Clemons WM, 2001, J MOL BIOL, V310, P827, DOI 10.1006/jmbi.2001.4778; CROWLEY KS, 1994, CELL, V78, P461, DOI 10.1016/0092-8674(94)90424-3; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Erdmann F, 2010, BIOCHEM BIOPH RES CO, V396, P714, DOI 10.1016/j.bbrc.2010.04.168; Erokhova L, 2011, J BIOL CHEM, V286, P39926, DOI 10.1074/jbc.M111.291864; Frauenfeld J, 2011, NAT STRUCT MOL BIOL, V18, P614, DOI 10.1038/nsmb.2026; FRESNO M, 1976, EUR J BIOCHEM, V68, P355, DOI 10.1111/j.1432-1033.1976.tb10822.x; Gumbart J, 2009, STRUCTURE, V17, P1453, DOI 10.1016/j.str.2009.09.010; Gumbart JC, 2013, J AM CHEM SOC, V135, P2291, DOI 10.1021/ja310777k; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Krylov AV, 2001, J GEN PHYSIOL, V118, P333, DOI 10.1085/jgp.118.4.333; Kusters I, 2011, STRUCTURE, V19, P430, DOI 10.1016/j.str.2010.12.016; Lange S, 2010, J PROTEOME RES, V9, P4113, DOI 10.1021/pr1003054; Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; Menetret JF, 2007, MOL CELL, V28, P1083, DOI 10.1016/j.molcel.2007.10.034; MILLER C, 1982, BIOPHYS J, V38, P227, DOI 10.1016/S0006-3495(82)84552-9; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Mori H, 2001, P NATL ACAD SCI USA, V98, P5128, DOI 10.1073/pnas.081617398; Nijeholt JALA, 2011, J BIOL CHEM, V286, P43881, DOI 10.1074/jbc.M111.297507; Park E, 2011, NATURE, V473, P239, DOI 10.1038/nature10014; Pohl P, 2001, P NATL ACAD SCI USA, V98, P9624, DOI 10.1073/pnas.161299398; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022; Saparov SM, 2001, J BIOL CHEM, V276, P31515, DOI 10.1074/jbc.M104267200; Schaletzky J, 2006, MOL BIOL CELL, V17, P3860, DOI 10.1091/mbc.e06-05-0439; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; SIMON SM, 1989, P NATL ACAD SCI USA, V86, P6176, DOI 10.1073/pnas.86.16.6176; SIMON SM, 1992, CELL, V69, P677, DOI 10.1016/0092-8674(92)90231-Z; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; Tjalsma H, 2000, MICROBIOL MOL BIOL R, V64, P515, DOI 10.1128/MMBR.64.3.515-547.2000; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Wonderlin WF, 2009, PFLUG ARCH EUR J PHY, V457, P917, DOI 10.1007/s00424-008-0545-y	38	37	37	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					17941	17946		10.1074/jbc.M113.477893	http://dx.doi.org/10.1074/jbc.M113.477893			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645666	hybrid, Green Published			2022-12-28	WOS:000320721900001
J	Mackie, AR; Krishnamurthy, P; Verma, SK; Thorne, T; Ramirez, V; Qin, G; Abramova, T; Hamada, H; Losordo, DW; Kishore, R				Mackie, Alexander R.; Krishnamurthy, Prasanna; Verma, Suresh K.; Thorne, Tina; Ramirez, Veronica; Qin, Gangjian; Abramova, Tatiana; Hamada, Hiromichi; Losordo, Douglas W.; Kishore, Raj			Alcohol Consumption Negates Estrogen-mediated Myocardial Repair in Ovariectomized Mice by Inhibiting Endothelial Progenitor Cell Mobilization and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE REPLACEMENT THERAPY; DOSE-DEPENDENT ACTIVATION; N-TERMINAL KINASE; CARDIOVASCULAR-DISEASE; ARTERIAL INJURY; CHRONIC ETHANOL; RECEPTOR-BETA; INFARCTION; ESTRADIOL; RECOVERY	We have shown previously that estrogen (estradiol, E2) supplementation enhances voluntary alcohol consumption in ovariectomized female rodents and that increased alcohol consumption impairs ischemic hind limb vascular repair. However, the effect of E2-induced alcohol consumption on post-infarct myocardial repair and on the phenotypic/functional properties of endothelial progenitor cells (EPCs) is not known. Additionally, the molecular signaling of alcohol-estrogen interactions remains to be elucidated. This study examined the effect of E2-induced increases in ethanol consumption on post-infarct myocardial function/repair. Ovariectomized female mice, implanted with 17 beta-E2 or placebo pellets were given access to alcohol for 6 weeks and subjected to acute myocardial infarction. Left ventricular functions were consistently depressed in mice consuming ethanol compared with those receiving only E2. Alcohol-consuming mice also displayed significantly increased infarct size and reduced capillary density. Ethanol consumption also reduced E2-induced mobilization and homing of EPCs to injured myocardium compared with the E2-alone group. In vitro, exposure of EPCs to ethanol suppressed E2-induced proliferation, survival, and migration and markedly altered E2-induced estrogen receptor-dependent cell survival signaling and gene expression. Furthermore, ethanol-mediated suppression of EPC biology was endothelial nitric oxide synthase-dependent because endothelial nitric oxide synthase-null mice displayed an exaggerated response to post-acute myocardial infarction left ventricular functions. These data suggest that E2 modulation of alcohol consumption, and the ensuing EPC dysfunction, may negatively compete with the beneficial effects of estrogen on post-infarct myocardial repair.	[Mackie, Alexander R.; Krishnamurthy, Prasanna; Verma, Suresh K.; Thorne, Tina; Ramirez, Veronica; Qin, Gangjian; Abramova, Tatiana; Hamada, Hiromichi; Losordo, Douglas W.; Kishore, Raj] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Kishore, R (corresponding author), Northwestern Univ, Feinberg Cardiovasc Res Inst, 303 E Super St, Chicago, IL 60611 USA.	r-kishore@northwestern.edu	Verma, Suresh/AAU-9979-2020	Losordo, Douglas/0000-0002-6857-7506; KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364; Verma, Suresh Kumar/0000-0002-0739-1302	National Institute of Health [HL091983, HL105597, HL095874, HL053354, HL108795, HL093439, HL113541]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108795, R01HL095874, R01HL113541, R01HL091983, R01HL093439, R01HL053354, R37HL053354, R01HL105597] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institute of Health Grants HL091983, HL105597, HL095874, HL053354, and HL108795 (to R. K.) and HL093439 and HL113541 (to G. Q.).	Albrecht-Schgoer K, 2012, CIRCULATION, V126, P2491, DOI 10.1161/CIRCULATIONAHA.111.076950; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Chilvers CED, 2003, EUR HEART J, V24, P2197, DOI 10.1016/j.ehj.2003.09.019; Ford MM, 2004, ALCOHOL CLIN EXP RES, V28, P20, DOI 10.1097/01.ALC.0000108647.62718.5A; Ford MM, 2002, ALCOHOL, V26, P103, DOI 10.1016/S0741-8329(01)00203-8; GAVALER JS, 1991, ALCOHOL ALCOHOLISM, P327; GAZIANO JM, 1993, NEW ENGL J MED, V329, P1829, DOI 10.1056/NEJM199312163292501; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Grodstein F, 2000, ANN INTERN MED, V133, P933, DOI 10.7326/0003-4819-133-12-200012190-00008; Hamada H, 2006, CIRCULATION, V114, P2261, DOI 10.1161/CIRCULATIONAHA.106.631465; HilakiviClarke L, 1996, J STUD ALCOHOL, V57, P162, DOI 10.15288/jsa.1996.57.162; Hill S. Y, 1984, ALCOHOL PROBLEMS WOM, P121; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Iwakura A, 2006, CIRCULATION, V113, P1605, DOI 10.1161/CIRCULATIONAHA.105.553925; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Jonsson ASM, 2001, J INFECT DIS, V184, P761, DOI 10.1086/322985; Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107; Jung Y, 2008, GASTROENTEROLOGY, V134, P1532, DOI 10.1053/j.gastro.2008.02.022; Kishore R, 2005, J CLIN INVEST, V115, P1785, DOI 10.1172/JCI22849; Kishore R, 2003, CIRC RES, V93, P932, DOI 10.1161/01.RES.0000102400.22370.20; Kishore R, 2001, J BIOL CHEM, V276, P41930, DOI 10.1074/jbc.M107181200; KLATSKY AL, 1994, ALCOHOL CLIN EXP RES, V18, P88, DOI 10.1111/j.1530-0277.1994.tb00886.x; Krasinski K, 1997, CIRCULATION, V95, P1768; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Kuhlmann CRW, 2004, ALCOHOL CLIN EXP RES, V28, P1005, DOI 10.1097/01.ALC.0000130811.92457.0D; Lindenfield J, 2003, J AM COLL CARDIOL, V42, P1238, DOI 10.1016/S0735-1097(03)00938-0; Liu J, 2002, J BIOL CHEM, V277, P20927, DOI 10.1074/jbc.M110712200; Losordo DW, 2011, CIRC RES, V109, P428, DOI 10.1161/CIRCRESAHA.111.245993; Luedemann C, 2005, ALCOHOL CLIN EXP RES, V29, P930, DOI 10.1097/01.ALC.0000171037.90100.6B; Mackie AR, 2012, CIRC RES, V111, P312, DOI 10.1161/CIRCRESAHA.112.266015; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; MEDINA KL, 1994, P NATL ACAD SCI USA, V91, P5382, DOI 10.1073/pnas.91.12.5382; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Merritt R, 1997, J CARDIOVASC PHARM, V30, P19, DOI 10.1097/00005344-199707000-00004; Mukamal KJ, 2003, ARTERIOSCL THROM VAS, V23, P2252, DOI 10.1161/01.ATV.0000101183.58453.39; Okubo Y, 1998, J BIOL CHEM, V273, P25961, DOI 10.1074/jbc.273.40.25961; PREEDY VR, 1993, BRIT HEART J, V69, P197; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Puddey IB, 2001, CLIN EXP PHARMACOL P, V28, P1020, DOI 10.1046/j.1440-1681.2001.03572.x; Rajasingh J, 2007, ENDOCRINOLOGY, V148, P3618, DOI 10.1210/en.2006-1357; REGAN TJ, 1990, JAMA-J AM MED ASSOC, V264, P377, DOI 10.1001/jama.264.3.377; Reid ML, 2003, PHARMACOL BIOCHEM BE, V74, P381, DOI 10.1016/S0091-3057(02)01008-0; Roncalli J, 2011, J AM COLL CARDIOL, V57, P2444, DOI 10.1016/j.jacc.2010.11.069; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; RUBIN E, 1994, ALCOHOL CLIN EXP RES, V18, P111, DOI 10.1111/j.1530-0277.1994.tb00889.x; Rubin E, 1996, ALCOHOL CARDIOVASCUL, P127; Schoppet M, 2001, HERZ, V26, P345, DOI 10.1007/PL00002037; Singh AK, 2009, ALCOHOL ALCOHOLISM, V44, P185, DOI 10.1093/alcalc/agn109; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Thal MA, 2012, CIRC RES, V111, P180, DOI 10.1161/CIRCRESAHA.112.270462; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Williams GD., 1989, ALCOHOL RES HEALTH, V1989, P366; Xin HB, 2002, NATURE, V416, P334, DOI 10.1038/416334a; Zhu Y, 2002, SCIENCE, V295, P505, DOI 10.1126/science.1065250	56	4	4	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 21	2013	288	25					18022	18034		10.1074/jbc.M113.468009	http://dx.doi.org/10.1074/jbc.M113.468009			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	168QZ	23645678	Green Published, hybrid			2022-12-28	WOS:000320721900009
J	Hayakawa, K; Hirosawa, M; Tabei, Y; Arai, D; Tanaka, S; Murakami, N; Yagi, S; Shiota, K				Hayakawa, Koji; Hirosawa, Mitsuko; Tabei, Yasuyuki; Arai, Daisuke; Tanaka, Satoshi; Murakami, Noboru; Yagi, Shintaro; Shiota, Kunio			Epigenetic Switching by the Metabolism-sensing Factors in the Generation of Orexin Neurons from Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLCNAC TRANSFERASE; DNA METHYLATION PROFILE; REGIONS T-DMRS; INSULIN-RESISTANCE; HISTONE MODIFICATION; GENE-EXPRESSION; PROTEIN; GLUCOSE; DIFFERENTIATION; IDENTIFICATION	The orexin system plays a central role in the integration of sleep/wake and feeding behaviors in a broad spectrum of neural-metabolic physiology. Orexin-A and orexin-B are produced by the cleavage of prepro-orexin, which is encoded on the Hcrt gene. To date, methods for generating other peptide neurons could not induce orexin neurons from pluripotent stem cells. Considering that the metabolic status affects orexin expression, we supplemented the culture medium with a nutrient factor, ManNAc, and succeeded in generating functional orexin neurons from mouse ES cells. Because DNA methylation inhibitors and histone deacetylase inhibitors could induce Hcrt expression in mouse ES cells, the epigenetic mechanism may be involved in this orexin neurogenesis. DNA methylation analysis showed the presence of a tissue-dependent differentially methylated region (T-DMR) around the transcription start site of the Hcrt gene. In the orexin neurons induced by supplementation of ManNAc, the T-DMR of the Hcrt gene was hypomethylated in association with higher H3/H4 acetylation. Concomitantly, the histone acetyltransferases p300, CREB-binding protein (CBP), and Mgea5 (also called O-GlcNAcase) were localized to the T-DMR in the orexin neurons. In non-orexin-expressing cells, H3/H4 hypoacetylation and hyper-O-GlcNAc modification were observed at the T-DMRs occupied by O-GlcNAc transferase and Sirt1. Therefore, the results of the present study suggest that the glucose metabolite, ManNAc, induces switching from the inactive state by Ogt-Sirt1 to the active state by Mgea5, p300, and CBP at the Hcrt gene locus.	[Hayakawa, Koji; Hirosawa, Mitsuko; Tabei, Yasuyuki; Arai, Daisuke; Tanaka, Satoshi; Yagi, Shintaro; Shiota, Kunio] Univ Tokyo, Dept Anim Resource Sci Vet Med Sci, Lab Cellular Biochem, Tokyo 1138657, Japan; [Murakami, Noboru] Miyazaki Univ, Fac Agr, Dept Vet Physiol, Physiol Lab, Miyazaki 8892192, Japan	University of Tokyo; University of Miyazaki	Shiota, K (corresponding author), Univ Tokyo, Dept Anim Resource Sci Vet Med Sci, Lab Cellular Biochem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	ashiota@mail.ecc.u-tokyo.ac.jp	Arai, Daisuke/AAZ-6229-2021	Arai, Daisuke/0000-0002-1723-5389; Hayakawa, Koji/0000-0003-0453-1303; Tanaka, Satoshi/0000-0002-4745-550X	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan	Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan	This work was supported by the Advanced Research for Medical Products Mining Program of the National Institute of Biomedical Innovation (NIBIO), Japan.	Anekonda TS, 2006, BRAIN RES REV, V52, P316, DOI 10.1016/j.brainresrev.2006.04.004; Armstrong L, 2012, STEM CELL REV REP, V8, P67, DOI 10.1007/s12015-011-9300-4; BALKAN B, 1994, DIABETES, V43, P1173, DOI 10.2337/diabetes.43.10.1173; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Burdakov D, 2007, PFLUG ARCH EUR J PHY, V454, P19, DOI 10.1007/s00424-006-0189-8; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Chou TC, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-19-j0003.2001; Dalal J, 2013, GENE DEV, V27, P565, DOI 10.1101/gad.207654.112; De la Herran-Arita AK, 2011, NEUROSCIENCE, V183, P134, DOI 10.1016/j.neuroscience.2011.03.029; De la Herran-Arita Alberto K, 2011, Front Neurol, V2, P26, DOI 10.3389/fneur.2011.00026; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dunn-Meynell AA, 2002, DIABETES, V51, P2056, DOI 10.2337/diabetes.51.7.2056; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fong JJ, 2012, J BIOL CHEM, V287, P12195, DOI 10.1074/jbc.M111.315804; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gu XJ, 1998, BIOTECHNOL BIOENG, V58, P642, DOI 10.1002/(SICI)1097-0290(19980620)58:6<642::AID-BIT10>3.0.CO;2-9; Hanover JA, 2010, CHEM BIOL, V17, P1272, DOI 10.1016/j.chembiol.2010.12.001; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Ikegami K, 2009, INT J DEV BIOL, V53, P203, DOI 10.1387/ijdb.082741ki; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Kontou M, 2009, BIOL CHEM, V390, P575, DOI 10.1515/BC.2009.058; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lieb JD, 2006, CYTOGENET GENOME RES, V114, P1, DOI 10.1159/000091922; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Luchansky SJ, 2003, J BIOL CHEM, V278, P8035, DOI 10.1074/jbc.M212127200; MARSHALL S, 1991, J BIOL CHEM, V266, P10155; Maru I, 1996, J BIOL CHEM, V271, P16294, DOI 10.1074/jbc.271.27.16294; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Moriguchi T, 2002, J BIOL CHEM, V277, P16985, DOI 10.1074/jbc.M107962200; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Panossian L, 2011, J NEUROSCI, V31, P4025, DOI 10.1523/JNEUROSCI.5166-10.2011; Patti ME, 1999, DIABETES, V48, P1562, DOI 10.2337/diabetes.48.8.1562; ROSSETTI L, 1995, J CLIN INVEST, V96, P132, DOI 10.1172/JCI118013; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sato S, 2010, GENES CELLS, V15, P607, DOI 10.1111/j.1365-2443.2010.01404.x; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Shiota K, 2004, CYTOGENET GENOME RES, V105, P325, DOI 10.1159/000078205; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takasugi M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-481; Tanaka S, 2010, BIOCHEM BIOPH RES CO, V403, P178, DOI 10.1016/j.bbrc.2010.11.001; Toleman C, 2004, J BIOL CHEM, V279, P53665, DOI 10.1074/jbc.M410406200; Toleman CA, 2006, J BIOL CHEM, V281, P3918, DOI 10.1074/JBC.m510485200; Tsujino N, 2009, PHARMACOL REV, V61, P162, DOI 10.1124/pr.109.001321; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Westmoreland JJ, 2001, BIOCHEM BIOPH RES CO, V284, P674, DOI 10.1006/bbrc.2001.5031; Yagi S, 2008, GENOME RES, V18, P1969, DOI 10.1101/gr.074070.107; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3	60	55	59	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17099	17110		10.1074/jbc.M113.455899	http://dx.doi.org/10.1074/jbc.M113.455899			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23625921	Green Published, hybrid			2022-12-28	WOS:000320380600008
J	Krest, CM; Onderko, EL; Yosca, TH; Calixto, JC; Karp, RF; Livada, J; Rittle, J; Green, MT				Krest, Courtney M.; Onderko, Elizabeth L.; Yosca, Timothy H.; Calixto, Julio C.; Karp, Richard F.; Livada, Jovan; Rittle, Jonathan; Green, Michael T.			Reactive Intermediates in Cytochrome P450 Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CHLOROPEROXIDASE COMPOUND-II; KINETIC CHARACTERIZATION; ALIPHATIC HYDROXYLATION; ELECTRON-TRANSFER; OXYGEN-TRANSFER; P450CAM; ACID; OXIDATION; PEROXYNITRITE; CRYOREDUCTION	Recently, we reported the spectroscopic and kinetic characterizations of cytochrome P450 compound I in CYP119A1, effectively closing the catalytic cycle of cytochrome P450-mediated hydroxylations. In this minireview, we focus on the developments that made this breakthrough possible. We examine the importance of enzyme purification in the quest for reactive intermediates and report the preparation of compound I in a second P450 (P450(ST)). In an effort to bring clarity to the field, we also examine the validity of controversial reports claiming the production of P450 compound I through the use of peroxynitrite and laser flash photolysis.	[Krest, Courtney M.; Onderko, Elizabeth L.; Yosca, Timothy H.; Calixto, Julio C.; Karp, Richard F.; Livada, Jovan; Rittle, Jonathan; Green, Michael T.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Green, MT (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	mtg10@psu.edu			NIGMS NIH HHS [R01 GM101390] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101390] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Behan RK, 2007, J AM CHEM SOC, V129, P5855, DOI 10.1021/ja064590y; Behan RK, 2006, J INORG BIOCHEM, V100, P448, DOI 10.1016/j.jinorgbio.2005.12.019; Behan RK, 2006, J AM CHEM SOC, V128, P11471, DOI 10.1021/ja062428p; Chen XH, 2011, ORG BIOMOL CHEM, V9, P7427, DOI 10.1039/c1ob06035j; Cherepanov AV, 2004, BBA-BIOENERGETICS, V1656, P1, DOI 10.1016/j.bbabio.2004.02.006; Daiber A, 2000, EUR J BIOCHEM, V267, P6729, DOI 10.1046/j.1432-1033.2000.01768.x; Davydov R, 1999, J INORG BIOCHEM, V74, P110; Davydov R, 1999, J AM CHEM SOC, V121, P10654, DOI 10.1021/ja9918829; Davydov R, 2005, J AM CHEM SOC, V127, P1403, DOI 10.1021/ja045351i; Davydov R, 2008, BIOCHEMISTRY-US, V47, P9661, DOI 10.1021/bi800926x; de Montellano PRO, 2010, CHEM REV, V110, P932, DOI 10.1021/cr9002193; Denisov IG, 2001, J BIOL CHEM, V276, P11648, DOI 10.1074/jbc.M010219200; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; DUNFORD HB, 1976, COORDIN CHEM REV, V19, P187, DOI 10.1016/S0010-8545(00)80316-1; EBLE KS, 1984, J BIOL CHEM, V259, P4389; EGAWA T, 1994, BIOCHEM BIOPH RES CO, V201, P1464, DOI 10.1006/bbrc.1994.1868; Ener ME, 2010, P NATL ACAD SCI USA, V107, P18783, DOI 10.1073/pnas.1012381107; Fujishiro T, 2011, J BIOL CHEM, V286, P29941, DOI 10.1074/jbc.M111.245225; Green MT, 2009, CURR OPIN CHEM BIOL, V13, P84, DOI 10.1016/j.cbpa.2009.02.028; Green MT, 2006, J AM CHEM SOC, V128, P1902, DOI 10.1021/ja054074s; Green MT, 2004, SCIENCE, V304, P1653, DOI 10.1126/science.1096897; GROVES JT, 1976, J AM CHEM SOC, V98, P859, DOI 10.1021/ja00419a049; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Jung C, 2011, BBA-PROTEINS PROTEOM, V1814, P46, DOI 10.1016/j.bbapap.2010.06.007; KADKHODAYAN S, 1995, J BIOL CHEM, V270, P28042; Kellner DG, 2002, J BIOL CHEM, V277, P9641, DOI 10.1074/jbc.C100745200; LAMBEIR AM, 1987, EUR J BIOCHEM, V163, P123, DOI 10.1111/j.1432-1033.1987.tb10744.x; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; Mayer JM, 1998, ACCOUNTS CHEM RES, V31, P441, DOI 10.1021/ar970171h; Mayer JM, 2004, ANNU REV PHYS CHEM, V55, P363, DOI 10.1146/annurev.physchem.55.091602.094446; McLean MA, 1998, BIOCHEM BIOPH RES CO, V252, P166, DOI 10.1006/bbrc.1998.9584; MOSS TH, 1969, BIOCHEMISTRY-US, V8, P4159, DOI 10.1021/bi00838a037; Newcomb M, 2006, J AM CHEM SOC, V128, P4580, DOI 10.1021/ja060048y; Oku Y, 2004, J INORG BIOCHEM, V98, P1194, DOI 10.1016/j.jinorgbio.2004.05.002; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; PALCIC MM, 1980, BIOCHEM BIOPH RES CO, V94, P1123, DOI 10.1016/0006-291X(80)90535-5; Rabe KS, 2008, CHEMBIOCHEM, V9, P420, DOI 10.1002/cbic.200700450; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Rittle J, 2010, INORG CHEM, V49, P3610, DOI 10.1021/ic902062d; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; SCHONBAUM GR, 1972, J BIOL CHEM, V247, P3353; Sheng X, 2008, J AM CHEM SOC, V130, P13310, DOI 10.1021/ja802652b; Sheng X, 2009, J AM CHEM SOC, V131, P2971, DOI 10.1021/ja808982g; Sheng X, 2009, BIOCHEMISTRY-US, V48, P1620, DOI 10.1021/bi802279d; Spolitak T, 2005, J BIOL CHEM, V280, P20300, DOI 10.1074/jbc.M501761200; Stone KL, 2006, P NATL ACAD SCI USA, V103, P12307, DOI 10.1073/pnas.0603159103; Stone KL, 2006, J AM CHEM SOC, V128, P6147, DOI 10.1021/ja057876w; Su Z, 2019, CHEM-EUR J, V25, P14015, DOI 10.1002/chem.201202254; Wang Q, 2009, J AM CHEM SOC, V131, P10629, DOI 10.1021/ja9031105; Whitehouse CJC, 2011, DALTON T, V40, P10383, DOI 10.1039/c1dt10098j; Wilker JJ, 1999, ANGEW CHEM INT EDIT, V38, P90; Wright RL, 1996, FEBS LETT, V384, P235, DOI 10.1016/0014-5793(96)00322-5; Yuan XT, 2009, BIOCHEMISTRY-US, V48, P9140, DOI 10.1021/bi901258m	54	132	134	4	147	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17074	17081		10.1074/jbc.R113.473108	http://dx.doi.org/10.1074/jbc.R113.473108			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23632017	hybrid, Green Published			2022-12-28	WOS:000320380600005
J	Zhang, MX; Patriarchi, T; Stein, IS; Qian, H; Matt, L; Nguyen, M; Xiang, YK; Hell, JW				Zhang, Mingxu; Patriarchi, Tommaso; Stein, Ivar S.; Qian, Hai; Matt, Lucas; Minh Nguyen; Xiang, Yang K.; Hell, Johannes W.			Adenylyl Cyclase Anchoring by a Kinase Anchor Protein AKAP5 (AKAP79/150) Is Important for Postsynaptic beta-Adrenergic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; RECEPTOR GLUR1 SUBUNIT; GLUR2-LACKING AMPA RECEPTORS; HIPPOCAMPAL CA1 REGION; D-ASPARTATE RECEPTOR; CALCIUM-CHANNEL CA(V)1.2; SYNAPTIC PLASTICITY; BETA(2)-ADRENERGIC RECEPTOR; GLUTAMATE RECEPTORS; PHOSPHORYLATION SITES	Recent evidence indicates that the A kinase anchor protein AKAP5 (AKAP79/150) interacts not only with PKA but also with various adenylyl cyclase (AC) isoforms. However, the physiological relevance of AC-AKAP5 binding is largely unexplored. We now show that postsynaptic targeting of AC by AKAP5 is important for phosphorylation of the AMPA-type glutamate receptor subunit GluA1 on Ser-845 by PKA and for synaptic plasticity. Phosphorylation of GluA1 on Ser-845 is strongly reduced (by 70%) under basal conditions in AKAP5 KO mice but not at all in D36 mice, in which the PKA binding site of AKAP5 (i.e. the C-terminal 36 residues) has been deleted without affecting AC association with GluA1. The increase in Ser-845 phosphorylation upon beta-adrenergic stimulation is much more severely impaired in AKAP5 KO than in D36 mice. In parallel, long term potentiation induced by a 5-Hz/180-s tetanus, which mimics the endogenous theta-rhythm and depends on beta-adrenergic stimulation, is only modestly affected in acute forebrain slices from D36 mice but completely abrogated in AKAP5 KO mice. Accordingly, anchoring of not only PKA but also AC by AKAP5 is important for regulation of postsynaptic functions and specifically AMPA receptor activity.	[Zhang, Mingxu; Stein, Ivar S.; Qian, Hai; Hell, Johannes W.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA; [Zhang, Mingxu; Patriarchi, Tommaso; Stein, Ivar S.; Matt, Lucas; Minh Nguyen; Xiang, Yang K.; Hell, Johannes W.] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95615 USA	University of Iowa; University of California System; University of California Davis	Hell, JW (corresponding author), 451 E Hlth Sci Dr, Davis, CA 95616 USA.	jwhell@ucdavis.edu	Hell, Johannes W./P-5085-2019; Patriarchi, Tommaso/AAK-8653-2020	Patriarchi, Tommaso/0000-0001-9351-3734; Matt, Lucas/0000-0003-3235-5140	National Institutes of Health [NS078792, AG017502]; University of Iowa; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017502, R56AG017502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS078792 and AG017502 (to J. W. H.). This work was also supported by a presidential predoctoral fellowship from the University of Iowa (to M. Z.).	Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Bhattacharyya S, 2009, NAT NEUROSCI, V12, P172, DOI 10.1038/nn.2249; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; CARR DW, 1992, J BIOL CHEM, V267, P16816; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Davare MA, 2003, P NATL ACAD SCI USA, V100, P16018, DOI 10.1073/pnas.2236970100; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Efendiev R, 2010, J BIOL CHEM, V285, P14450, DOI 10.1074/jbc.M110.109769; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; El-Hussein AE, 2000, SCIENCE, V290, P1364; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Gelinas JN, 2005, J NEUROSCI, V25, P3294, DOI 10.1523/JNEUROSCI.4175-04.2005; Gomez LL, 2002, J NEUROSCI, V22, P7027; Gorski JA, 2005, MOL BIOL CELL, V16, P3574, DOI 10.1091/mbc.E05-02-0134; Gray EE, 2007, J NEUROPHYSIOL, V98, P2488, DOI 10.1152/jn.00473.2007; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Hall DD, 2006, BIOCHEMISTRY-US, V45, P3448, DOI 10.1021/bi051593z; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; Hammond RS, 2008, J NEUROSCI, V28, P7513, DOI 10.1523/JNEUROSCI.1951-08.2008; Havekes R, 2012, J NEUROSCI, V32, P18137, DOI 10.1523/JNEUROSCI.3612-12.2012; He KW, 2009, P NATL ACAD SCI USA, V106, P20033, DOI 10.1073/pnas.0910338106; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hoogland TM, 2004, J NEUROSCI, V24, P8416, DOI 10.1523/JNEUROSCI.1677-04.2004; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Joiner MLA, 2010, EMBO J, V29, P482, DOI 10.1038/emboj.2009.344; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Kapiloff MS, 2009, J BIOL CHEM, V284, P23540, DOI 10.1074/jbc.M109.030072; Katsuki H, 1997, J NEUROPHYSIOL, V77, P3013, DOI 10.1152/jn.1997.77.6.3013; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; Lin FB, 2000, J BIOL CHEM, V275, P19025, DOI 10.1074/jbc.275.25.19025; Lin L, 2011, J NEUROSCI, V31, P1323, DOI 10.1523/JNEUROSCI.5383-10.2011; Lin YW, 2003, J NEUROSCI, V23, P4173; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Lu Y, 2008, J PHYSIOL-LONDON, V586, P4155, DOI 10.1113/jphysiol.2008.151662; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; Lu Y, 2011, J BIOL CHEM, V286, P26496, DOI 10.1074/jbc.M111.254912; Magazanik LG, 1997, J PHYSIOL-LONDON, V505, P655, DOI 10.1111/j.1469-7793.1997.655ba.x; Makino Y, 2011, P NATL ACAD SCI USA, V108, P8450, DOI 10.1073/pnas.1105261108; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mehta S, 2001, J BIOL CHEM, V276, P16092, DOI 10.1074/jbc.M100643200; Minzenberg MJ, 2008, SCIENCE, V322, P1700, DOI 10.1126/science.1164908; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; NIELSON KA, 1994, BEHAV NEURAL BIOL, V62, P190, DOI 10.1016/S0163-1047(05)80017-2; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Qian H, 2012, J NEUROPHYSIOL, V107, P2703, DOI 10.1152/jn.00374.2011; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; Sanderson JL, 2012, J NEUROSCI, V32, P15036, DOI 10.1523/JNEUROSCI.3326-12.2012; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Shankar S, 1998, J NEUROPHYSIOL, V79, P334, DOI 10.1152/jn.1998.79.1.334; Shih ML, 1999, J BIOL CHEM, V274, P1588, DOI 10.1074/jbc.274.3.1588; Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009; Strange BA, 2004, P NATL ACAD SCI USA, V101, P11454, DOI 10.1073/pnas.0404282101; Strange BA, 2003, P NATL ACAD SCI USA, V100, P13626, DOI 10.1073/pnas.1635116100; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Swayze RD, 2004, NEUROPHARMACOLOGY, V47, P764, DOI 10.1016/j.neuropharm.2004.07.014; Tao JC, 2003, EMBO J, V22, P6419, DOI 10.1093/emboj/cdg628; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Valtschanoff JG, 2000, EUR J NEUROSCI, V12, P3605, DOI 10.1046/j.1460-9568.2000.00256.x; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; Walling SG, 2004, J NEUROSCI, V24, P598, DOI 10.1523/JNEUROSCI.4426-03.2004; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Weisenhaus M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010325; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Willoughby D, 2010, J BIOL CHEM, V285, P20328, DOI 10.1074/jbc.M110.120725; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	108	49	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 14	2013	288	24					17918	17931		10.1074/jbc.M112.449462	http://dx.doi.org/10.1074/jbc.M112.449462			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	164AH	23649627	hybrid, Green Published			2022-12-28	WOS:000320380600079
